"
",O
1,O
.,O
Lancet,O
.,O
2020,O
Mar,O
11,O
.,O
pii,O
:,O
S01406736(20)305663,O
.,O
doi,O
:,O
"
",O
10.1016,O
S01406736(20)305663,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
course,O
and,O
risk,O
factors,O
for,O
mortality,O
of,O
adult,O
inpatients,O
with,O
COVID19,B-Disease_COVID-19
"
",O
in,O
Wuhan,O
",",O
China,O
:,O
a,O
retrospective,O
cohort,O
study,O
.,O
"

",O
Zhou,O
F(1,O
),O
",",O
Yu,O
T(2,O
),O
",",O
Du,O
R(3,O
),O
",",O
Fan,O
G(4,O
),O
",",O
Liu,O
Y(2,O
),O
",",O
Liu,O
Z(1,O
),O
",",O
Xiang,O
J(5,O
),O
",",O
Wang,O
Y(6,O
),O
",",O
"
",O
Song,O
B(2,O
),O
",",O
Gu,O
X(4,O
),O
",",O
Guan,O
L(3,O
),O
",",O
Wei,O
Y(2,O
),O
",",O
Li,O
H(1,O
),O
",",O
Wu,O
X(7,O
),O
",",O
Xu,O
J(8,O
),O
",",O
Tu,O
S(2,O
),O
",",O
"
",O
Zhang,O
Y(1,O
),O
",",O
Chen,O
H(9,O
),O
",",O
Cao,O
B(10,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Center,O
of,O
Respiratory,O
"
",O
Medicine,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Respiratory,O
Diseases,O
",",O
Institute,O
"
",O
of,O
Respiratory,O
Medicine,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Peking,O
Union,O
"
",O
Medical,O
College,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Tuberculosis,O
and,O
Respiratory,O
Disease,O
",",O
Jinyintan,O
Hospital,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Wuhan,O
Pulmonary,O
Hospital,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Center,O
of,O
Respiratory,O
"
",O
Medicine,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Respiratory,O
Diseases,O
",",O
Institute,O
"
",O
of,O
Respiratory,O
Medicine,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Peking,O
Union,O
"
",O
Medical,O
College,O
",",O
Beijing,O
",",O
China,O
;,O
Institute,O
of,O
Clinical,O
Medical,O
Sciences,O
",",O
"
",O
ChinaJapan,O
Friendship,O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Clinical,O
Laboratory,O
",",O
Jinyintan,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Center,O
of,O
Respiratory,O
"
",O
Medicine,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Respiratory,O
Diseases,O
",",O
Institute,O
"
",O
of,O
Respiratory,O
Medicine,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Peking,O
Union,O
"
",O
Medical,O
College,O
",",O
Beijing,O
",",O
China,O
;,O
Department,O
of,O
Respiratory,O
Medicine,O
",",O
Capital,O
"
",O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(7)GCP,O
Center,O
",",O
Jinyintan,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(8)Tsinghua,O
University,O
School,O
of,O
Medicine,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(9)Department,O
of,O
Tuberculosis,O
and,O
Respiratory,O
Disease,O
",",O
Jinyintan,O
Hospital,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
2716637947@qq.com,O
.,O
"
",O
(10)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Center,O
of,O
Respiratory,O
"
",O
Medicine,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Respiratory,O
Diseases,O
",",O
Institute,O
"
",O
of,O
Respiratory,O
Medicine,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Peking,O
Union,O
"
",O
Medical,O
College,O
",",O
Beijing,O
",",O
China,O
;,O
Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
"
",O
Medicine,O
",",O
ChinaJapan,O
Friendship,O
Hospital,O
",",O
Beijing,O
",",O
China,O
;,O
Department,O
of,O
"
",O
Respiratory,O
Medicine,O
",",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
;,O
Tsinghua,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Beijing,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
caobin_ben@163.com,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
Lancet,O
.,O
2020,O
Mar,O
12,O
;,O
:,O
.,O
"

",O
BACKGROUND,O
:,O
Since,O
December,O
",",O
2019,O
",",O
Wuhan,O
",",O
China,O
",",O
has,O
experienced,O
an,O
outbreak,O
of,O
"
",O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
",",O
caused,O
by,O
the,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
.,O
Epidemiological,O
and,O
clinical,O
characteristics,O
"
",O
of,O
patients,O
with,O
COVID19,B-Disease_COVID-19
have,O
been,O
reported,O
but,O
risk,O
factors,O
for,O
mortality,O
and,O
a,O
"
",O
detailed,O
clinical,O
course,O
of,O
illness,O
",",O
including,O
viral,O
shedding,O
",",O
have,O
not,O
been,O
well,O
"
",O
described,O
.,O
"
",O
METHODS,O
:,O
In,O
this,O
retrospective,O
",",O
multicentre,O
cohort,O
study,O
",",O
we,O
included,O
all,O
adult,O
"
",O
inpatients,O
(,O
â‰¥18,O
years,O
old,O
),O
with,O
laboratoryconfirmed,O
COVID19,B-Disease_COVID-19
from,O
Jinyintan,O
"
",O
Hospital,O
and,O
Wuhan,O
Pulmonary,O
Hospital,O
(,O
Wuhan,O
",",O
China,O
),O
who,O
had,O
been,O
discharged,O
or,O
"
",O
had,O
died,O
by,O
Jan,O
31,O
",",O
2020,O
.,O
Demographic,O
",",O
clinical,O
",",O
treatment,O
",",O
and,O
laboratory,O
data,O
",",O
"
",O
including,O
serial,O
samples,O
for,O
viral,O
RNA,O
detection,O
",",O
were,O
extracted,O
from,O
electronic,O
"
",O
medical,O
records,O
and,O
compared,O
between,O
survivors,O
and,O
nonsurvivors,O
.,O
We,O
used,O
"
",O
univariable,O
and,O
multivariable,O
logistic,O
regression,O
methods,O
to,O
explore,O
the,O
risk,O
"
",O
factors,O
associated,O
with,O
inhospital,O
death,O
.,O
"
",O
FINDINGS,O
:,O
191,O
patients,O
(,O
135,O
from,O
Jinyintan,O
Hospital,O
and,O
56,O
from,O
Wuhan,O
Pulmonary,O
"
",O
Hospital,O
),O
were,O
included,O
in,O
this,O
study,O
",",O
of,O
whom,O
137,O
were,O
discharged,O
and,O
54,O
died,O
in,O
"
",O
hospital,O
.,O
91,O
(,O
48,O
%,O
),O
patients,O
had,O
a,O
comorbidity,O
",",O
with,O
hypertension,O
being,O
the,O
most,O
"
",O
common,O
(,O
58,O
[,O
30,O
%,O
],O
patients,O
),O
",",O
followed,O
by,O
diabetes,O
(,O
36,O
[,O
19,O
%,O
],O
patients,O
),O
and,O
coronary,O
"
",O
heart,O
disease,O
(,O
15,O
[,O
8,O
%,O
],O
patients,O
),O
.,O
Multivariable,O
regression,O
showed,O
increasing,O
odds,O
"
",O
of,O
inhospital,O
death,O
associated,O
with,O
older,O
age,O
(,O
odds,O
ratio,O
1Â·10,O
",",O
95,O
%,O
CI,O
"
",O
1Â·031Â·17,O
",",O
per,O
year,O
increase,O
;,O
p=0Â·0043,O
),O
",",O
higher,O
Sequential,O
Organ,O
Failure,O
"
",O
Assessment,O
(,O
SOFA,O
),O
score,O
(,O
5Â·65,O
",",O
2Â·6112Â·23,O
;,O
p<0Â·0001,O
),O
",",O
and,O
ddimer,O
greater,O
than,O
1,O
"
",O
Î¼g,O
L,O
(,O
18Â·42,O
",",O
2Â·64128Â·55,O
;,O
p=0Â·0033,O
),O
on,O
admission,O
.,O
Median,O
duration,O
of,O
viral,O
"
",O
shedding,O
was,O
20Â·0,O
days,O
(,O
IQR,O
17Â·024Â·0,O
),O
in,O
survivors,O
",",O
but,O
SARSCoV2,B-Virus_SARS-CoV-2
was,O
"
",O
detectable,O
until,O
death,O
in,O
nonsurvivors,O
.,O
The,O
longest,O
observed,O
duration,O
of,O
viral,O
"
",O
shedding,O
in,O
survivors,O
was,O
37,O
days,O
.,O
"
",O
INTERPRETATION,O
:,O
The,O
potential,O
risk,O
factors,O
of,O
older,O
age,O
",",O
high,O
SOFA,O
score,O
",",O
and,O
"
",O
ddimer,O
greater,O
than,O
1,O
Î¼g,O
L,O
could,O
help,O
clinicians,O
to,O
identify,O
patients,O
with,O
poor,O
"
",O
prognosis,O
at,O
an,O
early,O
stage,O
.,O
Prolonged,O
viral,O
shedding,O
provides,O
the,O
rationale,O
for,O
"
",O
a,O
strategy,O
of,O
isolation,O
of,O
infected,O
patients,O
and,O
optimal,O
antiviral,O
interventions,O
"
",O
in,O
the,O
future,O
.,O
"
",O
FUNDING,O
:,O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
Innovation,O
Fund,O
for,O
Medical,O
"
",O
Sciences,O
;,O
National,O
Science,O
Grant,O
for,O
Distinguished,O
Young,O
Scholars,O
;,O
National,O
Key,O
"
",O
Research,O
and,O
Development,O
Program,O
of,O
China,O
;,O
The,O
Beijing,O
Science,O
and,O
Technology,O
"
",O
Project,O
;,O
and,O
Major,O
Projects,O
of,O
National,O
Science,O
and,O
Technology,O
on,O
New,O
Drug,O
"
",O
Creation,O
and,O
Development,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)305663,O
"
",O
PMID,O
:,O
32171076,O
"


",O
2,O
.,O
Lancet,O
.,O
2020,O
Mar,O
11,O
.,O
pii,O
:,O
S01406736(20)306000,O
.,O
doi,O
:,O
"
",O
10.1016,O
S01406736(20)306000,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
:,O
the,O
medium,O
is,O
the,O
message,O
.,O
"

",O
Garrett,O
L.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)306000,O
"
",O
PMID,O
:,O
32171075,O
"


",O
3,O
.,O
Lancet,O
.,O
2020,O
Mar,O
11,O
.,O
pii,O
:,O
S01406736(20)305584,O
.,O
doi,O
:,O
"
",O
10.1016,O
S01406736(20)305584,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Comorbidities,O
and,O
multiorgan,O
injuries,O
in,O
the,O
treatment,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Wang,O
T(1,O
),O
",",O
Du,O
Z(1,O
),O
",",O
Zhu,O
F(1,O
),O
",",O
Cao,O
Z(1,O
),O
",",O
An,O
Y(1,O
),O
",",O
Gao,O
Y(1,O
),O
",",O
Jiang,O
B(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Peking,O
University,O
People,O
's,O
Hospital,O
",",O
Beijing,O
100044,O
",",O
China,O
.,O
"
",O
(2)Peking,O
University,O
People,O
's,O
Hospital,O
",",O
Beijing,O
100044,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
jiangbaoguo@vip.163.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)305584,O
"
",O
PMID,O
:,O
32171074,O
"


",O
4,O
.,O
Lancet,O
Respir,O
Med,O
.,O
2020,O
Mar,O
11,O
.,O
pii,O
:,O
S22132600(20)30117X,O
.,O
doi,O
:,O
"
",O
10.1016,O
S22132600(20)30117X,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Sex,O
difference,O
and,O
smoking,O
predisposition,O
in,O
patients,O
with,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Cai,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Anesthesiology,O
and,O
Molecular,O
Medicine,O
",",O
Department,O
of,O
Medicine,O
",",O
"
",O
University,O
of,O
California,O
Los,O
Angeles,O
",",O
Los,O
Angeles,O
",",O
CA,O
90095,O
",",O
USA,O
.,O
Electronic,O
"
",O
address,O
:,O
hcai@mednet.ucla.edu,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22132600(20)30117X,O
"
",O
PMID,O
:,O
32171067,O
"


",O
5,O
.,O
Lancet,O
Respir,O
Med,O
.,O
2020,O
Mar,O
11,O
.,O
pii,O
:,O
S22132600(20)301144,O
.,O
doi,O
:,O
"
",O
10.1016,O
S22132600(20)301144,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Adoption,O
of,O
COVID19,B-Disease_COVID-19
triage,O
strategies,O
for,O
lowincome,O
settings,O
.,O
"

",O
Ayebare,O
RR(1,O
),O
",",O
Flick,O
R(2,O
),O
",",O
Okware,O
S(3,O
),O
",",O
Bodo,O
B(4,O
),O
",",O
Lamorde,O
M(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Global,O
Health,O
Security,O
Department,O
",",O
Infectious,O
Disease,O
Institute,O
",",O
Makerere,O
"
",O
University,O
",",O
Kampala,O
22418,O
",",O
Uganda,O
.,O
Electronic,O
address,O
:,O
rayebare@idi.co.ug,O
.,O
"
",O
(2)Department,O
of,O
Internal,O
Medicine,O
",",O
Johns,O
Hopkins,O
Hospital,O
",",O
Baltimore,O
",",O
MD,O
",",O
USA,O
.,O
"
",O
(3)Global,O
Health,O
Security,O
Department,O
",",O
Infectious,O
Disease,O
Institute,O
",",O
Makerere,O
"
",O
University,O
",",O
Kampala,O
22418,O
",",O
Uganda,O
.,O
"
",O
(4)WHO,O
Uganda,O
Office,O
",",O
Kampala,O
",",O
Uganda,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22132600(20)301144,O
"
",O
PMID,O
:,O
32171063,O
"


",O
6,O
.,O
Lancet,O
Respir,O
Med,O
.,O
2020,O
Mar,O
11,O
.,O
pii,O
:,O
S22132600(20)301168,O
.,O
doi,O
:,O
"
",O
10.1016,O
S22132600(20)301168,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Are,O
patients,O
with,O
hypertension,O
and,O
diabetes,O
mellitus,O
at,O
increased,O
risk,O
for,O
"
",O
COVID19,B-Disease_COVID-19
infection,O
?,O
"

",O
Fang,O
L(1,O
),O
",",O
Karakiulakis,O
G(2,O
),O
",",O
Roth,O
M(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Pulmonary,O
Cell,O
Research,O
and,O
Pneumology,O
",",O
Department,O
of,O
Biomedicine,O
and,O
Internal,O
"
",O
Medicine,O
",",O
University,O
Hospital,O
Basel,O
",",O
CH4031,O
Basel,O
",",O
Switzerland,O
.,O
"
",O
(2)Department,O
of,O
Pharmacology,O
",",O
School,O
of,O
Medicine,O
",",O
Aristotle,O
University,O
of,O
"
",O
Thessaloniki,O
",",O
Thessaloniki,O
",",O
Greece,O
.,O
"
",O
(3)Pulmonary,O
Cell,O
Research,O
and,O
Pneumology,O
",",O
Department,O
of,O
Biomedicine,O
and,O
Internal,O
"
",O
Medicine,O
",",O
University,O
Hospital,O
Basel,O
",",O
CH4031,O
Basel,O
",",O
Switzerland,O
.,O
Electronic,O
"
",O
address,O
:,O
michael.roth@usb.ch,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22132600(20)301168,O
"
",O
PMID,O
:,O
32171062,O
"


",O
7,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
11,O
.,O
pii,O
:,O
S14733099(20)301444,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301444,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Early,O
dynamics,O
of,O
transmission,O
and,O
control,O
of,O
COVID19,B-Disease_COVID-19
:,O
a,O
mathematical,O
modelling,O
"
",O
study,O
.,O
"

",O
Kucharski,O
AJ(1,O
),O
",",O
Russell,O
TW(2,O
),O
",",O
Diamond,O
C(2,O
),O
",",O
Liu,O
Y(2,O
),O
",",O
Edmunds,O
J(2,O
),O
",",O
Funk,O
S(2,O
),O
",",O
"
",O
Eggo,O
RM(2,O
),O
;,O
Centre,O
for,O
Mathematical,O
Modelling,O
of,O
Infectious,O
Diseases,O
COVID19,B-Disease_COVID-19
"
",O
working,O
group,O
.,O
"

",O
Collaborators,O
:,O
Sun,O
F,O
",",O
Jit,O
M,O
",",O
Munday,O
JD,O
",",O
Davies,O
N,O
",",O
Gimma,O
A,O
",",O
van,O
Zandvoort,O
K,O
",",O
Gibbs,O
"
",O
H,O
",",O
Hellewell,O
J,O
",",O
Jarvis,O
CI,O
",",O
Clifford,O
S,O
",",O
Quilty,O
BJ,O
",",O
Bosse,O
NI,O
",",O
Abbott,O
S,O
",",O
Klepac,O
P,O
",",O
"
",O
Flasche,O
S.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Centre,O
for,O
Mathematical,O
Modelling,O
of,O
Infectious,O
Diseases,O
",",O
London,O
School,O
of,O
"
",O
Hygiene,O
&,O
Tropical,O
Medicine,O
",",O
London,O
",",O
UK,O
.,O
Electronic,O
address,O
:,O
"
",O
adam.kucharski@lshtm.ac.uk,O
.,O
"
",O
(2)Centre,O
for,O
Mathematical,O
Modelling,O
of,O
Infectious,O
Diseases,O
",",O
London,O
School,O
of,O
"
",O
Hygiene,O
&,O
Tropical,O
Medicine,O
",",O
London,O
",",O
UK,O
.,O
"

",O
BACKGROUND,O
:,O
An,O
outbreak,O
of,O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
"
",O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
has,O
led,O
to,O
95,O
â€ˆ,O
333,O
confirmed,O
cases,O
as,O
of,O
March,O
5,O
",",O
2020,O
.,O
Understanding,O
"
",O
the,O
early,O
transmission,O
dynamics,O
of,O
the,O
infection,O
and,O
evaluating,O
the,O
effectiveness,O
"
",O
of,O
control,O
measures,O
is,O
crucial,O
for,O
assessing,O
the,O
potential,O
for,O
sustained,O
"
",O
transmission,O
to,O
occur,O
in,O
new,O
areas,O
.,O
Combining,O
a,O
mathematical,O
model,O
of,O
severe,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
transmission,O
with,O
four,O
datasets,O
from,O
within,O
and,O
outside,O
Wuhan,O
",",O
we,O
"
",O
estimated,O
how,O
transmission,O
in,O
Wuhan,O
varied,O
between,O
December,O
",",O
2019,O
",",O
and,O
February,O
",",O
"
",O
2020,O
.,O
We,O
used,O
these,O
estimates,O
to,O
assess,O
the,O
potential,O
for,O
sustained,O
"
",O
humantohuman,O
transmission,O
to,O
occur,O
in,O
locations,O
outside,O
Wuhan,O
if,O
cases,O
were,O
"
",O
introduced,O
.,O
"
",O
METHODS,O
:,O
We,O
combined,O
a,O
stochastic,O
transmission,O
model,O
with,O
data,O
on,O
cases,O
of,O
"
",O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
in,O
Wuhan,O
and,O
international,O
cases,O
that,O
"
",O
originated,O
in,O
Wuhan,O
to,O
estimate,O
how,O
transmission,O
had,O
varied,O
over,O
time,O
during,O
"
",O
January,O
",",O
2020,O
",",O
and,O
February,O
",",O
2020,O
.,O
Based,O
on,O
these,O
estimates,O
",",O
we,O
then,O
calculated,O
"
",O
the,O
probability,O
that,O
newly,O
introduced,O
cases,O
might,O
generate,O
outbreaks,O
in,O
other,O
"
",O
areas,O
.,O
To,O
estimate,O
the,O
early,O
dynamics,O
of,O
transmission,O
in,O
Wuhan,O
",",O
we,O
fitted,O
a,O
"
",O
stochastic,O
transmission,O
dynamic,O
model,O
to,O
multiple,O
publicly,O
available,O
datasets,O
on,O
"
",O
cases,O
in,O
Wuhan,O
and,O
internationally,O
exported,O
cases,O
from,O
Wuhan,O
.,O
The,O
four,O
datasets,O
"
",O
we,O
fitted,O
to,O
were,O
:,O
daily,O
number,O
of,O
new,O
internationally,O
exported,O
cases,O
(,O
or,O
lack,O
"
",O
thereof,O
),O
",",O
by,O
date,O
of,O
onset,O
",",O
as,O
of,O
Jan,O
26,O
",",O
2020,O
;,O
daily,O
number,O
of,O
new,O
cases,O
in,O
"
",O
Wuhan,O
with,O
no,O
market,O
exposure,O
",",O
by,O
date,O
of,O
onset,O
",",O
between,O
Dec,O
1,O
",",O
2019,O
",",O
and,O
Jan,O
1,O
",",O
"
",O
2020,O
;,O
daily,O
number,O
of,O
new,O
cases,O
in,O
China,O
",",O
by,O
date,O
of,O
onset,O
",",O
between,O
Dec,O
29,O
",",O
2019,O
",",O
"
",O
and,O
Jan,O
23,O
",",O
2020,O
;,O
and,O
proportion,O
of,O
infected,O
passengers,O
on,O
evacuation,O
flights,O
"
",O
between,O
Jan,O
29,O
",",O
2020,O
",",O
and,O
Feb,O
4,O
",",O
2020,O
.,O
We,O
used,O
an,O
additional,O
two,O
datasets,O
for,O
"
",O
comparison,O
with,O
model,O
outputs,O
:,O
daily,O
number,O
of,O
new,O
exported,O
cases,O
from,O
Wuhan,O
(,O
or,O
"
",O
lack,O
thereof,O
),O
in,O
countries,O
with,O
high,O
connectivity,O
to,O
Wuhan,O
(,O
ie,O
",",O
top,O
20,O
most,O
"
",O
atrisk,O
countries,O
),O
",",O
by,O
date,O
of,O
confirmation,O
",",O
as,O
of,O
Feb,O
10,O
",",O
2020,O
;,O
and,O
data,O
on,O
new,O
"
",O
confirmed,O
cases,O
reported,O
in,O
Wuhan,O
between,O
Jan,O
16,O
",",O
2020,O
",",O
and,O
Feb,O
11,O
",",O
2020,O
.,O
"
",O
FINDINGS,O
:,O
We,O
estimated,O
that,O
the,O
median,O
daily,O
reproduction,O
number,O
(,O
Rt,O
),O
in,O
Wuhan,O
"
",O
declined,O
from,O
2Â·35,O
(,O
95,O
%,O
CI,O
1Â·154Â·77,O
),O
1,O
week,O
before,O
travel,O
restrictions,O
were,O
"
",O
introduced,O
on,O
Jan,O
23,O
",",O
2020,O
",",O
to,O
1Â·05,O
(,O
0Â·412Â·39,O
),O
1,O
week,O
after,O
.,O
Based,O
on,O
our,O
"
",O
estimates,O
of,O
Rt,O
",",O
assuming,O
SARSlike,O
variation,O
",",O
we,O
calculated,O
that,O
in,O
locations,O
"
",O
with,O
similar,O
transmission,O
potential,O
to,O
Wuhan,O
in,O
early,O
January,O
",",O
once,O
there,O
are,O
at,O
"
",O
least,O
four,O
independently,O
introduced,O
cases,O
",",O
there,O
is,O
a,O
more,O
than,O
50,O
%,O
chance,O
the,O
"
",O
infection,O
will,O
establish,O
within,O
that,O
population,O
.,O
"
",O
INTERPRETATION,O
:,O
Our,O
results,O
show,O
that,O
COVID19,B-Disease_COVID-19
transmission,O
probably,O
declined,O
in,O
"
",O
Wuhan,O
during,O
late,O
January,O
",",O
2020,O
",",O
coinciding,O
with,O
the,O
introduction,O
of,O
travel,O
"
",O
control,O
measures,O
.,O
As,O
more,O
cases,O
arrive,O
in,O
international,O
locations,O
with,O
similar,O
"
",O
transmission,O
potential,O
to,O
Wuhan,O
before,O
these,O
control,O
measures,O
",",O
it,O
is,O
likely,O
many,O
"
",O
chains,O
of,O
transmission,O
will,O
fail,O
to,O
establish,O
initially,O
",",O
but,O
might,O
lead,O
to,O
new,O
"
",O
outbreaks,O
eventually,O
.,O
"
",O
FUNDING,O
:,O
Wellcome,O
Trust,O
",",O
Health,O
Data,O
Research,O
UK,O
",",O
Bill,O
&,O
Melinda,O
Gates,O
"
",O
Foundation,O
",",O
and,O
National,O
Institute,O
for,O
Health,O
Research,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Author(s,O
),O
.,O
Published,O
by,O
Elsevier,O
Ltd.,O
This,O
is,O
an,O
Open,O
Access,O
"
",O
article,O
under,O
the,O
CC,O
BY,O
4,O
license,O
.,O
Published,O
by,O
Elsevier,O
Ltd,O
..,O
All,O
rights,O
"
",O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301444,O
"
",O
PMID,O
:,O
32171059,O
"


",O
8,O
.,O
Lancet,O
Gastroenterol,O
Hepatol,O
.,O
2020,O
Mar,O
11,O
.,O
pii,O
:,O
S24681253(20)300765,O
.,O
doi,O
:,O
"
",O
10.1016,O
S24681253(20)300765,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Implications,O
of,O
COVID19,B-Disease_COVID-19
for,O
patients,O
with,O
preexisting,O
digestive,O
diseases,O
.,O
"

",O
Mao,O
R(1,O
),O
",",O
Liang,O
J(2,O
),O
",",O
Shen,O
J(3,O
),O
",",O
Ghosh,O
S(4,O
),O
",",O
Zhu,O
LR(5,O
),O
",",O
Yang,O
H(6,O
),O
",",O
Wu,O
KC(2,O
),O
",",O
Chen,O
"
",O
MH(7,O
),O
;,O
Chinese,O
Society,O
of,O
IBD,O
",",O
Chinese,O
Elite,O
IBD,O
Union,O
;,O
Chinese,O
IBD,O
Quality,O
Care,O
"
",O
Evaluation,O
Center,O
Committee,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Gastroenterology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Sun,O
Yatsen,O
"
",O
University,O
",",O
Guangzhou,O
510080,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Cancer,O
Biology,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
"
",O
Digestive,O
Diseases,O
and,O
Xijing,O
Hospital,O
of,O
Digestive,O
Diseases,O
",",O
Air,O
Force,O
Medical,O
"
",O
University,O
",",O
Xi'an,O
",",O
China,O
.,O
"
",O
(3)Division,O
of,O
Gastroenterology,O
and,O
Hepatology,O
",",O
Ren,O
Ji,O
Hospital,O
",",O
School,O
of,O
"
",O
Medicine,O
",",O
Shanghai,O
Jiao,O
Tong,O
University,O
",",O
Shanghai,O
Institute,O
of,O
Digestive,O
Disease,O
",",O
"
",O
Shanghai,O
Inflammatory,O
Bowel,O
Disease,O
Research,O
Center,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(4)NIHR,O
Biomedical,O
Research,O
Institute,O
",",O
Institute,O
Of,O
Translational,O
Medicine,O
",",O
"
",O
University,O
of,O
Birmingham,O
and,O
University,O
Hospitals,O
Birmingham,O
NHS,O
Foundation,O
"
",O
Trust,O
",",O
UK,O
.,O
"
",O
(5)Division,O
of,O
Gastroenterology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Gastroenterology,O
",",O
Peking,O
Union,O
Medical,O
College,O
Hospital,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Medical,O
Sciences,O
and,O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Gastroenterology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Sun,O
Yatsen,O
"
",O
University,O
",",O
Guangzhou,O
510080,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
chenminhu@mail.sysu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S24681253(20)300765,O
"
",O
PMID,O
:,O
32171057,O
"


",O
9,O
.,O
Lancet,O
Glob,O
Health,O
.,O
2020,O
Mar,O
11,O
.,O
pii,O
:,O
S2214109X(20)301017,O
.,O
doi,O
:,O
"
",O
10.1016,O
S2214109X(20)301017,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Can,O
Nigeria,O
contain,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
using,O
lessons,O
from,O
recent,O
epidemics,O
?,O
"

",O
Ebenso,O
B(1,O
),O
",",O
Otu,O
A(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Leeds,O
Institute,O
of,O
Health,O
Sciences,O
",",O
University,O
of,O
Leeds,O
",",O
Leeds,O
LS2,O
9NL,O
",",O
UK,O
.,O
"
",O
Electronic,O
address,O
:,O
b.e.ebenso@leeds.ac.uk,O
.,O
"
",O
(2)Department,O
of,O
Infection,O
and,O
Travel,O
Medicine,O
",",O
Leeds,O
Teaching,O
Hospitals,O
NHS,O
"
",O
Trust,O
",",O
Leeds,O
",",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S2214109X(20)301017,O
"
",O
PMID,O
:,O
32171055,O
"


",O
10,O
.,O
Lancet,O
Public,O
Health,O
.,O
2020,O
Mar,O
11,O
.,O
pii,O
:,O
S24682667(20)300530,O
.,O
doi,O
:,O
"
",O
10.1016,O
S24682667(20)300530,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
:,O
a,O
potential,O
public,O
health,O
problem,O
for,O
homeless,O
populations,O
.,O
"

",O
Tsai,O
J(1,O
),O
",",O
Wilson,O
M(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Public,O
Health,O
",",O
University,O
of,O
Texas,O
Health,O
Science,O
Center,O
at,O
Houston,O
",",O
"
",O
Houston,O
",",O
TX,O
78229,O
",",O
USA,O
;,O
National,O
Center,O
on,O
Homelessness,O
Among,O
Veterans,O
",",O
US,O
"
",O
Department,O
of,O
Veterans,O
Affairs,O
",",O
Tampa,O
",",O
FL,O
",",O
USA,O
;,O
Department,O
of,O
Psychiatry,O
",",O
Yale,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Yale,O
University,O
",",O
New,O
Haven,O
",",O
CT,O
",",O
USA,O
.,O
Electronic,O
"
",O
address,O
:,O
jack.tsai@uth.tmc.edu,O
.,O
"
",O
(2)School,O
of,O
Public,O
Health,O
",",O
University,O
of,O
Texas,O
Health,O
Science,O
Center,O
at,O
Houston,O
",",O
"
",O
Houston,O
",",O
TX,O
78229,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S24682667(20)300530,O
"
",O
PMID,O
:,O
32171054,O
"


",O
11,O
.,O
QJM,O
.,O
2020,O
Mar,O
14,O
.,O
pii,O
:,O
hcaa092,O
.,O
doi,O
:,O
10.1093,O
qjmed,O
hcaa092,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Limiting,O
spread,O
of,O
COVID19,B-Disease_COVID-19
from,O
cruise,O
ships,O
 ,O
lessons,O
to,O
be,O
learnt,O
from,O
Japan,O
.,O
"

",O
Sawano,O
T(1)(2,O
),O
",",O
Ozaki,O
A(3)(4,O
),O
",",O
RodriguezMorales,O
AJ(5,O
),O
",",O
Tanimoto,O
T(4,O
),O
",",O
Sah,O
R(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Surgery,O
",",O
Sendai,O
City,O
Medical,O
Center,O
",",O
Sendai,O
",",O
Miyagi,O
",",O
Japan,O
.,O
"
",O
(2)Department,O
of,O
Public,O
Health,O
",",O
Fukushima,O
Medical,O
University,O
School,O
of,O
Medicine,O
",",O
"
",O
Fukushima,O
",",O
Fukushima,O
",",O
Japan,O
.,O
"
",O
(3)Department,O
of,O
Breast,O
Surgery,O
",",O
Jyoban,O
Hospital,O
of,O
Tokiwa,O
Foundation,O
",",O
Iwaki,O
",",O
"
",O
Fukushima,O
",",O
Japan,O
.,O
"
",O
(4)Medical,O
Governance,O
Research,O
Institute,O
",",O
Shinagawa,O
",",O
Tokyo,O
",",O
Japan,O
.,O
"
",O
(5)Public,O
Health,O
and,O
Infection,O
Research,O
Group,O
",",O
Faculty,O
of,O
Health,O
Sciences,O
",",O
"
",O
Universidad,O
Tecnologica,O
de,O
Pereira,O
",",O
Pereira,O
",",O
Risaralda,O
",",O
Colombia,O
.,O
"
",O
(6)National,O
Public,O
Health,O
Laboratory,O
",",O
Kathmandu,O
",",O
Nepal,O
.,O
"

",O
DOI,O
:,O
10.1093,O
qjmed,O
hcaa092,O
"
",O
PMID,O
:,O
32170953,O
"


",O
12,O
.,O
Int,O
J,O
Clin,O
Pract,O
.,O
2020,O
Mar,O
14:e13501,O
.,O
doi,O
:,O
10.1111,O
ijcp.13501,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
and,O
Rationally,O
Layered,O
Social,O
Distancing,O
.,O
"

",O
Stein,O
R(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)New,O
York,O
University,O
Tandon,O
School,O
of,O
Engineering,O
 ,O
Chemical,O
and,O
Biomolecular,O
"
",O
Engineering,O
",",O
6,O
MetroTech,O
Center,O
Brooklyn,O
New,O
York,O
11201,O
",",O
United,O
States,O
.,O
"

",O
I,O
would,O
like,O
to,O
thank,O
Dr.,O
Thomson,O
for,O
the,O
very,O
pertinent,O
and,O
relevant,O
points,O
that,O
"
",O
he,O
raised,O
in,O
his,O
thoughtful,O
letter,O
Where,O
are,O
we,O
now,O
with,O
COVID19,B-Disease_COVID-19
?,O
[,O
1,O
],O
.,O
As,O
my,O
"
",O
response,O
will,O
illustrate,O
",",O
and,O
in,O
what,O
probably,O
will,O
become,O
a,O
defining,O
feature,O
of,O
"
",O
conversations,O
surrounding,O
COVID19,B-Disease_COVID-19
for,O
quite,O
some,O
time,O
",",O
attempts,O
to,O
answer,O
will,O
"
",O
only,O
make,O
room,O
for,O
more,O
questions,O
.,O
As,O
COVID19,B-Disease_COVID-19
is,O
unfolding,O
",",O
every,O
day,O
is,O
marked,O
"
",O
by,O
novel,O
developments,O
.,O
Since,O
the,O
editorial,O
went,O
to,O
press,O
[,O
2,O
],O
",",O
the,O
outbreak,O
has,O
"
",O
expanded,O
considerably,O
.,O
Over,O
128000,O
individuals,O
were,O
infected,O
worldwide,O
as,O
of,O
"
",O
March,O
13,O
",",O
2020,O
",",O
leading,O
to,O
4720,O
deaths,O
[,O
3,O
],O
.,O
In,O
early,O
March,O
",",O
while,O
the,O
outbreak,O
in,O
"
",O
China,O
appeared,O
to,O
start,O
to,O
subside,O
[,O
4,O
],O
",",O
it,O
started,O
to,O
amplify,O
in,O
Europe,O
and,O
the,O
"
",O
United,O
States,O
.,O
The,O
first,O
fatality,O
in,O
the,O
United,O
States,O
occurred,O
on,O
February,O
29,O
",",O
"
",O
2020,O
in,O
a,O
suburb,O
of,O
Seattle,O
.,O
On,O
March,O
4,O
m,O
the,O
first,O
death,O
was,O
reported,O
outside,O
WA,O
"
",O
state,O
",",O
in,O
CA,O
",",O
and,O
was,O
the,O
11th,O
death,O
in,O
the,O
United,O
States,O
.,O
On,O
March,O
6,O
",",O
the,O
first,O
"
",O
two,O
fatalities,O
were,O
reported,O
in,O
Florida,O
.,O
On,O
March,O
11,O
",",O
2020,O
",",O
the,O
World,O
Health,O
"
",O
Organization,O
declared,O
the,O
outbreak,O
a,O
pandemic,O
[,O
5,O
],O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1111,O
ijcp.13501,O
"
",O
PMID,O
:,O
32170898,O
"


",O
13,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
14,O
.,O
doi,O
:,O
10.1002,O
jmv.25766,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
:,O
What,O
we,O
know,O
?,O
"

",O
He,O
F(1,O
),O
",",O
Deng,O
Y(1,O
),O
",",O
Li,O
W(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Thoracic,O
Surgery,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
and,O
Institute,O
of,O
Infectious,O
Disease,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
In,O
late,O
December,O
2019,O
",",O
a,O
cluster,O
of,O
unexplained,O
pneumonia,O
cases,O
has,O
been,O
reported,O
"
",O
in,O
Wuhan,O
",",O
China,O
.,O
A,O
few,O
days,O
later,O
",",O
the,O
causative,O
agent,O
of,O
this,O
mysterious,O
"
",O
pneumonia,O
was,O
identified,O
as,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
.,O
This,O
causative,O
virus,O
has,O
been,O
"
",O
temporarily,O
named,O
as,O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
"
",O
and,O
the,O
relevant,O
infected,O
disease,O
has,O
been,O
named,O
as,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
by,O
the,O
World,O
Health,O
Organization,O
respectively,O
.,O
The,O
COVID19,B-Disease_COVID-19
epidemic,O
"
",O
is,O
spreading,O
in,O
China,O
and,O
all,O
over,O
the,O
world,O
now,O
.,O
The,O
purpose,O
of,O
this,O
review,O
is,O
"
",O
primarily,O
to,O
review,O
the,O
pathogen,O
",",O
clinical,O
features,O
",",O
diagnosis,O
",",O
and,O
treatment,O
of,O
"
",O
COVID19,B-Disease_COVID-19
",",O
but,O
also,O
to,O
comment,O
briefly,O
on,O
the,O
epidemiology,O
and,O
pathology,O
based,O
on,O
"
",O
the,O
current,O
evidences,O
.,O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
"
",O
reserved,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25766,O
"
",O
PMID,O
:,O
32170865,O
"


",O
14,O
.,O
Liver,O
Int,O
.,O
2020,O
Mar,O
14,O
.,O
doi,O
:,O
10.1111,O
liv.14435,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Liver,O
injury,O
during,O
highly,O
pathogenic,O
human,O
coronavirus,O
infections,O
.,O
"

",O
Xu,O
L(1)(2,O
),O
",",O
Liu,O
J(1)(2,O
),O
",",O
Lu,O
M(3)(2,O
),O
",",O
Yang,O
D(1)(2,O
),O
",",O
Zheng,O
X(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Diseases,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
(2)Joint,O
International,O
Laboratory,O
of,O
Infection,O
and,O
Immunity,O
",",O
Huazhong,O
University,O
"
",O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
(3)Institute,O
for,O
Virology,O
",",O
University,O
Hospital,O
of,O
Essen,O
",",O
University,O
of,O
"
",O
DuisburgEssen,O
",",O
Essen,O
",",O
45147,O
",",O
Germany,O
.,O
"

",O
The,O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
(,O
SARSCov2,B-Virus_SARS-CoV-2
),O
",",O
the,O
pathogen,O
of,O
"
",O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
",",O
has,O
posed,O
a,O
serious,O
threat,O
to,O
global,O
"
",O
public,O
health,O
.,O
The,O
WHO,O
has,O
declared,O
the,O
outbreak,O
of,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
an,O
"
",O
international,O
public,O
health,O
emergency,O
.,O
Lung,O
lesions,O
have,O
been,O
considered,O
as,O
the,O
"
",O
major,O
damage,O
caused,O
by,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
However,O
",",O
liver,O
injury,O
has,O
also,O
been,O
"
",O
reported,O
to,O
occur,O
during,O
the,O
course,O
of,O
the,O
disease,O
in,O
severe,O
cases,O
.,O
Similarly,O
",",O
"
",O
previous,O
studies,O
have,O
shown,O
that,O
liver,O
damage,O
was,O
common,O
in,O
the,O
patients,O
infected,O
"
",O
by,O
the,O
other,O
two,O
highly,O
pathogenic,O
coronavirus,O
 ,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
coronavirus,O
(,O
SARSCoV,O
),O
and,O
the,O
Middle,O
East,O
respiratory,O
syndrome,O
"
",O
coronavirus,O
(,O
MERSCoV,O
),O
",",O
and,O
associated,O
with,O
the,O
severity,O
of,O
diseases,O
.,O
In,O
this,O
"
",O
review,O
",",O
the,O
characteristics,O
and,O
mechanism,O
of,O
liver,O
injury,O
caused,O
by,O
SARSCoV,O
",",O
"
",O
MERSCoV,O
",",O
as,O
well,O
as,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
were,O
summarized,O
",",O
which,O
may,O
provide,O
help,O
"
",O
for,O
further,O
studies,O
on,O
the,O
liver,O
injury,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1111,O
liv.14435,O
"
",O
PMID,O
:,O
32170806,O
"


",O
15,O
.,O
Dermatol,O
Ther,O
.,O
2020,O
Mar,O
13:e13310,O
.,O
doi,O
:,O
10.1111,O
dth.13310,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Consensus,O
of,O
Chinese,O
experts,O
on,O
protection,O
of,O
skin,O
and,O
mucous,O
membrane,O
barrier,O
"
",O
for,O
healthcare,O
workers,O
fighting,O
against,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
.,O
"

",O
Yan,O
Y(1,O
),O
",",O
Chen,O
H(2,O
),O
",",O
Chen,O
L(3,O
),O
",",O
Cheng,O
B(4,O
),O
",",O
Diao,O
P(5,O
),O
",",O
Dong,O
L(6,O
),O
",",O
Gao,O
X(7,O
),O
",",O
Gu,O
"
",O
H(8,O
),O
",",O
He,O
L(9,O
),O
",",O
Ji,O
C(4,O
),O
",",O
Jin,O
H(10,O
),O
",",O
Lai,O
W(11,O
),O
",",O
Lei,O
T(12,O
),O
",",O
Li,O
L(5,O
),O
",",O
Li,O
L(13,O
),O
",",O
Li,O
"
",O
R(1,O
),O
",",O
Liu,O
D(2,O
),O
",",O
Liu,O
W(14,O
),O
",",O
Lu,O
Q(15,O
),O
",",O
Shi,O
Y(12,O
),O
",",O
Song,O
J(16,O
),O
",",O
Tao,O
J(6,O
),O
",",O
Wang,O
B(17,O
),O
",",O
"
",O
Wang,O
G(18,O
),O
",",O
Wu,O
Y(1,O
),O
",",O
Xiang,O
L(19,O
),O
",",O
Xie,O
J(16,O
),O
",",O
Xu,O
J(19,O
),O
",",O
Yao,O
Z(20,O
),O
",",O
Zhang,O
F(21,O
),O
",",O
"
",O
Zhang,O
J(22,O
),O
",",O
Zhong,O
S(1,O
),O
",",O
Li,O
H(23,O
),O
",",O
Li,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Dermatology,O
",",O
Peking,O
University,O
First,O
Hospital,O
",",O
National,O
Clinical,O
"
",O
Research,O
Center,O
for,O
Skin,O
and,O
Immune,O
Diseases,O
",",O
Beijing,O
Key,O
Laboratory,O
of,O
Molecular,O
"
",O
Diagnosis,O
on,O
Dermatoses,O
",",O
No.8,O
Xishiku,O
St.,O
",",O
Xicheng,O
District,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Dermatology,O
",",O
Tongji,O
Hospital,O
of,O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
1095,O
Jie,O
Fang,O
Avenue,O
",",O
Hankou,O
",",O
Wuhan,O
",",O
"
",O
430030,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Dermatology,O
",",O
Wuhan,O
No.1,O
Hospital,O
",",O
No.,O
215,O
Zhongshan,O
Avenue,O
",",O
"
",O
Qiaokou,O
District,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Dermatology,O
",",O
First,O
Affiliated,O
Hospital,O
of,O
Fujian,O
Medical,O
"
",O
University,O
",",O
No.,O
20,O
",",O
Chazhong,O
Rd,O
.,O
",",O
Taijiang,O
District,O
",",O
Fuzhou,O
",",O
Fujian,O
",",O
P.,O
R.,O
China,O
.,O
"
",O
(5)Department,O
of,O
Dermatology,O
",",O
West,O
China,O
Hospital,O
of,O
Sichuan,O
University,O
",",O
No.37,O
"
",O
Guoxue,O
Alley,O
",",O
Wuhou,O
District,O
",",O
Chengdu,O
City,O
",",O
Sichuan,O
Province,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Dermatology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
1277,O
Jiefang,O
Avenue,O
",",O
Wuhan,O
",",O
Hubei,O
Province,O
",",O
"
",O
P.,O
R.,O
China,O
.,O
"
",O
(7)Department,O
of,O
Dermatology,O
",",O
Chinese,O
Medical,O
University,O
First,O
Hospital,O
",",O
No.,O
155,O
"
",O
Nanjing,O
North,O
St.,O
",",O
Heping,O
District,O
",",O
Shenyang,O
",",O
Liaoning,O
Province,O
",",O
P.,O
R.,O
China,O
.,O
"
",O
(8)Hospital,O
for,O
Skin,O
Diseases,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
12,O
"
",O
Jiangwangmiao,O
St.,O
",",O
Nanjing,O
",",O
Jiangsu,O
Province,O
",",O
P.,O
R.,O
China,O
.,O
"
",O
(9)Department,O
of,O
Dermatology,O
",",O
First,O
Affiliated,O
Hospital,O
of,O
Kunming,O
Medical,O
"
",O
University,O
",",O
295,O
Xichang,O
Rd,O
.,O
",",O
Wuhua,O
District,O
",",O
Kunming,O
",",O
Yunnan,O
Province,O
",",O
P.,O
R.,O
"
",O
China,O
.,O
"
",O
(10)Department,O
of,O
Dermatology,O
",",O
Peking,O
Union,O
Medical,O
College,O
Hospital,O
",",O
No.1,O
"
",O
Shuaifuyuan,O
Wangfujing,O
Dongcheng,O
District,O
",",O
Beijing,O
",",O
China,O
",",O
100730,O
.,O
"
",O
(11)Department,O
of,O
Dermatology,O
",",O
The,O
Third,O
Affiliated,O
Hospital,O
",",O
Sun,O
YatSen,O
"
",O
University,O
",",O
No.,O
600,O
Tianhe,O
Road,O
",",O
Tianhe,O
District,O
",",O
Guangzhou,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(12)Department,O
of,O
Dermatology,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
.,O
"
",O
(13)Department,O
of,O
Infection,O
Control,O
",",O
Peking,O
University,O
First,O
Hospital,O
",",O
No.8,O
"
",O
Xishiku,O
St.,O
",",O
Xicheng,O
District,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(14)Department,O
of,O
Dermatology,O
",",O
Air,O
Force,O
General,O
Hospital,O
of,O
PLA,O
",",O
No.,O
30,O
Fucheng,O
"
",O
Rd,O
.,O
",",O
Haidian,O
District,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(15)Department,O
of,O
Dermatology,O
",",O
The,O
Second,O
Xiangya,O
Hospital,O
of,O
Central,O
South,O
"
",O
University,O
",",O
No.139,O
Renmin,O
Road,O
Central,O
ChangshaHunan,O
",",O
China,O
.,O
"
",O
(16)Department,O
of,O
Dermatology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
No.169,O
",",O
"
",O
East,O
Lake,O
Road,O
",",O
Wuchang,O
District,O
",",O
Wuhan,O
",",O
Hubei,O
Province,O
",",O
China,O
.,O
"
",O
(17)Plastic,O
Surgery,O
Hospital,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Peking,O
Union,O
"
",O
Medical,O
College,O
",",O
No.,O
33,O
",",O
Badachu,O
Road,O
",",O
Shijingshan,O
District,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(18)Department,O
of,O
Dermatology,O
",",O
Xijing,O
Hospital,O
",",O
Air,O
Force,O
Medical,O
University,O
of,O
"
",O
PLA,O
",",O
No.169,O
",",O
Changle,O
West,O
Road,O
",",O
Xi'an,O
",",O
Shaanxi,O
",",O
710032,O
",",O
P.R,O
China,O
.,O
"
",O
(19)Department,O
of,O
Dermatology,O
",",O
Huashan,O
Hospital,O
",",O
Fudan,O
University,O
",",O
No.,O
12,O
Urumqi,O
"
",O
Middle,O
Rd,O
",",O
Shanghai,O
",",O
P.R,O
China,O
.,O
"
",O
(20)Department,O
of,O
Dermatology,O
",",O
Xinhua,O
Hospital,O
Affiliated,O
to,O
Shanghai,O
Jiaotong,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
No.,O
1665,O
Kongjiang,O
Rd,O
.,O
",",O
Yangpu,O
District,O
",",O
Shanghai,O
",",O
"
",O
P.R.,O
China,O
.,O
"
",O
(21)Shandong,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
No.,O
18877,O
Jingshi,O
Rd,O
.,O
",",O
Ji'nan,O
",",O
Shandong,O
"
",O
Province,O
",",O
P.R.China,O
.,O
"
",O
(22)Department,O
of,O
Dermatology,O
",",O
Peking,O
University,O
People,O
's,O
Hospital,O
",",O
No.11,O
"
",O
Xizhimen,O
South,O
Street,O
",",O
Xicheng,O
District,O
",",O
Beijing,O
",",O
P.R.china,O
.,O
"
",O
(23)Department,O
of,O
Dermatology,O
",",O
Hainan,O
Hospital,O
of,O
PLA,O
General,O
Hospital,O
",",O
Haitang,O
"
",O
Bay,O
",",O
Sanya,O
",",O
Hainan,O
Province,O
",",O
China,O
.,O
"

",O
Health,O
professions,O
preventing,O
and,O
controlling,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
are,O
prone,O
"
",O
to,O
skin,O
and,O
mucous,O
membrane,O
injury,O
",",O
which,O
may,O
cause,O
acute,O
and,O
chronic,O
dermatitis,O
",",O
"
",O
secondary,O
infection,O
and,O
aggravation,O
of,O
underlying,O
skin,O
diseases,O
.,O
This,O
is,O
a,O
"
",O
consensus,O
of,O
Chinese,O
experts,O
on,O
protective,O
measures,O
and,O
advice,O
on,O
handcleaning,O
"
",O
and,O
medicalgloverelated,O
hand,O
protection,O
",",O
mask,O
and,O
gogglesrelated,O
face,O
"
",O
protection,O
",",O
UVrelated,O
protection,O
",",O
eye,O
protection,O
",",O
nasal,O
and,O
oral,O
mucosa,O
"
",O
protection,O
",",O
outer,O
ear,O
and,O
hair,O
protection,O
.,O
It,O
is,O
necessary,O
to,O
strictly,O
follow,O
"
",O
standards,O
of,O
wearing,O
protective,O
equipment,O
and,O
specification,O
of,O
sterilizing,O
and,O
"
",O
cleaning,O
.,O
Insufficient,O
and,O
excessive,O
protection,O
will,O
have,O
adverse,O
effects,O
on,O
the,O
"
",O
skin,O
and,O
mucous,O
membrane,O
barrier,O
.,O
At,O
the,O
same,O
time,O
",",O
using,O
moisturizing,O
products,O
"
",O
is,O
highly,O
recommended,O
to,O
achieve,O
better,O
protection,O
.,O
This,O
article,O
is,O
protected,O
by,O
"
",O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1111,O
dth.13310,O
"
",O
PMID,O
:,O
32170800,O
"


",O
16,O
.,O
Sci,O
China,O
Life,O
Sci,O
.,O
2020,O
Mar,O
5,O
.,O
doi,O
:,O
10.1007,O
s1142702016685,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Coinfections,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
with,O
multiple,O
common,O
respiratory,O
pathogens,O
in,O
"
",O
infected,O
patients,O
.,O
"

",O
Lin,O
D(1,O
),O
",",O
Liu,O
L(2,O
),O
",",O
Zhang,O
M(2,O
),O
",",O
Hu,O
Y(1,O
),O
",",O
Yang,O
Q(2,O
),O
",",O
Guo,O
J(1,O
),O
",",O
Guo,O
Y(1,O
),O
",",O
Dai,O
Y(1,O
),O
",",O
"
",O
Xu,O
Y(3,O
),O
",",O
Cai,O
Y(1,O
),O
",",O
Chen,O
X(1,O
),O
",",O
Zhang,O
Z(4,O
),O
",",O
Huang,O
K(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
Regional,O
Immunity,O
and,O
Disease,O
",",O
"
",O
Department,O
of,O
Pathology,O
Biology,O
",",O
School,O
of,O
Medicine,O
",",O
Shenzhen,O
University,O
",",O
"
",O
Shenzhen,O
",",O
518060,O
",",O
China,O
.,O
"
",O
(2)National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
Guangdong,O
Key,O
Lab,O
"
",O
for,O
Diagnosis,O
&,O
Treatment,O
of,O
Emerging,O
Infectious,O
Diseases,O
",",O
Shenzhen,O
Third,O
"
",O
People,O
's,O
Hospital,O
",",O
Southern,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Shenzhen,O
",",O
"
",O
518112,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Clinical,O
Laboratory,O
",",O
Shenzhen,O
Baoan,O
Hospital,O
",",O
The,O
Second,O
"
",O
Affiliated,O
Hospital,O
of,O
Shenzhen,O
University,O
",",O
Shenzhen,O
",",O
518071,O
",",O
China,O
.,O
"
",O
(4)National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
Guangdong,O
Key,O
Lab,O
"
",O
for,O
Diagnosis,O
&,O
Treatment,O
of,O
Emerging,O
Infectious,O
Diseases,O
",",O
Shenzhen,O
Third,O
"
",O
People,O
's,O
Hospital,O
",",O
Southern,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Shenzhen,O
",",O
"
",O
518112,O
",",O
China,O
.,O
zhangzheng1975@aliyun.com,O
.,O
"
",O
(5)Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
Regional,O
Immunity,O
and,O
Disease,O
",",O
"
",O
Department,O
of,O
Pathology,O
Biology,O
",",O
School,O
of,O
Medicine,O
",",O
Shenzhen,O
University,O
",",O
"
",O
Shenzhen,O
",",O
518060,O
",",O
China,O
.,O
kaisong@szu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s1142702016685,O
"
",O
PMID,O
:,O
32170625,O
"


",O
17,O
.,O
Front,O
Med,O
.,O
2020,O
Mar,O
12,O
.,O
doi,O
:,O
10.1007,O
s1168402007540,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Singlecell,O
RNAseq,O
data,O
analysis,O
on,O
the,O
receptor,O
ACE2,O
expression,O
reveals,O
the,O
"
",O
potential,O
risk,O
of,O
different,O
human,O
organs,O
vulnerable,O
to,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"

",O
Zou,O
X(1,O
),O
",",O
Chen,O
K(1,O
),O
",",O
Zou,O
J(1,O
),O
",",O
Han,O
P(2,O
),O
",",O
Hao,O
J(3,O
),O
",",O
Han,O
Z(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Systems,O
Biomedicine,O
(,O
Ministry,O
of,O
Education,O
),O
",",O
Shanghai,O
Centre,O
"
",O
for,O
Systems,O
Biomedicine,O
",",O
Shanghai,O
Jiao,O
Tong,O
University,O
",",O
Shanghai,O
",",O
200240,O
",",O
China,O
.,O
"
",O
(2)Ruijin,O
Hospital,O
Affiliated,O
to,O
Shanghai,O
Jiao,O
Tong,O
University,O
School,O
of,O
"
",O
Medicine,O
",",O
Shanghai,O
",",O
200025,O
",",O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Systems,O
Biomedicine,O
(,O
Ministry,O
of,O
Education,O
),O
",",O
Shanghai,O
Centre,O
"
",O
for,O
Systems,O
Biomedicine,O
",",O
Shanghai,O
Jiao,O
Tong,O
University,O
",",O
Shanghai,O
",",O
200240,O
",",O
China,O
.,O
"
",O
j.hao@sjtu.edu.cn,O
.,O
"
",O
(4)Key,O
Laboratory,O
of,O
Systems,O
Biomedicine,O
(,O
Ministry,O
of,O
Education,O
),O
",",O
Shanghai,O
Centre,O
"
",O
for,O
Systems,O
Biomedicine,O
",",O
Shanghai,O
Jiao,O
Tong,O
University,O
",",O
Shanghai,O
",",O
200240,O
",",O
China,O
.,O
"
",O
hanzg@sjtu.edu.cn,O
.,O
"

",O
It,O
has,O
been,O
known,O
that,O
",",O
the,O
novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
",",O
2019nCoV,B-Virus_SARS-CoV-2
",",O
which,O
is,O
considered,O
"
",O
similar,O
to,O
SARSCoV,O
and,O
originated,O
from,O
Wuhan,O
(,O
China,O
),O
",",O
invades,O
human,O
cells,O
via,O
"
",O
the,O
receptor,O
angiotensin,O
converting,O
enzyme,O
II,O
(,O
ACE2,O
),O
.,O
Moreover,O
",",O
lung,O
cells,O
that,O
"
",O
have,O
ACE2,O
expression,O
may,O
be,O
the,O
main,O
target,O
cells,O
during,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"
",O
However,O
",",O
some,O
patients,O
also,O
exhibit,O
nonrespiratory,O
symptoms,O
",",O
such,O
as,O
kidney,O
"
",O
failure,O
",",O
implying,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
could,O
also,O
invade,O
other,O
organs,O
.,O
To,O
construct,O
a,O
"
",O
risk,O
map,O
of,O
different,O
human,O
organs,O
",",O
we,O
analyzed,O
the,O
singlecell,O
RNA,O
sequencing,O
"
",O
(,O
scRNAseq,O
),O
datasets,O
derived,O
from,O
major,O
human,O
physiological,O
systems,O
",",O
including,O
"
",O
the,O
respiratory,O
",",O
cardiovascular,O
",",O
digestive,O
",",O
and,O
urinary,O
systems,O
.,O
Through,O
"
",O
scRNAseq,O
data,O
analyses,O
",",O
we,O
identified,O
the,O
organs,O
at,O
risk,O
",",O
such,O
as,O
lung,O
",",O
heart,O
",",O
"
",O
esophagus,O
",",O
kidney,O
",",O
bladder,O
",",O
and,O
ileum,O
",",O
and,O
located,O
specific,O
cell,O
types,O
(,O
i.e.,O
",",O
"
",O
type,O
II,O
alveolar,O
cells,O
(,O
AT2,O
),O
",",O
myocardial,O
cells,O
",",O
proximal,O
tubule,O
cells,O
of,O
the,O
"
",O
kidney,O
",",O
ileum,O
and,O
esophagus,O
epithelial,O
cells,O
",",O
and,O
bladder,O
urothelial,O
cells,O
),O
",",O
"
",O
which,O
are,O
vulnerable,O
to,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
Based,O
on,O
the,O
findings,O
",",O
we,O
"
",O
constructed,O
a,O
risk,O
map,O
indicating,O
the,O
vulnerability,O
of,O
different,O
organs,O
to,O
"
",O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
This,O
study,O
may,O
provide,O
potential,O
clues,O
for,O
further,O
"
",O
investigation,O
of,O
the,O
pathogenesis,O
and,O
route,O
of,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"

",O
DOI,O
:,O
10.1007,O
s1168402007540,O
"
",O
PMID,O
:,O
32170560,O
"


",O
18,O
.,O
Front,O
Med,O
.,O
2020,O
Mar,O
13,O
.,O
doi,O
:,O
10.1007,O
s116840200757x,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Combination,O
of,O
western,O
medicine,O
and,O
Chinese,O
traditional,O
patent,O
medicine,O
in,O
"
",O
treating,O
a,O
family,O
case,O
of,O
COVID19,B-Disease_COVID-19
in,O
Wuhan,O
.,O
"

",O
Ni,O
L(1,O
),O
",",O
Zhou,O
L(1,O
),O
",",O
Zhou,O
M(2,O
),O
",",O
Zhao,O
J(2,O
),O
",",O
Wang,O
DW(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Cardiology,O
",",O
Department,O
of,O
Internal,O
Medicine,O
and,O
Hubei,O
Key,O
"
",O
Laboratory,O
of,O
Genetics,O
and,O
Molecular,O
Mechanisms,O
of,O
Cardiological,O
Disorders,O
",",O
"
",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
",",O
430030,O
",",O
China,O
.,O
"
",O
(2)Division,O
of,O
Respiration,O
",",O
Department,O
of,O
Internal,O
Medicine,O
and,O
Hubei,O
Key,O
"
",O
Laboratory,O
of,O
Genetics,O
and,O
Molecular,O
Mechanisms,O
of,O
Cardiological,O
Disorders,O
",",O
"
",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
",",O
430030,O
",",O
China,O
.,O
"
",O
(3)Division,O
of,O
Cardiology,O
",",O
Department,O
of,O
Internal,O
Medicine,O
and,O
Hubei,O
Key,O
"
",O
Laboratory,O
of,O
Genetics,O
and,O
Molecular,O
Mechanisms,O
of,O
Cardiological,O
Disorders,O
",",O
"
",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
",",O
430030,O
",",O
China,O
.,O
dwwang@tjh.tjmu.edu.cn,O
.,O
"

",O
In,O
December,O
2019,O
",",O
an,O
outbreak,O
of,O
novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
occurred,O
in,O
Wuhan,O
",",O
"
",O
Hubei,O
Province,O
",",O
China,O
.,O
By,O
February,O
14,O
",",O
2020,O
",",O
it,O
has,O
led,O
to,O
66,O
492,O
confirmed,O
"
",O
patients,O
in,O
China,O
and,O
high,O
mortality,O
up,O
to,O
âˆ¼2.96,O
%,O
(,O
1123,O
37,O
914,O
),O
in,O
Wuhan,O
.,O
Here,O
we,O
"
",O
report,O
the,O
first,O
family,O
case,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
confirmed,O
in,O
"
",O
Wuhan,O
and,O
treated,O
using,O
the,O
combination,O
of,O
western,O
medicine,O
and,O
Chinese,O
"
",O
traditional,O
patent,O
medicine,O
Shuanghuanglian,O
oral,O
liquid,O
(,O
SHL,O
),O
.,O
This,O
report,O
"
",O
describes,O
the,O
identification,O
",",O
diagnosis,O
",",O
clinical,O
course,O
",",O
and,O
management,O
of,O
three,O
"
",O
cases,O
from,O
a,O
family,O
",",O
suggests,O
the,O
expected,O
therapeutic,O
effects,O
of,O
SHL,O
on,O
"
",O
COVID19,B-Disease_COVID-19
",",O
and,O
warrants,O
further,O
clinical,O
trials,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s116840200757x,O
"
",O
PMID,O
:,O
32170559,O
"


",O
19,O
.,O
Arch,O
Virol,O
.,O
2020,O
Mar,O
13,O
.,O
doi,O
:,O
10.1007,O
s0070502004559w,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Complete,O
genome,O
sequence,O
of,O
a,O
novel,O
rhabdolike,O
virus,O
from,O
the,O
Chinese,O
black,O
"
",O
cutworm,O
Agrotis,O
ipsilon,O
(,O
Lepidoptera,O
:,O
Noctuidae,O
),O
.,O
"

",O
Chen,O
S(1)(2,O
),O
",",O
Li,O
H(1,O
),O
",",O
Yuan,O
G(1,O
),O
",",O
Guan,O
R(3,O
),O
",",O
Li,O
T(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)College,O
of,O
Plant,O
Protection,O
",",O
Henan,O
Agricultural,O
University,O
",",O
Zhengzhou,O
",",O
450002,O
",",O
"
",O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)College,O
of,O
Plant,O
Protection,O
",",O
Henan,O
Agricultural,O
University,O
",",O
Zhengzhou,O
",",O
450002,O
",",O
"
",O
China,O
.,O
guanruobing@henau.edu.cn,O
.,O
"
",O
(4)Institute,O
of,O
Plant,O
Protection,O
Henan,O
Key,O
Laboratory,O
of,O
Crop,O
Pest,O
Control,O
Key,O
"
",O
Laboratory,O
of,O
Integrated,O
Pest,O
Management,O
on,O
Crops,O
in,O
Southern,O
Region,O
of,O
North,O
"
",O
China,O
",",O
Henan,O
Academy,O
of,O
Agricultural,O
Sciences,O
",",O
Zhengzhou,O
",",O
450002,O
",",O
China,O
.,O
"
",O
tongli84@hotmail.com,O
.,O
"

",O
This,O
work,O
identified,O
a,O
novel,O
rhabdolike,O
virus,O
in,O
a,O
Chinese,O
black,O
cutworm,O
"
",O
(,O
Agrotis,O
ipsilon,O
),O
",",O
which,O
we,O
tentatively,O
named,O
"""",O
Agrotis,O
ipsilon,O
virus,O
"""",O
(,O
AIpsV,O
),O
.,O
"
",O
The,O
complete,O
genome,O
of,O
AIpsV,O
is,O
15454,O
nucleotides,O
in,O
length,O
and,O
contains,O
seven,O
"
",O
open,O
reading,O
frames,O
",",O
collectively,O
encoding,O
more,O
than,O
160,O
amino,O
acids,O
.,O
The,O
AIpsV,O
"
",O
genome,O
is,O
predicted,O
to,O
encode,O
three,O
structural,O
proteins,O
",",O
nucleoprotein,O
(,O
N,O
),O
",",O
"
",O
glycoprotein,O
(,O
G,O
),O
",",O
and,O
large,O
polymerase,O
protein,O
(,O
L,O
),O
",",O
and,O
four,O
unknown,O
proteins,O
.,O
"
",O
Phylogenetic,O
analysis,O
revealed,O
that,O
the,O
AIpsV,O
clusters,O
with,O
Wuhan,O
ant,O
virus,O
and,O
"
",O
Hubei,O
rhabdolike,O
virus,O
1,O
within,O
the,O
rhabdolike,O
virus,O
clade,O
.,O
The,O
level,O
of,O
"
",O
expression,O
of,O
AIpsV,O
genes,O
was,O
found,O
to,O
be,O
higher,O
in,O
the,O
pupal,O
and,O
adult,O
stages,O
"
",O
than,O
in,O
the,O
egg,O
and,O
larval,O
stages,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s0070502004559w,O
"
",O
PMID,O
:,O
32170393,O
"


",O
20,O
.,O
BMJ,O
.,O
2020,O
Mar,O
13;368:m1059,O
.,O
doi,O
:,O
10.1136,O
bmj.m1059,O
.,O
"

",O
Trainees,O
and,O
covid19,B-Disease_COVID-19
:,O
your,O
questions,O
answered,O
.,O
"

",O
Rimmer,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m1059,O
"
",O
PMID,O
:,O
32170027,O
"


",O
21,O
.,O
Proc,O
Natl,O
Acad,O
Sci,O
U,O
S,O
A.,O
2020,O
Mar,O
13,O
.,O
pii,O
:,O
202002616,O
.,O
doi,O
:,O
"
",O
10.1073,O
pnas.2002616117,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Impact,O
of,O
international,O
travel,O
and,O
border,O
control,O
measures,O
on,O
the,O
global,O
spread,O
"
",O
of,O
the,O
novel,O
2019,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
outbreak,O
.,O
"

",O
Wells,O
CR(1,O
),O
",",O
Sah,O
P(1,O
),O
",",O
Moghadas,O
SM(2,O
),O
",",O
Pandey,O
A(1,O
),O
",",O
Shoukat,O
A(1,O
),O
",",O
Wang,O
Y(3,O
),O
",",O
Wang,O
"
",O
Z(4,O
),O
",",O
Meyers,O
LA(5)(6,O
),O
",",O
Singer,O
BH(7,O
),O
",",O
Galvani,O
AP(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Center,O
for,O
Infectious,O
Disease,O
Modeling,O
and,O
Analysis,O
",",O
Yale,O
School,O
of,O
Public,O
"
",O
Health,O
",",O
New,O
Haven,O
",",O
CT,O
6520,O
.,O
"
",O
(2)AgentBased,O
Modelling,O
Laboratory,O
",",O
York,O
University,O
",",O
Toronto,O
",",O
ON,O
M3J,O
1P3,O
",",O
"
",O
Canada,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Mycology,O
",",O
Institute,O
of,O
Microbiology,O
",",O
Chinese,O
Academy,O
"
",O
of,O
Sciences,O
",",O
100101,O
Beijing,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Biostatistics,O
",",O
Yale,O
School,O
of,O
Public,O
Health,O
",",O
New,O
Haven,O
",",O
CT,O
"
",O
6510,O
.,O
"
",O
(5)Department,O
of,O
Integrative,O
Biology,O
",",O
The,O
University,O
of,O
Texas,O
at,O
Austin,O
",",O
Austin,O
",",O
"
",O
TX,O
78712,O
.,O
"
",O
(6)Santa,O
Fe,O
Institute,O
",",O
Santa,O
Fe,O
",",O
NM,O
87501,O
.,O
"
",O
(7)Emerging,O
Pathogens,O
Institute,O
",",O
University,O
of,O
Florida,O
",",O
Gainesville,O
",",O
FL,O
32610,O
"
",O
bhsinger@epi.ufl.edu,O
.,O
"

",O
The,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
outbreak,O
(,O
COVID19,B-Disease_COVID-19
),O
in,O
mainland,O
China,O
has,O
rapidly,O
spread,O
"
",O
across,O
the,O
globe,O
.,O
Within,O
2,O
mo,O
since,O
the,O
outbreak,O
was,O
first,O
reported,O
on,O
December,O
"
",O
31,O
",",O
2019,O
",",O
a,O
total,O
of,O
566,O
Severe,O
Acute,O
Respiratory,O
Syndrome,O
(,O
SARS,O
CoV2,O
),O
cases,O
"
",O
have,O
been,O
confirmed,O
in,O
26,O
other,O
countries,O
.,O
Travel,O
restrictions,O
and,O
border,O
control,O
"
",O
measures,O
have,O
been,O
enforced,O
in,O
China,O
and,O
other,O
countries,O
to,O
limit,O
the,O
spread,O
of,O
"
",O
the,O
outbreak,O
.,O
We,O
estimate,O
the,O
impact,O
of,O
these,O
control,O
measures,O
and,O
investigate,O
"
",O
the,O
role,O
of,O
the,O
airport,O
travel,O
network,O
on,O
the,O
global,O
spread,O
of,O
the,O
COVID19,B-Disease_COVID-19
"
",O
outbreak,O
.,O
Our,O
results,O
show,O
that,O
the,O
daily,O
risk,O
of,O
exporting,O
at,O
least,O
a,O
single,O
"
",O
SARS,O
CoV2,O
case,O
from,O
mainland,O
China,O
via,O
international,O
travel,O
exceeded,O
95,O
%,O
on,O
"
",O
January,O
13,O
",",O
2020,O
.,O
We,O
found,O
that,O
779,O
cases,O
(,O
95,O
%,O
CI,O
:,O
632,O
to,O
967,O
),O
would,O
have,O
been,O
"
",O
exported,O
by,O
February,O
15,O
",",O
2020,O
without,O
any,O
border,O
or,O
travel,O
restrictions,O
and,O
that,O
"
",O
the,O
travel,O
lockdowns,O
enforced,O
by,O
the,O
Chinese,O
government,O
averted,O
70.5,O
%,O
(,O
95,O
%,O
CI,O
:,O
"
",O
68.8,O
to,O
72,O
%,O
),O
of,O
these,O
cases,O
.,O
In,O
addition,O
",",O
during,O
the,O
first,O
three,O
and,O
a,O
half,O
"
",O
weeks,O
of,O
implementation,O
",",O
the,O
travel,O
restrictions,O
decreased,O
the,O
daily,O
rate,O
of,O
"
",O
exportation,O
by,O
81.3,O
%,O
(,O
95,O
%,O
CI,O
:,O
80.5,O
to,O
82.1,O
%,O
),O
",",O
on,O
average,O
.,O
At,O
this,O
early,O
stage,O
of,O
"
",O
the,O
epidemic,O
",",O
reduction,O
in,O
the,O
rate,O
of,O
exportation,O
could,O
delay,O
the,O
importation,O
of,O
"
",O
cases,O
into,O
cities,O
unaffected,O
by,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
",",O
buying,O
time,O
to,O
coordinate,O
"
",O
an,O
appropriate,O
public,O
health,O
response,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
the,O
Author(s,O
),O
.,O
Published,O
by,O
PNAS,O
.,O
"

",O
DOI,O
:,O
10.1073,O
pnas.2002616117,O
"
",O
PMID,O
:,O
32170017,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
competing,O
interest,O
.,O
"


",O
22,O
.,O
BMJ,O
.,O
2020,O
Mar,O
13;368:m1060,O
.,O
doi,O
:,O
10.1136,O
bmj.m1060,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
UK,O
holds,O
off,O
closing,O
schools,O
and,O
restricts,O
testing,O
to,O
people,O
in,O
"
",O
hospital,O
.,O
"

",O
Mahase,O
E(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m1060,O
"
",O
PMID,O
:,O
32169967,O
"


",O
23,O
.,O
BMJ,O
.,O
2020,O
Mar,O
13;368:m1055,O
.,O
doi,O
:,O
10.1136,O
bmj.m1055,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
GPs,O
call,O
for,O
same,O
personal,O
protective,O
equipment,O
as,O
hospital,O
doctors,O
.,O
"

",O
Rimmer,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m1055,O
"
",O
PMID,O
:,O
32169866,O
"


",O
24,O
.,O
J,O
Immunol,O
.,O
2020,O
Mar,O
13,O
.,O
pii,O
:,O
ji1900667,O
.,O
doi,O
:,O
10.4049,O
jimmunol.1900667,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
NOD1,O
Promotes,O
Antiviral,O
Signaling,O
by,O
Binding,O
Viral,O
RNA,O
and,O
Regulating,O
the,O
"
",O
Interaction,O
of,O
MDA5,O
and,O
MAVS,O
.,O
"

",O
Wu,O
XM(1)(2,O
),O
",",O
Zhang,O
J(1,O
),O
",",O
Li,O
PW(1)(2,O
),O
",",O
Hu,O
YW(1)(2,O
),O
",",O
Cao,O
L(1)(2,O
),O
",",O
Ouyang,O
S(3)(4,O
),O
",",O
"
",O
Bi,O
YH(1,O
),O
",",O
Nie,O
P(1)(2)(5,O
),O
",",O
Chang,O
MX(6)(2)(5)(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
Hubei,O
Province,O
",",O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
10049,O
",",O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Innate,O
Immune,O
Biology,O
of,O
Fujian,O
Province,O
",",O
Biomedical,O
"
",O
Research,O
Center,O
of,O
South,O
China,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Fujian,O
Normal,O
"
",O
University,O
",",O
Fuzhou,O
350117,O
",",O
China,O
.,O
"
",O
(4)Key,O
Laboratory,O
of,O
OptoElectronic,O
Science,O
and,O
Technology,O
for,O
Medicine,O
",",O
Ministry,O
"
",O
of,O
Education,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Fujian,O
Normal,O
University,O
",",O
Fuzhou,O
350117,O
",",O
"
",O
China,O
.,O
"
",O
(5)Key,O
Laboratory,O
of,O
Aquaculture,O
Disease,O
Control,O
",",O
Ministry,O
of,O
Agriculture,O
",",O
Wuhan,O
"
",O
430072,O
",",O
Hubei,O
Province,O
",",O
China,O
;,O
and,O
.,O
"
",O
(6)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
Hubei,O
Province,O
",",O
China,O
;,O
"
",O
mingxianchang@ihb.ac.cn,O
.,O
"
",O
(7)Innovation,O
Academy,O
for,O
Seed,O
Design,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
"
",O
China,O
.,O
"

",O
Nucleotide,O
oligomerization,O
domainlike,O
receptors,O
(,O
NLRs,O
),O
and,O
RIGIlike,O
receptors,O
"
",O
(,O
RLRs,O
),O
detect,O
diverse,O
pathogenassociated,O
molecular,O
patterns,O
to,O
activate,O
the,O
"
",O
innate,O
immune,O
response,O
.,O
The,O
role,O
of,O
mammalian,O
NLR,O
NOD1,O
in,O
sensing,O
bacteria,O
is,O
"
",O
well,O
established,O
.,O
Although,O
several,O
studies,O
suggest,O
NOD1,O
also,O
plays,O
a,O
role,O
in,O
"
",O
sensing,O
viruses,O
",",O
the,O
mechanisms,O
behind,O
this,O
are,O
still,O
largely,O
unknown,O
.,O
In,O
this,O
"
",O
study,O
",",O
we,O
report,O
on,O
the,O
synergism,O
and,O
antagonism,O
between,O
NOD1,O
and,O
MDA5,O
isoforms,O
"
",O
in,O
teleost,O
.,O
In,O
zebrafish,O
",",O
the,O
overexpression,O
of,O
NOD1,O
enhances,O
the,O
antiviral,O
"
",O
response,O
and,O
mRNA,O
abundances,O
of,O
key,O
antiviral,O
genes,O
involved,O
in,O
RLRmediated,O
"
",O
signaling,O
",",O
whereas,O
the,O
loss,O
of,O
NOD1,O
has,O
the,O
opposite,O
effect,O
.,O
Notably,O
",",O
spring,O
"
",O
viremia,O
of,O
carp,O
virusinfected,O
NOD1,O
 ,O
zebrafish,O
exhibit,O
reduced,O
survival,O
"
",O
compared,O
with,O
wildtype,O
counterparts,O
.,O
Mechanistically,O
",",O
NOD1,O
targets,O
MDA5,O
isoforms,O
"
",O
and,O
TRAF3,O
to,O
modulate,O
the,O
formation,O
of,O
MDA5MAVS,O
and,O
TRAF3MAVS,O
complexes,O
.,O
The,O
"
",O
cumulative,O
effects,O
of,O
NOD1,O
and,O
MDA5a,O
(,O
MDA5,O
normal,O
form,O
),O
were,O
observed,O
for,O
the,O
"
",O
binding,O
with,O
poly(I,O
:,O
C,O
),O
and,O
the,O
formation,O
of,O
the,O
MDA5aMAVS,O
complex,O
",",O
which,O
led,O
to,O
"
",O
increased,O
transcription,O
of,O
type,O
I,O
IFNs,O
and,O
ISGs,O
.,O
However,O
",",O
the,O
antagonism,O
between,O
"
",O
NOD1,O
and,O
MDA5b,O
(,O
MDA5,O
truncated,O
form,O
),O
was,O
clearly,O
observed,O
during,O
proteasomal,O
"
",O
degradation,O
of,O
NOD1,O
by,O
MDA5b,O
.,O
In,O
humans,O
",",O
the,O
interactions,O
between,O
NOD1MDA5,O
and,O
"
",O
NOD1TRAF3,O
were,O
confirmed,O
.,O
Furthermore,O
",",O
the,O
roles,O
that,O
NOD1,O
plays,O
in,O
enhancing,O
"
",O
the,O
binding,O
of,O
MDA5,O
to,O
MAVS,O
and,O
poly(I,O
:,O
C,O
),O
are,O
also,O
evolutionarily,O
conserved,O
"
",O
across,O
species,O
.,O
Taken,O
together,O
",",O
our,O
findings,O
suggest,O
that,O
mutual,O
regulation,O
"
",O
between,O
NOD1,O
and,O
MDA5,O
isoforms,O
may,O
play,O
a,O
crucial,O
role,O
in,O
the,O
innate,O
immune,O
"
",O
response,O
and,O
that,O
NOD1,O
acts,O
as,O
a,O
positive,O
regulator,O
of,O
MDA5,O
MAVS,O
normal,O
"
",O
formmediated,O
immune,O
signaling,O
in,O
vertebrates,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
by,O
The,O
American,O
Association,O
of,O
Immunologists,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.4049,O
jimmunol.1900667,O
"
",O
PMID,O
:,O
32169843,O
"


",O
25,O
.,O
BMJ,O
.,O
2020,O
Mar,O
13;368:m1054,O
.,O
doi,O
:,O
10.1136,O
bmj.m1054,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
Medical,O
conferences,O
around,O
the,O
world,O
are,O
cancelled,O
after,O
US,O
cases,O
are,O
"
",O
linked,O
to,O
Massachusetts,O
meeting,O
.,O
"

",O
Rimmer,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m1054,O
"
",O
PMID,O
:,O
32169834,O
"


",O
26,O
.,O
BMJ,O
.,O
2020,O
Mar,O
13;368:m1053,O
.,O
doi,O
:,O
10.1136,O
bmj.m1053,O
.,O
"

",O
Budgeting,O
for,O
covid19,B-Disease_COVID-19
:,O
changing,O
the,O
narrative,O
and,O
narrating,O
the,O
change,O
.,O
"

",O
Cowper,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Health,O
Policy,O
Insight,O
",",O
London,O
",",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m1053,O
"
",O
PMID,O
:,O
32169833,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interests,O
:,O
None,O
declared,O
.,O
"


",O
27,O
.,O
BMJ,O
.,O
2020,O
Mar,O
13;368:m1052,O
.,O
doi,O
:,O
10.1136,O
bmj.m1052,O
.,O
"

",O
Bearing,O
the,O
brunt,O
of,O
covid19,B-Disease_COVID-19
:,O
older,O
people,O
in,O
low,O
and,O
middle,O
income,O
countries,O
.,O
"

",O
LloydSherlock,O
P(1,O
),O
",",O
Ebrahim,O
S(2,O
),O
",",O
Geffen,O
L(3,O
),O
",",O
McKee,O
M(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
International,O
Development,O
",",O
University,O
of,O
East,O
Anglia,O
",",O
Norwich,O
",",O
UK,O
"
",O
P.Lloydsherlock@uea.ac.uk,O
.,O
"
",O
(2)London,O
School,O
of,O
Hygiene,O
and,O
Tropical,O
Medicine,O
",",O
London,O
",",O
UK,O
.,O
"
",O
(3)Samson,O
Institute,O
For,O
Ageing,O
Research,O
(,O
SIFAR,O
),O
",",O
Cape,O
Town,O
",",O
South,O
Africa,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m1052,O
"
",O
PMID,O
:,O
32169830,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interests,O
:,O
We,O
have,O
read,O
and,O
understood,O
"
",O
BMJ,O
policy,O
on,O
declaration,O
of,O
interests,O
and,O
have,O
no,O
relevant,O
interests,O
to,O
declare,O
.,O
"


",O
28,O
.,O
Infect,O
Genet,O
Evol,O
.,O
2020,O
Mar,O
10:104285,O
.,O
doi,O
:,O
10.1016,O
j.meegid.2020.104285,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Genetic,O
evolution,O
analysis,O
of,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
and,O
coronavirus,O
from,O
other,O
"
",O
species,O
.,O
"

",O
Li,O
C(1,O
),O
",",O
Yang,O
Y(2,O
),O
",",O
Ren,O
L(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Chinese,O
Peoples,O
',O
Liberation,O
Army,O
964,O
Hospital,O
",",O
Changchun,O
",",O
China,O
.,O
"
",O
(2)Institute,O
of,O
Special,O
Wild,O
Economic,O
Animals,O
and,O
Plants,O
",",O
Chinese,O
Academy,O
of,O
"
",O
Agricultural,O
Sciences,O
",",O
Changchun,O
130112,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
m18043213639@163.com,O
.,O
"
",O
(3)College,O
of,O
Animal,O
Sciences,O
",",O
Jilin,O
University,O
",",O
Changchun,O
130062,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
renlz@jlu.edu.cn,O
.,O
"

",O
The,O
Corona,B-Disease_COVID-19
Virus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
caused,O
by,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
is,O
a,O
Public,O
Health,O
Emergency,O
of,O
International,O
"
",O
Concern,O
.,O
However,O
",",O
so,O
far,O
",",O
there,O
are,O
still,O
controversies,O
about,O
the,O
source,O
of,O
the,O
"
",O
virus,O
and,O
its,O
intermediate,O
host,O
.,O
Here,O
",",O
we,O
found,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
was,O
closely,O
"
",O
related,O
to,O
coronaviruses,O
derived,O
from,O
five,O
wild,O
animals,O
",",O
including,O
Paguma,O
"
",O
larvata,O
",",O
Paradoxurus,O
hermaphroditus,O
",",O
Civet,O
",",O
Aselliscus,O
stoliczkanus,O
and,O
"
",O
Rhinolophus,O
sinicus,O
",",O
and,O
was,O
in,O
the,O
same,O
branch,O
of,O
the,O
phylogenetic,O
tree,O
.,O
"
",O
However,O
",",O
genome,O
and,O
ORF1a,O
homology,O
show,O
that,O
the,O
virus,O
is,O
not,O
the,O
same,O
"
",O
coronavirus,O
as,O
the,O
coronavirus,O
derived,O
from,O
these,O
five,O
animals,O
",",O
whereas,O
the,O
virus,O
"
",O
has,O
the,O
highest,O
homology,O
with,O
Bat,O
coronavirus,O
isolate,O
RaTG13,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
.,O
Published,O
by,O
Elsevier,O
B.V.,O
"

",O
DOI,O
:,O
10.1016,O
j.meegid.2020.104285,O
"
",O
PMID,O
:,O
32169673,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
known,O
competing,O
financial,O
interests,O
or,O
personal,O
"
",O
relationships,O
that,O
could,O
have,O
appeared,O
to,O
influence,O
the,O
work,O
reported,O
in,O
this,O
"
",O
paper,O
.,O
"


",O
29,O
.,O
J,O
Hosp,O
Infect,O
.,O
2020,O
Mar,O
10,O
.,O
pii,O
:,O
S01956701(20)301092,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jhin.2020.03.010,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Washing,O
our,O
hands,O
of,O
the,O
problem,O
.,O
"

",O
Lynch,O
C,O
",",O
Mahida,O
N,O
",",O
Oppenheim,O
B,O
",",O
Gray,O
J.,O
"

",O
DOI,O
:,O
10.1016,O
j.jhin.2020.03.010,O
"
",O
PMID,O
:,O
32169616,O
"


",O
30,O
.,O
J,O
Hosp,O
Infect,O
.,O
2020,O
Mar,O
10,O
.,O
pii,O
:,O
S01956701(20)301079,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jhin.2020.03.008,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Makeshift,O
hospitals,O
for,O
COVID19,B-Disease_COVID-19
patients,O
:,O
where,O
healthcare,O
workers,O
and,O
patients,O
"
",O
need,O
sufficient,O
ventilation,O
for,O
more,O
protection,O
.,O
"

",O
Chen,O
C(1,O
),O
",",O
Zhao,O
B(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Building,O
Science,O
",",O
School,O
of,O
Architecture,O
",",O
Tsinghua,O
University,O
",",O
"
",O
Beijing,O
100084,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Building,O
Science,O
",",O
School,O
of,O
Architecture,O
",",O
Tsinghua,O
University,O
",",O
"
",O
Beijing,O
100084,O
",",O
China,O
;,O
Beijing,O
Key,O
Laboratory,O
of,O
Indoor,O
Air,O
Quality,O
Evaluation,O
"
",O
and,O
Control,O
",",O
Tsinghua,O
University,O
",",O
Beijing,O
100084,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
binzhao@tsinghua.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jhin.2020.03.008,O
"
",O
PMID,O
:,O
32169615,O
"


",O
31,O
.,O
Int,O
J,O
Surg,O
.,O
2020,O
Mar,O
10,O
.,O
pii,O
:,O
S17439191(20)302132,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ijsu.2020.03.001,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
A,O
Commentary,O
on,O
"""",O
World,O
Health,O
Organization,O
declares,O
Global,O
Emergency,O
:,O
A,O
review,O
of,O
"
",O
the,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
"""",O
.,O
"

",O
Sarwar,O
Shah,O
SG(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)NIHR,O
Oxford,O
Biomedical,O
Research,O
Centre,O
",",O
Oxford,O
University,O
Hospitals,O
NHS,O
",",O
"
",O
Foundation,O
Trust,O
",",O
John,O
Radcliffe,O
Hospital,O
",",O
Headington,O
Way,O
",",O
Headington,O
",",O
Oxford,O
",",O
"
",O
OX3,O
9DU,O
",",O
England,O
UK,O
.,O
Electronic,O
address,O
:,O
Sarwar.Shah@ouh.nhs.uk,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijsu.2020.03.001,O
"
",O
PMID,O
:,O
32169574,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
I,O
declare,O
no,O
"
",O
conflict,O
of,O
interest,O
.,O
"


",O
32,O
.,O
Int,O
J,O
Surg,O
.,O
2020,O
Mar,O
10,O
.,O
pii,O
:,O
S17439191(20)302144,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ijsu.2020.03.002,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
An,O
Invited,O
Commentary,O
on,O
"""",O
World,O
Health,O
Organization,O
declares,O
Global,O
Emergency,O
:,O
A,O
"
",O
review,O
of,O
the,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
"""",O
:,O
Emergency,O
or,O
New,O
Reality,O
?,O
"

",O
Purcell,O
LN(1,O
),O
",",O
Charles,O
AG(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Surgery,O
",",O
University,O
of,O
North,O
Carolina,O
at,O
Chapel,O
Hill,O
",",O
UNC,O
School,O
"
",O
of,O
Medicine,O
",",O
4008,O
Burnett,O
Womack,O
Building,O
",",O
CB,O
7228,O
.,O
"
",O
(2)Department,O
of,O
Surgery,O
",",O
University,O
of,O
North,O
Carolina,O
at,O
Chapel,O
Hill,O
",",O
UNC,O
School,O
"
",O
of,O
Medicine,O
",",O
4008,O
Burnett,O
Womack,O
Building,O
",",O
CB,O
7228,O
.,O
Electronic,O
address,O
:,O
"
",O
anthchar@med.unc.edu,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijsu.2020.03.002,O
"
",O
PMID,O
:,O
32169565,O
"


",O
33,O
.,O
Brain,O
Behav,O
Immun,O
.,O
2020,O
Mar,O
10,O
.,O
pii,O
:,O
S08891591(20)303093,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.bbi.2020.03.007,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Vicarious,O
traumatization,O
in,O
the,O
general,O
public,O
",",O
members,O
",",O
and,O
nonmembers,O
of,O
"
",O
medical,O
teams,O
aiding,O
in,O
COVID19,B-Disease_COVID-19
control,O
.,O
"

",O
Li,O
Z(1,O
),O
",",O
Ge,O
J(1,O
),O
",",O
Yang,O
M(1,O
),O
",",O
Feng,O
J(1,O
),O
",",O
Qiao,O
M(1,O
),O
",",O
Jiang,O
R(2,O
),O
",",O
Bi,O
J(3,O
),O
",",O
Zhan,O
"
",O
G(3,O
),O
",",O
Xu,O
X(3,O
),O
",",O
Wang,O
L(4,O
),O
",",O
Zhou,O
Q(2,O
),O
",",O
Zhou,O
C(5,O
),O
",",O
Pan,O
Y(1,O
),O
",",O
Liu,O
S(1,O
),O
",",O
Zhang,O
H(1,O
),O
",",O
"
",O
Yang,O
J(6,O
),O
",",O
Zhu,O
B(7,O
),O
",",O
Hu,O
Y(8,O
),O
",",O
Hashimoto,O
K(9,O
),O
",",O
Jia,O
Y(10,O
),O
",",O
Wang,O
H(11,O
),O
",",O
Wang,O
R(12,O
),O
",",O
"
",O
Liu,O
C(13,O
),O
",",O
Yang,O
C(14,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Anesthesiology,O
and,O
Perioperative,O
Medicine,O
",",O
The,O
First,O
Affiliated,O
"
",O
Hospital,O
of,O
Nanjing,O
Medical,O
University,O
",",O
Nanjing,O
210029,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Ultrasound,O
Imaging,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
"
",O
430060,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Anesthesiology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Wuhan,O
"
",O
430030,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Anesthesiology,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
"
",O
430060,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
430060,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Anesthesiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Zhengzhou,O
"
",O
University,O
",",O
Zhengzhou,O
450052,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
The,O
Third,O
Affiliated,O
Hospital,O
of,O
Soochow,O
"
",O
University,O
",",O
China,O
.,O
"
",O
(8)Department,O
of,O
Anesthesiology,O
",",O
The,O
Second,O
Affiliated,O
Changzhou,O
People,O
's,O
"
",O
Hospital,O
of,O
Nanjing,O
Medical,O
University,O
",",O
Changzhou,O
213000,O
",",O
China,O
.,O
"
",O
(9)Division,O
of,O
Clinical,O
Neuroscience,O
",",O
Chiba,O
University,O
Center,O
for,O
Forensic,O
Mental,O
"
",O
Health,O
",",O
Chiba,O
2608670,O
",",O
Japan,O
.,O
"
",O
(10)Department,O
of,O
Orthopedics,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Nanjing,O
Medical,O
"
",O
University,O
",",O
Nanjing,O
210029,O
",",O
China,O
.,O
"
",O
(11)Department,O
of,O
Psychology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Nanjing,O
Medical,O
"
",O
University,O
",",O
Nanjing,O
210029,O
",",O
China,O
.,O
"
",O
(12)Department,O
of,O
Nursing,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Nanjing,O
Medical,O
"
",O
University,O
",",O
Nanjing,O
210029,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
wangrong_nj@163.com,O
.,O
"
",O
(13)Department,O
of,O
Anesthesiology,O
and,O
Perioperative,O
Medicine,O
",",O
The,O
First,O
Affiliated,O
"
",O
Hospital,O
of,O
Nanjing,O
Medical,O
University,O
",",O
Nanjing,O
210029,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
1335587409@qq.com,O
.,O
"
",O
(14)Department,O
of,O
Anesthesiology,O
and,O
Perioperative,O
Medicine,O
",",O
The,O
First,O
Affiliated,O
"
",O
Hospital,O
of,O
Nanjing,O
Medical,O
University,O
",",O
Nanjing,O
210029,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
chunyang@njmu.edu.cn,O
.,O
"

",O
Since,O
December,O
2019,O
",",O
more,O
than,O
79000,O
people,O
have,O
been,O
diagnosed,O
with,O
infection,O
"
",O
of,O
the,O
Corona,B-Disease_COVID-19
Virus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
.,O
A,O
large,O
number,O
of,O
medical,O
staff,O
was,O
"
",O
sent,O
to,O
Wuhan,O
city,O
and,O
Hubei,O
province,O
to,O
aid,O
COVID19,B-Disease_COVID-19
control,O
.,O
Psychological,O
"
",O
stress,O
",",O
especially,O
vicarious,O
traumatization,O
caused,O
by,O
the,O
COVID19,B-Disease_COVID-19
pandemic,O
",",O
"
",O
should,O
not,O
be,O
ignored,O
.,O
To,O
address,O
this,O
concern,O
",",O
the,O
study,O
employed,O
a,O
total,O
of,O
214,O
"
",O
general,O
public,O
and,O
526,O
nurses,O
(,O
i.e.,O
",",O
234,O
frontline,O
nurses,O
and,O
292,O
nonfrontline,O
"
",O
nurses,O
),O
to,O
evaluate,O
vicarious,O
traumatization,O
scores,O
via,O
a,O
mobile,O
appbased,O
"
",O
questionnaire,O
.,O
Frontline,O
nurses,O
are,O
engaged,O
in,O
the,O
process,O
of,O
providing,O
care,O
for,O
"
",O
patients,O
with,O
COVID19,B-Disease_COVID-19
.,O
The,O
results,O
showed,O
that,O
the,O
vicarious,O
traumatization,O
"
",O
scores,O
for,O
frontline,O
nurses,O
including,O
scores,O
for,O
physiological,O
and,O
psychological,O
"
",O
responses,O
",",O
were,O
significantly,O
lower,O
than,O
those,O
of,O
nonfrontline,O
nurses,O
(,O
P,O
<,O
"
",O
0.001,O
),O
.,O
Interestingly,O
",",O
the,O
vicarious,O
traumatization,O
scores,O
of,O
the,O
general,O
public,O
"
",O
were,O
significantly,O
higher,O
than,O
those,O
of,O
the,O
frontline,O
nurses,O
(,O
P,O
<,O
0.001,O
),O
;,O
"
",O
however,O
",",O
no,O
statistical,O
difference,O
was,O
observed,O
compared,O
to,O
the,O
scores,O
of,O
"
",O
nonfrontline,O
nurses,O
(,O
P,O
>,O
0.05,O
),O
.,O
Therefore,O
",",O
increased,O
attention,O
should,O
be,O
paid,O
"
",O
to,O
the,O
psychological,O
problems,O
of,O
the,O
medical,O
staff,O
",",O
especially,O
nonfrontline,O
"
",O
nurses,O
",",O
and,O
general,O
public,O
under,O
the,O
situation,O
of,O
the,O
spread,O
and,O
control,O
of,O
"
",O
COVID19,B-Disease_COVID-19
.,O
Early,O
strategies,O
that,O
aim,O
to,O
prevent,O
and,O
treat,O
vicarious,O
traumatization,O
"
",O
in,O
medical,O
staff,O
and,O
general,O
public,O
are,O
extremely,O
necessary,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
Inc.,O
"

",O
DOI,O
:,O
10.1016,O
j.bbi.2020.03.007,O
"
",O
PMID,O
:,O
32169498,O
"


",O
34,O
.,O
J,O
Infect,O
.,O
2020,O
Mar,O
10,O
.,O
pii,O
:,O
S01634453(20)301079,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.026,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
Spikehost,O
cell,O
receptor,O
GRP78,O
binding,O
site,O
prediction,O
.,O
"

",O
Ibrahim,O
IM(1,O
),O
",",O
Abdelmalek,O
DH(1,O
),O
",",O
Elshahat,O
ME(1,O
),O
",",O
Elfiky,O
AA(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Biophysics,O
Department,O
",",O
Faculty,O
of,O
Sciences,O
",",O
Cairo,O
University,O
",",O
Giza,O
",",O
Egypt,O
.,O
"
",O
(2)Biophysics,O
Department,O
",",O
Faculty,O
of,O
Sciences,O
",",O
Cairo,O
University,O
",",O
Giza,O
",",O
Egypt,O
;,O
"
",O
College,O
of,O
Applied,O
Medical,O
Sciences,O
",",O
University,O
of,O
AlJouf,O
",",O
KSA,O
.,O
Electronic,O
"
",O
address,O
:,O
abdo@sci.cu.edu.eg,O
.,O
"

",O
OBJECTIVES,O
:,O
Understanding,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
mode,O
of,O
host,O
cell,O
"
",O
recognition,O
may,O
help,O
to,O
fight,O
the,O
disease,O
and,O
save,O
lives,O
.,O
The,O
spike,O
protein,O
of,O
"
",O
coronaviruses,O
is,O
the,O
main,O
driving,O
force,O
for,O
host,O
cell,O
recognition,O
.,O
"
",O
METHODS,O
:,O
In,O
this,O
study,O
",",O
the,O
COVID19,B-Disease_COVID-19
spike,O
binding,O
site,O
to,O
the,O
cellsurface,O
"
",O
receptor,O
(,O
Glucose,O
Regulated,O
Protein,O
78,O
(,O
GRP78,O
),O
),O
is,O
predicted,O
using,O
combined,O
"
",O
molecular,O
modeling,O
docking,O
and,O
structural,O
bioinformatics,O
.,O
The,O
COVID19,B-Disease_COVID-19
spike,O
"
",O
protein,O
is,O
modeled,O
using,O
its,O
counterpart,O
",",O
the,O
SARS,O
spike,O
.,O
"
",O
RESULTS,O
:,O
Sequence,O
and,O
structural,O
alignments,O
show,O
that,O
four,O
regions,O
",",O
in,O
addition,O
"
",O
to,O
its,O
cyclic,O
nature,O
have,O
sequence,O
and,O
physicochemical,O
similarities,O
to,O
the,O
cyclic,O
"
",O
Pep42,O
.,O
Proteinprotein,O
docking,O
was,O
performed,O
to,O
test,O
the,O
four,O
regions,O
of,O
the,O
"
",O
spike,O
that,O
fit,O
tightly,O
in,O
the,O
GRP78,O
Substrate,O
Binding,O
Domain,O
Î²,O
(,O
SBDÎ²,O
),O
.,O
The,O
"
",O
docking,O
pose,O
revealed,O
the,O
involvement,O
of,O
the,O
SBDÎ²,O
of,O
GRP78,O
and,O
the,O
"
",O
receptorbinding,O
domain,O
of,O
the,O
coronavirus,O
spike,O
protein,O
in,O
recognition,O
of,O
the,O
"
",O
host,O
cell,O
receptor,O
.,O
"
",O
CONCLUSIONS,O
:,O
We,O
reveal,O
that,O
the,O
binding,O
is,O
more,O
favorable,O
between,O
regions,O
III,O
"
",O
(,O
C391C525,O
),O
and,O
IV,O
(,O
C480C488,O
),O
of,O
the,O
spike,O
protein,O
model,O
and,O
GRP78,O
.,O
Region,O
IV,O
is,O
"
",O
the,O
main,O
driving,O
force,O
for,O
GRP78,O
binding,O
with,O
the,O
predicted,O
binding,O
affinity,O
of,O
"
",O
9.8,O
kcal,O
mol,O
.,O
These,O
nine,O
residues,O
can,O
be,O
used,O
to,O
develop,O
therapeutics,O
specific,O
"
",O
against,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
British,O
Infection,O
Association,O
.,O
Published,O
by,O
Elsevier,O
Ltd.,O
"
",O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.026,O
"
",O
PMID,O
:,O
32169481,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interests,O
All,O
of,O
the,O
"
",O
authors,O
declare,O
that,O
there,O
is,O
no,O
competing,O
interest,O
in,O
this,O
work,O
.,O
"


",O
35,O
.,O
Prog,O
Cardiovasc,O
Dis,O
.,O
2020,O
Mar,O
10,O
.,O
pii,O
:,O
S00330620(20)300554,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.pcad.2020.03.001,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Cardiac,O
troponin,O
I,O
in,O
patients,O
with,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
:,O
Evidence,O
"
",O
from,O
a,O
metaanalysis,O
.,O
"

",O
Lippi,O
G(1,O
),O
",",O
Lavie,O
CJ(2,O
),O
",",O
SanchisGomar,O
F(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Section,O
of,O
Clinical,O
Biochemistry,O
",",O
Department,O
of,O
Neuroscience,O
",",O
Biomedicine,O
and,O
"
",O
Movement,O
",",O
University,O
of,O
Verona,O
",",O
Verona,O
",",O
Italy,O
.,O
"
",O
(2)John,O
Ochsner,O
Heart,O
and,O
Vascular,O
Institute,O
",",O
Ochsner,O
Clinical,O
School,O
 ,O
The,O
"
",O
University,O
of,O
Queensland,O
School,O
of,O
Medicine,O
",",O
New,O
Orleans,O
",",O
LA,O
",",O
USA,O
.,O
"
",O
(3)Department,O
of,O
Physiology,O
",",O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Valencia,O
and,O
"
",O
INCLIVA,O
Biomedical,O
Research,O
Institute,O
",",O
Valencia,O
",",O
Spain,O
;,O
Division,O
of,O
"
",O
Cardiovascular,O
Medicine,O
",",O
Stanford,O
University,O
School,O
of,O
Medicine,O
",",O
Stanford,O
",",O
CA,O
",",O
"
",O
USA,O
.,O
Electronic,O
address,O
:,O
fabian.sanchis@uv.es,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.pcad.2020.03.001,O
"
",O
PMID,O
:,O
32169400,O
"


",O
36,O
.,O
J,O
Coll,O
Physicians,O
Surg,O
Pak,O
.,O
2020,O
Mar;30(3):268271,O
.,O
doi,O
:,O
"
",O
10.29271,O
jcpsp.2020.03.268,O
.,O
"

",O
Changes,O
and,O
Significance,O
of,O
Serum,O
sB7H3,O
and,O
Cytokines,O
in,O
Children,O
with,O
"
",O
Mycoplasma,O
pneumonae,O
Pneumonia,O
.,O
"

",O
Wu,O
P(1,O
),O
",",O
Wang,O
J(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Clinical,O
Laboratory,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Clinical,O
Laboratory,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
OBJECTIVE,O
:,O
To,O
explore,O
the,O
relationship,O
between,O
serum,O
sB7H3,O
and,O
cytokines,O
(,O
TNFÎ±,O
",",O
"
",O
IL1Î²,O
and,O
IL6,O
),O
and,O
to,O
evaluate,O
the,O
development,O
of,O
Mycoplasma,O
pneumonae,O
pneumonia,O
"
",O
(,O
MPP,O
),O
through,O
analysis,O
of,O
the,O
expression,O
levels,O
of,O
above,O
indices,O
in,O
serum,O
of,O
"
",O
children,O
with,O
MPP,O
.,O
"
",O
STUDY,O
DESIGN,O
:,O
An,O
experimental,O
study,O
.,O
"
",O
PLACE,O
AND,O
DURATION,O
OF,O
STUDY,O
:,O
Department,O
of,O
Clinical,O
Laboratory,O
",",O
Renmin,O
Hospital,O
"
",O
of,O
Wuhan,O
University,O
",",O
China,O
",",O
from,O
January,O
2018,O
to,O
August,O
2019,O
.,O
"
",O
METHODOLOGY,O
:,O
One,O
hundred,O
and,O
eight,O
children,O
with,O
MPP,O
were,O
divided,O
into,O
severe,O
MPP,O
"
",O
group,O
(,O
53,O
cases,O
),O
and,O
mild,O
MPP,O
group,O
(,O
55,O
cases,O
),O
according,O
to,O
children,O
's,O
condition,O
.,O
"
",O
Fifty,O
children,O
who,O
received,O
hernia,O
or,O
selective,O
operation,O
due,O
to,O
redundant,O
"
",O
prepuce,O
were,O
included,O
in,O
control,O
group,O
.,O
Serum,O
sB7H3,O
",",O
TNFÎ±,O
",",O
IL1Î²,O
and,O
IL6,O
were,O
"
",O
compared,O
.,O
"
",O
RESULTS,O
:,O
Serum,O
sB7H3,O
",",O
TNFÎ±,O
",",O
IL1Î²,O
",",O
and,O
IL6,O
levels,O
in,O
MPP,O
group,O
were,O
higher,O
"
",O
than,O
those,O
in,O
control,O
group,O
(,O
all,O
p<0.001,O
),O
;,O
above,O
indices,O
in,O
severe,O
MPP,O
group,O
were,O
"
",O
higher,O
than,O
those,O
in,O
mild,O
MPP,O
group,O
(,O
all,O
p<0.001,O
),O
.,O
Pearson,O
's,O
linear,O
correlation,O
"
",O
analysis,O
results,O
revealed,O
that,O
sB7H3,O
had,O
positive,O
correlation,O
with,O
TNFÎ±,O
",",O
IL1Î²,O
",",O
"
",O
and,O
IL6,O
in,O
MPP,O
group,O
(,O
r=0.986,O
",",O
p<0.001,O
;,O
r=0.987,O
",",O
p<0.001,O
;,O
and,O
r=0.991,O
",",O
p<0.001,O
",",O
"
",O
respectively,O
),O
.,O
"
",O
CONCLUSION,O
:,O
Detection,O
of,O
SB7H3,O
",",O
TNFÎ±,O
",",O
IL1Î²,O
and,O
IL6,O
levels,O
may,O
be,O
conducive,O
to,O
"
",O
early,O
diagnosis,O
of,O
MPP,O
and,O
the,O
judgement,O
of,O
the,O
severity,O
of,O
this,O
disease,O
.,O
"

",O
DOI,O
:,O
10.29271,O
jcpsp.2020.03.268,O
"
",O
PMID,O
:,O
32169134,O
"


",O
37,O
.,O
Mil,O
Med,O
Res,O
.,O
2020,O
Mar,O
13;7(1):11,O
.,O
doi,O
:,O
10.1186,O
s40779020002400,O
.,O
"

",O
The,O
origin,O
",",O
transmission,O
and,O
clinical,O
therapies,O
on,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
outbreak,O
 ,O
an,O
update,O
on,O
the,O
status,O
.,O
"

",O
Guo,O
YR(1,O
),O
",",O
Cao,O
QD(2,O
),O
",",O
Hong,O
ZS(3,O
),O
",",O
Tan,O
YY(1,O
),O
",",O
Chen,O
SD(1,O
),O
",",O
Jin,O
HJ(1,O
),O
",",O
Tan,O
KS(4,O
),O
",",O
"
",O
Wang,O
DY(5,O
),O
",",O
Yan,O
Y(6)(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
Biomedical,O
Imaging,O
and,O
Guangdong,O
"
",O
Provincial,O
Engineering,O
Research,O
Center,O
of,O
Molecular,O
Imaging,O
",",O
Zhuhai,O
",",O
519000,O
",",O
"
",O
Guangdong,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Cardiothoracic,O
Surgery,O
",",O
the,O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
"
",O
YatSen,O
University,O
",",O
Zhuhai,O
",",O
519000,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(3)Center,O
of,O
Infectious,O
Disease,O
",",O
the,O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
YatSen,O
"
",O
University,O
",",O
Zhuhai,O
",",O
519000,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Otolaryngology,O
",",O
Yong,O
Loo,O
Lin,O
School,O
of,O
Medicine,O
",",O
National,O
"
",O
University,O
of,O
Singapore,O
",",O
National,O
University,O
Health,O
System,O
",",O
Singapore,O
",",O
119228,O
",",O
"
",O
Singapore,O
.,O
"
",O
(5)Department,O
of,O
Otolaryngology,O
",",O
Yong,O
Loo,O
Lin,O
School,O
of,O
Medicine,O
",",O
National,O
"
",O
University,O
of,O
Singapore,O
",",O
National,O
University,O
Health,O
System,O
",",O
Singapore,O
",",O
119228,O
",",O
"
",O
Singapore,O
.,O
entwdy@nus.edu.sg,O
.,O
"
",O
(6)Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
Biomedical,O
Imaging,O
and,O
Guangdong,O
"
",O
Provincial,O
Engineering,O
Research,O
Center,O
of,O
Molecular,O
Imaging,O
",",O
Zhuhai,O
",",O
519000,O
",",O
"
",O
Guangdong,O
",",O
China,O
.,O
yanyan35@mail.sysu.edu.cn,O
.,O
"
",O
(7)Center,O
for,O
Interventional,O
Medicine,O
",",O
the,O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
YatSen,O
"
",O
University,O
",",O
Zhuhai,O
",",O
519000,O
",",O
Guangdong,O
",",O
China,O
.,O
yanyan35@mail.sysu.edu.cn,O
.,O
"

",O
An,O
acute,O
respiratory,O
disease,O
",",O
caused,O
by,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
"
",O
previously,O
known,O
as,O
2019nCoV,B-Virus_SARS-CoV-2
),O
",",O
the,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
has,O
"
",O
spread,O
throughout,O
China,O
and,O
received,O
worldwide,O
attention,O
.,O
On,O
30,O
January,O
2020,O
",",O
"
",O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
officially,O
declared,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
as,O
a,O
"
",O
public,O
health,O
emergency,O
of,O
international,O
concern,O
.,O
The,O
emergence,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
"
",O
since,O
the,O
severe,O
acute,O
respiratory,O
syndrome,O
coronavirus,O
(,O
SARSCoV,O
),O
in,O
2002,O
and,O
"
",O
Middle,O
East,O
respiratory,O
syndrome,O
coronavirus,O
(,O
MERSCoV,O
),O
in,O
2012,O
",",O
marked,O
the,O
third,O
"
",O
introduction,O
of,O
a,O
highly,O
pathogenic,O
and,O
largescale,O
epidemic,O
coronavirus,O
into,O
the,O
"
",O
human,O
population,O
in,O
the,O
twentyfirst,O
century,O
.,O
As,O
of,O
1,O
March,O
2020,O
",",O
a,O
total,O
of,O
"
",O
87137,O
confirmed,O
cases,O
globally,O
",",O
79968,O
confirmed,O
in,O
China,O
and,O
7169,O
outside,O
of,O
"
",O
China,O
",",O
with,O
2977,O
deaths,O
(,O
3.4,O
%,O
),O
had,O
been,O
reported,O
by,O
WHO,O
.,O
Meanwhile,O
",",O
several,O
"
",O
independent,O
research,O
groups,O
have,O
identified,O
that,O
SARSCoV2,B-Virus_SARS-CoV-2
belongs,O
to,O
"
",O
Î²coronavirus,O
",",O
with,O
highly,O
identical,O
genome,O
to,O
bat,O
coronavirus,O
",",O
pointing,O
to,O
bat,O
"
",O
as,O
the,O
natural,O
host,O
.,O
The,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
uses,O
the,O
same,O
receptor,O
",",O
"
",O
angiotensinconverting,O
enzyme,O
2,O
(,O
ACE2,O
),O
as,O
that,O
for,O
SARSCoV,O
",",O
and,O
mainly,O
spreads,O
"
",O
through,O
the,O
respiratory,O
tract,O
.,O
Importantly,O
",",O
increasingly,O
evidence,O
showed,O
"
",O
sustained,O
humantohuman,O
transmission,O
",",O
along,O
with,O
many,O
exported,O
cases,O
across,O
the,O
"
",O
globe,O
.,O
The,O
clinical,O
symptoms,O
of,O
COVID19,B-Disease_COVID-19
patients,O
include,O
fever,O
",",O
cough,O
",",O
fatigue,O
"
",O
and,O
a,O
small,O
population,O
of,O
patients,O
appeared,O
gastrointestinal,O
infection,O
symptoms,O
.,O
"
",O
The,O
elderly,O
and,O
people,O
with,O
underlying,O
diseases,O
are,O
susceptible,O
to,O
infection,O
and,O
"
",O
prone,O
to,O
serious,O
outcomes,O
",",O
which,O
may,O
be,O
associated,O
with,O
acute,O
respiratory,O
"
",O
distress,O
syndrome,O
(,O
ARDS,O
),O
and,O
cytokine,O
storm,O
.,O
Currently,O
",",O
there,O
are,O
few,O
specific,O
"
",O
antiviral,O
strategies,O
",",O
but,O
several,O
potent,O
candidates,O
of,O
antivirals,O
and,O
repurposed,O
"
",O
drugs,O
are,O
under,O
urgent,O
investigation,O
.,O
In,O
this,O
review,O
",",O
we,O
summarized,O
the,O
latest,O
"
",O
research,O
progress,O
of,O
the,O
epidemiology,O
",",O
pathogenesis,O
",",O
and,O
clinical,O
characteristics,O
"
",O
of,O
COVID19,B-Disease_COVID-19
",",O
and,O
discussed,O
the,O
current,O
treatment,O
and,O
scientific,O
advancements,O
to,O
"
",O
combat,O
the,O
epidemic,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
.,O
"

",O
DOI,O
:,O
10.1186,O
s40779020002400,O
"
",O
PMID,O
:,O
32169119,O
"


",O
38,O
.,O
Viruses,O
.,O
2020,O
Mar,O
11;12(3,O
),O
.,O
pii,O
:,O
E304,O
.,O
doi,O
:,O
10.339,O
v12030304,O
.,O
"

",O
Study,O
on,O
the,O
Antiviral,O
Activities,O
and,O
HemagglutininBased,O
Molecular,O
Mechanism,O
of,O
"
",O
Novel,O
Chlorogenin,O
3OÎ²Chacotrioside,O
Derivatives,O
Against,O
H5N1,O
Subtype,O
Viruses,O
.,O
"

",O
Shi,O
WZ(1,O
),O
",",O
Jiang,O
LZ(2,O
),O
",",O
Song,O
GP(1,O
),O
",",O
Wang,O
S(3,O
),O
",",O
Xiong,O
P(1,O
),O
",",O
Ke,O
CW(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pharmaceutical,O
Engineering,O
",",O
South,O
China,O
Agricultural,O
University,O
",",O
"
",O
Guangzhou,O
510640,O
",",O
China,O
.,O
"
",O
(2)Shenzhen,O
Key,O
Laboratory,O
of,O
Marine,O
Bioresource,O
and,O
Ecoenvironmental,O
Science,O
",",O
"
",O
College,O
of,O
Life,O
Sciences,O
and,O
Oceanography,O
",",O
Shenzhen,O
University,O
",",O
Shenzhen,O
518060,O
",",O
"
",O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Molecular,O
Biophysics,O
of,O
the,O
Ministry,O
of,O
Education,O
",",O
College,O
"
",O
of,O
Life,O
Science,O
and,O
Technology,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
430074,O
",",O
China,O
.,O
"
",O
(4)Guangdong,O
Provincial,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Guangzhou,O
"
",O
511430,O
",",O
China,O
.,O
"

",O
The,O
objective,O
of,O
this,O
study,O
was,O
to,O
investigate,O
the,O
inhibitory,O
effect,O
of,O
"
",O
chlorogenin,O
3OÎ²chacotrioside,O
derivatives,O
against,O
H5N1,O
subtype,O
of,O
the,O
highly,O
"
",O
pathogenic,O
avian,O
influenza,O
(,O
HPAI,O
),O
viruses,O
and,O
its,O
molecular,O
mechanism,O
.,O
A,O
series,O
"
",O
of,O
novel,O
small,O
molecule,O
pentacyclic,O
triterpene,O
derivatives,O
were,O
designed,O
and,O
"
",O
synthesized,O
and,O
their,O
antiviral,O
activities,O
on,O
HPAI,O
H5N1,O
viruses,O
were,O
detected,O
.,O
"
",O
The,O
results,O
displayed,O
that,O
the,O
derivatives,O
UANuph5,O
",",O
XC271,O
and,O
XC272,O
"
",O
strongly,O
inhibited,O
wildtype,O
A,O
Duck,O
Guangdong,O
212,O
2004,O
H5N1,O
viruses,O
with,O
the,O
IC50,O
"
",O
values,O
of,O
15.59,O
Â±,O
2.4,O
Î¼M,O
",",O
16.83,O
Â±,O
1.45,O
Î¼M,O
",",O
and,O
12.45,O
Â±,O
2.27,O
Î¼M,O
",",O
respectively,O
",",O
and,O
"
",O
had,O
the,O
selectivity,O
index,O
(,O
SI,O
),O
>,O
3,O
",",O
which,O
was,O
consistent,O
with,O
the,O
efficacy,O
"
",O
against,O
A,O
Thailand,O
kan353,O
2004,O
pseudotyped,O
viruses,O
.,O
Four,O
dealt,O
patterns,O
were,O
"
",O
compared,O
via,O
PRNT,O
.,O
The,O
prevention,O
dealt,O
pattern,O
showed,O
the,O
strongest,O
inhibitory,O
"
",O
effects,O
than,O
other,O
patterns,O
",",O
suggesting,O
that,O
these,O
derivatives,O
act,O
on,O
the,O
entry,O
"
",O
process,O
at,O
the,O
early,O
stages,O
of,O
H5N1,O
viral,O
infection,O
",",O
providing,O
protection,O
for,O
"
",O
cells,O
against,O
infection,O
.,O
Further,O
studies,O
through,O
hemagglutinin,O
inhibition,O
(,O
HI,O
),O
"
",O
and,O
neuraminidase,O
inhibitory,O
(,O
NAI,O
),O
assay,O
confirmed,O
that,O
these,O
derivatives,O
"
",O
inhibited,O
H5N1,O
virus,O
replication,O
by,O
interfering,O
with,O
the,O
viral,O
hemagglutinin,O
"
",O
function,O
.,O
The,O
derivatives,O
could,O
recognize,O
specifically,O
HA,O
protein,O
with,O
binding,O
"
",O
affinity,O
constant,O
KD,O
values,O
of,O
2.57,O
Ã—,O
104,O
M,O
and,O
3.67,O
Ã—,O
104,O
M.,O
In,O
addition,O
",",O
"
",O
through,O
sitedirected,O
mutagenesis,O
combined,O
with,O
a,O
pseudovirion,O
system,O
",",O
we,O
"
",O
identified,O
that,O
the,O
highaffinity,O
docking,O
sites,O
underlying,O
interaction,O
were,O
"
",O
closely,O
associated,O
with,O
amino,O
acid,O
residues,O
I391,O
and,O
T395,O
of,O
HA,O
.,O
However,O
",",O
the,O
"
",O
potential,O
binding,O
sites,O
of,O
the,O
derivatives,O
with,O
HA,O
did,O
not,O
locate,O
at,O
HA1,O
sialic,O
"
",O
acids,O
receptor,O
binding,O
domain,O
(,O
RBD,O
),O
.,O
Taken,O
together,O
",",O
these,O
study,O
data,O
manifested,O
"
",O
that,O
chlorogenin,O
3OÎ²chacotrioside,O
derivatives,O
generated,O
antiviral,O
effect,O
"
",O
against,O
HPAI,O
H5N1,O
viruses,O
by,O
targeting,O
the,O
hemagglutinin,O
fusion,O
machinery,O
.,O
"

",O
DOI,O
:,O
10.339,O
v12030304,O
"
",O
PMID,O
:,O
32168921,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
The,O
"
",O
funders,O
had,O
no,O
role,O
in,O
the,O
design,O
of,O
the,O
study,O
;,O
in,O
the,O
collection,O
",",O
analyses,O
",",O
or,O
"
",O
interpretation,O
of,O
data,O
;,O
in,O
the,O
writing,O
of,O
the,O
manuscript,O
",",O
or,O
in,O
the,O
decision,O
to,O
"
",O
publish,O
the,O
results,O
.,O
"


",O
39,O
.,O
Viruses,O
.,O
2020,O
Mar,O
11;12(3,O
),O
.,O
pii,O
:,O
E301,O
.,O
doi,O
:,O
10.339,O
v12030301,O
.,O
"

",O
UserFriendly,O
Reverse,O
Genetics,O
System,O
for,O
Modification,O
of,O
the,O
Right,O
End,O
of,O
Fowl,O
"
",O
Adenovirus,O
4,O
Genome,O
.,O
"

",O
Yan,O
B(1)(2,O
),O
",",O
Zou,O
X(2,O
),O
",",O
Liu,O
X(1)(2,O
),O
",",O
Zhao,O
J(2)(3,O
),O
",",O
Zhang,O
W(2)(3,O
),O
",",O
Guo,O
X(2,O
),O
",",O
Wang,O
"
",O
M(2,O
),O
",",O
Lv,O
Y(1,O
),O
",",O
Lu,O
Z(2)(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)College,O
of,O
Marine,O
Science,O
and,O
Biological,O
Engineering,O
",",O
Qingdao,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
Qingdao,O
266042,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Infectious,O
Disease,O
Prevention,O
and,O
Control,O
",",O
National,O
"
",O
Institute,O
for,O
Viral,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Chinese,O
Center,O
for,O
Disease,O
"
",O
Control,O
and,O
Prevention,O
",",O
Beijing,O
100052,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Laboratory,O
Medicine,O
",",O
School,O
of,O
Public,O
Health,O
and,O
Management,O
",",O
"
",O
Weifang,O
Medical,O
University,O
",",O
Weifang,O
261053,O
",",O
China,O
.,O
"
",O
(4)Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430071,O
",",O
"
",O
China,O
.,O
"
",O
(5)Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Joint,O
Research,O
Center,O
for,O
Emerging,O
Infectious,O
Diseases,O
and,O
Biosafety,O
",",O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430071,O
",",O
China,O
.,O
"

",O
A,O
novel,O
fowl,O
adenovirus,O
4,O
(,O
FAdV4,O
),O
has,O
caused,O
significant,O
economic,O
losses,O
to,O
the,O
"
",O
poultry,O
industry,O
in,O
China,O
since,O
2015,O
.,O
We,O
established,O
an,O
easytouse,O
reverse,O
"
",O
genetics,O
system,O
for,O
modification,O
of,O
the,O
whole,O
right,O
and,O
partial,O
left,O
ends,O
of,O
the,O
"
",O
novel,O
FAdV4,O
genome,O
",",O
which,O
worked,O
through,O
cellfree,O
reactions,O
of,O
restriction,O
"
",O
digestion,O
and,O
Gibson,O
assembly,O
.,O
Three,O
recombinant,O
viruses,O
were,O
constructed,O
to,O
test,O
"
",O
the,O
assumption,O
that,O
speciesspecific,O
viral,O
genes,O
of,O
ORF4,O
and,O
ORF19A,O
might,O
be,O
"
",O
responsible,O
for,O
the,O
enhanced,O
virulence,O
:,O
viral,O
genes,O
of,O
ORF1,O
",",O
ORF1b,O
and,O
ORF2,O
were,O
"
",O
replaced,O
with,O
GFP,O
to,O
generate,O
FAdV4GFP,O
",",O
ORF4,O
was,O
replaced,O
with,O
mCherry,O
in,O
"
",O
FAdV4GFP,O
to,O
generate,O
FAdV4GX4C,O
",",O
and,O
ORF19A,O
was,O
deleted,O
in,O
FAdV4GFP,O
to,O
generate,O
"
",O
FAdV4CX19A,O
.,O
Deletion,O
of,O
ORF4,O
made,O
FAdV4GX4C,O
form,O
smaller,O
plaques,O
while,O
ORF19A,O
"
",O
deletion,O
made,O
FAdV4CX19A,O
form,O
larger,O
ones,O
on,O
chicken,O
LMH,O
cells,O
.,O
Coding,O
sequence,O
"
",O
(,O
CDS,O
),O
replacement,O
with,O
reporter,O
mCherry,O
demonstrated,O
that,O
ORF4,O
had,O
a,O
weak,O
"
",O
promoter,O
.,O
Survival,O
analysis,O
showed,O
that,O
FAdV4CX19Ainfected,O
chicken,O
embryos,O
"
",O
survived,O
one,O
more,O
day,O
than,O
FAdV4GFP,O
or,O
FAdV4GX4Cinfected,O
ones,O
.,O
The,O
results,O
"
",O
illustrated,O
that,O
ORF4,O
and,O
ORF19A,O
were,O
nonessential,O
genes,O
for,O
FAdV4,O
replication,O
"
",O
although,O
deletion,O
of,O
either,O
gene,O
influenced,O
virus,O
growth,O
.,O
This,O
work,O
would,O
help,O
"
",O
function,O
study,O
of,O
genes,O
on,O
the,O
right,O
end,O
of,O
FAdV4,O
genome,O
and,O
facilitate,O
"
",O
development,O
of,O
attenuated,O
vaccines,O
.,O
"

",O
DOI,O
:,O
10.339,O
v12030301,O
"
",O
PMID,O
:,O
32168853,O
"


",O
40,O
.,O
Emerg,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
13;26(6,O
),O
.,O
doi,O
:,O
10.3201,O
eid2606.200251,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Epidemiology,O
of,O
2019,O
Novel,O
Coronavirus,B-Disease_COVID-19
Disease19,I-Disease_COVID-19
in,O
Gansu,O
Province,O
",",O
China,O
",",O
2020,O
.,O
"

",O
Fan,O
J,O
",",O
Liu,O
X,O
",",O
Pan,O
W,O
",",O
Douglas,O
MW,O
",",O
Bao,O
S.,O
"

",O
To,O
determine,O
the,O
epidemiology,O
of,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
in,O
a,O
"
",O
remote,O
region,O
of,O
China,O
",",O
far,O
from,O
Wuhan,O
",",O
we,O
analyzed,O
the,O
epidemiology,O
of,O
COVID19,B-Disease_COVID-19
"
",O
in,O
Gansu,O
Province,O
.,O
From,O
January,O
23,O
through,O
February,O
3,O
",",O
2020,O
",",O
a,O
total,O
of,O
35,O
"
",O
(,O
64.8,O
%,O
),O
of,O
54,O
reported,O
cases,O
were,O
imported,O
from,O
COVID19epidemic,O
areas,O
.,O
"
",O
Characteristics,O
that,O
differed,O
significantly,O
during,O
the,O
first,O
and,O
second,O
waves,O
of,O
"
",O
illness,O
in,O
Gansu,O
Province,O
were,O
mean,O
patient,O
age,O
",",O
occupation,O
",",O
having,O
visited,O
"
",O
epidemic,O
areas,O
",",O
and,O
mode,O
of,O
transportation,O
.,O
Time,O
from,O
infection,O
to,O
illness,O
onset,O
"
",O
for,O
family,O
clusters,O
was,O
shorter,O
in,O
Gansu,O
Province,O
than,O
in,O
Wuhan,O
",",O
consistent,O
with,O
"
",O
shortened,O
durations,O
from,O
onset,O
to,O
first,O
medical,O
visit,O
or,O
hospitalization,O
.,O
Spatial,O
"
",O
distribution,O
pattern,O
analysis,O
indicated,O
hot,O
spots,O
and,O
spatial,O
outliers,O
in,O
Gansu,O
"
",O
Province,O
.,O
As,O
a,O
result,O
of,O
adequate,O
interventions,O
",",O
transmission,O
of,O
the,O
COVID19,B-Disease_COVID-19
"
",O
virus,O
in,O
Gansu,O
Province,O
is,O
decreasing,O
.,O
"

",O
DOI,O
:,O
10.3201,O
eid2606.200251,O
"
",O
PMID,O
:,O
32168465,O
"


",O
41,O
.,O
Emerg,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
13;26(6,O
),O
.,O
doi,O
:,O
10.3201,O
eid2606.200233,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Estimating,O
Risk,O
for,O
Death,O
from,O
2019,B-Disease_COVID-19
Novel,I-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
",",O
China,O
",",O
"
",O
JanuaryFebruary,O
2020,O
.,O
"

",O
Mizumoto,O
K,O
",",O
Chowell,O
G.,O
"

",O
Since,O
December,O
2019,O
",",O
when,O
the,O
first,O
case,O
of,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
was,O
identified,O
in,O
the,O
city,O
of,O
Wuhan,O
in,O
the,O
Hubei,O
Province,O
of,O
China,O
",",O
"
",O
the,O
epidemic,O
has,O
generated,O
tens,O
of,O
thousands,O
of,O
cases,O
throughout,O
China,O
.,O
As,O
of,O
"
",O
February,O
28,O
",",O
2020,O
",",O
the,O
cumulative,O
number,O
of,O
reported,O
deaths,O
in,O
China,O
was,O
2858,O
.,O
"
",O
We,O
estimated,O
the,O
timedelay,O
adjusted,O
risk,O
for,O
death,O
from,O
COVID19,B-Disease_COVID-19
in,O
Wuhan,O
",",O
as,O
"
",O
well,O
as,O
for,O
China,O
excluding,O
Wuhan,O
",",O
to,O
assess,O
the,O
severity,O
of,O
the,O
epidemic,O
in,O
the,O
"
",O
country,O
.,O
Our,O
estimates,O
of,O
the,O
risk,O
for,O
death,O
in,O
Wuhan,O
reached,O
values,O
as,O
high,O
as,O
"
",O
12,O
%,O
in,O
the,O
epicenter,O
of,O
the,O
epidemic,O
and,O
â‰ˆ1,O
%,O
in,O
other,O
",",O
more,O
mildly,O
affected,O
"
",O
areas,O
.,O
The,O
elevated,O
death,O
risk,O
estimates,O
are,O
probably,O
associated,O
with,O
a,O
breakdown,O
"
",O
of,O
the,O
healthcare,O
system,O
",",O
indicating,O
that,O
enhanced,O
public,O
health,O
interventions,O
",",O
"
",O
including,O
social,O
distancing,O
and,O
movement,O
restrictions,O
",",O
should,O
be,O
implemented,O
to,O
"
",O
bring,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
under,O
control,O
.,O
"

",O
DOI,O
:,O
10.3201,O
eid2606.200233,O
"
",O
PMID,O
:,O
32168464,O
"


",O
42,O
.,O
Emerg,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
13;26(6,O
),O
.,O
doi,O
:,O
10.3201,O
eid2606.200320,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
CaseFatality,O
Risk,O
Estimates,O
for,O
COVID19,B-Disease_COVID-19
Calculated,O
by,O
Using,O
a,O
Lag,O
Time,O
for,O
"
",O
Fatality,O
.,O
"

",O
Wilson,O
N,O
",",O
Kvalsvig,O
A,O
",",O
Barnard,O
LT,O
",",O
Baker,O
MG,O
.,O
"

",O
We,O
estimated,O
the,O
casefatality,O
risk,O
for,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
cases,O
in,O
"
",O
China,O
(,O
3.5,O
%,O
),O
;,O
China,O
",",O
excluding,O
Hubei,O
Province,O
(,O
0.8,O
%,O
),O
;,O
82,O
countries,O
",",O
territories,O
",",O
"
",O
and,O
areas,O
(,O
4.2,O
%,O
),O
;,O
and,O
on,O
a,O
cruise,O
ship,O
(,O
0.6,O
%,O
),O
.,O
Lower,O
estimates,O
might,O
be,O
closest,O
"
",O
to,O
the,O
TRUE,O
value,O
",",O
but,O
a,O
broad,O
range,O
of,O
0.25%3.0,O
%,O
probably,O
should,O
be,O
considered,O
.,O
"

",O
DOI,O
:,O
10.3201,O
eid2606.200320,O
"
",O
PMID,O
:,O
32168463,O
"


",O
43,O
.,O
J,O
Thorac,O
Imaging,O
.,O
2020,O
Mar,O
12,O
.,O
doi,O
:,O
10.1097,O
RTI.0000000000000506,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
A,O
Diabetic,O
Patient,O
With,O
2019nCoV,B-Disease_COVID-19
Infection,I-Disease_COVID-19
Who,O
Recovered,O
and,O
Was,O
Discharged,O
From,O
"
",O
Hospital,O
.,O
"

",O
Han,O
X(1)(2,O
),O
",",O
Fan,O
Y(3,O
),O
",",O
Wan,O
YL(4,O
),O
",",O
Shi,O
H(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
.,O
"
",O
(2)Hubei,O
Province,O
Key,O
Laboratory,O
of,O
Molecular,O
Imaging,O
.,O
"
",O
(3)Department,O
of,O
Radiology,O
",",O
Wuhan,O
Jinyintan,O
Hospital,O
",",O
Wuhan,O
City,O
",",O
Hubei,O
Province,O
",",O
"
",O
The,O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(4)Department,O
of,O
Medical,O
Imaging,O
and,O
Intervention,O
",",O
Linkou,O
Chang,O
Gung,O
Memorial,O
"
",O
Hospital,O
",",O
College,O
of,O
Medicine,O
",",O
Chang,O
Gung,O
University,O
",",O
Taoyuan,O
City,O
",",O
Taiwan,O
.,O
"

",O
Novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
has,O
become,O
a,O
global,O
health,O
hazard,O
and,O
its,O
high,O
infectivity,O
is,O
"
",O
alarming,O
.,O
The,O
imaging,O
findings,O
of,O
the,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
in,O
our,O
young,O
diabetic,O
"
",O
patient,O
featured,O
groundglass,O
opacities,O
and,O
consolidations,O
in,O
both,O
lungs,O
.,O
The,O
"
",O
lung,O
lesions,O
may,O
involute,O
rapidly,O
during,O
the,O
course,O
.,O
The,O
patient,O
showed,O
"
",O
improvement,O
both,O
clinically,O
and,O
on,O
computed,O
tomography,O
imaging,O
at,O
discharged,O
"
",O
after,O
2,O
weeks'treatment,O
.,O
Computed,O
tomography,O
scans,O
of,O
patients,O
helped,O
monitor,O
the,O
"
",O
changes,O
continuously,O
",",O
which,O
could,O
timely,O
provide,O
the,O
information,O
of,O
the,O
evolution,O
"
",O
of,O
the,O
disease,O
or,O
therapeutic,O
effect,O
to,O
clinicians,O
.,O
"

",O
DOI,O
:,O
10.1097,O
RTI.0000000000000506,O
"
",O
PMID,O
:,O
32168162,O
"


",O
44,O
.,O
Radiology,O
.,O
2020,O
Mar,O
13:200847,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200847,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Can,O
Lung,O
US,O
Help,O
Critical,O
Care,O
Clinicians,O
in,O
the,O
Early,O
Diagnosis,O
of,O
Novel,O
"
",O
Coronavirus,O
(,O
COVID19,B-Disease_COVID-19
),O
Pneumonia,O
?,O
"

",O
Poggiali,O
E(1,O
),O
",",O
Dacrema,O
A(1,O
),O
",",O
Bastoni,O
D(1,O
),O
",",O
Tinelli,O
V(1,O
),O
",",O
Demichele,O
E(1,O
),O
",",O
Mateo,O
"
",O
Ramos,O
P(1,O
),O
",",O
MarcianÃ²,O
T(1,O
),O
",",O
Silva,O
M(1,O
),O
",",O
Vercelli,O
A(1,O
),O
",",O
Magnacavallo,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Emergency,O
Medicine,O
",",O
Ospedale,O
Guglielmo,O
da,O
Saliceto,O
",",O
via,O
Taverna,O
"
",O
49,O
",",O
Piacenza,O
29121,O
",",O
Italy,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200847,O
"
",O
PMID,O
:,O
32167853,O
"


",O
45,O
.,O
Br,O
J,O
Nurs,O
.,O
2020,O
Mar,O
12;29(5):326327,O
.,O
doi,O
:,O
10.12968,O
bjon.2020.29.5.326,O
.,O
"

",O
Using,O
public,O
health,O
law,O
to,O
contain,O
the,O
spread,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Griffith,O
R(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Senior,O
Lecturer,O
in,O
Health,O
Law,O
at,O
Swansea,O
University,O
.,O
"

",O
Richard,O
Griffith,O
",",O
Senior,O
Lecturer,O
in,O
Health,O
Law,O
at,O
Swansea,O
University,O
",",O
considers,O
"
",O
what,O
powers,O
are,O
available,O
to,O
ministers,O
",",O
health,O
and,O
local,O
authorities,O
to,O
minimise,O
"
",O
the,O
spread,O
of,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
and,O
the,O
disease,O
it,O
causes,O
.,O
"

",O
DOI,O
:,O
10.12968,O
bjon.2020.29.5.326,O
"
",O
PMID,O
:,O
32167816,O
"


",O
46,O
.,O
ACS,O
Chem,O
Neurosci,O
.,O
2020,O
Mar,O
13,O
.,O
doi,O
:,O
10.1021,O
acschemneuro.0c00122,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Evidence,O
of,O
the,O
COVID19,B-Virus_SARS-CoV-2
Virus,I-Virus_SARS-CoV-2
Targeting,O
the,O
CNS,O
:,O
Tissue,O
Distribution,O
",",O
HostVirus,O
"
",O
Interaction,O
",",O
and,O
Proposed,O
Neurotropic,O
Mechanisms,O
.,O
"

",O
Baig,O
AM(1,O
),O
",",O
Khaleeq,O
A(1,O
),O
",",O
Ali,O
U(2,O
),O
",",O
Syeda,O
H(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Biological,O
and,O
Biomedical,O
Sciences,O
",",O
Aga,O
Khan,O
University,O
",",O
Karachi,O
"
",O
74800,O
",",O
Pakistan,O
.,O
"
",O
(2)Medical,O
College,O
",",O
Aga,O
Khan,O
University,O
",",O
Karachi,O
74800,O
",",O
Pakistan,O
.,O
"
",O
(3)Department,O
of,O
Biosciences,O
",",O
Mohammad,O
Ali,O
Jinnah,O
University,O
",",O
Karachi,O
75400,O
",",O
"
",O
Pakistan,O
.,O
"

",O
The,O
recent,O
outbreak,O
of,O
coronavirus,O
infectious,O
disease,O
2019,O
(,O
COVID19,B-Disease_COVID-19
),O
has,O
gripped,O
"
",O
the,O
world,O
with,O
apprehension,O
and,O
has,O
evoked,O
a,O
scare,O
of,O
epic,O
proportion,O
regarding,O
"
",O
its,O
potential,O
to,O
spread,O
and,O
infect,O
humans,O
worldwide,O
.,O
As,O
we,O
are,O
in,O
the,O
midst,O
of,O
an,O
"
",O
ongoing,O
pandemic,O
of,O
COVID19,B-Disease_COVID-19
",",O
scientists,O
are,O
struggling,O
to,O
understand,O
how,O
it,O
"
",O
resembles,O
and,O
differs,O
from,O
the,O
severe,O
acute,O
respiratory,O
syndrome,O
coronavirus,O
"
",O
(,O
SARSCoV,O
),O
at,O
the,O
genomic,O
and,O
transcriptomic,O
level,O
.,O
In,O
a,O
short,O
time,O
following,O
the,O
"
",O
outbreak,O
",",O
it,O
has,O
been,O
shown,O
that,O
",",O
similar,O
to,O
SARSCoV,O
",",O
COVID19,B-Virus_SARS-CoV-2
virus,I-Virus_SARS-CoV-2
exploits,O
"
",O
the,O
angiotensinconverting,O
enzyme,O
2,O
(,O
ACE2,O
),O
receptor,O
to,O
gain,O
entry,O
inside,O
the,O
"
",O
cells,O
.,O
This,O
finding,O
raises,O
the,O
curiosity,O
of,O
investigating,O
the,O
expression,O
of,O
ACE2,O
"
",O
in,O
neurological,O
tissue,O
and,O
determining,O
the,O
possible,O
contribution,O
of,O
neurological,O
"
",O
tissue,O
damage,O
to,O
the,O
morbidity,O
and,O
mortality,O
caused,O
by,O
COIVD19,O
.,O
Here,O
",",O
we,O
"
",O
investigate,O
the,O
density,O
of,O
the,O
expression,O
levels,O
of,O
ACE2,O
in,O
the,O
CNS,O
",",O
the,O
"
",O
hostvirus,O
interaction,O
and,O
relate,O
it,O
to,O
the,O
pathogenesis,O
and,O
complications,O
seen,O
"
",O
in,O
the,O
recent,O
cases,O
resulting,O
from,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
.,O
Also,O
",",O
we,O
debate,O
the,O
"
",O
need,O
for,O
a,O
model,O
for,O
staging,O
COVID19,B-Disease_COVID-19
based,O
on,O
neurological,O
tissue,O
involvement,O
.,O
"

",O
DOI,O
:,O
10.1021,O
acschemneuro.0c00122,O
"
",O
PMID,O
:,O
32167747,O
"


",O
47,O
.,O
JAMA,O
.,O
2020,O
Mar,O
13,O
.,O
doi,O
:,O
10.1001,O
jama.2020.4031,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Critical,O
Care,O
Utilization,O
for,O
the,O
COVID19,B-Disease_COVID-19
Outbreak,O
in,O
Lombardy,O
",",O
Italy,O
:,O
Early,O
"
",O
Experience,O
and,O
Forecast,O
During,O
an,O
Emergency,O
Response,O
.,O
"

",O
Grasselli,O
G(1)(2,O
),O
",",O
Pesenti,O
A(1)(2,O
),O
",",O
Cecconi,O
M(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pathophysiology,O
and,O
Transplantation,O
",",O
University,O
of,O
Milan,O
",",O
Italy,O
.,O
"
",O
(2)Dipartimento,O
di,O
Anestesia,O
",",O
Rianimazione,O
ed,O
EmergenzaUrgenza,O
",",O
Fondazione,O
IRCCS,O
"
",O
Ca,O
',O
Granda,O
Ospedale,O
Maggiore,O
Policlinico,O
",",O
Milan,O
",",O
Italy,O
.,O
"
",O
(3)Dipartimento,O
Anestesia,O
e,O
Terapie,O
Intensive,O
",",O
Humanitas,O
Rozzano,O
",",O
Milan,O
",",O
Italy,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.4031,O
"
",O
PMID,O
:,O
32167538,O
"


",O
48,O
.,O
JAMA,O
Pediatr,O
.,O
2020,O
Mar,O
13,O
.,O
doi,O
:,O
10.1001,O
jamapediatrics.2020.0828,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
What,O
Does,O
the,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
Mean,O
for,O
Families,O
?,O
"

",O
Thompson,O
LA(1)(2,O
),O
",",O
Rasmussen,O
SA(1)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pediatrics,O
",",O
University,O
of,O
Florida,O
College,O
of,O
Medicine,O
",",O
"
",O
Gainesville,O
.,O
"
",O
(2)Department,O
of,O
Health,O
Outcomes,O
and,O
Biomedical,O
Informatics,O
",",O
University,O
of,O
"
",O
Florida,O
College,O
of,O
Medicine,O
",",O
Gainesville,O
.,O
"
",O
(3)Department,O
of,O
Epidemiology,O
",",O
University,O
of,O
Florida,O
College,O
of,O
Public,O
Health,O
and,O
"
",O
Health,O
Professions,O
and,O
College,O
of,O
Medicine,O
",",O
Gainesville,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jamapediatrics.2020.0828,O
"
",O
PMID,O
:,O
32167533,O
"


",O
49,O
.,O
JAMA,O
.,O
2020,O
Mar,O
13,O
.,O
doi,O
:,O
10.1001,O
jama.2020.3882,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
From,O
Containment,O
to,O
Mitigation,O
of,O
COVID19,B-Disease_COVID-19
in,O
the,O
US,O
.,O
"

",O
Parodi,O
SM(1)(2,O
),O
",",O
Liu,O
VX(1)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Permanente,O
Medical,O
Group,O
",",O
Kaiser,O
Permanente,O
",",O
Oakland,O
",",O
California,O
.,O
"
",O
(2)The,O
Permanente,O
Federation,O
",",O
Oakland,O
",",O
California,O
.,O
"
",O
(3)Kaiser,O
Permanente,O
Division,O
of,O
Research,O
",",O
Oakland,O
",",O
California,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.3882,O
"
",O
PMID,O
:,O
32167525,O
"


",O
50,O
.,O
JAMA,O
Intern,O
Med,O
.,O
2020,O
Mar,O
13,O
.,O
doi,O
:,O
10.1001,O
jamainternmed.2020.0994,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Risk,O
Factors,O
Associated,O
With,O
Acute,O
Respiratory,O
Distress,O
Syndrome,O
and,O
Death,O
in,O
"
",O
Patients,O
With,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
Pneumonia,O
in,O
Wuhan,O
",",O
China,O
.,O
"

",O
Wu,O
C(1)(2)(3,O
),O
",",O
Chen,O
X(3,O
),O
",",O
Cai,O
Y(2,O
),O
",",O
Xia,O
J(4,O
),O
",",O
Zhou,O
X(2,O
),O
",",O
Xu,O
S(2,O
),O
",",O
Huang,O
H(4,O
),O
",",O
"
",O
Zhang,O
L(4,O
),O
",",O
Zhou,O
X(4,O
),O
",",O
Du,O
C(1,O
),O
",",O
Zhang,O
Y(3,O
),O
",",O
Song,O
J(3,O
),O
",",O
Wang,O
S(3,O
),O
",",O
Chao,O
Y(3,O
),O
",",O
Yang,O
"
",O
Z(5,O
),O
",",O
Xu,O
J(6,O
),O
",",O
Zhou,O
X(7,O
),O
",",O
Chen,O
D(8,O
),O
",",O
Xiong,O
W(9,O
),O
",",O
Xu,O
L(10,O
),O
",",O
Zhou,O
F(1,O
),O
",",O
Jiang,O
J(3,O
),O
",",O
"
",O
Bai,O
C(3)(11,O
),O
",",O
Zheng,O
J(12,O
),O
",",O
Song,O
Y(1)(3)(11)(13,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pulmonary,O
Medicine,O
",",O
QingPu,O
Branch,O
of,O
Zhongshan,O
Hospital,O
"
",O
Affiliated,O
to,O
Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Infection,O
Division,O
",",O
Wuhan,O
Jinyintan,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Zhongshan,O
Hospital,O
",",O
Fudan,O
"
",O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(4)Tuberculosis,O
and,O
Respiratory,O
Department,O
",",O
Wuhan,O
Jinyintan,O
Hospital,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(5)Department,O
of,O
Anesthesiology,O
",",O
International,O
Peace,O
Maternity,O
and,O
Child,O
Health,O
"
",O
Hospital,O
",",O
Shanghai,O
Jiao,O
Tong,O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Infectious,O
Diseases,O
",",O
Fengxian,O
Guhua,O
Hospital,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Pulmonary,O
Medicine,O
",",O
Shanghai,O
General,O
Hospital,O
",",O
Shanghai,O
Jiao,O
"
",O
Tong,O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(8)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Ruijin,O
Hospital,O
",",O
Shanghai,O
Jiao,O
Tong,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(9)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Shanghai,O
Ninth,O
People,O
's,O
Hospital,O
",",O
Shanghai,O
"
",O
Jiao,O
Tong,O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(10)Department,O
of,O
Emergency,O
Medicine,O
",",O
Shanghai,O
Pudong,O
New,O
Area,O
Gongli,O
Hospital,O
",",O
"
",O
Shanghai,O
",",O
China,O
.,O
"
",O
(11)Shanghai,O
Respiratory,O
Research,O
Institute,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(12)Department,O
of,O
Urology,O
",",O
Shanghai,O
General,O
Hospital,O
",",O
Shanghai,O
Jiao,O
Tong,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(13)National,O
Clinical,O
Research,O
Center,O
for,O
Aging,O
and,O
Medicine,O
",",O
Huashan,O
Hospital,O
",",O
"
",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"

",O
Importance,O
:,O
Coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
is,O
an,O
emerging,O
infectious,O
disease,O
"
",O
that,O
was,O
first,O
reported,O
in,O
Wuhan,O
",",O
China,O
",",O
and,O
has,O
subsequently,O
spread,O
worldwide,O
.,O
"
",O
Risk,O
factors,O
for,O
the,O
clinical,O
outcomes,O
of,O
COVID19,B-Disease_COVID-19
pneumonia,O
have,O
not,O
yet,O
been,O
"
",O
well,O
delineated,O
.,O
"
",O
Objective,O
:,O
To,O
describe,O
the,O
clinical,O
characteristics,O
and,O
outcomes,O
in,O
patients,O
with,O
"
",O
COVID19,B-Disease_COVID-19
pneumonia,O
who,O
developed,O
acute,O
respiratory,O
distress,O
syndrome,O
(,O
ARDS,O
),O
or,O
"
",O
died,O
.,O
"
",O
Design,O
",",O
Setting,O
",",O
and,O
Participants,O
:,O
Retrospective,O
cohort,O
study,O
of,O
201,O
patients,O
"
",O
with,O
confirmed,O
COVID19,B-Disease_COVID-19
pneumonia,O
admitted,O
to,O
Wuhan,O
Jinyintan,O
Hospital,O
in,O
China,O
"
",O
between,O
December,O
25,O
",",O
2019,O
",",O
and,O
January,O
26,O
",",O
2020,O
.,O
The,O
final,O
date,O
of,O
followup,O
was,O
"
",O
February,O
13,O
",",O
2020,O
.,O
"
",O
Exposures,O
:,O
Confirmed,O
COVID19,B-Disease_COVID-19
pneumonia,O
.,O
"
",O
Main,O
Outcomes,O
and,O
Measures,O
:,O
The,O
development,O
of,O
ARDS,O
and,O
death,O
.,O
Epidemiological,O
",",O
"
",O
demographic,O
",",O
clinical,O
",",O
laboratory,O
",",O
management,O
",",O
treatment,O
",",O
and,O
outcome,O
data,O
were,O
"
",O
also,O
collected,O
and,O
analyzed,O
.,O
"
",O
Results,O
:,O
Of,O
201,O
patients,O
",",O
the,O
median,O
age,O
was,O
51,O
years,O
(,O
interquartile,O
range,O
",",O
4360,O
"
",O
years,O
),O
",",O
and,O
128,O
(,O
63.7,O
%,O
),O
patients,O
were,O
men,O
.,O
Eightyfour,O
patients,O
(,O
41.8,O
%,O
),O
developed,O
"
",O
ARDS,O
",",O
and,O
of,O
those,O
84,O
patients,O
",",O
44,O
(,O
52.4,O
%,O
),O
died,O
.,O
In,O
those,O
who,O
developed,O
ARDS,O
",",O
"
",O
compared,O
with,O
those,O
who,O
did,O
not,O
",",O
more,O
patients,O
presented,O
with,O
dyspnea,O
(,O
50,O
of,O
84,O
"
",O
[,O
59.5,O
%,O
],O
patients,O
and,O
30,O
of,O
117,O
[,O
25.6,O
%,O
],O
patients,O
",",O
respectively,O
[,O
difference,O
",",O
33.9,O
%,O
;,O
"
",O
95,O
%,O
CI,O
",",O
19.7%48.1,O
%,O
],O
),O
and,O
had,O
comorbidities,O
such,O
as,O
hypertension,O
(,O
23,O
of,O
84,O
"
",O
[,O
27.4,O
%,O
],O
patients,O
and,O
16,O
of,O
117,O
[,O
13.7,O
%,O
],O
patients,O
",",O
respectively,O
[,O
difference,O
",",O
13.7,O
%,O
;,O
"
",O
95,O
%,O
CI,O
",",O
1.3%26.1,O
%,O
],O
),O
and,O
diabetes,O
(,O
16,O
of,O
84,O
[,O
19,O
%,O
],O
patients,O
and,O
6,O
of,O
117,O
[,O
5.1,O
%,O
],O
"
",O
patients,O
",",O
respectively,O
[,O
difference,O
",",O
13.9,O
%,O
;,O
95,O
%,O
CI,O
",",O
3.6%24.2,O
%,O
],O
),O
.,O
In,O
bivariate,O
Cox,O
"
",O
regression,O
analysis,O
",",O
risk,O
factors,O
associated,O
with,O
the,O
development,O
of,O
ARDS,O
and,O
"
",O
progression,O
from,O
ARDS,O
to,O
death,O
included,O
older,O
age,O
(,O
hazard,O
ratio,O
[,O
HR,O
],O
",",O
3.26,O
;,O
95,O
%,O
"
",O
CI,O
2.085.11,O
;,O
and,O
HR,O
",",O
6.17,O
;,O
95,O
%,O
CI,O
",",O
3.2611.67,O
",",O
respectively,O
),O
",",O
neutrophilia,O
(,O
HR,O
",",O
"
",O
1.14,O
;,O
95,O
%,O
CI,O
",",O
1.091.19,O
;,O
and,O
HR,O
",",O
1.08,O
;,O
95,O
%,O
CI,O
",",O
1.011.17,O
",",O
respectively,O
),O
",",O
and,O
"
",O
organ,O
and,O
coagulation,O
dysfunction,O
(,O
eg,O
",",O
higher,O
lactate,O
dehydrogenase,O
[,O
HR,O
",",O
1.61,O
;,O
"
",O
95,O
%,O
CI,O
",",O
1.441.79,O
;,O
and,O
HR,O
",",O
1.3,O
;,O
95,O
%,O
CI,O
",",O
1.111.52,O
",",O
respectively,O
],O
and,O
Ddimer,O
"
",O
[,O
HR,O
",",O
1.03,O
;,O
95,O
%,O
CI,O
",",O
1.011.04,O
;,O
and,O
HR,O
",",O
1.02,O
;,O
95,O
%,O
CI,O
",",O
1.011.04,O
",",O
respectively,O
],O
),O
.,O
"
",O
High,O
fever,O
(,O
â‰¥39,O
Â°,O
C,O
),O
was,O
associated,O
with,O
higher,O
likelihood,O
of,O
ARDS,O
development,O
"
",O
(,O
HR,O
",",O
1.77,O
;,O
95,O
%,O
CI,O
",",O
1.112.84,O
),O
and,O
lower,O
likelihood,O
of,O
death,O
(,O
HR,O
",",O
0.41,O
;,O
95,O
%,O
CI,O
",",O
"
",O
0.210.82,O
),O
.,O
Among,O
patients,O
with,O
ARDS,O
",",O
treatment,O
with,O
methylprednisolone,O
decreased,O
"
",O
the,O
risk,O
of,O
death,O
(,O
HR,O
",",O
0.38,O
;,O
95,O
%,O
CI,O
",",O
0.200.72,O
),O
.,O
"
",O
Conclusions,O
and,O
Relevance,O
:,O
Older,O
age,O
was,O
associated,O
with,O
greater,O
risk,O
of,O
"
",O
development,O
of,O
ARDS,O
and,O
death,O
likely,O
owing,O
to,O
less,O
rigorous,O
immune,O
response,O
.,O
"
",O
Although,O
high,O
fever,O
was,O
associated,O
with,O
the,O
development,O
of,O
ARDS,O
",",O
it,O
was,O
also,O
"
",O
associated,O
with,O
better,O
outcomes,O
among,O
patients,O
with,O
ARDS,O
.,O
Moreover,O
",",O
treatment,O
"
",O
with,O
methylprednisolone,O
may,O
be,O
beneficial,O
for,O
patients,O
who,O
develop,O
ARDS,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jamainternmed.2020.0994,O
"
",O
PMID,O
:,O
32167524,O
"


",O
51,O
.,O
J,O
Clin,O
Invest,O
.,O
2020,O
Mar,O
13,O
.,O
pii,O
:,O
138003,O
.,O
doi,O
:,O
10.1172,O
JCI138003,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
The,O
convalescent,O
sera,O
option,O
for,O
containing,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Casadevall,O
A(1,O
),O
",",O
Pirofski,O
LA(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Molecular,O
Microbiology,O
and,O
Immunology,O
",",O
Johns,O
Hopkins,O
School,O
of,O
"
",O
Public,O
Health,O
",",O
Baltimore,O
",",O
Maryland,O
",",O
USA,O
.,O
"
",O
(2)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Medicine,O
",",O
Albert,O
Einstein,O
"
",O
College,O
of,O
Medicine,O
",",O
Bronx,O
",",O
New,O
York,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1172,O
JCI138003,O
"
",O
PMID,O
:,O
32167489,O
"


",O
52,O
.,O
Prehosp,O
Disaster,O
Med,O
.,O
2020,O
Apr;35(2):119,O
.,O
doi,O
:,O
10.1017,O
S1049023X2000031X,O
.,O
"

",O
COVID19,B-Disease_COVID-19
:,O
Not,O
a,O
Simple,O
Public,O
Health,O
Emergency,O
.,O
"

",O
Stratton,O
SJ,O
.,O
"

",O
DOI,O
:,O
10.1017,O
S1049023X2000031X,O
"
",O
PMID,O
:,O
32167445,O
"


",O
53,O
.,O
Infect,O
Control,O
Hosp,O
Epidemiol,O
.,O
2020,O
Mar,O
0.552777778,O
.,O
doi,O
:,O
10.1017,O
ice.2020.69,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Involving,O
Antimicrobial,O
Stewardship,O
Programs,O
in,O
COVID19,B-Disease_COVID-19
Response,O
Efforts,O
:,O
All,O
"
",O
Hands,O
on,O
Deck,O
.,O
"

",O
Stevens,O
MP(1,O
),O
",",O
Patel,O
PK(2,O
),O
",",O
Nori,O
P(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Healthcare,O
Infection,O
Prevention,O
Department,O
",",O
Virginia,O
Commonwealth,O
University,O
"
",O
Health,O
System,O
",",O
North,O
Hospital,O
",",O
1300,O
E.,O
Marshall,O
Street,O
",",O
Box,O
980019,O
",",O
Richmond,O
",",O
"
",O
Virginia23298,O
.,O
michael.stevens@vcuhealth.org,O
.,O
"
",O
(2)Infectious,O
Diseases,O
Section,O
",",O
Ann,O
Arbor,O
VA,O
Medical,O
Center,O
(,O
111i,O
),O
",",O
2215,O
Fuller,O
"
",O
Road,O
",",O
Ann,O
Arbor,O
",",O
MI48105,O
",",O
payalkp@umich.edu,O
.,O
"
",O
(3)Department,O
of,O
Medicine,O
",",O
Division,O
of,O
Infectious,O
Diseases,O
",",O
Montefiore,O
Medical,O
"
",O
Center,O
",",O
Albert,O
Einstein,O
College,O
of,O
Medicine,O
",",O
3411,O
Wayne,O
Avenue,O
4H,O
",",O
Bronx,O
",",O
"
",O
NY10467,O
",",O
pnori@montefiore.org,O
.,O
"

",O
DOI,O
:,O
10.1017,O
ice.2020.69,O
"
",O
PMID,O
:,O
32167442,O
"


",O
54,O
.,O
J,O
Evid,O
Based,O
Med,O
.,O
2020,O
Mar,O
13,O
.,O
doi,O
:,O
10.1111,O
jebm.12381,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Effectiveness,O
of,O
N95,O
respirators,O
versus,O
surgical,O
masks,O
against,O
influenza,O
:,O
A,O
"
",O
systematic,O
review,O
and,O
metaanalysis,O
.,O
"

",O
Long,O
Y(1,O
),O
",",O
Hu,O
T(2,O
),O
",",O
Liu,O
L(2,O
),O
",",O
Chen,O
R(3,O
),O
",",O
Guo,O
Q(1,O
),O
",",O
Yang,O
L(1,O
),O
",",O
Cheng,O
Y(1,O
),O
",",O
Huang,O
"
",O
J(4,O
),O
",",O
Du,O
L(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Chinese,O
EvidenceBased,O
Medicine,O
Center,O
",",O
West,O
China,O
Hospital,O
",",O
Sichuan,O
"
",O
University,O
",",O
Chengdu,O
",",O
P.R.,O
China,O
.,O
"
",O
(2)West,O
China,O
School,O
of,O
Medicine,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
",",O
P.R.,O
China,O
.,O
"
",O
(3)School,O
of,O
Clinical,O
Medicine,O
",",O
Chengdu,O
University,O
of,O
Traditional,O
Chinese,O
"
",O
Medicine,O
",",O
Chengdu,O
",",O
P.R.,O
China,O
.,O
"
",O
(4)West,O
China,O
Hospital,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
",",O
P.R.,O
China,O
.,O
"

",O
OBJECTIVE,O
:,O
Previous,O
metaanalyses,O
concluded,O
that,O
there,O
was,O
insufficient,O
evidence,O
"
",O
to,O
determine,O
the,O
effect,O
of,O
N95,O
respirators,O
.,O
We,O
aimed,O
to,O
assess,O
the,O
effectiveness,O
"
",O
of,O
N95,O
respirators,O
versus,O
surgical,O
masks,O
for,O
prevention,O
of,O
influenza,O
by,O
"
",O
collecting,O
randomized,O
controlled,O
trials,O
(,O
RCTs,O
),O
.,O
"
",O
METHODS,O
:,O
We,O
searched,O
PubMed,O
",",O
EMbase,O
and,O
The,O
Cochrane,O
Library,O
from,O
the,O
inception,O
"
",O
to,O
January,O
27,O
",",O
2020,O
to,O
identify,O
relevant,O
systematic,O
reviews,O
.,O
The,O
RCTs,O
included,O
in,O
"
",O
systematic,O
reviews,O
were,O
identified,O
.,O
Then,O
we,O
searched,O
the,O
latest,O
published,O
RCTs,O
"
",O
from,O
the,O
above,O
three,O
databases,O
and,O
searched,O
ClinicalTrials.gov,O
for,O
unpublished,O
"
",O
RCTs,O
.,O
Two,O
reviewers,O
independently,O
extracted,O
the,O
data,O
and,O
assessed,O
risk,O
of,O
bias,O
.,O
"
",O
Metaanalyses,O
were,O
conducted,O
to,O
calculate,O
pooled,O
estimates,O
by,O
using,O
RevMan,O
5.3,O
"
",O
software,O
.,O
"
",O
RESULTS,O
:,O
A,O
total,O
of,O
six,O
RCTs,O
involving,O
9,O
171,O
participants,O
were,O
included,O
.,O
There,O
"
",O
were,O
no,O
statistically,O
significant,O
differences,O
in,O
preventing,O
laboratoryconfirmed,O
"
",O
influenza,O
(,O
RR,O
Â ,O
=,O
Â ,O
1.09,O
",",O
95,O
%,O
CI,O
0.921.28,O
",",O
P,O
Â ,O
>,O
Â ,O
0.05,O
),O
",",O
laboratoryconfirmed,O
"
",O
respiratory,O
viral,O
infections,O
(,O
RR,O
Â ,O
=,O
Â ,O
0.89,O
",",O
95,O
%,O
CI,O
0.701.11,O
),O
",",O
laboratoryconfirmed,O
"
",O
respiratory,O
infection,O
(,O
RR,O
Â ,O
=,O
Â ,O
0.74,O
",",O
95,O
%,O
CI,O
0.421.29,O
),O
and,O
influenzalike,O
illness,O
"
",O
(,O
RR,O
Â ,O
=,O
Â ,O
0.61,O
",",O
95,O
%,O
CI,O
0.331.14,O
),O
using,O
N95,O
respirators,O
and,O
surgical,O
masks,O
.,O
"
",O
Metaanalysis,O
indicated,O
a,O
protective,O
effect,O
of,O
N95,O
respirators,O
against,O
"
",O
laboratoryconfirmed,O
bacterial,O
colonization,O
(,O
RR,O
Â ,O
=,O
Â ,O
0.58,O
",",O
95,O
%,O
CI,O
0.430.78,O
),O
.,O
"
",O
CONCLUSION,O
:,O
The,O
use,O
of,O
N95,O
respirators,O
compared,O
with,O
surgical,O
masks,O
is,O
not,O
"
",O
associated,O
with,O
a,O
lower,O
risk,O
of,O
laboratoryconfirmed,O
influenza,O
.,O
It,O
suggests,O
that,O
"
",O
N95,O
respirators,O
should,O
not,O
be,O
recommended,O
for,O
general,O
public,O
and,O
nonhighrisk,O
"
",O
medical,O
staff,O
those,O
are,O
not,O
in,O
close,O
contact,O
with,O
influenza,O
patients,O
or,O
suspected,O
"
",O
patients,O
.,O
"

",O
Â©,O
2020,O
Chinese,O
Cochrane,O
Center,O
",",O
West,O
China,O
Hospital,O
of,O
Sichuan,O
University,O
and,O
"
",O
John,O
Wiley,O
&,O
Sons,O
Australia,O
",",O
Ltd.,O
"

",O
DOI,O
:,O
10.1111,O
jebm.12381,O
"
",O
PMID,O
:,O
32167245,O
"


",O
55,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
13,O
.,O
doi,O
:,O
10.1002,O
jmv.25763,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Initial,O
clinical,O
features,O
of,O
suspected,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
in,O
two,O
emergency,O
"
",O
departments,O
outside,O
of,O
Hubei,O
",",O
China,O
.,O
"

",O
Zhu,O
W(1)(2,O
),O
",",O
Xie,O
K(1,O
),O
",",O
Lu,O
H(1)(3,O
),O
",",O
Xu,O
L(1,O
),O
",",O
Zhou,O
S(1)(4,O
),O
",",O
Fang,O
S(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
emergency,O
",",O
the,O
First,O
Affiliated,O
Hospital,O
of,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
of,O
China,O
",",O
Hefei,O
",",O
230001,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)Department,O
of,O
emergency,O
",",O
Affiliated,O
Anhui,O
Provincial,O
Hospital,O
of,O
Anhui,O
Medical,O
"
",O
University,O
",",O
Hefei,O
",",O
230001,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(3)Department,O
of,O
nursing,O
",",O
the,O
First,O
Affiliated,O
Hospital,O
of,O
University,O
of,O
Science,O
"
",O
and,O
Technology,O
of,O
China,O
",",O
Hefei,O
",",O
230001,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(4)Department,O
of,O
ICU,O
",",O
the,O
First,O
Affiliated,O
Hospital,O
of,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
of,O
China,O
",",O
Hefei,O
",",O
230001,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"

",O
BACKGROUND,O
:,O
With,O
an,O
increasing,O
number,O
of,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
"
",O
cases,O
outside,O
of,O
Hubei,O
",",O
emergency,O
departments,O
(,O
EDs,O
),O
and,O
fever,O
clinics,O
are,O
facing,O
"
",O
challenges,O
posed,O
by,O
the,O
large,O
number,O
of,O
admissions,O
of,O
patients,O
suspected,O
to,O
have,O
"
",O
COVID19,B-Disease_COVID-19
.,O
Therefore,O
",",O
it,O
is,O
of,O
crucial,O
importance,O
to,O
study,O
the,O
initial,O
clinical,O
"
",O
features,O
of,O
patients,O
",",O
to,O
better,O
differentiate,O
between,O
infected,O
and,O
uninfected,O
"
",O
patients,O
outside,O
Hubei,O
.,O
"
",O
METHODS,O
:,O
A,O
total,O
of,O
116,O
patients,O
suspected,O
of,O
having,O
COVID19,B-Disease_COVID-19
who,O
presented,O
to,O
"
",O
two,O
emergency,O
departments,O
in,O
Anhui,O
for,O
the,O
first,O
time,O
between,O
24,O
January,O
2020,O
and,O
"
",O
20,O
February,O
2020,O
were,O
enrolled,O
in,O
the,O
study,O
.,O
The,O
initial,O
clinical,O
data,O
of,O
these,O
"
",O
patients,O
",",O
such,O
as,O
epidemiological,O
features,O
",",O
symptoms,O
",",O
laboratory,O
results,O
",",O
and,O
"
",O
chest,O
computed,O
tomography,O
findings,O
were,O
collected,O
using,O
a,O
standard,O
case,O
report,O
"
",O
form,O
on,O
admission,O
.,O
"
",O
RESULTS,O
:,O
Thirtytwo,O
patients,O
were,O
diagnosed,O
with,O
COVID19,B-Disease_COVID-19
;,O
the,O
remaining,O
84,O
"
",O
patients,O
were,O
referred,O
to,O
as,O
negative,O
cases,O
.,O
The,O
median,O
age,O
of,O
the,O
diagnosed,O
"
",O
patients,O
was,O
46,O
years,O
",",O
but,O
only,O
35,O
years,O
for,O
negative,O
cases,O
.,O
History,O
of,O
exposure,O
"
",O
to,O
Wuhan,O
or,O
COVID19,B-Disease_COVID-19
patients,O
in,O
the,O
previous,O
2,O
weeks,O
was,O
observed,O
in,O
63,O
%,O
of,O
the,O
"
",O
diagnosed,O
and,O
44,O
%,O
of,O
negative,O
cases,O
.,O
Median,O
time,O
from,O
illness,O
onset,O
to,O
ED,O
"
",O
admission,O
was,O
5,O
days,O
for,O
all,O
patients,O
",",O
diagnosed,O
patients,O
",",O
and,O
negative,O
cases,O
",",O
"
",O
respectively,O
.,O
Fever,O
was,O
observed,O
in,O
27,O
(,O
84,O
%,O
),O
and,O
57,O
(,O
68,O
%,O
),O
diagnosed,O
and,O
negative,O
"
",O
cases,O
",",O
respectively,O
.,O
Nineteen,O
(,O
59,O
%,O
),O
diagnosed,O
and,O
24,O
(,O
29,O
%,O
),O
negative,O
cases,O
had,O
"
",O
lymphopenia,O
on,O
admission,O
in,O
ED,O
.,O
A,O
chest,O
CT,O
scan,O
on,O
admission,O
revealed,O
the,O
"
",O
presence,O
of,O
pneumonia,O
in,O
the,O
majority,O
of,O
the,O
diagnosed,O
patients,O
(,O
30,O
out,O
of,O
32,O
",",O
"
",O
94,O
%,O
),O
and,O
in,O
56,O
(,O
67,O
%,O
),O
negative,O
cases,O
.,O
Bilateral,O
involvement,O
and,O
groundglass,O
"
",O
opacity,O
(,O
GGO,O
),O
were,O
present,O
in,O
91,O
%,O
and,O
47,O
%,O
of,O
the,O
diagnosed,O
patients,O
.,O
"
",O
CONCLUSION,O
:,O
The,O
initial,O
clinical,O
features,O
of,O
patients,O
suspected,O
of,O
having,O
"
",O
COVID19,B-Disease_COVID-19
in,O
EDs,O
outside,O
Hubei,O
were,O
relatively,O
mild,O
.,O
Meanwhile,O
",",O
diagnosed,O
patients,O
"
",O
without,O
definite,O
exposure,O
history,O
tend,O
to,O
show,O
more,O
atypical,O
initial,O
clinical,O
"
",O
features,O
in,O
ED,O
.,O
No,O
initial,O
clinical,O
feature,O
was,O
found,O
to,O
be,O
specific,O
to,O
diagnosed,O
"
",O
patients,O
",",O
which,O
could,O
allow,O
for,O
early,O
clinical,O
diagnosis,O
of,O
COVID19,B-Disease_COVID-19
in,O
EDs,O
.,O
We,O
"
",O
recommend,O
strict,O
medical,O
observation,O
and,O
quarantine,O
of,O
all,O
patients,O
suspected,O
of,O
"
",O
having,O
COVID19,B-Disease_COVID-19
",",O
either,O
in,O
the,O
ED,O
itself,O
or,O
in,O
a,O
dedicated,O
quarantine,O
facility,O
",",O
"
",O
irrespective,O
of,O
initial,O
clinical,O
features,O
",",O
especially,O
in,O
underresourced,O
regions,O
"
",O
without,O
access,O
to,O
rapid,O
nucleic,O
acid,O
amplification,O
tests,O
.,O
This,O
article,O
is,O
"
",O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25763,O
"
",O
PMID,O
:,O
32167181,O
"


",O
56,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
13,O
.,O
doi,O
:,O
10.1002,O
jmv.25762,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
establishment,O
of,O
reference,O
sequence,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
and,O
variation,O
analysis,O
.,O
"

",O
Wang,O
C(1)(2)(3,O
),O
",",O
Liu,O
Z(1)(2,O
),O
",",O
Chen,O
Z(2,O
),O
",",O
Huang,O
X(2,O
),O
",",O
Xu,O
M(1)(2,O
),O
",",O
He,O
T(1)(2,O
),O
",",O
"
",O
Zhang,O
Z(1)(2)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Diseases,O
",",O
the,O
Second,O
Hospital,O
of,O
Anhui,O
Medical,O
"
",O
University,O
",",O
Hefei,O
",",O
230601,O
",",O
China,O
.,O
"
",O
(2)Institute,O
of,O
Clinical,O
Virology,O
",",O
the,O
Second,O
Hospital,O
of,O
Anhui,O
Medical,O
"
",O
University,O
",",O
Hefei,O
",",O
230601,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Infectious,O
Diseases,O
",",O
the,O
Affiliated,O
Anqing,O
Hospital,O
of,O
Anhui,O
"
",O
Medical,O
University,O
",",O
Anqing,O
",",O
246003,O
",",O
China,O
.,O
"
",O
(4)Anhui,O
Provincial,O
Laboratory,O
of,O
Inflammatory,O
and,O
Immunity,O
Disease,O
",",O
Anhui,O
"
",O
Medical,O
University,O
",",O
Hefei,O
",",O
230022,O
",",O
China,O
.,O
"

",O
Starting,O
around,O
December,O
2019,O
",",O
an,O
epidemic,O
of,O
pneumonia,O
",",O
which,O
was,O
named,O
COVID19,B-Disease_COVID-19
"
",O
by,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
",",O
broke,O
out,O
in,O
Wuhan,O
",",O
China,O
",",O
and,O
is,O
spreading,O
"
",O
throughout,O
the,O
world,O
.,O
A,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
named,O
SARSCoV2,B-Virus_SARS-CoV-2
by,O
the,O
Coronavirus,O
"
",O
Study,O
Group,O
of,O
the,O
International,O
Committee,O
on,O
Taxonomy,O
of,O
Viruses,O
(,O
ICTV,O
),O
was,O
soon,O
"
",O
found,O
to,O
be,O
the,O
cause,O
.,O
At,O
present,O
",",O
the,O
sensitivity,O
of,O
clinical,O
nucleic,O
acid,O
"
",O
detection,O
is,O
limited,O
",",O
and,O
it,O
is,O
still,O
unclear,O
whether,O
it,O
is,O
related,O
to,O
genetic,O
"
",O
variation,O
.,O
In,O
this,O
study,O
",",O
we,O
retrieved,O
95,O
fulllength,O
genomic,O
sequences,O
of,O
"
",O
SARASCoV2,O
strains,O
from,O
the,O
NCBI,O
and,O
GISAID,O
databases,O
",",O
established,O
the,O
reference,O
"
",O
sequence,O
by,O
conducting,O
multiple,O
sequence,O
alignment,O
and,O
phylogenetic,O
analyses,O
",",O
and,O
"
",O
analyzed,O
sequence,O
variations,O
along,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
genome,O
.,O
The,O
homology,O
among,O
all,O
"
",O
viral,O
strains,O
was,O
generally,O
high,O
",",O
among,O
them,O
99.99,O
%,O
(,O
99.91%100,O
%,O
),O
at,O
the,O
"
",O
nucleotide,O
level,O
",",O
99.99,O
%,O
(,O
99.79%100,O
%,O
),O
at,O
the,O
amino,O
acid,O
level,O
.,O
Although,O
overall,O
"
",O
variation,O
in,O
ORF,O
regions,O
is,O
low,O
",",O
13,O
variation,O
sites,O
in,O
1a,O
",",O
1b,O
",",O
S,O
",",O
3a,O
",",O
M,O
",",O
8,O
",",O
and,O
N,O
"
",O
regions,O
were,O
identified,O
",",O
among,O
which,O
positions,O
nt28144,O
in,O
ORF,O
8,O
and,O
nt8782,O
in,O
ORF,O
"
",O
1a,O
showed,O
mutation,O
rate,O
of,O
30.53,O
%,O
(,O
29,O
95,O
),O
and,O
29.47,O
%,O
(,O
28,O
95,O
),O
respectively,O
.,O
These,O
"
",O
findings,O
suggested,O
that,O
there,O
may,O
be,O
selective,O
mutations,O
in,O
SARSCOV2,B-Virus_SARS-CoV-2
",",O
and,O
it,O
is,O
"
",O
necessary,O
to,O
avoid,O
certain,O
regions,O
when,O
designing,O
primers,O
and,O
probes,O
.,O
"
",O
Establishment,O
of,O
the,O
reference,O
sequence,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
could,O
benefit,O
not,O
only,O
"
",O
biological,O
study,O
of,O
this,O
virus,O
but,O
also,O
diagnosis,O
",",O
clinical,O
monitoring,O
and,O
"
",O
intervention,O
of,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
in,O
the,O
future,O
.,O
This,O
article,O
is,O
protected,O
by,O
"
",O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25762,O
"
",O
PMID,O
:,O
32167180,O
"


",O
57,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
13,O
.,O
doi,O
:,O
10.1002,O
jmv.25761,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
potential,O
chemical,O
structure,O
of,O
antiSARSCoV2,O
RNAdependent,O
RNA,O
polymerase,O
.,O
"

",O
Lung,O
J(1,O
),O
",",O
Lin,O
YS(2,O
),O
",",O
Yang,O
YH(3)(4)(5,O
),O
",",O
Chou,O
YL(6,O
),O
",",O
Shu,O
LH(3,O
),O
",",O
Cheng,O
YC(3,O
),O
",",O
Liu,O
"
",O
HT(3,O
),O
",",O
Wu,O
CY(3)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Research,O
and,O
Development,O
",",O
Chiayi,O
Chang,O
Gung,O
Memorial,O
Hospital,O
",",O
"
",O
Chiayi,O
Branch,O
",",O
Putzu,O
",",O
Taiwan,O
.,O
"
",O
(2)Department,O
of,O
Pharmacy,O
",",O
Chiayi,O
Chang,O
Gung,O
Memorial,O
Hospital,O
",",O
Chiayi,O
Branch,O
",",O
"
",O
Putzu,O
",",O
Taiwan,O
.,O
"
",O
(3)Department,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
Chang,O
Gung,O
Memorial,O
Hospital,O
",",O
"
",O
Chiayi,O
Branch,O
",",O
Putzu,O
",",O
Taiwan,O
.,O
"
",O
(4)Health,O
Information,O
and,O
Epidemiology,O
Laboratory,O
of,O
Chang,O
Gung,O
Memorial,O
"
",O
Hospital,O
",",O
Chiayi,O
Branch,O
",",O
Putzu,O
",",O
Taiwan,O
.,O
"
",O
(5)School,O
of,O
Chinese,O
medicine,O
",",O
College,O
of,O
Medicine,O
",",O
Chang,O
Gung,O
University,O
",",O
"
",O
TaoYuan,O
",",O
Taiwan,O
.,O
"
",O
(6)Department,O
of,O
surgery,O
",",O
Kaohsiung,O
Chang,O
Gung,O
Memorial,O
Hospital,O
.,O
"

",O
An,O
outbreak,O
of,O
corona,B-Disease_COVID-19
virus,I-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
occurred,O
in,O
Wuhan,O
and,O
it,O
has,O
"
",O
rapidly,O
spread,O
to,O
almost,O
all,O
parts,O
of,O
the,O
world,O
.,O
For,O
coronaviruses,O
",",O
RNAdependent,O
"
",O
RNA,O
polymerase,O
(,O
RdRp,O
),O
is,O
an,O
important,O
protease,O
that,O
catalyze,O
the,O
replication,O
of,O
"
",O
RNA,O
from,O
RNA,O
template,O
and,O
is,O
an,O
attractive,O
therapeutic,O
target,O
.,O
In,O
this,O
study,O
",",O
we,O
"
",O
screened,O
these,O
chemical,O
structures,O
from,O
traditional,O
Chinese,O
medicinal,O
compounds,O
"
",O
proven,O
to,O
show,O
antiviral,O
activity,O
in,O
SARSCoV,O
and,O
the,O
similar,O
chemical,O
"
",O
structures,O
through,O
a,O
molecular,O
docking,O
study,O
to,O
target,O
RdRp,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
"
",O
SARSCoV,O
and,O
MERSCoV.,O
We,O
found,O
that,O
theaflavin,O
has,O
a,O
lower,O
idock,O
score,O
in,O
the,O
"
",O
catalytic,O
pocket,O
of,O
RdRp,O
in,O
SARSCoV2,B-Virus_SARS-CoV-2
(,O
9.11,O
kcal,O
mol,O
),O
",",O
SARSCoV,O
(,O
8.03,O
"
",O
kcal,O
mol,O
),O
and,O
MERSCoV,O
(,O
8.26,O
kcal,O
mol,O
),O
from,O
idock,O
.,O
To,O
confirm,O
the,O
result,O
",",O
we,O
"
",O
discovered,O
that,O
theaflavin,O
has,O
a,O
lower,O
binding,O
energy,O
of,O
8.8,O
kcal,O
mol,O
when,O
it,O
"
",O
docks,O
in,O
the,O
catalytic,O
pocket,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
RdRp,O
by,O
using,O
the,O
Blind,O
Docking,O
"
",O
server,O
.,O
Regarding,O
contact,O
modes,O
",",O
hydrophobic,O
interactions,O
contribute,O
"
",O
significantly,O
in,O
binding,O
and,O
additional,O
hydrogen,O
bonds,O
were,O
found,O
between,O
"
",O
theaflavin,O
and,O
RdRp,O
.,O
Moreover,O
",",O
one,O
Ï€cation,O
interaction,O
was,O
formed,O
between,O
"
",O
theaflavin,O
and,O
Arg553,O
from,O
the,O
Blind,O
Docking,O
server,O
.,O
Our,O
results,O
suggest,O
that,O
"
",O
theaflavin,O
could,O
be,O
potential,O
SARSCoV2,B-Virus_SARS-CoV-2
RdRp,O
inhibitor,O
for,O
further,O
study,O
.,O
This,O
"
",O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25761,O
"
",O
PMID,O
:,O
32167173,O
"


",O
58,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
13,O
.,O
doi,O
:,O
10.1002,O
jmv.25758,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
An,O
exclusive,O
42,O
amino,O
acid,O
signature,O
in,O
pp1ab,O
protein,O
provides,O
insights,O
into,O
the,O
"
",O
evolutive,O
history,O
of,O
the,O
2019,O
novel,O
humanpathogenic,O
coronavirus,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
.,O
"

",O
CÃ¡rdenasConejo,O
Y(1,O
),O
",",O
LiÃ±anRico,O
A(2,O
),O
",",O
GarcÃ­aRodrÃ­guez,O
DA(3,O
),O
",",O
CentenoLeija,O
"
",O
S(1,O
),O
",",O
SerranoPosada,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Laboratorio,O
de,O
AgrobiotecnologÃ­a,O
",",O
Consejo,O
Nacional,O
de,O
Ciencia,O
y,O
"
",O
TecnologÃ­aUniversidad,O
de,O
Colima,O
",",O
Colima,O
",",O
Colima,O
",",O
MÃ©xico,O
.,O
"
",O
(2)Centro,O
Universitario,O
de,O
Investigaciones,O
biomÃ©dicas,O
",",O
Consejo,O
Nacional,O
de,O
"
",O
Ciencia,O
y,O
TecnologÃ­aUniversidad,O
de,O
Colima,O
",",O
Colima,O
",",O
Colima,O
",",O
MÃ©xico,O
.,O
"
",O
(3)Laboratorio,O
de,O
AgrobiotecnologÃ­a,O
",",O
Universidad,O
de,O
Colima,O
",",O
Colima,O
",",O
Colima,O
",",O
"
",O
MÃ©xico,O
.,O
"

",O
The,O
city,O
of,O
Wuhan,O
",",O
Hubei,O
province,O
",",O
China,O
",",O
was,O
the,O
origin,O
of,O
a,O
severe,O
pneumonia,O
"
",O
outbreak,O
in,O
December,O
2019,O
",",O
attributed,O
to,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
causing,O
"
",O
a,O
total,O
of,O
2761,O
deaths,O
and,O
81109,O
cases,O
(,O
February,O
25,O
",",O
2020,O
),O
.,O
SARSCoV2,B-Virus_SARS-CoV-2
belongs,O
to,O
"
",O
genus,O
Betacoronavirus,O
",",O
subgenus,O
Sarbecovirus,O
.,O
The,O
polyprotein,O
1ab,O
(,O
pp1ab,O
),O
remains,O
"
",O
unstudied,O
thoroughly,O
since,O
it,O
is,O
similar,O
to,O
other,O
sarbecoviruses,O
.,O
In,O
this,O
short,O
"
",O
communication,O
",",O
we,O
performed,O
phylogeneticstructural,O
sequence,O
analysis,O
of,O
pp1ab,O
"
",O
protein,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
The,O
analysis,O
showed,O
that,O
the,O
viral,O
pp1ab,O
has,O
not,O
changed,O
in,O
"
",O
most,O
isolates,O
throughout,O
the,O
outbreak,O
time,O
",",O
but,O
interestingly,O
a,O
deletion,O
of,O
8,O
aa,O
"
",O
in,O
the,O
virulence,O
factor,O
nonstructural,O
protein,O
1,O
was,O
found,O
in,O
a,O
virus,O
isolated,O
"
",O
from,O
a,O
Japanese,O
patient,O
that,O
did,O
not,O
display,O
critical,O
symptoms,O
.,O
While,O
comparing,O
"
",O
pp1ab,O
protein,O
with,O
other,O
betacoronaviruses,O
",",O
we,O
found,O
a,O
42,O
amino,O
acid,O
signature,O
"
",O
that,O
is,O
only,O
present,O
in,O
SARSCoV2,B-Virus_SARS-CoV-2
(,O
ASSCoV2,O
),O
.,O
Members,O
from,O
clade,O
2,O
of,O
"
",O
sarbecoviruses,O
have,O
traces,O
of,O
this,O
signature,O
.,O
The,O
ASSCoV2,O
located,O
in,O
the,O
"
",O
acidicdomain,O
of,O
papainlike,O
protein,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
and,O
batSLRatG13,O
guided,O
us,O
to,O
"
",O
suggest,O
that,O
the,O
novel,O
2019,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
probably,O
emerged,O
by,O
genetic,O
drift,O
from,O
"
",O
batSLCoVRaTG13,O
.,O
The,O
implication,O
of,O
this,O
amino,O
acid,O
signature,O
in,O
papainlike,O
"
",O
protein,O
structure,O
arrangement,O
and,O
function,O
is,O
something,O
worth,O
to,O
be,O
explored,O
.,O
"
",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25758,O
"
",O
PMID,O
:,O
32167166,O
"


",O
59,O
.,O
Clin,O
Sci,O
(,O
Lond,O
),O
.,O
2020,O
Mar,O
13;134(5):543545,O
.,O
doi,O
:,O
10.1042,O
CS20200163,O
.,O
"

",O
Soluble,O
angiotensinconverting,O
enzyme,O
2,O
:,O
a,O
potential,O
approach,O
for,O
coronavirus,O
"
",O
infection,O
therapy,O
?,O
"

",O
Batlle,O
D(1,O
),O
",",O
Wysocki,O
J(1,O
),O
",",O
Satchell,O
K(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medicine,O
 ,O
Division,O
of,O
Nephrology,O
Hypertension,O
",",O
Northwestern,O
"
",O
University,O
Feinberg,O
School,O
of,O
Medicine,O
",",O
Chicago,O
",",O
IL,O
",",O
U.S.A.,O
"
",O
(2)Department,O
MicrobiologyImmunology,O
",",O
Northwestern,O
University,O
Feinberg,O
School,O
of,O
"
",O
Medicine,O
",",O
Chicago,O
",",O
IL,O
",",O
U.S.A.,O
"
",O
(3)Center,O
for,O
Structural,O
Genomics,O
of,O
Infectious,O
Diseases,O
",",O
Northwestern,O
University,O
"
",O
Feinberg,O
School,O
of,O
Medicine,O
",",O
Chicago,O
",",O
IL,O
",",O
U.S.A.,O
"

",O
A,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
referred,O
to,O
as,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
is,O
responsible,O
for,O
the,O
recent,O
"
",O
outbreak,O
of,O
severe,O
respiratory,O
disease,O
.,O
This,O
outbreak,O
first,O
detected,O
in,O
Wuhan,O
",",O
"
",O
China,O
in,O
December,O
2019,O
",",O
has,O
spread,O
to,O
other,O
regions,O
of,O
China,O
and,O
to,O
25,O
other,O
"
",O
countries,O
as,O
of,O
January,O
",",O
2020,O
.,O
It,O
has,O
been,O
known,O
since,O
the,O
2003,O
SARS,O
epidemic,O
"
",O
that,O
the,O
receptor,O
critical,O
for,O
SARSCoV,O
entry,O
into,O
host,O
cells,O
is,O
the,O
"
",O
angiotensinconverting,O
enzyme,O
2,O
(,O
ACE2,O
),O
.,O
The,O
S1,O
domain,O
of,O
the,O
spike,O
protein,O
of,O
"
",O
SARSCoV,O
attaches,O
the,O
virus,O
to,O
its,O
cellular,O
receptor,O
ACE2,O
on,O
the,O
host,O
cells,O
.,O
We,O
"
",O
thought,O
that,O
it,O
is,O
timely,O
to,O
explain,O
the,O
connection,O
between,O
the,O
SARSCoV,O
",",O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
ACE2,O
and,O
the,O
rationale,O
for,O
soluble,O
ACE2,O
as,O
a,O
potential,O
therapy,O
.,O
"

",O
Â©,O
2020,O
The,O
Author(s,O
),O
.,O
"

",O
DOI,O
:,O
10.1042,O
CS20200163,O
"
",O
PMID,O
:,O
32167153,O
"


",O
60,O
.,O
J,O
Travel,O
Med,O
.,O
2020,O
Mar,O
13,O
.,O
pii,O
:,O
taaa039,O
.,O
doi,O
:,O
10.1093,O
jtm,O
taaa039,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Interrupting,O
transmission,O
of,O
COVID19,B-Disease_COVID-19
:,O
lessons,O
from,O
containment,O
efforts,O
in,O
"
",O
Singapore,O
.,O
"

",O
Lee,O
VJ(1)(2,O
),O
",",O
Chiew,O
CJ(1,O
),O
",",O
Khong,O
WX(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Ministry,O
of,O
Health,O
",",O
Singapore,O
.,O
"
",O
(2)Saw,O
Swee,O
Hock,O
School,O
of,O
Public,O
Health,O
",",O
Singapore,O
.,O
"

",O
Despite,O
multiple,O
importations,O
resulting,O
in,O
local,O
chains,O
of,O
transmission,O
",",O
"
",O
Singapore,O
has,O
been,O
able,O
to,O
control,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
without,O
major,O
disruption,O
"
",O
to,O
daily,O
living,O
.,O
In,O
this,O
article,O
",",O
we,O
describe,O
the,O
combination,O
of,O
measures,O
taken,O
"
",O
by,O
Singapore,O
to,O
contain,O
COVID19,B-Disease_COVID-19
and,O
share,O
some,O
early,O
lessons,O
learnt,O
from,O
the,O
"
",O
experience,O
.,O
"

",O
Â©,O
International,O
Society,O
of,O
Travel,O
Medicine,O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
"
",O
Press,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
Permissions,O
",",O
please,O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jtm,O
taaa039,O
"
",O
PMID,O
:,O
32167146,O
"


",O
61,O
.,O
Curr,O
Med,O
Sci,O
.,O
2020,O
Feb;40(1):168171,O
.,O
doi,O
:,O
10.1007,O
s115960202160x,O
.,O
Epub,O
2020,O
"
",O
Mar,O
13,O
.,O
"

",O
EpsteinBarr,O
Virus,O
EAIgA,O
",",O
VCAIgA,O
",",O
and,O
EBVNAIgG,O
Antibodies,O
in,O
a,O
Population,O
of,O
"
",O
Wuhan,O
",",O
China,O
.,O
"

",O
Tang,O
ZG(1,O
),O
",",O
Li,O
HH(2,O
),O
",",O
Li,O
YC(1,O
),O
",",O
Lv,O
MX(3,O
),O
",",O
Xu,O
X(2,O
),O
",",O
Zeng,O
JC(2,O
),O
",",O
Kong,O
WJ(4,O
),O
",",O
Yang,O
"
",O
R(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Otolaryngology,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
(2)Physical,O
Examination,O
Center,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
(3)School,O
of,O
Public,O
Health,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Otolaryngology,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
entwjkong@hust.edu.cn,O
.,O
"
",O
(5)Physical,O
Examination,O
Center,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
408025245@qq.com,O
.,O
"

",O
The,O
study,O
investigated,O
the,O
distribution,O
of,O
EpsteinBarr,O
virus,O
(,O
EBV,O
),O
EAIgA,O
",",O
"
",O
VCAIgA,O
",",O
and,O
EBVNAIgG,O
antibodies,O
in,O
a,O
local,O
population,O
of,O
Wuhan,O
",",O
China,O
.,O
"
",O
Chemiluminescence,O
immunoassay,O
(,O
CLIA,O
),O
was,O
used,O
to,O
detect,O
EBV,O
EAIgA,O
",",O
VCAIgA,O
",",O
and,O
"
",O
EBVNAIgG,O
antibodies,O
in,O
972,O
subjects,O
undergoing,O
physical,O
examination,O
in,O
Wuhan,O
",",O
"
",O
and,O
the,O
results,O
were,O
analyzed,O
.,O
The,O
detection,O
rate,O
of,O
EBV,O
was,O
positively,O
"
",O
correlated,O
with,O
age,O
.,O
In,O
the,O
972,O
cases,O
",",O
there,O
was,O
significant,O
difference,O
between,O
"
",O
different,O
genders,O
in,O
the,O
positive,O
rate,O
of,O
VCAIgA,O
and,O
EBVNAIgG.,O
Moreover,O
",",O
the,O
"
",O
positive,O
rate,O
of,O
VCAIgA,O
and,O
EBVNAIgG,O
was,O
higher,O
in,O
men,O
â‰¥,O
60,O
years,O
old,O
than,O
in,O
"
",O
those,O
<,O
60,O
but,O
no,O
significant,O
differences,O
were,O
found,O
in,O
three,O
antibodies,O
among,O
"
",O
various,O
age,O
groups,O
.,O
Our,O
results,O
suggested,O
that,O
the,O
EBV,O
infection,O
should,O
be,O
"
",O
intensively,O
monitored,O
in,O
elderly,O
people,O
in,O
Wuhan,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s115960202160x,O
"
",O
PMID,O
:,O
32166679,O
"


",O
62,O
.,O
Curr,O
Med,O
Sci,O
.,O
2020,O
Feb;40(1):6368,O
.,O
doi,O
:,O
10.1007,O
s1159602021477,O
.,O
Epub,O
2020,O
Mar,O
"
",O
13,O
.,O
"

",O
Strengthened,O
Monitoring,O
of,O
H5,O
Avian,O
Influenza,O
Viruses,O
in,O
External,O
Environment,O
in,O
"
",O
Hubei,O
",",O
2018,O
.,O
"

",O
Liu,O
LL(1,O
),O
",",O
Fang,O
B(2,O
),O
",",O
Yu,O
X(1,O
),O
",",O
Li,O
X(1,O
),O
",",O
Lei,O
YK(1,O
),O
",",O
Chen,O
D(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Health,O
Inspection,O
and,O
Testing,O
",",O
Hubei,O
Provincial,O
Center,O
for,O
"
",O
Disease,O
Control,O
and,O
Prevention,O
",",O
Wuhan,O
",",O
430079,O
",",O
China,O
.,O
"
",O
(2)Institute,O
of,O
Health,O
Inspection,O
and,O
Testing,O
",",O
Hubei,O
Provincial,O
Center,O
for,O
"
",O
Disease,O
Control,O
and,O
Prevention,O
",",O
Wuhan,O
",",O
430079,O
",",O
China,O
.,O
nicolfang@163.com,O
.,O
"
",O
(3)Wuhan,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430065,O
",",O
China,O
.,O
"

",O
The,O
contamination,O
status,O
of,O
H5,O
avian,O
influenza,O
viruses,O
and,O
distribution,O
of,O
"
",O
subtypes,O
of,O
H5N1,O
and,O
H5N6,O
in,O
poultryrelated,O
environment,O
of,O
Hubei,O
areas,O
were,O
"
",O
investigated,O
.,O
Urban,O
and,O
rural,O
live,O
poultry,O
markets,O
",",O
poultry,O
farms,O
",",O
intensive,O
"
",O
livestock,O
farms,O
and,O
other,O
monitoring,O
types,O
of,O
103,O
counties,O
in,O
17,O
cities,O
were,O
"
",O
selected,O
in,O
Hubei,O
.,O
Wiping,O
samples,O
from,O
cage,O
surface,O
",",O
wiping,O
samples,O
from,O
chopping,O
"
",O
board,O
",",O
fecal,O
specimens,O
and,O
other,O
environmental,O
samples,O
were,O
collected,O
and,O
tested,O
"
",O
by,O
realtime,O
RTPCR,O
using,O
primers,O
and,O
probes,O
of,O
influenza,O
A,O
",",O
avian,O
influenza,O
of,O
"
",O
H5,O
",",O
N1,O
and,O
N6,O
from,O
December,O
2017,O
to,O
March,O
2018,O
.,O
The,O
avian,O
influenza,O
virus,O
"
",O
positive,O
rate,O
was,O
compared,O
among,O
different,O
monitoring,O
sites,O
",",O
samples,O
",",O
time,O
and,O
"
",O
regions,O
.,O
Totally,O
",",O
7132,O
environmental,O
samples,O
were,O
collected,O
in,O
1634,O
monitoring,O
"
",O
points,O
with,O
a,O
positive,O
rate,O
of,O
2.24,O
%,O
.,O
The,O
positive,O
rate,O
of,O
H5,O
avian,O
influenza,O
"
",O
virus,O
was,O
the,O
highest,O
in,O
urban,O
and,O
rural,O
live,O
poultry,O
markets,O
(,O
3.44,O
%,O
",",O
Ï‡2=61.329,O
",",O
"
",O
P<0.05,O
),O
in,O
6,O
monitoring,O
sites,O
and,O
wiping,O
samples,O
from,O
chopping,O
board,O
(,O
5.46,O
%,O
",",O
"
",O
Ï‡2=67.072,O
",",O
P<0.05,O
),O
in,O
6,O
sample,O
types,O
.,O
H5N6,O
avian,O
influenza,O
viruses,O
were,O
detected,O
"
",O
more,O
in,O
eastern,O
than,O
western,O
Hubei,O
",",O
and,O
H5N6,O
avian,O
influenza,O
viruses,O
were,O
"
",O
detected,O
only,O
in,O
Xiangyang,O
city,O
of,O
western,O
Hubei,O
.,O
There,O
were,O
important,O
highrisk,O
"
",O
places,O
of,O
human,O
infection,O
with,O
H5,O
avian,O
influenza,O
virus,O
in,O
urban,O
and,O
rural,O
live,O
"
",O
poultry,O
markets,O
and,O
the,O
poultry,O
slaughtering,O
plants,O
.,O
H5N6,O
has,O
been,O
the,O
"
",O
predominant,O
subtype,O
of,O
H5,O
avian,O
influenza,O
viruses,O
in,O
the,O
eastern,O
and,O
western,O
"
",O
Hubei,O
and,O
H5N6,O
avian,O
influenza,O
viruses,O
were,O
still,O
present,O
in,O
a,O
few,O
areas,O
of,O
"
",O
Hubei,O
.,O
Outbreaks,O
of,O
human,O
H5N1,O
and,O
H5N6,O
avian,O
influenza,O
remain,O
at,O
risk,O
in,O
Hubei,O
"
",O
province,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s1159602021477,O
"
",O
PMID,O
:,O
32166666,O
"


",O
63,O
.,O
Indian,O
J,O
Pediatr,O
.,O
2020,O
Mar,O
13,O
.,O
doi,O
:,O
10.1007,O
s12098020032636,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
A,O
Review,O
of,O
Coronavirus,O
Disease2019,O
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
Singhal,O
T(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pediatrics,O
and,O
Infectious,O
Disease,O
",",O
Kokilaben,O
Dhirubhai,O
Ambani,O
"
",O
Hospital,O
and,O
Medical,O
Research,O
Institute,O
",",O
Mumbai,O
",",O
India,O
.,O
tanusinghal@yahoo.com,O
.,O
"

",O
There,O
is,O
a,O
new,O
public,O
health,O
crises,O
threatening,O
the,O
world,O
with,O
the,O
emergence,O
and,O
"
",O
spread,O
of,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
or,O
the,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
.,O
The,O
virus,O
originated,O
in,O
bats,O
and,O
was,O
"
",O
transmitted,O
to,O
humans,O
through,O
yet,O
unknown,O
intermediary,O
animals,O
in,O
Wuhan,O
",",O
Hubei,O
"
",O
province,O
",",O
China,O
in,O
December,O
2019,O
.,O
There,O
have,O
been,O
around,O
96000,O
reported,O
cases,O
of,O
"
",O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID2019,O
),O
and,O
3300,O
reported,O
deaths,O
to,O
date,O
"
",O
(,O
5,O
3,O
2020,O
),O
.,O
The,O
disease,O
is,O
transmitted,O
by,O
inhalation,O
or,O
contact,O
with,O
infected,O
"
",O
droplets,O
and,O
the,O
incubation,O
period,O
ranges,O
from,O
2,O
to,O
14,O
d.,O
The,O
symptoms,O
are,O
"
",O
usually,O
fever,O
",",O
cough,O
",",O
sore,O
throat,O
",",O
breathlessness,O
",",O
fatigue,O
",",O
malaise,O
among,O
others,O
.,O
"
",O
The,O
disease,O
is,O
mild,O
in,O
most,O
people,O
;,O
in,O
some,O
(,O
usually,O
the,O
elderly,O
and,O
those,O
with,O
"
",O
comorbidities,O
),O
",",O
it,O
may,O
progress,O
to,O
pneumonia,O
",",O
acute,O
respiratory,O
distress,O
syndrome,O
"
",O
(,O
ARDS,O
),O
and,O
multi,O
organ,O
dysfunction,O
.,O
Many,O
people,O
are,O
asymptomatic,O
.,O
The,O
case,O
"
",O
fatality,O
rate,O
is,O
estimated,O
to,O
range,O
from,O
2,O
to,O
3,O
%,O
.,O
Diagnosis,O
is,O
by,O
demonstration,O
"
",O
of,O
the,O
virus,O
in,O
respiratory,O
secretions,O
by,O
special,O
molecular,O
tests,O
.,O
Common,O
"
",O
laboratory,O
findings,O
include,O
normal,O
 ,O
low,O
white,O
cell,O
counts,O
with,O
elevated,O
"
",O
Creactive,O
protein,O
(,O
CRP,O
),O
.,O
The,O
computerized,O
tomographic,O
chest,O
scan,O
is,O
usually,O
"
",O
abnormal,O
even,O
in,O
those,O
with,O
no,O
symptoms,O
or,O
mild,O
disease,O
.,O
Treatment,O
is,O
essentially,O
"
",O
supportive,O
;,O
role,O
of,O
antiviral,O
agents,O
is,O
yet,O
to,O
be,O
established,O
.,O
Prevention,O
entails,O
"
",O
home,O
isolation,O
of,O
suspected,O
cases,O
and,O
those,O
with,O
mild,O
illnesses,O
and,O
strict,O
"
",O
infection,O
control,O
measures,O
at,O
hospitals,O
that,O
include,O
contact,O
and,O
droplet,O
"
",O
precautions,O
.,O
The,O
virus,O
spreads,O
faster,O
than,O
its,O
two,O
ancestors,O
the,O
SARSCoV,O
and,O
"
",O
Middle,O
East,O
respiratory,O
syndrome,O
coronavirus,O
(,O
MERSCoV,O
),O
",",O
but,O
has,O
lower,O
fatality,O
.,O
"
",O
The,O
global,O
impact,O
of,O
this,O
new,O
epidemic,O
is,O
yet,O
uncertain,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12098020032636,O
"
",O
PMID,O
:,O
32166607,O
"


",O
64,O
.,O
Front,O
Med,O
.,O
2020,O
Mar,O
12,O
.,O
doi,O
:,O
10.1007,O
s116840200755z,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
China,O
's,O
local,O
governments,O
are,O
combating,O
COVID19,B-Disease_COVID-19
with,O
unprecedented,O
responses,O
"
",O
from,O
a,O
Wenzhou,O
governance,O
perspective,O
.,O
"

",O
Gong,O
F(1)(2,O
),O
",",O
Xiong,O
Y(2,O
),O
",",O
Xiao,O
J(1)(2,O
),O
",",O
Lin,O
L(1)(2,O
),O
",",O
Liu,O
X(3,O
),O
",",O
Wang,O
D(2,O
),O
",",O
Li,O
"
",O
X(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Pharmaceutical,O
Sciences,O
",",O
Wenzhou,O
Medical,O
University,O
",",O
Wenzhou,O
",",O
"
",O
325035,O
",",O
China,O
.,O
"
",O
(2)Biomedicine,O
Collaborative,O
Innovation,O
Center,O
",",O
Wenzhou,O
",",O
325035,O
",",O
China,O
.,O
"
",O
(3)School,O
of,O
Public,O
Health,O
and,O
Management,O
",",O
Wenzhou,O
Medical,O
University,O
",",O
Wenzhou,O
",",O
"
",O
325035,O
",",O
China,O
.,O
"
",O
(4)School,O
of,O
Pharmaceutical,O
Sciences,O
",",O
Wenzhou,O
Medical,O
University,O
",",O
Wenzhou,O
",",O
"
",O
325035,O
",",O
China,O
.,O
lixk1964@163.com,O
.,O
"
",O
(5)Biomedicine,O
Collaborative,O
Innovation,O
Center,O
",",O
Wenzhou,O
",",O
325035,O
",",O
China,O
.,O
"
",O
lixk1964@163.com,O
.,O
"

",O
The,O
COVID19,B-Disease_COVID-19
caused,O
by,O
a,O
novel,O
strain,O
of,O
Coronavirus,O
has,O
been,O
spreading,O
rapidly,O
"
",O
since,O
its,O
onset,O
in,O
Wuhan,O
",",O
the,O
capital,O
city,O
of,O
central,O
China,O
's,O
Hubei,O
Province,O
",",O
in,O
"
",O
December,O
2019,O
.,O
It,O
is,O
highly,O
communicable,O
through,O
humantohuman,O
transmission,O
.,O
"
",O
China,O
has,O
been,O
making,O
unprecedented,O
efforts,O
in,O
treating,O
the,O
confirmed,O
cases,O
",",O
"
",O
identifying,O
and,O
isolating,O
their,O
close,O
contacts,O
and,O
suspected,O
cases,O
to,O
control,O
the,O
"
",O
source,O
of,O
infection,O
and,O
cut,O
the,O
route,O
of,O
transmission,O
.,O
China,O
's,O
devotion,O
in,O
"
",O
handling,O
this,O
epidemic,O
has,O
effectively,O
and,O
efficiently,O
curbed,O
communication,O
"
",O
domestically,O
and,O
across,O
the,O
border,O
.,O
Representative,O
measures,O
adopted,O
by,O
Wenzhou,O
",",O
"
",O
the,O
worst,O
hit,O
city,O
out,O
of,O
Hubei,O
Province,O
",",O
are,O
examined,O
to,O
elucidate,O
those,O
massive,O
"
",O
undertakings,O
with,O
the,O
aim,O
of,O
enhancing,O
international,O
understanding,O
and,O
building,O
"
",O
global,O
rapport,O
in,O
fighting,O
this,O
evolving,O
epidemic,O
situation,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s116840200755z,O
"
",O
PMID,O
:,O
32166600,O
"


",O
65,O
.,O
Eur,O
J,O
Nucl,O
Med,O
Mol,O
Imaging,O
.,O
2020,O
Mar,O
12,O
.,O
doi,O
:,O
10.1007,O
s00259020047626,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
18FFDG,O
PET,O
CT,O
and,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Joob,O
B(1,O
),O
",",O
Wiwanitkit,O
V(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Sanitation1,O
Medical,O
Academic,O
Center,O
",",O
Bangkok,O
",",O
Thailand,O
.,O
beuyjoob@hotmail.com,O
.,O
"
",O
(2)Dr,O
DY,O
Patil,O
University,O
",",O
Pune,O
",",O
India,O
.,O
"
",O
(3)Hainan,O
Medical,O
University,O
",",O
Haikou,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00259020047626,O
"
",O
PMID,O
:,O
32166511,O
"


",O
66,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
12,O
.,O
pii,O
:,O
ciaa255,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa255,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Protecting,O
Health,O
Care,O
Workers,O
during,O
the,O
COVID19,B-Disease_COVID-19
Coronavirus,O
Outbreak,O
Lessons,O
"
",O
from,O
Taiwan,O
's,O
SARS,O
response,O
.,O
"

",O
Schwartz,O
J(1,O
),O
",",O
King,O
CC(2,O
),O
",",O
Yen,O
MY(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Political,O
Science,O
",",O
State,O
University,O
of,O
New,O
York,O
at,O
New,O
Paltz,O
",",O
"
",O
New,O
Paltz,O
",",O
NY,O
",",O
USA,O
.,O
"
",O
(2)Institute,O
of,O
Epidemiology,O
and,O
Preventive,O
Medicine,O
",",O
College,O
of,O
Public,O
Health,O
",",O
"
",O
National,O
Taiwan,O
University,O
",",O
Taipei,O
",",O
Taiwan,O
.,O
"
",O
(3)Division,O
of,O
Infectious,O
Diseases,O
",",O
Taipei,O
City,O
Hospital,O
",",O
and,O
National,O
YangMing,O
"
",O
University,O
",",O
School,O
of,O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
.,O
"

",O
During,O
major,O
epidemic,O
outbreaks,O
",",O
demand,O
for,O
health,O
care,O
workers,O
grows,O
even,O
as,O
the,O
"
",O
extreme,O
pressures,O
they,O
face,O
cause,O
declining,O
availability,O
.,O
We,O
draw,O
on,O
Taiwan,O
's,O
"
",O
SARS,O
experience,O
to,O
argue,O
that,O
a,O
modified,O
form,O
of,O
Traffic,O
Control,O
Bundling,O
"
",O
protects,O
health,O
care,O
worker,O
safety,O
and,O
by,O
extension,O
strengthens,O
overall,O
COVID19,B-Disease_COVID-19
"
",O
epidemic,O
control,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa255,O
"
",O
PMID,O
:,O
32166318,O
"


",O
67,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
12,O
.,O
pii,O
:,O
ciaa256,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa256,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
A,O
Novel,O
Approach,O
for,O
a,O
Novel,O
Pathogen,O
:,O
using,O
a,O
home,O
assessment,O
team,O
to,O
evaluate,O
"
",O
patients,O
for,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
.,O
"

",O
BrysonCahn,O
C(1)(2,O
),O
",",O
Duchin,O
J(1)(3,O
),O
",",O
Makarewicz,O
VA(2,O
),O
",",O
Kay,O
M(3,O
),O
",",O
Rietberg,O
K(2,O
),O
",",O
"
",O
Napolitano,O
N(2,O
),O
",",O
Kamangu,O
C(2,O
),O
",",O
Dellit,O
TH(1,O
),O
",",O
Lynch,O
JB(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Allergy,O
and,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Medicine,O
",",O
"
",O
University,O
of,O
Washington,O
School,O
of,O
Medicine,O
",",O
Seattle,O
",",O
WA,O
.,O
"
",O
(2)Infection,O
Prevention,O
and,O
Control,O
",",O
Harborview,O
Medical,O
Center,O
",",O
Seattle,O
",",O
WA,O
.,O
"
",O
(3)Communicable,O
Disease,O
Epidemiology,O
and,O
Immunization,O
",",O
Prevention,O
Division,O
",",O
"
",O
Public,O
HealthSeattle,O
&,O
King,O
County,O
",",O
Seattle,O
",",O
WA,O
.,O
"

",O
Thousands,O
of,O
people,O
in,O
the,O
United,O
States,O
have,O
required,O
testing,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"
",O
Evaluation,O
for,O
a,O
special,O
pathogen,O
is,O
resource,O
intensive,O
.,O
We,O
report,O
an,O
innovative,O
"
",O
approach,O
to,O
home,O
assessment,O
that,O
",",O
in,O
collaboration,O
with,O
public,O
health,O
",",O
enables,O
"
",O
safe,O
evaluation,O
and,O
specimen,O
collection,O
outside,O
the,O
healthcare,O
setting,O
",",O
avoiding,O
"
",O
unnecessary,O
exposures,O
and,O
resource,O
utilization,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa256,O
"
",O
PMID,O
:,O
32166310,O
"


",O
68,O
.,O
Glob,O
Health,O
Res,O
Policy,O
.,O
2020,O
Mar,O
9;5:9,O
.,O
doi,O
:,O
10.1186,O
s41256020001409,O
.,O
"
",O
eCollection,O
2020,O
.,O
"

",O
The,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
outbreak,O
:,O
what,O
can,O
be,O
learned,O
from,O
China,O
in,O
public,O
"
",O
reporting,O
?,O
"

",O
Li,O
H(1,O
),O
",",O
Chen,O
X(1)(2,O
),O
",",O
Huang,O
H(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)1Global,O
Health,O
Institute,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430072,O
China,O
.,O
"
",O
(2)2Department,O
of,O
Epidemiology,O
",",O
University,O
of,O
Florida,O
",",O
Gainesville,O
",",O
32610,O
USA,O
.,O
"
",O
(3)3School,O
of,O
Political,O
Science,O
and,O
Public,O
Administration,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
430072,O
China,O
.,O
"

",O
The,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
outbreak,O
gets,O
everyone,O
's,O
attention,O
.,O
China,O
's,O
national,O
actions,O
"
",O
against,O
the,O
outbreak,O
have,O
contributed,O
great,O
contributions,O
to,O
the,O
world,O
.,O
China,O
has,O
"
",O
been,O
learning,O
from,O
practice,O
for,O
better,O
reporting,O
and,O
is,O
fast,O
to,O
adapt,O
itself,O
.,O
In,O
"
",O
this,O
article,O
we,O
discuss,O
China,O
's,O
practice,O
in,O
public,O
reporting,O
and,O
its,O
implications,O
"
",O
to,O
global,O
health,O
.,O
Confirmed,O
cases,O
",",O
dynamic,O
suspected,O
cases,O
",",O
recovered,O
cases,O
",",O
and,O
"
",O
deaths,O
have,O
been,O
reported,O
both,O
in,O
accumulative,O
numbers,O
and,O
their,O
daily,O
updates,O
.,O
"
",O
Some,O
ratio,O
indictors,O
reporting,O
(,O
fatality,O
rate,O
",",O
recovery,O
rate,O
",",O
etc,O
.,O
),O
",",O
trend,O
"
",O
reporting,O
",",O
and,O
global,O
surveillance,O
have,O
been,O
applied,O
as,O
well,O
.,O
Some,O
improvements,O
"
",O
can,O
still,O
be,O
made,O
.,O
It,O
is,O
necessary,O
to,O
further,O
explore,O
the,O
influential,O
factors,O
"
",O
behind,O
the,O
indicators,O
for,O
interventions,O
.,O
Recommendations,O
are,O
made,O
to,O
the,O
World,O
"
",O
Health,O
Organization,O
and,O
other,O
countries,O
for,O
better,O
public,O
reporting,O
and,O
"
",O
surveillance,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s41256020001409,O
"
",O
PMCID,O
:,O
PMC7061470,O
"
",O
PMID,O
:,O
32166128,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interestsThe,O
authors,O
declare,O
that,O
they,O
"
",O
have,O
no,O
competing,O
interests,O
.,O
"


",O
69,O
.,O
Trop,O
Med,O
Health,O
.,O
2020,O
Mar,O
9;48:14,O
.,O
doi,O
:,O
10.1186,O
s41182020002012,O
.,O
eCollection,O
"
",O
2020,O
.,O
"

",O
Coronavirus,O
disease2019,O
:,O
is,O
fever,O
an,O
adequate,O
screening,O
for,O
the,O
returning,O
"
",O
travelers,O
?,O
"

",O
Bwire,O
GM(1,O
),O
",",O
Paulo,O
LS(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)1School,O
of,O
Pharmacy,O
",",O
Muhimbili,O
University,O
of,O
Health,O
and,O
Allied,O
Sciences,O
",",O
P.O.,O
"
",O
Box,O
65001,O
",",O
Dar,O
es,O
Salaam,O
",",O
Tanzania,O
.,O
"
",O
(2)2School,O
of,O
Public,O
Health,O
and,O
Social,O
Sciences,O
",",O
Muhimbili,O
University,O
of,O
Health,O
"
",O
and,O
Allied,O
Sciences,O
",",O
P.O.,O
Box,O
65001,O
",",O
Dar,O
es,O
Salaam,O
",",O
Tanzania,O
.,O
"

",O
On,O
Thursday,O
",",O
30,O
January,O
2020,O
",",O
World,O
Health,O
Organization,O
declared,O
Coronavirus,O
"
",O
disease2019,O
(,O
COVID2019,O
),O
a,O
Public,O
Health,O
Emergency,O
of,O
International,O
Concern,O
.,O
"
",O
Since,O
its,O
identification,O
in,O
late,O
December,O
2019,O
in,O
Wuhan,O
",",O
Hubei,O
Province,O
",",O
People,O
's,O
"
",O
Republic,O
of,O
China,O
",",O
the,O
number,O
of,O
cases,O
imported,O
into,O
other,O
countries,O
is,O
"
",O
increasing,O
",",O
and,O
the,O
epidemiological,O
map,O
is,O
changing,O
rapidly,O
.,O
On,O
the,O
other,O
hand,O
",",O
"
",O
body,O
temperature,O
screening,O
(,O
fever,O
),O
is,O
the,O
major,O
test,O
performed,O
at,O
points,O
of,O
"
",O
entry,O
",",O
i.e.,O
",",O
airports,O
",",O
in,O
the,O
returning,O
travelers,O
in,O
most,O
of,O
the,O
countries,O
with,O
"
",O
limited,O
resources,O
.,O
However,O
",",O
the,O
recent,O
report,O
on,O
asymptomatic,O
contact,O
"
",O
transmission,O
of,O
COVID19,B-Disease_COVID-19
and,O
travelers,O
who,O
passed,O
the,O
symptomsbased,O
screening,O
"
",O
and,O
tested,O
positive,O
for,O
COVID19,B-Disease_COVID-19
using,O
reverse,O
transcription,O
polymerase,O
chain,O
"
",O
reaction,O
(,O
RTPCR,O
),O
challenges,O
this,O
approach,O
as,O
body,O
temperature,O
screening,O
may,O
miss,O
"
",O
travelers,O
incubating,O
the,O
disease,O
or,O
travelers,O
concealing,O
fever,O
during,O
travel,O
.,O
On,O
"
",O
this,O
note,O
",",O
travel,O
restrictions,O
to,O
and,O
from,O
high,O
risk,O
areas,O
and,O
or,O
14,O
days,O
"
",O
quarantine,O
of,O
travelers,O
coming,O
from,O
high,O
risk,O
areas,O
are,O
recommended,O
to,O
prevent,O
"
",O
possible,O
importation,O
of,O
COVID19,B-Disease_COVID-19
.,O
Currently,O
",",O
RTPCR,O
is,O
a,O
reliable,O
test,O
in,O
"
",O
detecting,O
both,O
symptomatic,O
and,O
asymptomatic,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s41182020002012,O
"
",O
PMCID,O
:,O
PMC7061485,O
"
",O
PMID,O
:,O
32165854,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interestsThe,O
authors,O
declare,O
that,O
they,O
"
",O
have,O
no,O
competing,O
interests,O
.,O
"


",O
70,O
.,O
Proc,O
Natl,O
Acad,O
Sci,O
U,O
S,O
A.,O
2020,O
Mar,O
12,O
.,O
pii,O
:,O
202002589,O
.,O
doi,O
:,O
"
",O
10.1073,O
pnas.2002589117,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Enhanced,O
isolation,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
by,O
TMPRSS2expressing,O
cells,O
.,O
"

",O
Matsuyama,O
S(1,O
),O
",",O
Nao,O
N(2,O
),O
",",O
Shirato,O
K(2,O
),O
",",O
Kawase,O
M(2,O
),O
",",O
Saito,O
S(3,O
),O
",",O
Takayama,O
I(3,O
),O
",",O
"
",O
Nagata,O
N(4,O
),O
",",O
Sekizuka,O
T(5,O
),O
",",O
Katoh,O
H(2,O
),O
",",O
Kato,O
F(2,O
),O
",",O
Sakata,O
M(2,O
),O
",",O
Tahara,O
M(2,O
),O
",",O
"
",O
Kutsuna,O
S(6,O
),O
",",O
Ohmagari,O
N(6,O
),O
",",O
Kuroda,O
M(5,O
),O
",",O
Suzuki,O
T(4,O
),O
",",O
Kageyama,O
T(3,O
),O
",",O
Takeda,O
"
",O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Virology,O
3,O
",",O
National,O
Institute,O
of,O
Infectious,O
Diseases,O
",",O
Tokyo,O
"
",O
1628640,O
",",O
Japan,O
;,O
matuyama@nih.go.jp,O
mtakeda@nih.go.jp,O
.,O
"
",O
(2)Department,O
of,O
Virology,O
3,O
",",O
National,O
Institute,O
of,O
Infectious,O
Diseases,O
",",O
Tokyo,O
"
",O
1628640,O
",",O
Japan,O
.,O
"
",O
(3)Influenza,O
Virus,O
Research,O
Center,O
",",O
National,O
Institute,O
of,O
Infectious,O
Diseases,O
",",O
"
",O
Tokyo,O
1628640,O
",",O
Japan,O
.,O
"
",O
(4)Department,O
of,O
Pathology,O
",",O
National,O
Institute,O
of,O
Infectious,O
Diseases,O
",",O
Tokyo,O
"
",O
1628640,O
",",O
Japan,O
.,O
"
",O
(5)Pathogen,O
Genomics,O
Center,O
",",O
National,O
Institute,O
of,O
Infectious,O
Diseases,O
",",O
Tokyo,O
"
",O
1628640,O
",",O
Japan,O
.,O
"
",O
(6)Disease,O
Control,O
and,O
Prevention,O
Center,O
",",O
National,O
Center,O
for,O
Global,O
Health,O
and,O
"
",O
Medicine,O
",",O
Tokyo,O
1628655,O
",",O
Japan,O
.,O
"

",O
A,O
novel,O
betacoronavirus,O
",",O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
"
",O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
which,O
caused,O
a,O
large,O
respiratory,O
outbreak,O
in,O
Wuhan,O
",",O
China,O
in,O
"
",O
December,O
2019,O
",",O
is,O
currently,O
spreading,O
across,O
many,O
countries,O
globally,O
.,O
Here,O
",",O
we,O
"
",O
show,O
that,O
a,O
TMPRSS2expressing,O
VeroE6,O
cell,O
line,O
is,O
highly,O
susceptible,O
to,O
"
",O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
",",O
making,O
it,O
useful,O
for,O
isolating,O
and,O
propagating,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"
",O
Our,O
results,O
reveal,O
that,O
",",O
in,O
common,O
with,O
SARS,O
and,O
Middle,O
East,O
respiratory,O
"
",O
syndromeCoV,O
",",O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
is,O
enhanced,O
by,O
TMPRSS2,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
the,O
Author(s,O
),O
.,O
Published,O
by,O
PNAS,O
.,O
"

",O
DOI,O
:,O
10.1073,O
pnas.2002589117,O
"
",O
PMID,O
:,O
32165541,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
competing,O
interest,O
.,O
"


",O
71,O
.,O
Vet,O
Rec,O
.,O
2020,O
Mar,O
14;186(10):298,O
.,O
doi,O
:,O
10.1136,O
vr.m1009,O
.,O
"

",O
RCVS,O
may,O
relax,O
guidance,O
due,O
to,O
Covid19,B-Disease_COVID-19
.,O
"

",O
[,O
No,O
authors,O
listed,O
],O
"

",O
DOI,O
:,O
10.1136,O
vr.m1009,O
"
",O
PMID,O
:,O
32165502,O
"


",O
72,O
.,O
BMJ,O
.,O
2020,O
Mar,O
12;368:m1036,O
.,O
doi,O
:,O
10.1136,O
bmj.m1036,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
WHO,O
declares,O
pandemic,O
because,O
of,O
"""",O
alarming,O
levels,O
"""",O
of,O
spread,O
",",O
severity,O
",",O
"
",O
and,O
inaction,O
.,O
"

",O
Mahase,O
E(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m1036,O
"
",O
PMID,O
:,O
32165426,O
"


",O
73,O
.,O
BMJ,O
.,O
2020,O
Mar,O
12;368:m1037,O
.,O
doi,O
:,O
10.1136,O
bmj.m1037,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
Trump,O
cancels,O
all,O
flights,O
from,O
Europe,O
",",O
apart,O
from,O
the,O
UK,O
.,O
"

",O
Tanne,O
JH(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)New,O
York,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m1037,O
"
",O
PMID,O
:,O
32165415,O
"


",O
74,O
.,O
BMJ,O
.,O
2020,O
Mar,O
12;368:m1038,O
.,O
doi,O
:,O
10.1136,O
bmj.m1038,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
GPs,O
call,O
for,O
appraisals,O
and,O
CQC,O
inspections,O
to,O
be,O
suspended,O
.,O
"

",O
Rimmer,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m1038,O
"
",O
PMID,O
:,O
32165414,O
"


",O
75,O
.,O
Microbiol,O
Resour,O
Announc,O
.,O
2020,O
Mar,O
12;9(11,O
),O
.,O
pii,O
:,O
e0016920,O
.,O
doi,O
:,O
"
",O
10.1128,O
MRA.0016920,O
.,O
"

",O
Complete,O
Genome,O
Sequence,O
of,O
a,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
Strain,O
Isolated,O
"
",O
in,O
Nepal,O
.,O
"

",O
Sah,O
R(#)(1,O
),O
",",O
RodriguezMorales,O
AJ(#)(2)(3,O
),O
",",O
Jha,O
R(4,O
),O
",",O
Chu,O
DKW(5,O
),O
",",O
Gu,O
H(5,O
),O
",",O
Peiris,O
"
",O
M(5,O
),O
",",O
Bastola,O
A(6,O
),O
",",O
Lal,O
BK(7,O
),O
",",O
Ojha,O
HC(7,O
),O
",",O
Rabaan,O
AA(8,O
),O
",",O
Zambrano,O
LI(9,O
),O
",",O
Costello,O
"
",O
A(10,O
),O
",",O
Morita,O
K(11,O
),O
",",O
Pandey,O
BD(6,O
),O
",",O
Poon,O
LLM(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Public,O
Health,O
Laboratory,O
",",O
Kathmandu,O
",",O
Nepal,O
ranjitsah@iom.edu.np,O
.,O
"
",O
(2)Public,O
Health,O
and,O
Infection,O
Research,O
Group,O
",",O
Faculty,O
of,O
Health,O
Sciences,O
",",O
"
",O
Universidad,O
Tecnologica,O
de,O
Pereira,O
",",O
Pereira,O
",",O
Risaralda,O
",",O
Colombia,O
.,O
"
",O
(3)Grupo,O
de,O
InvestigaciÃ³n,O
Biomedicina,O
",",O
Faculty,O
of,O
Medicine,O
",",O
FundaciÃ³n,O
"
",O
Universitaria,O
AutÃ³noma,O
de,O
las,O
AmÃ©ricas,O
",",O
Pereira,O
",",O
Risaralda,O
",",O
Colombia,O
.,O
"
",O
(4)National,O
Public,O
Health,O
Laboratory,O
",",O
Kathmandu,O
",",O
Nepal,O
.,O
"
",O
(5)School,O
of,O
Public,O
Health,O
",",O
LKS,O
Faculty,O
of,O
Medicine,O
",",O
The,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(6)Sukraraj,O
Tropical,O
and,O
Infectious,O
Disease,O
Hospital,O
",",O
Kathmandu,O
",",O
Nepal,O
.,O
"
",O
(7)Epidemiology,O
and,O
Disease,O
Control,O
Division,O
",",O
Government,O
of,O
Nepal,O
",",O
Kathmandu,O
",",O
"
",O
Nepal,O
.,O
"
",O
(8)Johns,O
Hopkins,O
Aramco,O
Healthcare,O
",",O
Dhahran,O
",",O
Saudi,O
Arabia,O
.,O
"
",O
(9)Departments,O
of,O
Physiological,O
and,O
Morphological,O
Sciences,O
",",O
School,O
of,O
Medical,O
"
",O
Sciences,O
",",O
Universidad,O
Nacional,O
AutÃ³noma,O
de,O
Honduras,O
(,O
UNAH,O
),O
",",O
Tegucigalpa,O
",",O
"
",O
Honduras,O
.,O
"
",O
(10)Global,O
Health,O
and,O
Sustainable,O
Development,O
",",O
University,O
College,O
London,O
",",O
London,O
",",O
"
",O
United,O
Kingdom,O
.,O
"
",O
(11)Department,O
of,O
Virology,O
",",O
Institute,O
of,O
Tropical,O
Medicine,O
",",O
Nagasaki,O
University,O
",",O
"
",O
Nagasaki,O
",",O
Japan,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
A,O
complete,O
genome,O
sequence,O
was,O
obtained,O
for,O
a,O
severe,O
acute,O
respiratory,O
syndrome,O
"
",O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
strain,O
isolated,O
from,O
an,O
oropharyngeal,O
swab,O
specimen,O
of,O
"
",O
a,O
Nepalese,O
patient,O
with,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
",",O
who,O
had,O
returned,O
to,O
"
",O
Nepal,O
after,O
traveling,O
to,O
Wuhan,O
",",O
China,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Sah,O
et,O
al.,O
"

",O
DOI,O
:,O
10.1128,O
MRA.0016920,O
"
",O
PMID,O
:,O
32165386,O
"


",O
76,O
.,O
BMJ,O
.,O
2020,O
Mar,O
12;368:m998,O
.,O
doi,O
:,O
10.1136,O
bmj.m998,O
.,O
"

",O
Video,O
consultations,O
for,O
covid19,B-Disease_COVID-19
.,O
"

",O
Greenhalgh,O
T(1,O
),O
",",O
Wherton,O
J(1,O
),O
",",O
Shaw,O
S(1,O
),O
",",O
Morrison,O
C(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Nuffield,O
Department,O
of,O
Primary,O
Care,O
Health,O
Sciences,O
",",O
University,O
of,O
Oxford,O
",",O
"
",O
Oxford,O
",",O
UK,O
.,O
"
",O
(2)Technology,O
Enabled,O
Care,O
Programme,O
",",O
Scottish,O
Government,O
",",O
Edinburgh,O
",",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m998,O
"
",O
PMID,O
:,O
32165352,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interests,O
:,O
We,O
have,O
read,O
and,O
understood,O
"
",O
BMJ,O
policy,O
on,O
declaration,O
of,O
interests,O
and,O
declare,O
the,O
following,O
interests,O
:,O
CM,O
"
",O
coleads,O
the,O
video,O
consultation,O
programme,O
for,O
the,O
Scottish,O
Government,O
.,O
JW,O
and,O
TG,O
"
",O
are,O
undertaking,O
an,O
evaluation,O
of,O
the,O
Scottish,O
government,O
â€™s,O
video,O
consultation,O
"
",O
programme,O
.,O
"


",O
77,O
.,O
Microb,O
Pathog,O
.,O
2020,O
Mar,O
9:104135,O
.,O
doi,O
:,O
10.1016,O
j.micpath.2020.104135,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Identification,O
of,O
60,O
secreted,O
proteins,O
for,O
Mycoplasma,O
bovis,O
with,O
secretome,O
assay,O
.,O
"

",O
Zubair,O
M(1,O
),O
",",O
Muhamed,O
SA(1,O
),O
",",O
Khan,O
FA(2,O
),O
",",O
Zhao,O
G(1,O
),O
",",O
Menghwar,O
H(1,O
),O
",",O
Faisal,O
M(1,O
),O
",",O
"
",O
Zhang,O
H(1,O
),O
",",O
Zhu,O
X(1,O
),O
",",O
Rasheed,O
MA(3,O
),O
",",O
Chen,O
Y(4,O
),O
",",O
Marawan,O
MA(5,O
),O
",",O
Chen,O
H(4,O
),O
",",O
Guo,O
"
",O
A(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
;,O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
;,O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"
",O
(2)The,O
State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
;,O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
;,O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
;,O
The,O
University,O
of,O
Agriculture,O
",",O
"
",O
Peshawar,O
",",O
Department,O
of,O
Animal,O
Health,O
",",O
Khyber,O
Pakhtunkhwa,O
",",O
25120,O
",",O
Pakistan,O
.,O
"
",O
(3)The,O
State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
;,O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
;,O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
;,O
Department,O
of,O
Biosciences,O
",",O
COMSATS,O
"
",O
Institute,O
of,O
Information,O
Technology,O
",",O
Sahiwal,O
",",O
Pakistan,O
.,O
"
",O
(4)The,O
State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
;,O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
;,O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
;,O
Key,O
Laboratory,O
of,O
Development,O
of,O
"
",O
Veterinary,O
Diagnostic,O
Products,O
",",O
China,O
Ministry,O
of,O
Agriculture,O
;,O
Hubei,O
"
",O
International,O
Scientific,O
and,O
Technological,O
Cooperation,O
Base,O
of,O
Veterinary,O
"
",O
Epidemiology,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"
",O
(5)The,O
State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
;,O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
;,O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
;,O
Infectious,O
Diseases,O
",",O
Animal,O
"
",O
Medicine,O
Department,O
.,O
Faculty,O
of,O
Veterinary,O
Medicine,O
",",O
Benha,O
University,O
",",O
Qualyobia,O
",",O
"
",O
Egypt,O
.,O
"
",O
(6)The,O
State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
;,O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
;,O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
;,O
Key,O
Laboratory,O
of,O
Development,O
of,O
"
",O
Veterinary,O
Diagnostic,O
Products,O
",",O
China,O
Ministry,O
of,O
Agriculture,O
;,O
Hubei,O
"
",O
International,O
Scientific,O
and,O
Technological,O
Cooperation,O
Base,O
of,O
Veterinary,O
"
",O
Epidemiology,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
aizhen@mail.hzau.edu.cn,O
.,O
"

",O
Mycoplasma,O
bovis,O
is,O
a,O
risky,O
pathogen,O
mainly,O
responsible,O
for,O
pneumonia,O
and,O
"
",O
mastitis,O
in,O
cattle,O
.,O
Up,O
to,O
date,O
",",O
its,O
pathogenesis,O
is,O
not,O
clear,O
.,O
Since,O
secreted,O
"
",O
proteins,O
have,O
a,O
tricky,O
role,O
in,O
M.,O
bovis,O
pathogenesis,O
",",O
this,O
study,O
was,O
designed,O
to,O
"
",O
systematically,O
reveal,O
M.,O
bovis,O
secretome,O
and,O
potential,O
role,O
in,O
virulence,O
of,O
the,O
"
",O
pathogen,O
.,O
By,O
using,O
bioinformatics,O
tools,O
",",O
a,O
total,O
of,O
246,O
secreted,O
proteins,O
were,O
"
",O
predicted,O
based,O
on,O
M.,O
bovis,O
genome,O
.,O
Among,O
them,O
",",O
14,O
are,O
classical,O
",",O
154,O
"
",O
nonclassical,O
and,O
78,O
both,O
pathways,O
.,O
Then,O
by,O
using,O
2dimensional,O
gel,O
"
",O
electrophoresis,O
(,O
2DE,O
),O
and,O
Matrixassisted,O
laser,O
desorption,O
ionization,O
time,O
of,O
"
",O
flight,O
mass,O
spectrometry,O
(,O
MALDITOF,O
MS,O
),O
",",O
169,O
proteins,O
were,O
revealed,O
.,O
Of,O
them,O
",",O
60,O
"
",O
were,O
predicted,O
to,O
be,O
secreted,O
including,O
3,O
classical,O
",",O
43,O
nonclassical,O
",",O
and,O
14,O
"
",O
both,O
classical,O
and,O
nonclassical,O
.,O
Further,O
8,O
proteins,O
(,O
MbovP0038,O
",",O
MbovP0338,O
",",O
"
",O
MbovP0341,O
",",O
MbovP0520,O
",",O
MbovP0581,O
",",O
MbovP0674,O
",",O
MbovP0693,O
",",O
MbovP0845,O
),O
were,O
predicted,O
"
",O
to,O
be,O
virulencerelated,O
factors,O
with,O
VFDB,O
.,O
In,O
addition,O
",",O
MbovP0581,O
(,O
ABC,O
"
",O
transporter,O
protein,O
),O
was,O
validated,O
experimentally,O
as,O
secreted,O
in,O
nature,O
and,O
"
",O
highly,O
immunogenic,O
reacting,O
with,O
sera,O
of,O
cattle,O
experimentally,O
infected,O
with,O
M.,O
"
",O
bovis,O
.,O
In,O
conclusion,O
",",O
this,O
study,O
might,O
be,O
a,O
crucial,O
step,O
towards,O
a,O
better,O
"
",O
understanding,O
of,O
pathogenesis,O
and,O
leading,O
to,O
the,O
development,O
of,O
novel,O
diagnostic,O
"
",O
marker,O
and,O
potent,O
vaccine,O
against,O
M.,O
bovis,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
Ltd.,O
"

",O
DOI,O
:,O
10.1016,O
j.micpath.2020.104135,O
"
",O
PMID,O
:,O
32165330,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
78,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
9:101617,O
.,O
doi,O
:,O
10.1016,O
j.tmaid.2020.101617,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
 ,O
the,O
role,O
of,O
mass,O
gatherings,O
.,O
"

",O
Ebrahim,O
SH(1,O
),O
",",O
Memish,O
ZA(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)University,O
of,O
Sciences,O
",",O
Technique,O
and,O
Technology,O
",",O
Bamako,O
",",O
Mali,O
.,O
Electronic,O
"
",O
address,O
:,O
ebrahimsh2@gmail.com,O
.,O
"
",O
(2)Research,O
&,O
Innovation,O
Center,O
",",O
King,O
Saud,O
Medical,O
City,O
",",O
Ministry,O
of,O
Health,O
and,O
;,O
"
",O
College,O
of,O
Medicine,O
",",O
Alfaisal,O
University,O
",",O
Riyadh,O
",",O
Saudi,O
Arabia,O
.,O
Hubert,O
Department,O
"
",O
of,O
Global,O
Health,O
",",O
Rollins,O
School,O
of,O
Public,O
Health,O
",",O
Emory,O
University,O
",",O
Atlanta,O
",",O
GA,O
",",O
"
",O
USA,O
.,O
Electronic,O
address,O
:,O
zmemish@yahoo.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101617,O
"
",O
PMID,O
:,O
32165283,O
"


",O
79,O
.,O
Ann,O
Oncol,O
.,O
2020,O
Mar,O
9,O
.,O
pii,O
:,O
S09237534(20)360804,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.annonc.2020.03.001,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Atypical,O
lung,O
feature,O
on,O
chest,O
CT,O
in,O
a,O
lung,O
adenocarcinoma,O
cancer,O
patient,O
"
",O
infected,O
with,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Qu,O
J(1,O
),O
",",O
Yang,O
R(2,O
),O
",",O
Song,O
L(3,O
),O
",",O
Kamel,O
IR(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
the,O
Affiliated,O
Cancer,O
Hospital,O
&,O
Henan,O
Cancer,O
"
",O
Hospital,O
",",O
Zhengzhou,O
",",O
Henan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
qjryq@126.com,O
.,O
"
",O
(2)Department,O
of,O
Medical,O
Imaging,O
",",O
Henan,O
Chest,O
Hospital,O
",",O
Zhengzhou,O
",",O
Henan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Radiology,O
",",O
the,O
Sixth,O
People,O
Hospital,O
of,O
Zhengzhou,O
",",O
Zhengzhou,O
",",O
"
",O
Henan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Radiology,O
",",O
Johns,O
Hopkins,O
University,O
School,O
of,O
Medicine,O
",",O
"
",O
Baltimore,O
",",O
Maryland,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.annonc.2020.03.001,O
"
",O
PMID,O
:,O
32165205,O
"


",O
80,O
.,O
Ultrasound,O
Med,O
Biol,O
.,O
2020,O
Mar,O
9,O
.,O
pii,O
:,O
S03015629(20)300600,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ultrasmedbio.2020.02.001,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
ContrastEnhanced,O
Ultrasound,O
Findings,O
and,O
Differential,O
Diagnosis,O
of,O
Hepatic,O
"
",O
Epithelioid,O
Angiomyolipoma,O
Compared,O
With,O
Hepatocellular,O
Carcinoma,O
.,O
"

",O
Huang,O
Z(1,O
),O
",",O
Wu,O
X(1,O
),O
",",O
Li,O
S(1,O
),O
",",O
Li,O
K(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medical,O
Ultrasound,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Medical,O
Ultrasound,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
Liky20006@126.com,O
.,O
"

",O
Hepatic,O
epithelioid,O
angiomyolipoma,O
(,O
EAML,O
),O
has,O
malignant,O
potential,O
that,O
can,O
easily,O
"
",O
be,O
misdiagnosed,O
as,O
hepatocellular,O
carcinoma,O
(,O
HCC,O
),O
",",O
but,O
the,O
treatment,O
options,O
of,O
"
",O
these,O
conditions,O
are,O
different,O
.,O
This,O
retrospective,O
study,O
investigated,O
whether,O
"
",O
contrastenhanced,O
ultrasound,O
(,O
CEUS,O
),O
can,O
differentiate,O
EAML,O
from,O
HCC,O
.,O
We,O
included,O
"
",O
24,O
patients,O
with,O
pathologically,O
confirmed,O
EAML,O
and,O
36,O
patients,O
with,O
HCC,O
who,O
"
",O
underwent,O
preoperative,O
conventional,O
ultrasound,O
and,O
CEUS,O
.,O
The,O
conventional,O
"
",O
ultrasound,O
and,O
CEUS,O
features,O
of,O
the,O
two,O
groups,O
were,O
analyzed,O
.,O
Time,O
intensity,O
"
",O
curves,O
(,O
TICs,O
),O
were,O
analyzed,O
for,O
all,O
lesions,O
using,O
quantitative,O
perfusion,O
analysis,O
"
",O
software,O
.,O
This,O
study,O
found,O
that,O
significant,O
differences,O
existed,O
between,O
the,O
EAML,O
"
",O
and,O
HCC,O
groups,O
in,O
terms,O
of,O
clinical,O
features,O
such,O
as,O
sex,O
",",O
age,O
",",O
symptoms,O
",",O
"
",O
alphafetoprotein,O
and,O
history,O
of,O
hepatitis,O
B,O
virus,O
infection,O
(,O
p,O
<,O
0.05,O
),O
.,O
Tumor,O
"
",O
size,O
",",O
number,O
",",O
border,O
and,O
echogenicity,O
on,O
conventional,O
ultrasound,O
were,O
"
",O
significantly,O
different,O
between,O
EAML,O
and,O
HCC,O
(,O
p,O
<,O
0.05,O
),O
.,O
Regarding,O
CEUS,O
",",O
EAML,O
was,O
"
",O
more,O
likely,O
to,O
have,O
a,O
centripetal,O
enhancement,O
pattern,O
than,O
HCC,O
(,O
p,O
<,O
0.05,O
),O
.,O
The,O
"
",O
tumor,O
enhancement,O
degree,O
in,O
the,O
delayed,O
phase,O
in,O
CEUS,O
was,O
significantly,O
"
",O
different,O
Â ,O
between,O
EAML,O
and,O
HCC,O
(,O
p,O
<,O
0.05,O
),O
.,O
Quantitative,O
analysis,O
of,O
CEUS,O
"
",O
parameters,O
revealed,O
that,O
the,O
washin,O
area,O
under,O
the,O
curve,O
(,O
AUC,O
),O
was,O
larger,O
in,O
"
",O
EAML,O
than,O
in,O
HCC,O
(,O
p,O
<,O
0.05,O
),O
.,O
Time,O
to,O
peak,O
was,O
significantly,O
shorter,O
in,O
EAML,O
than,O
"
",O
in,O
HCC,O
(,O
p,O
<,O
0.05,O
),O
.,O
The,O
peak,O
intensity,O
was,O
significantly,O
stronger,O
in,O
EAML,O
than,O
in,O
"
",O
HCC,O
(,O
p,O
<,O
0.05,O
),O
.,O
Regarding,O
the,O
diagnostic,O
performance,O
of,O
CEUS,O
parameters,O
that,O
"
",O
showed,O
statistical,O
significance,O
on,O
univariate,O
analysis,O
",",O
the,O
sensitivity,O
and,O
"
",O
specificity,O
for,O
distinguishing,O
EAML,O
from,O
HCC,O
was,O
66.7%100.0,O
%,O
and,O
55.6%91.7,O
%,O
",",O
"
",O
respectively,O
.,O
Overall,O
",",O
CEUS,O
could,O
be,O
valuable,O
in,O
differentiating,O
EAML,O
from,O
HCC,O
.,O
"
",O
Specific,O
features,O
such,O
as,O
the,O
centripetal,O
filling,O
and,O
prolonged,O
enhancement,O
"
",O
patterns,O
on,O
CEUS,O
",",O
higher,O
peak,O
intensity,O
",",O
bigger,O
washin,O
AUC,O
and,O
shorter,O
time,O
to,O
"
",O
peak,O
on,O
TICs,O
may,O
contribute,O
to,O
a,O
more,O
confirmative,O
differential,O
diagnosis,O
of,O
"
",O
EAML,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
World,O
Federation,O
for,O
Ultrasound,O
in,O
Medicine,O
&,O
Biology,O
.,O
Published,O
"
",O
by,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ultrasmedbio.2020.02.001,O
"
",O
PMID,O
:,O
32165015,O
"


",O
81,O
.,O
Lancet,O
.,O
2020,O
Mar,O
9,O
.,O
pii,O
:,O
S01406736(20)305675,O
.,O
doi,O
:,O
"
",O
10.1016,O
S01406736(20)305675,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
How,O
will,O
countrybased,O
mitigation,O
measures,O
influence,O
the,O
course,O
of,O
the,O
COVID19,B-Disease_COVID-19
"
",O
epidemic,O
?,O
"

",O
Anderson,O
RM(1,O
),O
",",O
Heesterbeek,O
H(2,O
),O
",",O
Klinkenberg,O
D(3,O
),O
",",O
Hollingsworth,O
TD(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Disease,O
Epidemiology,O
",",O
MRC,O
Centre,O
for,O
Global,O
Health,O
"
",O
Analysis,O
",",O
Imperial,O
College,O
London,O
",",O
London,O
W2,O
1PG,O
",",O
UK,O
.,O
Electronic,O
address,O
:,O
"
",O
roy.anderson@imperial.ac.uk,O
.,O
"
",O
(2)Department,O
of,O
Population,O
Health,O
Sciences,O
",",O
Utrecht,O
University,O
",",O
Utrecht,O
",",O
"
",O
Netherlands,O
.,O
"
",O
(3)National,O
Institute,O
for,O
Public,O
Health,O
and,O
the,O
Environment,O
(,O
RIVM,O
),O
",",O
Bilthoven,O
",",O
"
",O
Netherlands,O
.,O
"
",O
(4)Big,O
Data,O
Institute,O
",",O
Li,O
Ka,O
Shing,O
Centre,O
for,O
Health,O
Information,O
and,O
Discovery,O
",",O
"
",O
University,O
of,O
Oxford,O
",",O
Oxford,O
",",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)305675,O
"
",O
PMID,O
:,O
32164834,O
"


",O
82,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
9,O
.,O
pii,O
:,O
S14733099(20)301560,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301560,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
with,O
spontaneous,O
pneumomediastinum,O
.,O
"

",O
Zhou,O
C(1,O
),O
",",O
Gao,O
C(1,O
),O
",",O
Xie,O
Y(2,O
),O
",",O
Xu,O
M(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Zhejiang,O
Chinese,O
"
",O
Medical,O
University,O
",",O
Hangzhou,O
",",O
Zhejiang,O
",",O
China,O
;,O
The,O
First,O
Clinical,O
Medical,O
College,O
"
",O
of,O
Zhejiang,O
Chinese,O
Medical,O
University,O
",",O
Hangzhou,O
",",O
Zhejiang,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
Central,O
Hospital,O
of,O
Wuhan,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Radiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Zhejiang,O
Chinese,O
"
",O
Medical,O
University,O
",",O
Hangzhou,O
",",O
Zhejiang,O
",",O
China,O
;,O
The,O
First,O
Clinical,O
Medical,O
College,O
"
",O
of,O
Zhejiang,O
Chinese,O
Medical,O
University,O
",",O
Hangzhou,O
",",O
Zhejiang,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
xums166@zcmu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301560,O
"
",O
PMID,O
:,O
32164830,O
"


",O
83,O
.,O
BMC,O
Med,O
.,O
2020,O
Mar,O
13;18(1):80,O
.,O
doi,O
:,O
10.1186,O
s12916020015518,O
.,O
"

",O
What,O
further,O
should,O
be,O
done,O
to,O
control,O
COVID19,B-Disease_COVID-19
outbreaks,O
in,O
addition,O
to,O
cases,O
"
",O
isolation,O
and,O
contact,O
tracing,O
measures,O
?,O
"

",O
He,O
Z(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Public,O
Health,O
",",O
Sun,O
Yatsen,O
University,O
",",O
Guangzhou,O
",",O
510080,O
",",O
China,O
.,O
"
",O
hezhenj3@mail.sysu.edu.cn,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Tropical,O
Disease,O
Control,O
(,O
Sun,O
Yatsen,O
University,O
),O
",",O
Ministry,O
"
",O
of,O
Education,O
",",O
Guangzhou,O
",",O
510080,O
",",O
China,O
.,O
hezhenj3@mail.sysu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s12916020015518,O
"
",O
PMID,O
:,O
32164708,O
"


",O
84,O
.,O
Am,O
J,O
Chin,O
Med,O
.,O
2020,O
Mar,O
0.629166667,O
.,O
doi,O
:,O
10.1142,O
S0192415X20500378,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
:,O
An,O
Update,O
on,O
the,O
Epidemiological,O
",",O
Clinical,O
",",O
Preventive,O
and,O
Therapeutic,O
"
",O
Evidence,O
and,O
Guidelines,O
of,O
Integrative,O
ChineseWestern,O
Medicine,O
for,O
the,O
"
",O
Management,O
of,O
2019,B-Disease_COVID-19
Novel,I-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
.,O
"

",O
Chan,O
KW(1,O
),O
",",O
Wong,O
VT(2,O
),O
",",O
Tang,O
SCW(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medicine,O
",",O
The,O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
.,O
"
",O
(2)School,O
of,O
Chinese,O
Medicine,O
The,O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
.,O
"

",O
As,O
of,O
22,O
February,O
2020,O
",",O
more,O
than,O
77662,O
cases,O
of,O
confirmed,O
COVID19,B-Disease_COVID-19
have,O
been,O
"
",O
documented,O
globally,O
with,O
over,O
2360,O
deaths,O
.,O
Common,O
presentations,O
of,O
confirmed,O
"
",O
cases,O
include,O
fever,O
",",O
fatigue,O
",",O
dry,O
cough,O
",",O
upper,O
airway,O
congestion,O
",",O
sputum,O
"
",O
production,O
",",O
shortness,O
of,O
breath,O
",",O
myalgia,O
arthralgia,O
with,O
lymphopenia,O
",",O
prolonged,O
"
",O
prothrombin,O
time,O
",",O
elevated,O
Creactive,O
protein,O
",",O
and,O
elevated,O
lactate,O
"
",O
dehydrogenase,O
.,O
The,O
reported,O
severe,O
critical,O
case,O
ratio,O
is,O
approximately,O
710,O
%,O
and,O
"
",O
median,O
time,O
to,O
intensive,O
care,O
admission,O
is,O
9.510.5,O
days,O
with,O
mortality,O
of,O
around,O
"
",O
12,O
%,O
varied,O
geographically,O
.,O
Similar,O
to,O
outbreaks,O
of,O
other,O
newly,O
identified,O
virus,O
",",O
"
",O
there,O
is,O
no,O
proven,O
regimen,O
from,O
conventional,O
medicine,O
and,O
most,O
reports,O
managed,O
"
",O
the,O
patients,O
with,O
lopinavir,O
ritonavir,O
",",O
ribavirin,O
",",O
betainterferon,O
",",O
glucocorticoid,O
"
",O
and,O
supportive,O
treatment,O
with,O
remdesivir,O
undergoing,O
clinical,O
trial,O
.,O
In,O
China,O
",",O
"
",O
Chinese,O
medicine,O
is,O
proposed,O
as,O
a,O
treatment,O
option,O
by,O
national,O
and,O
provincial,O
"
",O
guidelines,O
with,O
substantial,O
utilization,O
.,O
We,O
reviewed,O
the,O
latest,O
national,O
and,O
"
",O
provincial,O
clinical,O
guidelines,O
",",O
retrospective,O
cohort,O
studies,O
",",O
and,O
case,O
series,O
"
",O
regarding,O
the,O
treatment,O
of,O
COVID19,B-Disease_COVID-19
by,O
addon,O
Chinese,O
medicine,O
.,O
We,O
have,O
also,O
"
",O
reviewed,O
the,O
clinical,O
evidence,O
generated,O
from,O
SARS,O
and,O
H1N1,O
management,O
with,O
"
",O
hypothesized,O
mechanisms,O
and,O
latest,O
in,O
silico,O
findings,O
to,O
identify,O
candidate,O
"
",O
Chinese,O
medicines,O
for,O
the,O
consideration,O
of,O
possible,O
trials,O
and,O
management,O
.,O
Given,O
"
",O
the,O
paucity,O
of,O
strongly,O
evidencebased,O
regimens,O
",",O
the,O
available,O
data,O
suggest,O
that,O
"
",O
Chinese,O
medicine,O
could,O
be,O
considered,O
as,O
an,O
adjunctive,O
therapeutic,O
option,O
in,O
the,O
"
",O
management,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
DOI,O
:,O
10.1142,O
S0192415X20500378,O
"
",O
PMID,O
:,O
32164424,O
"


",O
85,O
.,O
Epidemiol,O
Health,O
.,O
2020,O
Mar,O
12:e2020011,O
.,O
doi,O
:,O
10.4178,O
epih.e2020011,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Estimating,O
the,O
reproductive,O
number,O
and,O
the,O
outbreak,O
size,O
of,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
"
",O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
using,O
mathematical,O
model,O
in,O
Republic,O
of,O
Korea,O
.,O
"

",O
Choi,O
SC(1,O
),O
",",O
Ki,O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Graduate,O
School,O
of,O
Cancer,O
Science,O
and,O
Policy,O
",",O
National,O
Cancer,O
Center,O
",",O
Goyang,O
",",O
"
",O
Korea,O
",",O
Goyang,O
",",O
Korea,O
.,O
"

",O
Objectives,O
:,O
Since,O
the,O
first,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
disease(COVID19,O
),O
patient,O
was,O
"
",O
diagnosed,O
on,O
43850,O
",",O
about,O
30,O
patients,O
were,O
diagnosed,O
in,O
Korea,O
until,O
43878,O
.,O
"
",O
However,O
",",O
5298,O
more,O
patient,O
were,O
confirmed,O
until,O
43894,O
.,O
The,O
purpose,O
is,O
to,O
"
",O
estimate,O
and,O
evaluate,O
the,O
effectiveness,O
of,O
preventive,O
measures,O
using,O
mathematical,O
"
",O
modeling,O
.,O
"
",O
Methods,O
:,O
Deterministic,O
mathematical,O
model(SEIHR,O
),O
has,O
been,O
established,O
to,O
suit,O
the,O
"
",O
Korean,O
outbreak,O
.,O
The,O
number,O
of,O
confirmed,O
patients,O
in,O
Daegu,O
and,O
North,O
Gyeongsang,O
"
",O
Province(Daegu,O
NGP,O
),O
",",O
the,O
main,O
area,O
of,O
outbreak,O
",",O
were,O
used,O
.,O
The,O
first,O
patient,O
's,O
"
",O
symptom,O
onset,O
date,O
was,O
assumed,O
on,O
43852,O
.,O
We,O
estimate,O
the,O
reproduction,O
number(R,O
),O
",",O
"
",O
and,O
the,O
effect,O
of,O
preventive,O
measures,O
",",O
assuming,O
that,O
the,O
effect,O
has,O
been,O
shown,O
"
",O
from,O
43890,O
.,O
or,O
43895,O
.,O
"
",O
Results,O
:,O
The,O
estimated,O
R,O
in,O
Hubei,O
Province,O
was,O
4.2655,O
",",O
while,O
the,O
estimated,O
"
",O
initial,O
R,O
in,O
Korea,O
was,O
0.5555,O
",",O
but,O
later,O
in,O
Daegu,O
NGP,O
",",O
the,O
value,O
was,O
between,O
"
",O
3.4721,O
and,O
3.5428,O
.,O
When,O
the,O
transmission,O
period,O
decreases,O
from,O
4,O
days,O
to,O
2,O
days,O
",",O
"
",O
the,O
outbreak,O
finished,O
early,O
",",O
but,O
the,O
peak,O
of,O
the,O
epidemic,O
has,O
increased,O
",",O
and,O
the,O
"
",O
total,O
number,O
of,O
patients,O
has,O
not,O
changed,O
much,O
.,O
If,O
transmission,O
rate,O
decreases,O
"
",O
about,O
90,O
%,O
or,O
99,O
%,O
",",O
the,O
outbreak,O
finished,O
early,O
",",O
and,O
the,O
size,O
of,O
the,O
peak,O
and,O
the,O
"
",O
total,O
number,O
of,O
patients,O
also,O
decreased,O
.,O
"
",O
Conclusion,O
:,O
To,O
early,O
end,O
of,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
",",O
efforts,O
to,O
reduce,O
the,O
spread,O
"
",O
of,O
the,O
virus,O
such,O
as,O
social,O
distancing,O
and,O
mask,O
wearing,O
are,O
absolutely,O
crucial,O
"
",O
with,O
the,O
participation,O
of,O
the,O
public,O
",",O
along,O
with,O
the,O
policy,O
of,O
reducing,O
the,O
"
",O
transmission,O
period,O
by,O
finding,O
and,O
isolating,O
patients,O
as,O
quickly,O
as,O
possible,O
"
",O
through,O
efforts,O
by,O
the,O
quarantine,O
authorities,O
.,O
"

",O
DOI,O
:,O
10.4178,O
epih.e2020011,O
"
",O
PMID,O
:,O
32164053,O
"


",O
86,O
.,O
Asian,O
J,O
Psychiatr,O
.,O
2020,O
Mar,O
4;51:101990,O
.,O
doi,O
:,O
10.1016,O
j.ajp.2020.101990,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Iranian,O
mental,O
health,O
during,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
.,O
"

",O
Zandifar,O
A(1,O
),O
",",O
Badrfam,O
R(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Imam,O
Ali,O
Hospital,O
",",O
Alborz,O
University,O
of,O
Medical,O
Sciences,O
",",O
Karaj,O
",",O
Iran,O
.,O
"
",O
Electronic,O
address,O
:,O
zandifaratefe@gmail.com,O
.,O
"
",O
(2)Roozbeh,O
Hospital,O
",",O
Tehran,O
University,O
of,O
Medical,O
Sciences,O
",",O
Tehran,O
",",O
Iran,O
.,O
"
",O
Electronic,O
address,O
:,O
rbadrfam@gmail.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ajp.2020.101990,O
"
",O
PMID,O
:,O
32163908,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
None,O
.,O
"


",O
87,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Mar,O
12,O
.,O
doi,O
:,O
10.1056,O
NEJMp2004361,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
History,O
in,O
a,O
Crisis,O
 ,O
Lessons,O
for,O
Covid19,B-Disease_COVID-19
.,O
"

",O
Jones,O
DS(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Department,O
of,O
Global,O
Health,O
and,O
Social,O
Medicine,O
",",O
Harvard,O
Medical,O
"
",O
School,O
",",O
Boston,O
",",O
and,O
the,O
Department,O
of,O
the,O
History,O
of,O
Science,O
",",O
Harvard,O
University,O
",",O
"
",O
Cambridge,O
",",O
MA,O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMp2004361,O
"
",O
PMID,O
:,O
32163699,O
"


",O
88,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Mar,O
12,O
.,O
doi,O
:,O
10.1056,O
NEJMc2003100,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
SARSCoV2,B-Disease_COVID-19
Infection,I-Disease_COVID-19
among,O
Travelers,O
Returning,O
from,O
Wuhan,O
",",O
China,O
.,O
"

",O
Ng,O
OT(1)(2,O
),O
",",O
Marimuthu,O
K(1)(2,O
),O
",",O
Chia,O
PY(1)(2,O
),O
",",O
Koh,O
V(1)(2,O
),O
",",O
Chiew,O
CJ(3,O
),O
",",O
De,O
Wang,O
"
",O
L(4,O
),O
",",O
Young,O
BE(4,O
),O
",",O
Chan,O
M(4,O
),O
",",O
Vasoo,O
S(4,O
),O
",",O
Ling,O
LM(4,O
),O
",",O
Lye,O
DC(4,O
),O
",",O
Kam,O
KQ(5,O
),O
",",O
Thoon,O
"
",O
KC(5,O
),O
",",O
Kurupatham,O
L(3,O
),O
",",O
Said,O
Z(3,O
),O
",",O
Goh,O
E(3,O
),O
",",O
Low,O
C(3,O
),O
",",O
Lim,O
SK(3,O
),O
",",O
Raj,O
P(3,O
),O
",",O
Oh,O
"
",O
O(3,O
),O
",",O
Koh,O
VTJ(3,O
),O
",",O
Poh,O
C(3,O
),O
",",O
Mak,O
TM(4,O
),O
",",O
Cui,O
L(4,O
),O
",",O
Cook,O
AR(6,O
),O
",",O
Lin,O
RTP(7,O
),O
",",O
Leo,O
"
",O
YS(7,O
),O
",",O
Lee,O
VJM(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Centre,O
for,O
Infectious,O
Diseases,O
",",O
Singapore,O
",",O
Singapore,O
"
",O
oon_tek_ng@ncid.sg,O
.,O
"
",O
(2)kalisvar_marimuthu@ncid.sg,O
.,O
"
",O
(3)Ministry,O
of,O
Health,O
",",O
Singapore,O
",",O
Singapore,O
.,O
"
",O
(4)National,O
Centre,O
for,O
Infectious,O
Diseases,O
",",O
Singapore,O
",",O
Singapore,O
.,O
"
",O
(5)KK,O
Women,O
's,O
and,O
Children,O
's,O
Hospital,O
",",O
Singapore,O
",",O
Singapore,O
.,O
"
",O
(6)Saw,O
Swee,O
Hock,O
School,O
of,O
Public,O
Health,O
",",O
Singapore,O
",",O
Singapore,O
.,O
"
",O
(7)National,O
Centre,O
for,O
Infectious,O
Diseases,O
",",O
Singapore,O
",",O
Singapore,O
"
",O
yee_sin_leo@ncid.sg,O
.,O
"
",O
(8)Ministry,O
of,O
Health,O
",",O
Singapore,O
",",O
Singapore,O
vernon_lee@moh.gov.sg,O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMc2003100,O
"
",O
PMID,O
:,O
32163698,O
"


",O
89,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Mar,O
12,O
.,O
doi,O
:,O
10.1056,O
NEJMc2003717,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Detection,O
of,O
Covid19,B-Disease_COVID-19
in,O
Children,O
in,O
Early,O
January,O
2020,O
in,O
Wuhan,O
",",O
China,O
.,O
"

",O
Liu,O
W(1,O
),O
",",O
Zhang,O
Q(2,O
),O
",",O
Chen,O
J(3,O
),O
",",O
Xiang,O
R(4,O
),O
",",O
Song,O
H(1,O
),O
",",O
Shu,O
S(1,O
),O
",",O
Chen,O
L(1,O
),O
",",O
"
",O
Liang,O
L(5,O
),O
",",O
Zhou,O
J(3,O
),O
",",O
You,O
L(3,O
),O
",",O
Wu,O
P(6,O
),O
",",O
Zhang,O
B(1,O
),O
",",O
Lu,O
Y(1,O
),O
",",O
Xia,O
L(1,O
),O
",",O
Huang,O
"
",O
L(1,O
),O
",",O
Yang,O
Y(2,O
),O
",",O
Liu,O
F(2,O
),O
",",O
Semple,O
MG(7,O
),O
",",O
Cowling,O
BJ(6,O
),O
",",O
Lan,O
K(8,O
),O
",",O
Sun,O
Z(9,O
),O
",",O
Yu,O
"
",O
H(10,O
),O
",",O
Liu,O
Y(11,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Tongji,O
Hospital,O
of,O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(2)Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(4)Central,O
South,O
University,O
",",O
Changsha,O
",",O
China,O
.,O
"
",O
(5)Sichuan,O
University,O
",",O
Chengdu,O
",",O
China,O
.,O
"
",O
(6)University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(7)University,O
of,O
Liverpool,O
",",O
Liverpool,O
",",O
United,O
Kingdom,O
.,O
"
",O
(8)Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
klan@whu.edu.cn,O
.,O
"
",O
(9)Tongji,O
Hospital,O
of,O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
"
",O
zysun@tjh.tjmu.edu.cn,O
.,O
"
",O
(10)Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
yhj@fudan.edu.cn,O
.,O
"
",O
(11)Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
mvlwu@whu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMc2003717,O
"
",O
PMID,O
:,O
32163697,O
"


",O
90,O
.,O
Ann,O
Intern,O
Med,O
.,O
2020,O
Mar,O
12,O
.,O
doi,O
:,O
10.7326,O
M200533,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Histopathologic,O
Changes,O
and,O
SARSCoV2,B-Virus_SARS-CoV-2
Immunostaining,O
in,O
the,O
Lung,O
of,O
a,O
Patient,O
"
",O
With,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Zhang,O
H(1,O
),O
",",O
Zhou,O
P(2,O
),O
",",O
Wei,O
Y(1,O
),O
",",O
Yue,O
H(1,O
),O
",",O
Wang,O
Y(1,O
),O
",",O
Hu,O
M(3,O
),O
",",O
Zhang,O
S(1,O
),O
",",O
Cao,O
"
",O
T(4,O
),O
",",O
Yang,O
C(3,O
),O
",",O
Li,O
M(3,O
),O
",",O
Guo,O
G(3,O
),O
",",O
Chen,O
X(3,O
),O
",",O
Chen,O
Y(2,O
),O
",",O
Lei,O
M(5,O
),O
",",O
Liu,O
H(1,O
),O
",",O
"
",O
Zhao,O
J(1,O
),O
",",O
Peng,O
P(3,O
),O
",",O
Wang,O
CY(1,O
),O
",",O
Du,O
R(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Center,O
for,O
Biomedical,O
Research,O
",",O
NHC,O
Key,O
Laboratory,O
of,O
Respiratory,O
Disease,O
",",O
"
",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
",",O
China,O
(,O
H.Z.,O
",",O
Y.W.,O
",",O
H.Y.,O
",",O
Y.W.,O
",",O
S.Z.,O
",",O
H.L.,O
",",O
J.Z.,O
",",O
C.W.,O
),O
.,O
"
",O
(2)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
"
",O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
(,O
P.Z.,O
",",O
"
",O
Y.C.,O
),O
.,O
"
",O
(3)Wuhan,O
Pulmonary,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
(,O
M.H.,O
",",O
C.Y.,O
",",O
M.L.,O
",",O
G.G.,O
",",O
X.C.,O
",",O
P.P.,O
",",O
"
",O
R.D.,O
),O
.,O
"
",O
(4)Pulmonary,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
(,O
T.C.,O
),O
.,O
"
",O
(5)Institution,O
of,O
Tuberculosis,O
for,O
Prevention,O
and,O
Cure,O
",",O
Wuhan,O
Pulmonary,O
Hospital,O
",",O
"
",O
Wuhan,O
",",O
China,O
(,O
M.L.,O
),O
.,O
"

",O
DOI,O
:,O
10.7326,O
M200533,O
"
",O
PMID,O
:,O
32163542,O
"


",O
91,O
.,O
J,O
Travel,O
Med,O
.,O
2020,O
Mar,O
12,O
.,O
pii,O
:,O
taaa033,O
.,O
doi,O
:,O
10.1093,O
jtm,O
taaa033,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Serial,O
interval,O
in,O
determining,O
the,O
estimation,O
of,O
reproduction,O
number,O
of,O
the,O
novel,O
"
",O
coronavirus,O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
during,O
the,O
early,O
outbreak,O
.,O
"

",O
Zhao,O
S(1)(2,O
),O
",",O
Cao,O
P(3,O
),O
",",O
Gao,O
D(4,O
),O
",",O
Zhuang,O
Z(5,O
),O
",",O
Cai,O
Y(6,O
),O
",",O
Ran,O
J(7,O
),O
",",O
Chong,O
"
",O
MKC(1)(2,O
),O
",",O
Wang,O
K(8,O
),O
",",O
Lou,O
Y(5,O
),O
",",O
Wang,O
W(6,O
),O
",",O
Yang,O
L(9,O
),O
",",O
He,O
D(5,O
),O
",",O
Wang,O
MH(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)JC,O
School,O
of,O
Public,O
Health,O
and,O
Primary,O
Care,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(2)Shenzhen,O
Research,O
Institute,O
of,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
Shenzhen,O
",",O
"
",O
China,O
.,O
"
",O
(3)Clinical,O
Research,O
Centre,O
",",O
Zhujiang,O
Hospital,O
",",O
Southern,O
Medical,O
University,O
",",O
"
",O
Guangzhou,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Mathematics,O
",",O
Shanghai,O
Normal,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
"
",O
(6)School,O
of,O
Mathematics,O
and,O
Statistics,O
",",O
Huaiyin,O
Normal,O
University,O
",",O
Huaian,O
",",O
"
",O
China,O
.,O
"
",O
(7)School,O
of,O
Public,O
Health,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Hong,O
"
",O
Kong,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(8)Department,O
of,O
Medical,O
Engineering,O
and,O
Technology,O
",",O
Xinjiang,O
Medical,O
University,O
",",O
"
",O
Urumqi,O
",",O
830011,O
",",O
China,O
.,O
"
",O
(9)School,O
of,O
Nursing,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jtm,O
taaa033,O
"
",O
PMID,O
:,O
32163140,O
"


",O
92,O
.,O
JAMA,O
.,O
2020,O
Mar,O
12,O
.,O
doi,O
:,O
10.1001,O
jama.2020.3972,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Supporting,O
the,O
Health,O
Care,O
Workforce,O
During,O
the,O
COVID19,B-Disease_COVID-19
Global,O
Epidemic,O
.,O
"

",O
Adams,O
JG(1)(2,O
),O
",",O
Walls,O
RM(3)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Northwestern,O
Memorial,O
HealthCare,O
",",O
Chicago,O
",",O
Illinois,O
.,O
"
",O
(2)Northwestern,O
University,O
Feinberg,O
School,O
of,O
Medicine,O
",",O
Department,O
of,O
Emergency,O
"
",O
Medicine,O
",",O
Chicago,O
",",O
Illinois,O
.,O
"
",O
(3)Brigham,O
and,O
Women,O
's,O
Hospital,O
",",O
Boston,O
",",O
Massachusetts,O
.,O
"
",O
(4)Harvard,O
Medical,O
School,O
",",O
Boston,O
",",O
Massachusetts,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.3972,O
"
",O
PMID,O
:,O
32163102,O
"


",O
93,O
.,O
Emerg,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
12;26(6,O
),O
.,O
doi,O
:,O
10.3201,O
eid2606.200412,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Indirect,O
Virus,O
Transmission,O
in,O
Cluster,O
of,O
COVID19,B-Disease_COVID-19
Cases,O
",",O
Wenzhou,O
",",O
China,O
",",O
2020,O
.,O
"

",O
Cai,O
J,O
",",O
Sun,O
W,O
",",O
Huang,O
J,O
",",O
Gamber,O
M,O
",",O
Wu,O
J,O
",",O
He,O
G.,O
"

",O
To,O
determine,O
possible,O
modes,O
of,O
virus,O
transmission,O
",",O
we,O
investigated,O
a,O
cluster,O
of,O
"
",O
COVID19,B-Disease_COVID-19
cases,O
associated,O
with,O
a,O
shopping,O
mall,O
in,O
Wenzhou,O
",",O
China,O
.,O
Data,O
indicated,O
"
",O
that,O
indirect,O
transmission,O
of,O
the,O
causative,O
virus,O
occurred,O
",",O
perhaps,O
resulting,O
"
",O
from,O
virus,O
contamination,O
of,O
common,O
objects,O
",",O
virus,O
aerosolization,O
in,O
a,O
confined,O
"
",O
space,O
",",O
or,O
spread,O
from,O
asymptomatic,O
infected,O
persons,O
.,O
"

",O
DOI,O
:,O
10.3201,O
eid2606.200412,O
"
",O
PMID,O
:,O
32163030,O
"


",O
94,O
.,O
J,O
Dent,O
Res,O
.,O
2020,O
Mar,O
12:22034520914246,O
.,O
doi,O
:,O
10.1177,O
2.20345E+13,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
:,O
Emerging,O
and,O
Future,O
Challenges,O
for,O
Dental,O
"
",O
and,O
Oral,O
Medicine,O
.,O
"

",O
Meng,O
L(1,O
),O
",",O
Hua,O
F(2,O
),O
",",O
Bian,O
Z(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
State,O
Key,O
Laboratory,O
Breeding,O
Base,O
of,O
Basic,O
Science,O
of,O
Stomatology,O
"
",O
(,O
HubeiMOST,O
),O
and,O
Key,O
Laboratory,O
of,O
Oral,O
Biomedicine,O
Ministry,O
of,O
Education,O
",",O
School,O
"
",O
and,O
Hospital,O
of,O
Stomatology,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Center,O
for,O
EvidenceBased,O
Stomatology,O
",",O
School,O
and,O
Hospital,O
of,O
Stomatology,O
",",O
"
",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
The,O
epidemic,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
",",O
originating,O
in,O
Wuhan,O
",",O
China,O
",",O
"
",O
has,O
become,O
a,O
major,O
public,O
health,O
challenge,O
for,O
not,O
only,O
China,O
but,O
also,O
countries,O
"
",O
around,O
the,O
world,O
.,O
The,O
World,O
Health,O
Organization,O
announced,O
that,O
the,O
outbreaks,O
of,O
"
",O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
have,O
constituted,O
a,O
public,O
health,O
emergency,O
of,O
international,O
"
",O
concern,O
.,O
As,O
of,O
February,O
26,O
",",O
2020,O
",",O
COVID19,B-Disease_COVID-19
has,O
been,O
recognized,O
in,O
34,O
countries,O
",",O
"
",O
with,O
a,O
total,O
of,O
80239,O
laboratoryconfirmed,O
cases,O
and,O
2700,O
deaths,O
.,O
Infection,O
"
",O
control,O
measures,O
are,O
necessary,O
to,O
prevent,O
the,O
virus,O
from,O
further,O
spreading,O
and,O
to,O
"
",O
help,O
control,O
the,O
epidemic,O
situation,O
.,O
Due,O
to,O
the,O
characteristics,O
of,O
dental,O
"
",O
settings,O
",",O
the,O
risk,O
of,O
cross,O
infection,O
can,O
be,O
high,O
between,O
patients,O
and,O
dental,O
"
",O
practitioners,O
.,O
For,O
dental,O
practices,O
and,O
hospitals,O
in,O
areas,O
that,O
are,O
(,O
potentially,O
),O
"
",O
affected,O
with,O
COVID19,B-Disease_COVID-19
",",O
strict,O
and,O
effective,O
infection,O
control,O
protocols,O
are,O
"
",O
urgently,O
needed,O
.,O
This,O
article,O
",",O
based,O
on,O
our,O
experience,O
and,O
relevant,O
guidelines,O
"
",O
and,O
research,O
",",O
introduces,O
essential,O
knowledge,O
about,O
COVID19,B-Disease_COVID-19
and,O
nosocomial,O
"
",O
infection,O
in,O
dental,O
settings,O
and,O
provides,O
recommended,O
management,O
protocols,O
for,O
"
",O
dental,O
practitioners,O
and,O
students,O
in,O
(,O
potentially,O
),O
affected,O
areas,O
.,O
"

",O
DOI,O
:,O
10.1177,O
2.20345E+13,O
"
",O
PMID,O
:,O
32162995,O
"


",O
95,O
.,O
Can,O
Assoc,O
Radiol,O
J.,O
2020,O
Mar,O
12:846537120914428,O
.,O
doi,O
:,O
10.1177,O
8.46537E+14,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
Infection,O
:,O
Early,O
Lessons,O
.,O
"

",O
Lei,O
Y(1,O
),O
",",O
Zhang,O
HW(1,O
),O
",",O
Yu,O
J(1,O
),O
",",O
Patlas,O
MN(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Shenzhen,O
University,O
",",O
"
",O
Health,O
Science,O
Center,O
",",O
Shenzhen,O
Second,O
People,O
's,O
Hospital,O
",",O
Shenzhen,O
",",O
China,O
.,O
"
",O
(2)Division,O
of,O
Emergency,O
Trauma,O
Radiology,O
",",O
Department,O
of,O
Radiology,O
",",O
McMaster,O
"
",O
University,O
",",O
Hamilton,O
",",O
Ontario,O
",",O
Canada,O
.,O
"

",O
DOI,O
:,O
10.1177,O
8.46537E+14,O
"
",O
PMID,O
:,O
32162990,O
"


",O
96,O
.,O
Minerva,O
Gastroenterol,O
Dietol,O
.,O
2020,O
Mar,O
12,O
.,O
doi,O
:,O
10.23736,O
S1121421X.20.026975,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Possible,O
therapeutic,O
role,O
of,O
a,O
highly,O
standardized,O
mixture,O
of,O
active,O
compounds,O
"
",O
derived,O
from,O
cultured,O
Lentinula,O
edodes,O
mycelia,O
(,O
AHCC,O
),O
in,O
patients,O
infected,O
with,O
"
",O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
.,O
"

",O
Di,O
Pierro,O
F(1,O
),O
",",O
Bertuccioli,O
A(2,O
),O
",",O
Cavecchia,O
I(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Scientific,O
&,O
amp,O
;,O
Research,O
Department,O
",",O
Velleja,O
Research,O
",",O
Milan,O
",",O
Italy,O
"
",O
f.dipierro@vellejaresearch.com,O
.,O
"
",O
(2)D.I.S.B.,O
",",O
Urbino,O
",",O
Italy,O
.,O
"
",O
(3)Scientific,O
&,O
amp,O
;,O
Research,O
Department,O
",",O
Velleja,O
Research,O
",",O
Milan,O
",",O
Italy,O
.,O
"

",O
The,O
outbreak,O
of,O
SARSCoV2,B-Disease_COVID-19
disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
is,O
currently,O
",",O
March,O
2020,O
",",O
affecting,O
"
",O
more,O
than,O
100000,O
people,O
worldwide,O
and,O
",",O
according,O
to,O
the,O
WHO,O
(,O
World,O
Health,O
"
",O
Organization,O
),O
",",O
a,O
pandemic,O
is,O
shortly,O
expected,O
.,O
The,O
virus,O
infects,O
the,O
lower,O
"
",O
respiratory,O
tract,O
and,O
causes,O
severe,O
pneumonia,O
and,O
mortality,O
in,O
approximately,O
10,O
%,O
"
",O
and,O
35,O
%,O
",",O
respectively,O
",",O
of,O
cases,O
",",O
mainly,O
among,O
the,O
elderly,O
and,O
or,O
people,O
affected,O
"
",O
by,O
other,O
diseases,O
.,O
AHCC,O
is,O
an,O
Î±glucanbased,O
standardized,O
mushroom,O
extract,O
that,O
"
",O
has,O
been,O
extensively,O
investigated,O
as,O
an,O
immunostimulant,O
both,O
in,O
animals,O
and,O
or,O
in,O
"
",O
humans,O
affected,O
by,O
West,O
Nile,O
virus,O
",",O
influenza,O
virus,O
",",O
avian,O
influenza,O
virus,O
",",O
"
",O
hepatitis,O
C,O
virus,O
",",O
papillomavirus,O
",",O
herpes,O
virus,O
",",O
hepatitis,O
B,O
virus,O
and,O
HIV,O
by,O
"
",O
promoting,O
a,O
regulated,O
and,O
protective,O
immune,O
response,O
.,O
Although,O
the,O
efficacy,O
of,O
"
",O
AHCC,O
has,O
not,O
yet,O
been,O
specifically,O
evaluated,O
with,O
respect,O
to,O
SARSCoV2,B-Disease_COVID-19
disease,I-Disease_COVID-19
",",O
"
",O
its,O
action,O
in,O
promoting,O
a,O
protective,O
response,O
to,O
a,O
wide,O
range,O
of,O
viral,O
"
",O
infections,O
",",O
and,O
the,O
current,O
absence,O
of,O
effective,O
vaccines,O
",",O
could,O
support,O
its,O
use,O
"
",O
in,O
the,O
prevention,O
of,O
diseases,O
provoked,O
by,O
human,O
pathogenic,O
coronavirus,O
",",O
including,O
"
",O
COVID19,B-Disease_COVID-19
.,O
"

",O
DOI,O
:,O
10.23736,O
S1121421X.20.026975,O
"
",O
PMID,O
:,O
32162896,O
"


",O
97,O
.,O
Mol,O
Genet,O
Genomic,O
Med,O
.,O
2020,O
Mar,O
12:e1199,O
.,O
doi,O
:,O
10.1002,O
mgg3.1199,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Systematic,O
analysis,O
of,O
a,O
mitochondrial,O
diseasecausing,O
ND6,O
mutation,O
in,O
"
",O
mitochondrial,O
deficiency,O
.,O
"

",O
Chen,O
D(1,O
),O
",",O
Zhao,O
Q(2,O
),O
",",O
Xiong,O
J(3,O
),O
",",O
Lou,O
X(1,O
),O
",",O
Han,O
Q(1,O
),O
",",O
Wei,O
X(1,O
),O
",",O
Xie,O
J(1,O
),O
",",O
Li,O
"
",O
X(1,O
),O
",",O
Zhou,O
H(1,O
),O
",",O
Shen,O
L(1,O
),O
",",O
Yang,O
Y(4,O
),O
",",O
Fang,O
H(1,O
),O
",",O
Lyu,O
J(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Laboratory,O
Medicine,O
",",O
Ministry,O
of,O
Education,O
",",O
Zhejiang,O
"
",O
Provincial,O
Key,O
Laboratory,O
of,O
Medical,O
Genetics,O
",",O
College,O
of,O
Laboratory,O
Medicine,O
and,O
"
",O
Life,O
sciences,O
",",O
Wenzhou,O
Medical,O
University,O
",",O
Wenzhou,O
",",O
China,O
.,O
"
",O
(2)Zhejiang,O
Provincial,O
People,O
's,O
Hospital,O
",",O
Affiliated,O
People,O
's,O
Hospital,O
of,O
"
",O
Hangzhou,O
Medical,O
College,O
",",O
College,O
of,O
Laboratory,O
Medicine,O
",",O
Hangzhou,O
Medical,O
"
",O
College,O
",",O
Hangzhou,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Laboratory,O
Medicine,O
",",O
Liyuan,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Pediatrics,O
",",O
Peking,O
University,O
First,O
Hospital,O
",",O
Peking,O
University,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
The,O
m.14487T,O
>,O
C,O
mutation,O
is,O
recognized,O
as,O
a,O
diagnostic,O
mutation,O
of,O
"
",O
mitochondrial,O
disease,O
during,O
the,O
past,O
16,O
Â ,O
years,O
",",O
emerging,O
evidence,O
suggests,O
that,O
"
",O
mutant,O
loads,O
of,O
m.14487T,O
>,O
C,O
and,O
disease,O
phenotype,O
are,O
not,O
closely,O
correlated,O
.,O
"
",O
METHODS,O
:,O
Immortalized,O
lymphocytes,O
were,O
generated,O
by,O
coculturing,O
the,O
EpsteinBarr,O
"
",O
virus,O
and,O
lymphocytes,O
from,O
m.14487T,O
>,O
C,O
carrier,O
Chinese,O
patient,O
with,O
Leigh,O
"
",O
syndrome,O
.,O
Fifteen,O
cytoplasmic,O
hybrid,O
(,O
cybrid,O
),O
cell,O
lines,O
were,O
generated,O
by,O
fusing,O
"
",O
mtDNA,O
lacking,O
143B,O
cells,O
with,O
platelets,O
donated,O
by,O
patients,O
.,O
Mitochondrial,O
"
",O
function,O
was,O
systematically,O
analyzed,O
at,O
transcriptomic,O
",",O
metabolomic,O
",",O
and,O
"
",O
biochemical,O
levels,O
.,O
"
",O
RESULTS,O
:,O
Unlike,O
previous,O
reports,O
",",O
we,O
found,O
that,O
the,O
assembly,O
of,O
mitochondrial,O
"
",O
respiratory,O
chain,O
complexes,O
",",O
mitochondrial,O
respiration,O
",",O
and,O
mitochondrial,O
OXPHOS,O
"
",O
function,O
was,O
barely,O
affected,O
in,O
cybrid,O
cells,O
carrying,O
homoplastic,O
m.14487T,O
>,O
C,O
"
",O
mutation,O
.,O
Mitochondrial,O
dysfunction,O
associated,O
transcriptomic,O
and,O
metabolomic,O
"
",O
reprogramming,O
were,O
not,O
detected,O
in,O
cybrid,O
carrying,O
homoplastic,O
m.14487T,O
>,O
C.,O
"
",O
However,O
",",O
we,O
found,O
that,O
mitochondrial,O
function,O
was,O
impaired,O
in,O
patientderived,O
"
",O
immortalized,O
lymphocytes,O
.,O
"
",O
CONCLUSION,O
:,O
Our,O
data,O
revealed,O
that,O
m.14487T,O
>,O
C,O
mutation,O
is,O
insufficient,O
to,O
cause,O
"
",O
mitochondrial,O
deficiency,O
;,O
additional,O
modifier,O
genes,O
may,O
be,O
involved,O
in,O
"
",O
m.14487T,O
>,O
Cassociated,O
mitochondrial,O
disease,O
.,O
Our,O
results,O
further,O
demonstrated,O
"
",O
that,O
a,O
caution,O
should,O
be,O
taken,O
by,O
solely,O
use,O
of,O
m.14487T,O
>,O
C,O
mutation,O
for,O
molecular,O
"
",O
diagnosis,O
of,O
mitochondrial,O
disease,O
.,O
"

",O
Â©,O
2020,O
The,O
Authors,O
.,O
Molecular,O
Genetics,O
&,O
Genomic,O
Medicine,O
published,O
by,O
Wiley,O
"
",O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
mgg3.1199,O
"
",O
PMID,O
:,O
32162843,O
"


",O
98,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
12,O
.,O
doi,O
:,O
10.1002,O
jmv.25757,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
patients,O
',O
clinical,O
characteristics,O
",",O
discharge,O
rate,O
and,O
"
",O
fatality,O
rate,O
of,O
metaanalysis,O
.,O
"

",O
Li,O
LQ(1)(2)(3,O
),O
",",O
Huang,O
T(1)(2)(3,O
),O
",",O
Wang,O
YQ(4,O
),O
",",O
Wang,O
ZP(5,O
),O
",",O
Liang,O
Y(1)(2)(3,O
),O
",",O
Huang,O
"
",O
TB(1)(2)(3,O
),O
",",O
Zhang,O
HY(1)(2)(3,O
),O
",",O
Sun,O
WM(6,O
),O
",",O
Wang,O
YP(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
First,O
Clinical,O
Medical,O
School,O
of,O
Lanzhou,O
University,O
",",O
Lanzhou,O
",",O
730000,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Gastroenterology,O
",",O
The,O
First,O
Hospital,O
of,O
Lanzhou,O
University,O
",",O
"
",O
Lanzhou,O
",",O
730000,O
",",O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
for,O
Gastrointestinal,O
Diseases,O
",",O
Gansu,O
Province,O
",",O
The,O
First,O
"
",O
Hospital,O
of,O
Lanzhou,O
University,O
",",O
Lanzhou,O
",",O
730000,O
",",O
China,O
.,O
"
",O
(4)Gansu,O
people,O
's,O
hospital,O
day,O
diagnostic,O
center,O
",",O
Lanzhou,O
",",O
730000,O
",",O
China,O
.,O
"
",O
(5)Gansu,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Lanzhou,O
",",O
730000,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Endocrinology,O
",",O
The,O
First,O
Hospital,O
of,O
Lanzhou,O
University,O
",",O
"
",O
Lanzhou,O
",",O
730000,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
To,O
study,O
the,O
clinical,O
data,O
",",O
discharge,O
rate,O
",",O
and,O
fatality,O
rate,O
of,O
"
",O
COVID19,B-Disease_COVID-19
patients,O
for,O
clinical,O
help,O
.,O
"
",O
METHODS,O
:,O
The,O
clinical,O
data,O
of,O
COVID19,B-Disease_COVID-19
patients,O
from,O
December,O
2019,O
to,O
February,O
"
",O
2020,O
were,O
retrieved,O
from,O
four,O
databases,O
.,O
We,O
statistically,O
analyzed,O
the,O
clinical,O
"
",O
symptoms,O
and,O
laboratory,O
results,O
of,O
COVID19,B-Disease_COVID-19
patients,O
and,O
explained,O
the,O
discharge,O
"
",O
rate,O
",",O
fatality,O
rate,O
with,O
a,O
singlearm,O
metaanalysis,O
.,O
"
",O
RESULTS,O
:,O
The,O
available,O
data,O
of,O
1994,O
patients,O
in,O
10,O
literatures,O
were,O
included,O
in,O
"
",O
our,O
study,O
.,O
The,O
main,O
clinical,O
symptoms,O
of,O
COVID19,B-Disease_COVID-19
patients,O
were,O
fever,O
(,O
88.5,O
%,O
),O
",",O
"
",O
cough,O
(,O
68.6,O
%,O
),O
",",O
myalgia,O
or,O
fatigue,O
(,O
35.8,O
%,O
),O
",",O
expectoration,O
(,O
28.2,O
%,O
),O
",",O
dyspnea,O
"
",O
(,O
21.9,O
%,O
),O
.,O
Minor,O
symptoms,O
include,O
headache,O
or,O
dizziness,O
:,O
(,O
12.1,O
%,O
),O
diarrhea,O
(,O
4.8,O
%,O
),O
",",O
"
",O
nausea,O
",",O
and,O
vomiting,O
(,O
3.9,O
%,O
),O
.,O
The,O
results,O
of,O
laboratory,O
results,O
showed,O
that,O
the,O
"
",O
lymphocytopenia,O
(,O
64.5,O
%,O
),O
",",O
increase,O
of,O
CRP,O
(,O
44.3,O
%,O
),O
",",O
increase,O
of,O
LDH,O
(,O
28.3,O
%,O
),O
",",O
and,O
"
",O
leukocytopenia,O
(,O
29.4,O
%,O
),O
were,O
more,O
common,O
.,O
"
",O
CONCLUSIONS,O
:,O
The,O
results,O
of,O
singlearm,O
metaanalysis,O
showed,O
that,O
:,O
the,O
male,O
took,O
a,O
"
",O
larger,O
percentage,O
in,O
the,O
gender,O
distribution,O
of,O
COVID19,B-Disease_COVID-19
patients,O
60%[95%CI,O
"
",O
(,O
"0.54,0.65",O
),O
],O
",",O
the,O
discharge,O
rate,O
of,O
COVID19,B-Disease_COVID-19
patients,O
was,O
42%[95%CI,O
(,O
"0.29,0.55",O
),O
],O
",",O
"
",O
and,O
the,O
fatality,O
rate,O
was,O
7%[95%CI,O
(,O
"0.04,0.10",O
),O
],O
.,O
This,O
article,O
is,O
protected,O
by,O
"
",O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25757,O
"
",O
PMID,O
:,O
32162702,O
"


",O
99,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
12,O
.,O
doi,O
:,O
10.1002,O
jmv.25755,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
A,O
report,O
of,O
clinical,O
diagnosis,O
and,O
treatment,O
of,O
9,O
cases,O
of,O
coronavirus,O
disease,O
"
",O
2019,O
.,O
"

",O
Chen,O
Q(1,O
),O
",",O
Quan,O
B(2,O
),O
",",O
Li,O
X(3,O
),O
",",O
Gao,O
G(1,O
),O
",",O
Zheng,O
W(1,O
),O
",",O
Zhang,O
J(4,O
),O
",",O
Zhang,O
Z(5,O
),O
",",O
Liu,O
"
",O
C(3,O
),O
",",O
Li,O
L(3,O
),O
",",O
Wang,O
C(3,O
),O
",",O
Zhang,O
G(3,O
),O
",",O
Li,O
J(6,O
),O
",",O
Dai,O
Y(1,O
),O
",",O
Yang,O
J(2,O
),O
",",O
Han,O
W(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Nuclear,O
Medicine,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Wanan,O
Medical,O
"
",O
College,O
",",O
Wuhu,O
",",O
241001,O
",",O
Anhui,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Wanan,O
"
",O
Medical,O
College,O
",",O
Wuhu,O
",",O
241001,O
",",O
Anhui,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Clinical,O
Laboratory,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Wanan,O
"
",O
Medical,O
College,O
",",O
Wuhu,O
",",O
241001,O
",",O
Anhui,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Clinical,O
Blood,O
Laboratory,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
"
",O
Wanan,O
Medical,O
College,O
",",O
Wuhu,O
",",O
241001,O
",",O
Anhui,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Nursing,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Wanan,O
Medical,O
College,O
",",O
"
",O
Wuhu,O
",",O
241001,O
",",O
Anhui,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Pathology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Wanan,O
Medical,O
"
",O
College,O
",",O
Wuhu,O
",",O
241001,O
",",O
Anhui,O
",",O
China,O
.,O
"

",O
Coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
caused,O
by,O
the,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
has,O
become,O
the,O
important,O
public,O
health,O
issue,O
"
",O
in,O
the,O
world,O
.,O
More,O
than,O
78000,O
cases,O
were,O
confirmed,O
around,O
the,O
world,O
.,O
The,O
main,O
"
",O
clinical,O
manifestations,O
were,O
respiratory,O
symptoms,O
and,O
occasional,O
gastrointestinal,O
"
",O
symptoms,O
.,O
However,O
",",O
there,O
is,O
no,O
unified,O
standard,O
for,O
the,O
diagnosis,O
and,O
treatment,O
"
",O
of,O
COVID19,B-Disease_COVID-19
.,O
In,O
retrospective,O
analysis,O
",",O
we,O
report,O
nine,O
cases,O
of,O
COVID19,B-Disease_COVID-19
",",O
"
",O
describe,O
the,O
history,O
of,O
contact,O
",",O
clinical,O
manifestations,O
",",O
the,O
course,O
of,O
diagnosis,O
"
",O
and,O
clinical,O
treatment,O
before,O
",",O
during,O
and,O
after,O
treatment,O
.,O
This,O
article,O
is,O
"
",O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25755,O
"
",O
PMID,O
:,O
32162699,O
"


",O
100,O
.,O
J,O
Am,O
Geriatr,O
Soc,O
.,O
2020,O
Mar,O
12,O
.,O
doi,O
:,O
10.1111,O
jgs.16407,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
Epidemic,O
:,O
What,O
Are,O
the,O
Risks,O
for,O
Older,O
Patients,O
?,O
"

",O
GarnierCrussard,O
A(1)(2,O
),O
",",O
Forestier,O
E(3,O
),O
",",O
Gilbert,O
T(1)(2)(4,O
),O
",",O
KrolakSalmon,O
"
",O
P(1)(2)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institut,O
du,O
Vieillissement,O
IVie,O
",",O
Hospices,O
Civils,O
de,O
Lyon,O
",",O
Lyon,O
",",O
France,O
.,O
"
",O
(2)Centre,O
MÃ©moire,O
Ressource,O
et,O
Recherche,O
de,O
Lyon,O
",",O
Hospices,O
Civils,O
de,O
Lyon,O
",",O
Lyon,O
",",O
"
",O
France,O
.,O
"
",O
(3)Service,O
de,O
Maladies,O
Infectieuses,O
",",O
Centre,O
Hospitalier,O
MÃ©tropole,O
Savoie,O
",",O
"
",O
ChambÃ©ry,O
",",O
France,O
.,O
"
",O
(4)Health,O
Services,O
and,O
Performance,O
Research,O
(,O
HESPER,O
EA7425,O
),O
",",O
Lyon,O
",",O
France,O
.,O
"
",O
(5)Centre,O
de,O
Recherche,O
Clinique,O
CRCVCF,O
(,O
VieillissementCerveauFragilitÃ©,O
),O
",",O
"
",O
HÃ´pital,O
des,O
Charpennes,O
",",O
Hospices,O
Civils,O
de,O
Lyon,O
",",O
Lyon,O
",",O
France,O
.,O
"

",O
DOI,O
:,O
10.1111,O
jgs.16407,O
"
",O
PMID,O
:,O
32162679,O
"


",O
101,O
.,O
Am,O
J,O
Trop,O
Med,O
Hyg,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.4269,O
ajtmh.200135,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
How,O
Is,O
the,O
World,O
Responding,O
to,O
the,O
2019,B-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
Compared,O
with,O
the,O
"
",O
2014,O
West,O
African,O
Ebola,O
Epidemic,O
?,O
The,O
Importance,O
of,O
China,O
as,O
a,O
Player,O
in,O
the,O
"
",O
Global,O
Economy,O
.,O
"

",O
Maffioli,O
EM(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Health,O
Management,O
and,O
Policy,O
",",O
School,O
of,O
Public,O
Health,O
",",O
"
",O
University,O
of,O
Michigan,O
",",O
Ann,O
Arbor,O
",",O
Michigan,O
.,O
"

",O
This,O
article,O
describes,O
similarities,O
and,O
differences,O
in,O
the,O
response,O
of,O
"
",O
governments,O
and,O
the,O
international,O
community,O
to,O
the,O
current,O
2019,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
and,O
the,O
2014,O
West,O
African,O
Ebola,O
epidemic,O
.,O
It,O
expresses,O
the,O
"
",O
opinion,O
that,O
the,O
speed,O
and,O
scale,O
of,O
the,O
response,O
to,O
the,O
2019,O
COVID19,B-Disease_COVID-19
are,O
"
",O
affected,O
by,O
the,O
important,O
role,O
that,O
China,O
plays,O
in,O
the,O
global,O
economy,O
.,O
By,O
"
",O
contrast,O
",",O
insufficient,O
and,O
less,O
timely,O
action,O
was,O
initially,O
undertaken,O
in,O
West,O
"
",O
African,O
countries,O
during,O
the,O
2014,O
Ebola,O
epidemic,O
.,O
It,O
concludes,O
by,O
stating,O
why,O
"
",O
preparedness,O
for,O
and,O
response,O
to,O
all,O
disease,O
outbreaks,O
",",O
also,O
in,O
countries,O
of,O
"
",O
lower,O
economic,O
importance,O
",",O
should,O
become,O
a,O
priority,O
in,O
the,O
global,O
health,O
agenda,O
.,O
"

",O
DOI,O
:,O
10.4269,O
ajtmh.200135,O
"
",O
PMID,O
:,O
32162604,O
"


",O
102,O
.,O
J,O
Diabetes,O
.,O
2020,O
Apr;12(4):347348,O
.,O
doi,O
:,O
10.1111,O
17530407.13,O
.,O
"

",O
Diabetes,O
and,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Bloomgarden,O
ZT(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medicine,O
",",O
Division,O
of,O
Endocrinology,O
",",O
Diabetes,O
",",O
and,O
Bone,O
Disease,O
",",O
"
",O
Icahn,O
School,O
of,O
Medicine,O
at,O
Mount,O
Sinai,O
",",O
New,O
York,O
",",O
New,O
York,O
.,O
"

",O
DOI,O
:,O
10.1111,O
17530407.13,O
"
",O
PMID,O
:,O
32162476,O
"


",O
103,O
.,O
Mol,O
Inform,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1002,O
minf.202000028,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Rapid,O
Identification,O
of,O
Potential,O
Inhibitors,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
Main,O
Protease,O
by,O
Deep,O
"
",O
Docking,O
of,O
1.3,O
Billion,O
Compounds,O
.,O
"

",O
Ton,O
AT(1,O
),O
",",O
Gentile,O
F(2,O
),O
",",O
Hsing,O
M(1,O
),O
",",O
Ban,O
F(3,O
),O
",",O
Cherkasov,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Vancouver,O
Prostate,O
Centre,O
",",O
Urologic,O
Sciences,O
",",O
2660,O
Oak,O
St,O
",",O
V6H,O
3Z6,O
",",O
Vancouver,O
",",O
"
",O
CANADA,O
.,O
"
",O
(2)Vancouver,O
Prostate,O
Centre,O
",",O
Urologic,O
Sciences,O
",",O
2660,O
Oak,O
Street,O
",",O
V6H,O
3Z6,O
",",O
"
",O
Vancouver,O
",",O
CANADA,O
.,O
"
",O
(3)Vancouver,O
Prostate,O
Centre,O
",",O
2660,O
Oak,O
St,O
",",O
V6H,O
3Z6,O
",",O
Vancouver,O
",",O
CANADA,O
.,O
"

",O
The,O
recently,O
emerged,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
and,O
associated,O
COVID19,B-Disease_COVID-19
"
",O
disease,O
cause,O
serious,O
or,O
even,O
fatal,O
respiratory,O
tract,O
infection,O
and,O
yet,O
no,O
"
",O
approved,O
therapeutics,O
or,O
effective,O
treatment,O
is,O
currently,O
available,O
to,O
"
",O
effectively,O
combat,O
the,O
outbreak,O
.,O
This,O
urgent,O
situation,O
is,O
pressing,O
the,O
world,O
to,O
"
",O
respond,O
with,O
the,O
development,O
of,O
novel,O
vaccine,O
or,O
a,O
small,O
molecule,O
therapeutics,O
"
",O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
Along,O
these,O
efforts,O
",",O
the,O
structure,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
main,O
protease,O
"
",O
(,O
Mpro,O
),O
has,O
been,O
rapidly,O
resolved,O
and,O
made,O
publicly,O
available,O
to,O
facilitate,O
global,O
"
",O
efforts,O
to,O
develop,O
novel,O
drug,O
candidates,O
.,O
Recently,O
",",O
our,O
group,O
has,O
developed,O
a,O
"
",O
novel,O
deep,O
learning,O
platform,O
 ,O
Deep,O
Docking,O
(,O
DD,O
),O
which,O
provides,O
fast,O
prediction,O
"
",O
of,O
docking,O
scores,O
of,O
Glide,O
(,O
or,O
any,O
other,O
docking,O
program,O
),O
and,O
",",O
hence,O
",",O
enables,O
"
",O
structurebased,O
virtual,O
screening,O
of,O
billions,O
of,O
purchasable,O
molecules,O
in,O
a,O
short,O
"
",O
time,O
.,O
In,O
the,O
current,O
study,O
we,O
applied,O
DD,O
to,O
all,O
1.3,O
billion,O
compounds,O
from,O
ZINC15,O
"
",O
library,O
to,O
identify,O
top,O
1000,O
potential,O
ligands,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
Mpro,O
protein,O
.,O
The,O
"
",O
compounds,O
are,O
made,O
publicly,O
available,O
for,O
further,O
characterization,O
and,O
"
",O
development,O
by,O
scientific,O
community,O
.,O
"

",O
Â©,O
2020,O
WILEYVCH,O
Verlag,O
GmbH,O
&,O
Co.,O
KGaA,O
",",O
Weinheim,O
.,O
"

",O
DOI,O
:,O
10.1002,O
minf.202000028,O
"
",O
PMID,O
:,O
32162456,O
"


",O
104,O
.,O
Can,O
J,O
Anaesth,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1007,O
s12630020016209,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Preparing,O
for,O
a,O
COVID19,B-Disease_COVID-19
pandemic,O
:,O
a,O
review,O
of,O
operating,O
room,O
outbreak,O
response,O
"
",O
measures,O
in,O
a,O
large,O
tertiary,O
hospital,O
in,O
Singapore,O
.,O
"

",O
Wong,O
J(1,O
),O
",",O
Goh,O
QY(2,O
),O
",",O
Tan,O
Z(2,O
),O
",",O
Lie,O
SA(2,O
),O
",",O
Tay,O
YC(2,O
),O
",",O
Ng,O
SY(2,O
),O
",",O
Soh,O
CR(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Anaesthesiology,O
",",O
Singapore,O
General,O
Hospital,O
",",O
Outram,O
Road,O
",",O
"
",O
Singapore,O
",",O
169608,O
",",O
Singapore,O
.,O
jolin.wong@singhealth.com.sg,O
.,O
"
",O
(2)Division,O
of,O
Anaesthesiology,O
",",O
Singapore,O
General,O
Hospital,O
",",O
Outram,O
Road,O
",",O
"
",O
Singapore,O
",",O
169608,O
",",O
Singapore,O
.,O
"

",O
The,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
outbreak,O
has,O
been,O
designated,O
a,O
public,O
"
",O
health,O
emergency,O
of,O
international,O
concern,O
.,O
To,O
prepare,O
for,O
a,O
pandemic,O
",",O
hospitals,O
"
",O
need,O
a,O
strategy,O
to,O
manage,O
their,O
space,O
",",O
staff,O
",",O
and,O
supplies,O
so,O
that,O
optimum,O
care,O
"
",O
is,O
provided,O
to,O
patients,O
.,O
In,O
addition,O
",",O
infection,O
prevention,O
measures,O
need,O
to,O
be,O
"
",O
implemented,O
to,O
reduce,O
inhospital,O
transmission,O
.,O
In,O
the,O
operating,O
room,O
",",O
these,O
"
",O
preparations,O
involve,O
multiple,O
stakeholders,O
and,O
can,O
present,O
a,O
significant,O
"
",O
challenge,O
.,O
Here,O
",",O
we,O
describe,O
the,O
outbreak,O
response,O
measures,O
of,O
the,O
anesthetic,O
"
",O
department,O
staffing,O
the,O
largest,O
(,O
"1,700bed",O
),O
academic,O
tertiary,O
level,O
acute,O
care,O
"
",O
hospital,O
in,O
Singapore,O
(,O
Singapore,O
General,O
Hospital,O
),O
and,O
a,O
smaller,O
regional,O
"
",O
hospital,O
(,O
Sengkang,O
General,O
Hospital,O
),O
.,O
These,O
include,O
engineering,O
controls,O
such,O
as,O
"
",O
identification,O
and,O
preparation,O
of,O
an,O
isolation,O
operating,O
room,O
",",O
administrative,O
"
",O
measures,O
such,O
as,O
modification,O
of,O
workflow,O
and,O
processes,O
",",O
introduction,O
of,O
personal,O
"
",O
protective,O
equipment,O
for,O
staff,O
",",O
and,O
formulation,O
of,O
clinical,O
guidelines,O
for,O
"
",O
anesthetic,O
management,O
.,O
Simulation,O
was,O
valuable,O
in,O
evaluating,O
the,O
feasibility,O
of,O
"
",O
new,O
operating,O
room,O
setups,O
or,O
workflow,O
.,O
We,O
also,O
discuss,O
how,O
the,O
hierarchy,O
of,O
"
",O
controls,O
can,O
be,O
used,O
as,O
a,O
framework,O
to,O
plan,O
the,O
necessary,O
measures,O
during,O
each,O
"
",O
phase,O
of,O
a,O
pandemic,O
",",O
and,O
review,O
the,O
evidence,O
for,O
the,O
measures,O
taken,O
.,O
These,O
"
",O
containment,O
measures,O
are,O
necessary,O
to,O
optimize,O
the,O
quality,O
of,O
care,O
provided,O
to,O
"
",O
COVID19,B-Disease_COVID-19
patients,O
and,O
to,O
reduce,O
the,O
risk,O
of,O
viral,O
transmission,O
to,O
other,O
patients,O
"
",O
or,O
healthcare,O
workers,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12630020016209,O
"
",O
PMID,O
:,O
32162212,O
"


",O
105,O
.,O
Can,O
J,O
Anaesth,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1007,O
s12630020016254,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Chest,O
computed,O
tomography,O
images,O
of,O
early,O
coronavirus,O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
Chen,O
R(1)(2,O
),O
",",O
Chen,O
J(3,O
),O
",",O
Meng,O
QT(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Anesthesiology,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Anesthesiology,O
",",O
East,O
Hospital,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Radiology,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Anesthesiology,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
mengqingtao2018@126.com,O
.,O
"
",O
(5)Department,O
of,O
Anesthesiology,O
",",O
East,O
Hospital,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
mengqingtao2018@126.com,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12630020016254,O
"
",O
PMID,O
:,O
32162211,O
"


",O
106,O
.,O
Pediatr,O
Radiol,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1007,O
s00247020046567,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Chest,O
computed,O
tomography,O
in,O
children,O
with,O
COVID19,B-Disease_COVID-19
respiratory,O
infection,O
.,O
"

",O
Li,O
W(1,O
),O
",",O
Cui,O
H(2,O
),O
",",O
Li,O
K(1,O
),O
",",O
Fang,O
Y(1,O
),O
",",O
Li,O
S(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
Biomedical,O
Imaging,O
",",O
Department,O
of,O
"
",O
Radiology,O
",",O
The,O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
University,O
",",O
52,O
East,O
Meihua,O
"
",O
Road,O
",",O
New,O
Xiangzhou,O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Medical,O
Affairs,O
",",O
The,O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
52,O
East,O
Meihua,O
Road,O
",",O
New,O
Xiangzhou,O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
",",O
"
",O
China,O
.,O
"
",O
(3)Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
Biomedical,O
Imaging,O
",",O
Department,O
of,O
"
",O
Radiology,O
",",O
The,O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
University,O
",",O
52,O
East,O
Meihua,O
"
",O
Road,O
",",O
New,O
Xiangzhou,O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
"
",O
lishlin5@mail.sysu.edu.cn,O
.,O
"

",O
BACKGROUND,O
:,O
Infection,O
with,O
COVID19,B-Disease_COVID-19
is,O
currently,O
rare,O
in,O
children,O
.,O
"
",O
OBJECTIVE,O
:,O
To,O
describe,O
chest,O
CT,O
findings,O
in,O
children,O
with,O
COVID19,B-Disease_COVID-19
.,O
"
",O
MATERIALS,O
AND,O
METHODS,O
:,O
We,O
studied,O
children,O
at,O
a,O
large,O
tertiarycare,O
hospital,O
in,O
"
",O
China,O
",",O
during,O
the,O
period,O
from,O
28,O
January,O
2019,O
to,O
8,O
February,O
2020,O
",",O
who,O
had,O
"
",O
positive,O
reverse,O
transcriptase,O
polymerase,O
chain,O
reaction,O
(,O
RTPCR,O
),O
for,O
COVID19,B-Disease_COVID-19
.,O
"
",O
We,O
recorded,O
findings,O
at,O
any,O
chest,O
CT,O
performed,O
in,O
the,O
included,O
children,O
",",O
along,O
"
",O
with,O
core,O
clinical,O
observations,O
.,O
"
",O
RESULTS,O
:,O
We,O
included,O
five,O
children,O
from,O
10,O
Â ,O
months,O
to,O
6,O
Â ,O
years,O
of,O
age,O
(,O
mean,O
"
",O
3.4,O
Â ,O
years,O
),O
.,O
All,O
had,O
had,O
at,O
least,O
one,O
CT,O
scan,O
after,O
admission,O
.,O
Three,O
of,O
these,O
five,O
"
",O
had,O
CT,O
abnormality,O
on,O
the,O
first,O
CT,O
scan,O
(,O
at,O
2,O
Â ,O
days,O
",",O
4,O
Â ,O
days,O
and,O
9,O
Â ,O
days,O
",",O
"
",O
respectively,O
",",O
after,O
onset,O
of,O
symptoms,O
),O
in,O
the,O
form,O
of,O
patchy,O
groundglass,O
"
",O
opacities,O
;,O
all,O
normalised,O
during,O
treatment,O
.,O
"
",O
CONCLUSION,O
:,O
Compared,O
to,O
reports,O
in,O
adults,O
",",O
we,O
found,O
similar,O
but,O
more,O
modest,O
lung,O
"
",O
abnormalities,O
at,O
CT,O
in,O
our,O
small,O
paediatric,O
cohort,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00247020046567,O
"
",O
PMID,O
:,O
32162081,O
"


",O
107,O
.,O
Intensive,O
Care,O
Med,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1007,O
s00134020059939,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
How,O
to,O
balance,O
acute,O
myocardial,O
infarction,O
and,O
COVID19,B-Disease_COVID-19
:,O
the,O
protocols,O
from,O
"
",O
Sichuan,O
Provincial,O
People,O
's,O
Hospital,O
.,O
"

",O
Zeng,O
J(1,O
),O
",",O
Huang,O
J(2,O
),O
",",O
Pan,O
L(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Cardiology,O
",",O
Sichuan,O
Academy,O
of,O
Medical,O
Sciences,O
and,O
Sichuan,O
"
",O
Provincial,O
People,O
's,O
Hospital,O
",",O
University,O
of,O
Electronic,O
Science,O
and,O
Technology,O
of,O
"
",O
China,O
",",O
Chengdu,O
",",O
610072,O
",",O
Sichuan,O
Province,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Anesthesiology,O
",",O
Sichuan,O
Academy,O
of,O
Medical,O
Sciences,O
and,O
Sichuan,O
"
",O
Provincial,O
People,O
's,O
Hospital,O
",",O
University,O
of,O
Electronic,O
Science,O
and,O
Technology,O
of,O
"
",O
China,O
",",O
Chengdu,O
",",O
610072,O
",",O
Sichuan,O
Province,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Sichuan,O
Academy,O
of,O
Medical,O
Sciences,O
and,O
"
",O
Sichuan,O
Provincial,O
People,O
's,O
Hospital,O
",",O
University,O
of,O
Electronic,O
Science,O
and,O
"
",O
Technology,O
of,O
China,O
",",O
Chengdu,O
",",O
610072,O
",",O
Sichuan,O
Province,O
",",O
China,O
.,O
"
",O
panlingai2004@163.com,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00134020059939,O
"
",O
PMID,O
:,O
32162032,O
"


",O
108,O
.,O
Clin,O
Res,O
Cardiol,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1007,O
s00392020016269,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Prevalence,O
and,O
impact,O
of,O
cardiovascular,O
metabolic,O
diseases,O
on,O
COVID19,B-Disease_COVID-19
in,O
China,O
.,O
"

",O
Li,O
B(1,O
),O
",",O
Yang,O
J(2)(3,O
),O
",",O
Zhao,O
F(4,O
),O
",",O
Zhi,O
L(5,O
),O
",",O
Wang,O
X(2,O
),O
",",O
Liu,O
L(2,O
),O
",",O
Bi,O
Z(2,O
),O
",",O
Zhao,O
"
",O
Y(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Cardiology,O
",",O
Zibo,O
Central,O
Hospital,O
",",O
Shandong,O
University,O
",",O
No.,O
10,O
",",O
"
",O
Sonth,O
Shanghai,O
Road,O
",",O
Zibo,O
",",O
255000,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
libosubmit@163.com,O
.,O
"
",O
(2)Department,O
of,O
Cardiology,O
",",O
Zibo,O
Central,O
Hospital,O
",",O
Shandong,O
University,O
",",O
No.,O
10,O
",",O
"
",O
Sonth,O
Shanghai,O
Road,O
",",O
Zibo,O
",",O
255000,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(3)Binzhou,O
Medical,O
University,O
",",O
No.,O
346,O
",",O
Guanhai,O
Road,O
",",O
Laishan,O
District,O
",",O
Yantai,O
",",O
"
",O
264003,O
",",O
Shandong,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(4)Department,O
of,O
Infectious,O
Diseases,O
",",O
No.,O
4,O
Hospital,O
of,O
Zibo,O
",",O
No.,O
210,O
",",O
Shan,O
Quan,O
"
",O
Road,O
",",O
Zibo,O
",",O
255000,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(5)Department,O
of,O
Allergy,O
",",O
Zibo,O
Central,O
Hospital,O
",",O
Shandong,O
University,O
",",O
No.,O
10,O
",",O
"
",O
Sonth,O
Shanghai,O
Road,O
",",O
Zibo,O
",",O
255000,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(6)Department,O
of,O
Cardiology,O
",",O
Zibo,O
Central,O
Hospital,O
",",O
Shandong,O
University,O
",",O
No.,O
10,O
",",O
"
",O
Sonth,O
Shanghai,O
Road,O
",",O
Zibo,O
",",O
255000,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
zhaoyunhe@medmail.com.cn,O
.,O
"

",O
BACKGROUND,O
:,O
Studies,O
have,O
reminded,O
that,O
cardiovascular,O
metabolic,O
comorbidities,O
"
",O
made,O
patients,O
more,O
susceptible,O
to,O
suffer,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
corona,I-Virus_SARS-CoV-2
virus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
"
",O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
",",O
and,O
exacerbated,O
the,O
infection,O
.,O
The,O
aim,O
of,O
this,O
analysis,O
is,O
to,O
"
",O
determine,O
the,O
association,O
of,O
cardiovascular,O
metabolic,O
diseases,O
with,O
the,O
"
",O
development,O
of,O
COVID19,B-Disease_COVID-19
.,O
"
",O
METHODS,O
:,O
A,O
metaanalysis,O
of,O
eligible,O
studies,O
that,O
summarized,O
the,O
prevalence,O
of,O
"
",O
cardiovascular,O
metabolic,O
diseases,O
in,O
COVID19,B-Disease_COVID-19
and,O
compared,O
the,O
incidences,O
of,O
the,O
"
",O
comorbidities,O
in,O
ICU,O
severe,O
and,O
nonICU,O
severe,O
patients,O
was,O
performed,O
.,O
Embase,O
and,O
"
",O
PubMed,O
were,O
searched,O
for,O
relevant,O
studies,O
.,O
"
",O
RESULTS,O
:,O
A,O
total,O
of,O
six,O
studies,O
with,O
1527,O
patients,O
were,O
included,O
in,O
this,O
"
",O
analysis,O
.,O
The,O
proportions,O
of,O
hypertension,O
",",O
cardiacerebrovascular,O
Â ,O
disease,O
and,O
"
",O
diabetes,O
in,O
patients,O
with,O
COVID19,B-Disease_COVID-19
were,O
17.1,O
%,O
",",O
16.4,O
%,O
and,O
9.7,O
%,O
",",O
respectively,O
.,O
The,O
"
",O
incidences,O
of,O
hypertension,O
",",O
cardiacerebrovascular,O
diseases,O
and,O
diabetes,O
were,O
"
",O
about,O
twofolds,O
",",O
threefolds,O
and,O
twofolds,O
",",O
respectively,O
",",O
higher,O
in,O
ICU,O
severe,O
cases,O
"
",O
than,O
in,O
their,O
nonICU,O
severe,O
counterparts,O
.,O
At,O
least,O
8,O
%,O
patients,O
with,O
COVID19,B-Disease_COVID-19
"
",O
suffered,O
the,O
acute,O
cardiac,O
injury,O
.,O
The,O
incidence,O
of,O
acute,O
cardiac,O
injury,O
was,O
"
",O
about,O
13,O
folds,O
higher,O
in,O
ICU,O
severe,O
patients,O
compared,O
with,O
the,O
nonICU,O
severe,O
"
",O
patients,O
.,O
"
",O
CONCLUSION,O
:,O
Patients,O
with,O
previous,O
cardiovascular,O
metabolic,O
diseases,O
may,O
face,O
a,O
"
",O
greater,O
risk,O
of,O
developing,O
into,O
the,O
severe,O
condition,O
and,O
the,O
comorbidities,O
can,O
"
",O
also,O
greatly,O
affect,O
the,O
prognosis,O
of,O
the,O
COVID19,B-Disease_COVID-19
.,O
On,O
the,O
other,O
hand,O
",",O
COVID19,B-Disease_COVID-19
"
",O
can,O
",",O
in,O
turn,O
",",O
aggravate,O
the,O
damage,O
to,O
the,O
heart,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00392020016269,O
"
",O
PMID,O
:,O
32161990,O
"


",O
109,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
12,O
.,O
pii,O
:,O
ciaa247,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa247,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
A,O
comparative,O
study,O
on,O
the,O
clinical,O
features,O
of,O
COVID19,B-Disease_COVID-19
pneumonia,O
to,O
other,O
"
",O
pneumonias,O
.,O
"

",O
Zhao,O
D(1,O
),O
",",O
Yao,O
F(2,O
),O
",",O
Wang,O
L(3,O
),O
",",O
Zheng,O
L(1,O
),O
",",O
Gao,O
Y(4,O
),O
",",O
Ye,O
J(5,O
),O
",",O
Guo,O
F(2,O
),O
",",O
Zhao,O
"
",O
H(1,O
),O
",",O
Gao,O
R(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
the,O
Second,O
Affiliated,O
"
",O
Hospital,O
",",O
Anhui,O
Medical,O
University,O
",",O
Hefei,O
",",O
Anhui,O
Province,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Suzhou,O
Municipal,O
Hospital,O
",",O
Suzhou,O
",",O
Anhui,O
",",O
"
",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Infectious,O
Disease,O
Prevention,O
and,O
Control,O
",",O
National,O
"
",O
Center,O
for,O
AIDS,O
STD,O
Control,O
and,O
Prevention,O
",",O
Collaborative,O
Innovation,O
Center,O
for,O
"
",O
Diagnosis,O
and,O
Treatment,O
of,O
Infectious,O
Diseases,O
",",O
Chinese,O
Center,O
for,O
Disease,O
"
",O
Control,O
and,O
Prevention,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)National,O
Institute,O
for,O
Viral,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Chinese,O
Center,O
"
",O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Key,O
Laboratory,O
for,O
Medical,O
Virology,O
",",O
National,O
"
",O
Health,O
and,O
Family,O
Planning,O
Commission,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)Infectious,O
disease,O
department,O
",",O
the,O
Second,O
Affiliated,O
Hospital,O
",",O
Anhui,O
Medical,O
"
",O
University,O
",",O
Hefei,O
",",O
Anhui,O
Province,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
has,O
raised,O
world,O
concern,O
since,O
it,O
"
",O
emerged,O
in,O
Wuhan,O
Hubei,O
China,O
in,O
December,O
",",O
2019,O
.,O
The,O
infection,O
may,O
result,O
into,O
"
",O
severe,O
pneumonia,O
with,O
clusters,O
illness,O
onsets,O
.,O
Its,O
impacts,O
on,O
public,O
health,O
make,O
"
",O
it,O
paramount,O
to,O
clarify,O
the,O
clinical,O
features,O
with,O
other,O
pneumonias,O
.,O
"
",O
METHODS,O
:,O
Nineteen,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
(,O
NCOVID19,O
),O
and,O
fifteen,O
other,O
pneumonia,O
"
",O
patients,O
(,O
NONNCOVID19,O
),O
in,O
out,O
of,O
Hubei,O
places,O
were,O
involved,O
in,O
this,O
study,O
.,O
Both,O
"
",O
NCOVID19,O
and,O
NONNCOVID19,O
patients,O
were,O
confirmed,O
to,O
be,O
infected,O
in,O
throat,O
"
",O
swabs,O
or,O
and,O
sputa,O
with,O
or,O
without,O
2019nCoV,B-Virus_SARS-CoV-2
by,O
realtime,O
RTPCR,O
.,O
We,O
analyzed,O
the,O
"
",O
demographic,O
",",O
epidemiological,O
",",O
clinical,O
",",O
and,O
radiological,O
features,O
from,O
those,O
"
",O
patients,O
",",O
and,O
compared,O
the,O
difference,O
between,O
NCOVID19,O
and,O
NONNCOVID19,O
.,O
"
",O
RESULTS,O
:,O
All,O
patients,O
had,O
a,O
history,O
of,O
exposure,O
to,O
confirmed,O
case,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
or,O
"
",O
travel,O
to,O
Hubei,O
before,O
illness,O
.,O
The,O
median,O
duration,O
",",O
respectively,O
",",O
was,O
8,O
"
",O
(,O
IQR:6~11,O
),O
and,O
5,O
(,O
IQR:4~11,O
),O
days,O
from,O
exposure,O
to,O
onset,O
in,O
NCOVID19,O
and,O
"
",O
NONNCOVID19,O
.,O
The,O
clinical,O
symptoms,O
were,O
similar,O
between,O
NCOVID19,O
and,O
"
",O
NONNCOVID19,O
.,O
The,O
most,O
common,O
symptoms,O
were,O
fever,O
and,O
cough,O
.,O
Fifteen,O
(,O
78.95,O
%,O
),O
"
",O
NCOVID19,O
but,O
4,O
(,O
26.67,O
%,O
),O
NONNCOVID19,O
patients,O
had,O
bilateral,O
involvement,O
while,O
"
",O
17,O
(,O
89.47,O
%,O
),O
NCOVID19,O
but,O
1,O
(,O
6.67,O
%,O
),O
NONNCOVID19,O
patients,O
had,O
multiple,O
mottling,O
"
",O
and,O
groundglass,O
opacity,O
of,O
chest,O
CT,O
images,O
.,O
Compared,O
to,O
NONNCOVID19,O
",",O
NCOVID19,O
"
",O
present,O
remarkably,O
more,O
abnormal,O
laboratory,O
tests,O
including,O
AST,O
",",O
ALT,O
",",O
Î³GT,O
",",O
LDH,O
"
",O
and,O
Î±HBDH,O
.,O
"
",O
CONCLUSION,O
:,O
The,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
caused,O
similar,O
onsets,O
to,O
other,O
pneumonias,O
.,O
CT,O
"
",O
scan,O
may,O
be,O
a,O
reliable,O
test,O
for,O
screening,O
NCOVID19,O
cases,O
.,O
Liver,O
function,O
damage,O
"
",O
is,O
more,O
frequent,O
in,O
NCOVID19,O
than,O
NONNCOVID19,O
patients,O
.,O
LDH,O
and,O
Î±HBDH,O
may,O
be,O
"
",O
considerable,O
markers,O
for,O
evaluation,O
of,O
NCOVID19,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa247,O
"
",O
PMID,O
:,O
32161968,O
"


",O
110,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
12,O
.,O
pii,O
:,O
ciaa225,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa225,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
A,O
case,O
report,O
of,O
neonatal,O
COVID19,B-Disease_COVID-19
infection,O
in,O
China,O
.,O
"

",O
Wang,O
S(1,O
),O
",",O
Guo,O
L(1,O
),O
",",O
Chen,O
L(2,O
),O
",",O
Liu,O
W(3,O
),O
",",O
Cao,O
Y(4,O
),O
",",O
Zhang,O
J(1,O
),O
",",O
Feng,O
L(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Obstetrics,O
and,O
Gynecology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
"
",O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pediatrics,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Laboratory,O
Medicine,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Infectious,O
Disease,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
In,O
December,O
2019,O
",",O
the,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
caused,O
by,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
emerged,O
in,O
China,O
and,O
now,O
has,O
spread,O
in,O
many,O
countries,O
.,O
Pregnant,O
women,O
"
",O
are,O
susceptible,O
population,O
of,O
COVID19,B-Disease_COVID-19
which,O
are,O
more,O
likely,O
to,O
have,O
"
",O
complications,O
and,O
even,O
progresse,O
to,O
severe,O
illness,O
.,O
We,O
report,O
a,O
case,O
of,O
neonatal,O
"
",O
COVID19,B-Disease_COVID-19
infection,O
in,O
China,O
with,O
pharyngeal,O
swabs,O
tested,O
positive,O
by,O
rRTPCR,O
"
",O
assay,O
36,O
hours,O
after,O
birth,O
.,O
However,O
",",O
whether,O
the,O
case,O
is,O
a,O
vertical,O
transmission,O
"
",O
from,O
mother,O
to,O
child,O
remains,O
to,O
be,O
confirmed,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa225,O
"
",O
PMID,O
:,O
32161941,O
"


",O
111,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
12,O
.,O
pii,O
:,O
ciaa248,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa248,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Dysregulation,O
of,O
immune,O
response,O
in,O
patients,O
with,O
COVID19,B-Disease_COVID-19
in,O
Wuhan,O
",",O
China,O
.,O
"

",O
Qin,O
C(1,O
),O
",",O
Zhou,O
L(1,O
),O
",",O
Hu,O
Z(1,O
),O
",",O
Zhang,O
S(1,O
),O
",",O
Yang,O
S(1,O
),O
",",O
Tao,O
Y(2,O
),O
",",O
Xie,O
C(3,O
),O
",",O
Ma,O
K(4,O
),O
",",O
"
",O
Shang,O
K(1,O
),O
",",O
Wang,O
W(1,O
),O
",",O
Tian,O
DS(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Neurology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Emergency,O
Medicine,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Infectious,O
Diseases,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
In,O
December,O
2019,O
",",O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
emerged,O
in,O
"
",O
Wuhan,O
and,O
rapidly,O
spread,O
throughout,O
China,O
.,O
"
",O
METHODS,O
:,O
Demographic,O
and,O
clinical,O
data,O
of,O
all,O
confirmed,O
cases,O
with,O
COVID19,B-Disease_COVID-19
on,O
"
",O
admission,O
at,O
Tongji,O
Hospital,O
from,O
January,O
10,O
to,O
February,O
12,O
",",O
2020,O
",",O
were,O
collected,O
"
",O
and,O
analyzed,O
.,O
The,O
data,O
of,O
laboratory,O
examinations,O
",",O
including,O
peripheral,O
"
",O
lymphocyte,O
subsets,O
",",O
were,O
analyzed,O
and,O
compared,O
between,O
severe,O
and,O
nonsevere,O
"
",O
patients,O
.,O
"
",O
RESULTS,O
:,O
Of,O
the,O
452,O
patients,O
with,O
COVID19,B-Disease_COVID-19
recruited,O
",",O
286,O
were,O
diagnosed,O
as,O
"
",O
severe,O
infection,O
.,O
The,O
median,O
age,O
was,O
58,O
years,O
and,O
235,O
were,O
male,O
.,O
The,O
most,O
common,O
"
",O
symptoms,O
were,O
fever,O
",",O
shortness,O
of,O
breath,O
",",O
expectoration,O
",",O
fatigue,O
",",O
dry,O
cough,O
and,O
"
",O
myalgia,O
.,O
Severe,O
cases,O
tend,O
to,O
have,O
lower,O
lymphocytes,O
counts,O
",",O
higher,O
leukocytes,O
"
",O
counts,O
and,O
neutrophillymphocyteratio,O
(,O
NLR,O
),O
",",O
as,O
well,O
as,O
lower,O
percentages,O
of,O
"
",O
monocytes,O
",",O
eosinophils,O
",",O
and,O
basophils,O
.,O
Most,O
of,O
severe,O
cases,O
demonstrated,O
elevated,O
"
",O
levels,O
of,O
infectionrelated,O
biomarkers,O
and,O
inflammatory,O
cytokines,O
.,O
The,O
number,O
of,O
"
",O
T,O
cells,O
significantly,O
decreased,O
",",O
and,O
more,O
hampered,O
in,O
severe,O
cases,O
.,O
Both,O
helper,O
T,O
"
",O
cells,O
and,O
suppressor,O
T,O
cells,O
in,O
patients,O
with,O
COVID19,B-Disease_COVID-19
were,O
below,O
normal,O
levels,O
",",O
"
",O
and,O
lower,O
level,O
of,O
helper,O
T,O
cells,O
in,O
severe,O
group,O
.,O
The,O
percentage,O
of,O
naÃ¯ve,O
helper,O
"
",O
T,O
cells,O
increased,O
and,O
memory,O
helper,O
T,O
cells,O
decreased,O
in,O
severe,O
cases,O
.,O
Patients,O
"
",O
with,O
COVID19,B-Disease_COVID-19
also,O
have,O
lower,O
level,O
of,O
regulatory,O
T,O
cells,O
",",O
and,O
more,O
obviously,O
"
",O
damaged,O
in,O
severe,O
cases,O
.,O
"
",O
CONCLUSIONS,O
:,O
The,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
might,O
mainly,O
act,O
on,O
lymphocytes,O
",",O
especially,O
T,O
"
",O
lymphocytes,O
.,O
Surveillance,O
of,O
NLR,O
and,O
lymphocyte,O
subsets,O
is,O
helpful,O
in,O
the,O
early,O
"
",O
screening,O
of,O
critical,O
illness,O
",",O
diagnosis,O
and,O
treatment,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa248,O
"
",O
PMID,O
:,O
32161940,O
"


",O
112,O
.,O
Diabetes,O
Metab,O
Syndr,O
Obes,O
.,O
2020,O
Feb,O
26;13:535544,O
.,O
doi,O
:,O
10.2147,O
DMSO.S235869,O
.,O
"
",O
eCollection,O
2020,O
.,O
"

",O
Protein,O
Arginine,O
Methyltransferase,O
4,O
Regulates,O
Adipose,O
Tissue,O
Lipolysis,O
in,O
Type,O
1,O
"
",O
Diabetic,O
Mice,O
.,O
"

",O
Li,O
Y(1,O
),O
",",O
Peng,O
M(1,O
),O
",",O
Zeng,O
T(1,O
),O
",",O
Zheng,O
J(1,O
),O
",",O
Liao,O
Y(1,O
),O
",",O
Zhang,O
H(1,O
),O
",",O
Yang,O
S(1,O
),O
",",O
Chen,O
"
",O
L(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Endocrinology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
430022,O
",",O
People,O
's,O
Republic,O
of,O
"
",O
China,O
.,O
"

",O
Purpose,O
:,O
Hypertriglyceridemia,O
is,O
considered,O
to,O
be,O
driven,O
by,O
increased,O
lipolysis,O
"
",O
in,O
type,O
1,O
diabetes,O
mellitus,O
(,O
T1DM,O
),O
.,O
However,O
",",O
information,O
regarding,O
the,O
"
",O
transcriptional,O
circuitry,O
that,O
governs,O
lipolysis,O
remains,O
incomplete,O
in,O
T1DM,O
.,O
"
",O
Protein,O
arginine,O
methyltransferase,O
4,O
(,O
PRMT4,O
),O
",",O
a,O
transcriptional,O
coactivation,O
"
",O
factor,O
",",O
promotes,O
autophagy,O
and,O
may,O
play,O
an,O
important,O
role,O
in,O
lipolysis,O
.,O
We,O
wonder,O
"
",O
whether,O
activated,O
lipolysis,O
in,O
T1DM,O
is,O
regulated,O
by,O
PRMT4,O
.,O
"
",O
Materials,O
and,O
Methods,O
:,O
Recombinant,O
adenoassociated,O
virus,O
was,O
adopted,O
to,O
"
",O
overexpress,O
PRMT4,O
in,O
adipose,O
tissue,O
of,O
mice,O
.,O
Streptozotocin,O
(,O
150,O
â€‰,O
mg,O
kg,O
),O
was,O
"
",O
injected,O
intraperitoneally,O
into,O
mice,O
to,O
induce,O
T1DM,O
.,O
Plasma,O
insulin,O
",",O
"
",O
triglycerides,O
",",O
free,O
fatty,O
acids,O
(,O
FFAs,O
),O
levels,O
were,O
determined,O
using,O
commercial,O
"
",O
assay,O
kits,O
.,O
Differentiated,O
adipocytes,O
were,O
applied,O
to,O
verify,O
the,O
regulation,O
of,O
"
",O
PRMT4,O
on,O
lipolysis,O
.,O
"
",O
Results,O
:,O
Elevated,O
serum,O
triglycerides,O
and,O
FFAs,O
were,O
observed,O
in,O
"
",O
PRMT4overexpressed,O
T1DM,O
mice,O
.,O
We,O
also,O
observed,O
that,O
PRMT4,O
overexpression,O
"
",O
induced,O
the,O
decrease,O
of,O
fat,O
pads,O
weights,O
and,O
adipocyte,O
sizes,O
.,O
Moreover,O
",",O
"
",O
expression,O
levels,O
of,O
lipolysisrelated,O
molecules,O
",",O
including,O
ATGL,O
",",O
HSL,O
",",O
and,O
MAGL,O
",",O
"
",O
and,O
HSL,O
phosphorylation,O
levels,O
were,O
increased,O
in,O
PRMT4overexpressed,O
mice,O
when,O
"
",O
compared,O
to,O
those,O
of,O
control,O
mice,O
.,O
In,O
vitro,O
",",O
PRMT4,O
promoted,O
FFAs,O
release,O
and,O
"
",O
activated,O
HSL,O
phosphorylation,O
",",O
whereas,O
PRMT4,O
knockdown,O
inhibited,O
these,O
processes,O
.,O
"
",O
Conclusion,O
:,O
PRMT4,O
promotes,O
lipolysis,O
and,O
increases,O
serum,O
triglyceride,O
in,O
T1DM,O
.,O
"

",O
Â©,O
2020,O
Li,O
et,O
al.,O
"

",O
DOI,O
:,O
10.2147,O
DMSO.S235869,O
"
",O
PMCID,O
:,O
PMC7049750,O
"
",O
PMID,O
:,O
32161480,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
report,O
no,O
conflicts,O
of,O
interest,O
in,O
"
",O
this,O
work,O
.,O
"


",O
113,O
.,O
N,O
Z,O
Med,O
J.,O
2020,O
Mar,O
13;133(1511):78,O
.,O
"

",O
Politicians,O
:,O
please,O
work,O
together,O
to,O
minimise,O
the,O
spread,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Murdoch,O
D(1,O
),O
",",O
Addidle,O
M(2,O
),O
",",O
Andersson,O
HS(3,O
),O
",",O
Arnold,O
B(4,O
),O
",",O
Balm,O
M(5,O
),O
",",O
Benschop,O
"
",O
J(6,O
),O
",",O
Betty,O
B(7,O
),O
",",O
Birch,O
M(8,O
),O
",",O
Bloomfield,O
M(9,O
),O
",",O
Brunton,O
C(10,O
),O
",",O
Burns,O
A(11,O
),O
",",O
"
",O
Chambers,O
S(12,O
),O
",",O
Cook,O
L(13,O
),O
",",O
Dalton,O
S(8,O
),O
",",O
Duncan,O
H(14,O
),O
",",O
Elvy,O
J(15,O
),O
",",O
Everts,O
R(16,O
),O
",",O
"
",O
Freeman,O
J(17,O
),O
",",O
French,O
N(18,O
),O
",",O
Grimwade,O
K(19,O
),O
",",O
Hammer,O
D(20,O
),O
",",O
Hayman,O
D(21,O
),O
",",O
Holland,O
"
",O
D(22,O
),O
",",O
Hudson,O
B(23,O
),O
",",O
Huggan,O
P(24,O
),O
",",O
Ikram,O
R(17,O
),O
",",O
Jack,O
S(25,O
),O
",",O
Kelly,O
M(26,O
),O
",",O
Lamont,O
"
",O
I(27,O
),O
",",O
Maze,O
M(28,O
),O
",",O
McAuliffe,O
G(29,O
),O
",",O
McBride,O
S(30,O
),O
",",O
Metcalf,O
S(8,O
),O
",",O
Morpeth,O
S(31,O
),O
",",O
"
",O
Morris,O
A(32,O
),O
",",O
Murton,O
S(33,O
),O
",",O
Pink,O
R(34,O
),O
",",O
Pithie,O
A(35,O
),O
",",O
Pitout,O
M(20,O
),O
",",O
Priest,O
P(36,O
),O
",",O
"
",O
Raymond,O
N(37,O
),O
",",O
Read,O
K(38,O
),O
",",O
Ritchie,O
S(39,O
),O
",",O
Rogers,O
M(40,O
),O
",",O
Schroeder,O
P(41,O
),O
",",O
Taylor,O
"
",O
S(42,O
),O
",",O
Taylor,O
J(9,O
),O
",",O
Thomas,O
M(43,O
),O
",",O
Upton,O
A(44,O
),O
",",O
Ussher,O
J(45,O
),O
",",O
Werno,O
A(46,O
),O
",",O
Wiles,O
"
",O
S(47,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Dean,O
and,O
Head,O
of,O
Campus,O
",",O
University,O
of,O
Otago,O
",",O
Christchurch,O
;,O
CoDirector,O
",",O
One,O
"
",O
Health,O
Aotearoa,O
.,O
"
",O
(2)Clinical,O
Microbiologist,O
",",O
Pathlab,O
",",O
Tauranga,O
.,O
"
",O
(3)Clinical,O
Microbiologist,O
",",O
Medlab,O
Central,O
",",O
Palmerston,O
North,O
.,O
"
",O
(4)Infectious,O
Disease,O
Physician,O
",",O
Southern,O
District,O
Health,O
Board,O
",",O
Dunedin,O
.,O
"
",O
(5)Infectious,O
Diseases,O
Physician,O
and,O
Clinical,O
Microbiologist,O
",",O
Capital,O
&,O
Coast,O
"
",O
District,O
Health,O
Board,O
",",O
Wellington,O
.,O
"
",O
(6)School,O
of,O
Veterinary,O
Science,O
",",O
Massey,O
University,O
",",O
Palmerston,O
North,O
.,O
"
",O
(7)Medical,O
Director,O
",",O
Royal,O
New,O
Zealand,O
College,O
of,O
General,O
Practitioners,O
.,O
"
",O
(8)Infectious,O
Diseases,O
Physician,O
",",O
Canterbury,O
District,O
Health,O
Board,O
",",O
Christchurch,O
.,O
"
",O
(9)Infectious,O
Diseases,O
Physician,O
",",O
Capital,O
&,O
Coast,O
District,O
Health,O
Board,O
",",O
"
",O
Wellington,O
.,O
"
",O
(10)Senior,O
Lecturer,O
in,O
Public,O
Health,O
",",O
University,O
of,O
Otago,O
",",O
Christchurch,O
;,O
Public,O
"
",O
Health,O
Specialist,O
",",O
Canterbury,O
District,O
Health,O
Board,O
",",O
Christchurch,O
.,O
"
",O
(11)Infectious,O
Diseases,O
Physician,O
",",O
Hawke,O
's,O
Bay,O
District,O
Health,O
Board,O
",",O
Hastings,O
.,O
"
",O
(12)Infectious,O
Diseases,O
Physician,O
",",O
University,O
of,O
Otago,O
",",O
Christchurch,O
.,O
"
",O
(13)Population,O
Health,O
Specialist,O
",",O
Pegasus,O
Health,O
",",O
Christchurch,O
.,O
"
",O
(14)Chief,O
Executive,O
",",O
New,O
Zealand,O
Sepsis,O
Trust,O
.,O
"
",O
(15)Clinical,O
Microbiologist,O
",",O
Medlab,O
South,O
",",O
Nelson,O
Marlborough,O
and,O
Wellington,O
"
",O
Southern,O
Community,O
Laboratories,O
.,O
"
",O
(16)Infectious,O
Disease,O
Physician,O
and,O
Microbiologist,O
",",O
Nelson,O
Bays,O
Primary,O
Health,O
",",O
"
",O
Nelson,O
.,O
"
",O
(17)Clinical,O
Microbiologist,O
",",O
Canterbury,O
Health,O
Laboratories,O
",",O
Christchurch,O
.,O
"
",O
(18)Professor,O
of,O
Food,O
Safety,O
and,O
Veterinary,O
Public,O
Health,O
",",O
Massey,O
University,O
",",O
"
",O
Palmerston,O
North,O
;,O
CoDirector,O
",",O
One,O
Health,O
Aotearoa,O
.,O
"
",O
(19)Infectious,O
Diseases,O
Physician,O
",",O
Bay,O
of,O
Plenty,O
District,O
Health,O
Board,O
",",O
Tauranga,O
.,O
"
",O
(20)Clinical,O
Microbiologist,O
",",O
Northland,O
District,O
Health,O
Board,O
",",O
Whangarei,O
.,O
"
",O
(21)Professor,O
of,O
Infectious,O
Disease,O
Ecology,O
",",O
Massey,O
University,O
",",O
Palmerston,O
North,O
.,O
"
",O
(22)Director,O
of,O
Infection,O
Services,O
",",O
Counties,O
Manukau,O
District,O
Health,O
Board,O
",",O
"
",O
Auckland,O
.,O
"
",O
(23)Head,O
of,O
General,O
Practice,O
",",O
University,O
of,O
Otago,O
",",O
Christchurch,O
",",O
Christchurch,O
.,O
"
",O
(24)Clinical,O
Director,O
of,O
Infectious,O
Disease,O
",",O
Waikato,O
District,O
Health,O
Board,O
",",O
"
",O
Hamilton,O
.,O
"
",O
(25)Medical,O
Officer,O
of,O
Health,O
Clinical,O
Director,O
",",O
Public,O
Health,O
South,O
",",O
Southern,O
"
",O
District,O
Health,O
Boards,O
",",O
Dunedin,O
.,O
"
",O
(26)Infectious,O
Diseases,O
Physician,O
",",O
Hutt,O
Valley,O
District,O
Health,O
Board,O
",",O
Lower,O
Hutt,O
.,O
"
",O
(27)Professor,O
",",O
University,O
of,O
Otago,O
",",O
Dunedin,O
.,O
"
",O
(28)Infectious,O
Diseases,O
and,O
Respiratory,O
Physician,O
",",O
Canterbury,O
District,O
Health,O
"
",O
Board,O
and,O
University,O
of,O
Otago,O
",",O
Christchurch,O
.,O
"
",O
(29)Clinical,O
Microbiologist,O
",",O
Auckland,O
District,O
Health,O
Board,O
",",O
Auckland,O
.,O
"
",O
(30)General,O
and,O
Infectious,O
Diseases,O
Physician,O
",",O
Clinical,O
Head,O
of,O
General,O
Medicine,O
",",O
"
",O
Counties,O
Manukau,O
District,O
Health,O
Board,O
",",O
Auckland,O
.,O
"
",O
(31)Clinical,O
Microbiologist,O
and,O
Infectious,O
Diseases,O
Physician,O
",",O
Counties,O
Manaukau,O
"
",O
District,O
Health,O
Board,O
",",O
Auckland,O
.,O
"
",O
(32)Clinical,O
Microbiologist,O
",",O
Auckland,O
City,O
Hospital,O
",",O
Auckland,O
.,O
"
",O
(33)President,O
",",O
Royal,O
New,O
Zealand,O
College,O
of,O
General,O
Practitioners,O
.,O
"
",O
(34)Public,O
Health,O
Physician,O
",",O
Canterbury,O
District,O
Health,O
Board,O
",",O
Christchurch,O
.,O
"
",O
(35)Consultant,O
Infectious,O
Diseases,O
Physician,O
",",O
Christchurch,O
.,O
"
",O
(36)Epidemiologist,O
",",O
University,O
of,O
Otago,O
",",O
Dunedin,O
.,O
"
",O
(37)Infectious,O
Diseases,O
and,O
General,O
Physician,O
",",O
Capital,O
and,O
Coast,O
District,O
Health,O
"
",O
Board,O
",",O
Wellington,O
.,O
"
",O
(38)Infectious,O
Diseases,O
Physician,O
",",O
Waitemata,O
District,O
Health,O
Board,O
",",O
Auckland,O
.,O
"
",O
(39)Infectious,O
Disease,O
Physician,O
",",O
Auckland,O
District,O
Health,O
Board,O
",",O
Auckland,O
.,O
"
",O
(40)Clinical,O
Director,O
",",O
Infection,O
Services,O
and,O
Laboratories,O
",",O
Waitemata,O
District,O
"
",O
Health,O
Board,O
",",O
Auckland,O
.,O
"
",O
(41)Emergency,O
Support,O
Services,O
for,O
Canterbury,O
Primary,O
Care,O
",",O
Christchurch,O
.,O
"
",O
(42)Clinical,O
Microbiologist,O
",",O
Counties,O
Manukau,O
District,O
Health,O
Board,O
",",O
Auckland,O
.,O
"
",O
(43)Infectious,O
Diseases,O
Physician,O
",",O
University,O
of,O
Auckland,O
and,O
Auckland,O
City,O
"
",O
Hospital,O
",",O
Auckland,O
.,O
"
",O
(44)Southern,O
Community,O
Laboratories,O
",",O
Dunedin,O
.,O
"
",O
(45)Clinical,O
Microbiologist,O
",",O
University,O
of,O
Otago,O
",",O
Dunedin,O
.,O
"
",O
(46)Chief,O
of,O
Pathology,O
",",O
Canterbury,O
Health,O
Laboratories,O
",",O
Christchurch,O
.,O
"
",O
(47)Associate,O
Professor,O
",",O
University,O
of,O
Auckland,O
",",O
Auckland,O
.,O
"


",O
PMID,O
:,O
32161416,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Nil,O
.,O
"


",O
114,O
.,O
Nat,O
Med,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1038,O
d41591020000042,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Nigeria,O
responds,O
to,O
COVID19,B-Disease_COVID-19
;,O
first,O
case,O
detected,O
in,O
subSaharan,O
Africa,O
.,O
"

",O
Adepoju,O
P.,O
"

",O
DOI,O
:,O
10.1038,O
d41591020000042,O
"
",O
PMID,O
:,O
32161414,O
"


",O
115,O
.,O
Nat,O
Med,O
.,O
2020,O
Mar;26(3):312,O
.,O
doi,O
:,O
10.1038,O
s415910200810y,O
.,O
"

",O
Lack,O
of,O
maternalfetal,O
SARSCoV2,B-Virus_SARS-CoV-2
transmission,O
.,O
"

",O
Stower,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Nature,O
Medicine,O
",",O
.,O
h.stower@us.nature.com,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s415910200810y,O
"
",O
PMID,O
:,O
32161408,O
"


",O
116,O
.,O
Sci,O
Transl,O
Med,O
.,O
2020,O
Mar,O
11;12(534,O
),O
.,O
pii,O
:,O
eabb1469,O
.,O
doi,O
:,O
"
",O
10.1126,O
scitranslmed.abb1469,O
.,O
"

",O
New,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
outbreak,O
:,O
Framing,O
questions,O
for,O
pandemic,O
prevention,O
.,O
"

",O
Layne,O
SP(1)(2)(3)(4,O
),O
",",O
Hyman,O
JM(1)(2)(3)(4,O
),O
",",O
Morens,O
DM(1)(2)(3)(4,O
),O
",",O
Taubenberger,O
"
",O
JK(5)(6)(7)(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Scott,O
P.,O
Layne,O
is,O
emeritus,O
professor,O
in,O
the,O
Department,O
of,O
Epidemiology,O
",",O
UCLA,O
"
",O
School,O
of,O
Public,O
Health,O
",",O
Los,O
Angeles,O
",",O
CA,O
90095,O
",",O
USA,O
.,O
Email,O
:,O
"
",O
scottplayne@gmail.com,O
.,O
"
",O
(2)James,O
M.,O
Hyman,O
is,O
the,O
Evelyn,O
and,O
John,O
G.,O
Phillips,O
Distinguished,O
Professor,O
in,O
"
",O
Mathematics,O
in,O
the,O
School,O
of,O
Science,O
and,O
Engineering,O
",",O
Tulane,O
University,O
",",O
New,O
"
",O
Orleans,O
",",O
LA,O
70118,O
",",O
USA,O
.,O
Email,O
:,O
mhyman@tulane.edu,O
.,O
"
",O
(3)David,O
M.,O
Morens,O
is,O
Senior,O
Advisor,O
to,O
the,O
Director,O
in,O
the,O
Office,O
of,O
the,O
"
",O
Director,O
",",O
National,O
Institute,O
of,O
Allergy,O
and,O
Infectious,O
Diseases,O
",",O
National,O
"
",O
Institutes,O
of,O
Health,O
",",O
Bethesda,O
",",O
MD,O
20892,O
",",O
USA,O
.,O
Email,O
:,O
dmorens@niaid.nih.gov,O
.,O
"
",O
(4)Jeffery,O
K.,O
Taubenberger,O
is,O
Chief,O
of,O
the,O
Viral,O
Pathogenesis,O
and,O
Evolution,O
"
",O
Section,O
",",O
Laboratory,O
of,O
Infectious,O
Diseases,O
",",O
National,O
Institute,O
of,O
Allergy,O
and,O
"
",O
Infectious,O
Diseases,O
",",O
National,O
Institutes,O
of,O
Health,O
",",O
Bethesda,O
",",O
MD,O
20892,O
",",O
USA,O
.,O
"
",O
(5)Scott,O
P.,O
Layne,O
is,O
emeritus,O
professor,O
in,O
the,O
Department,O
of,O
Epidemiology,O
",",O
UCLA,O
"
",O
School,O
of,O
Public,O
Health,O
",",O
Los,O
Angeles,O
",",O
CA,O
90095,O
",",O
USA,O
.,O
Email,O
:,O
scottplayne@gmail.com,O
"
",O
taubenbergerj@niaid.nih.gov,O
.,O
"
",O
(6)James,O
M.,O
Hyman,O
is,O
the,O
Evelyn,O
and,O
John,O
G.,O
Phillips,O
Distinguished,O
Professor,O
in,O
"
",O
Mathematics,O
in,O
the,O
School,O
of,O
Science,O
and,O
Engineering,O
",",O
Tulane,O
University,O
",",O
New,O
"
",O
Orleans,O
",",O
LA,O
70118,O
",",O
USA,O
.,O
Email,O
:,O
mhyman@tulane.edu,O
taubenbergerj@niaid.nih.gov,O
.,O
"
",O
(7)David,O
M.,O
Morens,O
is,O
Senior,O
Advisor,O
to,O
the,O
Director,O
in,O
the,O
Office,O
of,O
the,O
"
",O
Director,O
",",O
National,O
Institute,O
of,O
Allergy,O
and,O
Infectious,O
Diseases,O
",",O
National,O
"
",O
Institutes,O
of,O
Health,O
",",O
Bethesda,O
",",O
MD,O
20892,O
",",O
USA,O
.,O
Email,O
:,O
dmorens@niaid.nih.gov,O
"
",O
taubenbergerj@niaid.nih.gov,O
.,O
"
",O
(8)Jeffery,O
K.,O
Taubenberger,O
is,O
Chief,O
of,O
the,O
Viral,O
Pathogenesis,O
and,O
Evolution,O
"
",O
Section,O
",",O
Laboratory,O
of,O
Infectious,O
Diseases,O
",",O
National,O
Institute,O
of,O
Allergy,O
and,O
"
",O
Infectious,O
Diseases,O
",",O
National,O
Institutes,O
of,O
Health,O
",",O
Bethesda,O
",",O
MD,O
20892,O
",",O
USA,O
.,O
"
",O
taubenbergerj@niaid.nih.gov,O
.,O
"

",O
We,O
need,O
to,O
understand,O
and,O
quantify,O
the,O
dominant,O
variables,O
that,O
govern,O
the,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
outbreak,O
",",O
rather,O
than,O
relying,O
exclusively,O
on,O
confirmed,O
cases,O
and,O
their,O
"
",O
geospatial,O
spread,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Authors,O
",",O
some,O
rights,O
reserved,O
;,O
exclusive,O
licensee,O
American,O
"
",O
Association,O
for,O
the,O
Advancement,O
of,O
Science,O
.,O
No,O
claim,O
to,O
original,O
U.S.,O
Government,O
"
",O
Works,O
.,O
"

",O
DOI,O
:,O
10.1126,O
scitranslmed.abb1469,O
"
",O
PMID,O
:,O
32161107,O
"


",O
117,O
.,O
J,O
Clin,O
Microbiol,O
.,O
2020,O
Mar,O
11,O
.,O
pii,O
:,O
JCM.0018720,O
.,O
doi,O
:,O
10.1128,O
JCM.0018720,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
emergence,O
of,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
their,O
biology,O
and,O
therapeutic,O
"
",O
options,O
.,O
"

",O
Khan,O
S(1)(2,O
),O
",",O
Siddique,O
R(3)(2,O
),O
",",O
Shereen,O
MA(4,O
),O
",",O
Ali,O
A(5,O
),O
",",O
Liu,O
J(6,O
),O
",",O
Bai,O
Q(3)(2,O
),O
",",O
"
",O
Bashir,O
N(4,O
),O
",",O
Xue,O
M(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Department,O
of,O
Cerebrovascular,O
Diseases,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
"
",O
Zhengzhou,O
University,O
",",O
Zhengzhou,O
",",O
China,O
xuemengzhou@zzu.edu.cn,O
"
",O
Suliman.khan18@mails.ucas.ac.cn,O
.,O
"
",O
(2)Henan,O
Medical,O
Key,O
Laboratory,O
of,O
Translational,O
Cerebrovascular,O
Diseases,O
",",O
"
",O
Zhengzhou,O
",",O
China,O
.,O
"
",O
(3)The,O
Department,O
of,O
Cerebrovascular,O
Diseases,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
"
",O
Zhengzhou,O
University,O
",",O
Zhengzhou,O
",",O
China,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(5)Wuhan,O
institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Respiratory,O
Medicine,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
"
",O
Zhengzhou,O
University,O
.,O
"

",O
The,O
new,O
decade,O
of,O
the,O
21st,O
century,O
(,O
2020,O
),O
started,O
with,O
the,O
emergence,O
of,O
novel,O
"
",O
coronavirus,O
known,O
as,O
SARSCoV2,B-Virus_SARS-CoV-2
that,O
caused,O
an,O
epidemic,O
of,O
coronavirus,O
disease,O
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
in,O
Wuhan,O
",",O
China,O
.,O
It,O
is,O
the,O
third,O
highly,O
pathogenic,O
and,O
transmissible,O
"
",O
coronavirus,O
after,O
severe,O
acute,O
respiratory,O
syndrome,O
coronavirus,O
(,O
SARSCoV,O
),O
and,O
"
",O
Middle,O
East,O
respiratory,O
syndrome,O
coronavirus,O
(,O
MERSCoV,O
),O
emerged,O
in,O
humans,O
.,O
The,O
"
",O
source,O
of,O
origin,O
",",O
transmission,O
to,O
humans,O
and,O
mechanisms,O
associated,O
with,O
the,O
"
",O
pathogenicity,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
are,O
not,O
clear,O
yet,O
",",O
however,O
",",O
its,O
resemblance,O
with,O
"
",O
SARSCoV,O
and,O
several,O
other,O
bat,O
coronaviruses,O
was,O
recently,O
confirmed,O
through,O
"
",O
genome,O
sequencing,O
related,O
studies,O
.,O
The,O
development,O
of,O
therapeutic,O
strategies,O
is,O
"
",O
necessary,O
in,O
order,O
to,O
prevent,O
further,O
epidemics,O
and,O
cure,O
infected,O
people,O
.,O
In,O
this,O
"
",O
Review,O
",",O
we,O
summarize,O
current,O
information,O
about,O
the,O
emergence,O
",",O
origin,O
",",O
diversity,O
",",O
"
",O
and,O
epidemiology,O
of,O
three,O
pathogenic,O
coronaviruses,O
with,O
a,O
specific,O
focus,O
on,O
the,O
"
",O
current,O
outbreak,O
in,O
Wuhan,O
",",O
China,O
.,O
Furthermore,O
",",O
we,O
discuss,O
the,O
clinical,O
features,O
"
",O
and,O
potential,O
therapeutic,O
options,O
that,O
may,O
be,O
effective,O
against,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Copyright,O
Â©,O
2020,O
American,O
Society,O
for,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1128,O
JCM.0018720,O
"
",O
PMID,O
:,O
32161092,O
"


",O
118,O
.,O
BMJ,O
.,O
2020,O
Mar,O
11;368:m993,O
.,O
doi,O
:,O
10.1136,O
bmj.m993,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
Trump,O
proposes,O
tax,O
cuts,O
and,O
improved,O
health,O
insurance,O
",",O
but,O
millions,O
are,O
"
",O
not,O
covered,O
.,O
"

",O
Tanne,O
JH(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)New,O
York,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m993,O
"
",O
PMID,O
:,O
32161091,O
"


",O
119,O
.,O
BMJ,O
.,O
2020,O
Mar,O
11;368:m1001,O
.,O
doi,O
:,O
10.1136,O
bmj.m1001,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
UK,O
budget,O
gives,O
Â£,O
94,O
a,O
week,O
statutory,O
sick,O
pay,O
to,O
selfisolators,O
and,O
"
",O
their,O
carers,O
.,O
"

",O
Mahase,O
E(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m1001,O
"
",O
PMID,O
:,O
32161028,O
"


",O
120,O
.,O
BMJ,O
.,O
2020,O
Mar,O
11;368:m995,O
.,O
doi,O
:,O
10.1136,O
bmj.m995,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
China,O
's,O
president,O
Xi,O
visits,O
Wuhan,O
amid,O
confidence,O
that,O
virus,O
is,O
under,O
"
",O
control,O
.,O
"

",O
Dyer,O
O(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Montreal,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m995,O
"
",O
PMID,O
:,O
32160997,O
"


",O
121,O
.,O
BMJ,O
.,O
2020,O
Mar,O
11;368:m1003,O
.,O
doi,O
:,O
10.1136,O
bmj.m1003,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
UK,O
ramps,O
up,O
testing,O
by,O
500,O
%,O
as,O
health,O
minister,O
tests,O
positive,O
for,O
"
",O
virus,O
.,O
"

",O
Mahase,O
E(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m1003,O
"
",O
PMID,O
:,O
32160996,O
"


",O
122,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
8:101619,O
.,O
doi,O
:,O
10.1016,O
j.tmaid.2020.101619,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Positive,O
result,O
of,O
SarsCov2,B-Virus_SARS-CoV-2
in,O
sputum,O
from,O
a,O
cured,O
patient,O
with,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Qu,O
YM(1,O
),O
",",O
Cong,O
HY(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Weihai,O
Municipal,O
Hospital,O
",",O
Shandong,O
University,O
",",O
Weihai,O
",",O
China,O
.,O
"
",O
(2)Weihai,O
Municipal,O
Hospital,O
",",O
Shandong,O
University,O
",",O
Weihai,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
haiyanstu@163.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101619,O
"
",O
PMID,O
:,O
32160971,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
None,O
of,O
the,O
"
",O
authors,O
has,O
any,O
conflict,O
of,O
interest,O
to,O
declare,O
.,O
"


",O
123,O
.,O
J,O
Bus,O
Contin,O
Emer,O
Plan,O
.,O
2020,O
Jan,O
1;13(4):115,O
.,O
"

",O
Novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
outbreak,O
:,O
Now,O
is,O
the,O
time,O
to,O
refresh,O
"
",O
pandemic,O
plans,O
.,O
"

",O
Koonin,O
LM(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Health,O
Preparedness,O
Partners,O
.,O
"

",O
This,O
article,O
outlines,O
practical,O
steps,O
that,O
businesses,O
can,O
take,O
now,O
to,O
prepare,O
for,O
"
",O
a,O
pandemic,O
.,O
Given,O
the,O
current,O
growing,O
spread,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
around,O
the,O
world,O
",",O
it,O
is,O
imperative,O
that,O
businesses,O
review,O
their,O
"
",O
pandemic,O
plans,O
and,O
be,O
prepared,O
in,O
case,O
this,O
epidemic,O
expands,O
and,O
affects,O
more,O
"
",O
people,O
and,O
communities,O
.,O
Preparing,O
for,O
a,O
potential,O
infectious,O
disease,O
pandemic,O
"
",O
from,O
influenza,O
or,O
a,O
novel,B-Virus_SARS-CoV-2
corona,I-Virus_SARS-CoV-2
virus,I-Virus_SARS-CoV-2
is,O
an,O
essential,O
component,O
of,O
a,O
business,O
"
",O
continuity,O
plan,O
",",O
especially,O
for,O
businesses,O
that,O
provide,O
critical,O
healthcare,O
and,O
"
",O
infrastructure,O
services,O
.,O
Although,O
many,O
businesses,O
and,O
organisations,O
have,O
a,O
"
",O
pandemic,O
plan,O
or,O
address,O
pandemic,O
preparedness,O
in,O
their,O
business,O
continuity,O
"
",O
plans,O
",",O
few,O
have,O
recently,O
tested,O
and,O
updated,O
their,O
plans,O
.,O
Pandemics,O
can,O
not,O
only,O
"
",O
interrupt,O
an,O
organisation,O
's,O
operations,O
and,O
compromise,O
longterm,O
viability,O
of,O
an,O
"
",O
enterprise,O
",",O
but,O
also,O
disrupt,O
the,O
provision,O
of,O
critical,O
functions,O
.,O
Businesses,O
that,O
"
",O
regularly,O
test,O
and,O
update,O
their,O
pandemic,O
plan,O
can,O
significantly,O
reduce,O
harmful,O
"
",O
impacts,O
to,O
the,O
business,O
",",O
play,O
a,O
key,O
role,O
in,O
protecting,O
employees,O
',O
and,O
customers,O
',O
"
",O
health,O
and,O
safety,O
",",O
and,O
limit,O
the,O
negative,O
impact,O
of,O
a,O
pandemic,O
on,O
the,O
community,O
"
",O
and,O
economy,O
.,O
"


",O
PMID,O
:,O
32160942,O
"


",O
124,O
.,O
Int,O
J,O
Health,O
Geogr,O
.,O
2020,O
Mar,O
11;19(1):8,O
.,O
doi,O
:,O
10.1186,O
s12942020002028,O
.,O
"

",O
Geographical,O
tracking,O
and,O
mapping,O
of,O
coronavirus,O
disease,O
COVID19,B-Disease_COVID-19
severe,O
acute,O
"
",O
respiratory,O
syndrome,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
epidemic,O
and,O
associated,O
events,O
"
",O
around,O
the,O
world,O
:,O
how,O
21st,O
century,O
GIS,O
technologies,O
are,O
supporting,O
the,O
global,O
"
",O
fight,O
against,O
outbreaks,O
and,O
epidemics,O
.,O
"

",O
Kamel,O
Boulos,O
MN(1,O
),O
",",O
Geraghty,O
EM(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Information,O
Management,O
",",O
Sun,O
Yatsen,O
University,O
",",O
East,O
Campus,O
",",O
"
",O
Guangzhou,O
",",O
510006,O
",",O
Guangdong,O
",",O
China,O
.,O
mnkboulos@mail.sysu.edu.cn,O
.,O
"
",O
(2)Esri,O
(,O
Environmental,O
Systems,O
Research,O
Institute,O
),O
",",O
380,O
New,O
York,O
St,O
",",O
Redlands,O
",",O
"
",O
CA,O
",",O
92373,O
",",O
USA,O
.,O
"

",O
In,O
December,O
2019,O
",",O
a,O
new,O
virus,O
(,O
initially,O
called,O
',O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
2019nCoV,B-Virus_SARS-CoV-2
',O
and,O
"
",O
later,O
renamed,O
to,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
causing,O
severe,O
acute,O
respiratory,O
syndrome,O
"
",O
(,O
coronavirus,O
disease,O
COVID19,B-Disease_COVID-19
),O
emerged,O
in,O
Wuhan,O
",",O
Hubei,O
Province,O
",",O
China,O
",",O
and,O
"
",O
rapidly,O
spread,O
to,O
other,O
parts,O
of,O
China,O
and,O
other,O
countries,O
around,O
the,O
world,O
",",O
"
",O
despite,O
China,O
's,O
massive,O
efforts,O
to,O
contain,O
the,O
disease,O
within,O
Hubei,O
.,O
As,O
with,O
the,O
"
",O
original,O
SARSCoV,O
epidemic,O
of,O
2002,O
2003,O
and,O
with,O
seasonal,O
influenza,O
",",O
geographic,O
"
",O
information,O
systems,O
and,O
methods,O
",",O
including,O
",",O
among,O
other,O
application,O
"
",O
possibilities,O
",",O
online,O
realor,O
nearrealtime,O
mapping,O
of,O
disease,O
cases,O
and,O
of,O
"
",O
social,O
media,O
reactions,O
to,O
disease,O
spread,O
",",O
predictive,O
risk,O
mapping,O
using,O
"
",O
population,O
travel,O
data,O
",",O
and,O
tracing,O
and,O
mapping,O
superspreader,O
trajectories,O
and,O
"
",O
contacts,O
across,O
space,O
and,O
time,O
",",O
are,O
proving,O
indispensable,O
for,O
timely,O
and,O
"
",O
effective,O
epidemic,O
monitoring,O
and,O
response,O
.,O
This,O
paper,O
offers,O
pointers,O
to,O
",",O
and,O
"
",O
describes,O
",",O
a,O
range,O
of,O
practical,O
online,O
mobile,O
GIS,O
and,O
mapping,O
dashboards,O
and,O
"
",O
applications,O
for,O
tracking,O
the,O
2019,O
2020,O
coronavirus,O
epidemic,O
and,O
associated,O
"
",O
events,O
as,O
they,O
unfold,O
around,O
the,O
world,O
.,O
Some,O
of,O
these,O
dashboards,O
and,O
applications,O
"
",O
are,O
receiving,O
data,O
updates,O
in,O
nearrealtime,O
(,O
at,O
the,O
time,O
of,O
writing,O
),O
",",O
and,O
one,O
of,O
"
",O
them,O
is,O
meant,O
for,O
individual,O
users,O
(,O
in,O
China,O
),O
to,O
check,O
if,O
the,O
app,O
user,O
has,O
had,O
"
",O
any,O
close,O
contact,O
with,O
a,O
person,O
confirmed,O
or,O
suspected,O
to,O
have,O
been,O
infected,O
with,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
the,O
recent,O
past,O
.,O
We,O
also,O
discuss,O
additional,O
ways,O
GIS,O
can,O
support,O
"
",O
the,O
fight,O
against,O
infectious,O
disease,O
outbreaks,O
and,O
epidemics,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s12942020002028,O
"
",O
PMID,O
:,O
32160889,O
"


",O
125,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Mar,O
12;382(11):e25,O
.,O
doi,O
:,O
10.1056,O
NEJMe2004856,O
.,O
"

",O
Audio,O
Interview,O
:,O
Making,O
Decisions,O
about,O
Covid19,B-Disease_COVID-19
Testing,O
and,O
Treatment,O
for,O
Your,O
"
",O
Patients,O
.,O
"

",O
Rubin,O
EJ,O
",",O
Baden,O
LR,O
",",O
Morrissey,O
S.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMe2004856,O
"
",O
PMID,O
:,O
32160684,O
"


",O
126,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1056,O
NEJMp2003539,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Virtually,O
Perfect,O
?,O
Telemedicine,O
for,O
Covid19,B-Disease_COVID-19
.,O
"

",O
Hollander,O
JE(1,O
),O
",",O
Carr,O
BG(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
Sidney,O
Kimmel,O
Medical,O
College,O
of,O
Thomas,O
Jefferson,O
University,O
",",O
"
",O
Philadelphia,O
(,O
J.E.H.,O
),O
;,O
and,O
Icahn,O
School,O
of,O
Medicine,O
at,O
Mount,O
Sinai,O
",",O
New,O
York,O
"
",O
(,O
B.G.C.,O
),O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMp2003539,O
"
",O
PMID,O
:,O
32160451,O
"


",O
127,O
.,O
Ultrasound,O
Obstet,O
Gynecol,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1002,O
uog.22013,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
ISUOG,O
Interim,O
Guidance,O
on,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
during,O
pregnancy,O
and,O
"
",O
puerperium,O
:,O
information,O
for,O
healthcare,O
professionals,O
.,O
"

",O
Poon,O
LC(1,O
),O
",",O
Yang,O
H(2,O
),O
",",O
Lee,O
JCS(3,O
),O
",",O
Copel,O
JA(4,O
),O
",",O
Leung,O
TY(1,O
),O
",",O
Zhang,O
Y(5,O
),O
",",O
Chen,O
"
",O
D(6,O
),O
",",O
Prefumo,O
F(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Obstetrics,O
and,O
Gynaecology,O
",",O
The,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
SAR,O
.,O
"
",O
(2)Department,O
of,O
Obstetrics,O
and,O
Gynecology,O
",",O
Peking,O
University,O
First,O
Hospital,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Obstetrics,O
and,O
Gynaecology,O
",",O
KK,O
Women,O
's,O
and,O
Children,O
's,O
Hospital,O
",",O
"
",O
Singapore,O
.,O
"
",O
(4)Department,O
of,O
Obstetrics,O
",",O
Gynecology,O
&,O
Reproductive,O
Sciences,O
",",O
Yale,O
School,O
of,O
"
",O
Medicine,O
",",O
New,O
Haven,O
",",O
CT,O
",",O
USA,O
.,O
"
",O
(5)Department,O
of,O
Obstetrics,O
and,O
Gynaecology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Obstetrics,O
and,O
Gynaecology,O
",",O
The,O
Third,O
Affiliated,O
Hospital,O
of,O
"
",O
Guangzhou,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Clinical,O
and,O
Experimental,O
Sciences,O
",",O
University,O
of,O
Brescia,O
",",O
"
",O
Italy,O
.,O
"

",O
DOI,O
:,O
10.1002,O
uog.22013,O
"
",O
PMID,O
:,O
32160345,O
"


",O
128,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1002,O
jmv.25732,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Coinfection,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
and,O
HIV,O
in,O
a,O
patient,O
in,O
Wuhan,O
city,O
",",O
China,O
.,O
"

",O
Zhu,O
F(1,O
),O
",",O
Cao,O
Y(2,O
),O
",",O
Xu,O
S(3,O
),O
",",O
Zhou,O
M(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Cardiology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Hematology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25732,O
"
",O
PMID,O
:,O
32160316,O
"


",O
129,O
.,O
Ann,O
Intern,O
Med,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.7326,O
M200751,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
:,O
Protecting,O
Hospitals,O
From,O
the,O
Invisible,O
.,O
"

",O
Klompas,O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Harvard,O
Medical,O
School,O
",",O
Harvard,O
Pilgrim,O
Health,O
Care,O
Institute,O
",",O
and,O
Brigham,O
and,O
"
",O
Women,O
's,O
Hospital,O
",",O
Boston,O
",",O
Massachusetts,O
(,O
M.K.,O
),O
.,O
"

",O
DOI,O
:,O
10.7326,O
M200751,O
"
",O
PMID,O
:,O
32160299,O
"


",O
130,O
.,O
Ann,O
Intern,O
Med,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.7326,O
M200907,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
How,O
Should,O
U.S.,O
Hospitals,O
Prepare,O
for,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
?,O
"

",O
Chopra,O
V(1,O
),O
",",O
Toner,O
E(2,O
),O
",",O
Waldhorn,O
R(3,O
),O
",",O
Washer,O
L(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)University,O
of,O
Michigan,O
",",O
Ann,O
Arbor,O
",",O
Michigan,O
(,O
V.C.,O
",",O
L.W.,O
),O
.,O
"
",O
(2)Center,O
for,O
Health,O
Security,O
",",O
Bloomberg,O
School,O
of,O
Public,O
Health,O
",",O
Johns,O
Hopkins,O
"
",O
University,O
",",O
Baltimore,O
",",O
Maryland,O
(,O
E.T.,O
),O
.,O
"
",O
(3)Georgetown,O
University,O
",",O
Washington,O
",",O
DC,O
",",O
",",O
and,O
Center,O
for,O
Health,O
Security,O
",",O
"
",O
Bloomberg,O
School,O
of,O
Public,O
Health,O
",",O
Johns,O
Hopkins,O
University,O
",",O
Baltimore,O
",",O
Maryland,O
"
",O
(,O
R.W.,O
),O
.,O
"

",O
DOI,O
:,O
10.7326,O
M200907,O
"
",O
PMID,O
:,O
32160273,O
"


",O
131,O
.,O
Emerg,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
11;26(6,O
),O
.,O
doi,O
:,O
10.3201,O
eid2606.200516,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Severe,B-Virus_SARS-CoV-2
Acute,I-Virus_SARS-CoV-2
Respiratory,I-Virus_SARS-CoV-2
Syndrome,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
from,O
Patient,O
with,O
2019,O
Novel,O
"
",O
Coronavirus,O
Disease,O
",",O
United,O
States,O
.,O
"

",O
Harcourt,O
J,O
",",O
Tamin,O
A,O
",",O
Lu,O
X,O
",",O
Kamili,O
S,O
",",O
Sakthivel,O
SK,O
",",O
Murray,O
J,O
",",O
Queen,O
K,O
",",O
Tao,O
Y,O
",",O
"
",O
Paden,O
CR,O
",",O
Zhang,O
J,O
",",O
Li,O
Y,O
",",O
Uehara,O
A,O
",",O
Wang,O
H,O
",",O
Goldsmith,O
C,O
",",O
Bullock,O
HA,O
",",O
Wang,O
L,O
",",O
"
",O
Whitaker,O
B,O
",",O
Lynch,O
B,O
",",O
Gautam,O
R,O
",",O
Schindewolf,O
C,O
",",O
Lokugamage,O
KG,O
",",O
Scharton,O
D,O
",",O
Plante,O
"
",O
JA,O
",",O
Mirchandani,O
D,O
",",O
Widen,O
SG,O
",",O
Narayanan,O
K,O
",",O
Makino,O
S,O
",",O
Ksiazek,O
TG,O
",",O
Plante,O
KS,O
",",O
Weaver,O
"
",O
SC,O
",",O
Lindstrom,O
S,O
",",O
Tong,O
S,O
",",O
Menachery,O
VD,O
",",O
Thornburg,O
NJ,O
.,O
"

",O
The,O
etiologic,O
agent,O
of,O
an,O
outbreak,O
of,O
pneumonia,O
in,O
Wuhan,O
",",O
China,O
",",O
was,O
identified,O
"
",O
as,O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
in,O
January,O
2020,O
.,O
A,O
patient,O
in,O
"
",O
the,O
United,O
States,O
was,O
given,O
a,O
diagnosis,O
of,O
infection,O
with,O
this,O
virus,O
by,O
the,O
state,O
"
",O
of,O
Washington,O
and,O
the,O
US,O
Centers,O
for,O
Disease,O
Control,O
and,O
Prevention,O
on,O
January,O
"
",O
20,O
",",O
2020,O
.,O
We,O
isolated,O
virus,O
from,O
nasopharyngeal,O
and,O
oropharyngeal,O
specimens,O
from,O
"
",O
this,O
patient,O
and,O
characterized,O
the,O
viral,O
sequence,O
",",O
replication,O
properties,O
",",O
and,O
"
",O
cell,O
culture,O
tropism,O
.,O
We,O
found,O
that,O
the,O
virus,O
replicates,O
to,O
high,O
titer,O
in,O
"
",O
VeroCCL81,O
cells,O
and,O
Vero,O
E6,O
cells,O
in,O
the,O
absence,O
of,O
trypsin,O
.,O
We,O
also,O
deposited,O
"
",O
the,O
virus,O
into,O
2,O
virus,O
repositories,O
",",O
making,O
it,O
broadly,O
available,O
to,O
the,O
public,O
"
",O
health,O
and,O
research,O
communities,O
.,O
We,O
hope,O
that,O
open,O
access,O
to,O
this,O
reagent,O
will,O
"
",O
expedite,O
development,O
of,O
medical,O
countermeasures,O
.,O
"

",O
DOI,O
:,O
10.3201,O
eid2606.200516,O
"
",O
PMID,O
:,O
32160149,O
"


",O
132,O
.,O
Emerg,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
11;26(6,O
),O
.,O
doi,O
:,O
10.3201,O
eid2606.200299,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Coinfection,O
with,O
SARSCoV2,B-Virus_SARS-CoV-2
and,O
Influenza,O
A,O
Virus,O
in,O
Patient,O
with,O
Pneumonia,O
",",O
"
",O
China,O
.,O
"

",O
Wu,O
X,O
",",O
Cai,O
Y,O
",",O
Huang,O
X,O
",",O
Yu,O
X,O
",",O
Zhao,O
L,O
",",O
Wang,O
F,O
",",O
Li,O
Q,O
",",O
Gu,O
S,O
",",O
Xu,O
T,O
",",O
Li,O
Y,O
",",O
Lu,O
B,O
",",O
Zhan,O
Q.,O
"

",O
We,O
report,O
coinfection,O
with,O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
"
",O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
and,O
influenza,O
A,O
virus,O
in,O
a,O
patient,O
with,O
pneumonia,O
in,O
China,O
.,O
The,O
case,O
"
",O
highlights,O
possible,O
codetection,O
of,O
known,O
respiratory,O
viruses,O
.,O
We,O
noted,O
low,O
"
",O
sensitivity,O
of,O
upper,O
respiratory,O
specimens,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
which,O
could,O
further,O
"
",O
complicate,O
recognition,O
of,O
the,O
full,O
extent,O
of,O
disease,O
.,O
"

",O
DOI,O
:,O
10.3201,O
eid2606.200299,O
"
",O
PMID,O
:,O
32160148,O
"


",O
133,O
.,O
Tree,O
Physiol,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
tpaa024,O
.,O
doi,O
:,O
10.1093,O
treephys,O
tpaa024,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Nepal,O
's,O
First,O
Case,O
of,O
COVID19,B-Disease_COVID-19
and,O
public,O
health,O
response,O
.,O
"

",O
Shrestha,O
R(1,O
),O
",",O
Shrestha,O
S(2)(3,O
),O
",",O
Khanal,O
P(4,O
),O
",",O
Bhuvan,O
KC(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Infection,O
Control,O
Unit,O
",",O
Nepal,O
Cancer,O
Hospital,O
and,O
Research,O
Center,O
",",O
Harisidhhi,O
",",O
"
",O
Lalitpur,O
",",O
Nepal,O
.,O
"
",O
(2)Department,O
of,O
Pharmacy,O
",",O
Nepal,O
Cancer,O
Hospital,O
and,O
Research,O
Center,O
",",O
Harisidhhi,O
",",O
"
",O
Lalitpur,O
",",O
Nepal,O
.,O
"
",O
(3)Department,O
of,O
Pharmaceutical,O
and,O
Health,O
Service,O
Research,O
",",O
Nepal,O
Health,O
"
",O
Research,O
and,O
Innovation,O
Foundation,O
",",O
Lalitpur,O
",",O
Nepal,O
.,O
"
",O
(4)Central,O
Department,O
of,O
Public,O
Health,O
",",O
Institute,O
of,O
Medicine,O
",",O
Kathmandu,O
",",O
Nepal,O
.,O
"
",O
(5)School,O
of,O
Pharmacy,O
",",O
Monash,O
University,O
Malaysia,O
",",O
Jalan,O
Lagoon,O
Selatan,O
",",O
47500,O
",",O
"
",O
Subang,O
Jaya,O
",",O
Selangor,O
",",O
Malaysia,O
.,O
"

",O
DOI,O
:,O
10.1093,O
treephys,O
tpaa024,O
"
",O
PMID,O
:,O
32159805,O
"


",O
134,O
.,O
JAMA,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1001,O
jama.2020.3786,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Detection,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
Different,O
Types,O
of,O
Clinical,O
Specimens,O
.,O
"

",O
Wang,O
W(1,O
),O
",",O
Xu,O
Y(2,O
),O
",",O
Gao,O
R(3,O
),O
",",O
Lu,O
R(1,O
),O
",",O
Han,O
K(2,O
),O
",",O
Wu,O
G(1,O
),O
",",O
Tan,O
W(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Institute,O
for,O
Viral,O
Disease,O
Control,O
and,O
Prevention,O
",",O
China,O
CDC,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Beijing,O
Ditan,O
Hospital,O
",",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Qingdao,O
Municipal,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Qingdao,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.3786,O
"
",O
PMID,O
:,O
32159775,O
"


",O
135,O
.,O
JAMA,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1001,O
jama.2020.3633,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Care,O
for,O
Critically,O
Ill,O
Patients,O
With,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Murthy,O
S(1,O
),O
",",O
Gomersall,O
CD(2,O
),O
",",O
Fowler,O
RA(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)University,O
of,O
British,O
Columbia,O
",",O
Vancouver,O
",",O
British,O
Columbia,O
",",O
Canada,O
.,O
"
",O
(2)Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
.,O
"
",O
(3)Sunnybrook,O
Hospital,O
",",O
University,O
of,O
Toronto,O
",",O
Toronto,O
",",O
Ontario,O
",",O
Canada,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.3633,O
"
",O
PMID,O
:,O
32159735,O
"


",O
136,O
.,O
Int,O
J,O
Clin,O
Pract,O
.,O
2020,O
Mar,O
11:e13497,O
.,O
doi,O
:,O
10.1111,O
ijcp.13497,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Where,O
are,O
we,O
now,O
with,O
COVID19,B-Disease_COVID-19
?,O
"

",O
Thomson,O
GA(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Rotherham,O
NHS,O
Foundation,O
Trust,O
 ,O
Trust,O
HQ,O
.,O
"
",O
(2)Rotherham,O
Hospital,O
Moorgate,O
Road,O
Rotherham,O
",",O
South,O
Yorkshire,O
S60,O
2UD,O
",",O
England,O
.,O
"

",O
As,O
a,O
practicing,O
front,O
line,O
clinician,O
in,O
the,O
acute,O
adult,O
general,O
medical,O
field,O
",",O
I,O
"
",O
read,O
Dr,O
Stein,O
's,O
recent,O
insightful,O
article,O
on,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID,O
19)1,O
with,O
"
",O
great,O
interest,O
.,O
News,O
reports,O
in,O
the,O
UK,O
and,O
around,O
the,O
world,O
carry,O
daily,O
updates,O
"
",O
and,O
increasing,O
speculation,O
about,O
the,O
potential,O
global,O
impact,O
as,O
the,O
virus,O
spreads,O
"
",O
much,O
as,O
Dr,O
Stein,O
predicted,O
.,O
However,O
",",O
a,O
number,O
of,O
questions,O
appear,O
to,O
be,O
emerging,O
"
",O
that,O
were,O
not,O
covered,O
when,O
Dr,O
Stein,O
published,O
his,O
editorial,O
in,O
IJCP,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1111,O
ijcp.13497,O
"
",O
PMID,O
:,O
32159254,O
"


",O
137,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1002,O
jmv.25754,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
From,O
SARS,O
and,O
MERS,O
CoVs,O
to,O
SARSCoV2,B-Virus_SARS-CoV-2
:,O
moving,O
toward,O
more,O
biased,O
codon,O
usage,O
in,O
"
",O
viral,O
structural,O
and,O
nonstructural,O
genes,O
.,O
"

",O
Kandeel,O
M(1)(2,O
),O
",",O
Ibrahim,O
AA(3)(4,O
),O
",",O
Fayez,O
M(5)(6,O
),O
",",O
AlNazawi,O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Biomedical,O
Sciences,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
King,O
Faisal,O
"
",O
University,O
",",O
Alhofuf,O
",",O
Alahsa,O
",",O
Saudi,O
Arabia,O
.,O
"
",O
(2)Department,O
of,O
Pharmacology,O
",",O
Faculty,O
of,O
Veterinary,O
Medicine,O
",",O
Kafrelshikh,O
"
",O
University,O
",",O
Kafrelshikh,O
",",O
Egypt,O
.,O
"
",O
(3)Department,O
of,O
Pathology,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
King,O
Faisal,O
"
",O
University,O
",",O
Alhofuf,O
",",O
Alahsa,O
",",O
Saudi,O
Arabia,O
.,O
"
",O
(4)Department,O
of,O
Pathology,O
",",O
Faculty,O
of,O
Veterinary,O
Medicine,O
",",O
Suez,O
Canal,O
"
",O
University,O
",",O
Ismailia,O
",",O
Egypt,O
.,O
"
",O
(5)Al,O
Ahsa,O
Veterinary,O
Diagnostic,O
Laboratory,O
",",O
Ministry,O
of,O
Agriculture,O
",",O
AlAhsa,O
",",O
"
",O
Kingdom,O
of,O
Saudi,O
Arabia,O
.,O
"
",O
(6)Veterinary,O
Serum,O
and,O
Vaccine,O
Institute,O
",",O
Dokki,O
",",O
Cairo,O
",",O
Egypt,O
.,O
"

",O
BACKGROUND,O
:,O
SARSCoV2,B-Virus_SARS-CoV-2
is,O
an,O
emerging,O
disease,O
with,O
fatal,O
outcomes,O
.,O
In,O
this,O
study,O
",",O
"
",O
a,O
fundamental,O
knowledge,O
gap,O
question,O
is,O
to,O
be,O
resolved,O
by,O
evaluating,O
the,O
"
",O
differences,O
in,O
biological,O
and,O
pathogenic,O
aspects,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
and,O
the,O
changes,O
in,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
comparison,O
with,O
the,O
two,O
prior,O
major,O
COV,O
epidemics,O
",",O
SARS,O
and,O
MERS,O
"
",O
coronaviruses,O
.,O
"
",O
METHODS,O
:,O
The,O
genome,O
composition,O
",",O
nucleotides,O
analysis,O
",",O
codon,O
usage,O
indices,O
",",O
"
",O
relative,O
synonymous,O
codons,O
usage,O
(,O
RESU,O
),O
and,O
effective,O
number,O
of,O
codons,O
(,O
ENc,O
),O
were,O
"
",O
analysed,O
in,O
the,O
four,O
structural,O
genes,O
;,O
Spike,O
(,O
S,O
),O
",",O
Envelope,O
(,O
E,O
),O
",",O
membrane,O
(,O
M,O
),O
",",O
and,O
"
",O
Nucleocapsid,O
(,O
N,O
),O
genes,O
",",O
and,O
two,O
of,O
the,O
most,O
important,O
nonstructural,O
genes,O
"
",O
comprising,O
RNAdependent,O
RNA,O
polymerase,O
(,O
RdRP,O
),O
and,O
main,O
protease,O
(,O
Mpro,O
),O
of,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
BetaCoV,O
from,O
pangolins,O
",",O
bat,O
SARS,O
",",O
MERS,O
and,O
SARS,O
CoVs,O
.,O
These,O
genes,O
"
",O
include,O
Spike,O
(,O
S,O
),O
",",O
nucleocapsid,O
(,O
N,O
),O
",",O
Envelop(E,O
),O
and,O
membrane,O
(,O
M,O
),O
genes,O
.,O
"
",O
RESULTS,O
:,O
SARSCoV2,B-Virus_SARS-CoV-2
prefers,O
pyrimidine,O
rich,O
codons,O
to,O
purines,O
.,O
Most,O
"
",O
highfrequency,O
codons,O
were,O
ending,O
with,O
A,O
or,O
T,O
",",O
while,O
the,O
low,O
frequency,O
and,O
rare,O
"
",O
codons,O
were,O
ending,O
with,O
G,O
or,O
C.,O
SARSCoV2,B-Virus_SARS-CoV-2
structural,O
proteins,O
showed,O
520,O
lower,O
"
",O
ENc,O
values,O
",",O
compared,O
with,O
SARS,O
",",O
bat,O
SARS,O
and,O
MERS,O
CoVs,O
.,O
This,O
implies,O
higher,O
codon,O
"
",O
bias,O
and,O
higher,O
gene,O
expression,O
efficiency,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
structural,O
proteins,O
.,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
encoded,O
the,O
highest,O
number,O
of,O
over,O
biased,O
and,O
negatively,O
biased,O
"
",O
codons,O
.,O
Pangolin,O
BetaCoV,O
showed,O
little,O
differences,O
with,O
SARSCoV2,B-Virus_SARS-CoV-2
ENc,O
values,O
",",O
"
",O
compared,O
with,O
SARS,O
",",O
bat,O
SARS,O
and,O
MERS,O
CoV.,O
"
",O
CONCLUSION,O
:,O
Extreme,O
bias,O
and,O
lower,O
ENc,O
values,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
especially,O
in,O
Spike,O
",",O
"
",O
Envelope,O
and,O
Mpro,O
genes,O
",",O
are,O
suggestive,O
for,O
higher,O
gene,O
expression,O
efficiency,O
",",O
"
",O
compared,O
with,O
SARS,O
",",O
bat,O
SARS,O
and,O
MERS,O
CoVs,O
.,O
This,O
article,O
is,O
protected,O
by,O
"
",O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25754,O
"
",O
PMID,O
:,O
32159237,O
"


",O
138,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1002,O
jmv.25751,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Identification,O
of,O
Coronavirus,O
Sequences,O
in,O
Carp,O
cDNA,O
from,O
Wuhan,O
",",O
China,O
.,O
"

",O
Conway,O
MJ(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Foundational,O
Sciences,O
",",O
Central,O
Michigan,O
University,O
College,O
of,O
Medicine,O
",",O
Mt.,O
"
",O
Pleasant,O
",",O
MI,O
.,O
"

",O
Severe,O
acute,O
respiratory,O
syndrome,O
(SARS)like,O
coronavirus,O
sequences,O
were,O
"
",O
identified,O
in,O
two,O
separate,O
cDNA,O
pools,O
.,O
The,O
first,O
pool,O
was,O
from,O
a,O
Carassius,O
"
",O
auratus,O
(,O
crusian,O
carp,O
),O
cell,O
line,O
and,O
the,O
second,O
was,O
from,O
Ctenopharyngodon,O
idella,O
"
",O
(,O
grass,O
carp,O
),O
head,O
kidney,O
tissue,O
.,O
BLAST,O
analysis,O
suggests,O
that,O
these,O
sequences,O
"
",O
belong,O
to,O
SARSlike,O
coronaviruses,O
",",O
and,O
that,O
they,O
are,O
n't,O
evolutionarily,O
conserved,O
"
",O
in,O
other,O
species,O
.,O
Investigation,O
of,O
the,O
submitting,O
laboratories,O
revealed,O
that,O
two,O
"
",O
laboratories,O
from,O
the,O
Institute,O
of,O
Hydrobiology,O
at,O
the,O
Chinese,O
Academy,O
of,O
"
",O
Sciences,O
in,O
Wuhan,O
",",O
China,O
performed,O
the,O
research,O
and,O
submitted,O
the,O
cDNA,O
libraries,O
"
",O
to,O
GenBank,O
.,O
This,O
institution,O
is,O
very,O
close,O
in,O
proximity,O
to,O
the,O
Wuhan,O
South,O
China,O
"
",O
Seafood,O
Wholesale,O
Market,O
where,O
SARSCoV2,B-Virus_SARS-CoV-2
first,O
amplified,O
in,O
the,O
human,O
"
",O
population,O
.,O
It,O
is,O
possible,O
that,O
these,O
sequences,O
are,O
an,O
artifact,O
of,O
the,O
"
",O
bioinformatics,O
pipeline,O
that,O
was,O
used,O
.,O
It,O
is,O
also,O
possible,O
that,O
SARSlike,O
"
",O
coronaviruses,O
are,O
a,O
common,O
environmental,O
pathogen,O
in,O
the,O
region,O
that,O
may,O
be,O
in,O
"
",O
aquatic,O
habitats,O
.,O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25751,O
"
",O
PMID,O
:,O
32159234,O
"


",O
139,O
.,O
Glob,O
Health,O
Res,O
Policy,O
.,O
2020,O
Mar,O
2;5:7,O
.,O
doi,O
:,O
10.1186,O
s41256020001374,O
.,O
"
",O
eCollection,O
2020,O
.,O
"

",O
First,O
two,O
Â ,O
months,O
of,O
the,O
2019,B-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
epidemic,O
in,O
China,O
:,O
"
",O
realtime,O
surveillance,O
and,O
evaluation,O
with,O
a,O
second,O
derivative,O
model,O
.,O
"

",O
Chen,O
X(1)(2,O
),O
",",O
Yu,O
B(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)1Department,O
of,O
Epidemiology,O
",",O
University,O
of,O
Florida,O
",",O
2004,O
Mowry,O
Road,O
",",O
"
",O
Gainesville,O
",",O
FL,O
USA,O
.,O
"
",O
(2)2Global,O
Health,O
Institute,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
Provinces,O
China,O
.,O
"

",O
Background,O
:,O
Similar,O
to,O
outbreaks,O
of,O
many,O
other,O
infectious,O
diseases,O
",",O
success,O
in,O
"
",O
controlling,O
the,O
novel,O
2019,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
requires,O
a,O
timely,O
and,O
accurate,O
"
",O
monitoring,O
of,O
the,O
epidemic,O
",",O
particularly,O
during,O
its,O
early,O
period,O
with,O
rather,O
"
",O
limited,O
data,O
while,O
the,O
need,O
for,O
information,O
increases,O
explosively,O
.,O
"
",O
Methods,O
:,O
In,O
this,O
study,O
",",O
we,O
used,O
a,O
second,O
derivative,O
model,O
to,O
characterize,O
the,O
"
",O
coronavirus,O
epidemic,O
in,O
China,O
with,O
cumulatively,O
diagnosed,O
cases,O
during,O
the,O
first,O
"
",O
2,O
Â ,O
months,O
.,O
The,O
analysis,O
was,O
further,O
enhanced,O
by,O
an,O
exponential,O
model,O
with,O
a,O
"
",O
closepopulation,O
assumption,O
.,O
This,O
model,O
was,O
built,O
with,O
the,O
data,O
and,O
used,O
to,O
"
",O
assess,O
the,O
detection,O
rate,O
during,O
the,O
study,O
period,O
",",O
considering,O
the,O
differences,O
"
",O
between,O
the,O
TRUE,O
infections,O
",",O
detectable,O
and,O
detected,O
cases,O
.,O
"
",O
Results,O
:,O
Results,O
from,O
the,O
second,O
derivative,O
modeling,O
suggest,O
the,O
coronavirus,O
"
",O
epidemic,O
as,O
nonlinear,O
and,O
chaotic,O
in,O
nature,O
.,O
Although,O
it,O
emerged,O
gradually,O
",",O
the,O
"
",O
epidemic,O
was,O
highly,O
responsive,O
to,O
massive,O
interventions,O
initiated,O
on,O
January,O
21,O
",",O
"
",O
2020,O
",",O
as,O
indicated,O
by,O
results,O
from,O
both,O
second,O
derivative,O
and,O
exponential,O
"
",O
modeling,O
analyses,O
.,O
The,O
epidemic,O
started,O
to,O
decelerate,O
immediately,O
after,O
the,O
"
",O
massive,O
actions,O
.,O
The,O
results,O
derived,O
from,O
our,O
analysis,O
signaled,O
the,O
decline,O
of,O
"
",O
the,O
epidemic,O
14,O
â€‰,O
days,O
before,O
it,O
eventually,O
occurred,O
on,O
February,O
4,O
",",O
2020,O
.,O
Study,O
"
",O
findings,O
further,O
signaled,O
an,O
accelerated,O
decline,O
in,O
the,O
epidemic,O
starting,O
in,O
"
",O
14,O
â€‰,O
days,O
on,O
February,O
18,O
",",O
2020,O
.,O
"
",O
Conclusions,O
:,O
The,O
coronavirus,O
epidemic,O
appeared,O
to,O
be,O
nonlinear,O
and,O
chaotic,O
",",O
and,O
"
",O
was,O
responsive,O
to,O
effective,O
interventions,O
.,O
The,O
methods,O
used,O
in,O
this,O
study,O
can,O
be,O
"
",O
applied,O
in,O
surveillance,O
to,O
inform,O
and,O
encourage,O
the,O
general,O
public,O
",",O
public,O
health,O
"
",O
professionals,O
",",O
clinicians,O
and,O
decisionmakers,O
to,O
take,O
coordinative,O
and,O
"
",O
collaborative,O
efforts,O
to,O
control,O
the,O
epidemic,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s41256020001374,O
"
",O
PMCID,O
:,O
PMC7050133,O
"
",O
PMID,O
:,O
32158961,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interestsThe,O
authors,O
declare,O
that,O
they,O
"
",O
have,O
no,O
competing,O
interests,O
.,O
"


",O
140,O
.,O
Balkan,O
Med,O
J.,O
2020,O
Mar,O
6,O
.,O
doi,O
:,O
10.4274,O
balkanmedj.galenos.2020.2020.2.15,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
CT,O
Manifestations,O
of,O
Novel,B-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Pneumonia,I-Disease_COVID-19
:,O
A,O
Case,O
Report,O
"

",O
An,O
P(1)(2,O
),O
",",O
Song,O
P(1,O
),O
",",O
Lian,O
K(2,O
),O
",",O
Wang,O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Xiangyang,O
First,O
People,O
â€™s,O
Hospital,O
Affiliated,O
to,O
Hubei,O
"
",O
Medical,O
College,O
",",O
Hubei,O
",",O
China,O
"
",O
(2)Department,O
of,O
Infectious,O
Disease,O
and,O
Respiratory,O
and,O
Critical,O
Care,O
",",O
Xiangyang,O
"
",O
First,O
People,O
â€™s,O
Hospital,O
Affiliated,O
to,O
Hubei,O
Medical,O
College,O
",",O
Hubei,O
",",O
China,O
"

",O
Background,O
:,O
Since,O
December,O
2019,O
",",O
the,O
outbreak,O
of,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
has,O
"
",O
impacted,O
nearly,O
>,O
90000,O
people,O
in,O
more,O
than,O
75,O
countries,O
.,O
In,O
this,O
case,O
report,O
",",O
we,O
"
",O
aim,O
to,O
define,O
the,O
chest,O
computed,O
tomography,O
findings,O
of,O
2019novel,O
coronavirus,O
"
",O
associated,O
with,O
pneumonia,O
and,O
its,O
successful,O
resolution,O
after,O
treatment,O
.,O
"
",O
Case,O
Report,O
:,O
A,O
fiftyyearold,O
female,O
patient,O
",",O
who,O
is,O
a,O
businesswoman,O
",",O
presented,O
"
",O
with,O
chief,O
complaints,O
of,O
â€œ,O
fever,O
for,O
one,O
week,O
",",O
diarrhea,O
",",O
anorexia,O
",",O
and,O
asthenia,O
.,O
â€,O
"
",O
Initially,O
",",O
she,O
was,O
given,O
Tamiflu,O
.,O
The,O
influenza,O
A,O
virus,O
serology,O
was,O
negative,O
.,O
"
",O
Three,O
days,O
later,O
",",O
levofloxacin,O
was,O
started,O
because,O
the,O
patient,O
â€™s,O
symptoms,O
did,O
not,O
"
",O
improve,O
.,O
The,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
nucleic,O
acid,O
test,O
was,O
negative,O
.,O
It,O
was,O
noted,O
that,O
"
",O
before,O
the,O
onset,O
of,O
the,O
disease,O
",",O
the,O
patient,O
went,O
to,O
Wuhan,O
on,O
a,O
business,O
trip,O
.,O
"
",O
Despite,O
the,O
given,O
treatment,O
",",O
her,O
body,O
temperature,O
rose,O
to,O
39.2,O
Â°,O
C,O
and,O
she,O
was,O
"
",O
referred,O
to,O
our,O
clinic,O
for,O
further,O
evaluation,O
.,O
Then,O
",",O
chest,O
computed,O
tomography,O
"
",O
was,O
performed,O
and,O
showed,O
bilateral,O
multifocal,O
ground,O
glass,O
opacities,O
with,O
"
",O
consolidation,O
which,O
suggested,O
viral,O
pneumonia,O
as,O
a,O
differential,O
diagnosis,O
",",O
and,O
"
",O
the,O
subsequent,O
2019novel,O
coronavirus,O
pneumonia,O
nucleic,O
acid,O
test,O
was,O
positive,O
.,O
"
",O
Conclusion,O
:,O
Chest,O
computed,O
tomography,O
offers,O
fast,O
and,O
convenient,O
evaluation,O
of,O
"
",O
patients,O
with,O
suspected,O
2019novel,O
coronavirus,O
pneumonia,O
.,O
"

",O
DOI,O
:,O
10.4274,O
balkanmedj.galenos.2020.2020.2.15,O
"
",O
PMID,O
:,O
32157862,O
"


",O
141,O
.,O
Dermatol,O
Ther,O
.,O
2020,O
Mar,O
11:e13298,O
.,O
doi,O
:,O
10.1111,O
dth.13298,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
and,O
psoriasis,O
:,O
is,O
it,O
time,O
to,O
limit,O
treatment,O
with,O
immunosuppressants,O
?,O
A,O
"
",O
call,O
for,O
action,O
.,O
"

",O
Conforti,O
C(1,O
),O
",",O
Giuffrida,O
R(2,O
),O
",",O
Dianzani,O
C(3,O
),O
",",O
Di,O
Meo,O
N(1,O
),O
",",O
Zalaudek,O
I(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Dermatology,O
Clinic,O
",",O
Maggiore,O
Hospital,O
",",O
University,O
of,O
Trieste,O
",",O
Trieste,O
",",O
Italy,O
.,O
"
",O
(2)Department,O
of,O
Clinical,O
and,O
Experimental,O
Medicine,O
",",O
Dermatology,O
",",O
University,O
of,O
"
",O
Messina,O
",",O
Messina,O
",",O
Italy,O
.,O
"
",O
(3)Department,O
of,O
Plastic,O
",",O
Reconstructive,O
and,O
Cosmetic,O
Surgery,O
",",O
Dermatology,O
"
",O
Section,O
",",O
Campus,O
BioMedico,O
University,O
Hospital,O
",",O
Rome,O
",",O
Italy,O
.,O
"

",O
DOI,O
:,O
10.1111,O
dth.13298,O
"
",O
PMID,O
:,O
32157783,O
"


",O
142,O
.,O
Immunol,O
Cell,O
Biol,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1111,O
imcb.12326,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Harnessing,O
the,O
immune,O
system,O
via,O
FcÎ³R,O
function,O
in,O
immune,O
therapy,O
:,O
A,O
pathway,O
to,O
"
",O
nextgen,O
mAbs,O
.,O
"

",O
Chenoweth,O
AM(1)(2)(3,O
),O
",",O
Wines,O
BD(1)(3)(4,O
),O
",",O
Anania,O
JC(1)(3)(5,O
),O
",",O
Mark,O
Hogarth,O
"
",O
P(1)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Immune,O
therapies,O
laboratory,O
",",O
Burnet,O
Institute,O
",",O
Melbourne,O
",",O
3004,O
",",O
Australia,O
.,O
"
",O
(2)King,O
's,O
College,O
",",O
London,O
",",O
UK,O
.,O
"
",O
(3)Department,O
of,O
Immunology,O
and,O
Pathology,O
",",O
Central,O
Clinical,O
School,O
",",O
Monash,O
"
",O
University,O
Melbourne,O
",",O
Australia,O
.,O
"
",O
(4)Department,O
of,O
Clinical,O
Pathology,O
",",O
University,O
of,O
Melbourne,O
",",O
Parkville,O
",",O
"
",O
Australia,O
.,O
"
",O
(5)Uppsala,O
University,O
",",O
Uppsala,O
",",O
Sweden,O
.,O
"

",O
The,O
human,O
FcÎ³Rs,O
interact,O
with,O
antigencomplexed,O
IgG,O
ligands,O
to,O
both,O
activate,O
and,O
"
",O
modulate,O
a,O
powerful,O
network,O
of,O
inflammatory,O
hostprotective,O
effector,O
functions,O
"
",O
that,O
are,O
key,O
to,O
the,O
normal,O
physiology,O
of,O
immune,O
resistance,O
to,O
pathogens,O
.,O
More,O
"
",O
than,O
100,O
therapeutic,O
monoclonal,O
antibodies,O
(,O
mAbs,O
),O
are,O
approved,O
or,O
in,O
late,O
stage,O
"
",O
clinical,O
trials,O
",",O
many,O
of,O
which,O
harness,O
the,O
potent,O
FcÎ³Rmediated,O
effector,O
systems,O
"
",O
to,O
varying,O
degrees,O
.,O
This,O
is,O
most,O
evident,O
for,O
antibodies,O
targeting,O
cancer,O
cells,O
"
",O
inducing,O
antibodydependent,O
killing,O
or,O
phagocytosis,O
but,O
is,O
also,O
TRUE,O
to,O
some,O
"
",O
degree,O
for,O
the,O
mAbs,O
that,O
neutralise,O
or,O
remove,O
small,O
macromolecules,O
such,O
as,O
"
",O
cytokines,O
or,O
other,O
immunoglobulins,O
.,O
The,O
use,O
of,O
mAb,O
therapeutics,O
has,O
also,O
revealed,O
"
",O
a,O
"""",O
scaffolding,O
"""",O
role,O
for,O
FcÎ³R,O
which,O
",",O
in,O
different,O
contexts,O
",",O
may,O
either,O
underpin,O
"
",O
the,O
therapeutic,O
mAb,O
action,O
such,O
as,O
immune,O
agonism,O
or,O
may,O
trigger,O
catastrophic,O
"
",O
adverse,O
effects,O
.,O
The,O
still,O
unmet,O
therapeutic,O
need,O
in,O
many,O
cancers,O
",",O
inflammatory,O
"
",O
diseases,O
or,O
emerging,O
infections,O
such,O
as,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
requires,O
increased,O
effort,O
on,O
"
",O
the,O
development,O
of,O
improved,O
and,O
novel,O
mAbs,O
.,O
A,O
more,O
mature,O
appreciation,O
of,O
the,O
"
",O
immunobiology,O
of,O
individual,O
FcÎ³R,O
function,O
and,O
the,O
complexity,O
of,O
the,O
relationships,O
"
",O
between,O
FcÎ³Rs,O
and,O
antibodies,O
is,O
fuelling,O
efforts,O
to,O
develop,O
more,O
potent,O
"
",O
"""",O
nextgen,O
"""",O
therapeutic,O
antibodies,O
.,O
Such,O
development,O
strategies,O
now,O
include,O
"
",O
focused,O
glycan,O
or,O
protein,O
engineering,O
of,O
the,O
Fc,O
to,O
increase,O
affinity,O
and,O
or,O
"
",O
tailor,O
specificity,O
for,O
selective,O
engagement,O
of,O
individual,O
activating,O
FcÎ³Rs,O
or,O
the,O
"
",O
inhibitory,O
FcÎ³RIIb,O
or,O
alternatively,O
",",O
for,O
the,O
ablation,O
of,O
FcÎ³R,O
interaction,O
"
",O
altogether,O
.,O
This,O
review,O
touches,O
on,O
recent,O
aspects,O
FcÎ³R,O
and,O
IgG,O
immunobiology,O
and,O
"
",O
its,O
relationship,O
to,O
the,O
present,O
and,O
future,O
actions,O
of,O
therapeutic,O
mAbs,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1111,O
imcb.12326,O
"
",O
PMID,O
:,O
32157732,O
"


",O
143,O
.,O
Nature,O
.,O
2020,O
Mar;579(7798):193,O
.,O
doi,O
:,O
10.1038,O
d41586020006932,O
.,O
"

",O
COVID19,B-Disease_COVID-19
:,O
time,O
for,O
WHO,O
to,O
reconsider,O
its,O
stance,O
towards,O
Taiwan,O
.,O
"

",O
Nelson,O
CW,O
.,O
"

",O
DOI,O
:,O
10.1038,O
d41586020006932,O
"
",O
PMID,O
:,O
32157235,O
"


",O
144,O
.,O
BMJ,O
.,O
2020,O
Mar,O
10;368:m978,O
.,O
doi,O
:,O
10.1136,O
bmj.m978,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
What,O
's,O
the,O
current,O
advice,O
for,O
UK,O
doctors,O
?,O
"

",O
Rimmer,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
BMJ,O
.,O
2020,O
Mar,O
11;368:m991,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m978,O
"
",O
PMID,O
:,O
32156682,O
"


",O
145,O
.,O
BMJ,O
.,O
2020,O
Mar,O
10;368:m969,O
.,O
doi,O
:,O
10.1136,O
bmj.m969,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
roundup,O
of,O
latest,O
news,O
.,O
"

",O
Iacobucci,O
G(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m969,O
"
",O
PMID,O
:,O
32156680,O
"


",O
146,O
.,O
BMJ,O
.,O
2020,O
Mar,O
10;368:m988,O
.,O
doi,O
:,O
10.1136,O
bmj.m988,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
UK,O
trade,O
talks,O
with,O
EU,O
must,O
not,O
hinder,O
cooperation,O
in,O
tackling,O
threat,O
",",O
"
",O
BMA,O
warns,O
.,O
"

",O
Rimmer,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m988,O
"
",O
PMID,O
:,O
32156677,O
"


",O
147,O
.,O
BMJ,O
.,O
2020,O
Mar,O
10;368:m986,O
.,O
doi,O
:,O
10.1136,O
bmj.m986,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
Portugal,O
closes,O
all,O
medical,O
schools,O
after,O
31,O
cases,O
confirmed,O
in,O
the,O
"
",O
country,O
.,O
"

",O
Mahase,O
E(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m986,O
"
",O
PMID,O
:,O
32156675,O
"


",O
148,O
.,O
J,O
Glob,O
Antimicrob,O
Resist,O
.,O
2020,O
Mar,O
7,O
.,O
pii,O
:,O
S22137165(20)300503,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jgar.2020.02.021,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
2019novel,O
coronavirus,O
outbreak,O
:,O
A,O
new,O
challenge,O
.,O
"

",O
Lupia,O
T(1,O
),O
",",O
Scabini,O
S(2,O
),O
",",O
Pinna,O
SM(2,O
),O
",",O
Di,O
Perri,O
G(2,O
),O
",",O
De,O
Rosa,O
FG(2,O
),O
",",O
Corcione,O
"
",O
S(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medical,O
Sciences,O
",",O
Infectious,O
Diseases,O
",",O
University,O
of,O
Turin,O
",",O
"
",O
Turin,O
",",O
Italy,O
.,O
Electronic,O
address,O
:,O
tommaso.lupia89@gmail.com,O
.,O
"
",O
(2)Department,O
of,O
Medical,O
Sciences,O
",",O
Infectious,O
Diseases,O
",",O
University,O
of,O
Turin,O
",",O
"
",O
Turin,O
",",O
Italy,O
.,O
"

",O
OBJECTIVES,O
:,O
Following,O
the,O
public,O
health,O
emergency,O
declared,O
by,O
the,O
World,O
Health,O
"
",O
Organization,O
and,O
the,O
recent,O
outbreak,O
by,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
China,O
and,O
through,O
other,O
29,O
"
",O
countries,O
",",O
we,O
aimed,O
to,O
summarize,O
the,O
clinical,O
aspects,O
of,O
novel,O
betacoronavirus,O
"
",O
infection,O
and,O
its,O
possible,O
clinical,O
presentations,O
together,O
with,O
suggested,O
"
",O
therapeutic,O
algorithms,O
for,O
patients,O
who,O
may,O
require,O
antibiotic,O
treatment,O
.,O
"
",O
METHODS,O
:,O
We,O
reviewed,O
the,O
currently,O
available,O
literature,O
of,O
microbiologically,O
"
",O
confirmed,O
infections,O
by,O
2019ConV,O
(,O
or,O
COVID19,B-Disease_COVID-19
),O
occurred,O
at,O
the,O
time,O
of,O
writing,O
"
",O
(,O
13,O
February,O
2020,O
),O
.,O
A,O
literature,O
search,O
was,O
performed,O
using,O
the,O
PubMed,O
database,O
"
",O
and,O
the,O
Cochrane,O
library,O
.,O
Search,O
terms,O
included,O
"""",O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"""",O
or,O
"
",O
"""",O
2019nCoV,B-Virus_SARS-CoV-2
"""",O
or,O
"""",O
COVID19,B-Disease_COVID-19
"""",O
.,O
"
",O
RESULTS,O
:,O
Published,O
cases,O
occurred,O
mostly,O
in,O
males,O
(,O
age,O
ranged,O
from,O
8,O
to,O
92,O
),O
.,O
"
",O
Cardiovascular,O
",",O
digestive,O
and,O
endocrine,O
system,O
diseases,O
were,O
commonly,O
reported,O
",",O
"
",O
except,O
previous,O
chronic,O
pulmonary,O
diseases,O
(,O
e.g.,O
",",O
COPD,O
",",O
asthma,O
",",O
bronchiectasis,O
),O
"
",O
that,O
were,O
surprisingly,O
underreported,O
.,O
Fever,O
was,O
presented,O
in,O
all,O
the,O
case,O
series,O
"
",O
available,O
",",O
flanked,O
by,O
cough,O
",",O
dyspnea,O
",",O
myalgias,O
and,O
fatigue,O
.,O
Multiple,O
bilateral,O
"
",O
lobular,O
and,O
subsegmental,O
areas,O
of,O
consolidation,O
or,O
bilateral,O
groundglass,O
"
",O
opacities,O
were,O
the,O
main,O
reported,O
radiological,O
features,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
at,O
least,O
in,O
"
",O
the,O
early,O
phases,O
of,O
disease,O
.,O
"
",O
CONCLUSIONS,O
:,O
The,O
new,O
2019nCoV,B-Virus_SARS-CoV-2
epidemics,O
is,O
mainly,O
associated,O
with,O
respiratory,O
"
",O
disease,O
and,O
few,O
extrapulmonary,O
signs,O
.,O
However,O
",",O
there,O
is,O
a,O
low,O
rate,O
of,O
associated,O
"
",O
preexisting,O
respiratory,O
comorbidities,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
Ltd.,O
"

",O
DOI,O
:,O
10.1016,O
j.jgar.2020.02.021,O
"
",O
PMID,O
:,O
32156648,O
"


",O
149,O
.,O
Clin,O
Chim,O
Acta,O
.,O
2020,O
Mar,O
7;505:172175,O
.,O
doi,O
:,O
10.1016,O
j.cca.2020.03.009,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Positive,O
rate,O
of,O
RTPCR,O
detection,O
of,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
in,O
4880,O
cases,O
from,O
one,O
"
",O
hospital,O
in,O
Wuhan,O
",",O
China,O
",",O
from,O
Jan,O
to,O
Feb,O
2020,O
.,O
"

",O
Liu,O
R(1,O
),O
",",O
Han,O
H(1,O
),O
",",O
Liu,O
F(2,O
),O
",",O
Lv,O
Z(1,O
),O
",",O
Wu,O
K(3,O
),O
",",O
Liu,O
Y(3,O
),O
",",O
Feng,O
Y(4,O
),O
",",O
Zhu,O
C(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Dept,O
.,O
of,O
Clinical,O
Laboratory,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
"
",O
430060,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(2)Dept,O
.,O
State,O
Key,O
Laboratory,O
of,O
Virology,O
(,O
Wuhan,O
University,O
),O
",",O
College,O
of,O
Life,O
"
",O
Sciences,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
430072,O
",",O
Hubei,O
",",O
China,O
;,O
Dept,O
.,O
Wuhan,O
Institute,O
"
",O
of,O
Biotechnology,O
",",O
Wuhan,O
430075,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(3)Dept,O
.,O
State,O
Key,O
Laboratory,O
of,O
Virology,O
(,O
Wuhan,O
University,O
),O
",",O
College,O
of,O
Life,O
"
",O
Sciences,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
430072,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(4)School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
430071,O
",",O
Hubei,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
yongfeng@whu.edu.cn,O
.,O
"
",O
(5)Dept,O
.,O
of,O
Clinical,O
Laboratory,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
"
",O
430060,O
",",O
Hubei,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
xinchengzhu@163.com,O
.,O
"

",O
BACKGROUND,O
:,O
There,O
's,O
an,O
outbreak,O
of,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
infection,O
"
",O
since,O
December,O
2019,O
",",O
first,O
in,O
China,O
",",O
and,O
currently,O
with,O
more,O
than,O
80,O
thousand,O
"
",O
confirmed,O
infection,O
globally,O
in,O
29,O
countries,O
till,O
March,O
2,O
",",O
2020,O
.,O
Identification,O
",",O
"
",O
isolation,O
and,O
caring,O
for,O
patients,O
early,O
are,O
essential,O
to,O
limit,O
humantohuman,O
"
",O
transmission,O
including,O
reducing,O
secondary,O
infections,O
among,O
close,O
contacts,O
and,O
"
",O
health,O
care,O
workers,O
",",O
preventing,O
transmission,O
amplification,O
events,O
.,O
The,O
RTPCR,O
"
",O
detection,O
of,O
viral,O
nucleic,O
acid,O
test,O
(,O
NAT,O
),O
was,O
one,O
of,O
the,O
most,O
quickly,O
"
",O
established,O
laboratory,O
diagnosis,O
method,O
in,O
a,O
novel,O
viral,O
pandemic,O
",",O
just,O
as,O
in,O
"
",O
this,O
COVID19,B-Disease_COVID-19
outbreak,O
.,O
"
",O
METHODS,O
:,O
4880,O
cases,O
that,O
had,O
respiratory,O
infection,O
symptoms,O
or,O
close,O
contact,O
with,O
"
",O
COVID19,B-Disease_COVID-19
patients,O
in,O
hospital,O
in,O
Wuhan,O
",",O
China,O
",",O
were,O
tested,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
infection,O
by,O
use,O
of,O
quantitative,O
RTPCR,O
(,O
qRTPCR,O
),O
on,O
samples,O
from,O
the,O
respiratory,O
"
",O
tract,O
.,O
Positive,O
rates,O
were,O
calculated,O
in,O
groups,O
divided,O
by,O
genders,O
or,O
ages,O
.,O
"
",O
RESULTS,O
:,O
The,O
positive,O
rate,O
was,O
about,O
38,O
%,O
for,O
the,O
total,O
4880,O
specimens,O
.,O
Male,O
and,O
"
",O
older,O
population,O
had,O
a,O
significant,O
higher,O
positive,O
rates,O
.,O
However,O
",",O
57,O
%,O
was,O
"
",O
positive,O
among,O
the,O
specimens,O
from,O
the,O
Fever,O
Clinics,O
.,O
Binary,O
logistic,O
regression,O
"
",O
analysis,O
showed,O
that,O
age,O
",",O
not,O
gender,O
",",O
was,O
the,O
risk,O
factor,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
infection,O
in,O
fever,O
clinics,O
.,O
"
",O
CONCLUSIONS,O
:,O
Therefore,O
",",O
we,O
concluded,O
that,O
viral,O
NAT,O
played,O
an,O
important,O
role,O
in,O
"
",O
identifying,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.cca.2020.03.009,O
"
",O
PMID,O
:,O
32156607,O
"


",O
150,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Mar;25(9,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.9.2000202,O
.,O
"

",O
Potential,O
scenarios,O
for,O
the,O
progression,O
of,O
a,O
COVID19,B-Disease_COVID-19
epidemic,O
in,O
the,O
European,O
"
",O
Union,O
and,O
the,O
European,O
Economic,O
Area,O
",",O
March,O
2020,O
.,O
"

",O
Johnson,O
HC(1)(2,O
),O
",",O
Gossner,O
CM(1)(2,O
),O
",",O
Colzani,O
E(2,O
),O
",",O
Kinsman,O
J(2,O
),O
",",O
Alexakis,O
L(2,O
),O
",",O
"
",O
BeautÃ©,O
J(2,O
),O
",",O
WÃ¼rz,O
A(2,O
),O
",",O
Tsolova,O
S(2,O
),O
",",O
Bundle,O
N(2,O
),O
",",O
Ekdahl,O
K(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)These,O
authors,O
contributed,O
equally,O
.,O
"
",O
(2)European,O
Centre,O
for,O
Disease,O
Prevention,O
and,O
Control,O
",",O
Solna,O
",",O
Sweden,O
.,O
"

",O
Two,O
months,O
after,O
the,O
emergence,O
of,O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
"
",O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
the,O
possibility,O
of,O
established,O
and,O
widespread,O
community,O
"
",O
transmission,O
in,O
the,O
European,O
Union,O
and,O
European,O
Economic,O
Area,O
(,O
EU,O
EEA,O
),O
is,O
"
",O
becoming,O
more,O
likely,O
.,O
We,O
provide,O
scenarios,O
for,O
use,O
in,O
preparedness,O
for,O
a,O
possible,O
"
",O
widespread,O
epidemic,O
.,O
The,O
EU,O
EEA,O
is,O
moving,O
towards,O
the,O
',O
limited,O
sustained,O
"
",O
transmission,O
',O
phase,O
.,O
We,O
propose,O
actions,O
to,O
prepare,O
for,O
potential,O
mitigation,O
"
",O
phases,O
and,O
coordinate,O
efforts,O
to,O
protect,O
the,O
health,O
of,O
citizens,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.9.2000202,O
"
",O
PMID,O
:,O
32156332,O
"


",O
151,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Mar;25(9,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.9.2003051,O
.,O
"

",O
Updated,O
rapid,O
risk,O
assessment,O
from,O
ECDC,O
on,O
the,O
outbreak,O
of,O
COVID19,B-Disease_COVID-19
:,O
increased,O
"
",O
transmission,O
globally,O
.,O
"

",O
Eurosurveillance,O
Editorial,O
Team(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)European,O
Centre,O
for,O
Disease,O
Prevention,O
and,O
Control,O
(,O
ECDC,O
),O
",",O
Stockholm,O
",",O
Sweden,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.9.2003051,O
"
",O
PMID,O
:,O
32156331,O
"


",O
152,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Mar;25(9,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.9.2000173,O
.,O
"

",O
Rapid,O
establishment,O
of,O
laboratory,O
diagnostics,O
for,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
Bavaria,O
",",O
Germany,O
",",O
February,O
2020,O
.,O
"

",O
Konrad,O
R(1)(2,O
),O
",",O
Eberle,O
U(3)(1,O
),O
",",O
Dangel,O
A(1)(2,O
),O
",",O
Treis,O
B(3,O
),O
",",O
Berger,O
A(2,O
),O
",",O
Bengs,O
"
",O
K(2,O
),O
",",O
Fingerle,O
V(3,O
),O
",",O
Liebl,O
B(4)(5,O
),O
",",O
Ackermann,O
N(3)(1,O
),O
",",O
Sing,O
A(4)(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)These,O
authors,O
contributed,O
equally,O
to,O
this,O
work,O
.,O
"
",O
(2)Public,O
Health,O
Microbiology,O
Unit,O
",",O
Bavarian,O
Health,O
and,O
Food,O
Safety,O
Authority,O
",",O
"
",O
OberschleiÃŸheim,O
",",O
Germany,O
.,O
"
",O
(3)Unit,O
of,O
Virology,O
",",O
Bavarian,O
Health,O
and,O
Food,O
Safety,O
Authority,O
",",O
OberschleiÃŸheim,O
",",O
"
",O
Germany,O
.,O
"
",O
(4)Ludwig,O
MaximiliansUniversitÃ¤t,O
",",O
Munich,O
",",O
Germany,O
.,O
"
",O
(5)State,O
Institute,O
of,O
Health,O
",",O
Bavarian,O
Health,O
and,O
Food,O
Safety,O
Authority,O
",",O
"
",O
OberschleiÃŸheim,O
",",O
Germany,O
.,O
"

",O
The,O
need,O
for,O
timely,O
establishment,O
of,O
diagnostic,O
assays,O
arose,O
when,O
Germany,O
was,O
"
",O
confronted,O
with,O
the,O
first,O
travelassociated,O
outbreak,O
of,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
in,O
Europe,O
.,O
We,O
describe,O
our,O
laboratory,O
"
",O
experiences,O
during,O
a,O
large,O
contact,O
tracing,O
investigation,O
",",O
comparing,O
previously,O
"
",O
published,O
realtime,O
RTPCR,O
assays,O
in,O
different,O
PCR,O
systems,O
and,O
a,O
commercial,O
kit,O
.,O
"
",O
We,O
found,O
that,O
assay,O
performance,O
using,O
the,O
same,O
primers,O
and,O
probes,O
with,O
different,O
"
",O
PCR,O
systems,O
varied,O
and,O
the,O
commercial,O
kit,O
performed,O
well,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.9.2000173,O
"
",O
PMID,O
:,O
32156330,O
"


",O
153,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Mar;25(9,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.9.2000152,O
.,O
"

",O
Evaluation,O
of,O
a,O
quantitative,O
RTPCR,O
assay,O
for,O
the,O
detection,O
of,O
the,O
emerging,O
"
",O
coronavirus,O
SARSCoV2,B-Virus_SARS-CoV-2
using,O
a,O
high,O
throughput,O
system,O
.,O
"

",O
Pfefferle,O
S(1,O
),O
",",O
Reucher,O
S(1,O
),O
",",O
NÃ¶rz,O
D(1,O
),O
",",O
LÃ¼tgehetmann,O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Medical,O
Microbiology,O
",",O
Virology,O
and,O
Hygiene,O
",",O
University,O
Medical,O
"
",O
Center,O
HamburgEppendorf,O
(,O
UKE,O
),O
",",O
Hamburg,O
",",O
Germany,O
.,O
"

",O
Facing,O
the,O
emergence,O
of,O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
"
",O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
highvolume,O
respiratory,O
testing,O
is,O
demanded,O
in,O
laboratories,O
"
",O
worldwide,O
.,O
We,O
evaluated,O
the,O
performance,O
of,O
a,O
molecular,O
assay,O
for,O
the,O
detection,O
of,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
on,O
a,O
highthroughput,O
platform,O
",",O
the,O
cobas,O
6800,O
",",O
using,O
the,O
',O
open,O
"
",O
channel,O
',O
for,O
integration,O
of,O
a,O
laboratorydeveloped,O
assay,O
.,O
We,O
observed,O
good,O
"
",O
analytical,O
performance,O
in,O
clinical,O
specimens,O
.,O
The,O
fully,O
automated,O
workflow,O
"
",O
enables,O
highthroughput,O
testing,O
with,O
minimal,O
handson,O
time,O
",",O
while,O
offering,O
fast,O
"
",O
and,O
reliable,O
results,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.9.2000152,O
"
",O
PMID,O
:,O
32156329,O
"


",O
154,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Mar;25(9,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.9.2000178,O
.,O
"

",O
First,O
cases,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
in,O
the,O
WHO,O
European,O
Region,O
",",O
24,O
"
",O
January,O
to,O
21,O
February,O
2020,O
.,O
"

",O
Spiteri,O
G(1,O
),O
",",O
Fielding,O
J(2,O
),O
",",O
Diercke,O
M(3,O
),O
",",O
Campese,O
C(4,O
),O
",",O
Enouf,O
V(5,O
),O
",",O
Gaymard,O
"
",O
A(6,O
),O
",",O
Bella,O
A(7,O
),O
",",O
Sognamiglio,O
P(8,O
),O
",",O
Sierra,O
Moros,O
MJ(9,O
),O
",",O
Riutort,O
AN(10,O
),O
",",O
Demina,O
"
",O
YV(11,O
),O
",",O
Mahieu,O
R(12,O
),O
",",O
Broas,O
M(13,O
),O
",",O
BengnÃ©r,O
M(14,O
),O
",",O
Buda,O
S(3,O
),O
",",O
Schilling,O
J(3,O
),O
",",O
"
",O
Filleul,O
L(15,O
),O
",",O
Lepoutre,O
A(16,O
),O
",",O
Saura,O
C(17,O
),O
",",O
Mailles,O
A(4,O
),O
",",O
LevyBruhl,O
D(4,O
),O
",",O
"
",O
Coignard,O
B(4,O
),O
",",O
BernardStoecklin,O
S(4,O
),O
",",O
Behillil,O
S(5,O
),O
",",O
van,O
der,O
Werf,O
S(5,O
),O
",",O
Valette,O
"
",O
M(6,O
),O
",",O
Lina,O
B(6,O
),O
",",O
Riccardo,O
F(7,O
),O
",",O
Nicastri,O
E(8,O
),O
",",O
Casas,O
I(18,O
),O
",",O
Larrauri,O
A(19,O
),O
",",O
Salom,O
"
",O
Castell,O
M(20,O
),O
",",O
Pozo,O
F(18,O
),O
",",O
Maksyutov,O
RA(21,O
),O
",",O
Martin,O
C(22,O
),O
",",O
Van,O
Ranst,O
M(23,O
),O
",",O
"
",O
Bossuyt,O
N(24,O
),O
",",O
Siira,O
L(25,O
),O
",",O
Sane,O
J(26,O
),O
",",O
TegmarkWisell,O
K(27,O
),O
",",O
PalmÃ©rus,O
M(28,O
),O
",",O
"
",O
Broberg,O
EK(1,O
),O
",",O
BeautÃ©,O
J(1,O
),O
",",O
Jorgensen,O
P(2,O
),O
",",O
Bundle,O
N(1,O
),O
",",O
Pereyaslov,O
D(2,O
),O
",",O
Adlhoch,O
"
",O
C(1,O
),O
",",O
Pukkila,O
J(2,O
),O
",",O
Pebody,O
R(2,O
),O
",",O
Olsen,O
S(29)(2,O
),O
",",O
Ciancio,O
BC(29)(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)European,O
Centre,O
for,O
Disease,O
Prevention,O
and,O
Control,O
",",O
Stockholm,O
",",O
Sweden,O
.,O
"
",O
(2)World,O
Health,O
Organisation,O
Regional,O
Office,O
for,O
Europe,O
",",O
Copenhagen,O
",",O
Denmark,O
.,O
"
",O
(3)Robert,O
Koch,O
Institute,O
",",O
Berlin,O
",",O
Germany,O
.,O
"
",O
(4)SantÃ©,O
Publique,O
France,O
 ,O
Direction,O
des,O
maladies,O
infectieuses,O
",",O
SaintMaurice,O
",",O
"
",O
France,O
.,O
"
",O
(5)Centre,O
national,O
de,O
rÃ©fÃ©rence,O
Virus,O
des,O
infections,O
respiratoires,O
",",O
do,O
nt,O
la,O
"
",O
grippe,O
",",O
Institut,O
Pasteur,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(6)Centre,O
national,O
de,O
rÃ©fÃ©rence,O
Virus,O
des,O
infections,O
respiratoires,O
",",O
do,O
nt,O
la,O
"
",O
grippe,O
",",O
Hospices,O
civils,O
de,O
Lyon,O
",",O
Lyon,O
",",O
France,O
.,O
"
",O
(7)Istituto,O
Superiore,O
di,O
Sanita,O
",",O
Rome,O
",",O
Italy,O
.,O
"
",O
(8)Istituto,O
Nazionale,O
Malattie,O
Infettive,O
Lazzaro,O
Spallanzani,O
",",O
Rome,O
",",O
Italy,O
.,O
"
",O
(9)Coordination,O
Centre,O
for,O
Health,O
Alerts,O
and,O
Emergencies,O
.,O
Spanish,O
Ministry,O
of,O
"
",O
Health,O
",",O
Madrid,O
",",O
Spain,O
.,O
"
",O
(10)Servicio,O
de,O
EpidemiologÃ­a,O
",",O
DirecciÃ³n,O
General,O
de,O
Salut,O
PÃºblica,O
",",O
Islas,O
"
",O
Baleares,O
",",O
Spain,O
.,O
"
",O
(11)Federal,O
Service,O
for,O
Surveillance,O
on,O
Consumer,O
Rights,O
Protection,O
and,O
Human,O
"
",O
Wellbeing,O
(,O
Rospotrebnadzor,O
),O
",",O
Moscow,O
",",O
Russia,O
.,O
"
",O
(12)Department,O
of,O
Infectious,O
Disease,O
Prevention,O
and,O
Control,O
",",O
Common,O
Community,O
"
",O
Commission,O
",",O
BrusselsCapital,O
Region,O
",",O
Brussels,O
",",O
Belgium,O
.,O
"
",O
(13)Chief,O
Physician,O
",",O
Infection,O
control,O
unit,O
",",O
Lapland,O
Hospital,O
District,O
",",O
"
",O
Rovaniemi,O
",",O
Finland,O
.,O
"
",O
(14)County,O
Medical,O
Officer,O
",",O
JÃ¶nkÃ¶ping,O
Region,O
",",O
JÃ¶nkÃ¶ping,O
",",O
Sweden,O
.,O
"
",O
(15)SantÃ©,O
publique,O
France,O
 ,O
Direction,O
des,O
rÃ©gions,O
",",O
Cellule,O
rÃ©gionale,O
Nouvelle,O
"
",O
Aquitaine,O
",",O
Bordeaux,O
",",O
France,O
.,O
"
",O
(16)SantÃ©,O
publique,O
France,O
 ,O
Direction,O
des,O
rÃ©gions,O
",",O
Cellule,O
rÃ©gionale,O
"
",O
IledeFrance,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(17)SantÃ©,O
publique,O
France,O
 ,O
Direction,O
des,O
rÃ©gions,O
",",O
Cellule,O
rÃ©gionale,O
"
",O
AuvergneRhÃ´neAlpes,O
",",O
Lyon,O
",",O
France,O
.,O
"
",O
(18)National,O
Centre,O
for,O
Microbiology,O
",",O
WHONational,O
Influenza,O
Centre,O
",",O
Institute,O
of,O
"
",O
Health,O
Carlos,O
III,O
.,O
Madrid,O
",",O
Spain,O
.,O
"
",O
(19)National,O
Centre,O
of,O
Epidemiology,O
",",O
CIBERESP,O
",",O
Institute,O
of,O
Health,O
Carlos,O
III,O
.,O
"
",O
Madrid,O
",",O
Spain,O
.,O
"
",O
(20)DirecciÃ³n,O
General,O
de,O
Salut,O
PÃºblica,O
",",O
Islas,O
Baleares,O
",",O
Spain,O
.,O
"
",O
(21)State,O
Research,O
Center,O
of,O
Virology,O
and,O
Biotechnology,O
"""",O
Vector,O
"""",O
",",O
"
",O
Rospotrebnadzor,O
",",O
Moscow,O
",",O
Russia,O
.,O
"
",O
(22)St,O
.,O
Pierre,O
Hospital,O
",",O
Brussels,O
",",O
Belgium,O
.,O
"
",O
(23)Laboratory,O
of,O
Clinical,O
Virology,O
",",O
Department,O
of,O
Microbiology,O
and,O
Immunology,O
",",O
"
",O
Rega,O
Institute,O
",",O
KU,O
Leuven,O
 ,O
University,O
of,O
Leuven,O
",",O
Leuven,O
",",O
Belgium,O
.,O
"
",O
(24)Epidemiology,O
of,O
infectious,O
diseases,O
",",O
Sciensano,O
",",O
Brussels,O
",",O
Belgium,O
.,O
"
",O
(25)Expert,O
Microbiology,O
Unit,O
",",O
Department,O
of,O
Health,O
Security,O
",",O
Finnish,O
Institute,O
"
",O
for,O
Health,O
and,O
Welfare,O
(,O
THL,O
),O
",",O
Helsinki,O
",",O
Finland,O
.,O
"
",O
(26)Infectious,O
Disease,O
Control,O
and,O
Vaccinations,O
Unit,O
",",O
Department,O
of,O
Health,O
"
",O
Security,O
",",O
Finnish,O
Institute,O
for,O
Health,O
and,O
Welfare,O
(,O
THL,O
),O
",",O
Helsinki,O
",",O
Finland,O
.,O
"
",O
(27)Public,O
Health,O
Agency,O
of,O
Sweden,O
",",O
Solna,O
",",O
Sweden,O
.,O
"
",O
(28)JÃ¶nkÃ¶ping,O
Region,O
",",O
JÃ¶nkÃ¶ping,O
",",O
Sweden,O
.,O
"
",O
(29)These,O
authors,O
have,O
contributed,O
equally,O
to,O
the,O
manuscript,O
.,O
"

",O
In,O
the,O
WHO,O
European,O
Region,O
",",O
COVID19,B-Disease_COVID-19
surveillance,O
was,O
implemented,O
27,O
January,O
"
",O
2020,O
.,O
We,O
detail,O
the,O
first,O
European,O
cases,O
.,O
As,O
at,O
21,O
February,O
",",O
nine,O
European,O
"
",O
countries,O
reported,O
47,O
cases,O
.,O
Among,O
38,O
cases,O
studied,O
",",O
21,O
were,O
linked,O
to,O
two,O
"
",O
clusters,O
in,O
Germany,O
and,O
France,O
",",O
14,O
were,O
infected,O
in,O
China,O
.,O
Median,O
case,O
age,O
was,O
"
",O
42,O
â€‰,O
years,O
;,O
25,O
were,O
male,O
.,O
Late,O
detection,O
of,O
the,O
clusters,O
',O
index,O
cases,O
delayed,O
"
",O
isolation,O
of,O
further,O
local,O
cases,O
.,O
As,O
at,O
5,O
March,O
",",O
there,O
were,O
4250,O
cases,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.9.2000178,O
"
",O
PMID,O
:,O
32156327,O
"


",O
155,O
.,O
Commun,O
Dis,O
Intell,O
(,O
2018,O
),O
.,O
2020,O
Mar,O
11;44,O
.,O
doi,O
:,O
10.33321,O
cdi.2020.44.21,O
.,O
"

",O
COVID19,B-Disease_COVID-19
",",O
Australia,O
:,O
Epidemiology,O
Report,O
6,O
(,O
Reporting,O
week,O
ending,O
0.791666667,O
AEDT,O
7,O
"
",O
March,O
2020,O
),O
.,O
"

",O
COVID19,B-Disease_COVID-19
National,O
Incident,O
Room,O
Surveillance,O
Team,O
.,O
"

",O
This,O
is,O
the,O
sixth,O
epidemiological,O
report,O
for,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
",",O
"
",O
reported,O
in,O
Australia,O
as,O
at,O
0.791666667,O
Australian,O
Eastern,O
Daylight,O
Time,O
[,O
AEDT,O
],O
7,O
March,O
"
",O
2020,O
.,O
It,O
includes,O
data,O
on,O
COVID19,B-Disease_COVID-19
cases,O
diagnosed,O
in,O
Australia,O
",",O
the,O
"
",O
international,O
situation,O
and,O
a,O
review,O
of,O
current,O
evidence,O
.,O
"

",O
Â©,O
Commonwealth,O
of,O
Australia,O
CC,O
BYNCND,O
.,O
"

",O
DOI,O
:,O
10.33321,O
cdi.2020.44.21,O
"
",O
PMID,O
:,O
32156224,O
"


",O
156,O
.,O
Ann,O
Palliat,O
Med,O
.,O
2020,O
Feb,O
24,O
.,O
pii,O
:,O
apm.2020.02.33,O
.,O
doi,O
:,O
10.21037,O
apm.2020.02.33,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Protocol,O
for,O
the,O
development,O
of,O
a,O
rapid,O
advice,O
guideline,O
for,O
prevention,O
",",O
"
",O
management,O
and,O
care,O
of,O
children,O
with,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"

",O
Li,O
W(1,O
),O
",",O
Zhou,O
Q(2,O
),O
",",O
Tang,O
Y(1,O
),O
",",O
Ren,O
L(1,O
),O
",",O
Yu,O
X(3,O
),O
",",O
Li,O
Q(4,O
),O
",",O
Liu,O
E(5,O
),O
",",O
Chen,O
Y(6,O
),O
;,O
"
",O
COVID19,B-Disease_COVID-19
evidence,O
and,O
recommendations,O
working,O
group,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Children,O
's,O
Hospital,O
of,O
Chongqing,O
Medical,O
"
",O
University,O
",",O
Chongqing,O
400014,O
",",O
China,O
;,O
National,O
Clinical,O
Research,O
Center,O
for,O
Child,O
"
",O
Health,O
and,O
Diseases,O
",",O
Ministry,O
of,O
Education,O
Key,O
Laboratory,O
of,O
Child,O
Development,O
"
",O
and,O
Disorders,O
",",O
China,O
International,O
Science,O
and,O
Technology,O
Cooperation,O
Base,O
of,O
"
",O
Child,O
Development,O
and,O
Critical,O
Disorders,O
",",O
Children,O
's,O
Hospital,O
of,O
Chongqing,O
"
",O
Medical,O
University,O
",",O
Chongqing,O
400014,O
",",O
China,O
;,O
Chongqing,O
Key,O
Laboratory,O
of,O
"
",O
Pediatrics,O
",",O
Chongqing,O
400014,O
",",O
China,O
.,O
"
",O
(2)The,O
First,O
School,O
of,O
Clinical,O
Medicine,O
",",O
Lanzhou,O
University,O
",",O
Lanzhou,O
730000,O
",",O
"
",O
China,O
;,O
Evidencebased,O
Medicine,O
Center,O
",",O
School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Lanzhou,O
"
",O
University,O
",",O
Lanzhou,O
730000,O
",",O
China,O
.,O
"
",O
(3)Evidencebased,O
Medicine,O
Center,O
",",O
School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Lanzhou,O
"
",O
University,O
",",O
Lanzhou,O
730000,O
",",O
China,O
;,O
WHO,O
Collaborating,O
Centre,O
for,O
Guideline,O
"
",O
Implementation,O
and,O
Knowledge,O
Translation,O
",",O
Lanzhou,O
730000,O
",",O
China,O
;,O
Guideline,O
"
",O
International,O
Network,O
Asia,O
",",O
Lanzhou,O
730000,O
",",O
China,O
;,O
Key,O
Laboratory,O
of,O
Evidence,O
"
",O
Based,O
Medicine,O
and,O
Knowledge,O
Translation,O
of,O
Gansu,O
Province,O
",",O
Lanzhou,O
University,O
",",O
"
",O
Lanzhou,O
730000,O
",",O
China,O
;,O
Chinese,O
GRADE,O
Center,O
",",O
Lanzhou,O
730000,O
",",O
China,O
.,O
"
",O
(4)National,O
Clinical,O
Research,O
Center,O
for,O
Child,O
Health,O
and,O
Diseases,O
",",O
Ministry,O
of,O
"
",O
Education,O
Key,O
Laboratory,O
of,O
Child,O
Development,O
and,O
Disorders,O
",",O
China,O
International,O
"
",O
Science,O
and,O
Technology,O
Cooperation,O
Base,O
of,O
Child,O
Development,O
and,O
Critical,O
"
",O
Disorders,O
",",O
Children,O
's,O
Hospital,O
of,O
Chongqing,O
Medical,O
University,O
",",O
Chongqing,O
400014,O
",",O
"
",O
China,O
;,O
Chongqing,O
Key,O
Laboratory,O
of,O
Pediatrics,O
",",O
Chongqing,O
400014,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Children,O
's,O
Hospital,O
of,O
Chongqing,O
Medical,O
"
",O
University,O
",",O
Chongqing,O
400014,O
",",O
China,O
;,O
National,O
Clinical,O
Research,O
Center,O
for,O
Child,O
"
",O
Health,O
and,O
Diseases,O
",",O
Ministry,O
of,O
Education,O
Key,O
Laboratory,O
of,O
Child,O
Development,O
"
",O
and,O
Disorders,O
",",O
China,O
International,O
Science,O
and,O
Technology,O
Cooperation,O
Base,O
of,O
"
",O
Child,O
Development,O
and,O
Critical,O
Disorders,O
",",O
Children,O
's,O
Hospital,O
of,O
Chongqing,O
"
",O
Medical,O
University,O
",",O
Chongqing,O
400014,O
",",O
China,O
;,O
Chongqing,O
Key,O
Laboratory,O
of,O
"
",O
Pediatrics,O
",",O
Chongqing,O
400014,O
",",O
China,O
.,O
emliu186@126.com,O
.,O
"
",O
(6)Evidencebased,O
Medicine,O
Center,O
",",O
School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Lanzhou,O
"
",O
University,O
",",O
Lanzhou,O
730000,O
",",O
China,O
;,O
WHO,O
Collaborating,O
Centre,O
for,O
Guideline,O
"
",O
Implementation,O
and,O
Knowledge,O
Translation,O
",",O
Lanzhou,O
730000,O
",",O
China,O
;,O
Guideline,O
"
",O
International,O
Network,O
Asia,O
",",O
Lanzhou,O
730000,O
",",O
China,O
;,O
Key,O
Laboratory,O
of,O
Evidence,O
"
",O
Based,O
Medicine,O
and,O
Knowledge,O
Translation,O
of,O
Gansu,O
Province,O
",",O
Lanzhou,O
University,O
",",O
"
",O
Lanzhou,O
730000,O
",",O
China,O
;,O
Chinese,O
GRADE,O
Center,O
",",O
Lanzhou,O
730000,O
",",O
China,O
.,O
"
",O
chenyaolong@lzu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.21037,O
apm.2020.02.33,O
"
",O
PMID,O
:,O
32156144,O
"


",O
157,O
.,O
Exp,O
Neurobiol,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.5607,O
en20009,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Development,O
of,O
a,O
Laboratorysafe,O
and,O
Lowcost,O
Detection,O
Protocol,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
of,O
the,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
Won,O
J(1)(2,O
),O
",",O
Lee,O
S(1,O
),O
",",O
Park,O
M(1,O
),O
",",O
Kim,O
TY(1,O
),O
",",O
Park,O
MG(1)(3,O
),O
",",O
Choi,O
BY(4,O
),O
",",O
Kim,O
"
",O
D(5)(6,O
),O
",",O
Chang,O
H(5)(6,O
),O
",",O
Kim,O
VN(5)(6,O
),O
",",O
Lee,O
CJ(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Center,O
for,O
Cognition,O
and,O
Sociality,O
",",O
Cognitive,O
Glioscience,O
Group,O
",",O
Institute,O
for,O
"
",O
Basic,O
Science,O
",",O
Daejeon,O
34126,O
",",O
Korea,O
.,O
"
",O
(2)Department,O
of,O
Biological,O
Sciences,O
",",O
Korea,O
Advanced,O
Institute,O
of,O
Science,O
and,O
"
",O
Technology,O
(,O
KAIST,O
),O
",",O
Daejeon,O
34141,O
",",O
Korea,O
.,O
"
",O
(3)KUKIST,O
Graduate,O
School,O
of,O
Converging,O
Science,O
and,O
Technology,O
",",O
Korea,O
"
",O
University,O
",",O
Seoul,O
2841,O
",",O
Korea,O
.,O
"
",O
(4)Department,O
of,O
Otorhinolaryngology,O
",",O
Seoul,O
National,O
University,O
Bundang,O
Hospital,O
",",O
"
",O
Seongnam,O
13620,O
",",O
Korea,O
.,O
"
",O
(5)Center,O
for,O
RNA,O
Research,O
",",O
Institute,O
for,O
Basic,O
Science,O
",",O
Seoul,O
8826,O
",",O
Korea,O
.,O
"
",O
(6)School,O
of,O
Biological,O
Sciences,O
",",O
Seoul,O
National,O
University,O
",",O
Seoul,O
8826,O
",",O
Korea,O
.,O
"

",O
The,O
severe,O
acute,O
respiratory,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
which,O
emerged,O
in,O
"
",O
December,O
2019,O
in,O
Wuhan,O
",",O
China,O
",",O
has,O
spread,O
rapidly,O
to,O
over,O
a,O
dozen,O
countries,O
.,O
"
",O
Especially,O
",",O
the,O
spike,O
of,O
case,O
numbers,O
in,O
South,O
Korea,O
sparks,O
pandemic,O
worries,O
.,O
"
",O
This,O
virus,O
is,O
reported,O
to,O
spread,O
mainly,O
through,O
personto,O
person,O
contact,O
via,O
"
",O
respiratory,O
droplets,O
generated,O
by,O
coughing,O
and,O
sneezing,O
",",O
or,O
possibly,O
through,O
"
",O
surface,O
contaminated,O
by,O
people,O
coughing,O
or,O
sneezing,O
on,O
them,O
.,O
More,O
critically,O
",",O
"
",O
there,O
have,O
been,O
reports,O
about,O
the,O
possibility,O
of,O
this,O
virus,O
to,O
transmit,O
even,O
"
",O
before,O
a,O
viruscarrying,O
person,O
to,O
show,O
symptoms,O
.,O
Therefore,O
",",O
a,O
lowcost,O
",",O
"
",O
easyaccess,O
protocol,O
for,O
early,O
detection,O
of,O
this,O
virus,O
is,O
desperately,O
needed,O
.,O
"
",O
Here,O
",",O
we,O
have,O
established,O
a,O
realtime,O
reversetranscription,O
PCR,O
(rtPCR)based,O
"
",O
assay,O
protocol,O
composed,O
of,O
easy,O
specimen,O
selfcollection,O
from,O
a,O
subject,O
via,O
"
",O
pharyngeal,O
swab,O
",",O
Trizolbased,O
RNA,O
purification,O
",",O
and,O
SYBR,O
Greenbased,O
rtPCR,O
.,O
This,O
"
",O
protocol,O
shows,O
an,O
accuracy,O
and,O
sensitivity,O
limit,O
of,O
110,O
virus,O
particles,O
as,O
we,O
"
",O
tested,O
with,O
a,O
known,O
lentivirus,O
.,O
The,O
cost,O
for,O
each,O
sample,O
is,O
estimated,O
to,O
be,O
less,O
"
",O
than,O
15,O
US,O
dollars,O
.,O
Overall,O
time,O
it,O
takes,O
for,O
an,O
entire,O
protocol,O
is,O
estimated,O
to,O
"
",O
be,O
less,O
than,O
4,O
hours,O
.,O
We,O
propose,O
a,O
costeffective,O
",",O
quickandeasy,O
method,O
for,O
"
",O
early,O
detection,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
at,O
any,O
conventional,O
Biosafety,O
Level,O
II,O
laboratories,O
"
",O
that,O
are,O
equipped,O
with,O
a,O
rtPCR,O
machine,O
.,O
Our,O
newly,O
developed,O
protocol,O
should,O
be,O
"
",O
helpful,O
for,O
a,O
firsthand,O
screening,O
of,O
the,O
asymptomatic,O
viruscarriers,O
for,O
further,O
"
",O
prevention,O
of,O
transmission,O
and,O
early,O
intervention,O
and,O
treatment,O
for,O
the,O
rapidly,O
"
",O
propagating,O
virus,O
.,O
"

",O
DOI,O
:,O
10.5607,O
en20009,O
"
",O
PMID,O
:,O
32156101,O
"


",O
158,O
.,O
Int,O
J,O
Environ,O
Res,O
Public,O
Health,O
.,O
2020,O
Mar,O
6;17(5,O
),O
.,O
pii,O
:,O
E1729,O
.,O
doi,O
:,O
"
",O
10.339,O
ijerph17051729,O
.,O
"

",O
Immediate,O
Psychological,O
Responses,O
and,O
Associated,O
Factors,O
during,O
the,O
Initial,O
Stage,O
"
",O
of,O
the,O
2019,B-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
Epidemic,O
among,O
the,O
General,O
Population,O
"
",O
in,O
China,O
.,O
"

",O
Wang,O
C(1,O
),O
",",O
Pan,O
R(1,O
),O
",",O
Wan,O
X(1,O
),O
",",O
Tan,O
Y(1,O
),O
",",O
Xu,O
L(1,O
),O
",",O
Ho,O
CS(2)(3,O
),O
",",O
Ho,O
RC(1)(3)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Cognitive,O
Neuroscience,O
",",O
Faculty,O
of,O
Education,O
",",O
Huaibei,O
Normal,O
"
",O
University,O
",",O
Huaibei,O
235000,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Psychological,O
Medicine,O
",",O
National,O
University,O
Health,O
System,O
",",O
Kent,O
"
",O
Ridge,O
119228,O
",",O
Singapore,O
.,O
"
",O
(3)Department,O
of,O
Psychological,O
Medicine,O
",",O
Yong,O
Loo,O
Lin,O
School,O
of,O
Medicine,O
",",O
"
",O
National,O
University,O
of,O
Singapore,O
",",O
Kent,O
Ridge,O
119228,O
",",O
Singapore,O
.,O
"
",O
(4)Institute,O
of,O
Health,O
Innovation,O
and,O
Technology,O
(,O
iHealthtech,O
),O
",",O
National,O
"
",O
University,O
of,O
Singapore,O
",",O
Kent,O
Ridge,O
119077,O
",",O
Singapore,O
.,O
"

",O
Background,O
:,O
The,O
2019,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
epidemic,O
is,O
a,O
public,O
health,O
"
",O
emergency,O
of,O
international,O
concern,O
and,O
poses,O
a,O
challenge,O
to,O
psychological,O
"
",O
resilience,O
.,O
Research,O
data,O
are,O
needed,O
to,O
develop,O
evidencedriven,O
strategies,O
to,O
"
",O
reduce,O
adverse,O
psychological,O
impacts,O
and,O
psychiatric,O
symptoms,O
during,O
the,O
"
",O
epidemic,O
.,O
The,O
aim,O
of,O
this,O
study,O
was,O
to,O
survey,O
the,O
general,O
public,O
in,O
China,O
to,O
"
",O
better,O
understand,O
their,O
levels,O
of,O
psychological,O
impact,O
",",O
anxiety,O
",",O
depression,O
",",O
and,O
"
",O
stress,O
during,O
the,O
initial,O
stage,O
of,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
.,O
The,O
data,O
will,O
be,O
used,O
"
",O
for,O
future,O
reference,O
.,O
Methods,O
:,O
From,O
31,O
January,O
to,O
2,O
February,O
2020,O
",",O
we,O
conducted,O
"
",O
an,O
online,O
survey,O
using,O
snowball,O
sampling,O
techniques,O
.,O
The,O
online,O
survey,O
collected,O
"
",O
information,O
on,O
demographic,O
data,O
",",O
physical,O
symptoms,O
in,O
the,O
past,O
14,O
days,O
",",O
contact,O
"
",O
history,O
with,O
COVID19,B-Disease_COVID-19
",",O
knowledge,O
and,O
concerns,O
about,O
COVID19,B-Disease_COVID-19
",",O
precautionary,O
"
",O
measures,O
against,O
COVID19,B-Disease_COVID-19
",",O
and,O
additional,O
information,O
required,O
with,O
respect,O
to,O
"
",O
COVID19,B-Disease_COVID-19
.,O
Psychological,O
impact,O
was,O
assessed,O
by,O
the,O
Impact,O
of,O
Event,O
ScaleRevised,O
"
",O
(,O
IESR,O
),O
",",O
and,O
mental,O
health,O
status,O
was,O
assessed,O
by,O
the,O
Depression,O
",",O
Anxiety,O
and,O
"
",O
Stress,O
Scale,O
(,O
DASS21,O
),O
.,O
Results,O
:,O
This,O
study,O
included,O
1210,O
respondents,O
from,O
194,O
"
",O
cities,O
in,O
China,O
.,O
In,O
total,O
",",O
53.8,O
%,O
of,O
respondents,O
rated,O
the,O
psychological,O
impact,O
of,O
"
",O
the,O
outbreak,O
as,O
moderate,O
or,O
severe,O
;,O
16.5,O
%,O
reported,O
moderate,O
to,O
severe,O
depressive,O
"
",O
symptoms,O
;,O
28.8,O
%,O
reported,O
moderate,O
to,O
severe,O
anxiety,O
symptoms,O
;,O
and,O
8.1,O
%,O
reported,O
"
",O
moderate,O
to,O
severe,O
stress,O
levels,O
.,O
Most,O
respondents,O
spent,O
2024,O
h,O
per,O
day,O
at,O
home,O
"
",O
(,O
84.7,O
%,O
),O
;,O
were,O
worried,O
about,O
their,O
family,O
members,O
contracting,O
COVID19,B-Disease_COVID-19
(,O
75.2,O
%,O
),O
;,O
"
",O
and,O
were,O
satisfied,O
with,O
the,O
amount,O
of,O
health,O
information,O
available,O
(,O
75.1,O
%,O
),O
.,O
"
",O
Female,O
gender,O
",",O
student,O
status,O
",",O
specific,O
physical,O
symptoms,O
(,O
e.g.,O
",",O
myalgia,O
",",O
"
",O
dizziness,O
",",O
coryza,O
),O
",",O
and,O
poor,O
selfrated,O
health,O
status,O
were,O
significantly,O
"
",O
associated,O
with,O
a,O
greater,O
psychological,O
impact,O
of,O
the,O
outbreak,O
and,O
higher,O
levels,O
"
",O
of,O
stress,O
",",O
anxiety,O
",",O
and,O
depression,O
(,O
p,O
<,O
0.05,O
),O
.,O
Specific,O
uptodate,O
and,O
accurate,O
"
",O
health,O
information,O
(,O
e.g.,O
",",O
treatment,O
",",O
local,O
outbreak,O
situation,O
),O
and,O
particular,O
"
",O
precautionary,O
measures,O
(,O
e.g.,O
",",O
hand,O
hygiene,O
",",O
wearing,O
a,O
mask,O
),O
were,O
associated,O
with,O
"
",O
a,O
lower,O
psychological,O
impact,O
of,O
the,O
outbreak,O
and,O
lower,O
levels,O
of,O
stress,O
",",O
anxiety,O
",",O
"
",O
and,O
depression,O
(,O
p,O
<,O
0.05,O
),O
.,O
Conclusions,O
:,O
During,O
the,O
initial,O
phase,O
of,O
the,O
COVID19,B-Disease_COVID-19
"
",O
outbreak,O
in,O
China,O
",",O
more,O
than,O
half,O
of,O
the,O
respondents,O
rated,O
the,O
psychological,O
"
",O
impact,O
as,O
moderatetosevere,O
",",O
and,O
about,O
onethird,O
reported,O
moderatetosevere,O
"
",O
anxiety,O
.,O
Our,O
findings,O
identify,O
factors,O
associated,O
with,O
a,O
lower,O
level,O
of,O
"
",O
psychological,O
impact,O
and,O
better,O
mental,O
health,O
status,O
that,O
can,O
be,O
used,O
to,O
"
",O
formulate,O
psychological,O
interventions,O
to,O
improve,O
the,O
mental,O
health,O
of,O
vulnerable,O
"
",O
groups,O
during,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
.,O
"

",O
DOI,O
:,O
10.339,O
ijerph17051729,O
"
",O
PMID,O
:,O
32155789,O
"


",O
159,O
.,O
Cell,O
.,O
2020,O
Mar,O
6,O
.,O
pii,O
:,O
S00928674(20)302622,O
.,O
doi,O
:,O
10.1016,O
j.cell.2020.02.058,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Structure,O
",",O
Function,O
",",O
and,O
Antigenicity,O
of,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
Spike,O
Glycoprotein,O
.,O
"

",O
Walls,O
AC(1,O
),O
",",O
Park,O
YJ(1,O
),O
",",O
Tortorici,O
MA(2,O
),O
",",O
Wall,O
A(3,O
),O
",",O
McGuire,O
AT(4,O
),O
",",O
Veesler,O
D(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Biochemistry,O
",",O
University,O
of,O
Washington,O
",",O
Seattle,O
",",O
WA,O
98195,O
",",O
USA,O
.,O
"
",O
(2)Department,O
of,O
Biochemistry,O
",",O
University,O
of,O
Washington,O
",",O
Seattle,O
",",O
WA,O
98195,O
",",O
USA,O
;,O
"
",O
Institute,O
Pasteur,O
&,O
CNRS,O
UMR,O
3569,O
",",O
UnitÃ©,O
de,O
Virologie,O
Structurale,O
",",O
Paris,O
75015,O
",",O
"
",O
France,O
.,O
"
",O
(3)Vaccines,O
and,O
Infectious,O
Diseases,O
Division,O
",",O
Fred,O
Hutchinson,O
Cancer,O
Research,O
"
",O
Center,O
",",O
Seattle,O
",",O
WA,O
98195,O
",",O
USA,O
.,O
"
",O
(4)Vaccines,O
and,O
Infectious,O
Diseases,O
Division,O
",",O
Fred,O
Hutchinson,O
Cancer,O
Research,O
"
",O
Center,O
",",O
Seattle,O
",",O
WA,O
98195,O
",",O
USA,O
;,O
Department,O
of,O
Global,O
Health,O
",",O
University,O
of,O
"
",O
Washington,O
",",O
Seattle,O
",",O
WA,O
98195,O
",",O
USA,O
.,O
"
",O
(5)Department,O
of,O
Biochemistry,O
",",O
University,O
of,O
Washington,O
",",O
Seattle,O
",",O
WA,O
98195,O
",",O
USA,O
.,O
"
",O
Electronic,O
address,O
:,O
dveesler@uw.edu,O
.,O
"

",O
The,O
emergence,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
has,O
resulted,O
in,O
>,O
90000,O
infections,O
and,O
>,O
3000,O
deaths,O
.,O
"
",O
Coronavirus,O
spike,O
(,O
S,O
),O
glycoproteins,O
promote,O
entry,O
into,O
cells,O
and,O
are,O
the,O
main,O
"
",O
target,O
of,O
antibodies,O
.,O
We,O
show,O
that,O
SARSCoV2,B-Virus_SARS-CoV-2
Â ,O
S,O
uses,O
ACE2,O
to,O
enter,O
cells,O
and,O
that,O
"
",O
the,O
receptorbinding,O
domains,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
Â ,O
S,O
and,O
SARSCoV,O
S,O
bind,O
with,O
similar,O
"
",O
affinities,O
to,O
human,O
ACE2,O
",",O
correlating,O
with,O
the,O
efficient,O
spread,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
among,O
humans,O
.,O
We,O
found,O
that,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
Â ,O
S,O
glycoprotein,O
harbors,O
a,O
furin,O
"
",O
cleavage,O
site,O
at,O
the,O
boundary,O
between,O
the,O
S1,O
S2,O
subunits,O
",",O
which,O
is,O
processed,O
"
",O
during,O
biogenesis,O
and,O
sets,O
this,O
virus,O
apart,O
from,O
SARSCoV,O
and,O
SARSrelated,O
CoVs,O
.,O
"
",O
We,O
Â ,O
determined,O
cryoEM,O
structures,O
of,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
Â ,O
S,O
ectodomain,O
trimer,O
",",O
providing,O
"
",O
a,O
blueprint,O
for,O
the,O
design,O
of,O
vaccines,O
and,O
inhibitors,O
of,O
viral,O
entry,O
.,O
Â ,O
Finally,O
",",O
we,O
"
",O
demonstrate,O
that,O
SARSCoV,O
S,O
murine,O
polyclonal,O
antibodies,O
potently,O
inhibited,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
S,O
mediated,O
entry,O
into,O
cells,O
",",O
indicating,O
that,O
crossneutralizing,O
"
",O
antibodies,O
targeting,O
conserved,O
S,O
epitopes,O
can,O
be,O
elicited,O
upon,O
vaccination,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.cell.2020.02.058,O
"
",O
PMID,O
:,O
32155444,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Interests,O
The,O
authors,O
declare,O
no,O
"
",O
competing,O
financial,O
interests,O
.,O
"


",O
160,O
.,O
Trends,O
Microbiol,O
.,O
2020,O
Apr;28(4):239240,O
.,O
doi,O
:,O
10.1016,O
j.tim.2020.02.001,O
.,O
Epub,O
"
",O
2020,O
Feb,O
24,O
.,O
"

",O
Unveiling,O
the,O
Origin,O
and,O
Transmission,O
of,O
2019nCoV.,O
"

",O
Xu,O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Nuffield,O
Department,O
of,O
Medicine,O
",",O
University,O
of,O
Oxford,O
",",O
Oxford,O
",",O
UK,O
.,O
Electronic,O
"
",O
address,O
:,O
yifei.xu@ndm.ox.ac.uk,O
.,O
"

",O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
has,O
caused,O
thousands,O
of,O
human,O
infections,O
in,O
China,O
since,O
"
",O
December,O
2019,O
",",O
raising,O
a,O
global,O
public,O
health,O
concern,O
.,O
Recent,O
studies,O
(,O
Huang,O
et,O
"
",O
al.,O
",",O
Chan,O
et,O
al.,O
",",O
and,O
Zhou,O
et,O
al.,O
),O
have,O
provided,O
timely,O
insights,O
into,O
its,O
origin,O
"
",O
and,O
ability,O
to,O
spread,O
among,O
humans,O
",",O
informing,O
infection,O
prevention,O
and,O
control,O
"
",O
practices,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tim.2020.02.001,O
"
",O
PMID,O
:,O
32155431,O
"


",O
161,O
.,O
J,O
Clin,O
Nurs,O
.,O
2020,O
Mar,O
9,O
.,O
doi,O
:,O
10.1111,O
jocn.15231,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
:,O
Emerging,O
compassion,O
",",O
courage,O
and,O
resilience,O
in,O
the,O
face,O
of,O
"
",O
misinformation,O
and,O
adversity,O
.,O
"

",O
Smith,O
GD(1,O
),O
",",O
Ng,O
F(2,O
),O
",",O
Ho,O
Cheung,O
Li,O
W(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Caritas,O
Institute,O
of,O
Higher,O
Education,O
",",O
Tseung,O
Kwan,O
O,O
",",O
Hong,O
Kong,O
.,O
"
",O
(2)Hong,O
Kong,O
College,O
of,O
Health,O
Service,O
Executives,O
",",O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
.,O
"
",O
(3)School,O
of,O
Nursing,O
",",O
The,O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
.,O
"

",O
DOI,O
:,O
10.1111,O
jocn.15231,O
"
",O
PMID,O
:,O
32155302,O
"


",O
162,O
.,O
Pediatr,O
Ann,O
.,O
2020,O
Mar,O
1;49(3):e99e100,O
.,O
doi,O
:,O
10.3928,O
1.93824E+17,O
.,O
"

",O
The,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
Hageman,O
JR,O
.,O
"

",O
DOI,O
:,O
10.3928,O
1.93824E+17,O
"
",O
PMID,O
:,O
32155273,O
"


",O
163,O
.,O
Radiology,O
.,O
2020,O
Mar,O
10:200823,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200823,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Performance,O
of,O
radiologists,O
in,O
differentiating,O
COVID19,B-Disease_COVID-19
from,O
viral,O
pneumonia,O
on,O
"
",O
chest,O
CT,O
.,O
"

",O
Bai,O
HX(1,O
),O
",",O
Hsieh,O
B(1,O
),O
",",O
Xiong,O
Z(1,O
),O
",",O
Halsey,O
K(1,O
),O
",",O
Choi,O
JW(1,O
),O
",",O
Tran,O
TML(1,O
),O
",",O
Pan,O
"
",O
I(1,O
),O
",",O
Shi,O
LB(1,O
),O
",",O
Wang,O
DC(1,O
),O
",",O
Mei,O
J(1,O
),O
",",O
Jiang,O
XL(1,O
),O
",",O
Zeng,O
QH(1,O
),O
",",O
Egglin,O
TK(1,O
),O
",",O
Hu,O
"
",O
PF(1,O
),O
",",O
Agarwal,O
S(1,O
),O
",",O
Xie,O
F(1,O
),O
",",O
Li,O
S(1,O
),O
",",O
Healey,O
T(1,O
),O
",",O
Atalay,O
MK(1,O
),O
",",O
Liao,O
WH(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Department,O
of,O
Radiology,O
",",O
Xiangya,O
Hospital,O
",",O
Central,O
South,O
University,O
",",O
"
",O
Changsha,O
",",O
Hunan,O
",",O
China,O
410008,O
(,O
Z.X.,O
",",O
D.C.W.,O
",",O
F.X.,O
",",O
S.L.,O
",",O
W.H.L.,O
),O
",",O
Department,O
of,O
"
",O
Diagnostic,O
Imaging,O
",",O
Rhode,O
Island,O
Hospital,O
",",O
Providence,O
",",O
RI,O
",",O
USA,O
",",O
2903,O
(,O
H.X.B.,O
",",O
"
",O
B.H.,O
",",O
K.H.,O
",",O
I.P.,O
",",O
T.K.E.,O
",",O
S.A.,O
",",O
T.H.,O
",",O
M.K.A.,O
),O
",",O
Brown,O
University,O
Warren,O
Alpert,O
"
",O
Medical,O
School,O
",",O
Providence,O
",",O
RI,O
",",O
USA,O
2903,O
(,O
K.H.,O
",",O
J.W.C.,O
",",O
T.M.L.T.,O
",",O
I.P.,O
",",O
T.K.E.,O
),O
",",O
"
",O
Department,O
of,O
Pathology,O
and,O
Laboratory,O
Medicine,O
",",O
Brown,O
University,O
",",O
Providence,O
",",O
"
",O
RI,O
",",O
USA,O
2912,O
(,O
L.B.S.,O
),O
",",O
Department,O
of,O
Radiology,O
",",O
Changde,O
Second,O
People,O
's,O
"
",O
Hospital,O
",",O
Changde,O
",",O
Hunan,O
",",O
China,O
415001,O
(,O
J.M.,O
),O
",",O
Department,O
of,O
Radiology,O
",",O
"
",O
Affiliated,O
Nan,O
Hua,O
Hospital,O
",",O
University,O
of,O
South,O
China,O
",",O
Hengyang,O
",",O
Hunan,O
",",O
China,O
"
",O
421002,O
(,O
X.L.J.,O
),O
",",O
Department,O
of,O
Radiology,O
",",O
Loudi,O
Central,O
Hospital,O
",",O
Loudi,O
",",O
Hunan,O
",",O
"
",O
China,O
417000,O
(,O
Q.H.Z.,O
",",O
),O
",",O
and,O
Department,O
of,O
Radiology,O
",",O
Chenzhou,O
Second,O
People,O
's,O
"
",O
Hospital,O
",",O
Chenzhou,O
",",O
Hunan,O
",",O
China,O
423000,O
(,O
P.F.H.,O
),O
.,O
"

",O
Background,O
Despite,O
its,O
high,O
sensitivity,O
in,O
diagnosing,O
COVID19,B-Disease_COVID-19
in,O
a,O
screening,O
"
",O
population,O
",",O
chest,O
CT,O
appearances,O
of,O
COVID,B-Disease_COVID-19
19,I-Disease_COVID-19
pneumonia,O
are,O
thought,O
to,O
be,O
"
",O
nonspecific,O
.,O
Purpose,O
To,O
assess,O
the,O
performance,O
of,O
United,O
States,O
(,O
U.S.,O
),O
and,O
"
",O
Chinese,O
radiologists,O
in,O
differentiating,O
COVID19,B-Disease_COVID-19
from,O
viral,O
pneumonia,O
on,O
chest,O
"
",O
CT,O
.,O
Methods,O
A,O
total,O
of,O
219,O
patients,O
with,O
both,O
positive,O
COVID19,B-Disease_COVID-19
by,O
RTPCR,O
and,O
"
",O
abnormal,O
chest,O
CT,O
findings,O
were,O
retrospectively,O
identified,O
from,O
7,O
Chinese,O
"
",O
hospitals,O
in,O
Hunan,O
Providence,O
",",O
China,O
from,O
January,O
6,O
to,O
February,O
20,O
",",O
2020,O
.,O
A,O
total,O
"
",O
of,O
205,O
patients,O
with,O
positive,O
Respiratory,O
Pathogen,O
Panel,O
for,O
viral,O
pneumonia,O
and,O
"
",O
CT,O
findings,O
consistent,O
with,O
or,O
highly,O
suspicious,O
for,O
pneumonia,O
by,O
original,O
"
",O
radiology,O
interpretation,O
within,O
7,O
days,O
of,O
each,O
other,O
were,O
identified,O
from,O
Rhode,O
"
",O
Island,O
Hospital,O
in,O
Providence,O
",",O
RI,O
.,O
Three,O
Chinese,O
radiologists,O
blindly,O
reviewed,O
"
",O
all,O
chest,O
CTs,O
(,O
n=424,O
),O
to,O
differentiate,O
COVID19,B-Disease_COVID-19
from,O
viral,O
pneumonia,O
.,O
A,O
sample,O
of,O
"
",O
58,O
agematched,O
cases,O
was,O
randomly,O
selected,O
and,O
evaluated,O
by,O
4,O
U.S.,O
radiologists,O
"
",O
in,O
a,O
similar,O
fashion,O
.,O
Different,O
CT,O
features,O
were,O
recorded,O
and,O
compared,O
between,O
"
",O
the,O
two,O
groups,O
.,O
Results,O
For,O
all,O
chest,O
CTs,O
",",O
three,O
Chinese,O
radiologists,O
correctly,O
"
",O
differentiated,O
COVID19,B-Disease_COVID-19
from,O
nonCOVID19,O
pneumonia,O
83,O
%,O
(,O
350,O
424,O
),O
",",O
80,O
%,O
(,O
338,O
424,O
),O
",",O
"
",O
and,O
60,O
%,O
(,O
255,O
424,O
),O
of,O
the,O
time,O
",",O
respectively,O
.,O
The,O
seven,O
radiologists,O
had,O
"
",O
sensitivities,O
of,O
80,O
%,O
",",O
67,O
%,O
",",O
97,O
%,O
",",O
93,O
%,O
",",O
83,O
%,O
",",O
73,O
%,O
and,O
70,O
%,O
and,O
specificities,O
of,O
100,O
%,O
",",O
"
",O
93,O
%,O
",",O
7,O
%,O
",",O
100,O
%,O
",",O
93,O
%,O
",",O
93,O
%,O
",",O
100,O
%,O
.,O
Compared,O
to,O
nonCOVID19,O
pneumonia,O
",",O
COVID19,B-Disease_COVID-19
"
",O
pneumonia,O
was,O
more,O
likely,O
to,O
have,O
a,O
peripheral,O
distribution,O
(,O
80,O
%,O
vs.,O
57,O
%,O
",",O
"
",O
p<0.001,O
),O
",",O
groundglass,O
opacity,O
(,O
91,O
%,O
vs.,O
68,O
%,O
",",O
p<0.001,O
),O
",",O
fine,O
reticular,O
opacity,O
"
",O
(,O
56,O
%,O
vs.,O
22,O
%,O
",",O
p<0.001,O
),O
",",O
and,O
vascular,O
thickening,O
(,O
59,O
%,O
vs.,O
22,O
%,O
",",O
p<0.001,O
),O
",",O
but,O
less,O
"
",O
likely,O
to,O
have,O
a,O
central+peripheral,O
distribution,O
(,O
0.14,O
vs.,O
35,O
%,O
",",O
p<0.001,O
),O
",",O
pleural,O
"
",O
effusion,O
(,O
4.1,O
vs.,O
39,O
%,O
",",O
p<0.001,O
),O
and,O
lymphadenopathy,O
(,O
2.7,O
%,O
vs.,O
10.2,O
%,O
",",O
p<0.001,O
),O
.,O
"
",O
Conclusion,O
Radiologists,O
in,O
China,O
and,O
the,O
United,O
States,O
distinguished,O
COVID19,B-Disease_COVID-19
"
",O
from,O
viral,O
pneumonia,O
on,O
chest,O
CT,O
with,O
high,O
specificity,O
but,O
moderate,O
sensitivity,O
.,O
"
",O
A,O
translation,O
of,O
this,O
abstract,O
in,O
Farsi,O
is,O
available,O
in,O
the,O
supplement,O
.,O
 ,O
ØªØ±Ø¬Ù…Ù‡,O
"
",O
Ú†Ú©ÛŒØ¯Ù‡,O
Ø§ÛŒÙ†,O
Ù…Ù‚Ø§Ù„Ù‡,O
Ø¨Ù‡,O
ÙØ§Ø±Ø³ÛŒ,O
ØŒ,O
Ø¯Ø±,O
Ø¶Ù…ÛŒÙ…Ù‡,O
Ù…ÙˆØ¬ÙˆØ¯,O
Ø§Ø³Øª,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200823,O
"
",O
PMID,O
:,O
32155105,O
"


",O
164,O
.,O
J,O
Am,O
Geriatr,O
Soc,O
.,O
2020,O
Mar,O
10,O
.,O
doi,O
:,O
10.1111,O
jgs.16426,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
Presents,O
High,O
Risk,O
to,O
Older,O
Persons,O
.,O
"

",O
Applegate,O
WB(1,O
),O
",",O
Ouslander,O
JG(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Sticht,O
Center,O
on,O
Aging,O
",",O
Wake,O
Forest,O
Baptist,O
Medical,O
Center,O
",",O
WinstonSalem,O
",",O
"
",O
North,O
Carolina,O
.,O
"
",O
(2)Charles,O
E.,O
Schmidt,O
College,O
of,O
Medicine,O
",",O
Florida,O
Atlantic,O
University,O
",",O
Boca,O
"
",O
Raton,O
",",O
Florida,O
.,O
"

",O
DOI,O
:,O
10.1111,O
jgs.16426,O
"
",O
PMID,O
:,O
32154911,O
"


",O
165,O
.,O
Clin,O
Chem,O
.,O
2020,O
Mar,O
10,O
.,O
pii,O
:,O
hvaa080,O
.,O
doi,O
:,O
10.1093,O
clinchem,O
hvaa080,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
The,O
SARSCoV2,B-Virus_SARS-CoV-2
Outbreak,O
:,O
Diagnosis,O
",",O
Infection,O
Prevention,O
",",O
and,O
Public,O
Perception,O
.,O
"

",O
Wang,O
P(1,O
),O
",",O
Anderson,O
N(2,O
),O
",",O
Pan,O
Y(3,O
),O
",",O
Poon,O
L(4,O
),O
",",O
Charlton,O
C(5,O
),O
",",O
Zelyas,O
N(6,O
),O
",",O
"
",O
Persing,O
D(7,O
),O
",",O
Rhoads,O
D(8,O
),O
",",O
Babcock,O
H(9,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)University,O
of,O
Pennsylvania,O
Heath,O
System,O
",",O
and,O
the,O
Department,O
of,O
Pathology,O
and,O
"
",O
Laboratory,O
Medicine,O
",",O
Perelman,O
School,O
of,O
Medicine,O
",",O
University,O
of,O
Pennsylvania,O
",",O
"
",O
Philadelphia,O
",",O
PA,O
.,O
"
",O
(2)Department,O
of,O
Pathology,O
and,O
Immunology,O
",",O
Washington,O
University,O
School,O
of,O
"
",O
Medicine,O
",",O
St.,O
Louis,O
",",O
MO,O
.,O
"
",O
(3)Associate,O
Research,O
Professor,O
",",O
Institute,O
for,O
Infectious,O
Disease,O
and,O
Endemic,O
"
",O
Disease,O
Control,O
",",O
Beijing,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
.,O
Beijing,O
",",O
"
",O
China,O
.,O
"
",O
(4)Professor,O
",",O
School,O
of,O
Public,O
Health,O
",",O
The,O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
.,O
"
",O
(5)Clinical,O
Microbiologist,O
",",O
Public,O
Health,O
Laboratory,O
(,O
ProvLab,O
),O
",",O
University,O
of,O
"
",O
Alberta,O
Hospital,O
",",O
Edmonton,O
",",O
AB,O
.,O
"
",O
(6)Medical,O
Microbiologist,O
",",O
Provincial,O
Laboratory,O
for,O
Public,O
Health,O
(,O
ProvLab,O
),O
.,O
"
",O
Program,O
Director,O
",",O
Medical,O
Microbiology,O
Residency,O
Program,O
",",O
University,O
of,O
Alberta,O
",",O
"
",O
Edmonton,O
",",O
AB,O
.,O
"
",O
(7)Executive,O
Vice,O
President,O
and,O
Chief,O
Medical,O
and,O
Technology,O
Officer,O
",",O
Cepheid,O
",",O
"
",O
Sunnyvale,O
",",O
CA,O
.,O
"
",O
(8)Director,O
of,O
Microbiology,O
",",O
University,O
Hospitals,O
Cleveland,O
Medical,O
Center,O
",",O
"
",O
Cleveland,O
",",O
OH,O
.,O
"
",O
(9)Professor,O
of,O
Medicine,O
",",O
Infectious,O
Diseases,O
",",O
Medical,O
Director,O
",",O
BJC,O
Infection,O
"
",O
Prevention,O
and,O
Epidemiology,O
Consortium,O
",",O
Washington,O
University,O
School,O
of,O
Medicine,O
",",O
"
",O
Saint,O
Louis,O
",",O
MO,O
.,O
"

",O
DOI,O
:,O
10.1093,O
clinchem,O
hvaa080,O
"
",O
PMID,O
:,O
32154877,O
"


",O
166,O
.,O
EClinicalMedicine,O
.,O
2020,O
Mar,O
3;20:100289,O
.,O
doi,O
:,O
10.1016,O
j.eclinm.2020.100289,O
.,O
"
",O
eCollection,O
2020,O
Mar.,O
"

",O
The,O
coronavirus,O
2019nCoV,B-Virus_SARS-CoV-2
epidemic,O
:,O
Is,O
hindsight,O
20,O
20,O
?,O
"

",O
Malta,O
M(1)(2)(3,O
),O
",",O
Rimoin,O
AW(4,O
),O
",",O
Strathdee,O
SA(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Psychiatry,O
",",O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Toronto,O
",",O
Toronto,O
",",O
"
",O
ON,O
",",O
Canada,O
.,O
"
",O
(2)Institute,O
for,O
Mental,O
Health,O
Policy,O
Research,O
",",O
Centre,O
for,O
Addiction,O
and,O
Mental,O
"
",O
Health,O
",",O
Toronto,O
",",O
ON,O
",",O
Canada,O
.,O
"
",O
(3)Department,O
of,O
Social,O
Science,O
",",O
National,O
School,O
of,O
Public,O
Health,O
",",O
Oswaldo,O
Cruz,O
"
",O
Foundation,O
(,O
DCSENSP,O
FIOCRUZ,O
),O
",",O
Rio,O
de,O
Janeiro,O
",",O
Brazil,O
.,O
"
",O
(4)Department,O
of,O
Epidemiology,O
",",O
Jonathan,O
and,O
Karin,O
Fielding,O
School,O
of,O
Public,O
"
",O
Health,O
",",O
University,O
of,O
California,O
",",O
Los,O
Angeles,O
",",O
USA,O
.,O
"
",O
(5)Department,O
of,O
Medicine,O
",",O
University,O
of,O
California,O
San,O
Diego,O
School,O
of,O
Medicine,O
",",O
"
",O
La,O
Jolla,O
",",O
CA,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.eclinm.2020.100289,O
"
",O
PMCID,O
:,O
PMC7057189,O
"
",O
PMID,O
:,O
32154505,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
None,O
.,O
"


",O
167,O
.,O
Ann,O
Transl,O
Med,O
.,O
2020,O
Feb;8(3):47,O
.,O
doi,O
:,O
10.21037,O
atm.2020.02.20,O
.,O
"

",O
Chinese,O
expert,O
consensus,O
on,O
the,O
perinatal,O
and,O
neonatal,O
management,O
for,O
the,O
"
",O
prevention,O
and,O
control,O
of,O
the,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
(,O
First,O
edition,O
),O
.,O
"

",O
Wang,O
L(1,O
),O
",",O
Shi,O
Y(2,O
),O
",",O
Xiao,O
T(1)(3,O
),O
",",O
Fu,O
J(4,O
),O
",",O
Feng,O
X(5,O
),O
",",O
Mu,O
D(6,O
),O
",",O
Feng,O
Q(7,O
),O
",",O
Hei,O
"
",O
M(8,O
),O
",",O
Hu,O
X(1,O
),O
",",O
Li,O
Z(9,O
),O
",",O
Lu,O
G(1,O
),O
",",O
Tang,O
Z(7,O
),O
",",O
Wang,O
Y(8,O
),O
",",O
Wang,O
C(1,O
),O
",",O
Xia,O
S(10,O
),O
",",O
Xu,O
"
",O
J(11,O
),O
",",O
Yang,O
Y(12,O
),O
",",O
Yang,O
J(13,O
),O
",",O
Zeng,O
M(1,O
),O
",",O
Zheng,O
J(14,O
),O
",",O
Zhou,O
W(15,O
),O
",",O
Zhou,O
X(16,O
),O
",",O
"
",O
Zhou,O
X(16,O
),O
",",O
Du,O
L(17,O
),O
",",O
Lee,O
SK(18)(19,O
),O
",",O
Zhou,O
W(1,O
),O
;,O
Working,O
Committee,O
on,O
Perinatal,O
"
",O
and,O
Neonatal,O
Management,O
for,O
the,O
Prevention,O
and,O
Control,O
of,O
the,O
2019,O
Novel,O
"
",O
Coronavirus,O
Infection,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pediatrics,O
",",O
Children,O
's,O
Hospital,O
of,O
Fudan,O
University,O
",",O
Shanghai,O
"
",O
201102,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Neonatology,O
",",O
Children,O
's,O
Hospital,O
of,O
Chongqing,O
Medical,O
"
",O
University,O
",",O
Chongqing,O
401122,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Neonatology,O
",",O
Chengdu,O
Women,O
's,O
and,O
Children,O
's,O
Central,O
Hospital,O
",",O
"
",O
School,O
of,O
Medicine,O
",",O
University,O
of,O
Electronic,O
Science,O
and,O
Technology,O
of,O
China,O
",",O
"
",O
Chengdu,O
611731,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Neonatology,O
",",O
Shengjing,O
Hospital,O
",",O
China,O
Medical,O
University,O
",",O
"
",O
Shenyang,O
110004,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Neonatology,O
",",O
Children,O
's,O
Hospital,O
of,O
Soochow,O
University,O
",",O
Suzhou,O
"
",O
215025,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Pediatrics,O
",",O
West,O
China,O
Second,O
University,O
Hospital,O
",",O
Sichuan,O
"
",O
University,O
",",O
Chengdu,O
610041,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Pediatrics,O
",",O
Peking,O
University,O
First,O
Hospital,O
",",O
Beijing,O
100034,O
",",O
"
",O
China,O
.,O
"
",O
(8)Neonatal,O
Center,O
",",O
Beijing,O
Children,O
's,O
Hospital,O
",",O
Capital,O
Medical,O
University,O
",",O
"
",O
Beijing,O
100045,O
",",O
China,O
.,O
"
",O
(9)Department,O
of,O
Neonatology,O
",",O
Northwest,O
Women,O
and,O
Children,O
's,O
Hospital,O
",",O
Xi'an,O
"
",O
610113,O
",",O
China,O
.,O
"
",O
(10)Department,O
of,O
Neonatology,O
",",O
Hubei,O
Maternal,O
and,O
Child,O
Health,O
Hospital,O
",",O
Wuhan,O
"
",O
430070,O
",",O
China,O
.,O
"
",O
(11)Shanghai,O
Public,O
Health,O
Clinical,O
Center,O
&,O
Institutes,O
of,O
Biomedical,O
Sciences,O
",",O
"
",O
Fudan,O
University,O
",",O
Shanghai,O
200000,O
",",O
China,O
.,O
"
",O
(12)Department,O
of,O
Pediatrics,O
",",O
Xiangya,O
Hospital,O
",",O
Central,O
South,O
University,O
",",O
"
",O
Changsha,O
410008,O
",",O
China,O
.,O
"
",O
(13)Department,O
of,O
Neonatology,O
",",O
Guangdong,O
Maternal,O
and,O
Children,O
's,O
Hospital,O
",",O
"
",O
Guangzhou,O
Medical,O
College,O
",",O
Guangzhou,O
511400,O
",",O
China,O
.,O
"
",O
(14)Department,O
of,O
Neonatology,O
",",O
Tianjin,O
Central,O
Hospital,O
of,O
Gynecology,O
Obstetrics,O
",",O
"
",O
Tianjin,O
300052,O
",",O
China,O
.,O
"
",O
(15)Department,O
of,O
Neonatology,O
",",O
Guangzhou,O
Women,O
and,O
Children,O
's,O
Medical,O
Center,O
",",O
"
",O
Guangzhou,O
Medical,O
University,O
Guangzhou,O
510623,O
",",O
China,O
.,O
"
",O
(16)Neonatal,O
Medical,O
Center,O
",",O
Children,O
's,O
Hospital,O
of,O
Nanjing,O
Medical,O
University,O
",",O
"
",O
Nanjing,O
210008,O
",",O
China,O
.,O
"
",O
(17)Department,O
of,O
Neonatology,O
",",O
the,O
Children,O
's,O
Hospital,O
",",O
Zhejiang,O
University,O
"
",O
School,O
of,O
Medicine,O
",",O
Hangzhou,O
310052,O
",",O
China,O
.,O
"
",O
(18)MaternalInfant,O
Care,O
Research,O
Centre,O
and,O
Department,O
of,O
Pediatrics,O
",",O
Mount,O
"
",O
Sinai,O
Hospital,O
",",O
Toronto,O
",",O
Ontario,O
",",O
Canada,O
.,O
"
",O
(19)Department,O
of,O
Pediatrics,O
",",O
Department,O
of,O
Obstetrics,O
and,O
Gynecology,O
and,O
Dalla,O
"
",O
Lana,O
School,O
of,O
Public,O
Health,O
",",O
University,O
of,O
Toronto,O
",",O
Toronto,O
",",O
Ontario,O
",",O
Canada,O
.,O
"

",O
Since,O
December,O
2019,O
",",O
there,O
has,O
been,O
an,O
outbreak,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
"
",O
infection,O
in,O
China,O
.,O
Two,O
cases,O
of,O
neonates,O
with,O
positive,O
2019nCoV,B-Virus_SARS-CoV-2
tests,O
have,O
been,O
"
",O
reported,O
.,O
Due,O
to,O
the,O
immature,O
immune,O
system,O
and,O
the,O
possibility,O
of,O
vertical,O
"
",O
transmission,O
from,O
mother,O
to,O
infant,O
",",O
neonates,O
have,O
become,O
a,O
highrisk,O
group,O
"
",O
susceptible,O
to,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
which,O
emphasize,O
a,O
close,O
cooperation,O
from,O
both,O
perinatal,O
"
",O
and,O
neonatal,O
pediatrics,O
.,O
In,O
neonatal,O
intensive,O
care,O
unit,O
(,O
NICU,O
),O
",",O
to,O
prevent,O
and,O
"
",O
control,O
infection,O
",",O
there,O
should,O
be,O
practical,O
measures,O
to,O
ensure,O
the,O
optimal,O
"
",O
management,O
of,O
children,O
potentially,O
to,O
be,O
infected,O
.,O
According,O
to,O
the,O
latest,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
national,O
management,O
plan,O
and,O
the,O
actual,O
situation,O
",",O
the,O
Chinese,O
Neonatal,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
expert,O
working,O
Group,O
has,O
put,O
forward,O
measures,O
on,O
the,O
prevention,O
and,O
"
",O
control,O
of,O
neonatal,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"

",O
2020,O
Annals,O
of,O
Translational,O
Medicine,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.21037,O
atm.2020.02.20,O
"
",O
PMCID,O
:,O
PMC7036629,O
"
",O
PMID,O
:,O
32154287,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflicts,O
of,O
Interest,O
:,O
The,O
authors,O
have,O
no,O
"
",O
conflicts,O
of,O
interest,O
to,O
declare,O
.,O
"


",O
168,O
.,O
Transl,O
Pediatr,O
.,O
2020,O
Feb;9(1):5160,O
.,O
doi,O
:,O
10.21037,O
tp.2020.02.06,O
.,O
"

",O
Clinical,O
analysis,O
of,O
10,O
neonates,O
born,O
to,O
mothers,O
with,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
.,O
"

",O
Zhu,O
H(1,O
),O
",",O
Wang,O
L(2,O
),O
",",O
Fang,O
C(3,O
),O
",",O
Peng,O
S(1,O
),O
",",O
Zhang,O
L(4,O
),O
",",O
Chang,O
G(5,O
),O
",",O
Xia,O
S(1,O
),O
",",O
Zhou,O
"
",O
W(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Neonatology,O
",",O
Maternal,O
and,O
Child,O
Health,O
Hospital,O
of,O
Hubei,O
"
",O
Province,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Neonatology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
430022,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Neonatology,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
430060,O
",",O
"
",O
China,O
.,O
"
",O
(4)Department,O
of,O
Neonatology,O
",",O
Tianmen,O
First,O
People,O
's,O
Hospital,O
",",O
Tianmen,O
431700,O
",",O
"
",O
China,O
.,O
"
",O
(5)Department,O
of,O
Pediatrics,O
",",O
Jingzhou,O
Municipal,O
Maternal,O
and,O
Child,O
Health,O
"
",O
Hospital,O
",",O
Jingzhou,O
434020,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Neonatology,O
",",O
Pediatric,O
Hospital,O
Affiliated,O
to,O
Fudan,O
University,O
",",O
"
",O
Shanghai,O
200032,O
",",O
China,O
.,O
"

",O
Background,O
:,O
The,O
newly,O
identified,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
which,O
appears,O
to,O
have,O
originated,O
in,O
"
",O
Wuhan,O
",",O
the,O
capital,O
city,O
of,O
Hubei,O
province,O
in,O
central,O
China,O
",",O
is,O
spreading,O
rapidly,O
"
",O
nationwide,O
.,O
A,O
number,O
of,O
cases,O
of,O
neonates,O
born,O
to,O
mothers,O
with,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
pneumonia,O
have,O
been,O
recorded,O
.,O
However,O
",",O
the,O
clinical,O
features,O
of,O
these,O
cases,O
have,O
"
",O
not,O
been,O
reported,O
",",O
and,O
there,O
is,O
no,O
sufficient,O
evidence,O
for,O
the,O
proper,O
prevention,O
"
",O
and,O
control,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
infections,O
in,O
neonates,O
.,O
"
",O
Methods,O
:,O
The,O
clinical,O
features,O
and,O
outcomes,O
of,O
10,O
neonates,O
(,O
including,O
2,O
twins,O
),O
"
",O
born,O
to,O
9,O
mothers,O
with,O
confirmed,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
in,O
5,O
hospitals,O
from,O
January,O
"
",O
20,O
to,O
February,O
5,O
",",O
2020,O
were,O
retrospectively,O
analyzed,O
.,O
"
",O
Results,O
:,O
Among,O
these,O
9,O
pregnant,O
women,O
with,O
confirmed,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
",",O
onset,O
"
",O
of,O
clinical,O
symptoms,O
occurred,O
before,O
delivery,O
in,O
4,O
cases,O
",",O
on,O
the,O
day,O
of,O
delivery,O
"
",O
in,O
2,O
cases,O
",",O
and,O
after,O
delivery,O
in,O
3,O
cases,O
.,O
In,O
most,O
cases,O
",",O
fever,O
and,O
a,O
cough,O
were,O
"
",O
the,O
first,O
symptoms,O
experienced,O
",",O
and,O
1,O
patient,O
also,O
had,O
diarrhea,O
.,O
Of,O
the,O
newborns,O
"
",O
born,O
to,O
these,O
mothers,O
",",O
8,O
were,O
male,O
and,O
2,O
were,O
female,O
;,O
4,O
were,O
fullterm,O
infants,O
"
",O
and,O
6,O
were,O
born,O
premature,O
;,O
2,O
were,O
smallforgestationalage,O
(,O
SGA,O
),O
infants,O
and,O
1,O
"
",O
was,O
a,O
largeforgestationalage,O
(,O
LGA,O
),O
infant,O
;,O
there,O
were,O
8,O
singletons,O
and,O
2,O
"
",O
twins,O
.,O
Of,O
the,O
neonates,O
",",O
6,O
had,O
a,O
Pediatric,O
Critical,O
Illness,O
Score,O
(,O
PCIS,O
),O
score,O
of,O
"
",O
less,O
than,O
90,O
.,O
Clinically,O
",",O
the,O
first,O
symptom,O
in,O
the,O
neonates,O
was,O
shortness,O
of,O
"
",O
breath,O
(,O
n=6,O
),O
",",O
but,O
other,O
initial,O
symptoms,O
such,O
as,O
fever,O
(,O
n=2,O
),O
",",O
thrombocytopenia,O
"
",O
accompanied,O
by,O
abnormal,O
liver,O
function,O
(,O
n=2,O
),O
",",O
rapid,O
heart,O
rate,O
(,O
n=1,O
),O
",",O
vomiting,O
"
",O
(,O
n=1,O
),O
",",O
and,O
pneumothorax,O
(,O
n=1,O
),O
were,O
observed,O
.,O
Up,O
to,O
now,O
",",O
5,O
neonates,O
have,O
been,O
"
",O
cured,O
and,O
discharged,O
",",O
1,O
has,O
died,O
",",O
and,O
4,O
neonates,O
remain,O
in,O
hospital,O
in,O
a,O
stable,O
"
",O
condition,O
.,O
Pharyngeal,O
swab,O
specimens,O
were,O
collected,O
from,O
9,O
of,O
the,O
10,O
neonates,O
1,O
"
",O
to,O
9,O
days,O
after,O
birth,O
for,O
nucleic,O
acid,O
amplification,O
tests,O
for,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
all,O
of,O
"
",O
which,O
showed,O
negative,O
results,O
.,O
"
",O
Conclusions,O
:,O
Perinatal,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
may,O
have,O
adverse,O
effects,O
on,O
newborns,O
",",O
"
",O
causing,O
problems,O
such,O
as,O
fetal,O
distress,O
",",O
premature,O
labor,O
",",O
respiratory,O
distress,O
",",O
"
",O
thrombocytopenia,O
accompanied,O
by,O
abnormal,O
liver,O
function,O
",",O
and,O
even,O
death,O
.,O
However,O
",",O
"
",O
vertical,O
transmission,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
yet,O
to,O
be,O
confirmed,O
.,O
"

",O
2020,O
Translational,O
Pediatrics,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.21037,O
tp.2020.02.06,O
"
",O
PMCID,O
:,O
PMC7036645,O
"
",O
PMID,O
:,O
32154135,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflicts,O
of,O
Interest,O
:,O
The,O
authors,O
have,O
no,O
"
",O
conflicts,O
of,O
interest,O
to,O
declare,O
.,O
"


",O
169,O
.,O
Pediatr,O
Rep.,O
2020,O
Feb,O
11;12(1):8495,O
.,O
doi,O
:,O
10.4081,O
pr.2020.8495,O
.,O
eCollection,O
2020,O
"
",O
Feb,O
11,O
.,O
"

",O
2019nCoV,B-Virus_SARS-CoV-2
:,O
Polite,O
with,O
children,O
!,O
"

",O
Caselli,O
D(1,O
),O
",",O
AricÃ²,O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Giovanni,O
XXIII,O
Children,O
Hospital,O
",",O
Azienda,O
OspedalieroUniversitaria,O
"
",O
Consorziale,O
Policlinico,O
",",O
Bari,O
",",O
Italy,O
.,O
"

",O
DOI,O
:,O
10.4081,O
pr.2020.8495,O
"
",O
PMCID,O
:,O
PMC7036705,O
"
",O
PMID,O
:,O
32153742,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflict,O
of,O
interest,O
:,O
none,O
.,O
"


",O
170,O
.,O
Infect,O
Chemother,O
.,O
2020,O
Mar,O
10,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
",",O
A,O
Clinical,O
Syndrome,O
Manifesting,O
as,O
Hypersensitivity,O
Pneumonitis,O
.,O
"

",O
Song,O
YG(1,O
),O
",",O
Shin,O
HS(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
Gangnam,O
"
",O
Severance,O
Hospital,O
",",O
Yonsei,O
University,O
College,O
of,O
Medicine,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(2)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
National,O
"
",O
Medical,O
Center,O
",",O
Seoul,O
",",O
Korea,O
.,O
hyoungsshin@gmail.com,O
.,O
"


",O
PMID,O
:,O
32153144,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
YG,O
Song,O
is,O
an,O
editorial,O
board,O
of,O
the,O
journal,O
"
",O
Infect,O
Chemother,O
.,O
However,O
",",O
he,O
did,O
not,O
involve,O
in,O
the,O
reviewer,O
selection,O
",",O
"
",O
evaluation,O
",",O
and,O
decision,O
making,O
of,O
this,O
article,O
.,O
Otherwise,O
",",O
no,O
conflicts,O
of,O
"
",O
interest,O
were,O
reported,O
.,O
"


",O
171,O
.,O
Public,O
Health,O
Res,O
Pract,O
.,O
2020,O
Mar,O
10;30(1,O
),O
.,O
pii,O
:,O
3012000,O
.,O
doi,O
:,O
"
",O
10.17061,O
phrp3012000,O
.,O
"

",O
On,O
a,O
knife,O
's,O
edge,O
of,O
a,O
COVID19,B-Disease_COVID-19
pandemic,O
:,O
is,O
containment,O
still,O
possible,O
?,O
"

",O
MacIntyre,O
CR(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Biosecurity,O
Research,O
Program,O
",",O
Kirby,O
Institute,O
",",O
Faculty,O
of,O
Medicine,O
",",O
UNSW,O
"
",O
Sydney,O
",",O
Australia,O
;,O
r.macintyre@unsw.edu.au,O
.,O
"

",O
DOI,O
:,O
10.17061,O
phrp3012000,O
"
",O
PMID,O
:,O
32152612,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
Kirby,O
Institute,O
has,O
received,O
an,O
"
",O
investigatordriven,O
grant,O
from,O
Sanofi,O
for,O
work,O
in,O
influenza,O
.,O
This,O
is,O
not,O
related,O
"
",O
to,O
COVID19,B-Disease_COVID-19
",",O
however,O
Sanofi,O
is,O
developing,O
a,O
COVID19,B-Disease_COVID-19
vaccine,O
.,O
"


",O
172,O
.,O
Sci,O
Rep.,O
2020,O
Mar,O
9;10(1):4311,O
.,O
doi,O
:,O
10.1038,O
s41598020607004,O
.,O
"

",O
Effects,O
of,O
parental,O
smoking,O
and,O
indoor,O
tobacco,O
smoke,O
exposure,O
on,O
respiratory,O
"
",O
outcomes,O
in,O
children,O
.,O
"

",O
Zhuge,O
Y(1,O
),O
",",O
Qian,O
H(2,O
),O
",",O
Zheng,O
X(1,O
),O
",",O
Huang,O
C(3,O
),O
",",O
Zhang,O
Y(4,O
),O
",",O
Li,O
B(5,O
),O
",",O
Zhao,O
Z(6,O
),O
",",O
"
",O
Deng,O
Q(7,O
),O
",",O
Yang,O
X(8,O
),O
",",O
Sun,O
Y(9,O
),O
",",O
Zhang,O
X(10,O
),O
",",O
Sundell,O
J(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Energy,O
and,O
Environment,O
",",O
Southeast,O
University,O
",",O
Nanjing,O
",",O
China,O
.,O
"
",O
(2)School,O
of,O
Energy,O
and,O
Environment,O
",",O
Southeast,O
University,O
",",O
Nanjing,O
",",O
China,O
.,O
"
",O
qianh@seu.edu.cn,O
.,O
"
",O
(3)School,O
of,O
Environment,O
and,O
Architecture,O
",",O
University,O
of,O
Shanghai,O
for,O
Science,O
and,O
"
",O
Technology,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(4)Beijing,O
Key,O
Lab,O
of,O
Indoor,O
Air,O
Quality,O
Evaluation,O
and,O
Control,O
",",O
Tsinghua,O
"
",O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)Key,O
Laboratory,O
of,O
Three,O
Gorges,O
Reservoir,O
Region,O
's,O
EcoEnvironment,O
",",O
Chongqing,O
"
",O
University,O
",",O
Chongqing,O
",",O
China,O
.,O
"
",O
(6)School,O
of,O
Public,O
Health,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(7)School,O
of,O
Energy,O
Science,O
and,O
Engineering,O
",",O
Central,O
South,O
University,O
",",O
Changsha,O
",",O
"
",O
Hunan,O
",",O
China,O
.,O
"
",O
(8)College,O
of,O
Life,O
Science,O
",",O
Central,O
China,O
Normal,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(9)School,O
of,O
Environmental,O
Science,O
and,O
Engineering,O
",",O
Tianjin,O
University,O
",",O
Tianjin,O
",",O
"
",O
China,O
.,O
"
",O
(10)Institute,O
of,O
Environmental,O
Science,O
",",O
Shanxi,O
University,O
",",O
Taiyuan,O
",",O
China,O
.,O
"

",O
The,O
extensive,O
literature,O
has,O
reported,O
adverse,O
effects,O
on,O
environmental,O
tobacco,O
"
",O
smoke,O
(,O
ETS,O
),O
on,O
children,O
's,O
health,O
.,O
We,O
aim,O
to,O
analyze,O
associations,O
of,O
ETS,O
with,O
dry,O
"
",O
night,O
cough,O
",",O
croup,O
",",O
pneumonia,O
",",O
and,O
frequent,O
common,O
cold,O
and,O
to,O
disentangle,O
the,O
"
",O
effects,O
of,O
prenatal,O
",",O
infancy,O
and,O
childhood,O
exposure,O
by,O
multilevel,O
logistic,O
"
",O
regression,O
.,O
A,O
crosssectional,O
study,O
was,O
conducted,O
among,O
41176,O
children,O
aged,O
38,O
"
",O
years,O
in,O
8,O
major,O
cities,O
of,O
China,O
during,O
20102011,O
",",O
and,O
obtained,O
demographic,O
"
",O
information,O
",",O
smoke,O
exposure,O
information,O
",",O
and,O
respiratory,O
outcomes,O
.,O
Parents,O
',O
"
",O
smoking,O
habit,O
and,O
indoor,O
tobacco,O
smoke,O
odor,O
were,O
considered,O
as,O
two,O
indicators,O
of,O
"
",O
ETS,O
.,O
The,O
prevalences,O
of,O
respiratory,O
outcomes,O
were,O
6,O
%,O
for,O
croup,O
",",O
9.5,O
%,O
for,O
"
",O
frequency,O
common,O
cold,O
",",O
17.1,O
%,O
for,O
dry,O
night,O
cough,O
and,O
32.3,O
%,O
for,O
pneumonia,O
"
",O
respectively,O
in,O
the,O
study,O
.,O
The,O
associations,O
between,O
respiratory,O
outcomes,O
and,O
"
",O
parental,O
smoking,O
were,O
not,O
obvious,O
",",O
while,O
indoor,O
tobacco,O
smoke,O
odor,O
was,O
clearly,O
"
",O
and,O
strongly,O
associated,O
with,O
most,O
respiratory,O
outcomes,O
",",O
with,O
adjusted,O
odds,O
ratios,O
"
",O
ranging,O
from,O
1.06,O
to,O
1.95,O
.,O
Both,O
infancy,O
and,O
childhood,O
exposure,O
to,O
tobacco,O
smoke,O
"
",O
odor,O
were,O
independent,O
risk,O
factors,O
",",O
but,O
infancy,O
exposure,O
had,O
a,O
higher,O
risk,O
.,O
The,O
"
",O
results,O
explore,O
that,O
ETS,O
increased,O
the,O
risk,O
of,O
respiratory,O
outcomes,O
in,O
children,O
",",O
"
",O
highlighting,O
the,O
need,O
for,O
raising,O
awareness,O
about,O
the,O
detrimental,O
effects,O
of,O
"
",O
tobacco,O
smoke,O
exposure,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s41598020607004,O
"
",O
PMID,O
:,O
32152374,O
"


",O
173,O
.,O
Antimicrob,O
Agents,O
Chemother,O
.,O
2020,O
Mar,O
9,O
.,O
pii,O
:,O
AAC.0039920,O
.,O
doi,O
:,O
"
",O
10.1128,O
AAC.0039920,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Compounds,O
with,O
therapeutic,O
potential,O
against,O
novel,O
respiratory,O
2019,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
.,O
"

",O
Martinez,O
MA(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)IrsiCaixa,O
",",O
Hospital,O
Universitari,O
Germans,O
Trias,O
i,O
Pujol,O
",",O
Universitat,O
AutÃ²noma,O
"
",O
de,O
Barcelona,O
(,O
UAB,O
),O
",",O
Badalona,O
",",O
Spain,O
mmartinez@irsicaixa.es,O
.,O
"

",O
Currently,O
",",O
the,O
expansion,O
of,O
the,O
novel,O
human,O
respiratory,O
coronavirus,O
(,O
known,O
as,O
:,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
COVID2019,O
",",O
or,O
2019nCoV,B-Virus_SARS-CoV-2
),O
has,O
stressed,O
the,O
need,O
for,O
therapeutic,O
"
",O
alternatives,O
to,O
alleviate,O
and,O
stop,O
this,O
new,O
epidemic,O
.,O
The,O
previous,O
epidemics,O
of,O
"
",O
highmorbidity,O
human,O
coronaviruses,O
",",O
such,O
as,O
the,O
acute,O
respiratory,O
syndrome,O
"
",O
coronavirus,O
(,O
SARSCoV,O
),O
in,O
2003,O
",",O
and,O
the,O
Middle,O
East,O
respiratory,O
syndrome,O
corona,O
"
",O
virus,O
(,O
MERSCoV,O
),O
in,O
2012,O
",",O
prompted,O
the,O
characterization,O
of,O
compounds,O
that,O
could,O
"
",O
be,O
potentially,O
active,O
against,O
the,O
currently,O
emerging,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
The,O
most,O
promising,O
compound,O
is,O
remdesivir,O
(,O
GS5734,O
),O
",",O
a,O
nucleotide,O
"
",O
analog,O
prodrug,O
currently,O
in,O
clinical,O
trials,O
for,O
treating,O
Ebola,O
virus,O
infections,O
.,O
"
",O
Remdesivir,O
inhibited,O
the,O
replication,O
of,O
SARSCoV,O
and,O
MERSCoV,O
in,O
tissue,O
cultures,O
",",O
"
",O
and,O
it,O
displayed,O
efficacy,O
in,O
nonhuman,O
animal,O
models,O
.,O
In,O
addition,O
",",O
a,O
combination,O
"
",O
of,O
the,O
human,O
immunodeficiency,O
virus,O
type,O
1,O
(,O
HIV1,O
),O
protease,O
inhibitors,O
",",O
"
",O
lopinavir,O
ritonavir,O
",",O
and,O
interferon,O
beta,O
(,O
LPV,O
RTVINFb,O
),O
were,O
shown,O
to,O
be,O
"
",O
effective,O
in,O
patients,O
infected,O
with,O
SARSCoV.,O
LPV,O
RTVINFb,O
also,O
improved,O
clinical,O
"
",O
parameters,O
in,O
marmosets,O
and,O
mice,O
infected,O
with,O
MERSCoV.,O
Remarkably,O
",",O
the,O
"
",O
therapeutic,O
efficacy,O
of,O
remdesivir,O
appeared,O
to,O
be,O
superior,O
to,O
that,O
of,O
"
",O
LPV,O
RTVINFb,O
against,O
MERSCoV,O
in,O
a,O
transgenic,O
humanized,O
mice,O
model,O
.,O
The,O
"
",O
relatively,O
high,O
mortality,O
rates,O
associated,O
with,O
these,O
three,O
novel,O
human,O
"
",O
coronavirus,O
infections,O
",",O
SARSCoV,O
",",O
MERSCoV,O
",",O
and,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
has,O
suggested,O
that,O
"
",O
proinflammatory,O
responses,O
might,O
play,O
a,O
role,O
in,O
the,O
pathogenesis,O
.,O
It,O
remains,O
"
",O
unknown,O
whether,O
the,O
generated,O
inflammatory,O
state,O
should,O
be,O
targeted,O
.,O
Therapeutics,O
"
",O
that,O
target,O
the,O
coronavirus,O
alone,O
might,O
not,O
be,O
able,O
to,O
reverse,O
highly,O
pathogenic,O
"
",O
infections,O
.,O
This,O
minireview,O
aimed,O
to,O
provide,O
a,O
summary,O
of,O
therapeutic,O
compounds,O
"
",O
that,O
showed,O
potential,O
in,O
fighting,O
SARSCoV2,B-Virus_SARS-CoV-2
infections,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
American,O
Society,O
for,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1128,O
AAC.0039920,O
"
",O
PMID,O
:,O
32152082,O
"


",O
174,O
.,O
CMAJ,O
.,O
2020,O
Mar,O
9;192(10):E264E265,O
.,O
doi,O
:,O
10.1503,O
cmaj.1095852,O
.,O
"

",O
Proposed,O
protocol,O
to,O
keep,O
COVID19,B-Disease_COVID-19
out,O
of,O
hospitals,O
.,O
"

",O
Glauser,O
W(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Toronto,O
",",O
Ont,O
.,O
"

",O
DOI,O
:,O
10.1503,O
cmaj.1095852,O
"
",O
PMID,O
:,O
32152059,O
"


",O
175,O
.,O
BMJ,O
.,O
2020,O
Mar,O
9;368:m959,O
.,O
doi,O
:,O
10.1136,O
bmj.m959,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
outofhours,O
providers,O
are,O
drafted,O
in,O
to,O
manage,O
nonurgent,O
patients,O
in,O
"
",O
community,O
.,O
"

",O
Mahase,O
E(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m959,O
"
",O
PMID,O
:,O
32152010,O
"


",O
176,O
.,O
BMJ,O
.,O
2020,O
Mar,O
9;368:m953,O
.,O
doi,O
:,O
10.1136,O
bmj.m953,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
emergency,O
departments,O
lack,O
proper,O
isolation,O
facilities,O
",",O
senior,O
medic,O
"
",O
warns,O
.,O
"

",O
Iacobucci,O
G(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m953,O
"
",O
PMID,O
:,O
32152001,O
"


",O
177,O
.,O
Int,O
J,O
Antimicrob,O
Agents,O
.,O
2020,O
Mar,O
6:105937,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ijantimicag.2020.105937,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
VSI,O
:,O
COVID19,B-Disease_COVID-19
Therapeutic,O
.,O
"

",O
Raoult,O
D(1,O
),O
",",O
Hsueh,O
PR(2,O
),O
",",O
Stefania,O
S(3,O
),O
",",O
Rolain,O
JM(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)MEÐ¤I,O
",",O
IRD,O
",",O
Aix,O
Marseille,O
Univ,O
",",O
APHM,O
",",O
Marseille,O
",",O
France,O
;,O
IHUMÃ©diterranÃ©e,O
"
",O
Infection,O
",",O
Marseille,O
",",O
France,O
.,O
Electronic,O
address,O
:,O
didier.raoult@gmail.com,O
.,O
"
",O
(2)Department,O
of,O
Laboratory,O
Medicine,O
",",O
National,O
Taiwan,O
University,O
Hospital,O
",",O
"
",O
National,O
Taiwan,O
University,O
College,O
of,O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
;,O
Department,O
of,O
"
",O
Internal,O
Medicine,O
",",O
National,O
Taiwan,O
University,O
Hospital,O
",",O
National,O
Taiwan,O
"
",O
University,O
College,O
of,O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
.,O
"
",O
(3)University,O
of,O
Catania,O
",",O
Department,O
of,O
Biomedical,O
and,O
Biotechnological,O
Sciences,O
",",O
"
",O
Biological,O
Tower,O
",",O
Third,O
floor,O
Est,O
Tower,O
",",O
Catania,O
",",O
Italy,O
.,O
"
",O
(4)MEÐ¤I,O
",",O
IRD,O
",",O
Aix,O
Marseille,O
Univ,O
",",O
APHM,O
",",O
Marseille,O
",",O
France,O
;,O
IHUMÃ©diterranÃ©e,O
"
",O
Infection,O
",",O
Marseille,O
",",O
France,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijantimicag.2020.105937,O
"
",O
PMID,O
:,O
32151714,O
"


",O
178,O
.,O
J,O
Hosp,O
Infect,O
.,O
2020,O
Mar,O
6,O
.,O
pii,O
:,O
S01956701(20)30102X,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jhin.2020.03.003,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Duration,O
of,O
quarantine,O
in,O
hospitalized,O
patients,O
with,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
infection,O
:,O
a,O
question,O
needing,O
an,O
answer,O
.,O
"

",O
Lombardi,O
A(1,O
),O
",",O
Bozzi,O
G(2,O
),O
",",O
Mangioni,O
D(3,O
),O
",",O
Muscatello,O
A(2,O
),O
",",O
Peri,O
AM(2,O
),O
",",O
Taramasso,O
"
",O
L(3,O
),O
",",O
Ungaro,O
R(2,O
),O
",",O
Bandera,O
A(3,O
),O
",",O
Gori,O
A(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Infectious,O
Diseases,O
Unit,O
",",O
IRCCS,O
Ca,O
',O
Granda,O
Ospedale,O
Maggiore,O
Policlinico,O
"
",O
Foundation,O
",",O
Milano,O
",",O
Italy,O
.,O
Electronic,O
address,O
:,O
andrea.lombardi@policlinico.mi.it,O
.,O
"
",O
(2)Infectious,O
Diseases,O
Unit,O
",",O
IRCCS,O
Ca,O
',O
Granda,O
Ospedale,O
Maggiore,O
Policlinico,O
"
",O
Foundation,O
",",O
Milano,O
",",O
Italy,O
.,O
"
",O
(3)Infectious,O
Diseases,O
Unit,O
",",O
IRCCS,O
Ca,O
',O
Granda,O
Ospedale,O
Maggiore,O
Policlinico,O
"
",O
Foundation,O
",",O
Milano,O
",",O
Italy,O
;,O
Department,O
of,O
Pathophysiology,O
and,O
Transplantation,O
",",O
"
",O
University,O
of,O
Milano,O
",",O
Milano,O
",",O
Italy,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jhin.2020.03.003,O
"
",O
PMID,O
:,O
32151674,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflict,O
of,O
interests,O
none,O
related,O
to,O
the,O
content,O
"
",O
of,O
this,O
manuscript,O
.,O
"


",O
179,O
.,O
Pulmonology,O
.,O
2020,O
Mar,O
 ,O
Apr;26(2):114115,O
.,O
doi,O
:,O
10.1016,O
j.pulmoe.2020.02.010,O
.,O
"
",O
Epub,O
2020,O
Mar,O
6,O
.,O
"

",O
And,O
now,O
for,O
something,O
completely,O
different,O
:,O
from,O
2019nCoV,B-Virus_SARS-CoV-2
and,O
COVID19,B-Disease_COVID-19
to,O
"
",O
2020nMan,O
.,O
"

",O
Froes,O
F(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)ICU,O
",",O
Thorax,O
Department,O
",",O
Lisboa,O
",",O
Portugal,O
.,O
Electronic,O
address,O
:,O
"
",O
filipe.froes@gmail.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.pulmoe.2020.02.010,O
"
",O
PMID,O
:,O
32151613,O
"


",O
180,O
.,O
Lancet,O
.,O
2020,O
Mar,O
7;395(10226):809815,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303603,O
.,O
Epub,O
"
",O
2020,O
Feb,O
12,O
.,O
"

",O
Clinical,O
characteristics,O
and,O
intrauterine,O
vertical,O
transmission,O
potential,O
of,O
"
",O
COVID19,B-Disease_COVID-19
infection,O
in,O
nine,O
pregnant,O
women,O
:,O
a,O
retrospective,O
review,O
of,O
medical,O
"
",O
records,O
.,O
"

",O
Chen,O
H(1,O
),O
",",O
Guo,O
J(1,O
),O
",",O
Wang,O
C(2,O
),O
",",O
Luo,O
F(3,O
),O
",",O
Yu,O
X(1,O
),O
",",O
Zhang,O
W(4,O
),O
",",O
Li,O
J(1,O
),O
",",O
Zhao,O
"
",O
D(5,O
),O
",",O
Xu,O
D(1,O
),O
",",O
Gong,O
Q(1,O
),O
",",O
Liao,O
J(1,O
),O
",",O
Yang,O
H(6,O
),O
",",O
Hou,O
W(7,O
),O
",",O
Zhang,O
Y(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Gynaecology,O
and,O
Obstetrics,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
;,O
Clinical,O
Medicine,O
Research,O
Centre,O
of,O
Prenatal,O
"
",O
Diagnosis,O
and,O
Birth,O
Health,O
in,O
Hubei,O
Province,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Obstetrics,O
and,O
Gynaecology,O
",",O
Peking,O
University,O
First,O
Hospital,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Virology,O
Institute,O
of,O
Medical,O
Virology,O
",",O
School,O
of,O
"
",O
Basic,O
Medical,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Preventive,O
Medicine,O
",",O
Northwestern,O
University,O
Feinberg,O
School,O
of,O
"
",O
Medicine,O
",",O
Chicago,O
",",O
IL,O
",",O
USA,O
.,O
"
",O
(5)Department,O
of,O
Paediatrics,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
Hubei,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Obstetrics,O
and,O
Gynaecology,O
",",O
Peking,O
University,O
First,O
Hospital,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
yanghuixia@bjmu.edu.cn,O
.,O
"
",O
(7)State,O
Key,O
Laboratory,O
of,O
Virology,O
Institute,O
of,O
Medical,O
Virology,O
",",O
School,O
of,O
"
",O
Basic,O
Medical,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
houwei@whu.edu.cn,O
.,O
"
",O
(8)Department,O
of,O
Gynaecology,O
and,O
Obstetrics,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
;,O
Clinical,O
Medicine,O
Research,O
Centre,O
of,O
Prenatal,O
"
",O
Diagnosis,O
and,O
Birth,O
Health,O
in,O
Hubei,O
Province,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
zhangyuanzhen@whu.edu.cn,O
.,O
"

",O
BACKGROUND,O
:,O
Previous,O
studies,O
on,O
the,O
pneumonia,O
outbreak,O
caused,O
by,O
the,O
2019,O
novel,O
"
",O
coronavirus,O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
were,O
based,O
on,O
information,O
from,O
the,O
general,O
"
",O
population,O
.,O
Limited,O
data,O
are,O
available,O
for,O
pregnant,O
women,O
with,O
COVID19,B-Disease_COVID-19
"
",O
pneumonia,O
.,O
This,O
study,O
aimed,O
to,O
evaluate,O
the,O
clinical,O
characteristics,O
of,O
COVID19,B-Disease_COVID-19
"
",O
in,O
pregnancy,O
and,O
the,O
intrauterine,O
vertical,O
transmission,O
potential,O
of,O
COVID19,B-Disease_COVID-19
"
",O
infection,O
.,O
"
",O
METHODS,O
:,O
Clinical,O
records,O
",",O
laboratory,O
results,O
",",O
and,O
chest,O
CT,O
scans,O
were,O
"
",O
retrospectively,O
reviewed,O
for,O
nine,O
pregnant,O
women,O
with,O
laboratoryconfirmed,O
"
",O
COVID19,B-Disease_COVID-19
pneumonia,O
(,O
ie,O
",",O
with,O
maternal,O
throat,O
swab,O
samples,O
that,O
were,O
positive,O
for,O
"
",O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
[,O
SARSCoV2,B-Virus_SARS-CoV-2
],O
),O
who,O
were,O
admitted,O
"
",O
to,O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
",",O
from,O
Jan,O
20,O
to,O
Jan,O
31,O
",",O
"
",O
2020,O
.,O
Evidence,O
of,O
intrauterine,O
vertical,O
transmission,O
was,O
assessed,O
by,O
testing,O
for,O
"
",O
the,O
presence,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
amniotic,O
fluid,O
",",O
cord,O
blood,O
",",O
and,O
neonatal,O
throat,O
"
",O
swab,O
samples,O
.,O
Breastmilk,O
samples,O
were,O
also,O
collected,O
and,O
tested,O
from,O
patients,O
"
",O
after,O
the,O
first,O
lactation,O
.,O
"
",O
FINDINGS,O
:,O
All,O
nine,O
patients,O
had,O
a,O
caesarean,O
section,O
in,O
their,O
third,O
trimester,O
.,O
"
",O
Seven,O
patients,O
presented,O
with,O
a,O
fever,O
.,O
Other,O
symptoms,O
",",O
including,O
cough,O
(,O
in,O
four,O
"
",O
of,O
nine,O
patients,O
),O
",",O
myalgia,O
(,O
in,O
three,O
),O
",",O
sore,O
throat,O
(,O
in,O
two,O
),O
",",O
and,O
malaise,O
(,O
in,O
"
",O
two,O
),O
",",O
were,O
also,O
observed,O
.,O
Fetal,O
distress,O
was,O
monitored,O
in,O
two,O
cases,O
.,O
Five,O
of,O
nine,O
"
",O
patients,O
had,O
lymphopenia,O
(,O
<,O
1Â·0,O
â€‰,O
Ã—,O
â€‰,O
10â¹,O
cells,O
per,O
L,O
),O
.,O
Three,O
patients,O
had,O
increased,O
"
",O
aminotransferase,O
concentrations,O
.,O
None,O
of,O
the,O
patients,O
developed,O
severe,O
COVID19,B-Disease_COVID-19
"
",O
pneumonia,O
or,O
died,O
",",O
as,O
of,O
Feb,O
4,O
",",O
2020,O
.,O
Nine,O
livebirths,O
were,O
recorded,O
.,O
No,O
neonatal,O
"
",O
asphyxia,O
was,O
observed,O
in,O
newborn,O
babies,O
.,O
All,O
nine,O
livebirths,O
had,O
a,O
1min,O
Apgar,O
"
",O
score,O
of,O
89,O
and,O
a,O
5min,O
Apgar,O
score,O
of,O
910,O
.,O
Amniotic,O
fluid,O
",",O
cord,O
blood,O
",",O
"
",O
neonatal,O
throat,O
swab,O
",",O
and,O
breastmilk,O
samples,O
from,O
six,O
patients,O
were,O
tested,O
for,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
and,O
all,O
samples,O
tested,O
negative,O
for,O
the,O
virus,O
.,O
"
",O
INTERPRETATION,O
:,O
The,O
clinical,O
characteristics,O
of,O
COVID19,B-Disease_COVID-19
pneumonia,O
in,O
pregnant,O
"
",O
women,O
were,O
similar,O
to,O
those,O
reported,O
for,O
nonpregnant,O
adult,O
patients,O
who,O
"
",O
developed,O
COVID19,B-Disease_COVID-19
pneumonia,O
.,O
Findings,O
from,O
this,O
small,O
group,O
of,O
cases,O
suggest,O
"
",O
that,O
there,O
is,O
currently,O
no,O
evidence,O
for,O
intrauterine,O
infection,O
caused,O
by,O
vertical,O
"
",O
transmission,O
in,O
women,O
who,O
develop,O
COVID19,B-Disease_COVID-19
pneumonia,O
in,O
late,O
pregnancy,O
.,O
"
",O
FUNDING,O
:,O
Hubei,O
Science,O
and,O
Technology,O
Plan,O
",",O
Wuhan,O
University,O
Medical,O
Development,O
"
",O
Plan,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303603,O
"
",O
PMID,O
:,O
32151335,O
"


",O
181,O
.,O
Lancet,O
.,O
2020,O
Mar,O
7;395(10226):760762,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303652,O
.,O
Epub,O
"
",O
2020,O
Feb,O
12,O
.,O
"

",O
What,O
are,O
the,O
risks,O
of,O
COVID19,B-Disease_COVID-19
infection,O
in,O
pregnant,O
women,O
?,O
"

",O
Qiao,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Center,O
for,O
Reproductive,O
Medicine,O
",",O
Department,O
of,O
Obstetrics,O
and,O
Gynecology,O
",",O
"
",O
Peking,O
University,O
Third,O
Hospital,O
",",O
Beijing,O
100191,O
",",O
China,O
;,O
National,O
Clinical,O
"
",O
Research,O
Center,O
for,O
Obstetrics,O
and,O
Gynecology,O
",",O
Beijing,O
100191,O
",",O
China,O
;,O
Key,O
"
",O
Laboratory,O
of,O
Assisted,O
Reproduction,O
(,O
Peking,O
University,O
),O
",",O
Ministry,O
of,O
Education,O
",",O
"
",O
Beijing,O
100191,O
",",O
China,O
;,O
Beijing,O
Key,O
Laboratory,O
of,O
Reproductive,O
Endocrinology,O
and,O
"
",O
Assisted,O
Reproductive,O
Technology,O
",",O
Beijing,O
100191,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
jie.qiao@263.net,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303652,O
"
",O
PMID,O
:,O
32151334,O
"


",O
182,O
.,O
Lancet,O
.,O
2020,O
Mar,O
14;395(10227):848850,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)305511,O
.,O
Epub,O
"
",O
2020,O
Mar,O
6,O
.,O
"

",O
Are,O
highperforming,O
health,O
systems,O
resilient,O
against,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
?,O
"

",O
LegidoQuigley,O
H(1,O
),O
",",O
Asgari,O
N(2,O
),O
",",O
Teo,O
YY(3,O
),O
",",O
Leung,O
GM(4,O
),O
",",O
Oshitani,O
H(5,O
),O
",",O
Fukuda,O
"
",O
K(6,O
),O
",",O
Cook,O
AR(3,O
),O
",",O
Hsu,O
LY(3,O
),O
",",O
Shibuya,O
K(7,O
),O
",",O
Heymann,O
D(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Saw,O
Swee,O
Hock,O
School,O
of,O
Public,O
Health,O
",",O
National,O
University,O
of,O
Singapore,O
and,O
"
",O
National,O
University,O
Health,O
System,O
",",O
Singapore,O
.,O
Electronic,O
address,O
:,O
"
",O
ephhlq@nus.edu.sg,O
.,O
"
",O
(2)Asia,O
Pacific,O
Observatory,O
on,O
Health,O
Systems,O
and,O
Policies,O
",",O
World,O
Health,O
"
",O
Organization,O
Regional,O
Office,O
for,O
SouthEast,O
Asia,O
",",O
New,O
Delhi,O
",",O
India,O
.,O
"
",O
(3)Saw,O
Swee,O
Hock,O
School,O
of,O
Public,O
Health,O
",",O
National,O
University,O
of,O
Singapore,O
and,O
"
",O
National,O
University,O
Health,O
System,O
",",O
Singapore,O
.,O
"
",O
(4)WHO,O
Collaborating,O
Centre,O
for,O
Infectious,O
Disease,O
Epidemiology,O
and,O
Control,O
",",O
"
",O
School,O
of,O
Public,O
Health,O
",",O
LKS,O
Faculty,O
of,O
Medicine,O
",",O
The,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(5)Tohoku,O
University,O
School,O
of,O
Medicine,O
",",O
Sendai,O
",",O
Japan,O
.,O
"
",O
(6)School,O
of,O
Public,O
Health,O
",",O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(7)Institute,O
for,O
Population,O
Health,O
",",O
King,O
's,O
College,O
London,O
",",O
London,O
",",O
UK,O
.,O
"
",O
(8)London,O
School,O
of,O
Hygiene,O
&,O
Tropical,O
Medicine,O
",",O
London,O
",",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)305511,O
"
",O
PMID,O
:,O
32151326,O
"


",O
183,O
.,O
Lancet,O
.,O
2020,O
Mar,O
14;395(10227):846848,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)305262,O
.,O
Epub,O
"
",O
2020,O
Mar,O
6,O
.,O
"

",O
COVID19,B-Disease_COVID-19
:,O
the,O
gendered,O
impacts,O
of,O
the,O
outbreak,O
.,O
"

",O
Wenham,O
C(1,O
),O
",",O
Smith,O
J(2,O
),O
",",O
Morgan,O
R(3,O
),O
;,O
Gender,O
and,O
COVID19,B-Disease_COVID-19
Working,O
Group,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Health,O
Policy,O
",",O
London,O
School,O
of,O
Economics,O
and,O
Political,O
Science,O
",",O
"
",O
London,O
WC2A,O
2AE,O
",",O
UK,O
.,O
Electronic,O
address,O
:,O
c.wenham@lse.ac.uk,O
.,O
"
",O
(2)Faculty,O
of,O
Health,O
Sciences,O
",",O
Simon,O
Fraser,O
University,O
",",O
Burnaby,O
",",O
BC,O
",",O
Canada,O
.,O
"
",O
(3)Johns,O
Hopkins,O
Bloomberg,O
School,O
of,O
Public,O
Health,O
",",O
Baltimore,O
",",O
MD,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)305262,O
"
",O
PMID,O
:,O
32151325,O
"


",O
184,O
.,O
Lancet,O
.,O
2020,O
Mar,O
6,O
.,O
pii,O
:,O
S01406736(20)305572,O
.,O
doi,O
:,O
"
",O
10.1016,O
S01406736(20)305572,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
SARSCoV2,B-Virus_SARS-CoV-2
is,O
an,O
appropriate,O
name,O
for,O
the,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
.,O
"

",O
Wu,O
Y(1,O
),O
",",O
Ho,O
W(2,O
),O
",",O
Huang,O
Y(3,O
),O
",",O
Jin,O
DY(4,O
),O
",",O
Li,O
S(5,O
),O
",",O
Liu,O
SL(6,O
),O
",",O
Liu,O
X(7,O
),O
",",O
Qiu,O
J(8,O
),O
",",O
"
",O
Sang,O
Y(9,O
),O
",",O
Wang,O
Q(10,O
),O
",",O
Yuen,O
KY(11,O
),O
",",O
Zheng,O
ZM(12,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Center,O
for,O
Biodefense,O
and,O
Infectious,O
Diseases,O
",",O
School,O
of,O
Systems,O
"
",O
Biology,O
",",O
George,O
Mason,O
University,O
",",O
Manassas,O
",",O
VA,O
20110,O
",",O
USA,O
.,O
Electronic,O
address,O
:,O
"
",O
ywu8@gmu.edu,O
.,O
"
",O
(2)Department,O
of,O
Pathology,O
&,O
Laboratory,O
Medicine,O
and,O
Department,O
of,O
Anatomy,O
&,O
Cell,O
"
",O
Biology,O
",",O
Temple,O
University,O
Lewis,O
Katz,O
School,O
of,O
Medicine,O
",",O
Philadelphia,O
",",O
PA,O
",",O
USA,O
.,O
"
",O
(3)Institute,O
of,O
Preventive,O
Veterinary,O
Medicine,O
",",O
Key,O
Laboratory,O
of,O
Animal,O
Virology,O
"
",O
of,O
Ministry,O
of,O
Agriculture,O
",",O
College,O
of,O
Animal,O
Sciences,O
",",O
Zhejiang,O
University,O
",",O
"
",O
Hangzhou,O
",",O
China,O
.,O
"
",O
(4)School,O
of,O
Biomedical,O
Sciences,O
",",O
The,O
University,O
of,O
Hong,O
Kong,O
",",O
Pokfulam,O
",",O
Hong,O
"
",O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Epidemiology,O
",",O
Wuhan,O
University,O
School,O
of,O
Health,O
Sciences,O
",",O
Wuhan,O
",",O
"
",O
Hubei,O
",",O
China,O
.,O
"
",O
(6)Infectious,O
Diseases,O
Institute,O
",",O
Center,O
for,O
Retrovirus,O
Research,O
",",O
Departments,O
of,O
"
",O
Veterinary,O
Biosciences,O
",",O
Microbial,O
Infection,O
and,O
Immunity,O
",",O
and,O
Microbiology,O
",",O
The,O
"
",O
Ohio,O
State,O
University,O
",",O
Columbus,O
",",O
OH,O
",",O
USA,O
.,O
"
",O
(7)Department,O
of,O
Pathology,O
",",O
Georgetown,O
University,O
Medical,O
Center,O
",",O
Washington,O
",",O
DC,O
",",O
"
",O
USA,O
.,O
"
",O
(8)Department,O
of,O
Microbiology,O
",",O
Molecular,O
Genetics,O
and,O
Immunology,O
",",O
University,O
of,O
"
",O
Kansas,O
Medical,O
Center,O
",",O
Kansas,O
City,O
",",O
KS,O
",",O
USA,O
.,O
"
",O
(9)Department,O
of,O
Agricultural,O
and,O
Environmental,O
Sciences,O
",",O
College,O
of,O
Agriculture,O
",",O
"
",O
Human,O
and,O
Natural,O
Sciences,O
",",O
Tennessee,O
State,O
University,O
",",O
Nashville,O
",",O
TN,O
",",O
USA,O
.,O
"
",O
(10)Food,O
Animal,O
Health,O
Research,O
Program,O
",",O
Department,O
of,O
Veterinary,O
Preventive,O
"
",O
Medicine,O
",",O
The,O
Ohio,O
State,O
University,O
",",O
Wooster,O
",",O
OH,O
",",O
USA,O
.,O
"
",O
(11)Department,O
of,O
Microbiology,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
University,O
"
",O
of,O
Hong,O
Kong,O
",",O
Pokfulam,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(12)Center,O
for,O
Cancer,O
Research,O
",",O
National,O
Cancer,O
Institute,O
",",O
Frederick,O
",",O
MD,O
21702,O
",",O
"
",O
USA,O
.,O
Electronic,O
address,O
:,O
zhengt@exchange.nih.gov,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)305572,O
"
",O
PMID,O
:,O
32151324,O
"


",O
185,O
.,O
Lancet,O
Child,O
Adolesc,O
Health,O
.,O
2020,O
Mar,O
6,O
.,O
pii,O
:,O
S23524642(20)300730,O
.,O
doi,O
:,O
"
",O
10.1016,O
S23524642(20)300730,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Managing,O
neonates,O
with,O
respiratory,O
failure,O
due,O
to,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
De,O
Luca,O
D(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Pediatrics,O
and,O
Neonatal,O
Critical,O
Care,O
",",O
"""",O
A,O
BÃ©clÃ¨re,O
"""",O
Medical,O
Center,O
",",O
"
",O
Paris,O
Saclay,O
University,O
Hospitals,O
",",O
Assistance,O
PubliqueHopitaux,O
de,O
Paris,O
",",O
Paris,O
",",O
"
",O
France,O
;,O
Therapeutic,O
Innovation,O
Unit,O
",",O
U999,O
",",O
Paris,O
Saclay,O
University,O
",",O
Paris,O
",",O
"
",O
France,O
.,O
Electronic,O
address,O
:,O
dm.deluca@icloud.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S23524642(20)300730,O
"
",O
PMID,O
:,O
32151320,O
"


",O
186,O
.,O
Lancet,O
Child,O
Adolesc,O
Health,O
.,O
2020,O
Mar,O
6,O
.,O
pii,O
:,O
S23524642(20)300729,O
.,O
doi,O
:,O
"
",O
10.1016,O
S23524642(20)300729,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Managing,O
neonates,O
with,O
respiratory,O
failure,O
due,O
to,O
SARSCoV2,B-Virus_SARS-CoV-2
 ,O
Authors,O
',O
reply,O
.,O
"

",O
Wang,O
J(1,O
),O
",",O
Shi,O
Y(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Neonatology,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Child,O
Health,O
"
",O
and,O
Disorders,O
",",O
Ministry,O
of,O
Education,O
Key,O
Laboratory,O
of,O
Child,O
Development,O
and,O
"
",O
Disorders,O
",",O
China,O
International,O
Science,O
and,O
Technology,O
Cooperation,O
Base,O
of,O
Child,O
"
",O
Development,O
and,O
Critical,O
Disorders,O
",",O
Children,O
's,O
Hospital,O
of,O
Chongqing,O
Medical,O
"
",O
University,O
",",O
Chongqing,O
400014,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Neonatology,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Child,O
Health,O
"
",O
and,O
Disorders,O
",",O
Ministry,O
of,O
Education,O
Key,O
Laboratory,O
of,O
Child,O
Development,O
and,O
"
",O
Disorders,O
",",O
China,O
International,O
Science,O
and,O
Technology,O
Cooperation,O
Base,O
of,O
Child,O
"
",O
Development,O
and,O
Critical,O
Disorders,O
",",O
Children,O
's,O
Hospital,O
of,O
Chongqing,O
Medical,O
"
",O
University,O
",",O
Chongqing,O
400014,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
shiyuan@hospital.cqmu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S23524642(20)300729,O
"
",O
PMID,O
:,O
32151318,O
"


",O
187,O
.,O
Crit,O
Care,O
.,O
2020,O
Mar,O
9;24(1):83,O
.,O
doi,O
:,O
10.1186,O
s130540202814x,O
.,O
"

",O
Preparing,O
for,O
COVID19,B-Disease_COVID-19
:,O
early,O
experience,O
from,O
an,O
intensive,O
care,O
unit,O
in,O
"
",O
Singapore,O
.,O
"

",O
Liew,O
MF(1)(2,O
),O
",",O
Siow,O
WT(3)(4,O
),O
",",O
MacLaren,O
G(5,O
),O
",",O
See,O
KC(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
University,O
Medicine,O
"
",O
Cluster,O
",",O
National,O
University,O
Health,O
System,O
",",O
1E,O
Kent,O
Ridge,O
Rd,O
",",O
Singapore,O
",",O
119228,O
",",O
"
",O
Singapore,O
.,O
mei_fong_liew@nuhs.edu.sg,O
.,O
"
",O
(2)Fast,O
and,O
Chronic,O
Programmes,O
",",O
Alexandra,O
Hospital,O
",",O
National,O
University,O
Health,O
"
",O
System,O
",",O
Singapore,O
.,O
mei_fong_liew@nuhs.edu.sg,O
.,O
"
",O
(3)Division,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
University,O
Medicine,O
"
",O
Cluster,O
",",O
National,O
University,O
Health,O
System,O
",",O
1E,O
Kent,O
Ridge,O
Rd,O
",",O
Singapore,O
",",O
119228,O
",",O
"
",O
Singapore,O
.,O
"
",O
(4)Fast,O
and,O
Chronic,O
Programmes,O
",",O
Alexandra,O
Hospital,O
",",O
National,O
University,O
Health,O
"
",O
System,O
",",O
Singapore,O
.,O
"
",O
(5)Cardiothoracic,O
Intensive,O
Care,O
Unit,O
",",O
National,O
University,O
Health,O
System,O
",",O
"
",O
Singapore,O
.,O
"

",O
Comment,O
on,O
"
    ",O
Crit,O
Care,O
.,O
2020,O
Feb,O
19;24(1):56,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s130540202814x,O
"
",O
PMCID,O
:,O
PMC7063757,O
"
",O
PMID,O
:,O
32151274,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
188,O
.,O
J,O
Educ,O
Eval,O
Health,O
Prof.,O
2020,O
Jan;17:10,O
.,O
doi,O
:,O
10.3352,O
jeehp.2020.17.10,O
.,O
Epub,O
2020,O
"
",O
Mar,O
7,O
.,O
"

",O
How,O
to,O
train,O
the,O
health,O
personnel,O
for,O
protecting,O
themselves,O
from,O
novel,O
"
",O
coronavirus,O
(,O
COVID19,B-Disease_COVID-19
),O
infection,O
during,O
their,O
patient,O
or,O
suspected,O
case,O
care,O
.,O
"

",O
Huh,O
S(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Parasitology,O
and,O
Institute,O
of,O
Medical,O
Education,O
",",O
College,O
of,O
"
",O
Medicine,O
",",O
Hallym,O
University,O
",",O
Chuncheon,O
",",O
Korea,O
.,O
"

",O
DOI,O
:,O
10.3352,O
jeehp.2020.17.10,O
"
",O
PMID,O
:,O
32150796,O
"


",O
189,O
.,O
Features,O
",",O
Evaluation,O
and,O
Treatment,O
Coronavirus,O
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
Cascella,O
M(1,O
),O
",",O
Rajnik,O
M(2,O
),O
",",O
Cuomo,O
A(3,O
),O
",",O
Dulebohn,O
SC,O
",",O
Di,O
Napoli,O
R(4,O
),O
.,O
"
",O
In,O
:,O
StatPearls,O
[,O
Internet,O
],O
.,O
Treasure,O
Island,O
(,O
FL,O
),O
:,O
StatPearls,O
Publishing,O
;,O
2020,O
.,O
"
",O
2020,O
Mar,O
8,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Istituto,O
Nazionale,O
Tumori,O
 ,O
IRCCS,O
 ,O
Fondazione,O
Pascale,O
",",O
Via,O
Mariano,O
Semmola,O
"
",O
80100,O
",",O
Napoli,O
.,O
Italy,O
"
",O
(2)Uniformed,O
Services,O
Un,O
of,O
the,O
Health,O
Sc,O
"
",O
(3)Istituto,O
Nazionale,O
Tumori,O
 ,O
IRCCS,O
 ,O
Fondazione,O
Pascale,O
.,O
Napoli,O
",",O
Italy,O
"
",O
(4)Institut,O
Jules,O
Bordet,O
"

",O
According,O
to,O
the,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
",",O
viral,O
diseases,O
continue,O
to,O
"
",O
emerge,O
and,O
represent,O
a,O
serious,O
issue,O
to,O
public,O
health,O
.,O
In,O
the,O
last,O
twenty,O
years,O
",",O
"
",O
several,O
viral,O
epidemics,O
such,O
as,O
the,O
severe,O
acute,O
respiratory,O
Â ,O
syndrome,O
coronavirus,O
"
",O
(,O
SARSCoV,O
),O
in,O
2002,O
to,O
2003,O
",",O
and,O
H1N1,O
influenza,O
in,O
2009,O
",",O
have,O
been,O
recorded,O
.,O
Most,O
"
",O
recently,O
",",O
the,O
Middle,O
East,O
respiratory,O
syndrome,O
coronavirus,O
(,O
MERSCoV,O
),O
was,O
Â ,O
first,O
"
",O
identified,O
in,O
Saudi,O
Arabia,O
in,O
2012,O
.,O
In,O
a,O
timeline,O
that,O
reaches,O
the,O
present,O
day,O
",",O
"
",O
an,O
epidemic,O
of,O
cases,O
with,O
unexplained,O
low,O
respiratory,O
infections,O
detected,O
in,O
"
",O
Wuhan,O
",",O
the,O
largest,O
metropolitan,O
area,O
in,O
China,O
's,O
Hubei,O
province,O
",",O
was,O
first,O
"
",O
reported,O
to,O
the,O
WHO,O
Country,O
Office,O
in,O
China,O
",",O
on,O
December,O
31,O
",",O
2019,O
.,O
Published,O
"
",O
literature,O
can,O
trace,O
the,O
beginning,O
of,O
symptomatic,O
individuals,O
back,O
to,O
the,O
"
",O
beginning,O
of,O
December,O
2019,O
.,O
As,O
they,O
were,O
unable,O
to,O
identify,O
the,O
causative,O
agent,O
",",O
"
",O
these,O
first,O
cases,O
were,O
classified,O
as,O
"""",O
pneumonia,O
of,O
unknown,O
etiology,O
.,O
"""",O
The,O
Chinese,O
"
",O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
(,O
CDC,O
),O
and,O
local,O
CDCs,O
organized,O
an,O
"
",O
intensive,O
outbreak,O
investigation,O
program,O
.,O
The,O
etiology,O
of,O
this,O
illness,O
is,O
now,O
"
",O
attributed,O
to,O
a,O
novel,O
virus,O
belonging,O
to,O
the,O
coronavirus,O
(,O
CoV,O
),O
family,O
",",O
COVID19,B-Disease_COVID-19
.,O
"
",O
On,O
February,O
11,O
",",O
2020,O
",",O
the,O
WHO,O
DirectorGeneral,O
",",O
Dr.,O
Tedros,O
Adhanom,O
Ghebreyesus,O
",",O
"
",O
announced,O
that,O
the,O
disease,O
caused,O
by,O
this,O
new,O
CoV,O
was,O
a,O
"""",O
COVID19,B-Disease_COVID-19
",",O
"""",O
which,O
is,O
the,O
"
",O
acronym,O
of,O
"""",O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
"""",O
.,O
In,O
the,O
past,O
Â ,O
twenty,O
years,O
",",O
two,O
additional,O
"
",O
coronavirus,O
epidemics,O
have,O
occurred,O
.,O
Â ,O
SARSCoV,O
Â ,O
provoked,O
Â ,O
a,O
largescale,O
epidemic,O
"
",O
beginning,O
in,O
China,O
and,O
involving,O
two,O
dozen,O
countries,O
with,O
approximately,O
8000,O
"
",O
cases,O
and,O
800,O
deaths,O
",",O
and,O
the,O
MERSCoV,O
that,O
began,O
in,O
Saudi,O
Arabia,O
and,O
has,O
"
",O
approximately,O
2500,O
cases,O
and,O
800,O
deaths,O
and,O
still,O
causes,O
Â ,O
as,O
sporadic,O
cases,O
.,O
This,O
"
",O
new,O
virus,O
seems,O
to,O
be,O
very,O
contagious,O
and,O
has,O
quickly,O
spread,O
globally,O
.,O
In,O
a,O
"
",O
meeting,O
on,O
Â ,O
January,O
30,O
",",O
2020,O
",",O
per,O
the,O
Â ,O
International,O
Health,O
Regulations,O
(,O
IHR,O
",",O
"
",O
2005,O
),O
",",O
the,O
outbreak,O
was,O
declared,O
by,O
the,O
WHO,O
a,O
Public,O
Health,O
Emergency,O
of,O
"
",O
International,O
Concern,O
(,O
PHEIC,O
),O
as,O
it,O
had,O
spread,O
to,O
18,O
countries,O
with,O
Â ,O
four,O
"
",O
countries,O
reporting,O
Â ,O
humantohuman,O
transmission,O
.,O
An,O
additional,O
landmark,O
occurred,O
"
",O
on,O
February,O
26,O
",",O
2020,O
",",O
as,O
the,O
first,O
case,O
of,O
the,O
disease,O
",",O
Â ,O
not,O
Â ,O
imported,O
from,O
China,O
",",O
"
",O
was,O
recorded,O
in,O
the,O
United,O
States,O
.,O
Â  ,O
Initially,O
",",O
the,O
new,O
virus,O
was,O
called,O
"
",O
2019nCoV.,O
Subsequently,O
",",O
the,O
task,O
of,O
experts,O
of,O
the,O
International,O
Committee,O
on,O
"
",O
Taxonomy,O
of,O
Viruses,O
(,O
ICTV,O
),O
Â ,O
termed,O
it,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
virus,O
as,O
it,O
is,O
very,O
similar,O
"
",O
to,O
the,O
one,O
that,O
caused,O
the,O
SARS,O
outbreak,O
(,O
SARSCoVs,O
),O
.,O
The,O
CoVs,O
have,O
become,O
the,O
"
",O
major,O
pathogens,O
Â ,O
of,O
emerging,O
respiratory,O
disease,O
outbreaks,O
.,O
They,O
are,O
a,O
large,O
"
",O
family,O
of,O
singlestranded,O
RNA,O
viruses,O
(,O
+,O
ssRNA,O
),O
that,O
Â ,O
can,O
be,O
isolated,O
in,O
different,O
"
",O
animal,O
species.[1,O
],O
Â ,O
For,O
reasons,O
yet,O
to,O
be,O
explained,O
",",O
these,O
viruses,O
Â ,O
can,O
cross,O
"
",O
species,O
barriers,O
and,O
can,O
cause,O
",",O
in,O
humans,O
",",O
illness,O
ranging,O
from,O
the,O
common,O
cold,O
"
",O
to,O
more,O
severe,O
diseases,O
such,O
as,O
MERS,O
and,O
SARS,O
.,O
Â ,O
Interestingly,O
",",O
these,O
latter,O
"
",O
viruses,O
have,O
probably,O
originated,O
from,O
bats,O
and,O
then,O
Â ,O
moving,O
Â ,O
into,O
other,O
mammalian,O
"
",O
hosts,O
â€”,O
the,O
Himalayan,O
palm,O
civet,O
for,O
SARSCoV,O
",",O
and,O
the,O
dromedary,O
camel,O
for,O
"
",O
MERSCoV,O
â€”,O
before,O
jumping,O
to,O
humans,O
.,O
The,O
dynamics,O
of,O
SARSCov2,B-Virus_SARS-CoV-2
are,O
currently,O
"
",O
unknown,O
",",O
but,O
there,O
is,O
speculation,O
that,O
it,O
also,O
has,O
an,O
animal,O
origin,O
.,O
The,O
"
",O
potential,O
for,O
these,O
viruses,O
to,O
grow,O
to,O
become,O
a,O
pandemic,O
worldwide,O
seems,O
to,O
be,O
a,O
"
",O
serious,O
public,O
health,O
risk,O
.,O
Concerning,O
COVID19,B-Disease_COVID-19
",",O
the,O
Â ,O
WHO,O
raised,O
the,O
threat,O
to,O
"
",O
the,O
Â ,O
CoV,O
Â ,O
epidemic,O
to,O
the,O
"""",O
very,O
high,O
"""",O
level,O
",",O
on,O
February,O
28,O
",",O
2020,O
.,O
Probably,O
",",O
the,O
"
",O
effects,O
of,O
the,O
epidemic,O
caused,O
by,O
the,O
new,O
CoV,O
has,O
yet,O
to,O
emerge,O
as,O
the,O
situation,O
"
",O
is,O
quickly,O
Â ,O
evolving,O
.,O
World,O
governments,O
are,O
at,O
work,O
to,O
establish,O
countermeasures,O
"
",O
to,O
stem,O
possible,O
devastating,O
effects,O
.,O
Health,O
organizations,O
coordinate,O
information,O
"
",O
flows,O
and,O
issues,O
directives,O
and,O
guidelines,O
to,O
best,O
mitigate,O
the,O
impact,O
of,O
the,O
"
",O
threat,O
.,O
At,O
the,O
same,O
time,O
",",O
scientists,O
around,O
the,O
world,O
work,O
tirelessly,O
",",O
and,O
"
",O
information,O
about,O
the,O
transmission,O
mechanisms,O
",",O
the,O
clinical,O
spectrum,O
of,O
disease,O
",",O
"
",O
new,O
diagnostics,O
",",O
and,O
prevention,O
and,O
therapeutic,O
strategies,O
are,O
rapidly,O
"
",O
developing,O
.,O
Many,O
uncertainties,O
remain,O
with,O
regard,O
to,O
both,O
the,O
virushost,O
"
",O
interaction,O
and,O
the,O
evolution,O
of,O
the,O
epidemic,O
",",O
with,O
specific,O
reference,O
to,O
the,O
"
",O
times,O
when,O
the,O
epidemic,O
will,O
reach,O
its,O
peak,O
.,O
At,O
the,O
moment,O
",",O
the,O
therapeutic,O
"
",O
strategies,O
to,O
deal,O
with,O
the,O
infection,O
are,O
only,O
supportive,O
",",O
and,O
prevention,O
aimed,O
"
",O
at,O
reducing,O
transmission,O
in,O
the,O
community,O
is,O
our,O
best,O
weapon,O
.,O
Aggressive,O
"
",O
isolation,O
measures,O
in,O
China,O
have,O
led,O
to,O
a,O
progressive,O
reduction,O
of,O
cases,O
in,O
the,O
"
",O
last,O
few,O
days,O
.,O
In,O
Italy,O
",",O
in,O
geographic,O
regions,O
of,O
the,O
north,O
of,O
the,O
peninsula,O
",",O
"
",O
political,O
and,O
health,O
authorities,O
are,O
making,O
incredible,O
efforts,O
to,O
contain,O
a,O
shock,O
"
",O
wave,O
that,O
is,O
severely,O
testing,O
the,O
health,O
system,O
.,O
Â  ,O
In,O
the,O
midst,O
of,O
the,O
crisis,O
",",O
the,O
"
",O
authors,O
have,O
chosen,O
to,O
use,O
the,O
"""",O
Statpearls,O
"""",O
platform,O
because,O
",",O
within,O
the,O
PubMed,O
"
",O
scenario,O
",",O
it,O
represents,O
a,O
unique,O
tool,O
that,O
may,O
allow,O
them,O
to,O
make,O
updates,O
in,O
"
",O
realtime,O
.,O
Â ,O
The,O
aim,O
",",O
therefore,O
",",O
is,O
to,O
collect,O
information,O
and,O
scientific,O
evidence,O
"
",O
and,O
to,O
provide,O
an,O
overview,O
of,O
the,O
topic,O
that,O
will,O
be,O
continuously,O
updated,O
.,O
"

",O
PMID,O
:,O
32150360,O
"


",O
190,O
.,O
Ann,O
Intern,O
Med,O
.,O
2020,O
Mar,O
10:OC1,O
.,O
doi,O
:,O
10.7326,O
A200001,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Annals,O
On,O
Call,O
 ,O
Understanding,O
the,O
Spread,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Centor,O
RM(1,O
),O
",",O
Fisman,O
DN(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Huntsville,O
Regional,O
Medical,O
Campus,O
",",O
University,O
of,O
Alabama,O
Birmingham,O
School,O
of,O
"
",O
Medicine,O
",",O
Birmingham,O
",",O
Alabama,O
(,O
R.M.C.,O
),O
.,O
"
",O
(2)Dalla,O
Lana,O
School,O
of,O
Public,O
Health,O
",",O
University,O
of,O
Toronto,O
",",O
Toronto,O
",",O
Ontario,O
",",O
"
",O
Canada,O
(,O
D.N.F.,O
),O
.,O
"

",O
DOI,O
:,O
10.7326,O
A200001,O
"
",O
PMID,O
:,O
32150752,O
"


",O
191,O
.,O
Ann,O
Intern,O
Med,O
.,O
2020,O
Mar,O
10,O
.,O
doi,O
:,O
10.7326,O
M200504,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
Incubation,O
Period,O
of,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
From,O
Publicly,O
"
",O
Reported,O
Confirmed,O
Cases,O
:,O
Estimation,O
and,O
Application,O
.,O
"

",O
Lauer,O
SA(1,O
),O
",",O
Grantz,O
KH(1,O
),O
",",O
Bi,O
Q(1,O
),O
",",O
Jones,O
FK(1,O
),O
",",O
Zheng,O
Q(1,O
),O
",",O
Meredith,O
HR(1,O
),O
",",O
"
",O
Azman,O
AS(1,O
),O
",",O
Reich,O
NG(2,O
),O
",",O
Lessler,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Johns,O
Hopkins,O
Bloomberg,O
School,O
of,O
Public,O
Health,O
",",O
Baltimore,O
",",O
Maryland,O
(,O
S.A.L.,O
",",O
"
",O
K.H.G.,O
",",O
Q.B.,O
",",O
F.K.J.,O
",",O
Q.Z.,O
",",O
H.R.M.,O
",",O
A.S.A.,O
",",O
J.L.,O
),O
.,O
"
",O
(2)School,O
of,O
Public,O
Health,O
and,O
Health,O
Sciences,O
",",O
University,O
of,O
Massachusetts,O
",",O
"
",O
Amherst,O
",",O
Massachusetts,O
",",O
and,O
LudwigMaximiliansUniversitÃ¤t,O
",",O
Munich,O
",",O
Germany,O
"
",O
(,O
N.G.R.,O
),O
.,O
"

",O
Background,O
:,O
A,O
novel,O
human,O
coronavirus,O
",",O
severe,O
acute,O
respiratory,O
syndrome,O
"
",O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
was,O
identified,O
in,O
China,O
in,O
December,O
2019,O
.,O
There,O
is,O
"
",O
limited,O
support,O
for,O
many,O
of,O
its,O
key,O
epidemiologic,O
features,O
",",O
including,O
the,O
"
",O
incubation,O
period,O
for,O
clinical,O
disease,O
(,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
[,O
COVID19,B-Disease_COVID-19
],O
),O
",",O
"
",O
which,O
has,O
important,O
implications,O
for,O
surveillance,O
and,O
control,O
activities,O
.,O
"
",O
Objective,O
:,O
To,O
estimate,O
the,O
length,O
of,O
the,O
incubation,O
period,O
of,O
COVID19,B-Disease_COVID-19
and,O
"
",O
describe,O
its,O
public,O
health,O
implications,O
.,O
"
",O
Design,O
:,O
Pooled,O
analysis,O
of,O
confirmed,O
COVID19,B-Disease_COVID-19
cases,O
reported,O
between,O
4,O
January,O
"
",O
2020,O
and,O
24,O
February,O
2020,O
.,O
"
",O
Setting,O
:,O
News,O
reports,O
and,O
press,O
releases,O
from,O
50,O
provinces,O
",",O
regions,O
",",O
and,O
"
",O
countries,O
outside,O
Wuhan,O
",",O
Hubei,O
province,O
",",O
China,O
.,O
"
",O
Participants,O
:,O
Persons,O
with,O
confirmed,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
outside,O
Hubei,O
province,O
",",O
"
",O
China,O
.,O
"
",O
Measurements,O
:,O
Patient,O
demographic,O
characteristics,O
and,O
dates,O
and,O
times,O
of,O
possible,O
"
",O
exposure,O
",",O
symptom,O
onset,O
",",O
fever,O
onset,O
",",O
and,O
hospitalization,O
.,O
"
",O
Results,O
:,O
There,O
were,O
181,O
confirmed,O
cases,O
with,O
identifiable,O
exposure,O
and,O
symptom,O
"
",O
onset,O
windows,O
to,O
estimate,O
the,O
incubation,O
period,O
of,O
COVID19,B-Disease_COVID-19
.,O
The,O
median,O
"
",O
incubation,O
period,O
was,O
estimated,O
to,O
be,O
5.1,O
days,O
(,O
95,O
%,O
CI,O
",",O
4.5,O
to,O
5.8,O
days,O
),O
",",O
and,O
"
",O
97.5,O
%,O
of,O
those,O
who,O
develop,O
symptoms,O
will,O
do,O
so,O
within,O
11.5,O
days,O
(,O
CI,O
",",O
8.2,O
to,O
15.6,O
"
",O
days,O
),O
of,O
infection,O
.,O
These,O
estimates,O
imply,O
that,O
",",O
under,O
conservative,O
assumptions,O
",",O
"
",O
101,O
out,O
of,O
every,O
10,O
Â ,O
0,O
cases,O
(,O
99th,O
percentile,O
",",O
482,O
),O
will,O
develop,O
symptoms,O
after,O
"
",O
14,O
days,O
of,O
active,O
monitoring,O
or,O
quarantine,O
.,O
"
",O
Limitation,O
:,O
Publicly,O
reported,O
cases,O
may,O
overrepresent,O
severe,O
cases,O
",",O
the,O
"
",O
incubation,O
period,O
for,O
which,O
may,O
differ,O
from,O
that,O
of,O
mild,O
cases,O
.,O
"
",O
Conclusion,O
:,O
This,O
work,O
provides,O
additional,O
evidence,O
for,O
a,O
median,O
incubation,O
period,O
"
",O
for,O
COVID19,B-Disease_COVID-19
of,O
approximately,O
5,O
days,O
",",O
similar,O
to,O
SARS,O
.,O
Our,O
results,O
support,O
"
",O
current,O
proposals,O
for,O
the,O
length,O
of,O
quarantine,O
or,O
active,O
monitoring,O
of,O
persons,O
"
",O
potentially,O
exposed,O
to,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
although,O
longer,O
monitoring,O
periods,O
might,O
be,O
"
",O
justified,O
in,O
extreme,O
cases,O
.,O
"
",O
Primary,O
Funding,O
Source,O
:,O
U.S.,O
Centers,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
National,O
"
",O
Institute,O
of,O
Allergy,O
and,O
Infectious,O
Diseases,O
",",O
National,O
Institute,O
of,O
General,O
"
",O
Medical,O
Sciences,O
",",O
and,O
Alexander,O
von,O
Humboldt,O
Foundation,O
.,O
"

",O
DOI,O
:,O
10.7326,O
M200504,O
"
",O
PMID,O
:,O
32150748,O
"


",O
192,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
9,O
.,O
pii,O
:,O
ciaa237,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa237,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
In,O
Vitro,O
Antiviral,O
Activity,O
and,O
Projection,O
of,O
Optimized,O
Dosing,O
Design,O
of,O
"
",O
Hydroxychloroquine,O
for,O
the,O
Treatment,O
of,O
Severe,O
Acute,O
Respiratory,O
Syndrome,O
"
",O
Coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
.,O
"

",O
Yao,O
X(1,O
),O
",",O
Ye,O
F(2,O
),O
",",O
Zhang,O
M(1,O
),O
",",O
Cui,O
C(1,O
),O
",",O
Huang,O
B(2,O
),O
",",O
Niu,O
P(2,O
),O
",",O
Liu,O
X(1,O
),O
",",O
Zhao,O
"
",O
L(2,O
),O
",",O
Dong,O
E(3,O
),O
",",O
Song,O
C(4,O
),O
",",O
Zhan,O
S(5,O
),O
",",O
Lu,O
R(2,O
),O
",",O
Li,O
H(1)(3,O
),O
",",O
Tan,O
W(2,O
),O
",",O
Liu,O
D(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Drug,O
Clinical,O
Trial,O
Center,O
",",O
Peking,O
University,O
Third,O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)MHC,O
Key,O
Laboratory,O
of,O
Biosafety,O
",",O
National,O
Institute,O
for,O
Viral,O
Disease,O
Control,O
"
",O
and,O
Prevention,O
",",O
Â ,O
China,O
CDC,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Cardiology,O
and,O
Institute,O
of,O
Vascular,O
Medicine,O
",",O
Peking,O
University,O
"
",O
Third,O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Orthopedics,O
",",O
Peking,O
University,O
Third,O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)Research,O
Center,O
of,O
Clinical,O
Epidemiology,O
",",O
Peking,O
University,O
Third,O
Hospital,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
The,O
Severe,B-Virus_SARS-CoV-2
Acute,I-Virus_SARS-CoV-2
Respiratory,I-Virus_SARS-CoV-2
Syndrome,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
"
",O
first,O
broke,O
out,O
in,O
Wuhan,O
(,O
China,O
),O
and,O
subsequently,O
spread,O
worldwide,O
.,O
Chloroquine,O
"
",O
has,O
been,O
sporadically,O
used,O
in,O
treating,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
Hydroxychloroquine,O
"
",O
shares,O
the,O
same,O
mechanism,O
of,O
action,O
as,O
chloroquine,O
",",O
but,O
its,O
more,O
tolerable,O
safety,O
"
",O
profile,O
makes,O
it,O
the,O
preferred,O
drug,O
to,O
treat,O
malaria,O
and,O
autoimmune,O
conditions,O
.,O
"
",O
We,O
propose,O
that,O
the,O
immunomodulatory,O
effect,O
of,O
hydroxychloroquine,O
also,O
may,O
be,O
"
",O
useful,O
in,O
controlling,O
the,O
cytokine,O
storm,O
that,O
occurs,O
latephase,O
in,O
critically,O
ill,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
infected,O
patients,O
.,O
Currently,O
",",O
there,O
is,O
no,O
evidence,O
to,O
support,O
the,O
use,O
"
",O
of,O
hydroxychloroquine,O
in,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"
",O
METHODS,O
:,O
The,O
pharmacological,O
activity,O
of,O
chloroquine,O
and,O
hydroxychloroquine,O
was,O
"
",O
tested,O
using,O
SARSCoV2,B-Virus_SARS-CoV-2
infected,O
Vero,O
cells,O
.,O
Physiologicallybased,O
"
",O
pharmacokinetic,O
models,O
(,O
PBPK,O
),O
were,O
implemented,O
for,O
both,O
drugs,O
separately,O
by,O
"
",O
integrating,O
their,O
in,O
vitro,O
data,O
.,O
Using,O
the,O
PBPK,O
models,O
",",O
hydroxychloroquine,O
"
",O
concentrations,O
in,O
lung,O
fluid,O
were,O
simulated,O
under,O
5,O
different,O
dosing,O
regimens,O
to,O
"
",O
explore,O
the,O
most,O
effective,O
regimen,O
whilst,O
considering,O
the,O
drug,O
's,O
safety,O
profile,O
.,O
"
",O
RESULTS,O
:,O
Hydroxychloroquine,O
(,O
EC50=0.72,O
Î¼M,O
),O
was,O
found,O
to,O
be,O
more,O
potent,O
than,O
"
",O
chloroquine,O
(,O
EC50=5.47,O
Î¼M,O
),O
in,O
vitro,O
.,O
Based,O
on,O
PBPK,O
models,O
results,O
",",O
a,O
loading,O
dose,O
"
",O
of,O
400,O
mg,O
twice,O
daily,O
of,O
hydroxychloroquine,O
sulfate,O
given,O
orally,O
",",O
followed,O
by,O
a,O
"
",O
maintenance,O
dose,O
of,O
200,O
mg,O
given,O
twice,O
daily,O
for,O
4,O
days,O
is,O
recommended,O
for,O
"
",O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
",",O
as,O
it,O
reached,O
three,O
times,O
the,O
potency,O
of,O
chloroquine,O
"
",O
phosphate,O
when,O
given,O
500,O
mg,O
twice,O
daily,O
5,O
days,O
in,O
advance,O
.,O
"
",O
CONCLUSIONS,O
:,O
Hydroxychloroquine,O
was,O
found,O
to,O
be,O
more,O
potent,O
than,O
chloroquine,O
to,O
"
",O
inhibit,O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
vitro,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa237,O
"
",O
PMID,O
:,O
32150618,O
"


",O
193,O
.,O
PLoS,O
Pathog,O
.,O
2020,O
Mar,O
9;16(3):e1008392,O
.,O
doi,O
:,O
10.1371,O
journal.ppat.1008392,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Structure,O
of,O
mouse,O
coronavirus,O
spike,O
protein,O
complexed,O
with,O
receptor,O
reveals,O
"
",O
mechanism,O
for,O
viral,O
entry,O
.,O
"

",O
Shang,O
J(1,O
),O
",",O
Wan,O
Y(1,O
),O
",",O
Liu,O
C(1,O
),O
",",O
Yount,O
B(2,O
),O
",",O
Gully,O
K(2,O
),O
",",O
Yang,O
Y(1,O
),O
",",O
Auerbach,O
A(1,O
),O
",",O
"
",O
Peng,O
G(3,O
),O
",",O
Baric,O
R(2,O
),O
",",O
Li,O
F(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Veterinary,O
and,O
Biomedical,O
Sciences,O
",",O
University,O
of,O
Minnesota,O
",",O
"
",O
Saint,O
Paul,O
",",O
Minnesota,O
",",O
United,O
States,O
of,O
America,O
.,O
"
",O
(2)Department,O
of,O
Epidemiology,O
",",O
University,O
of,O
North,O
Carolina,O
",",O
Chapel,O
Hill,O
",",O
North,O
"
",O
Carolina,O
",",O
United,O
States,O
of,O
America,O
.,O
"
",O
(3)College,O
of,O
Life,O
Science,O
and,O
Technology,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"

",O
Coronaviruses,O
recognize,O
a,O
variety,O
of,O
receptors,O
using,O
different,O
domains,O
of,O
their,O
"
",O
envelopeanchored,O
spike,O
protein,O
.,O
How,O
these,O
diverse,O
receptor,O
recognition,O
patterns,O
"
",O
affect,O
viral,O
entry,O
is,O
unknown,O
.,O
Mouse,O
hepatitis,O
coronavirus,O
(,O
MHV,O
),O
is,O
the,O
only,O
"
",O
known,O
coronavirus,O
that,O
uses,O
the,O
Nterminal,O
domain,O
(,O
NTD,O
),O
of,O
its,O
spike,O
to,O
recognize,O
"
",O
a,O
protein,O
receptor,O
",",O
CEACAM1a,O
.,O
Here,O
we,O
determined,O
the,O
cryoEM,O
structure,O
of,O
MHV,O
"
",O
spike,O
complexed,O
with,O
mouse,O
CEACAM1a,O
.,O
The,O
trimeric,O
spike,O
contains,O
three,O
"
",O
receptorbinding,O
S1,O
heads,O
sitting,O
on,O
top,O
of,O
a,O
trimeric,O
membranefusion,O
S2,O
stalk,O
.,O
"
",O
Three,O
receptor,O
molecules,O
bind,O
to,O
the,O
sides,O
of,O
the,O
spike,O
trimer,O
",",O
where,O
three,O
NTDs,O
"
",O
are,O
located,O
.,O
Receptor,O
binding,O
induces,O
structural,O
changes,O
in,O
the,O
spike,O
",",O
weakening,O
"
",O
the,O
interactions,O
between,O
S1,O
and,O
S2,O
.,O
Using,O
protease,O
sensitivity,O
and,O
negativestain,O
"
",O
EM,O
analyses,O
",",O
we,O
further,O
showed,O
that,O
after,O
protease,O
treatment,O
of,O
the,O
spike,O
",",O
"
",O
receptor,O
binding,O
facilitated,O
the,O
dissociation,O
of,O
S1,O
from,O
S2,O
",",O
allowing,O
S2,O
to,O
"
",O
transition,O
from,O
prefusion,O
to,O
postfusion,O
conformation,O
.,O
Together,O
these,O
results,O
"
",O
reveal,O
a,O
new,O
role,O
of,O
receptor,O
binding,O
in,O
MHV,O
entry,O
:,O
in,O
addition,O
to,O
its,O
"
",O
wellcharacterized,O
role,O
in,O
viral,O
attachment,O
to,O
host,O
cells,O
",",O
receptor,O
binding,O
also,O
"
",O
induces,O
the,O
conformational,O
change,O
of,O
the,O
spike,O
and,O
hence,O
the,O
fusion,O
of,O
viral,O
and,O
"
",O
host,O
membranes,O
.,O
Our,O
study,O
provides,O
new,O
mechanistic,O
insight,O
into,O
coronavirus,O
entry,O
"
",O
and,O
highlights,O
the,O
diverse,O
entry,O
mechanisms,O
used,O
by,O
different,O
viruses,O
.,O
"

",O
DOI,O
:,O
10.1371,O
journal.ppat.1008392,O
"
",O
PMID,O
:,O
32150576,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
have,O
declared,O
that,O
no,O
competing,O
"
",O
interests,O
exist,O
.,O
"


",O
194,O
.,O
Emerg,O
Infect,O
Dis,O
.,O
2020,O
Jun,O
17;26(6,O
),O
.,O
doi,O
:,O
10.3201,O
eid2606.200301,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Detection,O
of,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
by,O
RTPCR,O
in,O
Stool,O
Specimen,O
from,O
Asymptomatic,O
"
",O
Child,O
",",O
China,O
.,O
"

",O
Tang,O
A,O
",",O
Tong,O
ZD,O
",",O
Wang,O
HL,O
",",O
Dai,O
YX,O
",",O
Li,O
KF,O
",",O
Liu,O
JN,O
",",O
Wu,O
WJ,O
",",O
Yuan,O
C,O
",",O
Yu,O
ML,O
",",O
Li,O
P,O
",",O
Yan,O
"
",O
JB,O
.,O
"

",O
We,O
report,O
an,O
asymptomatic,O
child,O
who,O
was,O
positive,O
for,O
a,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
by,O
"
",O
reverse,O
transcription,O
PCR,O
in,O
a,O
stool,O
specimen,O
17,O
days,O
after,O
the,O
last,O
virus,O
"
",O
exposure,O
.,O
The,O
child,O
was,O
virus,O
positive,O
in,O
stool,O
specimens,O
for,O
at,O
least,O
an,O
"
",O
additional,O
9,O
days,O
.,O
Respiratory,O
tract,O
specimens,O
were,O
negative,O
by,O
reverse,O
"
",O
transcription,O
PCR,O
.,O
"

",O
DOI,O
:,O
10.3201,O
eid2606.200301,O
"
",O
PMID,O
:,O
32150527,O
"


",O
195,O
.,O
Minerva,O
Cardioangiol,O
.,O
2020,O
Mar,O
9,O
.,O
doi,O
:,O
10.23736,O
S00264725.20.052500,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
SARSCoV2,B-Virus_SARS-CoV-2
and,O
COVID19,B-Disease_COVID-19
:,O
facing,O
the,O
pandemic,O
together,O
as,O
citizens,O
and,O
"
",O
cardiovascular,O
practitioners,O
.,O
"

",O
BiondiZoccai,O
G(1)(2,O
),O
",",O
Landoni,O
G(3)(4,O
),O
",",O
Carnevale,O
R(5)(6,O
),O
",",O
Cavarretta,O
E(5)(6,O
),O
",",O
"
",O
Sciarretta,O
S(5)(7,O
),O
",",O
Frati,O
G(5)(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
MedicoSurgical,O
Sciences,O
and,O
Biotechnologies,O
",",O
Sapienza,O
"
",O
University,O
of,O
Rome,O
",",O
Latina,O
",",O
Italy,O
 ,O
giuseppe.biondizoccai@uniroma1.it,O
.,O
"
",O
(2)Mediterranea,O
Cardiocentro,O
",",O
Napoli,O
",",O
Italy,O
 ,O
giuseppe.biondizoccai@uniroma1.it,O
.,O
"
",O
(3)Department,O
of,O
Anesthesia,O
and,O
Intensive,O
Care,O
",",O
IRCCS,O
San,O
Raffaele,O
Scientific,O
"
",O
Institute,O
",",O
Milan,O
",",O
Italy,O
.,O
"
",O
(4)Faculty,O
of,O
Medicine,O
",",O
VitaSalute,O
San,O
Raffaele,O
University,O
",",O
Milan,O
",",O
Italy,O
.,O
"
",O
(5)Department,O
of,O
MedicoSurgical,O
Sciences,O
and,O
Biotechnologies,O
",",O
Sapienza,O
"
",O
University,O
of,O
Rome,O
",",O
Latina,O
",",O
Italy,O
.,O
"
",O
(6)Mediterranea,O
Cardiocentro,O
",",O
Napoli,O
",",O
Italy,O
.,O
"
",O
(7)IRCCS,O
NEUROMED,O
",",O
Pozzilli,O
",",O
Isernia,O
",",O
Italy,O
.,O
"

",O
DOI,O
:,O
10.23736,O
S00264725.20.052500,O
"
",O
PMID,O
:,O
32150358,O
"


",O
196,O
.,O
Chin,O
Med,O
J,O
(,O
Engl,O
),O
.,O
2020,O
Mar,O
5,O
.,O
doi,O
:,O
10.1097,O
CM9.0000000000000791,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Effectiveness,O
of,O
glucocorticoid,O
therapy,O
in,O
patients,O
with,O
severe,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
pneumonia,O
:,O
protocol,O
of,O
a,O
randomized,O
controlled,O
trial,O
.,O
"

",O
Zhou,O
YH(1,O
),O
",",O
Qin,O
YY(2,O
),O
",",O
Lu,O
YQ(1,O
),O
",",O
Sun,O
F(2,O
),O
",",O
Yang,O
S(2,O
),O
",",O
Harypursat,O
V(2,O
),O
",",O
Tang,O
"
",O
SQ(2,O
),O
",",O
Huang,O
YQ(2,O
),O
",",O
He,O
XQ(1,O
),O
",",O
Zeng,O
YM(1,O
),O
",",O
Li,O
Y(2,O
),O
",",O
Xu,O
XL(1,O
),O
",",O
Zhao,O
T(2,O
),O
",",O
Chen,O
"
",O
YK(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infectious,O
Diseases,O
",",O
Chongqing,O
Public,O
Health,O
Medical,O
Center,O
",",O
"
",O
Chongqing,O
400036,O
",",O
China,O
.,O
"
",O
(2)Science,O
and,O
EducationDivision,O
",",O
Chongqing,O
Public,O
Health,O
Medical,O
Center,O
",",O
"
",O
Chongqing,O
400036,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
At,O
the,O
end,O
of,O
2019,O
",",O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
outbreak,O
emerged,O
in,O
Wuhan,O
",",O
"
",O
China,O
",",O
and,O
its,O
causative,O
organism,O
has,O
been,O
subsequently,O
designated,O
the,O
2019,O
novel,O
"
",O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
The,O
virus,O
has,O
since,O
rapidly,O
spread,O
to,O
all,O
provinces,O
and,O
"
",O
autonomous,O
regions,O
of,O
China,O
",",O
and,O
to,O
countries,O
outside,O
of,O
China,O
.,O
Patients,O
who,O
"
",O
become,O
infected,O
with,O
2019nCoV,B-Virus_SARS-CoV-2
may,O
initially,O
develop,O
mild,O
upper,O
respiratory,O
tract,O
"
",O
symptoms,O
.,O
However,O
",",O
a,O
significant,O
fraction,O
of,O
these,O
patients,O
goes,O
on,O
to,O
"
",O
subsequently,O
develop,O
serious,O
lower,O
respiratory,O
disease,O
.,O
The,O
effectiveness,O
of,O
"
",O
adjunctive,O
glucocorticoid,O
therapy,O
uses,O
in,O
the,O
management,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
infected,O
"
",O
patients,O
with,O
severe,O
lower,O
respiratory,O
tract,O
infections,O
is,O
not,O
clear,O
",",O
and,O
"
",O
warrants,O
further,O
investigation,O
.,O
"
",O
METHODS,O
:,O
The,O
present,O
study,O
will,O
be,O
conducted,O
as,O
an,O
openlabelled,O
",",O
randomised,O
"
",O
controlled,O
trial,O
.,O
We,O
will,O
enrol,O
48,O
subjects,O
from,O
Chongqing,O
Public,O
Health,O
Medical,O
"
",O
Center,O
.,O
Each,O
eligible,O
subject,O
will,O
be,O
assigned,O
to,O
an,O
intervention,O
group,O
"
",O
(,O
methylprednisolone,O
via,O
intravenous,O
injection,O
at,O
a,O
dose,O
of,O
12,O
mg,O
kg,O
day,O
for,O
3,O
"
",O
days,O
),O
or,O
a,O
control,O
group,O
(,O
no,O
glucocorticoid,O
use,O
),O
randomly,O
",",O
at,O
a,O
0.042361111,O
ratio,O
.,O
"
",O
Subjects,O
in,O
both,O
groups,O
will,O
be,O
invited,O
for,O
28,O
days,O
of,O
followup,O
which,O
will,O
be,O
"
",O
scheduled,O
at,O
4,O
consecutive,O
visit,O
points,O
.,O
We,O
will,O
use,O
the,O
clinical,O
improvement,O
"
",O
rate,O
as,O
our,O
primary,O
endpoint,O
.,O
Secondary,O
endpoints,O
include,O
the,O
timing,O
of,O
clinical,O
"
",O
improvement,O
after,O
intervention,O
",",O
duration,O
of,O
mechanical,O
ventilation,O
",",O
duration,O
of,O
"
",O
hospitalization,O
",",O
overall,O
incidence,O
of,O
adverse,O
events,O
",",O
as,O
well,O
as,O
rate,O
of,O
adverse,O
"
",O
events,O
at,O
each,O
visit,O
",",O
and,O
mortality,O
at,O
2,O
and,O
4,O
weeks,O
.,O
"
",O
DISCUSSION,O
:,O
The,O
present,O
coronavirus,O
outbreak,O
is,O
the,O
third,O
serious,O
global,O
"
",O
coronavirus,O
outbreak,O
in,O
the,O
past,O
two,O
decades,O
.,O
Oral,O
and,O
parenteral,O
glucocorticoids,O
"
",O
have,O
been,O
used,O
in,O
the,O
management,O
of,O
severe,O
respiratory,O
symptoms,O
in,O
"
",O
coronavirusinfected,O
patients,O
in,O
the,O
past,O
.,O
However,O
",",O
there,O
remains,O
no,O
definitive,O
"
",O
evidence,O
in,O
the,O
literature,O
for,O
or,O
against,O
the,O
utilization,O
of,O
systemic,O
"
",O
glucocorticoids,O
in,O
seriously,O
ill,O
patients,O
with,O
coronavirusrelated,O
severe,O
"
",O
respiratory,O
disease,O
",",O
or,O
indeed,O
in,O
other,O
types,O
of,O
severe,O
respiratory,O
disease,O
.,O
In,O
"
",O
this,O
study,O
",",O
we,O
hope,O
to,O
discover,O
evidence,O
either,O
supporting,O
or,O
opposing,O
the,O
"
",O
systemic,O
therapeutic,O
administration,O
of,O
glucocorticoids,O
in,O
severe,O
coronavirus,O
"
",O
disease,O
2019,O
(,O
COVID19,B-Disease_COVID-19
),O
patients,O
.,O
"
",O
TRIAL,O
REGISTRATION,O
:,O
ClinicalTrials.gov,O
",",O
ChiCTR2000029386,O
",",O
"
",O
http,O
:,O
 ,O
www.chictr.org.cn,O
showproj.aspx?proj=48777,O
.,O
"

",O
DOI,O
:,O
10.1097,O
CM9.0000000000000791,O
"
",O
PMID,O
:,O
32149773,O
"


",O
197,O
.,O
Chin,O
Med,O
J,O
(,O
Engl,O
),O
.,O
2020,O
Mar,O
5,O
.,O
doi,O
:,O
10.1097,O
CM9.0000000000000788,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
A,O
case,O
of,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
infected,O
pneumonia,O
with,O
twice,O
negative,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
nucleic,O
acid,O
testing,O
within,O
8,O
days,O
.,O
"

",O
Ruan,O
ZR(1,O
),O
",",O
Gong,O
P(2,O
),O
",",O
Han,O
W(1,O
),O
",",O
Huang,O
MQ(1,O
),O
",",O
Han,O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Emergency,O
",",O
the,O
Shenzhen,O
University,O
General,O
Hospital,O
",",O
Shenzhen,O
"
",O
University,O
",",O
Shenzhen,O
",",O
Guangdong,O
518000,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
General,O
surgery,O
",",O
the,O
Shenzhen,O
University,O
General,O
Hospital,O
",",O
"
",O
Shenzhen,O
University,O
",",O
Shenzhen,O
",",O
Guangdong,O
518000,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1097,O
CM9.0000000000000788,O
"
",O
PMID,O
:,O
32149771,O
"


",O
198,O
.,O
Chin,O
Med,O
J,O
(,O
Engl,O
),O
.,O
2020,O
Mar,O
6,O
.,O
doi,O
:,O
10.1097,O
CM9.0000000000000792,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Highthroughput,O
sequencing,O
for,O
confirmation,O
of,O
suspected,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
"
",O
identified,O
by,O
fluorescence,O
quantitative,O
polymerase,O
chain,O
reaction,O
.,O
"

",O
Guan,O
WD(1,O
),O
",",O
Chen,O
LP(2,O
),O
",",O
Ye,O
F(1,O
),O
",",O
Ye,O
D(3,O
),O
",",O
Wu,O
SG(1,O
),O
",",O
Zhou,O
HX(1,O
),O
",",O
He,O
JY(1,O
),O
",",O
Yang,O
"
",O
CG(1,O
),O
",",O
Zeng,O
ZQ(1,O
),O
",",O
Wang,O
YT(1,O
),O
",",O
Li,O
RF(1,O
),O
",",O
Du,O
QL(1,O
),O
",",O
Liang,O
XL(1,O
),O
",",O
Ma,O
QH(1,O
),O
",",O
Yang,O
"
",O
ZF(1)(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Guangzhou,O
Institute,O
of,O
Respiratory,O
Health,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
"
",O
Guangzhou,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
Guangdong,O
510120,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Respiratory,O
Disease,O
",",O
Guangzhou,O
Medical,O
University,O
",",O
"
",O
Guangzhou,O
",",O
Guangdong,O
510006,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Infection,O
Control,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
"
",O
medical,O
university,O
",",O
Guangzhou,O
",",O
Guangdong,O
510120,O
",",O
China,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Quality,O
Research,O
in,O
Chinese,O
Medicine,O
",",O
Macau,O
Institute,O
"
",O
for,O
Applied,O
Research,O
in,O
Medicine,O
and,O
Health,O
",",O
Macau,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Macau,O
999078,O
",",O
China,O
.,O
"
",O
(5)KingMed,O
Virology,O
Diagnostic,O
&,O
Translational,O
Center,O
",",O
Guangzhou,O
KingMed,O
Center,O
"
",O
for,O
Clinical,O
Laboratory,O
Co.,O
",",O
Ltd.,O
Guangzhou,O
",",O
Guangdong,O
510330,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1097,O
CM9.0000000000000792,O
"
",O
PMID,O
:,O
32149770,O
"


",O
199,O
.,O
Chin,O
Med,O
J,O
(,O
Engl,O
),O
.,O
2020,O
Mar,O
6,O
.,O
doi,O
:,O
10.1097,O
CM9.0000000000000797,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Repurposing,O
of,O
clinically,O
approved,O
drugs,O
for,O
treatment,O
of,O
coronavirus,O
disease,O
"
",O
2019,O
in,O
a,O
2019novel,O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
related,O
coronavirus,O
model,O
.,O
"

",O
Fan,O
HH(1,O
),O
",",O
Wang,O
LQ,O
",",O
Liu,O
WL,O
",",O
An,O
XP,O
",",O
Liu,O
ZD,O
",",O
He,O
XQ,O
",",O
Song,O
LH,O
",",O
Tong,O
YG,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Beijing,O
Advanced,O
Innovation,O
Center,O
for,O
Soft,O
Matter,O
Science,O
and,O
Engineering,O
",",O
"
",O
College,O
of,O
Life,O
Science,O
and,O
Technology,O
",",O
Beijing,O
University,O
of,O
Chemical,O
"
",O
Technology,O
",",O
Beijing,O
100029,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
Medicines,O
for,O
the,O
treatment,O
of,O
2019novel,O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
"
",O
infections,O
are,O
urgently,O
needed,O
.,O
However,O
",",O
drug,O
screening,O
using,O
live,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
requires,O
highlevel,O
biosafety,O
facilities,O
",",O
which,O
imposes,O
an,O
obstacle,O
for,O
those,O
"
",O
without,O
such,O
facilities,O
or,O
2019novel,O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
This,O
study,O
aims,O
to,O
"
",O
repurpose,O
the,O
clinically,O
approved,O
drugs,O
for,O
the,O
treatment,O
of,O
coronavirus,O
disease,O
"
",O
2019,O
(,O
COVID19,B-Disease_COVID-19
),O
in,O
a,O
2019nCoV,B-Virus_SARS-CoV-2
related,O
coronavirus,O
model,O
.,O
"
",O
METHODS,O
:,O
A,O
2019nCoV,B-Virus_SARS-CoV-2
related,O
pangolin,O
coronavirus,O
GX_P2V,O
pangolin,O
2017,O
 ,O
Guangxi,O
"
",O
was,O
described,O
.,O
Whether,O
GX_P2X,O
uses,O
angiotensinconverting,O
enzyme,O
2,O
(,O
ACE2,O
),O
as,O
the,O
"
",O
cell,O
receptor,O
was,O
investigated,O
by,O
using,O
small,O
interfering,O
RNA,O
(,O
siRNA,O
),O
mediated,O
"
",O
silencing,O
of,O
ACE2,O
.,O
The,O
pangolin,O
coronavirus,O
model,O
was,O
used,O
to,O
identify,O
drug,O
"
",O
candidates,O
for,O
treating,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
Two,O
libraries,O
of,O
2406,O
clinically,O
"
",O
approved,O
drugs,O
were,O
screened,O
for,O
their,O
ability,O
to,O
inhibit,O
cytopathic,O
effects,O
on,O
"
",O
Vero,O
E6,O
cells,O
by,O
GX_P2X,O
infection,O
.,O
The,O
antiviral,O
activities,O
and,O
antiviral,O
"
",O
mechanisms,O
of,O
potential,O
drugs,O
were,O
further,O
investigated,O
.,O
Viral,O
yields,O
of,O
RNAs,O
and,O
"
",O
infectious,O
particles,O
were,O
quantified,O
by,O
quantitative,O
realtime,O
polymerase,O
chain,O
"
",O
reaction,O
(,O
qRTPCR,O
),O
and,O
plaque,O
assay,O
",",O
respectively,O
.,O
"
",O
RESULTS,O
:,O
The,O
spike,O
protein,O
of,O
coronavirus,O
GX_P2V,O
shares,O
92.2,O
%,O
amino,O
acid,O
identity,O
"
",O
with,O
that,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
isolate,O
Wuhanhu1,O
",",O
and,O
uses,O
ACE2,O
as,O
the,O
receptor,O
for,O
"
",O
infection,O
just,O
like,O
2019nCoV.,O
Three,O
drugscepharanthine,O
(,O
CEP,O
),O
",",O
selamectin,O
and,O
"
",O
mefloquine,O
hydrochloride,O
exhibited,O
complete,O
inhibition,O
of,O
cytopathic,O
effects,O
in,O
"
",O
cell,O
culture,O
at,O
10,O
Î¼mol,O
L.,O
CEP,O
demonstrated,O
the,O
most,O
potent,O
inhibition,O
of,O
GX_P2V,O
"
",O
infection,O
",",O
with,O
a,O
concentration,O
for,O
50,O
%,O
of,O
maximal,O
effect,O
[,O
EC50,O
],O
of,O
0.98,O
Î¼mol,O
L.,O
"
",O
The,O
viral,O
RNA,O
yield,O
in,O
cells,O
treated,O
with,O
10,O
Î¼mol,O
L,O
CEP,O
was,O
"15,393fold",O
lower,O
"
",O
than,O
in,O
cells,O
without,O
CEP,O
treatment,O
(,O
[,O
6.48,O
â€Š,O
Â±,O
â€Š,O
0.02,O
],O
â€Š,O
Ã—,O
â€Š,O
10vs,O
.,O
1,O
â€Š,O
Â±,O
â€Š,O
0.12,O
",",O
"
",O
t,O
â€Š,O
=,O
â€Š,O
150.38,O
",",O
P,O
â€Š,O
<,O
â€Š,O
0.001,O
),O
at,O
72,O
h,O
postinfection,O
(,O
p.i,O
.,O
),O
.,O
Plaque,O
assays,O
found,O
no,O
"
",O
production,O
of,O
live,O
viruses,O
in,O
media,O
containing,O
10,O
Î¼mol,O
L,O
CEP,O
at,O
48,O
h,O
p.i,O
.,O
"
",O
Furthermore,O
",",O
we,O
found,O
CEP,O
has,O
potent,O
antiviral,O
activities,O
against,O
both,O
viral,O
"
",O
entry,O
(,O
1,O
â€Š,O
Â±,O
â€Š,O
0.37,O
vs.,O
0.46,O
â€Š,O
Â±,O
â€Š,O
0.12,O
",",O
t,O
â€Š,O
=,O
â€Š,O
2.42,O
",",O
P,O
â€Š,O
<,O
â€Š,O
0.05,O
),O
and,O
viral,O
replication,O
"
",O
(,O
1,O
â€Š,O
Â±,O
â€Š,O
0.43,O
vs.,O
[,O
6.18,O
â€Š,O
Â±,O
â€Š,O
0.95,O
],O
â€Š,O
Ã—,O
â€Š,O
10,O
",",O
t,O
â€Š,O
=,O
â€Š,O
3.98,O
",",O
P,O
â€Š,O
<,O
â€Š,O
0.05,O
),O
.,O
"
",O
CONCLUSIONS,O
:,O
Our,O
pangolin,O
coronavirus,O
GX_P2V,O
is,O
a,O
workable,O
model,O
for,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
research,O
.,O
CEP,O
",",O
selamectin,O
and,O
mefloquine,O
hydrochloride,O
are,O
potential,O
drugs,O
for,O
"
",O
treating,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
Our,O
results,O
strongly,O
suggest,O
that,O
CEP,O
is,O
a,O
"
",O
widespectrum,O
inhibitor,O
of,O
panbetacoronavirus,O
",",O
and,O
clinical,O
trial,O
of,O
CEP,O
for,O
"
",O
treatment,O
of,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
is,O
warranted,O
.,O
"

",O
DOI,O
:,O
10.1097,O
CM9.0000000000000797,O
"
",O
PMID,O
:,O
32149769,O
"


",O
200,O
.,O
Chin,O
Med,O
J,O
(,O
Engl,O
),O
.,O
2020,O
Mar,O
6,O
.,O
doi,O
:,O
10.1097,O
CM9.0000000000000798,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
A,O
confirmed,O
asymptomatic,O
carrier,O
of,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
.,O
"

",O
Luo,O
SH(1)(2,O
),O
",",O
Liu,O
W(3,O
),O
",",O
Liu,O
ZJ(3,O
),O
",",O
Zheng,O
XY(1)(2,O
),O
",",O
Hong,O
CX(3,O
),O
",",O
Liu,O
ZR(2)(4,O
),O
",",O
Liu,O
"
",O
J(3,O
),O
",",O
Weng,O
JP(1)(2)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
First,O
Affiliation,O
Hospital,O
of,O
University,O
of,O
Science,O
and,O
Technology,O
of,O
"
",O
China,O
(,O
Anhui,O
Provincial,O
Hospital,O
),O
",",O
Hefei,O
",",O
Anhui,O
230001,O
",",O
China,O
.,O
"
",O
(2)Joint,O
Laboratory,O
of,O
Public,O
Health,O
",",O
University,O
of,O
Science,O
and,O
Technology,O
of,O
"
",O
China,O
and,O
Health,O
Commission,O
of,O
Anhui,O
Province,O
",",O
Hefei,O
",",O
Anhui,O
230026,O
",",O
China,O
.,O
"
",O
(3)Anqing,O
Hospital,O
Affiliated,O
to,O
Anhui,O
Medical,O
University,O
(,O
Anqing,O
Municipal,O
"
",O
Hospital,O
),O
",",O
Anqing,O
",",O
Anhui,O
246003,O
",",O
China,O
.,O
"
",O
(4)Anhui,O
Provincial,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Hefei,O
",",O
Anhui,O
"
",O
230601,O
",",O
China,O
.,O
"
",O
(5)Division,O
of,O
Life,O
Sciences,O
and,O
Medicine,O
",",O
University,O
of,O
Science,O
and,O
Technology,O
"
",O
of,O
China,O
",",O
Hefei,O
",",O
Anhui,O
230026,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1097,O
CM9.0000000000000798,O
"
",O
PMID,O
:,O
32149768,O
"


",O
201,O
.,O
World,O
J,O
Clin,O
Cases,O
.,O
2020,O
Feb,O
26;8(4):652657,O
.,O
doi,O
:,O
10.12998,O
wjcc.v8.i4.652,O
.,O
"

",O
Fear,O
can,O
be,O
more,O
harmful,O
than,O
the,O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
"
",O
in,O
controlling,O
the,O
corona,B-Disease_COVID-19
virus,I-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
epidemic,O
.,O
"

",O
Ren,O
SY(1,O
),O
",",O
Gao,O
RD(2,O
),O
",",O
Chen,O
YL(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Vascular,O
Surgery,O
",",O
Department,O
of,O
General,O
Surgery,O
",",O
Aviation,O
General,O
Hospital,O
",",O
"
",O
China,O
Medical,O
University,O
",",O
Beijing,O
100012,O
",",O
China,O
.,O
rens66@126.com,O
.,O
"
",O
(2)Vascular,O
Surgery,O
",",O
Department,O
of,O
General,O
Surgery,O
",",O
Aviation,O
General,O
Hospital,O
",",O
"
",O
China,O
Medical,O
University,O
",",O
Beijing,O
100012,O
",",O
China,O
.,O
"
",O
(3)College,O
of,O
Robotics,O
",",O
Beijing,O
Union,O
University,O
",",O
Beijing,O
100101,O
",",O
China,O
.,O
"

",O
The,O
current,O
corona,B-Disease_COVID-19
virus,I-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
outbreak,O
caused,O
by,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
coronavirus,O
2,O
started,O
in,O
Wuhan,O
",",O
China,O
in,O
December,O
2019,O
and,O
has,O
put,O
the,O
"
",O
world,O
on,O
alert,O
.,O
To,O
safeguard,O
Chinese,O
citizens,O
and,O
to,O
strengthen,O
global,O
health,O
"
",O
security,O
",",O
China,O
has,O
made,O
great,O
efforts,O
to,O
control,O
the,O
epidemic,O
.,O
Many,O
in,O
the,O
"
",O
global,O
community,O
have,O
joined,O
China,O
to,O
limit,O
the,O
epidemic,O
.,O
However,O
",",O
discrimination,O
"
",O
and,O
prejudice,O
driven,O
by,O
fear,O
or,O
misinformation,O
have,O
been,O
flowing,O
globally,O
",",O
"
",O
superseding,O
evidence,O
and,O
jeopardizing,O
the,O
antisevere,O
acute,O
respiratory,O
syndrome,O
"
",O
coronavirus,O
2,O
efforts,O
.,O
We,O
analyze,O
this,O
phenomenon,O
and,O
its,O
underlying,O
causes,O
and,O
"
",O
suggest,O
practical,O
solutions,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Baishideng,O
Publishing,O
Group,O
Inc.,O
All,O
rights,O
"
",O
reserved,O
.,O
"

",O
DOI,O
:,O
10.12998,O
wjcc.v8.i4.652,O
"
",O
PMCID,O
:,O
PMC7052559,O
"
",O
PMID,O
:,O
32149049,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflictofinterest,O
statement,O
:,O
The,O
authors,O
"
",O
declare,O
no,O
conflict,O
of,O
interests,O
.,O
"


",O
202,O
.,O
Osong,O
Public,O
Health,O
Res,O
Perspect,O
.,O
2020,O
Feb;11(1):6063,O
.,O
doi,O
:,O
"
",O
10.24171,O
j.phrp.2020.11.1.09,O
.,O
"

",O
Contact,O
Transmission,O
of,O
COVID19,B-Disease_COVID-19
in,O
South,O
Korea,O
:,O
Novel,O
Investigation,O
Techniques,O
"
",O
for,O
Tracing,O
Contacts,O
.,O
"

",O
COVID19,B-Disease_COVID-19
National,O
Emergency,O
Response,O
Center,O
",",O
Epidemiology,O
&,O
Case,O
Management,O
Team,O
",",O
"
",O
Korea,O
Centers,O
for,O
Disease,O
Control,O
&,O
Prevention,O
.,O
"

",O
In,O
the,O
epidemiological,O
investigation,O
of,O
an,O
infectious,O
disease,O
",",O
investigating,O
",",O
"
",O
classifying,O
",",O
tracking,O
",",O
and,O
managing,O
contacts,O
by,O
identifying,O
the,O
patient,O
's,O
route,O
"
",O
are,O
important,O
for,O
preventing,O
further,O
transmission,O
of,O
the,O
disease,O
.,O
However,O
",",O
"
",O
omissions,O
and,O
errors,O
in,O
previous,O
activities,O
can,O
occur,O
when,O
the,O
investigation,O
is,O
"
",O
performed,O
through,O
only,O
a,O
proxy,O
interview,O
with,O
the,O
patient,O
.,O
To,O
overcome,O
these,O
"
",O
limitations,O
",",O
methods,O
that,O
can,O
objectively,O
verify,O
the,O
patient,O
's,O
claims,O
(,O
medical,O
"
",O
facility,O
records,O
",",O
Global,O
Positioning,O
System,O
",",O
card,O
transactions,O
",",O
and,O
"
",O
closedcircuit,O
television,O
),O
were,O
used,O
for,O
the,O
recent,O
ongoing,O
coronavirus,O
disease,O
"
",O
2019,O
contact,O
investigations,O
in,O
South,O
Korea,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
",",O
Korea,O
Centers,O
for,O
Disease,O
Control,O
and,O
Prevention,O
.,O
"

",O
DOI,O
:,O
10.24171,O
j.phrp.2020.11.1.09,O
"
",O
PMCID,O
:,O
PMC7045882,O
"
",O
PMID,O
:,O
32149043,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflicts,O
of,O
Interest,O
The,O
authors,O
declare,O
no,O
"
",O
competing,O
financial,O
interests,O
.,O
"


",O
203,O
.,O
Osong,O
Public,O
Health,O
Res,O
Perspect,O
.,O
2020,O
Feb;11(1):814,O
.,O
doi,O
:,O
"
",O
10.24171,O
j.phrp.2020.11.1.03,O
.,O
"

",O
Early,O
Epidemiological,O
and,O
Clinical,O
Characteristics,O
of,O
28,O
Cases,O
of,O
Coronavirus,O
"
",O
Disease,O
in,O
South,O
Korea,O
.,O
"

",O
COVID19,B-Disease_COVID-19
National,O
Emergency,O
Response,O
Center,O
",",O
Epidemiology,O
and,O
Case,O
Management,O
"
",O
Team,O
",",O
Korea,O
Centers,O
for,O
Disease,O
Control,O
and,O
Prevention,O
.,O
"

",O
Objectives,O
:,O
The,O
first,O
confirmed,O
case,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
in,O
"
",O
South,O
Korea,O
was,O
reported,O
in,O
January,O
2020,O
",",O
with,O
28,O
confirmed,O
cases,O
reported,O
as,O
of,O
"
",O
February,O
14th,O
",",O
2020,O
.,O
The,O
epidemiological,O
and,O
clinical,O
characteristics,O
of,O
all,O
28,O
"
",O
cases,O
were,O
analyzed,O
in,O
response,O
to,O
this,O
disease,O
.,O
"
",O
Methods,O
:,O
The,O
epidemiological,O
characteristics,O
and,O
early,O
clinical,O
features,O
of,O
the,O
"
",O
28,O
patients,O
from,O
Korea,O
with,O
confirmed,O
COVID19,B-Disease_COVID-19
were,O
analyzed,O
using,O
COVID19,B-Disease_COVID-19
"
",O
reporting,O
and,O
surveillance,O
data,O
and,O
the,O
epidemiological,O
investigation,O
reports,O
"
",O
prepared,O
by,O
the,O
rapid,O
response,O
team,O
.,O
"
",O
Results,O
:,O
There,O
were,O
16,O
patients,O
that,O
entered,O
Korea,O
from,O
foreign,O
countries,O
:,O
Wuhan,O
",",O
"
",O
China,O
(,O
11,O
patients,O
),O
",",O
Zhuhai,O
",",O
China,O
",",O
(,O
1,O
patient,O
),O
",",O
Singapore,O
(,O
2,O
patients,O
),O
",",O
Japan,O
(,O
1,O
"
",O
patient,O
),O
",",O
and,O
Thailand,O
(,O
1,O
patient,O
),O
.,O
The,O
early,O
symptoms,O
were,O
fever,O
",",O
sore,O
throat,O
",",O
"
",O
cough,O
or,O
sputum,O
production,O
",",O
chills,O
",",O
and,O
muscle,O
ache,O
.,O
Three,O
patients,O
were,O
"
",O
asymptomatic,O
",",O
however,O
",",O
18,O
developed,O
pneumonia,O
.,O
Of,O
the,O
28,O
cases,O
",",O
16,O
were,O
index,O
"
",O
cases,O
imported,O
from,O
abroad,O
",",O
with,O
10,O
cases,O
of,O
secondary,O
infection,O
originating,O
in,O
"
",O
Korea,O
",",O
and,O
the,O
route,O
of,O
transmission,O
still,O
under,O
investigation,O
for,O
2,O
patients,O
.,O
"
",O
The,O
10,O
patients,O
with,O
secondary,O
infection,O
were,O
infected,O
from,O
contact,O
with,O
family,O
"
",O
members,O
or,O
acquaintances,O
of,O
primary,O
patients,O
",",O
and,O
the,O
suspected,O
sites,O
of,O
"
",O
transmission,O
were,O
mostly,O
at,O
home,O
.,O
"
",O
Conclusion,O
:,O
COVID19,B-Disease_COVID-19
in,O
Korea,O
was,O
spread,O
by,O
16,O
infected,O
individuals,O
traveling,O
"
",O
from,O
other,O
countries,O
",",O
leading,O
to,O
secondgeneration,O
cases,O
.,O
The,O
initial,O
symptoms,O
"
",O
were,O
mostly,O
minor,O
",",O
but,O
the,O
disease,O
was,O
infectious,O
at,O
this,O
stage,O
",",O
resulting,O
from,O
"
",O
close,O
contact,O
",",O
particularly,O
at,O
home,O
.,O
Establishing,O
an,O
early,O
detection,O
strategy,O
for,O
"
",O
COVID19,B-Disease_COVID-19
is,O
crucial,O
for,O
managing,O
the,O
transmission,O
of,O
the,O
disease,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
",",O
Korea,O
Centers,O
for,O
Disease,O
Control,O
and,O
Prevention,O
.,O
"

",O
DOI,O
:,O
10.24171,O
j.phrp.2020.11.1.03,O
"
",O
PMCID,O
:,O
PMC7045878,O
"
",O
PMID,O
:,O
32149037,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflicts,O
of,O
Interest,O
The,O
authors,O
have,O
no,O
"
",O
conflicts,O
of,O
interest,O
to,O
declare,O
.,O
"


",O
204,O
.,O
Osong,O
Public,O
Health,O
Res,O
Perspect,O
.,O
2020,O
Feb;11(1):37,O
.,O
doi,O
:,O
"
",O
10.24171,O
j.phrp.2020.11.1.02,O
.,O
"

",O
Identification,O
of,O
Coronavirus,O
Isolated,O
from,O
a,O
Patient,O
in,O
Korea,O
with,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Kim,O
JM(1,O
),O
",",O
Chung,O
YS(1,O
),O
",",O
Jo,O
HJ(1,O
),O
",",O
Lee,O
NJ(1,O
),O
",",O
Kim,O
MS(1,O
),O
",",O
Woo,O
SH(1,O
),O
",",O
Park,O
S(1,O
),O
",",O
Kim,O
"
",O
JW(2,O
),O
",",O
Kim,O
HM(1,O
),O
",",O
Han,O
MG(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Viral,O
Diseases,O
",",O
Center,O
for,O
Laboratory,O
Control,O
of,O
Infectious,O
"
",O
Diseases,O
",",O
Korea,O
Centers,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Cheongju,O
",",O
Korea,O
.,O
"
",O
(2)Division,O
of,O
Biosafety,O
Evaluation,O
and,O
Control,O
",",O
National,O
Institute,O
of,O
Health,O
",",O
"
",O
Korea,O
Centers,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Cheongju,O
",",O
Korea,O
.,O
"

",O
Objectives,O
:,O
Following,O
reports,O
of,O
patients,O
with,O
unexplained,O
pneumonia,O
at,O
the,O
end,O
"
",O
of,O
December,O
2019,O
in,O
Wuhan,O
",",O
China,O
",",O
the,O
causative,O
agent,O
was,O
identified,O
as,O
"
",O
coronavirus,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
and,O
the,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
was,O
named,O
"
",O
COVID19,B-Disease_COVID-19
by,O
the,O
World,O
Health,O
Organization,O
.,O
Putative,O
patients,O
with,O
COVID19,B-Disease_COVID-19
have,O
"
",O
been,O
identified,O
in,O
South,O
Korea,O
",",O
and,O
attempts,O
have,O
been,O
made,O
to,O
isolate,O
the,O
"
",O
pathogen,O
from,O
these,O
patients,O
.,O
"
",O
Methods,O
:,O
Upper,O
and,O
lower,O
respiratory,O
tract,O
secretion,O
samples,O
from,O
putative,O
"
",O
patients,O
with,O
COVID19,B-Disease_COVID-19
were,O
inoculated,O
onto,O
cells,O
to,O
isolate,O
the,O
virus,O
.,O
Full,O
"
",O
genome,O
sequencing,O
and,O
electron,O
microscopy,O
were,O
used,O
to,O
identify,O
the,O
virus,O
.,O
"
",O
Results,O
:,O
The,O
virus,O
replicated,O
in,O
Vero,O
cells,O
and,O
cytopathic,O
effects,O
were,O
observed,O
.,O
"
",O
Full,O
genome,O
sequencing,O
showed,O
that,O
the,O
virus,O
genome,O
exhibited,O
sequence,O
homology,O
"
",O
of,O
more,O
than,O
99.9,O
%,O
with,O
SARSCoV2,B-Virus_SARS-CoV-2
which,O
was,O
isolated,O
from,O
patients,O
from,O
other,O
"
",O
countries,O
",",O
for,O
instance,O
China,O
.,O
Sequence,O
homology,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
with,O
SARSCoV,O
",",O
and,O
"
",O
MERSCoV,O
was,O
77.5,O
%,O
and,O
50,O
%,O
",",O
respectively,O
.,O
Coronavirusspecific,O
morphology,O
was,O
"
",O
observed,O
by,O
electron,O
microscopy,O
in,O
virusinfected,O
Vero,O
cells,O
.,O
"
",O
Conclusion,O
:,O
SARSCoV2,B-Virus_SARS-CoV-2
was,O
isolated,O
from,O
putative,O
patients,O
with,O
unexplained,O
"
",O
pneumonia,O
and,O
intermittent,O
coughing,O
and,O
fever,O
.,O
The,O
isolated,O
virus,O
was,O
named,O
"
",O
BetaCoV,O
Korea,O
KCDC03,O
2020,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
",",O
Korea,O
Centers,O
for,O
Disease,O
Control,O
and,O
Prevention,O
.,O
"

",O
DOI,O
:,O
10.24171,O
j.phrp.2020.11.1.02,O
"
",O
PMCID,O
:,O
PMC7045880,O
"
",O
PMID,O
:,O
32149036,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflicts,O
of,O
Interest,O
The,O
authors,O
have,O
no,O
"
",O
conflicts,O
of,O
interest,O
to,O
declare,O
.,O
"


",O
205,O
.,O
Osong,O
Public,O
Health,O
Res,O
Perspect,O
.,O
2020,O
Feb;11(1):12,O
.,O
doi,O
:,O
"
",O
10.24171,O
j.phrp.2020.11.1.01,O
.,O
"

",O
Effectiveness,O
for,O
the,O
Response,O
to,O
COVID19,B-Disease_COVID-19
:,O
The,O
MERS,O
Outbreak,O
Containment,O
"
",O
Procedures,O
.,O
"

",O
Cho,O
HW(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Osong,O
Public,O
Health,O
and,O
Research,O
Perspectives,O
",",O
Korea,O
Centers,O
for,O
Disease,O
"
",O
Control,O
and,O
Prevention,O
",",O
Cheongju,O
",",O
Korea,O
.,O
"
",O
(2)College,O
of,O
Medicine,O
",",O
Eulji,O
University,O
",",O
Daejeon,O
",",O
Korea,O
.,O
"

",O
DOI,O
:,O
10.24171,O
j.phrp.2020.11.1.01,O
"
",O
PMCID,O
:,O
PMC7045877,O
"
",O
PMID,O
:,O
32149035,O
"


",O
206,O
.,O
Emerg,O
Microbes,O
Infect,O
.,O
2020,O
Dec;9(1):545547,O
.,O
doi,O
:,O
10.108,O
22221751.2020.1738279,O
.,O
"

",O
Is,O
SARSCoV2,B-Virus_SARS-CoV-2
originated,O
from,O
laboratory,O
?,O
A,O
rebuttal,O
to,O
the,O
claim,O
of,O
formation,O
"
",O
via,O
laboratory,O
recombination,O
.,O
"

",O
Hao,O
P(1,O
),O
",",O
Zhong,O
W(2,O
),O
",",O
Song,O
S(1,O
),O
",",O
Fan,O
S(2,O
),O
",",O
Li,O
X(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Molecular,O
Virology,O
and,O
Immunology,O
",",O
Institute,O
Pasteur,O
of,O
"
",O
Shanghai,O
",",O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
"
",O
Shanghai,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)National,O
Engineering,O
Research,O
Center,O
For,O
the,O
Emergence,O
Drugs,O
",",O
Beijing,O
"
",O
Institute,O
of,O
Pharmacology,O
and,O
Toxicology,O
",",O
Beijing,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Synthetic,O
Biology,O
",",O
CAS,O
Center,O
for,O
Excellence,O
in,O
Molecular,O
"
",O
Plant,O
Sciences,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Shanghai,O
",",O
People,O
's,O
Republic,O
of,O
"
",O
China,O
.,O
"

",O
DOI,O
:,O
10.108,O
22221751.2020.1738279,O
"
",O
PMID,O
:,O
32148173,O
"


",O
207,O
.,O
Emerg,O
Microbes,O
Infect,O
.,O
2020,O
Dec;9(1):542544,O
.,O
doi,O
:,O
10.108,O
22221751.2020.1737580,O
.,O
"

",O
Timely,O
development,O
of,O
vaccines,O
against,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Lu,O
S(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Laboratory,O
of,O
Nucleic,O
Acid,O
Vaccines,O
",",O
Department,O
of,O
Medicine,O
",",O
University,O
of,O
"
",O
Massachusetts,O
Medical,O
School,O
",",O
Worcester,O
",",O
MA,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.108,O
22221751.2020.1737580,O
"
",O
PMID,O
:,O
32148172,O
"


",O
208,O
.,O
Acad,O
Emerg,O
Med,O
.,O
2020,O
Mar,O
9,O
.,O
doi,O
:,O
10.1111,O
acem.13958,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Emergency,O
management,O
of,O
the,O
prevention,O
and,O
control,O
of,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
"
",O
in,O
specialized,O
branches,O
of,O
hospital,O
.,O
"

",O
Qing,O
MX(1,O
),O
",",O
Li,O
S(1,O
),O
",",O
Yu,O
S(1,O
),O
",",O
Ouyang,O
Y(1,O
),O
",",O
Zeng,O
L(1,O
),O
",",O
Li,O
X(1,O
),O
",",O
Li,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)West,O
China,O
Hospital,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
",",O
610041,O
",",O
China,O
.,O
"

",O
In,O
December,O
2019,O
",",O
an,O
epidemic,O
of,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
(,O
NCP,B-Disease_COVID-19
),O
broke,O
out,O
in,O
"
",O
Wuhan,O
",",O
Hubei,O
Province,O
.,O
The,O
outbreak,O
was,O
severe,O
and,O
coincided,O
with,O
the,O
Spring,O
"
",O
Festival,O
travel,O
season,O
.,O
On,O
January,O
15,O
",",O
2020,O
",",O
the,O
West,O
China,O
Hospital,O
of,O
Sichuan,O
"
",O
University,O
",",O
a,O
large,O
hospital,O
in,O
China,O
",",O
held,O
a,O
seminar,O
on,O
prevention,O
and,O
control,O
"
",O
in,O
accordance,O
with,O
the,O
requirements,O
of,O
the,O
National,O
Health,O
Commission,O
on,O
"
",O
Prevention,O
and,O
Control,O
.,O
On,O
January,O
16,O
",",O
the,O
emergency,O
plan,O
for,O
the,O
prevention,O
and,O
"
",O
treatment,O
of,O
NCP,B-Disease_COVID-19
in,O
West,O
China,O
Hospital,O
of,O
Sichuan,O
University,O
was,O
formulated,O
for,O
"
",O
the,O
first,O
time,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1111,O
acem.13958,O
"
",O
PMID,O
:,O
32147890,O
"


",O
209,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
9,O
.,O
pii,O
:,O
ciaa227,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa227,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Diagnosis,O
and,O
Management,O
of,O
First,O
Case,O
of,O
COVID19,B-Disease_COVID-19
in,O
Canada,O
:,O
Lessons,O
applied,O
"
",O
from,O
SARS,O
.,O
"

",O
MarchandSenÃ©cal,O
X(1,O
),O
",",O
Kozak,O
R(1,O
),O
",",O
Mubareka,O
S(1)(2,O
),O
",",O
Salt,O
N(1,O
),O
",",O
Gubbay,O
JB(3,O
),O
",",O
"
",O
Eshaghi,O
A(3,O
),O
",",O
Allen,O
V(2)(3,O
),O
",",O
Li,O
Y(4,O
),O
",",O
Bastien,O
N(4,O
),O
",",O
Gilmour,O
M(4,O
),O
",",O
Ozaldin,O
O(5,O
),O
",",O
"
",O
Leis,O
JA(1)(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Sunnybrook,O
Health,O
Sciences,O
Centre,O
",",O
Toronto,O
",",O
ON,O
",",O
Canada,O
.,O
"
",O
(2)Department,O
of,O
Laboratory,O
Medicine,O
and,O
Pathobiology,O
",",O
University,O
of,O
Toronto,O
",",O
"
",O
Toronto,O
",",O
ON,O
",",O
Canada,O
.,O
"
",O
(3)Public,O
Health,O
Ontario,O
Laboratory,O
",",O
Toronto,O
",",O
ON,O
",",O
Canada,O
.,O
"
",O
(4)National,O
Microbiology,O
Laboratory,O
",",O
Public,O
Health,O
Agency,O
of,O
Canada,O
",",O
Winnipeg,O
",",O
"
",O
MB,O
",",O
Canada,O
.,O
"
",O
(5)Communicable,O
Disease,O
Control,O
",",O
Toronto,O
Public,O
Health,O
",",O
Toronto,O
",",O
ON,O
",",O
Canada,O
.,O
"
",O
(6)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Medicine,O
",",O
University,O
of,O
"
",O
Toronto,O
",",O
Toronto,O
",",O
ON,O
",",O
Canada,O
.,O
"

",O
We,O
report,O
diagnosis,O
and,O
management,O
of,O
the,O
first,O
laboratoryconfirmed,O
case,O
of,O
"
",O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
hospitalized,O
in,O
Toronto,O
",",O
Canada,O
.,O
No,O
"
",O
healthcareassociated,O
transmission,O
occurred,O
.,O
In,O
the,O
face,O
of,O
a,O
potential,O
pandemic,O
"
",O
of,O
COVID19,B-Disease_COVID-19
",",O
we,O
suggest,O
sustainable,O
and,O
scalable,O
control,O
measures,O
developed,O
based,O
"
",O
on,O
lessons,O
learned,O
from,O
SARS,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa227,O
"
",O
PMID,O
:,O
32147731,O
"


",O
210,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
ciaa229,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa229,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
"""",O
The,O
Art,O
of,O
War,O
"""",O
in,O
the,O
Era,O
of,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
Maxwell,O
DN(1,O
),O
",",O
Perl,O
TM(1,O
),O
",",O
Cutrell,O
JB(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infectious,O
Diseases,O
and,O
Geographic,O
Medicine,O
",",O
Department,O
of,O
"
",O
Medicine,O
",",O
University,O
of,O
Texas,O
Southwestern,O
Medical,O
Center,O
",",O
Dallas,O
",",O
TX,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa229,O
"
",O
PMID,O
:,O
32147715,O
"


",O
211,O
.,O
J,O
Burn,O
Care,O
Res,O
.,O
2020,O
Mar,O
9,O
.,O
pii,O
:,O
iraa039,O
.,O
doi,O
:,O
10.1093,O
jbcr,O
iraa039,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Characteristics,O
and,O
Evolution,O
of,O
Microbial,O
Drug,O
Resistance,O
in,O
Burnt,O
Patients,O
.,O
"

",O
Huang,O
Z(1,O
),O
",",O
Gan,O
Y(2,O
),O
",",O
Yang,O
K(3,O
),O
",",O
Gao,O
L(2,O
),O
",",O
Xiong,O
B(1,O
),O
",",O
Li,O
H(1,O
),O
",",O
Niu,O
X(3,O
),O
",",O
Wang,O
"
",O
K(2,O
),O
",",O
Lai,O
W(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Deparment,O
of,O
Burns,O
and,O
wound,O
repair,O
Surgery,O
",",O
Guangdong,O
Provincial,O
People,O
's,O
"
",O
Hospital,O
",",O
Guangdong,O
Academy,O
Medical,O
Sciences,O
",",O
Guangzhou,O
",",O
P.R.,O
China,O
.,O
"
",O
(2)Lin,O
He,O
's,O
Academician,O
Workstation,O
of,O
New,O
Medicine,O
and,O
Clinical,O
Translation,O
at,O
"
",O
The,O
Third,O
Affiliated,O
Hospital,O
",",O
Guangzhou,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
P.R.,O
"
",O
China,O
.,O
"
",O
(3)College,O
of,O
Informatics,O
",",O
Huazhong,O
Agriculture,O
University,O
",",O
Wuhan,O
",",O
P.R.,O
China,O
.,O
"

",O
Wound,O
infection,O
is,O
a,O
serious,O
complication,O
in,O
burnt,O
injury,O
",",O
which,O
is,O
a,O
common,O
form,O
"
",O
of,O
trauma,O
and,O
an,O
important,O
public,O
health,O
issue,O
.,O
We,O
investigated,O
samples,O
from,O
burn,O
"
",O
and,O
nonburn,O
wounds,O
for,O
microbial,O
characteristics,O
and,O
temporal,O
trends,O
of,O
"
",O
antibiotic,O
resistance,O
.,O
Wound,O
samples,O
were,O
collected,O
from,O
369,O
burnt,O
patients,O
and,O
"
",O
927,O
nonburnt,O
individuals,O
admitted,O
from,O
2007,O
to,O
2017,O
.,O
Higher,O
frequency,O
of,O
A.,O
"
",O
baumannii,O
",",O
K.,O
pneumonia,O
and,O
P.,O
aeruginosa,O
were,O
observed,O
in,O
samples,O
from,O
burnt,O
"
",O
individuals,O
when,O
compared,O
to,O
those,O
from,O
nonburnt,O
patients,O
.,O
The,O
prevalence,O
of,O
"
",O
different,O
groups,O
of,O
bacteria,O
varied,O
when,O
the,O
samples,O
were,O
stratified,O
according,O
to,O
"
",O
age,O
and,O
sex,O
.,O
The,O
antimicrobial,O
resistance,O
profiles,O
showed,O
significant,O
difference,O
"
",O
between,O
burnt,O
and,O
nonburnt,O
patients,O
.,O
The,O
different,O
temporal,O
trends,O
of,O
"
",O
antimicrobial,O
resistance,O
rates,O
were,O
also,O
found,O
",",O
which,O
may,O
be,O
critical,O
for,O
proper,O
"
",O
selection,O
of,O
antibiotics,O
in,O
burn,O
treatment,O
.,O
The,O
present,O
study,O
suggested,O
that,O
"
",O
frequent,O
pathogens,O
and,O
antibacterial,O
resistance,O
evolution,O
could,O
differ,O
between,O
"
",O
burn,O
wounds,O
and,O
other,O
wounds,O
.,O
Therefore,O
",",O
periodic,O
surveillance,O
of,O
antibiotic,O
"
",O
resistance,O
patterns,O
in,O
burn,O
unit,O
might,O
help,O
physicians,O
properly,O
select,O
of,O
"
",O
antibiotics,O
for,O
treatment,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
on,O
behalf,O
of,O
the,O
"
",O
American,O
Burn,O
Association,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
please,O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jbcr,O
iraa039,O
"
",O
PMID,O
:,O
32147708,O
"


",O
212,O
.,O
Drug,O
Discov,O
Ther,O
.,O
2020;14(1):5860,O
.,O
doi,O
:,O
10.5582,O
ddt.2020.01012,O
.,O
"

",O
Discovering,O
drugs,O
to,O
treat,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
Dong,O
L(1,O
),O
",",O
Hu,O
S(2,O
),O
",",O
Gao,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pharmacology,O
",",O
School,O
of,O
Pharmacy,O
",",O
Qingdao,O
University,O
",",O
Qingdao,O
",",O
"
",O
Shandong,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pathology,O
",",O
the,O
Affiliated,O
Hospital,O
of,O
Qingdao,O
University,O
",",O
"
",O
Qingdao,O
",",O
Shandong,O
",",O
China,O
.,O
"

",O
The,O
SARSCoV2,B-Virus_SARS-CoV-2
virus,O
emerged,O
in,O
December,O
2019,O
and,O
then,O
spread,O
rapidly,O
worldwide,O
",",O
"
",O
particularly,O
to,O
China,O
",",O
Japan,O
",",O
and,O
South,O
Korea,O
.,O
Scientists,O
are,O
endeavoring,O
to,O
find,O
"
",O
antivirals,O
specific,O
to,O
the,O
virus,O
.,O
Several,O
drugs,O
such,O
as,O
chloroquine,O
",",O
arbidol,O
",",O
"
",O
remdesivir,O
",",O
and,O
favipiravir,O
are,O
currently,O
undergoing,O
clinical,O
studies,O
to,O
test,O
"
",O
their,O
efficacy,O
and,O
safety,O
in,O
the,O
treatment,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
"
",O
in,O
China,O
;,O
some,O
promising,O
results,O
have,O
been,O
achieved,O
thus,O
far,O
.,O
This,O
article,O
"
",O
summarizes,O
agents,O
with,O
potential,O
efficacy,O
against,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
DOI,O
:,O
10.5582,O
ddt.2020.01012,O
"
",O
PMID,O
:,O
32147628,O
"


",O
213,O
.,O
J,O
Thorac,O
Oncol,O
.,O
2020,O
Mar,O
5,O
.,O
pii,O
:,O
S15560864(20)30191X,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jtho.2020.02.025,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
Treatment,O
and,O
Outcome,O
of,O
a,O
Lung,O
Cancer,O
Patient,O
Infected,O
with,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Zhang,O
H(1,O
),O
",",O
Huang,O
Y(2,O
),O
",",O
Xie,O
C(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiation,O
and,O
Medical,O
Oncology,O
",",O
Hubei,O
Key,O
Laboratory,O
of,O
Tumour,O
"
",O
Biological,O
Behaviors,O
",",O
Hubei,O
Cancer,O
Clinical,O
Study,O
Center,O
",",O
Zhongnan,O
Hospital,O
of,O
"
",O
Wuhan,O
University,O
",",O
Wuhan,O
430071,O
",",O
Peoples,O
Republic,O
of,O
China,O
.,O
"
",O
(2)Department,O
of,O
Medical,O
Oncology,O
",",O
State,O
Key,O
Laboratory,O
of,O
Oncology,O
in,O
South,O
"
",O
China,O
",",O
Collaborative,O
Innovation,O
Center,O
for,O
Cancer,O
Medicine,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
Cancer,O
Center,O
",",O
Guangzhou,O
510060,O
",",O
Peoples,O
Republic,O
of,O
China,O
.,O
"
",O
(3)Department,O
of,O
Radiation,O
and,O
Medical,O
Oncology,O
",",O
Hubei,O
Key,O
Laboratory,O
of,O
Tumour,O
"
",O
Biological,O
Behaviors,O
",",O
Hubei,O
Cancer,O
Clinical,O
Study,O
Center,O
",",O
Zhongnan,O
Hospital,O
of,O
"
",O
Wuhan,O
University,O
",",O
Wuhan,O
430071,O
",",O
Peoples,O
Republic,O
of,O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
chxie_65@hotmail.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jtho.2020.02.025,O
"
",O
PMID,O
:,O
32147577,O
"


",O
214,O
.,O
Int,O
J,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
5,O
.,O
pii,O
:,O
S12019712(20)301223,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ijid.2020.03.003,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Recurrence,O
of,O
positive,O
SARSCoV2,B-Virus_SARS-CoV-2
RNA,O
in,O
COVID19,B-Disease_COVID-19
:,O
A,O
case,O
report,O
.,O
"

",O
Chen,O
D(1,O
),O
",",O
Xu,O
W(1,O
),O
",",O
Lei,O
Z(1,O
),O
",",O
Huang,O
Z(1,O
),O
",",O
Liu,O
J(1,O
),O
",",O
Gao,O
Z(1,O
),O
",",O
Peng,O
L(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
Third,O
Affiliated,O
Hospital,O
of,O
Sun,O
"
",O
Yatsen,O
University,O
",",O
Guangzhou,O
510630,O
",",O
Guangdong,O
",",O
China,O
;,O
Guangdong,O
Key,O
Laboratory,O
"
",O
of,O
Liver,O
Disease,O
Research,O
",",O
The,O
Third,O
Affiliated,O
Hospital,O
of,O
Sun,O
Yatsen,O
"
",O
University,O
",",O
Guangzhou,O
510630,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
Third,O
Affiliated,O
Hospital,O
of,O
Sun,O
"
",O
Yatsen,O
University,O
",",O
Guangzhou,O
510630,O
",",O
Guangdong,O
",",O
China,O
;,O
Guangdong,O
Key,O
Laboratory,O
"
",O
of,O
Liver,O
Disease,O
Research,O
",",O
The,O
Third,O
Affiliated,O
Hospital,O
of,O
Sun,O
Yatsen,O
"
",O
University,O
",",O
Guangzhou,O
510630,O
",",O
Guangdong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
pliang@mail.sysu.edu.cn,O
.,O
"

",O
The,O
ongoing,O
outbreak,O
of,O
COVID19,B-Disease_COVID-19
that,O
began,O
in,O
Wuhan,O
",",O
China,O
",",O
has,O
constituted,O
a,O
"
",O
Public,O
Health,O
Emergency,O
of,O
International,O
Concern,O
",",O
with,O
cases,O
confirmed,O
in,O
"
",O
multiple,O
countries,O
.,O
Currently,O
patients,O
are,O
the,O
main,O
source,O
of,O
infection,O
.,O
We,O
"
",O
report,O
a,O
confirmed,O
case,O
of,O
COVID19,B-Disease_COVID-19
whose,O
oropharyngeal,O
swab,O
test,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
RNA,O
turned,O
positive,O
in,O
convalescence,O
.,O
This,O
case,O
highlights,O
the,O
importance,O
of,O
"
",O
dynamic,O
surveillance,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
RNA,O
for,O
infectivity,O
assessment,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
Ltd.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijid.2020.03.003,O
"
",O
PMID,O
:,O
32147538,O
"


",O
215,O
.,O
Int,O
J,O
Antimicrob,O
Agents,O
.,O
2020,O
Mar,O
5:105933,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ijantimicag.2020.105933,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Arguments,O
in,O
favor,O
of,O
remdesivir,O
for,O
treating,O
SARSCoV2,B-Virus_SARS-CoV-2
infections,O
.,O
"

",O
Ko,O
WC(1,O
),O
",",O
Rolain,O
JM(2,O
),O
",",O
Lee,O
NY(1,O
),O
",",O
Chen,O
PL(1,O
),O
",",O
Huang,O
CT(3,O
),O
",",O
Lee,O
PI(4,O
),O
",",O
Hsueh,O
"
",O
PR(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medicine,O
",",O
College,O
of,O
Medicine,O
",",O
National,O
Cheng,O
Kung,O
University,O
",",O
"
",O
Tainan,O
",",O
Taiwan,O
;,O
Center,O
for,O
Infection,O
Control,O
and,O
Department,O
of,O
Internal,O
Medicine,O
",",O
"
",O
National,O
Cheng,O
Kung,O
University,O
Hospital,O
",",O
Tainan,O
",",O
Taiwan,O
.,O
"
",O
(2)AixMarseille,O
Univ,O
.,O
",",O
Institut,O
de,O
Recherche,O
pour,O
le,O
DÃ©veloppement,O
(,O
IRD,O
),O
",",O
"
",O
Assistance,O
7,O
Publique,O
 ,O
HÃ´pitaux,O
de,O
Marseille,O
(,O
APHM,O
),O
",",O
MEPHI,O
",",O
27,O
boulevard,O
Jean,O
"
",O
Moulin,O
",",O
13005,O
8,O
Marseille,O
",",O
France,O
;,O
IHU,O
MÃ©diterranÃ©e,O
Infection,O
",",O
1921,O
boulevard,O
"
",O
Jean,O
Moulin,O
",",O
13005,O
Marseille,O
",",O
France,O
.,O
"
",O
(3)Department,O
of,O
Infectious,O
Diseases,O
",",O
Chang,O
Gung,O
Memorial,O
Hospital,O
",",O
Taoyuan,O
",",O
"
",O
Taiwan,O
.,O
"
",O
(4)Department,O
of,O
Pediatrics,O
",",O
National,O
Taiwan,O
University,O
Children,O
's,O
Hospital,O
and,O
"
",O
National,O
Taiwan,O
University,O
College,O
of,O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
.,O
"
",O
(5)Department,O
of,O
Infectious,O
Diseases,O
",",O
Chang,O
Gung,O
Memorial,O
Hospital,O
",",O
Taoyuan,O
",",O
"
",O
Taiwan,O
;,O
Department,O
of,O
Pediatrics,O
",",O
National,O
Taiwan,O
University,O
Children,O
's,O
Hospital,O
"
",O
and,O
National,O
Taiwan,O
University,O
College,O
of,O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
;,O
Department,O
of,O
"
",O
Laboratory,O
Medicine,O
",",O
National,O
Taiwan,O
University,O
Hospital,O
",",O
National,O
Taiwan,O
"
",O
University,O
College,O
of,O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
;,O
Department,O
of,O
Internal,O
Medicine,O
",",O
"
",O
National,O
Taiwan,O
University,O
Hospital,O
",",O
National,O
Taiwan,O
University,O
College,O
of,O
"
",O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
.,O
Electronic,O
address,O
:,O
hsporen@ntu.edu.tw,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijantimicag.2020.105933,O
"
",O
PMID,O
:,O
32147516,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
None,O
declared,O
.,O
"


",O
216,O
.,O
Antiviral,O
Res,O
.,O
2020,O
Mar,O
5;177:104762,O
.,O
doi,O
:,O
10.1016,O
j.antiviral.2020.104762,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Of,O
chloroquine,O
and,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Touret,O
F(1,O
),O
",",O
de,O
Lamballerie,O
X(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)UnitÃ©,O
des,O
Virus,O
Emergents,O
",",O
UVE,O
:,O
Aix,O
Marseille,O
Univ,O
",",O
IRD,O
190,O
",",O
INSERM,O
1207,O
",",O
IHU,O
"
",O
MÃ©diterranÃ©e,O
Infection,O
",",O
13005,O
",",O
Marseille,O
",",O
France,O
.,O
Electronic,O
address,O
:,O
"
",O
franck.touret@univamu.fr,O
.,O
"
",O
(2)UnitÃ©,O
des,O
Virus,O
Emergents,O
",",O
UVE,O
:,O
Aix,O
Marseille,O
Univ,O
",",O
IRD,O
190,O
",",O
INSERM,O
1207,O
",",O
IHU,O
"
",O
MÃ©diterranÃ©e,O
Infection,O
",",O
13005,O
",",O
Marseille,O
",",O
France,O
.,O
Electronic,O
address,O
:,O
"
",O
xavier.delamballerie@univamu.fr,O
.,O
"

",O
Recent,O
publications,O
have,O
brought,O
attention,O
to,O
the,O
possible,O
benefit,O
of,O
"
",O
chloroquine,O
",",O
a,O
broadly,O
used,O
antimalarial,O
drug,O
",",O
in,O
the,O
treatment,O
of,O
patients,O
"
",O
infected,O
by,O
the,O
novel,O
emerged,O
coronavirus,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
.,O
The,O
scientific,O
community,O
"
",O
should,O
consider,O
this,O
information,O
in,O
light,O
of,O
previous,O
experiments,O
with,O
"
",O
chloroquine,O
in,O
the,O
field,O
of,O
antiviral,O
research,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.antiviral.2020.104762,O
"
",O
PMID,O
:,O
32147496,O
"


",O
217,O
.,O
Antiviral,O
Res,O
.,O
2020,O
Mar,O
5:104761,O
.,O
doi,O
:,O
10.1016,O
j.antiviral.2020.104761,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
SOX9,O
represses,O
hepatitis,O
B,O
virus,O
replication,O
through,O
binding,O
to,O
HBV,O
EnhII,O
Cp,O
and,O
"
",O
inhibiting,O
the,O
promoter,O
activity,O
.,O
"

",O
Yang,O
H(1,O
),O
",",O
Zhou,O
Y(1,O
),O
",",O
Mo,O
J(1,O
),O
",",O
Xiang,O
Q(1,O
),O
",",O
Qin,O
M(1,O
),O
",",O
Liu,O
W(1,O
),O
",",O
Shang,O
J(1,O
),O
",",O
Yang,O
"
",O
Q(1,O
),O
",",O
Xu,O
W(1,O
),O
",",O
Ge,O
Y(1,O
),O
",",O
Tan,O
Q(2,O
),O
",",O
Wu,O
K(3,O
),O
",",O
Liu,O
Y(4,O
),O
",",O
Wu,O
J(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
430072,O
",",O
China,O
.,O
"
",O
(2)Guangdong,O
Longfan,O
Biological,O
Science,O
and,O
Technology,O
Company,O
",",O
Shunde,O
District,O
",",O
"
",O
Foshan,O
",",O
528315,O
",",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
430072,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
wukailang@whu.edu.cn,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
430072,O
",",O
China,O
;,O
Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Institute,O
"
",O
of,O
Medical,O
Microbiology,O
",",O
Jinan,O
University,O
",",O
Guangzhou,O
",",O
510632,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
mvlwu@whu.edu.cn,O
.,O
"
",O
(5)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
430072,O
",",O
China,O
;,O
Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Institute,O
"
",O
of,O
Medical,O
Microbiology,O
",",O
Jinan,O
University,O
",",O
Guangzhou,O
",",O
510632,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
jwu@whu.edu.cn,O
.,O
"

",O
Hepatitis,O
B,O
virus,O
(,O
HBV,O
),O
infection,O
affects,O
364,O
million,O
people,O
worldwide,O
and,O
causes,O
"
",O
a,O
serious,O
global,O
public,O
health,O
problem,O
.,O
The,O
SRYrelated,O
high,O
mobility,O
groupbox,O
9,O
"
",O
(,O
SOX9,O
),O
is,O
a,O
risk,O
of,O
developing,O
cirrhosis,O
in,O
patients,O
with,O
chronic,O
hepatitis,O
B,O
and,O
"
",O
a,O
cancer,O
stem,O
cell,O
marker,O
.,O
However,O
",",O
the,O
role,O
of,O
SOX9,O
in,O
HBV,O
replication,O
has,O
not,O
"
",O
been,O
reported,O
.,O
This,O
study,O
revealed,O
a,O
distinct,O
mechanism,O
underling,O
the,O
regulation,O
"
",O
of,O
HBV,O
replication,O
mediated,O
by,O
SOX9,O
.,O
HBV,O
induces,O
SOX9,O
mRNA,O
and,O
protein,O
expression,O
"
",O
in,O
human,O
hepatoma,O
cells,O
",",O
including,O
HepG2.2.15,O
",",O
HepG2,O
",",O
Huh7,O
",",O
and,O
HepG2NTCP,O
cells,O
.,O
"
",O
Further,O
study,O
demonstrated,O
that,O
HBV,O
activates,O
SOX9,O
expression,O
at,O
the,O
"
",O
transcriptional,O
level,O
through,O
inducing,O
SOX9,O
promoter,O
activity,O
and,O
HBc,O
could,O
"
",O
induce,O
the,O
activity,O
of,O
SOX9,O
promoter,O
.,O
Interestingly,O
",",O
SOX9,O
in,O
turn,O
represses,O
HBV,O
"
",O
replication,O
in,O
human,O
hepatoma,O
cells,O
.,O
More,O
importantly,O
",",O
SOX9,O
inhibits,O
HBV,O
"
",O
infection,O
in,O
HepG2NTCP,O
cells,O
and,O
C57,O
BL6,O
mice,O
.,O
Detailed,O
study,O
revealed,O
that,O
SOX9,O
"
",O
suppresses,O
HBV,O
replication,O
through,O
directly,O
binding,O
to,O
HBV,O
EnhII,O
Cp,O
(,O
HBV,O
"
",O
16671672,O
â€¯,O
nt,O
),O
to,O
inhibit,O
EnhII,O
Cp,O
activation,O
.,O
Results,O
from,O
deletion,O
mutant,O
"
",O
analysis,O
",",O
ChIP,O
assay,O
",",O
nuclear,O
and,O
cytoplasmic,O
extraction,O
analysis,O
",",O
and,O
"
",O
immunofluorescence,O
demonstrated,O
that,O
SOX9,O
high,O
mobility,O
group,O
(,O
HMG,O
),O
domain,O
is,O
"
",O
required,O
for,O
SOX9,O
antiHBV,O
activity,O
.,O
Moreover,O
",",O
we,O
demonstrated,O
that,O
SOX9,O
and,O
"
",O
hepatocyte,O
nuclear,O
factor,O
4,O
alpha,O
(,O
HNF4Î±,O
),O
can,O
bind,O
to,O
HBV,O
EnhII,O
Cp,O
(,O
HBV,O
"
",O
16671672,O
â€¯,O
nt,O
),O
individually,O
and,O
simultaneously,O
to,O
regulate,O
the,O
promoter,O
activity,O
.,O
"
",O
Collectively,O
",",O
the,O
results,O
revealed,O
a,O
distinct,O
negative,O
feedback,O
mechanism,O
"
",O
underlying,O
HBV,O
replication,O
and,O
SOX9,O
expression,O
",",O
and,O
identified,O
SOX9,O
as,O
a,O
new,O
host,O
"
",O
restriction,O
factor,O
in,O
HBV,O
replication,O
and,O
infection,O
.,O
IMPORTANCE,O
:,O
HBV,O
infection,O
is,O
"
",O
a,O
global,O
public,O
health,O
problem,O
by,O
causing,O
serious,O
liver,O
diseases,O
",",O
but,O
the,O
"
",O
mechanisms,O
underlying,O
HBV,O
pathogenesis,O
remain,O
largely,O
unknown,O
.,O
SOX9,O
is,O
a,O
risk,O
of,O
"
",O
developing,O
cirrhosis,O
and,O
a,O
cancer,O
stem,O
cell,O
marker,O
",",O
however,O
",",O
the,O
role,O
of,O
SOX9,O
in,O
"
",O
HBV,O
infection,O
has,O
not,O
been,O
reported,O
.,O
The,O
authors,O
revealed,O
a,O
distinct,O
mechanism,O
"
",O
underling,O
the,O
regulation,O
of,O
HBV,O
replication,O
and,O
SOX9,O
expression,O
.,O
On,O
one,O
hand,O
",",O
HBV,O
"
",O
induces,O
SOX9,O
expression,O
in,O
human,O
hepatoma,O
cells,O
through,O
activating,O
SOX9,O
promoter,O
.,O
"
",O
On,O
the,O
other,O
hand,O
",",O
SOX9,O
in,O
turn,O
represses,O
HBV,O
replication,O
in,O
human,O
hepatoma,O
cells,O
"
",O
by,O
binding,O
to,O
and,O
inhibiting,O
HBV,O
EnhII,O
Cp,O
through,O
its,O
HMG,O
domain,O
.,O
More,O
"
",O
importantly,O
",",O
SOX9,O
inhibits,O
HBV,O
infection,O
in,O
HepG2NTCP,O
cells,O
and,O
C57,O
BL6,O
mice,O
.,O
"
",O
Therefore,O
",",O
this,O
study,O
identifies,O
SOX9,O
as,O
a,O
novel,O
and,O
potential,O
therapeutic,O
"
",O
reagent,O
for,O
the,O
prevention,O
and,O
treatment,O
of,O
HBVassociated,O
diseases,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
B.V.,O
"

",O
DOI,O
:,O
10.1016,O
j.antiviral.2020.104761,O
"
",O
PMID,O
:,O
32147495,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
The,O
authors,O
"
",O
disclose,O
no,O
conflicts,O
.,O
"


",O
218,O
.,O
J,O
Microbiol,O
Immunol,O
Infect,O
.,O
2020,O
Feb,O
25,O
.,O
pii,O
:,O
S16841182(20)300396,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jmii.2020.02.011,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Are,O
children,O
less,O
susceptible,O
to,O
COVID19,B-Disease_COVID-19
?,O
"

",O
Lee,O
PI(1,O
),O
",",O
Hu,O
YL(2,O
),O
",",O
Chen,O
PY(3,O
),O
",",O
Huang,O
YC(4,O
),O
",",O
Hsueh,O
PR(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pediatrics,O
",",O
National,O
Taiwan,O
University,O
Children,O
's,O
Hospital,O
and,O
"
",O
National,O
Taiwan,O
University,O
College,O
of,O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
.,O
Electronic,O
"
",O
address,O
:,O
pinging@ntu.edu.tw,O
.,O
"
",O
(2)Department,O
of,O
Pediatrics,O
",",O
New,O
Taipei,O
City,O
Hospital,O
",",O
New,O
Taipei,O
City,O
",",O
Taiwan,O
.,O
"
",O
(3)Department,O
of,O
Pediatrics,O
",",O
Section,O
of,O
Infection,O
",",O
Taichung,O
Veterans,O
General,O
"
",O
Hospital,O
",",O
Taichung,O
",",O
Taiwan,O
.,O
"
",O
(4)Department,O
of,O
Pediatrics,O
",",O
Chang,O
Gung,O
Memorial,O
Hospital,O
and,O
Chang,O
Gung,O
"
",O
University,O
College,O
of,O
Medicine,O
at,O
Linkou,O
",",O
Taoyuan,O
",",O
Taiwan,O
.,O
"
",O
(5)Department,O
of,O
Laboratory,O
Medicine,O
",",O
National,O
Taiwan,O
University,O
Hospital,O
",",O
"
",O
National,O
Taiwan,O
University,O
College,O
of,O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
;,O
Department,O
of,O
"
",O
Internal,O
Medicine,O
",",O
National,O
Taiwan,O
University,O
Hospital,O
",",O
National,O
Taiwan,O
"
",O
University,O
College,O
of,O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jmii.2020.02.011,O
"
",O
PMID,O
:,O
32147409,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
author,O
"
",O
declares,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
219,O
.,O
J,O
Hosp,O
Infect,O
.,O
2020,O
Mar,O
5,O
.,O
pii,O
:,O
S01956701(20)301006,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jhin.2020.03.001,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Diagnosis,O
of,O
SARSCoV2,B-Disease_COVID-19
Infection,I-Disease_COVID-19
based,O
on,O
CT,O
scan,O
vs.,O
RTPCR,O
:,O
Reflecting,O
on,O
"
",O
Experience,O
from,O
MERSCoV.,O
"

",O
AlTawfiq,O
JA(1,O
),O
",",O
Memish,O
ZA(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Infectious,O
Disease,O
Unit,O
",",O
Specialty,O
Internal,O
Medicine,O
",",O
Johns,O
Hopkins,O
Aramco,O
"
",O
Healthcare,O
",",O
Dhahran,O
",",O
Saudi,O
Arabia,O
;,O
Department,O
of,O
Medicine,O
",",O
Indiana,O
University,O
"
",O
School,O
of,O
Medicine,O
",",O
Indianapolis,O
",",O
IN,O
",",O
USA,O
;,O
;,O
Department,O
of,O
Medicine,O
",",O
Johns,O
Hopkins,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Baltimore,O
",",O
MD,O
",",O
USA;.,O
Electronic,O
address,O
:,O
"
",O
jaffar.tawfiq@jhah.com,O
.,O
"
",O
(2)Director,O
Research,O
Center,O
",",O
King,O
Saud,O
Medical,O
City,O
",",O
Ministry,O
of,O
Health,O
;,O
"
",O
AlFaisal,O
University,O
",",O
Riyadh,O
",",O
Saudi,O
Arabia,O
;,O
Hubert,O
Department,O
of,O
Global,O
Health,O
",",O
"
",O
Rollins,O
School,O
of,O
Public,O
Health,O
",",O
Emory,O
University,O
",",O
Atlanta,O
",",O
GA,O
",",O
USA5,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jhin.2020.03.001,O
"
",O
PMID,O
:,O
32147407,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
All,O
authors,O
"
",O
have,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
220,O
.,O
J,O
Hosp,O
Infect,O
.,O
2020,O
Mar,O
5,O
.,O
pii,O
:,O
S01956701(20)301018,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jhin.2020.03.002,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Exploring,O
the,O
reasons,O
for,O
healthcare,O
workers,O
infected,O
with,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
disease,O
2019,O
(,O
COVID19,B-Disease_COVID-19
),O
in,O
China,O
.,O
"

",O
Wang,O
J(1,O
),O
",",O
Zhou,O
M(2,O
),O
",",O
Liu,O
F(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Global,O
Health,O
",",O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Geneva,O
",",O
Geneva,O
",",O
"
",O
Switzerland,O
.,O
Electronic,O
address,O
:,O
jiancong.wang@outlook.com,O
.,O
"
",O
(2)Dong,O
Guan,O
Nosocomial,O
Infection,O
Control,O
and,O
Quality,O
Improvement,O
Centre,O
",",O
"
",O
Dongguan,O
City,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
"
",O
(3)Institute,O
of,O
Global,O
Health,O
",",O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Geneva,O
",",O
Geneva,O
",",O
"
",O
Switzerland,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jhin.2020.03.002,O
"
",O
PMID,O
:,O
32147406,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
None,O
.,O
"


",O
221,O
.,O
Transfus,O
Med,O
Rev.,O
2020,O
Feb,O
26,O
.,O
pii,O
:,O
S08877963(20)300158,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.tmrv.2020.02.004,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
and,O
Blood,O
Safety,O
:,O
Help,O
with,O
a,O
Dilemma,O
.,O
"

",O
Dodd,O
RY(1,O
),O
",",O
Stramer,O
SL(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Medical,O
Office,O
",",O
American,O
Red,O
Cross,O
.,O
Electronic,O
address,O
:,O
"
",O
roger.dodd@redcross.org,O
.,O
"
",O
(2)Scientific,O
Affairs,O
",",O
American,O
Red,O
Cross,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmrv.2020.02.004,O
"
",O
PMID,O
:,O
32147378,O
"


",O
222,O
.,O
Lancet,O
Respir,O
Med,O
.,O
2020,O
Mar;8(3):230231,O
.,O
doi,O
:,O
10.1016,O
S22132600(20)300709,O
.,O
"
",O
Epub,O
2020,O
Feb,O
12,O
.,O
"

",O
Toning,O
down,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
media,O
hypeand,O
restoring,O
hope,O
.,O
"

",O
Ippolito,O
G(1,O
),O
",",O
Hui,O
DS(2,O
),O
",",O
Ntoumi,O
F(3,O
),O
",",O
Maeurer,O
M(4,O
),O
",",O
Zumla,O
A(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Lazzaro,O
Spallanzani,O
",",O
National,O
Institute,O
for,O
Infectious,O
Diseases,O
 ,O
IRCCS,O
",",O
Rome,O
",",O
"
",O
Italy,O
.,O
"
",O
(2)Department,O
of,O
Medicine,O
&,O
Therapeutics,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
Prince,O
"
",O
of,O
Wales,O
Hospital,O
",",O
Shatin,O
",",O
New,O
Territories,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(3)Fondation,O
Congolaise,O
pour,O
la,O
Recherche,O
MÃ©dicale,O
",",O
Brazzaville,O
",",O
Republic,O
of,O
the,O
"
",O
Congo,O
.,O
"
",O
(4)Champalimaud,O
Centre,O
for,O
the,O
Unknown,O
",",O
Lisbon,O
",",O
Portugal,O
and,O
I,O
Med,O
Clinic,O
",",O
"
",O
University,O
of,O
Mainz,O
",",O
Germany,O
.,O
"
",O
(5)Department,O
of,O
Infection,O
",",O
Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
University,O
"
",O
College,O
London,O
",",O
and,O
National,O
Institutes,O
of,O
Health,O
and,O
Research,O
Biomedical,O
"
",O
Research,O
Centre,O
",",O
University,O
College,O
London,O
Hospitals,O
NHS,O
Foundation,O
Trust,O
",",O
"
",O
London,O
",",O
UK,O
.,O
Electronic,O
address,O
:,O
a.zumla@ucl.ac.uk,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22132600(20)300709,O
"
",O
PMID,O
:,O
32146924,O
"


",O
223,O
.,O
Infect,O
Control,O
Hosp,O
Epidemiol,O
.,O
2020,O
Mar,O
0.3875,O
.,O
doi,O
:,O
10.1017,O
ice.2020.64,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
The,O
timevarying,O
serial,O
interval,O
of,O
the,O
coronavirus,O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
and,O
its,O
"
",O
genderspecific,O
difference,O
:,O
A,O
datadriven,O
analysis,O
using,O
public,O
surveillance,O
data,O
"
",O
in,O
Hong,O
Kong,O
and,O
Shenzhen,O
",",O
China,O
from,O
January,O
10,O
to,O
February,O
15,O
",",O
2020,O
.,O
"

",O
Zhao,O
S(1)(2,O
),O
",",O
Cao,O
P(3,O
),O
",",O
Chong,O
MK(1)(2,O
),O
",",O
Gao,O
D(4,O
),O
",",O
Lou,O
Y(5,O
),O
",",O
Ran,O
J(6,O
),O
",",O
Wang,O
K(7,O
),O
",",O
"
",O
Wang,O
W(8,O
),O
",",O
Yang,O
L(9,O
),O
",",O
He,O
D(5,O
),O
",",O
Wang,O
MH(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)JC,O
School,O
of,O
Public,O
Health,O
and,O
Primary,O
Care,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(2)Shenzhen,O
Research,O
Institute,O
of,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
Shenzhen,O
",",O
"
",O
China,O
.,O
"
",O
(3)Clinical,O
Research,O
Centre,O
",",O
Zhujiang,O
Hospital,O
",",O
Southern,O
Medical,O
University,O
",",O
"
",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Mathematics,O
",",O
Shanghai,O
Normal,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
"
",O
(6)School,O
of,O
Public,O
Health,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Hong,O
"
",O
Kong,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Medical,O
Engineering,O
and,O
Technology,O
",",O
Xinjiang,O
Medical,O
University,O
",",O
"
",O
Urumqi,O
",",O
830011,O
",",O
China,O
.,O
"
",O
(8)School,O
of,O
Mathematics,O
and,O
Statistics,O
",",O
Huaiyin,O
Normal,O
University,O
",",O
Huaian,O
",",O
"
",O
China,O
.,O
"
",O
(9)School,O
of,O
Nursing,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1017,O
ice.2020.64,O
"
",O
PMID,O
:,O
32146921,O
"


",O
224,O
.,O
Med,O
J,O
Aust,O
.,O
2020,O
Mar,O
8,O
.,O
doi,O
:,O
10.5694,O
mja2.50530,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
An,O
outbreak,O
of,O
COVID19,B-Disease_COVID-19
caused,O
by,O
a,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
:,O
what,O
we,O
know,O
so,O
far,O
.,O
"

",O
Cheng,O
AC(1)(2,O
),O
",",O
Williamson,O
DA(3)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Infection,O
Prevention,O
and,O
Healthcare,O
Epidemiology,O
Unit,O
",",O
Alfred,O
Health,O
",",O
"
",O
Melbourne,O
",",O
VIC,O
.,O
"
",O
(2)Monash,O
University,O
",",O
Melbourne,O
",",O
VIC,O
.,O
"
",O
(3)Microbiological,O
Diagnostic,O
Unit,O
Public,O
Health,O
Laboratory,O
",",O
University,O
of,O
"
",O
Melbourne,O
",",O
Melbourne,O
",",O
VIC,O
.,O
"
",O
(4)Peter,O
Doherty,O
Institute,O
for,O
Infection,O
and,O
Immunity,O
",",O
Melbourne,O
",",O
VIC,O
.,O
"

",O
DOI,O
:,O
10.5694,O
mja2.50530,O
"
",O
PMID,O
:,O
32146721,O
"


",O
225,O
.,O
Sci,O
China,O
Life,O
Sci,O
.,O
2020,O
Mar,O
4,O
.,O
doi,O
:,O
10.1007,O
s1142702016614,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Clinical,O
characteristics,O
of,O
24,O
asymptomatic,O
infections,O
with,O
COVID19,B-Disease_COVID-19
screened,O
"
",O
among,O
close,O
contacts,O
in,O
Nanjing,O
",",O
China,O
.,O
"

",O
Hu,O
Z(1)(2,O
),O
",",O
Song,O
C(2)(3,O
),O
",",O
Xu,O
C(4,O
),O
",",O
Jin,O
G(2)(3,O
),O
",",O
Chen,O
Y(1,O
),O
",",O
Xu,O
X(2,O
),O
",",O
Ma,O
H(2)(3,O
),O
",",O
"
",O
Chen,O
W(5,O
),O
",",O
Lin,O
Y(6,O
),O
",",O
Zheng,O
Y(7,O
),O
",",O
Wang,O
J(2,O
),O
",",O
Hu,O
Z(8,O
),O
",",O
Yi,O
Y(9,O
),O
",",O
Shen,O
H(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Nanjing,O
Infectious,O
Disease,O
Center,O
",",O
the,O
Second,O
Hospital,O
of,O
Nanjing,O
",",O
Nanjing,O
"
",O
University,O
of,O
Chinese,O
Medicine,O
",",O
Nanjing,O
",",O
210003,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Epidemiology,O
",",O
Center,O
for,O
Global,O
Health,O
",",O
School,O
of,O
Public,O
Health,O
",",O
"
",O
Nanjing,O
Medical,O
University,O
",",O
Nanjing,O
",",O
211166,O
",",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Reproductive,O
Medicine,O
",",O
Nanjing,O
Medical,O
University,O
",",O
"
",O
Nanjing,O
",",O
211166,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Radiology,O
",",O
the,O
Second,O
Hospital,O
of,O
Nanjing,O
",",O
Nanjing,O
University,O
of,O
"
",O
Chinese,O
Medicine,O
",",O
Nanjing,O
",",O
210003,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Clinical,O
Research,O
Center,O
",",O
the,O
Second,O
Hospital,O
of,O
Nanjing,O
",",O
"
",O
Nanjing,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Nanjing,O
",",O
210003,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Maternal,O
",",O
Child,O
and,O
Adolescent,O
Health,O
",",O
School,O
of,O
Public,O
Health,O
",",O
"
",O
Nanjing,O
Medical,O
University,O
",",O
Nanjing,O
",",O
211166,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Critical,O
Medicine,O
",",O
the,O
Second,O
Hospital,O
of,O
Nanjing,O
",",O
Nanjing,O
"
",O
University,O
of,O
Chinese,O
Medicine,O
",",O
Nanjing,O
",",O
210003,O
",",O
China,O
.,O
"
",O
(8)Nanjing,O
Infectious,O
Disease,O
Center,O
",",O
the,O
Second,O
Hospital,O
of,O
Nanjing,O
",",O
Nanjing,O
"
",O
University,O
of,O
Chinese,O
Medicine,O
",",O
Nanjing,O
",",O
210003,O
",",O
China,O
.,O
zhibin_hu@njmu.edu.cn,O
.,O
"
",O
(9)Nanjing,O
Infectious,O
Disease,O
Center,O
",",O
the,O
Second,O
Hospital,O
of,O
Nanjing,O
",",O
Nanjing,O
"
",O
University,O
of,O
Chinese,O
Medicine,O
",",O
Nanjing,O
",",O
210003,O
",",O
China,O
.,O
ian0126@126.com,O
.,O
"

",O
Previous,O
studies,O
have,O
showed,O
clinical,O
characteristics,O
of,O
patients,O
with,O
the,O
2019,O
"
",O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
and,O
the,O
evidence,O
of,O
persontoperson,O
"
",O
transmission,O
.,O
Limited,O
data,O
are,O
available,O
for,O
asymptomatic,O
infections,O
.,O
This,O
study,O
"
",O
aims,O
to,O
present,O
the,O
clinical,O
characteristics,O
of,O
24,O
cases,O
with,O
asymptomatic,O
"
",O
infection,O
screened,O
from,O
close,O
contacts,O
and,O
to,O
show,O
the,O
transmission,O
potential,O
of,O
"
",O
asymptomatic,O
COVID19,B-Virus_SARS-CoV-2
virus,I-Virus_SARS-CoV-2
carriers,O
.,O
Epidemiological,O
investigations,O
were,O
"
",O
conducted,O
among,O
all,O
close,O
contacts,O
of,O
COVID19,B-Disease_COVID-19
patients,O
(,O
or,O
suspected,O
patients,O
),O
"
",O
in,O
Nanjing,O
",",O
Jiangsu,O
Province,O
",",O
China,O
",",O
from,O
Jan,O
28,O
to,O
Feb,O
9,O
",",O
2020,O
",",O
both,O
in,O
clinic,O
"
",O
and,O
in,O
community,O
.,O
Asymptomatic,O
carriers,O
were,O
laboratoryconfirmed,O
positive,O
for,O
"
",O
the,O
COVID19,B-Virus_SARS-CoV-2
virus,I-Virus_SARS-CoV-2
by,O
testing,O
the,O
nucleic,O
acid,O
of,O
the,O
pharyngeal,O
swab,O
samples,O
.,O
"
",O
Their,O
clinical,O
records,O
",",O
laboratory,O
assessments,O
",",O
and,O
chest,O
CT,O
scans,O
were,O
reviewed,O
.,O
"
",O
As,O
a,O
result,O
",",O
none,O
of,O
the,O
24,O
asymptomatic,O
cases,O
presented,O
any,O
obvious,O
symptoms,O
"
",O
while,O
nucleic,O
acid,O
screening,O
.,O
Five,O
cases,O
(,O
20.8,O
%,O
),O
developed,O
symptoms,O
(,O
fever,O
",",O
"
",O
cough,O
",",O
fatigue,O
",",O
etc,O
.,O
),O
during,O
hospitalization,O
.,O
Twelve,O
(,O
50,O
%,O
),O
cases,O
showed,O
typical,O
"
",O
CT,O
images,O
of,O
groundglass,O
chest,O
and,O
5,O
(,O
20.8,O
%,O
),O
presented,O
stripe,O
shadowing,O
in,O
the,O
"
",O
lungs,O
.,O
The,O
remaining,O
7,O
(,O
29.2,O
%,O
),O
cases,O
showed,O
normal,O
CT,O
image,O
and,O
had,O
no,O
symptoms,O
"
",O
during,O
hospitalization,O
.,O
These,O
7,O
cases,O
were,O
younger,O
(,O
median,O
age,O
:,O
14,O
years,O
;,O
"
",O
P=0.012,O
),O
than,O
the,O
rest,O
.,O
None,O
of,O
the,O
24,O
cases,O
developed,O
severe,O
COVID19,B-Disease_COVID-19
pneumonia,O
"
",O
or,O
died,O
.,O
The,O
median,O
communicable,O
period,O
",",O
defined,O
as,O
the,O
interval,O
from,O
the,O
first,O
"
",O
day,O
of,O
positive,O
nucleic,O
acid,O
tests,O
to,O
the,O
first,O
day,O
of,O
continuous,O
negative,O
tests,O
",",O
"
",O
was,O
9.5,O
days,O
(,O
up,O
to,O
21,O
days,O
among,O
the,O
24,O
asymptomatic,O
cases,O
),O
.,O
Through,O
"
",O
epidemiological,O
investigation,O
",",O
we,O
observed,O
a,O
typical,O
asymptomatic,O
transmission,O
to,O
"
",O
the,O
cohabiting,O
family,O
members,O
",",O
which,O
even,O
caused,O
severe,O
COVID19,B-Disease_COVID-19
pneumonia,O
.,O
"
",O
Overall,O
",",O
the,O
asymptomatic,O
carriers,O
identified,O
from,O
close,O
contacts,O
were,O
prone,O
to,O
"
",O
be,O
mildly,O
ill,O
during,O
hospitalization,O
.,O
However,O
",",O
the,O
communicable,O
period,O
could,O
be,O
"
",O
up,O
to,O
three,O
weeks,O
and,O
the,O
communicated,O
patients,O
could,O
develop,O
severe,O
illness,O
.,O
"
",O
These,O
results,O
highlighted,O
the,O
importance,O
of,O
close,O
contact,O
tracing,O
and,O
"
",O
longitudinally,O
surveillance,O
via,O
virus,O
nucleic,O
acid,O
tests,O
.,O
Further,O
isolation,O
"
",O
recommendation,O
and,O
continuous,O
nucleic,O
acid,O
tests,O
may,O
also,O
be,O
recommended,O
to,O
the,O
"
",O
patients,O
discharged,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s1142702016614,O
"
",O
PMID,O
:,O
32146694,O
"


",O
226,O
.,O
Health,O
Care,O
Manag,O
Sci,O
.,O
2020,O
Mar,O
7,O
.,O
doi,O
:,O
10.1007,O
s10729020095046,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Containing,O
2019nCoV,B-Virus_SARS-CoV-2
(,O
Wuhan,O
),O
coronavirus,O
.,O
"

",O
Kaplan,O
EH(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)William,O
N.,O
and,O
Marie,O
A.,O
Beach,O
Professor,O
of,O
Operations,O
Research,O
",",O
Professor,O
of,O
"
",O
Public,O
Health,O
",",O
Professor,O
of,O
Engineering,O
",",O
Yale,O
School,O
of,O
Management,O
",",O
165,O
Whitney,O
"
",O
Avenue,O
",",O
New,O
Haven,O
",",O
6511,O
",",O
CT,O
",",O
USA,O
.,O
edward.kaplan@yale.edu,O
.,O
"

",O
The,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2019nCoV,B-Virus_SARS-CoV-2
first,O
appeared,O
in,O
December,O
2019,O
in,O
Wuhan,O
",",O
China,O
.,O
"
",O
While,O
most,O
of,O
the,O
initial,O
cases,O
were,O
linked,O
to,O
the,O
Huanan,O
Seafood,O
Wholesale,O
"
",O
Market,O
",",O
persontoperson,O
transmission,O
has,O
been,O
verified,O
.,O
Given,O
that,O
a,O
vaccine,O
"
",O
can,O
not,O
be,O
developed,O
and,O
deployed,O
for,O
at,O
least,O
a,O
year,O
",",O
preventing,O
further,O
"
",O
transmission,O
relies,O
upon,O
standard,O
principles,O
of,O
containment,O
",",O
two,O
of,O
which,O
are,O
the,O
"
",O
isolation,O
of,O
known,O
cases,O
and,O
the,O
quarantine,O
of,O
persons,O
believed,O
at,O
high,O
risk,O
of,O
"
",O
exposure,O
.,O
This,O
note,O
presents,O
probability,O
models,O
for,O
assessing,O
the,O
effectiveness,O
"
",O
of,O
case,O
isolation,O
and,O
quarantine,O
within,O
a,O
community,O
during,O
the,O
initial,O
phase,O
of,O
"
",O
an,O
outbreak,O
with,O
illustrations,O
based,O
on,O
early,O
observations,O
from,O
Wuhan,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s10729020095046,O
"
",O
PMID,O
:,O
32146554,O
"


",O
227,O
.,O
J,O
Infect,O
Dev,O
Ctries,O
.,O
2020,O
Feb,O
29;14(2):125128,O
.,O
doi,O
:,O
10.3855,O
jidc.12600,O
.,O
"

",O
Similarity,O
in,O
Case,O
Fatality,O
Rates,O
(,O
CFR,O
),O
of,O
COVID19,B-Disease_COVID-19
SARSCOV2,B-Virus_SARS-CoV-2
in,O
Italy,O
and,O
"
",O
China,O
.,O
"

",O
Porcheddu,O
R(1,O
),O
",",O
Serra,O
C(2,O
),O
",",O
Kelvin,O
D(3,O
),O
",",O
Kelvin,O
N(4,O
),O
",",O
Rubino,O
S(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Freelance,O
Journalist,O
",",O
JIDC,O
Italy,O
.,O
rporcheddu@jidc.org,O
.,O
"
",O
(2)Dipartimento,O
di,O
Scienze,O
Biomediche,O
",",O
UniversitÃ ,O
degli,O
Studi,O
di,O
Sassari,O
",",O
"
",O
Sassari,O
",",O
Italy,O
.,O
cserra@uniss.it,O
.,O
"
",O
(3)JIDCCanada,O
;,O
Department,O
of,O
Microbiology,O
and,O
Immunology,O
",",O
Canadian,O
Center,O
for,O
"
",O
Vaccinology,O
",",O
Dalhousie,O
University,O
",",O
Halifax,O
",",O
NS,O
",",O
Canada,O
.,O
International,O
Institute,O
"
",O
of,O
Infection,O
and,O
Immunity,O
",",O
Shantou,O
",",O
China,O
.,O
dkelvin@jidc.org,O
.,O
"
",O
(4)JIDCCanada,O
",",O
Department,O
of,O
Microbiology,O
and,O
Immunology,O
",",O
Dalhousie,O
University,O
",",O
"
",O
Halifax,O
",",O
NS,O
",",O
Canada,O
.,O
nkelvin@jidc.org,O
.,O
"
",O
(5)Dipartimento,O
di,O
Scienze,O
Biomediche,O
",",O
UniversitÃ ,O
degli,O
Studi,O
di,O
Sassari,O
",",O
"
",O
Sassari,O
",",O
Italy,O
.,O
srubino@jidc.org,O
.,O
"

",O
As,O
of,O
28,O
February,O
2020,O
",",O
Italy,O
had,O
888,O
cases,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
infections,O
",",O
with,O
most,O
"
",O
cases,O
in,O
Northern,O
Italy,O
in,O
the,O
Lombardia,O
and,O
Veneto,O
regions,O
.,O
Travelrelated,O
cases,O
"
",O
were,O
the,O
main,O
source,O
of,O
COVID19,B-Disease_COVID-19
cases,O
during,O
the,O
early,O
stages,O
of,O
the,O
current,O
"
",O
epidemic,O
in,O
Italy,O
.,O
The,O
month,O
of,O
February,O
",",O
however,O
",",O
has,O
been,O
dominated,O
by,O
two,O
"
",O
large,O
clusters,O
of,O
outbreaks,O
in,O
Northern,O
Italy,O
",",O
south,O
of,O
Milan,O
",",O
with,O
mainly,O
local,O
"
",O
transmission,O
the,O
source,O
of,O
infections,O
.,O
Contact,O
tracing,O
has,O
failed,O
to,O
identify,O
"
",O
patient,O
zero,O
in,O
one,O
of,O
the,O
outbreaks,O
.,O
As,O
of,O
28,O
February,O
2020,O
",",O
twentyone,O
cases,O
of,O
"
",O
COVID19,B-Disease_COVID-19
have,O
died,O
.,O
Comparison,O
between,O
case,O
fatality,O
rates,O
in,O
China,O
and,O
Italy,O
are,O
"
",O
identical,O
at,O
2.3,O
.,O
Additionally,O
",",O
deaths,O
are,O
similar,O
in,O
both,O
countries,O
with,O
"
",O
fatalities,O
in,O
mostly,O
the,O
elderly,O
with,O
known,O
comorbidities,O
.,O
It,O
will,O
be,O
important,O
"
",O
to,O
develop,O
pointofcare,O
devices,O
to,O
aid,O
clinicians,O
in,O
stratifying,O
elderly,O
"
",O
patients,O
as,O
early,O
as,O
possible,O
to,O
determine,O
the,O
potential,O
level,O
of,O
care,O
they,O
will,O
"
",O
require,O
to,O
improve,O
their,O
chances,O
of,O
survival,O
from,O
COVID19,B-Disease_COVID-19
disease,O
.,O
"

",O
Copyright,O
(,O
c,O
),O
2020,O
Rossella,O
Porcheddu,O
",",O
Caterina,O
Serra,O
",",O
David,O
Kelvin,O
",",O
Nikki,O
"
",O
Kelvin,O
",",O
Salvatore,O
Rubino,O
.,O
"

",O
DOI,O
:,O
10.3855,O
jidc.12600,O
"
",O
PMID,O
:,O
32146445,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
No,O
Conflict,O
of,O
Interest,O
is,O
declared,O
"


",O
228,O
.,O
Lancet,O
Respir,O
Med,O
.,O
2020,O
Mar,O
5,O
.,O
pii,O
:,O
S22132600(20)301107,O
.,O
doi,O
:,O
"
",O
10.1016,O
S22132600(20)301107,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Respiratory,O
support,O
for,O
patients,O
with,O
COVID19,B-Disease_COVID-19
infection,O
.,O
"

",O
Ã‘amendysSilva,O
SA(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Hospital,O
Medica,O
Sur,O
",",O
Mexico,O
City,O
14050,O
",",O
"
",O
Mexico,O
;,O
Instituto,O
Nacional,O
de,O
Cancerologia,O
",",O
Mexico,O
City,O
",",O
Mexico,O
;,O
Instituto,O
"
",O
Nacional,O
de,O
Ciencias,O
Medicas,O
y,O
Nutricion,O
Salvador,O
Zubiran,O
",",O
Mexico,O
City,O
",",O
Mexico,O
.,O
"
",O
Electronic,O
address,O
:,O
snamendyss@medicasur.org.mx,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22132600(20)301107,O
"
",O
PMID,O
:,O
32145829,O
"


",O
229,O
.,O
Lancet,O
.,O
2020,O
Mar,O
7;395(10226):755,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)305225,O
.,O
"

",O
COVID19,B-Disease_COVID-19
:,O
too,O
little,O
",",O
too,O
late,O
?,O
"

",O
The,O
Lancet,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)305225,O
"
",O
PMID,O
:,O
32145772,O
"


",O
230,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
5,O
.,O
pii,O
:,O
S14733099(20)301298,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301298,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Can,O
we,O
contain,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
with,O
the,O
same,O
measures,O
as,O
for,O
SARS,O
?,O
"

",O
WilderSmith,O
A(1,O
),O
",",O
Chiew,O
CJ(2,O
),O
",",O
Lee,O
VJ(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)London,O
School,O
of,O
Hygiene,O
and,O
Tropical,O
Medicine,O
",",O
London,O
",",O
UK,O
;,O
Heidelberg,O
"
",O
Institute,O
of,O
Global,O
Health,O
",",O
University,O
of,O
Heidelberg,O
",",O
Heidelberg,O
",",O
Germany,O
;,O
Lee,O
"
",O
Kong,O
Chian,O
School,O
of,O
Medicine,O
",",O
Singapore,O
",",O
Singapore,O
.,O
Electronic,O
address,O
:,O
"
",O
annelies.wildersmith@lshtm.ac.uk,O
.,O
"
",O
(2)National,O
University,O
Health,O
System,O
",",O
Singapore,O
",",O
Singapore,O
.,O
"
",O
(3)Saw,O
Swee,O
Hock,O
School,O
of,O
Public,O
Health,O
",",O
National,O
University,O
of,O
Singapore,O
",",O
"
",O
Singapore,O
",",O
Singapore,O
.,O
"

",O
The,O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
outbreak,O
in,O
2003,O
resulted,O
in,O
more,O
"
",O
than,O
8000,O
cases,O
and,O
800,O
deaths,O
.,O
SARS,O
was,O
eventually,O
contained,O
by,O
means,O
of,O
"
",O
syndromic,O
surveillance,O
",",O
prompt,O
isolation,O
of,O
patients,O
",",O
strict,O
enforcement,O
of,O
"
",O
quarantine,O
of,O
all,O
contacts,O
",",O
and,O
in,O
some,O
areas,O
topdown,O
enforcement,O
of,O
community,O
"
",O
quarantine,O
.,O
By,O
interrupting,O
all,O
humantohuman,O
transmission,O
",",O
SARS,O
was,O
effectively,O
"
",O
eradicated,O
.,O
By,O
contrast,O
",",O
by,O
Feb,O
28,O
",",O
2020,O
",",O
within,O
a,O
matter,O
of,O
2,O
months,O
since,O
the,O
"
",O
beginning,O
of,O
the,O
outbreak,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
",",O
more,O
than,O
"
",O
82,O
â€ˆ,O
0,O
confirmed,O
cases,O
of,O
COVID19,B-Disease_COVID-19
have,O
been,O
reported,O
with,O
more,O
than,O
2800,O
deaths,O
.,O
"
",O
Although,O
there,O
are,O
striking,O
similarities,O
between,O
SARS,O
and,O
COVID19,B-Disease_COVID-19
",",O
the,O
"
",O
differences,O
in,O
the,O
virus,O
characteristics,O
will,O
ultimately,O
determine,O
whether,O
the,O
"
",O
same,O
measures,O
for,O
SARS,O
will,O
also,O
be,O
successful,O
for,O
COVID19,B-Disease_COVID-19
.,O
COVID19,B-Disease_COVID-19
differs,O
"
",O
from,O
SARS,O
in,O
terms,O
of,O
infectious,O
period,O
",",O
transmissibility,O
",",O
clinical,O
severity,O
",",O
and,O
"
",O
extent,O
of,O
community,O
spread,O
.,O
Even,O
if,O
traditional,O
public,O
health,O
measures,O
are,O
not,O
"
",O
able,O
to,O
fully,O
contain,O
the,O
outbreak,O
of,O
COVID19,B-Disease_COVID-19
",",O
they,O
will,O
still,O
be,O
effective,O
in,O
"
",O
reducing,O
peak,O
incidence,O
and,O
global,O
deaths,O
.,O
Exportations,O
to,O
other,O
countries,O
need,O
"
",O
not,O
result,O
in,O
rapid,O
largescale,O
outbreaks,O
",",O
if,O
countries,O
have,O
the,O
political,O
will,O
"
",O
to,O
rapidly,O
implement,O
countermeasures,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301298,O
"
",O
PMID,O
:,O
32145768,O
"


",O
231,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
5,O
.,O
pii,O
:,O
S14733099(20)301523,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301523,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Taking,O
the,O
right,O
measures,O
to,O
control,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Xiao,O
Y(1,O
),O
",",O
Torok,O
ME(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Collaborative,O
Innovation,O
Centre,O
for,O
Diagnosis,O
and,O
Treatment,O
of,O
Infectious,O
"
",O
Diseases,O
",",O
State,O
Key,O
Laboratory,O
for,O
Diagnosis,O
and,O
Treatment,O
of,O
Infectious,O
"
",O
Diseases,O
",",O
First,O
Affiliated,O
Hospital,O
",",O
School,O
of,O
Medicine,O
",",O
Zhejiang,O
University,O
",",O
"
",O
Hangzhou,O
",",O
310003,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
yonghong@163.com,O
.,O
"
",O
(2)University,O
of,O
Cambridge,O
",",O
Department,O
of,O
Medicine,O
",",O
Addenbrooke,O
's,O
Hospital,O
",",O
"
",O
Cambridge,O
",",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301523,O
"
",O
PMID,O
:,O
32145766,O
"


",O
232,O
.,O
Int,O
J,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
S12019712(20)301193,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ijid.2020.02.060,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Serial,O
interval,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
infections,O
.,O
"

",O
Nishiura,O
H(1,O
),O
",",O
Linton,O
NM(2,O
),O
",",O
Akhmetzhanov,O
AR(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Graduate,O
School,O
of,O
Medicine,O
",",O
Hokkaido,O
University,O
",",O
Kia,O
15,O
Jo,O
Nishi,O
7,O
Chome,O
",",O
"
",O
Kitaku,O
",",O
Sapporo,O
",",O
608638,O
",",O
Japan,O
;,O
CREST,O
",",O
Japan,O
Science,O
and,O
Technology,O
Agency,O
",",O
"
",O
Honcho,O
418,O
",",O
Kawaguchi,O
",",O
Saitama,O
",",O
3320012,O
Japan,O
.,O
Electronic,O
address,O
:,O
"
",O
nishiurah@med.hokudai.ac.jp,O
.,O
"
",O
(2)Graduate,O
School,O
of,O
Medicine,O
",",O
Hokkaido,O
University,O
",",O
Kia,O
15,O
Jo,O
Nishi,O
7,O
Chome,O
",",O
"
",O
Kitaku,O
",",O
Sapporo,O
",",O
608638,O
",",O
Japan,O
.,O
"

",O
OBJECTIVE,O
:,O
To,O
estimate,O
the,O
serial,O
interval,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
from,O
"
",O
information,O
on,O
28,O
infectorinfectee,O
pairs,O
.,O
"
",O
METHODS,O
:,O
We,O
collected,O
dates,O
of,O
illness,O
onset,O
for,O
primary,O
cases,O
(,O
infectors,O
),O
and,O
"
",O
secondary,O
cases,O
(,O
infectees,O
),O
from,O
published,O
research,O
articles,O
and,O
case,O
"
",O
investigation,O
reports,O
.,O
We,O
subjectively,O
ranked,O
the,O
credibility,O
of,O
the,O
data,O
and,O
"
",O
performed,O
analyses,O
on,O
both,O
the,O
full,O
dataset,O
(,O
n,O
â€‰,O
=,O
â€‰,O
28,O
),O
and,O
a,O
subset,O
of,O
pairs,O
with,O
"
",O
highest,O
certainty,O
in,O
reporting,O
(,O
n,O
â€‰,O
=,O
â€‰,O
18,O
),O
.,O
In,O
addition,O
",",O
we,O
adjust,O
for,O
right,O
"
",O
truncation,O
of,O
the,O
data,O
as,O
the,O
epidemic,O
is,O
still,O
in,O
its,O
growth,O
phase,O
.,O
"
",O
RESULTS,O
:,O
Accounting,O
for,O
right,O
truncation,O
and,O
analyzing,O
all,O
pairs,O
",",O
we,O
estimated,O
"
",O
the,O
median,O
serial,O
interval,O
at,O
4,O
days,O
(,O
95,O
%,O
credible,O
interval,O
[,O
CrI,O
],O
:,O
3.1,O
",",O
4.9,O
),O
.,O
"
",O
Limiting,O
our,O
data,O
to,O
only,O
the,O
most,O
certain,O
pairs,O
",",O
the,O
median,O
serial,O
interval,O
was,O
"
",O
estimated,O
at,O
4.6,O
days,O
(,O
95,O
%,O
CrI,O
:,O
3.5,O
",",O
5.9,O
),O
.,O
"
",O
CONCLUSIONS,O
:,O
The,O
serial,O
interval,O
of,O
COVID19,B-Disease_COVID-19
is,O
close,O
to,O
or,O
shorter,O
than,O
its,O
"
",O
median,O
incubation,O
period,O
.,O
This,O
suggests,O
that,O
a,O
substantial,O
proportion,O
of,O
"
",O
secondary,O
transmission,O
may,O
occur,O
prior,O
to,O
illness,O
onset,O
.,O
The,O
COVID19,B-Disease_COVID-19
serial,O
"
",O
interval,O
is,O
also,O
shorter,O
than,O
the,O
serial,O
interval,O
of,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
(,O
SARS,O
),O
",",O
indicating,O
that,O
calculations,O
made,O
using,O
the,O
SARS,O
serial,O
interval,O
"
",O
may,O
introduce,O
bias,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
Ltd.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijid.2020.02.060,O
"
",O
PMID,O
:,O
32145466,O
"


",O
233,O
.,O
Int,O
J,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
4;93:211216,O
.,O
doi,O
:,O
10.1016,O
j.ijid.2020.02.058,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
A,O
conceptual,O
model,O
for,O
the,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
outbreak,O
in,O
Wuhan,O
",",O
"
",O
China,O
with,O
individual,O
reaction,O
and,O
governmental,O
action,O
.,O
"

",O
Lin,O
Q(1,O
),O
",",O
Zhao,O
S(2,O
),O
",",O
Gao,O
D(3,O
),O
",",O
Lou,O
Y(4,O
),O
",",O
Yang,O
S(5,O
),O
",",O
Musa,O
SS(6,O
),O
",",O
Wang,O
MH(7,O
),O
",",O
Cai,O
"
",O
Y(8,O
),O
",",O
Wang,O
W(9,O
),O
",",O
Yang,O
L(10,O
),O
",",O
He,O
D(11,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Michigan,O
Institute,O
for,O
Data,O
Science,O
",",O
University,O
of,O
Michigan,O
",",O
Ann,O
Arbor,O
",",O
MI,O
",",O
"
",O
USA,O
.,O
Electronic,O
address,O
:,O
qianying@umich.edu,O
.,O
"
",O
(2)JC,O
School,O
of,O
Public,O
Health,O
and,O
Primary,O
Care,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
",",O
China,O
;,O
Shenzhen,O
Research,O
Institute,O
of,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Shenzhen,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
shi.zhao@link.cuhk.edu.hk,O
.,O
"
",O
(3)Mathematics,O
and,O
Science,O
College,O
",",O
Shanghai,O
Normal,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
dzgao@shnu.edu.cn,O
.,O
"
",O
(4)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
yijun.lou@polyu.edu.hk,O
.,O
"
",O
(5)College,O
of,O
Medical,O
Information,O
Engineering,O
",",O
Chengdu,O
University,O
of,O
Traditional,O
"
",O
Chinese,O
Medicine,O
",",O
Chengdu,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
sishiyu1978@qq.com,O
.,O
"
",O
(6)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
salihusabiu.musa@connect.polyu.hk,O
.,O
"
",O
(7)JC,O
School,O
of,O
Public,O
Health,O
and,O
Primary,O
Care,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
",",O
China,O
;,O
Shenzhen,O
Research,O
Institute,O
of,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Shenzhen,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
maggiew@cuhk.edu.hk,O
.,O
"
",O
(8)School,O
of,O
Mathematics,O
and,O
Statistics,O
",",O
Huaiyin,O
Normal,O
University,O
",",O
Huai'an,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
yonglicai@hytc.edu.cn,O
.,O
"
",O
(9)School,O
of,O
Mathematics,O
and,O
Statistics,O
",",O
Huaiyin,O
Normal,O
University,O
",",O
Huai'an,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
weimingwang2003@163.com,O
.,O
"
",O
(10)School,O
of,O
Nursing,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
l.yang@polyu.edu.hk,O
.,O
"
",O
(11)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
daihai.he@polyu.edu.hk,O
.,O
"

",O
The,O
ongoing,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
outbreak,O
",",O
emerged,O
in,O
Wuhan,O
",",O
China,O
"
",O
in,O
the,O
end,O
of,O
2019,O
",",O
has,O
claimed,O
more,O
than,O
2600,O
lives,O
as,O
of,O
24,O
February,O
2020,O
and,O
"
",O
posed,O
a,O
huge,O
threat,O
to,O
global,O
public,O
health,O
.,O
The,O
Chinese,O
government,O
has,O
"
",O
implemented,O
control,O
measures,O
including,O
setting,O
up,O
special,O
hospitals,O
and,O
travel,O
"
",O
restriction,O
to,O
mitigate,O
the,O
spread,O
.,O
We,O
propose,O
conceptual,O
models,O
for,O
the,O
COVID19,B-Disease_COVID-19
"
",O
outbreak,O
in,O
Wuhan,O
with,O
the,O
consideration,O
of,O
individual,O
behavioural,O
reaction,O
and,O
"
",O
governmental,O
actions,O
",",O
e.g.,O
",",O
holiday,O
extension,O
",",O
travel,O
restriction,O
",",O
"
",O
hospitalisation,O
and,O
quarantine,O
.,O
We,O
employe,O
the,O
estimates,O
of,O
these,O
two,O
key,O
"
",O
components,O
from,O
the,O
1918,O
influenza,O
pandemic,O
in,O
London,O
",",O
United,O
Kingdom,O
",",O
"
",O
incorporated,O
zoonotic,O
introductions,O
and,O
the,O
emigration,O
",",O
and,O
then,O
compute,O
future,O
"
",O
trends,O
and,O
the,O
reporting,O
ratio,O
.,O
The,O
model,O
is,O
concise,O
in,O
structure,O
",",O
and,O
it,O
"
",O
successfully,O
captures,O
the,O
course,O
of,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
",",O
and,O
thus,O
sheds,O
light,O
"
",O
on,O
understanding,O
the,O
trends,O
of,O
the,O
outbreak,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
Ltd.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijid.2020.02.058,O
"
",O
PMID,O
:,O
32145465,O
"


",O
234,O
.,O
Pharmacol,O
Res,O
.,O
2020,O
Mar,O
4;155:104743,O
.,O
doi,O
:,O
10.1016,O
j.phrs.2020.104743,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Traditional,O
Chinese,O
medicine,O
for,O
COVID19,B-Disease_COVID-19
treatment,O
.,O
"

",O
Ren,O
JL(1,O
),O
",",O
Zhang,O
AH(1,O
),O
",",O
Wang,O
XJ(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Engineering,O
Research,O
Center,O
of,O
Efficacy,O
Evaluation,O
and,O
Industrial,O
Development,O
"
",O
of,O
TCM,O
Classic,O
Formulae,O
of,O
the,O
Ministry,O
of,O
Education,O
",",O
National,O
Chinmedomics,O
"
",O
Research,O
Center,O
",",O
SinoAmerica,O
Chinmedomics,O
Technology,O
Collaboration,O
Center,O
",",O
"
",O
Heilongjiang,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Heping,O
Road,O
24,O
",",O
Harbin,O
",",O
China,O
.,O
"
",O
(2)Engineering,O
Research,O
Center,O
of,O
Efficacy,O
Evaluation,O
and,O
Industrial,O
Development,O
"
",O
of,O
TCM,O
Classic,O
Formulae,O
of,O
the,O
Ministry,O
of,O
Education,O
",",O
National,O
Chinmedomics,O
"
",O
Research,O
Center,O
",",O
SinoAmerica,O
Chinmedomics,O
Technology,O
Collaboration,O
Center,O
",",O
"
",O
Heilongjiang,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Heping,O
Road,O
24,O
",",O
Harbin,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
xijunwangls@126.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.phrs.2020.104743,O
"
",O
PMID,O
:,O
32145402,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
There,O
are,O
no,O
"
",O
conflicts,O
to,O
declare,O
.,O
"


",O
235,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
5:101615,O
.,O
doi,O
:,O
10.1016,O
j.tmaid.2020.101615,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Remdesivir,O
as,O
a,O
possible,O
therapeutic,O
option,O
for,O
the,O
COVID19,B-Disease_COVID-19
.,O
"

",O
AlTawfiq,O
JA(1,O
),O
",",O
AlHomoud,O
AH(2,O
),O
",",O
Memish,O
ZA(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Infectious,O
Disease,O
Unit,O
",",O
Specialty,O
Internal,O
Medicine,O
and,O
Infection,O
Control,O
"
",O
Unit,O
",",O
Quality,O
and,O
Patient,O
Safety,O
",",O
Johns,O
Hopkins,O
Aramco,O
Healthcare,O
",",O
Dhahran,O
",",O
Saudi,O
"
",O
Arabia,O
;,O
Department,O
of,O
Medicine,O
",",O
Indiana,O
University,O
School,O
of,O
Medicine,O
",",O
"
",O
Indianapolis,O
",",O
IN,O
",",O
USA,O
;,O
Department,O
of,O
Medicine,O
",",O
Johns,O
Hopkins,O
University,O
School,O
of,O
"
",O
Medicine,O
",",O
Baltimore,O
",",O
MD,O
",",O
USA,O
.,O
Electronic,O
address,O
:,O
jaffar.tawfiq@jhah.com,O
.,O
"
",O
(2)Pharmacy,O
Services,O
Division,O
",",O
Johns,O
Hopkins,O
Aramco,O
Healthcare,O
",",O
Dhahran,O
",",O
Saudi,O
"
",O
Arabia,O
.,O
"
",O
(3)Director,O
Research,O
Center,O
",",O
King,O
Saud,O
Medical,O
City,O
",",O
Ministry,O
of,O
Health,O
",",O
Saudi,O
"
",O
Arabia,O
;,O
AlFaisal,O
University,O
",",O
Riyadh,O
",",O
Saudi,O
Arabia,O
;,O
Hubert,O
Department,O
of,O
Global,O
"
",O
Health,O
",",O
Rollins,O
School,O
of,O
Public,O
Health,O
",",O
Emory,O
University,O
",",O
Atlanta,O
",",O
GA,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101615,O
"
",O
PMID,O
:,O
32145386,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
All,O
authors,O
"
",O
have,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
236,O
.,O
Int,O
J,O
Antimicrob,O
Agents,O
.,O
2020,O
Mar,O
4:105932,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ijantimicag.2020.105932,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Chloroquine,O
and,O
hydroxychloroquine,O
as,O
available,O
weapons,O
to,O
fight,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Colson,O
P(1,O
),O
",",O
Rolain,O
JM(1,O
),O
",",O
Lagier,O
JC(1,O
),O
",",O
Brouqui,O
P(1,O
),O
",",O
Raoult,O
D(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)AixMarseille,O
UniveristÃ©,O
",",O
Institut,O
de,O
Recherche,O
pour,O
le,O
DÃ©veloppement,O
(,O
IRD,O
),O
",",O
"
",O
Assistance,O
PubliqueHÃ´pitaux,O
de,O
Marseille,O
(,O
APHM,O
),O
",",O
MEPHI,O
",",O
27,O
boulevard,O
Jean,O
"
",O
Moulin,O
",",O
13005,O
Marseille,O
",",O
France,O
;,O
IHUMÃ©diterranÃ©e,O
Infection,O
",",O
1921,O
boulevard,O
Jean,O
"
",O
Moulin,O
",",O
13005,O
Marseille,O
",",O
France,O
.,O
"
",O
(2)AixMarseille,O
UniveristÃ©,O
",",O
Institut,O
de,O
Recherche,O
pour,O
le,O
DÃ©veloppement,O
(,O
IRD,O
),O
",",O
"
",O
Assistance,O
PubliqueHÃ´pitaux,O
de,O
Marseille,O
(,O
APHM,O
),O
",",O
MEPHI,O
",",O
27,O
boulevard,O
Jean,O
"
",O
Moulin,O
",",O
13005,O
Marseille,O
",",O
France,O
;,O
IHUMÃ©diterranÃ©e,O
Infection,O
",",O
1921,O
boulevard,O
Jean,O
"
",O
Moulin,O
",",O
13005,O
Marseille,O
",",O
France,O
.,O
Electronic,O
address,O
:,O
didier.raoult@gmail.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijantimicag.2020.105932,O
"
",O
PMID,O
:,O
32145363,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
None,O
declared,O
.,O
"


",O
237,O
.,O
Clin,O
Chim,O
Acta,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
S00098981(20)301066,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.cca.2020.03.004,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Procalcitonin,O
in,O
patients,O
with,O
severe,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
:,O
a,O
"
",O
metaanalysis,O
.,O
"

",O
Lippi,O
G(1,O
),O
",",O
Plebani,O
M(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Section,O
of,O
Clinical,O
Biochemistry,O
",",O
Department,O
of,O
Neuroscience,O
",",O
Biomedicine,O
and,O
"
",O
Movement,O
",",O
University,O
of,O
Verona,O
",",O
Verona,O
",",O
Italy,O
.,O
"
",O
(2)Department,O
of,O
Laboratory,O
Medicine,O
",",O
University,O
Hospital,O
of,O
Padova,O
",",O
Padova,O
",",O
"
",O
Italy,O
.,O
Electronic,O
address,O
:,O
mario.plebani@unipd.it,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.cca.2020.03.004,O
"
",O
PMID,O
:,O
32145275,O
"


",O
238,O
.,O
J,O
Infect,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
S01634453(20)301110,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.031,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Public,O
health,O
might,O
be,O
endangered,O
by,O
possible,O
prolonged,O
discharge,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
in,O
stool,O
.,O
"

",O
He,O
Y(1,O
),O
",",O
Wang,O
Z(1,O
),O
",",O
Li,O
F(1,O
),O
",",O
Shi,O
Y(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Neonatology,O
",",O
Ministry,O
of,O
Education,O
Key,O
Laboratory,O
of,O
Child,O
"
",O
Development,O
and,O
Disorders,O
;,O
National,O
Clinical,O
Research,O
Center,O
for,O
Child,O
Health,O
and,O
"
",O
Disorders,O
;,O
China,O
International,O
Science,O
and,O
Technology,O
Cooperation,O
base,O
of,O
Child,O
"
",O
development,O
and,O
Critical,O
Disorders,O
;,O
Children,O
's,O
Hospital,O
of,O
Chongqing,O
Medical,O
"
",O
University,O
;,O
Chongqing,O
Key,O
Laboratory,O
of,O
Pediatrics,O
",",O
Chongqing,O
",",O
400014,O
",",O
P.R,O
China,O
.,O
"
",O
(2)Department,O
of,O
Neonatology,O
",",O
Ministry,O
of,O
Education,O
Key,O
Laboratory,O
of,O
Child,O
"
",O
Development,O
and,O
Disorders,O
;,O
National,O
Clinical,O
Research,O
Center,O
for,O
Child,O
Health,O
and,O
"
",O
Disorders,O
;,O
China,O
International,O
Science,O
and,O
Technology,O
Cooperation,O
base,O
of,O
Child,O
"
",O
development,O
and,O
Critical,O
Disorders,O
;,O
Children,O
's,O
Hospital,O
of,O
Chongqing,O
Medical,O
"
",O
University,O
;,O
Chongqing,O
Key,O
Laboratory,O
of,O
Pediatrics,O
",",O
Chongqing,O
",",O
400014,O
",",O
P.R,O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
shiyuan@hospital.cqmu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.031,O
"
",O
PMID,O
:,O
32145217,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
239,O
.,O
J,O
Infect,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
S01634453(20)301092,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.028,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
manifestations,O
and,O
outcome,O
of,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
during,O
pregnancy,O
.,O
"

",O
Liu,O
Y(1,O
),O
",",O
Chen,O
H(1,O
),O
",",O
Tang,O
K(1,O
),O
",",O
Guo,O
Y(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
First,O
Affiliated,O
Hospital,O
of,O
Sun,O
Yatsen,O
University,O
",",O
Guangzhou,O
510080,O
",",O
"
",O
Province,O
Guangdong,O
",",O
P.R.,O
China,O
.,O
"
",O
(2)The,O
First,O
Affiliated,O
Hospital,O
of,O
Sun,O
Yatsen,O
University,O
",",O
Guangzhou,O
510080,O
",",O
"
",O
Province,O
Guangdong,O
",",O
P.R.,O
China,O
.,O
Electronic,O
address,O
:,O
yubiao_guo@163.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.028,O
"
",O
PMID,O
:,O
32145216,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
All,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
competing,O
interests,O
.,O
"


",O
240,O
.,O
J,O
Infect,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
S01634453(20)301080,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.027,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Identification,O
of,O
the,O
hypervariable,O
genomic,O
hotspot,O
for,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Wen,O
F(1,O
),O
",",O
Yu,O
H(2,O
),O
",",O
Guo,O
J(3,O
),O
",",O
Li,O
Y(4,O
),O
",",O
Luo,O
K(5,O
),O
",",O
Huang,O
S(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)College,O
of,O
Life,O
Science,O
and,O
Engineering,O
",",O
Foshan,O
University,O
",",O
Foshan,O
",",O
528231,O
",",O
"
",O
Guangdong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
wenfengjlu@163.com,O
.,O
"
",O
(2)Shanghai,O
Veterinary,O
Research,O
Institute,O
",",O
Chinese,O
Academy,O
of,O
Agricultural,O
"
",O
Sciences,O
",",O
Shanghai,O
200241,O
",",O
China,O
;,O
"
",O
Jiangsu,O
Â ,O
Coinnovation,O
Â ,O
Center,O
Â ,O
for,O
Â ,O
Prevention,O
Â ,O
and,O
Â ,O
Control,O
Â ,O
of,O
Â ,O
Important,O
Â ,O
Animal,O
Â ,O
Infec,O
"
",O
tious,O
Â ,O
Diseases,O
Â ,O
and,O
Â ,O
Zoonoses,O
",",O
Â ,O
Yangzhou,O
Â ,O
225009,O
",",O
Â ,O
China,O
.,O
"
",O
(3)College,O
of,O
Life,O
Science,O
and,O
Engineering,O
",",O
Foshan,O
University,O
",",O
Foshan,O
",",O
528231,O
",",O
"
",O
Guangdong,O
",",O
China,O
.,O
"
",O
(4)College,O
of,O
Animal,O
Science,O
and,O
Technology,O
",",O
Jiangxi,O
Agricultural,O
University,O
",",O
"
",O
Nanchang,O
330045,O
",",O
Jiangxi,O
",",O
China,O
.,O
"
",O
(5)College,O
of,O
Veterinary,O
Medicine,O
",",O
South,O
China,O
Agricultural,O
University,O
",",O
Guangzhou,O
"
",O
510642,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(6)College,O
of,O
Life,O
Science,O
and,O
Engineering,O
",",O
Foshan,O
University,O
",",O
Foshan,O
",",O
528231,O
",",O
"
",O
Guangdong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
617955368@qq.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.027,O
"
",O
PMID,O
:,O
32145215,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
None,O
"


",O
241,O
.,O
J,O
Infect,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
S01634453(20)301109,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.029,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Lymphopenic,O
community,O
acquired,O
pneumonia,O
as,O
signature,O
of,O
severe,O
COVID19,B-Disease_COVID-19
"
",O
infection,O
:,O
Lymphopenia,O
in,O
severe,O
COVID19,B-Disease_COVID-19
infection,O
.,O
"

",O
BermejoMartin,O
JF(1,O
),O
",",O
Almansa,O
R(2,O
),O
",",O
MenÃ©ndez,O
R(3,O
),O
",",O
Mendez,O
R(4,O
),O
",",O
Kelvin,O
DJ(5,O
),O
",",O
"
",O
Torres,O
A(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Group,O
for,O
Biomedical,O
Research,O
in,O
Sepsis,O
(,O
BioSepsis,O
),O
",",O
Instituto,O
de,O
"
",O
InvestigaciÃ³n,O
BiomÃ©dica,O
de,O
Salamanca,O
(,O
IBSAL,O
),O
",",O
Paseo,O
de,O
San,O
Vicente,O
",",O
58182,O
",",O
37007,O
"
",O
Salamanca,O
",",O
Spain,O
;,O
Hospital,O
Universitario,O
RÃ­o,O
Hortega,O
de,O
Valladolid,O
.,O
Calle,O
"
",O
Dulzaina,O
",",O
2,O
",",O
47012,O
Valladolid,O
",",O
Spain,O
;,O
Centro,O
de,O
InvestigaciÃ³n,O
Biomedica,O
En,O
"
",O
RedEnfermedades,O
Respiratorias,O
",",O
Instituto,O
de,O
Salud,O
Carlos,O
III,O
",",O
Av,O
.,O
de,O
Monforte,O
de,O
"
",O
Lemos,O
",",O
5,O
",",O
28029,O
",",O
Madrid,O
",",O
Spain,O
.,O
Electronic,O
address,O
:,O
berinmuno@hotmail.com,O
.,O
"
",O
(2)Group,O
for,O
Biomedical,O
Research,O
in,O
Sepsis,O
(,O
BioSepsis,O
),O
",",O
Instituto,O
de,O
"
",O
InvestigaciÃ³n,O
BiomÃ©dica,O
de,O
Salamanca,O
(,O
IBSAL,O
),O
",",O
Paseo,O
de,O
San,O
Vicente,O
",",O
58182,O
",",O
37007,O
"
",O
Salamanca,O
",",O
Spain,O
;,O
Hospital,O
Universitario,O
RÃ­o,O
Hortega,O
de,O
Valladolid,O
.,O
Calle,O
"
",O
Dulzaina,O
",",O
2,O
",",O
47012,O
Valladolid,O
",",O
Spain,O
;,O
Centro,O
de,O
InvestigaciÃ³n,O
Biomedica,O
En,O
"
",O
RedEnfermedades,O
Respiratorias,O
",",O
Instituto,O
de,O
Salud,O
Carlos,O
III,O
",",O
Av,O
.,O
de,O
Monforte,O
de,O
"
",O
Lemos,O
",",O
5,O
",",O
28029,O
",",O
Madrid,O
",",O
Spain,O
.,O
"
",O
(3)Centro,O
de,O
InvestigaciÃ³n,O
Biomedica,O
En,O
RedEnfermedades,O
Respiratorias,O
",",O
Instituto,O
"
",O
de,O
Salud,O
Carlos,O
III,O
",",O
Av,O
.,O
de,O
Monforte,O
de,O
Lemos,O
",",O
5,O
",",O
28029,O
",",O
Madrid,O
",",O
Spain,O
;,O
"
",O
Pulmonology,O
Service,O
",",O
University,O
and,O
Polytechnic,O
Hospital,O
La,O
Fe,O
",",O
Avinguda,O
de,O
"
",O
Fernando,O
Abril,O
Martorell,O
",",O
106,O
",",O
46026,O
ValÃ¨ncia,O
",",O
Spain,O
.,O
"
",O
(4)Pulmonology,O
Service,O
",",O
University,O
and,O
Polytechnic,O
Hospital,O
La,O
Fe,O
",",O
Avinguda,O
de,O
"
",O
Fernando,O
Abril,O
Martorell,O
",",O
106,O
",",O
46026,O
ValÃ¨ncia,O
",",O
Spain,O
.,O
"
",O
(5)Department,O
of,O
Microbiology,O
and,O
Immunology,O
",",O
Dalhousie,O
University,O
",",O
Halifax,O
",",O
Nova,O
"
",O
Scotia,O
",",O
B3H,O
4R2,O
",",O
Canada,O
;,O
Division,O
of,O
Immunity,O
Shantou,O
University,O
Medical,O
College,O
",",O
"
",O
22,O
Xinling,O
Rd,O
",",O
Jinping,O
",",O
Shantou,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(6)Centro,O
de,O
InvestigaciÃ³n,O
Biomedica,O
En,O
RedEnfermedades,O
Respiratorias,O
",",O
Instituto,O
"
",O
de,O
Salud,O
Carlos,O
III,O
",",O
Av,O
.,O
de,O
Monforte,O
de,O
Lemos,O
",",O
5,O
",",O
28029,O
",",O
Madrid,O
",",O
Spain,O
;,O
"
",O
Department,O
of,O
Pneumology,O
",",O
Institut,O
Clinic,O
del,O
TÃ³rax,O
",",O
Hospital,O
Clinic,O
of,O
Barcelona,O
"
 ",O
Institut,O
d'Investigacions,O
BiomÃ¨diques,O
August,O
Pi,O
i,O
Sunyer,O
(,O
IDIBAPS,O
),O
",",O
University,O
"
",O
of,O
Barcelona,O
(,O
UB,O
),O
 ,O
SGR,O
911,O
Carrer,O
de,O
Villarroel,O
",",O
170,O
",",O
8036,O
Barcelona,O
",",O
Spain,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.029,O
"
",O
PMID,O
:,O
32145214,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
none,O
"


",O
242,O
.,O
Lancet,O
Gastroenterol,O
Hepatol,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
S24681253(20)300571,O
.,O
doi,O
:,O
"
",O
10.1016,O
S24681253(20)300571,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Liver,O
injury,O
in,O
COVID19,B-Disease_COVID-19
:,O
management,O
and,O
challenges,O
.,O
"

",O
Zhang,O
C(1,O
),O
",",O
Shi,O
L(1,O
),O
",",O
Wang,O
FS(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Treatment,O
and,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
The,O
Fifth,O
Medical,O
"
",O
Center,O
of,O
PLA,O
General,O
Hospital,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
"
",O
Diseases,O
",",O
Beijing,O
100039,O
",",O
China,O
.,O
"
",O
(2)Treatment,O
and,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
The,O
Fifth,O
Medical,O
"
",O
Center,O
of,O
PLA,O
General,O
Hospital,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
"
",O
Diseases,O
",",O
Beijing,O
100039,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
fswang302@163.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S24681253(20)300571,O
"
",O
PMID,O
:,O
32145190,O
"


",O
243,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
S14733099(20)301584,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301584,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Covert,O
COVID19,B-Disease_COVID-19
and,O
falsepositive,O
dengue,O
serology,O
in,O
Singapore,O
.,O
"

",O
Yan,O
G(1,O
),O
",",O
Lee,O
CK(2,O
),O
",",O
Lam,O
LTM(3,O
),O
",",O
Yan,O
B(2,O
),O
",",O
Chua,O
YX(3,O
),O
",",O
Lim,O
AYN(4,O
),O
",",O
Phang,O
KF(4,O
),O
",",O
"
",O
Kew,O
GS(4,O
),O
",",O
Teng,O
H(4,O
),O
",",O
Ngai,O
CH(4,O
),O
",",O
Lin,O
L(5,O
),O
",",O
Foo,O
RM(5,O
),O
",",O
Pada,O
S(5,O
),O
",",O
Ng,O
LC(6,O
),O
",",O
"
",O
Tambyah,O
PA(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medicine,O
",",O
National,O
University,O
Health,O
System,O
",",O
119228,O
",",O
Singapore,O
.,O
"
",O
Electronic,O
address,O
:,O
gabriel_zherong_yan@nuhs.edu.sg,O
.,O
"
",O
(2)Department,O
of,O
Laboratory,O
Medicine,O
",",O
University,O
Medicine,O
Cluster,O
",",O
National,O
"
",O
University,O
Health,O
System,O
",",O
Singapore,O
.,O
"
",O
(3)Pioneer,O
Polyclinic,O
",",O
National,O
University,O
Polyclinics,O
",",O
National,O
University,O
"
",O
Health,O
System,O
",",O
Singapore,O
.,O
"
",O
(4)Department,O
of,O
Medicine,O
",",O
National,O
University,O
Health,O
System,O
",",O
119228,O
",",O
Singapore,O
.,O
"
",O
(5)Department,O
of,O
Medicine,O
",",O
Ng,O
Teng,O
Fong,O
General,O
Hospital,O
",",O
Singapore,O
.,O
"
",O
(6)Environmental,O
Health,O
Institute,O
",",O
National,O
Environment,O
Agency,O
",",O
Singapore,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301584,O
"
",O
PMID,O
:,O
32145189,O
"


",O
244,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
S14733099(20)301596,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301596,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Outbreak,O
investigation,O
for,O
COVID19,B-Disease_COVID-19
in,O
northern,O
Vietnam,O
.,O
"

",O
Thanh,O
HN(1,O
),O
",",O
Van,O
TN(1,O
),O
",",O
Thu,O
HNT(1,O
),O
",",O
Van,O
BN(1,O
),O
",",O
Thanh,O
BD(1,O
),O
",",O
Thu,O
HPT(1,O
),O
",",O
Kieu,O
"
",O
ANT(1,O
),O
",",O
Viet,O
NN(2,O
),O
",",O
Marks,O
GB(3,O
),O
",",O
Fox,O
GJ(4,O
),O
",",O
Nguyen,O
TA(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Vinh,O
Phuc,O
Department,O
of,O
Health,O
",",O
Vinh,O
Phuc,O
",",O
Vietnam,O
.,O
"
",O
(2)National,O
Lung,O
Hospital,O
",",O
Hanoi,O
",",O
Vietnam,O
.,O
"
",O
(3)University,O
of,O
New,O
South,O
Wales,O
",",O
Sydney,O
",",O
NSW,O
",",O
Australia,O
;,O
Woolcock,O
Institute,O
of,O
"
",O
Medical,O
Research,O
",",O
Hanoi,O
",",O
Vietnam,O
.,O
"
",O
(4)Woolcock,O
Institute,O
of,O
Medical,O
Research,O
",",O
Hanoi,O
",",O
Vietnam,O
;,O
University,O
of,O
Sydney,O
",",O
"
",O
Sydney,O
",",O
NSW,O
2006,O
",",O
Australia,O
.,O
"
",O
(5)Woolcock,O
Institute,O
of,O
Medical,O
Research,O
",",O
Hanoi,O
",",O
Vietnam,O
;,O
University,O
of,O
Sydney,O
",",O
"
",O
Sydney,O
",",O
NSW,O
2006,O
",",O
Australia,O
.,O
Electronic,O
address,O
:,O
thuanh.nguyen@sydney.edu.au,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301596,O
"
",O
PMID,O
:,O
32145188,O
"


",O
245,O
.,O
Lancet,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
S01406736(20)305213,O
.,O
doi,O
:,O
"
",O
10.1016,O
S01406736(20)305213,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Has,O
China,O
faced,O
only,O
a,O
herald,O
wave,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
?,O
"

",O
Flahault,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Global,O
Health,O
",",O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Geneva,O
",",O
1205,O
"
",O
Geneva,O
",",O
Switzerland,O
.,O
Electronic,O
address,O
:,O
antoine.flahault@unige.ch,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)305213,O
"
",O
PMID,O
:,O
32145187,O
"


",O
246,O
.,O
Lancet,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
S01406736(20)30547X,O
.,O
doi,O
:,O
"
",O
10.1016,O
S01406736(20)30547X,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Mitigate,O
the,O
effects,O
of,O
home,O
confinement,O
on,O
children,O
during,O
the,O
COVID19,B-Disease_COVID-19
"
",O
outbreak,O
.,O
"

",O
Wang,O
G(1,O
),O
",",O
Zhang,O
Y(2,O
),O
",",O
Zhao,O
J(2,O
),O
",",O
Zhang,O
J(3,O
),O
",",O
Jiang,O
F(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Developmental,O
and,O
Behavioral,O
Pediatrics,O
",",O
Pediatric,O
Translational,O
"
",O
Medicine,O
Institute,O
",",O
Shanghai,O
Children,O
's,O
Medical,O
Center,O
affiliated,O
to,O
Shanghai,O
"
",O
Jiao,O
Tong,O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Child,O
Health,O
Advocacy,O
Institute,O
",",O
Shanghai,O
Children,O
's,O
Medical,O
Center,O
affiliated,O
"
",O
to,O
Shanghai,O
Jiao,O
Tong,O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(3)MOEShanghai,O
Key,O
Laboratory,O
of,O
Children,O
's,O
Environmental,O
Health,O
",",O
Xin,O
Hua,O
"
",O
Hospital,O
Affiliated,O
to,O
Shanghai,O
Jiao,O
Tong,O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
"
",O
200092,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Developmental,O
and,O
Behavioral,O
Pediatrics,O
",",O
Pediatric,O
Translational,O
"
",O
Medicine,O
Institute,O
",",O
Shanghai,O
Children,O
's,O
Medical,O
Center,O
affiliated,O
to,O
Shanghai,O
"
",O
Jiao,O
Tong,O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
;,O
MOEShanghai,O
Key,O
"
",O
Laboratory,O
of,O
Children,O
's,O
Environmental,O
Health,O
",",O
Xin,O
Hua,O
Hospital,O
Affiliated,O
to,O
"
",O
Shanghai,O
Jiao,O
Tong,O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
200092,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
fanjiang@shsmu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)30547X,O
"
",O
PMID,O
:,O
32145186,O
"


",O
247,O
.,O
Transbound,O
Emerg,O
Dis,O
.,O
2020,O
Mar,O
7,O
.,O
doi,O
:,O
10.1111,O
tbed.13536,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
ongoing,O
crises,O
in,O
China,O
illustrate,O
that,O
the,O
assessment,O
of,O
epidemics,O
in,O
"
",O
isolation,O
is,O
no,O
longer,O
sufficient,O
.,O
"

",O
Stoffel,O
C(1,O
),O
",",O
Schuppers,O
M(1,O
),O
",",O
Buholzer,O
P(1,O
),O
",",O
MuÃ±oz,O
V(1,O
),O
",",O
Lechner,O
I(1,O
),O
",",O
Sperling,O
"
",O
U(1,O
),O
",",O
KÃ¼ker,O
S(1,O
),O
",",O
De,O
Nardi,O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)SAFOSO,O
AG,O
",",O
Waldeggstrasse,O
1,O
",",O
CH,O
",",O
3097,O
",",O
Liebefeld,O
",",O
Switzerland,O
.,O
"

",O
The,O
interplay,O
of,O
simultaneous,O
COVID19,B-Disease_COVID-19
",",O
African,O
swine,O
fever,O
",",O
and,O
avian,O
influenza,O
"
",O
emergencies,O
on,O
global,O
health,O
and,O
industries,O
is,O
constantly,O
evolving,O
and,O
difficult,O
"
",O
to,O
predict,O
",",O
and,O
therefore,O
warrants,O
further,O
scrutiny,O
.,O
The,O
need,O
for,O
a,O
health,O
"
",O
network,O
of,O
global,O
scope,O
for,O
the,O
rapid,O
and,O
open,O
exchange,O
of,O
information,O
needs,O
to,O
"
",O
be,O
strengthened,O
in,O
order,O
to,O
address,O
ongoing,O
and,O
future,O
epidemics,O
under,O
competing,O
"
",O
resources,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1111,O
tbed.13536,O
"
",O
PMID,O
:,O
32145156,O
"


",O
248,O
.,O
Microb,O
Biotechnol,O
.,O
2020,O
Mar,O
6,O
.,O
doi,O
:,O
10.1111,O
17517915.14,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
The,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
 ,O
A,O
Snapshot,O
of,O
Current,O
Knowledge,O
.,O
"

",O
BrÃ¼ssow,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Biosystems,O
",",O
Group,O
of,O
Gene,O
Technology,O
",",O
KU,O
Leuven,O
",",O
Leuven,O
",",O
"
",O
Belgium,O
.,O
"

",O
Another,O
animal,O
to,O
human,O
transmission,O
of,O
a,O
coronavirus,O
occurred,O
in,O
December,O
2019,O
"
",O
on,O
a,O
live,O
animal,O
market,O
in,O
the,O
Chinese,O
city,O
of,O
Wuhan,O
causing,O
an,O
epidemic,O
in,O
"
",O
China,O
",",O
reaching,O
now,O
different,O
continents,O
.,O
This,O
minireview,O
summarizes,O
the,O
research,O
"
",O
literature,O
on,O
the,O
virological,O
",",O
clinical,O
and,O
epidemiological,O
aspects,O
of,O
this,O
"
",O
epidemic,O
published,O
until,O
end,O
of,O
February,O
2020,O
.,O
"

",O
Â©,O
2020,O
The,O
Authors,O
.,O
Microbial,O
Biotechnology,O
published,O
by,O
John,O
Wiley,O
&,O
Sons,O
Ltd,O
"
",O
and,O
Society,O
for,O
Applied,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1111,O
17517915.14,O
"
",O
PMID,O
:,O
32144890,O
"


",O
249,O
.,O
Can,O
J,O
Anaesth,O
.,O
2020,O
Mar,O
6,O
.,O
doi,O
:,O
10.1007,O
s12630020016174,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
What,O
we,O
do,O
when,O
a,O
COVID19,B-Disease_COVID-19
patient,O
needs,O
an,O
operation,O
:,O
operating,O
room,O
preparation,O
"
",O
and,O
guidance,O
.,O
"

",O
Ti,O
LK(1)(2,O
),O
",",O
Ang,O
LS(3,O
),O
",",O
Foong,O
TW(3,O
),O
",",O
Ng,O
BSW(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Anaesthesia,O
",",O
National,O
University,O
Health,O
System,O
",",O
Singapore,O
",",O
"
",O
Singapore,O
.,O
lian_kah_ti@nuhs.edu.sg,O
.,O
"
",O
(2)Department,O
of,O
Anaesthesia,O
",",O
Yong,O
Loo,O
Lin,O
School,O
of,O
Medicine,O
",",O
National,O
"
",O
University,O
of,O
Singapore,O
",",O
Singapore,O
",",O
Singapore,O
.,O
lian_kah_ti@nuhs.edu.sg,O
.,O
"
",O
(3)Department,O
of,O
Anaesthesia,O
",",O
National,O
University,O
Health,O
System,O
",",O
Singapore,O
",",O
"
",O
Singapore,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12630020016174,O
"
",O
PMID,O
:,O
32144591,O
"


",O
250,O
.,O
Arch,O
Virol,O
.,O
2020,O
Mar,O
6,O
.,O
doi,O
:,O
10.1007,O
s00705020045787,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Human,O
respiratory,O
syncytial,O
virus,O
F,O
protein,O
expressed,O
in,O
Pichia,O
pastoris,O
or,O
"
",O
Escherichia,O
coli,O
induces,O
protective,O
immunity,O
without,O
inducing,O
enhanced,O
"
",O
respiratory,O
disease,O
in,O
mice,O
.,O
"

",O
Li,O
H(1,O
),O
",",O
Cao,O
L(1,O
),O
",",O
Zhang,O
Y(1,O
),O
",",O
Ren,O
H(1,O
),O
",",O
Zhao,O
P(2,O
),O
",",O
Xu,O
W(3)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)NHC,O
Key,O
Laboratory,O
of,O
Medical,O
Virology,O
and,O
Viral,O
Diseases,O
",",O
National,O
Institute,O
"
",O
for,O
Viral,O
Disease,O
Control,O
and,O
Prevention,O
",",O
China,O
CDC,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Biochemistry,O
and,O
Molecular,O
Biology,O
",",O
School,O
of,O
Basic,O
Medical,O
"
",O
Sciences,O
",",O
Inner,O
Mongolia,O
Medical,O
University,O
",",O
Hohhot,O
",",O
China,O
.,O
"
",O
(3)NHC,O
Key,O
Laboratory,O
of,O
Medical,O
Virology,O
and,O
Viral,O
Diseases,O
",",O
National,O
Institute,O
"
",O
for,O
Viral,O
Disease,O
Control,O
and,O
Prevention,O
",",O
China,O
CDC,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
wenbo_xu1@aliyun.com,O
.,O
"
",O
(4)Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
wenbo_xu1@aliyun.com,O
.,O
"

",O
Human,O
respiratory,O
syncytial,O
virus,O
(,O
hRSV,O
),O
is,O
the,O
primary,O
cause,O
of,O
severe,O
"
",O
respiratory,O
tract,O
disease,O
in,O
children,O
and,O
infants,O
as,O
well,O
as,O
in,O
elderly,O
and,O
"
",O
immunocompromised,O
adults,O
.,O
The,O
fusion,O
protein,O
(,O
F,O
),O
of,O
hRSV,O
is,O
the,O
major,O
antigen,O
"
",O
eliciting,O
a,O
neutralizing,O
antibody,O
response,O
and,O
protective,O
immunity,O
in,O
the,O
host,O
",",O
"
",O
especially,O
those,O
recognizing,O
the,O
prefusion,O
F,O
protein,O
(,O
preF,O
),O
.,O
In,O
this,O
study,O
",",O
we,O
"
",O
made,O
genetic,O
constructs,O
for,O
expression,O
of,O
a,O
recombinant,O
prefusion,O
F,O
protein,O
in,O
"
",O
Pichia,O
pastoris,O
GS115,O
",",O
called,O
RGF,O
.,O
Using,O
Escherichia,O
coli,O
BL21,O
",",O
we,O
expressed,O
the,O
"
",O
preF,O
and,O
postfusion,O
F,O
protein,O
(,O
PostF,O
),O
",",O
called,O
RBF,O
and,O
PostRBF,O
",",O
respectively,O
.,O
"
",O
RGF,O
and,O
RBF,O
showed,O
high,O
affinity,O
for,O
5C4,O
",",O
a,O
highly,O
potent,O
monoclonal,O
antibody,O
"
",O
specific,O
for,O
preF.,O
We,O
studied,O
the,O
immunogenicity,O
of,O
RGF,O
and,O
RBF,O
in,O
mice,O
.,O
"
",O
Compared,O
to,O
mice,O
immunized,O
with,O
formalininactivated,O
RSV,O
(,O
FIRSV,O
),O
",",O
mice,O
immunized,O
"
",O
with,O
RGF,O
or,O
RBF,O
exhibited,O
superior,O
protective,O
immunity,O
",",O
which,O
was,O
confirmed,O
by,O
"
",O
serum,O
neutralizing,O
activity,O
and,O
viral,O
clearance,O
after,O
challenge,O
.,O
As,O
judged,O
from,O
"
",O
the,O
IgG1,O
IgG2a,O
ratios,O
and,O
numbers,O
of,O
IFNÎ³,O
and,O
IL4secreting,O
cells,O
",",O
RGF,O
or,O
RBF,O
"
",O
with,O
alum,O
adjuvant,O
induced,O
a,O
balanced,O
Th1biased,O
immune,O
response,O
and,O
produced,O
no,O
"
",O
signs,O
of,O
enhanced,O
respiratory,O
disease,O
(,O
ERD,O
),O
upon,O
hRSV,O
challenge,O
.,O
In,O
addition,O
",",O
the,O
"
",O
immunogenicity,O
and,O
protective,O
efficacy,O
of,O
RGF,O
were,O
superior,O
to,O
those,O
of,O
RBF,O
in,O
"
",O
mice,O
.,O
Therefore,O
",",O
RGF,O
represents,O
a,O
potential,O
vaccine,O
candidate,O
for,O
the,O
prevention,O
"
",O
of,O
human,O
infection,O
with,O
hRSV,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00705020045787,O
"
",O
PMID,O
:,O
32144542,O
"


",O
251,O
.,O
BMJ,O
.,O
2020,O
Mar,O
6;368:m941,O
.,O
doi,O
:,O
10.1136,O
bmj.m941,O
.,O
"

",O
Trump,O
claims,O
public,O
health,O
warnings,O
on,O
covid19,B-Disease_COVID-19
are,O
a,O
conspiracy,O
against,O
him,O
.,O
"

",O
Dyer,O
O(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Montreal,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m941,O
"
",O
PMID,O
:,O
32144176,O
"


",O
252,O
.,O
BMJ,O
.,O
2020,O
Mar,O
5;368:m800,O
.,O
doi,O
:,O
10.1136,O
bmj.m800,O
.,O
"

",O
Coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
covid19,B-Disease_COVID-19
),O
:,O
a,O
guide,O
for,O
UK,O
GPs,O
.,O
"

",O
Razai,O
MS(1,O
),O
",",O
Doerholt,O
K(2,O
),O
",",O
Ladhani,O
S(3,O
),O
",",O
Oakeshott,O
P(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Population,O
Health,O
Research,O
Institute,O
",",O
St,O
George,O
University,O
of,O
London,O
",",O
London,O
",",O
"
",O
UK,O
mrazai@sgul.ac.uk,O
.,O
"
",O
(2)St,O
George,O
's,O
University,O
Hospital,O
NHS,O
Foundation,O
Trust,O
",",O
London,O
",",O
UK,O
.,O
"
",O
(3)Public,O
Health,O
England,O
",",O
London,O
",",O
UK,O
.,O
"
",O
(4)Population,O
Health,O
Research,O
Institute,O
",",O
St,O
George,O
University,O
of,O
London,O
",",O
London,O
",",O
"
",O
UK,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
BMJ,O
.,O
2020,O
Mar,O
11;368:m989,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m800,O
"
",O
PMID,O
:,O
32144127,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interests,O
The,O
BMJ,O
has,O
judged,O
that,O
there,O
"
",O
are,O
no,O
disqualifying,O
financial,O
ties,O
to,O
commercial,O
companies,O
.,O
The,O
authors,O
declare,O
"
",O
the,O
following,O
other,O
interests,O
:,O
none,O
.,O
Further,O
details,O
of,O
The,O
BMJ,O
policy,O
on,O
"
",O
financial,O
interests,O
are,O
here,O
:,O
"
",O
https,O
:,O
 ,O
www.bmj.com,O
aboutbmj,O
resourcesauthors,O
formspoliciesandchecklists,O
dec,O
"
",O
larationcompetinginterests,O
"


",O
253,O
.,O
Science,O
.,O
2020,O
Mar,O
6,O
.,O
pii,O
:,O
eaba9757,O
.,O
doi,O
:,O
10.1126,O
science.aba9757,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
The,O
effect,O
of,O
travel,O
restrictions,O
on,O
the,O
spread,O
of,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
outbreak,O
.,O
"

",O
Chinazzi,O
M(1,O
),O
",",O
Davis,O
JT(1,O
),O
",",O
Ajelli,O
M(2,O
),O
",",O
Gioannini,O
C(3,O
),O
",",O
Litvinova,O
M(3,O
),O
",",O
Merler,O
"
",O
S(2,O
),O
",",O
Pastore,O
Y,O
Piontti,O
A(1,O
),O
",",O
Mu,O
K(1,O
),O
",",O
Rossi,O
L(3,O
),O
",",O
Sun,O
K(4,O
),O
",",O
Viboud,O
C(4,O
),O
",",O
Xiong,O
"
",O
X(1,O
),O
",",O
Yu,O
H(5,O
),O
",",O
Halloran,O
ME(6)(7,O
),O
",",O
Longini,O
IM,O
Jr(8,O
),O
",",O
Vespignani,O
A(9)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Laboratory,O
for,O
the,O
Modeling,O
of,O
Biological,O
and,O
Sociotechnical,O
Systems,O
",",O
"
",O
Northeastern,O
University,O
",",O
Boston,O
",",O
MA,O
",",O
USA,O
.,O
"
",O
(2)Bruno,O
Kessler,O
Foundation,O
",",O
Trento,O
",",O
Italy,O
.,O
"
",O
(3)ISI,O
Foundation,O
",",O
Turin,O
",",O
Italy,O
.,O
"
",O
(4)Fogarty,O
International,O
Center,O
",",O
NIH,O
",",O
USA,O
.,O
"
",O
(5)School,O
of,O
Public,O
Health,O
",",O
Fudan,O
University,O
",",O
Key,O
Laboratory,O
of,O
Public,O
Health,O
"
",O
Safety,O
",",O
Ministry,O
of,O
Education,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(6)Fred,O
Hutchinson,O
Cancer,O
Research,O
Center,O
",",O
Seattle,O
",",O
WA,O
",",O
USA,O
.,O
"
",O
(7)Department,O
of,O
Biostatistics,O
",",O
University,O
of,O
Washington,O
",",O
Seattle,O
",",O
WA,O
",",O
USA,O
.,O
"
",O
(8)Department,O
of,O
Biostatistics,O
",",O
College,O
of,O
Public,O
Health,O
and,O
Health,O
Professions,O
",",O
"
",O
University,O
of,O
Florida,O
",",O
Gainesville,O
",",O
FL,O
",",O
USA,O
.,O
a.vespignani@northeastern.edu,O
"
",O
ilongini@ufl.edu,O
.,O
"
",O
(9)Laboratory,O
for,O
the,O
Modeling,O
of,O
Biological,O
and,O
Sociotechnical,O
Systems,O
",",O
"
",O
Northeastern,O
University,O
",",O
Boston,O
",",O
MA,O
",",O
USA,O
.,O
a.vespignani@northeastern.edu,O
"
",O
ilongini@ufl.edu,O
.,O
"

",O
Motivated,O
by,O
the,O
rapid,O
spread,O
of,O
COVID19,B-Disease_COVID-19
in,O
Mainland,O
China,O
",",O
we,O
use,O
a,O
global,O
"
",O
metapopulation,O
disease,O
transmission,O
model,O
to,O
project,O
the,O
impact,O
of,O
travel,O
"
",O
limitations,O
on,O
the,O
national,O
and,O
international,O
spread,O
of,O
the,O
epidemic,O
.,O
The,O
model,O
"
",O
is,O
calibrated,O
based,O
on,O
internationally,O
reported,O
cases,O
",",O
and,O
shows,O
that,O
at,O
the,O
"
",O
start,O
of,O
the,O
travel,O
ban,O
from,O
Wuhan,O
on,O
23,O
January,O
2020,O
",",O
most,O
Chinese,O
cities,O
had,O
"
",O
already,O
received,O
many,O
infected,O
travelers,O
.,O
The,O
travel,O
quarantine,O
of,O
Wuhan,O
delayed,O
"
",O
the,O
overall,O
epidemic,O
progression,O
by,O
only,O
3,O
to,O
5,O
days,O
in,O
Mainland,O
China,O
",",O
but,O
has,O
a,O
"
",O
more,O
marked,O
effect,O
at,O
the,O
international,O
scale,O
",",O
where,O
case,O
importations,O
were,O
"
",O
reduced,O
by,O
nearly,O
80,O
%,O
until,O
mid,O
February,O
.,O
Modeling,O
results,O
also,O
indicate,O
that,O
"
",O
sustained,O
90,O
%,O
travel,O
restrictions,O
to,O
and,O
from,O
Mainland,O
China,O
only,O
modestly,O
affect,O
"
",O
the,O
epidemic,O
trajectory,O
unless,O
combined,O
with,O
a,O
50,O
%,O
or,O
higher,O
reduction,O
of,O
"
",O
transmission,O
in,O
the,O
community,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
",",O
American,O
Association,O
for,O
the,O
Advancement,O
of,O
Science,O
.,O
"

",O
DOI,O
:,O
10.1126,O
science.aba9757,O
"
",O
PMID,O
:,O
32144116,O
"


",O
254,O
.,O
BMJ,O
.,O
2020,O
Mar,O
6;368:m919,O
.,O
doi,O
:,O
10.1136,O
bmj.m919,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
are,O
we,O
getting,O
the,O
communications,O
right,O
?,O
"

",O
Cowper,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Health,O
Policy,O
Insight,O
",",O
London,O
",",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m919,O
"
",O
PMID,O
:,O
32144115,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interests,O
:,O
None,O
declared,O
.,O
"


",O
255,O
.,O
BMJ,O
.,O
2020,O
Mar,O
6;368:m936,O
.,O
doi,O
:,O
10.1136,O
bmj.m936,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
GP,O
surgeries,O
close,O
for,O
two,O
weeks,O
after,O
staff,O
test,O
positive,O
.,O
"

",O
Iacobucci,O
G(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m936,O
"
",O
PMID,O
:,O
32144111,O
"


",O
256,O
.,O
CMAJ,O
.,O
2020,O
Mar,O
6,O
.,O
pii,O
:,O
cmaj.200305,O
.,O
doi,O
:,O
10.1503,O
cmaj.200305,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
What,O
can,O
early,O
Canadian,O
experience,O
screening,O
for,O
COVID19,B-Disease_COVID-19
teach,O
us,O
about,O
how,O
to,O
"
",O
prepare,O
for,O
a,O
pandemic,O
?,O
"

",O
Lin,O
M(1,O
),O
",",O
Beliavsky,O
A(1,O
),O
",",O
Katz,O
K(1,O
),O
",",O
Powis,O
JE(1,O
),O
",",O
Ng,O
W(1,O
),O
",",O
Williams,O
V(1,O
),O
",",O
Science,O
"
",O
M(1,O
),O
",",O
Groves,O
H(1,O
),O
",",O
Muller,O
MP(1,O
),O
",",O
Vaisman,O
A(1,O
),O
",",O
Hota,O
S(1,O
),O
",",O
Johnstone,O
J(1,O
),O
",",O
Leis,O
"
",O
JA(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medicine,O
(,O
Lin,O
",",O
Beliavsky,O
",",O
Katz,O
",",O
Powis,O
",",O
Muller,O
",",O
Vaisman,O
",",O
Hota,O
",",O
"
",O
Leis,O
),O
",",O
University,O
of,O
Toronto,O
;,O
North,O
York,O
General,O
Hospital,O
(,O
Katz,O
",",O
Ng,O
),O
",",O
Toronto,O
",",O
"
",O
Ont,O
.,O
;,O
Michael,O
Garron,O
Hospital,O
(,O
Powis,O
),O
",",O
East,O
York,O
",",O
Ont,O
.,O
;,O
Sunnybrook,O
Health,O
"
",O
Sciences,O
Centre,O
(,O
Williams,O
",",O
Leis,O
),O
;,O
Hospital,O
for,O
Sick,O
Children,O
(,O
Science,O
",",O
Groves,O
),O
;,O
"
",O
Sinai,O
Health,O
System,O
(,O
Johnstone,O
),O
;,O
Departments,O
of,O
Paediatrics,O
(,O
Science,O
",",O
Groves,O
),O
",",O
"
",O
and,O
Laboratory,O
Medicine,O
and,O
Pathobiology,O
(,O
Katz,O
",",O
Johnstone,O
),O
",",O
University,O
of,O
"
",O
Toronto,O
;,O
Unity,O
Health,O
Toronto,O
(,O
Muller,O
),O
;,O
University,O
Health,O
Network,O
(,O
Vaisman,O
",",O
"
",O
Hota,O
),O
",",O
Toronto,O
",",O
Ont,O
.,O
"

",O
DOI,O
:,O
10.1503,O
cmaj.200305,O
"
",O
PMID,O
:,O
32144097,O
"


",O
257,O
.,O
BMJ,O
.,O
2020,O
Mar,O
6;368:m943,O
.,O
doi,O
:,O
10.1136,O
bmj.m943,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
UK,O
records,O
first,O
death,O
",",O
as,O
world,O
's,O
cases,O
exceed,O
100,O
â€‰,O
0,O
.,O
"

",O
Mahase,O
E(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m943,O
"
",O
PMID,O
:,O
32144096,O
"


",O
258,O
.,O
J,O
Autoimmun,O
.,O
2020,O
Mar,O
3:102434,O
.,O
doi,O
:,O
10.1016,O
j.jaut.2020.102434,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
The,O
deadly,O
coronaviruses,O
:,O
The,O
2003,O
SARS,O
pandemic,O
and,O
the,O
2020,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
epidemic,O
in,O
China,O
.,O
"

",O
Yang,O
Y(1,O
),O
",",O
Peng,O
F(2,O
),O
",",O
Wang,O
R(3,O
),O
",",O
Guan,O
K(1,O
),O
",",O
Jiang,O
T(4,O
),O
",",O
Xu,O
G(5,O
),O
",",O
Sun,O
J(6,O
),O
",",O
Chang,O
"
",O
C(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Allergy,O
&,O
Clinical,O
Immunology,O
",",O
Peking,O
Union,O
Medical,O
College,O
"
",O
Hospital,O
",",O
Peking,O
Union,O
Medical,O
College,O
&,O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
"
",O
National,O
Clinical,O
Research,O
Center,O
for,O
Immunologic,O
Diseases,O
",",O
Beijing,O
",",O
100730,O
",",O
"
",O
China,O
.,O
"
",O
(2)Center,O
for,O
Systems,O
Medicine,O
",",O
Institute,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Medical,O
Sciences,O
&,O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
",",O
100005,O
",",O
"
",O
China,O
;,O
Suzhou,O
Institute,O
of,O
Systems,O
Medicine,O
",",O
Suzhou,O
",",O
Jiangsu,O
215123,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Respiratory,O
Diseases,O
",",O
The,O
Second,O
Medical,O
Center,O
&,O
National,O
"
",O
Clinical,O
Research,O
Center,O
for,O
Geriatric,O
Diseases,O
",",O
Chinese,O
PLA,O
General,O
Hospital,O
",",O
"
",O
Beijing,O
",",O
100853,O
",",O
China,O
.,O
"
",O
(4)Center,O
for,O
Systems,O
Medicine,O
",",O
Institute,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Medical,O
Sciences,O
&,O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
",",O
100005,O
",",O
"
",O
China,O
;,O
Suzhou,O
Institute,O
of,O
Systems,O
Medicine,O
",",O
Suzhou,O
",",O
Jiangsu,O
215123,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
taijiao@ibms.pumc.edu.cn,O
.,O
"
",O
(5)Department,O
of,O
Infection,O
Prevention,O
and,O
Disease,O
Control,O
",",O
The,O
Second,O
Medical,O
"
",O
Center,O
&,O
National,O
Clinical,O
Research,O
Center,O
for,O
Geriatric,O
Diseases,O
",",O
Chinese,O
PLA,O
"
",O
General,O
Hospital,O
",",O
Beijing,O
",",O
100853,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
guogang_xu@qq.com,O
.,O
"
",O
(6)Department,O
of,O
Allergy,O
&,O
Clinical,O
Immunology,O
",",O
Peking,O
Union,O
Medical,O
College,O
"
",O
Hospital,O
",",O
Peking,O
Union,O
Medical,O
College,O
&,O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
"
",O
National,O
Clinical,O
Research,O
Center,O
for,O
Immunologic,O
Diseases,O
",",O
Beijing,O
",",O
100730,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
sunjinlv@pumch.cn,O
.,O
"
",O
(7)Division,O
of,O
Rheumatology,O
",",O
Allergy,O
and,O
Clinical,O
Immunology,O
",",O
University,O
of,O
"
",O
California,O
",",O
Davis,O
",",O
Davis,O
",",O
CA,O
",",O
95616,O
",",O
USA,O
;,O
Division,O
of,O
Pediatric,O
Immunology,O
and,O
"
",O
Allergy,O
",",O
Joe,O
DiMaggio,O
Children,O
's,O
Hospital,O
",",O
Hollywood,O
",",O
FL,O
",",O
USA,O
.,O
Electronic,O
"
",O
address,O
:,O
chrchang@ucdavis.edu,O
.,O
"

",O
The,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
officially,O
called,O
SARSCoV2,B-Virus_SARS-CoV-2
and,O
the,O
disease,O
is,O
named,O
COVID19,B-Disease_COVID-19
.,O
"
",O
This,O
viral,O
epidemic,O
in,O
China,O
has,O
led,O
to,O
the,O
deaths,O
of,O
over,O
1800,O
people,O
",",O
mostly,O
"
",O
elderly,O
or,O
those,O
with,O
an,O
underlying,O
chronic,O
disease,O
or,O
immunosuppressed,O
state,O
.,O
"
",O
This,O
is,O
the,O
third,O
serious,O
Coronavirus,O
outbreak,O
in,O
less,O
than,O
20,O
years,O
",",O
following,O
"
",O
SARS,O
in,O
20022003,O
and,O
MERS,O
in,O
2012,O
.,O
While,O
human,O
strains,O
of,O
Coronavirus,O
are,O
"
",O
associated,O
with,O
about,O
15,O
%,O
of,O
cases,O
of,O
the,O
common,O
cold,O
",",O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
may,O
present,O
"
",O
with,O
varying,O
degrees,O
of,O
severity,O
",",O
from,O
flulike,O
symptoms,O
to,O
death,O
.,O
It,O
is,O
"
",O
currently,O
believed,O
that,O
this,O
deadly,O
Coronavirus,O
strain,O
originated,O
from,O
wild,O
"
",O
animals,O
at,O
the,O
Huanan,O
market,O
in,O
Wuhan,O
",",O
a,O
city,O
in,O
Hubei,O
province,O
.,O
Bats,O
",",O
snakes,O
and,O
"
",O
pangolins,O
have,O
been,O
cited,O
as,O
potential,O
carriers,O
based,O
on,O
the,O
sequence,O
homology,O
of,O
"
",O
CoV,O
isolated,O
from,O
these,O
animals,O
and,O
the,O
viral,O
nucleic,O
acids,O
of,O
the,O
virus,O
isolated,O
"
",O
from,O
SARSCoV2,B-Virus_SARS-CoV-2
infected,O
patients,O
.,O
Extreme,O
quarantine,O
measures,O
",",O
including,O
sealing,O
"
",O
off,O
large,O
cities,O
",",O
closing,O
borders,O
and,O
confining,O
people,O
to,O
their,O
homes,O
",",O
were,O
"
",O
instituted,O
in,O
January,O
2020,O
to,O
prevent,O
spread,O
of,O
the,O
virus,O
",",O
but,O
by,O
that,O
time,O
much,O
"
",O
of,O
the,O
damage,O
had,O
been,O
done,O
",",O
as,O
humanhuman,O
transmission,O
became,O
evident,O
.,O
While,O
"
",O
these,O
quarantine,O
measures,O
are,O
necessary,O
and,O
have,O
prevented,O
a,O
historical,O
disaster,O
"
",O
along,O
the,O
lines,O
of,O
the,O
Spanish,O
flu,O
",",O
earlier,O
recognition,O
and,O
earlier,O
"
",O
implementation,O
of,O
quarantine,O
measures,O
may,O
have,O
been,O
even,O
more,O
effective,O
.,O
Lessons,O
"
",O
learned,O
from,O
SARS,O
resulted,O
in,O
faster,O
determination,O
of,O
the,O
nucleic,O
acid,O
sequence,O
"
",O
and,O
a,O
more,O
robust,O
quarantine,O
strategy,O
.,O
However,O
",",O
it,O
is,O
clear,O
that,O
finding,O
an,O
"
",O
effective,O
antiviral,O
and,O
developing,O
a,O
vaccine,O
are,O
still,O
significant,O
challenges,O
.,O
"
",O
The,O
costs,O
of,O
the,O
epidemic,O
are,O
not,O
limited,O
to,O
medical,O
aspects,O
",",O
as,O
the,O
virus,O
has,O
"
",O
led,O
to,O
significant,O
sociological,O
",",O
psychological,O
and,O
economic,O
effects,O
globally,O
.,O
"
",O
Unfortunately,O
",",O
emergence,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
has,O
led,O
to,O
numerous,O
reports,O
of,O
Asians,O
"
",O
being,O
subjected,O
to,O
racist,O
behavior,O
and,O
hate,O
crimes,O
across,O
the,O
world,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jaut.2020.102434,O
"
",O
PMID,O
:,O
32143990,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
The,O
authors,O
"
",O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
259,O
.,O
Int,O
J,O
Environ,O
Res,O
Public,O
Health,O
.,O
2020,O
Mar,O
4;17(5,O
),O
.,O
pii,O
:,O
E1679,O
.,O
doi,O
:,O
"
",O
10.339,O
ijerph17051679,O
.,O
"

",O
Prediction,O
of,O
Epidemic,O
Spread,O
of,O
the,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
Driven,O
by,O
Spring,O
"
",O
Festival,O
Transportation,O
in,O
China,O
:,O
A,O
PopulationBased,O
Study,O
.,O
"

",O
Fan,O
C(1,O
),O
",",O
Liu,O
L(2)(3,O
),O
",",O
Guo,O
W(3,O
),O
",",O
Yang,O
A(3,O
),O
",",O
Ye,O
C(3,O
),O
",",O
Jilili,O
M(3,O
),O
",",O
Ren,O
M(3,O
),O
",",O
Xu,O
"
",O
P(4,O
),O
",",O
Long,O
H(5,O
),O
",",O
Wang,O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Sociology,O
",",O
Central,O
China,O
Normal,O
University,O
",",O
Wuhan,O
430079,O
",",O
Hubei,O
"
",O
Province,O
",",O
China,O
.,O
"
",O
(2)School,O
of,O
Public,O
Administration,O
",",O
Hangzhou,O
Normal,O
University,O
",",O
Hangzhou,O
311121,O
",",O
"
",O
Zhejiang,O
Province,O
",",O
China,O
.,O
"
",O
(3)School,O
of,O
Social,O
and,O
Behavioral,O
Sciences,O
",",O
Nanjing,O
University,O
",",O
Nanjing,O
210046,O
",",O
"
",O
Jiangsu,O
Province,O
",",O
China,O
.,O
"
",O
(4)School,O
of,O
Sociology,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
430072,O
",",O
Hubei,O
Province,O
",",O
China,O
.,O
"
",O
(5)School,O
of,O
Economics,O
",",O
Minzu,O
University,O
of,O
China,O
",",O
Beijing,O
100081,O
",",O
China,O
.,O
"

",O
After,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
outbreak,O
",",O
we,O
estimated,O
the,O
"
",O
distribution,O
and,O
scale,O
of,O
more,O
than,O
5,O
million,O
migrants,O
residing,O
in,O
Wuhan,O
after,O
"
",O
they,O
returned,O
to,O
their,O
hometown,O
communities,O
in,O
Hubei,O
Province,O
or,O
other,O
provinces,O
"
",O
at,O
the,O
end,O
of,O
2019,O
by,O
using,O
the,O
data,O
from,O
the,O
20132018,O
China,O
Migrants,O
Dynamic,O
"
",O
Survey,O
(,O
CMDS,O
),O
.,O
We,O
found,O
that,O
the,O
distribution,O
of,O
Wuhan,O
's,O
migrants,O
is,O
centred,O
in,O
"
",O
Hubei,O
Province,O
(,O
approximately,O
75,O
%,O
),O
at,O
a,O
provincial,O
level,O
",",O
gradually,O
decreasing,O
in,O
"
",O
the,O
surrounding,O
provinces,O
in,O
layers,O
",",O
with,O
obvious,O
spatial,O
characteristics,O
of,O
"
",O
circle,O
layers,O
and,O
echelons,O
.,O
The,O
scale,O
of,O
Wuhan,O
's,O
migrants,O
",",O
whose,O
origins,O
in,O
Hubei,O
"
",O
Province,O
give,O
rise,O
to,O
a,O
gradient,O
reduction,O
from,O
east,O
to,O
west,O
within,O
the,O
province,O
",",O
"
",O
and,O
account,O
for,O
66,O
%,O
of,O
Wuhan,O
's,O
total,O
migrants,O
",",O
are,O
from,O
the,O
surrounding,O
"
",O
prefecturallevel,O
cities,O
of,O
Wuhan,O
.,O
The,O
distribution,O
comprises,O
94,O
districts,O
and,O
"
",O
counties,O
in,O
Hubei,O
Province,O
",",O
and,O
the,O
cumulative,O
percentage,O
of,O
the,O
top,O
30,O
districts,O
"
",O
and,O
counties,O
exceeds,O
80,O
%,O
.,O
Wuhan,O
's,O
migrants,O
have,O
a,O
large,O
proportion,O
of,O
middleaged,O
"
",O
and,O
highrisk,O
individuals,O
.,O
Their,O
social,O
characteristics,O
include,O
nuclear,O
family,O
"
",O
migration,O
(,O
84,O
%,O
),O
",",O
migration,O
with,O
families,O
of,O
34,O
members,O
(,O
71,O
%,O
),O
",",O
a,O
rural,O
household,O
"
",O
registration,O
(,O
85,O
%,O
),O
",",O
and,O
working,O
or,O
doing,O
business,O
(,O
84,O
%,O
),O
as,O
the,O
main,O
reason,O
for,O
"
",O
migration,O
.,O
Using,O
a,O
quasiexperimental,O
analysis,O
framework,O
",",O
we,O
found,O
that,O
the,O
size,O
"
",O
of,O
Wuhan,O
's,O
migrants,O
was,O
highly,O
correlated,O
with,O
the,O
daily,O
number,O
of,O
confirmed,O
"
",O
cases,O
.,O
Furthermore,O
",",O
we,O
compared,O
the,O
epidemic,O
situation,O
in,O
different,O
regions,O
and,O
"
",O
found,O
that,O
the,O
number,O
of,O
confirmed,O
cases,O
in,O
some,O
provinces,O
and,O
cities,O
in,O
Hubei,O
"
",O
Province,O
may,O
be,O
underestimated,O
",",O
while,O
the,O
epidemic,O
situation,O
in,O
some,O
regions,O
has,O
"
",O
increased,O
rapidly,O
.,O
The,O
results,O
are,O
conducive,O
to,O
monitoring,O
the,O
epidemic,O
"
",O
prevention,O
and,O
control,O
in,O
various,O
regions,O
.,O
"

",O
DOI,O
:,O
10.339,O
ijerph17051679,O
"
",O
PMID,O
:,O
32143519,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
260,O
.,O
Pathogens,O
.,O
2020,O
Mar,O
4;9(3,O
),O
.,O
pii,O
:,O
E186,O
.,O
doi,O
:,O
10.339,O
pathogens9030186,O
.,O
"

",O
Insights,O
into,O
the,O
Recent,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
in,O
Light,O
of,O
Past,O
"
",O
Human,O
Coronavirus,O
Outbreaks,O
.,O
"

",O
Ashour,O
HM(1)(2,O
),O
",",O
Elkhatib,O
WF(3)(4,O
),O
",",O
Rahman,O
MM(5,O
),O
",",O
Elshabrawy,O
HA(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Biological,O
Sciences,O
",",O
College,O
of,O
Arts,O
and,O
Sciences,O
",",O
University,O
of,O
"
",O
South,O
Florida,O
St.,O
Petersburg,O
",",O
St.,O
Petersburg,O
",",O
FL,O
33701,O
",",O
USA,O
.,O
"
",O
(2)Department,O
of,O
Microbiology,O
and,O
Immunology,O
",",O
Faculty,O
of,O
Pharmacy,O
",",O
Cairo,O
"
",O
University,O
",",O
Cairo,O
11562,O
",",O
Egypt,O
.,O
"
",O
(3)Department,O
of,O
Microbiology,O
and,O
Immunology,O
",",O
School,O
of,O
Pharmacy,O
&,O
Pharmaceutical,O
"
",O
Industries,O
",",O
Badr,O
University,O
in,O
Cairo,O
(,O
BUC,O
),O
",",O
Entertainment,O
Area,O
",",O
Badr,O
City,O
",",O
Cairo,O
"
",O
11829,O
",",O
Egypt,O
.,O
"
",O
(4)Microbiology,O
and,O
Immunology,O
Department,O
",",O
Faculty,O
of,O
Pharmacy,O
",",O
Ain,O
Shams,O
"
",O
University,O
",",O
African,O
Union,O
Organization,O
St.,O
",",O
Abbassia,O
",",O
Cairo,O
11566,O
",",O
Egypt,O
.,O
"
",O
(5)Department,O
of,O
Pathology,O
",",O
Faculty,O
of,O
Veterinary,O
",",O
Animal,O
and,O
Biomedical,O
"
",O
Sciences,O
",",O
Sylhet,O
Agricultural,O
University,O
",",O
Sylhet,O
3100,O
",",O
Bangladesh,O
.,O
"
",O
(6)Department,O
of,O
Molecular,O
and,O
Cellular,O
Biology,O
",",O
College,O
of,O
Osteopathic,O
Medicine,O
",",O
"
",O
Sam,O
Houston,O
State,O
University,O
",",O
Conroe,O
",",O
TX,O
77304,O
",",O
USA,O
.,O
"

",O
Coronaviruses,O
(,O
CoVs,O
),O
are,O
RNA,O
viruses,O
that,O
have,O
become,O
a,O
major,O
public,O
health,O
"
",O
concern,O
since,O
the,O
Severe,O
Acute,O
Respiratory,O
SyndromeCoV,O
(,O
SARSCoV,O
),O
outbreak,O
in,O
"
",O
2002,O
.,O
The,O
continuous,O
evolution,O
of,O
coronaviruses,O
was,O
further,O
highlighted,O
with,O
the,O
"
",O
emergence,O
of,O
the,O
Middle,O
East,O
Respiratory,O
SyndromeCoV,O
(,O
MERSCoV,O
),O
outbreak,O
in,O
"
",O
2012,O
.,O
Currently,O
",",O
the,O
world,O
is,O
concerned,O
about,O
the,O
2019,O
novel,O
CoV,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
"
",O
that,O
was,O
initially,O
identified,O
in,O
the,O
city,O
of,O
Wuhan,O
",",O
China,O
in,O
December,O
2019,O
.,O
"
",O
Patients,O
presented,O
with,O
severe,O
viral,O
pneumonia,O
and,O
respiratory,O
illness,O
.,O
The,O
"
",O
number,O
of,O
cases,O
has,O
been,O
mounting,O
since,O
then,O
.,O
As,O
of,O
late,O
February,O
2020,O
",",O
tens,O
of,O
"
",O
thousands,O
of,O
cases,O
and,O
several,O
thousand,O
deaths,O
have,O
been,O
reported,O
in,O
China,O
alone,O
",",O
"
",O
in,O
addition,O
to,O
thousands,O
of,O
cases,O
in,O
other,O
countries,O
.,O
Although,O
the,O
fatality,O
rate,O
"
",O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
is,O
currently,O
lower,O
than,O
SARSCoV,O
",",O
the,O
virus,O
seems,O
to,O
be,O
highly,O
"
",O
contagious,O
based,O
on,O
the,O
number,O
of,O
infected,O
cases,O
to,O
date,O
.,O
In,O
this,O
review,O
",",O
we,O
"
",O
discuss,O
structure,O
",",O
genome,O
organization,O
",",O
entry,O
of,O
CoVs,O
into,O
target,O
cells,O
",",O
and,O
"
",O
provide,O
insights,O
into,O
past,O
and,O
present,O
outbreaks,O
.,O
The,O
future,O
of,O
human,O
CoV,O
"
",O
outbreaks,O
will,O
not,O
only,O
depend,O
on,O
how,O
the,O
viruses,O
will,O
evolve,O
",",O
but,O
will,O
also,O
"
",O
depend,O
on,O
how,O
we,O
develop,O
efficient,O
prevention,O
and,O
treatment,O
strategies,O
to,O
deal,O
"
",O
with,O
this,O
continuous,O
threat,O
.,O
"

",O
DOI,O
:,O
10.339,O
pathogens9030186,O
"
",O
PMID,O
:,O
32143502,O
"


",O
261,O
.,O
J,O
Clin,O
Virol,O
.,O
2020,O
Feb,O
28;125:104305,O
.,O
doi,O
:,O
10.1016,O
j.jcv.2020.104305,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Rapid,O
random,O
access,O
detection,O
of,O
the,O
novel,O
SARScoronavirus2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
"
",O
previously,O
2019nCoV,B-Virus_SARS-CoV-2
),O
using,O
an,O
open,O
access,O
protocol,O
for,O
the,O
Panther,O
Fusion,O
.,O
"

",O
Cordes,O
AK(1,O
),O
",",O
Heim,O
A(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
for,O
Virology,O
",",O
Hannover,O
Medical,O
School,O
",",O
CarlNeubergStr,O
.,O
1,O
",",O
30625,O
",",O
"
",O
Hannover,O
",",O
Germany,O
.,O
"
",O
(2)Institute,O
for,O
Virology,O
",",O
Hannover,O
Medical,O
School,O
",",O
CarlNeubergStr,O
.,O
1,O
",",O
30625,O
",",O
"
",O
Hannover,O
",",O
Germany,O
.,O
Electronic,O
address,O
:,O
heim.albert@mhhannover.de,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jcv.2020.104305,O
"
",O
PMID,O
:,O
32143123,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
AH,O
:,O
Research,O
"
",O
grant,O
and,O
travel,O
grant,O
not,O
related,O
to,O
the,O
present,O
work,O
by,O
Hologic,O
Inc.,O
AC,O
:,O
Travel,O
"
",O
grant,O
and,O
speaker,O
honorarium,O
not,O
related,O
to,O
the,O
present,O
work,O
by,O
Hologic,O
Inc.,O
"


",O
262,O
.,O
Int,O
J,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
4;93:205207,O
.,O
doi,O
:,O
10.1016,O
j.ijid.2020.02.052,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Li,O
Wenliang,O
",",O
a,O
face,O
to,O
the,O
frontline,O
healthcare,O
worker,O
.,O
The,O
first,O
doctor,O
to,O
"
",O
notify,O
the,O
emergence,O
of,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
(,O
COVID19,B-Disease_COVID-19
),O
",",O
outbreak,O
.,O
"

",O
Petersen,O
E(1,O
),O
",",O
Hui,O
D(2,O
),O
",",O
Hamer,O
DH(3,O
),O
",",O
Blumberg,O
L(4,O
),O
",",O
Madoff,O
LC(5,O
),O
",",O
Pollack,O
M(6,O
),O
",",O
"
",O
Lee,O
SS(7,O
),O
",",O
McLellan,O
S(8,O
),O
",",O
Memish,O
Z(9,O
),O
",",O
Praharaj,O
I(10,O
),O
",",O
Wasserman,O
S(11,O
),O
",",O
Ntoumi,O
"
",O
F(12,O
),O
",",O
Azhar,O
EI(13,O
),O
",",O
Mchugh,O
TD(14,O
),O
",",O
Kock,O
R(15,O
),O
",",O
Ippolito,O
G(16,O
),O
",",O
Zumla,O
A(17,O
),O
",",O
"
",O
Koopmans,O
M(18,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Directorate,O
General,O
for,O
Disease,O
Surveillance,O
and,O
Control,O
",",O
Ministry,O
of,O
Health,O
",",O
"
",O
Muscat,O
",",O
Oman,O
;,O
European,O
Sociaty,O
for,O
Clinical,O
Microbiology,O
and,O
Infectious,O
Diseases,O
",",O
"
",O
Basel,O
",",O
Switzerland,O
;,O
Institute,O
for,O
Clinical,O
Medicine,O
",",O
Faculty,O
of,O
Health,O
Sciences,O
",",O
"
",O
University,O
of,O
Aarhus,O
",",O
Denmark,O
.,O
Electronic,O
address,O
:,O
eskild.petersen@gmail.com,O
.,O
"
",O
(2)Department,O
of,O
Medicine,O
&,O
Therapeutics,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
Prince,O
"
",O
of,O
Wales,O
Hospital,O
",",O
Shatin,O
",",O
New,O
Territories,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Global,O
Health,O
",",O
Boston,O
University,O
School,O
of,O
Public,O
Health,O
",",O
"
",O
Boston,O
",",O
MA,O
",",O
USA,O
;,O
Section,O
of,O
Infectious,O
Disease,O
",",O
Department,O
of,O
Medicine,O
",",O
Boston,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Boston,O
",",O
MA,O
",",O
USA,O
.,O
"
",O
(4)National,O
Institute,O
for,O
Communicable,O
Diseases,O
",",O
A,O
Division,O
of,O
the,O
National,O
"
",O
Health,O
Laboratory,O
Service,O
",",O
Johannesburg,O
",",O
South,O
Africa,O
.,O
"
",O
(5)International,O
Society,O
for,O
Infectious,O
Diseases,O
",",O
Boston,O
",",O
MA,O
",",O
USA,O
;,O
University,O
of,O
"
",O
Massachusetts,O
",",O
Division,O
of,O
Infectious,O
Diseases,O
",",O
Worcester,O
",",O
MA,O
",",O
USA,O
.,O
"
",O
(6)International,O
Society,O
for,O
Infectious,O
Diseases,O
",",O
Boston,O
",",O
MA,O
",",O
USA,O
.,O
"
",O
(7)Stanley,O
Ho,O
Centre,O
for,O
Emerging,O
Infectious,O
Diseases,O
",",O
The,O
Chinese,O
University,O
of,O
"
",O
Hong,O
Kong,O
",",O
Shatin,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(8)Biocontainment,O
Treatment,O
Unit,O
",",O
Biosafety,O
for,O
ResearchRelated,O
Infectious,O
"
",O
Pathogens,O
",",O
University,O
of,O
Texas,O
Medical,O
Branch,O
",",O
Galveston,O
",",O
TX,O
",",O
USA,O
.,O
"
",O
(9)Research,O
Centre,O
",",O
King,O
Saud,O
Medical,O
City,O
",",O
Ministry,O
of,O
Health,O
",",O
Riyadh,O
",",O
Saudi,O
"
",O
Arabia,O
;,O
College,O
of,O
Medicine,O
",",O
Alfaisal,O
University,O
",",O
Riyadh,O
",",O
Saudi,O
Arabia,O
;,O
Hubert,O
"
",O
Department,O
of,O
Global,O
Health,O
",",O
Rollins,O
School,O
of,O
Public,O
Health,O
",",O
Emory,O
University,O
",",O
"
",O
Atlanta,O
",",O
GA,O
",",O
USA,O
.,O
"
",O
(10)Indian,O
Council,O
of,O
Medical,O
Research,O
",",O
Department,O
of,O
Health,O
Research,O
",",O
New,O
Delhi,O
",",O
"
",O
India,O
.,O
"
",O
(11)Division,O
of,O
Infectious,O
Diseases,O
and,O
HIV,O
Medicine,O
",",O
Department,O
of,O
Medicine,O
",",O
"
",O
Groote,O
Schuur,O
Hospital,O
and,O
University,O
of,O
Cape,O
Town,O
",",O
Cape,O
Town,O
",",O
South,O
Africa,O
.,O
"
",O
(12)Fondation,O
Congolaise,O
pour,O
la,O
Recherche,O
MÃ©dicale,O
UniversitÃ©,O
Marien,O
Ngouabi,O
",",O
"
",O
Republic,O
of,O
Congo,O
and,O
Institute,O
for,O
Tropical,O
Medicine,O
",",O
University,O
of,O
TÃ¼bingen,O
",",O
"
",O
Germany,O
.,O
"
",O
(13)King,O
Fahd,O
Medical,O
Research,O
Center,O
(,O
KFMRC,O
),O
",",O
Medical,O
Laboratory,O
Technology,O
"
",O
Department,O
",",O
Faculty,O
of,O
Applied,O
Medical,O
Sciences,O
",",O
King,O
Abdulaziz,O
University,O
",",O
"
",O
Jeddah,O
",",O
Saudi,O
Arabia,O
.,O
"
",O
(14)Center,O
for,O
Clinical,O
Microbiology,O
",",O
Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
"
",O
University,O
College,O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
(15)The,O
Royal,O
Veterinary,O
College,O
",",O
University,O
of,O
London,O
",",O
Hatfield,O
",",O
Hertfordshire,O
",",O
"
",O
United,O
Kingdom,O
.,O
"
",O
(16)National,O
Institute,O
for,O
Infectious,O
Diseases,O
",",O
Lazzaro,O
Spallanzani,O
",",O
Rome,O
",",O
Italy,O
.,O
"
",O
(17)Center,O
for,O
Clinical,O
Microbiology,O
",",O
Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
"
",O
University,O
College,O
London,O
",",O
and,O
NIHR,O
Biomedical,O
Research,O
Centre,O
",",O
UCL,O
Hospitals,O
NHS,O
"
",O
Foundation,O
Trust,O
",",O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
(18)Department,O
of,O
Viroscience,O
",",O
Erasmus,O
Medical,O
Center,O
",",O
University,O
Medical,O
Center,O
",",O
"
",O
Rotterdam,O
",",O
Netherlands,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijid.2020.02.052,O
"
",O
PMID,O
:,O
32142979,O
"


",O
263,O
.,O
Anaesth,O
Crit,O
Care,O
Pain,O
Med,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
S23525568(20)300333,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.accpm.2020.03.001,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
:,O
A,O
critical,O
care,O
perspective,O
beyond,O
China,O
.,O
"

",O
Rello,O
J(1,O
),O
",",O
Tejada,O
S(2,O
),O
",",O
Userovici,O
C(3,O
),O
",",O
Arvaniti,O
K(4,O
),O
",",O
Pugin,O
J(5,O
),O
",",O
Waterer,O
G(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Centro,O
de,O
InvestigaciÃ³n,O
Biomedica,O
en,O
Red,O
de,O
Enfermedades,O
Respiratorias,O
"
",O
(,O
CIBERES,O
),O
",",O
Instituto,O
Salud,O
Carlos,O
III,O
",",O
Madrid,O
",",O
Spain,O
;,O
Clinical,O
"
",O
Research,O
Epidemiology,O
in,O
Pneumonia,O
and,O
Sepsis,O
(,O
CRIPS,O
),O
",",O
Vall,O
d'Hebron,O
Institut,O
of,O
"
",O
Research,O
(,O
VHIR,O
),O
",",O
Barcelona,O
",",O
Spain,O
;,O
Anaesthesiology,O
and,O
Critical,O
Care,O
Division,O
",",O
"
",O
CHU,O
NÃ®mes,O
",",O
University,O
MontpellierNÃ®mes,O
",",O
NÃ®mes,O
",",O
France,O
.,O
Electronic,O
address,O
:,O
"
",O
jrello@crips.es,O
.,O
"
",O
(2)Centro,O
de,O
InvestigaciÃ³n,O
Biomedica,O
en,O
Red,O
de,O
Enfermedades,O
Respiratorias,O
"
",O
(,O
CIBERES,O
),O
",",O
Instituto,O
Salud,O
Carlos,O
III,O
",",O
Madrid,O
",",O
Spain,O
;,O
Clinical,O
"
",O
Research,O
Epidemiology,O
in,O
Pneumonia,O
and,O
Sepsis,O
(,O
CRIPS,O
),O
",",O
Vall,O
d'Hebron,O
Institut,O
of,O
"
",O
Research,O
(,O
VHIR,O
),O
",",O
Barcelona,O
",",O
Spain,O
.,O
"
",O
(3)DÃ©partement,O
AnesthÃ©sie,O
RÃ©animation,O
",",O
HÃ´pital,O
PitiÃ©SalpÃªtriÃ¨re,O
",",O
Paris,O
",",O
France,O
;,O
"
",O
Junior,O
Group,O
of,O
the,O
French,O
Society,O
of,O
Anaesthesia,O
and,O
Intensive,O
Care,O
Medicine,O
"
",O
(,O
SFAR,O
),O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(4)Critical,O
Care,O
Department,O
",",O
General,O
Hospital,O
Papageorgiou,O
",",O
Thessaloniki,O
",",O
Greece,O
.,O
"
",O
(5)Division,O
of,O
Intensive,O
Care,O
",",O
University,O
Hospitals,O
of,O
Geneva,O
",",O
Geneva,O
",",O
"
",O
Switzerland,O
.,O
"
",O
(6)School,O
of,O
Medicine,O
",",O
University,O
of,O
Western,O
Australia,O
",",O
Perth,O
",",O
Australia,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.accpm.2020.03.001,O
"
",O
PMID,O
:,O
32142972,O
"


",O
264,O
.,O
Infect,O
Genet,O
Evol,O
.,O
2020,O
Mar,O
3;81:104272,O
.,O
doi,O
:,O
10.1016,O
j.meegid.2020.104272,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Nonstructural,O
proteins,O
NS7b,O
and,O
NS8,O
are,O
likely,O
to,O
be,O
phylogenetically,O
associated,O
"
",O
with,O
evolution,O
of,O
2019nCoV.,O
"

",O
Fahmi,O
M(1,O
),O
",",O
Kubota,O
Y(2,O
),O
",",O
Ito,O
M(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Advanced,O
Life,O
Sciences,O
Program,O
",",O
Graduate,O
School,O
of,O
Life,O
Sciences,O
",",O
Ritsumeikan,O
"
",O
University,O
",",O
111,O
Nojihigashi,O
",",O
Kusatsu,O
",",O
Shiga,O
5258577,O
",",O
Japan,O
.,O
"
",O
(2)Department,O
of,O
Bioinformatics,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Ritsumeikan,O
"
",O
University,O
",",O
111,O
Nojihigashi,O
",",O
Kusatsu,O
",",O
Shiga,O
5258577,O
",",O
Japan,O
.,O
"
",O
(3)Advanced,O
Life,O
Sciences,O
Program,O
",",O
Graduate,O
School,O
of,O
Life,O
Sciences,O
",",O
Ritsumeikan,O
"
",O
University,O
",",O
111,O
Nojihigashi,O
",",O
Kusatsu,O
",",O
Shiga,O
5258577,O
",",O
Japan,O
;,O
Department,O
of,O
"
",O
Bioinformatics,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Ritsumeikan,O
University,O
",",O
111,O
"
",O
Nojihigashi,O
",",O
Kusatsu,O
",",O
Shiga,O
5258577,O
",",O
Japan,O
.,O
Electronic,O
address,O
:,O
"
",O
maito@sk.ritsumei.ac.jp,O
.,O
"

",O
The,O
seventh,O
novel,O
human,O
infecting,O
Betacoronavirus,O
that,O
causes,O
pneumonia,O
(,O
2019,O
"
",O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
2019nCoV,B-Virus_SARS-CoV-2
),O
originated,O
in,O
Wuhan,O
",",O
China,O
.,O
The,O
evolutionary,O
"
",O
relationship,O
between,O
2019nCoV,B-Virus_SARS-CoV-2
and,O
the,O
other,O
human,O
respiratory,O
illnesscausing,O
"
",O
coronavirus,O
is,O
not,O
closely,O
related,O
.,O
We,O
sought,O
to,O
characterize,O
the,O
relationship,O
of,O
"
",O
the,O
translated,O
proteins,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
with,O
other,O
species,O
of,O
Orthocoronavirinae,O
.,O
A,O
"
",O
phylogenetic,O
tree,O
was,O
constructed,O
from,O
the,O
genome,O
sequences,O
.,O
A,O
cluster,O
tree,O
was,O
"
",O
developed,O
from,O
the,O
profiles,O
retrieved,O
from,O
the,O
presence,O
and,O
absence,O
of,O
homologs,O
"
",O
of,O
ten,O
2019nCoV,B-Virus_SARS-CoV-2
proteins,O
.,O
The,O
combined,O
data,O
were,O
used,O
to,O
characterize,O
the,O
"
",O
relationship,O
of,O
the,O
translated,O
proteins,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
to,O
other,O
species,O
of,O
"
",O
Orthocoronavirinae,O
.,O
Our,O
analysis,O
reliably,O
suggests,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
most,O
closely,O
"
",O
related,O
to,O
BatCoV,O
RaTG13,O
and,O
belongs,O
to,O
subgenus,O
Sarbecovirus,O
of,O
Betacoronavirus,O
",",O
"
",O
together,O
with,O
SARS,O
coronavirus,O
and,O
BatSARSlike,O
coronavirus,O
.,O
The,O
phylogenetic,O
"
",O
profiling,O
cluster,O
of,O
homolog,O
proteins,O
of,O
one,O
annotated,O
2019nCoV,B-Virus_SARS-CoV-2
protein,O
against,O
"
",O
other,O
genome,O
sequences,O
revealed,O
two,O
clades,O
of,O
ten,O
2019nCoV,B-Virus_SARS-CoV-2
proteins,O
.,O
Clade,O
1,O
"
",O
consisted,O
of,O
a,O
group,O
of,O
conserved,O
proteins,O
in,O
Orthocoronavirinae,O
comprising,O
"
",O
Orf1ab,O
polyprotein,O
",",O
Nucleocapsid,O
protein,O
",",O
Spike,O
glycoprotein,O
",",O
and,O
Membrane,O
"
",O
protein,O
.,O
Clade,O
2,O
comprised,O
six,O
proteins,O
exclusive,O
to,O
Sarbecovirus,O
and,O
"
",O
Hibecovirus,O
.,O
Two,O
of,O
six,O
Clade,O
2,O
nonstructural,O
proteins,O
",",O
NS7b,O
and,O
NS8,O
",",O
were,O
"
",O
exclusively,O
conserved,O
among,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
BetaCoV_RaTG,O
",",O
and,O
BatSARSlike,O
Cov,O
.,O
NS7b,O
"
",O
and,O
NS8,O
have,O
previously,O
been,O
shown,O
to,O
affect,O
immune,O
response,O
signaling,O
in,O
the,O
"
",O
SARSCoV,O
experimental,O
model,O
.,O
Thus,O
",",O
we,O
speculated,O
that,O
knowledge,O
of,O
the,O
functional,O
"
",O
changes,O
in,O
the,O
NS7b,O
and,O
NS8,O
proteins,O
during,O
evolution,O
may,O
provide,O
important,O
"
",O
information,O
to,O
explore,O
the,O
human,O
infective,O
property,O
of,O
2019nCoV.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Authors,O
.,O
Published,O
by,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.meegid.2020.104272,O
"
",O
PMID,O
:,O
32142938,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
no,O
competing,O
interest,O
.,O
"


",O
265,O
.,O
J,O
Infect,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
S01634453(20)301055,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.024,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Corona,B-Disease_COVID-19
Virus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
",",O
a,O
growing,O
threat,O
to,O
children,O
?,O
"

",O
Yang,O
P(1,O
),O
",",O
Liu,O
P(2,O
),O
",",O
Li,O
D(3,O
),O
",",O
Zhao,O
D(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pediatrics,O
",",O
Children,O
's,O
Digital,O
Health,O
and,O
Data,O
Center,O
",",O
Zhongnan,O
"
",O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
puer58@hotmail.com,O
.,O
"
",O
(2)Department,O
of,O
Pediatrics,O
",",O
Children,O
's,O
Digital,O
Health,O
and,O
Data,O
Center,O
",",O
Zhongnan,O
"
",O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
goddoor@163.com,O
.,O
"
",O
(3)East,O
Ward,O
of,O
People,O
's,O
Hospital,O
Attached,O
to,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
gone_333@163.com,O
.,O
"
",O
(4)Department,O
of,O
Pediatrics,O
",",O
Children,O
's,O
Digital,O
Health,O
and,O
Data,O
Center,O
",",O
Zhongnan,O
"
",O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
zhao_wh2004@hotmail.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.024,O
"
",O
PMID,O
:,O
32142929,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
None,O
reported,O
.,O
"


",O
266,O
.,O
J,O
Infect,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
S01634453(20)301043,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.022,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
and,O
CT,O
imaging,O
features,O
of,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
Zhu,O
Y(1,O
),O
",",O
Liu,O
YL(2,O
),O
",",O
Li,O
ZP(3,O
),O
",",O
Kuang,O
JY(3,O
),O
",",O
Li,O
XM(4,O
),O
",",O
Yang,O
YY(5,O
),O
",",O
Feng,O
ST(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
Guangzhou,O
510080,O
",",O
Province,O
Guangdong,O
",",O
"
",O
P.R.,O
China,O
;,O
Institution,O
of,O
Precision,O
Medicine,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
",",O
Sun,O
"
",O
Yatsen,O
University,O
",",O
Guangzhou,O
510080,O
",",O
Province,O
Guangdong,O
",",O
P.R.,O
China,O
.,O
"
",O
(2)Division,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
First,O
Affiliated,O
"
",O
Hospital,O
",",O
Sun,O
Yatsen,O
University,O
",",O
Guangzhou,O
510080,O
",",O
Province,O
Guangdong,O
",",O
P.R.,O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Radiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
Guangzhou,O
510080,O
",",O
Province,O
Guangdong,O
",",O
"
",O
P.R.,O
China,O
.,O
"
",O
(4)Department,O
of,O
Radiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
Guangzhou,O
510080,O
",",O
Province,O
Guangdong,O
",",O
"
",O
P.R.,O
China,O
.,O
Electronic,O
address,O
:,O
lixm.1111@163.com,O
.,O
"
",O
(5)Department,O
of,O
Radiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
Guangzhou,O
510080,O
",",O
Province,O
Guangdong,O
",",O
"
",O
P.R.,O
China,O
.,O
Electronic,O
address,O
:,O
jlyyyxc@126.com,O
.,O
"
",O
(6)Department,O
of,O
Radiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
Guangzhou,O
510080,O
",",O
Province,O
Guangdong,O
",",O
"
",O
P.R.,O
China,O
.,O
Electronic,O
address,O
:,O
fengsht@mail.sysu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.022,O
"
",O
PMID,O
:,O
32142928,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
competing,O
interests,O
.,O
"


",O
267,O
.,O
J,O
Hosp,O
Infect,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
S01956701(20)300967,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jhin.2020.02.020,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Practical,O
experiences,O
and,O
suggestions,O
on,O
the,O
eagleeyed,O
observer,O
",",O
a,O
novel,O
"
",O
promising,O
role,O
for,O
controlling,O
nosocomial,O
infection,O
of,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
.,O
"

",O
Peng,O
J(1,O
),O
",",O
Ren,O
N(2,O
),O
",",O
Wang,O
M(3,O
),O
",",O
Zhang,O
G(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Quality,O
Management,O
",",O
Guangdong,O
Second,O
Provincial,O
General,O
"
",O
Hospital,O
",",O
Guangzhou,O
510317,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(2)Guangdong,O
Online,O
Hospital,O
",",O
Guangdong,O
Second,O
Provincial,O
General,O
Hospital,O
",",O
"
",O
Guangzhou,O
510317,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Epidemic,O
Prevention,O
",",O
No.,O
92371,O
Unit,O
Hospital,O
of,O
PLA,O
",",O
Fuding,O
"
",O
355200,O
",",O
Fujian,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
wmke020@sina.com,O
.,O
"
",O
(4)Guangdong,O
Second,O
Provincial,O
General,O
Hospital,O
",",O
Guangzhou,O
510317,O
",",O
Guangdong,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
15813368002@163.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jhin.2020.02.020,O
"
",O
PMID,O
:,O
32142887,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
None,O
.,O
"


",O
268,O
.,O
J,O
Hosp,O
Infect,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
S01956701(20)300980,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jhin.2020.02.022,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Effective,O
strategies,O
to,O
prevent,O
coronavirus,O
disease2019,O
(,O
COVID19,B-Disease_COVID-19
),O
outbreak,O
in,O
"
",O
hospital,O
.,O
"

",O
Lee,O
IK(1,O
),O
",",O
Wang,O
CC(2,O
),O
",",O
Lin,O
MC(3,O
),O
",",O
Kung,O
CT(4,O
),O
",",O
Lan,O
KC(5,O
),O
",",O
Lee,O
CT(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
Kaohsiung,O
"
",O
Chang,O
Gung,O
Memorial,O
Hospital,O
",",O
Taiwan,O
.,O
"
",O
(2)Department,O
of,O
Surgery,O
",",O
Kaohsiung,O
Chang,O
Gung,O
Memorial,O
Hospital,O
",",O
Taiwan,O
.,O
"
",O
Electronic,O
address,O
:,O
ufel4996@ms26.hinet.net,O
.,O
"
",O
(3)Division,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Department,O
of,O
Internal,O
"
",O
Medicine,O
",",O
Kaohsiung,O
Chang,O
Gung,O
Memorial,O
Hospital,O
",",O
Taiwan,O
.,O
"
",O
(4)Department,O
of,O
Emergency,O
",",O
Kaohsiung,O
Chang,O
Gung,O
Memorial,O
Hospital,O
",",O
Taiwan,O
.,O
"
",O
(5)Department,O
of,O
Gynecology,O
and,O
Obstetrics,O
",",O
Kaohsiung,O
Chang,O
Gung,O
Memorial,O
"
",O
hospital,O
",",O
Taiwan,O
.,O
"
",O
(6)Division,O
of,O
Nephrology,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
Kaohsiung,O
Chang,O
Gung,O
"
",O
Memorial,O
Hospital,O
",",O
Taiwan,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jhin.2020.02.022,O
"
",O
PMID,O
:,O
32142886,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
None,O
.,O
"


",O
269,O
.,O
J,O
Hosp,O
Infect,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
S01956701(20)300979,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jhin.2020.02.021,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Association,O
between,O
2019nCoV,B-Virus_SARS-CoV-2
transmission,O
and,O
N95,O
respirator,O
use,O
.,O
"

",O
Wang,O
X(1,O
),O
",",O
Pan,O
Z(2,O
),O
",",O
Cheng,O
Z(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Urology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
wangxinghuan@whu.edu.cn,O
.,O
"
",O
(2)Department,O
of,O
Infection,O
Management,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Respiratory,O
medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jhin.2020.02.021,O
"
",O
PMID,O
:,O
32142885,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
None,O
declared,O
.,O
"


",O
270,O
.,O
Gastroenterology,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
S00165085(20)30281X,O
.,O
doi,O
:,O
"
",O
10.1053,O
j.gastro.2020.02.054,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
:,O
Gastrointestinal,O
manifestations,O
and,O
potential,O
fecaloral,O
transmission,O
.,O
"

",O
Gu,O
J(1,O
),O
",",O
Han,O
B(1,O
),O
",",O
Wang,O
J(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Transplantation,O
",",O
Xinhua,O
Hospital,O
Affiliated,O
to,O
Shanghai,O
Jiao,O
"
",O
Tong,O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
;,O
Department,O
of,O
General,O
"
",O
Surgery,O
",",O
Xinhua,O
Hospital,O
Affiliated,O
to,O
Shanghai,O
Jiao,O
Tong,O
University,O
School,O
of,O
"
",O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Transplantation,O
",",O
Xinhua,O
Hospital,O
Affiliated,O
to,O
Shanghai,O
Jiao,O
"
",O
Tong,O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
;,O
Department,O
of,O
General,O
"
",O
Surgery,O
",",O
Xinhua,O
Hospital,O
Affiliated,O
to,O
Shanghai,O
Jiao,O
Tong,O
University,O
School,O
of,O
"
",O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
gjynyd@126.com,O
.,O
"

",O
DOI,O
:,O
10.1053,O
j.gastro.2020.02.054,O
"
",O
PMID,O
:,O
32142785,O
"


",O
271,O
.,O
Gastroenterology,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
S00165085(20)302821,O
.,O
doi,O
:,O
"
",O
10.1053,O
j.gastro.2020.02.055,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Evidence,O
for,O
gastrointestinal,O
infection,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Xiao,O
F(1,O
),O
",",O
Tang,O
M(2,O
),O
",",O
Zheng,O
X(3,O
),O
",",O
Liu,O
Y(4,O
),O
",",O
Li,O
X(5,O
),O
",",O
Shan,O
H(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Diseases,O
",",O
the,O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
",",O
China,O
;,O
Guangdong,O
Provincial,O
Engineering,O
"
",O
Research,O
Center,O
of,O
Molecular,O
Imaging,O
",",O
the,O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
",",O
China,O
;,O
Guangdong,O
Provincial,O
Key,O
"
",O
Laboratory,O
of,O
Biomedical,O
Imaging,O
",",O
the,O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Hematology,O
",",O
the,O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
the,O
Fifth,O
Affiliated,O
"
",O
Hospital,O
",",O
Sun,O
Yatsen,O
University,O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Pathology,O
",",O
the,O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
ly77219@163.com,O
.,O
"
",O
(5)Department,O
of,O
Gastroenterology,O
",",O
the,O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
zdwylxf@163.com,O
.,O
"
",O
(6)Guangdong,O
Provincial,O
Engineering,O
Research,O
Center,O
of,O
Molecular,O
Imaging,O
",",O
the,O
"
",O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
University,O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
",",O
"
",O
China,O
;,O
Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
Biomedical,O
Imaging,O
",",O
the,O
Fifth,O
"
",O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
University,O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
",",O
China,O
;,O
"
",O
Department,O
of,O
Interventional,O
Medicine,O
",",O
the,O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
shanhong@mail.sysu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1053,O
j.gastro.2020.02.055,O
"
",O
PMID,O
:,O
32142773,O
"


",O
272,O
.,O
Cell,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
S00928674(20)302294,O
.,O
doi,O
:,O
10.1016,O
j.cell.2020.02.052,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
SARSCoV2,B-Virus_SARS-CoV-2
Cell,O
Entry,O
Depends,O
on,O
ACE2,O
and,O
TMPRSS2,O
and,O
Is,O
Blocked,O
by,O
a,O
Clinically,O
"
",O
Proven,O
Protease,O
Inhibitor,O
.,O
"

",O
Hoffmann,O
M(1,O
),O
",",O
KleineWeber,O
H(2,O
),O
",",O
Schroeder,O
S(3,O
),O
",",O
KrÃ¼ger,O
N(4,O
),O
",",O
Herrler,O
T(5,O
),O
",",O
"
",O
Erichsen,O
S(6,O
),O
",",O
Schiergens,O
TS(7,O
),O
",",O
Herrler,O
G(8,O
),O
",",O
Wu,O
NH(8,O
),O
",",O
Nitsche,O
A(9,O
),O
",",O
MÃ¼ller,O
"
",O
MA(10,O
),O
",",O
Drosten,O
C(3,O
),O
",",O
PÃ¶hlmann,O
S(11,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Infection,O
Biology,O
Unit,O
",",O
German,O
Primate,O
Center,O
 ,O
Leibniz,O
Institute,O
for,O
Primate,O
"
",O
Research,O
",",O
GÃ¶ttingen,O
",",O
Germany,O
.,O
Electronic,O
address,O
:,O
mhoffmann@dpz.eu,O
.,O
"
",O
(2)Infection,O
Biology,O
Unit,O
",",O
German,O
Primate,O
Center,O
 ,O
Leibniz,O
Institute,O
for,O
Primate,O
"
",O
Research,O
",",O
GÃ¶ttingen,O
",",O
Germany,O
;,O
Faculty,O
of,O
Biology,O
and,O
Psychology,O
",",O
University,O
"
",O
GÃ¶ttingen,O
",",O
GÃ¶ttingen,O
",",O
Germany,O
.,O
"
",O
(3)CharitÃ©UniversitÃ¤tsmedizin,O
Berlin,O
",",O
corporate,O
member,O
of,O
Freie,O
UniversitÃ¤t,O
"
",O
Berlin,O
",",O
HumboldtUniversitÃ¤t,O
zu,O
Berlin,O
",",O
and,O
Berlin,O
Institute,O
of,O
Health,O
",",O
Institute,O
"
",O
of,O
Virology,O
",",O
Berlin,O
",",O
Germany,O
;,O
German,O
Centre,O
for,O
Infection,O
Research,O
",",O
associated,O
"
",O
partner,O
CharitÃ©,O
",",O
Berlin,O
",",O
Germany,O
.,O
"
",O
(4)Institute,O
of,O
Virology,O
",",O
University,O
of,O
Veterinary,O
Medicine,O
Hannover,O
",",O
Hannover,O
",",O
"
",O
Germany,O
;,O
Research,O
Center,O
for,O
Emerging,O
Infections,O
and,O
Zoonoses,O
",",O
University,O
of,O
"
",O
Veterinary,O
Medicine,O
Hannover,O
",",O
Hannover,O
",",O
Germany,O
.,O
"
",O
(5)BG,O
Unfallklinik,O
Murnau,O
",",O
Murnau,O
",",O
Germany,O
.,O
"
",O
(6)Institute,O
for,O
Biomechanics,O
",",O
BG,O
Unfallklinik,O
Murnau,O
",",O
Murnau,O
",",O
Germany,O
;,O
Institute,O
"
",O
for,O
Biomechanics,O
",",O
Paracelsus,O
Medical,O
University,O
Salzburg,O
",",O
Salzburg,O
",",O
Austria,O
.,O
"
",O
(7)Biobank,O
of,O
the,O
Department,O
of,O
General,O
",",O
Visceral,O
",",O
and,O
Transplant,O
Surgery,O
",",O
"
",O
LudwigMaximiliansUniversity,O
Munich,O
",",O
Munich,O
",",O
Germany,O
.,O
"
",O
(8)Institute,O
of,O
Virology,O
",",O
University,O
of,O
Veterinary,O
Medicine,O
Hannover,O
",",O
Hannover,O
",",O
"
",O
Germany,O
.,O
"
",O
(9)Robert,O
Koch,O
Institute,O
",",O
ZBS,O
1,O
Highly,O
Pathogenic,O
Viruses,O
",",O
WHO,O
Collaborating,O
"
",O
Centre,O
for,O
Emerging,O
Infections,O
and,O
Biological,O
Threats,O
",",O
Berlin,O
",",O
Germany,O
.,O
"
",O
(10)CharitÃ©UniversitÃ¤tsmedizin,O
Berlin,O
",",O
corporate,O
member,O
of,O
Freie,O
UniversitÃ¤t,O
"
",O
Berlin,O
",",O
HumboldtUniversitÃ¤t,O
zu,O
Berlin,O
",",O
and,O
Berlin,O
Institute,O
of,O
Health,O
",",O
Institute,O
"
",O
of,O
Virology,O
",",O
Berlin,O
",",O
Germany,O
;,O
German,O
Centre,O
for,O
Infection,O
Research,O
",",O
associated,O
"
",O
partner,O
CharitÃ©,O
",",O
Berlin,O
",",O
Germany,O
;,O
Martsinovsky,O
Institute,O
of,O
Medical,O
Parasitology,O
",",O
"
",O
Tropical,O
and,O
Vector,O
Borne,O
Diseases,O
",",O
Sechenov,O
University,O
",",O
Moscow,O
",",O
Russia,O
.,O
"
",O
(11)Infection,O
Biology,O
Unit,O
",",O
German,O
Primate,O
Center,O
 ,O
Leibniz,O
Institute,O
for,O
Primate,O
"
",O
Research,O
",",O
GÃ¶ttingen,O
",",O
Germany,O
;,O
Faculty,O
of,O
Biology,O
and,O
Psychology,O
",",O
University,O
"
",O
GÃ¶ttingen,O
",",O
GÃ¶ttingen,O
",",O
Germany,O
.,O
Electronic,O
address,O
:,O
spoehlmann@dpz.eu,O
.,O
"

",O
The,O
recent,O
emergence,O
of,O
the,O
novel,O
",",O
pathogenic,O
SARScoronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
in,O
"
",O
China,O
and,O
its,O
rapid,O
national,O
and,O
international,O
spread,O
pose,O
a,O
global,O
health,O
"
",O
emergency,O
.,O
Cell,O
entry,O
of,O
coronaviruses,O
depends,O
on,O
binding,O
of,O
the,O
viral,O
spike,O
(,O
S,O
),O
"
",O
proteins,O
to,O
cellular,O
receptors,O
and,O
on,O
S,O
protein,O
priming,O
by,O
host,O
cell,O
proteases,O
.,O
"
",O
Unravelling,O
which,O
cellular,O
factors,O
are,O
used,O
by,O
SARSCoV2,B-Virus_SARS-CoV-2
for,O
entry,O
might,O
provide,O
"
",O
insights,O
into,O
viral,O
transmission,O
and,O
reveal,O
therapeutic,O
targets,O
.,O
Here,O
",",O
we,O
"
",O
demonstrate,O
that,O
SARSCoV2,B-Virus_SARS-CoV-2
uses,O
the,O
SARSCoV,O
receptor,O
ACE2,O
for,O
entry,O
and,O
the,O
"
",O
serine,O
protease,O
TMPRSS2,O
for,O
S,O
protein,O
priming,O
.,O
A,O
TMPRSS2,O
inhibitor,O
approved,O
for,O
"
",O
clinical,O
use,O
blocked,O
entry,O
and,O
might,O
constitute,O
a,O
treatment,O
option,O
.,O
Finally,O
",",O
we,O
"
",O
show,O
that,O
the,O
sera,O
from,O
convalescent,O
SARS,O
patients,O
crossneutralized,O
"
",O
SARS2Sdriven,O
entry,O
.,O
Our,O
results,O
reveal,O
important,O
commonalities,O
between,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
and,O
SARSCoV,O
infection,O
and,O
identify,O
a,O
potential,O
target,O
for,O
antiviral,O
"
",O
intervention,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.cell.2020.02.052,O
"
",O
PMID,O
:,O
32142651,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Interests,O
The,O
authors,O
declare,O
no,O
"
",O
competing,O
interests,O
.,O
"


",O
273,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
S14733099(20)301572,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301572,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Guidelines,O
for,O
pregnant,O
women,O
with,O
suspected,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"

",O
Favre,O
G(1,O
),O
",",O
Pomar,O
L(1,O
),O
",",O
Qi,O
X(2,O
),O
",",O
NielsenSaines,O
K(3,O
),O
",",O
Musso,O
D(4,O
),O
",",O
Baud,O
D(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Maternofetal,O
and,O
Obstetrics,O
Research,O
Unit,O
",",O
Department,O
WomanMotherChild,O
",",O
"
",O
Lausanne,O
University,O
Hospital,O
",",O
1011,O
Lausanne,O
",",O
Switzerland,O
.,O
"
",O
(2)CHESS,O
Center,O
",",O
The,O
First,O
Hospital,O
of,O
Lanzhou,O
University,O
",",O
Lanzhou,O
",",O
China,O
.,O
"
",O
(3)Division,O
of,O
Pediatric,O
Infectious,O
Diseases,O
",",O
David,O
Geffen,O
School,O
of,O
Medicine,O
",",O
"
",O
University,O
of,O
California,O
",",O
Los,O
Angeles,O
",",O
CA,O
",",O
USA,O
.,O
"
",O
(4)Aix,O
Marseille,O
UniversitÃ©,O
",",O
IRD,O
",",O
APHM,O
",",O
SSA,O
",",O
VITROME,O
",",O
IHUMÃ©diterranÃ©e,O
"
",O
infection,O
",",O
Marseille,O
",",O
France,O
;,O
Laboratoire,O
Eurofins,O
Labazur,O
Guyane,O
",",O
French,O
Guiana,O
",",O
"
",O
France,O
.,O
"
",O
(5)Maternofetal,O
and,O
Obstetrics,O
Research,O
Unit,O
",",O
Department,O
WomanMotherChild,O
",",O
"
",O
Lausanne,O
University,O
Hospital,O
",",O
1011,O
Lausanne,O
",",O
Switzerland,O
.,O
Electronic,O
address,O
:,O
"
",O
david.baud@chuv.ch,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301572,O
"
",O
PMID,O
:,O
32142639,O
"


",O
274,O
.,O
Lancet,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
S01406736(20)305201,O
.,O
doi,O
:,O
"
",O
10.1016,O
S01406736(20)305201,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Mass,O
masking,O
in,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
:,O
people,O
need,O
guidance,O
.,O
"

",O
Leung,O
CC(1,O
),O
",",O
Lam,O
TH(2,O
),O
",",O
Cheng,O
KK(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Hong,O
Kong,O
Tuberculosis,O
",",O
Chest,O
and,O
Heart,O
Diseases,O
Association,O
",",O
Hong,O
Kong,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
ccleungpnc@netvigator.com,O
.,O
"
",O
(2)School,O
of,O
Public,O
Health,O
.,O
The,O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(3)Institute,O
of,O
Applied,O
Health,O
Research,O
",",O
University,O
of,O
Birmingham,O
",",O
Birmingham,O
",",O
"
",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)305201,O
"
",O
PMID,O
:,O
32142626,O
"


",O
275,O
.,O
Lancet,O
Oncol,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
S14702045(20)301509,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14702045(20)301509,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Risk,O
of,O
COVID19,B-Disease_COVID-19
for,O
cancer,O
patients,O
.,O
"

",O
Xia,O
Y(1,O
),O
",",O
Jin,O
R(1,O
),O
",",O
Zhao,O
J(2,O
),O
",",O
Li,O
W(1,O
),O
",",O
Shen,O
H(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Respiratory,O
Disease,O
of,O
Zhejiang,O
Province,O
",",O
Department,O
of,O
"
",O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Second,O
Affiliated,O
Hospital,O
of,O
Zhejiang,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Hangzhou,O
",",O
Zhejiang,O
310052,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Medical,O
Oncology,O
",",O
Second,O
Affiliated,O
Hospital,O
of,O
Zhejiang,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Hangzhou,O
",",O
Zhejiang,O
310052,O
",",O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Respiratory,O
Disease,O
of,O
Zhejiang,O
Province,O
",",O
Department,O
of,O
"
",O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Second,O
Affiliated,O
Hospital,O
of,O
Zhejiang,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Hangzhou,O
",",O
Zhejiang,O
310052,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
huahaoshen@zju.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14702045(20)301509,O
"
",O
PMID,O
:,O
32142622,O
"


",O
276,O
.,O
Lancet,O
Oncol,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
S14702045(20)301492,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14702045(20)301492,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Risk,O
of,O
COVID19,B-Disease_COVID-19
for,O
patients,O
with,O
cancer,O
.,O
"

",O
Wang,O
H(1,O
),O
",",O
Zhang,O
L(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Peking,O
Union,O
Medical,O
College,O
Hospital,O
",",O
"
",O
Peking,O
Union,O
Medical,O
College,O
and,O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
100730,O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Peking,O
Union,O
Medical,O
College,O
Hospital,O
",",O
"
",O
Peking,O
Union,O
Medical,O
College,O
and,O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
100730,O
"
",O
Beijing,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
zhanglipumch1026@sina.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14702045(20)301492,O
"
",O
PMID,O
:,O
32142621,O
"


",O
277,O
.,O
Cytometry,O
A.,O
2020,O
Mar;97(3):215216,O
.,O
doi,O
:,O
10.1002,O
cyto.a.23990,O
.,O
"

",O
Machine,O
Learning,O
",",O
COVID19,B-Disease_COVID-19
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
",",O
and,O
multiOMICS,O
.,O
"

",O
TÃ¡rnok,O
A(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
for,O
Medical,O
Informatics,O
",",O
Statistics,O
and,O
Epidemiology,O
(,O
IMISE,O
),O
",",O
"
",O
University,O
of,O
Leipzig,O
",",O
Leipzig,O
",",O
Germany,O
.,O
"
",O
(2)Dept,O
.,O
Therapy,O
Validation,O
",",O
Fraunhofer,O
Institute,O
for,O
Cell,O
Therapy,O
and,O
Immunology,O
"
",O
IZI,O
",",O
Leipzig,O
",",O
Germany,O
.,O
"
",O
(3)Dept,O
.,O
for,O
Precision,O
Instrument,O
",",O
Tsinghua,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1002,O
cyto.a.23990,O
"
",O
PMID,O
:,O
32142596,O
"


",O
278,O
.,O
Radiology,O
.,O
2020,O
Mar,O
6:200770,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200770,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
FDG,O
PET,O
CT,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Zou,O
S(1,O
),O
",",O
Zhu,O
X(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Department,O
of,O
Nuclear,O
Medicine,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
"
",O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
1095,O
Jiefang,O
Ave,O
",",O
Wuhan,O
"
",O
430030,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200770,O
"
",O
PMID,O
:,O
32142399,O
"


",O
279,O
.,O
Radiology,O
.,O
2020,O
Mar,O
6:200702,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200702,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Patients,O
with,O
RTPCR,O
Confirmed,O
COVID19,B-Disease_COVID-19
and,O
Normal,O
Chest,O
CT,O
.,O
"

",O
Yang,O
W(1,O
),O
",",O
Yan,O
F(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Shanghai,O
Jiao,O
Tong,O
University,O
Medical,O
School,O
"
",O
Affiliated,O
Ruijin,O
Hospital,O
",",O
NO.197,O
Ruijin,O
Er,O
Road,O
",",O
Shanghai,O
200025,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200702,O
"
",O
PMID,O
:,O
32142398,O
"


",O
280,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
6,O
.,O
doi,O
:,O
10.1002,O
jmv.25750,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Transmission,O
dynamics,O
of,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
and,O
effectiveness,O
of,O
government,O
"
",O
interventions,O
:,O
A,O
datadriven,O
analysis,O
.,O
"

",O
Fang,O
Y(1,O
),O
",",O
Nie,O
Y(2,O
),O
",",O
Penny,O
M(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Public,O
Health,O
",",O
Hangzhou,O
Medical,O
College,O
",",O
Hangzhou,O
",",O
310053,O
",",O
China,O
.,O
"
",O
(2)Graduate,O
School,O
",",O
Harbin,O
Medical,O
University,O
",",O
Harbin,O
",",O
150081,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Public,O
Health,O
Sciences,O
",",O
California,O
Baptist,O
University,O
",",O
"
",O
Riverside,O
",",O
CA,O
",",O
92504,O
",",O
USA,O
.,O
"

",O
Using,O
the,O
parameterized,O
SEIR,O
model,O
",",O
we,O
simulated,O
the,O
spread,O
dynamics,O
of,O
COVID19,B-Disease_COVID-19
"
",O
outbreak,O
and,O
impact,O
of,O
different,O
control,O
measures,O
",",O
conducted,O
the,O
sensitivity,O
"
",O
analysis,O
to,O
identify,O
the,O
key,O
factor,O
",",O
plotted,O
the,O
trend,O
curve,O
of,O
effective,O
"
",O
reproductive,O
number(R,O
),O
and,O
performed,O
data,O
fitting,O
after,O
the,O
simulation,O
.,O
By,O
"
",O
simulation,O
and,O
data,O
fitting,O
",",O
the,O
model,O
showed,O
the,O
peak,O
existing,O
confirmed,O
cases,O
"
",O
of,O
59769,O
arriving,O
on,O
15,O
February,O
2020,O
",",O
with,O
coefficient,O
of,O
determination,O
close,O
to,O
"
",O
1,O
and,O
the,O
fitting,O
bias,O
3.02,O
%,O
",",O
suggesting,O
high,O
precision,O
of,O
the,O
data,O
fitting,O
"
",O
results,O
.,O
More,O
rigorous,O
government,O
control,O
policies,O
were,O
associated,O
with,O
slower,O
"
",O
increase,O
of,O
the,O
infected,O
population,O
.,O
Isolation,O
and,O
protective,O
procedures,O
would,O
be,O
"
",O
less,O
effective,O
as,O
more,O
cases,O
accrue,O
",",O
so,O
the,O
optimization,O
of,O
treatment,O
plan,O
and,O
"
",O
the,O
development,O
of,O
specific,O
drugs,O
would,O
be,O
of,O
more,O
importance,O
.,O
There,O
was,O
an,O
"
",O
upward,O
trend,O
of,O
R,O
in,O
the,O
beginning,O
",",O
followed,O
by,O
a,O
downward,O
trend,O
",",O
a,O
temporary,O
"
",O
rebound,O
and,O
another,O
continuous,O
decline,O
.,O
The,O
feature,O
of,O
high,O
infectiousness,O
for,O
"
",O
sarscov2,B-Virus_SARS-CoV-2
led,O
to,O
the,O
upward,O
trend,O
",",O
and,O
government,O
measures,O
contributed,O
to,O
the,O
"
",O
temporary,O
rebound,O
and,O
declines,O
.,O
The,O
declines,O
of,O
R,O
could,O
be,O
exploited,O
as,O
strong,O
"
",O
evidence,O
for,O
the,O
effectiveness,O
of,O
the,O
interventions,O
.,O
Evidence,O
from,O
the,O
fourphase,O
"
",O
stringent,O
measures,O
showed,O
that,O
it,O
was,O
significant,O
to,O
ensure,O
early,O
detection,O
",",O
"
",O
early,O
isolation,O
",",O
early,O
treatment,O
",",O
adequate,O
medical,O
supplies,O
",",O
patients,O
',O
being,O
"
",O
admitted,O
to,O
designated,O
hospitals,O
and,O
comprehensive,O
therapeutic,O
strategy,O
.,O
"
",O
Collaborative,O
efforts,O
are,O
required,O
to,O
combat,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
focusing,O
on,O
"
",O
both,O
persistent,O
strict,O
domestic,O
interventions,O
and,O
vigilance,O
against,O
exogenous,O
"
",O
imported,O
cases,O
.,O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25750,O
"
",O
PMID,O
:,O
32141624,O
"


",O
281,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
6,O
.,O
doi,O
:,O
10.1002,O
jmv.25749,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
transmission,O
and,O
diagnosis,O
of,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
disease,O
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
:,O
A,O
Chinese,O
perspective,O
.,O
"

",O
Han,O
Y(1,O
),O
",",O
Yang,O
H(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
First,O
Clinical,O
Medical,O
College,O
",",O
Shanxi,O
Medical,O
University,O
",",O
"
",O
Taiyuan,O
",",O
Shanxi,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Obstetrics,O
",",O
First,O
Hospital,O
of,O
Shanxi,O
Medical,O
University,O
",",O
"
",O
Taiyuan,O
",",O
Shanxi,O
",",O
China,O
.,O
"

",O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
which,O
originated,O
in,O
Wuhan,O
",",O
China,O
",",O
has,O
"
",O
attracted,O
the,O
world,O
's,O
attention,O
over,O
the,O
last,O
month,O
.,O
The,O
Chinese,O
government,O
has,O
"
",O
taken,O
emergency,O
measures,O
to,O
control,O
the,O
outbreak,O
and,O
has,O
undertaken,O
initial,O
steps,O
"
",O
in,O
the,O
diagnosis,O
and,O
treatment,O
of,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
disease,O
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
.,O
However,O
",",O
SARSCoV2,B-Virus_SARS-CoV-2
possesses,O
powerful,O
pathogenicity,O
as,O
well,O
as,O
"
",O
transmissibility,O
and,O
still,O
holds,O
many,O
mysteries,O
that,O
are,O
yet,O
to,O
be,O
solved,O
",",O
such,O
"
",O
as,O
whether,O
the,O
virus,O
can,O
be,O
transmitted,O
by,O
asymptomatic,O
patients,O
or,O
by,O
mothers,O
to,O
"
",O
their,O
infants,O
.,O
Our,O
research,O
presents,O
selected,O
available,O
cases,O
of,O
COVID19,B-Disease_COVID-19
in,O
"
",O
China,O
to,O
better,O
understand,O
the,O
transmission,O
and,O
diagnosis,O
regarding,O
this,O
"
",O
infectious,O
disease,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25749,O
"
",O
PMID,O
:,O
32141619,O
"


",O
282,O
.,O
East,O
Mediterr,O
Health,O
J.,O
2020,O
Feb,O
24;26(2):136137,O
.,O
doi,O
:,O
10.26719,O
2020.26.2.136,O
.,O
"

",O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
outbreak,O
:,O
preparedness,O
and,O
readiness,O
of,O
countries,O
in,O
the,O
"
",O
Eastern,O
Mediterranean,O
Region,O
.,O
"

",O
AlMandhari,O
A(1,O
),O
",",O
Samhouri,O
D(2,O
),O
",",O
Abubakar,O
A(3,O
),O
",",O
Brennan,O
R(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Regional,O
Director,O
",",O
World,O
Health,O
Organization,O
Regional,O
Office,O
for,O
the,O
Eastern,O
"
",O
Mediterranean,O
",",O
Cairo,O
",",O
Egypt,O
.,O
"
",O
(2)Programme,O
Area,O
Manager,O
",",O
Emergency,O
Preparedness,O
and,O
International,O
Health,O
"
",O
Regulations,O
",",O
World,O
Health,O
Organization,O
Regional,O
Office,O
for,O
the,O
Eastern,O
"
",O
Mediterranean,O
",",O
Cairo,O
",",O
Egypt,O
.,O
"
",O
(3)Acting,O
Programme,O
Area,O
Manager,O
",",O
Infectious,O
Hazard,O
Preparedness,O
Unit,O
",",O
World,O
"
",O
Health,O
Organization,O
Regional,O
Office,O
for,O
the,O
Eastern,O
Mediterranean,O
",",O
Cairo,O
",",O
Egypt,O
.,O
"
",O
(4)Regional,O
Emergency,O
Director,O
",",O
World,O
Health,O
Organization,O
Regional,O
Office,O
for,O
the,O
"
",O
Eastern,O
Mediterranean,O
",",O
Cairo,O
",",O
Egypt,O
.,O
"

",O
On,O
31,O
December,O
2019,O
",",O
a,O
cluster,O
of,O
acute,O
respiratory,O
illness,O
was,O
reported,O
from,O
"
",O
China,O
and,O
later,O
confirmed,O
as,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
on,O
7,O
January,O
2020,O
.,O
This,O
virus,O
is,O
"
",O
the,O
same,O
member,O
of,O
the,O
coronavirus,O
family,O
that,O
caused,O
the,O
severe,O
acute,O
"
",O
respiratory,O
syndrome,O
(,O
SARSCoV,O
),O
reported,O
in,O
China,O
2003,O
",",O
and,O
Middle,O
East,O
"
",O
respiratory,O
syndrome,O
(,O
MERSCoV,O
),O
reported,O
in,O
Saudi,O
Arabia,O
in,O
2012,O
.,O
The,O
initial,O
"
",O
cases,O
have,O
been,O
linked,O
to,O
a,O
live,O
seafood,O
market,O
in,O
Wuhan,O
",",O
China,O
",",O
and,O
the,O
specific,O
"
",O
animal,O
source,O
is,O
yet,O
to,O
be,O
determined,O
.,O
The,O
detection,O
of,O
this,O
new,O
virus,O
in,O
humans,O
"
",O
without,O
knowing,O
the,O
source,O
of,O
the,O
infection,O
has,O
raised,O
greatly,O
heightened,O
"
",O
concerns,O
not,O
only,O
in,O
China,O
",",O
but,O
also,O
internationally,O
.,O
To,O
date,O
",",O
the,O
outbreak,O
has,O
"
",O
spread,O
to,O
most,O
provinces,O
in,O
China,O
and,O
25,O
other,O
countries,O
within,O
a,O
relatively,O
"
",O
short,O
period,O
.,O
Consequent,O
to,O
its,O
spread,O
",",O
Dr,O
Tedros,O
Ghebreyesus,O
",",O
Director,O
General,O
"
",O
of,O
the,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
",",O
declared,O
the,O
outbreak,O
a,O
Public,O
Health,O
"
",O
Emergency,O
of,O
International,O
Concern,O
(,O
PHEIC,O
),O
on,O
30,O
January,O
2020,O
.,O
"

",O
Copyright,O
Â©,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
2020,O
.,O
Open,O
Access,O
.,O
Some,O
rights,O
"
",O
reserved,O
.,O
This,O
work,O
is,O
available,O
under,O
the,O
CC,O
BYNCSA,O
3,O
IGO,O
license,O
"
",O
(,O
https,O
:,O
 ,O
creativecommons.org,O
licenses,O
byncsa,O
3,O
igo,O
),O
.,O
"

",O
DOI,O
:,O
10.26719,O
2020.26.2.136,O
"
",O
PMID,O
:,O
32141588,O
"


",O
283,O
.,O
Eur,O
Rev,O
Med,O
Pharmacol,O
Sci,O
.,O
2020,O
Feb;24(4):20122019,O
.,O
doi,O
:,O
"
",O
10.26355,O
eurrev_202002_20379,O
.,O
"

",O
Novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2019nCoV,B-Virus_SARS-CoV-2
:,O
prevalence,O
",",O
biological,O
and,O
clinical,O
characteristics,O
"
",O
comparison,O
with,O
SARSCoV,O
and,O
MERSCoV.,O
"

",O
Meo,O
SA(1,O
),O
",",O
Alhowikan,O
AM,O
",",O
AlKhlaiwi,O
T,O
",",O
Meo,O
IM,O
",",O
Halepoto,O
DM,O
",",O
Iqbal,O
M,O
",",O
Usmani,O
AM,O
",",O
"
",O
Hajjar,O
W,O
",",O
Ahmed,O
N.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Physiology,O
",",O
Strategic,O
Centre,O
for,O
Diabetes,O
Research,O
",",O
Thoracic,O
"
",O
Surgery,O
",",O
College,O
of,O
Medicine,O
",",O
King,O
Saud,O
University,O
",",O
Riyadh,O
",",O
Saudi,O
Arabia,O
.,O
"
",O
sultanmeo@hotmail.com,O
.,O
"

",O
OBJECTIVE,O
:,O
Human,O
infections,O
with,O
zoonotic,O
coronavirus,O
contain,O
emerging,O
and,O
"
",O
reemerging,O
pathogenic,O
characteristics,O
which,O
have,O
raised,O
great,O
public,O
health,O
"
",O
concern,O
.,O
This,O
study,O
aimed,O
at,O
investigating,O
the,O
global,O
prevalence,O
",",O
biological,O
and,O
"
",O
clinical,O
characteristics,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
Wuhan,O
China,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
",",O
Severe,O
"
",O
Acute,O
Respiratory,O
Syndrome,O
Coronavirus,O
(,O
SARSCoV,O
),O
",",O
and,O
Middle,O
East,O
Respiratory,O
"
",O
Syndrome,O
Coronavirus,O
(,O
MERSCoV,O
),O
infection,O
outbreaks,O
.,O
"
",O
MATERIALS,O
AND,O
METHODS,O
:,O
The,O
data,O
on,O
the,O
global,O
outbreak,O
of,O
"""",O
2019nCoV,B-Virus_SARS-CoV-2
",",O
SARSCoV,O
",",O
"
",O
and,O
MERSCoV,O
"""",O
were,O
obtained,O
from,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
",",O
Centers,O
for,O
"
",O
Disease,O
Control,O
and,O
Prevention,O
(,O
CDC,O
),O
",",O
concerned,O
ministries,O
and,O
research,O
"
",O
institutes,O
.,O
We,O
also,O
recorded,O
the,O
information,O
from,O
research,O
documents,O
published,O
in,O
"
",O
global,O
scientific,O
journals,O
indexed,O
in,O
ISI,O
Web,O
of,O
Science,O
and,O
research,O
centers,O
on,O
"
",O
the,O
prevalence,O
",",O
biological,O
and,O
clinical,O
characteristics,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
SARSCoV,O
",",O
"
",O
and,O
MERSCoV.,O
"
",O
RESULTS,O
:,O
Worldwide,O
",",O
SARSCoV,O
involved,O
32,O
countries,O
",",O
with,O
8422,O
confirmed,O
cases,O
and,O
"
",O
916,O
(,O
10.87,O
%,O
),O
casualties,O
from,O
November,O
2002,O
to,O
August,O
2003,O
.,O
MERSCoV,O
spread,O
over,O
"
",O
27,O
states,O
",",O
causing,O
2496,O
cases,O
and,O
868,O
(,O
34.77,O
%,O
),O
fatalities,O
during,O
the,O
period,O
April,O
"
",O
2012,O
to,O
December,O
2019,O
.,O
However,O
",",O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2019nCoV,B-Virus_SARS-CoV-2
spread,O
swiftly,O
"
",O
the,O
global,O
borders,O
of,O
27,O
countries,O
.,O
It,O
infected,O
34799,O
people,O
and,O
resulted,O
in,O
724,O
"
",O
(,O
2.08,O
%,O
),O
casualties,O
during,O
the,O
period,O
December,O
29,O
",",O
2019,O
to,O
February,O
7,O
",",O
2020,O
.,O
The,O
"
",O
fatality,O
rate,O
of,O
coronavirus,O
MERSCoV,O
was,O
(,O
34.77,O
%,O
),O
higher,O
than,O
SARSCoV,O
(,O
10.87,O
%,O
),O
"
",O
and,O
2019nCoV,B-Virus_SARS-CoV-2
(,O
2.08,O
%,O
),O
;,O
however,O
",",O
the,O
2019nCoV,B-Virus_SARS-CoV-2
transmitted,O
rapidly,O
in,O
comparison,O
"
",O
to,O
SARSCoV,O
and,O
MERSCoV.,O
"
",O
CONCLUSIONS,O
:,O
The,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2019nCoV,B-Virus_SARS-CoV-2
has,O
diverse,O
epidemiological,O
and,O
"
",O
biological,O
characteristics,O
",",O
making,O
it,O
more,O
contagious,O
than,O
SARSCoV,O
and,O
MERSCoV.,O
"
",O
It,O
has,O
affected,O
more,O
people,O
in,O
a,O
short,O
time,O
period,O
compared,O
to,O
SARSCoV,O
and,O
"
",O
MERSCoV,O
",",O
although,O
the,O
fatality,O
rate,O
of,O
MERSCoV,O
was,O
higher,O
than,O
SARSCoV,O
and,O
"
",O
2019nCoV.,O
The,O
major,O
clinical,O
manifestations,O
in,O
coronavirus,O
infections,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
"
",O
MERSCoV,O
",",O
and,O
SARS,O
CoV,O
are,O
fever,O
",",O
chills,O
",",O
cough,O
",",O
shortness,O
of,O
breath,O
",",O
generalized,O
"
",O
myalgia,O
",",O
malaise,O
",",O
drowsy,O
",",O
diarrhea,O
",",O
confusion,O
",",O
dyspnea,O
",",O
and,O
pneumonia,O
.,O
Global,O
"
",O
health,O
authorities,O
should,O
take,O
immediate,O
measures,O
to,O
prevent,O
the,O
outbreaks,O
of,O
"
",O
such,O
emerging,O
and,O
reemerging,O
pathogens,O
across,O
the,O
globe,O
to,O
minimize,O
the,O
disease,O
"
",O
burden,O
locally,O
and,O
globally,O
.,O
"

",O
DOI,O
:,O
10.26355,O
eurrev_202002_20379,O
"
",O
PMID,O
:,O
32141570,O
"


",O
284,O
.,O
Eur,O
Rev,O
Med,O
Pharmacol,O
Sci,O
.,O
2020,O
Feb;24(4):20062011,O
.,O
doi,O
:,O
"
",O
10.26355,O
eurrev_202002_20378,O
.,O
"

",O
COVID19,B-Disease_COVID-19
(,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
2019,I-Virus_SARS-CoV-2
),O
 ,O
recent,O
trends,O
.,O
"

",O
Kannan,O
S(1,O
),O
",",O
Shaik,O
Syed,O
Ali,O
P,O
",",O
Sheeza,O
A,O
",",O
Hemalatha,O
K.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Medicine,O
",",O
The,O
Maldives,O
National,O
University,O
",",O
Male,O
',O
",",O
Maldives,O
.,O
"
",O
Kannan.subbaram@mnu.edu.mv,O
.,O
"

",O
The,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
has,O
issued,O
a,O
warning,O
that,O
",",O
although,O
the,O
2019,O
"
",O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
from,O
Wuhan,O
City,O
(,O
China,O
),O
",",O
is,O
not,O
pandemic,O
",",O
it,O
should,O
"
",O
be,O
contained,O
to,O
prevent,O
the,O
global,O
spread,O
.,O
The,O
COVID19,B-Virus_SARS-CoV-2
virus,I-Virus_SARS-CoV-2
was,O
known,O
earlier,O
"
",O
as,O
2019nCoV.,O
As,O
of,O
12,O
February,O
2020,O
",",O
WHO,O
reported,O
45171,O
cases,O
and,O
1115,O
deaths,O
"
",O
related,O
to,O
COVID19,B-Disease_COVID-19
.,O
COVID19,B-Disease_COVID-19
is,O
similar,O
to,O
Severe,O
Acute,O
Respiratory,O
Syndrome,O
"
",O
coronavirus,O
(,O
SARSCoV,O
),O
virus,O
in,O
its,O
pathogenicity,O
",",O
clinical,O
spectrum,O
",",O
and,O
"
",O
epidemiology,O
.,O
Comparison,O
of,O
the,O
genome,O
sequences,O
of,O
COVID19,B-Disease_COVID-19
",",O
SARSCoV,O
",",O
and,O
"
",O
Middle,O
East,O
Respiratory,O
Syndrome,O
coronavirus,O
(,O
MERSCoV,O
),O
showed,O
that,O
COVID19,B-Disease_COVID-19
has,O
"
",O
a,O
better,O
sequence,O
identity,O
with,O
SARSCoV,O
compared,O
to,O
MERS,O
CoV.,O
However,O
",",O
the,O
amino,O
"
",O
acid,O
sequence,O
of,O
COVID19,B-Disease_COVID-19
differs,O
from,O
other,O
coronaviruses,O
specifically,O
in,O
the,O
"
",O
regions,O
of,O
1ab,O
polyprotein,O
and,O
surface,O
glycoprotein,O
or,O
Sprotein,O
.,O
Although,O
"
",O
several,O
animals,O
have,O
been,O
speculated,O
to,O
be,O
a,O
reservoir,O
for,O
COVID19,B-Disease_COVID-19
",",O
no,O
animal,O
"
",O
reservoir,O
has,O
been,O
already,O
confirmed,O
.,O
COVID19,B-Disease_COVID-19
causes,O
COVID19,B-Disease_COVID-19
disease,O
that,O
has,O
"
",O
similar,O
symptoms,O
as,O
SARSCoV.,O
Studies,O
suggest,O
that,O
the,O
human,O
receptor,O
for,O
"
",O
COVID19,B-Disease_COVID-19
may,O
be,O
angiotensinconverting,O
enzyme,O
2,O
(,O
ACE2,O
),O
receptor,O
similar,O
to,O
that,O
"
",O
of,O
SARSCoV.,O
The,O
nucleocapsid,O
(,O
N,O
),O
protein,O
of,O
COVID19,B-Disease_COVID-19
has,O
nearly,O
90,O
%,O
amino,O
acid,O
"
",O
sequence,O
identity,O
with,O
SARSCoV.,O
The,O
N,O
protein,O
antibodies,O
of,O
SARSCoV,O
may,O
cross,O
"
",O
react,O
with,O
COVID19,B-Disease_COVID-19
but,O
may,O
not,O
provide,O
crossimmunity,O
.,O
In,O
a,O
similar,O
fashion,O
to,O
"
",O
SARSCoV,O
",",O
the,O
N,O
protein,O
of,O
COVID19,B-Disease_COVID-19
may,O
play,O
an,O
important,O
role,O
in,O
suppressing,O
the,O
"
",O
RNA,O
interference,O
(,O
RNAi,O
),O
to,O
overcome,O
the,O
host,O
defense,O
.,O
This,O
minireview,O
aims,O
at,O
"
",O
investigating,O
the,O
most,O
recent,O
trend,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
DOI,O
:,O
10.26355,O
eurrev_202002_20378,O
"
",O
PMID,O
:,O
32141569,O
"


",O
285,O
.,O
Acta,O
Obstet,O
Gynecol,O
Scand,O
.,O
2020,O
Mar,O
5,O
.,O
doi,O
:,O
10.1111,O
aogs.13836,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Novel,B-Disease_COVID-19
corona,I-Disease_COVID-19
virus,I-Disease_COVID-19
disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
in,O
pregnancy,O
:,O
What,O
clinical,O
recommendations,O
"
",O
to,O
follow,O
?,O
"

",O
Liang,O
H(1,O
),O
",",O
Acharya,O
G(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Obstetrics,O
and,O
Gynecology,O
Hospital,O
of,O
Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Division,O
of,O
Obstetrics,O
and,O
Gynecology,O
",",O
Department,O
of,O
Clinical,O
Science,O
",",O
"
",O
Intervention,O
and,O
Technology,O
",",O
Karolinska,O
Institutet,O
and,O
Karolinska,O
University,O
"
",O
Hospital,O
",",O
Stockholm,O
",",O
Sweden,O
.,O
"
",O
(3)Women,O
's,O
Health,O
and,O
Perinatology,O
Research,O
Group,O
",",O
UiTThe,O
Arctic,O
University,O
of,O
"
",O
Norway,O
and,O
University,O
Hospital,O
of,O
North,O
Norway,O
",",O
TromsÃ¸,O
",",O
Norway,O
.,O
"

",O
DOI,O
:,O
10.1111,O
aogs.13836,O
"
",O
PMID,O
:,O
32141062,O
"


",O
286,O
.,O
Br,O
J,O
Dermatol,O
.,O
2020,O
Mar,O
5,O
.,O
doi,O
:,O
10.1111,O
bjd.19011,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Emergency,O
management,O
for,O
preventing,O
and,O
controlling,O
nosocomial,O
infection,O
of,O
2019,O
"
",O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
:,O
implications,O
for,O
the,O
dermatology,O
department,O
.,O
"

",O
Tao,O
J(1)(2,O
),O
",",O
Song,O
Z(1)(3,O
),O
",",O
Yang,O
L(1)(4,O
),O
",",O
Huang,O
C(1)(2,O
),O
",",O
Feng,O
A(1)(2,O
),O
",",O
Man,O
X(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Dermatology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
(2)Hubei,O
Engineering,O
Research,O
Center,O
for,O
Skin,O
Repair,O
and,O
Theranostics,O
",",O
Wuhan,O
",",O
"
",O
430022,O
",",O
China,O
.,O
"
",O
(3)The,O
Second,O
Clinical,O
Medical,O
College,O
",",O
Chongqing,O
Medical,O
University,O
",",O
Chongqing,O
",",O
"
",O
400010,O
",",O
China,O
.,O
"
",O
(4)Hunan,O
Normal,O
University,O
School,O
of,O
Medicine,O
",",O
Changsha,O
",",O
410013,O
",",O
Hunan,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Dermatology,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
Zhejiang,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
310009,O
",",O
Zhejiang,O
",",O
China,O
.,O
"

",O
As,O
of,O
Feb,O
15,O
",",O
2020,O
",",O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
has,O
rapidly,O
spread,O
"
",O
throughout,O
China,O
and,O
across,O
the,O
world,O
with,O
more,O
than,O
60000,O
laboratoryconfirmed,O
"
",O
cases,O
.,O
Due,O
to,O
the,O
current,O
lack,O
of,O
specific,O
treatment,O
and,O
the,O
risk,O
of,O
transmission,O
"
",O
during,O
the,O
viral,O
incubation,O
period,O
",",O
infection,O
prevention,O
and,O
control,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
are,O
both,O
urgent,O
and,O
critical,O
to,O
global,O
health,O
.,O
In,O
this,O
article,O
",",O
we,O
aim,O
to,O
"
",O
highlight,O
the,O
necessity,O
of,O
implementing,O
protective,O
measures,O
",",O
and,O
recommend,O
how,O
to,O
"
",O
set,O
proper,O
emergency,O
management,O
plans,O
for,O
preventing,O
and,O
controlling,O
nosocomial,O
"
",O
infection,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
dermatology,O
departments,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1111,O
bjd.19011,O
"
",O
PMID,O
:,O
32141058,O
"


",O
287,O
.,O
Herz,O
.,O
2020,O
Mar,O
5,O
.,O
doi,O
:,O
10.1007,O
s0005902004909z,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
SARSCoV2,B-Virus_SARS-CoV-2
:,O
a,O
Â ,O
potential,O
novel,O
etiology,O
of,O
fulminant,O
myocarditis,O
.,O
"

",O
Chen,O
C(1,O
),O
",",O
Zhou,O
Y(2,O
),O
",",O
Wang,O
DW(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Cardiology,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
and,O
Hubei,O
Key,O
"
",O
Laboratory,O
of,O
Genetics,O
and,O
Molecular,O
Mechanisms,O
of,O
Cardiological,O
Disorders,O
",",O
"
",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
1095,O
#,O
Jiefang,O
Ave,O
.,O
",",O
430030,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Forensic,O
Medicine,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
"
",O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Division,O
of,O
Cardiology,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
and,O
Hubei,O
Key,O
"
",O
Laboratory,O
of,O
Genetics,O
and,O
Molecular,O
Mechanisms,O
of,O
Cardiological,O
Disorders,O
",",O
"
",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
1095,O
#,O
Jiefang,O
Ave,O
.,O
",",O
430030,O
",",O
Wuhan,O
",",O
China,O
.,O
dwwang@tjh.tjmu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s0005902004909z,O
"
",O
PMID,O
:,O
32140732,O
"


",O
288,O
.,O
One,O
Health,O
.,O
2020,O
Feb,O
14;9:100123,O
.,O
doi,O
:,O
10.1016,O
j.onehlt.2020.100123,O
.,O
eCollection,O
"
",O
2020,O
Jun.,O
"

",O
The,O
novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
is,O
a,O
one,O
health,O
issue,O
.,O
"

",O
Marty,O
AM(1,O
),O
",",O
Jones,O
MK(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Infectious,O
Diseases,O
",",O
Herbert,O
Wertheim,O
College,O
of,O
Medicine,O
",",O
Florida,O
"
",O
International,O
University,O
",",O
Miami,O
",",O
Florida,O
",",O
United,O
States,O
of,O
America,O
.,O
"
",O
(2)School,O
of,O
Veterinary,O
Science,O
",",O
The,O
University,O
of,O
Queensland,O
",",O
Brisbane,O
",",O
Qld,O
"
",O
4072,O
",",O
Australia,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.onehlt.2020.100123,O
"
",O
PMCID,O
:,O
PMC7049657,O
"
",O
PMID,O
:,O
32140538,O
"


",O
289,O
.,O
Front,O
Microbiol,O
.,O
2020,O
Feb,O
19;11:240,O
.,O
doi,O
:,O
10.3389,O
fmicb.2020.00240,O
.,O
eCollection,O
"
",O
2020,O
.,O
"

",O
Virome,O
Identification,O
and,O
Characterization,O
of,O
Fusarium,O
sacchari,O
and,O
F.,O
andiyazi,O
:,O
"
",O
Causative,O
Agents,O
of,O
Pokkah,O
Boeng,O
Disease,O
in,O
Sugarcane,O
.,O
"

",O
Yao,O
Z(1)(2,O
),O
",",O
Zou,O
C(1)(2,O
),O
",",O
Peng,O
N(1)(3,O
),O
",",O
Zhu,O
Y(4,O
),O
",",O
Bao,O
Y(1)(2,O
),O
",",O
Zhou,O
Q(1)(3,O
),O
",",O
Wu,O
"
",O
Q(4,O
),O
",",O
Chen,O
B(1)(2,O
),O
",",O
Zhang,O
M(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Lab,O
for,O
Conservation,O
and,O
Utilization,O
of,O
Subtropical,O
AgricBiological,O
"
",O
Resources,O
",",O
Guangxi,O
University,O
",",O
Nanning,O
",",O
China,O
.,O
"
",O
(2)Guangxi,O
Key,O
Laboratory,O
of,O
Sugarcane,O
Biology,O
",",O
Guangxi,O
University,O
",",O
Nanning,O
",",O
"
",O
China,O
.,O
"
",O
(3)College,O
of,O
Life,O
Sciences,O
and,O
Technology,O
",",O
Guangxi,O
University,O
",",O
Nanning,O
",",O
China,O
.,O
"
",O
(4)Hefei,O
National,O
Laboratory,O
for,O
Physical,O
Sciences,O
at,O
the,O
Microscale,O
",",O
University,O
"
",O
of,O
Science,O
and,O
Technology,O
of,O
China,O
",",O
Hefei,O
",",O
China,O
.,O
"

",O
Fusarium,O
sacchari,O
and,O
Fusarium,O
andiyazi,O
are,O
two,O
devastating,O
sugarcane,O
pathogens,O
"
",O
that,O
cause,O
pokkah,O
boeng,O
disease,O
(,O
PBD,O
),O
in,O
China,O
.,O
RNA_Seq,O
was,O
conducted,O
to,O
identify,O
"
",O
mycoviruses,O
in,O
F.,O
sacchari,O
and,O
F.,O
andiyazi,O
isolates,O
collected,O
from,O
PBD,O
"
",O
symptomshowing,O
sugarcane,O
plants,O
across,O
China,O
.,O
Fifteen,O
isolates,O
with,O
a,O
normal,O
",",O
"
",O
debilitated,O
",",O
or,O
abnormal,O
phenotype,O
in,O
colony,O
morphology,O
were,O
screened,O
out,O
for,O
the,O
"
",O
existence,O
of,O
dsRNA,O
from,O
104,O
Fusarium,O
isolates,O
.,O
By,O
sequencing,O
the,O
mixed,O
pool,O
of,O
"
",O
dsRNA,O
from,O
these,O
Fusarium,O
isolates,O
",",O
a,O
total,O
of,O
26,O
contigs,O
representing,O
complete,O
"
",O
or,O
partial,O
genome,O
sequences,O
of,O
ten,O
mycoviruses,O
and,O
their,O
strains,O
were,O
identified,O
",",O
"
",O
including,O
one,O
virus,O
belonging,O
to,O
Hypoviridae,O
",",O
two,O
mitoviruses,O
with,O
seven,O
strains,O
"
",O
belonging,O
to,O
Narnaviridae,O
",",O
one,O
virus,O
of,O
Chrysoviridae,O
",",O
and,O
one,O
alphaviruslike,O
"
",O
virus,O
.,O
RTPCR,O
amplification,O
with,O
primers,O
specific,O
to,O
individual,O
mycoviruses,O
"
",O
revealed,O
that,O
mitoviruses,O
were,O
the,O
most,O
prevalent,O
and,O
the,O
alphaviruslike,O
virus,O
"
",O
and,O
chrysovirus,O
were,O
the,O
least,O
prevalent,O
.,O
In,O
terms,O
of,O
host,O
preference,O
",",O
more,O
"
",O
mitoviruses,O
were,O
found,O
in,O
F.,O
andiyazi,O
than,O
in,O
F.,O
sacchari,O
.,O
Fusarium,O
sacchari,O
"
",O
hypovirus,O
1,O
with,O
a,O
13.9,O
kb,O
genome,O
and,O
a,O
defective,O
genome,O
of,O
12.2,O
kb,O
",",O
shares,O
54,O
%,O
"
",O
identity,O
at,O
the,O
amino,O
acid,O
level,O
to,O
the,O
Wuhan,O
insect,O
virus,O
14,O
",",O
which,O
is,O
an,O
"
",O
unclassified,O
hypovirus,O
identified,O
from,O
insect,O
metatranscriptomics,O
.,O
The,O
"
",O
alphaviruslike,O
virus,O
",",O
Fusarium,O
sacchari,O
alphaviruslike,O
virus,O
1,O
(,O
FsALV1,O
),O
",",O
seemed,O
"
",O
to,O
hold,O
a,O
distinct,O
status,O
amid,O
fungal,O
alphaviruslike,O
viruses,O
",",O
with,O
the,O
highest,O
"
",O
identity,O
of,O
27,O
%,O
at,O
the,O
amino,O
acid,O
level,O
to,O
Sclerotium,O
rolfsii,O
alphaviruslike,O
"
",O
virus,O
3,O
and,O
29,O
%,O
to,O
a,O
hepevirus,O
",",O
Ferret,O
hepatitis,O
E,O
virus,O
.,O
While,O
six,O
of,O
the,O
seven,O
"
",O
mitoviruses,O
shared,O
7294,O
%,O
identities,O
to,O
known,O
mitoviruses,O
",",O
Fusarium,O
andiyazi,O
"
",O
mitovirus,O
2,O
was,O
most,O
similar,O
to,O
Alternaria,O
brassicicola,O
mitovirus,O
with,O
an,O
"
",O
identity,O
of,O
only,O
49,O
%,O
between,O
the,O
two,O
viruses,O
.,O
Transmission,O
of,O
FsALV1,O
and,O
Fusarium,O
"
",O
sacchari,O
chrysovirus,O
1,O
(,O
FsCV1,O
),O
from,O
F.,O
sacharri,O
to,O
F.,O
commune,O
was,O
observed,O
and,O
"
",O
the,O
characterization,O
of,O
the,O
foursegment,O
dsRNA,O
chrysovirus,O
was,O
performed,O
with,O
aid,O
"
",O
of,O
electron,O
microscopy,O
and,O
analysis,O
of,O
the,O
encapsidated,O
RNAs,O
.,O
These,O
findings,O
"
",O
provide,O
insight,O
into,O
the,O
diversity,O
and,O
spectrum,O
of,O
mycoviruses,O
in,O
PBD,O
pathogens,O
"
",O
and,O
should,O
be,O
useful,O
for,O
exploring,O
agents,O
to,O
control,O
the,O
disease,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Yao,O
",",O
Zou,O
",",O
Peng,O
",",O
Zhu,O
",",O
Bao,O
",",O
Zhou,O
",",O
Wu,O
",",O
Chen,O
and,O
Zhang,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fmicb.2020.00240,O
"
",O
PMCID,O
:,O
PMC7042383,O
"
",O
PMID,O
:,O
32140150,O
"


",O
290,O
.,O
Nat,O
Rev,O
Cardiol,O
.,O
2020,O
Mar,O
5,O
.,O
doi,O
:,O
10.1038,O
s4156902003605,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
and,O
the,O
cardiovascular,O
system,O
.,O
"

",O
Zheng,O
YY(1)(2,O
),O
",",O
Ma,O
YT(3,O
),O
",",O
Zhang,O
JY(4)(5,O
),O
",",O
Xie,O
X(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Cardiology,O
",",O
First,O
Affiliated,O
Hospital,O
of,O
Zhengzhou,O
University,O
",",O
"
",O
Zhengzhou,O
",",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Cardiac,O
Injury,O
and,O
Repair,O
of,O
Henan,O
Province,O
",",O
Zhengzhou,O
",",O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Cardiology,O
",",O
First,O
Affiliated,O
Hospital,O
of,O
Xinjiang,O
Medical,O
"
",O
University,O
",",O
Urumqi,O
",",O
China,O
.,O
myt_xj@sina.com,O
.,O
"
",O
(4)Department,O
of,O
Cardiology,O
",",O
First,O
Affiliated,O
Hospital,O
of,O
Zhengzhou,O
University,O
",",O
"
",O
Zhengzhou,O
",",O
China,O
.,O
jyzhang@zzu.edu.cn,O
.,O
"
",O
(5)Key,O
Laboratory,O
of,O
Cardiac,O
Injury,O
and,O
Repair,O
of,O
Henan,O
Province,O
",",O
Zhengzhou,O
",",O
"
",O
China,O
.,O
jyzhang@zzu.edu.cn,O
.,O
"
",O
(6)Department,O
of,O
Cardiology,O
",",O
First,O
Affiliated,O
Hospital,O
of,O
Xinjiang,O
Medical,O
"
",O
University,O
",",O
Urumqi,O
",",O
China,O
.,O
xiangxie999@sina.com,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s4156902003605,O
"
",O
PMID,O
:,O
32139904,O
"


",O
291,O
.,O
Gut,O
.,O
2020,O
Mar,O
5,O
.,O
pii,O
:,O
gutjnl2020320891,O
.,O
doi,O
:,O
10.1136,O
gutjnl2020320891,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
SARSCoV2,B-Virus_SARS-CoV-2
induced,O
diarrhoea,O
as,O
onset,O
symptom,O
in,O
patient,O
with,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Song,O
Y(1,O
),O
",",O
Liu,O
P(1,O
),O
",",O
Shi,O
XL(1)(2,O
),O
",",O
Chu,O
YL(1,O
),O
",",O
Zhang,O
J(3,O
),O
",",O
Xia,O
J(4,O
),O
",",O
Gao,O
XZ(1,O
),O
",",O
Qu,O
"
",O
T(5,O
),O
",",O
Wang,O
MY(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Central,O
Lab,O
",",O
Weihai,O
Municipal,O
Hospital,O
",",O
Shandong,O
University,O
",",O
"
",O
Weihai,O
",",O
China,O
.,O
"
",O
(2)School,O
of,O
Laboratory,O
Medicine,O
",",O
Dalian,O
Medical,O
University,O
",",O
Dalian,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Infectious,O
Diseases,O
",",O
Weihai,O
Municipal,O
Hospital,O
",",O
Shandong,O
"
",O
University,O
",",O
Weihai,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Infectious,O
Diseases,O
",",O
Weihai,O
Chest,O
Hospital,O
",",O
Weihai,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Weihai,O
Municipal,O
Hospital,O
",",O
Shandong,O
"
",O
University,O
",",O
Weihai,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Central,O
Lab,O
",",O
Weihai,O
Municipal,O
Hospital,O
",",O
Shandong,O
University,O
",",O
"
",O
Weihai,O
",",O
China,O
wangmingyi1973@outlook.com,O
.,O
"

",O
DOI,O
:,O
10.1136,O
gutjnl2020320891,O
"
",O
PMID,O
:,O
32139552,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interests,O
:,O
None,O
declared,O
.,O
"


",O
292,O
.,O
Science,O
.,O
2020,O
Mar,O
6;367(6482):10611062,O
.,O
doi,O
:,O
10.1126,O
science.367.6482.1061,O
.,O
"

",O
Can,O
China,O
's,O
COVID19,B-Disease_COVID-19
strategy,O
work,O
elsewhere,O
?,O
"

",O
Kupferschmidt,O
K,O
",",O
Cohen,O
J.,O
"

",O
DOI,O
:,O
10.1126,O
science.367.6482.1061,O
"
",O
PMID,O
:,O
32139521,O
"


",O
293,O
.,O
Eur,O
Respir,O
J.,O
2020,O
Mar,O
5,O
.,O
pii,O
:,O
2000398,O
.,O
doi,O
:,O
10.1183,O
13993003,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
The,O
clinical,O
dynamics,O
of,O
18,O
cases,O
of,O
COVID19,B-Disease_COVID-19
outside,O
of,O
Wuhan,O
",",O
China,O
.,O
"

",O
Wang,O
L(1,O
),O
",",O
Gao,O
YH(2,O
),O
",",O
Lou,O
LL(1,O
),O
",",O
Zhang,O
GJ(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
First,O
Affiliated,O
"
",O
Hospital,O
of,O
Zhengzhou,O
University,O
",",O
Zhengzhou,O
",",O
Henan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
First,O
Affiliated,O
"
",O
Hospital,O
of,O
Zhengzhou,O
University,O
",",O
Zhengzhou,O
",",O
Henan,O
",",O
China,O
gaoyonghuahust@163.com,O
.,O
"

",O
DOI,O
:,O
10.1183,O
13993003,O
"
",O
PMID,O
:,O
32139464,O
"


",O
294,O
.,O
Eur,O
Respir,O
J.,O
2020,O
Mar,O
5,O
.,O
pii,O
:,O
2000310,O
.,O
doi,O
:,O
10.1183,O
13993003,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Epidemiological,O
characteristics,O
of,O
2019ncoV,B-Virus_SARS-CoV-2
infections,O
in,O
Shaanxi,O
",",O
China,O
by,O
"
",O
February,O
8,O
",",O
2020,O
.,O
"

",O
Yao,O
Y(1)(2,O
),O
",",O
Tian,O
Y(1)(2,O
),O
",",O
Zhou,O
J(1,O
),O
",",O
Ma,O
X(1,O
),O
",",O
Yang,O
M(1,O
),O
",",O
Wang,O
S(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
Xi'an,O
Medical,O
"
",O
University,O
Affiliated,O
Hospital,O
",",O
Xi'an,O
",",O
Shaanxi,O
",",O
PR,O
China,O
.,O
"
",O
(2)Yao,O
Y,O
and,O
Tian,O
Y,O
have,O
contributed,O
equally,O
to,O
this,O
work,O
.,O
"
",O
(3)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
Xi'an,O
Medical,O
"
",O
University,O
Affiliated,O
Hospital,O
",",O
Xi'an,O
",",O
Shaanxi,O
",",O
PR,O
China,O
wangshengyu@yeah.net,O
.,O
"

",O
DOI,O
:,O
10.1183,O
13993003,O
"
",O
PMID,O
:,O
32139462,O
"


",O
295,O
.,O
BMJ,O
.,O
2020,O
Mar,O
5;368:m918,O
.,O
doi,O
:,O
10.1136,O
bmj.m918,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
90,O
%,O
of,O
cases,O
will,O
hit,O
NHS,O
over,O
nine,O
week,O
period,O
",",O
chief,O
medical,O
officer,O
"
",O
warns,O
.,O
"

",O
Mahase,O
E(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m918,O
"
",O
PMID,O
:,O
32139397,O
"


",O
296,O
.,O
Clin,O
Med,O
(,O
Lond,O
),O
.,O
2020,O
Mar,O
5,O
.,O
pii,O
:,O
clinmed.2019coron,O
.,O
doi,O
:,O
"
",O
10.7861,O
clinmed.2019coron,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
What,O
we,O
know,O
so,O
far,O
:,O
COVID19,B-Disease_COVID-19
current,O
clinical,O
knowledge,O
and,O
research,O
.,O
"

",O
Lake,O
MA(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)University,O
of,O
Cambridge,O
",",O
Cambridge,O
",",O
UK,O
alexandra.lake@doctors.org.uk,O
.,O
"

",O
In,O
December,O
2019,O
",",O
health,O
authorities,O
in,O
Wuhan,O
",",O
China,O
",",O
identified,O
a,O
cluster,O
of,O
"
",O
pneumonia,O
cases,O
of,O
unknown,O
aetiology,O
linked,O
to,O
the,O
city,O
's,O
South,O
China,O
Seafood,O
"
",O
Market,O
.,O
Subsequent,O
investigations,O
revealed,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
as,O
"
",O
the,O
causative,O
agent,O
now,O
at,O
the,O
heart,O
of,O
a,O
major,O
outbreak,O
.,O
The,O
rising,O
case,O
numbers,O
"
",O
have,O
been,O
accompanied,O
by,O
unprecedented,O
public,O
health,O
action,O
",",O
including,O
the,O
"
",O
wholesale,O
isolation,O
of,O
Wuhan,O
.,O
Alongside,O
this,O
has,O
been,O
a,O
robust,O
scientific,O
"
",O
response,O
",",O
including,O
early,O
publication,O
of,O
the,O
pathogen,O
genome,O
",",O
and,O
rapid,O
"
",O
development,O
of,O
highly,O
specific,O
diagnostics,O
.,O
This,O
article,O
will,O
review,O
the,O
new,O
"
",O
knowledge,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
COVID19,B-Disease_COVID-19
acute,O
respiratory,O
disease,O
",",O
and,O
summarise,O
its,O
"
",O
clinical,O
features,O
.,O
"

",O
Â©,O
Royal,O
College,O
of,O
Physicians,O
2020,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.7861,O
clinmed.2019coron,O
"
",O
PMID,O
:,O
32139372,O
"


",O
297,O
.,O
J,O
Formos,O
Med,O
Assoc,O
.,O
2020,O
Mar;119(3):670673,O
.,O
doi,O
:,O
10.1016,O
j.jfma.2020.02.009,O
.,O
"
",O
Epub,O
2020,O
Mar,O
2,O
.,O
"

",O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
in,O
children,O
:,O
Transmission,O
dynamics,O
and,O
clinical,O
"
",O
characteristics,O
.,O
"

",O
Cao,O
Q(1,O
),O
",",O
Chen,O
YC(2,O
),O
",",O
Chen,O
CL(3,O
),O
",",O
Chiu,O
CH(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Diseases,O
",",O
Shanghai,O
Children,O
's,O
Medical,O
Center,O
",",O
"
",O
Shanghai,O
Jiao,O
Tong,O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Division,O
of,O
Pediatric,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Pediatrics,O
",",O
Chang,O
"
",O
Gung,O
Memorial,O
Hospital,O
",",O
Chang,O
Gung,O
University,O
College,O
of,O
Medicine,O
",",O
Taoyuan,O
",",O
"
",O
Taiwan,O
.,O
"
",O
(3)Molecular,O
Infectious,O
Disease,O
Research,O
Center,O
",",O
Chang,O
Gung,O
Memorial,O
Hospital,O
",",O
"
",O
Chang,O
Gung,O
University,O
College,O
of,O
Medicine,O
",",O
Taoyuan,O
",",O
Taiwan,O
.,O
"
",O
(4)Division,O
of,O
Pediatric,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Pediatrics,O
",",O
Chang,O
"
",O
Gung,O
Memorial,O
Hospital,O
",",O
Chang,O
Gung,O
University,O
College,O
of,O
Medicine,O
",",O
Taoyuan,O
",",O
"
",O
Taiwan,O
;,O
Molecular,O
Infectious,O
Disease,O
Research,O
Center,O
",",O
Chang,O
Gung,O
Memorial,O
"
",O
Hospital,O
",",O
Chang,O
Gung,O
University,O
College,O
of,O
Medicine,O
",",O
Taoyuan,O
",",O
Taiwan,O
.,O
Electronic,O
"
",O
address,O
:,O
chchiu@adm.cgmh.org.tw,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jfma.2020.02.009,O
"
",O
PMID,O
:,O
32139299,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
have,O
no,O
conflicts,O
of,O
interest,O
relevant,O
to,O
this,O
article,O
.,O
"


",O
298,O
.,O
J,O
Assoc,O
Physicians,O
India,O
.,O
2020,O
Mar;68(3):6771,O
.,O
"

",O
The,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
Outbreak,O
 ,O
A,O
Global,O
Threat,O
.,O
"

",O
Khot,O
WY(1,O
),O
",",O
Nadkar,O
MY(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Assistant,O
Professor,O
.,O
"
",O
(2)Professor,O
and,O
Head,O
",",O
Department,O
of,O
Medicine,O
",",O
Seth,O
GS,O
Medical,O
College,O
and,O
KEM,O
"
",O
Hospital,O
",",O
Mumbai,O
",",O
Maharashtra,O
.,O
"

",O
The,O
2019,B-Disease_COVID-19
Novel,I-Disease_COVID-19
Corona,I-Disease_COVID-19
virus,I-Disease_COVID-19
infection,I-Disease_COVID-19
(,O
COVID,B-Disease_COVID-19
19,I-Disease_COVID-19
),O
is,O
an,O
ongoing,O
public,O
health,O
"
",O
emergency,O
of,O
international,O
significance,O
.,O
There,O
are,O
significant,O
knowledge,O
gaps,O
in,O
"
",O
the,O
epidemiology,O
",",O
transmission,O
dynamics,O
",",O
investigation,O
tools,O
and,O
management,O
.,O
In,O
"
",O
this,O
article,O
",",O
we,O
review,O
the,O
available,O
evidence,O
about,O
this,O
disease,O
.,O
Every,O
decade,O
"
",O
has,O
witnessed,O
the,O
evolution,O
of,O
a,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
epidemic,O
since,O
the,O
last,O
three,O
"
",O
decades,O
.,O
The,O
varying,O
transmission,O
patterns,O
",",O
namely,O
",",O
nosocomial,O
transmission,O
and,O
"
",O
spread,O
through,O
mildly,O
symptomatic,O
cases,O
is,O
an,O
area,O
of,O
concern,O
.,O
There,O
is,O
a,O
"
",O
spectrum,O
of,O
clinical,O
features,O
from,O
mild,O
to,O
severe,O
life,O
threatening,O
disease,O
with,O
"
",O
major,O
complications,O
like,O
severe,O
pneumonia,O
",",O
ARDS,O
",",O
acute,O
cardiac,O
injury,O
and,O
septic,O
"
",O
shock,O
.,O
Presence,O
of,O
bilateral,O
ground,O
glass,O
opacity,O
and,O
consolidation,O
on,O
imaging,O
in,O
"
",O
appropriate,O
clinical,O
background,O
should,O
raise,O
a,O
suspicion,O
about,O
COVID,B-Disease_COVID-19
19,I-Disease_COVID-19
.,O
Poor,O
"
",O
prognostic,O
factors,O
include,O
Multilobular,O
infiltration,O
on,O
chest,O
imaging,O
",",O
"
",O
Lymphopenia,O
",",O
Bacterial,O
coinfection,O
",",O
Smoking,O
history,O
",",O
Chronic,O
medical,O
conditions,O
"
",O
like,O
Hypertension,O
and,O
age,O
>,O
60,O
years,O
(,O
MuLBSTA,O
score,O
),O
.,O
Diagnosis,O
is,O
confirmed,O
with,O
"
",O
PCR,O
based,O
testing,O
of,O
appropriate,O
respiratory,O
samples,O
.,O
Management,O
is,O
primarily,O
"
",O
supportive,O
",",O
with,O
newer,O
antivirals,O
(,O
lopinavir,O
ritonavir,O
and,O
Remdesivir,O
),O
under,O
"
",O
investigation,O
.,O
Role,O
of,O
steroids,O
is,O
still,O
inconclusive,O
.,O
Standard,O
infection,O
control,O
"
",O
and,O
prevention,O
techniques,O
should,O
be,O
followed,O
.,O
Vigilant,O
screening,O
of,O
suspected,O
"
",O
cases,O
and,O
their,O
contacts,O
is,O
important,O
.,O
Isolation,O
of,O
symptomatic,O
cases,O
and,O
home,O
"
",O
quarantine,O
of,O
asymptomatic,O
contacts,O
is,O
recommended,O
.,O
To,O
conclude,O
",",O
controlling,O
this,O
"
",O
highly,O
transmissible,O
disease,O
requires,O
international,O
coordination,O
.,O
"

",O
Â©,O
Journal,O
of,O
the,O
Association,O
of,O
Physicians,O
of,O
India,O
2011,O
.,O
"


",O
PMID,O
:,O
32138488,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
299,O
.,O
Int,O
J,O
Environ,O
Res,O
Public,O
Health,O
.,O
2020,O
Mar,O
3;17(5,O
),O
.,O
pii,O
:,O
E1633,O
.,O
doi,O
:,O
"
",O
10.339,O
ijerph17051633,O
.,O
"

",O
Potential,O
Factors,O
Influencing,O
Repeated,O
SARS,O
Outbreaks,O
in,O
China,O
.,O
"

",O
Sun,O
Z(1,O
),O
",",O
Thilakavathy,O
K(1)(2,O
),O
",",O
Kumar,O
SS(2)(3,O
),O
",",O
He,O
G(4,O
),O
",",O
Liu,O
SV(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Biomedical,O
Sciences,O
",",O
Faculty,O
of,O
Medicine,O
&,O
Health,O
Sciences,O
",",O
"
",O
University,O
Putra,O
Malaysia,O
",",O
UPM,O
Serdang,O
43400,O
",",O
Selangor,O
",",O
Malaysia,O
.,O
"
",O
(2)Genetics,O
and,O
Regenerative,O
Medicine,O
Research,O
Group,O
",",O
Faculty,O
of,O
Medicine,O
&,O
"
",O
Health,O
Sciences,O
",",O
University,O
Putra,O
Malaysia,O
",",O
UPM,O
Serdang,O
43400,O
",",O
Selangor,O
",",O
"
",O
Malaysia,O
.,O
"
",O
(3)Department,O
of,O
Medical,O
Microbiology,O
and,O
Parasitology,O
",",O
University,O
Putra,O
"
",O
Malaysia,O
",",O
UPM,O
Serdang,O
43400,O
",",O
Selangor,O
",",O
Malaysia,O
.,O
"
",O
(4)Institute,O
of,O
Health,O
",",O
Kunming,O
Medical,O
University,O
",",O
Kunming,O
650500,O
",",O
China,O
.,O
"
",O
(5)Eagle,O
Institute,O
of,O
Molecular,O
Medicine,O
",",O
Apex,O
",",O
NC,O
27523,O
",",O
USA,O
.,O
"

",O
Within,O
last,O
17,O
years,O
two,O
widespread,O
epidemics,O
of,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
(,O
SARS,O
),O
occurred,O
in,O
China,O
",",O
which,O
were,O
caused,O
by,O
related,O
coronaviruses,O
"
",O
(,O
CoVs,O
),O
:,O
SARSCoV,O
and,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
Although,O
the,O
origin(s,O
),O
of,O
these,O
viruses,O
are,O
"
",O
still,O
unknown,O
and,O
their,O
occurrences,O
in,O
nature,O
are,O
mysterious,O
",",O
some,O
general,O
"
",O
patterns,O
of,O
their,O
pathogenesis,O
and,O
epidemics,O
are,O
noticeable,O
.,O
Both,O
viruses,O
utilize,O
"
",O
the,O
same,O
receptorangiotensinconverting,O
enzyme,O
2,O
(ACE2)for,O
invading,O
human,O
"
",O
bodies,O
.,O
Both,O
epidemics,O
occurred,O
in,O
cold,O
dry,O
winter,O
seasons,O
celebrated,O
with,O
major,O
"
",O
holidays,O
",",O
and,O
started,O
in,O
regions,O
where,O
dietary,O
consumption,O
of,O
wildlife,O
is,O
a,O
"
",O
fashion,O
.,O
Thus,O
",",O
if,O
bats,O
were,O
the,O
natural,O
hosts,O
of,O
SARSCoVs,O
",",O
cold,O
temperature,O
and,O
"
",O
low,O
humidity,O
in,O
these,O
times,O
might,O
provide,O
conducive,O
environmental,O
conditions,O
for,O
"
",O
prolonged,O
viral,O
survival,O
in,O
these,O
regions,O
concentrated,O
with,O
bats,O
.,O
The,O
widespread,O
"
",O
existence,O
of,O
these,O
batcarried,O
or,O
released,O
viruses,O
might,O
have,O
an,O
easier,O
time,O
in,O
"
",O
breaking,O
through,O
human,O
defenses,O
when,O
harsh,O
winter,O
makes,O
human,O
bodies,O
more,O
"
",O
vulnerable,O
.,O
Once,O
succeeding,O
in,O
making,O
some,O
initial,O
human,O
infections,O
",",O
spreading,O
of,O
"
",O
the,O
disease,O
was,O
made,O
convenient,O
with,O
increased,O
social,O
gathering,O
and,O
holiday,O
"
",O
travel,O
.,O
These,O
natural,O
and,O
social,O
factors,O
influenced,O
the,O
general,O
progression,O
and,O
"
",O
trajectory,O
of,O
the,O
SARS,O
epidemiology,O
.,O
However,O
",",O
some,O
unique,O
factors,O
might,O
also,O
"
",O
contribute,O
to,O
the,O
origination,O
of,O
SARS,O
in,O
Wuhan,O
.,O
These,O
factors,O
are,O
discussed,O
in,O
"
",O
different,O
scenarios,O
in,O
order,O
to,O
promote,O
more,O
research,O
for,O
achieving,O
final,O
"
",O
validation,O
.,O
"

",O
DOI,O
:,O
10.339,O
ijerph17051633,O
"
",O
PMID,O
:,O
32138266,O
"


",O
300,O
.,O
Lancet,O
.,O
2020,O
Mar,O
14;395(10227):850852,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)304682,O
.,O
Epub,O
"
",O
2020,O
Mar,O
2,O
.,O
"

",O
COVID19,B-Disease_COVID-19
and,O
the,O
antilessons,O
of,O
history,O
.,O
"

",O
Peckham,O
R(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
History,O
and,O
Centre,O
for,O
the,O
Humanities,O
and,O
Medicine,O
",",O
Centennial,O
"
",O
Campus,O
",",O
The,O
University,O
of,O
Hong,O
Kong,O
",",O
Pokfulam,O
",",O
Hong,O
Kong,O
",",O
Special,O
Administrative,O
"
",O
Region,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
rpeckham@hku.hk,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)304682,O
"
",O
PMID,O
:,O
32135077,O
"


",O
301,O
.,O
MMWR,O
Morb,O
Mortal,O
Wkly,O
Rep.,O
2020,O
Mar,O
6;69(9):245246,O
.,O
doi,O
:,O
10.15585,O
mmwr.mm6909e1,O
.,O
"

",O
Active,O
Monitoring,O
of,O
Persons,O
Exposed,O
to,O
Patients,O
with,O
Confirmed,O
COVID19,B-Disease_COVID-19
 ,O
United,O
"
",O
States,O
",",O
JanuaryFebruary,O
2020,O
.,O
"

",O
Burke,O
RM,O
",",O
Midgley,O
CM,O
",",O
Dratch,O
A,O
",",O
Fenstersheib,O
M,O
",",O
Haupt,O
T,O
",",O
Holshue,O
M,O
",",O
Ghinai,O
I,O
",",O
"
",O
Jarashow,O
MC,O
",",O
Lo,O
J,O
",",O
McPherson,O
TD,O
",",O
Rudman,O
S,O
",",O
Scott,O
S,O
",",O
Hall,O
AJ,O
",",O
Fry,O
AM,O
",",O
Rolfes,O
MA,O
.,O
"

",O
In,O
December,O
2019,O
",",O
an,O
outbreak,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
",",O
caused,O
by,O
"
",O
the,O
virus,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
began,O
in,O
Wuhan,O
",",O
China,O
(,O
1,O
),O
.,O
The,O
disease,O
spread,O
widely,O
in,O
"
",O
China,O
",",O
and,O
",",O
as,O
of,O
February,O
26,O
",",O
2020,O
",",O
COVID19,B-Disease_COVID-19
cases,O
had,O
been,O
identified,O
in,O
36,O
"
",O
other,O
countries,O
and,O
territories,O
",",O
including,O
the,O
United,O
States,O
.,O
Persontoperson,O
"
",O
transmission,O
has,O
been,O
widely,O
documented,O
",",O
and,O
a,O
limited,O
number,O
of,O
countries,O
have,O
"
",O
reported,O
sustained,O
persontoperson,O
spread,O
.,O
*,O
On,O
January,O
20,O
",",O
state,O
and,O
local,O
"
",O
health,O
departments,O
in,O
the,O
United,O
States,O
",",O
in,O
collaboration,O
with,O
teams,O
deployed,O
"
",O
from,O
CDC,O
",",O
began,O
identifying,O
and,O
monitoring,O
all,O
persons,O
considered,O
to,O
have,O
had,O
"
",O
close,O
contactâ€ ,O
with,O
patients,O
with,O
confirmed,O
COVID19,B-Disease_COVID-19
(,O
2,O
),O
.,O
The,O
aims,O
of,O
these,O
"
",O
efforts,O
were,O
to,O
ensure,O
rapid,O
evaluation,O
and,O
care,O
of,O
patients,O
",",O
limit,O
further,O
"
",O
transmission,O
",",O
and,O
better,O
understand,O
risk,O
factors,O
for,O
transmission,O
.,O
"

",O
DOI,O
:,O
10.15585,O
mmwr.mm6909e1,O
"
",O
PMID,O
:,O
32134909,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
All,O
authors,O
have,O
completed,O
and,O
submitted,O
the,O
"
",O
International,O
Committee,O
of,O
Medical,O
Journal,O
Editors,O
form,O
for,O
disclosure,O
of,O
"
",O
potential,O
conflicts,O
of,O
interest,O
.,O
No,O
potential,O
conflicts,O
of,O
interest,O
were,O
"
",O
disclosed,O
.,O
"


",O
302,O
.,O
J,O
Chin,O
Med,O
Assoc,O
.,O
2020,O
Mar;83(3):217220,O
.,O
doi,O
:,O
10.1097,O
JCMA.0000000000000270,O
.,O
"

",O
The,O
outbreak,O
of,O
COVID19,B-Disease_COVID-19
:,O
An,O
overview,O
.,O
"

",O
Wu,O
YC(1,O
),O
",",O
Chen,O
CS(1,O
),O
",",O
Chan,O
YJ(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Microbiology,O
",",O
Department,O
of,O
Pathology,O
and,O
Laboratory,O
Medicine,O
",",O
"
",O
Taipei,O
Veterans,O
General,O
Hospital,O
",",O
Taipei,O
",",O
Taiwan,O
",",O
ROC,O
.,O
"
",O
(2)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Medicine,O
",",O
Taipei,O
Veterans,O
"
",O
General,O
Hospital,O
",",O
Taipei,O
",",O
Taiwan,O
",",O
ROC,O
.,O
"
",O
(3)Institute,O
of,O
Public,O
Health,O
",",O
School,O
of,O
Medicine,O
",",O
National,O
YangMing,O
University,O
",",O
"
",O
Taipei,O
",",O
Taiwan,O
",",O
ROC,O
.,O
"

",O
In,O
late,O
December,O
2019,O
",",O
a,O
previous,O
unidentified,O
coronavirus,O
",",O
currently,O
named,O
as,O
"
",O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
#,O
",",O
emerged,O
from,O
Wuhan,O
",",O
China,O
",",O
and,O
resulted,O
in,O
a,O
"
",O
formidable,O
outbreak,O
in,O
many,O
cities,O
in,O
China,O
and,O
expanded,O
globally,O
",",O
including,O
"
",O
Thailand,O
",",O
Republic,O
of,O
Korea,O
",",O
Japan,O
",",O
United,O
States,O
",",O
Philippines,O
",",O
Viet,O
Nam,O
",",O
and,O
our,O
"
",O
country,O
(,O
as,O
of,O
2,O
6,O
2020,O
at,O
least,O
25,O
countries,O
),O
.,O
The,O
disease,O
is,O
officially,O
named,O
"
",O
as,O
Coronavirus,O
Disease2019,O
(,O
COVID19,B-Disease_COVID-19
",",O
by,O
WHO,O
on,O
February,O
11,O
",",O
2020,O
),O
.,O
It,O
is,O
also,O
"
",O
named,O
as,O
Severe,O
Pneumonia,O
with,O
Novel,O
Pathogens,O
on,O
January,O
15,O
",",O
2019,O
by,O
the,O
Taiwan,O
"
",O
CDC,O
",",O
the,O
Ministry,O
of,O
Health,O
and,O
is,O
a,O
notifiable,O
communicable,O
disease,O
of,O
the,O
fifth,O
"
",O
category,O
.,O
COVID19,B-Disease_COVID-19
is,O
a,O
potential,O
zoonotic,O
disease,O
with,O
low,O
to,O
moderate,O
"
",O
(,O
estimated,O
2%5,O
%,O
),O
mortality,O
rate,O
.,O
Persontoperson,O
transmission,O
may,O
occur,O
through,O
"
",O
droplet,O
or,O
contact,O
transmission,O
and,O
if,O
there,O
is,O
a,O
lack,O
of,O
stringent,O
infection,O
"
",O
control,O
or,O
if,O
no,O
proper,O
personal,O
protective,O
equipment,O
available,O
",",O
it,O
may,O
"
",O
jeopardize,O
the,O
firstline,O
healthcare,O
workers,O
.,O
Currently,O
",",O
there,O
is,O
no,O
definite,O
"
",O
treatment,O
for,O
COVID19,B-Disease_COVID-19
although,O
some,O
drugs,O
are,O
under,O
investigation,O
.,O
To,O
promptly,O
"
",O
identify,O
patients,O
and,O
prevent,O
further,O
spreading,O
",",O
physicians,O
should,O
be,O
aware,O
of,O
"
",O
the,O
travel,O
or,O
contact,O
history,O
of,O
the,O
patient,O
with,O
compatible,O
symptoms,O
.,O
"

",O
DOI,O
:,O
10.1097,O
JCMA.0000000000000270,O
"
",O
PMID,O
:,O
32134861,O
"


",O
303,O
.,O
Invest,O
Radiol,O
.,O
2020,O
Mar,O
3,O
.,O
doi,O
:,O
10.1097,O
RLI.0000000000000674,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Clinical,O
and,O
HighResolution,O
CT,O
Features,O
of,O
the,O
COVID19,B-Disease_COVID-19
Infection,O
:,O
Comparison,O
of,O
"
",O
the,O
Initial,O
and,O
Followup,O
Changes,O
.,O
"

",O
Xiong,O
Y(1,O
),O
",",O
Sun,O
D(1,O
),O
",",O
Liu,O
Y(1,O
),O
",",O
Fan,O
Y(2,O
),O
",",O
Zhao,O
L(1,O
),O
",",O
Li,O
X(1,O
),O
",",O
Zhu,O
W(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Departments,O
of,O
Radiology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Departments,O
of,O
Radiology,O
",",O
Jin,O
Yintan,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
OBJECTIVES,O
:,O
In,O
late,O
December,O
",",O
2019,O
",",O
an,O
outbreak,O
of,O
coronavirus,O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
"
",O
in,O
Wuhan,O
",",O
China,O
was,O
caused,O
by,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
newly,O
named,O
severe,O
acute,O
"
",O
respiratory,O
syndrome,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
.,O
We,O
aimed,O
to,O
quantify,O
severity,O
of,O
"
",O
COVID19,B-Disease_COVID-19
infection,O
on,O
HighResolution,O
CT,O
and,O
to,O
determine,O
its,O
relationship,O
with,O
"
",O
clinical,O
parameters,O
.,O
"
",O
MATERIALS,O
AND,O
METHODS,O
:,O
From,O
Jan,O
11,O
",",O
2020,O
",",O
to,O
Feb,O
5,O
",",O
2020,O
",",O
the,O
clinical,O
",",O
"
",O
laboratory,O
and,O
HRCT,O
features,O
of,O
42,O
patients,O
(,O
2675,O
years,O
",",O
25,O
males,O
),O
with,O
COVID19,B-Disease_COVID-19
"
",O
were,O
analyzed,O
.,O
The,O
initial,O
and,O
followup,O
CT,O
obtained,O
a,O
mean,O
of,O
4.5,O
days,O
and,O
11.6,O
"
",O
days,O
from,O
the,O
illness,O
onset,O
were,O
retrospectively,O
assessed,O
for,O
the,O
severity,O
and,O
"
",O
progression,O
of,O
pneumonia,O
.,O
Correlations,O
among,O
clinical,O
parameters,O
",",O
initial,O
CT,O
"
",O
features,O
and,O
progression,O
of,O
opacifications,O
were,O
evaluated,O
with,O
Spearman,O
"
",O
correlation,O
and,O
linear,O
regression,O
analysis,O
.,O
"
",O
RESULTS,O
:,O
Thirtyfive,O
(,O
83,O
%,O
),O
patients,O
exhibited,O
a,O
progressive,O
process,O
according,O
to,O
"
",O
CT,O
features,O
during,O
the,O
early,O
stage,O
from,O
onset,O
.,O
Followup,O
CT,O
findings,O
showed,O
"
",O
progressive,O
opacifications,O
",",O
consolidation,O
",",O
interstitial,O
thickening,O
",",O
fibrous,O
"
",O
strips,O
and,O
air,O
bronchograms,O
",",O
compared,O
to,O
initial,O
CT,O
(,O
all,O
p<0.05,O
),O
.,O
Before,O
regular,O
"
",O
treatments,O
",",O
there,O
was,O
a,O
moderate,O
correlation,O
between,O
the,O
days,O
from,O
onset,O
and,O
sum,O
"
",O
score,O
of,O
opacifications,O
(,O
R=0.68,O
",",O
p<0.01,O
),O
.,O
The,O
Creactive,O
protein,O
",",O
erythrocyte,O
"
",O
sedimentation,O
rate,O
and,O
lactate,O
dehydrogenase,O
showed,O
significantly,O
positive,O
"
",O
correlation,O
with,O
the,O
severity,O
of,O
pneumonia,O
assessed,O
on,O
initial,O
CT,O
(,O
R,O
range,O
"
",O
0.360.75,O
",",O
p<0.05,O
),O
.,O
The,O
highest,O
temperature,O
and,O
the,O
severity,O
of,O
opacifications,O
"
",O
assessed,O
on,O
initial,O
CT,O
were,O
significantly,O
related,O
to,O
the,O
progression,O
of,O
"
",O
opacifications,O
on,O
followup,O
CT,O
(,O
p=0.0010.04,O
),O
.,O
"
",O
CONCLUSIONS,O
:,O
Patients,O
with,O
the,O
COVID19,B-Disease_COVID-19
infection,O
usually,O
presented,O
with,O
typical,O
"
",O
groundgrass,O
opacities,O
and,O
other,O
CT,O
features,O
",",O
which,O
showed,O
significant,O
"
",O
correlations,O
with,O
some,O
clinical,O
and,O
laboratory,O
measurements,O
.,O
Followup,O
CT,O
images,O
"
",O
often,O
demonstrated,O
progressions,O
during,O
the,O
early,O
stage,O
from,O
illness,O
onset,O
.,O
"

",O
DOI,O
:,O
10.1097,O
RLI.0000000000000674,O
"
",O
PMID,O
:,O
32134800,O
"


",O
304,O
.,O
AJR,O
Am,O
J,O
Roentgenol,O
.,O
2020,O
Mar,O
0.220833333,O
.,O
doi,O
:,O
10.2214,O
AJR.20.22975,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
CT,O
Features,O
of,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
Pneumonia,O
in,O
62,O
Patients,O
in,O
"
",O
Wuhan,O
",",O
China,O
.,O
"

",O
Zhou,O
S(1,O
),O
",",O
Wang,O
Y(1,O
),O
",",O
Zhu,O
T(1,O
),O
",",O
Xia,O
L(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
1095,O
Jiefang,O
Rd,O
",",O
Qiaokou,O
District,O
",",O
Wuhan,O
",",O
"
",O
Hubei,O
430030,O
",",O
China,O
.,O
"

",O
OBJECTIVE,O
.,O
The,O
purpose,O
of,O
this,O
study,O
was,O
to,O
investigate,O
62,O
subjects,O
in,O
Wuhan,O
",",O
"
",O
China,O
",",O
with,O
laboratoryconfirmed,O
coronavirus,O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
pneumonia,O
and,O
"
",O
describe,O
the,O
CT,O
features,O
of,O
this,O
epidemic,O
disease,O
.,O
MATERIALS,O
AND,O
METHODS,O
.,O
A,O
"
",O
retrospective,O
study,O
of,O
62,O
consecutive,O
patients,O
with,O
laboratoryconfirmed,O
COVID19,B-Disease_COVID-19
"
",O
pneumonia,O
was,O
performed,O
.,O
CT,O
images,O
and,O
clinical,O
data,O
were,O
reviewed,O
.,O
Two,O
thoracic,O
"
",O
radiologists,O
evaluated,O
the,O
distribution,O
and,O
CT,O
signs,O
of,O
the,O
lesions,O
and,O
also,O
"
",O
scored,O
the,O
extent,O
of,O
involvement,O
of,O
the,O
CT,O
signs,O
.,O
The,O
MannWhitney,O
U,O
test,O
was,O
"
",O
used,O
to,O
compare,O
lesion,O
distribution,O
and,O
CT,O
scores,O
.,O
The,O
chisquare,O
test,O
was,O
used,O
"
",O
to,O
compare,O
the,O
CT,O
signs,O
of,O
earlyphase,O
versus,O
advancedphase,O
COVID19,B-Disease_COVID-19
pneumonia,O
.,O
"
",O
RESULTS,O
.,O
A,O
total,O
of,O
62,O
patients,O
(,O
39,O
men,O
and,O
23,O
women,O
;,O
mean,O
[,O
Â±,O
SD,O
],O
age,O
",",O
52.8,O
Â±,O
"
",O
12.2,O
years,O
;,O
range,O
",",O
3077,O
years,O
),O
with,O
COVID19,B-Disease_COVID-19
pneumonia,O
were,O
evaluated,O
.,O
"
",O
Twentyfour,O
of,O
30,O
patients,O
who,O
underwent,O
routine,O
blood,O
tests,O
(,O
80,O
%,O
),O
had,O
a,O
"
",O
decreased,O
lymphocyte,O
count,O
.,O
Of,O
27,O
patients,O
who,O
had,O
their,O
erythrocyte,O
"
",O
sedimentation,O
rate,O
and,O
highsensitivity,O
Creactive,O
protein,O
level,O
assessed,O
",",O
18,O
"
",O
(,O
66.7,O
%,O
),O
had,O
an,O
increased,O
erythrocyte,O
sedimentation,O
rate,O
",",O
and,O
all,O
27,O
(,O
100,O
%,O
),O
had,O
"
",O
an,O
elevated,O
highsensitivity,O
Creactive,O
protein,O
level,O
.,O
Multiple,O
lesions,O
were,O
seen,O
"
",O
on,O
the,O
initial,O
CT,O
scan,O
of,O
52,O
of,O
62,O
patients,O
(,O
83.9,O
%,O
),O
.,O
Fortyeight,O
of,O
62,O
patients,O
"
",O
(,O
77.4,O
%,O
),O
had,O
predominantly,O
peripheral,O
distribution,O
of,O
lesions,O
.,O
The,O
mean,O
CT,O
score,O
"
",O
for,O
the,O
upper,O
zone,O
(,O
3,O
Â±,O
3.4,O
),O
was,O
significantly,O
lower,O
than,O
that,O
for,O
the,O
middle,O
"
",O
(,O
4.5,O
Â±,O
3.8,O
),O
and,O
lower,O
(,O
4.5,O
Â±,O
3.7,O
),O
zones,O
(,O
p,O
=,O
0.022,O
and,O
p,O
=,O
0.02,O
",",O
respectively,O
),O
",",O
"
",O
and,O
there,O
was,O
no,O
significant,O
difference,O
in,O
the,O
mean,O
CT,O
score,O
of,O
the,O
middle,O
and,O
"
",O
lower,O
zones,O
(,O
p,O
=,O
1,O
),O
.,O
The,O
mean,O
CT,O
score,O
for,O
the,O
anterior,O
area,O
(,O
4.4,O
Â±,O
4.1,O
),O
was,O
"
",O
significantly,O
lower,O
than,O
that,O
for,O
the,O
posterior,O
area,O
(,O
7.7,O
Â±,O
6.3,O
),O
(,O
p,O
=,O
0.003,O
),O
.,O
CT,O
"
",O
findings,O
for,O
the,O
patients,O
were,O
as,O
follows,O
:,O
25,O
patients,O
(,O
40.3,O
%,O
),O
had,O
groundglass,O
"
",O
opacities,O
(,O
GGO,O
),O
",",O
21,O
(,O
33.9,O
%,O
),O
",",O
consolidation,O
;,O
39,O
(,O
62.9,O
%,O
),O
",",O
GGO,O
plus,O
a,O
reticular,O
"
",O
pattern,O
;,O
34,O
(,O
54.8,O
%,O
),O
",",O
vacuolar,O
sign,O
;,O
28,O
(,O
45.2,O
%,O
),O
",",O
microvascular,O
dilation,O
sign,O
;,O
35,O
"
",O
(,O
56.5,O
%,O
),O
",",O
fibrotic,O
streaks,O
;,O
21,O
(,O
33.9,O
%,O
),O
",",O
a,O
subpleural,O
line,O
;,O
and,O
33,O
(,O
53.2,O
%,O
),O
",",O
a,O
"
",O
subpleural,O
transparent,O
line,O
.,O
With,O
regard,O
to,O
bronchial,O
changes,O
seen,O
on,O
CT,O
",",O
45,O
"
",O
patients,O
(,O
72.6,O
%,O
),O
had,O
air,O
bronchogram,O
",",O
and,O
11,O
(,O
17.7,O
%,O
),O
had,O
bronchus,O
distortion,O
.,O
In,O
"
",O
terms,O
of,O
pleural,O
changes,O
",",O
CT,O
showed,O
that,O
30,O
patients,O
(,O
48.4,O
%,O
),O
had,O
pleural,O
"
",O
thickening,O
",",O
35,O
(,O
56.5,O
%,O
),O
had,O
pleural,O
retraction,O
sign,O
",",O
and,O
six,O
(,O
9.7,O
%,O
),O
had,O
pleural,O
"
",O
effusion,O
.,O
Compared,O
with,O
earlyphase,O
disease,O
(,O
â‰¤,O
7,O
days,O
after,O
the,O
onset,O
of,O
"
",O
symptoms,O
),O
",",O
advancedphase,O
disease,O
(,O
814,O
days,O
after,O
the,O
onset,O
of,O
symptoms,O
),O
was,O
"
",O
characterized,O
by,O
significantly,O
increased,O
frequencies,O
of,O
GGO,O
plus,O
a,O
reticular,O
"
",O
pattern,O
",",O
vacuolar,O
sign,O
",",O
fibrotic,O
streaks,O
",",O
a,O
subpleural,O
line,O
",",O
a,O
subpleural,O
"
",O
transparent,O
line,O
",",O
air,O
bronchogram,O
",",O
bronchus,O
distortion,O
",",O
and,O
pleural,O
effusion,O
;,O
"
",O
however,O
",",O
GGO,O
significantly,O
decreased,O
in,O
advancedphase,O
disease,O
.,O
CONCLUSION,O
.,O
CT,O
"
",O
examination,O
of,O
patients,O
with,O
COVID19,B-Disease_COVID-19
pneumonia,O
showed,O
a,O
mixed,O
and,O
diverse,O
"
",O
pattern,O
with,O
both,O
lung,O
parenchyma,O
and,O
the,O
interstitium,O
involved,O
.,O
Identification,O
"
",O
of,O
GGO,O
and,O
a,O
single,O
lesion,O
on,O
the,O
initial,O
CT,O
scan,O
suggested,O
earlyphase,O
disease,O
.,O
"
",O
CT,O
signs,O
of,O
aggravation,O
and,O
repair,O
coexisted,O
in,O
advancedphase,O
disease,O
.,O
Lesions,O
"
",O
presented,O
with,O
a,O
characteristic,O
multifocal,O
distribution,O
in,O
the,O
middle,O
and,O
lower,O
"
",O
lung,O
regions,O
and,O
in,O
the,O
posterior,O
lung,O
area,O
.,O
A,O
decreased,O
lymphocyte,O
count,O
and,O
an,O
"
",O
increased,O
highsensitivity,O
Creactive,O
protein,O
level,O
were,O
the,O
most,O
common,O
"
",O
laboratory,O
findings,O
.,O
"

",O
DOI,O
:,O
10.2214,O
AJR.20.22975,O
"
",O
PMID,O
:,O
32134681,O
"


",O
305,O
.,O
Emerg,O
Infect,O
Dis,O
.,O
2020,O
Jun,O
17;26(6,O
),O
.,O
doi,O
:,O
10.3201,O
eid2606.200287,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Lack,O
of,O
Vertical,O
Transmission,O
of,O
Severe,B-Virus_SARS-CoV-2
Acute,I-Virus_SARS-CoV-2
Respiratory,I-Virus_SARS-CoV-2
Syndrome,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
",",O
"
",O
China,O
.,O
"

",O
Li,O
Y,O
",",O
Zhao,O
R,O
",",O
Zheng,O
S,O
",",O
Chen,O
X,O
",",O
Wang,O
J,O
",",O
Sheng,O
X,O
",",O
Zhou,O
J,O
",",O
Cai,O
H,O
",",O
Fang,O
Q,O
",",O
Yu,O
F,O
",",O
Fan,O
"
",O
J,O
",",O
Xu,O
K,O
",",O
Chen,O
Y,O
",",O
Sheng,O
J.,O
"

",O
A,O
woman,O
with,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
in,O
her,O
35th,O
week,O
of,O
pregnancy,O
"
",O
delivered,O
an,O
infant,O
by,O
cesarean,O
section,O
in,O
a,O
negativepressure,O
operating,O
room,O
.,O
"
",O
The,O
infant,O
was,O
negative,O
for,O
severe,O
acute,O
respiratory,O
coronavirus,O
2,O
.,O
This,O
case,O
"
",O
suggests,O
that,O
mothertochild,O
transmission,O
is,O
unlikely,O
for,O
this,O
virus,O
.,O
"

",O
DOI,O
:,O
10.3201,O
eid2606.200287,O
"
",O
PMID,O
:,O
32134381,O
"


",O
306,O
.,O
Asian,O
Pac,O
J,O
Allergy,O
Immunol,O
.,O
2020,O
Mar,O
4,O
.,O
doi,O
:,O
10.12932,O
AP2002200773,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Perspectives,O
on,O
monoclonal,O
antibody,O
therapy,O
as,O
potential,O
therapeutic,O
intervention,O
"
",O
for,O
Coronavirus,B-Disease_COVID-19
disease19,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
Shanmugaraj,O
B(1)(2,O
),O
",",O
Siriwattananon,O
K(1)(2,O
),O
",",O
Wangkanont,O
K(3,O
),O
",",O
Phoolcharoen,O
"
",O
W(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Research,O
unit,O
for,O
Plantproduced,O
Pharmaceuticals,O
",",O
Chulalongkorn,O
University,O
",",O
"
",O
Bangkok,O
",",O
Thailand,O
.,O
"
",O
(2)Department,O
of,O
Pharmacognosy,O
and,O
Pharmaceutical,O
Botany,O
",",O
Faculty,O
of,O
"
",O
Pharmaceutical,O
Sciences,O
",",O
Chulalongkorn,O
University,O
",",O
Bangkok,O
",",O
Thailand,O
.,O
"
",O
(3)Department,O
of,O
Biochemistry,O
",",O
Faculty,O
of,O
Science,O
",",O
Chulalongkorn,O
University,O
",",O
"
",O
Bangkok,O
",",O
Thailand,O
.,O
"

",O
Last,O
decade,O
witnessed,O
the,O
outbreak,O
of,O
many,O
lifethreatening,O
human,O
pathogens,O
"
",O
including,O
Nipah,O
",",O
Ebola,O
",",O
Chikungunya,O
",",O
Zika,O
",",O
Middle,O
East,O
respiratory,O
syndrome,O
"
",O
coronavirus,O
(,O
MERSCoV,O
),O
",",O
Severe,O
Acute,O
respiratory,O
syndrome,O
coronavirus,O
(,O
SARSCoV,O
),O
"
",O
and,O
more,O
recently,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
or,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
.,O
The,O
disease,O
"
",O
condition,O
associated,O
with,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
referred,O
to,O
as,O
Coronavirus,O
disease,O
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
.,O
The,O
emergence,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
in,O
2019,O
in,O
Wuhan,O
",",O
China,O
marked,O
the,O
"
",O
third,O
highly,O
pathogenic,O
coronavirus,O
infecting,O
humans,O
in,O
the,O
21st,O
century,O
.,O
The,O
"
",O
continuing,O
emergence,O
of,O
coronaviruses,O
at,O
regular,O
intervals,O
poses,O
a,O
significant,O
"
",O
threat,O
to,O
human,O
health,O
and,O
economy,O
.,O
Ironically,O
",",O
even,O
after,O
a,O
decade,O
of,O
research,O
"
",O
on,O
coronavirus,O
",",O
still,O
there,O
are,O
no,O
licensed,O
vaccines,O
or,O
therapeutic,O
agents,O
to,O
"
",O
treat,O
coronavirus,O
infection,O
which,O
highlights,O
an,O
urgent,O
need,O
to,O
develop,O
effective,O
"
",O
vaccines,O
or,O
postexposure,O
prophylaxis,O
to,O
prevent,O
future,O
epidemics,O
.,O
Several,O
"
",O
clinical,O
",",O
genetic,O
and,O
epidemiological,O
features,O
of,O
COVID19,B-Disease_COVID-19
resemble,O
SARSCoV,O
"
",O
infection,O
.,O
Hence,O
",",O
the,O
research,O
advancements,O
on,O
SARSCoV,O
treatment,O
might,O
help,O
"
",O
scientific,O
community,O
in,O
quick,O
understanding,O
of,O
this,O
virus,O
pathogenesis,O
and,O
"
",O
develop,O
effective,O
therapeutic,O
prophylactic,O
agents,O
to,O
treat,O
and,O
prevent,O
this,O
"
",O
infection,O
.,O
Monoclonal,O
antibodies,O
represent,O
the,O
major,O
class,O
of,O
biotherapeutics,O
for,O
"
",O
passive,O
immunotherapy,O
to,O
fight,O
against,O
viral,O
infection,O
.,O
The,O
therapeutic,O
potential,O
"
",O
of,O
monoclonal,O
antibodies,O
has,O
been,O
well,O
recognized,O
in,O
the,O
treatment,O
of,O
many,O
"
",O
diseases,O
.,O
Here,O
",",O
we,O
summarize,O
the,O
potential,O
monoclonal,O
antibody,O
based,O
therapeutic,O
"
",O
intervention,O
for,O
COVID19,B-Disease_COVID-19
by,O
considering,O
the,O
existing,O
knowledge,O
on,O
the,O
"
",O
neutralizing,O
monoclonal,O
antibodies,O
against,O
similar,O
coronaviruses,O
SARSCoV,O
and,O
"
",O
MERSCoV.,O
Further,O
research,O
on,O
COVID19,B-Disease_COVID-19
pathogenesis,O
could,O
identify,O
appropriate,O
"
",O
therapeutic,O
targets,O
to,O
develop,O
specific,O
antivirals,O
against,O
this,O
newly,O
emerging,O
"
",O
pathogen,O
.,O
"

",O
DOI,O
:,O
10.12932,O
AP2002200773,O
"
",O
PMID,O
:,O
32134278,O
"


",O
307,O
.,O
Pediatr,O
Pulmonol,O
.,O
2020,O
Mar,O
5,O
.,O
doi,O
:,O
10.1002,O
ppul.24718,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
and,O
CT,O
features,O
in,O
pediatric,O
patients,O
with,O
COVID19,B-Disease_COVID-19
infection,O
:,O
Different,O
"
",O
points,O
from,O
adults,O
.,O
"

",O
Xia,O
W(1,O
),O
",",O
Shao,O
J(1,O
),O
",",O
Guo,O
Y(1,O
),O
",",O
Peng,O
X(1,O
),O
",",O
Li,O
Z(2,O
),O
",",O
Hu,O
D(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Imaging,O
Center,O
",",O
Wuhan,O
Children,O
's,O
Hospital,O
(,O
Wuhan,O
Maternal,O
and,O
"
",O
Child,O
Healthcare,O
Hospital,O
),O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"

",O
PURPOSE,O
:,O
To,O
discuss,O
the,O
different,O
characteristics,O
of,O
clinical,O
",",O
laboratory,O
",",O
and,O
"
",O
chest,O
computed,O
tomography,O
(,O
CT,O
),O
in,O
pediatric,O
patients,O
from,O
adults,O
with,O
2019,O
novel,O
"
",O
coronavirus,O
(,O
COVID19,B-Disease_COVID-19
),O
infection,O
.,O
"
",O
METHODS,O
:,O
The,O
clinical,O
",",O
laboratory,O
",",O
and,O
chest,O
CT,O
features,O
of,O
20,O
pediatric,O
"
",O
inpatients,O
with,O
COVID19,B-Disease_COVID-19
infection,O
confirmed,O
by,O
pharyngeal,O
swab,O
COVID19,B-Disease_COVID-19
nucleic,O
"
",O
acid,O
test,O
were,O
retrospectively,O
analyzed,O
during,O
23,O
January,O
and,O
8,O
February,O
2020,O
.,O
"
",O
The,O
clinical,O
and,O
laboratory,O
information,O
was,O
obtained,O
from,O
inpatient,O
records,O
.,O
All,O
"
",O
the,O
patients,O
were,O
undergone,O
chest,O
CT,O
in,O
our,O
hospital,O
.,O
"
",O
RESULTS,O
:,O
Thirteen,O
pediatric,O
patients,O
(,O
13,O
20,O
",",O
65,O
%,O
),O
had,O
an,O
identified,O
history,O
of,O
"
",O
close,O
contact,O
with,O
COVID19,B-Disease_COVID-19
diagnosed,O
family,O
members,O
.,O
Fever,O
(,O
12,O
20,O
",",O
60,O
%,O
),O
and,O
"
",O
cough,O
(,O
13,O
20,O
",",O
65,O
%,O
),O
were,O
the,O
most,O
common,O
symptoms,O
.,O
For,O
laboratory,O
findings,O
",",O
"
",O
procalcitonin,O
elevation,O
(,O
16,O
20,O
",",O
80,O
%,O
),O
should,O
be,O
pay,O
attention,O
to,O
",",O
which,O
is,O
not,O
"
",O
common,O
in,O
adults,O
.,O
Coinfection,O
(,O
8,O
20,O
",",O
40,O
%,O
),O
is,O
common,O
in,O
pediatric,O
patients,O
.,O
A,O
"
",O
total,O
of,O
6,O
patients,O
presented,O
with,O
unilateral,O
pulmonary,O
lesions,O
(,O
6,O
20,O
",",O
30,O
%,O
),O
",",O
10,O
"
",O
with,O
bilateral,O
pulmonary,O
lesions,O
(,O
10,O
20,O
",",O
50,O
%,O
),O
",",O
and,O
4,O
cases,O
showed,O
no,O
abnormality,O
"
",O
on,O
chest,O
CT,O
(,O
4,O
20,O
",",O
20,O
%,O
),O
.,O
Consolidation,O
with,O
surrounding,O
halo,O
sign,O
was,O
observed,O
in,O
"
",O
10,O
patients,O
(,O
10,O
20,O
",",O
50,O
%,O
),O
",",O
groundglass,O
opacities,O
were,O
observed,O
in,O
12,O
patients,O
"
",O
(,O
12,O
20,O
",",O
60,O
%,O
),O
",",O
fine,O
mesh,O
shadow,O
was,O
observed,O
in,O
4,O
patients,O
(,O
4,O
20,O
",",O
20,O
%,O
),O
",",O
and,O
tiny,O
"
",O
nodules,O
were,O
observed,O
in,O
3,O
patients,O
(,O
3,O
20,O
",",O
15,O
%,O
),O
.,O
"
",O
CONCLUSION,O
:,O
Procalcitonin,O
elevation,O
and,O
consolidation,O
with,O
surrounding,O
halo,O
signs,O
"
",O
were,O
common,O
in,O
pediatric,O
patients,O
which,O
were,O
different,O
from,O
adults,O
.,O
It,O
is,O
"
",O
suggested,O
that,O
underlying,O
coinfection,O
may,O
be,O
more,O
common,O
in,O
pediatrics,O
",",O
and,O
the,O
"
",O
consolidation,O
with,O
surrounding,O
halo,O
sign,O
which,O
is,O
considered,O
as,O
a,O
typical,O
sign,O
in,O
"
",O
pediatric,O
patients,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
ppul.24718,O
"
",O
PMID,O
:,O
32134205,O
"


",O
308,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
5,O
.,O
doi,O
:,O
10.1002,O
jmv.25748,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Unique,O
epidemiological,O
and,O
clinical,O
features,O
of,O
the,O
emerging,O
2019,O
novel,O
"
",O
coronavirus,O
pneumonia,O
(,O
COVID19,B-Disease_COVID-19
),O
implicate,O
special,O
control,O
measures,O
.,O
"

",O
Wang,O
Y(1,O
),O
",",O
Wang,O
Y(1,O
),O
",",O
Chen,O
Y(2,O
),O
",",O
Qin,O
Q(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Laboratory,O
of,O
Human,O
Virology,O
and,O
Oncology,O
",",O
Shantou,O
University,O
Medical,O
College,O
",",O
"
",O
Shantou,O
",",O
Guangdong,O
Province,O
",",O
515041,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pediatric,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huang,O
zhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"

",O
By,O
Feb,O
27th,O
",",O
2020,O
",",O
the,O
outbreak,O
of,O
COVID19,B-Disease_COVID-19
caused,O
82623,O
confirmed,O
cases,O
and,O
"
",O
2858,O
deaths,O
globally,O
",",O
more,O
than,O
Severe,O
Acute,O
Respiratory,O
Syndrome,O
(,O
SARS,O
),O
(,O
8273,O
"
",O
cases,O
",",O
775,O
deaths,O
),O
and,O
Middle,O
East,O
Respiratory,O
Syndrome,O
(,O
MERS,O
),O
(,O
1139,O
cases,O
",",O
431,O
"
",O
deaths,O
),O
caused,O
in,O
2003,O
and,O
2013,O
respectively,O
.,O
COVID19,B-Disease_COVID-19
has,O
spread,O
to,O
46,O
countries,O
"
",O
internationally,O
.,O
Total,O
fatality,O
rate,O
of,O
COVID19,B-Disease_COVID-19
is,O
estimated,O
at,O
3.46,O
%,O
by,O
far,O
"
",O
based,O
on,O
published,O
data,O
from,O
Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
"
",O
(,O
China,O
CDC,O
),O
.,O
Average,O
incubation,O
period,O
of,O
COVID19,B-Disease_COVID-19
is,O
around,O
6.4,O
days,O
",",O
ranges,O
"
",O
from,O
24,O
days,O
.,O
The,O
basic,O
reproductive,O
number,O
(,O
R0,O
),O
of,O
COVID19,B-Disease_COVID-19
ranges,O
from,O
23.5,O
"
",O
at,O
the,O
early,O
phase,O
regardless,O
of,O
different,O
prediction,O
models,O
",",O
which,O
is,O
higher,O
"
",O
than,O
SARS,O
and,O
MERS,O
.,O
A,O
study,O
from,O
China,O
CDC,O
showed,O
majority,O
of,O
patients,O
(,O
80.9,O
%,O
),O
"
",O
were,O
considered,O
asymptomatic,O
or,O
mild,O
pneumonia,O
but,O
released,O
large,O
amounts,O
of,O
"
",O
viruses,O
at,O
the,O
early,O
phase,O
of,O
infection,O
",",O
which,O
posed,O
enormous,O
challenges,O
for,O
"
",O
containing,O
the,O
spread,O
of,O
COVID19,B-Disease_COVID-19
.,O
Nosocomial,O
transmission,O
was,O
another,O
severe,O
"
",O
problem,O
.,O
3019,O
health,O
workers,O
were,O
infected,O
by,O
Feb,O
12,O
",",O
2020,O
",",O
which,O
accounted,O
for,O
"
",O
3.83,O
%,O
of,O
total,O
number,O
of,O
infections,O
",",O
and,O
extremely,O
burdened,O
the,O
health,O
system,O
",",O
"
",O
especially,O
in,O
Wuhan,O
.,O
Limited,O
epidemiological,O
and,O
clinical,O
data,O
suggest,O
that,O
the,O
"
",O
disease,O
spectrum,O
of,O
COVID19,B-Disease_COVID-19
may,O
differ,O
from,O
SARS,O
or,O
MERS,O
.,O
We,O
summarize,O
latest,O
"
",O
literatures,O
on,O
genetic,O
",",O
epidemiological,O
",",O
and,O
clinical,O
features,O
of,O
COVID19,B-Disease_COVID-19
in,O
"
",O
comparison,O
to,O
SARS,O
and,O
MERS,O
and,O
emphasize,O
special,O
measures,O
on,O
diagnosis,O
and,O
"
",O
potential,O
interventions,O
.,O
This,O
review,O
will,O
improve,O
our,O
understanding,O
of,O
the,O
unique,O
"
",O
features,O
of,O
COVID19,B-Disease_COVID-19
and,O
enhance,O
our,O
control,O
measures,O
in,O
the,O
future,O
.,O
This,O
article,O
"
",O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25748,O
"
",O
PMID,O
:,O
32134116,O
"


",O
309,O
.,O
Swiss,O
Med,O
Wkly,O
.,O
2020,O
Mar,O
5;150:w20216,O
.,O
doi,O
:,O
10.4414,O
smw.2020.20216,O
.,O
eCollection,O
"
",O
2020,O
Feb,O
24,O
.,O
"

",O
Understanding,O
COVID19,B-Disease_COVID-19
new,O
diagnostic,O
guidelines,O
 ,O
a,O
message,O
of,O
reassurance,O
from,O
"
",O
an,O
internal,O
medicine,O
doctor,O
in,O
Shanghai,O
.,O
"

",O
Bischof,O
E(1,O
),O
",",O
Chen,O
G(2,O
),O
",",O
Ferretti,O
MT(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Shanghai,O
University,O
of,O
Medicine,O
and,O
Health,O
Sciences,O
",",O
College,O
of,O
Fundamental,O
"
",O
Medicine,O
",",O
Shanghai,O
",",O
China,O
  ,O
Shanghai,O
Jiao,O
Tong,O
University,O
",",O
School,O
of,O
Medicine,O
",",O
"
",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Emergency,O
Trauma,O
",",O
Shanghai,O
East,O
Hospital,O
",",O
Tongji,O
University,O
"
",O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(3)Women,O
's,O
Brain,O
Project,O
",",O
Switzerland,O
.,O
"

",O
DOI,O
:,O
10.4414,O
smw.2020.20216,O
"
",O
PMID,O
:,O
32134111,O
"


",O
310,O
.,O
Curr,O
Top,O
Med,O
Chem,O
.,O
2020,O
Mar,O
5,O
.,O
doi,O
:,O
10.2174,O
1.56803E+24,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Coronavirus,O
Disease,O
COVID19,B-Disease_COVID-19
:,O
A,O
New,O
Threat,O
to,O
Public,O
Health,O
.,O
"

",O
Kumar,O
S(1,O
),O
",",O
Poonam(1,O
),O
",",O
Rathi,O
B(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Chemistry,O
Miranda,O
House,O
University,O
of,O
Delhi,O
",",O
Delhi110007,O
.,O
"
",O
India,O
.,O
"
",O
(2)Laboratory,O
For,O
Translational,O
Chemistry,O
and,O
Drug,O
Discovery,O
Hansraj,O
College,O
",",O
"
",O
University,O
of,O
Delhi,O
Delhi110007,O
.,O
India,O
.,O
"

",O
DOI,O
:,O
10.2174,O
1.56803E+24,O
"
",O
PMID,O
:,O
32133964,O
"


",O
311,O
.,O
Curr,O
Top,O
Med,O
Chem,O
.,O
2020,O
Mar,O
5,O
.,O
doi,O
:,O
10.2174,O
1.56803E+24,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Effective,O
Chemicals,O
against,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
in,O
China,O
.,O
"

",O
Liu,O
W(1,O
),O
",",O
Zhu,O
HL(1,O
),O
",",O
Duan,O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Henan,O
Provincial,O
Key,O
Laboratory,O
of,O
Children,O
's,O
Genetics,O
and,O
Metabolic,O
Diseases,O
"
",O
Children,O
's,O
Hospital,O
Affiliated,O
to,O
Zhengzhou,O
University,O
Zhengzhou,O
",",O
450018,O
.,O
China,O
.,O
"

",O
DOI,O
:,O
10.2174,O
1.56803E+24,O
"
",O
PMID,O
:,O
32133962,O
"


",O
312,O
.,O
J,O
Gen,O
Intern,O
Med,O
.,O
2020,O
Mar,O
4,O
.,O
doi,O
:,O
10.1007,O
s1160602005762w,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Review,O
of,O
the,O
Clinical,O
Characteristics,O
of,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
Jiang,O
F(1,O
),O
",",O
Deng,O
L(2,O
),O
",",O
Zhang,O
L(3,O
),O
",",O
Cai,O
Y(1,O
),O
",",O
Cheung,O
CW(1,O
),O
",",O
Xia,O
Z(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Anesthesiology,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
University,O
"
",O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
",",O
SAR,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Affiliated,O
Hospital,O
of,O
Guangdong,O
Medical,O
"
",O
University,O
",",O
Zhanjiang,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Anesthesiology,O
",",O
Affiliated,O
Hospital,O
of,O
Guangdong,O
Medical,O
"
",O
University,O
",",O
Zhanjiang,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Anesthesiology,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
University,O
"
",O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
",",O
SAR,O
",",O
China,O
.,O
zyxia@hku.hk,O
.,O
"
",O
(5)Department,O
of,O
Anesthesiology,O
",",O
Affiliated,O
Hospital,O
of,O
Guangdong,O
Medical,O
"
",O
University,O
",",O
Zhanjiang,O
",",O
China,O
.,O
zyxia@hku.hk,O
.,O
"

",O
In,O
late,O
December,O
2019,O
",",O
a,O
cluster,O
of,O
cases,O
with,O
2019,B-Disease_COVID-19
Novel,I-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
"
",O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
in,O
Wuhan,O
",",O
China,O
",",O
aroused,O
worldwide,O
concern,O
.,O
Previous,O
studies,O
have,O
"
",O
reported,O
epidemiological,O
and,O
clinical,O
characteristics,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
.,O
The,O
purpose,O
of,O
this,O
brief,O
review,O
is,O
to,O
summarize,O
those,O
published,O
"
",O
studies,O
as,O
of,O
late,O
February,O
2020,O
on,O
the,O
clinical,O
features,O
",",O
symptoms,O
",",O
"
",O
complications,O
",",O
and,O
treatments,O
of,O
COVID19,B-Disease_COVID-19
and,O
help,O
provide,O
guidance,O
for,O
frontline,O
"
",O
medical,O
staff,O
in,O
the,O
clinical,O
management,O
of,O
this,O
outbreak,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s1160602005762w,O
"
",O
PMID,O
:,O
32133578,O
"


",O
313,O
.,O
J,O
Mol,O
Cell,O
Biol,O
.,O
2020,O
Mar,O
5,O
.,O
pii,O
:,O
mjaa004,O
.,O
doi,O
:,O
10.1093,O
jmcb,O
mjaa004,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
ZCCHC3,O
modulates,O
TLR3mediated,O
signaling,O
by,O
promoting,O
recruitment,O
of,O
TRIF,O
to,O
"
",O
TLR3,O
.,O
"

",O
Zang,O
R(1,O
),O
",",O
Lian,O
H(1,O
),O
",",O
Zhong,O
X(1,O
),O
",",O
Yang,O
Q(1,O
),O
",",O
Shu,O
HB(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Diseases,O
",",O
Frontier,O
Science,O
Center,O
for,O
Immunology,O
and,O
"
",O
Metabolism,O
",",O
Medical,O
Research,O
Institute,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
University,O
",",O
Wuhan,O
430071,O
",",O
China,O
.,O
"

",O
Tolllike,O
receptor,O
3,O
(TLR3)mediated,O
signaling,O
is,O
important,O
for,O
host,O
defense,O
"
",O
against,O
RNA,O
virus,O
.,O
Upon,O
viral,O
RNA,O
stimulation,O
",",O
TIR,O
domaincontaining,O
adaptor,O
"
",O
inducing,O
IFNÎ²,O
(,O
TRIF,O
),O
is,O
recruited,O
to,O
TLR3,O
and,O
then,O
undergoes,O
oligomerization,O
",",O
"
",O
which,O
is,O
required,O
for,O
the,O
recruitment,O
of,O
downstream,O
molecules,O
to,O
transmit,O
"
",O
signals,O
.,O
Here,O
we,O
identified,O
ZCCHC3,O
as,O
a,O
positive,O
regulator,O
of,O
TLR3mediated,O
"
",O
signaling,O
.,O
Overexpression,O
of,O
ZCCHC3,O
promoted,O
transcription,O
of,O
downstream,O
"
",O
antiviral,O
genes,O
stimulated,O
by,O
the,O
synthetic,O
TLR3,O
ligand,O
poly(I,O
:,O
C,O
),O
.,O
"
",O
ZCCHC3deficiency,O
markedly,O
inhibited,O
TLR3,O
but,O
not,O
TLR4mediated,O
induction,O
of,O
"
",O
type,O
I,O
interferons,O
(,O
IFNs,O
),O
and,O
proinflammatory,O
cytokines,O
.,O
Zcchc3,O
 ,O
mice,O
were,O
more,O
"
",O
resistant,O
to,O
poly(I,O
:,O
C,O
),O
but,O
not,O
LPSinduced,O
inflammatory,O
death,O
.,O
Mechanistically,O
",",O
"
",O
ZCCHC3,O
promoted,O
recruitment,O
of,O
TRIF,O
to,O
TLR3,O
after,O
poly(I,O
:,O
C,O
),O
stimulation,O
.,O
Our,O
"
",O
findings,O
reveal,O
that,O
ZCCHC3,O
plays,O
an,O
important,O
role,O
in,O
TLR3mediated,O
innate,O
"
",O
immune,O
response,O
by,O
promoting,O
the,O
recruitment,O
of,O
TRIF,O
to,O
TLR3,O
after,O
ligand,O
"
",O
stimulation,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
on,O
behalf,O
of,O
Journal,O
"
",O
of,O
Molecular,O
Cell,O
Biology,O
",",O
IBCB,O
",",O
SIBS,O
",",O
CAS,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jmcb,O
mjaa004,O
"
",O
PMID,O
:,O
32133501,O
"


",O
314,O
.,O
Signal,O
Transduct,O
Target,O
Ther,O
.,O
2020,O
Feb,O
21;5:18,O
.,O
doi,O
:,O
10.1038,O
s4139202001279,O
.,O
"
",O
eCollection,O
2020,O
.,O
"

",O
Potential,O
benefits,O
of,O
precise,O
corticosteroids,O
therapy,O
for,O
severe,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
pneumonia,O
.,O
"

",O
Zhou,O
W(#)(1,O
),O
",",O
Liu,O
Y(#)(2,O
),O
",",O
Tian,O
D(#)(3,O
),O
",",O
Wang,O
C(#)(4,O
),O
",",O
Wang,O
S(5,O
),O
",",O
Cheng,O
J(6,O
),O
",",O
Hu,O
"
",O
M(7,O
),O
",",O
Fang,O
M(8,O
),O
",",O
Gao,O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pharmaceutical,O
Sciences,O
",",O
Beijing,O
Institute,O
of,O
Radiation,O
"
",O
Medicine,O
",",O
100850,O
Beijing,O
",",O
P.,O
R.,O
China,O
.,O
"
",O
(2)2School,O
of,O
Nursing,O
",",O
Capital,O
Medical,O
University,O
",",O
100069,O
Beijing,O
",",O
P.,O
R.,O
China,O
.,O
"
",O
(3)3Department,O
of,O
Pharmacy,O
",",O
Hebei,O
General,O
Hospital,O
",",O
50000,O
Shijiazhuang,O
",",O
P.,O
R.,O
"
",O
China,O
.,O
"
",O
(4)4Department,O
of,O
Orthopedics,O
",",O
First,O
Medical,O
Center,O
",",O
General,O
Hospital,O
of,O
Chinese,O
"
",O
PLA,O
",",O
100853,O
Beijing,O
",",O
P.,O
R.,O
China,O
.,O
"
",O
(5)5Emergency,O
Department,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
Zhejiang,O
University,O
"
",O
School,O
of,O
Medicine,O
",",O
310009,O
Hangzhou,O
",",O
P.,O
R.,O
China,O
.,O
"
",O
(6)6Emergency,O
Surgery,O
Department,O
",",O
Tongji,O
Hospital,O
Affiliated,O
to,O
Tongji,O
Medical,O
"
",O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
430030,O
Wuhan,O
",",O
P.,O
R.,O
"
",O
China,O
.,O
"
",O
(7)Intensive,O
Care,O
Unit,O
",",O
Wuhan,O
Pulmonary,O
Hospital,O
",",O
430030,O
Wuhan,O
",",O
P.,O
R.,O
China,O
.,O
"
",O
(8)8Emergency,O
and,O
Intensive,O
Care,O
Unit,O
",",O
Tongji,O
Hospital,O
Affiliated,O
to,O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
430030,O
Wuhan,O
",",O
P.,O
"
",O
R.,O
China,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
DOI,O
:,O
10.1038,O
s4139202001279,O
"
",O
PMCID,O
:,O
PMC7035340,O
"
",O
PMID,O
:,O
32133159,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interestsThe,O
authors,O
declare,O
no,O
"
",O
competing,O
interests,O
.,O
"


",O
315,O
.,O
Cell,O
Discov,O
.,O
2020,O
Feb,O
24;6:11,O
.,O
doi,O
:,O
10.1038,O
s4142102001471,O
.,O
eCollection,O
2020,O
.,O
"

",O
Comparative,O
genetic,O
analysis,O
of,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
SARSCoV2,B-Virus_SARS-CoV-2
),O
"
",O
receptor,O
ACE2,O
in,O
different,O
populations,O
.,O
"

",O
Cao,O
Y(#)(1,O
),O
",",O
Li,O
L(#)(1,O
),O
",",O
Feng,O
Z(1,O
),O
",",O
Wan,O
S(1,O
),O
",",O
Huang,O
P(1,O
),O
",",O
Sun,O
X(1,O
),O
",",O
Wen,O
F(1,O
),O
",",O
"
",O
Huang,O
X(1,O
),O
",",O
Ning,O
G(1,O
),O
",",O
Wang,O
W(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Clinical,O
Research,O
Centre,O
for,O
Metabolic,O
Diseases,O
",",O
State,O
Key,O
Laboratory,O
"
",O
of,O
Medical,O
Genomics,O
",",O
Shanghai,O
Clinical,O
Center,O
for,O
Endocrine,O
and,O
Metabolic,O
"
",O
Diseases,O
",",O
Shanghai,O
Institute,O
for,O
Endocrine,O
and,O
Metabolic,O
Diseases,O
",",O
Ruijin,O
"
",O
Hospital,O
",",O
Shanghai,O
Jiaotong,O
University,O
School,O
of,O
Medicine,O
",",O
200025,O
Shanghai,O
",",O
"
",O
China,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
DOI,O
:,O
10.1038,O
s4142102001471,O
"
",O
PMCID,O
:,O
PMC7040011,O
"
",O
PMID,O
:,O
32133153,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflict,O
of,O
interestThe,O
authors,O
declare,O
that,O
they,O
"
",O
have,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
316,O
.,O
Cell,O
Discov,O
.,O
2020,O
Feb,O
24;6:10,O
.,O
doi,O
:,O
10.1038,O
s4142102001480,O
.,O
eCollection,O
2020,O
.,O
"

",O
Phaseadjusted,O
estimation,O
of,O
the,O
number,O
of,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
cases,O
in,O
"
",O
Wuhan,O
",",O
China,O
.,O
"

",O
Wang,O
H(#)(1,O
),O
",",O
Wang,O
Z(#)(2)(3,O
),O
",",O
Dong,O
Y(#)(4,O
),O
",",O
Chang,O
R(#)(1,O
),O
",",O
Xu,O
C(#)(1,O
),O
",",O
Yu,O
"
",O
X(#)(1,O
),O
",",O
Zhang,O
S(#)(1,O
),O
",",O
Tsamlag,O
L(#)(1,O
),O
",",O
Shang,O
M(5,O
),O
",",O
Huang,O
J(6,O
),O
",",O
Wang,O
Y(1,O
),O
",",O
Xu,O
"
",O
G(1,O
),O
",",O
Shen,O
T(1,O
),O
",",O
Zhang,O
X(7,O
),O
",",O
Cai,O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)1School,O
of,O
Public,O
Health,O
",",O
Shanghai,O
Jiao,O
Tong,O
University,O
School,O
of,O
Medicine,O
",",O
"
",O
200025,O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Cancer,O
Prevention,O
",",O
Shanghai,O
Cancer,O
Center,O
",",O
Fudan,O
University,O
",",O
"
",O
200032,O
Shanghai,O
",",O
China,O
.,O
"
",O
(3)3Department,O
of,O
Oncology,O
",",O
Shanghai,O
Medical,O
College,O
",",O
Fudan,O
University,O
",",O
200032,O
"
",O
Shanghai,O
",",O
China,O
.,O
"
",O
(4)4Department,O
of,O
Environmental,O
and,O
Occupational,O
Health,O
",",O
School,O
of,O
Public,O
Health,O
",",O
"
",O
China,O
Medical,O
University,O
",",O
110122,O
Shenyang,O
",",O
China,O
.,O
"
",O
(5)Sanlin,O
Community,O
Health,O
Service,O
Center,O
",",O
200124,O
Shanghai,O
",",O
China,O
.,O
"
",O
(6)6State,O
Key,O
Laboratory,O
of,O
Medical,O
Genomics,O
",",O
Shanghai,O
Institute,O
of,O
Hematology,O
",",O
"
",O
National,O
Research,O
Center,O
for,O
Translational,O
Medicine,O
(,O
Shanghai,O
),O
",",O
RuiJin,O
Hospital,O
",",O
"
",O
Shanghai,O
Jiao,O
Tong,O
University,O
School,O
of,O
Medicine,O
",",O
200025,O
Shanghai,O
",",O
China,O
.,O
"
",O
(7)7Research,O
Laboratory,O
of,O
Clinical,O
Virology,O
",",O
National,O
Research,O
Center,O
for,O
"
",O
Translational,O
Medicine,O
(,O
Shanghai,O
),O
",",O
RuiJin,O
Hospital,O
",",O
and,O
RuiJin,O
Hospital,O
North,O
",",O
"
",O
Shanghai,O
Jiao,O
Tong,O
University,O
School,O
of,O
Medicine,O
",",O
200025,O
Shanghai,O
",",O
China,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
An,O
outbreak,O
of,O
clusters,O
of,O
viral,O
pneumonia,O
due,O
to,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
SARSCoV2,B-Virus_SARS-CoV-2
),O
happened,O
in,O
Wuhan,O
",",O
Hubei,O
Province,O
in,O
China,O
in,O
December,O
"
",O
2019,O
.,O
Since,O
the,O
outbreak,O
",",O
several,O
groups,O
reported,O
estimated,O
R,O
0,O
of,O
Coronavirus,O
"
",O
Disease,O
2019,O
(,O
COVID19,B-Disease_COVID-19
),O
and,O
generated,O
valuable,O
prediction,O
for,O
the,O
early,O
phase,O
of,O
"
",O
this,O
outbreak,O
.,O
After,O
implementation,O
of,O
strict,O
prevention,O
and,O
control,O
measures,O
in,O
"
",O
China,O
",",O
new,O
estimation,O
is,O
needed,O
.,O
An,O
infectious,O
disease,O
dynamics,O
SEIR,O
"
",O
(,O
Susceptible,O
",",O
Exposed,O
",",O
Infectious,O
",",O
and,O
Removed,O
),O
model,O
was,O
applied,O
to,O
estimate,O
the,O
"
",O
epidemic,O
trend,O
in,O
Wuhan,O
",",O
China,O
under,O
two,O
assumptions,O
of,O
R,O
t,O
.,O
In,O
the,O
first,O
"
",O
assumption,O
",",O
R,O
t,O
was,O
assumed,O
to,O
maintain,O
over,O
1,O
.,O
The,O
estimated,O
number,O
of,O
"
",O
infections,O
would,O
continue,O
to,O
increase,O
throughout,O
February,O
without,O
any,O
indication,O
"
",O
of,O
dropping,O
with,O
R,O
t,O
â€‰,O
=,O
â€‰,O
1.9,O
",",O
2.6,O
",",O
or,O
3.1,O
.,O
The,O
number,O
of,O
infections,O
would,O
reach,O
"
",O
11044,O
",",O
70258,O
",",O
and,O
227989,O
",",O
respectively,O
",",O
by,O
29,O
February,O
2020,O
.,O
In,O
the,O
second,O
"
",O
assumption,O
",",O
R,O
t,O
was,O
assumed,O
to,O
gradually,O
decrease,O
at,O
different,O
phases,O
from,O
high,O
"
",O
level,O
of,O
transmission,O
(,O
R,O
t,O
â€‰,O
=,O
â€‰,O
3.1,O
",",O
2.6,O
",",O
and,O
1.9,O
),O
to,O
below,O
1,O
(,O
R,O
t,O
â€‰,O
=,O
â€‰,O
0.9,O
or,O
0.5,O
),O
"
",O
owing,O
to,O
increasingly,O
implemented,O
public,O
health,O
intervention,O
.,O
Several,O
phases,O
were,O
"
",O
divided,O
by,O
the,O
dates,O
when,O
various,O
levels,O
of,O
prevention,O
and,O
control,O
measures,O
were,O
"
",O
taken,O
in,O
effect,O
in,O
Wuhan,O
.,O
The,O
estimated,O
number,O
of,O
infections,O
would,O
reach,O
the,O
peak,O
"
",O
in,O
late,O
February,O
",",O
which,O
is,O
5807784520,O
or,O
5586981393,O
.,O
Whether,O
or,O
not,O
the,O
"
",O
peak,O
of,O
the,O
number,O
of,O
infections,O
would,O
occur,O
in,O
February,O
2020,O
may,O
be,O
an,O
important,O
"
",O
index,O
for,O
evaluating,O
the,O
sufficiency,O
of,O
the,O
current,O
measures,O
taken,O
in,O
China,O
.,O
"
",O
Regardless,O
of,O
the,O
occurrence,O
of,O
the,O
peak,O
",",O
the,O
currently,O
strict,O
measures,O
in,O
Wuhan,O
"
",O
should,O
be,O
continuously,O
implemented,O
and,O
necessary,O
strict,O
public,O
health,O
measures,O
"
",O
should,O
be,O
applied,O
in,O
other,O
locations,O
in,O
China,O
with,O
high,O
number,O
of,O
COVID19,B-Disease_COVID-19
cases,O
",",O
"
",O
in,O
order,O
to,O
reduce,O
R,O
t,O
to,O
an,O
ideal,O
level,O
and,O
control,O
the,O
infection,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s4142102001480,O
"
",O
PMCID,O
:,O
PMC7039910,O
"
",O
PMID,O
:,O
32133152,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflict,O
of,O
interestThe,O
authors,O
declare,O
that,O
they,O
"
",O
have,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
317,O
.,O
Front,O
Microbiol,O
.,O
2020,O
Feb,O
18;11:178,O
.,O
doi,O
:,O
10.3389,O
fmicb.2020.00178,O
.,O
eCollection,O
"
",O
2020,O
.,O
"

",O
Anthralin,O
Suppresses,O
the,O
Proliferation,O
of,O
Influenza,O
Virus,O
by,O
Inhibiting,O
the,O
"
",O
CapBinding,O
and,O
Endonuclease,O
Activity,O
of,O
Viral,O
RNA,O
Polymerase,O
.,O
"

",O
Hu,O
A(1)(2,O
),O
",",O
Li,O
J(1,O
),O
",",O
Tang,O
W(1,O
),O
",",O
Liu,O
G(1)(2,O
),O
",",O
Zhang,O
H(1,O
),O
",",O
Liu,O
C(1,O
),O
",",O
Chen,O
"
",O
X(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
"
",O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Guangdong,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Institute,O
of,O
Medical,O
Microbiology,O
",",O
Jinan,O
"
",O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"

",O
Influenza,O
virus,O
RNAdependent,O
RNA,O
polymerase,O
(,O
vRdRp,O
),O
does,O
not,O
have,O
capping,O
"
",O
activity,O
and,O
relies,O
on,O
the,O
capped,O
RNAs,O
produced,O
by,O
the,O
host,O
RNA,O
polymerase,O
II,O
"
",O
(,O
RNAPII,O
),O
.,O
The,O
viral,O
polymerases,O
process,O
the,O
capped,O
RNAs,O
to,O
produce,O
short,O
capped,O
"
",O
RNA,O
fragments,O
that,O
are,O
used,O
as,O
primers,O
to,O
initiate,O
the,O
transcription,O
of,O
viral,O
"
",O
mRNAs,O
.,O
This,O
process,O
",",O
known,O
as,O
capsnatching,O
",",O
can,O
be,O
targeted,O
by,O
antiviral,O
"
",O
therapeutics,O
.,O
Here,O
",",O
anthralin,O
was,O
identified,O
as,O
an,O
inhibitor,O
against,O
influenza,O
a,O
"
",O
virus,O
(,O
IAV,O
),O
infection,O
by,O
targeting,O
the,O
capsnatching,O
activity,O
of,O
the,O
viral,O
"
",O
polymerase,O
.,O
Anthralin,O
",",O
an,O
FDAapproved,O
drug,O
used,O
in,O
the,O
treatment,O
of,O
psoriasis,O
",",O
"
",O
shows,O
antiviral,O
activity,O
against,O
IAV,O
infection,O
in,O
vitro,O
and,O
in,O
vivo,O
.,O
Importantly,O
",",O
"
",O
anthralin,O
significantly,O
reduces,O
weight,O
loss,O
",",O
lung,O
injury,O
",",O
and,O
mortality,O
caused,O
by,O
"
",O
IAV,O
infection,O
in,O
mice,O
.,O
The,O
mechanism,O
of,O
action,O
study,O
revealed,O
that,O
anthralin,O
"
",O
inhibits,O
the,O
capbinding,O
function,O
of,O
PB2,O
subunit,O
and,O
endonuclease,O
activity,O
of,O
PA,O
.,O
"
",O
As,O
a,O
result,O
",",O
viral,O
mRNA,O
transcription,O
is,O
blocked,O
",",O
leading,O
to,O
the,O
decreases,O
in,O
"
",O
viral,O
RNA,O
replication,O
and,O
viral,O
protein,O
expression,O
.,O
In,O
conclusion,O
",",O
anthralin,O
has,O
"
",O
been,O
demonstrated,O
to,O
have,O
the,O
potential,O
of,O
an,O
alternative,O
antiviral,O
against,O
"
",O
influenza,O
virus,O
infection,O
.,O
Also,O
",",O
targeting,O
the,O
captive,O
pocket,O
structure,O
that,O
"
",O
includes,O
the,O
Nterminus,O
of,O
PA,O
endonuclease,O
domain,O
and,O
the,O
Cterminal,O
of,O
PB2,O
"
",O
capbinding,O
domain,O
of,O
IAV,O
RdRp,O
may,O
be,O
an,O
excellent,O
strategy,O
for,O
developing,O
"
",O
antiinfluenza,O
drugs,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Hu,O
",",O
Li,O
",",O
Tang,O
",",O
Liu,O
",",O
Zhang,O
",",O
Liu,O
and,O
Chen,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fmicb.2020.00178,O
"
",O
PMCID,O
:,O
PMC7040080,O
"
",O
PMID,O
:,O
32132985,O
"


",O
318,O
.,O
Bull,O
World,O
Health,O
Organ,O
.,O
2020,O
Mar,O
1;98(3):150,O
.,O
doi,O
:,O
10.2471,O
BLT.20.251561,O
.,O
"

",O
Data,O
sharing,O
for,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
Moorthy,O
V(1,O
),O
",",O
Henao,O
Restrepo,O
AM(2,O
),O
",",O
Preziosi,O
MP(3,O
),O
",",O
Swaminathan,O
S(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Science,O
Division,O
",",O
World,O
Health,O
Organization,O
",",O
avenue,O
Appia,O
20,O
",",O
1211,O
Geneva,O
27,O
",",O
"
",O
Switzerland,O
.,O
"
",O
(2)Health,O
Emergencies,O
Preparedness,O
and,O
Response,O
",",O
World,O
Health,O
Organization,O
",",O
"
",O
Geneva,O
",",O
Switzerland,O
.,O
"
",O
(3)Universal,O
Health,O
Coverage,O
Life,O
Course,O
",",O
World,O
Health,O
Organization,O
",",O
Geneva,O
",",O
"
",O
Switzerland,O
.,O
"

",O
DOI,O
:,O
10.2471,O
BLT.20.251561,O
"
",O
PMCID,O
:,O
PMC7047033,O
"
",O
PMID,O
:,O
32132744,O
"


",O
319,O
.,O
Cell,O
Mol,O
Immunol,O
.,O
2020,O
Mar,O
4,O
.,O
doi,O
:,O
10.1038,O
s414230200385z,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Novel,O
antibody,O
epitopes,O
dominate,O
the,O
antigenicity,O
of,O
spike,O
glycoprotein,O
in,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
compared,O
to,O
SARSCoV.,O
"

",O
Zheng,O
M(1,O
),O
",",O
Song,O
L(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Military,O
Cognition,O
and,O
Brain,O
Sciences,O
",",O
Academy,O
of,O
Military,O
"
",O
Medical,O
Sciences,O
",",O
27,O
Taiping,O
Road,O
",",O
Beijing,O
",",O
100850,O
",",O
China,O
.,O
mmzheng@fmmu.edu.cn,O
.,O
"
",O
(2)Institute,O
of,O
Military,O
Cognition,O
and,O
Brain,O
Sciences,O
",",O
Academy,O
of,O
Military,O
"
",O
Medical,O
Sciences,O
",",O
27,O
Taiping,O
Road,O
",",O
Beijing,O
",",O
100850,O
",",O
China,O
.,O
lunsong0752@163.com,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s414230200385z,O
"
",O
PMID,O
:,O
32132669,O
"


",O
320,O
.,O
Med,O
Sci,O
Monit,O
.,O
2020,O
Mar,O
5;26:e923549,O
.,O
doi,O
:,O
10.12659,O
MSM.923549,O
.,O
"

",O
The,O
Effects,O
of,O
Social,O
Support,O
on,O
Sleep,O
Quality,O
of,O
Medical,O
Staff,O
Treating,O
Patients,O
"
",O
with,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
in,O
January,O
and,O
February,O
2020,O
in,O
China,O
.,O
"

",O
Xiao,O
H(1,O
),O
",",O
Zhang,O
Y(2,O
),O
",",O
Kong,O
D(2,O
),O
",",O
Li,O
S(3,O
),O
",",O
Yang,O
N(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Respiration,O
",",O
Xuanwu,O
Hospital,O
Capital,O
Medical,O
University,O
",",O
"
",O
Beijing,O
",",O
China,O
(,O
mainland,O
),O
.,O
"
",O
(2)College,O
of,O
Humanities,O
and,O
Social,O
Sciences,O
",",O
Harbin,O
Engineering,O
University,O
",",O
"
",O
Harbin,O
",",O
Heilongjiang,O
",",O
China,O
(,O
mainland,O
),O
.,O
"
",O
(3)School,O
of,O
Health,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
(,O
mainland,O
),O
.,O
"

",O
BACKGROUND,O
Coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
",",O
formerly,O
known,O
as,O
severe,O
acute,O
"
",O
respiratory,O
syndrome,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
and,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
",",O
was,O
first,O
identified,O
in,O
December,O
2019,O
in,O
Wuhan,O
City,O
",",O
China,O
.,O
"
",O
Structural,O
equation,O
modeling,O
(,O
SEM,O
),O
is,O
a,O
multivariate,O
analysis,O
method,O
to,O
determine,O
"
",O
the,O
structural,O
relationship,O
between,O
measured,O
variables,O
.,O
This,O
observational,O
study,O
"
",O
aimed,O
to,O
use,O
SEM,O
to,O
determine,O
the,O
effects,O
of,O
social,O
support,O
on,O
sleep,O
quality,O
and,O
"
",O
function,O
of,O
medical,O
staff,O
who,O
treated,O
patients,O
with,O
COVID19,B-Disease_COVID-19
in,O
January,O
and,O
"
",O
February,O
2020,O
in,O
Wuhan,O
",",O
China,O
.,O
MATERIAL,O
AND,O
METHODS,O
A,O
onemonth,O
crosssectional,O
"
",O
observational,O
study,O
included,O
180,O
medical,O
staff,O
who,O
treated,O
patients,O
with,O
COVID19,B-Disease_COVID-19
"
",O
infection,O
.,O
Levels,O
of,O
anxiety,O
",",O
selfefficacy,O
",",O
stress,O
",",O
sleep,O
quality,O
",",O
and,O
social,O
"
",O
support,O
were,O
measured,O
using,O
the,O
and,O
the,O
SelfRating,O
Anxiety,O
Scale,O
(,O
SAS,O
),O
",",O
the,O
"
",O
General,O
SelfEfficacy,O
Scale,O
(,O
GSES,O
),O
",",O
the,O
Stanford,O
Acute,O
Stress,O
Reaction,O
(,O
SASR,O
),O
"
",O
questionnaire,O
",",O
the,O
Pittsburgh,O
Sleep,O
Quality,O
Index,O
(,O
PSQI,O
),O
",",O
and,O
the,O
Social,O
Support,O
"
",O
Rate,O
Scale,O
(,O
SSRS,O
),O
",",O
respectively,O
.,O
Pearson,O
's,O
correlation,O
analysis,O
and,O
SEM,O
"
",O
identified,O
the,O
interactions,O
between,O
these,O
factors,O
.,O
RESULTS,O
Levels,O
of,O
social,O
"
",O
support,O
for,O
medical,O
staff,O
were,O
significantly,O
associated,O
with,O
selfefficacy,O
and,O
"
",O
sleep,O
quality,O
and,O
negatively,O
associated,O
with,O
the,O
degree,O
of,O
anxiety,O
and,O
stress,O
.,O
"
",O
Levels,O
of,O
anxiety,O
were,O
significantly,O
associated,O
with,O
the,O
levels,O
of,O
stress,O
",",O
which,O
"
",O
negatively,O
impacted,O
selfefficacy,O
and,O
sleep,O
quality,O
.,O
Anxiety,O
",",O
stress,O
",",O
and,O
"
",O
selfefficacy,O
were,O
mediating,O
variables,O
associated,O
with,O
social,O
support,O
and,O
sleep,O
"
",O
quality,O
.,O
CONCLUSIONS,O
SEM,O
showed,O
that,O
medical,O
staff,O
in,O
China,O
who,O
were,O
treating,O
"
",O
patients,O
with,O
COVID19,B-Disease_COVID-19
infection,O
during,O
January,O
and,O
February,O
2020,O
had,O
levels,O
of,O
"
",O
anxiety,O
",",O
stress,O
",",O
and,O
selfefficacy,O
that,O
were,O
dependent,O
on,O
sleep,O
quality,O
and,O
"
",O
social,O
support,O
.,O
"

",O
DOI,O
:,O
10.12659,O
MSM.923549,O
"
",O
PMID,O
:,O
32132521,O
"


",O
321,O
.,O
Curr,O
Opin,O
Pulm,O
Med,O
.,O
2020,O
Mar,O
5,O
.,O
doi,O
:,O
10.1097,O
MCP.0000000000000676,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
The,O
explosive,O
epidemic,O
outbreak,O
of,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
2019,O
(,O
COVID19,B-Disease_COVID-19
),O
and,O
"
",O
the,O
persistent,O
threat,O
of,O
respiratory,O
tract,O
infectious,O
diseases,O
to,O
global,O
health,O
"
",O
security,O
.,O
"

",O
Zumla,O
A(1)(2,O
),O
",",O
Niederman,O
MS(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
Centre,O
for,O
Clinical,O
Microbiology,O
",",O
"
",O
University,O
College,O
London,O
.,O
"
",O
(2)NIHR,O
Biomedical,O
Research,O
Centre,O
",",O
UCL,O
Hospitals,O
NHS,O
Foundation,O
Trust,O
",",O
London,O
",",O
"
",O
UK,O
.,O
"
",O
(3)Division,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Weill,O
Cornell,O
Medical,O
"
",O
College,O
",",O
New,O
York,O
",",O
New,O
York,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1097,O
MCP.0000000000000676,O
"
",O
PMID,O
:,O
32132379,O
"


",O
322,O
.,O
J,O
Clin,O
Microbiol,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
JCM.0031020,O
.,O
doi,O
:,O
10.1128,O
JCM.0031020,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Improved,O
molecular,O
diagnosis,O
of,O
COVID19,B-Disease_COVID-19
by,O
the,O
novel,O
",",O
highly,O
sensitive,O
and,O
"
",O
specific,O
COVID19RdRp,O
Hel,O
realtime,O
reverse,O
transcriptionpolymerase,O
chain,O
"
",O
reaction,O
assay,O
validated,O
in,O
vitro,O
and,O
with,O
clinical,O
specimens,O
.,O
"

",O
Chan,O
JF(1)(2)(3)(4)(5,O
),O
",",O
Yip,O
CC(6,O
),O
",",O
To,O
KK(1)(2)(3)(4,O
),O
",",O
Tang,O
TH(7,O
),O
",",O
Wong,O
SC(8,O
),O
",",O
"
",O
Leung,O
KH(3,O
),O
",",O
Fung,O
AY(3,O
),O
",",O
Ng,O
AC(3,O
),O
",",O
Zou,O
Z(3,O
),O
",",O
Tsoi,O
HW(3,O
),O
",",O
Choi,O
GK(6,O
),O
",",O
Tam,O
AR(9,O
),O
",",O
"
",O
Cheng,O
VC(6,O
),O
",",O
Chan,O
KH(1)(3)(4,O
),O
",",O
Tsang,O
OT(10,O
),O
",",O
Yuen,O
KY(11)(3)(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Emerging,O
Infectious,O
Diseases,O
",",O
The,O
University,O
of,O
Hong,O
"
",O
Kong,O
",",O
Pokfulam,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Clinical,O
Microbiology,O
and,O
Infection,O
",",O
The,O
University,O
of,O
Hong,O
"
",O
KongShenzhen,O
Hospital,O
",",O
Shenzhen,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Microbiology,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
University,O
of,O
"
",O
Hong,O
Kong,O
",",O
Pokfulam,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(4)Carol,O
Yu,O
Centre,O
for,O
Infection,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
University,O
"
",O
of,O
Hong,O
Kong,O
",",O
Pokfulam,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(5)Hainan,O
Medical,O
UniversityThe,O
University,O
of,O
Hong,O
Kong,O
Joint,O
Laboratory,O
of,O
"
",O
Tropical,O
Infectious,O
Diseases,O
",",O
Hainan,O
Medical,O
University,O
",",O
Haikou,O
",",O
Hainan,O
",",O
and,O
The,O
"
",O
University,O
of,O
Hong,O
Kong,O
",",O
Pokfulam,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
"
",O
China,O
.,O
"
",O
(6)Department,O
of,O
Microbiology,O
",",O
Queen,O
Mary,O
Hospital,O
",",O
Pokfulam,O
",",O
Hong,O
Kong,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Medicine,O
",",O
Queen,O
Elizabeth,O
Hospital,O
",",O
Hong,O
Kong,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(8)Department,O
of,O
Pathology,O
",",O
Queen,O
Elizabeth,O
Hospital,O
",",O
Hong,O
Kong,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(9)Department,O
of,O
Medicine,O
",",O
Queen,O
Mary,O
Hospital,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
"
",O
Region,O
",",O
China,O
.,O
"
",O
(10)Department,O
of,O
Medicine,O
and,O
Geriatrics,O
",",O
Princess,O
Margaret,O
Hospital,O
",",O
Hong,O
Kong,O
"
",O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(11)Department,O
of,O
Clinical,O
Microbiology,O
and,O
Infection,O
",",O
The,O
University,O
of,O
Hong,O
"
",O
KongShenzhen,O
Hospital,O
",",O
Shenzhen,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
kyyuen@hku.hk,O
.,O
"

",O
On,O
31st,O
December,O
2019,O
",",O
the,O
World,O
Health,O
Organization,O
was,O
informed,O
of,O
a,O
cluster,O
of,O
"
",O
cases,O
of,O
pneumonia,O
of,O
unknown,O
etiology,O
in,O
Wuhan,O
",",O
China,O
.,O
Subsequent,O
investigations,O
"
",O
identified,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
now,O
named,O
as,O
severe,O
acute,O
respiratory,O
syndrome,O
"
",O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
from,O
the,O
affected,O
patients,O
.,O
Highly,O
sensitive,O
and,O
"
",O
specific,O
laboratory,O
diagnostics,O
are,O
important,O
for,O
controlling,O
the,O
rapidly,O
"
",O
evolving,O
SARSCoV2associated,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
epidemic,O
.,O
In,O
"
",O
this,O
study,O
",",O
we,O
developed,O
and,O
compared,O
the,O
performance,O
of,O
three,O
novel,O
realtime,O
"
",O
RTPCR,O
assays,O
targeting,O
the,O
RNAdependent,O
RNA,O
polymerase,O
(,O
RdRp,O
),O
helicase,O
(,O
Hel,O
),O
",",O
"
",O
spike,O
(,O
S,O
),O
",",O
and,O
nucleocapsid,O
(,O
N,O
),O
genes,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
with,O
that,O
of,O
the,O
reported,O
"
",O
RdRpP2,O
assay,O
which,O
is,O
used,O
in,O
>,O
30,O
European,O
laboratories,O
.,O
Among,O
the,O
three,O
novel,O
"
",O
assays,O
",",O
the,O
COVID19RdRp,O
Hel,O
assay,O
had,O
the,O
lowest,O
limit,O
of,O
detection,O
in,O
vitro,O
"
",O
(,O
1.8,O
TCID50,O
ml,O
with,O
genomic,O
RNA,O
and,O
11.2,O
RNA,O
copies,O
reaction,O
with,O
in,O
vitro,O
RNA,O
"
",O
transcripts,O
),O
.,O
Among,O
273,O
specimens,O
from,O
15,O
patients,O
with,O
laboratoryconfirmed,O
"
",O
COVID19,B-Disease_COVID-19
in,O
Hong,O
Kong,O
",",O
77,O
(,O
28.2,O
%,O
),O
were,O
positive,O
by,O
both,O
the,O
COVID19RdRp,O
Hel,O
and,O
"
",O
RdRpP2,O
assays,O
.,O
The,O
COVID19RdRp,O
Hel,O
assay,O
was,O
positive,O
for,O
an,O
additional,O
42,O
"
",O
RdRdP2negative,O
specimens,O
[,O
119,O
273,O
(,O
43.6,O
%,O
),O
vs,O
77,O
273,O
(,O
28.2,O
%,O
),O
",",O
P<0.001,O
],O
",",O
"
",O
including,O
29,O
120,O
(,O
24.2,O
%,O
),O
respiratory,O
tract,O
specimens,O
and,O
13,O
153,O
(,O
8.5,O
%,O
),O
"
",O
nonrespiratory,O
tract,O
specimens,O
.,O
The,O
mean,O
viral,O
load,O
of,O
these,O
specimens,O
was,O
"
",O
3.21,O
Ã—,O
104,O
RNA,O
copies,O
ml,O
(,O
range,O
",",O
2.21,O
Ã—,O
102,O
to,O
4.71,O
Ã—,O
105,O
RNA,O
copies,O
ml,O
),O
.,O
The,O
"
",O
COVID19RdRp,O
Hel,O
assay,O
did,O
not,O
crossreact,O
with,O
other,O
humanpathogenic,O
"
",O
coronaviruses,O
and,O
respiratory,O
pathogens,O
in,O
cell,O
culture,O
and,O
clinical,O
specimens,O
",",O
"
",O
whereas,O
the,O
RdRpP2,O
assay,O
crossreacted,O
with,O
SARSCoV,O
in,O
cell,O
culture,O
.,O
The,O
highly,O
"
",O
sensitive,O
and,O
specific,O
COVID19RdRp,O
Hel,O
assay,O
may,O
help,O
to,O
improve,O
the,O
laboratory,O
"
",O
diagnosis,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Copyright,O
Â©,O
2020,O
American,O
Society,O
for,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1128,O
JCM.0031020,O
"
",O
PMID,O
:,O
32132196,O
"


",O
323,O
.,O
Science,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
eabb2762,O
.,O
doi,O
:,O
10.1126,O
science.abb2762,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Structural,O
basis,O
for,O
the,O
recognition,O
of,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
by,O
fulllength,O
human,O
ACE2,O
.,O
"

",O
Yan,O
R(1)(2,O
),O
",",O
Zhang,O
Y(1)(2,O
),O
",",O
Li,O
Y(3,O
),O
",",O
Xia,O
L(1)(2,O
),O
",",O
Guo,O
Y(1)(2,O
),O
",",O
Zhou,O
Q(4)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Structural,O
Biology,O
of,O
Zhejiang,O
Province,O
",",O
Institute,O
of,O
"
",O
Biology,O
",",O
Westlake,O
Institute,O
for,O
Advanced,O
Study,O
",",O
18,O
Shilongshan,O
Road,O
",",O
Hangzhou,O
"
",O
310024,O
",",O
Zhejiang,O
Province,O
",",O
China,O
.,O
"
",O
(2)School,O
of,O
Life,O
Sciences,O
",",O
Westlake,O
University,O
",",O
18,O
Shilongshan,O
Road,O
",",O
Hangzhou,O
"
",O
310024,O
",",O
Zhejiang,O
Province,O
",",O
China,O
.,O
"
",O
(3)Beijing,O
Advanced,O
Innovation,O
Center,O
for,O
Structural,O
Biology,O
",",O
TsinghuaPeking,O
"
",O
Joint,O
Center,O
for,O
Life,O
Sciences,O
",",O
School,O
of,O
Life,O
Sciences,O
",",O
Tsinghua,O
University,O
",",O
"
",O
Beijing,O
100084,O
",",O
China,O
.,O
"
",O
(4)Key,O
Laboratory,O
of,O
Structural,O
Biology,O
of,O
Zhejiang,O
Province,O
",",O
Institute,O
of,O
"
",O
Biology,O
",",O
Westlake,O
Institute,O
for,O
Advanced,O
Study,O
",",O
18,O
Shilongshan,O
Road,O
",",O
Hangzhou,O
"
",O
310024,O
",",O
Zhejiang,O
Province,O
",",O
China,O
.,O
zhouqiang@westlake.edu.cn,O
.,O
"

",O
Angiotensinconverting,O
enzyme,O
2,O
(,O
ACE2,O
),O
is,O
the,O
cellular,O
receptor,O
for,O
SARS,O
"
",O
coronavirus,O
(,O
SARSCoV,O
),O
and,O
the,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
that,O
is,O
causing,O
the,O
"
",O
serious,O
epidemic,O
COVID19,B-Disease_COVID-19
.,O
Here,O
we,O
present,O
cryoEM,O
structures,O
of,O
fulllength,O
"
",O
human,O
ACE2,O
",",O
in,O
the,O
presence,O
of,O
a,O
neutral,O
amino,O
acid,O
transporter,O
B0AT1,O
",",O
with,O
or,O
"
",O
without,O
the,O
receptor,O
binding,O
domain,O
(,O
RBD,O
),O
of,O
the,O
surface,O
spike,O
glycoprotein,O
(,O
S,O
"
",O
protein,O
),O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
both,O
at,O
an,O
overall,O
resolution,O
of,O
2.9,O
Ã…,O
",",O
with,O
a,O
local,O
"
",O
resolution,O
of,O
3.5,O
Ã…,O
at,O
the,O
ACE2RBD,O
interface,O
.,O
The,O
ACE2B0AT1,O
complex,O
is,O
"
",O
assembled,O
as,O
a,O
dimer,O
of,O
heterodimers,O
",",O
with,O
the,O
Collectrinlike,O
domain,O
(,O
CLD,O
),O
of,O
"
",O
ACE2,O
mediating,O
homodimerization,O
.,O
The,O
RBD,O
is,O
recognized,O
by,O
the,O
extracellular,O
"
",O
peptidase,O
domain,O
(,O
PD,O
),O
of,O
ACE2,O
mainly,O
through,O
polar,O
residues,O
.,O
These,O
findings,O
"
",O
provide,O
important,O
insights,O
to,O
the,O
molecular,O
basis,O
for,O
coronavirus,O
recognition,O
and,O
"
",O
infection,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
",",O
American,O
Association,O
for,O
the,O
Advancement,O
of,O
Science,O
.,O
"

",O
DOI,O
:,O
10.1126,O
science.abb2762,O
"
",O
PMID,O
:,O
32132184,O
"


",O
324,O
.,O
BMJ,O
.,O
2020,O
Mar,O
4;368:m869,O
.,O
doi,O
:,O
10.1136,O
bmj.m869,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
hoarding,O
and,O
misuse,O
of,O
protective,O
gear,O
is,O
jeopardising,O
the,O
response,O
",",O
"
",O
WHO,O
warns,O
.,O
"

",O
Mahase,O
E(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m869,O
"
",O
PMID,O
:,O
32132096,O
"


",O
325,O
.,O
Infect,O
Control,O
Hosp,O
Epidemiol,O
.,O
2020,O
Mar,O
0.21875,O
.,O
doi,O
:,O
10.1017,O
ice.2020.62,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
The,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
infection,O
in,O
Hangzhou,O
:,O
An,O
experience,O
to,O
share,O
.,O
"

",O
Diao,O
M(#)(1,O
),O
",",O
Zhang,O
S(#)(2,O
),O
",",O
Chen,O
D(2,O
),O
",",O
Hu,O
W(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Affiliated,O
Hangzhou,O
First,O
People,O
's,O
"
",O
Hospital,O
",",O
Zhejiang,O
University,O
School,O
of,O
Medicine,O
",",O
Hangzhou,O
",",O
Zhejiang,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Ruijin,O
Hospital,O
",",O
Shanghai,O
Jiao,O
Tong,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
DOI,O
:,O
10.1017,O
ice.2020.62,O
"
",O
PMID,O
:,O
32131914,O
"


",O
326,O
.,O
Infect,O
Control,O
Hosp,O
Epidemiol,O
.,O
2020,O
Mar,O
0.294444444,O
.,O
doi,O
:,O
10.1017,O
ice.2020.58,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Escalating,O
infection,O
control,O
response,O
to,O
the,O
rapidly,O
evolving,O
epidemiology,O
of,O
the,O
"
",O
Coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
due,O
to,O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
Hong,O
Kong,O
.,O
"

",O
Cheng,O
VCC(#)(1)(2,O
),O
",",O
Wong,O
SC(#)(2,O
),O
",",O
Chen,O
JHK(1,O
),O
",",O
Yip,O
CCY(1,O
),O
",",O
Chuang,O
VWM(3,O
),O
",",O
Tsang,O
"
",O
OTY(4,O
),O
",",O
Sridhar,O
S(5,O
),O
",",O
Chan,O
JFW(5,O
),O
",",O
Ho,O
PL(5,O
),O
",",O
Yuen,O
KY(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Microbiology,O
",",O
Queen,O
Mary,O
Hospital,O
",",O
Hong,O
Kong,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(2)Infection,O
Control,O
Team,O
",",O
Queen,O
Mary,O
Hospital,O
",",O
Hong,O
Kong,O
West,O
Cluster,O
",",O
Hong,O
Kong,O
"
",O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(3)Quality,O
&,O
Safety,O
Division,O
(,O
Infection,O
",",O
Emergency,O
",",O
and,O
Contingency,O
),O
",",O
Hospital,O
"
",O
Authority,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(4)Infectious,O
Disease,O
Center,O
",",O
Hospital,O
Authority,O
",",O
Hong,O
Kong,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Microbiology,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
University,O
of,O
"
",O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
BACKGROUND,O
:,O
To,O
describe,O
the,O
infection,O
control,O
preparedness,O
for,O
Coronavirus,O
"
",O
Disease,O
(,O
COVID19,B-Disease_COVID-19
),O
due,O
to,O
SARSCoV2,B-Virus_SARS-CoV-2
[,O
previously,O
known,O
as,O
2019novel,O
coronavirus,O
],O
"
",O
in,O
the,O
first,O
42,O
days,O
after,O
announcement,O
of,O
a,O
cluster,O
of,O
pneumonia,O
in,O
China,O
",",O
on,O
31,O
"
",O
December,O
2019,O
(,O
day,O
1,O
),O
in,O
Hong,O
Kong,O
.,O
"
",O
METHODS,O
:,O
A,O
bundle,O
approach,O
of,O
active,O
and,O
enhanced,O
laboratory,O
surveillance,O
",",O
early,O
"
",O
airborne,O
infection,O
isolation,O
",",O
rapid,O
molecular,O
diagnostic,O
testing,O
",",O
and,O
contact,O
"
",O
tracing,O
for,O
healthcare,O
workers,O
(,O
HCWs,O
),O
with,O
unprotected,O
exposure,O
in,O
the,O
hospitals,O
"
",O
was,O
implemented,O
.,O
Epidemiological,O
characteristics,O
of,O
confirmed,O
cases,O
",",O
"
",O
environmental,O
and,O
air,O
samples,O
were,O
collected,O
and,O
analyzed,O
.,O
"
",O
RESULTS,O
:,O
From,O
day,O
1,O
to,O
day,O
42,O
",",O
fortytwo,O
(,O
3.3,O
%,O
),O
of,O
1275,O
patients,O
fulfilling,O
"
",O
active,O
(,O
n=29,O
),O
and,O
enhanced,O
laboratory,O
surveillance,O
(,O
n=13,O
),O
confirmed,O
to,O
have,O
"
",O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
The,O
number,O
of,O
locally,O
acquired,O
case,O
significantly,O
increased,O
"
",O
from,O
1,O
(,O
7.7,O
%,O
),O
of,O
13,O
[,O
day,O
22,O
to,O
day,O
32,O
],O
to,O
27,O
(,O
93.1,O
%,O
),O
of,O
29,O
confirmed,O
case,O
[,O
day,O
33,O
"
",O
to,O
day,O
42,O
],O
(,O
p<0.001,O
),O
.,O
Twentyeight,O
patients,O
(,O
66.6,O
%,O
),O
came,O
from,O
8,O
family,O
clusters,O
.,O
"
",O
Eleven,O
(,O
2.7,O
%,O
),O
of,O
413,O
HCWs,O
caring,O
these,O
confirmed,O
cases,O
were,O
found,O
to,O
have,O
"
",O
unprotected,O
exposure,O
requiring,O
quarantine,O
for,O
14,O
days,O
.,O
None,O
of,O
them,O
was,O
infected,O
"
",O
and,O
nosocomial,O
transmission,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
was,O
not,O
observed,O
.,O
Environmental,O
"
",O
surveillance,O
performed,O
in,O
a,O
patient,O
with,O
viral,O
load,O
of,O
3.3x106,O
copies,O
ml,O
(,O
pooled,O
"
",O
nasopharyngeal,O
 ,O
throat,O
swab,O
),O
and,O
5.9x106,O
copies,O
ml,O
(,O
saliva,O
),O
respectively,O
.,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
revealed,O
in,O
1,O
(,O
7.7,O
%,O
),O
of,O
13,O
environmental,O
samples,O
",",O
but,O
not,O
in,O
8,O
air,O
"
",O
samples,O
collected,O
at,O
a,O
distance,O
of,O
10,O
cm,O
from,O
patient,O
's,O
chin,O
with,O
or,O
without,O
"
",O
wearing,O
a,O
surgical,O
mask,O
.,O
"
",O
CONCLUSION,O
:,O
Appropriate,O
hospital,O
infection,O
control,O
measures,O
could,O
prevent,O
"
",O
nosocomial,O
transmission,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
DOI,O
:,O
10.1017,O
ice.2020.58,O
"
",O
PMID,O
:,O
32131908,O
"


",O
327,O
.,O
Infect,O
Control,O
Hosp,O
Epidemiol,O
.,O
2020,O
Mar,O
0.218055556,O
.,O
doi,O
:,O
10.1017,O
ice.2020.60,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Protecting,O
Chinese,O
Healthcare,O
Workers,O
While,O
Combating,O
the,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
.,O
"

",O
Zhou,O
P(1,O
),O
",",O
Huang,O
Z(2,O
),O
",",O
Xiao,O
Y(2)(3,O
),O
",",O
Huang,O
X(1,O
),O
",",O
Fan,O
XG(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Infection,O
Control,O
Centre,O
",",O
Xiangya,O
Hospital,O
",",O
Central,O
South,O
University,O
",",O
"
",O
Changsha,O
",",O
410008,O
",",O
China,O
.,O
"
",O
(2)Hunan,O
Key,O
Laboratory,O
of,O
Viral,O
Hepatitis,O
&,O
Department,O
of,O
Infectious,O
Diseases,O
"
",O
Xiangya,O
Hospital,O
",",O
Central,O
South,O
University,O
",",O
Changsha,O
",",O
410008,O
",",O
China,O
.,O
"
",O
(3)Burnet,O
Institute,O
",",O
St,O
Vincent,O
's,O
Hospital,O
Melbourne,O
",",O
and,O
University,O
of,O
"
",O
Melbourne,O
",",O
Melbourne,O
",",O
3065,O
",",O
Australia,O
.,O
"

",O
Hospitalassociated,O
transmission,O
is,O
an,O
important,O
route,O
of,O
spreading,O
the,O
2019,O
"
",O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
infection,O
and,O
pneumonia,O
(,O
Corona,B-Disease_COVID-19
Virus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
",",O
"
",O
COVID19,B-Disease_COVID-19
),O
[,O
1,O
],O
.,O
Healthcare,O
workers,O
(,O
HCWs,O
),O
are,O
at,O
high,O
risk,O
while,O
combating,O
"
",O
COVID19,B-Disease_COVID-19
at,O
the,O
very,O
frontline,O
",",O
and,O
nosocomial,O
outbreaks,O
among,O
HCWs,O
are,O
not,O
"
",O
unusual,O
in,O
similar,O
settings,O
;,O
the,O
2003,O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
"
",O
outbreak,O
led,O
to,O
over,O
966,O
HCW,O
infections,O
with,O
1.4,O
%,O
deaths,O
in,O
mainland,O
China,O
[,O
2,O
],O
.,O
"
",O
As,O
of,O
11,O
February,O
2020,O
",",O
3019,O
HCWs,O
might,O
have,O
been,O
infected,O
with,O
2019nCov,B-Virus_SARS-CoV-2
in,O
"
",O
China,O
",",O
1716,O
HCW,O
cases,O
were,O
confirmed,O
by,O
nucleic,O
acid,O
testing[3,O
],O
",",O
and,O
at,O
least,O
6,O
"
",O
HCWs,O
died,O
",",O
including,O
the,O
famous,O
whistleblower,O
Dr,O
Li,O
Wenliang,O
.,O
In,O
view,O
of,O
this,O
"
",O
severe,O
situation,O
",",O
we,O
are,O
recommending,O
urgent,O
interventions,O
to,O
help,O
to,O
protect,O
"
",O
HCWs,O
.,O
"

",O
DOI,O
:,O
10.1017,O
ice.2020.60,O
"
",O
PMID,O
:,O
32131906,O
"


",O
328,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Mar,O
2;9(3,O
),O
.,O
pii,O
:,O
E674,O
.,O
doi,O
:,O
10.339,O
jcm9030674,O
.,O
"

",O
Optimization,O
Method,O
for,O
Forecasting,O
Confirmed,O
Cases,O
of,O
COVID19,B-Disease_COVID-19
in,O
China,O
.,O
"

",O
AlQaness,O
MAA(1,O
),O
",",O
Ewees,O
AA(2)(3,O
),O
",",O
Fan,O
H(1,O
),O
",",O
Abd,O
El,O
Aziz,O
M(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
for,O
Information,O
Engineering,O
in,O
Surveying,O
",",O
Mapping,O
and,O
"
",O
Remote,O
Sensing,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
430079,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
eSystems,O
",",O
University,O
of,O
Bisha,O
",",O
Bisha,O
61922,O
",",O
Saudi,O
Arabia,O
.,O
"
",O
(3)Department,O
of,O
Computer,O
",",O
Damietta,O
University,O
",",O
Damietta,O
34517,O
",",O
Egypt,O
.,O
"
",O
(4)Department,O
of,O
Mathematics,O
",",O
Faculty,O
of,O
Science,O
",",O
Zagazig,O
University,O
",",O
Zagazig,O
"
",O
44519,O
",",O
Egypt,O
.,O
"

",O
In,O
December,O
2019,O
",",O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
called,O
COVID19,B-Disease_COVID-19
",",O
was,O
discovered,O
in,O
Wuhan,O
",",O
"
",O
China,O
",",O
and,O
has,O
spread,O
to,O
different,O
cities,O
in,O
China,O
as,O
well,O
as,O
to,O
24,O
other,O
"
",O
countries,O
.,O
The,O
number,O
of,O
confirmed,O
cases,O
is,O
increasing,O
daily,O
and,O
reached,O
34598,O
"
",O
on,O
8,O
February,O
2020,O
.,O
In,O
the,O
current,O
study,O
",",O
we,O
present,O
a,O
new,O
forecasting,O
model,O
to,O
"
",O
estimate,O
and,O
forecast,O
the,O
number,O
of,O
confirmed,O
cases,O
of,O
COVID19,B-Disease_COVID-19
in,O
the,O
upcoming,O
"
",O
ten,O
days,O
based,O
on,O
the,O
previously,O
confirmed,O
cases,O
recorded,O
in,O
China,O
.,O
The,O
proposed,O
"
",O
model,O
is,O
an,O
improved,O
adaptive,O
neurofuzzy,O
inference,O
system,O
(,O
ANFIS,O
),O
using,O
an,O
"
",O
enhanced,O
flower,O
pollination,O
algorithm,O
(,O
FPA,O
),O
by,O
using,O
the,O
salp,O
swarm,O
algorithm,O
"
",O
(,O
SSA,O
),O
.,O
In,O
general,O
",",O
SSA,O
is,O
employed,O
to,O
improve,O
FPA,O
to,O
avoid,O
its,O
drawbacks,O
(,O
i.e.,O
",",O
"
",O
getting,O
trapped,O
at,O
the,O
local,O
optima,O
),O
.,O
The,O
main,O
idea,O
of,O
the,O
proposed,O
model,O
",",O
called,O
"
",O
FPASSAANFIS,O
",",O
is,O
to,O
improve,O
the,O
performance,O
of,O
ANFIS,O
by,O
determining,O
the,O
"
",O
parameters,O
of,O
ANFIS,O
using,O
FPASSA,O
.,O
The,O
FPASSAANFIS,O
model,O
is,O
evaluated,O
using,O
the,O
"
",O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
official,O
data,O
of,O
the,O
outbreak,O
of,O
the,O
COVID19,B-Disease_COVID-19
to,O
"
",O
forecast,O
the,O
confirmed,O
cases,O
of,O
the,O
upcoming,O
ten,O
days,O
.,O
More,O
so,O
",",O
the,O
FPASSAANFIS,O
"
",O
model,O
is,O
compared,O
to,O
several,O
existing,O
models,O
",",O
and,O
it,O
showed,O
better,O
performance,O
in,O
"
",O
terms,O
of,O
Mean,O
Absolute,O
Percentage,O
Error,O
(,O
MAPE,O
),O
",",O
Root,O
Mean,O
Squared,O
Relative,O
Error,O
"
",O
(,O
RMSRE,O
),O
",",O
Root,O
Mean,O
Squared,O
Relative,O
Error,O
(,O
RMSRE,O
),O
",",O
coefficient,O
of,O
determination,O
(,O
"
",O
R,O
2,O
),O
",",O
and,O
computing,O
time,O
.,O
Furthermore,O
",",O
we,O
tested,O
the,O
proposed,O
model,O
using,O
two,O
"
",O
different,O
datasets,O
of,O
weekly,O
influenza,O
confirmed,O
cases,O
in,O
two,O
countries,O
",",O
namely,O
"
",O
the,O
USA,O
and,O
China,O
.,O
The,O
outcomes,O
also,O
showed,O
good,O
performances,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9030674,O
"
",O
PMID,O
:,O
32131537,O
"


",O
329,O
.,O
BJOG,O
.,O
2020,O
Mar,O
4,O
.,O
doi,O
:,O
10.1111,O
14710528.16,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
From,O
the,O
frontlines,O
of,O
COVID19,B-Disease_COVID-19
 ,O
How,O
prepared,O
are,O
we,O
as,O
obstetricians,O
:,O
a,O
"
",O
commentary,O
.,O
"

",O
Chua,O
MSQ(1,O
),O
",",O
Lee,O
JCS(2,O
),O
",",O
Sulaiman,O
S(1,O
),O
",",O
Tan,O
HK(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Obstetrics,O
and,O
Gynaecology,O
",",O
KK,O
Women,O
's,O
and,O
Children,O
's,O
Hospital,O
",",O
"
",O
Singapore,O
",",O
100,O
Bukit,O
Timah,O
Road,O
",",O
Singapore,O
",",O
229899,O
.,O
"
",O
(2)Department,O
of,O
Urogynaecology,O
",",O
KK,O
Women,O
's,O
and,O
Children,O
's,O
Hospital,O
",",O
Singapore,O
",",O
"
",O
100,O
Bukit,O
Timah,O
Road,O
",",O
Singapore,O
",",O
229899,O
.,O
"
",O
(3)Division,O
of,O
Obstetrics,O
and,O
Gynaecology,O
",",O
KK,O
Women,O
's,O
and,O
Children,O
's,O
Hospital,O
",",O
"
",O
Singapore,O
",",O
100,O
Bukit,O
Timah,O
Road,O
",",O
Singapore,O
",",O
229899,O
.,O
"

",O
The,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
has,O
declared,O
the,O
outbreak,O
of,O
novel,O
"
",O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
 ,O
now,O
known,O
as,O
Coronavirus,O
Disease,O
(COVID19)1,O
 ,O
as,O
a,O
"
",O
global,O
health,O
emergency,O
.,O
Singapore,O
currently,O
stands,O
as,O
the,O
country,O
with,O
the,O
"
",O
highest,O
number,O
of,O
reported,O
cases,O
of,O
COVID19,B-Disease_COVID-19
outside,O
of,O
China2,O
",",O
excluding,O
"
",O
patients,O
on,O
a,O
cruise,O
ship,O
offshore,O
of,O
Japan,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1111,O
14710528.16,O
"
",O
PMID,O
:,O
32131142,O
"


",O
330,O
.,O
Antiviral,O
Res,O
.,O
2020,O
Mar,O
1;177:104759,O
.,O
doi,O
:,O
10.1016,O
j.antiviral.2020.104759,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
A,O
potential,O
role,O
for,O
integrins,O
in,O
host,O
cell,O
entry,O
by,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Sigrist,O
CJ(1,O
),O
",",O
Bridge,O
A(2,O
),O
",",O
Le,O
Mercier,O
P(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)SwissProt,O
Group,O
",",O
SIB,O
Swiss,O
Institute,O
of,O
Bioinformatics,O
",",O
Switzerland,O
.,O
"
",O
Electronic,O
address,O
:,O
christian.sigrist@sib.swiss,O
.,O
"
",O
(2)SwissProt,O
Group,O
",",O
SIB,O
Swiss,O
Institute,O
of,O
Bioinformatics,O
",",O
Switzerland,O
.,O
"
",O
Electronic,O
address,O
:,O
alan.bridge@sib.swiss,O
.,O
"
",O
(3)SwissProt,O
Group,O
",",O
SIB,O
Swiss,O
Institute,O
of,O
Bioinformatics,O
",",O
Switzerland,O
.,O
"
",O
Electronic,O
address,O
:,O
philippe.lemercier@sib.swiss,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.antiviral.2020.104759,O
"
",O
PMID,O
:,O
32130973,O
"


",O
331,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Mar,O
5;382(10):e19,O
.,O
doi,O
:,O
10.1056,O
NEJMe2004244,O
.,O
"

",O
Audio,O
Interview,O
:,O
What,O
Clinicians,O
Need,O
to,O
Know,O
in,O
Diagnosing,O
and,O
Treating,O
"
",O
Covid19,B-Disease_COVID-19
.,O
"

",O
Rubin,O
EJ,O
",",O
Baden,O
LR,O
",",O
Morrissey,O
S.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMe2004244,O
"
",O
PMID,O
:,O
32130833,O
"


",O
332,O
.,O
J,O
Exp,O
Med,O
.,O
2020,O
May,O
4;217(5,O
),O
.,O
pii,O
:,O
e20191174,O
.,O
doi,O
:,O
10.1084,O
jem.20191174,O
.,O
"

",O
USP22,O
promotes,O
IRF3,O
nuclear,O
translocation,O
and,O
antiviral,O
responses,O
by,O
"
",O
deubiquitinating,O
the,O
importin,O
protein,O
KPNA2,O
.,O
"

",O
Cai,O
Z(1)(2,O
),O
",",O
Zhang,O
MX(1)(2,O
),O
",",O
Tang,O
Z(1)(2,O
),O
",",O
Zhang,O
Q(1)(2,O
),O
",",O
Ye,O
J(1)(2,O
),O
",",O
Xiong,O
"
",O
TC(1)(2,O
),O
",",O
Zhang,O
ZD(1)(2,O
),O
",",O
Zhong,O
B(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Department,O
of,O
"
",O
Gastrointestinal,O
Surgery,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Immunology,O
",",O
Frontier,O
Science,O
Center,O
for,O
Immunology,O
and,O
"
",O
Metabolism,O
",",O
Medical,O
Research,O
Institute,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
USP22,O
is,O
a,O
cytoplasmic,O
and,O
nuclear,O
deubiquitinating,O
enzyme,O
",",O
and,O
the,O
functions,O
of,O
"
",O
cytoplasmic,O
USP22,O
are,O
unclear,O
.,O
Here,O
",",O
we,O
discovered,O
that,O
cytoplasmic,O
USP22,O
"
",O
promoted,O
nuclear,O
translocation,O
of,O
IRF3,O
by,O
deubiquitianting,O
and,O
stabilizing,O
KPNA2,O
"
",O
after,O
viral,O
infection,O
.,O
Viral,O
infection,O
induced,O
USP22IRF3,O
association,O
in,O
the,O
"
",O
cytoplasm,O
in,O
a,O
KPNA2depedent,O
manner,O
",",O
and,O
knockdown,O
or,O
knockout,O
of,O
USP22,O
or,O
KPNA2,O
"
",O
impaired,O
IRF3,O
nuclear,O
translocation,O
and,O
expression,O
of,O
downstream,O
genes,O
after,O
"
",O
viral,O
infection,O
.,O
Consistently,O
",",O
CreER,O
Usp22fl,O
fl,O
or,O
Lyz2Cre,O
Usp22fl,O
fl,O
mice,O
"
",O
produced,O
decreased,O
levels,O
of,O
type,O
I,O
IFNs,O
after,O
viral,O
infection,O
and,O
exhibited,O
"
",O
increased,O
susceptibility,O
to,O
lethal,O
viral,O
infection,O
compared,O
with,O
the,O
respective,O
"
",O
control,O
littermates,O
.,O
Mechanistically,O
",",O
USP22,O
deubiquitinated,O
and,O
stabilized,O
KPNA2,O
"
",O
after,O
viral,O
infection,O
to,O
facilitate,O
efficient,O
nuclear,O
translocation,O
of,O
IRF3,O
.,O
"
",O
Reconstitution,O
of,O
KPNA2,O
into,O
USP22,O
knockout,O
cells,O
restored,O
virustriggered,O
"
",O
nuclear,O
translocation,O
of,O
IRF3,O
and,O
cellular,O
antiviral,O
responses,O
.,O
These,O
findings,O
"
",O
define,O
a,O
previously,O
unknown,O
function,O
of,O
cytoplasmic,O
USP22,O
and,O
establish,O
a,O
"
",O
mechanistic,O
link,O
between,O
USP22,O
and,O
IRF3,O
nuclear,O
translocation,O
that,O
expands,O
"
",O
potential,O
therapeutic,O
strategies,O
for,O
infectious,O
diseases,O
.,O
"

",O
Â©,O
2020,O
Cai,O
et,O
al.,O
"

",O
DOI,O
:,O
10.1084,O
jem.20191174,O
"
",O
PMID,O
:,O
32130408,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Disclosures,O
:,O
The,O
authors,O
declare,O
no,O
competing,O
"
",O
interests,O
exist,O
.,O
"


",O
333,O
.,O
AJR,O
Am,O
J,O
Roentgenol,O
.,O
2020,O
Mar,O
0.177083333,O
.,O
doi,O
:,O
10.2214,O
AJR.20.22927,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
DÃ©jÃ ,O
Vu,O
or,O
Jamais,O
Vu,O
?,O
How,O
the,O
Severe,O
Acute,O
Respiratory,O
Syndrome,O
Experience,O
"
",O
Influenced,O
a,O
Singapore,O
Radiology,O
Department,O
's,O
Response,O
to,O
the,O
Coronavirus,O
Disease,O
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
Epidemic,O
.,O
"

",O
Cheng,O
LT(1,O
),O
",",O
Chan,O
LP(1,O
),O
",",O
Tan,O
BH(2,O
),O
",",O
Chen,O
RC(1,O
),O
",",O
Tay,O
KH(3,O
),O
",",O
Ling,O
ML(4,O
),O
",",O
Tan,O
BS(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Diagnostic,O
Radiology,O
",",O
Singapore,O
General,O
Hospital,O
",",O
Outram,O
Rd,O
",",O
"
",O
Singapore,O
169608,O
",",O
Republic,O
of,O
Singapore,O
.,O
"
",O
(2)Department,O
of,O
Infectious,O
Diseases,O
",",O
Singapore,O
General,O
Hospital,O
",",O
Singapore,O
",",O
"
",O
Republic,O
of,O
Singapore,O
.,O
"
",O
(3)Department,O
of,O
Vascular,O
and,O
Interventional,O
Radiology,O
",",O
Singapore,O
General,O
"
",O
Hospital,O
",",O
Singapore,O
",",O
Republic,O
of,O
Singapore,O
.,O
"
",O
(4)Infection,O
Prevention,O
and,O
Epidemiology,O
",",O
Singapore,O
General,O
Hospital,O
",",O
Singapore,O
",",O
"
",O
Republic,O
of,O
Singapore,O
.,O
"
",O
(5)Division,O
of,O
Radiological,O
Sciences,O
",",O
Singapore,O
General,O
Hospital,O
",",O
Singapore,O
",",O
"
",O
Republic,O
of,O
Singapore,O
.,O
"

",O
OBJECTIVE,O
.,O
This,O
article,O
shares,O
the,O
ground,O
operational,O
perspective,O
of,O
how,O
a,O
"
",O
tertiary,O
hospital,O
radiology,O
department,O
in,O
Singapore,O
is,O
responding,O
to,O
the,O
"
",O
coronavirus,O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
epidemic,O
.,O
This,O
same,O
department,O
was,O
also,O
deeply,O
"
",O
impacted,O
by,O
the,O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
outbreak,O
in,O
2003,O
.,O
"
",O
CONCLUSION,O
.,O
Though,O
similar,O
to,O
SARS,O
",",O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
has,O
several,O
"
",O
differences,O
.,O
We,O
share,O
how,O
lessons,O
from,O
2003,O
are,O
applied,O
and,O
modified,O
in,O
our,O
"
",O
ongoing,O
operational,O
response,O
to,O
this,O
evolving,O
novel,O
pathogen,O
.,O
"

",O
DOI,O
:,O
10.2214,O
AJR.20.22927,O
"
",O
PMID,O
:,O
32130047,O
"


",O
334,O
.,O
AJR,O
Am,O
J,O
Roentgenol,O
.,O
2020,O
Mar,O
0.178472222,O
.,O
doi,O
:,O
10.2214,O
AJR.20.22954,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
:,O
Role,O
of,O
Chest,O
CT,O
in,O
Diagnosis,O
and,O
"
",O
Management,O
.,O
"

",O
Li,O
Y(1,O
),O
",",O
Xia,O
L(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Tongji,O
Hospital,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
1095,O
Jiefang,O
Ave,O
",",O
Wuhan,O
",",O
Hubei,O
430030,O
",",O
China,O
.,O
"

",O
OBJECTIVE,O
.,O
The,O
objective,O
of,O
our,O
study,O
was,O
to,O
determine,O
the,O
misdiagnosis,O
rate,O
of,O
"
",O
radiologists,O
for,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
and,O
evaluate,O
the,O
performance,O
"
",O
of,O
chest,O
CT,O
in,O
the,O
diagnosis,O
and,O
management,O
of,O
COVID19,B-Disease_COVID-19
.,O
The,O
CT,O
features,O
of,O
"
",O
COVID19,B-Disease_COVID-19
are,O
reported,O
and,O
compared,O
with,O
the,O
CT,O
features,O
of,O
other,O
viruses,O
to,O
"
",O
familiarize,O
radiologists,O
with,O
possible,O
CT,O
patterns,O
.,O
MATERIALS,O
AND,O
METHODS,O
.,O
This,O
"
",O
study,O
included,O
the,O
first,O
51,O
patients,O
with,O
a,O
diagnosis,O
of,O
COVID19,B-Disease_COVID-19
infection,O
"
",O
confirmed,O
by,O
nucleic,O
acid,O
testing,O
(,O
23,O
women,O
and,O
28,O
men,O
;,O
age,O
range,O
",",O
2683,O
years,O
),O
"
",O
and,O
two,O
patients,O
with,O
adenovirus,O
(,O
one,O
woman,O
and,O
one,O
man,O
;,O
ages,O
",",O
58,O
and,O
66,O
years,O
),O
.,O
"
",O
We,O
reviewed,O
the,O
clinical,O
information,O
",",O
CT,O
images,O
",",O
and,O
corresponding,O
image,O
reports,O
"
",O
of,O
these,O
53,O
patients,O
.,O
The,O
CT,O
images,O
included,O
images,O
from,O
99,O
chest,O
CT,O
"
",O
examinations,O
",",O
including,O
initial,O
and,O
followup,O
CT,O
studies,O
.,O
We,O
compared,O
the,O
image,O
"
",O
reports,O
of,O
the,O
initial,O
CT,O
study,O
with,O
the,O
laboratory,O
test,O
results,O
and,O
identified,O
"
",O
CT,O
patterns,O
suggestive,O
of,O
viral,O
infection,O
.,O
RESULTS,O
.,O
COVID19,B-Disease_COVID-19
was,O
misdiagnosed,O
as,O
"
",O
a,O
common,O
infection,O
at,O
the,O
initial,O
CT,O
study,O
in,O
two,O
inpatients,O
with,O
underlying,O
"
",O
disease,O
and,O
COVID19,B-Disease_COVID-19
.,O
Viral,O
pneumonia,O
was,O
correctly,O
diagnosed,O
at,O
the,O
initial,O
CT,O
"
",O
study,O
in,O
the,O
remaining,O
49,O
patients,O
with,O
COVID19,B-Disease_COVID-19
and,O
two,O
patients,O
with,O
"
",O
adenovirus,O
.,O
These,O
patients,O
were,O
isolated,O
and,O
obtained,O
treatment,O
.,O
Groundglass,O
"
",O
opacities,O
(,O
GGOs,O
),O
and,O
consolidation,O
with,O
or,O
without,O
vascular,O
enlargement,O
",",O
"
",O
interlobular,O
septal,O
thickening,O
",",O
and,O
air,O
bronchogram,O
sign,O
are,O
common,O
CT,O
features,O
"
",O
of,O
COVID19,B-Disease_COVID-19
.,O
The,O
The,O
"""",O
reversed,O
halo,O
"""",O
sign,O
and,O
pulmonary,O
nodules,O
with,O
a,O
halo,O
sign,O
"
",O
are,O
uncommon,O
CT,O
features,O
.,O
The,O
CT,O
findings,O
of,O
COVID19,B-Disease_COVID-19
overlap,O
with,O
the,O
CT,O
"
",O
findings,O
of,O
adenovirus,O
infection,O
.,O
There,O
are,O
differences,O
as,O
well,O
as,O
similarities,O
"
",O
in,O
the,O
CT,O
features,O
of,O
COVID19,B-Disease_COVID-19
compared,O
with,O
those,O
of,O
the,O
severe,O
acute,O
"
",O
respiratory,O
syndrome,O
.,O
CONCLUSION,O
.,O
We,O
found,O
that,O
chest,O
CT,O
had,O
a,O
low,O
rate,O
of,O
missed,O
"
",O
diagnosis,O
of,O
COVID19,B-Disease_COVID-19
(,O
3.9,O
%,O
",",O
2,O
51,O
),O
and,O
may,O
be,O
useful,O
as,O
a,O
standard,O
method,O
for,O
the,O
"
",O
rapid,O
diagnosis,O
of,O
COVID19,B-Disease_COVID-19
to,O
optimize,O
the,O
management,O
of,O
patients,O
.,O
However,O
",",O
CT,O
"
",O
is,O
still,O
limited,O
for,O
identifying,O
specific,O
viruses,O
and,O
distinguishing,O
between,O
"
",O
viruses,O
.,O
"

",O
DOI,O
:,O
10.2214,O
AJR.20.22954,O
"
",O
PMID,O
:,O
32130038,O
"


",O
335,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
ciaa203,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa203,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Genomic,O
diversity,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
patients,O
.,O
"

",O
Shen,O
Z(1)(2,O
),O
",",O
Xiao,O
Y(3,O
),O
",",O
Kang,O
L(1)(2,O
),O
",",O
Ma,O
W(1)(2,O
),O
",",O
Shi,O
L(1)(2,O
),O
",",O
Zhang,O
L(1,O
),O
",",O
Zhou,O
"
",O
Z(4,O
),O
",",O
Yang,O
J(1)(2,O
),O
",",O
Zhong,O
J(1)(2,O
),O
",",O
Yang,O
D(5,O
),O
",",O
Guo,O
L(3,O
),O
",",O
Zhang,O
G(6,O
),O
",",O
Li,O
H(7,O
),O
",",O
Xu,O
"
",O
Y(5,O
),O
",",O
Chen,O
M(8,O
),O
",",O
Gao,O
Z(5,O
),O
",",O
Wang,O
J(3,O
),O
",",O
Ren,O
L(3,O
),O
",",O
Li,O
M(1)(9,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Genomic,O
and,O
Precision,O
Medicine,O
",",O
Beijing,O
Institute,O
of,O
"
",O
Genomics,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
and,O
China,O
National,O
Center,O
for,O
"
",O
Bioinformation,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)National,O
Health,O
Commission,O
of,O
the,O
People,O
's,O
Republic,O
of,O
China,O
Key,O
Laboratory,O
of,O
"
",O
Systems,O
Biology,O
of,O
Pathogens,O
and,O
Christophe,O
MÃ©rieux,O
Laboratory,O
",",O
Institute,O
of,O
"
",O
Pathogen,O
Biology,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
&,O
Peking,O
Union,O
Medical,O
"
",O
College,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)Biomedical,O
Pioneering,O
Innovation,O
Center,O
",",O
Beijing,O
Advanced,O
Innovation,O
Center,O
"
",O
for,O
Genomics,O
",",O
PekingTsinghua,O
Center,O
for,O
Life,O
Sciences,O
",",O
Peking,O
University,O
Genome,O
"
",O
Editing,O
Research,O
Center,O
",",O
State,O
Key,O
Laboratory,O
of,O
Protein,O
and,O
Plant,O
Gene,O
Research,O
",",O
"
",O
School,O
of,O
Life,O
Sciences,O
",",O
Peking,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Peking,O
University,O
"
",O
People,O
's,O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(6)National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
Guangdong,O
Key,O
"
",O
Laboratory,O
for,O
Emerging,O
Infectious,O
Diseases,O
",",O
Shenzhen,O
Third,O
People,O
's,O
Hospital,O
",",O
"
",O
Southern,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Shenzhen,O
",",O
China,O
.,O
"
",O
(7)Fujian,O
Provincial,O
Hospital,O
",",O
Fujian,O
",",O
PR,O
China,O
.,O
"
",O
(8)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
the,O
First,O
Affiliated,O
"
",O
Hospital,O
of,O
Xi'an,O
Jiaotong,O
University,O
",",O
Shaanxi,O
Province,O
",",O
P.R.,O
China,O
.,O
"
",O
(9)Center,O
for,O
Excellence,O
in,O
Animal,O
Evolution,O
and,O
Genetics,O
",",O
Chinese,O
Academy,O
of,O
"
",O
Sciences,O
",",O
Kunming,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
has,O
infected,O
more,O
than,O
75000,O
"
",O
individuals,O
and,O
spread,O
to,O
over,O
20,O
countries,O
.,O
It,O
is,O
still,O
unclear,O
how,O
fast,O
the,O
"
",O
virus,O
evolved,O
and,O
how,O
the,O
virus,O
interacts,O
with,O
other,O
microorganisms,O
in,O
the,O
lung,O
.,O
"
",O
METHODS,O
:,O
We,O
have,O
conducted,O
metatranscriptome,O
sequencing,O
for,O
the,O
bronchoalveolar,O
"
",O
lavage,O
fluid,O
of,O
eight,O
SARSCoV2,B-Virus_SARS-CoV-2
patients,O
",",O
25,O
communityacquired,O
pneumonia,O
(,O
CAP,O
),O
"
",O
patients,O
",",O
and,O
20,O
healthy,O
controls,O
.,O
"
",O
RESULTS,O
:,O
The,O
median,O
number,O
of,O
intrahost,O
variants,O
was,O
14,O
in,O
SARSCoV2,B-Virus_SARS-CoV-2
infected,O
"
",O
patients,O
",",O
which,O
ranged,O
between,O
0,O
and,O
51,O
in,O
different,O
samples,O
.,O
The,O
distribution,O
of,O
"
",O
variants,O
on,O
genes,O
was,O
similar,O
to,O
those,O
observed,O
in,O
the,O
population,O
data,O
(,O
110,O
"
",O
sequences,O
),O
.,O
However,O
",",O
very,O
few,O
intrahost,O
variants,O
were,O
observed,O
in,O
the,O
population,O
"
",O
as,O
polymorphism,O
",",O
implying,O
either,O
a,O
bottleneck,O
or,O
purifying,O
selection,O
involved,O
in,O
"
",O
the,O
transmission,O
of,O
the,O
virus,O
",",O
or,O
a,O
consequence,O
of,O
the,O
limited,O
diversity,O
"
",O
represented,O
in,O
the,O
current,O
polymorphism,O
data,O
.,O
Although,O
current,O
evidence,O
did,O
not,O
"
",O
support,O
the,O
transmission,O
of,O
intrahost,O
variants,O
in,O
a,O
persontoperson,O
spread,O
",",O
the,O
"
",O
risk,O
should,O
not,O
be,O
overlooked,O
.,O
The,O
microbiota,O
in,O
SARSCoV2,B-Virus_SARS-CoV-2
infected,O
patients,O
was,O
"
",O
similar,O
to,O
those,O
in,O
CAP,O
",",O
either,O
dominated,O
by,O
the,O
pathogens,O
or,O
with,O
elevated,O
"
",O
levels,O
of,O
oral,O
and,O
upper,O
respiratory,O
commensal,O
bacteria,O
.,O
"
",O
CONCLUSION,O
:,O
SARSCoV2,B-Virus_SARS-CoV-2
evolves,O
in,O
vivo,O
after,O
infection,O
",",O
which,O
may,O
affect,O
its,O
"
",O
virulence,O
",",O
infectivity,O
",",O
and,O
transmissibility,O
.,O
Although,O
how,O
the,O
intrahost,O
variant,O
"
",O
spreads,O
in,O
the,O
population,O
is,O
still,O
elusive,O
",",O
it,O
is,O
necessary,O
to,O
strengthen,O
the,O
"
",O
surveillance,O
of,O
the,O
viral,O
evolution,O
in,O
the,O
population,O
and,O
associated,O
clinical,O
"
",O
changes,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa203,O
"
",O
PMID,O
:,O
32129843,O
"


",O
336,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
4,O
.,O
pii,O
:,O
ciaa213,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa213,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
A,O
glimpse,O
into,O
the,O
origins,O
of,O
genetic,O
diversity,O
in,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Wertheim,O
JO(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medicine,O
",",O
University,O
of,O
California,O
San,O
Diego,O
",",O
San,O
Diego,O
",",O
CA,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa213,O
"
",O
PMID,O
:,O
32129842,O
"


",O
337,O
.,O
JAMA,O
.,O
2020,O
Mar,O
4,O
.,O
doi,O
:,O
10.1001,O
jama.2020.3227,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Air,O
",",O
Surface,O
Environmental,O
",",O
and,O
Personal,O
Protective,O
Equipment,O
Contamination,O
by,O
"
",O
Severe,B-Virus_SARS-CoV-2
Acute,I-Virus_SARS-CoV-2
Respiratory,I-Virus_SARS-CoV-2
Syndrome,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
From,O
a,O
Symptomatic,O
"
",O
Patient,O
.,O
"

",O
Ong,O
SWX(1,O
),O
",",O
Tan,O
YK(2,O
),O
",",O
Chia,O
PY(1,O
),O
",",O
Lee,O
TH(1,O
),O
",",O
Ng,O
OT(1,O
),O
",",O
Wong,O
MSY(2,O
),O
",",O
Marimuthu,O
"
",O
K(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Centre,O
for,O
Infectious,O
Diseases,O
",",O
Singapore,O
.,O
"
",O
(2)DSO,O
National,O
Laboratories,O
",",O
Singapore,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.3227,O
"
",O
PMID,O
:,O
32129805,O
"


",O
338,O
.,O
Can,O
Assoc,O
Radiol,O
J.,O
2020,O
Mar,O
4:846537120913497,O
.,O
doi,O
:,O
10.1177,O
8.46537E+14,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
:,O
What,O
Can,O
We,O
Learn,O
From,O
Stories,O
From,O
the,O
Trenches,O
?,O
"

",O
Patlas,O
MN(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
McMaster,O
University,O
",",O
Hamilton,O
",",O
Ontario,O
",",O
Canada,O
.,O
"

",O
DOI,O
:,O
10.1177,O
8.46537E+14,O
"
",O
PMID,O
:,O
32129672,O
"


",O
339,O
.,O
Can,O
Assoc,O
Radiol,O
J.,O
2020,O
Mar,O
4:846537120913033,O
.,O
doi,O
:,O
10.1177,O
8.46537E+14,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
CT,O
Imaging,O
and,O
Differential,O
Diagnosis,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Dai,O
WC(1)(2,O
),O
",",O
Zhang,O
HW(3,O
),O
",",O
Yu,O
J(3,O
),O
",",O
Xu,O
HJ(3,O
),O
",",O
Chen,O
H(3,O
),O
",",O
Luo,O
SP(3,O
),O
",",O
Zhang,O
H(3,O
),O
",",O
"
",O
Liang,O
LH(3,O
),O
",",O
Wu,O
XL(3,O
),O
",",O
Lei,O
Y(3,O
),O
",",O
Lin,O
F(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Guangzhou,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(2)Imaging,O
Department,O
",",O
Fifth,O
People,O
's,O
Hospital,O
of,O
Longgang,O
District,O
",",O
Shenzhen,O
",",O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Radiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Shenzhen,O
University,O
",",O
"
",O
Health,O
Science,O
Center,O
",",O
Shenzhen,O
Second,O
People,O
's,O
Hospital,O
",",O
Shenzhen,O
",",O
China,O
.,O
"

",O
Since,O
the,O
beginning,O
of,O
2020,O
",",O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
has,O
spread,O
"
",O
throughout,O
China,O
.,O
This,O
study,O
explains,O
the,O
findings,O
from,O
lung,O
computed,O
tomography,O
"
",O
images,O
of,O
some,O
patients,O
with,O
COVID19,B-Disease_COVID-19
treated,O
in,O
this,O
medical,O
institution,O
and,O
"
",O
discusses,O
the,O
difference,O
between,O
COVID19,B-Disease_COVID-19
and,O
other,O
lung,O
diseases,O
.,O
"

",O
DOI,O
:,O
10.1177,O
8.46537E+14,O
"
",O
PMID,O
:,O
32129670,O
"


",O
340,O
.,O
Drug,O
Dev,O
Res,O
.,O
2020,O
Mar,O
4,O
.,O
doi,O
:,O
10.1002,O
ddr.21656,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Angiotensin,O
receptor,O
blockers,O
as,O
tentative,O
SARSCoV2,B-Virus_SARS-CoV-2
therapeutics,O
.,O
"

",O
Gurwitz,O
D(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Human,O
Molecular,O
Genetics,O
and,O
Biochemistry,O
",",O
Sackler,O
Faculty,O
of,O
"
",O
Medicine,O
",",O
TelAviv,O
University,O
",",O
TelAviv,O
",",O
Israel,O
.,O
"

",O
At,O
the,O
time,O
of,O
writing,O
this,O
commentary,O
(,O
February,O
2020,O
),O
",",O
the,O
coronavirus,O
COVID19,B-Disease_COVID-19
"
",O
epidemic,O
has,O
already,O
resulted,O
in,O
more,O
fatalities,O
compared,O
with,O
the,O
SARS,O
and,O
MERS,O
"
",O
coronavirus,O
epidemics,O
combined,O
.,O
Therapeutics,O
that,O
may,O
assist,O
to,O
contain,O
its,O
rapid,O
"
",O
spread,O
and,O
reduce,O
its,O
high,O
mortality,O
rates,O
are,O
urgently,O
needed,O
.,O
Developing,O
"
",O
vaccines,O
against,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
virus,O
may,O
take,O
many,O
months,O
.,O
Moreover,O
",",O
vaccines,O
"
",O
based,O
on,O
viralencoded,O
peptides,O
may,O
not,O
be,O
effective,O
against,O
future,O
coronavirus,O
"
",O
epidemics,O
",",O
as,O
virus,O
mutations,O
could,O
make,O
them,O
futile,O
.,O
Indeed,O
",",O
new,O
Influenza,O
virus,O
"
",O
strains,O
emerge,O
every,O
year,O
",",O
requiring,O
new,O
immunizations,O
.,O
A,O
tentative,O
suggestion,O
"
",O
based,O
on,O
existing,O
therapeutics,O
",",O
which,O
would,O
likely,O
be,O
resistant,O
to,O
new,O
"
",O
coronavirus,O
mutations,O
",",O
is,O
to,O
use,O
available,O
angiotensin,O
receptor,O
1,O
(,O
AT1R,O
),O
"
",O
blockers,O
",",O
such,O
as,O
losartan,O
",",O
as,O
therapeutics,O
for,O
reducing,O
the,O
aggressiveness,O
and,O
"
",O
mortality,O
from,O
SARSCoV2,B-Virus_SARS-CoV-2
virus,O
infections,O
.,O
This,O
idea,O
is,O
based,O
on,O
observations,O
"
",O
that,O
the,O
angiotensinconverting,O
enzyme,O
2,O
(,O
ACE2,O
),O
very,O
likely,O
serves,O
as,O
the,O
binding,O
"
",O
site,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
the,O
strain,O
implicated,O
in,O
the,O
current,O
COVID19,B-Disease_COVID-19
epidemic,O
",",O
"
",O
similarly,O
to,O
strain,O
SARSCoV,O
implicated,O
in,O
the,O
20022003,O
SARS,O
epidemic,O
.,O
This,O
"
",O
commentary,O
elaborates,O
on,O
the,O
idea,O
of,O
considering,O
AT1R,O
blockers,O
as,O
tentative,O
"
",O
treatment,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
infections,O
",",O
and,O
proposes,O
a,O
research,O
direction,O
based,O
on,O
"
",O
datamining,O
of,O
clinical,O
patient,O
records,O
for,O
assessing,O
its,O
feasibility,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
ddr.21656,O
"
",O
PMID,O
:,O
32129518,O
"


",O
341,O
.,O
Am,O
J,O
Hematol,O
.,O
2020,O
Mar,O
4,O
.,O
doi,O
:,O
10.1002,O
ajh.25774,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Hematologic,O
parameters,O
in,O
patients,O
with,O
COVID19,B-Disease_COVID-19
infection,O
.,O
"

",O
Fan,O
BE(1)(2,O
),O
",",O
Chong,O
VCL(1,O
),O
",",O
Chan,O
SSW(1)(2,O
),O
",",O
Lim,O
GH(1,O
),O
",",O
Lim,O
KGE(1,O
),O
",",O
Tan,O
GB(1,O
),O
",",O
"
",O
Mucheli,O
SS(3)(4,O
),O
",",O
Kuperan,O
P(1)(2,O
),O
",",O
Ong,O
KH(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Haematology,O
",",O
Tan,O
Tock,O
Seng,O
Hospital,O
",",O
Singapore,O
.,O
"
",O
(2)Department,O
of,O
Laboratory,O
Medicine,O
",",O
Khoo,O
Teck,O
Puat,O
Hospital,O
",",O
Singapore,O
.,O
"
",O
(3)Department,O
of,O
Infectious,O
Diseases,O
",",O
Tan,O
Tock,O
Seng,O
Hospital,O
",",O
Singapore,O
.,O
"
",O
(4)National,O
Centre,O
for,O
Infectious,O
Diseases,O
",",O
Singapore,O
.,O
"

",O
DOI,O
:,O
10.1002,O
ajh.25774,O
"
",O
PMID,O
:,O
32129508,O
"


",O
342,O
.,O
Nature,O
.,O
2020,O
Mar;579(7797):29,O
.,O
doi,O
:,O
10.1038,O
d41586020006134,O
.,O
"

",O
Open,O
peerreview,O
platform,O
for,O
COVID19,B-Disease_COVID-19
preprints,O
.,O
"

",O
Johansson,O
MA,O
",",O
Saderi,O
D.,O
"

",O
DOI,O
:,O
10.1038,O
d41586020006134,O
"
",O
PMID,O
:,O
32127711,O
"


",O
343,O
.,O
Nat,O
Rev,O
Drug,O
Discov,O
.,O
2020,O
Mar;19(3):149150,O
.,O
doi,O
:,O
10.1038,O
d41573020000160,O
.,O
"

",O
Therapeutic,O
options,O
for,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
"

",O
Li,O
G,O
",",O
De,O
Clercq,O
E.,O
"

",O
DOI,O
:,O
10.1038,O
d41573020000160,O
"
",O
PMID,O
:,O
32127666,O
"


",O
344,O
.,O
Int,O
J,O
Oral,O
Sci,O
.,O
2020,O
Mar,O
3;12(1):9,O
.,O
doi,O
:,O
10.1038,O
s4136802000759,O
.,O
"

",O
Transmission,O
routes,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
and,O
controls,O
in,O
dental,O
practice,O
.,O
"

",O
Peng,O
X(1,O
),O
",",O
Xu,O
X(1,O
),O
",",O
Li,O
Y(1,O
),O
",",O
Cheng,O
L(1,O
),O
",",O
Zhou,O
X(2,O
),O
",",O
Ren,O
B(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Oral,O
Diseases,O
&,O
National,O
Clinical,O
Research,O
Center,O
for,O
"
",O
Oral,O
Diseases,O
&,O
Department,O
of,O
Cariology,O
and,O
Endodontics,O
",",O
West,O
China,O
Hospital,O
of,O
"
",O
Stomatology,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Oral,O
Diseases,O
&,O
National,O
Clinical,O
Research,O
Center,O
for,O
"
",O
Oral,O
Diseases,O
&,O
Department,O
of,O
Cariology,O
and,O
Endodontics,O
",",O
West,O
China,O
Hospital,O
of,O
"
",O
Stomatology,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
",",O
China,O
.,O
zhouxd@scu.edu.cn,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Oral,O
Diseases,O
&,O
National,O
Clinical,O
Research,O
Center,O
for,O
"
",O
Oral,O
Diseases,O
&,O
Department,O
of,O
Cariology,O
and,O
Endodontics,O
",",O
West,O
China,O
Hospital,O
of,O
"
",O
Stomatology,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
",",O
China,O
.,O
renbiao@scu.edu.cn,O
.,O
"

",O
A,O
novel,O
Î²coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
caused,O
severe,O
and,O
even,O
fetal,O
pneumonia,O
explored,O
"
",O
in,O
a,O
seafood,O
market,O
of,O
Wuhan,O
city,O
",",O
Hubei,O
province,O
",",O
China,O
",",O
and,O
rapidly,O
spread,O
to,O
"
",O
other,O
provinces,O
of,O
China,O
and,O
other,O
countries,O
.,O
The,O
2019nCoV,B-Virus_SARS-CoV-2
was,O
different,O
from,O
"
",O
SARSCoV,O
",",O
but,O
shared,O
the,O
same,O
host,O
receptor,O
the,O
human,O
angiotensinconverting,O
"
",O
enzyme,O
2,O
(,O
ACE2,O
),O
.,O
The,O
natural,O
host,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
may,O
be,O
the,O
bat,O
Rhinolophus,O
affinis,O
"
",O
as,O
2019nCoV,B-Virus_SARS-CoV-2
showed,O
96.2,O
%,O
of,O
wholegenome,O
identity,O
to,O
BatCoV,O
RaTG13,O
.,O
The,O
"
",O
persontoperson,O
transmission,O
routes,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
included,O
direct,O
transmission,O
",",O
"
",O
such,O
as,O
cough,O
",",O
sneeze,O
",",O
droplet,O
inhalation,O
transmission,O
",",O
and,O
contact,O
transmission,O
",",O
"
",O
such,O
as,O
the,O
contact,O
with,O
oral,O
",",O
nasal,O
",",O
and,O
eye,O
mucous,O
membranes,O
.,O
2019nCoV,B-Virus_SARS-CoV-2
can,O
"
",O
also,O
be,O
transmitted,O
through,O
the,O
saliva,O
",",O
and,O
the,O
fetaloral,O
routes,O
may,O
also,O
be,O
a,O
"
",O
potential,O
persontoperson,O
transmission,O
route,O
.,O
The,O
participants,O
in,O
dental,O
"
",O
practice,O
expose,O
to,O
tremendous,O
risk,O
of,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
due,O
to,O
the,O
facetoface,O
"
",O
communication,O
and,O
the,O
exposure,O
to,O
saliva,O
",",O
blood,O
",",O
and,O
other,O
body,O
fluids,O
",",O
and,O
the,O
"
",O
handling,O
of,O
sharp,O
instruments,O
.,O
Dental,O
professionals,O
play,O
great,O
roles,O
in,O
"
",O
preventing,O
the,O
transmission,O
of,O
2019nCoV.,O
Here,O
we,O
recommend,O
the,O
infection,O
control,O
"
",O
measures,O
during,O
dental,O
practice,O
to,O
block,O
the,O
persontoperson,O
transmission,O
routes,O
"
",O
in,O
dental,O
clinics,O
and,O
hospitals,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s4136802000759,O
"
",O
PMID,O
:,O
32127517,O
"


",O
345,O
.,O
BMJ,O
.,O
2020,O
Mar,O
3;368:m854,O
.,O
doi,O
:,O
10.1136,O
bmj.m854,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
UK,O
could,O
delay,O
nonurgent,O
care,O
and,O
call,O
doctors,O
back,O
from,O
leave,O
and,O
"
",O
retirement,O
.,O
"

",O
Mahase,O
E(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m854,O
"
",O
PMID,O
:,O
32127353,O
"


",O
346,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Feb;25(8,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.8.2002271,O
.,O
"

",O
Latest,O
assessment,O
on,O
COVID19,B-Disease_COVID-19
from,O
the,O
European,O
Centre,O
for,O
Disease,O
Prevention,O
and,O
"
",O
Control,O
(,O
ECDC,O
),O
.,O
"

",O
Eurosurveillance,O
Editorial,O
Team(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)European,O
Centre,O
for,O
Disease,O
Prevention,O
and,O
Control,O
(,O
ECDC,O
),O
",",O
Stockholm,O
",",O
Sweden,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.8.2002271,O
"
",O
PMID,O
:,O
32127126,O
"


",O
347,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Feb;25(8,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.8.2000197,O
.,O
"

",O
Authors,O
',O
response,O
:,O
Plenty,O
of,O
coronaviruses,O
but,O
no,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Reusken,O
CB(1,O
),O
",",O
Haagmans,O
B(2,O
),O
",",O
Meijer,O
A(1,O
),O
",",O
Corman,O
VM(3,O
),O
",",O
Papa,O
A(4,O
),O
",",O
Charrel,O
R(5,O
),O
",",O
"
",O
Drosten,O
C(3,O
),O
",",O
Koopmans,O
M(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Centre,O
for,O
Infectious,O
Disease,O
Control,O
",",O
National,O
Institute,O
for,O
Public,O
Health,O
"
",O
and,O
the,O
Environment,O
",",O
Bilthoven,O
",",O
the,O
Netherlands,O
.,O
"
",O
(2)Viroscience,O
department,O
",",O
Erasmus,O
MC,O
",",O
Rotterdam,O
",",O
the,O
Netherlands,O
.,O
"
",O
(3)CharitÃ©,O
 ,O
UniversitÃ¤tsmedizin,O
Berlin,O
Institute,O
of,O
Virology,O
",",O
Berlin,O
",",O
Germany,O
"
",O
and,O
German,O
Centre,O
for,O
Infection,O
Research,O
(,O
DZIF,O
),O
",",O
Berlin,O
",",O
Germany,O
.,O
"
",O
(4)Department,O
of,O
Microbiology,O
",",O
Medical,O
School,O
",",O
Aristotle,O
University,O
of,O
"
",O
Thessaloniki,O
",",O
Thessaloniki,O
",",O
Greece,O
.,O
"
",O
(5)UnitÃ©,O
des,O
Virus,O
Emergents,O
(,O
AixMarseille,O
UnivIRD,O
190Inserm,O
1207IHU,O
"
",O
MÃ©diterranÃ©e,O
Infection,O
),O
",",O
Marseille,O
",",O
France,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.8.2000197,O
"
",O
PMID,O
:,O
32127125,O
"


",O
348,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Feb;25(8,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.8.2000097,O
.,O
"

",O
Early,O
transmission,O
patterns,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
in,O
travellers,O
"
",O
from,O
Wuhan,O
to,O
Thailand,O
",",O
January,O
2020,O
.,O
"

",O
Okada,O
P(1,O
),O
",",O
Buathong,O
R(2,O
),O
",",O
Phuygun,O
S(1,O
),O
",",O
Thanadachakul,O
T(1,O
),O
",",O
Parnmen,O
S(1,O
),O
",",O
"
",O
Wongboot,O
W(1,O
),O
",",O
Waicharoen,O
S(1,O
),O
",",O
Wacharapluesadee,O
S(3,O
),O
",",O
Uttayamakul,O
S(2,O
),O
",",O
"
",O
Vachiraphan,O
A(2,O
),O
",",O
Chittaganpitch,O
M(1,O
),O
",",O
Mekha,O
N(1,O
),O
",",O
Janejai,O
N(1,O
),O
",",O
Iamsirithaworn,O
"
",O
S(2,O
),O
",",O
Lee,O
RT(4,O
),O
",",O
MaurerStroh,O
S(5)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medical,O
Sciences,O
",",O
Ministry,O
of,O
Public,O
Health,O
",",O
Thailand,O
.,O
"
",O
(2)Department,O
of,O
Disease,O
Control,O
",",O
Ministry,O
of,O
Public,O
Health,O
",",O
Thailand,O
.,O
"
",O
(3)Thai,O
Red,O
Cross,O
Emerging,O
Infectious,O
Diseases,O
 ,O
Health,O
Science,O
Centre,O
",",O
"
",O
Chulalongkorn,O
University,O
",",O
Thailand,O
.,O
"
",O
(4)Bioinformatics,O
Institute,O
",",O
Agency,O
for,O
Science,O
Technology,O
and,O
Research,O
",",O
"
",O
Singapore,O
.,O
"
",O
(5)Department,O
of,O
Biological,O
Sciences,O
",",O
National,O
University,O
of,O
Singapore,O
",",O
"
",O
Singapore,O
.,O
"

",O
We,O
report,O
two,O
cases,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
in,O
travellers,O
from,O
"
",O
Wuhan,O
",",O
China,O
to,O
Thailand,O
.,O
Both,O
were,O
independent,O
introductions,O
on,O
separate,O
"
",O
flights,O
",",O
discovered,O
with,O
thermoscanners,O
and,O
confirmed,O
with,O
RTPCR,O
and,O
genome,O
"
",O
sequencing,O
.,O
Both,O
cases,O
do,O
not,O
seem,O
directly,O
linked,O
to,O
the,O
Huanan,O
Seafood,O
Market,O
"
",O
in,O
Hubei,O
but,O
the,O
viral,O
genomes,O
are,O
identical,O
to,O
four,O
other,O
sequences,O
from,O
Wuhan,O
",",O
"
",O
suggesting,O
early,O
spread,O
within,O
the,O
city,O
already,O
in,O
the,O
first,O
week,O
of,O
January,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.8.2000097,O
"
",O
PMID,O
:,O
32127124,O
"


",O
349,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Feb;25(8,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.8.2000170,O
.,O
"

",O
Differential,O
diagnosis,O
of,O
illness,O
in,O
patients,O
under,O
investigation,O
for,O
the,O
novel,O
"
",O
coronavirus,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
Italy,O
",",O
February,O
2020,O
.,O
"

",O
Bordi,O
L(1,O
),O
",",O
Nicastri,O
E(1,O
),O
",",O
Scorzolini,O
L(1,O
),O
",",O
Di,O
Caro,O
A(1,O
),O
",",O
Capobianchi,O
MR(1,O
),O
",",O
"
",O
Castilletti,O
C(1,O
),O
",",O
Lalle,O
E(1,O
),O
",",O
On,O
Behalf,O
Of,O
Inmi,O
CovidStudy,O
Group,O
And,O
"
",O
Collaborating,O
Centers(2)(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Institute,O
for,O
Infectious,O
Diseases,O
',O
Lazzaro,O
Spallanzani,O
',O
IRCCS,O
",",O
Rome,O
",",O
"
",O
Italy,O
.,O
"
",O
(2)The,O
participating,O
members,O
of,O
INMI,O
COVID19,B-Disease_COVID-19
study,O
group,O
and,O
Collaborating,O
"
",O
Centers,O
are,O
acknowledged,O
at,O
the,O
end,O
of,O
the,O
article,O
.,O
"

",O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
has,O
been,O
identified,O
as,O
the,O
causative,O
pathogen,O
of,O
"
",O
an,O
ongoing,O
outbreak,O
of,O
respiratory,O
disease,O
",",O
now,O
named,O
COVID19,B-Disease_COVID-19
.,O
Most,O
cases,O
and,O
"
",O
sustained,O
transmission,O
occurred,O
in,O
China,O
",",O
but,O
travelassociated,O
cases,O
have,O
been,O
"
",O
reported,O
in,O
other,O
countries,O
",",O
including,O
Europe,O
and,O
Italy,O
.,O
Since,O
the,O
symptoms,O
are,O
"
",O
similar,O
to,O
other,O
respiratory,O
infections,O
",",O
differential,O
diagnosis,O
in,O
travellers,O
"
",O
arriving,O
from,O
countries,O
with,O
widespread,O
COVID19,B-Disease_COVID-19
must,O
include,O
other,O
more,O
common,O
"
",O
infections,O
such,O
as,O
influenza,O
and,O
other,O
respiratory,O
tract,O
diseases,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.8.2000170,O
"
",O
PMID,O
:,O
32127123,O
"


",O
350,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Feb;25(8,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.8.2000171,O
.,O
"

",O
Letter,O
to,O
the,O
editor,O
:,O
Plenty,O
of,O
coronaviruses,O
but,O
no,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Colson,O
P(1)(2,O
),O
",",O
La,O
Scola,O
B(1)(2,O
),O
",",O
EstevesVieira,O
V(2,O
),O
",",O
Ninove,O
L(3)(2,O
),O
",",O
Zandotti,O
"
",O
C(3)(2,O
),O
",",O
Jimeno,O
MT(4,O
),O
",",O
Gazin,O
C(2,O
),O
",",O
Bedotto,O
M(2,O
),O
",",O
Filosa,O
V(2,O
),O
",",O
GiraudGatineau,O
"
",O
A(5)(6)(2,O
),O
",",O
Chaudet,O
H(5)(6)(2,O
),O
",",O
Brouqui,O
P(1)(2,O
),O
",",O
Lagier,O
JC(1)(2,O
),O
",",O
Raoult,O
D(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)AixMarseille,O
University,O
",",O
Institut,O
de,O
Recherche,O
pour,O
le,O
DÃ©veloppement,O
(,O
IRD,O
),O
",",O
"
",O
Assistance,O
Publique,O
 ,O
HÃ´pitaux,O
de,O
Marseille,O
(,O
APHM,O
),O
",",O
Microbes,O
Evolution,O
Phylogeny,O
"
",O
and,O
Infections,O
(,O
MEPHI,O
),O
",",O
France,O
.,O
"
",O
(2)Institut,O
HospitaloUniversitaire,O
(,O
IHU,O
),O
MÃ©diterranÃ©e,O
Infection,O
",",O
Marseille,O
",",O
"
",O
France,O
.,O
"
",O
(3)UnitÃ©,O
des,O
Virus,O
Emergents,O
(,O
UVE,O
),O
",",O
AixMarseille,O
University,O
",",O
IRD,O
190,O
",",O
Inserm,O
"
",O
1207,O
",",O
IHU,O
MÃ©diterranÃ©e,O
Infection,O
",",O
Marseille,O
",",O
France,O
.,O
"
",O
(4)Service,O
de,O
l'Information,O
MÃ©dicale,O
",",O
HÃ´pital,O
de,O
la,O
Timone,O
",",O
Marseille,O
",",O
France,O
.,O
"
",O
(5)French,O
Armed,O
Forces,O
Center,O
for,O
Epidemiology,O
and,O
Public,O
Health,O
(,O
CESPA,O
),O
",",O
Service,O
"
",O
de,O
SantÃ©,O
des,O
ArmÃ©es,O
(,O
SSA,O
),O
",",O
Marseille,O
",",O
France,O
.,O
"
",O
(6)AixMarseille,O
University,O
",",O
Institut,O
de,O
Recherche,O
pour,O
le,O
DÃ©veloppement,O
(,O
IRD,O
),O
",",O
"
",O
Assistance,O
Publique,O
 ,O
HÃ´pitaux,O
de,O
Marseille,O
(,O
APHM,O
),O
",",O
Vecteurs,O
 ,O
Infections,O
"
",O
Tropicales,O
et,O
MÃ©diterranÃ©ennes,O
(,O
VITROME,O
),O
",",O
Marseille,O
",",O
France,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.8.2000171,O
"
",O
PMID,O
:,O
32127122,O
"


",O
351,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
29:101613,O
.,O
doi,O
:,O
10.1016,O
j.tmaid.2020.101613,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
in,O
Latin,O
America,O
:,O
The,O
implications,O
of,O
the,O
first,O
confirmed,O
case,O
in,O
"
",O
Brazil,O
.,O
"

",O
RodriguezMorales,O
AJ(1,O
),O
",",O
Gallego,O
V(2,O
),O
",",O
EscaleraAntezana,O
JP(3,O
),O
",",O
MÃ©ndez,O
CA(4,O
),O
",",O
"
",O
Zambrano,O
LI(5,O
),O
",",O
FrancoParedes,O
C(6,O
),O
",",O
SuÃ¡rez,O
JA(7,O
),O
",",O
RodriguezEnciso,O
HD(8,O
),O
",",O
"
",O
BalbinRamon,O
GJ(9,O
),O
",",O
SavioLarriera,O
E(10,O
),O
",",O
Risquez,O
A(11,O
),O
",",O
Cimerman,O
S(12,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Public,O
Health,O
and,O
Infection,O
Research,O
Group,O
",",O
Faculty,O
of,O
Health,O
Sciences,O
",",O
"
",O
Universidad,O
TecnolÃ³gica,O
de,O
Pereira,O
",",O
Pereira,O
",",O
Colombia,O
;,O
Master,O
in,O
Clinical,O
"
",O
Epidemiology,O
and,O
Biostatistics,O
",",O
Universidad,O
Cientifica,O
del,O
Sur,O
",",O
Lima,O
",",O
Peru,O
.,O
"
",O
Electronic,O
address,O
:,O
arodriguezm@utp.edu.co,O
.,O
"
",O
(2)Panel,O
of,O
Sports,O
and,O
Travel,O
",",O
Latin,O
American,O
Society,O
for,O
Travel,O
Medicine,O
"
",O
(,O
SLAMVI,O
),O
",",O
Buenos,O
Aires,O
",",O
Argentina,O
.,O
"
",O
(3)National,O
Responsible,O
for,O
Telehealth,O
Program,O
",",O
Ministry,O
of,O
Health,O
",",O
La,O
Paz,O
",",O
"
",O
Bolivia,O
.,O
"
",O
(4)Instituto,O
de,O
Salud,O
PÃºblica,O
",",O
Facultad,O
de,O
Medicina,O
",",O
Universidad,O
Austral,O
de,O
"
",O
Chile,O
",",O
Valdivia,O
",",O
Chile,O
.,O
"
",O
(5)Departments,O
of,O
Physiological,O
and,O
Morphological,O
Sciences,O
",",O
School,O
of,O
Medical,O
"
",O
Sciences,O
",",O
Universidad,O
Nacional,O
AutÃ³noma,O
de,O
Honduras,O
",",O
Tegucigalpa,O
",",O
Honduras,O
.,O
"
",O
(6)Hospital,O
Infantil,O
de,O
MÃ©xico,O
Federico,O
GÃ³mez,O
",",O
MÃ©xico,O
City,O
",",O
Mexico,O
.,O
"
",O
(7)Investigador,O
SNI,O
Senacyt,O
PanamÃ¡,O
",",O
Clinical,O
Research,O
Deparment,O
",",O
Instituto,O
"
",O
Conmemorativo,O
Gorgas,O
de,O
Estudios,O
de,O
la,O
Salud,O
",",O
PanamÃ¡,O
City,O
",",O
Panama,O
.,O
"
",O
(8)DirecciÃ³n,O
de,O
Vigilancia,O
de,O
Enfermedades,O
Transmisibles,O
",",O
Ministerio,O
de,O
Salud,O
"
",O
PÃºblica,O
y,O
Bienestar,O
Social,O
",",O
AsunciÃ³n,O
",",O
Paraguay,O
.,O
"
",O
(9)Master,O
in,O
Clinical,O
Epidemiology,O
and,O
Biostatistics,O
",",O
Universidad,O
Cientifica,O
del,O
"
",O
Sur,O
",",O
Lima,O
",",O
Peru,O
;,O
Hospital,O
de,O
Emergencias,O
JosÃ©,O
Casimiro,O
Ulloa,O
",",O
Lima,O
",",O
Peru,O
.,O
"
",O
(10)Hospital,O
EvangÃ©lico,O
de,O
Montevideo,O
",",O
Montevideo,O
",",O
Uruguay,O
.,O
"
",O
(11)Faculty,O
of,O
Medicine,O
",",O
Universidad,O
Central,O
de,O
Venezuela,O
",",O
Caracas,O
",",O
Venezuela,O
.,O
"
",O
(12)Institute,O
of,O
Infectious,O
Diseases,O
Emilio,O
Ribas,O
",",O
SÃ£o,O
Paulo,O
",",O
Brazil,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101613,O
"
",O
PMID,O
:,O
32126292,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
None,O
of,O
the,O
"
",O
authors,O
has,O
any,O
conflict,O
of,O
interest,O
to,O
declare,O
.,O
All,O
authors,O
report,O
no,O
potential,O
"
",O
conflicts,O
.,O
All,O
authors,O
have,O
submitted,O
the,O
Form,O
for,O
Disclosure,O
of,O
Potential,O
.,O
"


",O
352,O
.,O
Commun,O
Dis,O
Intell,O
(,O
2018,O
),O
.,O
2020,O
Mar,O
4;44,O
.,O
doi,O
:,O
10.33321,O
cdi.2020.44.20,O
.,O
"

",O
COVID19,B-Disease_COVID-19
",",O
Australia,O
:,O
Epidemiology,O
Report,O
5,O
(,O
Reporting,O
week,O
ending,O
0.791666667,O
AEDT,O
29,O
"
",O
February,O
2020,O
),O
.,O
"

",O
COVID19,B-Disease_COVID-19
National,O
Incident,O
Room,O
Surveillance,O
Team,O
.,O
"

",O
This,O
is,O
the,O
fifth,O
epidemiological,O
report,O
for,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
",",O
"
",O
reported,O
in,O
Australia,O
as,O
at,O
0.791666667,O
Australian,O
Eastern,O
Daylight,O
Time,O
[,O
AEDT,O
],O
29,O
"
",O
February,O
2020,O
.,O
It,O
includes,O
data,O
on,O
COVID19,B-Disease_COVID-19
cases,O
diagnosed,O
in,O
Australia,O
",",O
the,O
"
",O
international,O
situation,O
and,O
a,O
review,O
of,O
current,O
evidence,O
.,O
"

",O
Â©,O
Commonwealth,O
of,O
Australia,O
CC,O
BYNCND,O
.,O
"

",O
DOI,O
:,O
10.33321,O
cdi.2020.44.20,O
"
",O
PMID,O
:,O
32126197,O
"


",O
353,O
.,O
PLoS,O
Negl,O
Trop,O
Dis,O
.,O
2020,O
Mar,O
3;14(3):e0008049,O
.,O
doi,O
:,O
10.1371,O
journal.pntd.0008049,O
.,O
"
",O
eCollection,O
2020,O
Mar.,O
"

",O
Genomic,O
epidemiological,O
characteristics,O
of,O
dengue,O
fever,O
in,O
Guangdong,O
province,O
",",O
"
",O
China,O
from,O
2013,O
to,O
2017,O
.,O
"

",O
Sun,O
B(1)(2)(3,O
),O
",",O
Zhang,O
X(4,O
),O
",",O
Zhang,O
H(4,O
),O
",",O
Liu,O
H(1)(2,O
),O
",",O
Sun,O
L(5,O
),O
",",O
Tan,O
Q(4,O
),O
",",O
Liang,O
"
",O
M(5,O
),O
",",O
Wu(4,O
),O
",",O
Liu,O
D(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Computational,O
Virology,O
Group,O
",",O
Center,O
for,O
Bacteria,O
and,O
Viruses,O
Resources,O
and,O
"
",O
Bioinformation,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(3)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)Institute,O
of,O
Microbiology,O
",",O
Guangdong,O
provincial,O
Center,O
for,O
Disease,O
Control,O
and,O
"
",O
Prevention,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(5)National,O
Institute,O
for,O
Viral,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Chinese,O
Center,O
"
",O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
Dengue,O
fever,O
",",O
a,O
mosquitoborne,O
viral,O
disease,O
in,O
humans,O
",",O
has,O
been,O
endemic,O
in,O
many,O
"
",O
Southeast,O
Asian,O
countries,O
.,O
Since,O
its,O
first,O
outbreak,O
in,O
1978,O
in,O
Foshan,O
",",O
Guangdong,O
"
",O
province,O
",",O
China,O
",",O
dengue,O
has,O
been,O
continually,O
epidemic,O
in,O
recent,O
years,O
in,O
"
",O
Guangdong,O
",",O
which,O
raised,O
the,O
concern,O
whether,O
dengue,O
infection,O
is,O
endemic,O
in,O
"
",O
Guangdong,O
.,O
In,O
this,O
study,O
",",O
we,O
performed,O
phylogenetic,O
",",O
recombinant,O
",",O
and,O
nucleotide,O
"
",O
variation,O
analyses,O
of,O
114,O
complete,O
genome,O
sequences,O
of,O
dengue,O
virus,O
serotypes,O
14,O
"
",O
(,O
DENV14,O
),O
collected,O
from,O
2013,O
to,O
2017,O
in,O
18,O
of,O
21,O
cities,O
of,O
Guangdong,O
.,O
"
",O
Phylogenetic,O
analyses,O
revealed,O
that,O
DENV,O
sequences,O
did,O
not,O
form,O
a,O
single,O
cluster,O
",",O
"
",O
indicating,O
that,O
dengue,O
fever,O
was,O
not,O
endemic,O
in,O
Guangdong,O
",",O
although,O
DENV14,O
"
",O
cocirculated,O
in,O
Guangdong,O
.,O
Twenty,O
intraserotype,O
recombinant,O
isolates,O
involving,O
"
",O
DENV14,O
were,O
detected,O
",",O
but,O
no,O
interserotype,O
recombinant,O
events,O
were,O
identified,O
"
",O
in,O
this,O
study,O
.,O
Additionally,O
",",O
the,O
most,O
recombinant,O
events,O
were,O
detected,O
"
",O
simultaneously,O
in,O
the,O
gene,O
NS3,O
of,O
DENV14,O
.,O
Nucleotide,O
variation,O
analyses,O
showed,O
"
",O
that,O
no,O
significant,O
intraserotype,O
differences,O
were,O
observed,O
",",O
whereas,O
more,O
"
",O
significant,O
intersubtype,O
differences,O
were,O
discovered,O
in,O
nonstructural,O
genes,O
"
",O
than,O
in,O
structural,O
genes,O
.,O
Our,O
investigation,O
will,O
facilitate,O
the,O
understanding,O
of,O
"
",O
the,O
current,O
prevalent,O
status,O
of,O
dengue,O
fever,O
in,O
Guangdong,O
and,O
contribute,O
to,O
"
",O
designing,O
more,O
effective,O
preventive,O
and,O
control,O
strategies,O
for,O
dengue,O
infection,O
.,O
"

",O
DOI,O
:,O
10.1371,O
journal.pntd.0008049,O
"
",O
PMCID,O
:,O
PMC7053713,O
"
",O
PMID,O
:,O
32126080,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
have,O
declared,O
that,O
no,O
competing,O
"
",O
interests,O
exist,O
.,O
"


",O
354,O
.,O
Radiology,O
.,O
2020,O
Mar,O
3:200661,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200661,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Helping,O
the,O
Radiologist,O
:,O
The,O
Role,O
of,O
Scientific,O
Journals,O
to,O
Help,O
Prevent,O
the,O
"
",O
Spread,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Li,O
X(1,O
),O
",",O
Qian,O
Y(1,O
),O
",",O
Liu,O
B(1,O
),O
",",O
Yu,O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Anhui,O
Medical,O
"
",O
University,O
",",O
No,O
218,O
Jixi,O
Road,O
",",O
Hefei,O
",",O
Anhui,O
",",O
China,O
230022,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200661,O
"
",O
PMID,O
:,O
32125934,O
"


",O
355,O
.,O
AJR,O
Am,O
J,O
Roentgenol,O
.,O
2020,O
Mar,O
0.136111111,O
.,O
doi,O
:,O
10.2214,O
AJR.20.22976,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Relation,O
Between,O
Chest,O
CT,O
Findings,O
and,O
Clinical,O
Conditions,O
of,O
Coronavirus,O
Disease,O
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
Pneumonia,O
:,O
A,O
Multicenter,O
Study,O
.,O
"

",O
Zhao,O
W(1,O
),O
",",O
Zhong,O
Z(2)(3,O
),O
",",O
Xie,O
X(1,O
),O
",",O
Yu,O
Q(2)(3,O
),O
",",O
Liu,O
J(1)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
The,O
Second,O
Xiangya,O
Hospital,O
",",O
Central,O
South,O
"
",O
University,O
",",O
No.,O
139,O
Middle,O
Remin,O
Rd,O
",",O
Changsha,O
",",O
Hunan,O
",",O
410011,O
",",O
P.R.,O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
First,O
Hospital,O
of,O
Changsha,O
",",O
Hunan,O
",",O
P.R.,O
China,O
.,O
"
",O
(3)Changsha,O
Public,O
Health,O
Treatment,O
Center,O
",",O
Hunan,O
",",O
P.R.,O
China,O
.,O
"
",O
(4)Department,O
of,O
Radiology,O
",",O
Quality,O
Control,O
Center,O
",",O
Changsha,O
",",O
Hunan,O
",",O
P.R.,O
China,O
.,O
"

",O
OBJECTIVE,O
.,O
The,O
increasing,O
number,O
of,O
cases,O
of,O
confirmed,O
coronavirus,O
disease,O
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
in,O
China,O
is,O
striking,O
.,O
The,O
purpose,O
of,O
this,O
study,O
was,O
to,O
investigate,O
the,O
"
",O
relation,O
between,O
chest,O
CT,O
findings,O
and,O
the,O
clinical,O
conditions,O
of,O
COVID19,B-Disease_COVID-19
"
",O
pneumonia,O
.,O
MATERIALS,O
AND,O
METHODS,O
.,O
Data,O
on,O
101,O
cases,O
of,O
COVID19,B-Disease_COVID-19
pneumonia,O
were,O
"
",O
retrospectively,O
collected,O
from,O
four,O
institutions,O
in,O
Hunan,O
",",O
China,O
.,O
Basic,O
clinical,O
"
",O
characteristics,O
and,O
detailed,O
imaging,O
features,O
were,O
evaluated,O
and,O
compared,O
between,O
"
",O
two,O
groups,O
on,O
the,O
basis,O
of,O
clinical,O
status,O
:,O
nonemergency,O
(,O
mild,O
or,O
common,O
disease,O
),O
"
",O
and,O
emergency,O
(,O
severe,O
or,O
fatal,O
disease,O
),O
.,O
RESULTS,O
.,O
Patients,O
2150,O
years,O
old,O
"
",O
accounted,O
for,O
most,O
(,O
70.2,O
%,O
),O
of,O
the,O
cohort,O
",",O
and,O
five,O
(,O
5,O
%,O
),O
patients,O
had,O
disease,O
"
",O
associated,O
with,O
a,O
family,O
outbreak,O
.,O
Most,O
patients,O
(,O
78.2,O
%,O
),O
had,O
fever,O
as,O
the,O
onset,O
"
",O
symptom,O
.,O
Most,O
patients,O
with,O
COVID19,B-Disease_COVID-19
pneumonia,O
had,O
typical,O
imaging,O
features,O
",",O
such,O
"
",O
as,O
groundglass,O
opacities,O
(,O
GGO,O
),O
(,O
87,O
[,O
86.1,O
%,O
],O
),O
or,O
mixed,O
GGO,O
and,O
consolidation,O
(,O
65,O
"
",O
[,O
64.4,O
%,O
],O
),O
",",O
vascular,O
enlargement,O
in,O
the,O
lesion,O
(,O
72,O
[,O
71.3,O
%,O
],O
),O
",",O
and,O
traction,O
"
",O
bronchiectasis,O
(,O
53,O
[,O
52.5,O
%,O
],O
),O
.,O
Lesions,O
present,O
on,O
CT,O
images,O
were,O
more,O
likely,O
to,O
"
",O
have,O
a,O
peripheral,O
distribution,O
(,O
88,O
[,O
87.1,O
%,O
],O
),O
and,O
bilateral,O
involvement,O
(,O
83,O
"
",O
[,O
82.2,O
%,O
],O
),O
and,O
be,O
lower,O
lung,O
predominant,O
(,O
55,O
[,O
54.5,O
%,O
],O
),O
and,O
multifocal,O
(,O
55,O
[,O
54.5,O
%,O
],O
),O
.,O
"
",O
Patients,O
in,O
the,O
emergency,O
group,O
were,O
older,O
than,O
those,O
in,O
the,O
nonemergency,O
group,O
.,O
"
",O
Architectural,O
distortion,O
",",O
traction,O
bronchiectasis,O
",",O
and,O
CT,O
involvement,O
score,O
aided,O
"
",O
in,O
evaluation,O
of,O
the,O
severity,O
and,O
extent,O
of,O
the,O
disease,O
.,O
CONCLUSION,O
.,O
Patients,O
"
",O
with,O
confirmed,O
COVID19,B-Disease_COVID-19
pneumonia,O
have,O
typical,O
imaging,O
features,O
that,O
can,O
be,O
"
",O
helpful,O
in,O
early,O
screening,O
of,O
highly,O
suspected,O
cases,O
and,O
in,O
evaluation,O
of,O
the,O
"
",O
severity,O
and,O
extent,O
of,O
disease,O
.,O
Most,O
patients,O
with,O
COVID19,B-Disease_COVID-19
pneumonia,O
have,O
GGO,O
or,O
"
",O
mixed,O
GGO,O
and,O
consolidation,O
and,O
vascular,O
enlargement,O
in,O
the,O
lesion,O
.,O
Lesions,O
are,O
"
",O
more,O
likely,O
to,O
have,O
peripheral,O
distribution,O
and,O
bilateral,O
involvement,O
and,O
be,O
"
",O
lower,O
lung,O
predominant,O
and,O
multifocal,O
.,O
CT,O
involvement,O
score,O
can,O
help,O
in,O
"
",O
evaluation,O
of,O
the,O
severity,O
and,O
extent,O
of,O
the,O
disease,O
.,O
"

",O
DOI,O
:,O
10.2214,O
AJR.20.22976,O
"
",O
PMID,O
:,O
32125873,O
"


",O
356,O
.,O
Virol,O
Sin,O
.,O
2020,O
Mar,O
3,O
.,O
doi,O
:,O
10.1007,O
s12250020002074,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Understanding,O
SARSCoV2Mediated,O
Inflammatory,O
Responses,O
:,O
From,O
Mechanisms,O
to,O
"
",O
Potential,O
Therapeutic,O
Tools,O
.,O
"

",O
Fu,O
Y(1)(2,O
),O
",",O
Cheng,O
Y(3,O
),O
",",O
Wu,O
Y(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)NHC,O
Key,O
Laboratory,O
of,O
AIDS,O
Immunology,O
(,O
China,O
Medical,O
University,O
),O
",",O
Department,O
"
",O
of,O
Laboratory,O
Medicine,O
",",O
the,O
First,O
Affiliated,O
Hospital,O
of,O
China,O
Medical,O
"
",O
University,O
",",O
Shenyang,O
",",O
110001,O
",",O
China,O
.,O
fufu80s@sina.com,O
.,O
"
",O
(2)National,O
Clinical,O
Research,O
Center,O
for,O
Laboratory,O
Medicine,O
",",O
The,O
First,O
"
",O
Affiliated,O
Hospital,O
of,O
China,O
Medical,O
University,O
",",O
Shenyang,O
",",O
110001,O
",",O
China,O
.,O
"
",O
fufu80s@sina.com,O
.,O
"
",O
(3)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
Third,O
Affiliated,O
"
",O
Hospital,O
of,O
Southern,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
510275,O
",",O
China,O
.,O
"
",O
(4)National,O
Center,O
for,O
Biodefense,O
and,O
Infectious,O
Diseases,O
",",O
School,O
of,O
Systems,O
"
",O
Biology,O
",",O
George,O
Mason,O
University,O
",",O
Manassas,O
",",O
VA,O
",",O
20110,O
",",O
USA,O
.,O
ywu8@gmu.edu,O
.,O
"

",O
Currently,O
there,O
is,O
no,O
effective,O
antiviral,O
therapy,O
for,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
",",O
which,O
"
",O
frequently,O
leads,O
to,O
fatal,O
inflammatory,O
responses,O
and,O
acute,O
lung,O
injury,O
.,O
Here,O
",",O
we,O
"
",O
discuss,O
the,O
various,O
mechanisms,O
of,O
SARSCoVmediated,O
inflammation,O
.,O
We,O
also,O
assume,O
"
",O
that,O
SARSCoV2,B-Virus_SARS-CoV-2
likely,O
shares,O
similar,O
inflammatory,O
responses,O
.,O
Potential,O
"
",O
therapeutic,O
tools,O
to,O
reduce,O
SARSCoV2induced,O
inflammatory,O
responses,O
include,O
"
",O
various,O
methods,O
to,O
block,O
FcR,O
activation,O
.,O
In,O
the,O
absence,O
of,O
a,O
proven,O
clinical,O
FcR,O
"
",O
blocker,O
",",O
the,O
use,O
of,O
intravenous,O
immunoglobulin,O
to,O
block,O
FcR,O
activation,O
may,O
be,O
a,O
"
",O
viable,O
option,O
for,O
the,O
urgent,O
treatment,O
of,O
pulmonary,O
inflammation,O
to,O
prevent,O
"
",O
severe,O
lung,O
injury,O
.,O
Such,O
treatment,O
may,O
also,O
be,O
combined,O
with,O
systemic,O
"
",O
antiinflammatory,O
drugs,O
or,O
corticosteroids,O
.,O
However,O
",",O
these,O
strategies,O
",",O
as,O
"
",O
proposed,O
here,O
",",O
remain,O
to,O
be,O
clinically,O
tested,O
for,O
effectiveness,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12250020002074,O
"
",O
PMID,O
:,O
32125642,O
"


",O
357,O
.,O
Intensive,O
Care,O
Med,O
.,O
2020,O
Mar,O
3,O
.,O
doi,O
:,O
10.1007,O
s00134020059551,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
:,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
and,O
a,O
novel,O
challenge,O
for,O
critical,O
care,O
.,O
"

",O
Arabi,O
YM(1)(2)(3,O
),O
",",O
Murthy,O
S(4,O
),O
",",O
Webb,O
S(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Intensive,O
Care,O
Department,O
",",O
Ministry,O
of,O
National,O
Guard,O
Health,O
Affairs,O
",",O
Riyadh,O
",",O
"
",O
Kingdom,O
of,O
Saudi,O
Arabia,O
.,O
arabi@ngha.med.sa,O
.,O
"
",O
(2)King,O
Abdullah,O
International,O
Medical,O
Research,O
Center,O
",",O
Riyadh,O
",",O
Kingdom,O
of,O
Saudi,O
"
",O
Arabia,O
.,O
arabi@ngha.med.sa,O
.,O
"
",O
(3)King,O
Saud,O
Bin,O
Abdulaziz,O
University,O
for,O
Health,O
Sciences,O
",",O
ICU,O
1425,O
",",O
PO,O
Box,O
"
",O
22490,O
",",O
Riyadh,O
",",O
11426,O
",",O
Kingdom,O
of,O
Saudi,O
Arabia,O
.,O
arabi@ngha.med.sa,O
.,O
"
",O
(4)University,O
of,O
British,O
Columbia,O
",",O
Vancouver,O
",",O
BC,O
",",O
V6H,O
3V4,O
",",O
Canada,O
.,O
"
",O
(5)School,O
of,O
Public,O
Health,O
and,O
Preventive,O
Medicine,O
",",O
Monash,O
University,O
",",O
Melbourne,O
",",O
"
",O
Australia,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00134020059551,O
"
",O
PMID,O
:,O
32125458,O
"


",O
358,O
.,O
Intensive,O
Care,O
Med,O
.,O
2020,O
Mar,O
3,O
.,O
doi,O
:,O
10.1007,O
s00134020059859,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Angiotensinconverting,O
enzyme,O
2,O
(,O
ACE2,O
),O
as,O
a,O
SARSCoV2,B-Virus_SARS-CoV-2
receptor,O
:,O
molecular,O
"
",O
mechanisms,O
and,O
potential,O
therapeutic,O
target,O
.,O
"

",O
Zhang,O
H(1)(2)(3,O
),O
",",O
Penninger,O
JM(4)(5,O
),O
",",O
Li,O
Y(2,O
),O
",",O
Zhong,O
N(2,O
),O
",",O
Slutsky,O
AS(6)(7)(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Keenan,O
Research,O
Centre,O
for,O
Biomedical,O
Science,O
",",O
Li,O
Ka,O
Shing,O
Knowledge,O
"
",O
Institute,O
",",O
St.,O
Michaels,O
Hospital,O
",",O
209,O
Victoria,O
Street,O
",",O
Room,O
608,O
",",O
Toronto,O
",",O
ON,O
",",O
M5B,O
"
",O
1T8,O
",",O
Canada,O
.,O
"
",O
(2)The,O
State,O
Key,O
Laboratory,O
of,O
Respiratory,O
Disease,O
",",O
Guangzhou,O
Institute,O
of,O
"
",O
Respiratory,O
Health,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
Medical,O
"
",O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(3)Interdepartmental,O
Division,O
of,O
Critical,O
Care,O
Medicine,O
;,O
Departments,O
of,O
"
",O
Anesthesia,O
and,O
Physiology,O
",",O
University,O
of,O
Toronto,O
",",O
Toronto,O
",",O
Canada,O
.,O
"
",O
(4)Department,O
of,O
Medical,O
Genetics,O
",",O
Life,O
Science,O
Institute,O
",",O
University,O
of,O
British,O
"
",O
Columbia,O
",",O
Vancouver,O
",",O
BC,O
",",O
Canada,O
.,O
"
",O
(5)IMBA,O
",",O
Institute,O
of,O
Molecular,O
Biotechnology,O
",",O
Austrian,O
Academy,O
of,O
Sciences,O
",",O
"
",O
Vienna,O
",",O
Austria,O
.,O
"
",O
(6)The,O
Keenan,O
Research,O
Centre,O
for,O
Biomedical,O
Science,O
",",O
Li,O
Ka,O
Shing,O
Knowledge,O
"
",O
Institute,O
",",O
St.,O
Michaels,O
Hospital,O
",",O
209,O
Victoria,O
Street,O
",",O
Room,O
608,O
",",O
Toronto,O
",",O
ON,O
",",O
M5B,O
"
",O
1T8,O
",",O
Canada,O
.,O
arthur.slutsky@unityhealth.to,O
.,O
"
",O
(7)Interdepartmental,O
Division,O
of,O
Critical,O
Care,O
Medicine,O
",",O
University,O
of,O
Toronto,O
",",O
"
",O
Toronto,O
",",O
Canada,O
.,O
arthur.slutsky@unityhealth.to,O
.,O
"
",O
(8)The,O
State,O
Key,O
Laboratory,O
of,O
Respiratory,O
Disease,O
",",O
Guangzhou,O
Institute,O
of,O
"
",O
Respiratory,O
Health,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
Medical,O
"
",O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
arthur.slutsky@unityhealth.to,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00134020059859,O
"
",O
PMID,O
:,O
32125455,O
"


",O
359,O
.,O
Intensive,O
Care,O
Med,O
.,O
2020,O
Mar,O
3,O
.,O
doi,O
:,O
10.1007,O
s0013402005976w,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Imaging,O
changes,O
in,O
severe,O
COVID19,B-Disease_COVID-19
pneumonia,O
.,O
"

",O
Zhang,O
W(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Emergency,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Affiliated,O
Hospital,O
of,O
"
",O
Zunyi,O
Medical,O
University,O
",",O
Zunyi,O
Medical,O
University,O
",",O
149,O
Dalian,O
Road,O
",",O
Zunyi,O
",",O
"
",O
563000,O
",",O
Guizhou,O
",",O
China,O
.,O
zhangwei_hxicu@163.com,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s0013402005976w,O
"
",O
PMID,O
:,O
32125453,O
"


",O
360,O
.,O
Intensive,O
Care,O
Med,O
.,O
2020,O
Mar,O
3,O
.,O
doi,O
:,O
10.1007,O
s0013402005991x,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Clinical,O
predictors,O
of,O
mortality,O
due,O
to,O
COVID19,B-Disease_COVID-19
based,O
on,O
an,O
analysis,O
of,O
data,O
of,O
"
",O
150,O
patients,O
from,O
Wuhan,O
",",O
China,O
.,O
"

",O
Ruan,O
Q(1)(2,O
),O
",",O
Yang,O
K(3,O
),O
",",O
Wang,O
W(4,O
),O
",",O
Jiang,O
L(5,O
),O
",",O
Song,O
J(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Pathology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
1095,O
Jiefang,O
Avenue,O
",",O
Wuhan,O
",",O
430030,O
",",O
Hubei,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pathology,O
",",O
School,O
of,O
Basic,O
Medicine,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
1095,O
Jiefang,O
Avenue,O
",",O
Wuhan,O
",",O
"
",O
430030,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Dermatology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
1095,O
Jiefang,O
Avenue,O
",",O
Wuhan,O
",",O
430030,O
",",O
Hubei,O
",",O
"
",O
China,O
.,O
"
",O
(4)Department,O
of,O
Infectious,O
Diseases,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
1095,O
Jiefang,O
Avenue,O
",",O
Wuhan,O
",",O
"
",O
430030,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Clinical,O
Immunology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
1095,O
Jiefang,O
Avenue,O
",",O
Wuhan,O
",",O
"
",O
430030,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Infectious,O
Diseases,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
1095,O
Jiefang,O
Avenue,O
",",O
Wuhan,O
",",O
"
",O
430030,O
",",O
Hubei,O
",",O
China,O
.,O
songsingsjx@sina.com,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s0013402005991x,O
"
",O
PMID,O
:,O
32125452,O
"


",O
361,O
.,O
J,O
Travel,O
Med,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
taaa027,O
.,O
doi,O
:,O
10.1093,O
jtm,O
taaa027,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Solidarity,O
with,O
China,O
as,O
it,O
holds,O
the,O
global,O
front,O
line,O
during,O
COVID19,B-Disease_COVID-19
outbreak,O
.,O
"

",O
Lin,O
L(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Global,O
Health,O
and,O
Development,O
",",O
Faculty,O
of,O
Public,O
Health,O
and,O
"
",O
Policy,O
",",O
London,O
School,O
of,O
Hygiene,O
&,O
Tropical,O
Medicine,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jtm,O
taaa027,O
"
",O
PMID,O
:,O
32125432,O
"


",O
362,O
.,O
QJM,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
hcaa081,O
.,O
doi,O
:,O
10.1093,O
qjmed,O
hcaa081,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
:,O
Update,O
on,O
3rd,O
Coronavirus,O
Outbreak,O
of,O
21st,O
"
",O
Century,O
.,O
"

",O
Sahu,O
KK(1,O
),O
",",O
Mishra,O
AK(1,O
),O
",",O
Lal,O
A(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Internal,O
Medicine,O
",",O
Saint,O
Vincent,O
Hospital,O
",",O
Worcester,O
",",O
"
",O
Massachusetts,O
",",O
United,O
States,O
of,O
America,O
.,O
"
",O
(2)Division,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Mayo,O
Clinic,O
",",O
Rochester,O
",",O
"
",O
Minnesota,O
",",O
United,O
States,O
of,O
America,O
.,O
"

",O
DOI,O
:,O
10.1093,O
qjmed,O
hcaa081,O
"
",O
PMID,O
:,O
32125418,O
"


",O
363,O
.,O
J,O
Travel,O
Med,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
taaa031,O
.,O
doi,O
:,O
10.1093,O
jtm,O
taaa031,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
The,O
pandemic,O
of,O
social,O
media,O
panic,O
travels,O
faster,O
than,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
.,O
"

",O
Depoux,O
A(1)(2)(3,O
),O
",",O
Martin,O
S(1)(2)(3,O
),O
",",O
Karafillakis,O
E(1)(2)(3,O
),O
",",O
Bsd,O
RP(1)(2)(3,O
),O
",",O
"
",O
WilderSmith,O
A(1)(2)(3,O
),O
",",O
Larson,O
H(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Centre,O
VirchowVillerme,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(2)London,O
School,O
of,O
Hygiene,O
and,O
Tropical,O
Medicine,O
",",O
London,O
",",O
UK,O
.,O
"
",O
(3)Department,O
of,O
Epidemiology,O
and,O
Global,O
Health,O
",",O
UmeÃ¥,O
University,O
",",O
UmeÃ¥,O
",",O
Sweden,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jtm,O
taaa031,O
"
",O
PMID,O
:,O
32125413,O
"


",O
364,O
.,O
JAMA,O
.,O
2020,O
Mar,O
3,O
.,O
doi,O
:,O
10.1001,O
jama.2020.3151,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Response,O
to,O
COVID19,B-Disease_COVID-19
in,O
Taiwan,O
:,O
Big,O
Data,O
Analytics,O
",",O
New,O
Technology,O
",",O
and,O
Proactive,O
"
",O
Testing,O
.,O
"

",O
Wang,O
CJ(1)(2,O
),O
",",O
Ng,O
CY(2,O
),O
",",O
Brook,O
RH(3)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Departments,O
of,O
Pediatrics,O
",",O
Medicine,O
",",O
and,O
Health,O
Research,O
and,O
Policy,O
",",O
Stanford,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Stanford,O
",",O
California,O
.,O
"
",O
(2)The,O
New,O
School,O
for,O
Leadership,O
in,O
Health,O
Care,O
",",O
Koo,O
Foundation,O
Sun,O
YatSen,O
"
",O
Cancer,O
Center,O
",",O
Taipei,O
",",O
Taiwan,O
.,O
"
",O
(3)David,O
Geffen,O
School,O
of,O
Medicine,O
",",O
Department,O
of,O
Medicine,O
",",O
University,O
of,O
"
",O
California,O
",",O
Los,O
Angeles,O
.,O
"
",O
(4)The,O
Pardee,O
RAND,O
Graduate,O
School,O
",",O
RAND,O
Corporation,O
",",O
Santa,O
Monica,O
",",O
California,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.3151,O
"
",O
PMID,O
:,O
32125371,O
"


",O
365,O
.,O
JAMA,O
.,O
2020,O
Mar,O
3,O
.,O
doi,O
:,O
10.1001,O
jama.2020.3204,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Epidemiologic,O
Features,O
and,O
Clinical,O
Course,O
of,O
Patients,O
Infected,O
With,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
in,O
Singapore,O
.,O
"

",O
Young,O
BE(1)(2)(3,O
),O
",",O
Ong,O
SWX(1)(2,O
),O
",",O
Kalimuddin,O
S(4)(5,O
),O
",",O
Low,O
JG(4)(6,O
),O
",",O
Tan,O
SY(7,O
),O
",",O
"
",O
Loh,O
J(8,O
),O
",",O
Ng,O
OT(1)(2)(3,O
),O
",",O
Marimuthu,O
K(1)(2)(9,O
),O
",",O
Ang,O
LW(1,O
),O
",",O
Mak,O
TM(1,O
),O
",",O
Lau,O
SK(10,O
),O
",",O
"
",O
Anderson,O
DE(6,O
),O
",",O
Chan,O
KS(4,O
),O
",",O
Tan,O
TY(6)(7,O
),O
",",O
Ng,O
TY(8,O
),O
",",O
Cui,O
L(1,O
),O
",",O
Said,O
Z(11,O
),O
",",O
"
",O
Kurupatham,O
L(11,O
),O
",",O
Chen,O
MI(1)(12,O
),O
",",O
Chan,O
M(1)(2,O
),O
",",O
Vasoo,O
S(1)(2,O
),O
",",O
Wang,O
LF(6,O
),O
",",O
Tan,O
"
",O
BH(3)(10,O
),O
",",O
Lin,O
RTP(1,O
),O
",",O
Lee,O
VJM(11)(12,O
),O
",",O
Leo,O
YS(1)(2)(3)(9)(12,O
),O
",",O
Lye,O
"
",O
DC(1)(2)(3)(9,O
),O
;,O
Singapore,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
Outbreak,O
Research,O
Team,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Centre,O
for,O
Infectious,O
Diseases,O
",",O
Singapore,O
.,O
"
",O
(2)Tan,O
Tock,O
Seng,O
Hospital,O
",",O
Singapore,O
.,O
"
",O
(3)Lee,O
Kong,O
Chian,O
School,O
of,O
Medicine,O
",",O
Singapore,O
.,O
"
",O
(4)Singapore,O
General,O
Hospital,O
",",O
Singapore,O
.,O
"
",O
(5)DukeNUS,O
Graduate,O
Medical,O
School,O
",",O
Singapore,O
.,O
"
",O
(6)DukeNUS,O
Medical,O
School,O
",",O
Singapore,O
.,O
"
",O
(7)Changi,O
General,O
Hospital,O
",",O
Singapore,O
.,O
"
",O
(8)Sengkang,O
General,O
Hospital,O
",",O
Singapore,O
.,O
"
",O
(9)Yong,O
Loo,O
Lin,O
School,O
of,O
Medicine,O
",",O
Singapore,O
.,O
"
",O
(10)DSO,O
National,O
Laboratories,O
",",O
Singapore,O
.,O
"
",O
(11)Ministry,O
of,O
Health,O
",",O
Singapore,O
.,O
"
",O
(12)Saw,O
Swee,O
Hock,O
School,O
of,O
Public,O
Health,O
",",O
Singapore,O
.,O
"

",O
Importance,O
:,O
Severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
emerged,O
"
",O
in,O
Wuhan,O
",",O
China,O
",",O
in,O
December,O
2019,O
and,O
has,O
spread,O
globally,O
with,O
sustained,O
"
",O
humantohuman,O
transmission,O
outside,O
China,O
.,O
"
",O
Objective,O
:,O
To,O
report,O
the,O
initial,O
experience,O
in,O
Singapore,O
with,O
the,O
epidemiologic,O
"
",O
investigation,O
of,O
this,O
outbreak,O
",",O
clinical,O
features,O
",",O
and,O
management,O
.,O
"
",O
Design,O
",",O
Setting,O
",",O
and,O
Participants,O
:,O
Descriptive,O
case,O
series,O
of,O
the,O
first,O
18,O
"
",O
patients,O
diagnosed,O
with,O
polymerase,O
chain,O
reaction,O
(PCR)confirmed,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
infection,O
at,O
4,O
hospitals,O
in,O
Singapore,O
from,O
January,O
23,O
to,O
February,O
3,O
",",O
2020,O
;,O
final,O
"
",O
followup,O
date,O
was,O
February,O
25,O
",",O
2020,O
.,O
"
",O
Exposures,O
:,O
Confirmed,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"
",O
Main,O
Outcomes,O
and,O
Measures,O
:,O
Clinical,O
",",O
laboratory,O
",",O
and,O
radiologic,O
data,O
were,O
"
",O
collected,O
",",O
including,O
PCR,O
cycle,O
threshold,O
values,O
from,O
nasopharyngeal,O
swabs,O
and,O
"
",O
viral,O
shedding,O
in,O
blood,O
",",O
urine,O
",",O
and,O
stool,O
.,O
Clinical,O
course,O
was,O
summarized,O
",",O
"
",O
including,O
requirement,O
for,O
supplemental,O
oxygen,O
and,O
intensive,O
care,O
and,O
use,O
of,O
"
",O
empirical,O
treatment,O
with,O
lopinavirritonavir,O
.,O
"
",O
Results,O
:,O
Among,O
the,O
18,O
hospitalized,O
patients,O
with,O
PCRconfirmed,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
infection,O
(,O
median,O
age,O
",",O
47,O
years,O
;,O
9,O
[,O
50,O
%,O
],O
women,O
),O
",",O
clinical,O
presentation,O
was,O
an,O
"
",O
upper,O
respiratory,O
tract,O
infection,O
in,O
12,O
(,O
67,O
%,O
),O
",",O
and,O
viral,O
shedding,O
from,O
the,O
"
",O
nasopharynx,O
was,O
prolonged,O
for,O
7,O
days,O
or,O
longer,O
among,O
15,O
(,O
83,O
%,O
),O
.,O
Six,O
individuals,O
"
",O
(,O
33,O
%,O
),O
required,O
supplemental,O
oxygen,O
;,O
of,O
these,O
",",O
2,O
required,O
intensive,O
care,O
.,O
There,O
"
",O
were,O
no,O
deaths,O
.,O
Virus,O
was,O
detectable,O
in,O
the,O
stool,O
(,O
4,O
8,O
[,O
50,O
%,O
],O
),O
and,O
blood,O
(,O
1,O
12,O
"
",O
[,O
8,O
%,O
],O
),O
by,O
PCR,O
but,O
not,O
in,O
urine,O
.,O
Five,O
individuals,O
requiring,O
supplemental,O
oxygen,O
"
",O
were,O
treated,O
with,O
lopinavirritonavir,O
.,O
For,O
3,O
of,O
the,O
5,O
patients,O
",",O
fever,O
resolved,O
"
",O
and,O
supplemental,O
oxygen,O
requirement,O
was,O
reduced,O
within,O
3,O
days,O
",",O
whereas,O
2,O
"
",O
deteriorated,O
with,O
progressive,O
respiratory,O
failure,O
.,O
Four,O
of,O
the,O
5,O
patients,O
treated,O
"
",O
with,O
lopinavirritonavir,O
developed,O
nausea,O
",",O
vomiting,O
",",O
and,O
or,O
diarrhea,O
",",O
and,O
3,O
"
",O
developed,O
abnormal,O
liver,O
function,O
test,O
results,O
.,O
"
",O
Conclusions,O
and,O
Relevance,O
:,O
Among,O
the,O
first,O
18,O
patients,O
diagnosed,O
with,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
infection,O
in,O
Singapore,O
",",O
clinical,O
presentation,O
was,O
frequently,O
a,O
mild,O
respiratory,O
"
",O
tract,O
infection,O
.,O
Some,O
patients,O
required,O
supplemental,O
oxygen,O
and,O
had,O
variable,O
"
",O
clinical,O
outcomes,O
following,O
treatment,O
with,O
an,O
antiretroviral,O
agent,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.3204,O
"
",O
PMID,O
:,O
32125362,O
"


",O
366,O
.,O
JAMA,O
.,O
2020,O
Mar,O
3,O
.,O
doi,O
:,O
10.1001,O
jama.2020.3413,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Priorities,O
for,O
the,O
US,O
Health,O
Community,O
Responding,O
to,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Adalja,O
AA(1,O
),O
",",O
Toner,O
E(1,O
),O
",",O
Inglesby,O
TV(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Johns,O
Hopkins,O
Center,O
for,O
Health,O
Security,O
and,O
the,O
Department,O
of,O
Environmental,O
"
",O
Health,O
and,O
Engineering,O
",",O
Johns,O
Hopkins,O
Bloomberg,O
School,O
of,O
Public,O
Health,O
",",O
Johns,O
"
",O
Hopkins,O
University,O
",",O
Baltimore,O
",",O
Maryland,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.3413,O
"
",O
PMID,O
:,O
32125355,O
"


",O
367,O
.,O
Emerg,O
Infect,O
Dis,O
.,O
2020,O
Jun,O
17;26(6,O
),O
.,O
doi,O
:,O
10.3201,O
eid2606.200239,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Community,O
Transmission,O
of,O
Severe,B-Virus_SARS-CoV-2
Acute,I-Virus_SARS-CoV-2
Respiratory,I-Virus_SARS-CoV-2
Syndrome,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
",",O
"
",O
Shenzhen,O
",",O
China,O
",",O
2020,O
.,O
"

",O
Liu,O
J,O
",",O
Liao,O
X,O
",",O
Qian,O
S,O
",",O
Yuan,O
J,O
",",O
Wang,O
F,O
",",O
Liu,O
Y,O
",",O
Wang,O
Z,O
",",O
Wang,O
FS,O
",",O
Liu,O
L,O
",",O
Zhang,O
Z.,O
"

",O
Since,O
early,O
January,O
2020,O
",",O
after,O
the,O
outbreak,O
of,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
"
",O
in,O
Wuhan,O
",",O
China,O
",",O
â‰ˆ365,O
confirmed,O
cases,O
have,O
been,O
reported,O
in,O
Shenzhen,O
",",O
China,O
.,O
The,O
"
",O
mode,O
of,O
community,O
and,O
intrafamily,O
transmission,O
is,O
threatening,O
residents,O
in,O
"
",O
Shenzhen,O
.,O
Strategies,O
to,O
strengthen,O
prevention,O
and,O
interruption,O
of,O
these,O
"
",O
transmissions,O
should,O
be,O
urgently,O
addressed,O
.,O
"

",O
DOI,O
:,O
10.3201,O
eid2606.200239,O
"
",O
PMID,O
:,O
32125269,O
"


",O
368,O
.,O
ACS,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
10,O
.,O
doi,O
:,O
10.1021,O
acsinfecdis.0c00052,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Broad,O
Spectrum,O
Antiviral,O
Agent,O
Niclosamide,O
and,O
Its,O
Therapeutic,O
Potential,O
.,O
"

",O
Xu,O
J,O
",",O
Shi,O
PY,O
",",O
Li,O
H(1,O
),O
",",O
Zhou,O
J.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Wadsworth,O
Center,O
",",O
New,O
York,O
State,O
Department,O
of,O
Health,O
",",O
120,O
New,O
Scotland,O
"
",O
Avenue,O
",",O
Albany,O
",",O
New,O
York,O
12208,O
",",O
United,O
States,O
.,O
"

",O
The,O
recent,O
outbreak,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
highlights,O
an,O
urgent,O
"
",O
need,O
for,O
therapeutics,O
.,O
Through,O
a,O
series,O
of,O
drug,O
repurposing,O
screening,O
campaigns,O
",",O
"
",O
niclosamide,O
",",O
an,O
FDAapproved,O
anthelminthic,O
drug,O
",",O
was,O
found,O
to,O
be,O
effective,O
"
",O
against,O
various,O
viral,O
infections,O
with,O
nanomolar,O
to,O
micromolar,O
potency,O
such,O
as,O
"
",O
SARSCoV,O
",",O
MERSCoV,O
",",O
ZIKV,O
",",O
HCV,O
",",O
and,O
human,O
adenovirus,O
",",O
indicating,O
its,O
potential,O
as,O
"
",O
an,O
antiviral,O
agent,O
.,O
In,O
this,O
brief,O
review,O
",",O
we,O
summarize,O
the,O
broad,O
antiviral,O
"
",O
activity,O
of,O
niclosamide,O
and,O
highlight,O
its,O
potential,O
clinical,O
use,O
in,O
the,O
treatment,O
"
",O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
DOI,O
:,O
10.1021,O
acsinfecdis.0c00052,O
"
",O
PMID,O
:,O
32125140,O
"


",O
369,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
3,O
.,O
doi,O
:,O
10.1002,O
jmv.25742,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Fecal,O
specimen,O
diagnosis,O
2019,O
novel,O
coronavirusinfected,O
pneumonia,O
.,O
"

",O
Zhang,O
J(1,O
),O
",",O
Wang,O
S(1,O
),O
",",O
Xue,O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Respiration,O
",",O
Jinhua,O
Municipal,O
Central,O
Hospital,O
",",O
Jinhua,O
Hospital,O
"
",O
of,O
Zhejiang,O
University,O
",",O
Jinhua,O
",",O
China,O
.,O
"

",O
The,O
emergence,O
and,O
spread,O
of,O
2019,O
novel,O
coronavirusinfected,O
pneumonia,O
(,O
COVID19,B-Disease_COVID-19
),O
"
",O
from,O
Wuhan,O
",",O
China,O
",",O
it,O
has,O
spread,O
globally,O
.,O
We,O
extracted,O
the,O
data,O
on,O
14,O
patients,O
"
",O
with,O
laboratoryconfirmed,O
COVID19,B-Disease_COVID-19
from,O
Jinhua,O
Municipal,O
Central,O
hospital,O
through,O
"
",O
27,O
January,O
2020,O
.,O
We,O
found,O
that,O
compared,O
to,O
pharyngeal,O
swab,O
specimens,O
",",O
nucleic,O
"
",O
acid,O
detection,O
of,O
COVID19,B-Disease_COVID-19
in,O
fecal,O
specimens,O
was,O
equally,O
accurate,O
.,O
And,O
we,O
found,O
"
",O
that,O
patients,O
with,O
a,O
positive,O
stool,O
test,O
did,O
not,O
experience,O
gastrointestinal,O
"
",O
symptoms,O
and,O
had,O
nothing,O
to,O
do,O
with,O
the,O
severity,O
of,O
the,O
lung,O
infection,O
.,O
These,O
"
",O
results,O
may,O
help,O
to,O
understand,O
the,O
clinical,O
diagnosis,O
and,O
the,O
changes,O
in,O
clinical,O
"
",O
parameters,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25742,O
"
",O
PMID,O
:,O
32124995,O
"


",O
370,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
3,O
.,O
doi,O
:,O
10.1002,O
jmv.25743,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Analyzing,O
the,O
epidemiological,O
outbreak,O
of,O
COVID19,B-Disease_COVID-19
:,O
A,O
visual,O
exploratory,O
data,O
"
",O
analysis,O
approach,O
.,O
"

",O
Dey,O
SK(1,O
),O
",",O
Rahman,O
MM(2,O
),O
",",O
Siddiqi,O
UR(3,O
),O
",",O
Howlader,O
A(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Computer,O
Science,O
and,O
Engineering,O
",",O
Dhaka,O
International,O
University,O
"
",O
(,O
DIU,O
),O
",",O
Dhaka,O
",",O
Bangladesh,O
.,O
"
",O
(2)Department,O
of,O
Computer,O
Science,O
and,O
Engineering,O
",",O
Military,O
Institute,O
of,O
Science,O
"
",O
and,O
Technology,O
(,O
MIST,O
),O
",",O
Mirpur,O
Cantonment,O
",",O
Dhaka,O
",",O
Bangladesh,O
.,O
"
",O
(3)Department,O
of,O
Physiology,O
",",O
Shaheed,O
Suhrawardy,O
Medical,O
College,O
(,O
ShSMC,O
),O
",",O
Dhaka,O
",",O
"
",O
Bangladesh,O
.,O
"
",O
(4)Department,O
of,O
Computer,O
and,O
Communication,O
Engineering,O
",",O
Patuakhali,O
Science,O
and,O
"
",O
Technology,O
University,O
(,O
PSTU,O
),O
",",O
Dumki,O
",",O
Bangladesh,O
.,O
"

",O
There,O
is,O
an,O
obvious,O
concern,O
globally,O
regarding,O
the,O
fact,O
about,O
the,O
emerging,O
"
",O
coronavirus,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
as,O
a,O
worldwide,O
public,O
health,O
"
",O
threat,O
.,O
As,O
the,O
outbreak,O
of,O
COVID19,B-Disease_COVID-19
causes,O
by,O
the,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
progresses,O
within,O
China,O
and,O
beyond,O
",",O
rapidly,O
"
",O
available,O
epidemiological,O
data,O
are,O
needed,O
to,O
guide,O
strategies,O
for,O
situational,O
"
",O
awareness,O
and,O
intervention,O
.,O
The,O
recent,O
outbreak,O
of,O
pneumonia,O
in,O
Wuhan,O
",",O
China,O
",",O
"
",O
caused,O
by,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
emphasizes,O
the,O
importance,O
of,O
analyzing,O
the,O
"
",O
epidemiological,O
data,O
of,O
this,O
novel,O
virus,O
and,O
predicting,O
their,O
risks,O
of,O
infecting,O
"
",O
people,O
all,O
around,O
the,O
globe,O
.,O
In,O
this,O
study,O
",",O
we,O
present,O
an,O
effort,O
to,O
compile,O
and,O
"
",O
analyze,O
epidemiological,O
outbreak,O
information,O
on,O
COVID19,B-Disease_COVID-19
based,O
on,O
the,O
several,O
"
",O
open,O
datasets,O
on,O
2019nCoV,B-Virus_SARS-CoV-2
provided,O
by,O
the,O
Johns,O
Hopkins,O
University,O
",",O
World,O
Health,O
"
",O
Organization,O
",",O
Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
National,O
Health,O
"
",O
Commission,O
",",O
and,O
DXY,O
.,O
An,O
exploratory,O
data,O
analysis,O
with,O
visualizations,O
has,O
been,O
"
",O
made,O
to,O
understand,O
the,O
number,O
of,O
different,O
cases,O
reported,O
(,O
confirmed,O
",",O
death,O
",",O
and,O
"
",O
recovered,O
),O
in,O
different,O
provinces,O
of,O
China,O
and,O
outside,O
of,O
China,O
.,O
Overall,O
",",O
at,O
the,O
"
",O
outset,O
of,O
an,O
outbreak,O
like,O
this,O
",",O
it,O
is,O
highly,O
important,O
to,O
readily,O
provide,O
"
",O
information,O
to,O
begin,O
the,O
evaluation,O
necessary,O
to,O
understand,O
the,O
risks,O
and,O
begin,O
"
",O
containment,O
activities,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25743,O
"
",O
PMID,O
:,O
32124990,O
"


",O
371,O
.,O
Acad,O
Emerg,O
Med,O
.,O
2020,O
Mar,O
2,O
.,O
doi,O
:,O
10.1111,O
acem.13951,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Hospital,O
Emergency,O
Management,O
Plan,O
During,O
the,O
COVID19,B-Disease_COVID-19
Epidemic,O
.,O
"

",O
Cao,O
Y(1)(2,O
),O
",",O
Li,O
Q(3)(4)(5,O
),O
",",O
Chen,O
J(2)(6,O
),O
",",O
Guo,O
X(7,O
),O
",",O
Miao,O
C(1)(2,O
),O
",",O
Yang,O
H(2)(6,O
),O
",",O
"
",O
Chen,O
Z(8,O
),O
",",O
Li,O
C(1)(2)(9,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Head,O
and,O
Neck,O
Oncology,O
",",O
West,O
China,O
Hospital,O
of,O
Stomatology,O
",",O
"
",O
Sichuan,O
University,O
",",O
Chengdu,O
",",O
610041,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Oral,O
Diseases,O
",",O
West,O
China,O
College,O
of,O
Stomatology,O
",",O
"
",O
Sichuan,O
University,O
",",O
610041,O
",",O
China,O
.,O
"
",O
(3)Emergency,O
Department,O
",",O
West,O
China,O
Hospital,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
",",O
"
",O
610041,O
",",O
China,O
.,O
"
",O
(4)Institute,O
of,O
Disaster,O
Medicine,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
",",O
610041,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Emergency,O
and,O
Trauma,O
Nursing,O
",",O
West,O
China,O
Nursing,O
School,O
",",O
Sichuan,O
"
",O
University,O
",",O
Chengdu,O
",",O
610041,O
",",O
China,O
.,O
"
",O
(6)Operation,O
room,O
",",O
West,O
China,O
Hospital,O
of,O
Stomatology,O
",",O
Chengdu,O
",",O
610041,O
",",O
China,O
.,O
"
",O
(7)College,O
of,O
Foreign,O
Languages,O
and,O
Cultures,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
",",O
"
",O
610207,O
",",O
China,O
.,O
"
",O
(8)Department,O
of,O
Pathology,O
",",O
West,O
China,O
Hospital,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
",",O
"
",O
610041,O
",",O
China,O
.,O
"
",O
(9)Medical,O
Administration,O
Department,O
",",O
West,O
China,O
Hospital,O
of,O
Stomatology,O
",",O
Sichuan,O
"
",O
University,O
",",O
Chengdu,O
",",O
610041,O
",",O
China,O
.,O
"

",O
The,O
confirmed,O
and,O
suspected,O
cases,O
of,O
the,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
have,O
increased,O
not,O
only,O
in,O
Wuhan,O
",",O
Hubei,O
Province,O
but,O
also,O
China,O
and,O
"
",O
the,O
world,O
.,O
Enormous,O
demand,O
for,O
handling,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
challenged,O
both,O
the,O
"
",O
healthcare,O
personnel,O
and,O
medical,O
supply,O
system,O
.,O
In,O
West,O
China,O
Hospital,O
",",O
Emergency,O
"
",O
Department,O
(,O
ED,O
),O
undertook,O
the,O
mission,O
of,O
clinical,O
reception,O
",",O
primary,O
diagnosis,O
",",O
"
",O
and,O
interim,O
treatment,O
for,O
the,O
suspected,O
cases,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1111,O
acem.13951,O
"
",O
PMID,O
:,O
32124506,O
"


",O
372,O
.,O
Sci,O
China,O
Life,O
Sci,O
.,O
2020,O
Feb,O
29,O
.,O
doi,O
:,O
10.1007,O
s1142702016602,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Clinical,O
trials,O
for,O
the,O
treatment,O
of,O
Coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
:,O
A,O
rapid,O
"
",O
response,O
to,O
urgent,O
need,O
.,O
"

",O
Zhang,O
T(1,O
),O
",",O
He,O
Y(2,O
),O
",",O
Xu,O
W(2,O
),O
",",O
Ma,O
A(3,O
),O
",",O
Yang,O
Y(2,O
),O
",",O
Xu,O
KF(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Internal,O
Medicine,O
",",O
Peking,O
Union,O
Medical,O
College,O
Hospital,O
",",O
"
",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
100730,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Peking,O
Union,O
Medical,O
"
",O
College,O
Hospital,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
100730,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
First,O
Affiliated,O
"
",O
Hospital,O
",",O
College,O
of,O
Medicine,O
",",O
Xiamen,O
University,O
",",O
Xiamen,O
",",O
361003,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Peking,O
Union,O
Medical,O
"
",O
College,O
Hospital,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
100730,O
",",O
China,O
.,O
"
",O
xukf@pumch.cn,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s1142702016602,O
"
",O
PMID,O
:,O
32124179,O
"


",O
373,O
.,O
Graefes,O
Arch,O
Clin,O
Exp,O
Ophthalmol,O
.,O
2020,O
Mar,O
3,O
.,O
doi,O
:,O
10.1007,O
s00417020046418,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Stepping,O
up,O
infection,O
control,O
measures,O
in,O
ophthalmology,O
during,O
the,O
novel,O
"
",O
coronavirus,O
outbreak,O
:,O
an,O
experience,O
from,O
Hong,O
Kong,O
.,O
"

",O
Lai,O
THT(1)(2,O
),O
",",O
Tang,O
EWH(1)(2,O
),O
",",O
Chau,O
SKY(3,O
),O
",",O
Fung,O
KSC(4,O
),O
",",O
Li,O
KKW(5)(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Ophthalmology,O
",",O
United,O
Christian,O
Hospital,O
",",O
130,O
Hip,O
Wo,O
Street,O
",",O
"
",O
Kwun,O
Tong,O
",",O
Kowloon,O
",",O
Hong,O
Kong,O
SAR,O
.,O
"
",O
(2)Department,O
of,O
Ophthalmology,O
",",O
Tseung,O
Kwan,O
O,O
Hospital,O
",",O
2,O
Po,O
Ning,O
Path,O
",",O
Tseung,O
"
",O
Kwan,O
O,O
",",O
Hong,O
Kong,O
SAR,O
.,O
"
",O
(3)Department,O
of,O
Pathology,O
",",O
Tseung,O
Kwan,O
O,O
Hospital,O
",",O
2,O
Po,O
Ning,O
Path,O
",",O
Tseung,O
Kwan,O
"
",O
O,O
",",O
Hong,O
Kong,O
SAR,O
.,O
"
",O
(4)Department,O
of,O
Pathology,O
",",O
United,O
Christian,O
Hospital,O
",",O
130,O
Hip,O
Wo,O
Street,O
",",O
Kwun,O
"
",O
Tong,O
",",O
Kowloon,O
",",O
Hong,O
Kong,O
SAR,O
.,O
"
",O
(5)Department,O
of,O
Ophthalmology,O
",",O
United,O
Christian,O
Hospital,O
",",O
130,O
Hip,O
Wo,O
Street,O
",",O
"
",O
Kwun,O
Tong,O
",",O
Kowloon,O
",",O
Hong,O
Kong,O
SAR,O
.,O
kennethli@rcsed.ac.uk,O
.,O
"
",O
(6)Department,O
of,O
Ophthalmology,O
",",O
Tseung,O
Kwan,O
O,O
Hospital,O
",",O
2,O
Po,O
Ning,O
Path,O
",",O
Tseung,O
"
",O
Kwan,O
O,O
",",O
Hong,O
Kong,O
SAR,O
.,O
kennethli@rcsed.ac.uk,O
.,O
"

",O
PURPOSE,O
:,O
Coronavirus,O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
has,O
rapidly,O
emerged,O
as,O
a,O
global,O
health,O
"
",O
threat,O
.,O
The,O
purpose,O
of,O
this,O
article,O
is,O
to,O
share,O
our,O
local,O
experience,O
of,O
stepping,O
"
",O
up,O
infection,O
control,O
measures,O
in,O
ophthalmology,O
to,O
minimise,O
COVID19,B-Disease_COVID-19
infection,O
of,O
"
",O
both,O
healthcare,O
workers,O
and,O
patients,O
.,O
"
",O
METHODS,O
:,O
Infection,O
control,O
measures,O
implemented,O
in,O
our,O
ophthalmology,O
clinic,O
are,O
"
",O
discussed,O
.,O
The,O
measures,O
are,O
based,O
on,O
detailed,O
risk,O
assessment,O
by,O
both,O
local,O
"
",O
ophthalmologists,O
and,O
infection,O
control,O
experts,O
.,O
"
",O
RESULTS,O
:,O
A,O
threelevel,O
hierarchy,O
of,O
control,O
measures,O
was,O
adopted,O
.,O
First,O
",",O
for,O
"
",O
administrative,O
control,O
",",O
in,O
order,O
to,O
lower,O
patient,O
attendance,O
",",O
text,O
messages,O
"
",O
with,O
Â ,O
an,O
enquiry,O
phone,O
Â ,O
number,O
were,O
sent,O
to,O
patients,O
to,O
reschedule,O
appointments,O
or,O
"
",O
arrange,O
drug,O
refill,O
.,O
In,O
order,O
to,O
minimise,O
crossinfection,O
of,O
COVID19,B-Disease_COVID-19
",",O
a,O
triage,O
"
",O
system,O
was,O
set,O
up,O
to,O
identify,O
patients,O
with,O
fever,O
",",O
respiratory,O
symptoms,O
",",O
acute,O
"
",O
conjunctivitis,O
or,O
recent,O
travel,O
to,O
outbreak,O
areas,O
and,O
to,O
encourage,O
these,O
"
",O
individuals,O
to,O
postpone,O
their,O
appointments,O
for,O
at,O
least,O
14,O
Â ,O
days,O
.,O
Microaerosol,O
"
",O
generating,O
procedures,O
",",O
such,O
as,O
noncontact,O
tonometry,O
and,O
operations,O
under,O
general,O
"
",O
anaesthesia,O
were,O
avoided,O
.,O
Nasal,O
endoscopy,O
was,O
avoided,O
as,O
it,O
may,O
provoke,O
sneezing,O
"
",O
and,O
cause,O
generation,O
of,O
droplets,O
.,O
All,O
elective,O
clinical,O
services,O
were,O
suspended,O
.,O
"
",O
Infection,O
control,O
training,O
was,O
provided,O
to,O
all,O
clinical,O
staff,O
.,O
Second,O
",",O
for,O
"
",O
environmental,O
control,O
",",O
to,O
reduce,O
droplet,O
transmission,O
of,O
COVID19,B-Disease_COVID-19
",",O
installation,O
"
",O
of,O
protective,O
shields,O
on,O
slit,O
lamps,O
",",O
frequent,O
disinfection,O
of,O
equipment,O
",",O
and,O
"
",O
provision,O
of,O
eye,O
protection,O
to,O
staff,O
were,O
implemented,O
.,O
All,O
staff,O
were,O
advised,O
to,O
"
",O
measure,O
their,O
own,O
body,O
temperatures,O
before,O
work,O
and,O
promptly,O
report,O
any,O
symptoms,O
"
",O
of,O
upper,O
respiratory,O
tract,O
infection,O
",",O
vomiting,O
or,O
diarrhoea,O
.,O
Third,O
",",O
universal,O
"
",O
masking,O
",",O
hand,O
hygiene,O
",",O
and,O
appropriate,O
use,O
of,O
personal,O
protective,O
equipment,O
(,O
PPE,O
),O
"
",O
were,O
promoted,O
.,O
"
",O
CONCLUSION,O
:,O
We,O
hope,O
our,O
initial,O
experience,O
in,O
stepping,O
up,O
infection,O
control,O
"
",O
measures,O
for,O
COVID19,B-Disease_COVID-19
infection,O
in,O
ophthalmology,O
can,O
help,O
ophthalmologists,O
"
",O
globally,O
to,O
prepare,O
for,O
the,O
potential,O
community,O
outbreak,O
or,O
pandemic,O
.,O
In,O
order,O
to,O
"
",O
minimise,O
transmission,O
of,O
COVID19,B-Disease_COVID-19
",",O
ophthalmologists,O
should,O
work,O
closely,O
with,O
"
",O
local,O
infection,O
control,O
teams,O
to,O
implement,O
infection,O
control,O
measures,O
that,O
are,O
"
",O
appropriate,O
for,O
their,O
own,O
clinical,O
settings,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00417020046418,O
"
",O
PMID,O
:,O
32124000,O
"


",O
374,O
.,O
Intensive,O
Care,O
Med,O
.,O
2020,O
Mar,O
2,O
.,O
doi,O
:,O
10.1007,O
s00134020059797,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Critical,O
care,O
crisis,O
and,O
some,O
recommendations,O
during,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
in,O
"
",O
China,O
.,O
"

",O
Xie,O
J(1,O
),O
",",O
Tong,O
Z(2,O
),O
",",O
Guan,O
X(3,O
),O
",",O
Du,O
B(4,O
),O
",",O
Qiu,O
H(5,O
),O
",",O
Slutsky,O
AS(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Zhongda,O
Hospital,O
",",O
School,O
of,O
Medicine,O
",",O
"
",O
Southeast,O
University,O
",",O
Nanjing,O
",",O
210009,O
",",O
Jiangsu,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Beijing,O
Institute,O
of,O
"
",O
Respiratory,O
Medicine,O
",",O
Beijing,O
Chaoyang,O
Hospital,O
",",O
Capital,O
Medical,O
University,O
",",O
"
",O
Beijing,O
",",O
100020,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Sun,O
"
",O
Yatsen,O
University,O
",",O
Guangzhou,O
",",O
510080,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(4)Medical,O
ICU,O
",",O
Peking,O
Union,O
Medical,O
College,O
Hospital,O
",",O
Peking,O
Union,O
Medical,O
"
",O
College,O
and,O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
100730,O
",",O
China,O
.,O
"
",O
dubin98@gmail.com,O
.,O
"
",O
(5)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Zhongda,O
Hospital,O
",",O
School,O
of,O
Medicine,O
",",O
"
",O
Southeast,O
University,O
",",O
Nanjing,O
",",O
210009,O
",",O
Jiangsu,O
",",O
China,O
.,O
haiboq2000@163.com,O
.,O
"
",O
(6)Keenan,O
Research,O
Center,O
at,O
the,O
Li,O
Ka,O
Shing,O
Knowledge,O
Institute,O
",",O
St.,O
Michael,O
's,O
"
",O
Hospital,O
and,O
Departments,O
of,O
Medicine,O
",",O
Surgery,O
",",O
and,O
Biomedical,O
Engineering,O
",",O
"
",O
University,O
of,O
Toronto,O
",",O
Toronto,O
",",O
Canada,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00134020059797,O
"
",O
PMID,O
:,O
32123994,O
"


",O
375,O
.,O
Intensive,O
Care,O
Med,O
.,O
2020,O
Mar,O
2,O
.,O
doi,O
:,O
10.1007,O
s00134020059877,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Clinical,O
features,O
and,O
shortterm,O
outcomes,O
of,O
18,O
patients,O
with,O
corona,O
virus,O
"
",O
disease,O
2019,O
in,O
intensive,O
care,O
unit,O
.,O
"

",O
Cao,O
J(1,O
),O
",",O
Hu,O
X(1,O
),O
",",O
Cheng,O
W(1,O
),O
",",O
Yu,O
L(2,O
),O
",",O
Tu,O
WJ(3,O
),O
",",O
Liu,O
Q(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Cardiology,O
",",O
Zhongnan,O
Hospital,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
People,O
's,O
"
",O
Republic,O
of,O
China,O
.,O
"
",O
(2)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
Fourth,O
Affiliated,O
Hospital,O
of,O
Harbin,O
"
",O
Medical,O
University,O
",",O
Harbin,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(3)Institute,O
of,O
Radiation,O
Medicine,O
",",O
China,O
Academy,O
of,O
Medical,O
Science,O
and,O
Peking,O
"
",O
Union,O
Medical,O
College,O
",",O
No.,O
238,O
",",O
Baiti,O
Road,O
",",O
Tianjin,O
",",O
300192,O
",",O
People,O
's,O
Republic,O
of,O
"
",O
China,O
.,O
tuwenjun@irmcams.ac.cn,O
.,O
"
",O
(4)Institute,O
of,O
Radiation,O
Medicine,O
",",O
China,O
Academy,O
of,O
Medical,O
Science,O
and,O
Peking,O
"
",O
Union,O
Medical,O
College,O
",",O
No.,O
238,O
",",O
Baiti,O
Road,O
",",O
Tianjin,O
",",O
300192,O
",",O
People,O
's,O
Republic,O
of,O
"
",O
China,O
.,O
liuqiang@irmcams.ac.cn,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00134020059877,O
"
",O
PMID,O
:,O
32123993,O
"


",O
376,O
.,O
Intensive,O
Care,O
Med,O
.,O
2020,O
Mar,O
2,O
.,O
doi,O
:,O
10.1007,O
s00134020059779,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
The,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
infections,O
in,O
China,O
:,O
prevention,O
",",O
control,O
and,O
"
",O
challenges,O
.,O
"

",O
Zhang,O
S(1,O
),O
",",O
Diao,O
MY(2,O
),O
",",O
Duan,O
L(3,O
),O
",",O
Lin,O
Z(4,O
),O
",",O
Chen,O
D(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Ruijin,O
Hospital,O
",",O
Shanghai,O
Jiao,O
Tong,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
200025,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Affiliated,O
Hangzhou,O
First,O
People,O
's,O
"
",O
Hospital,O
",",O
Zhejiang,O
University,O
School,O
of,O
Medicine,O
",",O
Hangzhou,O
",",O
310006,O
",",O
Zhejiang,O
",",O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Emergency,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Changzheng,O
Hospital,O
",",O
Naval,O
"
",O
Medical,O
University,O
(,O
Second,O
Military,O
Medical,O
University,O
),O
",",O
Shanghai,O
",",O
200433,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Emergency,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Changzheng,O
Hospital,O
",",O
Naval,O
"
",O
Medical,O
University,O
(,O
Second,O
Military,O
Medical,O
University,O
),O
",",O
Shanghai,O
",",O
200433,O
",",O
China,O
.,O
"
",O
linzhaofen@hotmail.com,O
.,O
"
",O
(5)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Ruijin,O
Hospital,O
",",O
Shanghai,O
Jiao,O
Tong,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
200025,O
",",O
China,O
.,O
"
",O
chendechangsh@hotmail.com,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00134020059779,O
"
",O
PMID,O
:,O
32123989,O
"


",O
377,O
.,O
Intensive,O
Care,O
Med,O
.,O
2020,O
Mar,O
2,O
.,O
doi,O
:,O
10.1007,O
s0013402005990y,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Imaging,O
changes,O
of,O
severe,O
COVID19,B-Disease_COVID-19
pneumonia,O
in,O
advanced,O
stage,O
.,O
"

",O
Zhang,O
W(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Emergency,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Affiliated,O
Hospital,O
of,O
"
",O
Zunyi,O
Medical,O
University,O
",",O
Zunyi,O
Medical,O
University,O
",",O
149,O
Dalian,O
Road,O
",",O
Zunyi,O
",",O
"
",O
563000,O
",",O
Guizhou,O
",",O
China,O
.,O
zhangwei_hxicu@163.com,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s0013402005990y,O
"
",O
PMID,O
:,O
32123986,O
"


",O
378,O
.,O
Nat,O
Microbiol,O
.,O
2020,O
Mar,O
2,O
.,O
doi,O
:,O
10.1038,O
s415640200695z,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
species,O
Severe,O
acute,O
respiratory,O
syndromerelated,O
coronavirus,O
:,O
classifying,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
and,O
naming,O
it,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Coronaviridae,O
Study,O
Group,O
of,O
the,O
International,O
Committee,O
on,O
Taxonomy,O
of,O
Viruses,O
.,O
"

",O
Collaborators,O
:,O
Gorbalenya,O
AE,O
",",O
Baker,O
SC,O
",",O
Baric,O
RS,O
",",O
de,O
Groot,O
RJ,O
",",O
Drosten,O
C,O
",",O
"
",O
Gulyaeva,O
AA,O
",",O
Haagmans,O
BL,O
",",O
Lauber,O
C,O
",",O
Leontovich,O
AM,O
",",O
Neuman,O
BW,O
",",O
Penzar,O
D,O
",",O
Perlman,O
"
",O
S,O
",",O
Poon,O
LLM,O
",",O
Samborskiy,O
DV,O
",",O
Sidorov,O
IA,O
",",O
Sola,O
I,O
",",O
Ziebuhr,O
J.,O
"

",O
DOI,O
:,O
10.1038,O
s415640200695z,O
"
",O
PMID,O
:,O
32123347,O
"


",O
379,O
.,O
Cell,O
Death,O
Dis,O
.,O
2020,O
Mar,O
2;11(3):160,O
.,O
doi,O
:,O
10.1038,O
s4141902023164,O
.,O
"

",O
Highmobility,O
group,O
AThook,O
1,O
promotes,O
cardiac,O
dysfunction,O
in,O
diabetic,O
"
",O
cardiomyopathy,O
via,O
autophagy,O
inhibition,O
.,O
"

",O
Wu,O
QQ(1)(2)(3,O
),O
",",O
Liu,O
C(1)(2)(3,O
),O
",",O
Cai,O
Z(1)(2)(3,O
),O
",",O
Xie,O
Q(1)(2)(3,O
),O
",",O
Hu,O
T(1)(2)(3,O
),O
",",O
"
",O
Duan,O
M(1)(2)(3,O
),O
",",O
Wu,O
H(1)(2)(3,O
),O
",",O
Yuan,O
Y(4)(5)(6,O
),O
",",O
Tang,O
Q(7)(8)(9,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Cardiology,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430060,O
",",O
"
",O
P.,O
R.,O
China,O
.,O
"
",O
(2)Cardiovascular,O
Research,O
Institute,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430060,O
",",O
P.,O
R.,O
"
",O
China,O
.,O
"
",O
(3)Hubei,O
Key,O
Laboratory,O
of,O
Cardiology,O
",",O
Wuhan,O
",",O
430060,O
",",O
P.,O
R.,O
China,O
.,O
"
",O
(4)Department,O
of,O
Cardiology,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430060,O
",",O
"
",O
P.,O
R.,O
China,O
.,O
whuyuanyuan@whu.edu.cn,O
.,O
"
",O
(5)Cardiovascular,O
Research,O
Institute,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430060,O
",",O
P.,O
R.,O
"
",O
China,O
.,O
whuyuanyuan@whu.edu.cn,O
.,O
"
",O
(6)Hubei,O
Key,O
Laboratory,O
of,O
Cardiology,O
",",O
Wuhan,O
",",O
430060,O
",",O
P.,O
R.,O
China,O
.,O
"
",O
whuyuanyuan@whu.edu.cn,O
.,O
"
",O
(7)Department,O
of,O
Cardiology,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430060,O
",",O
"
",O
P.,O
R.,O
China,O
.,O
qztang@whu.edu.cn,O
.,O
"
",O
(8)Cardiovascular,O
Research,O
Institute,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430060,O
",",O
P.,O
R.,O
"
",O
China,O
.,O
qztang@whu.edu.cn,O
.,O
"
",O
(9)Hubei,O
Key,O
Laboratory,O
of,O
Cardiology,O
",",O
Wuhan,O
",",O
430060,O
",",O
P.,O
R.,O
China,O
.,O
"
",O
qztang@whu.edu.cn,O
.,O
"

",O
Highmobility,O
group,O
AThook1,O
(,O
HMGA1,O
",",O
formerly,O
HMGI,O
Y,O
),O
",",O
an,O
architectural,O
"
",O
transcription,O
factor,O
",",O
participates,O
in,O
a,O
number,O
of,O
biological,O
processes,O
.,O
However,O
",",O
"
",O
its,O
effect,O
on,O
cardiac,O
remodeling,O
(,O
refer,O
to,O
cardiac,O
inflammation,O
",",O
apoptosis,O
and,O
"
",O
dysfunction,O
),O
in,O
diabetic,O
cardiomyopathy,O
remains,O
largely,O
indistinct,O
.,O
In,O
this,O
"
",O
study,O
",",O
we,O
found,O
that,O
HMGA1,O
was,O
upregulated,O
in,O
diabetic,O
mouse,O
hearts,O
and,O
"
",O
highglucosestimulated,O
cardiomyocytes,O
.,O
Overexpression,O
of,O
HMGA1,O
accelerated,O
"
",O
highglucoseinduced,O
cardiomyocyte,O
inflammation,O
and,O
apoptosis,O
",",O
while,O
HMGA1,O
"
",O
knockdown,O
relieved,O
inflammation,O
and,O
apoptosis,O
in,O
cardiomyocytes,O
in,O
response,O
to,O
"
",O
high,O
glucose,O
.,O
Overexpression,O
of,O
HMGA1,O
in,O
mice,O
heart,O
by,O
adenoassociated,O
virus,O
9,O
"
",O
(,O
AAV9,O
),O
delivery,O
system,O
deteriorated,O
the,O
inflammatory,O
response,O
",",O
increased,O
"
",O
apoptosis,O
and,O
accelerated,O
cardiac,O
dysfunction,O
in,O
streptozotocininduced,O
diabetic,O
"
",O
mouse,O
model,O
.,O
Knockdown,O
of,O
HMGA1,O
by,O
AAV9shHMGA1,O
in,O
vivo,O
ameliorated,O
cardiac,O
"
",O
remodeling,O
in,O
diabetic,O
mice,O
.,O
Mechanistically,O
",",O
we,O
found,O
that,O
HMGA1,O
inhibited,O
the,O
"
",O
formation,O
rather,O
than,O
the,O
degradation,O
of,O
autophagy,O
by,O
regulating,O
P27,O
CDK2,O
mTOR,O
"
",O
signaling,O
.,O
CDK2,O
knockdown,O
or,O
P27,O
overexpression,O
blurred,O
HMGA1,O
"
",O
overexpressioninduced,O
deteriorating,O
effects,O
in,O
vitro,O
.,O
P27,O
overexpression,O
in,O
mice,O
"
",O
heart,O
counteracted,O
HMGA1,O
overexpressioninduced,O
increased,O
cardiac,O
remodeling,O
in,O
"
",O
diabetic,O
mice,O
.,O
The,O
luciferase,O
reporter,O
experiment,O
confirmed,O
that,O
the,O
regulatory,O
"
",O
effect,O
of,O
HMGA1,O
on,O
P27,O
was,O
mediated,O
by,O
miR222,O
.,O
In,O
addition,O
",",O
a,O
miR222,O
antagomir,O
"
",O
counteracted,O
HMGA1,O
overexpressioninduced,O
deteriorating,O
effects,O
in,O
vitro,O
.,O
Taken,O
"
",O
together,O
",",O
our,O
data,O
indicate,O
that,O
HMGA1,O
aggravates,O
diabetic,O
cardiomyopathy,O
by,O
"
",O
directly,O
regulating,O
miR222,O
promoter,O
activity,O
",",O
which,O
inhibits,O
P27,O
mTORinduced,O
"
",O
autophagy,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s4141902023164,O
"
",O
PMCID,O
:,O
PMC7052237,O
"
",O
PMID,O
:,O
32123163,O
"


",O
380,O
.,O
Proc,O
Natl,O
Acad,O
Sci,O
U,O
S,O
A.,O
2020,O
Mar,O
2,O
.,O
pii,O
:,O
201906954,O
.,O
doi,O
:,O
"
",O
10.1073,O
pnas.1906954117,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Assessing,O
the,O
role,O
of,O
live,O
poultry,O
trade,O
in,O
communitystructured,O
transmission,O
of,O
"
",O
avian,O
influenza,O
in,O
China,O
.,O
"

",O
Yang,O
Q(1,O
),O
",",O
Zhao,O
X(2,O
),O
",",O
Lemey,O
P(3,O
),O
",",O
Suchard,O
MA(4)(5)(6,O
),O
",",O
Bi,O
Y(7)(8,O
),O
",",O
Shi,O
W(9,O
),O
",",O
Liu,O
"
",O
D(10,O
),O
",",O
Qi,O
W(11,O
),O
",",O
Zhang,O
G(12,O
),O
",",O
Stenseth,O
NC(13,O
),O
",",O
Pybus,O
OG(14)(15,O
),O
",",O
Tian,O
H(16,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Remote,O
Sensing,O
Science,O
",",O
College,O
of,O
Global,O
Change,O
and,O
"
",O
Earth,O
System,O
Science,O
",",O
Beijing,O
Normal,O
University,O
",",O
100875,O
Beijing,O
",",O
China,O
.,O
"
",O
(2)National,O
Institute,O
for,O
Viral,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Collaboration,O
"
",O
Innovation,O
Center,O
for,O
Diagnosis,O
and,O
Treatment,O
of,O
Infectious,O
Diseases,O
",",O
Chinese,O
"
",O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Key,O
Laboratory,O
for,O
Medical,O
Virology,O
",",O
"
",O
National,O
Health,O
and,O
Family,O
Planning,O
Commission,O
",",O
102206,O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Microbiology,O
",",O
Immunology,O
and,O
Transplantation,O
",",O
Rega,O
Institute,O
",",O
"
",O
Clinical,O
and,O
Epidemiological,O
Virology,O
",",O
KU,O
Leuven,O
",",O
3000,O
Leuven,O
",",O
Belgium,O
.,O
"
",O
(4)Department,O
of,O
Biomathematics,O
",",O
David,O
Geffen,O
School,O
of,O
Medicine,O
",",O
University,O
of,O
"
",O
California,O
",",O
Los,O
Angeles,O
",",O
CA,O
90095,O
.,O
"
",O
(5)Department,O
of,O
Human,O
Genetics,O
",",O
David,O
Geffen,O
School,O
of,O
Medicine,O
",",O
University,O
of,O
"
",O
California,O
",",O
Los,O
Angeles,O
",",O
CA,O
90095,O
.,O
"
",O
(6)Department,O
of,O
Biostatistics,O
",",O
UCLA,O
Fielding,O
School,O
of,O
Public,O
Health,O
",",O
University,O
"
",O
of,O
California,O
",",O
Los,O
Angeles,O
",",O
CA,O
90095,O
.,O
"
",O
(7)Shenzhen,O
Key,O
Laboratory,O
of,O
Pathogen,O
and,O
Immunity,O
",",O
Guangdong,O
Key,O
Laboratory,O
for,O
"
",O
Diagnosis,O
and,O
Treatment,O
of,O
Emerging,O
Infectious,O
Diseases,O
",",O
State,O
Key,O
Discipline,O
of,O
"
",O
Infectious,O
Disease,O
",",O
Second,O
Hospital,O
Affiliated,O
to,O
Southern,O
University,O
of,O
Science,O
"
",O
and,O
Technology,O
",",O
Shenzhen,O
Third,O
People,O
's,O
Hospital,O
",",O
518112,O
Shenzhen,O
",",O
China,O
.,O
"
",O
(8)Key,O
Laboratory,O
of,O
Pathogenic,O
Microbiology,O
and,O
Immunology,O
",",O
Institute,O
of,O
"
",O
Microbiology,O
",",O
Center,O
for,O
Influenza,O
Research,O
and,O
EarlyWarning,O
(,O
CASCIRE,O
),O
",",O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
10010,O
Beijing,O
",",O
China,O
.,O
"
",O
(9)Institute,O
of,O
Pathogen,O
Biology,O
",",O
Taishan,O
Medical,O
College,O
",",O
271000,O
Taian,O
",",O
"
",O
Shandong,O
",",O
China,O
.,O
"
",O
(10)Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
430071,O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(11)National,O
and,O
Regional,O
Joint,O
Engineering,O
Laboratory,O
for,O
Medicament,O
of,O
Zoonoses,O
"
",O
Prevention,O
and,O
Control,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
South,O
China,O
Agricultural,O
"
",O
University,O
",",O
510642,O
Guangzhou,O
",",O
China,O
.,O
"
",O
(12)Research,O
Institute,O
of,O
Forest,O
Ecology,O
",",O
Environment,O
and,O
Protection,O
",",O
National,O
"
",O
Bird,O
Banding,O
Center,O
of,O
China,O
",",O
Chinese,O
Academy,O
of,O
Forestry,O
",",O
Key,O
Laboratory,O
of,O
"
",O
Forest,O
Protection,O
of,O
State,O
Forestry,O
and,O
Grassland,O
Administration,O
",",O
100091,O
Beijing,O
",",O
"
",O
China,O
.,O
"
",O
(13)Centre,O
for,O
Ecological,O
and,O
Evolutionary,O
Synthesis,O
(,O
CEES,O
),O
",",O
Department,O
of,O
"
",O
Biosciences,O
",",O
University,O
of,O
Oslo,O
",",O
N0316,O
Oslo,O
",",O
Norway,O
;,O
n.c.stenseth@ibv.uio.no,O
"
",O
oliver.pybus@zoo.ox.ac.uk,O
tianhuaiyu@gmail.com,O
.,O
"
",O
(14)Department,O
of,O
Zoology,O
",",O
University,O
of,O
Oxford,O
",",O
OX1,O
3PS,O
Oxford,O
",",O
United,O
Kingdom,O
;,O
"
",O
n.c.stenseth@ibv.uio.no,O
oliver.pybus@zoo.ox.ac.uk,O
tianhuaiyu@gmail.com,O
.,O
"
",O
(15)Department,O
of,O
Pathobiology,O
and,O
Population,O
Sciences,O
",",O
The,O
Royal,O
Veterinary,O
"
",O
College,O
",",O
AL9,O
7TA,O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
(16)State,O
Key,O
Laboratory,O
of,O
Remote,O
Sensing,O
Science,O
",",O
College,O
of,O
Global,O
Change,O
and,O
"
",O
Earth,O
System,O
Science,O
",",O
Beijing,O
Normal,O
University,O
",",O
100875,O
Beijing,O
",",O
China,O
;,O
"
",O
n.c.stenseth@ibv.uio.no,O
oliver.pybus@zoo.ox.ac.uk,O
tianhuaiyu@gmail.com,O
.,O
"

",O
The,O
live,O
poultry,O
trade,O
is,O
thought,O
to,O
play,O
an,O
important,O
role,O
in,O
the,O
spread,O
and,O
"
",O
maintenance,O
of,O
highly,O
pathogenic,O
avian,O
influenza,O
A,O
viruses,O
(,O
HP,O
AIVs,O
),O
in,O
Asia,O
.,O
"
",O
Despite,O
an,O
abundance,O
of,O
smallscale,O
observational,O
studies,O
",",O
the,O
role,O
of,O
the,O
"
",O
poultry,O
trade,O
in,O
disseminating,O
AIV,O
over,O
large,O
geographic,O
areas,O
is,O
still,O
unclear,O
",",O
"
",O
especially,O
for,O
developing,O
countries,O
with,O
complex,O
poultry,O
production,O
systems,O
.,O
Here,O
"
",O
we,O
combine,O
virus,O
genomes,O
and,O
reconstructed,O
poultry,O
transportation,O
data,O
to,O
measure,O
"
",O
and,O
compare,O
the,O
spatial,O
spread,O
in,O
China,O
of,O
three,O
key,O
subtypes,O
of,O
AIV,O
:,O
H5N1,O
",",O
H7N9,O
",",O
"
",O
and,O
H5N6,O
.,O
Although,O
it,O
is,O
difficult,O
to,O
disentangle,O
the,O
contribution,O
of,O
confounding,O
"
",O
factors,O
",",O
such,O
as,O
bird,O
migration,O
and,O
spatial,O
distance,O
",",O
we,O
find,O
evidence,O
that,O
the,O
"
",O
dissemination,O
of,O
these,O
subtypes,O
among,O
domestic,O
poultry,O
is,O
geographically,O
"
",O
continuous,O
and,O
likely,O
associated,O
with,O
the,O
intensity,O
of,O
the,O
live,O
poultry,O
trade,O
in,O
"
",O
China,O
.,O
Using,O
two,O
independent,O
data,O
sources,O
and,O
network,O
analysis,O
methods,O
",",O
we,O
report,O
"
",O
a,O
regionalscale,O
community,O
structure,O
in,O
China,O
that,O
might,O
explain,O
the,O
spread,O
of,O
"
",O
AIV,O
subtypes,O
in,O
the,O
country,O
.,O
The,O
identification,O
of,O
this,O
structure,O
has,O
the,O
"
",O
potential,O
to,O
inform,O
more,O
targeted,O
strategies,O
for,O
the,O
prevention,O
and,O
control,O
of,O
"
",O
AIV,O
in,O
China,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
the,O
Author(s,O
),O
.,O
Published,O
by,O
PNAS,O
.,O
"

",O
DOI,O
:,O
10.1073,O
pnas.1906954117,O
"
",O
PMID,O
:,O
32123088,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
competing,O
interest,O
.,O
"


",O
381,O
.,O
BMJ,O
.,O
2020,O
Mar,O
2;368:m831,O
.,O
doi,O
:,O
10.1136,O
bmj.m831,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
retired,O
doctors,O
could,O
be,O
asked,O
to,O
return,O
to,O
work,O
",",O
says,O
Hancock,O
.,O
"

",O
Mahase,O
E(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m831,O
"
",O
PMID,O
:,O
32122881,O
"


",O
382,O
.,O
BMJ,O
.,O
2020,O
Mar,O
2;368:m764,O
.,O
doi,O
:,O
10.1136,O
bmj.m764,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
a,O
digital,O
epidemic,O
.,O
"

",O
Chiolero,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Population,O
Health,O
Laboratory,O
",",O
#,O
PopHealthLab,O
",",O
University,O
of,O
Fribourg,O
",",O
1700,O
"
",O
Fribourg,O
",",O
Switzerland,O
.,O
"

",O
Comment,O
on,O
"
    ",O
BMJ,O
.,O
2020,O
Feb,O
7;368:m516,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m764,O
"
",O
PMID,O
:,O
32122876,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interests,O
:,O
None,O
declared,O
.,O
"


",O
383,O
.,O
BMJ,O
.,O
2020,O
Mar,O
2;368:m833,O
.,O
doi,O
:,O
10.1136,O
bmj.m833,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
US,O
health,O
department,O
staff,O
sent,O
to,O
meet,O
citizens,O
returning,O
from,O
China,O
"
",O
were,O
n't,O
protected,O
",",O
claims,O
whistleblower,O
.,O
"

",O
Dyer,O
O(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Montreal,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m833,O
"
",O
PMID,O
:,O
32122875,O
"


",O
384,O
.,O
J,O
Integr,O
Med,O
.,O
2020,O
Feb,O
19,O
.,O
pii,O
:,O
S20954964(20)300145,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.joim.2020.02.004,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Traditional,O
Chinese,O
medicine,O
is,O
a,O
resource,O
for,O
drug,O
discovery,O
against,O
2019,O
novel,O
"
",O
coronavirus,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
.,O
"

",O
Ling,O
CQ(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
Naval,O
Medical,O
University,O
",",O
Shanghai,O
"
",O
200433,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
changquanling@smmu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.joim.2020.02.004,O
"
",O
PMID,O
:,O
32122812,O
"


",O
385,O
.,O
Vet,O
Microbiol,O
.,O
2020,O
Mar;242:108578,O
.,O
doi,O
:,O
10.1016,O
j.vetmic.2020.108578,O
.,O
Epub,O
2020,O
"
",O
Jan,O
11,O
.,O
"

",O
AAVexpressed,O
G,O
protein,O
induces,O
robust,O
humoral,O
and,O
cellular,O
immune,O
response,O
and,O
"
",O
provides,O
durable,O
protection,O
from,O
rabies,O
virus,O
challenges,O
in,O
mice,O
.,O
"

",O
Liu,O
C(1,O
),O
",",O
Li,O
J(2,O
),O
",",O
Yao,O
Q(1,O
),O
",",O
Gao,O
Z(3,O
),O
",",O
Cheng,O
Y(2,O
),O
",",O
Zhou,O
M(4,O
),O
",",O
Tang,O
Y(2,O
),O
",",O
Sun,O
"
",O
L(2,O
),O
",",O
Dai,O
J(2,O
),O
",",O
Cao,O
G(2,O
),O
",",O
Zhang,O
XL(5,O
),O
",",O
Zhang,O
R(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
and,O
Hubei,O
Province,O
Key,O
Laboratory,O
of,O
Allergy,O
"
",O
and,O
ImmuneRelated,O
Diseases,O
",",O
Medical,O
Research,O
Institute,O
and,O
Department,O
of,O
"
",O
Immunology,O
of,O
Wuhan,O
University,O
School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Wuhan,O
430061,O
",",O
"
",O
Hubei,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Science,O
and,O
Technology,O
",",O
The,O
Second,O
Hospital,O
of,O
Hebei,O
Medical,O
"
",O
University,O
",",O
Shijiazhuang,O
50000,O
",",O
Hebei,O
",",O
China,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Antibody,O
Research,O
&,O
Development,O
",",O
New,O
Drug,O
Research,O
and,O
"
",O
Development,O
Company,O
Ltd.,O
",",O
North,O
China,O
Pharmaceutical,O
Corporation,O
",",O
Shijiazhuang,O
"
",O
50015,O
",",O
China,O
.,O
"
",O
(5)State,O
Key,O
Laboratory,O
of,O
Virology,O
and,O
Hubei,O
Province,O
Key,O
Laboratory,O
of,O
Allergy,O
"
",O
and,O
ImmuneRelated,O
Diseases,O
",",O
Medical,O
Research,O
Institute,O
and,O
Department,O
of,O
"
",O
Immunology,O
of,O
Wuhan,O
University,O
School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Wuhan,O
430061,O
",",O
"
",O
Hubei,O
",",O
China,O
;,O
State,O
Key,O
Laboratory,O
of,O
Antibody,O
Research,O
&,O
Development,O
",",O
New,O
Drug,O
"
",O
Research,O
and,O
Development,O
Company,O
Ltd.,O
",",O
North,O
China,O
Pharmaceutical,O
Corporation,O
",",O
"
",O
Shijiazhuang,O
50015,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
zhangxiaolian@whu.edu.cn,O
.,O
"
",O
(6)College,O
of,O
Life,O
Sciences,O
",",O
Hebei,O
Normal,O
University,O
",",O
Shijiazhuang,O
50024,O
",",O
Hebei,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
zhangranvet@163.com,O
.,O
"

",O
Rabies,O
is,O
a,O
highly,O
lethal,O
infectious,O
zoonosis,O
caused,O
by,O
rabies,O
virus,O
(,O
RABV,O
),O
",",O
and,O
"
",O
the,O
mortality,O
rate,O
is,O
almost,O
100,O
%,O
once,O
clinical,O
symptoms,O
appear,O
",",O
which,O
poses,O
a,O
"
",O
huge,O
threat,O
to,O
public,O
health,O
security,O
across,O
the,O
many,O
parts,O
of,O
the,O
word,O
.,O
"
",O
Vaccination,O
is,O
reported,O
to,O
be,O
the,O
most,O
effective,O
approach,O
to,O
prevent,O
the,O
disease,O
.,O
"
",O
G,O
protein,O
is,O
the,O
only,O
protein,O
present,O
on,O
the,O
surface,O
of,O
RABV,O
",",O
it,O
also,O
could,O
"
",O
induce,O
humoral,O
immunity,O
to,O
produce,O
virus,O
neutralizing,O
antibodies,O
(,O
VNA,O
),O
and,O
"
",O
stimulate,O
T,O
cells,O
to,O
produce,O
cellular,O
immunity,O
.,O
Adenoassociated,O
viruses,O
(,O
AAVs,O
),O
"
",O
have,O
been,O
used,O
as,O
vectors,O
for,O
gene,O
therapy,O
of,O
different,O
human,O
diseases,O
for,O
its,O
"
",O
low,O
immunogenicity,O
",",O
high,O
safety,O
and,O
longterm,O
stable,O
expression,O
.,O
To,O
develop,O
a,O
"
",O
safe,O
and,O
effective,O
vaccine,O
",",O
recombinant,O
AAVs,O
containing,O
different,O
kind,O
of,O
G,O
gene,O
"
",O
were,O
constructed,O
.,O
After,O
intramuscular,O
(,O
i.m,O
.,O
),O
immunization,O
in,O
mice,O
",",O
all,O
of,O
these,O
"
",O
rAAVG,O
vaccines,O
could,O
induce,O
the,O
production,O
of,O
high,O
levels,O
of,O
VNA,O
and,O
effective,O
"
",O
cellular,O
immune,O
response,O
.,O
Consistently,O
",",O
all,O
of,O
the,O
rAAVG,O
vaccines,O
could,O
provide,O
"
",O
protection,O
against,O
lethal,O
RABV,O
challenge,O
.,O
Our,O
results,O
shown,O
that,O
the,O
rAAVG,O
"
",O
vaccines,O
could,O
be,O
potential,O
candidates,O
used,O
in,O
the,O
control,O
of,O
RABV,O
infection,O
.,O
In,O
"
",O
addition,O
",",O
rAAVG,O
as,O
a,O
vaccine,O
has,O
many,O
advantages,O
of,O
low,O
preparation,O
cost,O
",",O
simple,O
"
",O
storage,O
and,O
transportation,O
conditions,O
(,O
4,O
Â°,O
C,O
storage,O
and,O
transportation,O
),O
",",O
simple,O
"
",O
immunization,O
program,O
(,O
only,O
one,O
immunization,O
),O
and,O
so,O
on,O
.,O
Thence,O
",",O
the,O
rAAVG,O
"
",O
vaccines,O
could,O
be,O
potential,O
candidates,O
used,O
in,O
the,O
control,O
of,O
RABV,O
infection,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.vetmic.2020.108578,O
"
",O
PMID,O
:,O
32122589,O
"


",O
386,O
.,O
Lancet,O
.,O
2020,O
Feb,O
29;395(10225):686687,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303585,O
.,O
Epub,O
"
",O
2020,O
Feb,O
12,O
.,O
"

",O
AntiChinese,O
sentiment,O
during,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
outbreak,O
.,O
"

",O
Chung,O
RY(1,O
),O
",",O
Li,O
MM(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Public,O
Health,O
&,O
Primary,O
Care,O
",",O
Faculty,O
of,O
Medicine,O
",",O
The,O
Chinese,O
"
",O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
;,O
Institute,O
of,O
Health,O
Equity,O
",",O
The,O
Chinese,O
"
",O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
.,O
Electronic,O
address,O
:,O
rychung@cuhk.edu.hk,O
.,O
"
",O
(2)Department,O
of,O
Social,O
Sciences,O
",",O
Faculty,O
of,O
Liberal,O
Arts,O
and,O
Social,O
Sciences,O
",",O
"
",O
The,O
Education,O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
.,O
"

",O
Comment,O
in,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
22;395(10224):539540,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303585,O
"
",O
PMID,O
:,O
32122469,O
"


",O
387,O
.,O
Lancet,O
.,O
2020,O
Feb,O
29;395(10225):683684,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303615,O
.,O
Epub,O
"
",O
2020,O
Feb,O
12,O
.,O
"

",O
On,O
the,O
use,O
of,O
corticosteroids,O
for,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
.,O
"

",O
Shang,O
L(1,O
),O
",",O
Zhao,O
J(2,O
),O
",",O
Hu,O
Y(3,O
),O
",",O
Du,O
R(4,O
),O
",",O
Cao,O
B(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Beijing,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Beijing,O
",",O
China,O
;,O
Department,O
of,O
"
",O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
"
",O
Respiratory,O
Diseases,O
",",O
ChinaJapan,O
Friendship,O
Hospital,O
",",O
Beijing,O
100029,O
",",O
China,O
;,O
"
",O
Institute,O
of,O
Respiratory,O
Medicine,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
Central,O
Hospital,O
of,O
"
",O
Wuhan,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Wuhan,O
Pulmonary,O
Hospital,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
National,O
Clinical,O
Research,O
"
",O
Center,O
for,O
Respiratory,O
Diseases,O
",",O
ChinaJapan,O
Friendship,O
Hospital,O
",",O
Beijing,O
100029,O
",",O
"
",O
China,O
;,O
Institute,O
of,O
Respiratory,O
Medicine,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
"
",O
Beijing,O
",",O
China,O
;,O
Department,O
of,O
Respiratory,O
Medicine,O
",",O
Capital,O
Medical,O
University,O
",",O
"
",O
Beijing,O
",",O
China,O
;,O
Tsinghua,O
UniversityPeking,O
University,O
Joint,O
Center,O
for,O
Life,O
"
",O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
caobin_ben@163.com,O
.,O
"

",O
Comment,O
on,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):473475,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303615,O
"
",O
PMID,O
:,O
32122468,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
388,O
.,O
Infect,O
Control,O
Hosp,O
Epidemiol,O
.,O
2020,O
Mar,O
0.206944444,O
.,O
doi,O
:,O
10.1017,O
ice.2020.61,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Identification,O
of,O
COVID19,B-Disease_COVID-19
Can,O
be,O
Quicker,O
through,O
Artificial,O
Intelligence,O
"
",O
framework,O
using,O
a,O
Mobile,O
PhoneBased,O
Survey,O
in,O
the,O
Populations,O
when,O
Cities,O
Towns,O
"
",O
Are,O
Under,O
Quarantine,O
.,O
"

",O
Rao,O
ASRS(1,O
),O
",",O
Vazquez,O
JA(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Professor,O
",",O
Division,O
of,O
Health,O
Economics,O
and,O
Modeling,O
",",O
Department,O
of,O
Population,O
"
",O
Health,O
Sciences,O
",",O
Medical,O
College,O
of,O
Georgia,O
",",O
Augusta,O
University,O
",",O
Augusta,O
",",O
USA,O
"
",O
Director,O
",",O
Laboratory,O
for,O
Theory,O
and,O
Mathematical,O
Modeling,O
",",O
Division,O
of,O
Infectious,O
"
",O
Diseases,O
",",O
Department,O
of,O
Medicine,O
",",O
Medical,O
College,O
of,O
Georgia,O
",",O
Augusta,O
",",O
GA30912,O
",",O
"
",O
USA,O
.,O
Department,O
of,O
Mathematics,O
Augusta,O
University,O
",",O
1120,O
",",O
15th,O
Street,O
",",O
AE,O
1015,O
"
",O
Augusta,O
",",O
GA,O
",",O
30912,O
",",O
USA,O
Tel,O
:,O
+,O
17067213786,O
(,O
office,O
),O
.,O
"
",O
(2)Chief,O
and,O
Professor,O
",",O
Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Medicine,O
",",O
"
",O
Medical,O
College,O
of,O
Georgia,O
",",O
Augusta,O
University,O
",",O
1120,O
",",O
15th,O
Street,O
",",O
AE,O
1015,O
"
",O
Augusta,O
",",O
GA,O
",",O
30912,O
",",O
USA,O
Tel,O
:,O
+,O
17067230105,O
(,O
office,O
),O
.,O
"

",O
We,O
are,O
proposing,O
to,O
use,O
machine,O
learning,O
algorithms,O
to,O
be,O
able,O
to,O
improve,O
"
",O
possible,O
case,O
identifications,O
of,O
COVID19,B-Disease_COVID-19
more,O
quicker,O
when,O
we,O
use,O
a,O
mobile,O
"
",O
phonebased,O
web,O
survey,O
.,O
This,O
will,O
also,O
reduce,O
the,O
spread,O
in,O
the,O
susceptible,O
"
",O
populations,O
.,O
"

",O
DOI,O
:,O
10.1017,O
ice.2020.61,O
"
",O
PMID,O
:,O
32122430,O
"


",O
389,O
.,O
Viruses,O
.,O
2020,O
Feb,O
29;12(3,O
),O
.,O
pii,O
:,O
E273,O
.,O
doi,O
:,O
10.339,O
v12030273,O
.,O
"

",O
SOX2,O
Represses,O
Hepatitis,O
B,O
Virus,O
Replication,O
by,O
Binding,O
to,O
the,O
Viral,O
EnhII,O
Cp,O
and,O
"
",O
Inhibiting,O
the,O
Promoter,O
Activation,O
.,O
"

",O
Yang,O
H(1,O
),O
",",O
Mo,O
J(1,O
),O
",",O
Xiang,O
Q(1,O
),O
",",O
Zhao,O
P(1,O
),O
",",O
Song,O
Y(1,O
),O
",",O
Yang,O
G(1,O
),O
",",O
Wu,O
K(1,O
),O
",",O
Liu,O
"
",O
Y(1)(2,O
),O
",",O
Liu,O
W(3,O
),O
",",O
Wu,O
J(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
430072,O
",",O
China,O
.,O
"
",O
(2)Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Institute,O
of,O
Medical,O
"
",O
Microbiology,O
",",O
Jinan,O
University,O
",",O
Guangzhou,O
510632,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Clinical,O
Laboratory,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
430030,O
",",O
China,O
.,O
"

",O
Hepatitis,O
B,O
virus,O
(,O
HBV,O
),O
replication,O
is,O
controlled,O
by,O
four,O
promoters,O
(,O
preS1,O
",",O
"
",O
preS2,O
",",O
Cp,O
",",O
and,O
Xp,O
),O
and,O
two,O
enhancers,O
(,O
EnhI,O
and,O
EnhII,O
),O
.,O
EnhII,O
stimulates,O
Cp,O
"
",O
activity,O
to,O
regulate,O
the,O
transcriptions,O
of,O
precore,O
",",O
core,O
",",O
polymerase,O
",",O
and,O
"
",O
pregenomic,O
RNAs,O
",",O
and,O
therefore,O
",",O
EnhII,O
Cp,O
is,O
essential,O
for,O
the,O
regulation,O
of,O
HBV,O
"
",O
replication,O
.,O
This,O
study,O
revealed,O
a,O
distinct,O
mechanism,O
underlying,O
the,O
suppression,O
"
",O
of,O
EnhII,O
Cp,O
activation,O
and,O
HBV,O
replication,O
.,O
On,O
the,O
one,O
hand,O
",",O
the,O
sex,O
determining,O
"
",O
region,O
Y,O
box2,O
(,O
SOX2,O
),O
",",O
a,O
transcription,O
factor,O
",",O
is,O
induced,O
by,O
HBV,O
.,O
On,O
the,O
other,O
"
",O
hand,O
",",O
SOX2,O
",",O
in,O
turn,O
",",O
represses,O
the,O
expression,O
levels,O
of,O
HBV,O
RNAs,O
",",O
HBV,O
"
",O
coreassociated,O
DNA,O
",",O
hepatitis,O
B,O
surface,O
antigen,O
(,O
HBsAg,O
),O
",",O
and,O
hepatitis,O
B,O
e,O
"
",O
antigen,O
(,O
HBeAg,O
),O
",",O
thereby,O
playing,O
an,O
inhibitory,O
role,O
during,O
HBV,O
replication,O
.,O
"
",O
Further,O
studies,O
indicated,O
that,O
SOX2,O
bound,O
to,O
the,O
EnhII,O
Cp,O
DNA,O
and,O
repressed,O
the,O
"
",O
promoter,O
activation,O
.,O
With,O
the,O
deletion,O
of,O
the,O
high,O
mobility,O
group,O
(,O
HMG,O
),O
domain,O
",",O
"
",O
SOX2,O
loses,O
the,O
ability,O
to,O
repress,O
EnhII,O
Cp,O
activation,O
",",O
viral,O
RNA,O
transcription,O
",",O
"
",O
HBV,O
coreassociated,O
DNA,O
replication,O
",",O
HBsAg,O
and,O
HBeAg,O
production,O
",",O
as,O
well,O
as,O
fails,O
"
",O
to,O
enter,O
the,O
nucleus,O
",",O
demonstrating,O
that,O
the,O
HMG,O
domain,O
is,O
required,O
for,O
the,O
"
",O
SOX2mediated,O
repression,O
of,O
HBV,O
replication,O
.,O
Moreover,O
",",O
SOX2,O
represses,O
HBsAg,O
and,O
"
",O
HBeAg,O
secretion,O
in,O
BALB,O
c,O
mice,O
sera,O
",",O
and,O
attenuates,O
HBV,O
3.5,O
kb,O
RNA,O
transcription,O
"
",O
and,O
hepatitis,O
B,O
virus,O
core,O
protein,O
(,O
HBc,O
),O
production,O
in,O
the,O
liver,O
tissues,O
",",O
"
",O
demonstrating,O
that,O
SOX2,O
suppresses,O
HBV,O
replication,O
in,O
mice,O
.,O
Furthermore,O
",",O
the,O
"
",O
results,O
revealed,O
that,O
the,O
HMG,O
domain,O
was,O
required,O
for,O
SOX2mediated,O
repression,O
of,O
"
",O
HBV,O
replication,O
in,O
the,O
mice,O
.,O
Taken,O
together,O
",",O
the,O
above,O
facts,O
indicate,O
that,O
SOX2,O
"
",O
acts,O
as,O
a,O
new,O
host,O
restriction,O
factor,O
to,O
repress,O
HBV,O
replication,O
by,O
binding,O
to,O
"
",O
the,O
viral,O
EnhII,O
Cp,O
and,O
inhibiting,O
the,O
promoter,O
activation,O
through,O
the,O
HMG,O
domain,O
.,O
"

",O
DOI,O
:,O
10.339,O
v12030273,O
"
",O
PMID,O
:,O
32121397,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
390,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
29;9(3,O
),O
.,O
pii,O
:,O
E657,O
.,O
doi,O
:,O
10.339,O
jcm9030657,O
.,O
"

",O
Backcalculating,O
the,O
Incidence,O
of,O
Infection,O
with,O
COVID19,B-Disease_COVID-19
on,O
the,O
Diamond,O
Princess,O
.,O
"

",O
Nishiura,O
H(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Graduate,O
School,O
of,O
Medicine,O
",",O
Hokkaido,O
University,O
",",O
Kita,O
15,O
Jo,O
Nishi,O
7,O
Chome,O
",",O
"
",O
Kitaku,O
",",O
Sapporoshi,O
",",O
Hokkaido,O
608638,O
",",O
Japan,O
.,O
"
",O
(2)Core,O
Research,O
for,O
Evolutional,O
Science,O
and,O
Technology,O
(,O
CREST,O
),O
",",O
Japan,O
Science,O
"
",O
and,O
Technology,O
Agency,O
",",O
Honcho,O
418,O
",",O
Kawaguchi,O
",",O
Saitama,O
3320012,O
",",O
Japan,O
.,O
"

",O
To,O
understand,O
the,O
timedependent,O
risk,O
of,O
infection,O
on,O
a,O
cruise,O
ship,O
",",O
the,O
Diamond,O
"
",O
Princess,O
",",O
I,O
estimated,O
the,O
incidence,O
of,O
infection,O
with,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
.,O
The,O
epidemic,O
curve,O
of,O
a,O
total,O
of,O
199,O
confirmed,O
cases,O
was,O
drawn,O
",",O
"
",O
classifying,O
individuals,O
into,O
passengers,O
with,O
and,O
without,O
close,O
contact,O
and,O
crew,O
"
",O
members,O
.,O
A,O
backcalculation,O
method,O
was,O
employed,O
to,O
estimate,O
the,O
incidence,O
of,O
"
",O
infection,O
.,O
The,O
peak,O
time,O
of,O
infection,O
was,O
seen,O
for,O
the,O
time,O
period,O
from,O
2,O
to,O
4,O
"
",O
February,O
2020,O
",",O
and,O
the,O
incidence,O
has,O
abruptly,O
declined,O
afterwards,O
.,O
The,O
estimated,O
"
",O
number,O
of,O
new,O
infections,O
among,O
passengers,O
without,O
close,O
contact,O
was,O
very,O
small,O
"
",O
from,O
5,O
February,O
on,O
which,O
a,O
movement,O
restriction,O
policy,O
was,O
imposed,O
.,O
Without,O
the,O
"
",O
intervention,O
from,O
5,O
February,O
",",O
it,O
was,O
predicted,O
that,O
the,O
cumulative,O
incidence,O
with,O
"
",O
and,O
without,O
close,O
contact,O
would,O
have,O
been,O
as,O
large,O
as,O
1373,O
(,O
95,O
%,O
CI,O
:,O
570,O
",",O
2176,O
),O
"
",O
and,O
766,O
(,O
95,O
%,O
CI,O
:,O
587,O
",",O
946,O
),O
cases,O
",",O
respectively,O
",",O
while,O
these,O
were,O
kept,O
to,O
be,O
102,O
"
",O
and,O
47,O
cases,O
",",O
respectively,O
.,O
Based,O
on,O
an,O
analysis,O
of,O
illness,O
onset,O
data,O
on,O
board,O
",",O
"
",O
the,O
risk,O
of,O
infection,O
among,O
passengers,O
without,O
close,O
contact,O
was,O
considered,O
to,O
be,O
"
",O
very,O
limited,O
.,O
Movement,O
restriction,O
greatly,O
reduced,O
the,O
number,O
of,O
infections,O
from,O
"
",O
5,O
February,O
onwards,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9030657,O
"
",O
PMID,O
:,O
32121356,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
author,O
declares,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
391,O
.,O
Healthcare,O
(,O
Basel,O
),O
.,O
2020,O
Feb,O
27;8(1,O
),O
.,O
pii,O
:,O
E51,O
.,O
doi,O
:,O
10.339,O
healthcare8010051,O
.,O
"

",O
Outbreak,O
of,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCov2,B-Virus_SARS-CoV-2
),O
:,O
First,O
Evidences,O
From,O
International,O
"
",O
Scientific,O
Literature,O
and,O
Pending,O
Questions,O
.,O
"

",O
Amodio,O
E(1,O
),O
",",O
Vitale,O
F(1,O
),O
",",O
Cimino,O
L(1,O
),O
",",O
Casuccio,O
A(1,O
),O
",",O
Tramuto,O
F(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Health,O
Promotion,O
",",O
Maternal,O
and,O
Infant,O
Care,O
",",O
Internal,O
Medicine,O
"
",O
and,O
Medical,O
Specialties,O
",",O
"""",O
G.,O
D'Alessandro,O
"""",O
",",O
University,O
of,O
Palermo,O
",",O
Via,O
del,O
Vespro,O
"
",O
133,O
",",O
Palermo,O
90127,O
",",O
Italy,O
.,O
"

",O
On,O
31,O
December,O
",",O
2019,O
",",O
a,O
cluster,O
of,O
27,O
pneumonia,O
cases,O
of,O
unknown,O
etiology,O
was,O
"
",O
reported,O
by,O
Chinese,O
health,O
authorities,O
in,O
Wuhan,O
City,O
(,O
China,O
),O
[,O
...,O
],O
.,O
"

",O
DOI,O
:,O
10.339,O
healthcare8010051,O
"
",O
PMID,O
:,O
32120965,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Funding,O
:,O
No,O
funding,O
.,O
"


",O
392,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
27;9(3,O
),O
.,O
pii,O
:,O
E637,O
.,O
doi,O
:,O
10.339,O
jcm9030637,O
.,O
"

",O
Epidemiological,O
Identification,O
of,O
A,O
Novel,O
Pathogen,O
in,O
Real,O
Time,O
:,O
Analysis,O
of,O
the,O
"
",O
Atypical,O
Pneumonia,O
Outbreak,O
in,O
Wuhan,O
",",O
China,O
",",O
20192020,O
.,O
"

",O
Jung,O
SM(1,O
),O
",",O
Kinoshita,O
R(1,O
),O
",",O
Thompson,O
RN(2)(3,O
),O
",",O
Linton,O
NM(1,O
),O
",",O
Yang,O
Y(1,O
),O
",",O
"
",O
Akhmetzhanov,O
AR(1,O
),O
",",O
Nishiura,O
H(1)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Graduate,O
School,O
of,O
Medicine,O
",",O
Hokkaido,O
University,O
",",O
Kita,O
15,O
Jo,O
Nishi,O
7,O
Chome,O
",",O
"
",O
Kitaku,O
",",O
Sapporoshi,O
",",O
Hokkaido,O
608638,O
",",O
Japan,O
.,O
"
",O
(2)Mathematical,O
Institute,O
",",O
University,O
of,O
Oxford,O
",",O
Andrew,O
Wiles,O
Building,O
",",O
Radcliffe,O
"
",O
Observatory,O
Quarter,O
",",O
Woodstock,O
Road,O
",",O
Oxford,O
OX2,O
6GG,O
",",O
UK,O
.,O
"
",O
(3)Christ,O
Church,O
",",O
University,O
of,O
Oxford,O
",",O
St,O
Aldates,O
",",O
Oxford,O
OX1,O
1DP,O
",",O
UK,O
.,O
"
",O
(4)CREST,O
",",O
Japan,O
Science,O
and,O
Technology,O
Agency,O
",",O
Honcho,O
418,O
",",O
Kawaguchi,O
",",O
Saitama,O
"
",O
3320012,O
",",O
Japan,O
.,O
"

",O
Virological,O
tests,O
have,O
now,O
shown,O
conclusively,O
that,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
is,O
causing,O
"
",O
the,O
20192020,O
atypical,O
pneumonia,O
outbreak,O
in,O
Wuhan,O
",",O
China,O
.,O
We,O
demonstrate,O
that,O
"
",O
nonvirological,O
descriptive,O
characteristics,O
could,O
have,O
determined,O
that,O
the,O
"
",O
outbreak,O
is,O
caused,O
by,O
a,O
novel,O
pathogen,O
in,O
advance,O
of,O
virological,O
testing,O
.,O
"
",O
Characteristics,O
of,O
the,O
ongoing,O
outbreak,O
were,O
collected,O
in,O
real,O
time,O
from,O
two,O
"
",O
medical,O
social,O
media,O
sites,O
.,O
These,O
were,O
compared,O
against,O
characteristics,O
of,O
eleven,O
"
",O
pathogens,O
that,O
have,O
previously,O
caused,O
cases,O
of,O
atypical,O
pneumonia,O
.,O
The,O
"
",O
probability,O
that,O
the,O
current,O
outbreak,O
is,O
due,O
to,O
"""",O
Disease,O
X,O
"""",O
(,O
i.e.,O
",",O
previously,O
"
",O
unknown,O
etiology,O
),O
as,O
opposed,O
to,O
one,O
of,O
the,O
known,O
pathogens,O
was,O
inferred,O
",",O
and,O
this,O
"
",O
estimate,O
was,O
updated,O
as,O
the,O
outbreak,O
continued,O
.,O
The,O
probability,O
(,O
expressed,O
as,O
a,O
"
",O
percentage,O
),O
that,O
Disease,O
X,O
is,O
driving,O
the,O
outbreak,O
was,O
assessed,O
as,O
over,O
29,O
%,O
on,O
31,O
"
",O
December,O
2019,O
",",O
one,O
week,O
before,O
virus,O
identification,O
.,O
After,O
some,O
specific,O
"
",O
pathogens,O
were,O
ruled,O
out,O
by,O
laboratory,O
tests,O
on,O
5,O
January,O
2020,O
",",O
the,O
inferred,O
"
",O
probability,O
of,O
Disease,O
X,O
was,O
over,O
49,O
%,O
.,O
We,O
showed,O
quantitatively,O
that,O
the,O
emerging,O
"
",O
outbreak,O
of,O
atypical,O
pneumonia,O
cases,O
is,O
consistent,O
with,O
causation,O
by,O
a,O
novel,O
"
",O
pathogen,O
.,O
The,O
proposed,O
approach,O
",",O
which,O
uses,O
only,O
routinely,O
observed,O
"
",O
nonvirological,O
data,O
",",O
can,O
aid,O
ongoing,O
risk,O
assessments,O
in,O
advance,O
of,O
virological,O
"
",O
test,O
results,O
becoming,O
available,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9030637,O
"
",O
PMID,O
:,O
32120913,O
"


",O
393,O
.,O
Healthcare,O
(,O
Basel,O
),O
.,O
2020,O
Feb,O
27;8(1,O
),O
.,O
pii,O
:,O
E46,O
.,O
doi,O
:,O
10.339,O
healthcare8010046,O
.,O
"

",O
On,O
the,O
Coronavirus,O
(,O
COVID19,B-Disease_COVID-19
),O
Outbreak,O
and,O
the,O
Smart,O
City,O
Network,O
:,O
Universal,O
Data,O
"
",O
Sharing,O
Standards,O
Coupled,O
with,O
Artificial,O
Intelligence,O
(,O
AI,O
),O
to,O
Benefit,O
Urban,O
"
",O
Health,O
Monitoring,O
and,O
Management,O
.,O
"

",O
Allam,O
Z(1,O
),O
",",O
Jones,O
DS(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Port,O
Louis,O
Development,O
Initiative,O
(,O
PLDI,O
),O
",",O
Port,O
Louis,O
11302,O
",",O
Mauritius,O
.,O
"
",O
(2)School,O
of,O
Architecture,O
&,O
Built,O
Environment,O
",",O
Deakin,O
University,O
",",O
Geelong,O
",",O
VIC,O
"
",O
3220,O
",",O
Australia,O
.,O
"

",O
As,O
the,O
Coronavirus,O
(,O
COVID19,B-Disease_COVID-19
),O
expands,O
its,O
impact,O
from,O
China,O
",",O
expanding,O
its,O
"
",O
catchment,O
into,O
surrounding,O
regions,O
and,O
other,O
countries,O
",",O
increased,O
national,O
and,O
"
",O
international,O
measures,O
are,O
being,O
taken,O
to,O
contain,O
the,O
outbreak,O
.,O
The,O
placing,O
of,O
"
",O
entire,O
cities,O
in,O
',O
lockdown,O
',O
directly,O
affects,O
urban,O
economies,O
on,O
a,O
multilateral,O
"
",O
level,O
",",O
including,O
from,O
social,O
and,O
economic,O
standpoints,O
.,O
This,O
is,O
being,O
emphasised,O
"
",O
as,O
the,O
outbreak,O
gains,O
ground,O
in,O
other,O
countries,O
",",O
leading,O
towards,O
a,O
global,O
health,O
"
",O
emergency,O
",",O
and,O
as,O
global,O
collaboration,O
is,O
sought,O
in,O
numerous,O
quarters,O
.,O
However,O
",",O
"
",O
while,O
effective,O
protocols,O
in,O
regard,O
to,O
the,O
sharing,O
of,O
health,O
data,O
is,O
emphasised,O
",",O
"
",O
urban,O
data,O
",",O
on,O
the,O
other,O
hand,O
",",O
specifically,O
relating,O
to,O
urban,O
health,O
and,O
safe,O
"
",O
city,O
concepts,O
",",O
is,O
still,O
viewed,O
from,O
a,O
nationalist,O
perspective,O
as,O
solely,O
"
",O
benefiting,O
a,O
nation,O
's,O
economy,O
and,O
its,O
economic,O
and,O
political,O
influence,O
.,O
This,O
"
",O
perspective,O
paper,O
",",O
written,O
one,O
month,O
after,O
detection,O
and,O
during,O
the,O
outbreak,O
",",O
"
",O
surveys,O
the,O
virus,O
outbreak,O
from,O
an,O
urban,O
standpoint,O
and,O
advances,O
how,O
smart,O
city,O
"
",O
networks,O
should,O
work,O
towards,O
enhancing,O
standardization,O
protocols,O
for,O
increased,O
"
",O
data,O
sharing,O
in,O
the,O
event,O
of,O
outbreaks,O
or,O
disasters,O
",",O
leading,O
to,O
better,O
global,O
"
",O
understanding,O
and,O
management,O
of,O
the,O
same,O
.,O
"

",O
DOI,O
:,O
10.339,O
healthcare8010046,O
"
",O
PMID,O
:,O
32120822,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflict,O
of,O
interests,O
.,O
"


",O
394,O
.,O
Clin,O
Imaging,O
.,O
2020,O
Feb,O
22;63:79,O
.,O
doi,O
:,O
10.1016,O
j.clinimag.2020.02.008,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Asymptomatic,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
patient,O
outside,O
Wuhan,O
:,O
The,O
value,O
of,O
CT,O
"
",O
images,O
in,O
the,O
course,O
of,O
the,O
disease,O
.,O
"

",O
Lin,O
C(1,O
),O
",",O
Ding,O
Y(2,O
),O
",",O
Xie,O
B(2,O
),O
",",O
Sun,O
Z(2,O
),O
",",O
Li,O
X(3,O
),O
",",O
Chen,O
Z(4,O
),O
",",O
Niu,O
M(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Lanzhou,O
Lung,O
Hospital,O
",",O
Lanzhou,O
730000,O
",",O
People,O
's,O
"
",O
Republic,O
of,O
China,O
;,O
Gansu,O
Provincial,O
Infectious,O
Disease,O
Hospital,O
",",O
Lanzhou,O
730000,O
",",O
"
",O
People,O
's,O
Republic,O
of,O
China,O
;,O
The,O
First,O
Clinical,O
Medical,O
College,O
",",O
Lanzhou,O
"
",O
University,O
",",O
Lanzhou,O
730000,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
1204731562@qq.com,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
Lanzhou,O
Lung,O
Hospital,O
",",O
Lanzhou,O
730000,O
",",O
People,O
's,O
"
",O
Republic,O
of,O
China,O
;,O
Gansu,O
Provincial,O
Infectious,O
Disease,O
Hospital,O
",",O
Lanzhou,O
730000,O
",",O
"
",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(3)Gansu,O
Provincial,O
Infectious,O
Disease,O
Hospital,O
",",O
Lanzhou,O
730000,O
",",O
People,O
's,O
"
",O
Republic,O
of,O
China,O
;,O
Department,O
of,O
Respiratory,O
",",O
Lanzhou,O
Lung,O
Hospital,O
",",O
Lanzhou,O
"
",O
730000,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(4)Department,O
of,O
Radiology,O
",",O
The,O
First,O
Hospital,O
of,O
Lanzhou,O
University,O
",",O
Lanzhou,O
"
",O
730000,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"

",O
The,O
purpose,O
of,O
this,O
case,O
report,O
is,O
to,O
describe,O
the,O
imaging,O
and,O
associated,O
"
",O
clinical,O
features,O
of,O
an,O
asymptomatic,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
"
",O
patient,O
outside,O
Wuhan,O
",",O
China,O
.,O
The,O
principle,O
findings,O
are,O
that,O
in,O
this,O
patient,O
"
",O
with,O
laboratoryconfirmed,O
COVID19,B-Disease_COVID-19
",",O
CT,O
findings,O
preceded,O
symptoms,O
and,O
included,O
"
",O
bilateral,O
pleural,O
effusions,O
",",O
previously,O
not,O
reported,O
in,O
association,O
with,O
"
",O
COVID19,B-Disease_COVID-19
.,O
The,O
role,O
of,O
this,O
case,O
report,O
is,O
promotion,O
of,O
potential,O
recognition,O
"
",O
amongst,O
radiologists,O
of,O
this,O
new,O
disease,O
",",O
which,O
has,O
been,O
declared,O
a,O
global,O
health,O
"
",O
emergency,O
by,O
the,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
Inc.,O
"

",O
DOI,O
:,O
10.1016,O
j.clinimag.2020.02.008,O
"
",O
PMID,O
:,O
32120312,O
"


",O
395,O
.,O
Int,O
J,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
28,O
.,O
pii,O
:,O
S12019712(20)301077,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ijid.2020.02.049,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Is,O
the,O
Africa,O
prepared,O
for,O
tackling,O
the,O
COVID19,B-Disease_COVID-19
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
epidemic,O
?,O
 ,O
lessons,O
"
",O
from,O
past,O
outbreaks,O
",",O
ongoing,O
panAfrican,O
public,O
health,O
efforts,O
",",O
and,O
implications,O
"
",O
for,O
the,O
future,O
.,O
"

",O
Kapata,O
N(1,O
),O
",",O
Ihekweazu,O
C(2,O
),O
",",O
Ntoumi,O
F(3,O
),O
",",O
Tajudeen,O
R(4,O
),O
",",O
ChandaKapata,O
P(5,O
),O
",",O
"
",O
Mwaba,O
P(6,O
),O
",",O
Mukonka,O
V(7,O
),O
",",O
Bates,O
M(8,O
),O
",",O
Tembo,O
J(9,O
),O
",",O
Corman,O
V(10,O
),O
",",O
Mfinanga,O
S(11,O
),O
",",O
"
",O
Asogun,O
D(12,O
),O
",",O
Elton,O
L(13,O
),O
",",O
Arruda,O
LB(14,O
),O
",",O
Thomason,O
MJ(15,O
),O
",",O
Mboera,O
L(16,O
),O
",",O
"
",O
Yavlinsky,O
A(17,O
),O
",",O
Haider,O
N(18,O
),O
",",O
Simons,O
D(19,O
),O
",",O
Hollmann,O
L(20,O
),O
",",O
Lule,O
SA(21,O
),O
",",O
Veas,O
"
",O
F(22,O
),O
",",O
Abdel,O
Hamid,O
MM(23,O
),O
",",O
Dar,O
O(24,O
),O
",",O
Edwards,O
S(25,O
),O
",",O
Vairo,O
F(26,O
),O
",",O
McHugh,O
TD(27,O
),O
",",O
"
",O
Drosten,O
C(28,O
),O
",",O
Kock,O
R(29,O
),O
",",O
Ippolito,O
G(30,O
),O
",",O
Zumla,O
A(31,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Zambia,O
National,O
Public,O
Health,O
Institute,O
",",O
Minsitry,O
of,O
Health,O
",",O
Lusaka,O
",",O
Zambia,O
.,O
"
",O
Electronic,O
address,O
:,O
nkapata@gmail.com,O
.,O
"
",O
(2)Nigeria,O
Centre,O
for,O
Disease,O
Control,O
",",O
Jabi,O
",",O
Abuja,O
",",O
Nigeria,O
.,O
Electronic,O
address,O
:,O
"
",O
chikwe.ihekweazu@ncdc.gov.ng,O
.,O
"
",O
(3)University,O
Marien,O
NGouabi,O
",",O
Brazzaville,O
",",O
Congo,O
;,O
Institute,O
for,O
Tropical,O
"
",O
Medicine,O
University,O
of,O
TÃ¼bingen,O
",",O
Germany,O
.,O
Electronic,O
address,O
:,O
"
",O
fntoumi@fcrmcongo.com,O
.,O
"
",O
(4)Africa,O
Centres,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Addis,O
Ababa,O
",",O
Ethiopia,O
.,O
"
",O
Electronic,O
address,O
:,O
TajudeenR@africaunion.org,O
.,O
"
",O
(5)Ministry,O
of,O
Health,O
",",O
Lusaka,O
",",O
Zambia,O
.,O
Electronic,O
address,O
:,O
pascykapata@gmail.com,O
.,O
"
",O
(6)Lusaka,O
Apex,O
Medical,O
University,O
",",O
Lusaka,O
",",O
Zambia,O
.,O
Electronic,O
address,O
:,O
"
",O
pbmwaba2000@gmail.com,O
.,O
"
",O
(7)Zambia,O
National,O
Public,O
Health,O
Institute,O
",",O
Minsitry,O
of,O
Health,O
",",O
Lusaka,O
",",O
Zambia,O
.,O
"
",O
Electronic,O
address,O
:,O
vmukonka@gmail.com,O
.,O
"
",O
(8)School,O
of,O
Life,O
Sciences,O
",",O
University,O
of,O
Lincoln,O
",",O
Lincoln,O
",",O
United,O
Kingdom,O
.,O
"
",O
Electronic,O
address,O
:,O
mbates@lincoln.ac.uk,O
.,O
"
",O
(9)HerpeZ,O
and,O
UNZAUCLMS,O
Project,O
",",O
University,O
Teaching,O
Hospital,O
",",O
Lusaka,O
",",O
Zambia,O
.,O
"
",O
Electronic,O
address,O
:,O
john.tembo@gmail.com,O
.,O
"
",O
(10)CharitÃ©,O
 ,O
UniversitÃ¤tsmedizin,O
Berlin,O
",",O
Institute,O
of,O
Virology,O
",",O
Berlin,O
",",O
Germany,O
;,O
"
",O
German,O
Centre,O
for,O
Infection,O
Research,O
(,O
DZIF,O
),O
",",O
Berlin,O
",",O
Germany,O
.,O
Electronic,O
address,O
:,O
"
",O
victor.corman@charite.de,O
.,O
"
",O
(11)National,O
Institute,O
of,O
Medical,O
Research,O
",",O
Dar,O
es,O
Salaam,O
",",O
Tanzania,O
.,O
Electronic,O
"
",O
address,O
:,O
gsmfinanga@yahoo.com,O
.,O
"
",O
(12)Institute,O
of,O
Lassa,O
Fever,O
Research,O
and,O
Control,O
",",O
Irrua,O
Specialist,O
Teaching,O
"
",O
Hospital,O
",",O
Irrua,O
",",O
Nigeria,O
.,O
Electronic,O
address,O
:,O
asogun2001@yahoo.com,O
.,O
"
",O
(13)Center,O
for,O
Clinical,O
Microbiology,O
",",O
Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
"
",O
University,O
College,O
London,O
",",O
Royal,O
Free,O
Hospital,O
campus,O
",",O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
Electronic,O
address,O
:,O
linzy.elton@ucl.ac.uk,O
.,O
"
",O
(14)Center,O
for,O
Clinical,O
Microbiology,O
",",O
Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
"
",O
University,O
College,O
London,O
",",O
Royal,O
Free,O
Hospital,O
campus,O
",",O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
Electronic,O
address,O
:,O
l.arruda@ucl.ac.uk,O
.,O
"
",O
(15)Center,O
for,O
Clinical,O
Microbiology,O
",",O
Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
"
",O
University,O
College,O
London,O
",",O
Royal,O
Free,O
Hospital,O
campus,O
",",O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
Electronic,O
address,O
:,O
m.thomason@ucl.ac.uk,O
.,O
"
",O
(16)SACIDS,O
Foundation,O
for,O
One,O
Health,O
",",O
Sokoine,O
University,O
of,O
Agriculture,O
",",O
Chuo,O
"
",O
Kikuu,O
",",O
Morogoro,O
",",O
Tanzania,O
.,O
Electronic,O
address,O
:,O
leonard.mboera@sacids.org,O
.,O
"
",O
(17)Institute,O
of,O
Health,O
Informatics,O
",",O
Faculty,O
of,O
Pop,O
Health,O
Sciences,O
",",O
UCL,O
",",O
London,O
",",O
"
",O
United,O
Kingdom,O
.,O
Electronic,O
address,O
:,O
a.yavlinsky@ucl.ac.uk,O
.,O
"
",O
(18)The,O
Royal,O
Veterinary,O
College,O
",",O
University,O
of,O
London,O
",",O
Hatfield,O
",",O
Hertfordshire,O
",",O
"
",O
United,O
Kingdom,O
.,O
Electronic,O
address,O
:,O
nhaider@rvc.ac.uk,O
.,O
"
",O
(19)The,O
Royal,O
Veterinary,O
College,O
",",O
University,O
of,O
London,O
",",O
Hatfield,O
",",O
Hertfordshire,O
",",O
"
",O
United,O
Kingdom,O
.,O
Electronic,O
address,O
:,O
dsimons19@rvc.ac.uk,O
.,O
"
",O
(20)Chatham,O
House,O
Centre,O
on,O
Global,O
Health,O
Security,O
",",O
Royal,O
Institute,O
of,O
"
",O
International,O
Affairs,O
",",O
London,O
",",O
United,O
Kingdom,O
.,O
Electronic,O
address,O
:,O
"
",O
LHollmann@chathamhouse.org,O
.,O
"
",O
(21)Institute,O
for,O
Global,O
Health,O
",",O
University,O
College,O
London,O
",",O
London,O
",",O
United,O
"
",O
Kingdom,O
.,O
Electronic,O
address,O
:,O
swaiblule@gmail.com,O
.,O
"
",O
(22)Faculty,O
of,O
Pharmacy,O
",",O
Montpellier,O
University,O
",",O
IRD,O
UMR5569,O
",",O
Montpellier,O
",",O
"
",O
France,O
.,O
Electronic,O
address,O
:,O
francisco.veas@ird.fr,O
.,O
"
",O
(23)Dept,O
of,O
Parasitology,O
and,O
Medical,O
Entomology,O
",",O
Institute,O
of,O
Endemic,O
Diseases,O
",",O
"
",O
University,O
of,O
Khartoum,O
",",O
Sudan,O
.,O
Electronic,O
address,O
:,O
mahdi@iend.org,O
.,O
"
",O
(24)Chatham,O
House,O
Centre,O
on,O
Global,O
Health,O
Security,O
",",O
Royal,O
Institute,O
of,O
"
",O
International,O
Affairs,O
",",O
London,O
",",O
United,O
Kingdom,O
.,O
Electronic,O
address,O
:,O
"
",O
Osman.Dar@phe.gov.uk,O
.,O
"
",O
(25)Ethics,O
and,O
Governance,O
",",O
University,O
College,O
London,O
",",O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
Electronic,O
address,O
:,O
sarah.edwards@ucl.ac.uk,O
.,O
"
",O
(26)National,O
Institute,O
for,O
Infectious,O
Diseases,O
Lazzaro,O
Spallanzani,O
 ,O
IRCCS,O
",",O
Rome,O
",",O
"
",O
Italy,O
.,O
Electronic,O
address,O
:,O
francesco.vairo@inmi.it,O
.,O
"
",O
(27)Center,O
for,O
Clinical,O
Microbiology,O
",",O
Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
"
",O
University,O
College,O
London,O
",",O
Royal,O
Free,O
Hospital,O
campus,O
",",O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
Electronic,O
address,O
:,O
t.mchugh@ucl.ac.uk,O
.,O
"
",O
(28)CharitÃ©,O
 ,O
UniversitÃ¤tsmedizin,O
Berlin,O
",",O
Institute,O
of,O
Virology,O
",",O
Berlin,O
",",O
Germany,O
;,O
"
",O
German,O
Centre,O
for,O
Infection,O
Research,O
(,O
DZIF,O
),O
",",O
Berlin,O
",",O
Germany,O
.,O
Electronic,O
address,O
:,O
"
",O
christian.drosten@charite.de,O
.,O
"
",O
(29)The,O
Royal,O
Veterinary,O
College,O
",",O
University,O
of,O
London,O
",",O
Hatfield,O
",",O
Hertfordshire,O
",",O
"
",O
United,O
Kingdom,O
.,O
Electronic,O
address,O
:,O
rkock@rvc.ac.uk,O
.,O
"
",O
(30)National,O
Institute,O
for,O
Infectious,O
Diseases,O
 ,O
Lazzaro,O
Spallanzani,O
IRCCS,O
",",O
"
",O
Rome,O
",",O
Italy,O
.,O
Electronic,O
address,O
:,O
giuseppe.ippolito@inmi.it,O
.,O
"
",O
(31)Center,O
for,O
Clinical,O
Microbiology,O
",",O
Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
"
",O
University,O
College,O
London,O
",",O
Royal,O
Free,O
Hospital,O
campus,O
",",O
London,O
",",O
United,O
Kingdom,O
;,O
"
",O
Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
University,O
College,O
London,O
and,O
NIHR,O
Biomedical,O
"
",O
Research,O
Centre,O
",",O
UCL,O
Hospitals,O
NHS,O
Foundation,O
Trust,O
",",O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
Electronic,O
address,O
:,O
a.zumla@ucl.ac.uk,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijid.2020.02.049,O
"
",O
PMID,O
:,O
32119980,O
"


",O
396,O
.,O
Life,O
Sci,O
.,O
2020,O
Feb,O
28;248:117477,O
.,O
doi,O
:,O
10.1016,O
j.lfs.2020.117477,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
AntiHCV,O
",",O
nucleotide,O
inhibitors,O
",",O
repurposing,O
against,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Elfiky,O
AA(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Biophysics,O
Department,O
",",O
Faculty,O
of,O
Sciences,O
",",O
Cairo,O
University,O
",",O
Giza,O
",",O
Egypt,O
;,O
"
",O
College,O
of,O
Applied,O
Medical,O
Sciences,O
",",O
University,O
of,O
AlJouf,O
",",O
Saudi,O
Arabia,O
.,O
"
",O
Electronic,O
address,O
:,O
abdo@sci.cu.edu.eg,O
.,O
"

",O
AIMS,O
:,O
A,O
newly,O
emerged,O
Human,O
Coronavirus,O
(,O
HCoV,O
),O
is,O
reported,O
two,O
months,O
ago,O
in,O
"
",O
Wuhan,O
",",O
China,O
(,O
COVID19,B-Disease_COVID-19
),O
.,O
Until,O
today,O
>,O
2700,O
deaths,O
from,O
the,O
80000,O
confirmed,O
cases,O
"
",O
reported,O
mainly,O
in,O
China,O
and,O
40,O
other,O
countries,O
.,O
Human,O
to,O
human,O
transmission,O
is,O
"
",O
confirmed,O
for,O
COVID19,B-Disease_COVID-19
by,O
China,O
a,O
month,O
ago,O
.,O
Based,O
on,O
the,O
World,O
Health,O
"
",O
Organization,O
(,O
WHO,O
),O
reports,O
",",O
SARS,O
HCoV,O
is,O
responsible,O
for,O
>,O
8000,O
cases,O
with,O
"
",O
confirmed,O
774,O
deaths,O
.,O
Additionally,O
",",O
MERS,O
HCoV,O
is,O
responsible,O
for,O
858,O
deaths,O
out,O
"
",O
of,O
about,O
2500,O
reported,O
cases,O
.,O
The,O
current,O
study,O
aims,O
to,O
test,O
antiHCV,O
drugs,O
"
",O
against,O
COVID19,B-Disease_COVID-19
RNA,O
dependent,O
RNA,O
polymerase,O
(,O
RdRp,O
),O
.,O
"
",O
MATERIALS,O
AND,O
METHODS,O
:,O
In,O
this,O
study,O
",",O
sequence,O
analysis,O
",",O
modeling,O
",",O
and,O
docking,O
"
",O
are,O
used,O
to,O
build,O
a,O
model,O
for,O
Wuhan,O
COVID19,B-Disease_COVID-19
RdRp,O
.,O
Additionally,O
",",O
the,O
newly,O
"
",O
emerged,O
Wuhan,O
HCoV,O
RdRp,O
model,O
is,O
targeted,O
by,O
antipolymerase,O
drugs,O
",",O
including,O
the,O
"
",O
approved,O
drugs,O
Sofosbuvir,O
and,O
Ribavirin,O
.,O
"
",O
KEY,O
FINDINGS,O
:,O
The,O
results,O
suggest,O
the,O
effectiveness,O
of,O
Sofosbuvir,O
",",O
IDX184,O
",",O
"
",O
Ribavirin,O
",",O
and,O
Remidisvir,O
as,O
potent,O
drugs,O
against,O
the,O
newly,O
emerged,O
HCoV,O
disease,O
.,O
"
",O
SIGNIFICANCE,O
:,O
The,O
present,O
study,O
presents,O
a,O
perfect,O
model,O
for,O
COVID19,B-Disease_COVID-19
RdRp,O
"
",O
enabling,O
its,O
testing,O
in,O
silico,O
against,O
antipolymerase,O
drugs,O
.,O
Besides,O
",",O
the,O
study,O
"
",O
presents,O
some,O
drugs,O
that,O
previously,O
proved,O
its,O
efficiency,O
against,O
the,O
newly,O
"
",O
emerged,O
viral,O
infection,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.lfs.2020.117477,O
"
",O
PMID,O
:,O
32119961,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
The,O
author,O
"
",O
declares,O
that,O
there,O
is,O
no,O
competing,O
interest,O
in,O
this,O
work,O
.,O
"


",O
397,O
.,O
J,O
Infect,O
.,O
2020,O
Feb,O
28,O
.,O
pii,O
:,O
S01634453(20)30102X,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.020,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
(,O
Covid19,B-Disease_COVID-19
),O
:,O
the,O
first,O
two,O
patients,O
in,O
the,O
UK,O
with,O
"
",O
person,O
to,O
person,O
transmission,O
.,O
"

",O
Lillie,O
PJ(1,O
),O
",",O
Samson,O
A(1,O
),O
",",O
Li,O
A(2,O
),O
",",O
Adams,O
K(1,O
),O
",",O
Capstick,O
R(2,O
),O
",",O
Barlow,O
GD(3,O
),O
",",O
"
",O
Easom,O
N(1,O
),O
",",O
Hamilton,O
E(2,O
),O
",",O
Moss,O
PJ(1,O
),O
",",O
Evans,O
A(2,O
),O
",",O
Ivan,O
M(1,O
),O
",",O
Phe,O
Incident,O
"
",O
Team(4,O
),O
",",O
Taha,O
Y(2,O
),O
",",O
Duncan,O
CJA(5,O
),O
",",O
Schmid,O
ML(6,O
),O
;,O
Airborne,O
HCID,O
Network(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infection,O
",",O
Hull,O
University,O
Teaching,O
Hospitals,O
NHS,O
Trust,O
",",O
Hull,O
",",O
"
",O
United,O
Kingdom,O
.,O
"
",O
(2)Department,O
of,O
Infection,O
&,O
Tropical,O
Medicine,O
",",O
The,O
Newcastle,O
Upon,O
Tyne,O
Hospitals,O
"
",O
NHS,O
Foundation,O
Trust,O
",",O
Newcastle,O
upon,O
Tyne,O
",",O
United,O
Kingdom,O
.,O
"
",O
(3)Department,O
of,O
Infection,O
",",O
Hull,O
University,O
Teaching,O
Hospitals,O
NHS,O
Trust,O
",",O
Hull,O
",",O
"
",O
United,O
Kingdom,O
;,O
Hull,O
York,O
Medical,O
School,O
",",O
University,O
of,O
York,O
",",O
United,O
Kingdom4,O
.,O
"
",O
National,O
Infection,O
Service,O
.,O
"
",O
(4)PHE,O
Incident,O
Team,O
",",O
Public,O
Health,O
England,O
",",O
London,O
NW9,O
5EQ,O
",",O
United,O
Kingdom,O
.,O
"
",O
(5)Department,O
of,O
Infection,O
&,O
Tropical,O
Medicine,O
",",O
The,O
Newcastle,O
Upon,O
Tyne,O
Hospitals,O
"
",O
NHS,O
Foundation,O
Trust,O
",",O
Newcastle,O
upon,O
Tyne,O
",",O
United,O
Kingdom,O
;,O
Translational,O
and,O
"
",O
Clinical,O
Research,O
Institute,O
",",O
Immunity,O
and,O
Inflammation,O
Theme,O
",",O
Newcastle,O
"
",O
University,O
",",O
United,O
Kingdom,O
.,O
Electronic,O
address,O
:,O
christopher.duncan@ncl.ac.uk,O
.,O
"
",O
(6)Department,O
of,O
Infection,O
&,O
Tropical,O
Medicine,O
",",O
The,O
Newcastle,O
Upon,O
Tyne,O
Hospitals,O
"
",O
NHS,O
Foundation,O
Trust,O
",",O
Newcastle,O
upon,O
Tyne,O
",",O
United,O
Kingdom,O
.,O
Electronic,O
address,O
:,O
"
",O
Matthias.schmid1@nhs.net,O
.,O
"
",O
(7)Airborne,O
HCID,O
Network,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.020,O
"
",O
PMID,O
:,O
32119884,O
"


",O
398,O
.,O
Lancet,O
Glob,O
Health,O
.,O
2020,O
Feb,O
28,O
.,O
pii,O
:,O
S2214109X(20)300747,O
.,O
doi,O
:,O
"
",O
10.1016,O
S2214109X(20)300747,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Feasibility,O
of,O
controlling,O
COVID19,B-Disease_COVID-19
outbreaks,O
by,O
isolation,O
of,O
cases,O
and,O
contacts,O
.,O
"

",O
Hellewell,O
J(1,O
),O
",",O
Abbott,O
S(1,O
),O
",",O
Gimma,O
A(1,O
),O
",",O
Bosse,O
NI(1,O
),O
",",O
Jarvis,O
CI(1,O
),O
",",O
Russell,O
"
",O
TW(1,O
),O
",",O
Munday,O
JD(1,O
),O
",",O
Kucharski,O
AJ(1,O
),O
",",O
Edmunds,O
WJ(1,O
),O
;,O
Centre,O
for,O
the,O
Mathematical,O
"
",O
Modelling,O
of,O
Infectious,O
Diseases,O
COVID19,B-Disease_COVID-19
Working,O
Group,O
",",O
Funk,O
S(1,O
),O
",",O
Eggo,O
RM(2,O
),O
.,O
"

",O
Collaborators,O
:,O
Sun,O
F,O
",",O
Flasche,O
S,O
",",O
Quilty,O
BJ,O
",",O
Davies,O
N,O
",",O
Liu,O
Y,O
",",O
Clifford,O
S,O
",",O
Klepac,O
"
",O
P,O
",",O
Jit,O
M,O
",",O
Diamond,O
C,O
",",O
Gibbs,O
H,O
",",O
van,O
Zandvoort,O
K.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Centre,O
for,O
the,O
Mathematical,O
Modelling,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
"
",O
Infectious,O
Disease,O
Epidemiology,O
",",O
London,O
School,O
of,O
Hygiene,O
&,O
Tropical,O
Medicine,O
",",O
"
",O
London,O
",",O
UK,O
.,O
"
",O
(2)Centre,O
for,O
the,O
Mathematical,O
Modelling,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
"
",O
Infectious,O
Disease,O
Epidemiology,O
",",O
London,O
School,O
of,O
Hygiene,O
&,O
Tropical,O
Medicine,O
",",O
"
",O
London,O
",",O
UK,O
.,O
Electronic,O
address,O
:,O
r.eggo@lshtm.ac.uk,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
Lancet,O
Glob,O
Health,O
.,O
2020,O
Mar,O
5,O
;,O
:,O
.,O
"

",O
BACKGROUND,O
:,O
Isolation,O
of,O
cases,O
and,O
contact,O
tracing,O
is,O
used,O
to,O
control,O
outbreaks,O
"
",O
of,O
infectious,O
diseases,O
",",O
and,O
has,O
been,O
used,O
for,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
.,O
Whether,O
this,O
strategy,O
will,O
achieve,O
control,O
depends,O
on,O
characteristics,O
"
",O
of,O
both,O
the,O
pathogen,O
and,O
the,O
response,O
.,O
Here,O
we,O
use,O
a,O
mathematical,O
model,O
to,O
assess,O
"
",O
if,O
isolation,O
and,O
contact,O
tracing,O
are,O
able,O
to,O
control,O
onwards,O
transmission,O
from,O
"
",O
imported,O
cases,O
of,O
COVID19,B-Disease_COVID-19
.,O
"
",O
METHODS,O
:,O
We,O
developed,O
a,O
stochastic,O
transmission,O
model,O
",",O
parameterised,O
to,O
the,O
"
",O
COVID19,B-Disease_COVID-19
outbreak,O
.,O
We,O
used,O
the,O
model,O
to,O
quantify,O
the,O
potential,O
effectiveness,O
of,O
"
",O
contact,O
tracing,O
and,O
isolation,O
of,O
cases,O
at,O
controlling,O
a,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
coronavirus,O
2,O
(SARSCoV2)like,O
pathogen,O
.,O
We,O
considered,O
scenarios,O
that,O
"
",O
varied,O
in,O
the,O
number,O
of,O
initial,O
cases,O
",",O
the,O
basic,O
reproduction,O
number,O
(,O
R0,O
),O
",",O
the,O
"
",O
delay,O
from,O
symptom,O
onset,O
to,O
isolation,O
",",O
the,O
probability,O
that,O
contacts,O
were,O
traced,O
",",O
"
",O
the,O
proportion,O
of,O
transmission,O
that,O
occurred,O
before,O
symptom,O
onset,O
",",O
and,O
the,O
"
",O
proportion,O
of,O
subclinical,O
infections,O
.,O
We,O
assumed,O
isolation,O
prevented,O
all,O
further,O
"
",O
transmission,O
in,O
the,O
model,O
.,O
Outbreaks,O
were,O
deemed,O
controlled,O
if,O
transmission,O
ended,O
"
",O
within,O
12,O
weeks,O
or,O
before,O
5000,O
cases,O
in,O
total,O
.,O
We,O
measured,O
the,O
success,O
of,O
"
",O
controlling,O
outbreaks,O
using,O
isolation,O
and,O
contact,O
tracing,O
",",O
and,O
quantified,O
the,O
"
",O
weekly,O
maximum,O
number,O
of,O
cases,O
traced,O
to,O
measure,O
feasibility,O
of,O
public,O
health,O
"
",O
effort,O
.,O
"
",O
FINDINGS,O
:,O
Simulated,O
outbreaks,O
starting,O
with,O
five,O
initial,O
cases,O
",",O
an,O
R0,O
of,O
1Â·5,O
",",O
and,O
"
",O
0,O
%,O
transmission,O
before,O
symptom,O
onset,O
could,O
be,O
controlled,O
even,O
with,O
low,O
contact,O
"
",O
tracing,O
probability,O
;,O
however,O
",",O
the,O
probability,O
of,O
controlling,O
an,O
outbreak,O
"
",O
decreased,O
with,O
the,O
number,O
of,O
initial,O
cases,O
",",O
when,O
R0,O
was,O
2Â·5,O
or,O
3Â·5,O
and,O
with,O
more,O
"
",O
transmission,O
before,O
symptom,O
onset,O
.,O
Across,O
different,O
initial,O
numbers,O
of,O
cases,O
",",O
the,O
"
",O
majority,O
of,O
scenarios,O
with,O
an,O
R0,O
of,O
1Â·5,O
were,O
controllable,O
with,O
less,O
than,O
50,O
%,O
of,O
"
",O
contacts,O
successfully,O
traced,O
.,O
To,O
control,O
the,O
majority,O
of,O
outbreaks,O
",",O
for,O
R0,O
of,O
2Â·5,O
"
",O
more,O
than,O
70,O
%,O
of,O
contacts,O
had,O
to,O
be,O
traced,O
",",O
and,O
for,O
an,O
R0,O
of,O
3Â·5,O
more,O
than,O
90,O
%,O
of,O
"
",O
contacts,O
had,O
to,O
be,O
traced,O
.,O
The,O
delay,O
between,O
symptom,O
onset,O
and,O
isolation,O
had,O
the,O
"
",O
largest,O
role,O
in,O
determining,O
whether,O
an,O
outbreak,O
was,O
controllable,O
when,O
R0,O
was,O
1Â·5,O
.,O
"
",O
For,O
R0,O
values,O
of,O
2Â·5,O
or,O
3Â·5,O
",",O
if,O
there,O
were,O
40,O
initial,O
cases,O
",",O
contact,O
tracing,O
and,O
"
",O
isolation,O
were,O
only,O
potentially,O
feasible,O
when,O
less,O
than,O
1,O
%,O
of,O
transmission,O
"
",O
occurred,O
before,O
symptom,O
onset,O
.,O
"
",O
INTERPRETATION,O
:,O
In,O
most,O
scenarios,O
",",O
highly,O
effective,O
contact,O
tracing,O
and,O
case,O
"
",O
isolation,O
is,O
enough,O
to,O
control,O
a,O
new,O
outbreak,O
of,O
COVID19,B-Disease_COVID-19
within,O
3,O
months,O
.,O
The,O
"
",O
probability,O
of,O
control,O
decreases,O
with,O
long,O
delays,O
from,O
symptom,O
onset,O
to,O
"
",O
isolation,O
",",O
fewer,O
cases,O
ascertained,O
by,O
contact,O
tracing,O
",",O
and,O
increasing,O
"
",O
transmission,O
before,O
symptoms,O
.,O
This,O
model,O
can,O
be,O
modified,O
to,O
reflect,O
updated,O
"
",O
transmission,O
characteristics,O
and,O
more,O
specific,O
definitions,O
of,O
outbreak,O
control,O
to,O
"
",O
assess,O
the,O
potential,O
success,O
of,O
local,O
response,O
efforts,O
.,O
"
",O
FUNDING,O
:,O
Wellcome,O
Trust,O
",",O
Global,O
Challenges,O
Research,O
Fund,O
",",O
and,O
Health,O
Data,O
"
",O
Research,O
UK,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Author(s,O
),O
.,O
Published,O
by,O
Elsevier,O
Ltd.,O
This,O
is,O
an,O
Open,O
Access,O
"
",O
article,O
under,O
the,O
CC,O
BYNCND,O
4,O
license,O
.,O
Published,O
by,O
Elsevier,O
Ltd,O
..,O
All,O
rights,O
"
",O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S2214109X(20)300747,O
"
",O
PMID,O
:,O
32119825,O
"


",O
399,O
.,O
Lancet,O
.,O
2020,O
Mar,O
14;395(10227):e49e50,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)304931,O
.,O
Epub,O
"
",O
2020,O
Feb,O
28,O
.,O
"

",O
The,O
response,O
of,O
Milan,O
's,O
Emergency,O
Medical,O
System,O
to,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
in,O
"
",O
Italy,O
.,O
"

",O
Spina,O
S(1,O
),O
",",O
Marrazzo,O
F(1,O
),O
",",O
Migliari,O
M(1,O
),O
",",O
Stucchi,O
R(1,O
),O
",",O
Sforza,O
A(2,O
),O
",",O
Fumagalli,O
"
",O
R(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)SOREU,O
Metropolitana,O
",",O
Azienda,O
Regionale,O
Emergenza,O
Urgenza,O
",",O
Lombardy,O
",",O
Milan,O
",",O
"
",O
Italy,O
;,O
Department,O
of,O
Anesthesia,O
",",O
Critical,O
Care,O
and,O
Pain,O
Medicine,O
",",O
ASST,O
Grande,O
"
",O
Ospedale,O
Metropolitano,O
Niguarda,O
",",O
School,O
of,O
Medicine,O
and,O
Surgery,O
",",O
University,O
of,O
"
",O
MilanoBicocca,O
",",O
Milan,O
",",O
Italy,O
.,O
"
",O
(2)SOREU,O
Metropolitana,O
",",O
Azienda,O
Regionale,O
Emergenza,O
Urgenza,O
",",O
Lombardy,O
",",O
Milan,O
",",O
"
",O
Italy,O
.,O
"
",O
(3)SOREU,O
Metropolitana,O
",",O
Azienda,O
Regionale,O
Emergenza,O
Urgenza,O
",",O
Lombardy,O
",",O
Milan,O
",",O
"
",O
Italy,O
;,O
Department,O
of,O
Anesthesia,O
",",O
Critical,O
Care,O
and,O
Pain,O
Medicine,O
",",O
ASST,O
Grande,O
"
",O
Ospedale,O
Metropolitano,O
Niguarda,O
",",O
School,O
of,O
Medicine,O
and,O
Surgery,O
",",O
University,O
of,O
"
",O
MilanoBicocca,O
",",O
Milan,O
",",O
Italy,O
.,O
Electronic,O
address,O
:,O
roberto.fumagalli@unimib.it,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)304931,O
"
",O
PMID,O
:,O
32119824,O
"


",O
400,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
28,O
.,O
pii,O
:,O
S14733099(20)30147X,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)30147X,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
A,O
family,O
cluster,O
of,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
involving,O
11,O
patients,O
in,O
Nanjing,O
",",O
China,O
.,O
"

",O
Huang,O
R(1,O
),O
",",O
Xia,O
J(1,O
),O
",",O
Chen,O
Y(2,O
),O
",",O
Shan,O
C(3,O
),O
",",O
Wu,O
C(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Diseases,O
",",O
Nanjing,O
Drum,O
Tower,O
Hospital,O
",",O
The,O
Affiliated,O
"
",O
Hospital,O
of,O
Nanjing,O
University,O
Medical,O
School,O
",",O
Nanjing,O
210008,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Laboratory,O
Medicine,O
",",O
Nanjing,O
Drum,O
Tower,O
Hospital,O
",",O
The,O
Affiliated,O
"
",O
Hospital,O
of,O
Nanjing,O
University,O
Medical,O
School,O
",",O
Nanjing,O
210008,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Infectious,O
Diseases,O
",",O
Zhongda,O
Hospital,O
Southeast,O
University,O
",",O
"
",O
Nanjing,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Infectious,O
Diseases,O
",",O
Nanjing,O
Drum,O
Tower,O
Hospital,O
",",O
The,O
Affiliated,O
"
",O
Hospital,O
of,O
Nanjing,O
University,O
Medical,O
School,O
",",O
Nanjing,O
210008,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
dr.wu@nju.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)30147X,O
"
",O
PMID,O
:,O
32119823,O
"


",O
401,O
.,O
Clin,O
Chem,O
Lab,O
Med,O
.,O
2020,O
Mar,O
3,O
.,O
pii,O
:,O
"
 ",O
j,O
cclm.aheadofprint,O
cclm20200198,O
cclm20200198.xml,O
.,O
doi,O
:,O
"
",O
10.1515,O
cclm20200198,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Laboratory,O
abnormalities,O
in,O
patients,O
with,O
COVID2019,O
infection,O
.,O
"

",O
Lippi,O
G(1,O
),O
",",O
Plebani,O
M(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Section,O
of,O
Clinical,O
Biochemistry,O
",",O
Department,O
of,O
Neuroscience,O
",",O
Biomedicine,O
and,O
"
",O
Movement,O
",",O
University,O
Hospital,O
of,O
Verona,O
",",O
Piazzale,O
L.A.,O
Scuro,O
",",O
10,O
",",O
37134,O
Verona,O
",",O
"
",O
Italy,O
.,O
"
",O
(2)Department,O
of,O
Laboratory,O
Medicine,O
",",O
University,O
Hospital,O
of,O
Padova,O
",",O
Padova,O
",",O
"
",O
Italy,O
.,O
"

",O
DOI,O
:,O
10.1515,O
cclm20200198,O
"
",O
PMID,O
:,O
32119647,O
"


",O
402,O
.,O
ACS,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
11,O
.,O
doi,O
:,O
10.1021,O
acsinfecdis.9b00427,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Immunoglobulin,O
A,O
Targeting,O
on,O
the,O
NTerminal,O
Moiety,O
of,O
Viral,O
Phosphoprotein,O
"
",O
Prevents,O
Measles,O
Virus,O
from,O
Evading,O
InterferonÎ²,O
Signaling,O
.,O
"

",O
Yang,O
Y(1)(2,O
),O
",",O
Zhou,O
D(3)(4)(1,O
),O
",",O
Zhao,O
B(1)(2,O
),O
",",O
Cao,O
Y(1)(2,O
),O
",",O
Yu,O
J(1)(2,O
),O
",",O
Yan,O
"
",O
H(1)(2,O
),O
",",O
Zhao,O
W(1)(2,O
),O
",",O
Zhang,O
E(1,O
),O
",",O
Yang,O
J(1,O
),O
",",O
Zhong,O
M(1,O
),O
",",O
Hu,O
Q(5,O
),O
",",O
Deng,O
L(3)(4,O
),O
",",O
"
",O
Yan,O
H(3)(4)(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Mucosal,O
Immunity,O
Research,O
Group,O
",",O
State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
"
",O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
Hubei,O
430071,O
",",O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
100049,O
",",O
China,O
.,O
"
",O
(3)The,O
Joint,O
Laboratory,O
for,O
Translational,O
Precision,O
Medicine,O
",",O
Guangzhou,O
Women,O
and,O
"
",O
Children,O
's,O
Medical,O
Center,O
",",O
Guangzhou,O
",",O
Guangdong,O
510623,O
",",O
China,O
.,O
"
",O
(4)The,O
Joint,O
Laboratory,O
for,O
Translational,O
Precision,O
Medicine,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
Hubei,O
430071,O
",",O
China,O
.,O
"
",O
(5)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
"
",O
of,O
Sciences,O
",",O
Wuhan,O
",",O
Hubei,O
430071,O
",",O
China,O
.,O
"

",O
Immunoglobulin,O
A,O
(,O
IgA,O
),O
can,O
inhibit,O
intracellular,O
viral,O
replication,O
during,O
its,O
"
",O
transport,O
across,O
the,O
epithelial,O
cells,O
.,O
We,O
find,O
a,O
monoclonal,O
IgA,O
antibody,O
7F1IgA,O
"
",O
against,O
the,O
Nterminal,O
moiety,O
of,O
the,O
phosphoprotein,O
(,O
PNT,O
),O
of,O
measles,O
virus,O
(,O
MV,O
),O
",",O
"
",O
which,O
inhibits,O
the,O
intracellular,O
replication,O
of,O
MV,O
in,O
Caco2,O
cells,O
but,O
not,O
in,O
"
",O
interferondeficient,O
VeropIgR,O
cells,O
.,O
Transcytosis,O
of,O
7F1IgA,O
across,O
the,O
"
",O
MVinfected,O
Caco2,O
cells,O
enhances,O
the,O
production,O
of,O
interferonÎ²,O
(,O
IFNÎ²,O
),O
and,O
the,O
"
",O
expression,O
of,O
IFNstimulated,O
genes,O
",",O
rendering,O
Caco2,O
cells,O
with,O
higher,O
antiviral,O
"
",O
immunity,O
.,O
7F1IgA,O
specifically,O
interacts,O
with,O
MV,O
phosphoprotein,O
inside,O
the,O
"
",O
MVinfected,O
Caco2,O
cell,O
and,O
prevents,O
MV,O
phosphoprotein,O
from,O
inhibiting,O
the,O
"
",O
phosphorylation,O
of,O
JAK1,O
and,O
STAT1,O
.,O
The,O
intraepithelial,O
interaction,O
between,O
"
",O
7F1IgA,O
and,O
the,O
viral,O
phosphoprotein,O
results,O
in,O
an,O
earlier,O
and,O
stronger,O
"
",O
phosphorylation,O
of,O
JAK1,O
and,O
STAT1,O
and,O
",",O
consequently,O
",",O
a,O
more,O
efficient,O
nuclear,O
"
",O
translocation,O
of,O
STAT1,O
for,O
the,O
activation,O
of,O
the,O
type,O
I,O
interferon,O
pathway,O
.,O
Thus,O
",",O
"
",O
IgA,O
against,O
phosphoprotein,O
prevents,O
a,O
virus,O
from,O
evading,O
type,O
I,O
IFN,O
signaling,O
and,O
"
",O
confers,O
host,O
epithelial,O
cells,O
efficient,O
innate,O
antiviral,O
immunity,O
",",O
which,O
"
",O
potentiates,O
a,O
new,O
antiviral,O
target,O
and,O
an,O
antiviral,O
strategy,O
.,O
"

",O
DOI,O
:,O
10.1021,O
acsinfecdis.9b00427,O
"
",O
PMID,O
:,O
32119519,O
"


",O
403,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
28,O
.,O
pii,O
:,O
ciaa200,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa200,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
A,O
case,O
of,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
in,O
a,O
pregnant,O
woman,O
with,O
preterm,O
delivery,O
.,O
"

",O
Wang,O
X(1,O
),O
",",O
Zhou,O
Z(2,O
),O
",",O
Zhang,O
J(3,O
),O
",",O
Zhu,O
F(4,O
),O
",",O
Tang,O
Y(5,O
),O
",",O
Shen,O
X(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Hepatology,O
and,O
Gastroenterology,O
",",O
The,O
Affiliated,O
Infectious,O
"
",O
Hospital,O
of,O
Soochow,O
University,O
",",O
Suzhou,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Orthopedics,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
Soochow,O
"
",O
University,O
",",O
Suzhou,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Tuberculosis,O
",",O
The,O
Affiliated,O
Infectious,O
Hospital,O
of,O
Soochow,O
"
",O
University,O
",",O
Suzhou,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
The,O
Affiliated,O
Infectious,O
Hospital,O
of,O
"
",O
Soochow,O
University,O
",",O
Suzhou,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Obstetrics,O
and,O
Gynecology,O
",",O
The,O
Affiliated,O
Infectious,O
Hospital,O
of,O
"
",O
Soochow,O
University,O
",",O
Suzhou,O
",",O
China,O
.,O
"

",O
We,O
presented,O
a,O
case,O
of,O
a,O
30week,O
pregnant,O
woman,O
with,O
COVID19,B-Disease_COVID-19
delivering,O
a,O
"
",O
healthy,O
baby,O
with,O
no,O
evidence,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa200,O
"
",O
PMID,O
:,O
32119083,O
"


",O
404,O
.,O
Chin,O
Med,O
J,O
(,O
Engl,O
),O
.,O
2020,O
Feb,O
28,O
.,O
doi,O
:,O
10.1097,O
CM9.0000000000000783,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Singlecell,O
RNA,O
sequencing,O
data,O
suggest,O
a,O
role,O
for,O
angiotensinconverting,O
enzyme,O
"
",O
2,O
in,O
kidney,O
impairment,O
in,O
patients,O
infected,O
with,O
2019nCoV.,O
"

",O
Deng,O
YY(1,O
),O
",",O
Zheng,O
Y,O
",",O
Cai,O
GY,O
",",O
Chen,O
XM,O
",",O
Hong,O
Q.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Nephrology,O
",",O
Chinese,O
People,O
's,O
Liberation,O
Army,O
General,O
Hospital,O
",",O
"
",O
Chinese,O
People,O
's,O
Liberation,O
Army,O
Institute,O
of,O
Nephrology,O
",",O
State,O
Key,O
Laboratory,O
of,O
"
",O
Kidney,O
Diseases,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Kidney,O
Diseases,O
",",O
Beijing,O
"
",O
Key,O
Laboratory,O
of,O
Kidney,O
Diseases,O
",",O
Beijing,O
100039,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1097,O
CM9.0000000000000783,O
"
",O
PMID,O
:,O
32118645,O
"


",O
405,O
.,O
Chin,O
Med,O
J,O
(,O
Engl,O
),O
.,O
2020,O
Feb,O
28,O
.,O
doi,O
:,O
10.1097,O
CM9.0000000000000782,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Distribution,O
of,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
and,O
correlation,O
with,O
population,O
emigration,O
"
",O
from,O
wuhan,O
",",O
China,O
.,O
"

",O
Chen,O
ZL(1,O
),O
",",O
Zhang,O
Q(2,O
),O
",",O
Lu,O
Y(3,O
),O
",",O
Guo,O
ZM(4,O
),O
",",O
Zhang,O
X(1,O
),O
",",O
Zhang,O
WJ(5,O
),O
",",O
Guo,O
C(6,O
),O
",",O
"
",O
Liao,O
CH(1,O
),O
",",O
Li,O
QL(1,O
),O
",",O
Han,O
XH(2,O
),O
",",O
Lu,O
JH(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)One,O
Health,O
Center,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Sun,O
Yatsen,O
University,O
",",O
Guangzhou,O
",",O
"
",O
Guangdong,O
510080,O
",",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Livestock,O
Infectious,O
Diseases,O
in,O
Northeast,O
China,O
",",O
Ministry,O
"
",O
of,O
Education,O
",",O
Shenyang,O
Agricultural,O
University,O
",",O
Shenyang,O
",",O
Liaoning,O
110866,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Health,O
Law,O
",",O
Policy,O
and,O
Management,O
",",O
School,O
of,O
Public,O
Health,O
",",O
"
",O
Boston,O
University,O
",",O
Boston,O
",",O
MA,O
",",O
2215,O
",",O
USA,O
.,O
"
",O
(4)Animal,O
Experiment,O
Center,O
",",O
Sun,O
Yatsen,O
University,O
",",O
Guangzhou,O
",",O
Guangdong,O
510080,O
",",O
"
",O
China,O
.,O
"
",O
(5)Department,O
of,O
Biological,O
Science,O
and,O
Technology,O
",",O
School,O
of,O
Life,O
Sciences,O
",",O
Sun,O
"
",O
Yatsen,O
University,O
",",O
Guangzhou,O
",",O
Guangdong,O
510080,O
",",O
China,O
.,O
"
",O
(6)Center,O
for,O
Infection,O
and,O
Immunity,O
",",O
Mailman,O
School,O
of,O
Public,O
Health,O
",",O
Columbia,O
"
",O
University,O
",",O
New,O
York,O
",",O
NY,O
",",O
10032,O
",",O
USA,O
.,O
"

",O
BACKGROUND,O
:,O
The,O
ongoing,O
new,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
(,O
Corona,B-Disease_COVID-19
Virus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
",",O
"
",O
COVID19,B-Disease_COVID-19
),O
outbreak,O
is,O
spreading,O
in,O
China,O
",",O
but,O
it,O
has,O
not,O
yet,O
reached,O
its,O
peak,O
.,O
"
",O
Five,O
million,O
people,O
emigrated,O
from,O
Wuhan,O
before,O
lockdown,O
",",O
potentially,O
"
",O
representing,O
a,O
source,O
of,O
virus,O
infection,O
.,O
Determining,O
case,O
distribution,O
and,O
its,O
"
",O
correlation,O
with,O
population,O
emigration,O
from,O
Wuhan,O
in,O
the,O
early,O
stage,O
of,O
the,O
"
",O
epidemic,O
is,O
of,O
great,O
importance,O
for,O
early,O
warning,O
and,O
for,O
the,O
prevention,O
of,O
"
",O
future,O
outbreaks,O
.,O
"
",O
METHODS,O
:,O
The,O
official,O
case,O
report,O
on,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
was,O
collected,O
as,O
of,O
"
",O
January,O
30,O
",",O
2020,O
.,O
Time,O
and,O
location,O
information,O
on,O
COVID19,B-Disease_COVID-19
cases,O
was,O
extracted,O
"
",O
and,O
analyzed,O
using,O
ArcGIS,O
and,O
WinBUGS,O
software,O
.,O
Data,O
on,O
population,O
migration,O
from,O
"
",O
Wuhan,O
city,O
and,O
Hubei,O
province,O
were,O
extracted,O
from,O
Baidu,O
Qianxi,O
",",O
and,O
their,O
"
",O
correlation,O
with,O
the,O
number,O
of,O
cases,O
was,O
analyzed,O
.,O
"
",O
RESULTS,O
:,O
The,O
COVID19,B-Disease_COVID-19
confirmed,O
and,O
death,O
cases,O
in,O
Hubei,O
province,O
accounted,O
for,O
"
",O
59.91,O
%,O
(,O
5806,O
9692,O
),O
and,O
95.77,O
%,O
(,O
204,O
213,O
),O
of,O
the,O
total,O
cases,O
in,O
China,O
respectively,O
.,O
"
",O
Hot,O
spot,O
provinces,O
included,O
Sichuan,O
and,O
Yunnan,O
",",O
which,O
are,O
adjacent,O
to,O
Hubei,O
.,O
The,O
"
",O
time,O
risk,O
of,O
Hubei,O
province,O
on,O
the,O
following,O
day,O
was,O
1.96,O
times,O
that,O
on,O
the,O
"
",O
previous,O
day,O
.,O
The,O
number,O
of,O
cases,O
in,O
some,O
cities,O
was,O
relatively,O
low,O
",",O
but,O
the,O
time,O
"
",O
risk,O
appeared,O
to,O
be,O
continuously,O
rising,O
.,O
The,O
correlation,O
coefficient,O
between,O
the,O
"
",O
provincial,O
number,O
of,O
cases,O
and,O
emigration,O
from,O
Wuhan,O
was,O
up,O
to,O
0.943,O
.,O
The,O
"
",O
lockdown,O
of,O
17,O
cities,O
in,O
Hubei,O
province,O
and,O
the,O
implementation,O
of,O
nationwide,O
"
",O
control,O
measures,O
efficiently,O
prevented,O
an,O
exponential,O
growth,O
in,O
the,O
number,O
of,O
"
",O
cases,O
.,O
"
",O
CONCLUSIONS,O
:,O
The,O
population,O
that,O
emigrated,O
from,O
Wuhan,O
was,O
the,O
main,O
infection,O
"
",O
source,O
in,O
other,O
cities,O
and,O
provinces,O
.,O
Some,O
cities,O
with,O
a,O
low,O
number,O
of,O
cases,O
"
",O
showed,O
a,O
rapid,O
increase,O
in,O
case,O
load,O
.,O
Owing,O
to,O
the,O
upcoming,O
Spring,O
Festival,O
"
",O
return,O
wave,O
",",O
understanding,O
the,O
risk,O
trends,O
in,O
different,O
regions,O
is,O
crucial,O
to,O
"
",O
ensure,O
preparedness,O
at,O
both,O
the,O
individual,O
and,O
organization,O
levels,O
and,O
to,O
prevent,O
"
",O
new,O
outbreaks,O
.,O
"

",O
DOI,O
:,O
10.1097,O
CM9.0000000000000782,O
"
",O
PMID,O
:,O
32118644,O
"


",O
406,O
.,O
Chin,O
Med,O
J,O
(,O
Engl,O
),O
.,O
2020,O
Feb,O
28,O
.,O
doi,O
:,O
10.1097,O
CM9.0000000000000776,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
From,O
SARSCoV,O
to,O
2019nCoV,B-Virus_SARS-CoV-2
Outbreak,O
:,O
Similarities,O
in,O
the,O
Early,O
Epidemics,O
and,O
"
",O
Prediction,O
of,O
Future,O
Trends,O
.,O
"

",O
Chen,O
ZL(1,O
),O
",",O
Zhang,O
WJ(2,O
),O
",",O
Lu,O
Y(3,O
),O
",",O
Guo,O
C(4,O
),O
",",O
Guo,O
ZM(5,O
),O
",",O
Liao,O
CH(1,O
),O
",",O
Zhang,O
X(6,O
),O
",",O
"
",O
Zhang,O
Y(6,O
),O
",",O
Han,O
XH(6,O
),O
",",O
Li,O
QL(1,O
),O
",",O
Lu,O
JH(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)One,O
Health,O
Center,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Sun,O
Yatsen,O
University,O
",",O
Guangzhou,O
",",O
"
",O
Guangdong,O
510080,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Biological,O
Science,O
and,O
Technology,O
",",O
School,O
of,O
Life,O
Sciences,O
",",O
Sun,O
"
",O
Yatsen,O
University,O
",",O
Guangzhou,O
",",O
Guangdong,O
510080,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Health,O
Law,O
",",O
Policy,O
and,O
Management,O
",",O
School,O
of,O
Public,O
Health,O
",",O
"
",O
Boston,O
University,O
",",O
Massachusetts,O
2215,O
",",O
USA,O
.,O
"
",O
(4)Center,O
for,O
Infection,O
and,O
Immunity,O
",",O
Mailman,O
School,O
of,O
Public,O
Health,O
",",O
Columbia,O
"
",O
University,O
",",O
New,O
York,O
10032,O
",",O
USA,O
.,O
"
",O
(5)Animal,O
Experiment,O
Center,O
",",O
Sun,O
Yatsen,O
University,O
",",O
Guangzhou,O
",",O
Guangdong,O
510080,O
",",O
"
",O
China,O
.,O
"
",O
(6)Key,O
Laboratory,O
of,O
Livestock,O
Infectious,O
Diseases,O
in,O
Northeast,O
China,O
",",O
Ministry,O
"
",O
of,O
Education,O
",",O
Shenyang,O
Agricultural,O
University,O
",",O
Shenyang,O
",",O
Liaoning,O
110866,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1097,O
CM9.0000000000000776,O
"
",O
PMID,O
:,O
32118641,O
"


",O
407,O
.,O
Chin,O
Med,O
J,O
(,O
Engl,O
),O
.,O
2020,O
Feb,O
28,O
.,O
doi,O
:,O
10.1097,O
CM9.0000000000000775,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Analysis,O
of,O
factors,O
associated,O
with,O
disease,O
outcomes,O
in,O
hospitalized,O
patients,O
"
",O
with,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
.,O
"

",O
Liu,O
W(1,O
),O
",",O
Tao,O
ZW(2,O
),O
",",O
Lei,O
W(1,O
),O
",",O
MingLi,O
Y(1,O
),O
",",O
Kui,O
L(3,O
),O
",",O
Ling,O
Z(3,O
),O
",",O
Shuang,O
W(3,O
),O
",",O
"
",O
Yan,O
D(3,O
),O
",",O
Jing,O
L(4,O
),O
",",O
Liu,O
HG(3,O
),O
",",O
Ming,O
Y(5,O
),O
",",O
Yi,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
Central,O
Hospital,O
of,O
"
",O
Wuhan,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
Hubei,O
430014,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Respiratory,O
Intensive,O
Care,O
Unit,O
",",O
The,O
Central,O
Hospital,O
of,O
Wuhan,O
",",O
"
",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
"
",O
Hubei,O
430014,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
"
",O
430030,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Radiology,O
",",O
Wuhan,O
Pulmonary,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
430030,O
",",O
China,O
.,O
"
",O
(5)The,O
Provost,O
's,O
Office,O
",",O
The,O
Central,O
Hospital,O
of,O
Wuhan,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
430014,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
Since,O
early,O
December,O
2019,O
",",O
the,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
has,O
caused,O
pneumonia,O
epidemic,O
in,O
Wuhan,O
",",O
Hubei,O
province,O
of,O
China,O
.,O
This,O
"
",O
study,O
aims,O
to,O
investigate,O
the,O
factors,O
affecting,O
the,O
progression,O
of,O
pneumonia,O
in,O
"
",O
COVID19,B-Disease_COVID-19
patients,O
.,O
Associated,O
results,O
will,O
be,O
used,O
to,O
evaluate,O
the,O
prognosis,O
and,O
"
",O
to,O
find,O
the,O
optimal,O
treatment,O
regimens,O
for,O
COVID19,B-Disease_COVID-19
pneumonia,O
.,O
"
",O
METHODS,O
:,O
Patients,O
tested,O
positive,O
for,O
the,O
COVID19,B-Disease_COVID-19
based,O
on,O
nucleic,O
acid,O
"
",O
detection,O
were,O
included,O
in,O
this,O
study,O
.,O
Patients,O
were,O
admitted,O
to,O
3,O
tertiary,O
"
",O
hospitals,O
in,O
Wuhan,O
between,O
December,O
30,O
",",O
2019,O
",",O
and,O
January,O
15,O
",",O
2020,O
.,O
Individual,O
"
",O
data,O
",",O
laboratory,O
indices,O
",",O
imaging,O
characteristics,O
",",O
and,O
clinical,O
data,O
were,O
"
",O
collected,O
",",O
and,O
statistical,O
analysis,O
was,O
performed,O
.,O
Based,O
on,O
clinical,O
typing,O
"
",O
results,O
",",O
the,O
patients,O
were,O
divided,O
into,O
a,O
progression,O
group,O
or,O
an,O
"
",O
improvement,O
stabilization,O
group,O
.,O
Continuous,O
variables,O
were,O
analyzed,O
using,O
"
",O
independent,O
samples,O
ttest,O
or,O
MannWhitney,O
U,O
test,O
.,O
Categorical,O
variables,O
were,O
"
",O
analyzed,O
using,O
Chisquared,O
test,O
or,O
Fisher,O
exact,O
test,O
.,O
Logistic,O
regression,O
"
",O
analysis,O
was,O
performed,O
to,O
explore,O
the,O
risk,O
factors,O
for,O
disease,O
progression,O
.,O
"
",O
RESULTS,O
:,O
Seventyeight,O
patients,O
with,O
COVID19induced,O
pneumonia,O
met,O
the,O
inclusion,O
"
",O
criteria,O
and,O
were,O
included,O
in,O
this,O
study,O
.,O
Efficacy,O
evaluation,O
at,O
2,O
weeks,O
after,O
"
",O
hospitalization,O
indicated,O
that,O
11,O
patients,O
(,O
14.1,O
%,O
),O
had,O
deteriorated,O
",",O
and,O
67,O
"
",O
patients,O
(,O
85.9,O
%,O
),O
had,O
improved,O
stabilized,O
.,O
The,O
patients,O
in,O
the,O
progression,O
group,O
"
",O
were,O
significantly,O
older,O
than,O
those,O
in,O
the,O
disease,O
improvement,O
stabilization,O
"
",O
group,O
(,O
66,O
[,O
51,O
",",O
70,O
],O
vs.,O
37,O
[,O
32,O
",",O
41,O
],O
years,O
",",O
U,O
â€Š,O
=,O
â€Š,O
4.932,O
",",O
P,O
â€Š,O
=,O
â€Š,O
0.001,O
),O
.,O
The,O
progression,O
"
",O
group,O
had,O
a,O
significantly,O
higher,O
proportion,O
of,O
patients,O
with,O
a,O
history,O
of,O
smoking,O
"
",O
than,O
the,O
improvement,O
stabilization,O
group,O
(,O
27.3,O
%,O
vs.,O
3,O
%,O
",",O
Ï‡,O
â€Š,O
=,O
â€Š,O
9.291,O
",",O
P,O
â€Š,O
=,O
â€Š,O
0.018,O
),O
.,O
"
",O
For,O
all,O
the,O
78,O
patients,O
",",O
fever,O
was,O
the,O
most,O
common,O
initial,O
symptom,O
",",O
and,O
the,O
"
",O
maximum,O
body,O
temperature,O
at,O
admission,O
was,O
significantly,O
higher,O
in,O
the,O
progression,O
"
",O
group,O
than,O
in,O
the,O
improvement,O
stabilization,O
group,O
(,O
38.2,O
[,O
37.8,O
",",O
38.6,O
],O
vs.,O
37.5,O
"
",O
[,O
37,O
",",O
38.4],O
Â°,O
C,O
",",O
U,O
â€Š,O
=,O
â€Š,O
2.057,O
",",O
P,O
â€Š,O
=,O
â€Š,O
0.027,O
),O
.,O
Moreover,O
",",O
the,O
proportion,O
of,O
patients,O
with,O
"
",O
respiratory,O
failure,O
(,O
54.5,O
%,O
vs.,O
20.9,O
%,O
",",O
Ï‡,O
â€Š,O
=,O
â€Š,O
5.611,O
",",O
P,O
â€Š,O
=,O
â€Š,O
0.028,O
),O
and,O
respiratory,O
rate,O
"
",O
(,O
34,O
[,O
18,O
",",O
48,O
],O
vs.,O
24,O
[,O
16,O
",",O
60,O
],O
breaths,O
min,O
",",O
U,O
â€Š,O
=,O
â€Š,O
4.03,O
",",O
P,O
â€Š,O
=,O
â€Š,O
0.004,O
),O
were,O
"
",O
significantly,O
higher,O
in,O
the,O
progression,O
group,O
than,O
in,O
the,O
"
",O
improvement,O
stabilization,O
group,O
.,O
Creactive,O
protein,O
was,O
significantly,O
elevated,O
in,O
"
",O
the,O
progression,O
group,O
compared,O
to,O
the,O
improvement,O
stabilization,O
group,O
(,O
38.9,O
"
",O
[,O
14.3,O
",",O
64.8,O
],O
vs.,O
10.6,O
[,O
1.9,O
",",O
33.1,O
],O
mg,O
L,O
",",O
U,O
â€Š,O
=,O
â€Š,O
1.315,O
",",O
P,O
â€Š,O
=,O
â€Š,O
0.024,O
),O
.,O
Albumin,O
was,O
"
",O
significantly,O
lower,O
in,O
the,O
progression,O
group,O
than,O
in,O
the,O
"
",O
improvement,O
stabilization,O
group,O
(,O
36.62,O
â€Š,O
Â±,O
â€Š,O
6.6,O
vs.,O
41.27,O
â€Š,O
Â±,O
â€Š,O
4.55,O
â€Š,O
g,O
L,O
",",O
U,O
â€Š,O
=,O
â€Š,O
2.843,O
",",O
"
",O
P,O
â€Š,O
=,O
â€Š,O
0.006,O
),O
.,O
Patients,O
in,O
the,O
progression,O
group,O
were,O
more,O
likely,O
to,O
receive,O
"
",O
highlevel,O
respiratory,O
support,O
than,O
in,O
the,O
improvement,O
stabilization,O
group,O
"
",O
(,O
Ï‡,O
â€Š,O
=,O
â€Š,O
16.01,O
",",O
P,O
â€Š,O
=,O
â€Š,O
0.001,O
),O
.,O
Multivariate,O
logistic,O
analysis,O
indicated,O
that,O
age,O
(,O
odds,O
"
",O
ratio,O
[,O
OR,O
],O
",",O
8.546,O
;,O
95,O
%,O
confidence,O
interval,O
[,O
CI,O
],O
:,O
1.62844.864,O
;,O
P,O
â€Š,O
=,O
â€Š,O
0.011,O
),O
",",O
"
",O
history,O
of,O
smoking,O
(,O
OR,O
",",O
14.285,O
;,O
95,O
%,O
CI,O
:,O
1.57725.000,O
;,O
P,O
â€Š,O
=,O
â€Š,O
0.018,O
),O
",",O
maximum,O
body,O
"
",O
temperature,O
at,O
admission,O
(,O
OR,O
",",O
8.999,O
;,O
95,O
%,O
CI,O
:,O
1.03678.147,O
",",O
P,O
â€Š,O
=,O
â€Š,O
0.046,O
),O
",",O
"
",O
respiratory,O
failure,O
(,O
OR,O
",",O
8.772,O
",",O
95,O
%,O
CI,O
:,O
1.94240.000,O
;,O
P,O
â€Š,O
=,O
â€Š,O
0.016,O
),O
",",O
albumin,O
(,O
OR,O
",",O
"
",O
7.353,O
",",O
95,O
%,O
CI,O
:,O
1.09850.000,O
;,O
P,O
â€Š,O
=,O
â€Š,O
0.003,O
),O
",",O
and,O
Creactive,O
protein,O
(,O
OR,O
",",O
10.53,O
;,O
95,O
%,O
"
",O
CI,O
:,O
1.22434.701,O
",",O
P,O
â€Š,O
=,O
â€Š,O
0.028,O
),O
were,O
risk,O
factors,O
for,O
disease,O
progression,O
.,O
"
",O
CONCLUSIONS,O
:,O
Several,O
factors,O
that,O
led,O
to,O
the,O
progression,O
of,O
COVID19,B-Disease_COVID-19
pneumonia,O
"
",O
were,O
identified,O
",",O
including,O
age,O
",",O
history,O
of,O
smoking,O
",",O
maximum,O
body,O
temperature,O
on,O
"
",O
admission,O
",",O
respiratory,O
failure,O
",",O
albumin,O
",",O
Creactive,O
protein,O
.,O
These,O
results,O
can,O
be,O
"
",O
used,O
to,O
further,O
enhance,O
the,O
ability,O
of,O
management,O
of,O
COVID19,B-Disease_COVID-19
pneumonia,O
.,O
"

",O
DOI,O
:,O
10.1097,O
CM9.0000000000000775,O
"
",O
PMID,O
:,O
32118640,O
"


",O
408,O
.,O
Chin,O
Med,O
J,O
(,O
Engl,O
),O
.,O
2020,O
Feb,O
28,O
.,O
doi,O
:,O
10.1097,O
CM9.0000000000000774,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Persistence,O
and,O
clearance,O
of,O
viral,O
RNA,O
in,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
"
",O
rehabilitation,O
patients,O
.,O
"

",O
Ling,O
Y(1,O
),O
",",O
Xu,O
SB(2,O
),O
",",O
Lin,O
YX(3,O
),O
",",O
Tian,O
D(1,O
),O
",",O
Zhu,O
ZQ(1,O
),O
",",O
Dai,O
FH(1,O
),O
",",O
Wu,O
F(1,O
),O
",",O
Song,O
"
",O
ZG(1,O
),O
",",O
Huang,O
W(1,O
),O
",",O
Chen,O
J(2,O
),O
",",O
Hu,O
BJ(4,O
),O
",",O
Wang,O
S(5,O
),O
",",O
Mao,O
EQ(6,O
),O
",",O
Zhu,O
L(7,O
),O
",",O
Zhang,O
"
",O
WH(8,O
),O
",",O
Lu,O
HZ(1)(2)(8)(9,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Disease,O
",",O
Shanghai,O
Public,O
Health,O
Clinical,O
Center,O
",",O
"
",O
Shanghai,O
201508,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Infectious,O
Disease,O
and,O
Immunology,O
",",O
Shanghai,O
Public,O
Health,O
"
",O
Clinical,O
Center,O
",",O
Shanghai,O
201508,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Hepatology,O
",",O
Shanghai,O
Public,O
Health,O
Clinical,O
Center,O
",",O
Shanghai,O
"
",O
201508,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Infectious,O
Disease,O
",",O
Zhongshan,O
Hospital,O
",",O
Fudan,O
University,O
",",O
"
",O
Shanghai,O
200032,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Shanghai,O
Tenth,O
People,O
's,O
Hospital,O
",",O
Tongji,O
"
",O
University,O
",",O
Shanghai,O
200072,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Emergency,O
",",O
Ruijin,O
Hospital,O
",",O
Shanghai,O
Jiaotong,O
University,O
School,O
"
",O
of,O
Medicine,O
",",O
Shanghai,O
200025,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Pulmonology,O
",",O
Zhongshan,O
Hospital,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
"
",O
200032,O
",",O
China,O
.,O
"
",O
(8)Department,O
of,O
Infectious,O
Disease,O
",",O
Huashan,O
Hospital,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
"
",O
200041,O
",",O
China,O
.,O
"
",O
(9)Shanghai,O
Medical,O
College,O
of,O
Fudan,O
University,O
",",O
Shanghai,O
200032,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
A,O
patient,O
's,O
infectivity,O
is,O
determined,O
by,O
the,O
presence,O
of,O
the,O
virus,O
in,O
"
",O
different,O
body,O
fluids,O
",",O
secretions,O
",",O
and,O
excreta,O
.,O
The,O
persistence,O
and,O
clearance,O
of,O
"
",O
viral,O
RNA,O
from,O
different,O
specimens,O
of,O
patients,O
with,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
remain,O
unclear,O
.,O
This,O
study,O
analyzed,O
the,O
clearance,O
time,O
and,O
"
",O
factors,O
influencing,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
RNA,O
in,O
different,O
samples,O
"
",O
from,O
patients,O
with,O
COVID19,B-Disease_COVID-19
",",O
providing,O
further,O
evidence,O
to,O
improve,O
the,O
management,O
"
",O
of,O
patients,O
during,O
convalescence,O
.,O
"
",O
METHODS,O
:,O
The,O
clinical,O
data,O
and,O
laboratory,O
test,O
results,O
of,O
convalescent,O
patients,O
"
",O
with,O
COVID19,B-Disease_COVID-19
who,O
were,O
admitted,O
to,O
from,O
January,O
20,O
",",O
2020,O
to,O
February,O
10,O
",",O
2020,O
"
",O
were,O
collected,O
retrospectively,O
.,O
The,O
reverse,O
transcription,O
polymerase,O
chain,O
"
",O
reaction,O
(,O
RTPCR,O
),O
results,O
for,O
patients,O
',O
oropharyngeal,O
swab,O
",",O
stool,O
",",O
urine,O
",",O
and,O
"
",O
serum,O
samples,O
were,O
collected,O
and,O
analyzed,O
.,O
Convalescent,O
patients,O
refer,O
to,O
"
",O
recovered,O
nonfebrile,O
patients,O
without,O
respiratory,O
symptoms,O
who,O
had,O
two,O
"
",O
successive,O
(,O
minimum,O
24,O
h,O
sampling,O
interval,O
),O
negative,O
RTPCR,O
results,O
for,O
viral,O
RNA,O
"
",O
from,O
oropharyngeal,O
swabs,O
.,O
The,O
effects,O
of,O
cluster,O
of,O
differentiation,O
4,O
(CD4)+,O
T,O
"
",O
lymphocytes,O
",",O
inflammatory,O
indicators,O
",",O
and,O
glucocorticoid,O
treatment,O
on,O
viral,O
"
",O
nucleic,O
acid,O
clearance,O
were,O
analyzed,O
.,O
"
",O
RESULTS,O
:,O
In,O
the,O
292,O
confirmed,O
cases,O
",",O
66,O
patients,O
recovered,O
after,O
treatment,O
and,O
"
",O
were,O
included,O
in,O
our,O
study,O
.,O
In,O
total,O
",",O
28,O
(,O
42.4,O
%,O
),O
women,O
and,O
38,O
men,O
(,O
57.6,O
%,O
),O
with,O
a,O
"
",O
median,O
age,O
of,O
44,O
(,O
34.062.0,O
),O
years,O
were,O
analyzed,O
.,O
After,O
inhospital,O
treatment,O
",",O
"
",O
patients,O
',O
inflammatory,O
indicators,O
decreased,O
with,O
improved,O
clinical,O
condition,O
.,O
The,O
"
",O
median,O
time,O
from,O
the,O
onset,O
of,O
symptoms,O
to,O
first,O
negative,O
RTPCR,O
results,O
for,O
"
",O
oropharyngeal,O
swabs,O
in,O
convalescent,O
patients,O
was,O
9.5,O
(,O
6.011.0,O
),O
days,O
.,O
By,O
February,O
"
",O
10,O
",",O
2020,O
",",O
11,O
convalescent,O
patients,O
(,O
16.7,O
%,O
),O
still,O
tested,O
positive,O
for,O
viral,O
RNA,O
"
",O
from,O
stool,O
specimens,O
and,O
the,O
other,O
55,O
patients,O
',O
stool,O
specimens,O
were,O
negative,O
for,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
following,O
a,O
median,O
duration,O
of,O
11,O
(,O
9.016.0,O
),O
days,O
after,O
symptom,O
"
",O
onset,O
.,O
Among,O
these,O
55,O
patients,O
",",O
43,O
had,O
a,O
longer,O
duration,O
until,O
stool,O
specimens,O
"
",O
were,O
negative,O
for,O
viral,O
RNA,O
than,O
for,O
throat,O
swabs,O
",",O
with,O
a,O
median,O
delay,O
of,O
2,O
"
",O
(,O
1.04.0,O
),O
days,O
.,O
Results,O
for,O
only,O
four,O
(,O
6.9,O
%,O
),O
urine,O
samples,O
were,O
positive,O
for,O
"
",O
viral,O
nucleic,O
acid,O
out,O
of,O
58,O
cases,O
;,O
viral,O
RNA,O
was,O
still,O
present,O
in,O
three,O
"
",O
patients,O
',O
urine,O
specimens,O
after,O
throat,O
swabs,O
were,O
negative,O
.,O
Using,O
a,O
multiple,O
"
",O
linear,O
regression,O
model,O
(,O
F,O
â€Š,O
=,O
â€Š,O
2.669,O
",",O
P,O
â€Š,O
=,O
â€Š,O
0.044,O
",",O
and,O
adjusted,O
R,O
â€Š,O
=,O
â€Š,O
0.122,O
),O
",",O
the,O
"
",O
analysis,O
showed,O
that,O
the,O
CD4,O
+,O
T,O
lymphocyte,O
count,O
may,O
help,O
predict,O
the,O
duration,O
of,O
"
",O
viral,O
RNA,O
detection,O
in,O
patients,O
',O
stools,O
(,O
t,O
â€Š,O
=,O
â€Š,O
2.699,O
",",O
P,O
â€Š,O
=,O
â€Š,O
0.01,O
),O
.,O
The,O
duration,O
of,O
"
",O
viral,O
RNA,O
detection,O
from,O
oropharyngeal,O
swabs,O
and,O
fecal,O
samples,O
in,O
the,O
"
",O
glucocorticoid,O
treatment,O
group,O
was,O
longer,O
than,O
that,O
in,O
the,O
nonglucocorticoid,O
"
",O
treatment,O
group,O
(,O
15,O
days,O
vs.,O
8,O
days,O
",",O
respectively,O
;,O
t,O
â€Š,O
=,O
â€Š,O
2.55,O
",",O
P,O
â€Š,O
=,O
â€Š,O
0.013,O
),O
and,O
"
",O
the,O
duration,O
of,O
viral,O
RNA,O
detection,O
in,O
fecal,O
samples,O
in,O
the,O
glucocorticoid,O
"
",O
treatment,O
group,O
was,O
longer,O
than,O
that,O
in,O
the,O
nonglucocorticoid,O
treatment,O
group,O
"
",O
(,O
20,O
days,O
vs.,O
11,O
days,O
",",O
respectively,O
;,O
t,O
â€Š,O
=,O
â€Š,O
4.631,O
",",O
P,O
â€Š,O
<,O
â€Š,O
0.001,O
),O
.,O
There,O
was,O
no,O
"
",O
statistically,O
significant,O
difference,O
in,O
inflammatory,O
indicators,O
between,O
patients,O
"
",O
with,O
positive,O
fecal,O
viral,O
RNA,O
test,O
results,O
and,O
those,O
with,O
negative,O
results,O
"
",O
(,O
P,O
â€Š,O
>,O
â€Š,O
0.05,O
),O
.,O
"
",O
CONCLUSIONS,O
:,O
In,O
brief,O
",",O
as,O
the,O
clearance,O
of,O
viral,O
RNA,O
in,O
patients,O
',O
stools,O
was,O
"
",O
delayed,O
compared,O
to,O
that,O
in,O
oropharyngeal,O
swabs,O
",",O
it,O
is,O
important,O
to,O
identify,O
"
",O
viral,O
RNA,O
in,O
feces,O
during,O
convalescence,O
.,O
Because,O
of,O
the,O
delayed,O
clearance,O
of,O
"
",O
viral,O
RNA,O
in,O
the,O
glucocorticoid,O
treatment,O
group,O
",",O
glucocorticoids,O
are,O
not,O
"
",O
recommended,O
in,O
the,O
treatment,O
of,O
COVID19,B-Disease_COVID-19
",",O
especially,O
for,O
mild,O
disease,O
.,O
The,O
"
",O
duration,O
of,O
RNA,O
detection,O
may,O
relate,O
to,O
host,O
cell,O
immunity,O
.,O
"

",O
DOI,O
:,O
10.1097,O
CM9.0000000000000774,O
"
",O
PMID,O
:,O
32118639,O
"


",O
409,O
.,O
Invest,O
Radiol,O
.,O
2020,O
Feb,O
29,O
.,O
doi,O
:,O
10.1097,O
RLI.0000000000000672,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
The,O
Clinical,O
and,O
Chest,O
CT,O
Features,O
Associated,O
with,O
Severe,O
and,O
Critical,O
COVID19,B-Disease_COVID-19
"
",O
Pneumonia,O
.,O
"

",O
Li,O
K(1,O
),O
",",O
Wu,O
J(2,O
),O
",",O
Wu,O
F(3,O
),O
",",O
Guo,O
D(1,O
),O
",",O
Chen,O
L(1,O
),O
",",O
Fang,O
Z(1,O
),O
",",O
Li,O
C(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
the,O
Second,O
Affiliated,O
Hospital,O
of,O
Chongqing,O
Medical,O
"
",O
University,O
",",O
Chongqing,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
Chongqing,O
Three,O
Gorges,O
Central,O
Hospital,O
",",O
Chongqing,O
",",O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Medical,O
Service,O
",",O
Yanzhuang,O
Central,O
Hospital,O
of,O
Gangcheng,O
"
",O
District,O
",",O
Jinan,O
",",O
China,O
.,O
"

",O
OBJECTIVE,O
:,O
To,O
investigate,O
the,O
clinical,O
and,O
CT,O
features,O
associated,O
with,O
severe,O
and,O
"
",O
critical,O
Corona,B-Disease_COVID-19
Virus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
pneumonia,O
.,O
"
",O
MATERIALS,O
AND,O
METHODS,O
:,O
Eightythree,O
patients,O
with,O
COVID19,B-Disease_COVID-19
pneumonia,O
including,O
25,O
"
",O
severe,O
critical,O
cases,O
and,O
58,O
ordinary,O
cases,O
were,O
enrolled,O
.,O
The,O
chest,O
CT,O
images,O
"
",O
and,O
clinical,O
data,O
of,O
them,O
were,O
reviewed,O
and,O
compared,O
.,O
The,O
risk,O
factors,O
associated,O
"
",O
with,O
disease,O
severity,O
were,O
analyzed,O
.,O
"
",O
RESULTS,O
:,O
Compared,O
with,O
the,O
ordinary,O
patients,O
",",O
the,O
severe,O
critical,O
patients,O
had,O
"
",O
older,O
ages,O
",",O
higher,O
incidence,O
of,O
comorbidities,O
",",O
cough,O
",",O
expectoration,O
",",O
chest,O
pain,O
"
",O
and,O
dyspnea,O
.,O
The,O
incidences,O
of,O
consolidation,O
",",O
linear,O
opacities,O
",",O
crazypaving,O
"
",O
pattern,O
and,O
bronchial,O
wall,O
thickening,O
in,O
severe,O
critical,O
patients,O
were,O
"
",O
significantly,O
higher,O
than,O
those,O
of,O
the,O
ordinary,O
patients,O
.,O
Besides,O
",",O
"
",O
severe,O
critical,O
patients,O
showed,O
higher,O
incidences,O
of,O
lymph,O
node,O
enlargement,O
",",O
"
",O
pericardial,O
effusion,O
and,O
pleural,O
effusion,O
than,O
the,O
ordinary,O
patients,O
.,O
The,O
CT,O
"
",O
scores,O
of,O
severe,O
critical,O
patients,O
were,O
significantly,O
higher,O
than,O
those,O
of,O
the,O
"
",O
ordinary,O
patients,O
(,O
P,O
<,O
0.001,O
),O
.,O
Receiver,O
operating,O
characteristic,O
(,O
ROC,O
),O
curve,O
"
",O
showed,O
that,O
the,O
sensitivity,O
and,O
specificity,O
of,O
CT,O
Score,O
were,O
80,O
%,O
and,O
82.8,O
%,O
"
",O
respectively,O
for,O
the,O
discrimination,O
of,O
the,O
two,O
types,O
.,O
The,O
clinical,O
factors,O
of,O
age,O
"
",O
>,O
50,O
years,O
old,O
",",O
comorbidities,O
",",O
dyspnea,O
",",O
chest,O
pain,O
",",O
cough,O
",",O
expectoration,O
",",O
"
",O
decreased,O
lymphocytes,O
and,O
increased,O
inflammation,O
indicators,O
were,O
risk,O
factors,O
for,O
"
",O
severe,O
critical,O
COVID19,B-Disease_COVID-19
pneumonia,O
.,O
CT,O
findings,O
of,O
consolidation,O
",",O
linear,O
"
",O
opacities,O
",",O
crazypaving,O
pattern,O
",",O
bronchial,O
wall,O
thickening,O
",",O
high,O
CT,O
scores,O
and,O
"
",O
extrapulmonary,O
lesions,O
were,O
features,O
of,O
severe,O
critical,O
COVID19,B-Disease_COVID-19
pneumonia,O
.,O
"
",O
CONCLUSIONS,O
:,O
There,O
are,O
significant,O
differences,O
in,O
clinical,O
symptoms,O
",",O
laboratory,O
"
",O
examinations,O
and,O
CT,O
manifestations,O
between,O
the,O
ordinary,O
patients,O
and,O
the,O
"
",O
severe,O
critical,O
patients,O
.,O
Many,O
factors,O
are,O
related,O
to,O
the,O
severity,O
of,O
the,O
"
",O
disease,O
",",O
which,O
can,O
help,O
clinicians,O
to,O
judge,O
the,O
severity,O
of,O
the,O
patient,O
and,O
"
",O
evaluate,O
the,O
prognosis,O
.,O
"

",O
DOI,O
:,O
10.1097,O
RLI.0000000000000672,O
"
",O
PMID,O
:,O
32118615,O
"


",O
410,O
.,O
Emerg,O
Infect,O
Dis,O
.,O
2020,O
Jun,O
17;26(6,O
),O
.,O
doi,O
:,O
10.3201,O
eid2606.200452,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
in,O
2,O
Persons,O
with,O
Mild,O
Upper,O
Respiratory,O
Symptoms,O
on,O
a,O
Cruise,O
Ship,O
",",O
"
",O
Japan,O
.,O
"

",O
Arashiro,O
T,O
",",O
Furukawa,O
K,O
",",O
Nakamura,O
A.,O
"

",O
We,O
describe,O
2,O
cases,O
of,O
COVID19,B-Disease_COVID-19
in,O
patients,O
with,O
mild,O
upper,O
respiratory,O
symptoms,O
.,O
"
",O
Both,O
patients,O
worked,O
on,O
a,O
cruise,O
ship,O
quarantined,O
off,O
the,O
coast,O
of,O
Japan,O
.,O
One,O
"
",O
patient,O
had,O
persistent,O
",",O
lowgrade,O
upper,O
respiratory,O
tract,O
symptoms,O
without,O
fever,O
.,O
"
",O
The,O
other,O
patient,O
had,O
rapid,O
symptom,O
cessation,O
but,O
persistent,O
viral,O
RNA,O
detection,O
.,O
"

",O
DOI,O
:,O
10.3201,O
eid2606.200452,O
"
",O
PMID,O
:,O
32118533,O
"


",O
411,O
.,O
F1000Res,O
.,O
2020,O
Jan,O
31;9:72,O
.,O
doi,O
:,O
10.12688,O
f1000research.22211.2,O
.,O
eCollection,O
"
",O
2020,O
.,O
"

",O
Therapeutic,O
strategies,O
in,O
an,O
outbreak,O
scenario,O
to,O
treat,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
originating,O
in,O
Wuhan,O
",",O
China,O
.,O
"

",O
Kruse,O
RL(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pathology,O
",",O
Johns,O
Hopkins,O
Hospital,O
",",O
Baltimore,O
",",O
Maryland,O
",",O
21287,O
",",O
"
",O
USA,O
.,O
"

",O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
originating,O
in,O
Wuhan,O
",",O
China,O
presents,O
a,O
potential,O
"
",O
respiratory,O
viral,O
pandemic,O
to,O
the,O
world,O
population,O
.,O
Current,O
efforts,O
are,O
focused,O
"
",O
on,O
containment,O
and,O
quarantine,O
of,O
infected,O
individuals,O
.,O
Ultimately,O
",",O
the,O
outbreak,O
"
",O
could,O
be,O
controlled,O
with,O
a,O
protective,O
vaccine,O
to,O
prevent,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"
",O
While,O
vaccine,O
research,O
should,O
be,O
pursued,O
intensely,O
",",O
there,O
exists,O
today,O
no,O
therapy,O
"
",O
to,O
treat,O
2019nCoV,B-Virus_SARS-CoV-2
upon,O
infection,O
",",O
despite,O
an,O
urgent,O
need,O
to,O
find,O
options,O
to,O
help,O
"
",O
these,O
patients,O
and,O
preclude,O
potential,O
death,O
.,O
Herein,O
",",O
I,O
review,O
the,O
potential,O
"
",O
options,O
to,O
treat,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
patients,O
",",O
with,O
an,O
emphasis,O
on,O
the,O
necessity,O
for,O
"
",O
speed,O
and,O
timeliness,O
in,O
developing,O
new,O
and,O
effective,O
therapies,O
in,O
this,O
outbreak,O
.,O
"
",O
I,O
consider,O
the,O
options,O
of,O
drug,O
repurposing,O
",",O
developing,O
neutralizing,O
monoclonal,O
"
",O
antibody,O
therapy,O
",",O
and,O
an,O
oligonucleotide,O
strategy,O
targeting,O
the,O
viral,O
RNA,O
genome,O
",",O
"
",O
emphasizing,O
the,O
promise,O
and,O
pitfalls,O
of,O
these,O
approaches,O
.,O
Finally,O
",",O
I,O
advocate,O
for,O
"
",O
the,O
fastest,O
strategy,O
to,O
develop,O
a,O
treatment,O
now,O
",",O
which,O
could,O
be,O
resistant,O
to,O
any,O
"
",O
mutations,O
the,O
virus,O
may,O
have,O
in,O
the,O
future,O
.,O
The,O
proposal,O
is,O
a,O
biologic,O
that,O
"
",O
blocks,O
2019nCoV,B-Virus_SARS-CoV-2
entry,O
using,O
a,O
soluble,O
version,O
of,O
the,O
viral,O
receptor,O
",",O
"
",O
angiotensinconverting,O
enzyme,O
2,O
(,O
ACE2,O
),O
",",O
fused,O
to,O
an,O
immunoglobulin,O
Fc,O
domain,O
",",O
"
",O
providing,O
a,O
neutralizing,O
antibody,O
with,O
maximal,O
breath,O
to,O
avoid,O
any,O
viral,O
escape,O
",",O
"
",O
while,O
also,O
helping,O
to,O
recruit,O
the,O
immune,O
system,O
to,O
build,O
lasting,O
immunity,O
.,O
The,O
"
",O
sequence,O
of,O
the,O
ACE2Fc,O
protein,O
is,O
provided,O
to,O
investigators,O
",",O
allowing,O
its,O
"
",O
possible,O
use,O
in,O
recombinant,O
protein,O
expression,O
systems,O
to,O
start,O
producing,O
drug,O
"
",O
today,O
to,O
treat,O
patients,O
under,O
compassionate,O
use,O
",",O
while,O
formal,O
clinical,O
trials,O
are,O
"
",O
later,O
undertaken,O
.,O
Such,O
a,O
treatment,O
could,O
help,O
infected,O
patients,O
before,O
a,O
"
",O
protective,O
vaccine,O
is,O
developed,O
and,O
widely,O
available,O
in,O
the,O
coming,O
months,O
to,O
"
",O
year(s,O
),O
.,O
"

",O
Copyright,O
:,O
Â©,O
2020,O
Kruse,O
RL,O
.,O
"

",O
DOI,O
:,O
10.12688,O
f1000research.22211.2,O
"
",O
PMCID,O
:,O
PMC7029759,O
"
",O
PMID,O
:,O
32117569,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
No,O
competing,O
interests,O
were,O
disclosed,O
.,O
"


",O
412,O
.,O
Front,O
Immunol,O
.,O
2020,O
Feb,O
14;11:51,O
.,O
doi,O
:,O
10.3389,O
fimmu.2020.00051,O
.,O
eCollection,O
"
",O
2020,O
.,O
"

",O
NS5,O
Conservative,O
Site,O
Is,O
Required,O
for,O
Zika,O
Virus,O
to,O
Restrict,O
the,O
RIGI,O
Signaling,O
.,O
"

",O
Li,O
A(1,O
),O
",",O
Wang,O
W(2,O
),O
",",O
Wang,O
Y(1,O
),O
",",O
Chen,O
K(1,O
),O
",",O
Xiao,O
F(1,O
),O
",",O
Hu,O
D(1,O
),O
",",O
Hui,O
L(1,O
),O
",",O
Liu,O
W(1,O
),O
",",O
"
",O
Feng,O
Y(2,O
),O
",",O
Li,O
G(2,O
),O
",",O
Tan,O
Q(3,O
),O
",",O
Liu,O
Y(2,O
),O
",",O
Wu,O
K(1,O
),O
",",O
Wu,O
J(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Guangzhou,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Institute,O
of,O
Medical,O
Microbiology,O
",",O
Jinan,O
"
",O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(3)Guangdong,O
LongFan,O
Biological,O
Science,O
and,O
Technology,O
Company,O
",",O
Foshan,O
",",O
China,O
.,O
"

",O
During,O
hostvirus,O
coevolution,O
",",O
cells,O
develop,O
innate,O
immune,O
systems,O
to,O
inhibit,O
"
",O
virus,O
invasion,O
",",O
while,O
viruses,O
employ,O
strategies,O
to,O
suppress,O
immune,O
responses,O
and,O
"
",O
maintain,O
infection,O
.,O
Here,O
",",O
we,O
reveal,O
that,O
Zika,O
virus,O
(,O
ZIKV,O
),O
",",O
a,O
reemerging,O
"
",O
arbovirus,O
causing,O
public,O
concerns,O
and,O
devastating,O
complications,O
",",O
restricts,O
host,O
"
",O
immune,O
responses,O
through,O
a,O
distinct,O
mechanism,O
.,O
ZIKV,O
nonstructural,O
protein,O
5,O
(,O
NS5,O
),O
"
",O
interacts,O
with,O
the,O
host,O
retinoic,O
acidinducible,O
gene,O
I,O
(,O
RIGI,O
),O
",",O
an,O
essential,O
"
",O
signaling,O
molecule,O
for,O
defending,O
pathogen,O
infections,O
.,O
NS5,O
subsequently,O
represses,O
"
",O
K63linked,O
polyubiquitination,O
of,O
RIGI,O
",",O
attenuates,O
the,O
phosphorylation,O
and,O
"
",O
nuclear,O
translocation,O
of,O
interferon,O
regulatory,O
factor,O
3,O
(,O
IRF3,O
),O
",",O
and,O
inhibits,O
the,O
"
",O
expression,O
and,O
production,O
of,O
interferonÎ²,O
(,O
IFNÎ²,O
),O
",",O
thereby,O
restricting,O
the,O
RIGI,O
"
",O
signaling,O
pathway,O
.,O
Interestingly,O
",",O
we,O
demonstrate,O
that,O
the,O
methyltransferase,O
"
",O
(,O
MTase,O
),O
domain,O
of,O
NS5,O
is,O
required,O
for,O
the,O
repression,O
of,O
RIGI,O
ubiquitination,O
",",O
"
",O
IRF3,O
activation,O
",",O
and,O
IFNÎ²,O
production,O
.,O
Detailed,O
studies,O
further,O
reveal,O
that,O
the,O
"
",O
conservative,O
active,O
site,O
D146,O
of,O
NS5,O
is,O
critical,O
for,O
the,O
suppression,O
of,O
the,O
RIGI,O
"
",O
signaling,O
.,O
Therefore,O
",",O
we,O
uncover,O
an,O
essential,O
role,O
of,O
NS5,O
conservative,O
site,O
D146,O
"
",O
in,O
ZIKVmediated,O
repression,O
of,O
innate,O
immune,O
system,O
",",O
illustrate,O
a,O
distinct,O
"
",O
mechanism,O
by,O
which,O
ZIKV,O
evades,O
host,O
immune,O
responses,O
",",O
and,O
discover,O
a,O
potential,O
"
",O
target,O
for,O
antiviral,O
infection,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Li,O
",",O
Wang,O
",",O
Wang,O
",",O
Chen,O
",",O
Xiao,O
",",O
Hu,O
",",O
Hui,O
",",O
Liu,O
",",O
Feng,O
",",O
Li,O
",",O
Tan,O
",",O
Liu,O
",",O
Wu,O
"
",O
and,O
Wu,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fimmu.2020.00051,O
"
",O
PMCID,O
:,O
PMC7033454,O
"
",O
PMID,O
:,O
32117232,O
"


",O
413,O
.,O
Front,O
Microbiol,O
.,O
2020,O
Feb,O
13;11:220,O
.,O
doi,O
:,O
10.3389,O
fmicb.2020.00220,O
.,O
eCollection,O
"
",O
2020,O
.,O
"

",O
Novel,O
Reassortant,O
Avian,O
Influenza,O
A(H9N2,O
),O
Virus,O
Isolate,O
in,O
Migratory,O
Waterfowl,O
in,O
"
",O
Hubei,O
Province,O
",",O
China,O
.,O
"

",O
Li,O
X(1,O
),O
",",O
Sun,O
J(1,O
),O
",",O
Lv,O
X(1,O
),O
",",O
Wang,O
Y(1,O
),O
",",O
Li,O
Y(2,O
),O
",",O
Li,O
M(2,O
),O
",",O
Liu,O
W(3,O
),O
",",O
Zhi,O
M(1,O
),O
",",O
Yang,O
"
",O
X(1,O
),O
",",O
Fu,O
T(1,O
),O
",",O
Ma,O
P(1,O
),O
",",O
Li,O
Y(1,O
),O
",",O
Zhou,O
X(4,O
),O
",",O
Li,O
Y(4,O
),O
",",O
Yang,O
G(4,O
),O
",",O
Chen,O
G(4,O
),O
",",O
Zhang,O
"
",O
J(4,O
),O
",",O
Zheng,O
H(4,O
),O
",",O
Zhang,O
G(5,O
),O
",",O
Hua,O
Y(1,O
),O
",",O
Yang,O
S(6,O
),O
",",O
Li,O
Y(2,O
),O
",",O
Richt,O
JA(7,O
),O
",",O
Chai,O
"
",O
H(1)(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)College,O
of,O
Wildlife,O
and,O
Protected,O
Area,O
",",O
Northeast,O
Forestry,O
University,O
",",O
Harbin,O
",",O
"
",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Veterinary,O
Biotechnology,O
",",O
Harbin,O
Veterinary,O
Research,O
"
",O
Institute,O
of,O
Chinese,O
Academy,O
of,O
Agricultural,O
Sciences,O
",",O
Harbin,O
",",O
China,O
.,O
"
",O
(3)Investigation,O
and,O
Planning,O
Institute,O
of,O
Hubei,O
Forestry,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Hubei,O
Wildlife,O
Rescue,O
",",O
Research,O
and,O
Development,O
Center,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(5)Research,O
Institute,O
of,O
Forest,O
Ecology,O
",",O
Environment,O
and,O
Protection,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Forestry,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(6)Heilongjiang,O
Vocational,O
College,O
for,O
Nationalities,O
",",O
Harbin,O
",",O
China,O
.,O
"
",O
(7)Diagnostic,O
Medicine,O
Pathobiology,O
",",O
Center,O
of,O
Excellence,O
for,O
Emerging,O
and,O
"
",O
Zoonotic,O
Animal,O
Diseases,O
(,O
CEEZAD,O
),O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Kansas,O
State,O
"
",O
University,O
",",O
Manhattan,O
",",O
KS,O
",",O
United,O
States,O
.,O
"

",O
In,O
December,O
2017,O
",",O
an,O
influenza,O
A(H9N2,O
),O
virus,O
(,O
B51,O
),O
was,O
isolated,O
from,O
migratory,O
"
",O
waterfowl,O
in,O
Hubei,O
Province,O
",",O
China,O
.,O
Phylogenetic,O
analysis,O
demonstrated,O
that,O
B51,O
"
",O
is,O
a,O
novel,O
reassortant,O
influenza,O
virus,O
containing,O
segments,O
from,O
human,O
H7N4,O
virus,O
"
",O
and,O
North,O
American,O
wild,O
bird,O
influenza,O
viruses,O
.,O
This,O
suggest,O
that,O
B51,O
has,O
"
",O
undergone,O
multiple,O
reassortment,O
events,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Li,O
",",O
Sun,O
",",O
Lv,O
",",O
Wang,O
",",O
Li,O
",",O
Li,O
",",O
Liu,O
",",O
Zhi,O
",",O
Yang,O
",",O
Fu,O
",",O
Ma,O
",",O
Li,O
",",O
Zhou,O
",",O
Li,O
",",O
"
",O
Yang,O
",",O
Chen,O
",",O
Zhang,O
",",O
Zheng,O
",",O
Zhang,O
",",O
Hua,O
",",O
Yang,O
",",O
Li,O
",",O
Richt,O
and,O
Chai,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fmicb.2020.00220,O
"
",O
PMCID,O
:,O
PMC7031422,O
"
",O
PMID,O
:,O
32117193,O
"


",O
414,O
.,O
Front,O
Neural,O
Circuits,O
.,O
2020,O
Feb,O
7;14:4,O
.,O
doi,O
:,O
10.3389,O
fncir.2020.00004,O
.,O
"
",O
eCollection,O
2020,O
.,O
"

",O
CellTypeSpecific,O
WholeBrain,O
Direct,O
Inputs,O
to,O
the,O
Anterior,O
and,O
Posterior,O
"
",O
Piriform,O
Cortex,O
.,O
"

",O
Wang,O
L(1)(2,O
),O
",",O
Zhang,O
Z(2,O
),O
",",O
Chen,O
J(3,O
),O
",",O
Manyande,O
A(4,O
),O
",",O
Haddad,O
R(5,O
),O
",",O
Liu,O
Q(2)(6,O
),O
",",O
Xu,O
"
",O
F(1)(2)(6)(7)(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Wuhan,O
National,O
Laboratory,O
for,O
Optoelectronics,O
",",O
Huazhong,O
University,O
of,O
Science,O
"
",O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Center,O
for,O
Brain,O
Science,O
",",O
State,O
Key,O
Laboratory,O
of,O
Magnetic,O
Resonance,O
and,O
"
",O
Atomic,O
and,O
Molecular,O
Physics,O
",",O
Key,O
Laboratory,O
of,O
Magnetic,O
Resonance,O
in,O
Biological,O
"
",O
Systems,O
",",O
Wuhan,O
Center,O
for,O
Magnetic,O
Resonance,O
",",O
Wuhan,O
Institute,O
of,O
Physics,O
and,O
"
",O
Mathematics,O
",",O
Innovation,O
Academy,O
for,O
Precision,O
Measurement,O
Science,O
and,O
Technology,O
",",O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)School,O
of,O
Human,O
and,O
Social,O
Sciences,O
",",O
University,O
of,O
West,O
London,O
",",O
Middlesex,O
",",O
"
",O
United,O
Kingdom,O
.,O
"
",O
(5)The,O
Gonda,O
Multidisciplinary,O
Brain,O
Research,O
Center,O
",",O
BarIlan,O
University,O
",",O
"
",O
RamatGan,O
",",O
Israel,O
.,O
"
",O
(6)University,O
of,O
the,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(7)Center,O
for,O
Excellence,O
in,O
Brain,O
Science,O
and,O
Intelligence,O
Technology,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(8)Shenzhen,O
Key,O
Lab,O
of,O
Neuropsychiatric,O
Modulation,O
and,O
Collaborative,O
Innovation,O
"
",O
Center,O
for,O
Brain,O
Science,O
",",O
Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
Brain,O
Connectome,O
"
",O
and,O
Behavior,O
",",O
Brain,O
Cognition,O
and,O
Brain,O
Disease,O
Institute,O
(,O
BCBDI,O
),O
",",O
Shenzhen,O
"
",O
Institutes,O
of,O
Advanced,O
Technology,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
ShenzhenHong,O
Kong,O
"
",O
Institute,O
of,O
Brain,O
ScienceShenzhen,O
Fundamental,O
Research,O
Institutions,O
",",O
Shenzhen,O
",",O
"
",O
China,O
.,O
"

",O
The,O
piriform,O
cortex,O
(,O
PC,O
),O
is,O
a,O
key,O
brain,O
area,O
involved,O
in,O
both,O
processing,O
and,O
"
",O
coding,O
of,O
olfactory,O
information,O
.,O
It,O
is,O
implicated,O
in,O
various,O
brain,O
disorders,O
",",O
"
",O
such,O
as,O
epilepsy,O
",",O
Alzheimer,O
's,O
disease,O
",",O
and,O
autism,O
.,O
The,O
PC,O
consists,O
of,O
the,O
"
",O
anterior,O
(,O
APC,O
),O
and,O
posterior,O
(,O
PPC,O
),O
parts,O
",",O
which,O
are,O
different,O
anatomically,O
and,O
"
",O
functionally,O
.,O
However,O
",",O
the,O
direct,O
input,O
networks,O
to,O
specific,O
neuronal,O
populations,O
"
",O
within,O
the,O
APC,O
and,O
PPC,O
remain,O
poorly,O
understood,O
.,O
Here,O
",",O
we,O
mapped,O
the,O
wholebrain,O
"
",O
direct,O
inputs,O
to,O
the,O
two,O
major,O
neuronal,O
populations,O
",",O
the,O
excitatory,O
glutamatergic,O
"
",O
principal,O
neurons,O
and,O
inhibitory,O
Î³aminobutyric,O
acid,O
(GABA)ergic,O
interneurons,O
"
",O
within,O
the,O
APC,O
and,O
PPC,O
using,O
the,O
rabies,O
virus,O
(RV)mediated,O
retrograde,O
"
",O
transsynaptic,O
tracing,O
system,O
.,O
We,O
found,O
that,O
for,O
both,O
types,O
of,O
neurons,O
",",O
APC,O
and,O
"
",O
PPC,O
share,O
some,O
similarities,O
in,O
input,O
networks,O
",",O
with,O
dominant,O
inputs,O
originating,O
"
",O
from,O
the,O
olfactory,O
region,O
(,O
OLF,O
),O
",",O
followed,O
by,O
the,O
cortical,O
subplate,O
(,O
CTXsp,O
),O
",",O
"
",O
isocortex,O
",",O
cerebral,O
nuclei,O
(,O
CNU,O
),O
",",O
hippocampal,O
formation,O
(,O
HPF,O
),O
and,O
interbrain,O
"
",O
(,O
IB,O
),O
",",O
whereas,O
the,O
midbrain,O
(,O
MB,O
),O
and,O
hindbrain,O
(,O
HB,O
),O
were,O
rarely,O
labeled,O
.,O
However,O
",",O
"
",O
APC,O
and,O
PPC,O
also,O
show,O
distinct,O
features,O
in,O
their,O
input,O
distribution,O
patterns,O
.,O
For,O
"
",O
both,O
types,O
of,O
neurons,O
",",O
the,O
input,O
proportion,O
from,O
the,O
OLF,O
to,O
the,O
APC,O
was,O
higher,O
"
",O
than,O
that,O
to,O
the,O
PPC,O
;,O
while,O
the,O
PPC,O
received,O
higher,O
proportions,O
of,O
inputs,O
from,O
"
",O
the,O
HPF,O
and,O
CNU,O
than,O
the,O
APC,O
did,O
.,O
Overall,O
",",O
our,O
results,O
revealed,O
the,O
direct,O
input,O
"
",O
networks,O
of,O
both,O
excitatory,O
and,O
inhibitory,O
neuronal,O
populations,O
of,O
different,O
PC,O
"
",O
subareas,O
",",O
providing,O
a,O
structural,O
basis,O
to,O
analyze,O
the,O
diverse,O
PC,O
functions,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Wang,O
",",O
Zhang,O
",",O
Chen,O
",",O
Manyande,O
",",O
Haddad,O
",",O
Liu,O
and,O
Xu,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fncir.2020.00004,O
"
",O
PMCID,O
:,O
PMC7019026,O
"
",O
PMID,O
:,O
32116571,O
"


",O
415,O
.,O
Rev,O
Recent,O
Clin,O
Trials,O
.,O
2020,O
Feb,O
27,O
.,O
doi,O
:,O
10.2174,O
1.57489E+24,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
:,O
Perspectives,O
on,O
the,O
Potential,O
Novel,O
Global,O
Threat,O
.,O
"

",O
Gentile,O
I(1,O
),O
",",O
Abenavoli,O
L(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Clinical,O
Medicine,O
and,O
Surgery,O
",",O
Section,O
of,O
Infectious,O
Diseases,O
",",O
"
",O
University,O
of,O
Naples,O
"""",O
Federico,O
II,O
"""",O
",",O
Naples,O
.,O
Italy,O
.,O
"
",O
(2)Department,O
of,O
Health,O
Sciences,O
",",O
University,O
"""",O
Magna,O
Graecia,O
"""",O
Viale,O
Europa,O
",",O
88100,O
",",O
"
",O
Catanzaro,O
.,O
Italy,O
.,O
"

",O
DOI,O
:,O
10.2174,O
1.57489E+24,O
"
",O
PMID,O
:,O
32116200,O
"


",O
416,O
.,O
J,O
Histotechnol,O
.,O
2020,O
Mar,O
0.050694444,O
.,O
doi,O
:,O
10.108,O
01478885.2020.1734718,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Coronavirus,O
disinfection,O
in,O
histopathology,O
.,O
"

",O
Henwood,O
AF(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Histopathology,O
Department,O
",",O
The,O
Children,O
's,O
Hospital,O
at,O
Westmead,O
",",O
Sydney,O
",",O
"
",O
Australia,O
.,O
"
",O
(2)School,O
of,O
Medicine,O
",",O
University,O
of,O
Western,O
Sydney,O
",",O
Sydney,O
",",O
Australia,O
.,O
"

",O
The,O
2019,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
epidemic,O
",",O
provisionally,O
called,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
was,O
first,O
"
",O
identified,O
in,O
Wuhan,O
",",O
China,O
",",O
in,O
persons,O
exposed,O
to,O
a,O
seafood,O
or,O
wet,O
market,O
.,O
There,O
"
",O
is,O
an,O
international,O
push,O
to,O
contain,O
the,O
virus,O
and,O
prevent,O
its,O
spread,O
.,O
It,O
is,O
"
",O
feasible,O
that,O
potentially,O
infectious,O
samples,O
may,O
be,O
received,O
in,O
histopathology,O
"
",O
laboratories,O
for,O
diagnosis,O
.,O
This,O
technical,O
note,O
presents,O
disinfection,O
procedures,O
"
",O
and,O
histotechnology,O
processes,O
that,O
should,O
alleviate,O
the,O
risk,O
of,O
infection,O
to,O
"
",O
laboratory,O
staff,O
.,O
Using,O
data,O
obtained,O
from,O
similar,O
coronaviruses,O
",",O
e.g.,O
severe,O
"
",O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
and,O
Middle,O
East,O
respiratory,O
syndrome,O
(,O
MERS,O
),O
",",O
"
",O
experts,O
are,O
confident,O
that,O
70,O
%,O
ethanol,O
and,O
0.1,O
%,O
sodium,O
hypochlorite,O
should,O
"
",O
inactivate,O
the,O
virus,O
.,O
Formalin,O
fixation,O
and,O
heating,O
samples,O
to,O
56oC,O
",",O
as,O
used,O
in,O
"
",O
routine,O
tissue,O
processing,O
",",O
were,O
found,O
to,O
inactivate,O
several,O
coronaviruses,O
and,O
it,O
"
",O
is,O
believed,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
would,O
be,O
similarly,O
affected,O
.,O
"

",O
DOI,O
:,O
10.108,O
01478885.2020.1734718,O
"
",O
PMID,O
:,O
32116147,O
"


",O
417,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
1,O
.,O
doi,O
:,O
10.1002,O
jmv.25740,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Coronavirus,O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
and,O
neonate,O
:,O
What,O
neonatologist,O
need,O
to,O
know,O
.,O
"

",O
Lu,O
Q(1,O
),O
",",O
Shi,O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Neonatology,O
",",O
Key,O
Laboratory,O
of,O
Pediatrics,O
in,O
Chongqing,O
",",O
Ministry,O
"
",O
of,O
Education,O
Key,O
Laboratory,O
of,O
Child,O
Development,O
and,O
Disorders,O
",",O
Children,O
's,O
"
",O
Hospital,O
",",O
Chongqing,O
Medical,O
University,O
",",O
Chongqing,O
",",O
China,O
.,O
"

",O
Severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
cause,O
china,O
"
",O
epidemics,O
with,O
high,O
morbidity,O
and,O
mortality,O
",",O
the,O
infection,O
has,O
been,O
transmitted,O
"
",O
to,O
other,O
countries,O
.,O
About,O
three,O
neonates,O
and,O
more,O
than,O
230,O
children,O
cases,O
are,O
"
",O
reported,O
.,O
The,O
disease,O
condition,O
of,O
the,O
main,O
children,O
was,O
mild,O
.,O
There,O
is,O
currently,O
"
",O
no,O
evidence,O
that,O
SARSCoV2,B-Virus_SARS-CoV-2
can,O
be,O
transmitted,O
transplacentally,O
from,O
mother,O
to,O
"
",O
the,O
newborn,O
.,O
The,O
treatment,O
strategy,O
for,O
children,O
with,O
Coronavirus,O
disease,O
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
is,O
based,O
on,O
adult,O
experience,O
.,O
Thus,O
far,O
",",O
no,O
deaths,O
have,O
been,O
reported,O
"
",O
in,O
the,O
pediatric,O
age,O
group,O
.,O
This,O
review,O
describes,O
the,O
current,O
understanding,O
of,O
"
",O
COVID19,B-Disease_COVID-19
infection,O
in,O
newborns,O
and,O
children,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25740,O
"
",O
PMID,O
:,O
32115733,O
"


",O
418,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Mar,O
1,O
.,O
doi,O
:,O
10.1002,O
jmv.25738,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
Wuhan,O
SARSCoV2,B-Virus_SARS-CoV-2
 ,O
What,O
's,O
Next,O
for,O
China,O
.,O
"

",O
Lu,O
H(1,O
),O
",",O
Stratton,O
CW(2,O
),O
",",O
Tang,O
YW(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Shanghai,O
Public,O
Health,O
Clinical,O
Center,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
201508,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pathology,O
",",O
Microbiology,O
and,O
Immunology,O
",",O
Vanderbilt,O
University,O
"
",O
Medical,O
Center,O
",",O
Nashville,O
",",O
TN,O
",",O
37232,O
",",O
USA,O
.,O
"
",O
(3)Cepheid,O
",",O
Danaher,O
Diagnostic,O
Platform,O
",",O
Shanghai,O
",",O
200325,O
",",O
China,O
.,O
"

",O
When,O
an,O
outbreak,O
of,O
pneumonia,O
of,O
unknown,O
etiology,O
occurred,O
in,O
Wuhan,O
city,O
",",O
Hubei,O
"
",O
Province,O
",",O
China,O
in,O
December,O
of,O
2019,O
",",O
the,O
mystery1,O
was,O
the,O
nature,O
of,O
the,O
causative,O
"
",O
agent,O
.,O
Because,O
many,O
of,O
the,O
patients,O
had,O
visited,O
a,O
fish,O
and,O
wild,O
animal,O
market,O
",",O
"
",O
the,O
possibility,O
of,O
a,O
recurrence,O
of,O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
"
",O
needed,O
to,O
be,O
investigated2,O
.,O
Finally,O
",",O
could,O
this,O
outbreak,O
of,O
pneumonia,O
be,O
caused,O
"
",O
by,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
that,O
was,O
different,O
from,O
those,O
causing,O
SARS,O
or,O
Middle,O
East,O
"
",O
respiratory,O
syndrome,O
(MERS)3,O
?,O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
"
",O
reserved,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25738,O
"
",O
PMID,O
:,O
32115732,O
"


",O
419,O
.,O
J,O
Infect,O
Dis,O
.,O
2020,O
Mar,O
2,O
.,O
pii,O
:,O
jiaa093,O
.,O
doi,O
:,O
10.1093,O
infdis,O
jiaa093,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Effect,O
of,O
Emodin,O
on,O
Coxsackievirus,O
B3,O
m,O
mediatedEncephalitis,O
in,O
Hand,O
",",O
Foot,O
and,O
"
",O
Mouth,O
Disease,O
by,O
inhibiting,O
TollLike,O
Receptor,O
3,O
pathway,O
in,O
vitro,O
and,O
in,O
vivo,O
.,O
"

",O
Ding,O
Y(1,O
),O
",",O
Xu,O
J(2)(3,O
),O
",",O
Cheng,O
LB(4,O
),O
",",O
Huang,O
YQ(5,O
),O
",",O
Wang,O
YQ(6,O
),O
",",O
Li,O
H(7,O
),O
",",O
Li,O
Y(8,O
),O
",",O
Ji,O
"
",O
JY(9,O
),O
",",O
Zhang,O
JH(3,O
),O
",",O
Zhao,O
L(10,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Diseases,O
and,O
Immunology,O
",",O
Medical,O
and,O
Health,O
Center,O
"
",O
for,O
Women,O
and,O
Children,O
",",O
Wuhan,O
Children,O
's,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
P.R.,O
China,O
.,O
"
",O
(2)Clinical,O
College,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
Hubei,O
University,O
of,O
Chinese,O
"
",O
Medicine,O
",",O
Wuhan,O
",",O
P.R.,O
China,O
.,O
"
",O
(3)Department,O
of,O
Hepatology,O
",",O
Yichang,O
Hospital,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
"
",O
Yichang,O
",",O
P.R.,O
China,O
.,O
"
",O
(4)Department,O
of,O
Liver,O
Diseases,O
",",O
Hubei,O
Hospital,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
"
",O
Wuhan,O
",",O
P.R.,O
China,O
.,O
"
",O
(5)Department,O
of,O
Neurology,O
",",O
Puren,O
Hospital,O
Affiliated,O
to,O
Wuhan,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
P.R.,O
China,O
.,O
"
",O
(6)Department,O
of,O
Pediatrics,O
",",O
Central,O
Hospital,O
",",O
Hubei,O
University,O
of,O
Medicine,O
",",O
"
",O
Suizhou,O
",",O
P.R.,O
China,O
.,O
"
",O
(7)Department,O
of,O
integrated,O
TCM,O
&,O
Western,O
Medicine,O
",",O
Tianyou,O
Hospital,O
Affiliated,O
"
",O
to,O
Wuhan,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
P.R.,O
China,O
.,O
"
",O
(8)Department,O
of,O
Vascular,O
surgery,O
",",O
Yichang,O
Central,O
People,O
's,O
Hospital,O
",",O
Yichang,O
",",O
"
",O
P.R.,O
China,O
.,O
"
",O
(9)Department,O
of,O
Vascular,O
surgery,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
P.R.,O
China,O
.,O
"
",O
(10)Department,O
of,O
Infectious,O
Diseases,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
P.R.,O
China,O
.,O
"

",O
BACKGROUND,O
:,O
Encephalitis,O
in,O
Hand,O
",",O
Foot,O
and,O
Mouth,O
Disease,O
is,O
a,O
serious,O
threat,O
to,O
"
",O
children,O
's,O
health,O
and,O
life,O
.,O
Tolllike,O
receptor,O
3,O
is,O
an,O
innate,O
immunerecognition,O
"
",O
receptor,O
which,O
can,O
recognize,O
virus,O
and,O
initiate,O
innate,O
immune,O
responses,O
.,O
Emodin,O
"
",O
have,O
the,O
effects,O
of,O
antiinflammatory,O
and,O
regulating,O
immune,O
function,O
",",O
but,O
the,O
"
",O
mechanism,O
is,O
not,O
very,O
clear,O
.,O
"
",O
METHODS,O
:,O
Cells,O
and,O
mice,O
were,O
pretreated,O
with,O
CVB3,O
and,O
treated,O
with,O
emodin,O
.,O
The,O
"
",O
mRNA,O
and,O
protein,O
levels,O
of,O
TLR3,O
and,O
downstream,O
molecules,O
were,O
respectively,O
"
",O
detected,O
by,O
qTPCR,O
and,O
WesternBlotting,O
.,O
TLR3,O
expression,O
was,O
also,O
downregulated,O
"
",O
by,O
antiTLR3Ab,O
or,O
siRNA,O
.,O
Pathological,O
changes,O
were,O
assessed,O
with,O
H&E,O
staining,O
.,O
"
",O
Immunohistochemistry,O
was,O
used,O
to,O
examine,O
the,O
expression,O
of,O
TLR3,O
in,O
brain,O
"
",O
tissues,O
.,O
The,O
expression,O
of,O
IL6,O
",",O
NFÎºB,O
and,O
IFNÎ²,O
in,O
serum,O
were,O
tested,O
with,O
ELISA,O
.,O
"
",O
RESULTS,O
:,O
Emodin,O
decreased,O
the,O
mRNA,O
and,O
protein,O
levels,O
of,O
TLR3,O
and,O
downstream,O
"
",O
molecules,O
in,O
vitro,O
and,O
in,O
vivo,O
.,O
After,O
downregulating,O
TLR3,O
using,O
antiTLR3Ab,O
or,O
"
",O
siRNA,O
",",O
emodin,O
could,O
still,O
decrease,O
the,O
mRNA,O
and,O
protein,O
levels,O
of,O
TLR3,O
and,O
"
",O
downstream,O
molecules,O
.,O
Emodin,O
also,O
displayed,O
notable,O
effects,O
on,O
pathology,O
",",O
TLR3,O
"
",O
protein,O
in,O
brain,O
tissues,O
and,O
expression,O
of,O
IL6,O
",",O
NFÎºB,O
",",O
IFNÎ²,O
in,O
serum,O
.,O
"
",O
CONCLUSIONS,O
:,O
Emodin,O
exerts,O
a,O
protective,O
effect,O
in,O
CVB3,O
mediatedencephalitis,O
in,O
"
",O
HFMD,O
by,O
inhibiting,O
the,O
TLR3,O
pathway,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
infdis,O
jiaa093,O
"
",O
PMID,O
:,O
32115640,O
"


",O
420,O
.,O
Br,O
J,O
Anaesth,O
.,O
2020,O
Feb,O
27,O
.,O
pii,O
:,O
S00070912(20)300982,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.bja.2020.02.008,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Outbreak,O
of,O
a,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
:,O
what,O
anaesthetists,O
should,O
know,O
.,O
"

",O
Peng,O
PWH(1,O
),O
",",O
Ho,O
PL(2,O
),O
",",O
Hota,O
SS(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Anesthesiology,O
and,O
Pain,O
Medicine,O
",",O
University,O
Health,O
Network,O
",",O
"
",O
University,O
of,O
Toronto,O
",",O
Toronto,O
",",O
ON,O
",",O
Canada,O
.,O
Electronic,O
address,O
:,O
"
",O
Philip.peng@uhn.ca,O
.,O
"
",O
(2)Department,O
of,O
Microbiology,O
and,O
Carol,O
Yu,O
Centre,O
for,O
Infection,O
",",O
University,O
of,O
"
",O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
.,O
"
",O
(3)Infection,O
Prevention,O
and,O
Control,O
Department,O
",",O
University,O
Health,O
Network,O
",",O
"
",O
Toronto,O
",",O
ON,O
",",O
Canada,O
;,O
Department,O
of,O
Medicine,O
",",O
University,O
of,O
Toronto,O
",",O
Toronto,O
",",O
ON,O
",",O
"
",O
Canada,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.bja.2020.02.008,O
"
",O
PMID,O
:,O
32115186,O
"


",O
421,O
.,O
J,O
Prev,O
Med,O
Public,O
Health,O
.,O
2020,O
Mar,O
2,O
.,O
doi,O
:,O
10.3961,O
jpmph.20.048,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
A,O
Chinese,O
Case,O
of,O
COVID19,B-Disease_COVID-19
Did,O
Not,O
Show,O
Infectivity,O
During,O
the,O
Incubation,O
Period,O
:,O
"
",O
Based,O
on,O
an,O
Epidemiological,O
Survey,O
.,O
"

",O
Bae,O
JM(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Preventive,O
Medicine,O
",",O
Jeju,O
National,O
University,O
School,O
of,O
"
",O
Medicine,O
",",O
Jeju,O
",",O
Korea,O
.,O
"

",O
Controversy,O
remains,O
over,O
whether,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2019,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
virus,O
may,O
"
",O
have,O
infectivity,O
during,O
the,O
incubation,O
period,O
before,O
the,O
onset,O
of,O
symptoms,O
.,O
The,O
"
",O
author,O
had,O
the,O
opportunity,O
to,O
examine,O
the,O
infectivity,O
of,O
COVID19,B-Disease_COVID-19
during,O
the,O
"
",O
incubation,O
period,O
by,O
conducting,O
an,O
epidemiological,O
survey,O
on,O
a,O
confirmed,O
patient,O
"
",O
who,O
had,O
visited,O
Jeju,O
Island,O
during,O
the,O
incubation,O
period,O
.,O
The,O
epidemiological,O
"
",O
findings,O
support,O
the,O
claim,O
that,O
the,O
COVID19,B-Virus_SARS-CoV-2
virus,I-Virus_SARS-CoV-2
does,O
not,O
have,O
infectivity,O
"
",O
during,O
the,O
incubation,O
period,O
.,O
"

",O
DOI,O
:,O
10.3961,O
jpmph.20.048,O
"
",O
PMID,O
:,O
32114755,O
"


",O
422,O
.,O
Int,O
J,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
27,O
.,O
pii,O
:,O
S12019712(20)301089,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ijid.2020.02.050,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Comparison,O
of,O
different,O
samples,O
for,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
detection,O
by,O
nucleic,O
"
",O
acid,O
amplification,O
tests,O
.,O
"

",O
Xie,O
C(1,O
),O
",",O
Jiang,O
L(1,O
),O
",",O
Huang,O
G(1,O
),O
",",O
Pu,O
H(2,O
),O
",",O
Gong,O
B(3,O
),O
",",O
Lin,O
H(1,O
),O
",",O
Ma,O
S(1,O
),O
",",O
Chen,O
"
",O
X(4,O
),O
",",O
Long,O
B(5,O
),O
",",O
Si,O
G(5,O
),O
",",O
Yu,O
H(1,O
),O
",",O
Jiang,O
L(1,O
),O
",",O
Yang,O
X(6,O
),O
",",O
Shi,O
Y(7,O
),O
",",O
Yang,O
Z(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Sichuan,O
Provincial,O
Key,O
Laboratory,O
for,O
Human,O
Disease,O
Gene,O
Study,O
and,O
Institute,O
"
",O
of,O
Laboratory,O
Medicine,O
",",O
Sichuan,O
Provincial,O
People,O
's,O
Hospital,O
",",O
University,O
of,O
"
",O
Electronic,O
Science,O
and,O
Technology,O
of,O
China,O
",",O
Chengdu,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
Sichuan,O
Provincial,O
People,O
's,O
Hospital,O
",",O
University,O
of,O
"
",O
Electronic,O
Science,O
and,O
Technology,O
of,O
China,O
",",O
Chengdu,O
",",O
China,O
.,O
"
",O
(3)Sichuan,O
Provincial,O
Key,O
Laboratory,O
for,O
Human,O
Disease,O
Gene,O
Study,O
and,O
Institute,O
"
",O
of,O
Laboratory,O
Medicine,O
",",O
Sichuan,O
Provincial,O
People,O
's,O
Hospital,O
",",O
University,O
of,O
"
",O
Electronic,O
Science,O
and,O
Technology,O
of,O
China,O
",",O
Chengdu,O
",",O
China,O
;,O
Institute,O
of,O
Biology,O
",",O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
Sichuan,O
Translational,O
Medicine,O
Research,O
Hospital,O
",",O
"
",O
Chengdu,O
",",O
Sichuan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Infectious,O
Disease,O
",",O
Sichuan,O
Provincial,O
People,O
's,O
Hospital,O
",",O
"
",O
University,O
of,O
Electronic,O
Science,O
and,O
Technology,O
of,O
China,O
",",O
Chengdu,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Infectious,O
Disease,O
",",O
Sichuan,O
Mianyang,O
404,O
Hospital,O
",",O
Mianyang,O
",",O
"
",O
China,O
.,O
"
",O
(6)Department,O
of,O
Infectious,O
Disease,O
",",O
Sichuan,O
Provincial,O
People,O
's,O
Hospital,O
",",O
"
",O
University,O
of,O
Electronic,O
Science,O
and,O
Technology,O
of,O
China,O
",",O
Chengdu,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
350686908@qq.com,O
.,O
"
",O
(7)Sichuan,O
Provincial,O
Key,O
Laboratory,O
for,O
Human,O
Disease,O
Gene,O
Study,O
and,O
Institute,O
"
",O
of,O
Laboratory,O
Medicine,O
",",O
Sichuan,O
Provincial,O
People,O
's,O
Hospital,O
",",O
University,O
of,O
"
",O
Electronic,O
Science,O
and,O
Technology,O
of,O
China,O
",",O
Chengdu,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
shiyi1614@126.com,O
.,O
"
",O
(8)Sichuan,O
Provincial,O
Key,O
Laboratory,O
for,O
Human,O
Disease,O
Gene,O
Study,O
and,O
Institute,O
"
",O
of,O
Laboratory,O
Medicine,O
",",O
Sichuan,O
Provincial,O
People,O
's,O
Hospital,O
",",O
University,O
of,O
"
",O
Electronic,O
Science,O
and,O
Technology,O
of,O
China,O
",",O
Chengdu,O
",",O
China,O
;,O
Institute,O
of,O
Biology,O
",",O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
Sichuan,O
Translational,O
Medicine,O
Research,O
Hospital,O
",",O
"
",O
Chengdu,O
",",O
Sichuan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
zhenglin.yang@hsc.utah.edu,O
.,O
"

",O
A,O
severe,O
respiratory,O
ongoing,O
outbreak,O
of,O
pneumonia,O
associated,O
with,O
2019,O
novel,O
"
",O
coronavirus,O
was,O
recently,O
emerged,O
in,O
China,O
.,O
Here,O
",",O
we,O
reported,O
the,O
epidemiological,O
",",O
"
",O
clinical,O
",",O
laboratory,O
and,O
radiological,O
characteristics,O
of,O
19,O
suspect,O
cases,O
.,O
We,O
"
",O
compared,O
the,O
positive,O
ratio,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
nucleic,O
acid,O
amplification,O
test,O
from,O
"
",O
different,O
samples,O
including,O
oropharyngeal,O
swab,O
",",O
blood,O
",",O
urine,O
and,O
stool,O
with,O
"
",O
3different,O
Fluorescent,O
RTPCR,O
kits,O
.,O
Nine,O
out,O
of,O
the,O
19,O
patients,O
were,O
detected,O
"
",O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
using,O
oropharyngeal,O
swab,O
samples,O
",",O
and,O
the,O
virus,O
nucleic,O
acid,O
"
",O
was,O
also,O
detected,O
in,O
eight,O
of,O
these,O
nine,O
patients,O
using,O
stool,O
samples,O
.,O
None,O
of,O
"
",O
positive,O
results,O
was,O
identified,O
in,O
the,O
blood,O
and,O
urine,O
samples,O
.,O
Thses,O
three,O
"
",O
different,O
kits,O
got,O
the,O
same,O
result,O
for,O
each,O
sample,O
and,O
the,O
positive,O
ratio,O
of,O
"
",O
nucleic,O
acid,O
detection,O
for,O
2019nCoV,B-Virus_SARS-CoV-2
was,O
only,O
47.4,O
%,O
in,O
the,O
suspect,O
patients,O
.,O
"
",O
Therefore,O
",",O
it,O
is,O
possible,O
that,O
the,O
really,O
infected,O
patients,O
have,O
been,O
missed,O
by,O
"
",O
using,O
nucleic,O
acid,O
detection,O
only,O
.,O
It,O
might,O
be,O
better,O
to,O
make,O
a,O
diagnosis,O
"
",O
combining,O
the,O
Computed,O
Tomography,O
scans,O
and,O
the,O
nucleic,O
acid,O
detection,O
together,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
Ltd.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijid.2020.02.050,O
"
",O
PMID,O
:,O
32114193,O
"


",O
423,O
.,O
J,O
Thorac,O
Oncol,O
.,O
2020,O
Feb,O
27,O
.,O
pii,O
:,O
S15560864(20)301325,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jtho.2020.02.010,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Pulmonary,O
pathology,O
of,O
early,O
phase,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
pneumonia,O
in,O
"
",O
two,O
patients,O
with,O
lung,O
cancer,O
.,O
"

",O
Tian,O
S(1,O
),O
",",O
Hu,O
W(2,O
),O
",",O
Niu,O
L(1,O
),O
",",O
Liu,O
H(1,O
),O
",",O
Xu,O
H(3,O
),O
",",O
Xiao,O
SY(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pathology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Thoracic,O
Surgery,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Radiology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Pathology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
;,O
"
",O
Department,O
of,O
Pathology,O
",",O
University,O
of,O
Chicago,O
Medicine,O
",",O
Chicago,O
",",O
IL,O
60637,O
.,O
"
",O
Electronic,O
address,O
:,O
syxiao@uchicago.edu,O
.,O
"

",O
There,O
is,O
currently,O
a,O
lack,O
of,O
pathologic,O
data,O
on,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
pneumonia,O
",",O
or,O
COVID19,B-Disease_COVID-19
",",O
from,O
autopsy,O
or,O
biopsy,O
.,O
Two,O
patients,O
who,O
"
",O
recently,O
underwent,O
lung,O
lobectomies,O
for,O
adenocarcinoma,O
were,O
retrospectively,O
found,O
"
",O
to,O
have,O
had,O
COVID19,B-Disease_COVID-19
at,O
the,O
time,O
of,O
surgery,O
.,O
These,O
two,O
cases,O
thus,O
provide,O
"
",O
important,O
first,O
opportunities,O
to,O
study,O
the,O
pathology,O
of,O
COVID19,B-Disease_COVID-19
.,O
Pathologic,O
"
",O
examinations,O
revealed,O
that,O
",",O
apart,O
from,O
the,O
tumors,O
",",O
the,O
lungs,O
of,O
both,O
patients,O
"
",O
exhibited,O
edema,O
",",O
proteinaceous,O
exudate,O
",",O
focal,O
reactive,O
hyperplasia,O
of,O
pneumocytes,O
"
",O
with,O
patchy,O
inflammatory,O
cellular,O
infiltration,O
",",O
and,O
multinucleated,O
giant,O
cells,O
.,O
"
",O
Hyaline,O
membranes,O
were,O
not,O
prominent,O
.,O
Since,O
both,O
patients,O
did,O
not,O
exhibit,O
"
",O
symptoms,O
of,O
pneumonia,O
at,O
the,O
time,O
of,O
surgery,O
",",O
these,O
changes,O
likely,O
represent,O
an,O
"
",O
early,O
phase,O
of,O
the,O
lung,O
pathology,O
of,O
COVID19,B-Disease_COVID-19
pneumonia,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
International,O
Association,O
for,O
the,O
Study,O
of,O
Lung,O
Cancer,O
.,O
"
",O
Published,O
by,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jtho.2020.02.010,O
"
",O
PMID,O
:,O
32114094,O
"


",O
424,O
.,O
J,O
Control,O
Release,O
.,O
2020,O
Feb,O
28;321:654668,O
.,O
doi,O
:,O
10.1016,O
j.jconrel.2020.02.045,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Hyperbranched,O
poly(Î²amino,O
ester,O
),O
based,O
polyplex,O
nanopaticles,O
for,O
delivery,O
of,O
"
",O
CRISPR,O
Cas9,O
system,O
and,O
treatment,O
of,O
HPV,O
infection,O
associated,O
cervical,O
cancer,O
.,O
"

",O
Gao,O
X(1,O
),O
",",O
Jin,O
Z(2,O
),O
",",O
Tan,O
X(3,O
),O
",",O
Zhang,O
C(4,O
),O
",",O
Zou,O
C(1,O
),O
",",O
Zhang,O
W(4,O
),O
",",O
Ding,O
J(4,O
),O
",",O
Das,O
"
",O
BC(5,O
),O
",",O
Severinov,O
K(6,O
),O
",",O
Hitzeroth,O
II(7,O
),O
",",O
Debata,O
PR(8,O
),O
",",O
He,O
D(9,O
),O
",",O
Ma,O
X(10,O
),O
",",O
Tian,O
"
",O
X(11,O
),O
",",O
Gao,O
Q(3,O
),O
",",O
Wu,O
J(12,O
),O
",",O
Tian,O
R(2,O
),O
",",O
Cui,O
Z(2,O
),O
",",O
Fan,O
W(2,O
),O
",",O
Huang,O
Z(2,O
),O
",",O
Cao,O
C(11,O
),O
",",O
"
",O
Bao,O
Y(13,O
),O
",",O
Tan,O
S(14,O
),O
",",O
Hu,O
Z(15,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pharmacy,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
430022,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Obstetrics,O
and,O
Gynecology,O
",",O
the,O
First,O
Affiliated,O
Hospital,O
",",O
Sun,O
"
",O
Yatsen,O
University,O
",",O
Guangzhou,O
510080,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Obstetrics,O
and,O
Gynecology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
"
",O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
430030,O
",",O
Hubei,O
",",O
"
",O
China,O
.,O
"
",O
(4)School,O
of,O
Pharmacy,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
430030,O
",",O
China,O
.,O
"
",O
(5)Amity,O
Institute,O
of,O
Molecular,O
Medicine,O
&,O
Stem,O
Cell,O
Research,O
",",O
Amity,O
University,O
",",O
"
",O
Uttar,O
Pradesh,O
",",O
Noida,O
201313,O
",",O
India,O
.,O
"
",O
(6)Skolkovo,O
Institute,O
of,O
Science,O
and,O
Technology,O
",",O
Skolkovo,O
",",O
Moscow,O
Region,O
143025,O
",",O
"
",O
Russia,O
.,O
"
",O
(7)Biopharming,O
Research,O
Unit,O
",",O
Department,O
of,O
Molecular,O
and,O
Cell,O
Biology,O
",",O
"
",O
University,O
of,O
Cape,O
Town,O
",",O
South,O
Africa,O
.,O
"
",O
(8)Department,O
of,O
Zoology,O
",",O
North,O
Orissa,O
University,O
",",O
Takatpur,O
",",O
Baripada,O
",",O
Odisha,O
"
",O
757003,O
",",O
India,O
.,O
"
",O
(9)Department,O
of,O
Neurology,O
",",O
the,O
First,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
Guangzhou,O
510080,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(10)Department,O
of,O
Urology,O
",",O
General,O
Hospital,O
of,O
People,O
's,O
Liberation,O
Army,O
",",O
Beijing,O
"
",O
100039,O
",",O
China,O
.,O
"
",O
(11)Department,O
of,O
Obstetrics,O
and,O
Gynecology,O
",",O
Academician,O
expert,O
workstation,O
",",O
The,O
"
",O
Central,O
Hospital,O
of,O
Wuhan,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
"
",O
and,O
Technology,O
",",O
Wuhan,O
430014,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(12)School,O
of,O
Biomedical,O
Engineering,O
",",O
Sun,O
Yatsen,O
University,O
",",O
Guangzhou,O
510006,O
",",O
"
",O
Guangdong,O
",",O
China,O
.,O
"
",O
(13)Generulor,O
Company,O
BioX,O
Lab,O
",",O
Guangzhou,O
510006,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(14)School,O
of,O
Pharmacy,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
"
",O
and,O
Technology,O
",",O
Wuhan,O
430030,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
tansongwei@gmail.com,O
.,O
"
",O
(15)Department,O
of,O
Obstetrics,O
and,O
Gynecology,O
",",O
the,O
First,O
Affiliated,O
Hospital,O
",",O
Sun,O
"
",O
Yatsen,O
University,O
",",O
Guangzhou,O
510080,O
",",O
China,O
;,O
Department,O
of,O
Obstetrics,O
and,O
"
",O
Gynecology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
Wuhan,O
430030,O
",",O
Hubei,O
",",O
China,O
;,O
Precision,O
Medicine,O
Institute,O
",",O
"
",O
the,O
First,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
University,O
",",O
Guangzhou,O
510080,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
huzheng1998@163.com,O
.,O
"

",O
Persistent,O
highrisk,O
HPV,O
infection,O
is,O
the,O
main,O
factor,O
for,O
cervical,O
cancer,O
.,O
HPV,O
E7,O
"
",O
oncogene,O
plays,O
an,O
important,O
role,O
in,O
HPV,O
carcinogenesis,O
.,O
Downregulation,O
of,O
E7,O
"
",O
oncogene,O
expression,O
could,O
induce,O
growth,O
inhibition,O
in,O
HPVpositive,O
cells,O
and,O
thus,O
"
",O
treats,O
HPV,O
related,O
cervical,O
cancer,O
.,O
Here,O
we,O
developed,O
a,O
nonvirus,O
gene,O
vector,O
"
",O
based,O
on,O
poly(amideamine)poly(Î²amino,O
ester,O
),O
hyperbranched,O
copolymer,O
(,O
hPPC,O
),O
for,O
"
",O
the,O
delivery,O
of,O
CRISPR,O
Cas9,O
system,O
to,O
specifically,O
cleave,O
HPV,O
E7,O
oncogene,O
in,O
"
",O
HPVpositive,O
cervical,O
cancer,O
cells,O
.,O
The,O
diameter,O
of,O
polyplex,O
nanoparticles,O
(,O
NPs,O
),O
"
",O
formed,O
by,O
hPPCs,O
linear,O
poly(Î²amino,O
ester,O
),O
(,O
PBAE,O
),O
and,O
plasmids,O
were,O
approximately,O
"
",O
300,O
Â ,O
nm,O
.,O
These,O
hPPCs,O
PBAEgreen,O
fluorescence,O
protein,O
plasmids,O
polyplex,O
NPs,O
showed,O
"
",O
high,O
transfection,O
efficiency,O
and,O
low,O
toxicity,O
in,O
cells,O
and,O
mouse,O
organs,O
.,O
By,O
"
",O
cleaving,O
HPV16,O
E7,O
oncogene,O
",",O
reducing,O
the,O
expression,O
of,O
HPV16,O
E7,O
protein,O
and,O
"
",O
increasing,O
intracellular,O
retinoblastoma,O
1,O
(,O
RB1,O
),O
amount,O
",",O
hPPCs,O
PBAECRISPR,O
Cas9,O
"
",O
therapeutic,O
plasmids,O
polyplex,O
NPs,O
",",O
especially,O
highly,O
branched,O
hPPC1plasmids,O
"
",O
polyplex,O
NPs,O
",",O
exhibited,O
strong,O
growth,O
inhibition,O
of,O
cervical,O
cancer,O
cells,O
in,O
"
",O
vitro,O
and,O
xenograft,O
tumors,O
in,O
nude,O
mice,O
.,O
Together,O
",",O
the,O
hPPCs,O
PBAE,O
polyplex,O
NPs,O
to,O
"
",O
deliver,O
HPV16,O
E7,O
targeted,O
CRISPR,O
Cas9,O
system,O
in,O
this,O
study,O
could,O
potentially,O
be,O
"
",O
applied,O
to,O
treat,O
HPVrelated,O
cervical,O
cancer,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jconrel.2020.02.045,O
"
",O
PMID,O
:,O
32114092,O
"


",O
425,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
27:101608,O
.,O
doi,O
:,O
10.1016,O
j.tmaid.2020.101608,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Asymptomatic,O
coronavirus,O
infection,O
:,O
MERSCoV,O
and,O
SARSCoV2,B-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
AlTawfiq,O
JA(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Specialty,O
Internal,O
Medicine,O
and,O
Quality,O
Department,O
",",O
Johns,O
Hopkins,O
Aramco,O
"
",O
Healthcare,O
",",O
Dhahran,O
",",O
Saudi,O
Arabia,O
;,O
Indiana,O
University,O
School,O
of,O
Medicine,O
",",O
"
",O
Indiana,O
",",O
USA,O
;,O
Johns,O
Hopkins,O
University,O
School,O
of,O
Medicine,O
",",O
Baltimore,O
",",O
MD,O
",",O
USA,O
.,O
"
",O
Electronic,O
address,O
:,O
jaffar.tawfiq@jhah.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101608,O
"
",O
PMID,O
:,O
32114075,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
None,O
.,O
"


",O
426,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
27:101606,O
.,O
doi,O
:,O
10.1016,O
j.tmaid.2020.101606,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
characteristics,O
of,O
laboratory,O
confirmed,O
positive,O
cases,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
infection,O
in,O
Wuhan,O
",",O
China,O
:,O
A,O
retrospective,O
single,O
center,O
analysis,O
.,O
"

",O
Huang,O
Y(1,O
),O
",",O
Tu,O
M(2,O
),O
",",O
Wang,O
S(1,O
),O
",",O
Chen,O
S(1,O
),O
",",O
Zhou,O
W(1,O
),O
",",O
Chen,O
D(1,O
),O
",",O
Zhou,O
L(1,O
),O
",",O
Wang,O
"
",O
M(1,O
),O
",",O
Zhao,O
Y(3,O
),O
",",O
Zeng,O
W(4,O
),O
",",O
Huang,O
Q(5,O
),O
",",O
Xu,O
H(6,O
),O
",",O
Liu,O
Z(7,O
),O
",",O
Guo,O
L(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Plastic,O
Surgery,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
430071,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430071,O
",",O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Emergency,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Ophthalmology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
430071,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
NHC,O
Key,O
Laboratory,O
of,O
"
",O
Pulmonary,O
Diseases,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
"
",O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Radiology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430071,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
714380246@qq.com,O
.,O
"
",O
(7)Department,O
of,O
Plastic,O
Surgery,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
430071,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
6myt@163.com,O
.,O
"
",O
(8)Department,O
of,O
Plastic,O
Surgery,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
430071,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
guoliangwhzn@163.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101606,O
"
",O
PMID,O
:,O
32114074,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
The,O
authors,O
"
",O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
427,O
.,O
J,O
Hosp,O
Infect,O
.,O
2020,O
Feb,O
27,O
.,O
pii,O
:,O
S01956701(20)300906,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jhin.2020.02.016,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
in,O
medical,O
personnel,O
:,O
observation,O
from,O
Thailand,O
.,O
"

",O
Joob,O
B(1,O
),O
",",O
Wiwanitkit,O
V(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Sanitation,O
1,O
Medical,O
Academic,O
Center,O
",",O
Bangkok,O
Thailand,O
.,O
Electronic,O
address,O
:,O
"
",O
beuyjoob@hotmail.com,O
.,O
"
",O
(2)Dr,O
DY,O
Patil,O
University,O
",",O
Pune,O
",",O
India,O
;,O
Hainan,O
Medical,O
University,O
",",O
Haikou,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jhin.2020.02.016,O
"
",O
PMID,O
:,O
32114054,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflict,O
of,O
interest,O
None,O
"


",O
428,O
.,O
J,O
Infect,O
.,O
2020,O
Feb,O
27,O
.,O
pii,O
:,O
S01634453(20)300955,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.014,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Trend,O
and,O
forecasting,O
of,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
in,O
China,O
.,O
"

",O
Li,O
Q(1,O
),O
",",O
Feng,O
W(2,O
),O
",",O
Quan,O
YH(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Physical,O
Science,O
and,O
Technology,O
",",O
Northwestern,O
Polytechnical,O
"
",O
University,O
",",O
Xi'an,O
710129,O
",",O
PR,O
China,O
.,O
Electronic,O
address,O
:,O
liruo@nwpu.edu.cn,O
.,O
"
",O
(2)School,O
of,O
Electronic,O
Engineering,O
",",O
Xidian,O
University,O
",",O
Xi'an,O
710071,O
",",O
PR,O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
wfeng@xidian.edu.cn,O
.,O
"
",O
(3)School,O
of,O
Electronic,O
Engineering,O
",",O
Xidian,O
University,O
",",O
Xi'an,O
710071,O
",",O
PR,O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
yhquan@mail.xidian.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.014,O
"
",O
PMID,O
:,O
32113991,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
429,O
.,O
Acad,O
Radiol,O
.,O
2020,O
Feb,O
26,O
.,O
pii,O
:,O
S10766332(20)300891,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.acra.2020.02.003,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Corona,O
Virus,O
International,O
Public,O
Health,O
Emergencies,O
:,O
Implications,O
for,O
Radiology,O
"
",O
Management,O
.,O
"

",O
Zhang,O
HW(1,O
),O
",",O
Yu,O
J(1,O
),O
",",O
Xu,O
HJ(1,O
),O
",",O
Lei,O
Y(2,O
),O
",",O
Pu,O
ZH(3,O
),O
",",O
Dai,O
WC(1,O
),O
",",O
Lin,O
F(1,O
),O
",",O
Wang,O
"
",O
YL(1,O
),O
",",O
Wu,O
XL(1,O
),O
",",O
Liu,O
LH(1,O
),O
",",O
Li,O
M(1,O
),O
",",O
Mo,O
YQ(1,O
),O
",",O
Zhang,O
H(1,O
),O
",",O
Luo,O
SP(1,O
),O
",",O
Chen,O
H(1,O
),O
",",O
"
",O
Lyu,O
GW(1,O
),O
",",O
Zhou,O
ZG(1,O
),O
",",O
Liu,O
WM(1,O
),O
",",O
Liu,O
XL(1,O
),O
",",O
Song,O
HY(1,O
),O
",",O
Chen,O
FZ(1,O
),O
",",O
Zeng,O
L(1,O
),O
",",O
"
",O
Zhong,O
H(1,O
),O
",",O
Guo,O
TT(1,O
),O
",",O
Hu,O
YQ(1,O
),O
",",O
Yang,O
XX(1,O
),O
",",O
Liu,O
PN(1,O
),O
",",O
Li,O
DF(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Shenzhen,O
University,O
",",O
"
",O
Health,O
Science,O
Center,O
",",O
Shenzhen,O
Second,O
People,O
's,O
Hospital,O
",",O
3002,O
SunGangXi,O
Road,O
",",O
"
",O
Shenzhen,O
",",O
518035,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Shenzhen,O
University,O
",",O
"
",O
Health,O
Science,O
Center,O
",",O
Shenzhen,O
Second,O
People,O
's,O
Hospital,O
",",O
3002,O
SunGangXi,O
Road,O
",",O
"
",O
Shenzhen,O
",",O
518035,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
13602658583@163.com,O
.,O
"
",O
(3)Department,O
of,O
Radiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Shenzhen,O
University,O
",",O
"
",O
Health,O
Science,O
Center,O
",",O
Shenzhen,O
Second,O
People,O
's,O
Hospital,O
",",O
3002,O
SunGangXi,O
Road,O
",",O
"
",O
Shenzhen,O
",",O
518035,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
pupeter190@163.com,O
.,O
"

",O
The,O
outbreak,O
of,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
pneumonia,O
was,O
reported,O
in,O
"
",O
Wuhan,O
",",O
Hubei,O
Province,O
",",O
China,O
in,O
December,O
2019,O
and,O
has,O
spread,O
internationally,O
.,O
"
",O
This,O
article,O
discusses,O
how,O
radiology,O
departments,O
can,O
most,O
effectively,O
respond,O
to,O
"
",O
this,O
public,O
health,O
emergency,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Association,O
of,O
University,O
Radiologists,O
.,O
Published,O
by,O
"
",O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.acra.2020.02.003,O
"
",O
PMID,O
:,O
32113880,O
"


",O
430,O
.,O
J,O
Integr,O
Med,O
.,O
2020,O
Feb,O
20,O
.,O
pii,O
:,O
S20954964(20)300157,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.joim.2020.02.005,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
In,O
silico,O
screening,O
of,O
Chinese,O
herbal,O
medicines,O
with,O
the,O
potential,O
to,O
directly,O
"
",O
inhibit,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
.,O
"

",O
Zhang,O
DH(1,O
),O
",",O
Wu,O
KL(2,O
),O
",",O
Zhang,O
X(3,O
),O
",",O
Deng,O
SQ(4,O
),O
",",O
Peng,O
B(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Shanghai,O
Health,O
Commission,O
Key,O
Lab,O
of,O
Artificial,O
Intelligence,O
(AI)Based,O
"
",O
Management,O
of,O
Inflammation,O
and,O
Chronic,O
Diseases,O
",",O
SinoFrench,O
Cooperative,O
Central,O
"
",O
Lab,O
",",O
Shanghai,O
Pudong,O
Gongli,O
Hospital,O
",",O
Secondary,O
Military,O
Medical,O
University,O
",",O
"
",O
Shanghai,O
200135,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
shanghai_zhang@hotmail.com,O
.,O
"
",O
(2)Department,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
Shanghai,O
Pudong,O
Gongli,O
Hospital,O
",",O
"
",O
Secondary,O
Military,O
Medical,O
University,O
",",O
Shanghai,O
200135,O
",",O
China,O
.,O
"
",O
(3)Shanghai,O
Health,O
Commission,O
Key,O
Lab,O
of,O
Artificial,O
Intelligence,O
(AI)Based,O
"
",O
Management,O
of,O
Inflammation,O
and,O
Chronic,O
Diseases,O
",",O
SinoFrench,O
Cooperative,O
Central,O
"
",O
Lab,O
",",O
Shanghai,O
Pudong,O
Gongli,O
Hospital,O
",",O
Secondary,O
Military,O
Medical,O
University,O
",",O
"
",O
Shanghai,O
200135,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Research,O
Affair,O
Management,O
",",O
Shanghai,O
Pudong,O
Gongli,O
Hospital,O
",",O
"
",O
Secondary,O
Military,O
Medical,O
University,O
",",O
Shanghai,O
200135,O
",",O
China,O
.,O
"

",O
OBJECTIVE,O
:,O
In,O
this,O
study,O
we,O
execute,O
a,O
rational,O
screen,O
to,O
identify,O
Chinese,O
medical,O
"
",O
herbs,O
that,O
are,O
commonly,O
used,O
in,O
treating,O
viral,O
respiratory,O
infections,O
and,O
also,O
"
",O
contain,O
compounds,O
that,O
might,O
directly,O
inhibit,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
",",O
"
",O
an,O
ongoing,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
that,O
causes,O
pneumonia,O
.,O
"
",O
METHODS,O
:,O
There,O
were,O
two,O
main,O
steps,O
in,O
the,O
screening,O
process,O
.,O
In,O
the,O
first,O
step,O
we,O
"
",O
conducted,O
a,O
literature,O
search,O
for,O
natural,O
compounds,O
that,O
had,O
been,O
biologically,O
"
",O
confirmed,O
as,O
against,O
sever,O
acute,O
respiratory,O
syndrome,O
coronavirus,O
or,O
Middle,O
East,O
"
",O
respiratory,O
syndrome,O
coronavirus,O
.,O
Resulting,O
compounds,O
were,O
crosschecked,O
for,O
"
",O
listing,O
in,O
the,O
Traditional,O
Chinese,O
Medicine,O
Systems,O
Pharmacology,O
Database,O
.,O
"
",O
Compounds,O
meeting,O
both,O
requirements,O
were,O
subjected,O
to,O
absorption,O
",",O
distribution,O
",",O
"
",O
metabolism,O
and,O
excretion,O
(,O
ADME,O
),O
evaluation,O
to,O
verify,O
that,O
oral,O
administration,O
"
",O
would,O
be,O
effective,O
.,O
Next,O
",",O
a,O
docking,O
analysis,O
was,O
used,O
to,O
test,O
whether,O
the,O
"
",O
compound,O
had,O
the,O
potential,O
for,O
direct,O
2019nCoV,B-Virus_SARS-CoV-2
protein,O
interaction,O
.,O
In,O
the,O
"
",O
second,O
step,O
we,O
searched,O
Chinese,O
herbal,O
databases,O
to,O
identify,O
plants,O
containing,O
"
",O
the,O
selected,O
compounds,O
.,O
Plants,O
containing,O
2,O
or,O
more,O
of,O
the,O
compounds,O
identified,O
"
",O
in,O
our,O
screen,O
were,O
then,O
checked,O
against,O
the,O
catalogue,O
for,O
classic,O
herbal,O
usage,O
.,O
"
",O
Finally,O
",",O
network,O
pharmacology,O
analysis,O
was,O
used,O
to,O
predict,O
the,O
general,O
in,O
vivo,O
"
",O
effects,O
of,O
each,O
selected,O
herb,O
.,O
"
",O
RESULTS,O
:,O
Of,O
the,O
natural,O
compounds,O
screened,O
",",O
13,O
that,O
exist,O
in,O
traditional,O
Chinese,O
"
",O
medicines,O
were,O
also,O
found,O
to,O
have,O
potential,O
anti2019nCoV,O
activity,O
.,O
Further,O
",",O
125,O
"
",O
Chinese,O
herbs,O
were,O
found,O
to,O
contain,O
2,O
or,O
more,O
of,O
these,O
13,O
compounds,O
.,O
Of,O
these,O
125,O
"
",O
herbs,O
",",O
26,O
are,O
classically,O
catalogued,O
as,O
treating,O
viral,O
respiratory,O
infections,O
.,O
"
",O
Network,O
pharmacology,O
analysis,O
predicted,O
that,O
the,O
general,O
in,O
vivo,O
roles,O
of,O
these,O
"
",O
26,O
herbal,O
plants,O
were,O
related,O
to,O
regulating,O
viral,O
infection,O
",",O
immune,O
inflammation,O
"
",O
reactions,O
and,O
hypoxia,O
response,O
.,O
"
",O
CONCLUSION,O
:,O
Chinese,O
herbal,O
treatments,O
classically,O
used,O
for,O
treating,O
viral,O
"
",O
respiratory,O
infection,O
might,O
contain,O
direct,O
anti2019nCoV,O
compounds,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Shanghai,O
Changhai,O
Hospital,O
.,O
Published,O
by,O
Elsevier,O
B.V.,O
All,O
"
",O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.joim.2020.02.005,O
"
",O
PMID,O
:,O
32113846,O
"


",O
431,O
.,O
Virus,O
Res,O
.,O
2020,O
Feb,O
27;281:197907,O
.,O
doi,O
:,O
10.1016,O
j.virusres.2020.197907,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
IL6,O
STAT3,O
mediates,O
the,O
HPV18,O
E6,O
E7,O
stimulated,O
upregulation,O
of,O
MALAT1,O
gene,O
in,O
"
",O
cervical,O
cancer,O
HeLa,O
cells,O
.,O
"

",O
Hao,O
Y(1,O
),O
",",O
Yan,O
Z(1,O
),O
",",O
Zhang,O
A(1,O
),O
",",O
Hu,O
S(1,O
),O
",",O
Wang,O
N(1,O
),O
",",O
Luo,O
XG(1,O
),O
",",O
Ma,O
W(1,O
),O
",",O
Zhang,O
"
",O
TC(2,O
),O
",",O
He,O
H(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Industrial,O
Microbiology,O
",",O
Ministry,O
of,O
Education,O
and,O
Tianjin,O
"
",O
City,O
",",O
State,O
Key,O
Laboratory,O
of,O
Food,O
Nutrition,O
and,O
Safety,O
",",O
College,O
of,O
"
",O
Biotechnology,O
",",O
Tianjin,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
300457,O
",",O
Tianjin,O
",",O
PR,O
"
",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Industrial,O
Microbiology,O
",",O
Ministry,O
of,O
Education,O
and,O
Tianjin,O
"
",O
City,O
",",O
State,O
Key,O
Laboratory,O
of,O
Food,O
Nutrition,O
and,O
Safety,O
",",O
College,O
of,O
"
",O
Biotechnology,O
",",O
Tianjin,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
300457,O
",",O
Tianjin,O
",",O
PR,O
"
",O
China,O
;,O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
430081,O
",",O
Wuhan,O
",",O
PR,O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Industrial,O
Microbiology,O
",",O
Ministry,O
of,O
Education,O
and,O
Tianjin,O
"
",O
City,O
",",O
State,O
Key,O
Laboratory,O
of,O
Food,O
Nutrition,O
and,O
Safety,O
",",O
College,O
of,O
"
",O
Biotechnology,O
",",O
Tianjin,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
300457,O
",",O
Tianjin,O
",",O
PR,O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
hehongpeng@tust.edu.cn,O
.,O
"

",O
MALAT1,O
",",O
a,O
long,O
noncoding,O
RNA,O
",",O
is,O
highly,O
expressed,O
in,O
cervical,O
cancer,O
cells,O
and,O
"
",O
plays,O
an,O
important,O
role,O
in,O
the,O
development,O
of,O
cervical,O
cancer,O
.,O
However,O
",",O
the,O
"
",O
mechanism,O
for,O
the,O
excessive,O
expression,O
of,O
MALAT1,O
in,O
cervical,O
cancer,O
remains,O
"
",O
unclear,O
.,O
Highrisk,O
HPVs,O
are,O
causative,O
agents,O
of,O
cervical,O
cancer,O
and,O
the,O
"
",O
IL6,O
STAT3,O
signaling,O
is,O
closely,O
correlated,O
with,O
the,O
development,O
of,O
various,O
"
",O
cancers,O
including,O
cervical,O
cancer,O
.,O
In,O
this,O
study,O
",",O
the,O
roles,O
of,O
HPV18,O
E6,O
E7,O
and,O
"
",O
IL6,O
STAT3,O
in,O
the,O
regulation,O
of,O
MALAT1,O
transcription,O
in,O
cervical,O
cancer,O
cells,O
"
",O
were,O
investigated,O
.,O
It,O
was,O
found,O
that,O
HPV18,O
E6,O
E7,O
activated,O
the,O
IL6,O
STAT3,O
"
",O
signaling,O
and,O
",",O
in,O
reciprocal,O
",",O
IL6,O
STAT3,O
strengthened,O
HPV18,O
E6,O
E7,O
expression,O
in,O
"
",O
HeLa,O
cells,O
.,O
Both,O
HPV18,O
E6,O
E7,O
and,O
IL6,O
STAT3,O
were,O
involved,O
in,O
MALAT1,O
expression,O
"
",O
and,O
they,O
worked,O
synergistically,O
in,O
the,O
upregulation,O
of,O
MALAT1,O
gene,O
.,O
With,O
"
",O
luciferase,O
reporter,O
assays,O
",",O
a,O
STAT3binding,O
sequence,O
in,O
the,O
enhancer,O
region,O
of,O
"
",O
MALAT1,O
gene,O
was,O
demonstrated,O
to,O
be,O
crucial,O
for,O
the,O
IL6,O
or,O
STAT3induced,O
MALAT1,O
"
",O
promoter,O
activation,O
.,O
Taken,O
together,O
",",O
our,O
data,O
suggest,O
that,O
IL6,O
STAT3,O
mediates,O
"
",O
the,O
HPV18,O
E6,O
E7,O
stimulated,O
upregulation,O
of,O
MALAT1,O
gene,O
in,O
cervical,O
cancer,O
HeLa,O
"
",O
cells,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.virusres.2020.197907,O
"
",O
PMID,O
:,O
32113834,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
All,O
of,O
the,O
"
",O
authors,O
declare,O
no,O
conflict,O
of,O
interests,O
.,O
"


",O
432,O
.,O
J,O
Formos,O
Med,O
Assoc,O
.,O
2020,O
Mar;119(3):747751,O
.,O
doi,O
:,O
10.1016,O
j.jfma.2020.02.007,O
.,O
"
",O
Epub,O
2020,O
Feb,O
26,O
.,O
"

",O
First,O
case,O
of,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
pneumonia,O
in,O
Taiwan,O
.,O
"

",O
Cheng,O
SC(1,O
),O
",",O
Chang,O
YC(2,O
),O
",",O
Fan,O
Chiang,O
YL(3,O
),O
",",O
Chien,O
YC(2,O
),O
",",O
Cheng,O
M(4,O
),O
",",O
Yang,O
CH(5,O
),O
",",O
"
",O
Huang,O
CH(6,O
),O
",",O
Hsu,O
YN(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Pulmonary,O
Medicine,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
Sinwu,O
Branch,O
",",O
"
",O
Taoyuan,O
General,O
Hospital,O
",",O
Ministry,O
of,O
Health,O
and,O
Welfare,O
",",O
Taoyuan,O
",",O
Taiwan,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
Taoyuan,O
General,O
Hospital,O
",",O
Ministry,O
of,O
Health,O
and,O
"
",O
Welfare,O
",",O
Taoyuan,O
",",O
Taiwan,O
.,O
"
",O
(3)Department,O
of,O
Internal,O
Medicine,O
",",O
Sinwu,O
Branch,O
",",O
Taoyuan,O
General,O
Hospital,O
",",O
"
",O
Ministry,O
of,O
Health,O
and,O
Welfare,O
",",O
Taoyuan,O
",",O
Taiwan,O
.,O
"
",O
(4)Department,O
of,O
Orthopedic,O
Surgery,O
",",O
Sinwu,O
Branch,O
",",O
Taoyuan,O
General,O
Hospital,O
",",O
"
",O
Ministry,O
of,O
Health,O
and,O
Welfare,O
",",O
Taoyuan,O
",",O
Taiwan,O
.,O
"
",O
(5)Department,O
of,O
Radiology,O
",",O
Taoyuan,O
General,O
Hospital,O
",",O
Ministry,O
of,O
Health,O
and,O
"
",O
Welfare,O
",",O
Taoyuan,O
",",O
Taiwan,O
;,O
Department,O
of,O
Medical,O
Imaging,O
",",O
National,O
Taiwan,O
"
",O
University,O
Hospital,O
",",O
Taipei,O
",",O
Taiwan,O
;,O
Department,O
of,O
Biomedical,O
Engineering,O
and,O
"
",O
Environmental,O
Science,O
",",O
National,O
Tsing,O
Hua,O
University,O
",",O
Hsinchu,O
",",O
Taiwan,O
.,O
"
",O
(6)Division,O
of,O
Gastroenterology,O
and,O
Hepatology,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
"
",O
Sinwu,O
Branch,O
",",O
Taoyuan,O
General,O
Hospital,O
",",O
Ministry,O
of,O
Health,O
and,O
Welfare,O
",",O
Taoyuan,O
",",O
"
",O
Taiwan,O
.,O
Electronic,O
address,O
:,O
4719@mail.tygh.gov.tw,O
.,O
"
",O
(7)Department,O
of,O
Family,O
Medicine,O
",",O
Taoyuan,O
General,O
Hospital,O
",",O
Ministry,O
of,O
Health,O
"
",O
and,O
Welfare,O
",",O
Taoyuan,O
",",O
Taiwan,O
.,O
Electronic,O
address,O
:,O
kingjen@mail.tygh.gov.tw,O
.,O
"

",O
An,O
outbreak,O
of,O
respiratory,O
illness,O
proved,O
to,O
be,O
infected,O
by,O
a,O
2019,O
novel,O
"
",O
coronavirus,O
",",O
officially,O
named,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
",",O
was,O
notified,O
"
",O
first,O
in,O
Wuhan,O
",",O
China,O
",",O
and,O
has,O
spread,O
rapidly,O
in,O
China,O
and,O
to,O
other,O
parts,O
of,O
the,O
"
",O
world,O
.,O
Herein,O
",",O
we,O
reported,O
the,O
first,O
confirmed,O
case,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
pneumonia,O
(,O
NCP,B-Disease_COVID-19
),O
imported,O
from,O
China,O
in,O
Taiwan,O
.,O
This,O
case,O
report,O
revealed,O
a,O
"
",O
natural,O
course,O
of,O
NCP,B-Disease_COVID-19
with,O
selfrecovery,O
",",O
which,O
may,O
be,O
a,O
good,O
example,O
in,O
"
",O
comparison,O
with,O
medical,O
treatments,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
B.V.,O
"

",O
DOI,O
:,O
10.1016,O
j.jfma.2020.02.007,O
"
",O
PMID,O
:,O
32113824,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflict,O
of,O
Interest,O
The,O
authors,O
have,O
no,O
"
",O
conflicts,O
of,O
interest,O
relevant,O
to,O
this,O
article,O
.,O
"


",O
433,O
.,O
J,O
Autoimmun,O
.,O
2020,O
Feb,O
26:102433,O
.,O
doi,O
:,O
10.1016,O
j.jaut.2020.102433,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
The,O
epidemiology,O
and,O
pathogenesis,O
of,O
coronavirus,O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
outbreak,O
.,O
"

",O
Rothan,O
HA(1,O
),O
",",O
Byrareddy,O
SN(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Biology,O
",",O
College,O
of,O
Arts,O
and,O
Sciences,O
",",O
Georgia,O
State,O
University,O
",",O
"
",O
Atlanta,O
",",O
GA,O
",",O
USA,O
.,O
Electronic,O
address,O
:,O
hrothan@gsu.edu,O
.,O
"
",O
(2)Department,O
of,O
Pharmacology,O
and,O
Experimental,O
Neuroscience,O
",",O
University,O
of,O
"
",O
Nebraska,O
Medical,O
Centre,O
",",O
Omaha,O
",",O
NE,O
",",O
USA,O
;,O
Department,O
of,O
Genetics,O
",",O
Cell,O
Biology,O
and,O
"
",O
Anatomy,O
",",O
Omaha,O
",",O
NE,O
",",O
USA,O
;,O
Department,O
of,O
Biochemistry,O
and,O
Molecular,O
Biology,O
",",O
"
",O
University,O
of,O
Nebraska,O
Medical,O
Centre,O
",",O
Omaha,O
",",O
NE,O
",",O
USA,O
.,O
Electronic,O
address,O
:,O
"
",O
sid.byrareddy@unmc.edu,O
.,O
"

",O
Coronavirus,O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
is,O
caused,O
by,O
SARSCOV2,B-Virus_SARS-CoV-2
and,O
represents,O
the,O
"
",O
causative,O
agent,O
of,O
a,O
potentially,O
fatal,O
disease,O
that,O
is,O
of,O
great,O
global,O
public,O
"
",O
health,O
concern,O
.,O
Based,O
on,O
the,O
large,O
number,O
of,O
infected,O
people,O
that,O
were,O
exposed,O
to,O
"
",O
the,O
wet,O
animal,O
market,O
in,O
Wuhan,O
City,O
",",O
China,O
",",O
it,O
is,O
suggested,O
that,O
this,O
is,O
likely,O
"
",O
the,O
zoonotic,O
origin,O
of,O
COVID19,B-Disease_COVID-19
.,O
Persontoperson,O
transmission,O
of,O
COVID19,B-Disease_COVID-19
"
",O
infection,O
led,O
to,O
the,O
isolation,O
of,O
patients,O
that,O
were,O
subsequently,O
administered,O
a,O
"
",O
variety,O
of,O
treatments,O
.,O
Extensive,O
measures,O
to,O
reduce,O
persontoperson,O
transmission,O
"
",O
of,O
COVID19,B-Disease_COVID-19
have,O
been,O
implemented,O
to,O
control,O
the,O
current,O
outbreak,O
.,O
Special,O
"
",O
attention,O
and,O
efforts,O
to,O
protect,O
or,O
reduce,O
transmission,O
should,O
be,O
applied,O
in,O
"
",O
susceptible,O
populations,O
including,O
children,O
",",O
health,O
care,O
providers,O
",",O
and,O
elderly,O
"
",O
people,O
.,O
In,O
this,O
review,O
",",O
we,O
highlights,O
the,O
symptoms,O
",",O
epidemiology,O
",",O
transmission,O
",",O
"
",O
pathogenesis,O
",",O
phylogenetic,O
analysis,O
and,O
future,O
directions,O
to,O
control,O
the,O
spread,O
"
",O
of,O
this,O
fatal,O
disease,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jaut.2020.102433,O
"
",O
PMID,O
:,O
32113704,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
The,O
authors,O
"
",O
declare,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
434,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
27,O
.,O
pii,O
:,O
S14733099(20)301419,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301419,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Convalescent,O
plasma,O
as,O
a,O
potential,O
therapy,O
for,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Chen,O
L(1,O
),O
",",O
Xiong,O
J(1,O
),O
",",O
Bao,O
L(1,O
),O
",",O
Shi,O
Y(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Neonatology,O
",",O
Ministry,O
of,O
Education,O
Key,O
Laboratory,O
of,O
Child,O
"
",O
Development,O
and,O
Disorders,O
",",O
Chongqing,O
Key,O
Laboratory,O
of,O
Pediatrics,O
",",O
Chongqing,O
",",O
"
",O
400014,O
",",O
China,O
;,O
National,O
Clinical,O
Research,O
Center,O
for,O
Child,O
Health,O
and,O
Disorders,O
",",O
"
",O
Chongqing,O
Key,O
Laboratory,O
of,O
Pediatrics,O
",",O
Chongqing,O
",",O
400014,O
",",O
China,O
;,O
China,O
"
",O
International,O
Science,O
and,O
Technology,O
Cooperation,O
base,O
of,O
Child,O
development,O
and,O
"
",O
Critical,O
Disorders,O
",",O
Chongqing,O
Key,O
Laboratory,O
of,O
Pediatrics,O
",",O
Chongqing,O
",",O
400014,O
",",O
"
",O
China,O
;,O
Children,O
's,O
Hospital,O
of,O
Chongqing,O
Medical,O
University,O
;,O
Chongqing,O
Key,O
"
",O
Laboratory,O
of,O
Pediatrics,O
",",O
Chongqing,O
",",O
400014,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Neonatology,O
",",O
Ministry,O
of,O
Education,O
Key,O
Laboratory,O
of,O
Child,O
"
",O
Development,O
and,O
Disorders,O
",",O
Chongqing,O
Key,O
Laboratory,O
of,O
Pediatrics,O
",",O
Chongqing,O
",",O
"
",O
400014,O
",",O
China,O
;,O
National,O
Clinical,O
Research,O
Center,O
for,O
Child,O
Health,O
and,O
Disorders,O
",",O
"
",O
Chongqing,O
Key,O
Laboratory,O
of,O
Pediatrics,O
",",O
Chongqing,O
",",O
400014,O
",",O
China,O
;,O
China,O
"
",O
International,O
Science,O
and,O
Technology,O
Cooperation,O
base,O
of,O
Child,O
development,O
and,O
"
",O
Critical,O
Disorders,O
",",O
Chongqing,O
Key,O
Laboratory,O
of,O
Pediatrics,O
",",O
Chongqing,O
",",O
400014,O
",",O
"
",O
China,O
;,O
Children,O
's,O
Hospital,O
of,O
Chongqing,O
Medical,O
University,O
;,O
Chongqing,O
Key,O
"
",O
Laboratory,O
of,O
Pediatrics,O
",",O
Chongqing,O
",",O
400014,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
petshi530@vip.163.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301419,O
"
",O
PMID,O
:,O
32113510,O
"


",O
435,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
27,O
.,O
pii,O
:,O
S14733099(20)301328,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301328,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
:,O
combining,O
antiviral,O
and,O
antiinflammatory,O
treatments,O
.,O
"

",O
Stebbing,O
J(1,O
),O
",",O
Phelan,O
A(2,O
),O
",",O
Griffin,O
I(2,O
),O
",",O
Tucker,O
C(2,O
),O
",",O
Oechsle,O
O(2,O
),O
",",O
Smith,O
D(2,O
),O
",",O
"
",O
Richardson,O
P(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Surgery,O
and,O
Cancer,O
",",O
Imperial,O
College,O
London,O
",",O
London,O
W12,O
0NN,O
",",O
UK,O
.,O
"
",O
Electronic,O
address,O
:,O
j.stebbing@imperial.ac.uk,O
.,O
"
",O
(2)Benevolent,O
AI,O
",",O
London,O
",",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301328,O
"
",O
PMID,O
:,O
32113509,O
"


",O
436,O
.,O
Lancet,O
.,O
2020,O
Mar,O
14;395(10227):841842,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)304645,O
.,O
Epub,O
"
",O
2020,O
Feb,O
27,O
.,O
"

",O
Looming,O
threat,O
of,O
COVID19,B-Disease_COVID-19
infection,O
in,O
Africa,O
:,O
act,O
collectively,O
",",O
and,O
fast,O
.,O
"

",O
Nkengasong,O
JN(1,O
),O
",",O
Mankoula,O
W(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Africa,O
Centres,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Addis,O
Ababa,O
W21K19,O
",",O
"
",O
Ethiopia,O
.,O
Electronic,O
address,O
:,O
nkengasongJ@africaunion.org,O
.,O
"
",O
(2)Africa,O
Centres,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Addis,O
Ababa,O
W21K19,O
",",O
"
",O
Ethiopia,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)304645,O
"
",O
PMID,O
:,O
32113508,O
"


",O
437,O
.,O
Lancet,O
.,O
2020,O
Mar,O
14;395(10227):e46,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)304633,O
.,O
Epub,O
2020,O
"
",O
Feb,O
27,O
.,O
"

",O
Lessons,O
for,O
managing,O
highconsequence,O
infections,O
from,O
first,O
COVID19,B-Disease_COVID-19
cases,O
in,O
the,O
"
",O
UK,O
.,O
"

",O
Moss,O
P(1,O
),O
",",O
Barlow,O
G(2,O
),O
",",O
Easom,O
N(2,O
),O
",",O
Lillie,O
P(2,O
),O
",",O
Samson,O
A(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infection,O
",",O
Hull,O
University,O
Teaching,O
Hospitals,O
NHS,O
Trust,O
",",O
Hull,O
"
",O
HU16,O
5JQ,O
",",O
UK,O
.,O
Electronic,O
address,O
:,O
peter.moss@hey.nhs.uk,O
.,O
"
",O
(2)Department,O
of,O
Infection,O
",",O
Hull,O
University,O
Teaching,O
Hospitals,O
NHS,O
Trust,O
",",O
Hull,O
"
",O
HU16,O
5JQ,O
",",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)304633,O
"
",O
PMID,O
:,O
32113507,O
"


",O
438,O
.,O
Lancet,O
.,O
2020,O
Mar,O
14;395(10227):e48,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)304669,O
.,O
Epub,O
2020,O
"
",O
Feb,O
27,O
.,O
"

",O
COVID19,B-Disease_COVID-19
:,O
preparing,O
for,O
superspreader,O
potential,O
among,O
Umrah,O
pilgrims,O
to,O
Saudi,O
"
",O
Arabia,O
.,O
"

",O
Ebrahim,O
SH(1,O
),O
",",O
Memish,O
ZA(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)University,O
of,O
Sciences,O
",",O
Technique,O
and,O
Technology,O
",",O
Bamako,O
",",O
Mali,O
.,O
"
",O
(2)Research,O
&,O
Innovation,O
Center,O
",",O
King,O
Saud,O
Medical,O
City,O
",",O
Ministry,O
of,O
Health,O
",",O
"
",O
Riyadh,O
12746,O
",",O
Saudi,O
Arabia,O
;,O
College,O
of,O
Medicine,O
",",O
Alfaisal,O
University,O
",",O
Riyadh,O
",",O
"
",O
Saudi,O
Arabia,O
;,O
Hubert,O
Department,O
of,O
Global,O
Health,O
",",O
Rollins,O
School,O
of,O
Public,O
"
",O
Health,O
",",O
Emory,O
University,O
",",O
Atlanta,O
",",O
GA,O
",",O
USA,O
.,O
Electronic,O
address,O
:,O
"
",O
zmemish@yahoo.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)304669,O
"
",O
PMID,O
:,O
32113506,O
"


",O
439,O
.,O
Lancet,O
.,O
2020,O
Mar,O
14;395(10227):e47,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)304621,O
.,O
Epub,O
2020,O
"
",O
Feb,O
27,O
.,O
"

",O
Secondary,O
attack,O
rate,O
and,O
superspreading,O
events,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Liu,O
Y(1,O
),O
",",O
Eggo,O
RM(1,O
),O
",",O
Kucharski,O
AJ(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Disease,O
Epidemiology,O
",",O
London,O
School,O
of,O
Hygiene,O
&,O
"
",O
Tropical,O
Medicine,O
",",O
London,O
WC1E,O
7HT,O
",",O
UK,O
.,O
"
",O
(2)Department,O
of,O
Infectious,O
Disease,O
Epidemiology,O
",",O
London,O
School,O
of,O
Hygiene,O
&,O
"
",O
Tropical,O
Medicine,O
",",O
London,O
WC1E,O
7HT,O
",",O
UK,O
.,O
Electronic,O
address,O
:,O
"
",O
adam.kucharski@lshtm.ac.uk,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)304621,O
"
",O
PMID,O
:,O
32113505,O
"


",O
440,O
.,O
Lancet,O
Glob,O
Health,O
.,O
2020,O
Feb,O
27,O
.,O
pii,O
:,O
S2214109X(20)300760,O
.,O
doi,O
:,O
"
",O
10.1016,O
S2214109X(20)300760,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
RetractionChinese,O
medical,O
staff,O
request,O
international,O
medical,O
assistance,O
in,O
"
",O
fighting,O
against,O
COVID19,B-Disease_COVID-19
.,O
"

",O
The,O
Editors,O
Of,O
The,O
Lancet,O
Global,O
Health(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Lancet,O
Global,O
Health,O
",",O
London,O
EC2Y,O
5AS,O
",",O
UK,O
.,O
"

",O
Retraction,O
of,O
"
    ",O
Lancet,O
Glob,O
Health,O
.,O
2020,O
Feb,O
24,O
;,O
:,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S2214109X(20)300760,O
"
",O
PMID,O
:,O
32113504,O
"


",O
441,O
.,O
Lancet,O
.,O
2020,O
Feb,O
29;395(10225):675,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)304591,O
.,O
"

",O
Indian,O
pharma,O
threatened,O
by,O
COVID19,B-Disease_COVID-19
shutdowns,O
in,O
China,O
.,O
"

",O
Chatterjee,O
P.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)304591,O
"
",O
PMID,O
:,O
32113494,O
"


",O
442,O
.,O
Int,O
J,O
Surg,O
.,O
2020,O
Feb,O
26;76:7176,O
.,O
doi,O
:,O
10.1016,O
j.ijsu.2020.02.034,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
World,O
Health,O
Organization,O
declares,O
global,O
emergency,O
:,O
A,O
review,O
of,O
the,O
2019,O
novel,O
"
",O
coronavirus,O
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
Sohrabi,O
C(1,O
),O
",",O
Alsafi,O
Z(2,O
),O
",",O
O'Neill,O
N(3,O
),O
",",O
Khan,O
M(2,O
),O
",",O
Kerwan,O
A(4,O
),O
",",O
AlJabir,O
A(4,O
),O
",",O
"
",O
Iosifidis,O
C(1,O
),O
",",O
Agha,O
R(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Barts,O
and,O
The,O
London,O
School,O
of,O
Medicine,O
and,O
Dentistry,O
",",O
Queen,O
Mary,O
University,O
"
",O
of,O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
(2)UCL,O
Medical,O
School,O
",",O
University,O
College,O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
(3)Barts,O
and,O
The,O
London,O
School,O
of,O
Medicine,O
and,O
Dentistry,O
",",O
Queen,O
Mary,O
University,O
"
",O
of,O
London,O
",",O
United,O
Kingdom,O
.,O
Electronic,O
address,O
:,O
niamh@ijspg.com,O
.,O
"
",O
(4)GKT,O
School,O
of,O
Medical,O
Education,O
",",O
King,O
's,O
College,O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
(5)Barts,O
Health,O
NHS,O
Trust,O
",",O
London,O
",",O
United,O
Kingdom,O
.,O
"

",O
An,O
unprecedented,O
outbreak,O
of,O
pneumonia,O
of,O
unknown,O
aetiology,O
in,O
Wuhan,O
City,O
",",O
Hubei,O
"
",O
province,O
in,O
China,O
emerged,O
in,O
December,O
2019,O
.,O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
was,O
identified,O
as,O
"
",O
the,O
causative,O
agent,O
and,O
was,O
subsequently,O
termed,O
COVID19,B-Disease_COVID-19
by,O
the,O
World,O
Health,O
"
",O
Organization,O
(,O
WHO,O
),O
.,O
Considered,O
a,O
relative,O
of,O
severe,O
acute,O
respiratory,O
syndrome,O
"
",O
(,O
SARS,O
),O
and,O
Middle,O
East,O
respiratory,O
syndrome,O
(,O
MERS,O
),O
",",O
COVID19,B-Disease_COVID-19
is,O
caused,O
by,O
a,O
"
",O
betacoronavirus,O
named,O
SARSCoV2,B-Virus_SARS-CoV-2
that,O
affects,O
the,O
lower,O
respiratory,O
tract,O
and,O
"
",O
manifests,O
as,O
pneumonia,O
in,O
humans,O
.,O
Despite,O
rigorous,O
global,O
containment,O
and,O
"
",O
quarantine,O
efforts,O
",",O
the,O
incidence,O
of,O
COVID19,B-Disease_COVID-19
continues,O
to,O
rise,O
",",O
with,O
90870,O
"
",O
laboratoryconfirmed,O
cases,O
and,O
over,O
3000,O
deaths,O
worldwide,O
.,O
In,O
response,O
to,O
this,O
"
",O
global,O
outbreak,O
",",O
we,O
summarise,O
the,O
current,O
state,O
of,O
knowledge,O
surrounding,O
"
",O
COVID19,B-Disease_COVID-19
.,O
"

",O
Copyright,O
Â©,O
2020,O
IJS,O
Publishing,O
Group,O
Ltd.,O
Published,O
by,O
Elsevier,O
Ltd.,O
All,O
rights,O
"
",O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijsu.2020.02.034,O
"
",O
PMID,O
:,O
32112977,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
No,O
conflicts,O
of,O
"
",O
interest,O
to,O
declare,O
.,O
"


",O
443,O
.,O
Int,O
J,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
26;93:192197,O
.,O
doi,O
:,O
10.1016,O
j.ijid.2020.02.043,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
2019novel,O
Coronavirus,O
severe,O
adult,O
respiratory,O
distress,O
syndrome,O
in,O
two,O
cases,O
in,O
"
",O
Italy,O
:,O
An,O
uncommon,O
radiological,O
presentation,O
.,O
"

",O
Albarello,O
F(1,O
),O
",",O
Pianura,O
E(1,O
),O
",",O
Di,O
Stefano,O
F(1,O
),O
",",O
Cristofaro,O
M(1,O
),O
",",O
Petrone,O
A(1,O
),O
",",O
"
",O
Marchioni,O
L(1,O
),O
",",O
Palazzolo,O
C(1,O
),O
",",O
SchininÃ ,O
V(2,O
),O
",",O
Nicastri,O
E(1,O
),O
",",O
Petrosillo,O
N(1,O
),O
",",O
"
",O
Campioni,O
P(1,O
),O
",",O
Eskild,O
P(3,O
),O
",",O
Zumla,O
A(4,O
),O
",",O
Ippolito,O
G(1,O
),O
;,O
COVID,B-Disease_COVID-19
19,I-Disease_COVID-19
INMI,O
Study,O
Group,O
.,O
"

",O
Collaborators,O
:,O
Abbonizio,O
MA,O
",",O
Agrati,O
C,O
",",O
Albarello,O
F,O
",",O
Amadei,O
G,O
",",O
Amendola,O
A,O
",",O
"
",O
Antonini,O
M,O
",",O
Barbaro,O
R,O
",",O
Bartolini,O
B,O
",",O
Benigni,O
M,O
",",O
Bevilacqua,O
N,O
",",O
Bordi,O
L,O
",",O
Bordoni,O
V,O
",",O
"
",O
Branca,O
M,O
",",O
Campioni,O
P,O
",",O
Capobianchi,O
MR,O
",",O
Caporale,O
C,O
",",O
Caravella,O
I,O
",",O
Carletti,O
F,O
",",O
"
",O
Castilletti,O
C,O
",",O
Chiappini,O
R,O
",",O
Ciaralli,O
C,O
",",O
Colavita,O
F,O
",",O
Corpolongo,O
A,O
",",O
Cristofaro,O
M,O
",",O
"
",O
Curiale,O
S,O
",",O
D'Abramo,O
A,O
",",O
Dantimi,O
C,O
",",O
Angelis,O
A,O
",",O
Angelis,O
G,O
",",O
Lorenzo,O
RD,O
",",O
Stefano,O
FD,O
",",O
"
",O
Ferraro,O
F,O
",",O
Fiorentini,O
L,O
",",O
Frustaci,O
A,O
",",O
GallÃ¬,O
P,O
",",O
Garotto,O
G,O
",",O
Giancola,O
ML,O
",",O
Giansante,O
"
",O
F,O
",",O
Giombini,O
E,O
",",O
Greci,O
MC,O
",",O
Ippolito,O
G,O
",",O
Lalle,O
E,O
",",O
Lanini,O
S,O
",",O
Lapa,O
D,O
",",O
Lepore,O
L,O
",",O
Lucia,O
"
",O
A,O
",",O
Lufrani,O
F,O
",",O
Macchione,O
M,O
",",O
Marani,O
A,O
",",O
Marchioni,O
L,O
",",O
Mariano,O
A,O
",",O
Marini,O
MC,O
",",O
Maritti,O
"
",O
M,O
",",O
Matusali,O
G,O
",",O
Meschi,O
S,O
",",O
Montaldo,O
FMC,O
",",O
Murachelli,O
S,O
",",O
Nicastri,O
E,O
",",O
Noto,O
R,O
",",O
"
",O
Palazzolo,O
C,O
",",O
Pallini,O
E,O
",",O
Passeri,O
V,O
",",O
Pelliccioni,O
F,O
",",O
Petrecchia,O
A,O
",",O
Petrone,O
A,O
",",O
"
",O
Petrosillo,O
N,O
",",O
Pianura,O
E,O
",",O
Pisciotta,O
M,O
",",O
Pittalis,O
S,O
",",O
Proietti,O
C,O
",",O
Puro,O
V,O
",",O
Rinonapoli,O
"
",O
G,O
",",O
Rueca,O
M,O
",",O
Sacchi,O
A,O
",",O
Sanasi,O
F,O
",",O
Santagata,O
C,O
",",O
Scarcia,O
S,O
",",O
SchininÃ ,O
V,O
",",O
Scognamiglio,O
"
",O
P,O
",",O
Scorzolini,O
L,O
",",O
Stazi,O
G,O
",",O
Vaia,O
F,O
",",O
Vairo,O
F,O
",",O
Valli,O
MB,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Lazzaro,O
Spallanzani,O
",",O
National,O
Institute,O
for,O
Infectious,O
Diseases,O
 ,O
IRCCS,O
",",O
Via,O
"
",O
Portuense,O
",",O
292,O
",",O
cap,O
148,O
Rome,O
",",O
Italy,O
.,O
"
",O
(2)Lazzaro,O
Spallanzani,O
",",O
National,O
Institute,O
for,O
Infectious,O
Diseases,O
 ,O
IRCCS,O
",",O
Via,O
"
",O
Portuense,O
",",O
292,O
",",O
cap,O
148,O
Rome,O
",",O
Italy,O
.,O
Electronic,O
address,O
:,O
"
",O
vincenzo.schinina@inmi.it,O
.,O
"
",O
(3)Directorate,O
General,O
for,O
Disease,O
Surveillance,O
and,O
Control,O
",",O
Ministry,O
of,O
Health,O
",",O
"
",O
Muscat,O
",",O
Oman,O
;,O
Institute,O
for,O
Clinical,O
Medicine,O
",",O
Faculty,O
of,O
Health,O
Science,O
",",O
"
",O
University,O
of,O
Aarhus,O
",",O
Denmark,O
;,O
ESCMID,O
Emerging,O
Infections,O
Task,O
Force,O
",",O
Basel,O
",",O
"
",O
Switzerland,O
.,O
"
",O
(4)Department,O
of,O
Infection,O
",",O
Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
University,O
"
",O
College,O
London,O
",",O
and,O
NIHR,O
Biomedical,O
Research,O
Centre,O
",",O
University,O
College,O
London,O
"
",O
Hospitals,O
NHS,O
Foundation,O
Trust,O
",",O
London,O
",",O
United,O
Kingdom,O
.,O
"

",O
INTRODUCTION,O
:,O
Several,O
recent,O
case,O
reports,O
have,O
described,O
common,O
early,O
chest,O
"
",O
imaging,O
findings,O
of,O
lung,O
pathology,O
caused,O
by,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCOV2,B-Virus_SARS-CoV-2
),O
"
",O
which,O
appear,O
to,O
be,O
similar,O
to,O
those,O
seen,O
previously,O
in,O
SARSCoV,O
and,O
MERSCoV,O
"
",O
infected,O
patients,O
.,O
"
",O
OBJECTIVE,O
:,O
We,O
present,O
some,O
remarkable,O
imaging,O
findings,O
of,O
the,O
first,O
two,O
patients,O
"
",O
identified,O
in,O
Italy,O
with,O
COVID19,B-Disease_COVID-19
infection,O
travelling,O
from,O
Wuhan,O
",",O
China,O
.,O
The,O
"
",O
followup,O
with,O
chest,O
XRays,O
and,O
CT,O
scans,O
was,O
also,O
included,O
",",O
showing,O
a,O
progressive,O
"
",O
adult,O
respiratory,O
distress,O
syndrome,O
(,O
ARDS,O
),O
.,O
"
",O
RESULTS,O
:,O
Moderate,O
to,O
severe,O
progression,O
of,O
the,O
lung,O
infiltrates,O
",",O
with,O
increasing,O
"
",O
percentage,O
of,O
highdensity,O
infiltrates,O
sustained,O
by,O
a,O
bilateral,O
and,O
"
",O
multisegmental,O
extension,O
of,O
lung,O
opacities,O
",",O
were,O
seen,O
.,O
During,O
the,O
followup,O
",",O
"
",O
apart,O
from,O
pleural,O
effusions,O
",",O
a,O
tubular,O
and,O
enlarged,O
appearance,O
of,O
pulmonary,O
"
",O
vessels,O
with,O
a,O
sudden,O
caliber,O
reduction,O
was,O
seen,O
",",O
mainly,O
found,O
in,O
the,O
dichotomic,O
"
",O
tracts,O
",",O
where,O
the,O
center,O
of,O
a,O
new,O
insurgent,O
pulmonary,O
lesion,O
was,O
seen,O
.,O
It,O
could,O
"
",O
be,O
an,O
early,O
alert,O
radiological,O
sign,O
to,O
predict,O
initial,O
lung,O
deterioration,O
.,O
"
",O
Another,O
uncommon,O
element,O
was,O
the,O
presence,O
of,O
mediastinal,O
lymphadenopathy,O
with,O
"
",O
shortaxis,O
oval,O
nodes,O
.,O
"
",O
CONCLUSIONS,O
:,O
Although,O
only,O
two,O
patients,O
have,O
been,O
studied,O
",",O
these,O
findings,O
are,O
"
",O
consistent,O
with,O
the,O
radiological,O
pattern,O
described,O
in,O
literature,O
.,O
Finally,O
",",O
the,O
"
",O
pulmonary,O
vessels,O
enlargement,O
in,O
areas,O
where,O
new,O
lung,O
infiltrates,O
develop,O
in,O
the,O
"
",O
followup,O
CT,O
scan,O
",",O
could,O
describe,O
an,O
early,O
predictor,O
radiological,O
sign,O
of,O
lung,O
"
",O
impairment,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Authors,O
.,O
Published,O
by,O
Elsevier,O
Ltd,O
..,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijid.2020.02.043,O
"
",O
PMID,O
:,O
32112966,O
"


",O
444,O
.,O
J,O
Infect,O
.,O
2020,O
Feb,O
26,O
.,O
pii,O
:,O
S01634453(20)300980,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.019,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Simulating,O
and,O
Forecasting,O
the,O
Cumulative,O
Confirmed,O
Cases,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
China,O
"
",O
by,O
Boltzmann,O
Functionbased,O
Regression,O
Analyses,O
.,O
"

",O
Fu,O
X(1,O
),O
",",O
Ying,O
Q(2,O
),O
",",O
Zeng,O
T(3,O
),O
",",O
Long,O
T(4,O
),O
",",O
Wang,O
Y(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Provincial,O
University,O
Key,O
Laboratory,O
of,O
Cellular,O
Stress,O
Response,O
and,O
Metabolic,O
"
",O
Regulation,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Fujian,O
Normal,O
University,O
",",O
Fuzhou,O
City,O
",",O
"
",O
Fujian,O
Province,O
350117,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
xmfu@fjnu.edu.cn,O
.,O
"
",O
(2)Department,O
of,O
Civil,O
and,O
Environmental,O
Engineering,O
",",O
Texas,O
A&M,O
University,O
",",O
"
",O
College,O
Station,O
",",O
TX,O
",",O
77843,O
",",O
USA,O
.,O
"
",O
(3)Department,O
of,O
mathematics,O
",",O
The,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
Shatin,O
",",O
NT,O
",",O
"
",O
Hong,O
Kong,O
",",O
99999,O
",",O
China,O
.,O
"
",O
(4)Nanjing,O
Institute,O
of,O
Environmental,O
Sciences,O
",",O
Ministry,O
of,O
Ecology,O
and,O
"
",O
Environment,O
",",O
China,O
.,O
"
",O
(5)Provincial,O
University,O
Key,O
Laboratory,O
of,O
Cellular,O
Stress,O
Response,O
and,O
Metabolic,O
"
",O
Regulation,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Fujian,O
Normal,O
University,O
",",O
Fuzhou,O
City,O
",",O
"
",O
Fujian,O
Province,O
350117,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.019,O
"
",O
PMID,O
:,O
32112887,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
None,O
.,O
"


",O
445,O
.,O
J,O
Infect,O
.,O
2020,O
Feb,O
27,O
.,O
pii,O
:,O
S01634453(20)301018,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.018,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Characteristics,O
of,O
COVID19,B-Disease_COVID-19
infection,O
in,O
Beijing,O
.,O
"

",O
Tian,O
S(1,O
),O
",",O
Hu,O
N(2,O
),O
",",O
Lou,O
J(1,O
),O
",",O
Chen,O
K(3,O
),O
",",O
Kang,O
X(1,O
),O
",",O
Xiang,O
Z(2,O
),O
",",O
Chen,O
H(2,O
),O
",",O
Wang,O
"
",O
D(4,O
),O
",",O
Liu,O
N(5,O
),O
",",O
Liu,O
D(6,O
),O
",",O
Chen,O
G(7,O
),O
",",O
Zhang,O
Y(8,O
),O
",",O
Li,O
D(2,O
),O
",",O
Li,O
J(2,O
),O
",",O
Lian,O
H(1,O
),O
",",O
Niu,O
"
",O
S(1,O
),O
",",O
Zhang,O
L(1,O
),O
",",O
Zhang,O
J(9,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Beijing,O
Emergency,O
Medicine,O
Research,O
Institute,O
",",O
Beijing,O
Emergency,O
Medical,O
"
",O
Center,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Beijing,O
Emergency,O
Medical,O
Center,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Beijing,O
Chao,O
Yang,O
District,O
Emergency,O
Medical,O
Center,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)Beijing,O
Haidian,O
District,O
Medical,O
Rescue,O
Center,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)Beijing,O
Luhe,O
Hospital,O
",",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(6)Beijing,O
Dongcheng,O
District,O
Emergency,O
Medical,O
Center,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(7)Beijing,O
Shijingshan,O
District,O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(8)Beijing,O
Daxing,O
District,O
People,O
's,O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(9)Beijing,O
Emergency,O
Medicine,O
Research,O
Institute,O
",",O
Beijing,O
Emergency,O
Medical,O
"
",O
Center,O
",",O
Beijing,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
zhang92560@163.com,O
.,O
"

",O
BACKGROUND,O
:,O
Since,O
the,O
first,O
case,O
of,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
infection,O
"
",O
pneumonia,O
was,O
detected,O
in,O
Wuhan,O
",",O
China,O
",",O
a,O
series,O
of,O
confirmed,O
cases,O
of,O
the,O
"
",O
COVID19,B-Disease_COVID-19
were,O
found,O
in,O
Beijing,O
.,O
We,O
analyzed,O
the,O
data,O
of,O
262,O
confirmed,O
cases,O
to,O
"
",O
determine,O
the,O
clinical,O
and,O
epidemiological,O
characteristics,O
of,O
COVID19,B-Disease_COVID-19
in,O
"
",O
Beijing,O
.,O
"
",O
METHODS,O
:,O
We,O
collected,O
patients,O
who,O
were,O
transferred,O
by,O
Beijing,O
Emergency,O
Medical,O
"
",O
Service,O
to,O
the,O
designated,O
hospitals,O
.,O
The,O
information,O
on,O
demographic,O
",",O
"
",O
epidemiological,O
",",O
clinical,O
",",O
laboratory,O
test,O
for,O
the,O
COVID19,B-Virus_SARS-CoV-2
virus,I-Virus_SARS-CoV-2
",",O
diagnostic,O
"
",O
classification,O
",",O
cluster,O
case,O
and,O
outcome,O
were,O
obtained,O
.,O
Furthermore,O
we,O
compared,O
"
",O
the,O
characteristics,O
between,O
severe,O
and,O
common,O
confirmed,O
cases,O
which,O
including,O
"
",O
mild,O
cases,O
",",O
nopneumonia,O
cases,O
and,O
asymptomatic,O
cases,O
",",O
and,O
we,O
also,O
compared,O
the,O
"
",O
features,O
between,O
COVID19,B-Disease_COVID-19
and,O
2003,O
SARS,O
.,O
"
",O
FINDINGS,O
:,O
By,O
Feb,O
10,O
",",O
2020,O
",",O
262,O
patients,O
were,O
transferred,O
from,O
the,O
hospitals,O
"
",O
across,O
Beijing,O
to,O
the,O
designated,O
hospitals,O
for,O
special,O
treatment,O
of,O
the,O
COVID19,B-Disease_COVID-19
"
",O
infected,O
by,O
Beijing,O
emergency,O
medical,O
service,O
.,O
Among,O
of,O
262,O
patients,O
",",O
46,O
(,O
17.6,O
%,O
),O
"
",O
were,O
severe,O
cases,O
",",O
216,O
(,O
82.4,O
%,O
),O
were,O
common,O
cases,O
",",O
which,O
including,O
192,O
(,O
73.3,O
%,O
),O
"
",O
mild,O
cases,O
",",O
11(4.2,O
%,O
),O
nonpneumonia,O
cases,O
and,O
13,O
(,O
5,O
%,O
),O
asymptomatic,O
cases,O
"
",O
respectively,O
.,O
The,O
median,O
age,O
of,O
patients,O
was,O
47.5,O
years,O
old,O
and,O
48.5,O
%,O
were,O
male,O
.,O
"
",O
192,O
(,O
73.3,O
%,O
),O
patients,O
were,O
residents,O
of,O
Beijing,O
",",O
50,O
(,O
26,O
%,O
),O
of,O
which,O
had,O
been,O
to,O
"
",O
Wuhan,O
",",O
116,O
(,O
60.4,O
%,O
),O
had,O
close,O
contact,O
with,O
confirmed,O
cases,O
",",O
21,O
(,O
10.9,O
%,O
),O
had,O
no,O
"
",O
contact,O
history,O
.,O
The,O
most,O
common,O
symptoms,O
at,O
the,O
onset,O
of,O
illness,O
were,O
fever,O
"
",O
(,O
82.1,O
%,O
),O
",",O
cough,O
(,O
45.8,O
%,O
),O
",",O
fatigue,O
(,O
26.3,O
%,O
),O
",",O
dyspnea,O
(,O
6.9,O
%,O
),O
and,O
headache,O
(,O
6.5,O
%,O
),O
.,O
The,O
"
",O
median,O
incubation,O
period,O
was,O
6.7,O
days,O
",",O
the,O
interval,O
time,O
from,O
between,O
illness,O
"
",O
onset,O
and,O
seeing,O
a,O
doctor,O
was,O
4.5,O
days,O
.,O
As,O
of,O
Feb,O
10,O
",",O
17.2,O
%,O
patients,O
have,O
"
",O
discharged,O
and,O
81.7,O
%,O
patients,O
remain,O
in,O
hospital,O
in,O
our,O
study,O
",",O
the,O
fatality,O
of,O
"
",O
COVID19,B-Disease_COVID-19
infection,O
in,O
Beijing,O
was,O
0.9,O
%,O
.,O
"
",O
INTERPRETATION,O
:,O
On,O
the,O
basis,O
of,O
this,O
study,O
",",O
we,O
provided,O
the,O
ratio,O
of,O
the,O
COVID19,B-Disease_COVID-19
"
",O
infection,O
on,O
the,O
severe,O
cases,O
to,O
the,O
mild,O
",",O
asymptomatic,O
and,O
nonpneumonia,O
cases,O
"
",O
in,O
Beijing,O
.,O
Population,O
was,O
generally,O
susceptible,O
",",O
and,O
with,O
a,O
relatively,O
low,O
"
",O
fatality,O
rate,O
.,O
The,O
measures,O
to,O
prevent,O
transmission,O
was,O
very,O
successful,O
at,O
early,O
"
",O
stage,O
",",O
the,O
next,O
steps,O
on,O
the,O
COVID19,B-Disease_COVID-19
infection,O
should,O
be,O
focused,O
on,O
early,O
"
",O
isolation,O
of,O
patients,O
and,O
quarantine,O
for,O
close,O
contacts,O
in,O
families,O
and,O
"
",O
communities,O
in,O
Beijing,O
.,O
"
",O
FUNDING,O
:,O
Beijing,O
Municipal,O
Science,O
and,O
Technology,O
Commission,O
and,O
Ministry,O
of,O
"
",O
Science,O
and,O
Technology,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.018,O
"
",O
PMID,O
:,O
32112886,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
All,O
authors,O
"
",O
declare,O
no,O
competing,O
interests,O
.,O
"


",O
446,O
.,O
J,O
Infect,O
.,O
2020,O
Feb,O
26,O
.,O
pii,O
:,O
S01634453(20)300992,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.016,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
characteristics,O
and,O
imaging,O
manifestations,O
of,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
disease,O
(COVID19):A,O
multicenter,O
study,O
in,O
Wenzhou,O
city,O
",",O
Zhejiang,O
",",O
China,O
.,O
"

",O
Yang,O
W(1,O
),O
",",O
Cao,O
Q(1,O
),O
",",O
Qin,O
L(1,O
),O
",",O
Wang,O
X(2,O
),O
",",O
Cheng,O
Z(1,O
),O
",",O
Pan,O
A(3,O
),O
",",O
Dai,O
J(4,O
),O
",",O
Sun,O
"
",O
Q(5,O
),O
",",O
Zhao,O
F(4,O
),O
",",O
Qu,O
J(6,O
),O
",",O
Yan,O
F(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Shanghai,O
Jiao,O
Tong,O
University,O
Medical,O
School,O
"
",O
Affiliated,O
Ruijin,O
Hospital,O
",",O
No.197,O
Ruijin,O
Er,O
Road,O
",",O
Shanghai,O
200025,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
Ruian,O
People,O
's,O
Hospital,O
",",O
Ruian,O
325200,O
",",O
Zhejiang,O
"
",O
province,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Radiology,O
",",O
Yueqing,O
People,O
's,O
Hospital,O
",",O
Yueqing,O
325600,O
",",O
Zhejiang,O
"
",O
province,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Infectious,O
Diseases,O
",",O
Wenzhou,O
Central,O
Hospital,O
",",O
Wenzhou,O
325000,O
",",O
"
",O
Zhejiang,O
province,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Infectious,O
Diseases,O
",",O
Ruian,O
People,O
's,O
Hospital,O
",",O
Ruian,O
325200,O
",",O
"
",O
Zhejiang,O
province,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Shanghai,O
Jiao,O
Tong,O
"
",O
University,O
Medical,O
School,O
Affiliated,O
Ruijin,O
Hospital,O
",",O
No.197,O
Ruijin,O
Er,O
Road,O
",",O
"
",O
Shanghai,O
200025,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
jmqu0906@163.com,O
.,O
"
",O
(7)Department,O
of,O
Radiology,O
",",O
Shanghai,O
Jiao,O
Tong,O
University,O
Medical,O
School,O
"
",O
Affiliated,O
Ruijin,O
Hospital,O
",",O
No.197,O
Ruijin,O
Er,O
Road,O
",",O
Shanghai,O
200025,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
yanfuhua@yahoo.com,O
.,O
"

",O
BACKGROUND,O
:,O
Little,O
is,O
known,O
about,O
COVID19,B-Disease_COVID-19
outside,O
Hubei,O
.,O
The,O
aim,O
of,O
this,O
paper,O
"
",O
was,O
to,O
describe,O
the,O
clinical,O
characteristics,O
and,O
imaging,O
manifestations,O
of,O
"
",O
hospitalized,O
patients,O
with,O
confirmed,O
COVID19,B-Disease_COVID-19
infection,O
in,O
Wenzhou,O
",",O
Zhejiang,O
",",O
"
",O
China,O
.,O
"
",O
METHODS,O
:,O
In,O
this,O
retrospective,O
cohort,O
study,O
",",O
149,O
RTPCR,O
confirmed,O
positive,O
"
",O
patients,O
were,O
consecutively,O
enrolled,O
from,O
January,O
17th,O
to,O
February,O
10th,O
",",O
2020,O
in,O
"
",O
three,O
tertiary,O
hospitals,O
of,O
Wenzhou,O
.,O
Outcomes,O
were,O
followed,O
up,O
until,O
Feb,O
15th,O
",",O
"
",O
2020,O
.,O
"
",O
FINDINGS,O
:,O
A,O
total,O
of,O
85,O
patients,O
had,O
Hubei,O
travel,O
residence,O
history,O
",",O
while,O
"
",O
another,O
49,O
had,O
contact,O
with,O
people,O
from,O
Hubei,O
and,O
15,O
had,O
no,O
traceable,O
exposure,O
"
",O
history,O
to,O
Hubei,O
.,O
Fever,O
",",O
cough,O
and,O
expectoration,O
were,O
the,O
most,O
common,O
symptoms,O
",",O
"
",O
14,O
patients,O
had,O
decreased,O
oxygen,O
saturation,O
",",O
33,O
had,O
leukopenia,O
",",O
53,O
had,O
"
",O
lymphopenia,O
",",O
and,O
82,O
had,O
elevated,O
Creactive,O
protein,O
.,O
On,O
chest,O
computed,O
tomography,O
"
",O
(,O
CT,O
),O
",",O
lung,O
segments,O
6,O
and,O
10,O
were,O
mostly,O
involved,O
.,O
A,O
total,O
of,O
287,O
segments,O
"
",O
presented,O
ground,O
glass,O
opacity,O
",",O
637,O
presented,O
mixed,O
opacity,O
and,O
170,O
presented,O
"
",O
consolidation,O
.,O
Lesions,O
were,O
more,O
localized,O
in,O
the,O
peripheral,O
lung,O
with,O
a,O
patchy,O
"
",O
form,O
.,O
No,O
significant,O
difference,O
was,O
found,O
between,O
patients,O
with,O
or,O
without,O
Hubei,O
"
",O
exposure,O
history,O
.,O
Seventeen,O
patients,O
had,O
normal,O
CT,O
on,O
admission,O
of,O
these,O
",",O
12,O
had,O
"
",O
negative,O
findings,O
even10,O
days,O
later,O
.,O
"
",O
INTERPRETATION,O
:,O
Most,O
patients,O
presented,O
with,O
a,O
mild,O
infection,O
in,O
our,O
study,O
.,O
The,O
"
",O
imaging,O
pattern,O
of,O
multifocal,O
peripheral,O
ground,O
glass,O
or,O
mixed,O
opacity,O
with,O
"
",O
predominance,O
in,O
the,O
lower,O
lung,O
is,O
highly,O
suspicious,O
of,O
COVID19,B-Disease_COVID-19
in,O
the,O
first,O
week,O
"
",O
of,O
disease,O
onset,O
.,O
Nevetheless,O
",",O
some,O
patients,O
can,O
present,O
with,O
a,O
normal,O
chest,O
"
",O
finding,O
despite,O
testing,O
positive,O
for,O
COVID19,B-Disease_COVID-19
.,O
"
",O
FUNDING,O
:,O
We,O
did,O
not,O
receive,O
any,O
fundings,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
Ltd.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.016,O
"
",O
PMID,O
:,O
32112884,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
of,O
"
",O
this,O
study,O
declare,O
that,O
they,O
each,O
have,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
447,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
26:101604,O
.,O
doi,O
:,O
10.1016,O
j.tmaid.2020.101604,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
COVID19,B-Disease_COVID-19
outbreak,O
and,O
implications,O
for,O
the,O
Tokyo,O
2020,O
Summer,O
Olympic,O
Games,O
.,O
"

",O
Gallego,O
V(1,O
),O
",",O
Nishiura,O
H(2,O
),O
",",O
Sah,O
R(3,O
),O
",",O
RodriguezMorales,O
AJ(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Panel,O
of,O
Sports,O
and,O
Travel,O
",",O
Latin,O
American,O
Society,O
for,O
Travel,O
Medicine,O
"
",O
(,O
SLAMVI,O
),O
",",O
Buenos,O
Aires,O
",",O
Argentina,O
.,O
"
",O
(2)Graduate,O
School,O
of,O
Medicine,O
",",O
Hokkaido,O
University,O
",",O
Kita,O
15,O
Jo,O
Nishi,O
7,O
Chome,O
",",O
"
",O
Kitaku,O
",",O
Sapporoshi,O
",",O
Hokkaido,O
",",O
608638,O
",",O
Japan,O
.,O
"
",O
(3)National,O
Public,O
Health,O
Laboratory,O
",",O
Kathmandu,O
",",O
44600,O
",",O
Nepal,O
.,O
"
",O
(4)Public,O
Health,O
and,O
Infection,O
Research,O
Group,O
",",O
Faculty,O
of,O
Health,O
Sciences,O
",",O
"
",O
Universidad,O
TecnolÃ³gica,O
de,O
Pereira,O
",",O
Pereira,O
",",O
Colombia,O
;,O
Grupo,O
de,O
InvestigaciÃ³n,O
"
",O
Biomedicina,O
",",O
Faculty,O
of,O
Medicine,O
",",O
FundaciÃ³n,O
Universitaria,O
AutÃ³noma,O
de,O
las,O
"
",O
AmÃ©ricas,O
",",O
Pereira,O
",",O
Risaralda,O
",",O
Colombia,O
;,O
Panel,O
of,O
Scientific,O
Publications,O
and,O
"
",O
Teaching,O
",",O
Latin,O
American,O
Society,O
for,O
Travel,O
Medicine,O
(,O
SLAMVI,O
),O
",",O
Pereira,O
",",O
Colombia,O
.,O
"
",O
Electronic,O
address,O
:,O
arodriguezm@utp.edu.co,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101604,O
"
",O
PMID,O
:,O
32112859,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
All,O
authors,O
"
",O
report,O
no,O
potential,O
conflicts,O
.,O
All,O
authors,O
have,O
submitted,O
the,O
Form,O
for,O
Disclosure,O
"
",O
of,O
Potential,O
.,O
"


",O
448,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
27:101607,O
.,O
doi,O
:,O
10.1016,O
j.tmaid.2020.101607,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
:,O
Zoonotic,O
aspects,O
.,O
"

",O
Ahmad,O
T(1,O
),O
",",O
Khan,O
M(2,O
),O
",",O
Haroon(3,O
),O
",",O
Musa,O
TH(1,O
),O
",",O
Nasir,O
S(4,O
),O
",",O
Hui,O
J(1,O
),O
",",O
"
",O
BonillaAldana,O
DK(5,O
),O
",",O
RodriguezMorales,O
AJ(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Epidemiology,O
and,O
Health,O
Statistics,O
",",O
School,O
of,O
Public,O
Health,O
",",O
"
",O
Southeast,O
University,O
",",O
Nanjing,O
",",O
210009,O
",",O
China,O
;,O
Key,O
Laboratory,O
of,O
Environmental,O
"
",O
Medicine,O
Engineering,O
",",O
Ministry,O
of,O
Education,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Southeast,O
"
",O
University,O
",",O
Nanjing,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Genetics,O
",",O
Centre,O
for,O
Human,O
Genetics,O
",",O
Hazara,O
University,O
Mansehra,O
",",O
"
",O
Khyber,O
Pakhtunkhwa,O
",",O
Islamic,O
",",O
Pakistan,O
.,O
"
",O
(3)College,O
of,O
Life,O
Science,O
",",O
Northwest,O
University,O
",",O
Xian,O
",",O
China,O
.,O
"
",O
(4)Allama,O
Iqbal,O
Open,O
University,O
",",O
Islamabad,O
",",O
Islamic,O
",",O
Pakistan,O
.,O
"
",O
(5)Incubator,O
in,O
Zoonosis,O
(,O
SIZOO,O
),O
",",O
Biodiversity,O
and,O
Ecosystem,O
Conservation,O
"
",O
Research,O
Group,O
(,O
BIOECOS,O
),O
",",O
FundaciÃ³n,O
Universitaria,O
AutÃ³noma,O
de,O
las,O
AmÃ©ricas,O
",",O
Sede,O
"
",O
Pereira,O
",",O
Pereira,O
",",O
Risaralda,O
",",O
Colombia,O
;,O
Public,O
Health,O
and,O
Infection,O
Research,O
"
",O
Group,O
",",O
Faculty,O
of,O
Health,O
Sciences,O
",",O
Universidad,O
TecnolÃ³gica,O
de,O
Pereira,O
",",O
Pereira,O
",",O
"
",O
Colombia,O
.,O
"
",O
(6)Public,O
Health,O
and,O
Infection,O
Research,O
Group,O
",",O
Faculty,O
of,O
Health,O
Sciences,O
",",O
"
",O
Universidad,O
TecnolÃ³gica,O
de,O
Pereira,O
",",O
Pereira,O
",",O
Colombia,O
;,O
Grupo,O
de,O
InvestigaciÃ³n,O
"
",O
Biomedicina,O
",",O
Faculty,O
of,O
Medicine,O
",",O
FundaciÃ³n,O
Universitaria,O
AutÃ³noma,O
de,O
las,O
"
",O
AmÃ©ricas,O
",",O
Pereira,O
",",O
Risaralda,O
",",O
Colombia,O
.,O
Electronic,O
address,O
:,O
"
",O
arodriguezm@utp.edu.co,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101607,O
"
",O
PMID,O
:,O
32112857,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
All,O
authors,O
"
",O
report,O
no,O
potential,O
conflicts,O
.,O
All,O
authors,O
have,O
submitted,O
the,O
Form,O
for,O
Disclosure,O
"
",O
of,O
Potential,O
.,O
"


",O
449,O
.,O
World,O
J,O
Pediatr,O
.,O
2020,O
Feb,O
28,O
.,O
doi,O
:,O
10.1007,O
s12519020003473,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Management,O
strategies,O
of,O
neonatal,O
jaundice,O
during,O
the,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
"
",O
outbreak,O
.,O
"

",O
Ma,O
XL(1)(2,O
),O
",",O
Chen,O
Z(1)(2,O
),O
",",O
Zhu,O
JJ(3,O
),O
",",O
Shen,O
XX(1)(2,O
),O
",",O
Wu,O
MY(3,O
),O
",",O
Shi,O
LP(1)(2,O
),O
",",O
Du,O
"
",O
LZ(1)(2,O
),O
",",O
Fu,O
JF(4)(5,O
),O
",",O
Shu,O
Q(6)(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Children,O
's,O
Hospital,O
",",O
Zhejiang,O
University,O
School,O
of,O
Medicine,O
",",O
Hangzhou,O
",",O
310052,O
",",O
"
",O
China,O
.,O
"
",O
(2)National,O
Clinical,O
Research,O
Center,O
for,O
Child,O
Health,O
",",O
National,O
Children,O
's,O
"
",O
Regional,O
Medical,O
Center,O
",",O
Hangzhou,O
",",O
310052,O
",",O
China,O
.,O
"
",O
(3)Women,O
's,O
Hospital,O
",",O
Zhejiang,O
University,O
School,O
of,O
Medicine,O
",",O
Hangzhou,O
",",O
310003,O
",",O
"
",O
China,O
.,O
"
",O
(4)Children,O
's,O
Hospital,O
",",O
Zhejiang,O
University,O
School,O
of,O
Medicine,O
",",O
Hangzhou,O
",",O
310052,O
",",O
"
",O
China,O
.,O
fjf68@zju.edu.cn,O
.,O
"
",O
(5)National,O
Clinical,O
Research,O
Center,O
for,O
Child,O
Health,O
",",O
National,O
Children,O
's,O
"
",O
Regional,O
Medical,O
Center,O
",",O
Hangzhou,O
",",O
310052,O
",",O
China,O
.,O
fjf68@zju.edu.cn,O
.,O
"
",O
(6)Children,O
's,O
Hospital,O
",",O
Zhejiang,O
University,O
School,O
of,O
Medicine,O
",",O
Hangzhou,O
",",O
310052,O
",",O
"
",O
China,O
.,O
shuqiang@zju.edu.cn,O
.,O
"
",O
(7)National,O
Clinical,O
Research,O
Center,O
for,O
Child,O
Health,O
",",O
National,O
Children,O
's,O
"
",O
Regional,O
Medical,O
Center,O
",",O
Hangzhou,O
",",O
310052,O
",",O
China,O
.,O
shuqiang@zju.edu.cn,O
.,O
"

",O
The,O
outbreak,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
;,O
formally,O
known,O
as,O
2019nCoV,B-Virus_SARS-CoV-2
),O
"
",O
has,O
become,O
a,O
most,O
challenging,O
health,O
emergency,O
.,O
Owing,O
to,O
rigorous,O
quarantine,O
and,O
"
",O
control,O
measures,O
taken,O
in,O
China,O
",",O
routine,O
neonatal,O
health,O
surveillance,O
and,O
"
",O
followup,O
have,O
Â ,O
become,O
challenging,O
.,O
Without,O
followup,O
surveillance,O
",",O
some,O
rapid,O
Â ,O
and,O
"
",O
progressive,O
newborn,O
diseases,O
",",O
such,O
as,O
bilirubin,O
encephalopathy,O
",",O
may,O
be,O
ignored,O
.,O
"
",O
The,O
characteristics,O
of,O
onset,O
age,O
of,O
kernicterus,O
suggest,O
that,O
monitoring,O
of,O
"
",O
bilirubin,O
level,O
at,O
home,O
provides,O
a,O
useful,O
way,O
to,O
alert,O
hospital,O
visits,O
and,O
"
",O
to,O
Â ,O
prevent,O
the,O
development,O
of,O
extremely,O
hyperbilirubinemia,O
.,O
Therefore,O
",",O
we,O
"
",O
developed,O
an,O
online,O
followup,O
program,O
for,O
convenient,O
monitoring,O
of,O
Â ,O
bilirubin,O
"
",O
level,O
of,O
newborns,O
Â ,O
that,O
is,O
based,O
on,O
our,O
practical,O
experiences,O
.,O
The,O
aim,O
is,O
to,O
make,O
"
",O
our,O
management,O
strategies,O
of,O
neonatal,O
jaundice,O
tailored,O
to,O
the,O
infection,O
"
",O
prevention,O
and,O
control,O
during,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12519020003473,O
"
",O
PMID,O
:,O
32112336,O
"


",O
450,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
28,O
.,O
pii,O
:,O
ciaa201,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa201,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
A,O
Well,O
Infant,O
with,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
with,O
High,O
Viral,O
Load,O
.,O
"

",O
Kam,O
KQ(1,O
),O
",",O
Yung,O
CF(1,O
),O
",",O
Cui,O
L(2,O
),O
",",O
Lin,O
Tzer,O
Pin,O
R(2,O
),O
",",O
Mak,O
TM(2,O
),O
",",O
Maiwald,O
M(3,O
),O
",",O
Li,O
"
",O
J(1,O
),O
",",O
Chong,O
CY(1,O
),O
",",O
Nadua,O
K(1,O
),O
",",O
Tan,O
NWH(1,O
),O
",",O
Thoon,O
KC(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Infectious,O
Disease,O
Service,O
",",O
Department,O
of,O
Pediatrics,O
",",O
KK,O
Women,O
's,O
and,O
"
",O
Children,O
's,O
Hospital,O
",",O
Â ,O
Singapore,O
.,O
"
",O
(2)National,O
Public,O
Health,O
Laboratory,O
",",O
National,O
Centre,O
for,O
Infectious,O
Disease,O
",",O
"
",O
Singapore,O
.,O
"
",O
(3)Department,O
of,O
Pathology,O
and,O
Laboratory,O
Medicine,O
",",O
KK,O
Women,O
's,O
and,O
Children,O
's,O
"
",O
Hospital,O
",",O
Â ,O
Singapore,O
.,O
"

",O
A,O
well,O
6monthold,O
infant,O
with,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
had,O
"
",O
persistently,O
positive,O
nasopharyngeal,O
swabs,O
to,O
day,O
16,O
of,O
admission,O
.,O
This,O
case,O
"
",O
highlights,O
the,O
difficulties,O
in,O
establishing,O
the,O
TRUE,O
incidence,O
of,O
COVID19,B-Disease_COVID-19
as,O
"
",O
asymptomatic,O
individuals,O
can,O
excrete,O
the,O
virus,O
.,O
These,O
patients,O
may,O
play,O
important,O
"
",O
roles,O
in,O
humantohuman,O
transmission,O
in,O
the,O
community,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa201,O
"
",O
PMID,O
:,O
32112082,O
"


",O
451,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
28,O
.,O
pii,O
:,O
ciaa198,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa198,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
A,O
Case,O
Series,O
of,O
children,O
with,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
:,O
clinical,O
and,O
"
",O
epidemiological,O
features,O
.,O
"

",O
Cai,O
J(1,O
),O
",",O
Xu,O
J(2,O
),O
",",O
Lin,O
D(3,O
),O
",",O
Yang,O
Z(4,O
),O
",",O
Xu,O
L(5,O
),O
",",O
Qu,O
Z(5,O
),O
",",O
Zhang,O
Y(6,O
),O
",",O
Zhang,O
H(7,O
),O
",",O
"
",O
Jia,O
R(2,O
),O
",",O
Liu,O
P(2,O
),O
",",O
Wang,O
X(1,O
),O
",",O
Ge,O
Y(1,O
),O
",",O
Xia,O
A(1,O
),O
",",O
Tian,O
H(1,O
),O
",",O
Chang,O
H(1,O
),O
",",O
Wang,O
"
",O
C(1,O
),O
",",O
Li,O
J(1,O
),O
",",O
Wang,O
J(1,O
),O
",",O
Zeng,O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
infectious,O
diseases,O
",",O
Children,O
's,O
Hospital,O
of,O
Fudan,O
University,O
",",O
"
",O
National,O
Children,O
's,O
Medical,O
Center,O
.,O
"
",O
(2)Divison,O
of,O
virology,O
",",O
Department,O
of,O
clinical,O
laboratory,O
",",O
Children,O
's,O
Hospital,O
of,O
"
",O
Fudan,O
University,O
",",O
National,O
Children,O
's,O
Medical,O
Center,O
.,O
"
",O
(3)Department,O
of,O
infectious,O
diseases,O
",",O
Hainan,O
Women,O
and,O
Children,O
's,O
Medical,O
Center,O
.,O
"
",O
(4)Department,O
of,O
infectious,O
diseases,O
",",O
Anhui,O
Provincial,O
Children,O
's,O
Hospital,O
.,O
"
",O
(5)Children,O
's,O
medical,O
center,O
",",O
The,O
Affiliated,O
Hospital,O
of,O
Qingdao,O
University,O
.,O
"
",O
(6)Department,O
of,O
pediatric,O
infectious,O
diseases,O
",",O
Haikou,O
People,O
's,O
Hospital,O
.,O
"
",O
(7)Department,O
of,O
pediatrics,O
",",O
Sanya,O
Central,O
Hospital,O
.,O
"

",O
We,O
first,O
described,O
the,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
in,O
10,O
children,O
occurring,O
"
",O
in,O
areas,O
other,O
than,O
Wuhan,O
.,O
The,O
coronavirus,O
diseases,O
in,O
children,O
are,O
usually,O
mild,O
"
",O
and,O
epidemiological,O
exposure,O
is,O
a,O
key,O
clue,O
to,O
recognize,O
pediatric,O
case,O
.,O
Prolonged,O
"
",O
virus,O
shedding,O
is,O
observed,O
in,O
respiratory,O
tract,O
and,O
feces,O
at,O
the,O
convalescent,O
"
",O
stage,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa198,O
"
",O
PMID,O
:,O
32112072,O
"


",O
452,O
.,O
BMJ,O
.,O
2020,O
Feb,O
28;368:m806,O
.,O
doi,O
:,O
10.1136,O
bmj.m806,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
school,O
closures,O
and,O
bans,O
on,O
mass,O
gatherings,O
will,O
need,O
to,O
be,O
considered,O
",",O
"
",O
says,O
England,O
's,O
CMO,O
.,O
"

",O
Moberly,O
T(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m806,O
"
",O
PMID,O
:,O
32111656,O
"


",O
453,O
.,O
BMJ,O
.,O
2020,O
Feb,O
28;368:m810,O
.,O
doi,O
:,O
10.1136,O
bmj.m810,O
.,O
"

",O
Preventing,O
a,O
covid19,B-Disease_COVID-19
pandemic,O
.,O
"

",O
Watkins,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Public,O
Health,O
Wales,O
",",O
Cardiff,O
",",O
UK,O
John.Watkins@wales.nhs.uk,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m810,O
"
",O
PMID,O
:,O
32111649,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interests,O
:,O
I,O
have,O
read,O
and,O
understood,O
"
",O
BMJ,O
policy,O
on,O
declaration,O
of,O
interests,O
and,O
declare,O
that,O
I,O
was,O
a,O
member,O
of,O
the,O
"
",O
Department,O
of,O
Health,O
â€™s,O
pandemic,O
influenza,O
preparedness,O
team,O
.,O
"


",O
454,O
.,O
BMJ,O
.,O
2020,O
Feb,O
28;368:bmj.m799,O
.,O
doi,O
:,O
10.1136,O
bmj.m799,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
preparedness,O
",",O
decentralisation,O
",",O
and,O
the,O
hunt,O
for,O
patient,O
zero,O
.,O
"

",O
Carinci,O
F(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Statistical,O
Sciences,O
",",O
University,O
of,O
Bologna,O
",",O
Italy,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m799,O
"
",O
PMID,O
:,O
32111645,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interests,O
:,O
I,O
have,O
read,O
and,O
understood,O
"
",O
BMJ,O
policy,O
on,O
declaration,O
of,O
interests,O
and,O
declare,O
that,O
I,O
am,O
a,O
former,O
Italian,O
"
",O
National,O
delegate,O
for,O
the,O
OECD,O
expert,O
group,O
on,O
health,O
care,O
quality,O
indicators,O
.,O
"


",O
455,O
.,O
J,O
Microbiol,O
Immunol,O
Infect,O
.,O
2020,O
Feb,O
19,O
.,O
pii,O
:,O
S16841182(20)300372,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jmii.2020.02.009,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
in,O
Taiwan,O
:,O
Reports,O
of,O
two,O
cases,O
from,O
"
",O
Wuhan,O
",",O
China,O
.,O
"

",O
Huang,O
WH(1,O
),O
",",O
Teng,O
LC(2,O
),O
",",O
Yeh,O
TK(2,O
),O
",",O
Chen,O
YJ(2,O
),O
",",O
Lo,O
WJ(2,O
),O
",",O
Wu,O
MJ(2,O
),O
",",O
Chin,O
CS(3,O
),O
",",O
"
",O
Tsan,O
YT(4,O
),O
",",O
Lin,O
TC(4,O
),O
",",O
Chai,O
JW(5,O
),O
",",O
Lin,O
CF(6,O
),O
",",O
Tseng,O
CH(1,O
),O
",",O
Liu,O
CW(1,O
),O
",",O
Wu,O
CM(7,O
),O
",",O
"
",O
Chen,O
PY(8,O
),O
",",O
Shi,O
ZY(9,O
),O
",",O
Liu,O
PY(10,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
Taichung,O
"
",O
Veterans,O
General,O
Hospital,O
",",O
Taichung,O
",",O
Taiwan,O
.,O
"
",O
(2)Department,O
of,O
Internal,O
Medicine,O
",",O
Taichung,O
Veterans,O
General,O
Hospital,O
",",O
Taichung,O
",",O
"
",O
Taiwan,O
.,O
"
",O
(3)Division,O
of,O
Chest,O
Medicine,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
Taichung,O
Veterans,O
"
",O
General,O
Hospital,O
",",O
Taichung,O
",",O
Taiwan,O
.,O
"
",O
(4)Department,O
of,O
Emergency,O
Medicine,O
",",O
Taichung,O
Veterans,O
General,O
Hospital,O
",",O
"
",O
Taichung,O
",",O
Taiwan,O
.,O
"
",O
(5)Department,O
of,O
Radiology,O
",",O
Taichung,O
Veterans,O
General,O
Hospital,O
",",O
Taichung,O
",",O
Taiwan,O
.,O
"
",O
(6)Department,O
of,O
Pathology,O
and,O
Laboratory,O
Medicine,O
",",O
Taichung,O
Veterans,O
General,O
"
",O
Hospital,O
",",O
Taichung,O
",",O
Taiwan,O
.,O
"
",O
(7)Department,O
of,O
Nursing,O
",",O
Taichung,O
Veteran,O
General,O
Hospital,O
",",O
Taichung,O
",",O
Taiwan,O
.,O
"
",O
(8)Department,O
of,O
Pediatrics,O
",",O
Taichung,O
Veterans,O
General,O
Hospital,O
",",O
Taichung,O
",",O
"
",O
Taiwan,O
.,O
"
",O
(9)Infection,O
Control,O
Center,O
",",O
Taichung,O
Veterans,O
General,O
Hospital,O
",",O
Taichung,O
",",O
"
",O
Taiwan,O
.,O
Electronic,O
address,O
:,O
zyshi@vghtc.gov.tw,O
.,O
"
",O
(10)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
Taichung,O
"
",O
Veterans,O
General,O
Hospital,O
",",O
Taichung,O
",",O
Taiwan,O
;,O
Ph.D.,O
Program,O
in,O
Translational,O
"
",O
Medicine,O
",",O
National,O
Chung,O
Hsing,O
University,O
",",O
Taichung,O
",",O
Taiwan,O
;,O
Rong,O
Hsing,O
Research,O
"
",O
Center,O
for,O
Translational,O
Medicine,O
",",O
National,O
Chung,O
Hsing,O
University,O
",",O
Taichung,O
",",O
"
",O
Taiwan,O
.,O
Electronic,O
address,O
:,O
pyliu@vghtc.gov.tw,O
.,O
"

",O
We,O
reported,O
two,O
cases,O
with,O
communityacquired,O
pneumonia,O
caused,O
by,O
severe,O
acute,O
"
",O
respiratory,O
syndrome,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
who,O
returned,O
from,O
Wuhan,O
",",O
China,O
in,O
"
",O
January,O
",",O
2020,O
.,O
The,O
reported,O
cases,O
highlight,O
nonspecific,O
clinical,O
presentations,O
"
",O
of,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
as,O
well,O
as,O
the,O
importance,O
of,O
rapid,O
"
",O
laboratorybased,O
diagnosis,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
B.V.,O
"

",O
DOI,O
:,O
10.1016,O
j.jmii.2020.02.009,O
"
",O
PMID,O
:,O
32111449,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
Â ,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
456,O
.,O
Public,O
Health,O
.,O
2020,O
Feb;179:A1A2,O
.,O
doi,O
:,O
10.1016,O
j.puhe.2020.02.001,O
.,O
"

",O
Wuhan,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
:,O
why,O
global,O
control,O
is,O
challenging,O
?,O
"

",O
Lee,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Global,O
Public,O
Health,O
",",O
ScHARR,O
",",O
The,O
University,O
of,O
Sheffield,O
",",O
England,O
.,O
Electronic,O
"
",O
address,O
:,O
andrew.lee@sheffield.ac.uk,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.puhe.2020.02.001,O
"
",O
PMID,O
:,O
32111295,O
"


",O
457,O
.,O
Infect,O
Dis,O
Poverty,O
.,O
2020,O
Feb,O
28;9(1):24,O
.,O
doi,O
:,O
10.1186,O
s40249020006403,O
.,O
"

",O
A,O
mathematical,O
model,O
for,O
simulating,O
the,O
phasebased,O
transmissibility,O
of,O
a,O
novel,O
"
",O
coronavirus,O
.,O
"

",O
Chen,O
TM(1,O
),O
",",O
Rui,O
J(2,O
),O
",",O
Wang,O
QP(2,O
),O
",",O
Zhao,O
ZY(2,O
),O
",",O
Cui,O
JA(3,O
),O
",",O
Yin,O
L(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Molecular,O
Vaccinology,O
and,O
Molecular,O
Diagnostics,O
",",O
"
",O
School,O
of,O
Public,O
Health,O
",",O
Xiamen,O
University,O
",",O
4221117,O
South,O
Xiang'an,O
Road,O
",",O
"
",O
Xiang'an,O
District,O
",",O
Xiamen,O
",",O
Fujian,O
Province,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
13698665@qq.com,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Molecular,O
Vaccinology,O
and,O
Molecular,O
Diagnostics,O
",",O
"
",O
School,O
of,O
Public,O
Health,O
",",O
Xiamen,O
University,O
",",O
4221117,O
South,O
Xiang'an,O
Road,O
",",O
"
",O
Xiang'an,O
District,O
",",O
Xiamen,O
",",O
Fujian,O
Province,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(3)Department,O
of,O
Mathematics,O
",",O
School,O
of,O
Science,O
",",O
Beijing,O
University,O
of,O
Civil,O
"
",O
Engineering,O
and,O
Architecture,O
",",O
Beijing,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(4)Shenzhen,O
Institutes,O
of,O
Advanced,O
Technology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
"
",O
Shenzhen,O
",",O
Guangdong,O
Province,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"

",O
BACKGROUND,O
:,O
As,O
reported,O
by,O
the,O
World,O
Health,O
Organization,O
",",O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
was,O
identified,O
as,O
the,O
causative,O
virus,O
of,O
Wuhan,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
of,O
unknown,O
"
",O
etiology,O
by,O
Chinese,O
authorities,O
on,O
7,O
January,O
",",O
2020,O
.,O
The,O
virus,O
was,O
named,O
as,O
severe,O
"
",O
acute,O
respiratory,O
syndrome,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
by,O
International,O
Committee,O
"
",O
on,O
Taxonomy,O
of,O
Viruses,O
on,O
11,O
February,O
",",O
2020,O
.,O
This,O
study,O
aimed,O
to,O
develop,O
a,O
"
",O
mathematical,O
model,O
for,O
calculating,O
the,O
transmissibility,O
of,O
the,O
virus,O
.,O
"
",O
METHODS,O
:,O
In,O
this,O
study,O
",",O
we,O
developed,O
a,O
BatsHostsReservoirPeople,O
transmission,O
"
",O
network,O
model,O
for,O
simulating,O
the,O
potential,O
transmission,O
from,O
the,O
infection,O
source,O
"
",O
(,O
probably,O
be,O
bats,O
),O
to,O
the,O
human,O
infection,O
.,O
Since,O
the,O
BatsHostsReservoir,O
network,O
"
",O
was,O
hard,O
to,O
explore,O
clearly,O
and,O
public,O
concerns,O
were,O
focusing,O
on,O
the,O
transmission,O
"
",O
from,O
Huanan,O
Seafood,O
Wholesale,O
Market,O
(,O
reservoir,O
),O
to,O
people,O
",",O
we,O
simplified,O
the,O
"
",O
model,O
as,O
ReservoirPeople,O
(,O
RP,O
),O
transmission,O
network,O
model,O
.,O
The,O
next,O
generation,O
"
",O
matrix,O
approach,O
was,O
adopted,O
to,O
calculate,O
the,O
basic,O
reproduction,O
number,O
(,O
R0,O
),O
from,O
"
",O
the,O
RP,O
model,O
to,O
assess,O
the,O
transmissibility,O
of,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"
",O
RESULTS,O
:,O
The,O
value,O
of,O
R0,O
was,O
estimated,O
of,O
2.3,O
from,O
reservoir,O
to,O
person,O
and,O
3.58,O
"
",O
from,O
person,O
to,O
person,O
which,O
means,O
that,O
the,O
expected,O
number,O
of,O
secondary,O
"
",O
infections,O
that,O
result,O
from,O
introducing,O
a,O
single,O
infected,O
individual,O
into,O
an,O
"
",O
otherwise,O
susceptible,O
population,O
was,O
3.58,O
.,O
"
",O
CONCLUSIONS,O
:,O
Our,O
model,O
showed,O
that,O
the,O
transmissibility,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
was,O
higher,O
"
",O
than,O
the,O
Middle,O
East,O
respiratory,O
syndrome,O
in,O
the,O
Middle,O
East,O
countries,O
",",O
similar,O
"
",O
to,O
severe,O
acute,O
respiratory,O
syndrome,O
",",O
but,O
lower,O
than,O
MERS,O
in,O
the,O
Republic,O
of,O
"
",O
Korea,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s40249020006403,O
"
",O
PMCID,O
:,O
PMC7047374,O
"
",O
PMID,O
:,O
32111262,O
"


",O
458,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
26;9(3,O
),O
.,O
pii,O
:,O
E623,O
.,O
doi,O
:,O
10.339,O
jcm9030623,O
.,O
"

",O
Potential,O
Rapid,O
Diagnostics,O
",",O
Vaccine,O
and,O
Therapeutics,O
for,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
:,O
A,O
Systematic,O
Review,O
.,O
"

",O
Pang,O
J(1)(2,O
),O
",",O
Wang,O
MX(1)(2,O
),O
",",O
Ang,O
IYH(1,O
),O
",",O
Tan,O
SHX(1,O
),O
",",O
Lewis,O
RF(1,O
),O
",",O
Chen,O
JI(1,O
),O
",",O
"
",O
Gutierrez,O
RA(3,O
),O
",",O
Gwee,O
SXW(1)(2,O
),O
",",O
Chua,O
PEY(1)(2,O
),O
",",O
Yang,O
Q(1,O
),O
",",O
Ng,O
XY(1,O
),O
",",O
Yap,O
RK(1,O
),O
",",O
"
",O
Tan,O
HY(1,O
),O
",",O
Teo,O
YY(1,O
),O
",",O
Tan,O
CC(4,O
),O
",",O
Cook,O
AR(1,O
),O
",",O
Yap,O
JC(1,O
),O
",",O
Hsu,O
LY(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Saw,O
Swee,O
Hock,O
School,O
of,O
Public,O
Health,O
",",O
National,O
University,O
of,O
Singapore,O
and,O
"
",O
National,O
University,O
Health,O
System,O
",",O
Singapore,O
117549,O
",",O
Singapore,O
.,O
"
",O
(2)Centre,O
for,O
Infectious,O
Disease,O
Epidemiology,O
and,O
Research,O
",",O
National,O
University,O
"
",O
of,O
Singapore,O
",",O
Singapore,O
117549,O
",",O
Singapore,O
.,O
"
",O
(3)National,O
Centre,O
for,O
Infectious,O
Diseases,O
",",O
Singapore,O
308442,O
",",O
Singapore,O
.,O
"
",O
(4)Ministry,O
of,O
Health,O
",",O
Singapore,O
169854,O
",",O
Singapore,O
.,O
"

",O
Rapid,O
diagnostics,O
",",O
vaccines,O
and,O
therapeutics,O
are,O
important,O
interventions,O
for,O
the,O
"
",O
management,O
of,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
outbreak,O
.,O
It,O
is,O
timely,O
to,O
"
",O
systematically,O
review,O
the,O
potential,O
of,O
these,O
interventions,O
",",O
including,O
those,O
for,O
"
",O
Middle,O
East,O
respiratory,O
syndromeCoronavirus,O
(,O
MERSCoV,O
),O
and,O
severe,O
acute,O
"
",O
respiratory,O
syndrome,O
(SARS)CoV,O
",",O
to,O
guide,O
policymakers,O
globally,O
on,O
their,O
"
",O
prioritization,O
of,O
resources,O
for,O
research,O
and,O
development,O
.,O
A,O
systematic,O
search,O
was,O
"
",O
carried,O
out,O
in,O
three,O
major,O
electronic,O
databases,O
(,O
PubMed,O
",",O
Embase,O
and,O
Cochrane,O
"
",O
Library,O
),O
to,O
identify,O
published,O
studies,O
in,O
accordance,O
with,O
the,O
Preferred,O
Reporting,O
"
",O
Items,O
for,O
Systematic,O
Reviews,O
and,O
MetaAnalyses,O
(,O
PRISMA,O
),O
guidelines,O
.,O
Supplementary,O
"
",O
strategies,O
through,O
Google,O
Search,O
and,O
personal,O
communications,O
were,O
used,O
.,O
A,O
total,O
"
",O
of,O
27,O
studies,O
fulfilled,O
the,O
criteria,O
for,O
review,O
.,O
Several,O
laboratory,O
protocols,O
for,O
"
",O
confirmation,O
of,O
suspected,O
2019nCoV,B-Virus_SARS-CoV-2
cases,O
using,O
realtime,O
reverse,O
transcription,O
"
",O
polymerase,O
chain,O
reaction,O
(,O
RTPCR,O
),O
have,O
been,O
published,O
.,O
A,O
commercial,O
RTPCR,O
kit,O
"
",O
developed,O
by,O
the,O
Beijing,O
Genomic,O
Institute,O
is,O
currently,O
widely,O
used,O
in,O
China,O
and,O
"
",O
likely,O
in,O
Asia,O
.,O
However,O
",",O
serological,O
assays,O
as,O
well,O
as,O
pointofcare,O
testing,O
kits,O
"
",O
have,O
not,O
been,O
developed,O
but,O
are,O
likely,O
in,O
the,O
near,O
future,O
.,O
Several,O
vaccine,O
"
",O
candidates,O
are,O
in,O
the,O
pipeline,O
.,O
The,O
likely,O
earliest,O
Phase,O
1,O
vaccine,O
trial,O
is,O
a,O
"
",O
synthetic,O
DNAbased,O
candidate,O
.,O
A,O
number,O
of,O
novel,O
compounds,O
as,O
well,O
as,O
"
",O
therapeutics,O
licensed,O
for,O
other,O
conditions,O
appear,O
to,O
have,O
in,O
vitro,O
efficacy,O
"
",O
against,O
the,O
2019nCoV.,O
Some,O
are,O
being,O
tested,O
in,O
clinical,O
trials,O
against,O
MERSCoV,O
"
",O
and,O
SARSCoV,O
",",O
while,O
others,O
have,O
been,O
listed,O
for,O
clinical,O
trials,O
against,O
"
",O
2019nCoV.,O
However,O
",",O
there,O
are,O
currently,O
no,O
effective,O
specific,O
antivirals,O
or,O
drug,O
"
",O
combinations,O
supported,O
by,O
highlevel,O
evidence,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9030623,O
"
",O
PMID,O
:,O
32110875,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
459,O
.,O
Infect,O
Dis,O
Model,O
.,O
2020,O
Feb,O
14;5:256263,O
.,O
doi,O
:,O
10.1016,O
j.idm.2020.02.002,O
.,O
"
",O
eCollection,O
2020,O
.,O
"

",O
Realtime,O
forecasts,O
of,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
in,O
China,O
from,O
February,O
5th,O
to,O
"
",O
February,O
24th,O
",",O
2020,O
.,O
"

",O
Roosa,O
K(1,O
),O
",",O
Lee,O
Y(1,O
),O
",",O
Luo,O
R(1,O
),O
",",O
Kirpich,O
A(1,O
),O
",",O
Rothenberg,O
R(1,O
),O
",",O
Hyman,O
JM(2,O
),O
",",O
Yan,O
"
",O
P(3,O
),O
",",O
Chowell,O
G(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Population,O
Health,O
Sciences,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Georgia,O
"
",O
State,O
University,O
",",O
Atlanta,O
",",O
GA,O
",",O
USA,O
.,O
"
",O
(2)Department,O
of,O
Mathematics,O
",",O
Center,O
for,O
Computational,O
Science,O
",",O
Tulane,O
"
",O
University,O
",",O
New,O
Orleans,O
",",O
LA,O
",",O
USA,O
.,O
"
",O
(3)Infectious,O
Disease,O
Prevention,O
and,O
Control,O
Branch,O
",",O
Public,O
Health,O
Agency,O
of,O
"
",O
Canada,O
",",O
Ottawa,O
",",O
Canada,O
.,O
"

",O
The,O
initial,O
cluster,O
of,O
severe,O
pneumonia,O
cases,O
that,O
triggered,O
the,O
COVID19,B-Disease_COVID-19
"
",O
epidemic,O
was,O
identified,O
in,O
Wuhan,O
",",O
China,O
in,O
December,O
2019,O
.,O
While,O
early,O
cases,O
of,O
"
",O
the,O
disease,O
were,O
linked,O
to,O
a,O
wet,O
market,O
",",O
humantohuman,O
transmission,O
has,O
driven,O
"
",O
the,O
rapid,O
spread,O
of,O
the,O
virus,O
throughout,O
China,O
.,O
The,O
Chinese,O
government,O
has,O
"
",O
implemented,O
containment,O
strategies,O
of,O
citywide,O
lockdowns,O
",",O
screening,O
at,O
airports,O
"
",O
and,O
train,O
stations,O
",",O
and,O
isolation,O
of,O
suspected,O
patients,O
;,O
however,O
",",O
the,O
cumulative,O
"
",O
case,O
count,O
keeps,O
growing,O
every,O
day,O
.,O
The,O
ongoing,O
outbreak,O
presents,O
a,O
challenge,O
for,O
"
",O
modelers,O
",",O
as,O
limited,O
data,O
are,O
available,O
on,O
the,O
early,O
growth,O
trajectory,O
",",O
and,O
the,O
"
",O
epidemiological,O
characteristics,O
of,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
are,O
yet,O
to,O
be,O
fully,O
"
",O
elucidated,O
.,O
We,O
use,O
phenomenological,O
models,O
that,O
have,O
been,O
validated,O
during,O
"
",O
previous,O
outbreaks,O
to,O
generate,O
and,O
assess,O
shortterm,O
forecasts,O
of,O
the,O
cumulative,O
"
",O
number,O
of,O
confirmed,O
reported,O
cases,O
in,O
Hubei,O
province,O
",",O
the,O
epicenter,O
of,O
the,O
"
",O
epidemic,O
",",O
and,O
for,O
the,O
overall,O
trajectory,O
in,O
China,O
",",O
excluding,O
the,O
province,O
of,O
"
",O
Hubei,O
.,O
We,O
collect,O
daily,O
reported,O
cumulative,O
confirmed,O
cases,O
for,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
outbreak,O
for,O
each,O
Chinese,O
province,O
from,O
the,O
National,O
Health,O
Commission,O
of,O
China,O
.,O
"
",O
Here,O
",",O
we,O
provide,O
5,O
",",O
10,O
",",O
and,O
15,O
day,O
forecasts,O
for,O
five,O
consecutive,O
days,O
",",O
February,O
"
",O
5th,O
through,O
February,O
9th,O
",",O
with,O
quantified,O
uncertainty,O
based,O
on,O
a,O
generalized,O
"
",O
logistic,O
growth,O
model,O
",",O
the,O
Richards,O
growth,O
model,O
",",O
and,O
a,O
subepidemic,O
wave,O
model,O
.,O
"
",O
Our,O
most,O
recent,O
forecasts,O
reported,O
here,O
",",O
based,O
on,O
data,O
up,O
until,O
February,O
9,O
",",O
2020,O
",",O
"
",O
largely,O
agree,O
across,O
the,O
three,O
models,O
presented,O
and,O
suggest,O
an,O
average,O
range,O
of,O
"
",O
74097496,O
additional,O
confirmed,O
cases,O
in,O
Hubei,O
and,O
11281929,O
additional,O
cases,O
in,O
"
",O
other,O
provinces,O
within,O
the,O
next,O
five,O
days,O
.,O
Models,O
also,O
predict,O
an,O
average,O
total,O
"
",O
cumulative,O
case,O
count,O
between,O
37415,O
and,O
38028,O
in,O
Hubei,O
and,O
1158813499,O
in,O
"
",O
other,O
provinces,O
by,O
February,O
24,O
",",O
2020,O
.,O
Mean,O
estimates,O
and,O
uncertainty,O
bounds,O
for,O
"
",O
both,O
Hubei,O
and,O
other,O
provinces,O
have,O
remained,O
relatively,O
stable,O
in,O
the,O
last,O
three,O
"
",O
reporting,O
dates,O
(,O
February,O
7th,O
 ,O
9th,O
),O
.,O
We,O
also,O
observe,O
that,O
each,O
of,O
the,O
models,O
"
",O
predicts,O
that,O
the,O
epidemic,O
has,O
reached,O
saturation,O
in,O
both,O
Hubei,O
and,O
other,O
"
",O
provinces,O
.,O
Our,O
findings,O
suggest,O
that,O
the,O
containment,O
strategies,O
implemented,O
in,O
"
",O
China,O
are,O
successfully,O
reducing,O
transmission,O
and,O
that,O
the,O
epidemic,O
growth,O
has,O
"
",O
slowed,O
in,O
recent,O
days,O
.,O
"

",O
Â©,O
2020,O
The,O
Authors,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.idm.2020.02.002,O
"
",O
PMCID,O
:,O
PMC7033348,O
"
",O
PMID,O
:,O
32110742,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Authors,O
declare,O
no,O
competing,O
interests,O
.,O
"


",O
460,O
.,O
J,O
Infect,O
.,O
2020,O
Feb,O
25,O
.,O
pii,O
:,O
S01634453(20)300876,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.010,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Coronavirus,O
2019nCoV,B-Virus_SARS-CoV-2
:,O
A,O
brief,O
perspective,O
from,O
the,O
front,O
line,O
.,O
"

",O
Han,O
Q(1,O
),O
",",O
Lin,O
Q(1,O
),O
",",O
Jin,O
S(2,O
),O
",",O
You,O
L(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Hematology,O
",",O
the,O
First,O
Affiliated,O
Hospital,O
",",O
College,O
of,O
Medicine,O
",",O
"
",O
Zhejiang,O
University,O
",",O
79,O
#,O
Qingchun,O
Road,O
",",O
Hangzhou,O
310003,O
",",O
Zhejiang,O
",",O
People,O
's,O
"
",O
Republic,O
of,O
China,O
;,O
Malignant,O
Lymphoma,O
Diagnosis,O
and,O
Therapy,O
Center,O
",",O
the,O
First,O
"
",O
Affiliated,O
Hospital,O
",",O
College,O
of,O
Medicine,O
",",O
Zhejiang,O
University,O
",",O
Hangzhou,O
310003,O
",",O
"
",O
Zhejiang,O
",",O
People,O
's,O
Republic,O
of,O
China,O
;,O
Institute,O
of,O
Hematology,O
",",O
Zhejiang,O
"
",O
University,O
",",O
Hangzhou,O
31003,O
",",O
Zhejiang,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)Department,O
of,O
Hematology,O
",",O
Sir,O
Run,O
Run,O
Shaw,O
Hospital,O
",",O
College,O
of,O
Medicine,O
",",O
"
",O
Zhejiang,O
University,O
",",O
Hangzhou,O
310009,O
",",O
Zhejiang,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(3)Department,O
of,O
Hematology,O
",",O
the,O
First,O
Affiliated,O
Hospital,O
",",O
College,O
of,O
Medicine,O
",",O
"
",O
Zhejiang,O
University,O
",",O
79,O
#,O
Qingchun,O
Road,O
",",O
Hangzhou,O
310003,O
",",O
Zhejiang,O
",",O
People,O
's,O
"
",O
Republic,O
of,O
China,O
;,O
Malignant,O
Lymphoma,O
Diagnosis,O
and,O
Therapy,O
Center,O
",",O
the,O
First,O
"
",O
Affiliated,O
Hospital,O
",",O
College,O
of,O
Medicine,O
",",O
Zhejiang,O
University,O
",",O
Hangzhou,O
310003,O
",",O
"
",O
Zhejiang,O
",",O
People,O
's,O
Republic,O
of,O
China,O
;,O
Institute,O
of,O
Hematology,O
",",O
Zhejiang,O
"
",O
University,O
",",O
Hangzhou,O
31003,O
",",O
Zhejiang,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
youliangshun@zju.edu.cn,O
.,O
"

",O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
designated,O
as,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
hit,O
the,O
central,O
Chinese,O
city,O
of,O
"
",O
Wuhan,O
in,O
late,O
December,O
2019,O
",",O
and,O
subsequently,O
spread,O
rapidly,O
to,O
all,O
provinces,O
of,O
"
",O
China,O
and,O
multiple,O
countries,O
.,O
As,O
of,O
0,O
am,O
February,O
9,O
",",O
2020,O
",",O
a,O
total,O
of,O
37287,O
"
",O
cases,O
have,O
been,O
confirmed,O
infection,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
China,O
mainland,O
",",O
and,O
302,O
cases,O
"
",O
have,O
also,O
been,O
cumulatively,O
reported,O
from,O
24,O
countries,O
.,O
According,O
to,O
the,O
latest,O
"
",O
data,O
",",O
a,O
total,O
of,O
813,O
deaths,O
occurred,O
in,O
China,O
mainland,O
",",O
with,O
the,O
mortality,O
"
",O
reaching,O
approximately,O
2.2,O
%,O
.,O
At,O
present,O
",",O
there,O
is,O
no,O
vaccine,O
or,O
specific,O
drugs,O
"
",O
for,O
the,O
human,O
coronavirus,O
.,O
Therefore,O
",",O
it,O
is,O
critical,O
to,O
understand,O
the,O
nature,O
of,O
"
",O
the,O
virus,O
and,O
its,O
clinical,O
characteristics,O
",",O
in,O
order,O
to,O
respond,O
to,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
outbreak,O
.,O
Thus,O
",",O
the,O
present,O
study,O
briefly,O
but,O
comprehensively,O
summarizes,O
the,O
not,O
"
",O
much,O
but,O
timely,O
reports,O
on,O
the,O
2019nCoV.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
Ltd.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.010,O
"
",O
PMID,O
:,O
32109444,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
competing,O
interests,O
.,O
"


",O
461,O
.,O
J,O
Infect,O
.,O
2020,O
Feb,O
25,O
.,O
pii,O
:,O
S01634453(20)301006,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.017,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
and,O
computed,O
tomographic,O
imaging,O
features,O
of,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
"
",O
caused,O
by,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Xu,O
YH(1,O
),O
",",O
Dong,O
JH(1,O
),O
",",O
An,O
WM(1,O
),O
",",O
Lv,O
XY(2,O
),O
",",O
Yin,O
XP(3,O
),O
",",O
Zhang,O
JZ(1,O
),O
",",O
Dong,O
L(4,O
),O
",",O
Ma,O
"
",O
X(5,O
),O
",",O
Zhang,O
HJ(6,O
),O
",",O
Gao,O
BL(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
The,O
Fifth,O
Medical,O
Center,O
of,O
Chinese,O
PLA,O
General,O
"
",O
Hospital,O
",",O
100,O
West,O
Fourth,O
Ring,O
Road,O
",",O
Fengtai,O
District,O
",",O
Beijing,O
100039,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
The,O
Fifth,O
Medical,O
Center,O
of,O
Chinese,O
PLA,O
General,O
"
",O
Hospital,O
",",O
100,O
West,O
Fourth,O
Ring,O
Road,O
",",O
Fengtai,O
District,O
",",O
Beijing,O
100039,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
15001008285@139.com,O
.,O
"
",O
(3)CT,O
MRI,O
Room,O
",",O
Affiliated,O
Hospital,O
of,O
Hebei,O
University,O
",",O
212,O
Eastern,O
Yuhua,O
Road,O
",",O
"
",O
Baoding,O
",",O
Hebei,O
Province,O
71000,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
yinxiaoping78@sina.com,O
.,O
"
",O
(4)Department,O
of,O
Radiology,O
",",O
Baoding,O
City,O
People,O
's,O
Hospital,O
",",O
Baoding,O
",",O
Hebei,O
"
",O
Province,O
71000,O
",",O
China,O
.,O
"
",O
(5)CT,O
MRI,O
Room,O
",",O
Affiliated,O
Hospital,O
of,O
Hebei,O
University,O
",",O
212,O
Eastern,O
Yuhua,O
Road,O
",",O
"
",O
Baoding,O
",",O
Hebei,O
Province,O
71000,O
",",O
China,O
.,O
"
",O
(6)Clinical,O
College,O
",",O
Hebei,O
University,O
",",O
Boding,O
",",O
Hebei,O
Province,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Radiology,O
",",O
The,O
Fifth,O
Medical,O
Center,O
of,O
Chinese,O
PLA,O
General,O
"
",O
Hospital,O
",",O
100,O
West,O
Fourth,O
Ring,O
Road,O
",",O
Fengtai,O
District,O
",",O
Beijing,O
100039,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
browngao@163.com,O
.,O
"

",O
PURPOSE,O
:,O
To,O
investigate,O
the,O
clinical,O
and,O
imaging,O
characteristics,O
of,O
computed,O
"
",O
tomography,O
(,O
CT,O
),O
in,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
(,O
NCP,B-Disease_COVID-19
),O
caused,O
by,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"
",O
MATERIALS,O
AND,O
METHODS,O
:,O
A,O
retrospective,O
analysis,O
was,O
performed,O
on,O
the,O
imaging,O
"
",O
findings,O
of,O
patients,O
confirmed,O
with,O
COVID19,B-Disease_COVID-19
pneumonia,O
who,O
had,O
chest,O
CT,O
scanning,O
"
",O
and,O
treatment,O
after,O
disease,O
onset,O
.,O
The,O
clinical,O
and,O
imaging,O
data,O
were,O
analyzed,O
.,O
"
",O
RESULTS,O
:,O
Fifty,O
patients,O
were,O
enrolled,O
",",O
including,O
mild,O
type,O
in,O
nine,O
",",O
common,O
in,O
28,O
",",O
"
",O
severe,O
in,O
10,O
and,O
critically,O
severe,O
in,O
the,O
rest,O
three,O
.,O
Mild,O
patients,O
(,O
29,O
years,O
),O
"
",O
were,O
significantly,O
(,O
P<0.03,O
),O
younger,O
than,O
either,O
common,O
(,O
44.5,O
years,O
),O
or,O
severe,O
"
",O
(,O
54.7,O
),O
and,O
critically,O
severe,O
(,O
65.7,O
years,O
),O
patients,O
",",O
and,O
common,O
patients,O
were,O
also,O
"
",O
significantly,O
(,O
P<0.03,O
),O
younger,O
than,O
severe,O
and,O
critically,O
severe,O
patients,O
.,O
Mild,O
"
",O
patients,O
had,O
low,O
to,O
moderate,O
fever,O
(,O
<,O
39.1,O
â€¯,O
Â°,O
C,O
),O
",",O
49,O
(,O
98,O
%,O
),O
patients,O
had,O
normal,O
or,O
"
",O
slightly,O
reduced,O
leukocyte,O
count,O
",",O
14,O
(,O
28,O
%,O
),O
had,O
decreased,O
counts,O
of,O
lymphocytes,O
",",O
"
",O
and,O
26,O
(,O
52,O
%,O
),O
patients,O
had,O
increased,O
Creactive,O
protein,O
.,O
Nine,O
mild,O
patients,O
were,O
"
",O
negative,O
in,O
CT,O
imaging,O
.,O
For,O
all,O
the,O
other,O
types,O
of,O
NCP,B-Disease_COVID-19
",",O
the,O
lesion,O
was,O
in,O
the,O
"
",O
right,O
upper,O
lobe,O
in,O
30,O
cases,O
",",O
right,O
middle,O
lobe,O
in,O
22,O
",",O
right,O
lower,O
lobe,O
in,O
39,O
",",O
"
",O
left,O
upper,O
lobe,O
in,O
33,O
and,O
left,O
lower,O
lobe,O
in,O
36,O
.,O
The,O
lesion,O
was,O
primarily,O
located,O
"
",O
in,O
the,O
peripheral,O
area,O
under,O
the,O
pleura,O
with,O
possible,O
extension,O
towards,O
the,O
"
",O
pulmonary,O
hilum,O
.,O
Symmetrical,O
lesions,O
were,O
seen,O
in,O
26,O
cases,O
and,O
asymmetrical,O
in,O
"
",O
15,O
.,O
The,O
density,O
of,O
lesion,O
was,O
mostly,O
uneven,O
with,O
ground,O
glass,O
opacity,O
as,O
the,O
"
",O
primary,O
presentation,O
accompanied,O
by,O
partial,O
consolidation,O
and,O
fibrosis,O
.,O
"
",O
CONCLUSION,O
:,O
CT,O
imaging,O
presentations,O
of,O
NCP,B-Disease_COVID-19
are,O
mostly,O
patchy,O
ground,O
glass,O
"
",O
opacities,O
in,O
the,O
peripheral,O
areas,O
under,O
the,O
pleura,O
with,O
partial,O
consolidation,O
"
",O
which,O
will,O
be,O
absorbed,O
with,O
formation,O
of,O
fibrotic,O
stripes,O
if,O
improved,O
.,O
CT,O
"
",O
scanning,O
provides,O
important,O
bases,O
for,O
early,O
diagnosis,O
and,O
treatment,O
of,O
NCP,B-Disease_COVID-19
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
British,O
Infection,O
Association,O
.,O
Published,O
by,O
Elsevier,O
Ltd.,O
"
",O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.017,O
"
",O
PMID,O
:,O
32109443,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
None,O
.,O
"


",O
462,O
.,O
Lancet,O
Glob,O
Health,O
.,O
2020,O
Feb,O
25,O
.,O
pii,O
:,O
S2214109X(20)300681,O
.,O
doi,O
:,O
"
",O
10.1016,O
S2214109X(20)300681,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Potential,O
association,O
between,O
COVID19,B-Disease_COVID-19
mortality,O
and,O
healthcare,O
resource,O
"
",O
availability,O
.,O
"

",O
Ji,O
Y(1,O
),O
",",O
Ma,O
Z(2,O
),O
",",O
Peppelenbosch,O
MP(3,O
),O
",",O
Pan,O
Q(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Biotechnology,O
and,O
Bioengineering,O
of,O
State,O
Ethnic,O
Affairs,O
"
",O
Commission,O
",",O
Biomedical,O
Research,O
Center,O
",",O
Northwest,O
Minzu,O
University,O
",",O
Lanzhou,O
",",O
"
",O
Gansu,O
",",O
China,O
;,O
Department,O
of,O
Gastroenterology,O
and,O
Hepatology,O
",",O
Erasmus,O
"
",O
MCUniversity,O
Medical,O
Center,O
",",O
Rotterdam,O
",",O
Netherlands,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Biotechnology,O
and,O
Bioengineering,O
of,O
State,O
Ethnic,O
Affairs,O
"
",O
Commission,O
",",O
Biomedical,O
Research,O
Center,O
",",O
Northwest,O
Minzu,O
University,O
",",O
Lanzhou,O
",",O
"
",O
Gansu,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Gastroenterology,O
and,O
Hepatology,O
",",O
Erasmus,O
MCUniversity,O
Medical,O
"
",O
Center,O
",",O
Rotterdam,O
",",O
Netherlands,O
.,O
"
",O
(4)Key,O
Laboratory,O
of,O
Biotechnology,O
and,O
Bioengineering,O
of,O
State,O
Ethnic,O
Affairs,O
"
",O
Commission,O
",",O
Biomedical,O
Research,O
Center,O
",",O
Northwest,O
Minzu,O
University,O
",",O
Lanzhou,O
",",O
"
",O
Gansu,O
",",O
China,O
;,O
Department,O
of,O
Gastroenterology,O
and,O
Hepatology,O
",",O
Erasmus,O
"
",O
MCUniversity,O
Medical,O
Center,O
",",O
Rotterdam,O
",",O
Netherlands,O
.,O
Electronic,O
address,O
:,O
"
",O
q.pan@erasmusmc.nl,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S2214109X(20)300681,O
"
",O
PMID,O
:,O
32109372,O
"


",O
463,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
29,O
.,O
pii,O
:,O
ciaa199,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa199,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Clinical,O
Characteristics,O
of,O
Imported,O
Cases,O
of,O
COVID19,B-Disease_COVID-19
in,O
Jiangsu,O
Province,O
:,O
A,O
"
",O
Multicenter,O
Descriptive,O
Study,O
.,O
"

",O
Wu,O
J(1)(2,O
),O
",",O
Liu,O
J(3,O
),O
",",O
Zhao,O
X(4,O
),O
",",O
Liu,O
C(5,O
),O
",",O
Wang,O
W(2,O
),O
",",O
Wang,O
D(6,O
),O
",",O
Xu,O
W(7,O
),O
",",O
Zhang,O
"
",O
C(8,O
),O
",",O
Yu,O
J(1,O
),O
",",O
Jiang,O
B(9,O
),O
",",O
Cao,O
H(1)(10,O
),O
",",O
Li,O
L(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
for,O
the,O
Diagnosis,O
and,O
Treatment,O
of,O
Infectious,O
Diseases,O
",",O
"
",O
National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
The,O
First,O
Affiliated,O
"
",O
Hospital,O
",",O
College,O
of,O
Medicine,O
",",O
Zhejiang,O
University,O
",",O
Hangzhou,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Laboratory,O
Medicine,O
",",O
The,O
First,O
People,O
's,O
Hospital,O
of,O
Yancheng,O
"
",O
City,O
",",O
Yancheng,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Laboratory,O
Medicine,O
",",O
The,O
Fifth,O
People,O
's,O
Hospital,O
of,O
Wuxi,O
",",O
"
",O
Affiliated,O
to,O
Jiangnan,O
University,O
",",O
Wuxi,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Respiration,O
",",O
The,O
Fifth,O
People,O
's,O
Hospital,O
of,O
Wuxi,O
",",O
Affiliated,O
to,O
"
",O
Jiangnan,O
University,O
",",O
Wuxi,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Infectious,O
Disease,O
",",O
The,O
First,O
People,O
's,O
Hospital,O
of,O
Yancheng,O
"
",O
City,O
",",O
Yancheng,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Infectious,O
Disease,O
",",O
The,O
second,O
People,O
's,O
Hospital,O
of,O
Yancheng,O
"
",O
City,O
",",O
Yancheng,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Preventive,O
Medicine,O
and,O
Public,O
Health,O
Laboratory,O
Sciences,O
",",O
"
",O
School,O
of,O
Medicine,O
",",O
Jiangsu,O
University,O
",",O
Zhenjiang,O
",",O
Jiangsu,O
",",O
China,O
.,O
"
",O
(8)Department,O
of,O
Laboratory,O
Medicine,O
",",O
The,O
second,O
People,O
's,O
Hospital,O
of,O
Yancheng,O
"
",O
City,O
",",O
Yancheng,O
",",O
China,O
.,O
"
",O
(9)Department,O
of,O
Laboratory,O
Medicine,O
",",O
The,O
Central,O
Blood,O
Station,O
of,O
Yancheng,O
City,O
",",O
"
",O
Yancheng,O
",",O
Jiangsu,O
",",O
China,O
.,O
"
",O
(10)Zhejiang,O
Provincial,O
Key,O
Laboratory,O
for,O
Diagnosis,O
and,O
Treatment,O
of,O
Aging,O
and,O
"
",O
Physicchemical,O
Injury,O
Diseases,O
",",O
Hangzhou,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
We,O
aimed,O
to,O
report,O
the,O
clinical,O
characteristics,O
of,O
imported,O
"
",O
coronavirus,B-Disease_COVID-19
disease19,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
in,O
Jiangsu,O
Province,O
.,O
"
",O
METHODS,O
:,O
We,O
retrospectively,O
investigated,O
the,O
Â ,O
clinical,O
",",O
imaging,O
",",O
and,O
laboratory,O
"
",O
characteristics,O
of,O
confirmed,O
cases,O
of,O
COVID19,B-Disease_COVID-19
with,O
WHO,O
interim,O
guidance,O
in,O
three,O
"
",O
Grade,O
â…¢A,O
Â ,O
hospitals,O
of,O
Jiangsu,O
from,O
Jan,O
22,O
to,O
Feb,O
14,O
",",O
2020,O
.,O
Real,O
time,O
RTPCR,O
was,O
"
",O
used,O
to,O
detect,O
the,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
in,O
respiratory,O
samples,O
.,O
"
",O
RESULTS,O
:,O
Of,O
the,O
80,O
patients,O
infected,O
with,O
COVID19,B-Disease_COVID-19
",",O
41,O
patients,O
were,O
female,O
",",O
with,O
"
",O
a,O
median,O
age,O
of,O
46.1,O
years,O
.,O
Except,O
for,O
3,O
severe,O
patients,O
",",O
the,O
rest,O
of,O
the,O
77,O
"
",O
patients,O
exhibited,O
mild,O
or,O
moderate,O
symptoms,O
.,O
9,O
patients,O
were,O
unconfirmed,O
until,O
a,O
"
",O
thirdtime,O
nucleic,O
acid,O
test,O
.,O
38,O
cases,O
had,O
a,O
history,O
of,O
chronic,O
diseases,O
.,O
The,O
"
",O
main,O
clinical,O
manifestations,O
of,O
the,O
patients,O
were,O
fever,O
and,O
cough,O
",",O
which,O
"
",O
accounted,O
for,O
63,O
cases,O
(,O
78.75,O
%,O
),O
and,O
51,O
cases,O
(,O
63.75,O
%,O
),O
respectively,O
.,O
Only,O
3,O
"
",O
patients,O
(,O
3.75,O
%,O
),O
showed,O
liver,O
dysfunction,O
.,O
Imaging,O
examination,O
showed,O
that,O
55,O
"
",O
patients,O
(,O
68.75,O
%,O
),O
showed,O
abnormal,O
",",O
25,O
cases,O
(,O
31.25,O
%,O
),O
had,O
no,O
abnormal,O
density,O
"
",O
shadow,O
in,O
the,O
parenchyma,O
of,O
both,O
lungs,O
.,O
Up,O
to,O
now,O
",",O
21,O
cases,O
were,O
discharged,O
from,O
"
",O
the,O
hospital,O
",",O
and,O
no,O
patient,O
died,O
.,O
The,O
average,O
length,O
of,O
stay,O
for,O
discharged,O
"
",O
patients,O
was,O
8,O
days,O
.,O
"
",O
CONCLUSIONS,O
:,O
Compared,O
with,O
the,O
cases,O
in,O
Wuhan,O
",",O
the,O
Â ,O
cases,O
in,O
Jiangsu,O
exhibited,O
"
",O
mild,O
or,O
moderate,O
symptoms,O
and,O
no,O
obvious,O
gender,O
susceptivity,O
.,O
The,O
proportion,O
of,O
"
",O
patients,O
having,O
liver,O
dysfunction,O
and,O
abnormal,O
CT,O
imaging,O
was,O
relatively,O
lower,O
"
",O
than,O
that,O
of,O
Wuhan,O
.,O
Notably,O
",",O
infected,O
patients,O
may,O
be,O
falsely,O
excluded,O
based,O
on,O
"
",O
two,O
consecutively,O
negative,O
respiratory,O
pathogenic,O
nucleic,O
acid,O
test,O
results,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa199,O
"
",O
PMID,O
:,O
32109279,O
"


",O
464,O
.,O
J,O
Travel,O
Med,O
.,O
2020,O
Feb,O
28,O
.,O
pii,O
:,O
taaa029,O
.,O
doi,O
:,O
10.1093,O
jtm,O
taaa029,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Saudi,O
Arabia`s,O
measures,O
to,O
curb,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
:,O
temporary,O
suspension,O
of,O
"
",O
the,O
Umrah,O
pilgrimage,O
.,O
"

",O
Ebrahim,O
SH(1,O
),O
",",O
Memish,O
ZA(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)University,O
of,O
Sciences,O
",",O
Technique,O
and,O
Technology,O
",",O
Bamako,O
",",O
Mali,O
.,O
"
",O
(2)Research,O
&,O
Innovation,O
Center,O
",",O
King,O
Saud,O
Medical,O
City,O
",",O
Ministry,O
of,O
Health,O
and,O
"
",O
College,O
of,O
Medicine,O
",",O
Alfaisal,O
University,O
",",O
Riyadh,O
",",O
Saudi,O
Arabia,O
.,O
Hubert,O
Department,O
"
",O
of,O
Global,O
Health,O
",",O
Rollins,O
School,O
of,O
Public,O
Health,O
",",O
Emory,O
University,O
",",O
Atlanta,O
",",O
GA,O
",",O
"
",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jtm,O
taaa029,O
"
",O
PMID,O
:,O
32109274,O
"


",O
465,O
.,O
J,O
Travel,O
Med,O
.,O
2020,O
Feb,O
28,O
.,O
pii,O
:,O
taaa030,O
.,O
doi,O
:,O
10.1093,O
jtm,O
taaa030,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
outbreak,O
on,O
the,O
Diamond,O
Princess,O
cruise,O
ship,O
:,O
estimating,O
the,O
epidemic,O
"
",O
potential,O
and,O
effectiveness,O
of,O
public,O
health,O
countermeasures,O
.,O
"

",O
RocklÃ¶v,O
J(1,O
),O
",",O
SjÃ¶din,O
H(1,O
),O
",",O
WilderSmith,O
A(2)(3)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Public,O
Health,O
and,O
Clinical,O
Medicine,O
",",O
Section,O
of,O
Sustainable,O
"
",O
Health,O
",",O
UmeÃ¥,O
University,O
",",O
UmeÃ¥,O
",",O
Sweden,O
.,O
"
",O
(2)Department,O
of,O
Epidemiology,O
and,O
Global,O
Health,O
",",O
UmeÃ¥,O
University,O
",",O
UmeÃ¥,O
",",O
Sweden,O
.,O
"
",O
(3)Department,O
of,O
Disease,O
Control,O
",",O
London,O
School,O
of,O
Hygiene,O
and,O
Tropical,O
Medicine,O
",",O
"
",O
UK,O
.,O
"
",O
(4)Heidelberg,O
Institute,O
of,O
Global,O
Health,O
",",O
University,O
of,O
Heidelberg,O
",",O
Germany,O
.,O
"

",O
BACKGROUND,O
:,O
Cruise,O
ships,O
carry,O
a,O
large,O
number,O
of,O
people,O
in,O
confined,O
spaces,O
with,O
"
",O
relative,O
homogeneous,O
mixing,O
.,O
On,O
3,O
February,O
",",O
2020,O
",",O
an,O
outbreak,O
of,O
COVID19,B-Disease_COVID-19
on,O
"
",O
cruise,O
ship,O
Diamond,O
Princess,O
was,O
reported,O
with,O
10,O
initial,O
cases,O
",",O
following,O
an,O
"
",O
index,O
case,O
on,O
board,O
around,O
2125,O
January,O
.,O
By,O
4,O
February,O
",",O
public,O
health,O
measures,O
"
",O
such,O
as,O
removal,O
and,O
isolation,O
of,O
ill,O
passengers,O
and,O
quarantine,O
of,O
nonill,O
"
",O
passengers,O
were,O
implemented,O
.,O
By,O
20,O
February,O
",",O
619,O
of,O
3700,O
passengers,O
and,O
crew,O
"
",O
(,O
17,O
%,O
),O
were,O
tested,O
positive,O
.,O
"
",O
METHODS,O
:,O
We,O
estimated,O
the,O
basic,O
reproduction,O
number,O
from,O
the,O
initial,O
period,O
of,O
"
",O
the,O
outbreak,O
using,O
(,O
SEIR,O
),O
models,O
.,O
We,O
calibrated,O
the,O
models,O
with,O
transient,O
"
",O
functions,O
of,O
countermeasures,O
to,O
incidence,O
data,O
.,O
We,O
additionally,O
estimated,O
a,O
"
",O
counterfactual,O
scenario,O
in,O
absence,O
of,O
countermeasures,O
",",O
and,O
established,O
a,O
model,O
"
",O
stratified,O
by,O
crew,O
and,O
guests,O
to,O
study,O
the,O
impact,O
of,O
differential,O
contact,O
rates,O
"
",O
among,O
the,O
groups,O
.,O
We,O
also,O
compared,O
scenarios,O
of,O
an,O
earlier,O
versus,O
later,O
"
",O
evacuation,O
of,O
the,O
ship,O
.,O
"
",O
RESULTS,O
:,O
The,O
basic,O
reproduction,O
rate,O
was,O
initially,O
4,O
times,O
higher,O
onboard,O
"
",O
compared,O
to,O
the,O
$,O
{R}_0,O
$,O
in,O
the,O
epicentre,O
in,O
Wuhan,O
",",O
but,O
the,O
countermeasures,O
"
",O
lowered,O
it,O
substantially,O
.,O
Based,O
on,O
the,O
modeled,O
initial,O
$,O
{R}_0,O
$,O
of,O
14.8,O
",",O
we,O
"
",O
estimated,O
that,O
without,O
any,O
interventions,O
within,O
the,O
time,O
period,O
of,O
21,O
January,O
to,O
"
",O
19,O
February,O
",",O
2920,O
out,O
of,O
the,O
3700,O
(,O
79,O
%,O
),O
would,O
have,O
been,O
infected,O
.,O
Isolation,O
and,O
"
",O
quarantine,O
therefore,O
prevented,O
2307,O
cases,O
",",O
and,O
lowered,O
the,O
$,O
{R}_0,O
$,O
to,O
1.78,O
.,O
We,O
"
",O
showed,O
that,O
an,O
early,O
evacuation,O
of,O
all,O
passengers,O
on,O
3,O
February,O
would,O
have,O
been,O
"
",O
associated,O
with,O
76,O
infected,O
persons,O
in,O
their,O
incubation,O
time,O
.,O
"
",O
CONCLUSIONS,O
:,O
The,O
cruise,O
ship,O
conditions,O
clearly,O
amplified,O
an,O
already,O
highly,O
"
",O
transmissible,O
disease,O
.,O
The,O
public,O
health,O
measures,O
prevented,O
more,O
than,O
2000,O
"
",O
additional,O
cases,O
compared,O
to,O
no,O
interventions,O
.,O
However,O
",",O
evacuating,O
all,O
passengers,O
"
",O
and,O
crew,O
early,O
on,O
in,O
the,O
outbreak,O
would,O
have,O
prevented,O
many,O
more,O
passengers,O
and,O
"
",O
crew,O
from,O
infection,O
.,O
"

",O
Â©,O
International,O
Society,O
of,O
Travel,O
Medicine,O
2019,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
"
",O
Permissions,O
",",O
please,O
email,O
:,O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jtm,O
taaa030,O
"
",O
PMID,O
:,O
32109273,O
"


",O
466,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Feb,O
28,O
.,O
doi,O
:,O
10.1056,O
NEJMoa2002032,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
Characteristics,O
of,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
in,O
China,O
.,O
"

",O
Guan,O
WJ(1,O
),O
",",O
Ni,O
ZY(1,O
),O
",",O
Hu,O
Y(1,O
),O
",",O
Liang,O
WH(1,O
),O
",",O
Ou,O
CQ(1,O
),O
",",O
He,O
JX(1,O
),O
",",O
Liu,O
L(1,O
),O
",",O
Shan,O
"
",O
H(1,O
),O
",",O
Lei,O
CL(1,O
),O
",",O
Hui,O
DSC(1,O
),O
",",O
Du,O
B(1,O
),O
",",O
Li,O
LJ(1,O
),O
",",O
Zeng,O
G(1,O
),O
",",O
Yuen,O
KY(1,O
),O
",",O
Chen,O
"
",O
RC(1,O
),O
",",O
Tang,O
CL(1,O
),O
",",O
Wang,O
T(1,O
),O
",",O
Chen,O
PY(1,O
),O
",",O
Xiang,O
J(1,O
),O
",",O
Li,O
SY(1,O
),O
",",O
Wang,O
JL(1,O
),O
",",O
Liang,O
"
",O
ZJ(1,O
),O
",",O
Peng,O
YX(1,O
),O
",",O
Wei,O
L(1,O
),O
",",O
Liu,O
Y(1,O
),O
",",O
Hu,O
YH(1,O
),O
",",O
Peng,O
P(1,O
),O
",",O
Wang,O
JM(1,O
),O
",",O
Liu,O
"
",O
JY(1,O
),O
",",O
Chen,O
Z(1,O
),O
",",O
Li,O
G(1,O
),O
",",O
Zheng,O
ZJ(1,O
),O
",",O
Qiu,O
SQ(1,O
),O
",",O
Luo,O
J(1,O
),O
",",O
Ye,O
CJ(1,O
),O
",",O
Zhu,O
SY(1,O
),O
",",O
"
",O
Zhong,O
NS(1,O
),O
;,O
China,O
Medical,O
Treatment,O
Expert,O
Group,O
for,O
Covid19,B-Disease_COVID-19
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
State,O
Key,O
Laboratory,O
of,O
Respiratory,O
Disease,O
",",O
National,O
Clinical,O
"
",O
Research,O
Center,O
for,O
Respiratory,O
Disease,O
",",O
Guangzhou,O
Institute,O
of,O
Respiratory,O
"
",O
Health,O
",",O
First,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
Medical,O
University,O
(,O
W.G.,O
",",O
W.L.,O
",",O
"
",O
J.H.,O
",",O
R.C.,O
",",O
C.T.,O
",",O
T.W.,O
",",O
S.L.,O
",",O
Jinlin,O
Wang,O
",",O
N.Z.,O
",",O
J.H.,O
",",O
W.L.,O
),O
",",O
the,O
Departments,O
of,O
"
",O
Thoracic,O
Oncology,O
(,O
W.L.,O
),O
",",O
Thoracic,O
Surgery,O
and,O
Oncology,O
(,O
J.H.,O
),O
",",O
and,O
Emergency,O
"
",O
Medicine,O
(,O
Z.L.,O
),O
",",O
First,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
Medical,O
University,O
",",O
and,O
"
",O
Guangzhou,O
Eighth,O
People,O
's,O
Hospital,O
",",O
Guangzhou,O
Medical,O
University,O
(,O
C.L.,O
),O
",",O
and,O
the,O
"
",O
State,O
Key,O
Laboratory,O
of,O
Organ,O
Failure,O
Research,O
",",O
Department,O
of,O
Biostatistics,O
",",O
"
",O
Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
Tropical,O
Disease,O
Research,O
",",O
School,O
of,O
"
",O
Public,O
Health,O
",",O
Southern,O
Medical,O
University,O
(,O
C.O.,O
",",O
P.C.,O
),O
",",O
Guangzhou,O
",",O
Wuhan,O
"
",O
Jinyintan,O
Hospital,O
(,O
Z.N.,O
",",O
J.X.,O
),O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
(,O
Yu,O
Hu,O
),O
",",O
the,O
Central,O
Hospital,O
of,O
Wuhan,O
"
",O
(,O
Y.P.,O
),O
",",O
Wuhan,O
No.,O
1,O
Hospital,O
",",O
Wuhan,O
Hospital,O
of,O
Traditional,O
Chinese,O
and,O
Western,O
"
",O
Medicine,O
(,O
L.W.,O
),O
",",O
Wuhan,O
Pulmonary,O
Hospital,O
(,O
P.P.,O
),O
",",O
Tianyou,O
Hospital,O
Affiliated,O
to,O
"
",O
Wuhan,O
University,O
of,O
Science,O
and,O
Technology,O
(,O
Jianming,O
Wang,O
),O
",",O
and,O
the,O
People,O
's,O
"
",O
Hospital,O
of,O
Huangpi,O
District,O
(,O
S.Z.,O
),O
",",O
Wuhan,O
",",O
Shenzhen,O
Third,O
People,O
's,O
Hospital,O
and,O
"
",O
the,O
Second,O
Affiliated,O
Hospital,O
of,O
Southern,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
(,O
L.,O
Liu,O
),O
",",O
and,O
the,O
"
",O
Department,O
of,O
Clinical,O
Microbiology,O
and,O
Infection,O
Control,O
",",O
University,O
of,O
Hong,O
"
",O
KongShenzhen,O
Hospital,O
(,O
K.Y.Y.,O
),O
",",O
Shenzhen,O
",",O
the,O
Fifth,O
Affiliated,O
Hospital,O
of,O
Sun,O
"
",O
Yatsen,O
University,O
",",O
Zhuhai,O
(,O
H.S.,O
),O
",",O
the,O
Department,O
of,O
Medicine,O
and,O
Therapeutics,O
",",O
"
",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
Shatin,O
(,O
D.S.C.H.,O
),O
",",O
and,O
the,O
Department,O
of,O
"
",O
Microbiology,O
and,O
the,O
Carol,O
Yu,O
Center,O
for,O
Infection,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
"
",O
Medicine,O
",",O
University,O
of,O
Hong,O
Kong,O
",",O
Pok,O
Fu,O
Lam,O
(,O
K.Y.Y.,O
),O
",",O
Hong,O
Kong,O
",",O
Medical,O
ICU,O
",",O
"
",O
Peking,O
Union,O
Medical,O
College,O
Hospital,O
",",O
Peking,O
Union,O
Medical,O
College,O
and,O
Chinese,O
"
",O
Academy,O
of,O
Medical,O
Sciences,O
(,O
B.D.,O
),O
",",O
and,O
the,O
Chinese,O
Center,O
for,O
Disease,O
Control,O
"
",O
and,O
Prevention,O
(,O
G.Z.,O
),O
",",O
Beijing,O
",",O
the,O
State,O
Key,O
Laboratory,O
for,O
Diagnosis,O
and,O
"
",O
Treatment,O
of,O
Infectious,O
Diseases,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
"
",O
Infectious,O
Diseases,O
",",O
First,O
Affiliated,O
Hospital,O
",",O
College,O
of,O
Medicine,O
",",O
Zhejiang,O
"
",O
University,O
",",O
Hangzhou,O
(,O
L.,O
Li,O
),O
",",O
Chengdu,O
Public,O
Health,O
Clinical,O
Medical,O
Center,O
",",O
"
",O
Chengdu,O
(,O
Y.L.,O
),O
",",O
Huangshi,O
Central,O
Hospital,O
of,O
Edong,O
Healthcare,O
Group,O
",",O
Affiliated,O
"
",O
Hospital,O
of,O
Hubei,O
Polytechnic,O
University,O
",",O
Huangshi,O
(,O
Yahua,O
Hu,O
),O
",",O
the,O
First,O
"
",O
Hospital,O
of,O
Changsha,O
",",O
Changsha,O
(,O
J.,O
Liu,O
),O
",",O
the,O
Third,O
People,O
's,O
Hospital,O
of,O
Hainan,O
"
",O
Province,O
",",O
Sanya,O
(,O
Z.C.,O
),O
",",O
Huanggang,O
Central,O
Hospital,O
",",O
Huanggang,O
(,O
G.L.,O
),O
",",O
Wenling,O
"
",O
First,O
People,O
's,O
Hospital,O
",",O
Wenling,O
(,O
Z.Z.,O
),O
",",O
the,O
Third,O
People,O
's,O
Hospital,O
of,O
Yichang,O
",",O
"
",O
Yichang,O
(,O
S.Q.,O
),O
",",O
Affiliated,O
Taihe,O
Hospital,O
of,O
Hubei,O
University,O
of,O
Medicine,O
",",O
Shiyan,O
"
",O
(,O
J.,O
Luo,O
),O
",",O
and,O
Xiantao,O
First,O
People,O
's,O
Hospital,O
",",O
Xiantao,O
(,O
C.Y.,O
),O
 ,O
all,O
in,O
China,O
.,O
"

",O
BACKGROUND,O
:,O
Since,O
December,O
2019,O
",",O
when,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
Covid19,B-Disease_COVID-19
),O
emerged,O
"
",O
in,O
Wuhan,O
city,O
and,O
rapidly,O
spread,O
throughout,O
China,O
",",O
data,O
have,O
been,O
needed,O
on,O
the,O
"
",O
clinical,O
characteristics,O
of,O
the,O
affected,O
patients,O
.,O
"
",O
METHODS,O
:,O
We,O
extracted,O
data,O
regarding,O
1099,O
patients,O
with,O
laboratoryconfirmed,O
"
",O
Covid19,B-Disease_COVID-19
from,O
552,O
hospitals,O
in,O
30,O
provinces,O
",",O
autonomous,O
regions,O
",",O
and,O
"
",O
municipalities,O
in,O
China,O
through,O
January,O
29,O
",",O
2020,O
.,O
The,O
primary,O
composite,O
end,O
point,O
"
",O
was,O
admission,O
to,O
an,O
intensive,O
care,O
unit,O
(,O
ICU,O
),O
",",O
the,O
use,O
of,O
mechanical,O
ventilation,O
",",O
"
",O
or,O
death,O
.,O
"
",O
RESULTS,O
:,O
The,O
median,O
age,O
of,O
the,O
patients,O
was,O
47,O
years,O
;,O
41.9,O
%,O
of,O
the,O
patients,O
were,O
"
",O
female,O
.,O
The,O
primary,O
composite,O
end,O
point,O
occurred,O
in,O
67,O
patients,O
(,O
6.1,O
%,O
),O
",",O
including,O
"
",O
5,O
%,O
who,O
were,O
admitted,O
to,O
the,O
ICU,O
",",O
2.3,O
%,O
who,O
underwent,O
invasive,O
mechanical,O
"
",O
ventilation,O
",",O
and,O
1.4,O
%,O
who,O
died,O
.,O
Only,O
1.9,O
%,O
of,O
the,O
patients,O
had,O
a,O
history,O
of,O
direct,O
"
",O
contact,O
with,O
wildlife,O
.,O
Among,O
nonresidents,O
of,O
Wuhan,O
",",O
72.3,O
%,O
had,O
contact,O
with,O
"
",O
residents,O
of,O
Wuhan,O
",",O
including,O
31.3,O
%,O
who,O
had,O
visited,O
the,O
city,O
.,O
The,O
most,O
common,O
"
",O
symptoms,O
were,O
fever,O
(,O
43.8,O
%,O
on,O
admission,O
and,O
88.7,O
%,O
during,O
hospitalization,O
),O
and,O
"
",O
cough,O
(,O
67.8,O
%,O
),O
.,O
Diarrhea,O
was,O
uncommon,O
(,O
3.8,O
%,O
),O
.,O
The,O
median,O
incubation,O
period,O
was,O
4,O
"
",O
days,O
(,O
interquartile,O
range,O
",",O
2,O
to,O
7,O
),O
.,O
On,O
admission,O
",",O
groundglass,O
opacity,O
was,O
the,O
"
",O
most,O
common,O
radiologic,O
finding,O
on,O
chest,O
computed,O
tomography,O
(,O
CT,O
),O
(,O
56.4,O
%,O
),O
.,O
No,O
"
",O
radiographic,O
or,O
CT,O
abnormality,O
was,O
found,O
in,O
157,O
of,O
877,O
patients,O
(,O
17.9,O
%,O
),O
with,O
"
",O
nonsevere,O
disease,O
and,O
in,O
5,O
of,O
173,O
patients,O
(,O
2.9,O
%,O
),O
with,O
severe,O
disease,O
.,O
"
",O
Lymphocytopenia,O
was,O
present,O
in,O
83.2,O
%,O
of,O
the,O
patients,O
on,O
admission,O
.,O
"
",O
CONCLUSIONS,O
:,O
During,O
the,O
first,O
2,O
months,O
of,O
the,O
current,O
outbreak,O
",",O
Covid19,B-Disease_COVID-19
spread,O
"
",O
rapidly,O
throughout,O
China,O
and,O
caused,O
varying,O
degrees,O
of,O
illness,O
.,O
Patients,O
often,O
"
",O
presented,O
without,O
fever,O
",",O
and,O
many,O
did,O
not,O
have,O
abnormal,O
radiologic,O
findings,O
.,O
"
",O
(,O
Funded,O
by,O
the,O
National,O
Health,O
Commission,O
of,O
China,O
and,O
others,O
.,O
),O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Massachusetts,O
Medical,O
Society,O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMoa2002032,O
"
",O
PMID,O
:,O
32109013,O
"


",O
467,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Feb,O
28,O
.,O
doi,O
:,O
10.1056,O
NEJMp2003762,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Responding,O
to,O
Covid19,B-Disease_COVID-19
 ,O
A,O
OnceinaCentury,O
Pandemic,O
?,O
"

",O
Gates,O
B(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Bill,O
and,O
Melinda,O
Gates,O
Foundation,O
",",O
Seattle,O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMp2003762,O
"
",O
PMID,O
:,O
32109012,O
"


",O
468,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Feb,O
28,O
.,O
doi,O
:,O
10.1056,O
NEJMe2002387,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Covid19,B-Disease_COVID-19
 ,O
Navigating,O
the,O
Uncharted,O
.,O
"

",O
Fauci,O
AS(1,O
),O
",",O
Lane,O
HC(1,O
),O
",",O
Redfield,O
RR(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
National,O
Institute,O
of,O
Allergy,O
and,O
Infectious,O
Diseases,O
",",O
National,O
"
",O
Institutes,O
of,O
Health,O
",",O
Bethesda,O
",",O
MD,O
(,O
A.S.F.,O
",",O
H.C.L.,O
),O
;,O
and,O
the,O
Centers,O
for,O
Disease,O
"
",O
Control,O
and,O
Prevention,O
",",O
Atlanta,O
(,O
R.R.R.,O
),O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMe2002387,O
"
",O
PMID,O
:,O
32109011,O
"


",O
469,O
.,O
FEMS,O
Microbiol,O
Lett,O
.,O
2020,O
Feb,O
28,O
.,O
pii,O
:,O
fnaa007,O
.,O
doi,O
:,O
10.1093,O
femsle,O
fnaa007,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Astragaloside,O
IV,O
attenuates,O
IL1Î²,O
secretion,O
by,O
enhancing,O
autophagy,O
in,O
H1N1,O
"
",O
infection,O
.,O
"

",O
Zhang,O
J(1,O
),O
",",O
Zhang,O
W(2,O
),O
",",O
Ren,O
L(3,O
),O
",",O
He,O
Y(1,O
),O
",",O
Mei,O
Z(1,O
),O
",",O
Feng,O
J(1,O
),O
",",O
Shi,O
T(1,O
),O
",",O
Zhang,O
"
",O
H(2,O
),O
",",O
Song,O
Z(2,O
),O
",",O
Jie,O
Z(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Shanghai,O
Fifth,O
People,O
's,O
"
",O
Hospital,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
200240,O
",",O
China,O
.,O
"
",O
(2)Shanghai,O
Public,O
Health,O
Clinical,O
Center,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
201508,O
",",O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
430022,O
",",O
China,O
.,O
"

",O
Excessive,O
secretion,O
of,O
inflammatory,O
factors,O
(,O
cytokine,O
storm,O
),O
plays,O
a,O
significant,O
"
",O
role,O
in,O
H1N1induced,O
acute,O
pneumonia,O
",",O
and,O
autophagy,O
acts,O
as,O
a,O
cellintrinsic,O
"
",O
mechanism,O
to,O
regulate,O
inflammation,O
.,O
Astragaloside,O
IV,O
(,O
ASIV,O
),O
",",O
originating,O
from,O
"
",O
the,O
Astragalus,O
root,O
",",O
possesses,O
multiple,O
pharmacological,O
activities,O
",",O
such,O
as,O
"
",O
antiinflammation,O
.,O
However,O
",",O
the,O
influences,O
of,O
ASIV,O
on,O
H1N1induced,O
autophagy,O
and,O
"
",O
inflammation,O
have,O
still,O
remained,O
elusive,O
.,O
It,O
has,O
been,O
reported,O
that,O
H1N1,O
"
",O
infection,O
leads,O
to,O
the,O
accumulation,O
of,O
autophagosomes,O
but,O
obstructs,O
"
",O
autophagosomes,O
incorporating,O
into,O
lysosomes,O
",",O
while,O
in,O
this,O
study,O
",",O
it,O
showed,O
that,O
"
",O
ASIV,O
enhanced,O
the,O
autophagy,O
activation,O
in,O
H1N1,O
infection,O
.,O
Furthermore,O
",",O
we,O
found,O
"
",O
that,O
ASIV,O
promoted,O
H1N1triggered,O
formation,O
of,O
autophagosomes,O
and,O
autolysosomes,O
.,O
"
",O
Additionally,O
",",O
it,O
was,O
noted,O
that,O
ASIV,O
did,O
not,O
affect,O
viral,O
replication,O
",",O
mRNA,O
"
",O
level,O
of,O
interleukin1,O
beta,O
(,O
IL1Î²,O
),O
",",O
and,O
proIL1Î²,O
protein,O
level,O
",",O
whereas,O
"
",O
significantly,O
decreased,O
secretion,O
of,O
IL1Î²,O
",",O
and,O
chloroquine,O
(,O
CQ,O
",",O
as,O
an,O
inhibitor,O
"
",O
of,O
autophagy,O
),O
increased,O
secretion,O
of,O
IL1Î²,O
in,O
H1N1,O
infection,O
.,O
In,O
conclusion,O
",",O
"
",O
ASIV,O
stimulates,O
the,O
formation,O
of,O
autophagosomes,O
and,O
the,O
fusion,O
of,O
autophagosome,O
"
",O
and,O
lysosomes,O
in,O
H1N1,O
infection,O
and,O
it,O
may,O
lead,O
to,O
the,O
decreased,O
IL1Î²,O
secretion,O
.,O
"

",O
Â©,O
FEMS,O
2020,O
.,O
"

",O
DOI,O
:,O
10.1093,O
femsle,O
fnaa007,O
"
",O
PMID,O
:,O
32108899,O
"


",O
470,O
.,O
Bioinformatics,O
.,O
2020,O
Feb,O
28,O
.,O
pii,O
:,O
btaa145,O
.,O
doi,O
:,O
10.1093,O
bioinformatics,O
btaa145,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Genome,O
Detective,O
Coronavirus,O
Typing,O
Tool,O
for,O
rapid,O
identification,O
and,O
"
",O
characterization,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
genomes,O
.,O
"

",O
Cleemput,O
S(1,O
),O
",",O
Dumon,O
W(1,O
),O
",",O
Fonseca,O
V(2)(3)(4,O
),O
",",O
Karim,O
WA(2,O
),O
",",O
Giovanetti,O
M(5,O
),O
",",O
"
",O
Alcantara,O
LC(3)(5,O
),O
",",O
Deforche,O
K(1,O
),O
",",O
de,O
Oliveira,O
T(2)(6)(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Emweb,O
bv,O
",",O
Herent,O
",",O
Belgium,O
.,O
"
",O
(2)KwaZuluNatal,O
Research,O
Innovation,O
and,O
Sequencing,O
Platform,O
(,O
KRISP,O
),O
",",O
School,O
of,O
"
",O
Laboratory,O
Medicine,O
and,O
Medical,O
Sciences,O
",",O
College,O
of,O
Health,O
Sciences,O
",",O
University,O
"
",O
of,O
KwaZuluNatal,O
",",O
Durban,O
",",O
South,O
Africa,O
.,O
"
",O
(3)LaboratÃ³rio,O
de,O
GenÃ©tica,O
Celular,O
e,O
Molecular,O
",",O
Instituto,O
de,O
CiÃªncias,O
BiolÃ³gicas,O
",",O
"
",O
Universidade,O
Federal,O
de,O
Minas,O
Gerais,O
",",O
Belo,O
Horizonte,O
",",O
Brazil,O
.,O
"
",O
(4)CoordenaÃ§Ã£o,O
Geral,O
dos,O
LaboratÃ³rios,O
de,O
SaÃºde,O
PÃºblica,O
Secretaria,O
de,O
VigilÃ¢ncia,O
"
",O
em,O
SaÃºde,O
",",O
MinistÃ©rio,O
da,O
SaÃºde,O
",",O
(,O
CGLAB,O
SVSMS,O
),O
BrasÃ­lia,O
",",O
Brazil,O
.,O
"
",O
(5)LaboratÃ³rio,O
de,O
FlavivÃ­rus,O
",",O
Instituto,O
Oswaldo,O
Cruz,O
",",O
FundaÃ§Ã£o,O
Oswaldo,O
Cruz,O
",",O
Rio,O
"
",O
de,O
Janeiro,O
",",O
RJ,O
",",O
Brazil,O
.,O
"
",O
(6)Centre,O
for,O
the,O
AIDS,O
Programme,O
of,O
Research,O
in,O
South,O
Africa,O
(,O
CAPRISA,O
),O
",",O
Durban,O
",",O
"
",O
South,O
Africa,O
.,O
"
",O
(7)Department,O
of,O
Global,O
Health,O
",",O
University,O
of,O
Washington,O
",",O
Seattle,O
",",O
USA,O
.,O
"

",O
SUMMARY,O
:,O
Genome,O
Detective,O
is,O
a,O
webbased,O
",",O
userfriendly,O
software,O
application,O
to,O
"
",O
quickly,O
and,O
accurately,O
assemble,O
all,O
known,O
virus,O
genomes,O
from,O
next,O
generation,O
"
",O
sequencing,O
datasets,O
.,O
This,O
application,O
allows,O
the,O
identification,O
of,O
phylogenetic,O
"
",O
clusters,O
and,O
genotypes,O
from,O
assembled,O
genomes,O
in,O
FASTA,O
format,O
.,O
Since,O
its,O
release,O
"
",O
in,O
2019,O
",",O
we,O
have,O
produced,O
a,O
number,O
of,O
typing,O
tools,O
for,O
emergent,O
viruses,O
that,O
have,O
"
",O
caused,O
large,O
outbreaks,O
",",O
such,O
as,O
Zika,O
and,O
Yellow,O
Fever,O
Virus,O
in,O
Brazil,O
.,O
Here,O
",",O
we,O
"
",O
present,O
The,O
Genome,O
Detective,O
Coronavirus,O
Typing,O
Tool,O
that,O
can,O
accurately,O
identify,O
"
",O
the,O
novel,O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
related,O
coronavirus,O
"
",O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
sequences,O
isolated,O
in,O
China,O
and,O
around,O
the,O
world,O
.,O
The,O
tool,O
can,O
"
",O
accept,O
up,O
to,O
2000,O
sequences,O
per,O
submission,O
and,O
the,O
analysis,O
of,O
a,O
new,O
whole,O
"
",O
genome,O
sequence,O
will,O
take,O
approximately,O
one,O
minute,O
.,O
The,O
tool,O
has,O
been,O
tested,O
and,O
"
",O
validated,O
with,O
hundreds,O
of,O
whole,O
genomes,O
from,O
ten,O
coronavirus,O
species,O
",",O
and,O
"
",O
correctly,O
classified,O
all,O
of,O
the,O
SARSrelated,O
coronavirus,O
(,O
SARSrCoV,O
),O
and,O
all,O
of,O
"
",O
the,O
available,O
public,O
data,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
The,O
tool,O
also,O
allows,O
tracking,O
of,O
new,O
"
",O
viral,O
mutations,O
as,O
the,O
outbreak,O
expands,O
globally,O
",",O
which,O
may,O
help,O
to,O
accelerate,O
"
",O
the,O
development,O
of,O
novel,O
diagnostics,O
",",O
drugs,O
and,O
vaccines,O
to,O
stop,O
the,O
COVID19,B-Disease_COVID-19
"
",O
disease,O
.,O
"
",O
AVAILABILITY,O
:,O
https,O
:,O
 ,O
www.genomedetective.com,O
app,O
typingtool,O
cov,O
.,O
"
",O
SUPPLEMENTARY,O
INFORMATION,O
:,O
Supplementary,O
data,O
are,O
available,O
at,O
Bioinformatics,O
"
",O
online,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
.,O
"

",O
DOI,O
:,O
10.1093,O
bioinformatics,O
btaa145,O
"
",O
PMID,O
:,O
32108862,O
"


",O
471,O
.,O
JAMA,O
.,O
2020,O
Feb,O
28,O
.,O
doi,O
:,O
10.1001,O
jama.2020.3072,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19New,O
Insights,O
on,O
a,O
Rapidly,O
Changing,O
Epidemic,O
.,O
"

",O
Del,O
Rio,O
C(1,O
),O
",",O
Malani,O
PN(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Internal,O
Medicine,O
",",O
Division,O
of,O
Infectious,O
Diseases,O
",",O
Emory,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Atlanta,O
",",O
Georgia,O
.,O
"
",O
(2)Department,O
of,O
Internal,O
Medicine,O
",",O
Division,O
of,O
Infectious,O
Diseases,O
",",O
University,O
"
",O
of,O
Michigan,O
",",O
Ann,O
Arbor,O
.,O
"
",O
(3)Associate,O
Editor,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.3072,O
"
",O
PMID,O
:,O
32108857,O
"


",O
472,O
.,O
AJR,O
Am,O
J,O
Roentgenol,O
.,O
2020,O
Feb,O
1.177083333,O
.,O
doi,O
:,O
10.2214,O
AJR.20.22969,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Radiology,O
Perspective,O
of,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
:,O
Lessons,O
From,O
Severe,O
"
",O
Acute,O
Respiratory,O
Syndrome,O
and,O
Middle,O
East,O
Respiratory,O
Syndrome,O
.,O
"

",O
Hosseiny,O
M(1,O
),O
",",O
Kooraki,O
S(2,O
),O
",",O
Gholamrezanezhad,O
A(2)(3,O
),O
",",O
Reddy,O
S(2,O
),O
",",O
Myers,O
L(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiological,O
Sciences,O
",",O
David,O
Geffen,O
School,O
of,O
Medicine,O
",",O
"
",O
University,O
of,O
California,O
at,O
Los,O
Angeles,O
",",O
Los,O
Angeles,O
",",O
CA,O
.,O
"
",O
(2)Department,O
of,O
Radiological,O
Sciences,O
",",O
Keck,O
School,O
of,O
Medicine,O
",",O
University,O
of,O
"
",O
Southern,O
California,O
",",O
Los,O
Angeles,O
",",O
CA,O
.,O
"
",O
(3)Department,O
of,O
Radiological,O
Sciences,O
",",O
Division,O
of,O
Emergency,O
Radiology,O
",",O
Keck,O
"
",O
School,O
of,O
Medicine,O
",",O
University,O
of,O
Southern,O
California,O
",",O
1500,O
San,O
Pablo,O
St,O
",",O
Los,O
"
",O
Angeles,O
",",O
CA,O
90033,O
.,O
"

",O
OBJECTIVE,O
.,O
Since,O
the,O
outbreak,O
of,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
pulmonary,O
illness,O
"
",O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
in,O
China,O
",",O
more,O
than,O
79000,O
people,O
have,O
"
",O
contracted,O
the,O
virus,O
worldwide,O
.,O
The,O
virus,O
is,O
rapidly,O
spreading,O
with,O
"
",O
humantohuman,O
transmission,O
despite,O
imposed,O
precautions,O
.,O
Because,O
similar,O
"
",O
pulmonary,O
syndromes,O
have,O
been,O
reported,O
from,O
other,O
strains,O
of,O
the,O
coronavirus,O
"
",O
family,O
",",O
our,O
aim,O
is,O
to,O
review,O
the,O
lessons,O
from,O
imaging,O
studies,O
obtained,O
during,O
"
",O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
and,O
Middle,O
East,O
respiratory,O
syndrome,O
"
",O
(,O
MERS,O
),O
outbreaks,O
.,O
CONCLUSION,O
.,O
The,O
review,O
of,O
experiences,O
with,O
the,O
MERS,O
and,O
SARS,O
"
",O
outbreaks,O
will,O
help,O
us,O
better,O
understand,O
the,O
role,O
of,O
the,O
radiologist,O
in,O
combating,O
"
",O
the,O
outbreak,O
of,O
COVID19,B-Disease_COVID-19
.,O
The,O
known,O
imaging,O
manifestations,O
of,O
the,O
novel,O
"
",O
coronavirus,O
and,O
the,O
possible,O
unknowns,O
will,O
also,O
be,O
discussed,O
.,O
"

",O
DOI,O
:,O
10.2214,O
AJR.20.22969,O
"
",O
PMID,O
:,O
32108495,O
"


",O
473,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
28,O
.,O
doi,O
:,O
10.1002,O
jmv.25736,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Development,O
of,O
epitopebased,O
peptide,O
vaccine,O
against,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2019,I-Virus_SARS-CoV-2
"
",O
(,O
SARSCOV2,B-Virus_SARS-CoV-2
),O
:,O
Immunoinformatics,O
approach,O
.,O
"

",O
Bhattacharya,O
M(1)(2,O
),O
",",O
Sharma,O
AR(1,O
),O
",",O
Patra,O
P(2,O
),O
",",O
Ghosh,O
P(2,O
),O
",",O
Sharma,O
G(3,O
),O
",",O
Patra,O
"
",O
BC(2,O
),O
",",O
Lee,O
SS(1,O
),O
",",O
Chakraborty,O
C(1)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
for,O
Skeletal,O
Aging,O
and,O
Orthopedic,O
Surgery,O
",",O
Hallym,O
"
",O
UniversityChuncheon,O
Sacred,O
Heart,O
Hospital,O
",",O
Chuncheonsi,O
",",O
Gangwondo,O
",",O
Republic,O
of,O
"
",O
Korea,O
.,O
"
",O
(2)Department,O
of,O
Zoology,O
",",O
Vidyasagar,O
University,O
",",O
Midnapore,O
",",O
West,O
Bengal,O
",",O
India,O
.,O
"
",O
(3)Neuropsychopharmacology,O
and,O
Toxicology,O
Program,O
",",O
College,O
of,O
Pharmacy,O
",",O
Kangwon,O
"
",O
National,O
University,O
",",O
Chuncheon,O
",",O
Republic,O
of,O
Korea,O
.,O
"
",O
(4)Department,O
of,O
Biotechnology,O
",",O
School,O
of,O
Life,O
Science,O
and,O
Biotechnology,O
",",O
Adamas,O
"
",O
University,O
",",O
Kolkata,O
",",O
West,O
Bengal,O
",",O
India,O
.,O
"

",O
Recently,O
",",O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCOV2,B-Virus_SARS-CoV-2
),O
emerged,O
which,O
is,O
responsible,O
for,O
the,O
"
",O
recent,O
outbreak,O
in,O
Wuhan,O
",",O
China,O
.,O
Genetically,O
",",O
it,O
is,O
closely,O
related,O
to,O
SARSCoV,O
"
",O
and,O
MERSCoV.,O
The,O
situation,O
is,O
getting,O
worse,O
and,O
worse,O
",",O
therefore,O
",",O
there,O
is,O
an,O
"
",O
urgent,O
need,O
for,O
designing,O
a,O
suitable,O
peptide,O
vaccine,O
component,O
against,O
the,O
"
",O
SARSCOV2,B-Virus_SARS-CoV-2
.,O
Here,O
",",O
we,O
characterized,O
spike,O
glycoprotein,O
to,O
obtain,O
immunogenic,O
"
",O
epitopes,O
.,O
Next,O
",",O
we,O
chose,O
13,O
Major,O
Histocompatibility,O
Complex(MHC,O
),O
I,O
and,O
3,O
MHCII,O
"
",O
epitopes,O
",",O
having,O
antigenic,O
properties,O
.,O
These,O
epitopes,O
are,O
usually,O
linked,O
to,O
"
",O
specific,O
linkers,O
to,O
build,O
vaccine,O
components,O
and,O
molecularly,O
dock,O
on,O
tolllike,O
"
",O
receptor5,O
to,O
get,O
binding,O
affinity,O
.,O
Therefore,O
",",O
to,O
provide,O
a,O
fast,O
immunogenic,O
"
",O
profile,O
of,O
these,O
epitopes,O
",",O
we,O
performed,O
immunoinformatics,O
analysis,O
so,O
that,O
the,O
"
",O
rapid,O
development,O
of,O
the,O
vaccine,O
might,O
bring,O
this,O
disastrous,O
situation,O
to,O
the,O
end,O
"
",O
earlier,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25736,O
"
",O
PMID,O
:,O
32108359,O
"


",O
474,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
28,O
.,O
doi,O
:,O
10.1002,O
jmv.25733,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
trial,O
analysis,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
therapy,O
registered,O
in,O
China,O
.,O
"

",O
Zhang,O
Q(1,O
),O
",",O
Wang,O
Y(1,O
),O
",",O
Qi,O
C(1,O
),O
",",O
Shen,O
L(1,O
),O
",",O
Li,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Carcinogenesis,O
and,O
Translational,O
Research,O
(,O
Ministry,O
of,O
"
",O
Education,O
),O
",",O
Department,O
of,O
Gastrointestinal,O
Oncology,O
",",O
Peking,O
University,O
Cancer,O
"
",O
Hospital,O
and,O
Institute,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
So,O
far,O
",",O
there,O
is,O
a,O
lack,O
of,O
effective,O
drugs,O
for,O
the,O
new,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
.,O
"
",O
With,O
more,O
and,O
more,O
patients,O
diagnosed,O
",",O
China,O
has,O
carried,O
out,O
more,O
than,O
100,O
"
",O
clinical,O
studies,O
of,O
new,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
",",O
including,O
antiviral,O
drugs,O
",",O
"
",O
antimalarial,O
drugs,O
",",O
glucocorticoids,O
",",O
plasma,O
therapy,O
",",O
virus,O
vaccine,O
",",O
and,O
other,O
"
",O
Western,O
drugs,O
",",O
while,O
Chinese,O
medicine,O
research,O
accounted,O
for,O
half,O
of,O
the,O
studies,O
.,O
"
",O
Most,O
of,O
the,O
trials,O
were,O
initiated,O
by,O
investigators,O
and,O
the,O
study,O
period,O
would,O
"
",O
last,O
for,O
1,O
to,O
11,O
months,O
.,O
The,O
primary,O
endpoints,O
included,O
symptom,O
improvement,O
and,O
"
",O
virus,O
nucleic,O
acid,O
turning,O
negative,O
",",O
but,O
the,O
optimal,O
endpoint,O
has,O
not,O
been,O
"
",O
determined,O
.,O
Although,O
the,O
final,O
results,O
of,O
studies,O
will,O
take,O
a,O
long,O
time,O
to,O
"
",O
complete,O
",",O
the,O
interim,O
research,O
data,O
may,O
provide,O
some,O
help,O
for,O
the,O
current,O
urgent,O
"
",O
demand,O
for,O
drug,O
treatment,O
.,O
Compared,O
with,O
that,O
of,O
during,O
SARS,O
period,O
in,O
2003,O
",",O
"
",O
China,O
has,O
the,O
stronger,O
capability,O
to,O
carry,O
out,O
clinical,O
trials,O
of,O
new,O
drugs,O
in,O
"
",O
emergency,O
period,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25733,O
"
",O
PMID,O
:,O
32108352,O
"


",O
475,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
28,O
.,O
doi,O
:,O
10.1002,O
jmv.25735,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
characteristics,O
of,O
50,O
â€‰,O
466,O
hospitalized,O
patients,O
with,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
infection,O
.,O
"

",O
Sun,O
P(1,O
),O
",",O
Qie,O
S(2,O
),O
",",O
Liu,O
Z(2,O
),O
",",O
Ren,O
J(3,O
),O
",",O
Li,O
K(4,O
),O
",",O
Xi,O
J(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Plastic,O
Surgery,O
",",O
Zibo,O
Central,O
Hospital,O
",",O
Zibo,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Rehabilitation,O
",",O
Beijing,O
Rehabilitation,O
Hospital,O
of,O
Capital,O
"
",O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Plastic,O
Surgery,O
",",O
Affiliated,O
Hospital,O
of,O
Qingdao,O
University,O
",",O
"
",O
Qingdao,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Plastic,O
Surgery,O
",",O
Qingdao,O
Eighth,O
People,O
's,O
Hospital,O
",",O
Qingdao,O
",",O
"
",O
China,O
.,O
"
",O
(5)Department,O
of,O
Respiratory,O
Rehabilitation,O
",",O
Beijing,O
Rehabilitation,O
Hospital,O
of,O
"
",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
We,O
aim,O
to,O
summarize,O
reliable,O
evidence,O
of,O
evidencebased,O
medicine,O
for,O
the,O
"
",O
treatment,O
and,O
prevention,O
of,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
by,O
analyzing,O
"
",O
all,O
the,O
published,O
studies,O
on,O
the,O
clinical,O
characteristics,O
of,O
patients,O
with,O
"
",O
2019nCoV.,O
PubMed,O
",",O
Cochrane,O
Library,O
",",O
Embase,O
",",O
and,O
other,O
databases,O
were,O
searched,O
.,O
"
",O
Several,O
studies,O
on,O
the,O
clinical,O
characteristics,O
of,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
were,O
"
",O
collected,O
for,O
metaanalysis,O
.,O
Ten,O
studies,O
were,O
included,O
in,O
the,O
metaanalysis,O
",",O
"
",O
including,O
a,O
total,O
number,O
of,O
50,O
â€‰,O
466,O
patients,O
with,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"
",O
Metaanalysis,O
shows,O
that,O
among,O
these,O
patients,O
",",O
the,O
incidence,O
of,O
fever,O
was,O
89.1,O
%,O
",",O
"
",O
the,O
incidence,O
of,O
cough,O
was,O
72.2,O
%,O
",",O
and,O
the,O
incidence,O
of,O
muscle,O
soreness,O
or,O
fatigue,O
"
",O
was,O
42.5,O
%,O
.,O
The,O
incidence,O
of,O
acute,O
respiratory,O
distress,O
syndrome,O
(,O
ARDS,O
),O
was,O
14.8,O
%,O
",",O
"
",O
the,O
incidence,O
of,O
abnormal,O
chest,O
computer,O
tomography,O
(,O
CT,O
),O
was,O
96.6,O
%,O
",",O
the,O
"
",O
percentage,O
of,O
severe,O
cases,O
in,O
all,O
infected,O
cases,O
was,O
18.1,O
%,O
",",O
and,O
the,O
case,O
fatality,O
"
",O
rate,O
of,O
patients,O
with,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
was,O
4.3,O
%,O
.,O
Fever,O
and,O
cough,O
are,O
the,O
most,O
"
",O
common,O
symptoms,O
in,O
patients,O
with,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
",",O
and,O
most,O
of,O
these,O
patients,O
"
",O
have,O
abnormal,O
chest,O
CT,O
examination,O
.,O
Several,O
people,O
have,O
muscle,O
soreness,O
or,O
"
",O
fatigue,O
as,O
well,O
as,O
ARDS,O
.,O
Diarrhea,O
",",O
hemoptysis,O
",",O
headache,O
",",O
sore,O
throat,O
",",O
shock,O
",",O
and,O
"
",O
other,O
symptoms,O
only,O
occur,O
in,O
a,O
small,O
number,O
of,O
patients,O
.,O
The,O
case,O
fatality,O
rate,O
"
",O
of,O
patients,O
with,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
is,O
lower,O
than,O
that,O
of,O
the,O
severe,O
acute,O
"
",O
respiratory,O
syndrome,O
and,O
Middle,O
East,O
respiratory,O
syndrome,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25735,O
"
",O
PMID,O
:,O
32108351,O
"


",O
476,O
.,O
Vet,O
Rec,O
.,O
2020,O
Feb,O
29;186(8):254,O
.,O
doi,O
:,O
10.1136,O
vr.m740,O
.,O
"

",O
Where,O
did,O
SARSCoV2,B-Virus_SARS-CoV-2
come,O
from,O
?,O
"

",O
Zhai,O
SL(1,O
),O
",",O
Wei,O
WK(1,O
),O
",",O
Lv,O
DH(1,O
),O
",",O
Xu,O
ZH(1,O
),O
",",O
Chen,O
QL(1,O
),O
",",O
Sun,O
MF(1,O
),O
",",O
Li,O
F(2,O
),O
",",O
Wang,O
"
",O
D(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Animal,O
Health,O
",",O
Guangdong,O
Academy,O
of,O
Agricultural,O
Sciences,O
",",O
"
",O
Scientific,O
Observation,O
and,O
Experiment,O
Station,O
of,O
Veterinary,O
Drugs,O
and,O
Diagnostic,O
"
",O
Techniques,O
of,O
Guangdong,O
Province,O
",",O
Ministry,O
of,O
Agriculture,O
of,O
Rural,O
Affairs,O
",",O
and,O
"
",O
Key,O
Laboratory,O
of,O
Animal,O
Disease,O
Prevention,O
of,O
Guangdong,O
Province,O
",",O
Guangzhou,O
",",O
"
",O
510640,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Biology,O
and,O
Microbiology,O
",",O
Department,O
of,O
Veterinary,O
Science,O
",",O
"
",O
South,O
Dakota,O
State,O
University,O
",",O
Brookings,O
",",O
SD,O
57007,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1136,O
vr.m740,O
"
",O
PMID,O
:,O
32108071,O
"


",O
477,O
.,O
Eur,O
J,O
Nucl,O
Med,O
Mol,O
Imaging,O
.,O
2020,O
Feb,O
28,O
.,O
doi,O
:,O
10.1007,O
s00259020047359,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Imaging,O
and,O
clinical,O
features,O
of,O
patients,O
with,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Xu,O
X(1,O
),O
",",O
Yu,O
C(2,O
),O
",",O
Qu,O
J(2,O
),O
",",O
Zhang,O
L(2,O
),O
",",O
Jiang,O
S(2,O
),O
",",O
Huang,O
D(2,O
),O
",",O
Chen,O
B(2,O
),O
",",O
Zhang,O
"
",O
Z(2,O
),O
",",O
Guan,O
W(2,O
),O
",",O
Ling,O
Z(2,O
),O
",",O
Jiang,O
R(2,O
),O
",",O
Hu,O
T(2,O
),O
",",O
Ding,O
Y(2,O
),O
",",O
Lin,O
L(2,O
),O
",",O
Gan,O
Q(2,O
),O
",",O
"
",O
Luo,O
L(3,O
),O
",",O
Tang,O
X(4,O
),O
",",O
Liu,O
J(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medical,O
Imaging,O
Center,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
",",O
Jinan,O
"
",O
University,O
",",O
No.,O
613,O
",",O
Huangpu,O
Road,O
West,O
",",O
Tianhe,O
District,O
",",O
Guangzhou,O
",",O
510630,O
",",O
"
",O
Guangdong,O
Province,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
Guangzhou,O
Eighth,O
People,O
's,O
Hospital,O
",",O
Guangzhou,O
Medical,O
"
",O
University,O
",",O
No.,O
8,O
",",O
Huaying,O
Road,O
",",O
Baiyun,O
District,O
",",O
Guangzhou,O
",",O
510060,O
",",O
Guangdong,O
"
",O
Province,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Medical,O
Imaging,O
Center,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
",",O
Jinan,O
"
",O
University,O
",",O
No.,O
613,O
",",O
Huangpu,O
Road,O
West,O
",",O
Tianhe,O
District,O
",",O
Guangzhou,O
",",O
510630,O
",",O
"
",O
Guangdong,O
Province,O
",",O
China,O
.,O
tluolp@jnu.edu.cn,O
.,O
"
",O
(4)Department,O
of,O
Radiology,O
",",O
Guangzhou,O
Eighth,O
People,O
's,O
Hospital,O
",",O
Guangzhou,O
Medical,O
"
",O
University,O
",",O
No.,O
8,O
",",O
Huaying,O
Road,O
",",O
Baiyun,O
District,O
",",O
Guangzhou,O
",",O
510060,O
",",O
Guangdong,O
"
",O
Province,O
",",O
China,O
.,O
xtang@21cn.com,O
.,O
"
",O
(5)Department,O
of,O
Radiology,O
",",O
Guangzhou,O
Eighth,O
People,O
's,O
Hospital,O
",",O
Guangzhou,O
Medical,O
"
",O
University,O
",",O
No.,O
8,O
",",O
Huaying,O
Road,O
",",O
Baiyun,O
District,O
",",O
Guangzhou,O
",",O
510060,O
",",O
Guangdong,O
"
",O
Province,O
",",O
China,O
.,O
Liujx83710378@126.com,O
.,O
"

",O
BACKGROUND,O
:,O
The,O
pneumonia,O
caused,O
by,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
also,O
"
",O
called,O
2019nCoV,B-Virus_SARS-CoV-2
),O
recently,O
break,O
out,O
in,O
Wuhan,O
",",O
China,O
",",O
and,O
was,O
named,O
as,O
COVID19,B-Disease_COVID-19
.,O
"
",O
With,O
the,O
spread,O
of,O
the,O
disease,O
",",O
similar,O
cases,O
have,O
also,O
been,O
confirmed,O
in,O
other,O
"
",O
regions,O
of,O
China,O
.,O
We,O
aimed,O
to,O
report,O
the,O
imaging,O
and,O
clinical,O
characteristics,O
of,O
"
",O
these,O
patients,O
infected,O
with,O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
Guangzhou,O
",",O
China,O
.,O
"
",O
METHODS,O
:,O
All,O
patients,O
with,O
laboratoryidentified,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
by,O
"
",O
realtime,O
polymerase,O
chain,O
reaction,O
(,O
PCR,O
),O
were,O
collected,O
between,O
January,O
23,O
",",O
"
",O
2020,O
",",O
and,O
February,O
4,O
",",O
2020,O
",",O
in,O
a,O
designated,O
hospital,O
(,O
Guangzhou,O
Eighth,O
People,O
's,O
"
",O
Hospital,O
),O
.,O
This,O
analysis,O
included,O
90,O
patients,O
(,O
39,O
men,O
and,O
51,O
women,O
;,O
median,O
age,O
",",O
"
",O
50,O
Â ,O
years,O
(,O
age,O
range,O
",",O
1886,O
Â ,O
years,O
),O
.,O
All,O
the,O
included,O
SARSCoV2infected,O
patients,O
"
",O
underwent,O
noncontrast,O
enhanced,O
chest,O
computed,O
tomography,O
(,O
CT,O
),O
.,O
We,O
analyzed,O
the,O
"
",O
clinical,O
characteristics,O
of,O
the,O
patients,O
",",O
as,O
well,O
as,O
the,O
distribution,O
"
",O
characteristics,O
",",O
pattern,O
",",O
morphology,O
",",O
and,O
accompanying,O
manifestations,O
of,O
lung,O
"
",O
lesions,O
.,O
In,O
addition,O
",",O
after,O
16,O
Â ,O
days,O
(,O
mean,O
3.5,O
Â ,O
days,O
),O
",",O
followup,O
chest,O
CT,O
images,O
"
",O
were,O
evaluated,O
to,O
assess,O
radiological,O
evolution,O
.,O
"
",O
FINDINGS,O
:,O
The,O
majority,O
of,O
infected,O
patients,O
had,O
a,O
history,O
of,O
exposure,O
in,O
Wuhan,O
or,O
"
",O
to,O
infected,O
patients,O
and,O
mostly,O
presented,O
with,O
fever,O
and,O
cough,O
.,O
More,O
than,O
half,O
of,O
"
",O
the,O
patients,O
presented,O
bilateral,O
",",O
multifocal,O
lung,O
lesions,O
",",O
with,O
peripheral,O
"
",O
distribution,O
",",O
and,O
53,O
(,O
59,O
%,O
),O
patients,O
had,O
more,O
than,O
two,O
lobes,O
involved,O
.,O
Of,O
all,O
"
",O
included,O
patients,O
",",O
COVID19,B-Disease_COVID-19
pneumonia,O
presented,O
with,O
ground,O
glass,O
opacities,O
in,O
65,O
"
",O
(,O
72,O
%,O
),O
",",O
consolidation,O
in,O
12,O
(,O
13,O
%,O
),O
",",O
crazy,O
paving,O
pattern,O
in,O
11,O
(,O
12,O
%,O
),O
",",O
interlobular,O
"
",O
thickening,O
in,O
33,O
(,O
37,O
%,O
),O
",",O
adjacent,O
pleura,O
thickening,O
in,O
50,O
(,O
56,O
%,O
),O
",",O
and,O
linear,O
"
",O
opacities,O
combined,O
in,O
55,O
(,O
61,O
%,O
),O
.,O
Pleural,O
effusion,O
",",O
pericardial,O
effusion,O
",",O
and,O
"
",O
lymphadenopathy,O
were,O
uncommon,O
findings,O
.,O
In,O
addition,O
",",O
baseline,O
chest,O
CT,O
did,O
not,O
"
",O
show,O
any,O
abnormalities,O
in,O
21,O
patients,O
(,O
23,O
%,O
),O
",",O
but,O
3,O
patients,O
presented,O
bilateral,O
"
",O
ground,O
glass,O
opacities,O
on,O
the,O
second,O
CT,O
after,O
34,O
Â ,O
days,O
.,O
"
",O
CONCLUSION,O
:,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
can,O
be,O
confirmed,O
based,O
on,O
the,O
patient,O
's,O
history,O
",",O
"
",O
clinical,O
manifestations,O
",",O
imaging,O
characteristics,O
",",O
and,O
laboratory,O
tests,O
.,O
Chest,O
CT,O
"
",O
examination,O
plays,O
an,O
important,O
role,O
in,O
the,O
initial,O
diagnosis,O
of,O
the,O
novel,O
"
",O
coronavirus,O
pneumonia,O
.,O
Multiple,O
patchy,O
ground,O
glass,O
opacities,O
in,O
bilateral,O
"
",O
multiple,O
lobular,O
with,O
periphery,O
distribution,O
are,O
typical,O
chest,O
CT,O
imaging,O
"
",O
features,O
of,O
the,O
COVID19,B-Disease_COVID-19
pneumonia,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00259020047359,O
"
",O
PMID,O
:,O
32107577,O
"


",O
478,O
.,O
Occup,O
Med,O
(,O
Lond,O
),O
.,O
2020,O
Mar,O
12;70(1):35,O
.,O
doi,O
:,O
10.1093,O
occmed,O
kqaa036,O
.,O
"

",O
Occupational,O
risks,O
for,O
COVID19,B-Disease_COVID-19
infection,O
.,O
"

",O
Koh,O
D(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)PAPRSB,O
Institute,O
of,O
Health,O
Sciences,O
",",O
Universiti,O
Brunei,O
Darussalam,O
",",O
Brunei,O
"
",O
Darussalam,O
.,O
"
",O
(2)SSH,O
School,O
of,O
Public,O
Health,O
",",O
National,O
University,O
of,O
Singapore,O
",",O
Singapore,O
.,O
"

",O
DOI,O
:,O
10.1093,O
occmed,O
kqaa036,O
"
",O
PMID,O
:,O
32107548,O
"


",O
479,O
.,O
Nat,O
Commun,O
.,O
2020,O
Feb,O
27;11(1):1101,O
.,O
doi,O
:,O
10.1038,O
s41467020149318,O
.,O
"

",O
Cerebellumenriched,O
protein,O
INPP5A,O
contributes,O
to,O
selective,O
neuropathology,O
in,O
"
",O
mouse,O
model,O
of,O
spinocerebellar,O
ataxias,O
type,O
17,O
.,O
"

",O
Liu,O
Q(1)(2,O
),O
",",O
Huang,O
S(3,O
),O
",",O
Yin,O
P(4,O
),O
",",O
Yang,O
S(4,O
),O
",",O
Zhang,O
J(2,O
),O
",",O
Jing,O
L(5,O
),O
",",O
Cheng,O
"
",O
S(1)(2,O
),O
",",O
Tang,O
B(1)(6)(7,O
),O
",",O
Li,O
XJ(4,O
),O
",",O
Pan,O
Y(8)(9,O
),O
",",O
Li,O
S(10,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Hunan,O
Province,O
in,O
Neurodegenerative,O
Disorders,O
",",O
Department,O
of,O
"
",O
Neurology,O
",",O
Xiangya,O
Hospital,O
",",O
Central,O
South,O
University,O
",",O
Changsha,O
",",O
Hunan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Human,O
Genetics,O
",",O
Emory,O
University,O
School,O
of,O
Medicine,O
",",O
Atlanta,O
",",O
"
",O
GA,O
",",O
30322,O
",",O
USA,O
.,O
"
",O
(3)Department,O
of,O
Neurology,O
",",O
Tongji,O
Hospital,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)GuangdongHongkongMacau,O
Institute,O
of,O
CNS,O
Regeneration,O
",",O
Ministry,O
of,O
Education,O
"
",O
CNS,O
Regeneration,O
Collaborative,O
Joint,O
Laboratory,O
",",O
Jinan,O
University,O
",",O
Guangzhou,O
",",O
"
",O
China,O
.,O
"
",O
(5)Department,O
of,O
Emergency,O
",",O
Tongji,O
Hospital,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(6)National,O
Clinical,O
Research,O
Center,O
for,O
Geriatric,O
Disorders,O
",",O
Xiangya,O
Hospital,O
",",O
"
",O
Central,O
South,O
University,O
",",O
Changsha,O
",",O
Hunan,O
",",O
China,O
.,O
"
",O
(7)Center,O
for,O
Medical,O
Genetics,O
",",O
School,O
of,O
Life,O
Sciences,O
",",O
Central,O
South,O
"
",O
University,O
",",O
Changsha,O
",",O
Hunan,O
",",O
China,O
.,O
"
",O
(8)Key,O
Laboratory,O
of,O
Hunan,O
Province,O
in,O
Neurodegenerative,O
Disorders,O
",",O
Department,O
of,O
"
",O
Neurology,O
",",O
Xiangya,O
Hospital,O
",",O
Central,O
South,O
University,O
",",O
Changsha,O
",",O
Hunan,O
",",O
China,O
.,O
"
",O
panyongcheng@csu.edu.cn,O
.,O
"
",O
(9)Department,O
of,O
Human,O
Genetics,O
",",O
Emory,O
University,O
School,O
of,O
Medicine,O
",",O
Atlanta,O
",",O
"
",O
GA,O
",",O
30322,O
",",O
USA,O
.,O
panyongcheng@csu.edu.cn,O
.,O
"
",O
(10)GuangdongHongkongMacau,O
Institute,O
of,O
CNS,O
Regeneration,O
",",O
Ministry,O
of,O
Education,O
"
",O
CNS,O
Regeneration,O
Collaborative,O
Joint,O
Laboratory,O
",",O
Jinan,O
University,O
",",O
Guangzhou,O
",",O
"
",O
China,O
.,O
lishihualis@jnu.edu.cn,O
.,O
"

",O
Spinocerebellar,O
ataxias,O
17,O
(,O
SCA17,O
),O
is,O
caused,O
by,O
polyglutamine,O
(,O
polyQ,O
),O
expansion,O
"
",O
in,O
the,O
TATA,O
boxbinding,O
protein,O
(,O
TBP,O
),O
.,O
The,O
selective,O
neurodegeneration,O
in,O
the,O
"
",O
cerebellum,O
in,O
SCA17,O
raises,O
the,O
question,O
of,O
why,O
ubiquitously,O
expressed,O
polyQ,O
"
",O
proteins,O
can,O
cause,O
neurodegeneration,O
in,O
distinct,O
brain,O
regions,O
in,O
different,O
polyQ,O
"
",O
diseases,O
.,O
By,O
expressing,O
mutant,O
TBP,O
in,O
different,O
brain,O
regions,O
in,O
adult,O
wildtype,O
"
",O
mice,O
via,O
stereotaxic,O
injection,O
of,O
adenoassociated,O
virus,O
",",O
we,O
found,O
that,O
adult,O
"
",O
cerebellar,O
neurons,O
are,O
particularly,O
vulnerable,O
to,O
mutant,O
TBP,O
.,O
In,O
SCA17,O
knockin,O
"
",O
mice,O
",",O
mutant,O
TBP,O
inhibits,O
SP1mediated,O
gene,O
transcription,O
to,O
downregulate,O
"
",O
INPP5A,O
",",O
a,O
protein,O
that,O
is,O
highly,O
abundant,O
in,O
the,O
cerebellum,O
.,O
CRISPR,O
Cas9mediated,O
"
",O
deletion,O
of,O
Inpp5a,O
in,O
the,O
cerebellum,O
of,O
wildtype,O
mice,O
leads,O
to,O
Purkinje,O
cell,O
"
",O
degeneration,O
",",O
and,O
Inpp5a,O
overexpression,O
decreases,O
inositol,O
"1,4,5trisphosphate",O
"
",O
(,O
IP3,O
),O
levels,O
and,O
ameliorates,O
Purkinje,O
cell,O
degeneration,O
in,O
SCA17,O
knockin,O
mice,O
.,O
"
",O
Our,O
findings,O
demonstrate,O
the,O
important,O
contribution,O
of,O
a,O
tissuespecific,O
protein,O
"
",O
to,O
the,O
polyQ,O
proteinmediated,O
selective,O
neuropathology,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s41467020149318,O
"
",O
PMCID,O
:,O
PMC7046734,O
"
",O
PMID,O
:,O
32107387,O
"


",O
480,O
.,O
BMJ,O
.,O
2020,O
Feb,O
27;368:m793,O
.,O
doi,O
:,O
10.1136,O
bmj.m793,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
Trump,O
says,O
risk,O
to,O
Americans,O
is,O
"""",O
very,O
low,O
"""",O
.,O
"

",O
Tanne,O
JH(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)New,O
York,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m793,O
"
",O
PMID,O
:,O
32107254,O
"


",O
481,O
.,O
BMJ,O
.,O
2020,O
Feb,O
27;368:m792,O
.,O
doi,O
:,O
10.1136,O
bmj.m792,O
.,O
"

",O
Clinical,O
findings,O
in,O
a,O
group,O
of,O
patients,O
infected,O
with,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
SARSCov2,B-Virus_SARS-CoV-2
),O
outside,O
of,O
Wuhan,O
",",O
China,O
:,O
retrospective,O
case,O
series,O
.,O
"

",O
[,O
No,O
authors,O
listed,O
],O
"

",O
Erratum,O
for,O
"
    ",O
BMJ,O
.,O
2020,O
Feb,O
19;368:m606,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m792,O
"
",O
PMID,O
:,O
32107200,O
"


",O
482,O
.,O
Transfus,O
Med,O
Rev.,O
2020,O
Feb,O
21,O
.,O
pii,O
:,O
S08877963(20)300146,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.tmrv.2020.02.003,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
:,O
Coronaviruses,O
and,O
Blood,O
Safety,O
.,O
"

",O
Chang,O
L(1,O
),O
",",O
Yan,O
Y(1,O
),O
",",O
Wang,O
L(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Center,O
for,O
Clinical,O
Laboratories,O
",",O
Beijing,O
Hospital,O
",",O
National,O
Center,O
"
",O
of,O
Gerontology,O
;,O
Institute,O
of,O
Geriatric,O
Medicine,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
"
",O
Sciences,O
",",O
Beijing,O
",",O
PR,O
China,O
;,O
Beijing,O
Engineering,O
Research,O
Center,O
of,O
Laboratory,O
"
",O
Medicine,O
",",O
Beijing,O
Hospital,O
",",O
PR,O
China,O
.,O
"
",O
(2)National,O
Center,O
for,O
Clinical,O
Laboratories,O
",",O
Beijing,O
Hospital,O
",",O
National,O
Center,O
"
",O
of,O
Gerontology,O
;,O
Institute,O
of,O
Geriatric,O
Medicine,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
"
",O
Sciences,O
",",O
Beijing,O
",",O
PR,O
China,O
;,O
Beijing,O
Engineering,O
Research,O
Center,O
of,O
Laboratory,O
"
",O
Medicine,O
",",O
Beijing,O
Hospital,O
",",O
PR,O
China,O
;,O
Graduate,O
School,O
",",O
Peking,O
Union,O
Medical,O
"
",O
College,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
PR,O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
lunan99@163.com,O
.,O
"

",O
With,O
the,O
outbreak,O
of,O
unknown,O
pneumonia,O
in,O
Wuhan,O
",",O
China,O
",",O
in,O
December,O
2019,O
",",O
a,O
new,O
"
",O
coronavirus,O
",",O
Severe,B-Virus_SARS-CoV-2
Acute,I-Virus_SARS-CoV-2
Respiratory,I-Virus_SARS-CoV-2
Syndrome,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
"
",O
aroused,O
the,O
attention,O
of,O
the,O
entire,O
world,O
.,O
The,O
current,O
outbreak,O
of,O
infections,O
"
",O
with,O
SARSCoV2,B-Virus_SARS-CoV-2
is,O
termed,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
.,O
The,O
World,O
Health,O
"
",O
Organization,O
declared,O
COVID19,B-Disease_COVID-19
in,O
China,O
as,O
a,O
Public,O
Health,O
Emergency,O
of,O
"
",O
International,O
Concern,O
.,O
Two,O
other,O
coronavirus,O
infectionsSARS,O
in,O
20022003,O
and,O
"
",O
Middle,O
East,O
Respiratory,O
Syndrome,O
(,O
MERS,O
),O
in,O
2012both,O
caused,O
severe,O
respiratory,O
"
",O
syndrome,O
in,O
humans,O
.,O
All,O
3,O
of,O
these,O
emerging,O
infectious,O
diseases,O
leading,O
to,O
a,O
"
",O
global,O
spread,O
are,O
caused,O
by,O
Î²coronaviruses,O
.,O
Although,O
coronaviruses,O
usually,O
"
",O
infect,O
the,O
upper,O
or,O
lower,O
respiratory,O
tract,O
",",O
viral,O
shedding,O
in,O
plasma,O
or,O
serum,O
is,O
"
",O
common,O
.,O
Therefore,O
",",O
there,O
is,O
still,O
a,O
theoretical,O
risk,O
of,O
transmission,O
of,O
"
",O
coronaviruses,O
through,O
the,O
transfusion,O
of,O
labile,O
blood,O
products,O
.,O
Because,O
more,O
and,O
"
",O
more,O
asymptomatic,O
infections,O
are,O
being,O
found,O
among,O
COVID19,B-Disease_COVID-19
cases,O
",",O
considerations,O
"
",O
of,O
blood,O
safety,O
and,O
coronaviruses,O
have,O
arisen,O
especially,O
in,O
endemic,O
areas,O
.,O
In,O
"
",O
this,O
review,O
",",O
we,O
detail,O
current,O
evidence,O
and,O
understanding,O
of,O
the,O
transmission,O
of,O
"
",O
SARSCoV,O
",",O
MERSCoV,O
",",O
and,O
SARSCoV2,B-Virus_SARS-CoV-2
through,O
blood,O
products,O
as,O
of,O
February,O
10,O
",",O
"
",O
2020,O
",",O
and,O
also,O
discuss,O
pathogen,O
inactivation,O
methods,O
on,O
coronaviruses,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmrv.2020.02.003,O
"
",O
PMID,O
:,O
32107119,O
"


",O
483,O
.,O
BMC,O
Med,O
.,O
2020,O
Feb,O
28;18(1):57,O
.,O
doi,O
:,O
10.1186,O
s1291602001533w,O
.,O
"

",O
Q&A,O
:,O
The,O
Â ,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
outbreak,O
Â ,O
causing,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Fisher,O
D(1)(2,O
),O
",",O
Heymann,O
D(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
infectious,O
Diseases,O
",",O
University,O
Medicine,O
Cluster,O
",",O
National,O
"
",O
University,O
Health,O
Systems,O
",",O
Singapore,O
",",O
Singapore,O
.,O
mdcfda@nus.edu.sg,O
.,O
"
",O
(2)Yong,O
Loo,O
Lin,O
School,O
of,O
Medicine,O
",",O
National,O
University,O
of,O
Singapore,O
",",O
Singapore,O
",",O
"
",O
Singapore,O
.,O
mdcfda@nus.edu.sg,O
.,O
"
",O
(3)London,O
School,O
of,O
Hygiene,O
&,O
Tropical,O
Medicine,O
",",O
London,O
",",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s1291602001533w,O
"
",O
PMCID,O
:,O
PMC7047369,O
"
",O
PMID,O
:,O
32106852,O
"


",O
484,O
.,O
Viruses,O
.,O
2020,O
Feb,O
25;12(3,O
),O
.,O
pii,O
:,O
E254,O
.,O
doi,O
:,O
10.339,O
v12030254,O
.,O
"

",O
Preliminary,O
Identification,O
of,O
Potential,O
Vaccine,O
Targets,O
for,O
the,O
COVID19,B-Disease_COVID-19
"
",O
Coronavirus,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
Based,O
on,O
SARSCoV,O
Immunological,O
Studies,O
.,O
"

",O
Ahmed,O
SF(1,O
),O
",",O
Quadeer,O
AA(1,O
),O
",",O
McKay,O
MR(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Electronic,O
and,O
Computer,O
Engineering,O
",",O
The,O
Hong,O
Kong,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Chemical,O
and,O
Biological,O
Engineering,O
",",O
The,O
Hong,O
Kong,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"

",O
The,O
beginning,O
of,O
2020,O
has,O
seen,O
the,O
emergence,O
of,O
COVID19,B-Disease_COVID-19
outbreak,O
caused,O
by,O
a,O
"
",O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
Severe,B-Virus_SARS-CoV-2
Acute,I-Virus_SARS-CoV-2
Respiratory,I-Virus_SARS-CoV-2
Syndrome,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
.,O
"
",O
There,O
is,O
an,O
imminent,O
need,O
to,O
better,O
understand,O
this,O
new,O
virus,O
and,O
to,O
develop,O
ways,O
"
",O
to,O
control,O
its,O
spread,O
.,O
In,O
this,O
study,O
",",O
we,O
sought,O
to,O
gain,O
insights,O
for,O
vaccine,O
"
",O
design,O
against,O
SARSCoV2,B-Virus_SARS-CoV-2
by,O
considering,O
the,O
high,O
genetic,O
similarity,O
between,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
and,O
SARSCoV,O
",",O
which,O
caused,O
the,O
outbreak,O
in,O
2003,O
",",O
and,O
leveraging,O
"
",O
existing,O
immunological,O
studies,O
of,O
SARSCoV.,O
By,O
screening,O
the,O
"
",O
experimentallydetermined,O
SARSCoVderived,O
B,O
cell,O
and,O
T,O
cell,O
epitopes,O
in,O
the,O
"
",O
immunogenic,O
structural,O
proteins,O
of,O
SARSCoV,O
",",O
we,O
identified,O
a,O
set,O
of,O
B,O
cell,O
and,O
T,O
"
",O
cell,O
epitopes,O
derived,O
from,O
the,O
spike,O
(,O
S,O
),O
and,O
nucleocapsid,O
(,O
N,O
),O
proteins,O
that,O
map,O
"
",O
identically,O
to,O
SARSCoV2,B-Virus_SARS-CoV-2
proteins,O
.,O
As,O
no,O
mutation,O
has,O
been,O
observed,O
in,O
these,O
"
",O
identified,O
epitopes,O
among,O
the,O
120,O
available,O
SARSCoV2,B-Virus_SARS-CoV-2
sequences,O
(,O
as,O
of,O
21,O
"
",O
February,O
2020,O
),O
",",O
immune,O
targeting,O
of,O
these,O
epitopes,O
may,O
potentially,O
offer,O
"
",O
protection,O
against,O
this,O
novel,O
virus,O
.,O
For,O
the,O
T,O
cell,O
epitopes,O
",",O
we,O
performed,O
a,O
"
",O
population,O
coverage,O
analysis,O
of,O
the,O
associated,O
MHC,O
alleles,O
and,O
proposed,O
a,O
set,O
of,O
"
",O
epitopes,O
that,O
is,O
estimated,O
to,O
provide,O
broad,O
coverage,O
globally,O
",",O
as,O
well,O
as,O
in,O
"
",O
China,O
.,O
Our,O
findings,O
provide,O
a,O
screened,O
set,O
of,O
epitopes,O
that,O
can,O
help,O
guide,O
"
",O
experimental,O
efforts,O
towards,O
the,O
development,O
of,O
vaccines,O
against,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
DOI,O
:,O
10.339,O
v12030254,O
"
",O
PMID,O
:,O
32106567,O
"


",O
485,O
.,O
Pathogens,O
.,O
2020,O
Feb,O
25;9(3,O
),O
.,O
pii,O
:,O
E154,O
.,O
doi,O
:,O
10.339,O
pathogens9030154,O
.,O
"

",O
Orthohepevirus,O
C,O
:,O
An,O
Expanding,O
Species,O
of,O
Emerging,O
Hepatitis,O
E,O
Virus,O
Variants,O
.,O
"

",O
Wang,O
B(1,O
),O
",",O
Harms,O
D(2,O
),O
",",O
Yang,O
XL(3,O
),O
",",O
Bock,O
CT(2)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Biomedical,O
Sciences,O
and,O
Pathobiology,O
",",O
VirginiaMaryland,O
College,O
"
",O
of,O
Veterinary,O
Medicine,O
",",O
Virginia,O
Polytechnic,O
Institute,O
and,O
State,O
University,O
",",O
"
",O
Blacksburg,O
",",O
VA,O
24061,O
",",O
USA,O
.,O
"
",O
(2)Division,O
of,O
Viral,O
Gastroenteritis,O
and,O
Hepatitis,O
Pathogens,O
and,O
Enteroviruses,O
",",O
"
",O
Department,O
of,O
Infectious,O
Diseases,O
",",O
Robert,O
Koch,O
Institute,O
",",O
13353,O
Berlin,O
",",O
Germany,O
.,O
"
",O
(3)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
"
",O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430071,O
",",O
China,O
.,O
"
",O
(4)Institute,O
of,O
Tropical,O
Medicine,O
",",O
University,O
of,O
TÃ¼bingen,O
",",O
72074,O
TÃ¼bingen,O
",",O
"
",O
Germany,O
.,O
"

",O
Hepatitis,O
E,O
virus,O
(,O
HEV,O
),O
is,O
an,O
emerging,O
zoonotic,O
pathogen,O
that,O
has,O
received,O
an,O
"
",O
increasing,O
amount,O
of,O
attention,O
from,O
virologists,O
",",O
clinicians,O
",",O
veterinarians,O
",",O
and,O
"
",O
epidemiologists,O
over,O
the,O
past,O
decade,O
.,O
The,O
host,O
range,O
and,O
animal,O
reservoirs,O
of,O
HEV,O
"
",O
are,O
rapidly,O
expanding,O
and,O
a,O
plethora,O
of,O
emerging,O
HEV,O
variants,O
have,O
been,O
recently,O
"
",O
identified,O
",",O
some,O
of,O
which,O
have,O
the,O
potential,O
for,O
interspecies,O
infection,O
.,O
In,O
this,O
"
",O
review,O
",",O
the,O
detection,O
of,O
genetically,O
diverse,O
HEV,O
variants,O
",",O
classified,O
into,O
and,O
"
",O
presumably,O
associated,O
with,O
the,O
species,O
Orthohepevirus,O
C,O
",",O
currently,O
comprising,O
HEV,O
"
",O
genotypes,O
C1,O
and,O
C2,O
",",O
by,O
either,O
serological,O
or,O
molecular,O
approach,O
is,O
summarized,O
.,O
"
",O
The,O
distribution,O
",",O
genomic,O
variability,O
",",O
and,O
evolution,O
of,O
Orthohepevirus,O
C,O
are,O
"
",O
analyzed,O
.,O
Moreover,O
",",O
the,O
potential,O
risk,O
of,O
crossspecies,O
infection,O
and,O
zoonotic,O
"
",O
transmission,O
of,O
Orthohepevirus,O
C,O
are,O
discussed,O
.,O
"

",O
DOI,O
:,O
10.339,O
pathogens9030154,O
"
",O
PMID,O
:,O
32106525,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
486,O
.,O
Micromachines,O
(,O
Basel,O
),O
.,O
2020,O
Feb,O
25;11(3,O
),O
.,O
pii,O
:,O
E238,O
.,O
doi,O
:,O
10.339,O
mi11030238,O
.,O
"

",O
Disposable,O
DNA,O
Amplification,O
Chips,O
with,O
Integrated,O
LowCost,O
Heaters,O
.,O
"

",O
Veltkamp,O
HW(1,O
),O
",",O
Akegawa,O
Monteiro,O
F(1,O
),O
",",O
Sanders,O
R(1,O
),O
",",O
Wiegerink,O
R(1,O
),O
",",O
LÃ¶tters,O
"
",O
J(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Integrated,O
Devices,O
and,O
Systems,O
",",O
University,O
of,O
Twente,O
",",O
PO,O
Box,O
"
",O
217,O
",",O
7500,O
AE,O
Enschede,O
",",O
The,O
Netherlands,O
.,O
"
",O
(2)Bronkhorst,O
HighTech,O
BV,O
",",O
Nijverheidsstraat,O
1A,O
",",O
7261,O
AK,O
Ruurlo,O
",",O
The,O
"
",O
Netherlands,O
.,O
"

",O
Fast,O
pointofuse,O
detection,O
of,O
",",O
for,O
example,O
",",O
earlystage,O
zoonoses,O
",",O
e.g.,O
",",O
Qfever,O
",",O
"
",O
bovine,O
tuberculosis,O
",",O
or,O
the,O
Covid19,B-Disease_COVID-19
coronavirus,O
",",O
is,O
beneficial,O
for,O
both,O
humans,O
"
",O
and,O
animal,O
husbandry,O
as,O
it,O
can,O
save,O
lives,O
and,O
livestock,O
.,O
The,O
latter,O
prevents,O
"
",O
farmers,O
from,O
going,O
bankrupt,O
after,O
a,O
zoonoses,O
outbreak,O
.,O
This,O
paper,O
describes,O
the,O
"
",O
development,O
of,O
a,O
fabrication,O
process,O
and,O
the,O
proofofprinciple,O
of,O
a,O
disposable,O
"
",O
DNA,O
amplification,O
chip,O
with,O
an,O
integrated,O
heater,O
.,O
Based,O
on,O
the,O
analysis,O
of,O
the,O
"
",O
milling,O
process,O
",",O
metal,O
adhesion,O
studies,O
",",O
and,O
COMSOL,O
MultiPhysics,O
heat,O
transfer,O
"
",O
simulations,O
",",O
the,O
first,O
batch,O
of,O
chips,O
has,O
been,O
fabricated,O
and,O
successful,O
multiple,O
"
",O
displacement,O
amplification,O
reactions,O
are,O
performed,O
inside,O
these,O
chips,O
.,O
This,O
"
",O
research,O
is,O
the,O
first,O
step,O
towards,O
the,O
development,O
of,O
an,O
earlystage,O
zoonoses,O
"
",O
detection,O
device,O
.,O
Tests,O
with,O
real,O
zoonoses,O
and,O
DNA,O
specific,O
amplification,O
"
",O
reactions,O
still,O
need,O
to,O
be,O
done,O
.,O
"

",O
DOI,O
:,O
10.339,O
mi11030238,O
"
",O
PMID,O
:,O
32106462,O
"


",O
487,O
.,O
MMWR,O
Morb,O
Mortal,O
Wkly,O
Rep.,O
2020,O
Feb,O
28;69(8):216219,O
.,O
doi,O
:,O
"
",O
10.15585,O
mmwr.mm6908e1,O
.,O
"

",O
Update,O
:,O
Public,O
Health,O
Response,O
to,O
the,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
Outbreak,O
 ,O
United,O
"
",O
States,O
",",O
February,O
24,O
",",O
2020,O
.,O
"

",O
Jernigan,O
DB(1,O
),O
;,O
CDC,O
COVID19,B-Disease_COVID-19
Response,O
Team,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)CDC,O
COVID19,B-Disease_COVID-19
Response,O
Team,O
",",O
CDC,O
.,O
"

",O
An,O
outbreak,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
caused,O
by,O
the,O
2019,O
novel,O
"
",O
coronavirus,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
began,O
in,O
Wuhan,O
",",O
Hubei,O
Province,O
",",O
China,O
in,O
December,O
2019,O
",",O
"
",O
and,O
has,O
spread,O
throughout,O
China,O
and,O
to,O
31,O
other,O
countries,O
and,O
territories,O
",",O
"
",O
including,O
the,O
United,O
States,O
(,O
1,O
),O
.,O
As,O
of,O
February,O
23,O
",",O
2020,O
",",O
there,O
were,O
76936,O
"
",O
reported,O
cases,O
in,O
mainland,O
China,O
and,O
1875,O
cases,O
in,O
locations,O
outside,O
mainland,O
"
",O
China,O
(,O
1,O
),O
.,O
There,O
have,O
been,O
2462,O
associated,O
deaths,O
worldwide,O
;,O
no,O
deaths,O
have,O
been,O
"
",O
reported,O
in,O
the,O
United,O
States,O
.,O
Fourteen,O
cases,O
have,O
been,O
diagnosed,O
in,O
the,O
United,O
"
",O
States,O
",",O
and,O
an,O
additional,O
39,O
cases,O
have,O
occurred,O
among,O
repatriated,O
persons,O
from,O
"
",O
highrisk,O
settings,O
",",O
for,O
a,O
current,O
total,O
of,O
53,O
cases,O
within,O
the,O
United,O
States,O
.,O
"
",O
This,O
report,O
summarizes,O
the,O
aggressive,O
measures,O
(,O
"2,3",O
),O
that,O
CDC,O
",",O
state,O
and,O
local,O
"
",O
health,O
departments,O
",",O
multiple,O
other,O
federal,O
agencies,O
",",O
and,O
other,O
partners,O
are,O
"
",O
implementing,O
to,O
slow,O
and,O
try,O
to,O
contain,O
transmission,O
of,O
COVID19,B-Disease_COVID-19
in,O
the,O
United,O
"
",O
States,O
.,O
These,O
measures,O
require,O
the,O
identification,O
of,O
cases,O
and,O
contacts,O
of,O
"
",O
persons,O
with,O
COVID19,B-Disease_COVID-19
in,O
the,O
United,O
States,O
and,O
the,O
recommended,O
assessment,O
",",O
"
",O
monitoring,O
",",O
and,O
care,O
of,O
travelers,O
arriving,O
from,O
areas,O
with,O
substantial,O
COVID19,B-Disease_COVID-19
"
",O
transmission,O
.,O
Although,O
these,O
measures,O
might,O
not,O
prevent,O
widespread,O
transmission,O
"
",O
of,O
the,O
virus,O
in,O
the,O
United,O
States,O
",",O
they,O
are,O
being,O
implemented,O
to,O
1,O
),O
slow,O
the,O
"
",O
spread,O
of,O
illness,O
;,O
2,O
),O
provide,O
time,O
to,O
better,O
prepare,O
state,O
and,O
local,O
health,O
"
",O
departments,O
",",O
health,O
care,O
systems,O
",",O
businesses,O
",",O
educational,O
organizations,O
",",O
and,O
the,O
"
",O
general,O
public,O
in,O
the,O
event,O
that,O
widespread,O
transmission,O
occurs,O
;,O
and,O
3,O
),O
better,O
"
",O
characterize,O
COVID19,B-Disease_COVID-19
to,O
guide,O
public,O
health,O
recommendations,O
and,O
the,O
development,O
"
",O
and,O
deployment,O
of,O
medical,O
countermeasures,O
",",O
including,O
diagnostics,O
",",O
therapeutics,O
",",O
"
",O
and,O
vaccines,O
.,O
U.S.,O
public,O
health,O
authorities,O
are,O
monitoring,O
the,O
situation,O
"
",O
closely,O
",",O
and,O
CDC,O
is,O
coordinating,O
efforts,O
with,O
the,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
"
",O
and,O
other,O
global,O
partners,O
.,O
Interim,O
guidance,O
is,O
available,O
at,O
"
",O
https,O
:,O
 ,O
www.cdc.gov,O
coronavirus,O
index.html,O
.,O
As,O
more,O
is,O
learned,O
about,O
this,O
novel,O
"
",O
virus,O
and,O
this,O
outbreak,O
",",O
CDC,O
will,O
rapidly,O
incorporate,O
new,O
knowledge,O
into,O
guidance,O
"
",O
for,O
action,O
by,O
CDC,O
",",O
state,O
and,O
local,O
health,O
departments,O
",",O
health,O
care,O
providers,O
",",O
and,O
"
",O
communities,O
.,O
"

",O
DOI,O
:,O
10.15585,O
mmwr.mm6908e1,O
"
",O
PMID,O
:,O
32106216,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
author,O
has,O
completed,O
and,O
submitted,O
the,O
"
",O
International,O
Committee,O
of,O
Medical,O
Journal,O
Editors,O
form,O
for,O
disclosure,O
of,O
"
",O
potential,O
conflicts,O
of,O
interest,O
.,O
No,O
potential,O
conflicts,O
of,O
interest,O
were,O
"
",O
disclosed,O
.,O
"


",O
488,O
.,O
Am,O
J,O
Obstet,O
Gynecol,O
.,O
2020,O
Feb,O
24,O
.,O
pii,O
:,O
S00029378(20)301976,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ajog.2020.02.017,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
and,O
Pregnancy,O
:,O
What,O
obstetricians,O
need,O
to,O
"
",O
know,O
.,O
"

",O
Rasmussen,O
SA(1,O
),O
",",O
Smulian,O
JC(2,O
),O
",",O
Lednicky,O
JA(3,O
),O
",",O
Wen,O
TS(2,O
),O
",",O
Jamieson,O
DJ(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pediatrics,O
",",O
University,O
of,O
Florida,O
College,O
of,O
Medicine,O
",",O
"
",O
Gainesville,O
",",O
Florida,O
",",O
USA,O
;,O
Department,O
of,O
Epidemiology,O
",",O
University,O
of,O
Florida,O
"
",O
College,O
of,O
Public,O
Health,O
and,O
Health,O
Professions,O
and,O
College,O
of,O
Medicine,O
",",O
"
",O
Gainesville,O
",",O
Florida,O
",",O
USA,O
.,O
Electronic,O
address,O
:,O
skr9@ufl.edu,O
.,O
"
",O
(2)Department,O
of,O
Obstetrics,O
and,O
Gynecology,O
",",O
University,O
of,O
Florida,O
College,O
of,O
"
",O
Medicine,O
",",O
Gainesville,O
",",O
Florida,O
",",O
USA,O
.,O
"
",O
(3)Department,O
of,O
Environmental,O
and,O
Global,O
Health,O
",",O
University,O
of,O
Florida,O
College,O
"
",O
of,O
Public,O
Health,O
and,O
Health,O
Professions,O
",",O
and,O
University,O
of,O
Florida,O
Emerging,O
"
",O
Pathogens,O
Institute,O
",",O
Gainesville,O
",",O
Florida,O
",",O
USA,O
.,O
"
",O
(4)Department,O
of,O
Gynecology,O
and,O
Obstetrics,O
",",O
Emory,O
University,O
School,O
of,O
Medicine,O
",",O
"
",O
Atlanta,O
",",O
GA,O
",",O
USA,O
.,O
"

",O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
is,O
an,O
emerging,O
disease,O
with,O
a,O
rapid,O
increase,O
"
",O
in,O
cases,O
and,O
deaths,O
since,O
its,O
first,O
identification,O
in,O
Wuhan,O
",",O
China,O
",",O
in,O
December,O
"
",O
2019,O
.,O
Limited,O
data,O
are,O
available,O
about,O
COVID19,B-Disease_COVID-19
during,O
pregnancy,O
;,O
however,O
",",O
"
",O
information,O
on,O
illnesses,O
associated,O
with,O
other,O
highly,O
pathogenic,O
coronaviruses,O
"
",O
(,O
i.e.,O
",",O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
and,O
the,O
Middle,O
East,O
respiratory,O
"
",O
syndrome,O
(,O
MERS,O
),O
),O
might,O
provide,O
insights,O
into,O
COVID19,B-Disease_COVID-19
's,O
effects,O
during,O
pregnancy,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ajog.2020.02.017,O
"
",O
PMID,O
:,O
32105680,O
"


",O
489,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
24,O
.,O
pii,O
:,O
S14733099(20)301341,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301341,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
pneumonia,O
:,O
what,O
has,O
CT,O
taught,O
us,O
?,O
"

",O
Lee,O
EYP(1,O
),O
",",O
Ng,O
MY(2,O
),O
",",O
Khong,O
PL(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Diagnostic,O
Radiology,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
"
",O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
eyplee77@hku.hk,O
.,O
"
",O
(2)Department,O
of,O
Diagnostic,O
Radiology,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
"
",O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301341,O
"
",O
PMID,O
:,O
32105641,O
"


",O
490,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
24,O
.,O
pii,O
:,O
S14733099(20)301134,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301134,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Viral,O
load,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
clinical,O
samples,O
.,O
"

",O
Pan,O
Y(1,O
),O
",",O
Zhang,O
D(2,O
),O
",",O
Yang,O
P(1,O
),O
",",O
Poon,O
LLM(3,O
),O
",",O
Wang,O
Q(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Beijing,O
Center,O
for,O
Disease,O
Prevention,O
and,O
Control,O
",",O
Beijing,O
100013,O
",",O
China,O
;,O
"
",O
Beijing,O
Research,O
Center,O
for,O
Preventive,O
Medicine,O
",",O
Beijing,O
",",O
China,O
;,O
School,O
of,O
Public,O
"
",O
Health,O
",",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Beijing,O
Center,O
for,O
Disease,O
Prevention,O
and,O
Control,O
",",O
Beijing,O
100013,O
",",O
China,O
;,O
"
",O
Beijing,O
Research,O
Center,O
for,O
Preventive,O
Medicine,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)School,O
of,O
Public,O
Health,O
",",O
LKS,O
Faculty,O
of,O
Medicine,O
",",O
The,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
999077,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
llmpoon@hku.hk,O
.,O
"
",O
(4)Beijing,O
Center,O
for,O
Disease,O
Prevention,O
and,O
Control,O
",",O
Beijing,O
100013,O
",",O
China,O
;,O
"
",O
Beijing,O
Research,O
Center,O
for,O
Preventive,O
Medicine,O
",",O
Beijing,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
bjcdcxm@126.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301134,O
"
",O
PMID,O
:,O
32105638,O
"


",O
491,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
24,O
.,O
pii,O
:,O
S14733099(20)300864,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)300864,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Radiological,O
findings,O
from,O
81,O
patients,O
with,O
COVID19,B-Disease_COVID-19
pneumonia,O
in,O
Wuhan,O
",",O
China,O
:,O
a,O
"
",O
descriptive,O
study,O
.,O
"

",O
Shi,O
H(1,O
),O
",",O
Han,O
X(1,O
),O
",",O
Jiang,O
N(1,O
),O
",",O
Cao,O
Y(1,O
),O
",",O
Alwalid,O
O(1,O
),O
",",O
Gu,O
J(1,O
),O
",",O
Fan,O
Y(2,O
),O
",",O
Zheng,O
"
",O
C(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
;,O
Hubei,O
Province,O
Key,O
"
",O
Laboratory,O
of,O
Molecular,O
Imaging,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
Wuhan,O
Jinyintan,O
Hospital,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
1024932023@qq.com,O
.,O
"
",O
(3)Department,O
of,O
Radiology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
;,O
Hubei,O
Province,O
Key,O
"
",O
Laboratory,O
of,O
Molecular,O
Imaging,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
hqzcsxh@sina.com,O
.,O
"

",O
BACKGROUND,O
:,O
A,O
cluster,O
of,O
patients,O
with,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
"
",O
pneumonia,O
caused,O
by,O
infection,O
with,O
severe,O
acute,O
respiratory,O
syndrome,O
coronavirus,O
"
",O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
were,O
successively,O
reported,O
in,O
Wuhan,O
",",O
China,O
.,O
We,O
aimed,O
to,O
describe,O
"
",O
the,O
CT,O
findings,O
across,O
different,O
timepoints,O
throughout,O
the,O
disease,O
course,O
.,O
"
",O
METHODS,O
:,O
Patients,O
with,O
COVID19,B-Disease_COVID-19
pneumonia,O
(,O
confirmed,O
by,O
nextgeneration,O
"
",O
sequencing,O
or,O
RTPCR,O
),O
who,O
were,O
admitted,O
to,O
one,O
of,O
two,O
hospitals,O
in,O
Wuhan,O
and,O
who,O
"
",O
underwent,O
serial,O
chest,O
CT,O
scans,O
were,O
retrospectively,O
enrolled,O
.,O
Patients,O
were,O
"
",O
grouped,O
on,O
the,O
basis,O
of,O
the,O
interval,O
between,O
symptom,O
onset,O
and,O
the,O
first,O
CT,O
scan,O
:,O
"
",O
group,O
1,O
(,O
subclinical,O
patients,O
;,O
scans,O
done,O
before,O
symptom,O
onset,O
),O
",",O
group,O
2,O
(,O
scans,O
"
",O
done,O
â‰¤1,O
week,O
after,O
symptom,O
onset,O
),O
",",O
group,O
3,O
(,O
>,O
1,O
week,O
to,O
2,O
weeks,O
),O
",",O
and,O
group,O
4,O
(,O
>,O
2,O
"
",O
weeks,O
to,O
3,O
weeks,O
),O
.,O
Imaging,O
features,O
and,O
their,O
distribution,O
were,O
analysed,O
and,O
"
",O
compared,O
across,O
the,O
four,O
groups,O
.,O
"
",O
FINDINGS,O
:,O
81,O
patients,O
admitted,O
to,O
hospital,O
between,O
Dec,O
20,O
",",O
2019,O
",",O
and,O
Jan,O
23,O
",",O
"
",O
2020,O
",",O
were,O
retrospectively,O
enrolled,O
.,O
The,O
cohort,O
included,O
42,O
(,O
52,O
%,O
),O
men,O
and,O
39,O
"
",O
(,O
48,O
%,O
),O
women,O
",",O
and,O
the,O
mean,O
age,O
was,O
49Â·5,O
years,O
(,O
SD,O
11Â·0,O
),O
.,O
The,O
mean,O
number,O
of,O
"
",O
involved,O
lung,O
segments,O
was,O
10Â·5,O
(,O
SD,O
6Â·4,O
),O
overall,O
",",O
2Â·8,O
(,O
3Â·3,O
),O
in,O
group,O
1,O
",",O
11Â·1,O
"
",O
(,O
5Â·4,O
),O
in,O
group,O
2,O
",",O
13Â·0,O
(,O
5Â·7,O
),O
in,O
group,O
3,O
",",O
and,O
12Â·1,O
(,O
5Â·9,O
),O
in,O
group,O
4,O
.,O
The,O
"
",O
predominant,O
pattern,O
of,O
abnormality,O
observed,O
was,O
bilateral,O
(,O
64,O
[,O
79,O
%,O
],O
patients,O
),O
",",O
"
",O
peripheral,O
(,O
44,O
[,O
54,O
%,O
],O
),O
",",O
illdefined,O
(,O
66,O
[,O
81,O
%,O
],O
),O
",",O
and,O
groundglass,O
opacification,O
(,O
53,O
"
",O
[,O
65,O
%,O
],O
),O
",",O
mainly,O
involving,O
the,O
right,O
lower,O
lobes,O
(,O
225,O
[,O
27,O
%,O
],O
of,O
849,O
affected,O
"
",O
segments,O
),O
.,O
In,O
group,O
1,O
(,O
n=15,O
),O
",",O
the,O
predominant,O
pattern,O
was,O
unilateral,O
(,O
nine,O
[,O
60,O
%,O
],O
),O
"
",O
and,O
multifocal,O
(,O
eight,O
[,O
53,O
%,O
],O
),O
groundglass,O
opacities,O
(,O
14,O
[,O
93,O
%,O
],O
),O
.,O
Lesions,O
quickly,O
"
",O
evolved,O
to,O
bilateral,O
(,O
19,O
[,O
90,O
%,O
],O
),O
",",O
diffuse,O
(,O
11,O
[,O
52,O
%,O
],O
),O
groundglass,O
opacity,O
"
",O
predominance,O
(,O
17,O
[,O
81,O
%,O
],O
),O
in,O
group,O
2,O
(,O
n=21,O
),O
.,O
Thereafter,O
",",O
the,O
prevalence,O
of,O
"
",O
groundglass,O
opacities,O
continued,O
to,O
decrease,O
(,O
17,O
[,O
57,O
%,O
],O
of,O
30,O
patients,O
in,O
group,O
3,O
",",O
"
",O
and,O
five,O
[,O
33,O
%,O
],O
of,O
15,O
in,O
group,O
4,O
),O
",",O
and,O
consolidation,O
and,O
mixed,O
patterns,O
became,O
"
",O
more,O
frequent,O
(,O
12,O
[,O
40,O
%,O
],O
in,O
group,O
3,O
",",O
eight,O
[,O
53,O
%,O
],O
in,O
group,O
4,O
),O
.,O
"
",O
INTERPRETATION,O
:,O
COVID19,B-Disease_COVID-19
pneumonia,O
manifests,O
with,O
chest,O
CT,O
imaging,O
abnormalities,O
",",O
"
",O
even,O
in,O
asymptomatic,O
patients,O
",",O
with,O
rapid,O
evolution,O
from,O
focal,O
unilateral,O
to,O
"
",O
diffuse,O
bilateral,O
groundglass,O
opacities,O
that,O
progressed,O
to,O
or,O
coexisted,O
with,O
"
",O
consolidations,O
within,O
13,O
weeks,O
.,O
Combining,O
assessment,O
of,O
imaging,O
features,O
with,O
"
",O
clinical,O
and,O
laboratory,O
findings,O
could,O
facilitate,O
early,O
diagnosis,O
of,O
COVID19,B-Disease_COVID-19
"
",O
pneumonia,O
.,O
"
",O
FUNDING,O
:,O
None,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)300864,O
"
",O
PMID,O
:,O
32105637,O
"


",O
492,O
.,O
Lancet,O
Respir,O
Med,O
.,O
2020,O
Feb,O
24,O
.,O
pii,O
:,O
S22132600(20)300849,O
.,O
doi,O
:,O
"
",O
10.1016,O
S22132600(20)300849,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Staff,O
safety,O
during,O
emergency,O
airway,O
management,O
for,O
COVID19,B-Disease_COVID-19
in,O
Hong,O
Kong,O
.,O
"

",O
Cheung,O
JC(1,O
),O
",",O
Ho,O
LT(2,O
),O
",",O
Cheng,O
JV(2,O
),O
",",O
Cham,O
EYK(2,O
),O
",",O
Lam,O
KN(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Intensive,O
Care,O
Unit,O
",",O
North,O
District,O
Hospital,O
",",O
Sheung,O
Shui,O
",",O
Hong,O
Kong,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
jonathanchunheicheung@gmail.com,O
.,O
"
",O
(2)Intensive,O
Care,O
Unit,O
",",O
North,O
District,O
Hospital,O
",",O
Sheung,O
Shui,O
",",O
Hong,O
Kong,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22132600(20)300849,O
"
",O
PMID,O
:,O
32105633,O
"


",O
493,O
.,O
Lancet,O
Respir,O
Med,O
.,O
2020,O
Feb,O
24,O
.,O
pii,O
:,O
S22132600(20)300795,O
.,O
doi,O
:,O
"
",O
10.1016,O
S22132600(20)300795,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
course,O
and,O
outcomes,O
of,O
critically,O
ill,O
patients,O
with,O
SARSCoV2,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
"
",O
in,O
Wuhan,O
",",O
China,O
:,O
a,O
singlecentered,O
",",O
retrospective,O
",",O
observational,O
study,O
.,O
"

",O
Yang,O
X(1,O
),O
",",O
Yu,O
Y(2,O
),O
",",O
Xu,O
J(2,O
),O
",",O
Shu,O
H(2,O
),O
",",O
Xia,O
J(3,O
),O
",",O
Liu,O
H(1,O
),O
",",O
Wu,O
Y(2,O
),O
",",O
Zhang,O
L(4,O
),O
",",O
"
",O
Yu,O
Z(5,O
),O
",",O
Fang,O
M(6,O
),O
",",O
Yu,O
T(3,O
),O
",",O
Wang,O
Y(2,O
),O
",",O
Pan,O
S(2,O
),O
",",O
Zou,O
X(2,O
),O
",",O
Yuan,O
S(2,O
),O
",",O
Shang,O
"
",O
Y(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
;,O
Institute,O
of,O
Anesthesiology,O
"
",O
and,O
Critical,O
Care,O
Medicine,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
;,O
Jin,O
Yintan,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
;,O
Institute,O
of,O
Anesthesiology,O
"
",O
and,O
Critical,O
Care,O
Medicine,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Jin,O
Yintan,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Xiangyang,O
Central,O
Hospital,O
",",O
Affiliated,O
"
",O
Hospital,O
of,O
Hubei,O
University,O
of,O
Arts,O
and,O
Science,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(6)Union,O
Hospital,O
",",O
and,O
Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Tongji,O
Hospital,O
",",O
"
",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(7)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
;,O
Institute,O
of,O
Anesthesiology,O
"
",O
and,O
Critical,O
Care,O
Medicine,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
;,O
Jin,O
Yintan,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
you_shang@yahoo.com,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
Lancet,O
Respir,O
Med,O
.,O
2020,O
Feb,O
28,O
;,O
:,O
.,O
"

",O
BACKGROUND,O
:,O
An,O
ongoing,O
outbreak,O
of,O
pneumonia,O
associated,O
with,O
the,O
severe,O
acute,O
"
",O
respiratory,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
started,O
in,O
December,O
",",O
2019,O
",",O
in,O
Wuhan,O
",",O
"
",O
China,O
.,O
Information,O
about,O
critically,O
ill,O
patients,O
with,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
is,O
"
",O
scarce,O
.,O
We,O
aimed,O
to,O
describe,O
the,O
clinical,O
course,O
and,O
outcomes,O
of,O
critically,O
ill,O
"
",O
patients,O
with,O
SARSCoV2,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
.,O
"
",O
METHODS,O
:,O
In,O
this,O
singlecentered,O
",",O
retrospective,O
",",O
observational,O
study,O
",",O
we,O
enrolled,O
"
",O
52,O
critically,O
ill,O
adult,O
patients,O
with,O
SARSCoV2,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
who,O
were,O
admitted,O
to,O
"
",O
the,O
intensive,O
care,O
unit,O
(,O
ICU,O
),O
of,O
Wuhan,O
Jin,O
Yintan,O
hospital,O
(,O
Wuhan,O
",",O
China,O
),O
"
",O
between,O
late,O
December,O
",",O
2019,O
",",O
and,O
Jan,O
26,O
",",O
2020,O
.,O
Demographic,O
data,O
",",O
symptoms,O
",",O
"
",O
laboratory,O
values,O
",",O
comorbidities,O
",",O
treatments,O
",",O
and,O
clinical,O
outcomes,O
were,O
all,O
"
",O
collected,O
.,O
Data,O
were,O
compared,O
between,O
survivors,O
and,O
nonsurvivors,O
.,O
The,O
primary,O
"
",O
outcome,O
was,O
28day,O
mortality,O
",",O
as,O
of,O
Feb,O
9,O
",",O
2020,O
.,O
Secondary,O
outcomes,O
included,O
"
",O
incidence,O
of,O
SARSCoV2related,O
acute,O
respiratory,O
distress,O
syndrome,O
(,O
ARDS,O
),O
and,O
"
",O
the,O
proportion,O
of,O
patients,O
requiring,O
mechanical,O
ventilation,O
.,O
"
",O
FINDINGS,O
:,O
Of,O
710,O
patients,O
with,O
SARSCoV2,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
",",O
52,O
critically,O
ill,O
adult,O
"
",O
patients,O
were,O
included,O
.,O
The,O
mean,O
age,O
of,O
the,O
52,O
patients,O
was,O
59Â·7,O
(,O
SD,O
13Â·3,O
),O
years,O
",",O
"
",O
35,O
(,O
67,O
%,O
),O
were,O
men,O
",",O
21,O
(,O
40,O
%,O
),O
had,O
chronic,O
illness,O
",",O
51,O
(,O
98,O
%,O
),O
had,O
fever,O
.,O
32,O
(,O
61Â·5,O
%,O
),O
"
",O
patients,O
had,O
died,O
at,O
28,O
days,O
",",O
and,O
the,O
median,O
duration,O
from,O
admission,O
to,O
the,O
"
",O
intensive,O
care,O
unit,O
(,O
ICU,O
),O
to,O
death,O
was,O
7,O
(,O
IQR,O
311,O
),O
days,O
for,O
nonsurvivors,O
.,O
"
",O
Compared,O
with,O
survivors,O
",",O
nonsurvivors,O
were,O
older,O
(,O
64Â·6,O
years,O
[,O
11Â·2,O
],O
vs,O
51Â·9,O
"
",O
years,O
[,O
12Â·9,O
],O
),O
",",O
more,O
likely,O
to,O
develop,O
ARDS,O
(,O
26,O
[,O
81,O
%,O
],O
patients,O
vs,O
9,O
[,O
45,O
%,O
],O
"
",O
patients,O
),O
",",O
and,O
more,O
likely,O
to,O
receive,O
mechanical,O
ventilation,O
(,O
30,O
[,O
94,O
%,O
],O
patients,O
"
",O
vs,O
7,O
[,O
35,O
%,O
],O
patients,O
),O
",",O
either,O
invasively,O
or,O
noninvasively,O
.,O
Most,O
patients,O
had,O
"
",O
organ,O
function,O
damage,O
",",O
including,O
35,O
(,O
67,O
%,O
),O
with,O
ARDS,O
",",O
15,O
(,O
29,O
%,O
),O
with,O
acute,O
kidney,O
"
",O
injury,O
",",O
12,O
(,O
23,O
%,O
),O
with,O
cardiac,O
injury,O
",",O
15,O
(,O
29,O
%,O
),O
with,O
liver,O
dysfunction,O
",",O
and,O
one,O
"
",O
(,O
2,O
%,O
),O
with,O
pneumothorax,O
.,O
37,O
(,O
71,O
%,O
),O
patients,O
required,O
mechanical,O
ventilation,O
.,O
"
",O
Hospitalacquired,O
infection,O
occurred,O
in,O
seven,O
(,O
13Â·5,O
%,O
),O
patients,O
.,O
"
",O
INTERPRETATION,O
:,O
The,O
mortality,O
of,O
critically,O
ill,O
patients,O
with,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
pneumonia,O
is,O
considerable,O
.,O
The,O
survival,O
time,O
of,O
the,O
nonsurvivors,O
is,O
likely,O
to,O
be,O
"
",O
within,O
12,O
weeks,O
after,O
ICU,O
admission,O
.,O
Older,O
patients,O
(,O
>,O
65,O
years,O
),O
with,O
"
",O
comorbidities,O
and,O
ARDS,O
are,O
at,O
increased,O
risk,O
of,O
death,O
.,O
The,O
severity,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
pneumonia,O
poses,O
great,O
strain,O
on,O
critical,O
care,O
resources,O
in,O
hospitals,O
",",O
especially,O
"
",O
if,O
they,O
are,O
not,O
adequately,O
staffed,O
or,O
resourced,O
.,O
"
",O
FUNDING,O
:,O
None,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22132600(20)300795,O
"
",O
PMID,O
:,O
32105632,O
"


",O
494,O
.,O
RETRACTED,O
ARTICLE,O
"

",O
Lancet,O
Glob,O
Health,O
.,O
2020,O
Feb,O
24,O
.,O
pii,O
:,O
S2214109X(20)300656,O
.,O
doi,O
:,O
"
",O
10.1016,O
S2214109X(20)300656,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Chinese,O
medical,O
staff,O
request,O
international,O
medical,O
assistance,O
in,O
fighting,O
"
",O
against,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Zeng,O
Y(1,O
),O
",",O
Zhen,O
Y(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Nursing,O
",",O
Third,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
Medical,O
"
",O
Hospital,O
",",O
Guangzhou,O
510150,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
596830447@qq.com,O
.,O
"
",O
(2)Department,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
Sun,O
Yetsen,O
Memorial,O
Hospital,O
",",O
Sun,O
"
",O
Yetsen,O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"

",O
Retraction,O
in,O
"
    ",O
Lancet,O
Glob,O
Health,O
.,O
2020,O
Feb,O
27,O
;,O
:,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S2214109X(20)300656,O
"
",O
PMID,O
:,O
32105614,O
"


",O
495,O
.,O
Lancet,O
.,O
2020,O
Mar,O
7;395(10226):764766,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)304219,O
.,O
Epub,O
"
",O
2020,O
Feb,O
24,O
.,O
"

",O
COVID19,B-Disease_COVID-19
control,O
in,O
China,O
during,O
mass,O
population,O
movements,O
at,O
New,O
Year,O
.,O
"

",O
Chen,O
S(1,O
),O
",",O
Yang,O
J(2,O
),O
",",O
Yang,O
W(3,O
),O
",",O
Wang,O
C(4,O
),O
",",O
BÃ¤rnighausen,O
T(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Heidelberg,O
Institute,O
of,O
Global,O
Health,O
",",O
Heidelberg,O
Medical,O
School,O
",",O
Heidelberg,O
"
",O
University,O
",",O
Heidelberg,O
",",O
Germany,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Medical,O
Molecular,O
Biology,O
",",O
Institute,O
of,O
Basic,O
Medical,O
"
",O
Sciences,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
and,O
Peking,O
Union,O
Medical,O
College,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
and,O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
",",O
"
",O
China,O
.,O
"
",O
(4)Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
and,O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
",",O
"
",O
China,O
;,O
Chinese,O
Academy,O
of,O
Engineering,O
",",O
Beijing,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
wangchen@pumc.edu.cn,O
.,O
"
",O
(5)Heidelberg,O
Institute,O
of,O
Global,O
Health,O
",",O
Heidelberg,O
Medical,O
School,O
",",O
Heidelberg,O
"
",O
University,O
",",O
Heidelberg,O
",",O
Germany,O
;,O
Harvard,O
T,O
H,O
Chan,O
School,O
of,O
Public,O
Health,O
",",O
"
",O
Harvard,O
University,O
",",O
Boston,O
MA,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)304219,O
"
",O
PMID,O
:,O
32105609,O
"


",O
496,O
.,O
Radiology,O
.,O
2020,O
Feb,O
27:200527,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200527,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Essentials,O
for,O
Radiologists,O
on,O
COVID19,B-Disease_COVID-19
:,O
An,O
UpdateRadiology,O
Scientific,O
Expert,O
"
",O
Panel,O
.,O
"

",O
Kanne,O
JP(1,O
),O
",",O
Little,O
BP(1,O
),O
",",O
Chung,O
JH(1,O
),O
",",O
Elicker,O
BM(1,O
),O
",",O
Ketai,O
LH(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
University,O
of,O
Wisconsin,O
School,O
of,O
Medicine,O
and,O
Public,O
"
",O
Health,O
Madison,O
WI,O
(,O
J.P.K.,O
),O
",",O
Department,O
of,O
Radiology,O
Massachusetts,O
General,O
"
",O
Hospital,O
Boston,O
MA,O
(,O
B.P.L.,O
),O
",",O
and,O
Department,O
of,O
Radiology,O
University,O
of,O
Chicago,O
"
",O
Chicago,O
IL,O
(,O
J.H.C.,O
),O
",",O
Department,O
of,O
Radiology,O
University,O
of,O
California,O
San,O
"
",O
Francisco,O
San,O
Francisco,O
CA,O
(,O
B.M.E.,O
),O
",",O
Department,O
of,O
Radiology,O
University,O
of,O
New,O
"
",O
Mexico,O
Albuquerque,O
NM,O
(,O
L.H.K.,O
),O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200527,O
"
",O
PMID,O
:,O
32105562,O
"


",O
497,O
.,O
Psychiatry,O
Clin,O
Neurosci,O
.,O
2020,O
Feb,O
27,O
.,O
doi,O
:,O
10.1111,O
pcn.12995,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Trust,O
is,O
a,O
key,O
factor,O
in,O
the,O
willingness,O
of,O
health,O
professionals,O
to,O
work,O
during,O
"
",O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
:,O
Experience,O
from,O
the,O
H1N1,O
pandemic,O
in,O
Japan,O
2009,O
.,O
"

",O
Imai,O
H(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Health,O
Promotion,O
and,O
Human,O
Behavior,O
",",O
Graduate,O
School,O
of,O
Medicine,O
School,O
of,O
"
",O
Public,O
Health,O
",",O
Kyoto,O
University,O
",",O
Kyoto,O
",",O
Japan,O
.,O
"
",O
(2)Ohashi,O
Clinic,O
",",O
Tokyo,O
",",O
Japan,O
.,O
"

",O
DOI,O
:,O
10.1111,O
pcn.12995,O
"
",O
PMID,O
:,O
32105381,O
"


",O
498,O
.,O
JAMA,O
.,O
2020,O
Feb,O
27,O
.,O
doi,O
:,O
10.1001,O
jama.2020.2783,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Positive,O
RTPCR,O
Test,O
Results,O
in,O
Patients,O
Recovered,O
From,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Lan,O
L(1,O
),O
",",O
Xu,O
D(1,O
),O
",",O
Ye,O
G(2,O
),O
",",O
Xia,O
C(3,O
),O
",",O
Wang,O
S(3,O
),O
",",O
Li,O
Y(2,O
),O
",",O
Xu,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Laboratory,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Beijing,O
Infervision,O
Technology,O
Co,O
Ltd,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.2783,O
"
",O
PMID,O
:,O
32105304,O
"


",O
499,O
.,O
Asian,O
Pac,O
J,O
Allergy,O
Immunol,O
.,O
2020,O
Feb,O
27,O
.,O
doi,O
:,O
10.12932,O
AP2002200772,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Immune,O
responses,O
in,O
COVID19,B-Disease_COVID-19
and,O
potential,O
vaccines,O
:,O
Lessons,O
learned,O
from,O
SARS,O
"
",O
and,O
MERS,O
epidemic,O
.,O
"

",O
Prompetchara,O
E(1)(2)(3,O
),O
",",O
Ketloy,O
C(1)(2,O
),O
",",O
Palaga,O
T(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Center,O
of,O
Excellence,O
in,O
Vaccine,O
Research,O
and,O
Development,O
(,O
Chula,O
Vaccine,O
"
",O
Research,O
Center,O
Chula,O
VRC,O
),O
",",O
Faculty,O
of,O
Medicine,O
",",O
Chulalongkorn,O
University,O
",",O
"
",O
Bangkok,O
10330,O
",",O
Thailand,O
.,O
"
",O
(2)Department,O
of,O
Laboratory,O
Medicine,O
",",O
Faculty,O
of,O
Medicine,O
",",O
Chulalongkorn,O
"
",O
University,O
",",O
Bangkok,O
10330,O
",",O
Thailand,O
"
",O
(3)Department,O
of,O
Microbiology,O
",",O
Faculty,O
of,O
Science,O
",",O
Chulalongkorn,O
University,O
",",O
"
",O
Bangkok,O
10330,O
",",O
Thailand,O
.,O
"
",O
(4)Center,O
of,O
Excellence,O
in,O
Immunology,O
and,O
Immunemediated,O
Diseases,O
",",O
Chulalongkorn,O
"
",O
University,O
",",O
Bangkok,O
10330,O
",",O
Thailand,O
.,O
"
",O
(5)Vaccines,O
and,O
Therapeutic,O
Proteins,O
Research,O
Group,O
",",O
the,O
Special,O
Task,O
Force,O
for,O
"
",O
Activating,O
Research,O
(,O
STAR,O
),O
",",O
Chulalongkorn,O
University,O
",",O
Bangkok,O
10330,O
",",O
Thailand,O
.,O
"

",O
As,O
the,O
world,O
is,O
witnessing,O
the,O
epidemic,O
of,O
COVID19,B-Disease_COVID-19
",",O
a,O
disease,O
caused,O
by,O
a,O
novel,O
"
",O
coronavirus,O
",",O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
emerging,O
genetics,O
and,O
clinical,O
evidences,O
suggest,O
a,O
"
",O
similar,O
path,O
to,O
those,O
of,O
SARS,O
and,O
MERS,O
.,O
The,O
rapid,O
genomic,O
sequencing,O
and,O
open,O
"
",O
access,O
data,O
",",O
together,O
with,O
advanced,O
vaccine,O
technology,O
",",O
are,O
expected,O
to,O
give,O
us,O
"
",O
more,O
knowledge,O
on,O
the,O
pathogen,O
itself,O
",",O
including,O
the,O
host,O
immune,O
response,O
as,O
well,O
"
",O
as,O
the,O
plan,O
for,O
therapeutic,O
vaccines,O
in,O
the,O
near,O
future,O
.,O
This,O
review,O
aims,O
to,O
"
",O
provide,O
a,O
comparative,O
view,O
among,O
SARSCoV,O
",",O
MERSCoV,O
and,O
the,O
newly,O
epidemic,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
in,O
the,O
hope,O
to,O
gain,O
a,O
better,O
understanding,O
of,O
the,O
hostpathogen,O
"
",O
interaction,O
",",O
host,O
immune,O
responses,O
",",O
and,O
the,O
pathogen,O
immune,O
evasion,O
strategies,O
.,O
"
",O
This,O
predictive,O
view,O
may,O
help,O
in,O
designing,O
an,O
immune,O
intervention,O
or,O
preventive,O
"
",O
vaccine,O
for,O
COVID19,B-Disease_COVID-19
in,O
the,O
near,O
future,O
.,O
"

",O
DOI,O
:,O
10.12932,O
AP2002200772,O
"
",O
PMID,O
:,O
32105090,O
"


",O
500,O
.,O
Emerg,O
Med,O
Pract,O
.,O
2020,O
Feb,O
27;22(2,O
Suppl,O
2):121,O
.,O
"

",O
Novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
COVID19,B-Disease_COVID-19
:,O
an,O
overview,O
for,O
emergency,O
clinicians,O
"

",O
Giwa,O
A(1,O
),O
",",O
Desai,O
A(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Associate,O
Professor,O
of,O
Emergency,O
Medicine,O
",",O
Icahn,O
School,O
of,O
Medicine,O
at,O
Mount,O
"
",O
Sinai,O
",",O
New,O
York,O
",",O
NY,O
"
",O
(2)Icahn,O
School,O
of,O
Medicine,O
at,O
Mount,O
Sinai,O
",",O
New,O
York,O
",",O
NY,O
"

",O
Prior,O
to,O
the,O
global,O
outbreak,O
of,O
SARSCoV,O
in,O
2003,O
",",O
HCoV229E,O
and,O
HCoVOC43,O
were,O
"
",O
the,O
only,O
coronaviruses,O
known,O
to,O
infect,O
humans,O
.,O
Following,O
the,O
SARS,O
outbreak,O
",",O
5,O
"
",O
additional,O
coronaviruses,O
have,O
been,O
discovered,O
in,O
humans,O
",",O
most,O
recently,O
the,O
novel,O
"
",O
coronavirus,O
COVID19,B-Disease_COVID-19
",",O
believed,O
to,O
have,O
originated,O
in,O
Wuhan,O
",",O
Hubei,O
Province,O
",",O
"
",O
China,O
.,O
SARSCoV,O
and,O
MERSCoV,O
are,O
particularly,O
pathogenic,O
in,O
humans,O
and,O
are,O
"
",O
associated,O
with,O
high,O
mortality,O
.,O
In,O
this,O
review,O
",",O
the,O
epidemiology,O
",",O
"
",O
pathophysiology,O
",",O
and,O
management,O
of,O
the,O
recently,O
discovered,O
COVID19,B-Disease_COVID-19
are,O
reviewed,O
",",O
"
",O
with,O
a,O
focus,O
on,O
best,O
practices,O
and,O
the,O
public,O
health,O
implications,O
.,O
"


",O
PMID,O
:,O
32105049,O
"


",O
501,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
27,O
.,O
doi,O
:,O
10.1002,O
jmv.25727,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Development,O
and,O
Clinical,O
Application,O
of,O
A,O
Rapid,O
IgMIgG,O
Combined,O
Antibody,O
Test,O
"
",O
for,O
SARSCoV2,B-Disease_COVID-19
Infection,I-Disease_COVID-19
Diagnosis,O
.,O
"

",O
Li,O
Z(1)(2,O
),O
",",O
Yi,O
Y(3)(2,O
),O
",",O
Luo,O
X(4)(2,O
),O
",",O
Xiong,O
N(5)(2,O
),O
",",O
Liu,O
Y(6)(2,O
),O
",",O
Li,O
S(1)(2,O
),O
",",O
Sun,O
"
",O
R(6)(2,O
),O
",",O
Wang,O
Y(1)(2,O
),O
",",O
Hu,O
B(2)(7,O
),O
",",O
Chen,O
W(2)(8,O
),O
",",O
Zhang,O
Y(4)(2,O
),O
",",O
Wang,O
J(5)(2,O
),O
",",O
"
",O
Huang,O
B(2)(9,O
),O
",",O
Lin,O
Y(1)(2,O
),O
",",O
Yang,O
J(3)(2,O
),O
",",O
Cai,O
W(2)(9,O
),O
",",O
Wang,O
X(2)(9,O
),O
",",O
Cheng,O
"
",O
J(1)(2,O
),O
",",O
Chen,O
Z(2)(9,O
),O
",",O
Sun,O
K(2)(9,O
),O
",",O
Pan,O
W(2)(9,O
),O
",",O
Zhan,O
Z(2)(10,O
),O
",",O
Chen,O
L(1)(2,O
),O
",",O
Ye,O
"
",O
F(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Respiratory,O
Disease,O
",",O
National,O
Clinical,O
Research,O
Center,O
"
",O
for,O
Respiratory,O
Disease,O
",",O
Guangzhou,O
Institute,O
of,O
Respiratory,O
Health,O
",",O
the,O
First,O
"
",O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
510120,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Guangdong,O
Second,O
"
",O
Provincial,O
General,O
Hospital,O
",",O
Guangzhou,O
Guangdong,O
",",O
510317,O
",",O
China,O
.,O
"
",O
(3)The,O
2nd,O
Hospital,O
of,O
Nanjing,O
",",O
Nanjing,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Nanjing,O
",",O
"
",O
210003,O
",",O
China,O
.,O
"
",O
(4)Chongqing,O
Public,O
Health,O
Medical,O
Center,O
",",O
Chongqing,O
",",O
400036,O
",",O
China,O
.,O
"
",O
(5)Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
;,O
Wuhan,O
Red,O
Cross,O
Hospital,O
",",O
Wuhan,O
",",O
430015,O
",",O
China,O
.,O
"
",O
(6)The,O
1st,O
Affiliated,O
Hospital,O
of,O
Nanchang,O
University,O
",",O
Nanchang,O
",",O
330006,O
",",O
China,O
.,O
"
",O
(7)Wuhan,O
No.,O
1,O
Hospital,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
(8)The,O
1st,O
Affiliated,O
Hospital,O
of,O
Xi'an,O
Jiaotong,O
University,O
",",O
Xi'an,O
",",O
710061,O
",",O
"
",O
China,O
.,O
"
",O
(9)Jiangsu,O
Medomics,O
Medical,O
Technology,O
Co.,O
",",O
Ltd,O
",",O
Nanjing,O
",",O
210061,O
",",O
China,O
.,O
"
",O
(10)Hunan,O
Provincial,O
Center,O
For,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Changsha,O
",",O
410000,O
",",O
"
",O
China,O
.,O
"

",O
The,O
outbreak,O
of,O
the,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
quickly,O
spread,O
all,O
over,O
"
",O
China,O
and,O
to,O
more,O
than,O
20,O
other,O
countries,O
.,O
Although,O
the,O
virus,O
(,O
SARSCov2,B-Virus_SARS-CoV-2
),O
"
",O
nucleic,O
acid,O
RTPCR,O
test,O
has,O
become,O
the,O
standard,O
method,O
for,O
diagnosis,O
of,O
"
",O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
",",O
these,O
realtime,O
PCR,O
test,O
kits,O
have,O
many,O
limitations,O
.,O
In,O
"
",O
addition,O
",",O
high,O
FALSE,O
negative,O
rates,O
were,O
reported,O
.,O
There,O
is,O
an,O
urgent,O
need,O
for,O
an,O
"
",O
accurate,O
and,O
rapid,O
test,O
method,O
to,O
quickly,O
identify,O
large,O
number,O
of,O
infected,O
"
",O
patients,O
and,O
asymptomatic,O
carriers,O
to,O
prevent,O
virus,O
transmission,O
and,O
assure,O
"
",O
timely,O
treatment,O
of,O
patients,O
.,O
We,O
have,O
developed,O
a,O
rapid,O
and,O
simple,O
pointofcare,O
"
",O
lateral,O
flow,O
immunoassay,O
which,O
can,O
detect,O
IgM,O
and,O
IgG,O
antibodies,O
simultaneously,O
"
",O
against,O
SARSCoV2,B-Virus_SARS-CoV-2
virus,O
in,O
human,O
blood,O
within,O
15,O
minutes,O
which,O
can,O
detect,O
"
",O
patients,O
at,O
different,O
infection,O
stages,O
.,O
With,O
this,O
test,O
kit,O
",",O
we,O
carried,O
out,O
"
",O
clinical,O
studies,O
to,O
validate,O
its,O
clinical,O
efficacy,O
uses,O
.,O
The,O
clinical,O
detection,O
"
",O
sensitivity,O
and,O
specificity,O
of,O
this,O
test,O
were,O
measured,O
using,O
blood,O
samples,O
"
",O
collected,O
from,O
397,O
PCR,O
confirmed,O
COVID19,B-Disease_COVID-19
patients,O
and,O
128,O
negative,O
patients,O
at,O
8,O
"
",O
different,O
clinical,O
sites,O
.,O
The,O
overall,O
testing,O
sensitivity,O
was,O
88.66,O
%,O
and,O
"
",O
specificity,O
was,O
90.63,O
%,O
.,O
In,O
addition,O
",",O
we,O
evaluated,O
clinical,O
diagnosis,O
results,O
"
",O
obtained,O
from,O
different,O
types,O
of,O
venous,O
and,O
fingerstick,O
blood,O
samples,O
.,O
The,O
"
",O
results,O
indicated,O
great,O
detection,O
consistency,O
among,O
samples,O
from,O
fingerstick,O
"
",O
blood,O
",",O
serum,O
and,O
plasma,O
of,O
venous,O
blood,O
.,O
The,O
IgMIgG,O
combined,O
assay,O
has,O
better,O
"
",O
utility,O
and,O
sensitivity,O
compared,O
with,O
a,O
single,O
IgM,O
or,O
IgG,O
test,O
.,O
It,O
can,O
be,O
used,O
"
",O
for,O
the,O
rapid,O
screening,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
carriers,O
",",O
symptomatic,O
or,O
asymptomatic,O
",",O
in,O
"
",O
hospitals,O
",",O
clinics,O
",",O
and,O
test,O
laboratories,O
.,O
This,O
article,O
is,O
protected,O
by,O
"
",O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25727,O
"
",O
PMID,O
:,O
32104917,O
"


",O
502,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
27,O
.,O
doi,O
:,O
10.1002,O
jmv.25728,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
neuroinvasive,O
potential,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
may,O
be,O
at,O
least,O
partially,O
responsible,O
"
",O
for,O
the,O
respiratory,O
failure,O
of,O
COVID19,B-Disease_COVID-19
patients,O
.,O
"

",O
Li,O
YC(1,O
),O
",",O
Bai,O
WZ(2,O
),O
",",O
Hashikawa,O
T(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Histology,O
and,O
Embryology,O
",",O
College,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
"
",O
Norman,O
Bethune,O
College,O
of,O
Medicine,O
",",O
Jilin,O
University,O
",",O
Changchun,O
",",O
Jilin,O
",",O
China,O
.,O
"
",O
(2)Institute,O
of,O
Acupuncture,O
and,O
Moxibustion,O
",",O
China,O
Academy,O
of,O
Chinese,O
Medical,O
"
",O
Science,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Neural,O
Architecture,O
",",O
Advanced,O
Technology,O
Development,O
Group,O
",",O
RIKEN,O
Brain,O
"
",O
Science,O
Institute,O
",",O
Saitama,O
",",O
Japan,O
.,O
"

",O
Following,O
the,O
severe,O
acute,O
respiratory,O
syndrome,O
coronavirus,O
(,O
SARSCoV,O
),O
and,O
Middle,O
"
",O
East,O
respiratory,O
syndrome,O
coronavirus,O
(,O
MERSCoV,O
),O
",",O
another,O
highly,O
pathogenic,O
"
",O
coronavirus,O
named,O
SARSCoV2,B-Virus_SARS-CoV-2
(,O
previously,O
known,O
as,O
2019nCoV,B-Virus_SARS-CoV-2
),O
emerged,O
in,O
December,O
"
",O
2019,O
in,O
Wuhan,O
",",O
China,O
",",O
and,O
rapidly,O
spreads,O
around,O
the,O
world,O
.,O
This,O
virus,O
shares,O
"
",O
highly,O
homological,O
sequence,O
with,O
SARSCoV,O
",",O
and,O
causes,O
acute,O
",",O
highly,O
lethal,O
"
",O
pneumonia,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
with,O
clinical,O
symptoms,O
similar,O
to,O
"
",O
those,O
reported,O
for,O
SARSCoV,O
and,O
MERSCoV.,O
The,O
most,O
characteristic,O
symptom,O
of,O
"
",O
patients,O
with,O
COVID19,B-Disease_COVID-19
is,O
respiratory,O
distress,O
",",O
and,O
most,O
of,O
the,O
patients,O
admitted,O
"
",O
to,O
the,O
intensive,O
care,O
could,O
not,O
breathe,O
spontaneously,O
.,O
Additionally,O
",",O
some,O
"
",O
patients,O
with,O
COVID19,B-Disease_COVID-19
also,O
showed,O
neurologic,O
signs,O
",",O
such,O
as,O
headache,O
",",O
nausea,O
",",O
"
",O
and,O
vomiting,O
.,O
Increasing,O
evidence,O
shows,O
that,O
coronaviruses,O
are,O
not,O
always,O
"
",O
confined,O
to,O
the,O
respiratory,O
tract,O
and,O
that,O
they,O
may,O
also,O
invade,O
the,O
central,O
"
",O
nervous,O
system,O
inducing,O
neurological,O
diseases,O
.,O
The,O
infection,O
of,O
SARSCoV,O
has,O
been,O
"
",O
reported,O
in,O
the,O
brains,O
from,O
both,O
patients,O
and,O
experimental,O
animals,O
",",O
where,O
the,O
"
",O
brainstem,O
was,O
heavily,O
infected,O
.,O
Furthermore,O
",",O
some,O
coronaviruses,O
have,O
been,O
"
",O
demonstrated,O
able,O
to,O
spread,O
via,O
a,O
synapseconnected,O
route,O
to,O
the,O
medullary,O
"
",O
cardiorespiratory,O
center,O
from,O
the,O
mechanoreceptors,O
and,O
chemoreceptors,O
in,O
the,O
lung,O
"
",O
and,O
lower,O
respiratory,O
airways,O
.,O
In,O
light,O
of,O
the,O
high,O
similarity,O
between,O
SARSCoV,O
"
",O
and,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
it,O
is,O
quite,O
likely,O
that,O
the,O
potential,O
invasion,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
is,O
"
",O
partially,O
responsible,O
for,O
the,O
acute,O
respiratory,O
failure,O
of,O
patients,O
with,O
"
",O
COVID19,B-Disease_COVID-19
.,O
Awareness,O
of,O
this,O
will,O
have,O
important,O
guiding,O
significance,O
for,O
the,O
"
",O
prevention,O
and,O
treatment,O
of,O
the,O
SARSCoV2induced,O
respiratory,O
failure,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25728,O
"
",O
PMID,O
:,O
32104915,O
"


",O
503,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
27,O
.,O
doi,O
:,O
10.1002,O
jmv.25731,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Evolutionary,O
history,O
",",O
potential,O
intermediate,O
animal,O
host,O
",",O
and,O
crossspecies,O
"
",O
analyses,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Li,O
X(1,O
),O
",",O
Zai,O
J(2,O
),O
",",O
Zhao,O
Q(3,O
),O
",",O
Nie,O
Q(4,O
),O
",",O
Li,O
Y(1,O
),O
",",O
Foley,O
BT(5,O
),O
",",O
Chaillon,O
A(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Hubei,O
Engineering,O
Research,O
Center,O
of,O
Viral,O
Vector,O
",",O
Wuhan,O
University,O
of,O
"
",O
Bioengineering,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Immunology,O
Innovation,O
Team,O
",",O
School,O
of,O
Medicine,O
",",O
Ningbo,O
University,O
",",O
Ningbo,O
",",O
"
",O
China,O
.,O
"
",O
(3)Precision,O
Cancer,O
Center,O
Airport,O
Center,O
",",O
Tianjin,O
Cancer,O
Hospital,O
Airport,O
"
",O
Hospital,O
",",O
Tianjin,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Microbiology,O
",",O
Weifang,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
"
",O
Weifang,O
",",O
China,O
.,O
"
",O
(5)HIV,O
Databases,O
",",O
Theoretical,O
Biology,O
and,O
Biophysics,O
Group,O
",",O
Los,O
Alamos,O
National,O
"
",O
Laboratory,O
",",O
Los,O
Alamos,O
",",O
New,O
Mexico,O
.,O
"
",O
(6)Department,O
of,O
Medicine,O
",",O
University,O
of,O
California,O
San,O
Diego,O
",",O
La,O
Jolla,O
",",O
"
",O
California,O
.,O
"

",O
To,O
investigate,O
the,O
evolutionary,O
history,O
of,O
the,O
recent,O
outbreak,O
of,O
severe,O
acute,O
"
",O
respiratory,O
syndrome,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
in,O
China,O
",",O
a,O
total,O
of,O
70,O
genomes,O
"
",O
of,O
virus,O
strains,O
from,O
China,O
and,O
elsewhere,O
with,O
sampling,O
dates,O
between,O
24,O
December,O
"
",O
2019,O
and,O
3,O
February,O
2020,O
were,O
analyzed,O
.,O
To,O
explore,O
the,O
potential,O
intermediate,O
"
",O
animal,O
host,O
of,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
virus,O
",",O
we,O
reanalyzed,O
virome,O
data,O
sets,O
from,O
"
",O
pangolins,O
and,O
representative,O
SARSrelated,O
coronaviruses,O
isolates,O
from,O
bats,O
",",O
with,O
"
",O
particular,O
attention,O
paid,O
to,O
the,O
spike,O
glycoprotein,O
gene,O
.,O
We,O
performed,O
"
",O
phylogenetic,O
",",O
split,O
network,O
",",O
transmission,O
network,O
",",O
likelihoodmapping,O
",",O
and,O
"
",O
comparative,O
analyses,O
of,O
the,O
genomes,O
.,O
Based,O
on,O
Bayesian,O
timescaled,O
phylogenetic,O
"
",O
analysis,O
using,O
the,O
tipdating,O
method,O
",",O
we,O
estimated,O
the,O
time,O
to,O
the,O
most,O
recent,O
"
",O
common,O
ancestor,O
and,O
evolutionary,O
rate,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
which,O
ranged,O
from,O
22,O
to,O
24,O
"
",O
November,O
2019,O
and,O
1.19,O
to,O
1.31,O
â€‰,O
Ã—,O
â€‰,O
103,O
substitutions,O
per,O
site,O
per,O
year,O
",",O
"
",O
respectively,O
.,O
Our,O
results,O
also,O
revealed,O
that,O
the,O
BetaCoV,O
bat,O
Yunnan,O
RaTG13,O
2013,O
"
",O
virus,O
was,O
more,O
similar,O
to,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
virus,O
than,O
the,O
coronavirus,O
obtained,O
from,O
"
",O
the,O
two,O
pangolin,O
samples,O
(,O
SRR10168377,O
and,O
SRR10168378,O
),O
.,O
We,O
also,O
identified,O
a,O
"
",O
unique,O
peptide,O
(,O
PRRA,O
),O
insertion,O
in,O
the,O
human,O
SARSCoV2,B-Virus_SARS-CoV-2
virus,O
",",O
which,O
may,O
be,O
"
",O
involved,O
in,O
the,O
proteolytic,O
cleavage,O
of,O
the,O
spike,O
protein,O
by,O
cellular,O
proteases,O
",",O
"
",O
and,O
thus,O
could,O
impact,O
host,O
range,O
and,O
transmissibility,O
.,O
Interestingly,O
",",O
the,O
"
",O
coronavirus,O
carried,O
by,O
pangolins,O
did,O
not,O
have,O
the,O
RRAR,O
motif,O
.,O
Therefore,O
",",O
we,O
"
",O
concluded,O
that,O
the,O
human,O
SARSCoV2,B-Virus_SARS-CoV-2
virus,O
",",O
which,O
is,O
responsible,O
for,O
the,O
recent,O
"
",O
outbreak,O
of,O
COVID19,B-Disease_COVID-19
",",O
did,O
not,O
come,O
directly,O
from,O
pangolins,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25731,O
"
",O
PMID,O
:,O
32104911,O
"


",O
504,O
.,O
Eur,O
J,O
Immunol,O
.,O
2020,O
Mar;50(3):308311,O
.,O
doi,O
:,O
10.1002,O
eji.202070035,O
.,O
Epub,O
2020,O
Feb,O
"
",O
27,O
.,O
"

",O
COVID19,B-Disease_COVID-19
:,O
Lessons,O
from,O
SARS,O
and,O
MERS,O
.,O
"

",O
Park,O
M(1,O
),O
",",O
Thwaites,O
RS(1,O
),O
",",O
Openshaw,O
PJM(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Heart,O
and,O
Lung,O
Institute,O
",",O
Imperial,O
College,O
London,O
",",O
London,O
",",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1002,O
eji.202070035,O
"
",O
PMID,O
:,O
32104909,O
"


",O
505,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
27,O
.,O
doi,O
:,O
10.1002,O
jmv.25729,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
A,O
systematic,O
review,O
of,O
lopinavir,O
therapy,O
for,O
SARS,O
coronavirus,O
and,O
MERS,O
"
",O
coronavirusA,O
possible,O
reference,O
for,O
coronavirus,B-Disease_COVID-19
disease19,I-Disease_COVID-19
treatment,O
option,O
.,O
"

",O
Yao,O
TT(1,O
),O
",",O
Qian,O
JD(1,O
),O
",",O
Zhu,O
WY(1,O
),O
",",O
Wang,O
Y(1,O
),O
",",O
Wang,O
GQ(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Diseases,O
and,O
the,O
Center,O
for,O
Liver,O
Diseases,O
",",O
Peking,O
"
",O
University,O
First,O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)The,O
Collaborative,O
Innovation,O
Center,O
for,O
Diagnosis,O
and,O
Treatment,O
of,O
Infectious,O
"
",O
Diseases,O
",",O
Zhejiang,O
University,O
",",O
Hangzhou,O
",",O
Zhejiang,O
",",O
China,O
.,O
"
",O
(3)Peking,O
University,O
International,O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
In,O
the,O
past,O
few,O
decades,O
",",O
coronaviruses,O
have,O
risen,O
as,O
a,O
global,O
threat,O
to,O
public,O
"
",O
health,O
.,O
Currently,O
",",O
the,O
outbreak,O
of,O
coronavirus,B-Disease_COVID-19
disease19,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
from,O
Wuhan,O
"
",O
caused,O
a,O
worldwide,O
panic,O
.,O
There,O
are,O
no,O
specific,O
antiviral,O
therapies,O
for,O
COVID19,B-Disease_COVID-19
.,O
"
",O
However,O
",",O
there,O
are,O
agents,O
that,O
were,O
used,O
during,O
the,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
(,O
SARS,O
),O
and,O
Middle,O
East,O
respiratory,O
syndrome,O
(,O
MERS,O
),O
epidemics,O
.,O
We,O
could,O
"
",O
learn,O
from,O
SARS,O
and,O
MERS,O
.,O
Lopinavir,O
(,O
LPV,O
),O
is,O
an,O
effective,O
agent,O
that,O
inhibits,O
the,O
"
",O
protease,O
activity,O
of,O
coronavirus,O
.,O
In,O
this,O
review,O
",",O
we,O
discuss,O
the,O
literature,O
on,O
"
",O
the,O
efficacy,O
of,O
LPV,O
in,O
vitro,O
and,O
in,O
vivo,O
",",O
especially,O
in,O
patients,O
with,O
SARS,O
and,O
"
",O
MERS,O
",",O
so,O
that,O
we,O
might,O
clarify,O
the,O
potential,O
for,O
the,O
use,O
of,O
LPV,O
in,O
patients,O
with,O
"
",O
COVID19,B-Disease_COVID-19
.,O
"

",O
Â©,O
2020,O
The,O
Authors,O
.,O
Journal,O
of,O
Medical,O
Virology,O
published,O
by,O
Wiley,O
Periodicals,O
",",O
"
",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25729,O
"
",O
PMID,O
:,O
32104907,O
"


",O
506,O
.,O
J,O
Travel,O
Med,O
.,O
2020,O
Feb,O
27,O
.,O
pii,O
:,O
taaa024,O
.,O
doi,O
:,O
10.1093,O
jtm,O
taaa024,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Nepal,O
's,O
First,O
Case,O
of,O
COVID19,B-Disease_COVID-19
and,O
public,O
health,O
response,O
.,O
"

",O
Shrestha,O
R(1,O
),O
",",O
Shrestha,O
S(2)(3,O
),O
",",O
Khanal,O
P(4,O
),O
",",O
Bhuvan,O
KC(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Infection,O
Control,O
Unit,O
",",O
Nepal,O
Cancer,O
Hospital,O
and,O
Research,O
Center,O
",",O
Harisidhhi,O
",",O
"
",O
Lalitpur,O
",",O
Nepal,O
.,O
"
",O
(2)Department,O
of,O
Pharmacy,O
",",O
Nepal,O
Cancer,O
Hospital,O
and,O
Research,O
Center,O
",",O
Harisidhhi,O
",",O
"
",O
Lalitpur,O
",",O
Nepal,O
.,O
"
",O
(3)Department,O
of,O
Pharmaceutical,O
and,O
Health,O
Service,O
Research,O
",",O
Nepal,O
Health,O
"
",O
Research,O
and,O
Innovation,O
Foundation,O
",",O
Lalitpur,O
",",O
Nepal,O
.,O
"
",O
(4)Central,O
Department,O
of,O
Public,O
Health,O
",",O
Institute,O
of,O
Medicine,O
",",O
Kathmandu,O
",",O
Nepal,O
.,O
"
",O
(5)School,O
of,O
Pharmacy,O
",",O
Monash,O
University,O
Malaysia,O
",",O
Jalan,O
Lagoon,O
Selatan,O
",",O
47500,O
",",O
"
",O
Subang,O
Jaya,O
",",O
Selangor,O
",",O
Malaysia,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jtm,O
taaa024,O
"
",O
PMID,O
:,O
32104884,O
"


",O
507,O
.,O
Intensive,O
Care,O
Med,O
.,O
2020,O
Feb,O
26,O
.,O
doi,O
:,O
10.1007,O
s0013402005967x,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Severe,O
SARSCoV2,B-Virus_SARS-CoV-2
infections,O
:,O
practical,O
considerations,O
and,O
management,O
strategy,O
"
",O
for,O
intensivists,O
.,O
"

",O
Bouadma,O
L(1)(2,O
),O
",",O
Lescure,O
FX(2)(3,O
),O
",",O
Lucet,O
JC(2)(4,O
),O
",",O
Yazdanpanah,O
Y(2)(3,O
),O
",",O
Timsit,O
"
",O
JF(5)(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)APHP,O
",",O
Bichat,O
Claude,O
Bernard,O
Hospital,O
",",O
Medial,O
and,O
infectious,O
diseases,O
ICU,O
"
",O
(,O
MI2,O
),O
",",O
75018,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(2)UniversitÃ©,O
de,O
Paris,O
",",O
IAME,O
",",O
INSERM,O
",",O
75018,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(3)APHP,O
",",O
HÃ´pital,O
Bichat,O
",",O
Infectious,O
Diseases,O
",",O
75018,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(4)APHP,O
",",O
HÃ´pital,O
Bichat,O
",",O
Infection,O
Control,O
Unit,O
",",O
75018,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(5)APHP,O
",",O
Bichat,O
Claude,O
Bernard,O
Hospital,O
",",O
Medial,O
and,O
infectious,O
diseases,O
ICU,O
"
",O
(,O
MI2,O
),O
",",O
75018,O
",",O
Paris,O
",",O
France,O
.,O
JeanFrancois.timsit@aphp.fr,O
.,O
"
",O
(6)UniversitÃ©,O
de,O
Paris,O
",",O
IAME,O
",",O
INSERM,O
",",O
75018,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
JeanFrancois.timsit@aphp.fr,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s0013402005967x,O
"
",O
PMID,O
:,O
32103284,O
"


",O
508,O
.,O
J,O
Virol,O
.,O
2020,O
Feb,O
26,O
.,O
pii,O
:,O
JVI.0011120,O
.,O
doi,O
:,O
10.1128,O
JVI.0011120,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
The,O
dual,O
role,O
of,O
TLR7,O
in,O
the,O
pathogenesis,O
of,O
rabies,O
virus,O
in,O
a,O
mouse,O
model,O
.,O
"

",O
Luo,O
Z(1)(2,O
),O
",",O
Lv,O
L(1)(2,O
),O
",",O
Li,O
Y(1)(2,O
),O
",",O
Sui,O
B(1)(2,O
),O
",",O
Wu,O
Q(1)(2,O
),O
",",O
Zhang,O
Y(1)(2,O
),O
",",O
Pei,O
"
",O
J(1)(2,O
),O
",",O
Li,O
M(1)(2,O
),O
",",O
Zhou,O
M(1)(2,O
),O
",",O
Hooper,O
DC(3,O
),O
",",O
Fu,O
ZF(1)(2)(4,O
),O
",",O
Zhao,O
L(5)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
College,O
of,O
"
",O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Cancer,O
Biology,O
",",O
Thomas,O
Jefferson,O
University,O
",",O
Philadelphia,O
",",O
PA,O
",",O
"
",O
United,O
States,O
.,O
"
",O
(4)Department,O
of,O
Pathology,O
",",O
University,O
of,O
Georgia,O
",",O
Athens,O
",",O
GA,O
",",O
United,O
States,O
.,O
"
",O
(5)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
",",O
China,O
zling604@yahoo.com,O
.,O
"

",O
Rabies,O
",",O
caused,O
by,O
rabies,O
virus,O
(,O
RABV,O
),O
",",O
is,O
a,O
fatal,O
encephalitis,O
in,O
humans,O
and,O
"
",O
other,O
mammals,O
",",O
which,O
continues,O
to,O
present,O
a,O
public,O
health,O
threat,O
in,O
most,O
parts,O
of,O
"
",O
the,O
world,O
.,O
Our,O
previous,O
study,O
demonstrated,O
that,O
tolllike,O
receptor,O
7,O
(,O
TLR7,O
),O
is,O
"
",O
essential,O
in,O
the,O
induction,O
of,O
antiRABV,O
antibodies,O
via,O
the,O
facilitation,O
of,O
"
",O
germinal,O
center,O
formation,O
.,O
In,O
the,O
current,O
study,O
",",O
we,O
investigated,O
the,O
role,O
of,O
TLR7,O
"
",O
in,O
the,O
pathogenicity,O
of,O
RABV,O
in,O
a,O
mouse,O
model,O
.,O
Using,O
isolated,O
plasmacytoid,O
"
",O
dendritic,O
cells,O
(,O
pDCs,O
),O
",",O
we,O
demonstrated,O
that,O
TLR7,O
is,O
an,O
innate,O
recognition,O
"
",O
receptor,O
for,O
RABV,O
.,O
When,O
RABV,O
invaded,O
from,O
the,O
periphery,O
",",O
TLR7,O
detected,O
viral,O
"
",O
single,O
stranded,O
RNA,O
and,O
triggered,O
immune,O
responses,O
that,O
limited,O
the,O
virus,O
's,O
entry,O
"
",O
into,O
the,O
central,O
nervous,O
system,O
(,O
CNS,O
),O
.,O
When,O
RABV,O
had,O
invaded,O
the,O
CNS,O
",",O
its,O
"
",O
detection,O
by,O
TLR7,O
led,O
to,O
the,O
production,O
of,O
cytokines,O
and,O
chemokines,O
",",O
and,O
an,O
"
",O
increase,O
the,O
permeability,O
of,O
the,O
bloodbrain,O
barrier,O
(,O
BBB,O
),O
.,O
Consequently,O
",",O
"
",O
peripheral,O
immune,O
cells,O
including,O
pDCs,O
",",O
macrophages,O
",",O
neutrophils,O
and,O
B,O
cells,O
"
",O
infiltrated,O
the,O
CNS,O
.,O
While,O
this,O
immune,O
response,O
",",O
triggered,O
by,O
TLR7,O
",",O
helped,O
to,O
"
",O
clear,O
viruses,O
",",O
it,O
also,O
increased,O
neuroinflammation,O
and,O
caused,O
immunopathology,O
in,O
"
",O
the,O
mouse,O
brain,O
.,O
Our,O
results,O
demonstrate,O
that,O
TLR7,O
is,O
an,O
innate,O
recognition,O
"
",O
receptor,O
for,O
RABV,O
",",O
which,O
restricts,O
RABV,O
invasion,O
into,O
the,O
CNS,O
in,O
the,O
early,O
stage,O
"
",O
of,O
viral,O
infection,O
",",O
but,O
also,O
contributes,O
to,O
immunopathology,O
by,O
inducing,O
"
",O
neuroinflammation,O
.,O
IMPORTANCEDeveloping,O
targeted,O
treatment,O
for,O
RABV,O
requires,O
"
",O
understanding,O
the,O
innate,O
immune,O
response,O
to,O
the,O
virus,O
",",O
because,O
early,O
virus,O
"
",O
clearance,O
is,O
essential,O
for,O
preventing,O
the,O
fatality,O
when,O
the,O
infection,O
has,O
"
",O
progressed,O
to,O
the,O
CNS,O
.,O
Previous,O
studies,O
have,O
revealed,O
that,O
TLR7,O
is,O
involved,O
in,O
"
",O
the,O
immune,O
response,O
to,O
RABV,O
.,O
Here,O
",",O
we,O
establish,O
that,O
TLR7,O
recognizes,O
RABV,O
and,O
"
",O
facilitates,O
the,O
production,O
of,O
some,O
interferonstimulated,O
genes,O
.,O
We,O
also,O
"
",O
demonstrated,O
that,O
when,O
RABV,O
invades,O
into,O
the,O
CNS,O
",",O
TLR7,O
enhances,O
the,O
production,O
of,O
"
",O
inflammatory,O
cytokines,O
which,O
contribute,O
to,O
immunopathology,O
in,O
the,O
mouse,O
brain,O
.,O
"
",O
Taken,O
together,O
",",O
our,O
findings,O
suggest,O
that,O
treatments,O
for,O
RABV,O
must,O
consider,O
the,O
"
",O
balance,O
between,O
the,O
beneficial,O
and,O
harmful,O
effects,O
of,O
TLR7triggered,O
immune,O
"
",O
responses,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
American,O
Society,O
for,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1128,O
JVI.0011120,O
"
",O
PMID,O
:,O
32102880,O
"


",O
509,O
.,O
J,O
Clin,O
Microbiol,O
.,O
2020,O
Feb,O
26,O
.,O
pii,O
:,O
JCM.0029720,O
.,O
doi,O
:,O
10.1128,O
JCM.0029720,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Negative,O
Nasopharyngeal,O
and,O
Oropharyngeal,O
Swab,O
Does,O
Not,O
Rule,O
Out,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Winichakoon,O
P(1,O
),O
",",O
Chaiwarith,O
R(1,O
),O
",",O
Liwsrisakun,O
C(2,O
),O
",",O
Salee,O
P(1,O
),O
",",O
Goonna,O
A(3,O
),O
",",O
"
",O
Limsukon,O
A(2,O
),O
",",O
Kaewpoowat,O
Q(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infectious,O
Diseases,O
and,O
Tropical,O
Medicine,O
",",O
Department,O
of,O
Medicine,O
",",O
"
",O
Faculty,O
of,O
Medicine,O
",",O
Chiang,O
Mai,O
University,O
",",O
Chiang,O
Mai,O
",",O
Thailand,O
.,O
"
",O
(2)Division,O
of,O
Pulmonology,O
and,O
Critical,O
Care,O
",",O
Department,O
of,O
Medicine,O
",",O
Faculty,O
of,O
"
",O
Medicine,O
",",O
Chiang,O
Mai,O
University,O
",",O
Chiang,O
Mai,O
",",O
Thailand,O
.,O
"
",O
(3)Infection,O
Control,O
Unit,O
",",O
Maharaj,O
Nakorn,O
Chiang,O
Mai,O
Hospital,O
",",O
Chiang,O
Mai,O
"
",O
University,O
",",O
Chiang,O
Mai,O
",",O
Thailand,O
.,O
"
",O
(4)Division,O
of,O
Infectious,O
Diseases,O
and,O
Tropical,O
Medicine,O
",",O
Department,O
of,O
Medicine,O
",",O
"
",O
Faculty,O
of,O
Medicine,O
",",O
Chiang,O
Mai,O
University,O
",",O
Chiang,O
Mai,O
",",O
Thailand,O
"
",O
quanhathai@rihes.org,O
.,O
"
",O
(5)Research,O
Institute,O
for,O
Health,O
Sciences,O
",",O
Chiang,O
Mai,O
University,O
",",O
Chiang,O
Mai,O
",",O
"
",O
Thailand,O
.,O
"

",O
Coronavirus,O
Disease,O
19,O
(,O
COVID19,B-Disease_COVID-19
),O
",",O
has,O
become,O
the,O
Public,O
Health,O
Emergency,O
of,O
"
",O
International,O
Concern.,O
â€¦,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
American,O
Society,O
for,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1128,O
JCM.0029720,O
"
",O
PMID,O
:,O
32102856,O
"


",O
510,O
.,O
BMJ,O
.,O
2020,O
Feb,O
26;368:m757,O
.,O
doi,O
:,O
10.1136,O
bmj.m757,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
Italy,O
confirms,O
11,O
deaths,O
as,O
cases,O
spread,O
from,O
north,O
.,O
"

",O
Day,O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)London,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m757,O
"
",O
PMID,O
:,O
32102793,O
"


",O
511,O
.,O
Yi,O
Chuan,O
.,O
2020,O
Feb,O
20;42(2):212221,O
.,O
doi,O
:,O
10.16288,O
j.yczz.20030,O
.,O
"

",O
The,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
resource,O
.,O
"

",O
Zhao,O
WM(1,O
),O
",",O
Song,O
SH(2,O
),O
",",O
Chen,O
ML(2,O
),O
",",O
Zou,O
D(2,O
),O
",",O
Ma,O
LN(2,O
),O
",",O
Ma,O
YK(2,O
),O
",",O
Li,O
RJ(2,O
),O
",",O
Hao,O
"
",O
LL(2,O
),O
",",O
Li,O
CP(2,O
),O
",",O
Tian,O
DM(2,O
),O
",",O
Tang,O
BX(2,O
),O
",",O
Wang,O
YQ(2,O
),O
",",O
Zhu,O
JW(2,O
),O
",",O
Chen,O
HX(2,O
),O
",",O
Zhang,O
"
",O
Z(1,O
),O
",",O
Xue,O
YB(3,O
),O
",",O
Bao,O
YM(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)China,O
National,O
Center,O
for,O
Bioinformation,O
&,O
National,O
Genomics,O
Data,O
Center,O
",",O
"
",O
Beijing,O
Institute,O
of,O
Genomics,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
100101,O
",",O
"
",O
China,O
;,O
CAS,O
Key,O
Laboratory,O
of,O
Genome,O
Sciences,O
and,O
Information,O
",",O
Beijing,O
Institute,O
"
",O
of,O
Genomics,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
100101,O
",",O
China,O
;,O
University,O
of,O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
100049,O
",",O
China,O
.,O
"
",O
(2)China,O
National,O
Center,O
for,O
Bioinformation,O
&,O
National,O
Genomics,O
Data,O
Center,O
",",O
"
",O
Beijing,O
Institute,O
of,O
Genomics,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
100101,O
",",O
"
",O
China,O
;,O
CAS,O
Key,O
Laboratory,O
of,O
Genome,O
Sciences,O
and,O
Information,O
",",O
Beijing,O
Institute,O
"
",O
of,O
Genomics,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
100101,O
",",O
China,O
.,O
"
",O
(3)China,O
National,O
Center,O
for,O
Bioinformation,O
&,O
National,O
Genomics,O
Data,O
Center,O
",",O
"
",O
Beijing,O
Institute,O
of,O
Genomics,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
100101,O
",",O
"
",O
China,O
;,O
University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
100049,O
",",O
China,O
.,O
"

",O
An,O
ongoing,O
outbreak,O
of,O
a,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
in,O
Wuhan,O
",",O
China,O
since,O
"
",O
December,O
2019,O
has,O
led,O
to,O
31516,O
infected,O
persons,O
and,O
638,O
deaths,O
across,O
25,O
"
",O
countries,O
(,O
till,O
0.666666667,O
on,O
February,O
7,O
",",O
2020,O
),O
.,O
The,O
virus,O
causing,O
this,O
pneumonia,O
was,O
"
",O
then,O
named,O
as,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
by,O
the,O
World,O
Health,O
"
",O
Organization,O
.,O
To,O
promote,O
the,O
data,O
sharing,O
and,O
make,O
all,O
relevant,O
information,O
of,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
publicly,O
available,O
",",O
we,O
construct,O
the,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
Resource,O
"
",O
(,O
2019nCoVR,O
",",O
https,O
:,O
 ,O
bigd.big.ac.cn,O
ncov,O
),O
.,O
2019nCoVR,O
features,O
comprehensive,O
"
",O
integration,O
of,O
genomic,O
and,O
proteomic,O
sequences,O
as,O
well,O
as,O
their,O
metadata,O
"
",O
information,O
from,O
the,O
Global,O
Initiative,O
on,O
Sharing,O
All,O
Influenza,O
Data,O
",",O
National,O
"
",O
Center,O
for,O
Biotechnology,O
Information,O
",",O
China,O
National,O
GeneBank,O
",",O
National,O
"
",O
Microbiology,O
Data,O
Center,O
and,O
China,O
National,O
Center,O
for,O
Bioinformation,O
"
",O
(,O
CNCB,O
),O
National,O
Genomics,O
Data,O
Center,O
(,O
NGDC,O
),O
.,O
It,O
also,O
incorporates,O
a,O
wide,O
range,O
of,O
"
",O
relevant,O
information,O
including,O
scientific,O
literatures,O
",",O
news,O
",",O
and,O
popular,O
articles,O
"
",O
for,O
science,O
dissemination,O
",",O
and,O
provides,O
visualization,O
functionalities,O
for,O
genome,O
"
",O
variation,O
analysis,O
results,O
based,O
on,O
all,O
collected,O
2019nCoV,B-Virus_SARS-CoV-2
strains,O
.,O
Moreover,O
",",O
by,O
"
",O
linking,O
seamlessly,O
with,O
related,O
databases,O
in,O
CNCB,O
NGDC,O
",",O
2019nCoVR,O
offers,O
virus,O
"
",O
data,O
submission,O
and,O
sharing,O
services,O
for,O
raw,O
sequence,O
reads,O
and,O
assembled,O
"
",O
sequences,O
.,O
In,O
this,O
report,O
",",O
we,O
provide,O
comprehensive,O
descriptions,O
on,O
data,O
"
",O
deposition,O
",",O
management,O
",",O
release,O
and,O
utility,O
in,O
2019nCoVR,O
",",O
laying,O
important,O
"
",O
foundations,O
in,O
aid,O
of,O
studies,O
on,O
virus,O
classification,O
and,O
origin,O
",",O
genome,O
"
",O
variation,O
and,O
evolution,O
",",O
fast,O
detection,O
",",O
drug,O
development,O
and,O
pneumonia,O
precision,O
"
",O
prevention,O
and,O
therapy,O
.,O
"

",O
Publisher,O
:,O
"
",O
2019å¹´12æœˆåœ¨ä¸­å›½æ­¦æ±‰å¼€å§‹çˆ†å‘çš„æ–°åž‹è‚ºç‚Žå·²é€ æˆå…¨çƒ25ä¸ªå›½å®¶,O
"åœ°åŒºçš„31516äººæ„ŸæŸ“ã€638äººæ­»äº¡(æˆªæ­¢2020å¹´2æœˆ7æ—¥16æ—¶),å¼•èµ·è¯¥è‚ºç‚Žçš„ç—…æ¯’è¢«ä¸–ç•Œå«ç”Ÿ",O
"
",O
"ç»„ç»‡å‘½åä¸º2019æ–°åž‹å† çŠ¶ç—…æ¯’(2019nCoV)ã€‚ä¸ºä¿ƒè¿›2019nCoVæ•°æ®å…±äº«åº”ç”¨å¹¶åŠæ—¶å‘å…¨çƒå…¬ä¼—æä¾›ç—…æ¯’çš„ç›¸å…³ä¿¡æ¯,å›½å®¶ç”Ÿç‰©ä¿¡æ¯ä¸­å¿ƒ(CNCB",O
),O
å›½å®¶åŸº,O
"
",O
å› ç»„ç§‘å­¦æ•°æ®ä¸­å¿ƒ(NGDC)å»ºç«‹äº†2019æ–°åž‹å† çŠ¶ç—…æ¯’ä¿¡æ¯åº“(2019nCoVR,O
",",O
https,O
:,O
 ,O
bigd.big.ac.cn,O
ncov)ã€‚è¯¥ä¿¡æ¯åº“æ•´åˆäº†æ¥è‡ªå¾·å›½,O
"
",O
å…¨çƒæµæ„Ÿç—…æ¯’æ•°æ®åº“ã€ç¾Žå›½å›½å®¶ç”Ÿç‰©æŠ€æœ¯ä¿¡æ¯ä¸­å¿ƒã€æ·±åœ³(å›½å®¶)åŸºå› åº“ã€å›½å®¶å¾®ç”Ÿç‰©ç§‘å­¦æ•°æ®ä¸­å¿ƒåŠCNCB,O
NGDCç­‰æœºæž„å…¬å¼€å‘å¸ƒçš„2019nCoVæ ¸è‹·é…¸å’Œè›‹ç™½è´¨åºåˆ—æ•°,O
"
",O
"æ®ã€å…ƒä¿¡æ¯ã€å­¦æœ¯æ–‡çŒ®ã€æ–°é—»åŠ¨æ€ã€ç§‘æ™®æ–‡ç« ç­‰ä¿¡æ¯,å¼€å±•äº†ä¸åŒå† çŠ¶ç—…æ¯’æ ªçš„åŸºå› ç»„åºåˆ—å˜å¼‚åˆ†æžå¹¶æä¾›å¯è§†åŒ–å±•ç¤ºã€‚åŒæ—¶,2019nCoVRæ— ç¼å¯¹æŽ¥CNCB",O
NGDCçš„ç›¸å…³,O
"
",O
"æ•°æ®åº“,æä¾›æ–°æµ‹åºç—…æ¯’æ ªç³»çš„åŸºå› ç»„åŽŸå§‹æµ‹åºæ•°æ®ã€ç»„è£…åŽåºåˆ—çš„åœ¨çº¿æ±‡äº¤ã€ç®¡ç†ä¸Žå…±äº«ã€å›½é™…æ•°æ®åº“åŒæ­¥å‘å¸ƒç­‰æ•°æ®æœåŠ¡ã€‚æœ¬æ–‡å¯¹2019nCoVRæ•°æ®æ±‡äº¤ã€ç®¡ç†ã€å‘å¸ƒåŠä½¿ç”¨",O
"
",O
"ç­‰è¿›è¡Œå…¨é¢é˜è¿°,ä»¥æ–¹ä¾¿ç”¨æˆ·äº†è§£è¯¥ä¿¡æ¯åº“å„é¡¹åŠŸèƒ½åŠæ•°æ®çŠ¶å†µ,ä¸ºåŠ é€Ÿå¼€å±•ç—…æ¯’çš„åˆ†ç±»æº¯æºã€å˜å¼‚æ¼”åŒ–ã€å¿«é€Ÿæ£€æµ‹ã€è¯ç‰©ç ”å‘ä»¥åŠæ–°åž‹è‚ºç‚Žçš„ç²¾å‡†é¢„é˜²ä¸Žæ²»ç–—ç­‰ç ”ç©¶æä¾›é‡è¦åŸºç¡€ã€‚.",O
"
",O
DOI,O
:,O
10.16288,O
j.yczz.20030,O
"
",O
PMID,O
:,O
32102777,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
512,O
.,O
Chin,O
Med,O
Sci,O
J.,O
2020,O
Feb,O
27,O
.,O
doi,O
:,O
10.2492,O
3724,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Expert,O
Recommendations,O
for,O
Tracheal,O
Intubation,O
in,O
Critically,O
ill,O
Patients,O
with,O
"
",O
Noval,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
.,O
"

",O
Zuo,O
MZ(1,O
),O
",",O
Huang,O
YG(2,O
),O
",",O
Ma,O
WH(3,O
),O
",",O
Xue,O
ZG(4,O
),O
",",O
Zhang,O
JQ(5,O
),O
",",O
Gong,O
YH(2,O
),O
",",O
Che,O
L(2,O
),O
;,O
"
",O
Chinese,O
Society,O
of,O
Anesthesiology,O
Task,O
Force,O
on,O
Airway,O
Management,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Anesthesiology,O
",",O
Beijing,O
Hospital,O
",",O
National,O
Center,O
of,O
"
",O
Gerontology,O
;,O
Institute,O
of,O
Geriatric,O
Medicine,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
"
",O
Sciences,O
",",O
Beijing,O
",",O
100730,O
China,O
.,O
"
",O
(2)Department,O
of,O
Anesthesiology,O
",",O
Peking,O
Union,O
Medical,O
College,O
Hospital,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
100730,O
China,O
.,O
"
",O
(3)Department,O
of,O
Anesthesiology,O
",",O
First,O
Affiliated,O
Hospital,O
",",O
Guangzhou,O
University,O
"
",O
of,O
Chinese,O
Medicine,O
",",O
Guangzhou,O
",",O
510405,O
China,O
.,O
"
",O
(4)Department,O
of,O
Anesthesiology,O
",",O
Zhongshan,O
Hospital,O
Fudan,O
University,O
",",O
Shanghai,O
",",O
"
",O
200032,O
China,O
.,O
"
",O
(5)Department,O
of,O
Anesthesiology,O
",",O
Henan,O
Provincial,O
People,O
's,O
Hospital,O
",",O
Zhengzhou,O
",",O
"
",O
450003,O
China,O
.,O
"

",O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
",",O
caused,O
by,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
"
",O
is,O
a,O
highly,O
contagious,O
disease,O
.,O
It,O
firstly,O
appeared,O
in,O
Wuhan,O
",",O
Hubei,O
province,O
of,O
"
",O
China,O
in,O
December,O
2019,O
.,O
During,O
the,O
next,O
two,O
months,O
",",O
it,O
moved,O
rapidly,O
throughout,O
"
",O
China,O
and,O
spread,O
to,O
multiple,O
countries,O
through,O
infected,O
persons,O
travelling,O
by,O
"
",O
air,O
.,O
Most,O
of,O
the,O
infected,O
patients,O
have,O
mild,O
symptoms,O
including,O
fever,O
",",O
fatigue,O
"
",O
and,O
cough,O
.,O
But,O
in,O
severe,O
cases,O
",",O
patients,O
can,O
progress,O
rapidly,O
and,O
develop,O
to,O
the,O
"
",O
acute,O
respiratory,O
distress,O
syndrome,O
",",O
septic,O
shock,O
",",O
metabolic,O
acidosis,O
and,O
"
",O
coagulopathy,O
.,O
The,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
was,O
reported,O
to,O
spread,O
via,O
droplets,O
",",O
contact,O
"
",O
and,O
natural,O
aerosols,O
from,O
humantohuman,O
.,O
Therefore,O
",",O
highrisk,O
aerosolproducing,O
"
",O
procedures,O
such,O
as,O
endotracheal,O
intubation,O
may,O
put,O
the,O
anesthesiologists,O
at,O
high,O
"
",O
risk,O
of,O
nosocomial,O
infections,O
.,O
In,O
fact,O
",",O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
of,O
anesthesiologists,O
"
",O
after,O
endotracheal,O
intubation,O
for,O
confirmed,O
COVID19,B-Disease_COVID-19
patients,O
have,O
been,O
reported,O
"
",O
in,O
hospitals,O
in,O
Wuhan,O
.,O
The,O
expert,O
panel,O
of,O
airway,O
management,O
in,O
Chinese,O
Society,O
"
",O
of,O
Anaesthesiology,O
has,O
deliberated,O
and,O
drafted,O
this,O
recommendation,O
",",O
by,O
which,O
we,O
"
",O
hope,O
to,O
guide,O
the,O
performance,O
of,O
endotracheal,O
intubation,O
by,O
frontline,O
"
",O
anesthesiologists,O
and,O
critical,O
care,O
physicians,O
.,O
During,O
the,O
airway,O
management,O
",",O
"
",O
enhanced,O
droplet,O
airborne,O
PPE,O
should,O
be,O
applied,O
to,O
the,O
health,O
care,O
providers,O
.,O
A,O
"
",O
good,O
airway,O
assessment,O
before,O
airway,O
intervention,O
is,O
of,O
vital,O
importance,O
.,O
For,O
"
",O
patients,O
with,O
normal,O
airway,O
",",O
awake,O
intubation,O
should,O
be,O
avoided,O
and,O
modified,O
"
",O
rapid,O
sequence,O
induction,O
is,O
strongly,O
recommended,O
.,O
Sufficient,O
muscle,O
relaxant,O
"
",O
should,O
be,O
assured,O
before,O
intubation,O
.,O
For,O
patients,O
with,O
difficult,O
airway,O
",",O
good,O
"
",O
preparation,O
of,O
airway,O
devices,O
and,O
detailed,O
intubation,O
plans,O
should,O
be,O
made,O
.,O
"

",O
DOI,O
:,O
10.2492,O
3724,O
"
",O
PMID,O
:,O
32102726,O
"


",O
513,O
.,O
Emerg,O
Microbes,O
Infect,O
.,O
2020,O
Dec;9(1):469473,O
.,O
doi,O
:,O
10.108,O
22221751.2020.1732837,O
.,O
"

",O
Detectable,O
2019nCoV,B-Virus_SARS-CoV-2
viral,O
RNA,O
in,O
blood,O
is,O
a,O
strong,O
indicator,O
for,O
the,O
further,O
"
",O
clinical,O
severity,O
.,O
"

",O
Chen,O
W(1,O
),O
",",O
Lan,O
Y(1,O
),O
",",O
Yuan,O
X(1,O
),O
",",O
Deng,O
X(1,O
),O
",",O
Li,O
Y(1,O
),O
",",O
Cai,O
X(1,O
),O
",",O
Li,O
L(1,O
),O
",",O
He,O
R(1,O
),O
",",O
"
",O
Tan,O
Y(1,O
),O
",",O
Deng,O
X(1,O
),O
",",O
Gao,O
M(1,O
),O
",",O
Tang,O
G(1,O
),O
",",O
Zhao,O
L(1,O
),O
",",O
Wang,O
J(1,O
),O
",",O
Fan,O
Q(1,O
),O
",",O
Wen,O
"
",O
C(1,O
),O
",",O
Tong,O
Y(1,O
),O
",",O
Tang,O
Y(1,O
),O
",",O
Hu,O
F(1,O
),O
",",O
Li,O
F(1,O
),O
",",O
Tang,O
X(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Guangzhou,O
Eighth,O
People,O
's,O
Hospital,O
",",O
Guangzhou,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
"
",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"

",O
The,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
infection,O
caused,O
pneumonia,O
.,O
we,O
retrospectively,O
"
",O
analyzed,O
the,O
virus,O
presence,O
in,O
the,O
pharyngeal,O
swab,O
",",O
blood,O
",",O
and,O
the,O
anal,O
swab,O
"
",O
detected,O
by,O
realtime,O
PCR,O
in,O
the,O
clinical,O
lab,O
.,O
Unexpectedly,O
",",O
the,O
2109nCoV,O
RNA,O
"
",O
was,O
readily,O
detected,O
in,O
the,O
blood,O
(,O
6,O
of,O
57,O
patients,O
),O
and,O
the,O
anal,O
swabs,O
(,O
11,O
of,O
28,O
"
",O
patients,O
),O
.,O
Importantly,O
",",O
all,O
of,O
the,O
6,O
patients,O
with,O
detectable,O
viral,O
RNA,O
in,O
the,O
"
",O
blood,O
cohort,O
progressed,O
to,O
severe,O
symptom,O
stage,O
",",O
indicating,O
a,O
strong,O
correlation,O
"
",O
of,O
serum,O
viral,O
RNA,O
with,O
the,O
disease,O
severity,O
(,O
pvalue,O
â€‰,O
=,O
â€‰,O
0.0001,O
),O
.,O
Meanwhile,O
",",O
8,O
of,O
"
",O
the,O
11,O
patients,O
with,O
annal,O
swab,O
viruspositive,O
was,O
in,O
severe,O
clinical,O
stage,O
.,O
"
",O
However,O
",",O
the,O
concentration,O
of,O
viral,O
RNA,O
in,O
the,O
anal,O
swab,O
(,O
Ct,O
value,O
â€‰,O
=,O
â€‰,O
24,O
â€‰,O
+,O
â€‰,O
39,O
),O
was,O
"
",O
higher,O
than,O
in,O
the,O
blood,O
(,O
Ct,O
value,O
â€‰,O
=,O
â€‰,O
34,O
â€‰,O
+,O
â€‰,O
39,O
),O
from,O
patient,O
2,O
",",O
suggesting,O
that,O
the,O
"
",O
virus,O
might,O
replicate,O
in,O
the,O
digestive,O
tract,O
.,O
Altogether,O
",",O
our,O
results,O
confirmed,O
"
",O
the,O
presence,O
of,O
virus,O
RNA,O
in,O
extrapulmonary,O
sites,O
.,O
"

",O
DOI,O
:,O
10.108,O
22221751.2020.1732837,O
"
",O
PMCID,O
:,O
PMC7054964,O
"
",O
PMID,O
:,O
32102625,O
"


",O
514,O
.,O
Emerg,O
Microbes,O
Infect,O
.,O
2020,O
Dec;9(1):505507,O
.,O
doi,O
:,O
10.108,O
22221751.2020.1733440,O
.,O
"

",O
No,O
credible,O
evidence,O
supporting,O
claims,O
of,O
the,O
laboratory,O
engineering,O
of,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Liu,O
SL(1)(2)(3)(4,O
),O
",",O
Saif,O
LJ(4)(5,O
),O
",",O
Weiss,O
SR(6,O
),O
",",O
Su,O
L(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Center,O
for,O
Retrovirus,O
Research,O
",",O
The,O
Ohio,O
State,O
University,O
",",O
Columbus,O
",",O
OH,O
",",O
USA,O
.,O
"
",O
(2)Department,O
of,O
Veterinary,O
Biosciences,O
",",O
The,O
Ohio,O
State,O
University,O
",",O
Columbus,O
",",O
OH,O
",",O
"
",O
USA,O
.,O
"
",O
(3)Department,O
of,O
Microbial,O
Infection,O
and,O
Immunity,O
",",O
The,O
Ohio,O
State,O
University,O
",",O
"
",O
Columbus,O
",",O
OH,O
",",O
USA,O
.,O
"
",O
(4)Viruses,O
and,O
Emerging,O
Pathogens,O
Program,O
",",O
Infectious,O
Diseases,O
Institute,O
",",O
The,O
"
",O
Ohio,O
State,O
University,O
",",O
Columbus,O
",",O
OH,O
",",O
USA,O
.,O
"
",O
(5)Food,O
Animal,O
Health,O
Research,O
Program,O
",",O
Ohio,O
Agricultural,O
Research,O
and,O
"
",O
Development,O
Center,O
",",O
CFAES,O
",",O
Department,O
of,O
Veterinary,O
Preventive,O
Medicine,O
",",O
The,O
Ohio,O
"
",O
State,O
University,O
",",O
Wooster,O
",",O
OH,O
",",O
USA,O
.,O
"
",O
(6)Department,O
of,O
Microbiology,O
",",O
Perelman,O
School,O
of,O
Medicine,O
",",O
University,O
of,O
"
",O
Pennsylvania,O
",",O
Philadelphia,O
",",O
PA,O
",",O
USA,O
.,O
"
",O
(7)Lineberger,O
Comprehensive,O
Cancer,O
Center,O
",",O
Department,O
of,O
Microbiology,O
and,O
"
",O
Immunology,O
",",O
University,O
of,O
North,O
Carolina,O
at,O
Chapel,O
Hill,O
",",O
Chapel,O
Hill,O
",",O
NC,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.108,O
22221751.2020.1733440,O
"
",O
PMCID,O
:,O
PMC7054935,O
"
",O
PMID,O
:,O
32102621,O
"


",O
515,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
24;9(2,O
),O
.,O
pii,O
:,O
E601,O
.,O
doi,O
:,O
10.339,O
jcm9020601,O
.,O
"

",O
Assessing,O
the,O
Impact,O
of,O
Reduced,O
Travel,O
on,O
Exportation,O
Dynamics,O
of,O
Novel,O
"
",O
Coronavirus,O
Infection,O
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
Anzai,O
A(1,O
),O
",",O
Kobayashi,O
T(1,O
),O
",",O
Linton,O
NM(1,O
),O
",",O
Kinoshita,O
R(1,O
),O
",",O
Hayashi,O
K(1,O
),O
",",O
Suzuki,O
"
",O
A(1,O
),O
",",O
Yang,O
Y(1,O
),O
",",O
Jung,O
SM(1,O
),O
",",O
Miyama,O
T(2,O
),O
",",O
Akhmetzhanov,O
AR(1,O
),O
",",O
Nishiura,O
H(1)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Graduate,O
School,O
of,O
Medicine,O
",",O
Hokkaido,O
University,O
",",O
Kita,O
15,O
Jo,O
Nishi,O
7,O
Chome,O
",",O
"
",O
Kitaku,O
",",O
Sapporoshi,O
",",O
Hokkaido,O
608638,O
",",O
Japan,O
.,O
"
",O
(2)Osaka,O
Institute,O
of,O
Public,O
Health,O
",",O
Nakamichi,O
1369,O
",",O
Higashinari,O
",",O
Osaka,O
"
",O
5370025,O
",",O
Japan,O
.,O
"
",O
(3)CREST,O
",",O
Japan,O
Science,O
and,O
Technology,O
Agency,O
",",O
Honcho,O
418,O
",",O
Kawaguchi,O
",",O
Saitama,O
"
",O
3320012,O
",",O
Japan,O
.,O
"

",O
The,O
impact,O
of,O
the,O
drastic,O
reduction,O
in,O
travel,O
volume,O
within,O
mainland,O
China,O
in,O
"
",O
January,O
and,O
February,O
2020,O
was,O
quantified,O
with,O
respect,O
to,O
reports,O
of,O
novel,O
"
",O
coronavirus,O
(,O
COVID19,B-Disease_COVID-19
),O
infections,O
outside,O
China,O
.,O
Data,O
on,O
confirmed,O
cases,O
"
",O
diagnosed,O
outside,O
China,O
were,O
analyzed,O
using,O
statistical,O
models,O
to,O
estimate,O
the,O
"
",O
impact,O
of,O
travel,O
reduction,O
on,O
three,O
epidemiological,O
outcome,O
measures,O
:,O
(,O
i,O
),O
the,O
"
",O
number,O
of,O
exported,O
cases,O
",",O
(,O
ii,O
),O
the,O
probability,O
of,O
a,O
major,O
epidemic,O
",",O
and,O
(,O
iii,O
),O
the,O
"
",O
time,O
delay,O
to,O
a,O
major,O
epidemic,O
.,O
From,O
28,O
January,O
to,O
7,O
February,O
2020,O
",",O
we,O
estimated,O
"
",O
that,O
226,O
exported,O
cases,O
(,O
95,O
%,O
confidence,O
interval,O
:,O
86449,O
),O
were,O
prevented,O
",",O
"
",O
corresponding,O
to,O
a,O
70.4,O
%,O
reduction,O
in,O
incidence,O
compared,O
to,O
the,O
counterfactual,O
"
",O
scenario,O
.,O
The,O
reduced,O
probability,O
of,O
a,O
major,O
epidemic,O
ranged,O
from,O
7,O
%,O
to,O
20,O
%,O
in,O
"
",O
Japan,O
",",O
which,O
resulted,O
in,O
a,O
median,O
time,O
delay,O
to,O
a,O
major,O
epidemic,O
of,O
two,O
days,O
.,O
"
",O
Depending,O
on,O
the,O
scenario,O
",",O
the,O
estimated,O
delay,O
may,O
be,O
less,O
than,O
one,O
day,O
.,O
As,O
the,O
"
",O
delay,O
is,O
small,O
",",O
the,O
decision,O
to,O
control,O
travel,O
volume,O
through,O
restrictions,O
on,O
"
",O
freedom,O
of,O
movement,O
should,O
be,O
balanced,O
between,O
the,O
resulting,O
estimated,O
"
",O
epidemiological,O
impact,O
and,O
predicted,O
economic,O
fallout,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9020601,O
"
",O
PMID,O
:,O
32102279,O
"


",O
516,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Feb,O
27;382(9):e18,O
.,O
doi,O
:,O
10.1056,O
NEJMe2003319,O
.,O
"

",O
Audio,O
Interview,O
:,O
Preparing,O
for,O
the,O
Spread,O
of,O
Covid19,B-Disease_COVID-19
.,O
"

",O
Rubin,O
EJ,O
",",O
Baden,O
LR,O
",",O
Morrissey,O
S.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMe2003319,O
"
",O
PMID,O
:,O
32101683,O
"


",O
517,O
.,O
Radiology,O
.,O
2020,O
Feb,O
26:200642,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200642,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Correlation,O
of,O
Chest,O
CT,O
and,O
RTPCR,O
Testing,O
in,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
"
",O
in,O
China,O
:,O
A,O
Report,O
of,O
1014,O
Cases,O
.,O
"

",O
Ai,O
T(1,O
),O
",",O
Yang,O
Z(1,O
),O
",",O
Hou,O
H(1,O
),O
",",O
Zhan,O
C(1,O
),O
",",O
Chen,O
C(1,O
),O
",",O
Lv,O
W(1,O
),O
",",O
Tao,O
Q(1,O
),O
",",O
Sun,O
Z(1,O
),O
",",O
"
",O
Xia,O
L(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
430030,O
",",O
China,O
(,O
T.A.,O
",",O
Z.Y.,O
",",O
"
",O
"C.Z.,C.C.",O
",",O
L.X.,O
),O
",",O
and,O
Department,O
of,O
Laboratory,O
Medicine,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
"
",O
430030,O
",",O
China,O
(,O
H.H.,O
",",O
Z.S.,O
),O
",",O
Department,O
of,O
Artificial,O
Intelligence,O
",",O
Julei,O
"
",O
Technology,O
Company,O
",",O
Wuhan,O
",",O
430030,O
",",O
China,O
(,O
W.L.,O
),O
",",O
Division,O
of,O
Imaging,O
Processing,O
",",O
"
",O
Department,O
of,O
Radiology,O
",",O
Leiden,O
University,O
Medical,O
Center,O
",",O
Leiden,O
",",O
the,O
"
",O
Netherlands,O
(,O
Q.T.,O
),O
.,O
"

",O
Background,O
Chest,O
CT,O
is,O
used,O
for,O
diagnosis,O
of,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
",",O
as,O
an,O
important,O
complement,O
to,O
the,O
reversetranscription,O
polymerase,O
"
",O
chain,O
reaction,O
(,O
RTPCR,O
),O
tests,O
.,O
Purpose,O
To,O
investigate,O
the,O
diagnostic,O
value,O
and,O
"
",O
consistency,O
of,O
chest,O
CT,O
as,O
compared,O
with,O
comparison,O
to,O
RTPCR,O
assay,O
in,O
COVID19,B-Disease_COVID-19
.,O
"
",O
Methods,O
From,O
January,O
6,O
to,O
February,O
6,O
",",O
2020,O
",",O
1014,O
patients,O
in,O
Wuhan,O
",",O
China,O
who,O
"
",O
underwent,O
both,O
chest,O
CT,O
and,O
RTPCR,O
tests,O
were,O
included,O
.,O
With,O
RTPCR,O
as,O
reference,O
"
",O
standard,O
",",O
the,O
performance,O
of,O
chest,O
CT,O
in,O
diagnosing,O
COVID19,B-Disease_COVID-19
was,O
assessed,O
.,O
"
",O
Besides,O
",",O
for,O
patients,O
with,O
multiple,O
RTPCR,O
assays,O
",",O
the,O
dynamic,O
conversion,O
of,O
"
",O
RTPCR,O
results,O
(,O
negative,O
to,O
positive,O
",",O
positive,O
to,O
negative,O
",",O
respectively,O
),O
was,O
"
",O
analyzed,O
as,O
compared,O
with,O
serial,O
chest,O
CT,O
scans,O
for,O
those,O
with,O
timeinterval,O
of,O
4,O
"
",O
days,O
or,O
more,O
.,O
Results,O
Of,O
1014,O
patients,O
",",O
59,O
%,O
(,O
601,O
1014,O
),O
had,O
positive,O
RTPCR,O
"
",O
results,O
",",O
and,O
88,O
%,O
(,O
888,O
1014,O
),O
had,O
positive,O
chest,O
CT,O
scans,O
.,O
The,O
sensitivity,O
of,O
chest,O
"
",O
CT,O
in,O
suggesting,O
COVID19,B-Disease_COVID-19
was,O
97,O
%,O
(,O
95%CI,O
",",O
9598,O
%,O
",",O
580,O
601,O
patients,O
),O
based,O
on,O
"
",O
positive,O
RTPCR,O
results,O
.,O
In,O
patients,O
with,O
negative,O
RTPCR,O
results,O
",",O
75,O
%,O
(,O
308,O
413,O
),O
"
",O
had,O
positive,O
chest,O
CT,O
findings,O
;,O
of,O
308,O
",",O
48,O
%,O
were,O
considered,O
as,O
highly,O
likely,O
"
",O
cases,O
",",O
with,O
33,O
%,O
as,O
probable,O
cases,O
.,O
By,O
analysis,O
of,O
serial,O
RTPCR,O
assays,O
and,O
CT,O
"
",O
scans,O
",",O
the,O
mean,O
interval,O
time,O
between,O
the,O
initial,O
negative,O
to,O
positive,O
RTPCR,O
"
",O
results,O
was,O
5.1,O
Â±,O
1.5,O
days,O
;,O
the,O
initial,O
positive,O
to,O
subsequent,O
negative,O
RTPCR,O
"
",O
result,O
was,O
6.9,O
Â±,O
2.3,O
days,O
),O
.,O
60,O
%,O
to,O
93,O
%,O
of,O
cases,O
had,O
initial,O
positive,O
CT,O
"
",O
consistent,O
with,O
COVID19,B-Disease_COVID-19
prior,O
(,O
or,O
parallel,O
),O
to,O
the,O
initial,O
positive,O
RTPCR,O
"
",O
results,O
.,O
42,O
%,O
(,O
24,O
57,O
),O
cases,O
showed,O
improvement,O
in,O
followup,O
chest,O
CT,O
scans,O
before,O
"
",O
the,O
RTPCR,O
results,O
turning,O
negative,O
.,O
Conclusion,O
Chest,O
CT,O
has,O
a,O
high,O
sensitivity,O
"
",O
for,O
diagnosis,O
of,O
COVID19,B-Disease_COVID-19
.,O
Chest,O
CT,O
may,O
be,O
considered,O
as,O
a,O
primary,O
tool,O
for,O
the,O
"
",O
current,O
COVID19,B-Disease_COVID-19
detection,O
in,O
epidemic,O
areas,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200642,O
"
",O
PMID,O
:,O
32101510,O
"


",O
518,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
26,O
.,O
doi,O
:,O
10.1002,O
jmv.25726,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Composition,O
and,O
divergence,O
of,O
coronavirus,O
spike,O
proteins,O
and,O
host,O
ACE2,O
receptors,O
"
",O
predict,O
potential,O
intermediate,O
hosts,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Liu,O
Z(1)(2,O
),O
",",O
Xiao,O
X(1,O
),O
",",O
Wei,O
X(1,O
),O
",",O
Li,O
J(1,O
),O
",",O
Yang,O
J(1,O
),O
",",O
Tan,O
H(1,O
),O
",",O
Zhu,O
J(1,O
),O
",",O
Zhang,O
"
",O
Q(3)(4,O
),O
",",O
Wu,O
J(2)(3,O
),O
",",O
Liu,O
L(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Respiratory,O
",",O
Department,O
of,O
Infectious,O
Diseases,O
",",O
School,O
of,O
Basic,O
"
",O
Medical,O
Sciences,O
",",O
Renmin,O
Hospital,O
",",O
Hubei,O
University,O
of,O
Medicine,O
",",O
Shiyan,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Virology,O
and,O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Institute,O
of,O
Medical,O
"
",O
Microbiology,O
",",O
Jinan,O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(4)School,O
of,O
Public,O
Health,O
",",O
Southern,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"

",O
From,O
the,O
beginning,O
of,O
2002,O
and,O
2012,O
",",O
severe,O
respiratory,O
syndrome,O
coronavirus,O
"
",O
(,O
SARSCoV,O
),O
and,O
Middle,O
East,O
respiratory,O
syndrome,O
coronavirus,O
(,O
MERSCoV,O
),O
crossed,O
"
",O
the,O
species,O
barriers,O
to,O
infect,O
humans,O
",",O
causing,O
thousands,O
of,O
infections,O
and,O
"
",O
hundreds,O
of,O
deaths,O
",",O
respectively,O
.,O
Currently,O
",",O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
"
",O
which,O
has,O
become,O
the,O
cause,O
of,O
the,O
outbreak,O
of,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
",",O
was,O
discovered,O
.,O
Until,O
18,O
February,O
2020,O
",",O
there,O
were,O
72,O
â€‰,O
533,O
confirmed,O
"
",O
COVID19,B-Disease_COVID-19
cases,O
(,O
including,O
10,O
â€‰,O
644,O
severe,O
cases,O
),O
and,O
1872,O
deaths,O
in,O
China,O
.,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
is,O
spreading,O
among,O
the,O
public,O
and,O
causing,O
substantial,O
burden,O
due,O
to,O
"
",O
its,O
humantohuman,O
transmission,O
.,O
However,O
",",O
the,O
intermediate,O
host,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
is,O
"
",O
still,O
unclear,O
.,O
Finding,O
the,O
possible,O
intermediate,O
host,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
is,O
imperative,O
"
",O
to,O
prevent,O
further,O
spread,O
of,O
the,O
epidemic,O
.,O
In,O
this,O
study,O
",",O
we,O
used,O
systematic,O
"
",O
comparison,O
and,O
analysis,O
to,O
predict,O
the,O
interaction,O
between,O
the,O
receptorbinding,O
"
",O
domain,O
(,O
RBD,O
),O
of,O
coronavirus,O
spike,O
protein,O
and,O
the,O
host,O
receptor,O
",",O
"
",O
angiotensinconverting,O
enzyme,O
2,O
(,O
ACE2,O
),O
.,O
The,O
interaction,O
between,O
the,O
key,O
amino,O
"
",O
acids,O
of,O
S,O
protein,O
RBD,O
and,O
ACE2,O
indicated,O
that,O
",",O
other,O
than,O
pangolins,O
and,O
snakes,O
",",O
"
",O
as,O
previously,O
suggested,O
",",O
turtles,O
(,O
Chrysemys,O
picta,O
bellii,O
",",O
Chelonia,O
mydas,O
",",O
and,O
"
",O
Pelodiscus,O
sinensis,O
),O
may,O
act,O
as,O
the,O
potential,O
intermediate,O
hosts,O
transmitting,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
to,O
humans,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25726,O
"
",O
PMID,O
:,O
32100877,O
"


",O
519,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
26,O
.,O
doi,O
:,O
10.1002,O
jmv.25725,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Evaluation,O
of,O
coronavirus,O
in,O
tears,O
and,O
conjunctival,O
secretions,O
of,O
patients,O
with,O
"
",O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"

",O
Xia,O
J(1,O
),O
",",O
Tong,O
J(1,O
),O
",",O
Liu,O
M(1,O
),O
",",O
Shen,O
Y(1,O
),O
",",O
Guo,O
D(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Ophthalmology,O
",",O
Zhejiang,O
University,O
School,O
of,O
Medicine,O
First,O
"
",O
Affiliated,O
Hospital,O
",",O
Hangzhou,O
",",O
Zhejiang,O
",",O
China,O
.,O
"

",O
OBJECTIVE,O
:,O
This,O
study,O
aimed,O
to,O
assess,O
the,O
presence,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
in,O
tears,O
"
",O
and,O
conjunctival,O
secretions,O
of,O
SARSCoV2infected,O
patients,O
.,O
"
",O
METHODS,O
:,O
A,O
prospective,O
interventional,O
case,O
series,O
study,O
was,O
performed,O
",",O
and,O
30,O
"
",O
confirmed,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
(,O
NCP,B-Disease_COVID-19
),O
patients,O
were,O
selected,O
at,O
the,O
First,O
"
",O
Affiliated,O
Hospital,O
of,O
Zhejiang,O
University,O
from,O
26,O
January,O
2020,O
to,O
9,O
February,O
"
",O
2020,O
.,O
At,O
an,O
interval,O
of,O
2,O
to,O
3,O
days,O
",",O
tear,O
and,O
conjunctival,O
secretions,O
were,O
"
",O
collected,O
twice,O
with,O
disposable,O
sampling,O
swabs,O
for,O
reversetranscription,O
"
",O
polymerase,O
chain,O
reaction,O
(,O
RTPCR,O
),O
assay,O
.,O
"
",O
RESULTS,O
:,O
Twentyone,O
commontype,O
and,O
nine,O
severetype,O
NCP,B-Disease_COVID-19
patients,O
were,O
enrolled,O
.,O
"
",O
Two,O
samples,O
of,O
tear,O
and,O
conjunctival,O
secretions,O
were,O
obtained,O
from,O
the,O
only,O
one,O
"
",O
patient,O
with,O
conjunctivitis,O
yielded,O
positive,O
RTPCR,O
results,O
.,O
Fiftyeight,O
samples,O
"
",O
from,O
other,O
patents,O
were,O
all,O
negative,O
.,O
"
",O
CONCLUSION,O
:,O
We,O
speculate,O
that,O
SARSCoV2,B-Virus_SARS-CoV-2
may,O
be,O
detected,O
in,O
the,O
tears,O
and,O
"
",O
conjunctival,O
secretions,O
in,O
NCP,B-Disease_COVID-19
patients,O
with,O
conjunctivitis,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25725,O
"
",O
PMID,O
:,O
32100876,O
"


",O
520,O
.,O
Clin,O
Sci,O
(,O
Lond,O
),O
.,O
2020,O
Mar,O
13;134(5):529542,O
.,O
doi,O
:,O
10.1042,O
CS20190900,O
.,O
"

",O
Chronic,O
hepatitis,O
C,O
virus,O
infection,O
impairs,O
insulin,O
secretion,O
by,O
regulation,O
of,O
"
",O
p38Î´,O
MAPKdependent,O
exocytosis,O
in,O
pancreatic,O
Î²cells,O
.,O
"

",O
Chen,O
J(1,O
),O
",",O
Wang,O
F(2,O
),O
",",O
Zhou,O
Y(3,O
),O
",",O
Jiang,O
J(4,O
),O
",",O
Ksimu,O
S(5,O
),O
",",O
Zhang,O
X(2,O
),O
",",O
Li,O
JZ(2,O
),O
",",O
"
",O
Niu,O
J(4,O
),O
",",O
Wang,O
Q(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Lab,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
"
",O
Sciences,O
",",O
Wuhan,O
430071,O
",",O
China,O
.,O
"
",O
(2)Jiangsu,O
Province,O
Key,O
Lab,O
of,O
Human,O
Functional,O
Genomics,O
",",O
Department,O
of,O
"
",O
Biochemistry,O
and,O
Molecular,O
Biology,O
",",O
Nanjing,O
Medical,O
University,O
",",O
Nanjing,O
210029,O
",",O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Thoracic,O
Surgery,O
",",O
First,O
Affiliated,O
Hospital,O
of,O
Nanjing,O
Medical,O
"
",O
University,O
",",O
Nanjing,O
210029,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Hepatology,O
",",O
the,O
First,O
Hospital,O
of,O
Jilin,O
University,O
",",O
Changchun,O
"
",O
130021,O
",",O
China,O
.,O
"
",O
(5)The,O
Center,O
for,O
Technology,O
and,O
Education,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
"
",O
Xinjiang,O
Medical,O
University,O
",",O
Urumchi,O
830054,O
",",O
China,O
.,O
"

",O
Chronic,O
hepatitis,O
C,O
virus,O
(,O
HCV,O
),O
infection,O
has,O
a,O
close,O
association,O
with,O
type,O
2,O
"
",O
diabetes,O
mellitus,O
.,O
Although,O
the,O
mechanisms,O
of,O
insulin,O
resistance,O
in,O
chronic,O
"
",O
hepatitis,O
C,O
(,O
CHC,O
),O
patients,O
have,O
been,O
extensively,O
studied,O
",",O
little,O
attention,O
has,O
"
",O
been,O
given,O
to,O
the,O
role,O
of,O
Î²cell,O
function,O
in,O
HCVassociated,O
diabetes,O
.,O
Here,O
",",O
we,O
"
",O
analysed,O
Î²cell,O
function,O
in,O
CHC,O
patients,O
and,O
HCVinfected,O
mouse,O
model,O
and,O
found,O
"
",O
in,O
addition,O
to,O
insulin,O
resistance,O
",",O
impaired,O
pancreatic,O
Î²cell,O
function,O
occurred,O
"
",O
in,O
CHC,O
patients,O
and,O
HCVinfected,O
C,O
OTg,O
mice,O
",",O
not,O
only,O
in,O
diabetic,O
individuals,O
but,O
"
",O
also,O
in,O
individuals,O
with,O
impaired,O
fasting,O
glucose,O
levels,O
.,O
Both,O
firstphase,O
and,O
"
",O
secondphase,O
insulin,O
secretion,O
were,O
impaired,O
",",O
at,O
least,O
partially,O
due,O
to,O
the,O
"
",O
reduction,O
of,O
exocytosis,O
of,O
secretory,O
insulincontaining,O
granules,O
following,O
HCV,O
"
",O
infection,O
.,O
Upregulated,O
p38Î´,O
in,O
HCVinfected,O
Î²cells,O
resulted,O
in,O
inactivation,O
of,O
"
",O
protein,O
kinase,O
D,O
(,O
PKD,O
),O
",",O
which,O
was,O
responsible,O
for,O
impaired,O
insulin,O
secretory,O
"
",O
capacity,O
of,O
Î²cells,O
.,O
Thus,O
",",O
impaired,O
insulin,O
secretion,O
due,O
to,O
HCV,O
infection,O
in,O
"
",O
Î²cells,O
contributes,O
to,O
HCVassociated,O
type,O
2,O
diabetes,O
.,O
These,O
findings,O
provided,O
a,O
"
",O
new,O
inspiration,O
for,O
the,O
important,O
prognostic,O
and,O
therapeutic,O
implications,O
in,O
the,O
"
",O
management,O
of,O
CHC,O
patients,O
with,O
impaired,O
fasting,O
glucose,O
.,O
"

",O
Â©,O
2020,O
The,O
Author(s,O
),O
.,O
Published,O
by,O
Portland,O
Press,O
Limited,O
on,O
behalf,O
of,O
the,O
"
",O
Biochemical,O
Society,O
.,O
"

",O
DOI,O
:,O
10.1042,O
CS20190900,O
"
",O
PMID,O
:,O
32100852,O
"


",O
521,O
.,O
Epidemiol,O
Infect,O
.,O
2020,O
Feb,O
26;148:e41,O
.,O
doi,O
:,O
10.1017,O
S0950268820000424,O
.,O
"

",O
Passengers,O
',O
destinations,O
from,O
China,O
:,O
low,O
risk,O
of,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
"
",O
transmission,O
into,O
Africa,O
and,O
South,O
America,O
.,O
"

",O
Haider,O
N(1,O
),O
",",O
Yavlinsky,O
A(2,O
),O
",",O
Simons,O
D(1,O
),O
",",O
Osman,O
AY(1,O
),O
",",O
Ntoumi,O
F(3)(4,O
),O
",",O
Zumla,O
"
",O
A(5)(6,O
),O
",",O
Kock,O
R(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Royal,O
Veterinary,O
College,O
",",O
University,O
of,O
London,O
",",O
Hawkshead,O
Lane,O
",",O
North,O
"
",O
Mymms,O
",",O
Hatfield,O
",",O
Hertfordshire,O
.,O
"
",O
(2)Institute,O
of,O
Health,O
Informatics,O
",",O
University,O
College,O
London,O
",",O
London,O
",",O
UK,O
.,O
"
",O
(3)Fondation,O
Congolaise,O
pour,O
la,O
Recherche,O
MÃ©dicale,O
(,O
FCRM,O
),O
",",O
Brazzaville,O
",",O
Republic,O
"
",O
of,O
Congo,O
.,O
"
",O
(4)Institute,O
for,O
Tropical,O
Medicine,O
University,O
of,O
TÃ¼bingen,O
",",O
Tubingen,O
",",O
Germany,O
.,O
"
",O
(5)Department,O
of,O
Infection,O
",",O
Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
UCL,O
Centre,O
for,O
"
",O
Clinical,O
Microbiology,O
",",O
Royal,O
Free,O
campus,O
",",O
London,O
",",O
UK,O
.,O
"
",O
(6)NIHR,O
Biomedical,O
Research,O
Centre,O
",",O
UCL,O
Hospitals,O
NHS,O
Foundation,O
Trust,O
",",O
London,O
",",O
"
",O
UK,O
.,O
"

",O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
[,O
SARSCOV2,B-Virus_SARS-CoV-2
],O
),O
was,O
detected,O
in,O
humans,O
during,O
the,O
last,O
"
",O
week,O
of,O
December,O
2019,O
at,O
Wuhan,O
city,O
in,O
China,O
",",O
and,O
caused,O
24,O
554,O
cases,O
in,O
27,O
"
",O
countries,O
and,O
territories,O
as,O
of,O
5,O
February,O
2020,O
.,O
The,O
objective,O
of,O
this,O
study,O
was,O
"
",O
to,O
estimate,O
the,O
risk,O
of,O
transmission,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
through,O
human,O
passenger,O
air,O
"
",O
flight,O
from,O
four,O
major,O
cities,O
of,O
China,O
(,O
Wuhan,O
",",O
Beijing,O
",",O
Shanghai,O
and,O
Guangzhou,O
),O
"
",O
to,O
the,O
passengers,O
',O
destination,O
countries,O
.,O
We,O
extracted,O
the,O
weekly,O
simulated,O
"
",O
passengers,O
',O
end,O
destination,O
data,O
for,O
the,O
period,O
of,O
131,O
January,O
2020,O
from,O
FLIRT,O
",",O
"
",O
an,O
online,O
air,O
travel,O
dataset,O
that,O
uses,O
information,O
from,O
800,O
airlines,O
to,O
show,O
the,O
"
",O
direct,O
flight,O
and,O
passengers,O
',O
end,O
destination,O
.,O
We,O
estimated,O
a,O
risk,O
index,O
of,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
transmission,O
based,O
on,O
the,O
number,O
of,O
travellers,O
to,O
destination,O
"
",O
countries,O
",",O
weighted,O
by,O
the,O
number,O
of,O
confirmed,O
cases,O
of,O
the,O
departed,O
city,O
"
",O
reported,O
by,O
the,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
.,O
We,O
ranked,O
each,O
country,O
based,O
on,O
"
",O
the,O
risk,O
index,O
in,O
four,O
quantiles,O
(,O
4th,O
quantile,O
being,O
the,O
highest,O
risk,O
and,O
1st,O
"
",O
quantile,O
being,O
the,O
lowest,O
risk,O
),O
.,O
During,O
the,O
period,O
",",O
388,O
287,O
passengers,O
were,O
"
",O
destined,O
for,O
1297,O
airports,O
in,O
168,O
countries,O
or,O
territories,O
across,O
the,O
world,O
.,O
The,O
"
",O
risk,O
index,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
among,O
the,O
countries,O
had,O
a,O
very,O
high,O
correlation,O
with,O
the,O
"
",O
WHOreported,O
confirmed,O
cases,O
(,O
0.97,O
),O
.,O
According,O
to,O
our,O
risk,O
score,O
classification,O
",",O
"
",O
of,O
the,O
countries,O
that,O
reported,O
at,O
least,O
one,O
Coronavirusinfected,O
pneumonia,O
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
case,O
as,O
of,O
5,O
February,O
2020,O
",",O
24,O
countries,O
were,O
in,O
the,O
4th,O
quantile,O
of,O
"
",O
the,O
risk,O
index,O
",",O
two,O
in,O
the,O
3rd,O
quantile,O
",",O
one,O
in,O
the,O
2nd,O
quantile,O
and,O
none,O
in,O
the,O
"
",O
1st,O
quantile,O
.,O
Outside,O
China,O
",",O
countries,O
with,O
a,O
higher,O
risk,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
transmission,O
are,O
Thailand,O
",",O
Cambodia,O
",",O
Malaysia,O
",",O
Canada,O
and,O
the,O
USA,O
",",O
all,O
of,O
which,O
"
",O
reported,O
at,O
least,O
one,O
case,O
.,O
In,O
panEurope,O
",",O
UK,O
",",O
France,O
",",O
Russia,O
",",O
Germany,O
and,O
Italy,O
;,O
"
",O
in,O
North,O
America,O
",",O
USA,O
and,O
Canada,O
;,O
in,O
Oceania,O
",",O
Australia,O
had,O
high,O
risk,O
",",O
all,O
of,O
"
",O
them,O
reported,O
at,O
least,O
one,O
case,O
.,O
In,O
Africa,O
and,O
South,O
America,O
",",O
the,O
risk,O
of,O
"
",O
transmission,O
is,O
very,O
low,O
with,O
Ethiopia,O
",",O
South,O
Africa,O
",",O
Egypt,O
",",O
Mauritius,O
and,O
Brazil,O
"
",O
showing,O
a,O
similar,O
risk,O
of,O
transmission,O
compared,O
to,O
the,O
risk,O
of,O
any,O
of,O
the,O
"
",O
countries,O
where,O
at,O
least,O
one,O
case,O
is,O
detected,O
.,O
The,O
risk,O
of,O
transmission,O
on,O
31,O
"
",O
January,O
2020,O
was,O
very,O
high,O
in,O
neighbouring,O
Asian,O
countries,O
",",O
followed,O
by,O
Europe,O
"
",O
(,O
UK,O
",",O
France,O
",",O
Russia,O
and,O
Germany,O
),O
",",O
Oceania,O
(,O
Australia,O
),O
and,O
North,O
America,O
(,O
USA,O
and,O
"
",O
Canada,O
),O
.,O
Increased,O
public,O
health,O
response,O
including,O
early,O
case,O
recognition,O
",",O
"
",O
isolation,O
of,O
identified,O
case,O
",",O
contract,O
tracing,O
and,O
targeted,O
airport,O
screening,O
",",O
"
",O
public,O
awareness,O
and,O
vigilance,O
of,O
health,O
workers,O
will,O
help,O
mitigate,O
the,O
force,O
of,O
"
",O
further,O
spread,O
to,O
naÃ¯ve,O
countries,O
.,O
"

",O
DOI,O
:,O
10.1017,O
S0950268820000424,O
"
",O
PMID,O
:,O
32100667,O
"


",O
522,O
.,O
Infect,O
Chemother,O
.,O
2020,O
Feb,O
25,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Emergent,O
Strategies,O
for,O
the,O
Next,O
Phase,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Huh,O
K(#)(1,O
),O
",",O
Shin,O
HS(#)(2,O
),O
",",O
Peck,O
KR(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Medicine,O
",",O
Samsung,O
Medical,O
"
",O
Center,O
",",O
Sungkyunkwan,O
University,O
School,O
of,O
Medicine,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(2)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Medicine,O
",",O
National,O
Medical,O
"
",O
Center,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(3)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Medicine,O
",",O
Samsung,O
Medical,O
"
",O
Center,O
",",O
Sungkyunkwan,O
University,O
School,O
of,O
Medicine,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
krpeck@skku.edu,O
.,O
"
",O
(#)Contributed,O
equally,O
"


",O
PMID,O
:,O
32100487,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
No,O
conflicts,O
of,O
interest,O
.,O
"


",O
523,O
.,O
Korean,O
J,O
Radiol,O
.,O
2020,O
Feb,O
26,O
.,O
doi,O
:,O
10.3348,O
kjr.2020.0112,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
Pneumonia,O
:,O
Serial,O
Computed,O
Tomography,O
Findings,O
.,O
"

",O
Wei,O
J(#)(1,O
),O
",",O
Xu,O
H(#)(2,O
),O
",",O
Xiong,O
J(3,O
),O
",",O
Shen,O
Q(4,O
),O
",",O
Fan,O
B(5,O
),O
",",O
Ye,O
C(1,O
),O
",",O
Dong,O
W(1,O
),O
",",O
Hu,O
"
",O
F(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Jiangxi,O
Provincial,O
People,O
's,O
Hospital,O
",",O
Nanchang,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Medical,O
Cosmetology,O
",",O
Jiangxi,O
Provincial,O
People,O
's,O
Hospital,O
",",O
"
",O
Nanchang,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Radiology,O
",",O
Jiangxi,O
Chest,O
Hospital,O
",",O
Nanchang,O
",",O
China,O
.,O
"
",O
(4)Institute,O
of,O
Clinical,O
Medicine,O
",",O
Jiangxi,O
Provincial,O
People,O
's,O
Hospital,O
",",O
"
",O
Nanchang,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Radiology,O
",",O
Jiangxi,O
Provincial,O
People,O
's,O
Hospital,O
",",O
Nanchang,O
",",O
"
",O
China,O
.,O
26171381@qq.com,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
From,O
December,O
2019,O
",",O
Coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
pneumonia,O
(,O
formerly,O
known,O
"
",O
as,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
[,O
2019nCoV,B-Virus_SARS-CoV-2
],O
),O
broke,O
out,O
in,O
Wuhan,O
",",O
China,O
.,O
In,O
this,O
"
",O
study,O
",",O
we,O
present,O
serial,O
CT,O
findings,O
in,O
a,O
40yearold,O
female,O
patient,O
with,O
"
",O
COVID19,B-Disease_COVID-19
pneumonia,O
who,O
presented,O
with,O
the,O
symptoms,O
of,O
fever,O
",",O
chest,O
tightness,O
",",O
and,O
"
",O
fatigue,O
.,O
She,O
was,O
diagnosed,O
with,O
COVID19,B-Disease_COVID-19
infection,O
confirmed,O
by,O
realtime,O
"
",O
reversetranscriptasepolymerase,O
chain,O
reaction,O
.,O
CT,O
showed,O
rapidly,O
progressing,O
"
",O
peripheral,O
consolidations,O
and,O
groundglass,O
opacities,O
in,O
both,O
lungs,O
.,O
After,O
"
",O
treatment,O
",",O
the,O
lesions,O
were,O
shown,O
to,O
be,O
almost,O
absorbed,O
leaving,O
the,O
fibrous,O
"
",O
lesions,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Korean,O
Society,O
of,O
Radiology,O
.,O
"

",O
DOI,O
:,O
10.3348,O
kjr.2020.0112,O
"
",O
PMID,O
:,O
32100486,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
have,O
no,O
potential,O
conflicts,O
of,O
"
",O
interest,O
to,O
disclose,O
.,O
"


",O
524,O
.,O
Korean,O
J,O
Radiol,O
.,O
2020,O
Feb,O
26,O
.,O
doi,O
:,O
10.3348,O
kjr.2020.0132,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Chest,O
Radiographic,O
and,O
CT,O
Findings,O
of,O
the,O
2019,B-Disease_COVID-19
Novel,I-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
:,O
Analysis,O
of,O
Nine,O
Patients,O
Treated,O
in,O
Korea,O
.,O
"

",O
Yoon,O
SH(1,O
),O
",",O
Lee,O
KH(2,O
),O
",",O
Kim,O
JY(3,O
),O
",",O
Lee,O
YK(4,O
),O
",",O
Ko,O
H(5,O
),O
",",O
Kim,O
KH(6,O
),O
",",O
Park,O
CM(7,O
),O
",",O
Kim,O
"
",O
YH(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Seoul,O
National,O
University,O
College,O
of,O
Medicine,O
",",O
Seoul,O
"
",O
National,O
University,O
Hospital,O
",",O
Seoul,O
",",O
Korea,O
.,O
yshoka@gmail.com,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
Seoul,O
National,O
University,O
Bundang,O
Hospital,O
",",O
Seongnam,O
",",O
"
",O
Korea,O
.,O
"
",O
(3)Department,O
of,O
Internal,O
Medicine,O
",",O
Incheon,O
Medical,O
Center,O
",",O
Incheon,O
",",O
Korea,O
.,O
"
",O
(4)Department,O
of,O
Radiology,O
",",O
Seoul,O
Medical,O
Center,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(5)Department,O
of,O
Radiology,O
",",O
National,O
Medical,O
Center,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(6)Department,O
of,O
Radiology,O
",",O
Myongji,O
Hospital,O
",",O
Goyang,O
",",O
Korea,O
.,O
"
",O
(7)Department,O
of,O
Radiology,O
",",O
Seoul,O
National,O
University,O
College,O
of,O
Medicine,O
",",O
Seoul,O
"
",O
National,O
University,O
Hospital,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(8)Department,O
of,O
Radiology,O
",",O
Chonnam,O
National,O
University,O
Hospital,O
",",O
Gwangju,O
",",O
Korea,O
.,O
"

",O
OBJECTIVE,O
:,O
This,O
study,O
presents,O
a,O
preliminary,O
report,O
on,O
the,O
chest,O
radiographic,O
and,O
"
",O
computed,O
tomography,O
(,O
CT,O
),O
findings,O
of,O
the,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
pneumonia,O
in,O
Korea,O
.,O
"
",O
MATERIALS,O
AND,O
METHODS,O
:,O
As,O
part,O
of,O
a,O
multiinstitutional,O
collaboration,O
coordinated,O
"
",O
by,O
the,O
Korean,O
Society,O
of,O
Thoracic,O
Radiology,O
",",O
we,O
collected,O
nine,O
patients,O
with,O
"
",O
COVID19,B-Disease_COVID-19
infections,O
who,O
had,O
undergone,O
chest,O
radiography,O
and,O
CT,O
scans,O
.,O
We,O
analyzed,O
"
",O
the,O
radiographic,O
and,O
CT,O
findings,O
of,O
COVID19,B-Disease_COVID-19
pneumonia,O
at,O
baseline,O
.,O
Fisher,O
's,O
"
",O
exact,O
test,O
was,O
used,O
to,O
compare,O
CT,O
findings,O
depending,O
on,O
the,O
shape,O
of,O
pulmonary,O
"
",O
lesions,O
.,O
"
",O
RESULTS,O
:,O
Three,O
of,O
the,O
nine,O
patients,O
(,O
33.3,O
%,O
),O
had,O
parenchymal,O
abnormalities,O
"
",O
detected,O
by,O
chest,O
radiography,O
",",O
and,O
most,O
of,O
the,O
abnormalities,O
were,O
peripheral,O
"
",O
consolidations,O
.,O
Chest,O
CT,O
images,O
showed,O
bilateral,O
involvement,O
in,O
eight,O
of,O
the,O
nine,O
"
",O
patients,O
",",O
and,O
a,O
unilobar,O
reversed,O
halo,O
sign,O
in,O
the,O
other,O
patient,O
.,O
In,O
total,O
",",O
77,O
"
",O
pulmonary,O
lesions,O
were,O
found,O
",",O
including,O
patchy,O
lesions,O
(,O
39,O
%,O
),O
",",O
large,O
confluent,O
"
",O
lesions,O
(,O
13,O
%,O
),O
",",O
and,O
small,O
nodular,O
lesions,O
(,O
48,O
%,O
),O
.,O
The,O
peripheral,O
and,O
posterior,O
lung,O
"
",O
fields,O
were,O
involved,O
in,O
78,O
%,O
and,O
67,O
%,O
of,O
the,O
lesions,O
",",O
respectively,O
.,O
The,O
lesions,O
"
",O
were,O
typically,O
illdefined,O
and,O
were,O
composed,O
of,O
mixed,O
groundglass,O
opacities,O
and,O
"
",O
consolidation,O
or,O
pure,O
groundglass,O
opacities,O
.,O
Patchy,O
to,O
confluent,O
lesions,O
were,O
"
",O
primarily,O
distributed,O
in,O
the,O
lower,O
lobes,O
(,O
p,O
=,O
0.04,O
),O
and,O
along,O
the,O
pleura,O
(,O
p,O
<,O
"
",O
0.001,O
),O
",",O
whereas,O
nodular,O
lesions,O
were,O
primarily,O
distributed,O
along,O
the,O
"
",O
bronchovascular,O
bundles,O
(,O
p,O
=,O
0.006,O
),O
.,O
"
",O
CONCLUSION,O
:,O
COVID19,B-Disease_COVID-19
pneumonia,O
in,O
Korea,O
primarily,O
manifested,O
as,O
pure,O
to,O
mixed,O
"
",O
groundglass,O
opacities,O
with,O
a,O
patchy,O
to,O
confluent,O
or,O
nodular,O
shape,O
in,O
the,O
"
",O
bilateral,O
peripheral,O
posterior,O
lungs,O
.,O
A,O
considerable,O
proportion,O
of,O
patients,O
with,O
"
",O
COVID19,B-Disease_COVID-19
pneumonia,O
had,O
normal,O
chest,O
radiographs,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Korean,O
Society,O
of,O
Radiology,O
.,O
"

",O
DOI,O
:,O
10.3348,O
kjr.2020.0132,O
"
",O
PMID,O
:,O
32100485,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
have,O
no,O
potential,O
conflicts,O
of,O
"
",O
interest,O
to,O
disclose,O
.,O
"


",O
525,O
.,O
J,O
Neurol,O
.,O
2020,O
Feb,O
25,O
.,O
doi,O
:,O
10.1007,O
s00415020097739,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
2019,O
novel,O
cornoavirus,O
pneumonia,O
with,O
onset,O
of,O
oculomotor,O
nerve,O
palsy,O
:,O
a,O
case,O
"
",O
study,O
.,O
"

",O
Wei,O
H(1,O
),O
",",O
Yin,O
H(2,O
),O
",",O
Huang,O
M(3,O
),O
",",O
Guo,O
Z(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Neurology,O
",",O
Hubei,O
Provincial,O
Hospital,O
of,O
Integrated,O
Chinese,O
and,O
"
",O
Western,O
Medicine,O
",",O
Hubei,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Wuhan,O
",",O
430000,O
",",O
China,O
.,O
"
",O
tonywei2011@126.com,O
.,O
"
",O
(2)Department,O
of,O
Neurology,O
",",O
Hubei,O
Provincial,O
Hospital,O
of,O
Integrated,O
Chinese,O
and,O
"
",O
Western,O
Medicine,O
",",O
Hubei,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Wuhan,O
",",O
430000,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Endocrinology,O
",",O
Hubei,O
Provincial,O
Hospital,O
of,O
Integrated,O
Chinese,O
"
",O
and,O
Western,O
Medicine,O
",",O
Hubei,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Wuhan,O
",",O
430000,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00415020097739,O
"
",O
PMID,O
:,O
32100124,O
"


",O
526,O
.,O
Intensive,O
Care,O
Med,O
.,O
2020,O
Feb,O
25,O
.,O
doi,O
:,O
10.1007,O
s00134020059788,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Challenges,O
and,O
countermeasures,O
for,O
organ,O
donation,O
during,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
epidemic,O
:,O
"
",O
the,O
experience,O
of,O
Sichuan,O
Provincial,O
People,O
's,O
Hospital,O
.,O
"

",O
Pan,O
L(1,O
),O
",",O
Zeng,O
J(2,O
),O
",",O
Yang,O
H(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Sichuan,O
Academy,O
of,O
Medical,O
Sciences,O
and,O
"
",O
Sichuan,O
Provincial,O
People,O
's,O
Hospital,O
",",O
University,O
of,O
Electronic,O
Science,O
and,O
"
",O
Technology,O
of,O
China,O
",",O
Chengdu,O
",",O
610072,O
",",O
Sichuan,O
Province,O
",",O
China,O
.,O
"
",O
panlingai2004@163.com,O
.,O
"
",O
(2)Department,O
of,O
Cardiology,O
",",O
Sichuan,O
Academy,O
of,O
Medical,O
Sciences,O
and,O
Sichuan,O
"
",O
Provincial,O
People,O
's,O
Hospital,O
",",O
University,O
of,O
Electronic,O
Science,O
and,O
Technology,O
of,O
"
",O
China,O
",",O
Chengdu,O
",",O
610072,O
",",O
Sichuan,O
Province,O
",",O
China,O
.,O
"
",O
(3)Organ,O
Transplant,O
Center,O
",",O
Sichuan,O
Academy,O
of,O
Medical,O
Sciences,O
and,O
Sichuan,O
"
",O
Provincial,O
People,O
's,O
Hospital,O
",",O
University,O
of,O
Electronic,O
Science,O
and,O
Technology,O
of,O
"
",O
China,O
",",O
Chengdu,O
",",O
610072,O
",",O
Sichuan,O
Province,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00134020059788,O
"
",O
PMID,O
:,O
32100062,O
"


",O
527,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
26,O
.,O
pii,O
:,O
ciaa179,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa179,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Deisolating,O
COVID19,B-Disease_COVID-19
Suspect,O
Cases,O
:,O
A,O
Continuing,O
Challenge,O
.,O
"

",O
Tay,O
JY(1)(2,O
),O
",",O
Lim,O
PL(1)(2,O
),O
",",O
Marimuthu,O
K(1)(2,O
),O
",",O
Sadarangani,O
SP(1)(2,O
),O
",",O
Ling,O
"
",O
LM(1)(2,O
),O
",",O
Ang,O
BSP(1)(2,O
),O
",",O
Chan,O
M(1)(2,O
),O
",",O
Leo,O
YS(1)(2,O
),O
",",O
Vasoo,O
S(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Centre,O
for,O
Infectious,O
Diseases,O
.,O
"
",O
(2)Department,O
of,O
Infectious,O
Diseases,O
",",O
Tan,O
Tock,O
Seng,O
Hospital,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa179,O
"
",O
PMID,O
:,O
32100024,O
"


",O
528,O
.,O
Infect,O
Dis,O
Model,O
.,O
2020,O
Feb,O
11;5:248255,O
.,O
doi,O
:,O
10.1016,O
j.idm.2020.02.001,O
.,O
"
",O
eCollection,O
2020,O
.,O
"

",O
An,O
updated,O
estimation,O
of,O
the,O
risk,O
of,O
transmission,O
of,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCov,B-Virus_SARS-CoV-2
),O
.,O
"

",O
Tang,O
B(1)(2,O
),O
",",O
Bragazzi,O
NL(2,O
),O
",",O
Li,O
Q(2)(3,O
),O
",",O
Tang,O
S(4,O
),O
",",O
Xiao,O
Y(1)(3,O
),O
",",O
Wu,O
J(1)(2)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Interdisplinary,O
Research,O
Center,O
for,O
Mathematics,O
and,O
Life,O
Sciences,O
",",O
Xi'an,O
"
",O
Jiaotong,O
University,O
",",O
Xi'an,O
",",O
710049,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)Laboratory,O
for,O
Industrial,O
and,O
Applied,O
Mathematics,O
",",O
Department,O
of,O
Mathematics,O
"
",O
and,O
Statistics,O
",",O
York,O
University,O
",",O
Toronto,O
",",O
Ontario,O
",",O
M3J,O
1P3,O
",",O
Canada,O
.,O
"
",O
(3)School,O
of,O
Mathematics,O
and,O
Statistics,O
",",O
Xi'an,O
Jiaotong,O
University,O
",",O
Xi'an,O
",",O
"
",O
710049,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(4)School,O
of,O
Mathematics,O
and,O
Information,O
Science,O
",",O
Shaanxi,O
Normal,O
University,O
",",O
"
",O
Xi'an,O
",",O
710119,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(5)FieldsCQAM,O
Laboratory,O
of,O
Mathematics,O
for,O
Public,O
Health,O
",",O
York,O
University,O
",",O
"
",O
Toronto,O
",",O
Ontario,O
",",O
M3J,O
1P3,O
",",O
Canada,O
.,O
"

",O
The,O
basic,O
reproduction,O
number,O
of,O
an,O
infectious,O
agent,O
is,O
the,O
average,O
number,O
of,O
"
",O
infections,O
one,O
case,O
can,O
generate,O
over,O
the,O
course,O
of,O
the,O
infectious,O
period,O
",",O
in,O
a,O
"
",O
naÃ¯ve,O
",",O
uninfected,O
population,O
.,O
It,O
is,O
wellknown,O
that,O
the,O
estimation,O
of,O
this,O
number,O
"
",O
may,O
vary,O
due,O
to,O
several,O
methodological,O
issues,O
",",O
including,O
different,O
assumptions,O
"
",O
and,O
choice,O
of,O
parameters,O
",",O
utilized,O
models,O
",",O
used,O
datasets,O
and,O
estimation,O
period,O
.,O
"
",O
With,O
the,O
spreading,O
of,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
infection,O
",",O
the,O
"
",O
reproduction,O
number,O
has,O
been,O
found,O
to,O
vary,O
",",O
reflecting,O
the,O
dynamics,O
of,O
"
",O
transmission,O
of,O
the,O
coronavirus,O
outbreak,O
as,O
well,O
as,O
the,O
case,O
reporting,O
rate,O
.,O
Due,O
"
",O
to,O
significant,O
variations,O
in,O
the,O
control,O
strategies,O
",",O
which,O
have,O
been,O
changing,O
"
",O
over,O
time,O
",",O
and,O
thanks,O
to,O
the,O
introduction,O
of,O
detection,O
technologies,O
that,O
have,O
"
",O
been,O
rapidly,O
improved,O
",",O
enabling,O
to,O
shorten,O
the,O
time,O
from,O
infection,O
symptoms,O
onset,O
"
",O
to,O
diagnosis,O
",",O
leading,O
to,O
faster,O
confirmation,O
of,O
the,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
cases,O
",",O
our,O
"
",O
previous,O
estimations,O
on,O
the,O
transmission,O
risk,O
of,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
need,O
to,O
be,O
"
",O
revised,O
.,O
By,O
using,O
timedependent,O
contact,O
and,O
diagnose,O
rates,O
",",O
we,O
refit,O
our,O
"
",O
previously,O
proposed,O
dynamics,O
transmission,O
model,O
to,O
the,O
data,O
available,O
until,O
"
",O
January,O
29th,O
",",O
2020,O
and,O
reestimated,O
the,O
effective,O
daily,O
reproduction,O
ratio,O
that,O
"
",O
better,O
quantifies,O
the,O
evolution,O
of,O
the,O
interventions,O
.,O
We,O
estimated,O
when,O
the,O
"
",O
effective,O
daily,O
reproduction,O
ratio,O
has,O
fallen,O
below,O
1,O
and,O
when,O
the,O
epidemics,O
will,O
"
",O
peak,O
.,O
Our,O
updated,O
findings,O
suggest,O
that,O
the,O
best,O
measure,O
is,O
persistent,O
and,O
strict,O
"
",O
selfisolation,O
.,O
The,O
epidemics,O
will,O
continue,O
to,O
grow,O
",",O
and,O
can,O
peak,O
soon,O
with,O
the,O
"
",O
peak,O
time,O
depending,O
highly,O
on,O
the,O
public,O
health,O
interventions,O
practically,O
"
",O
implemented,O
.,O
"

",O
Â©,O
2020,O
The,O
Authors,O
.,O
Production,O
and,O
hosting,O
by,O
Elsevier,O
B.V.,O
on,O
behalf,O
of,O
KeAi,O
"
",O
Communications,O
Co.,O
",",O
Ltd.,O
"

",O
DOI,O
:,O
10.1016,O
j.idm.2020.02.001,O
"
",O
PMCID,O
:,O
PMC7029158,O
"
",O
PMID,O
:,O
32099934,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
None,O
.,O
"


",O
529,O
.,O
J,O
Sport,O
Health,O
Sci,O
.,O
2020,O
Mar;9(2):103104,O
.,O
doi,O
:,O
10.1016,O
j.jshs.2020.02.001,O
.,O
Epub,O
"
",O
2020,O
Feb,O
4,O
.,O
"

",O
Wuhan,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
:,O
The,O
need,O
to,O
maintain,O
regular,O
physical,O
activity,O
"
",O
while,O
taking,O
precautions,O
.,O
"

",O
Chen,O
P(1,O
),O
",",O
Mao,O
L(1)(2,O
),O
",",O
Nassis,O
GP(1)(3,O
),O
",",O
Harmer,O
P(4,O
),O
",",O
Ainsworth,O
BE(1)(5,O
),O
",",O
Li,O
"
",O
F(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Shanghai,O
University,O
of,O
Sport,O
",",O
Shanghai,O
200438,O
",",O
China,O
.,O
"
",O
(2)Shanghai,O
Municipal,O
Education,O
Commission,O
",",O
Shanghai,O
200003,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Sports,O
Science,O
and,O
Clinical,O
Biomechanics,O
",",O
University,O
of,O
Southern,O
"
",O
Denmark,O
",",O
Odense,O
5230,O
",",O
Denmark,O
.,O
"
",O
(4)Department,O
of,O
Exercise,O
and,O
Health,O
Science,O
",",O
Willamette,O
University,O
",",O
Salem,O
",",O
OR,O
"
",O
97301,O
",",O
USA,O
.,O
"
",O
(5)School,O
of,O
Nutrition,O
and,O
Health,O
Promotion,O
",",O
Arizona,O
State,O
University,O
",",O
Phoenix,O
",",O
"
",O
AZ,O
85004,O
",",O
USA,O
.,O
"
",O
(6)Oregon,O
Research,O
Institute,O
",",O
Eugene,O
",",O
OR,O
97403,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jshs.2020.02.001,O
"
",O
PMCID,O
:,O
PMC7031771,O
"
",O
PMID,O
:,O
32099716,O
"


",O
530,O
.,O
BMJ,O
.,O
2020,O
Feb,O
25;368:m751,O
.,O
doi,O
:,O
10.1136,O
bmj.m751,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
surge,O
in,O
cases,O
in,O
Italy,O
and,O
South,O
Korea,O
makes,O
pandemic,O
look,O
more,O
"
",O
likely,O
.,O
"

",O
Day,O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)London,O
",",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m751,O
"
",O
PMID,O
:,O
32098875,O
"


",O
531,O
.,O
Commun,O
Dis,O
Intell,O
(,O
2018,O
),O
.,O
2020,O
Feb,O
26;44,O
.,O
doi,O
:,O
10.33321,O
cdi.2020.44.17,O
.,O
"

",O
COVID19,B-Disease_COVID-19
",",O
Australia,O
:,O
Epidemiology,O
Report,O
4,O
(,O
Reporting,O
week,O
ending,O
0.791666667,O
AEDT,O
22,O
"
",O
February,O
2020,O
),O
.,O
"

",O
COVID19,B-Disease_COVID-19
National,O
Incident,O
Room,O
Surveillance,O
Team,O
.,O
"

",O
This,O
is,O
the,O
fourth,O
epidemiological,O
report,O
for,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
",",O
reported,O
in,O
Australia,O
as,O
at,O
0.791666667,O
Australian,O
Eastern,O
Daylight,O
Time,O
"
",O
[,O
AEDT,O
],O
22,O
February,O
2020,O
.,O
It,O
includes,O
data,O
on,O
COVID19,B-Disease_COVID-19
cases,O
diagnosed,O
in,O
"
",O
Australia,O
",",O
the,O
international,O
situation,O
and,O
a,O
review,O
of,O
current,O
evidence,O
.,O
"

",O
Â©,O
Commonwealth,O
of,O
Australia,O
CC,O
BYNCND,O
.,O
"

",O
DOI,O
:,O
10.33321,O
cdi.2020.44.17,O
"
",O
PMID,O
:,O
32098616,O
"


",O
532,O
.,O
Viruses,O
.,O
2020,O
Feb,O
22;12(2,O
),O
.,O
pii,O
:,O
E244,O
.,O
doi,O
:,O
10.339,O
v12020244,O
.,O
"

",O
Systematic,O
Comparison,O
of,O
Two,O
AnimaltoHuman,O
Transmitted,O
Human,O
Coronaviruses,O
:,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
and,O
SARSCoV.,O
"

",O
Xu,O
J(1,O
),O
",",O
Zhao,O
S(1,O
),O
",",O
Teng,O
T(1,O
),O
",",O
Abdalla,O
AE(2,O
),O
",",O
Zhu,O
W(3,O
),O
",",O
Xie,O
L(1,O
),O
",",O
Wang,O
Y(4,O
),O
",",O
Guo,O
"
",O
X(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Preventive,O
Medicine,O
",",O
Institute,O
of,O
Biomedical,O
Informatics,O
",",O
"
",O
Bioinformatics,O
Center,O
",",O
Henan,O
Provincial,O
Engineering,O
Center,O
for,O
Tumor,O
Molecular,O
"
",O
Medicine,O
",",O
School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Henan,O
University,O
",",O
Kaifeng,O
475004,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Clinical,O
Laboratory,O
Sciences,O
",",O
College,O
of,O
Applied,O
Medical,O
"
",O
Sciences,O
",",O
Jouf,O
University,O
",",O
Sakaka,O
2014,O
",",O
Saudi,O
Arabia,O
.,O
"
",O
(3)Department,O
of,O
Anesthesia,O
",",O
Stanford,O
University,O
",",O
California,O
94305,O
",",O
USA,O
.,O
"
",O
(4)Henan,O
Bioengineering,O
Research,O
Center,O
",",O
Zhengzhou,O
450046,O
",",O
China,O
.,O
"

",O
After,O
the,O
outbreak,O
of,O
the,O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
in,O
the,O
world,O
"
",O
in,O
2003,O
",",O
human,O
coronaviruses,O
(,O
HCoVs,O
),O
have,O
been,O
reported,O
as,O
pathogens,O
that,O
cause,O
"
",O
severe,O
symptoms,O
in,O
respiratory,O
tract,O
infections,O
.,O
Recently,O
",",O
a,O
new,O
emerged,O
HCoV,O
"
",O
isolated,O
from,O
the,O
respiratory,O
epithelium,O
of,O
unexplained,O
pneumonia,O
patients,O
in,O
the,O
"
",O
Wuhan,O
seafood,O
market,O
caused,O
a,O
major,O
disease,O
outbreak,O
and,O
has,O
been,O
named,O
the,O
"
",O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
.,O
This,O
virus,O
causes,O
"
",O
acute,O
lung,O
symptoms,O
",",O
leading,O
to,O
a,O
condition,O
that,O
has,O
been,O
named,O
as,O
"""",O
coronavirus,O
"
",O
disease,O
2019,O
"""",O
(,O
COVID19,B-Disease_COVID-19
),O
.,O
The,O
emergence,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
and,O
of,O
SARSCoV,O
caused,O
"
",O
widespread,O
fear,O
and,O
concern,O
and,O
has,O
threatened,O
global,O
health,O
security,O
.,O
There,O
are,O
"
",O
some,O
similarities,O
and,O
differences,O
in,O
the,O
epidemiology,O
and,O
clinical,O
features,O
"
",O
between,O
these,O
two,O
viruses,O
and,O
diseases,O
that,O
are,O
caused,O
by,O
these,O
viruses,O
.,O
The,O
goal,O
"
",O
of,O
this,O
work,O
is,O
to,O
systematically,O
review,O
and,O
compare,O
between,O
SARSCoV,O
and,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
the,O
context,O
of,O
their,O
virus,O
incubation,O
",",O
originations,O
",",O
diagnosis,O
and,O
"
",O
treatment,O
methods,O
",",O
genomic,O
and,O
proteomic,O
sequences,O
",",O
and,O
pathogenic,O
mechanisms,O
.,O
"

",O
DOI,O
:,O
10.339,O
v12020244,O
"
",O
PMID,O
:,O
32098422,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
533,O
.,O
Pathogens,O
.,O
2020,O
Feb,O
22;9(2,O
),O
.,O
pii,O
:,O
E148,O
.,O
doi,O
:,O
10.339,O
pathogens9020148,O
.,O
"

",O
Emergence,O
of,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
2019nCoV,B-Virus_SARS-CoV-2
:,O
Need,O
for,O
Rapid,O
Vaccine,O
and,O
Biologics,O
"
",O
Development,O
.,O
"

",O
Shanmugaraj,O
B(1)(2,O
),O
",",O
Malla,O
A(1)(2,O
),O
",",O
Phoolcharoen,O
W(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Research,O
unit,O
for,O
Plantproduced,O
Pharmaceuticals,O
",",O
Chulalongkorn,O
University,O
",",O
"
",O
Bangkok,O
10330,O
",",O
Thailand,O
.,O
"
",O
(2)Department,O
of,O
Pharmacognosy,O
and,O
Pharmaceutical,O
Botany,O
",",O
Chulalongkorn,O
"
",O
University,O
",",O
Bangkok,O
10330,O
",",O
Thailand,O
.,O
"

",O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
is,O
an,O
emerging,O
pathogen,O
that,O
was,O
first,O
identified,O
"
",O
in,O
Wuhan,O
",",O
China,O
in,O
late,O
December,O
2019,O
.,O
This,O
virus,O
is,O
responsible,O
for,O
the,O
ongoing,O
"
",O
outbreak,O
that,O
causes,O
severe,O
respiratory,O
illness,O
and,O
pneumonialike,O
infection,O
in,O
"
",O
humans,O
.,O
Due,O
to,O
the,O
increasing,O
number,O
of,O
cases,O
in,O
China,O
and,O
outside,O
China,O
",",O
the,O
WHO,O
"
",O
declared,O
coronavirus,O
as,O
a,O
global,O
health,O
emergency,O
.,O
Nearly,O
35000,O
cases,O
were,O
"
",O
reported,O
and,O
at,O
least,O
24,O
other,O
countries,O
or,O
territories,O
have,O
reported,O
coronavirus,O
"
",O
cases,O
as,O
early,O
on,O
as,O
February,O
.,O
Interhuman,O
transmission,O
was,O
reported,O
in,O
a,O
few,O
"
",O
countries,O
",",O
including,O
the,O
United,O
States,O
.,O
Neither,O
an,O
effective,O
antiviral,O
nor,O
a,O
"
",O
vaccine,O
is,O
currently,O
available,O
to,O
treat,O
this,O
infection,O
.,O
As,O
the,O
virus,O
is,O
a,O
newly,O
"
",O
emerging,O
pathogen,O
",",O
many,O
questions,O
remain,O
unanswered,O
regarding,O
the,O
virus,O
's,O
"
",O
reservoirs,O
",",O
pathogenesis,O
",",O
transmissibility,O
",",O
and,O
much,O
more,O
is,O
unknown,O
.,O
The,O
"
",O
collaborative,O
efforts,O
of,O
researchers,O
are,O
needed,O
to,O
fill,O
the,O
knowledge,O
gaps,O
about,O
"
",O
this,O
new,O
virus,O
",",O
to,O
develop,O
the,O
proper,O
diagnostic,O
tools,O
",",O
and,O
effective,O
treatment,O
"
",O
to,O
combat,O
this,O
infection,O
.,O
Recent,O
advancements,O
in,O
plant,O
biotechnology,O
proved,O
that,O
"
",O
plants,O
have,O
the,O
ability,O
to,O
produce,O
vaccines,O
or,O
biopharmaceuticals,O
rapidly,O
in,O
a,O
"
",O
short,O
time,O
.,O
In,O
this,O
review,O
",",O
the,O
outbreak,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
China,O
",",O
the,O
need,O
for,O
"
",O
rapid,O
vaccine,O
development,O
",",O
and,O
the,O
potential,O
of,O
a,O
plant,O
system,O
for,O
"
",O
biopharmaceutical,O
development,O
are,O
discussed,O
.,O
"

",O
DOI,O
:,O
10.339,O
pathogens9020148,O
"
",O
PMID,O
:,O
32098302,O
"


",O
534,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
22;9(2,O
),O
.,O
pii,O
:,O
E596,O
.,O
doi,O
:,O
10.339,O
jcm9020596,O
.,O
"

",O
Shortterm,O
Forecasts,O
of,O
the,O
COVID19,B-Disease_COVID-19
Epidemic,O
in,O
Guangdong,O
and,O
Zhejiang,O
",",O
China,O
:,O
"
",O
February,O
1323,O
",",O
2020,O
.,O
"

",O
Roosa,O
K(1,O
),O
",",O
Lee,O
Y(1,O
),O
",",O
Luo,O
R(1,O
),O
",",O
Kirpich,O
A(1,O
),O
",",O
Rothenberg,O
R(1,O
),O
",",O
Hyman,O
JM(2,O
),O
",",O
Yan,O
"
",O
P(3,O
),O
",",O
Chowell,O
G(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Population,O
Health,O
Sciences,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Georgia,O
"
",O
State,O
University,O
",",O
Atlanta,O
",",O
GA,O
30302,O
",",O
USA,O
.,O
"
",O
(2)Department,O
of,O
Mathematics,O
",",O
Center,O
for,O
Computational,O
Science,O
",",O
Tulane,O
"
",O
University,O
",",O
New,O
Orleans,O
",",O
LA,O
70118,O
",",O
USA,O
.,O
"
",O
(3)Infectious,O
Disease,O
Prevention,O
and,O
Control,O
Branch,O
",",O
Public,O
Health,O
Agency,O
of,O
"
",O
Canada,O
",",O
Ottawa,O
",",O
ON,O
K1A,O
0K9,O
",",O
Canada,O
.,O
"

",O
The,O
ongoing,O
COVID19,B-Disease_COVID-19
epidemic,O
continues,O
to,O
spread,O
within,O
and,O
outside,O
of,O
China,O
",",O
"
",O
despite,O
several,O
social,O
distancing,O
measures,O
implemented,O
by,O
the,O
Chinese,O
government,O
.,O
"
",O
Limited,O
epidemiological,O
data,O
are,O
available,O
",",O
and,O
recent,O
changes,O
in,O
case,O
definition,O
"
",O
and,O
reporting,O
further,O
complicate,O
our,O
understanding,O
of,O
the,O
impact,O
of,O
the,O
epidemic,O
",",O
"
",O
particularly,O
in,O
the,O
epidemic,O
's,O
epicenter,O
.,O
Here,O
we,O
use,O
previously,O
validated,O
"
",O
phenomenological,O
models,O
to,O
generate,O
shortterm,O
forecasts,O
of,O
cumulative,O
reported,O
"
",O
cases,O
in,O
Guangdong,O
and,O
Zhejiang,O
",",O
China,O
.,O
Using,O
daily,O
reported,O
cumulative,O
case,O
data,O
"
",O
up,O
until,O
13,O
February,O
2020,O
from,O
the,O
National,O
Health,O
Commission,O
of,O
China,O
",",O
we,O
report,O
"
",O
5,O
and,O
10day,O
ahead,O
forecasts,O
of,O
cumulative,O
case,O
reports,O
.,O
Specifically,O
",",O
we,O
"
",O
generate,O
forecasts,O
using,O
a,O
generalized,O
logistic,O
growth,O
model,O
",",O
the,O
Richards,O
growth,O
"
",O
model,O
",",O
and,O
a,O
subepidemic,O
wave,O
model,O
",",O
which,O
have,O
each,O
been,O
previously,O
used,O
to,O
"
",O
forecast,O
outbreaks,O
due,O
to,O
different,O
infectious,O
diseases,O
.,O
Forecasts,O
from,O
each,O
of,O
"
",O
the,O
models,O
suggest,O
the,O
outbreaks,O
may,O
be,O
nearing,O
extinction,O
in,O
both,O
Guangdong,O
and,O
"
",O
Zhejiang,O
;,O
however,O
",",O
the,O
subepidemic,O
model,O
predictions,O
also,O
include,O
the,O
potential,O
"
",O
for,O
further,O
sustained,O
transmission,O
",",O
particularly,O
in,O
Zhejiang,O
.,O
Our,O
10day,O
"
",O
forecasts,O
across,O
the,O
three,O
models,O
predict,O
an,O
additional,O
6581,O
cases,O
(,O
upper,O
"
",O
bounds,O
:,O
169507,O
),O
in,O
Guangdong,O
and,O
an,O
additional,O
44354,O
(,O
upper,O
bounds,O
:,O
141875,O
),O
"
",O
cases,O
in,O
Zhejiang,O
by,O
February,O
23,O
",",O
2020,O
.,O
In,O
the,O
bestcase,O
scenario,O
",",O
current,O
data,O
"
",O
suggest,O
that,O
transmission,O
in,O
both,O
provinces,O
is,O
slowing,O
down,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9020596,O
"
",O
PMID,O
:,O
32098289,O
"


",O
535,O
.,O
Viruses,O
.,O
2020,O
Feb,O
21;12(2,O
),O
.,O
pii,O
:,O
E240,O
.,O
doi,O
:,O
10.339,O
v12020240,O
.,O
"

",O
Structural,O
Basis,O
for,O
Inhibiting,O
Porcine,O
Epidemic,O
Diarrhea,O
Virus,O
Replication,O
with,O
"
",O
the,O
3CLike,O
Protease,O
Inhibitor,O
GC376,O
.,O
"

",O
Ye,O
G(1,O
),O
",",O
Wang,O
X(1,O
),O
",",O
Tong,O
X(1,O
),O
",",O
Shi,O
Y(1,O
),O
",",O
Fu,O
ZF(1)(2)(3,O
),O
",",O
Peng,O
G(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
The,O
"
",O
Cooperative,O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Wuhan,O
430070,O
",",O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Pathology,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
University,O
of,O
"
",O
Georgia,O
",",O
Athens,O
",",O
GA,O
30602,O
",",O
USA,O
.,O
"

",O
Porcine,O
epidemic,O
diarrhea,O
virus,O
(,O
PEDV,O
),O
",",O
being,O
highly,O
virulent,O
and,O
contagious,O
in,O
"
",O
piglets,O
",",O
has,O
caused,O
significant,O
damage,O
to,O
the,O
pork,O
industries,O
of,O
many,O
countries,O
"
",O
worldwide,O
.,O
There,O
are,O
no,O
commercial,O
drugs,O
targeting,O
coronaviruses,O
(,O
CoVs,O
),O
",",O
and,O
few,O
"
",O
studies,O
on,O
antiPEDV,O
inhibitors,O
.,O
The,O
coronavirus,O
3Clike,O
protease,O
(,O
3CLpro,O
),O
has,O
a,O
"
",O
conserved,O
structure,O
and,O
catalytic,O
mechanism,O
and,O
plays,O
a,O
key,O
role,O
during,O
viral,O
"
",O
polyprotein,O
processing,O
",",O
thus,O
serving,O
as,O
an,O
appealing,O
antiviral,O
drug,O
target,O
.,O
Here,O
",",O
"
",O
we,O
report,O
the,O
antiPEDV,O
effect,O
of,O
the,O
broadspectrum,O
inhibitor,O
GC376,O
(,O
targeting,O
"
",O
3Cpro,O
or,O
3CLpro,O
of,O
viruses,O
in,O
the,O
picornaviruslike,O
supercluster,O
),O
.,O
GC376,O
was,O
"
",O
highly,O
effective,O
against,O
the,O
PEDV,O
3CLpro,O
and,O
exerted,O
similar,O
inhibitory,O
effects,O
"
",O
on,O
two,O
PEDV,O
strains,O
.,O
Furthermore,O
",",O
the,O
structure,O
of,O
the,O
PEDV,O
3CLpro,O
in,O
complex,O
"
",O
with,O
GC376,O
was,O
determined,O
at,O
1.65,O
Ã….,O
We,O
elucidated,O
structural,O
details,O
and,O
"
",O
analyzed,O
the,O
differences,O
between,O
GC376,O
binding,O
with,O
the,O
PEDV,O
3CLpro,O
and,O
GC376,O
"
",O
binding,O
with,O
the,O
transmissible,O
gastroenteritis,O
virus,O
(,O
TGEV,O
),O
3CLpro,O
.,O
Finally,O
",",O
we,O
"
",O
explored,O
the,O
substrate,O
specificity,O
of,O
PEDV,O
3CLpro,O
at,O
the,O
P2,O
site,O
and,O
analyzed,O
the,O
"
",O
effects,O
of,O
Leu,O
group,O
modification,O
in,O
GC376,O
on,O
inhibiting,O
PEDV,O
infection,O
.,O
This,O
"
",O
study,O
helps,O
us,O
to,O
understand,O
better,O
the,O
PEDV,O
3CLpro,O
substrate,O
specificity,O
",",O
"
",O
providing,O
information,O
on,O
the,O
optimization,O
of,O
GC376,O
for,O
development,O
as,O
an,O
"
",O
antiviral,O
therapeutic,O
against,O
coronaviruses,O
.,O
"

",O
DOI,O
:,O
10.339,O
v12020240,O
"
",O
PMID,O
:,O
32098094,O
"


",O
536,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
21;9(2,O
),O
.,O
pii,O
:,O
E580,O
.,O
doi,O
:,O
10.339,O
jcm9020580,O
.,O
"

",O
Communicating,O
the,O
Risk,O
of,O
Death,O
from,O
Novel,B-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
.,O
"

",O
Kobayashi,O
T(1,O
),O
",",O
Jung,O
SM(1,O
),O
",",O
Linton,O
NM(1,O
),O
",",O
Kinoshita,O
R(1,O
),O
",",O
Hayashi,O
K(1,O
),O
",",O
Miyama,O
"
",O
T(2,O
),O
",",O
Anzai,O
A(1,O
),O
",",O
Yang,O
Y(1,O
),O
",",O
Yuan,O
B(1,O
),O
",",O
Akhmetzhanov,O
AR(1,O
),O
",",O
Suzuki,O
A(1,O
),O
",",O
Nishiura,O
"
",O
H(1)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Graduate,O
School,O
of,O
Medicine,O
",",O
Hokkaido,O
University,O
",",O
Kita,O
15,O
Jo,O
Nishi,O
7,O
Chome,O
",",O
"
",O
Kitaku,O
",",O
Sapporoshi,O
",",O
Hokkaido,O
608638,O
",",O
Japan,O
.,O
"
",O
(2)Osaka,O
Institute,O
of,O
Public,O
Health,O
",",O
Nakamichi,O
1369,O
",",O
Higashinari,O
",",O
Osaka,O
"
",O
5370025,O
",",O
Japan,O
.,O
"
",O
(3)Core,O
Research,O
for,O
Evolutional,O
Science,O
and,O
Technology,O
(,O
CREST,O
),O
",",O
Japan,O
Science,O
"
",O
and,O
Technology,O
Agency,O
",",O
Honcho,O
418,O
",",O
Kawaguchi,O
",",O
Saitama,O
3320012,O
",",O
Japan,O
.,O
"

",O
To,O
understand,O
the,O
severity,O
of,O
infection,O
for,O
a,O
given,O
disease,O
",",O
it,O
is,O
common,O
"
",O
epidemiological,O
practice,O
to,O
estimate,O
the,O
case,O
fatality,O
risk,O
",",O
defined,O
as,O
the,O
risk,O
"
",O
of,O
death,O
among,O
cases,O
.,O
However,O
",",O
there,O
are,O
three,O
technical,O
obstacles,O
that,O
should,O
be,O
"
",O
addressed,O
to,O
appropriately,O
measure,O
this,O
risk,O
.,O
First,O
",",O
division,O
of,O
the,O
cumulative,O
"
",O
number,O
of,O
deaths,O
by,O
that,O
of,O
cases,O
tends,O
to,O
underestimate,O
the,O
actual,O
risk,O
because,O
"
",O
deaths,O
that,O
will,O
occur,O
have,O
not,O
yet,O
observed,O
",",O
and,O
so,O
the,O
delay,O
in,O
time,O
from,O
"
",O
illness,O
onset,O
to,O
death,O
must,O
be,O
addressed,O
.,O
Second,O
",",O
the,O
observed,O
dataset,O
of,O
"
",O
reported,O
cases,O
represents,O
only,O
a,O
proportion,O
of,O
all,O
infected,O
individuals,O
and,O
there,O
"
",O
can,O
be,O
a,O
substantial,O
number,O
of,O
asymptomatic,O
and,O
mildly,O
infected,O
individuals,O
who,O
"
",O
are,O
never,O
diagnosed,O
.,O
Third,O
",",O
ascertainment,O
bias,O
and,O
risk,O
of,O
death,O
among,O
all,O
those,O
"
",O
infected,O
would,O
be,O
smaller,O
when,O
estimated,O
using,O
shorter,O
virus,O
detection,O
windows,O
"
",O
and,O
less,O
sensitive,O
diagnostic,O
laboratory,O
tests,O
.,O
In,O
the,O
ongoing,O
COVID19,B-Disease_COVID-19
epidemic,O
",",O
"
",O
health,O
authorities,O
must,O
cope,O
with,O
the,O
uncertainty,O
in,O
the,O
risk,O
of,O
death,O
from,O
"
",O
COVID19,B-Disease_COVID-19
",",O
and,O
highrisk,O
individuals,O
should,O
be,O
identified,O
using,O
approaches,O
that,O
"
",O
can,O
address,O
the,O
abovementioned,O
three,O
problems,O
.,O
Although,O
COVID19,B-Disease_COVID-19
involves,O
mostly,O
"
",O
mild,O
infections,O
among,O
the,O
majority,O
of,O
the,O
general,O
population,O
",",O
the,O
risk,O
of,O
death,O
"
",O
among,O
young,O
adults,O
is,O
higher,O
than,O
that,O
of,O
seasonal,O
influenza,O
",",O
and,O
elderly,O
with,O
"
",O
underlying,O
comorbidities,O
require,O
additional,O
care,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9020580,O
"
",O
PMID,O
:,O
32098019,O
"


",O
537,O
.,O
Int,O
J,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
22;93:201204,O
.,O
doi,O
:,O
10.1016,O
j.ijid.2020.02.033,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Estimation,O
of,O
the,O
reproductive,O
number,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
and,O
the,O
"
",O
probable,O
outbreak,O
size,O
on,O
the,O
Diamond,O
Princess,O
cruise,O
ship,O
:,O
A,O
datadriven,O
"
",O
analysis,O
.,O
"

",O
Zhang,O
S(1,O
),O
",",O
Diao,O
M(2,O
),O
",",O
Yu,O
W(3,O
),O
",",O
Pei,O
L(3,O
),O
",",O
Lin,O
Z(4,O
),O
",",O
Chen,O
D(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Ruijin,O
Hospital,O
",",O
Shanghai,O
Jiao,O
Tong,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
200025,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Affiliated,O
Hangzhou,O
First,O
People,O
's,O
"
",O
Hospital,O
",",O
Zhejiang,O
University,O
School,O
of,O
Medicine,O
",",O
Hangzhou,O
",",O
Zhejiang,O
310006,O
",",O
"
",O
China,O
.,O
"
",O
(3)Graduate,O
School,O
",",O
Naval,O
Medical,O
University,O
(,O
Second,O
Military,O
Medical,O
"
",O
University,O
),O
",",O
Shanghai,O
200433,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Emergency,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Changzheng,O
Hospital,O
",",O
Naval,O
"
",O
Medical,O
University,O
(,O
Second,O
Military,O
Medical,O
University,O
),O
",",O
Shanghai,O
200433,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
linzhaofen@hotmail.com,O
.,O
"
",O
(5)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Ruijin,O
Hospital,O
",",O
Shanghai,O
Jiao,O
Tong,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
200025,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
chendechangsh@hotmail.com,O
.,O
"

",O
BACKGROUNDS,O
:,O
Up,O
to,O
February,O
16,O
",",O
2020,O
",",O
355,O
cases,O
have,O
been,O
confirmed,O
as,O
having,O
"
",O
COVID19,B-Disease_COVID-19
infection,O
on,O
the,O
Diamond,O
Princess,O
cruise,O
ship,O
.,O
It,O
is,O
of,O
crucial,O
"
",O
importance,O
to,O
estimate,O
the,O
reproductive,O
number,O
(,O
R0,O
),O
of,O
the,O
novel,O
virus,O
in,O
the,O
"
",O
early,O
stage,O
of,O
outbreak,O
and,O
make,O
a,O
prediction,O
of,O
daily,O
new,O
cases,O
on,O
the,O
ship,O
.,O
"
",O
METHOD,O
:,O
We,O
fitted,O
the,O
reported,O
serial,O
interval,O
(,O
mean,O
and,O
standard,O
deviation,O
),O
with,O
"
",O
a,O
gamma,O
distribution,O
and,O
applied,O
"""",O
earlyR,O
"""",O
package,O
in,O
R,O
to,O
estimate,O
the,O
R0,O
in,O
the,O
"
",O
early,O
stage,O
of,O
COVID19,B-Disease_COVID-19
outbreak,O
.,O
We,O
applied,O
"""",O
projections,O
"""",O
package,O
in,O
R,O
to,O
"
",O
simulate,O
the,O
plausible,O
cumulative,O
epidemic,O
trajectories,O
and,O
future,O
daily,O
"
",O
incidence,O
by,O
fitting,O
the,O
data,O
of,O
existing,O
daily,O
incidence,O
",",O
a,O
serial,O
interval,O
"
",O
distribution,O
",",O
and,O
the,O
estimated,O
R0,O
into,O
a,O
model,O
based,O
on,O
the,O
assumption,O
that,O
"
",O
daily,O
incidence,O
obeys,O
approximately,O
Poisson,O
distribution,O
determined,O
by,O
daily,O
"
",O
infectiousness,O
.,O
"
",O
RESULTS,O
:,O
The,O
MaximumLikelihood,O
(,O
ML,O
),O
value,O
of,O
R0,O
was,O
2.28,O
for,O
COVID19,B-Disease_COVID-19
outbreak,O
"
",O
at,O
the,O
early,O
stage,O
on,O
the,O
ship,O
.,O
The,O
median,O
with,O
95,O
%,O
confidence,O
interval,O
(,O
CI,O
),O
of,O
"
",O
R0,O
values,O
was,O
2.28,O
(,O
2.062.52,O
),O
estimated,O
by,O
the,O
bootstrap,O
resampling,O
method,O
.,O
The,O
"
",O
probable,O
number,O
of,O
new,O
cases,O
for,O
the,O
next,O
ten,O
days,O
would,O
gradually,O
increase,O
",",O
and,O
"
",O
the,O
estimated,O
cumulative,O
cases,O
would,O
reach,O
1514,O
(,O
13841656,O
),O
at,O
the,O
tenth,O
day,O
in,O
"
",O
the,O
future,O
.,O
However,O
",",O
if,O
R0,O
value,O
was,O
reduced,O
by,O
25,O
%,O
and,O
50,O
%,O
",",O
the,O
estimated,O
total,O
"
",O
number,O
of,O
cumulative,O
cases,O
would,O
be,O
reduced,O
to,O
1081,O
(,O
9811177,O
),O
and,O
758,O
(,O
697817,O
),O
",",O
"
",O
respectively,O
.,O
"
",O
CONCLUSION,O
:,O
The,O
median,O
with,O
95,O
%,O
CI,O
of,O
R0,O
of,O
COVID19,B-Disease_COVID-19
was,O
about,O
2.28,O
(,O
2.062.52,O
),O
"
",O
during,O
the,O
early,O
stage,O
experienced,O
on,O
the,O
Diamond,O
Princess,O
cruise,O
ship,O
.,O
The,O
"
",O
future,O
daily,O
incidence,O
and,O
probable,O
outbreak,O
size,O
is,O
largely,O
dependent,O
on,O
the,O
"
",O
change,O
of,O
R0,O
.,O
Unless,O
strict,O
infection,O
management,O
and,O
control,O
are,O
taken,O
",",O
our,O
"
",O
findings,O
indicate,O
the,O
potential,O
of,O
COVID19,B-Disease_COVID-19
to,O
cause,O
greater,O
outbreak,O
on,O
the,O
"
",O
ship,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Author(s,O
),O
.,O
Published,O
by,O
Elsevier,O
Ltd,O
..,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijid.2020.02.033,O
"
",O
PMID,O
:,O
32097725,O
"


",O
538,O
.,O
Shock,O
.,O
2020,O
Feb,O
24,O
.,O
doi,O
:,O
10.1097,O
SHK.0000000000001527,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Analysis,O
of,O
Severe,O
fever,O
with,O
thrombocytopenia,O
syndrome,O
in,O
critical,O
ill,O
patients,O
"
",O
in,O
central,O
China,O
.,O
"

",O
Nie,O
Q(1,O
),O
",",O
Wang,O
D(1,O
),O
",",O
Ning,O
Z(2,O
),O
",",O
Li,O
T(3,O
),O
",",O
Tian,O
X(4,O
),O
",",O
Bian,O
P(2,O
),O
",",O
Ding,O
K(5,O
),O
",",O
Hu,O
"
",O
C(1,O
),O
",",O
Peng,O
ZY(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
430071,O
Wuhan,O
",",O
Hubei,O
province,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Jinan,O
Infectious,O
Disease,O
Hospital,O
",",O
"
",O
Shandong,O
University,O
",",O
250021,O
Jinan,O
",",O
Shandong,O
province,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Emergency,O
Medicine,O
",",O
Weihai,O
Municipal,O
Hospital,O
",",O
264200,O
Weihai,O
",",O
"
",O
Shandong,O
province,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
The,O
Affiliated,O
Yantai,O
Yuhuangding,O
"
",O
Hospital,O
of,O
Qingdao,O
University,O
",",O
264000,O
Yantai,O
",",O
Shandong,O
province,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
General,O
Medicine,O
",",O
Yantai,O
Infectious,O
Disease,O
Hospital,O
",",O
264001,O
"
",O
Yantai,O
",",O
Shandong,O
province,O
",",O
China,O
.,O
"

",O
INTRODUCTION,O
:,O
Severe,O
fever,O
with,O
thrombocytopenia,O
syndrome,O
(,O
SFTS,O
),O
is,O
an,O
emerging,O
"
",O
zoonosis,O
infected,O
by,O
virus,O
(,O
SFTSV,O
),O
in,O
central,O
and,O
eastern,O
China,O
",",O
which,O
is,O
"
",O
associated,O
with,O
high,O
mortality,O
.,O
However,O
",",O
limited,O
clinical,O
data,O
have,O
been,O
reported,O
"
",O
about,O
this,O
critical,O
illness,O
.,O
"
",O
MATERIALS,O
AND,O
METHODS,O
:,O
Retrospective,O
cohort,O
study,O
in,O
ICU,O
patients,O
with,O
SFTSV,O
"
",O
infection,O
admitted,O
in,O
20142019,O
.,O
Diagnosis,O
was,O
confirmed,O
using,O
reverse,O
"
",O
transcription,O
polymerase,O
chain,O
reaction,O
on,O
serum,O
samples,O
.,O
"
",O
RESULTS,O
:,O
116,O
patients,O
with,O
SFTSV,O
infection,O
were,O
included,O
(,O
mean,O
age,O
63,O
â€Š,O
Â±,O
â€Š,O
9,O
years,O
",",O
"
",O
59,O
[,O
51.3,O
%,O
],O
males,O
),O
.,O
Nonsurvivors,O
(,O
43.1,O
%,O
),O
were,O
older,O
",",O
and,O
had,O
lower,O
Glasgow,O
Coma,O
"
",O
Score,O
(,O
GCS,O
),O
",",O
higher,O
Acute,O
Physiology,O
and,O
Chronic,O
Health,O
Evaluation,O
II,O
(,O
APACHE,O
II,O
),O
"
",O
and,O
sequential,O
organ,O
failure,O
assessment,O
(,O
SOFA,O
),O
score,O
at,O
ICU,O
admission,O
.,O
In,O
"
",O
addition,O
",",O
nonsurvivors,O
had,O
more,O
severe,O
respiratory,O
failure,O
(,O
PaO2,O
FiO2,O
:,O
208,O
â€Š,O
Â±,O
â€Š,O
14,O
"
",O
mmHg,O
vs,O
297,O
â€Š,O
Â±,O
â€Š,O
15,O
mmHg,O
),O
",",O
more,O
frequent,O
shock,O
(,O
25[50,O
%,O
],O
vs,O
7[10.6,O
%,O
],O
),O
",",O
and,O
required,O
"
",O
more,O
frequently,O
mechanical,O
ventilation,O
(,O
78,O
%,O
vs,O
19.7,O
%,O
;,O
p,O
â€Š,O
<,O
â€Š,O
0.001,O
),O
and,O
vasopressor,O
"
",O
support,O
(,O
56,O
%,O
vs,O
9.1,O
%,O
;,O
p,O
â€Š,O
<,O
â€Š,O
0.001,O
),O
.,O
Nonsurvivors,O
experienced,O
more,O
obvious,O
monocyte,O
"
",O
loss,O
.,O
After,O
adjustment,O
for,O
potential,O
confounding,O
factors,O
",",O
older,O
age,O
",",O
elevated,O
"
",O
lactate,O
level,O
and,O
elevated,O
creatinine,O
level,O
were,O
the,O
independent,O
risk,O
factors,O
for,O
"
",O
death,O
.,O
"
",O
CONCLUSION,O
:,O
We,O
provided,O
knowledge,O
about,O
the,O
clinical,O
characteristics,O
of,O
SFTS,O
"
",O
admitted,O
in,O
ICU,O
.,O
older,O
age,O
",",O
elevated,O
lactate,O
level,O
and,O
elevated,O
creatinine,O
level,O
"
",O
may,O
be,O
useful,O
for,O
identifying,O
patients,O
with,O
poor,O
outcome,O
and,O
intensive,O
medical,O
"
",O
intervention,O
can,O
be,O
provided,O
for,O
patients,O
as,O
soon,O
as,O
possible,O
to,O
reduce,O
"
",O
mortality,O
.,O
"

",O
DOI,O
:,O
10.1097,O
SHK.0000000000001527,O
"
",O
PMID,O
:,O
32097243,O
"


",O
539,O
.,O
Chin,O
Med,O
J,O
(,O
Engl,O
),O
.,O
2020,O
Feb,O
24,O
.,O
doi,O
:,O
10.1097,O
CM9.0000000000000760,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Six,O
weeks,O
into,O
the,O
2019,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
outbreak,O
it,O
is,O
time,O
to,O
"
",O
consider,O
strategies,O
to,O
impede,O
the,O
emergence,O
of,O
new,O
zoonotic,O
infections,O
.,O
"

",O
Harypursat,O
V(1,O
),O
",",O
Chen,O
YK,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infectious,O
Diseases,O
",",O
Chongqing,O
Public,O
Health,O
Medical,O
Center,O
",",O
"
",O
Chongqing,O
400036,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1097,O
CM9.0000000000000760,O
"
",O
PMID,O
:,O
32097202,O
"


",O
540,O
.,O
Chin,O
Med,O
J,O
(,O
Engl,O
),O
.,O
2020,O
Feb,O
24,O
.,O
doi,O
:,O
10.1097,O
CM9.0000000000000761,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Noninvasive,O
respiratory,O
support,O
for,O
patients,O
with,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
:,O
"
",O
clinical,O
efficacy,O
and,O
reduction,O
in,O
risk,O
of,O
infection,O
transmission,O
.,O
"

",O
Xia,O
JG(1,O
),O
",",O
Zhao,O
JP(2,O
),O
",",O
Cheng,O
ZS(3,O
),O
",",O
Hu,O
Y(4,O
),O
",",O
Duan,O
J(5,O
),O
",",O
Zhan,O
QY(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
National,O
Clinical,O
Research,O
"
",O
Center,O
for,O
Respiratory,O
Diseases,O
",",O
ChinaJapan,O
Friendship,O
Hospital,O
",",O
Beijing,O
100029,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
"
",O
430030,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
",",O
Hubei,O
430071,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
Central,O
Hospital,O
of,O
"
",O
Wuhan,O
",",O
Wuhan,O
",",O
Hubei,O
430030,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Surgical,O
Intensive,O
Care,O
Unit,O
",",O
ChinaJapan,O
Friendship,O
Hospital,O
",",O
"
",O
Beijing,O
100029,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1097,O
CM9.0000000000000761,O
"
",O
PMID,O
:,O
32097201,O
"


",O
541,O
.,O
Surg,O
Infect,O
(,O
Larchmt,O
),O
.,O
2020,O
Feb,O
25,O
.,O
doi,O
:,O
10.1089,O
sur.2020.040,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Anesthesia,O
Procedure,O
of,O
Emergency,O
Operation,O
for,O
Patients,O
with,O
Suspected,O
or,O
"
",O
Confirmed,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Wen,O
X(1)(2,O
),O
",",O
Li,O
Y(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pain,O
Management,O
",",O
the,O
First,O
Affiliated,O
Hospital,O
of,O
Jinan,O
"
",O
University,O
",",O
Guangzhou,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Anesthesiology,O
",",O
the,O
Second,O
People,O
's,O
Hospital,O
of,O
Foshan,O
City,O
",",O
"
",O
Foshan,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Orthopaedics,O
",",O
the,O
Second,O
People,O
's,O
Hospital,O
of,O
Foshan,O
City,O
",",O
"
",O
Foshan,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1089,O
sur.2020.040,O
"
",O
PMID,O
:,O
32096692,O
"


",O
542,O
.,O
DNA,O
Cell,O
Biol,O
.,O
2020,O
Feb,O
25,O
.,O
doi,O
:,O
10.1089,O
dna.2019.5057,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
BGC823,O
Cell,O
Line,O
with,O
the,O
Stable,O
Expression,O
of,O
iRFP720,O
Retains,O
Its,O
Primary,O
"
",O
Properties,O
with,O
Promising,O
Fluorescence,O
Imaging,O
Ability,O
.,O
"

",O
Hu,O
H(1,O
),O
",",O
Zhang,O
Z(1,O
),O
",",O
Wang,O
R(2,O
),O
",",O
Wang,O
Y(1,O
),O
",",O
Jin,O
J(2,O
),O
",",O
Cai,O
L(2,O
),O
",",O
Yang,O
J(1,O
),O
",",O
Duan,O
"
",O
H(1,O
),O
",",O
Wu,O
Z(2,O
),O
",",O
Fang,O
Z(2,O
),O
",",O
Liu,O
B(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
"""",O
111,O
"""",O
Center,O
for,O
Cellular,O
Regulation,O
and,O
Molecular,O
Pharmaceutics,O
",",O
Key,O
"
",O
Laboratory,O
of,O
Fermentation,O
Engineering,O
(,O
Ministry,O
of,O
Education,O
),O
",",O
Hubei,O
Provincial,O
"
",O
Cooperative,O
Innovation,O
Center,O
of,O
Industrial,O
Fermentation,O
",",O
College,O
of,O
"
",O
Bioengineering,O
",",O
Hubei,O
University,O
of,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Wuhan,O
Binhui,O
Biotechnology,O
Co.,O
Ltd.,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
Reliable,O
animal,O
models,O
are,O
required,O
for,O
understanding,O
the,O
molecular,O
events,O
of,O
"
",O
gastric,O
tumor,O
growth,O
and,O
metastasis,O
.,O
Tracing,O
techniques,O
based,O
on,O
iRFP720,O
may,O
"
",O
optimize,O
the,O
noninvasive,O
monitoring,O
of,O
tumors,O
in,O
vivo,O
.,O
The,O
present,O
study,O
"
",O
established,O
a,O
human,O
gastric,O
adenocarcinoma,O
cell,O
line,O
BGC823iRFP720GFP,O
"
",O
(,O
abbreviated,O
as,O
BGC823iRFP,O
),O
that,O
stably,O
expressed,O
iRFP720,O
and,O
green,O
fluorescent,O
"
",O
protein,O
(,O
GFP,O
),O
by,O
piggyBac,O
transposon,O
system,O
.,O
The,O
monoclonal,O
cell,O
line,O
BGC823iRFP,O
"
",O
was,O
isolated,O
under,O
puromycin,O
selection,O
.,O
The,O
cell,O
morphology,O
and,O
proliferation,O
"
",O
ability,O
of,O
BGC823iRFP,O
cells,O
in,O
vitro,O
were,O
similar,O
to,O
that,O
of,O
the,O
BGC823,O
cells,O
.,O
"
",O
The,O
iRFP720,O
and,O
GFP,O
expressions,O
were,O
confirmed,O
by,O
laser,O
confocal,O
microscopy,O
and,O
"
",O
Cytation,O
â„¢,O
5,O
.,O
Hematoxylin,O
and,O
eosin,O
staining,O
",",O
immunohistochemical,O
analysis,O
",",O
and,O
"
",O
animal,O
experiments,O
also,O
revealed,O
that,O
BGC823iRFP,O
exhibited,O
no,O
significant,O
"
",O
changes,O
in,O
morphology,O
",",O
growth,O
kinetics,O
",",O
and,O
tumorigenicity,O
in,O
vivo,O
.,O
IVIS,O
Lumina,O
"
",O
III,O
imaging,O
indicated,O
that,O
the,O
iRFP720,O
signals,O
of,O
the,O
BGC823iRFP,O
cells,O
could,O
be,O
"
",O
used,O
to,O
evaluate,O
the,O
antitumor,O
efficacy,O
of,O
oncolytic,O
viruses,O
and,O
chemotherapy,O
"
",O
drugs,O
.,O
Therefore,O
",",O
the,O
BGC823iRFP,O
cells,O
would,O
be,O
a,O
useful,O
tool,O
for,O
gastric,O
cancer,O
"
",O
research,O
and,O
antitumor,O
drug,O
evaluation,O
.,O
"

",O
DOI,O
:,O
10.1089,O
dna.2019.5057,O
"
",O
PMID,O
:,O
32096664,O
"


",O
543,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
25,O
.,O
doi,O
:,O
10.1002,O
jmv.25722,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Understanding,O
of,O
COVID19,B-Disease_COVID-19
based,O
on,O
current,O
evidence,O
.,O
"

",O
Sun,O
P(1,O
),O
",",O
Lu,O
X(2,O
),O
",",O
Xu,O
C(1,O
),O
",",O
Sun,O
W(3,O
),O
",",O
Pan,O
B(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Plastic,O
Surgery,O
",",O
Zibo,O
Central,O
Hospital,O
",",O
Zibo,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Plastic,O
Surgery,O
",",O
Affiliated,O
Hospital,O
of,O
Weifang,O
Medical,O
"
",O
University,O
",",O
Weifang,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Medicine,O
",",O
People,O
's,O
Hospital,O
of,O
Boxing,O
",",O
Binzhou,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Plastic,O
Surgery,O
",",O
Plastic,O
Surgery,O
Hospital,O
",",O
Peking,O
Union,O
Medical,O
"
",O
College,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
Since,O
December,O
2019,O
",",O
a,O
series,O
of,O
unexplained,O
pneumonia,O
cases,O
have,O
been,O
reported,O
"
",O
in,O
Wuhan,O
",",O
China,O
.,O
On,O
12,O
January,O
Â ,O
2020,O
",",O
the,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
"
",O
temporarily,O
named,O
this,O
new,O
virus,O
as,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
On,O
11,O
"
",O
February,O
Â ,O
2020,O
",",O
the,O
WHO,O
officially,O
named,O
the,O
disease,O
caused,O
by,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
as,O
"
",O
coronavirus,O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
.,O
The,O
COVID19,B-Disease_COVID-19
epidemic,O
is,O
spreading,O
all,O
over,O
the,O
"
",O
world,O
",",O
especially,O
in,O
China,O
.,O
Based,O
on,O
the,O
published,O
evidence,O
",",O
we,O
systematically,O
"
",O
discuss,O
the,O
characteristics,O
of,O
COVID19,B-Disease_COVID-19
in,O
the,O
hope,O
of,O
providing,O
a,O
reference,O
for,O
"
",O
future,O
studies,O
and,O
help,O
for,O
the,O
prevention,O
and,O
control,O
of,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25722,O
"
",O
PMID,O
:,O
32096567,O
"


",O
544,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
25,O
.,O
doi,O
:,O
10.1002,O
jmv.25723,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Early,O
phylogenetic,O
estimate,O
of,O
the,O
effective,O
reproduction,O
number,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Lai,O
A(1)(2,O
),O
",",O
Bergna,O
A(1,O
),O
",",O
Acciarri,O
C(1,O
),O
",",O
Galli,O
M(1)(2,O
),O
",",O
Zehender,O
G(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Biomedical,O
and,O
Clinical,O
Sciences,O
"""",O
L.,O
Sacco,O
"""",O
",",O
University,O
of,O
"
",O
Milan,O
",",O
Milano,O
",",O
Italy,O
.,O
"
",O
(2)Coordinated,O
Research,O
Center,O
"""",O
EpiSoMI,O
"""",O
",",O
University,O
of,O
Milan,O
",",O
Milano,O
",",O
Italy,O
.,O
"
",O
(3)Romeo,O
ed,O
Enrica,O
Invernizzi,O
Pediatric,O
Research,O
Center,O
",",O
University,O
of,O
Milan,O
",",O
"
",O
Milano,O
",",O
Italy,O
.,O
"

",O
To,O
reconstruct,O
the,O
evolutionary,O
dynamics,O
of,O
the,O
2019,O
novelcoronavirus,O
recently,O
"
",O
causing,O
an,O
outbreak,O
in,O
Wuhan,O
",",O
China,O
",",O
52,O
SARSCoV2,B-Virus_SARS-CoV-2
genomes,O
available,O
on,O
4,O
"
",O
February,O
2020,O
at,O
Global,O
Initiative,O
on,O
Sharing,O
All,O
Influenza,O
Data,O
were,O
analyzed,O
.,O
"
",O
The,O
two,O
models,O
used,O
to,O
estimate,O
the,O
reproduction,O
number,O
(,O
coalescentbased,O
"
",O
exponential,O
growth,O
and,O
a,O
birthdeath,O
skyline,O
method,O
),O
indicated,O
an,O
estimated,O
mean,O
"
",O
evolutionary,O
rate,O
of,O
7.8,O
â€‰,O
Ã—,O
â€‰,O
104,O
subs,O
site,O
year,O
(,O
range,O
",",O
1.1,O
â€‰,O
Ã—,O
â€‰,O
104,O
15,O
â€‰,O
Ã—,O
â€‰,O
104,O
),O
"
",O
and,O
a,O
mean,O
tMRCA,O
of,O
the,O
tree,O
root,O
of,O
73,O
days,O
.,O
The,O
estimated,O
R,O
value,O
was,O
2.6,O
"
",O
(,O
range,O
",",O
2.15.1,O
),O
",",O
and,O
increased,O
from,O
0.8,O
to,O
2.4,O
in,O
December,O
2019,O
.,O
The,O
estimated,O
"
",O
mean,O
doubling,O
time,O
of,O
the,O
epidemic,O
was,O
between,O
3.6,O
and,O
4.1,O
days,O
.,O
This,O
study,O
"
",O
proves,O
the,O
usefulness,O
of,O
phylogeny,O
in,O
supporting,O
the,O
surveillance,O
of,O
emerging,O
new,O
"
",O
infections,O
even,O
as,O
the,O
epidemic,O
is,O
growing,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25723,O
"
",O
PMID,O
:,O
32096566,O
"


",O
545,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
25,O
.,O
doi,O
:,O
10.1002,O
jmv.25721,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Combination,O
of,O
RTqPCR,O
testing,O
and,O
clinical,O
features,O
for,O
diagnosis,O
of,O
COVID19,B-Disease_COVID-19
"
",O
facilitates,O
management,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
outbreak,O
.,O
"

",O
Wang,O
Y(1,O
),O
",",O
Kang,O
H(1,O
),O
",",O
Liu,O
X(2,O
),O
",",O
Tong,O
Z(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Beijing,O
Institute,O
of,O
"
",O
Respiratory,O
Medicine,O
",",O
Beijing,O
ChaoYang,O
Hospital,O
",",O
Capital,O
Medical,O
University,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pathology,O
",",O
Georgetown,O
University,O
Medical,O
Center,O
",",O
Washington,O
",",O
"
",O
District,O
of,O
Columbia,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25721,O
"
",O
PMID,O
:,O
32096564,O
"


",O
546,O
.,O
Neurosci,O
Bull,O
.,O
2020,O
Mar;36(3):299302,O
.,O
doi,O
:,O
10.1007,O
s12264020004769,O
.,O
Epub,O
2020,O
"
",O
Feb,O
25,O
.,O
"

",O
The,O
Risk,O
and,O
Prevention,O
of,O
Novel,B-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Pneumonia,I-Disease_COVID-19
Infections,O
Among,O
"
",O
Inpatients,O
in,O
Psychiatric,O
Hospitals,O
.,O
"

",O
Zhu,O
Y(1,O
),O
",",O
Chen,O
L(2,O
),O
",",O
Ji,O
H(2,O
),O
",",O
Xi,O
M(3,O
),O
",",O
Fang,O
Y(4)(5)(6,O
),O
",",O
Li,O
Y(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Shanghai,O
Mental,O
Health,O
Center,O
",",O
Shanghai,O
Jiao,O
Tong,O
University,O
School,O
of,O
"
",O
Medicine,O
",",O
Shanghai,O
",",O
200030,O
",",O
China,O
.,O
"
",O
(2)Shanghai,O
Changning,O
Mental,O
Health,O
Center,O
(,O
Affiliated,O
to,O
East,O
China,O
Normal,O
"
",O
University,O
),O
",",O
Shanghai,O
",",O
200335,O
",",O
China,O
.,O
"
",O
(3)Institute,O
of,O
Burns,O
",",O
Tongren,O
Hospital,O
of,O
Wuhan,O
University,O
(,O
Wuhan,O
Third,O
"
",O
Hospital,O
),O
",",O
Wuhan,O
",",O
430000,O
",",O
China,O
.,O
"
",O
(4)Shanghai,O
Mental,O
Health,O
Center,O
",",O
Shanghai,O
Jiao,O
Tong,O
University,O
School,O
of,O
"
",O
Medicine,O
",",O
Shanghai,O
",",O
200030,O
",",O
China,O
.,O
yirufang@aliyun.com,O
.,O
"
",O
(5)CAS,O
Center,O
for,O
Excellence,O
in,O
Brain,O
Science,O
and,O
Intelligence,O
Technology,O
",",O
"
",O
Shanghai,O
",",O
200031,O
",",O
China,O
.,O
yirufang@aliyun.com,O
.,O
"
",O
(6)Shanghai,O
Key,O
Laboratory,O
of,O
Psychotic,O
Disorders,O
",",O
Shanghai,O
",",O
201108,O
",",O
China,O
.,O
"
",O
yirufang@aliyun.com,O
.,O
"
",O
(7)Affiliated,O
Wuhan,O
Mental,O
Health,O
Center,O
",",O
Tongji,O
Medical,O
College,O
of,O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430012,O
",",O
China,O
.,O
psylee@163.com,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12264020004769,O
"
",O
PMID,O
:,O
32096116,O
"


",O
547,O
.,O
Nat,O
Microbiol,O
.,O
2020,O
Feb,O
24,O
.,O
doi,O
:,O
10.1038,O
s415640200688y,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Functional,O
assessment,O
of,O
cell,O
entry,O
and,O
receptor,O
usage,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
and,O
other,O
"
",O
lineage,O
B,O
betacoronaviruses,O
.,O
"

",O
Letko,O
M(1,O
),O
",",O
Marzi,O
A(2,O
),O
",",O
Munster,O
V(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Laboratory,O
of,O
Virology,O
",",O
Division,O
of,O
Intramural,O
Research,O
",",O
National,O
Institute,O
of,O
"
",O
Allergy,O
and,O
Infectious,O
Diseases,O
",",O
National,O
Institutes,O
of,O
Health,O
",",O
Hamilton,O
",",O
MT,O
",",O
"
",O
USA,O
.,O
michael.letko@wsu.edu,O
.,O
"
",O
(2)Laboratory,O
of,O
Virology,O
",",O
Division,O
of,O
Intramural,O
Research,O
",",O
National,O
Institute,O
of,O
"
",O
Allergy,O
and,O
Infectious,O
Diseases,O
",",O
National,O
Institutes,O
of,O
Health,O
",",O
Hamilton,O
",",O
MT,O
",",O
"
",O
USA,O
.,O
"
",O
(3)Laboratory,O
of,O
Virology,O
",",O
Division,O
of,O
Intramural,O
Research,O
",",O
National,O
Institute,O
of,O
"
",O
Allergy,O
and,O
Infectious,O
Diseases,O
",",O
National,O
Institutes,O
of,O
Health,O
",",O
Hamilton,O
",",O
MT,O
",",O
"
",O
USA,O
.,O
vincent.munster@nih.gov,O
.,O
"

",O
Over,O
the,O
past,O
20,O
â€‰,O
years,O
",",O
several,O
coronaviruses,O
have,O
crossed,O
the,O
species,O
barrier,O
"
",O
into,O
humans,O
",",O
causing,O
outbreaks,O
of,O
severe,O
",",O
and,O
often,O
fatal,O
",",O
respiratory,O
illness,O
.,O
"
",O
Since,O
SARSCoV,O
was,O
first,O
identified,O
in,O
animal,O
markets,O
",",O
global,O
viromics,O
projects,O
"
",O
have,O
discovered,O
thousands,O
of,O
coronavirus,O
sequences,O
in,O
diverse,O
animals,O
and,O
"
",O
geographic,O
regions,O
.,O
Unfortunately,O
",",O
there,O
are,O
few,O
tools,O
available,O
to,O
functionally,O
"
",O
test,O
these,O
viruses,O
for,O
their,O
ability,O
to,O
infect,O
humans,O
",",O
which,O
has,O
severely,O
"
",O
hampered,O
efforts,O
to,O
predict,O
the,O
next,O
zoonotic,O
viral,O
outbreak,O
.,O
Here,O
",",O
we,O
developed,O
"
",O
an,O
approach,O
to,O
rapidly,O
screen,O
lineage,O
B,O
betacoronaviruses,O
",",O
such,O
as,O
SARSCoV,O
and,O
"
",O
the,O
recent,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
for,O
receptor,O
usage,O
and,O
their,O
ability,O
to,O
infect,O
cell,O
types,O
"
",O
from,O
different,O
species,O
.,O
We,O
show,O
that,O
host,O
protease,O
processing,O
during,O
viral,O
entry,O
"
",O
is,O
a,O
significant,O
barrier,O
for,O
several,O
lineage,O
B,O
viruses,O
and,O
that,O
bypassing,O
this,O
"
",O
barrier,O
allows,O
several,O
lineage,O
B,O
viruses,O
to,O
enter,O
human,O
cells,O
through,O
an,O
unknown,O
"
",O
receptor,O
.,O
We,O
also,O
demonstrate,O
how,O
different,O
lineage,O
B,O
viruses,O
can,O
recombine,O
to,O
"
",O
gain,O
entry,O
into,O
human,O
cells,O
",",O
and,O
confirm,O
that,O
human,O
ACE2,O
is,O
the,O
receptor,O
for,O
the,O
"
",O
recently,O
emerging,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
DOI,O
:,O
10.1038,O
s415640200688y,O
"
",O
PMID,O
:,O
32094589,O
"


",O
548,O
.,O
Cell,O
Mol,O
Immunol,O
.,O
2020,O
Feb,O
24,O
.,O
doi,O
:,O
10.1038,O
s414230200377z,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Epitopes,O
for,O
a,O
2019nCoV,B-Virus_SARS-CoV-2
vaccine,O
.,O
"

",O
Lucchese,O
G(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)UniversitÃ¤tsmedizin,O
Greifswald,O
",",O
Department,O
of,O
Neurology,O
",",O
17475,O
",",O
Greifswald,O
",",O
"
",O
Germany,O
.,O
guglielmo.lucchese@unigreifswald.de,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s414230200377z,O
"
",O
PMID,O
:,O
32094505,O
"


",O
549,O
.,O
Int,O
J,O
Oral,O
Sci,O
.,O
2020,O
Feb,O
24;12(1):8,O
.,O
doi,O
:,O
10.1038,O
s413680200074x,O
.,O
"

",O
High,O
expression,O
of,O
ACE2,O
receptor,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
on,O
the,O
epithelial,O
cells,O
of,O
oral,O
"
",O
mucosa,O
.,O
"

",O
Xu,O
H(1,O
),O
",",O
Zhong,O
L(1,O
),O
",",O
Deng,O
J(1,O
),O
",",O
Peng,O
J(1,O
),O
",",O
Dan,O
H(1,O
),O
",",O
Zeng,O
X(1,O
),O
",",O
Li,O
T(2,O
),O
",",O
Chen,O
"
",O
Q(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Oral,O
Diseases,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
"
",O
Oral,O
Diseases,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
Research,O
Unit,O
of,O
Oral,O
"
",O
Carcinogenesis,O
and,O
Management,O
",",O
West,O
China,O
Hospital,O
of,O
Stomatology,O
",",O
Sichuan,O
"
",O
University,O
",",O
Chengdu,O
",",O
Sichuan,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Oral,O
Diseases,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
"
",O
Oral,O
Diseases,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
Research,O
Unit,O
of,O
Oral,O
"
",O
Carcinogenesis,O
and,O
Management,O
",",O
West,O
China,O
Hospital,O
of,O
Stomatology,O
",",O
Sichuan,O
"
",O
University,O
",",O
Chengdu,O
",",O
Sichuan,O
",",O
China,O
.,O
litaiwen@scu.edu.cn,O
.,O
"

",O
It,O
has,O
been,O
reported,O
that,O
ACE2,O
is,O
the,O
main,O
host,O
cell,O
receptor,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
and,O
"
",O
plays,O
a,O
crucial,O
role,O
in,O
the,O
entry,O
of,O
virus,O
into,O
the,O
cell,O
to,O
cause,O
the,O
final,O
"
",O
infection,O
.,O
To,O
investigate,O
the,O
potential,O
route,O
of,O
2019nCov,B-Disease_COVID-19
infection,I-Disease_COVID-19
on,O
the,O
"
",O
mucosa,O
of,O
oral,O
cavity,O
",",O
bulk,O
RNAseq,O
profiles,O
from,O
two,O
public,O
databases,O
including,O
"
",O
The,O
Cancer,O
Genome,O
Atlas,O
(,O
TCGA,O
),O
and,O
Functional,O
Annotation,O
of,O
The,O
Mammalian,O
Genome,O
"
",O
Cap,O
Analysis,O
of,O
Gene,O
Expression,O
(,O
FANTOM5,O
CAGE,O
),O
dataset,O
were,O
collected,O
.,O
RNAseq,O
"
",O
profiling,O
data,O
of,O
13,O
organ,O
types,O
with,O
paracarcinoma,O
normal,O
tissues,O
from,O
TCGA,O
and,O
"
",O
14,O
organ,O
types,O
with,O
normal,O
tissues,O
from,O
FANTOM5,O
CAGE,O
were,O
analyzed,O
in,O
order,O
to,O
"
",O
explore,O
and,O
validate,O
the,O
expression,O
of,O
ACE2,O
on,O
the,O
mucosa,O
of,O
oral,O
cavity,O
.,O
"
",O
Further,O
",",O
singlecell,O
transcriptomes,O
from,O
an,O
independent,O
data,O
generated,O
inhouse,O
"
",O
were,O
used,O
to,O
identify,O
and,O
confirm,O
the,O
ACE2expressing,O
cell,O
composition,O
and,O
"
",O
proportion,O
in,O
oral,O
cavity,O
.,O
The,O
results,O
demonstrated,O
that,O
the,O
ACE2,O
expressed,O
on,O
"
",O
the,O
mucosa,O
of,O
oral,O
cavity,O
.,O
Interestingly,O
",",O
this,O
receptor,O
was,O
highly,O
enriched,O
in,O
"
",O
epithelial,O
cells,O
of,O
tongue,O
.,O
Preliminarily,O
",",O
those,O
findings,O
have,O
explained,O
the,O
"
",O
basic,O
mechanism,O
that,O
the,O
oral,O
cavity,O
is,O
a,O
potentially,O
high,O
risk,O
for,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
infectious,O
susceptibility,O
and,O
provided,O
a,O
piece,O
of,O
evidence,O
for,O
the,O
future,O
"
",O
prevention,O
strategy,O
in,O
dental,O
clinical,O
practice,O
as,O
well,O
as,O
daily,O
life,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s413680200074x,O
"
",O
PMCID,O
:,O
PMC7039956,O
"
",O
PMID,O
:,O
32094336,O
"


",O
550,O
.,O
J,O
Biol,O
Chem,O
.,O
2020,O
Feb,O
24,O
.,O
pii,O
:,O
jbc,O
.,O
AC120.013056,O
.,O
doi,O
:,O
10.1074,O
jbc,O
.,O
AC120.013056,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
antiviral,O
compound,O
remdesivir,O
potently,O
inhibits,O
RNAdependent,O
RNA,O
polymerase,O
"
",O
from,O
Middle,O
East,O
respiratory,O
syndrome,O
coronavirus,O
.,O
"

",O
Gordon,O
CJ(1,O
),O
",",O
Tchesnokov,O
EP(1,O
),O
",",O
Feng,O
JY(2,O
),O
",",O
Porter,O
DP(3,O
),O
",",O
Gotte,O
M(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)University,O
of,O
Alberta,O
",",O
Canada,O
.,O
"
",O
(2)Biology,O
",",O
Gilead,O
Sciences,O
",",O
United,O
States,O
.,O
"
",O
(3)Gilead,O
",",O
United,O
States,O
.,O
"
",O
(4)Medical,O
Microbiology,O
and,O
Immunology,O
",",O
University,O
of,O
Alberta,O
",",O
Canada,O
.,O
"

",O
Antiviral,O
drugs,O
for,O
managing,O
infections,O
with,O
human,O
coronaviruses,O
are,O
not,O
yet,O
"
",O
approved,O
",",O
posing,O
a,O
serious,O
challenge,O
to,O
current,O
global,O
efforts,O
aimed,O
at,O
"
",O
containing,O
the,O
outbreak,O
of,O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
"
",O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
.,O
Remdesivir,O
(,O
RDV,O
),O
is,O
an,O
investigational,O
compound,O
with,O
a,O
broad,O
"
",O
spectrum,O
of,O
antiviral,O
activities,O
against,O
RNA,O
viruses,O
",",O
including,O
SARSCoV,O
and,O
"
",O
Middle,O
East,O
respiratory,O
syndrome,O
(,O
MERSCoV,O
),O
.,O
RDV,O
is,O
a,O
nucleotide,O
analog,O
inhibitor,O
"
",O
of,O
RNAdependent,O
RNA,O
polymerases,O
(,O
RdRps,O
),O
.,O
Here,O
",",O
we,O
coexpressed,O
the,O
MERSCoV,O
"
",O
nonstructural,O
proteins,O
nsp5,O
",",O
nsp7,O
",",O
nsp8,O
",",O
and,O
nsp12,O
(,O
RdRp,O
),O
in,O
insect,O
cells,O
as,O
a,O
"
",O
part,O
a,O
polyprotein,O
to,O
study,O
the,O
mechanism,O
of,O
inhibition,O
of,O
MERSCoV,O
RdRp,O
by,O
RDV,O
.,O
"
",O
We,O
initially,O
demonstrated,O
that,O
nsp8,O
and,O
nsp12,O
form,O
an,O
active,O
complex,O
.,O
The,O
"
",O
triphosphate,O
form,O
of,O
the,O
inhibitor,O
(,O
RDVTP,O
),O
competes,O
with,O
its,O
natural,O
counterpart,O
"
",O
ATP,O
.,O
Of,O
note,O
",",O
the,O
selectivity,O
value,O
for,O
RDVTP,O
obtained,O
here,O
with,O
a,O
steadystate,O
"
",O
approach,O
suggests,O
that,O
it,O
is,O
more,O
efficiently,O
incorporated,O
than,O
ATP,O
and,O
two,O
other,O
"
",O
nucleotide,O
analogues,O
.,O
Once,O
incorporated,O
at,O
position,O
i,O
",",O
the,O
inhibitor,O
caused,O
RNA,O
"
",O
synthesis,O
arrest,O
at,O
position,O
i+3,O
.,O
Hence,O
",",O
the,O
likely,O
mechanism,O
of,O
action,O
is,O
"
",O
delayed,O
RNA,O
chain,O
termination,O
.,O
The,O
additional,O
three,O
nucleotides,O
may,O
protect,O
the,O
"
",O
inhibitor,O
from,O
excision,O
by,O
the,O
viral,O
3'5,O
',O
exonuclease,O
activity,O
.,O
Together,O
",",O
these,O
"
",O
results,O
help,O
to,O
explain,O
the,O
high,O
potency,O
of,O
RDV,O
against,O
RNA,O
viruses,O
in,O
cellbased,O
"
",O
assays,O
.,O
"

",O
Published,O
under,O
license,O
by,O
The,O
American,O
Society,O
for,O
Biochemistry,O
and,O
Molecular,O
"
",O
Biology,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1074,O
jbc,O
.,O
AC120.013056,O
"
",O
PMID,O
:,O
32094225,O
"



",O
551,O
.,O
J,O
Pediatr,O
.,O
2020,O
Feb,O
21,O
.,O
pii,O
:,O
S00223476(20)301153,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jpeds.2020.01.044,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Pediatric,O
Antibiotic,O
Prescribing,O
in,O
China,O
According,O
to,O
the,O
2019,O
World,O
Health,O
"
",O
Organization,O
Access,O
",",O
Watch,O
",",O
and,O
Reserve,O
(,O
AWaRe,O
),O
Antibiotic,O
Categories,O
.,O
"

",O
Wang,O
CN(1,O
),O
",",O
Huttner,O
BD(2,O
),O
",",O
Magrini,O
N(3,O
),O
",",O
Cheng,O
Y(4,O
),O
",",O
Tong,O
J(5,O
),O
",",O
Li,O
S(6,O
),O
",",O
Wan,O
"
",O
C(7,O
),O
",",O
Zhu,O
Q(8,O
),O
",",O
Zhao,O
S(9,O
),O
",",O
Zhuo,O
Z(10,O
),O
",",O
Lin,O
D(11,O
),O
",",O
Yi,O
B(12,O
),O
",",O
Shan,O
Q(13,O
),O
",",O
Long,O
"
",O
M(14,O
),O
",",O
Jia,O
C(15,O
),O
",",O
Zhao,O
D(16,O
),O
",",O
Sun,O
X(17,O
),O
",",O
Liu,O
J(18,O
),O
",",O
Zhou,O
Y(19,O
),O
",",O
Li,O
R(5,O
),O
",",O
Liu,O
"
",O
J(20,O
),O
",",O
Zhu,O
Y(7,O
),O
",",O
Miao,O
R(7,O
),O
",",O
Zhu,O
C(8,O
),O
",",O
Qi,O
Z(9,O
),O
",",O
Wang,O
C(10,O
),O
",",O
Wu,O
S(11,O
),O
",",O
Xu,O
X(21,O
),O
",",O
"
",O
Zhou,O
L(21,O
),O
",",O
Ye,O
W(13,O
),O
",",O
Luo,O
N(14,O
),O
",",O
Gao,O
H(22,O
),O
",",O
Yang,O
P(16,O
),O
",",O
Bieerding,O
M(17,O
),O
",",O
Tang,O
"
",O
J(23,O
),O
",",O
Zeng,O
M(24,O
),O
;,O
Collaborative,O
Working,O
Group,O
of,O
the,O
Pediatric,O
Subgroup,O
of,O
the,O
"
",O
China,O
Society,O
of,O
Infectious,O
Diseases,O
.,O
"

",O
Collaborators,O
:,O
Xia,O
J,O
",",O
Yan,O
H,O
",",O
Liu,O
T,O
",",O
Su,O
Z,O
",",O
Liang,O
X,O
",",O
Chen,O
J,O
",",O
Wang,O
D,O
",",O
Zhao,O
Y,O
",",O
Zhang,O
"
",O
L,O
",",O
Gu,O
SF,O
",",O
Zhu,O
J,O
",",O
Lan,O
C,O
",",O
Hu,O
H.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Diseases,O
",",O
Children,O
's,O
Hospital,O
of,O
Fudan,O
University,O
",",O
"
",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Division,O
of,O
Infectious,O
Diseases,O
",",O
Geneva,O
University,O
Hospitals,O
and,O
Faculty,O
of,O
"
",O
Medicine,O
",",O
University,O
of,O
Geneva,O
",",O
Geneva,O
",",O
Switzerland,O
.,O
"
",O
(3)Department,O
of,O
Essential,O
Medicines,O
and,O
Health,O
Products,O
",",O
World,O
Health,O
"
",O
Organization,O
",",O
Geneva,O
",",O
Switzerland,O
.,O
"
",O
(4)Emergency,O
Department,O
",",O
Henan,O
Children,O
's,O
Hospital,O
Affiliated,O
to,O
Zhengzhou,O
"
",O
University,O
",",O
Zhengzhou,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Pediatric,O
Gastroenterology,O
and,O
Infectious,O
Diseases,O
",",O
Qingdao,O
"
",O
Women,O
and,O
Children,O
's,O
Hospital,O
",",O
Qingdao,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Hepatology,O
",",O
Hunan,O
Children,O
's,O
Hospital,O
",",O
Changsha,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Pediatrics,O
",",O
West,O
China,O
Second,O
Hospital,O
",",O
Sichuan,O
University,O
",",O
"
",O
Chengdu,O
",",O
China,O
.,O
"
",O
(8)Department,O
of,O
Infectious,O
Diseases,O
",",O
Jiangxi,O
Provincial,O
Children,O
's,O
Hospital,O
",",O
"
",O
Nanchang,O
",",O
China,O
.,O
"
",O
(9)Department,O
of,O
Infectious,O
Diseases,O
",",O
Hangzhou,O
Children,O
's,O
Hospital,O
",",O
Hangzhou,O
",",O
"
",O
China,O
.,O
"
",O
(10)Department,O
of,O
Infectious,O
Diseases,O
",",O
Xiamen,O
Children,O
's,O
Hospital,O
",",O
Xiamen,O
",",O
China,O
.,O
"
",O
(11)Department,O
of,O
Infectious,O
Diseases,O
",",O
Hainan,O
Women,O
and,O
Children,O
's,O
Medical,O
"
",O
Center,O
",",O
Hainan,O
",",O
China,O
.,O
"
",O
(12)Department,O
of,O
Neonatology,O
",",O
Gansu,O
Provincial,O
Maternity,O
and,O
Child,O
Care,O
"
",O
Hospital,O
",",O
Lanzhou,O
",",O
China,O
.,O
"
",O
(13)Department,O
of,O
Pediatrics,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Guangxi,O
Medical,O
"
",O
University,O
",",O
Nanning,O
",",O
China,O
.,O
"
",O
(14)Department,O
of,O
Pediatric,O
Gastroenterology,O
",",O
Guiyang,O
Maternal,O
and,O
Child,O
"
",O
Hospital,O
",",O
Guiyang,O
",",O
China,O
.,O
"
",O
(15)Department,O
of,O
Pediatrics,O
",",O
The,O
Fourth,O
Hospital,O
of,O
Baotou,O
",",O
Baotou,O
",",O
China,O
.,O
"
",O
(16)Department,O
of,O
Pediatrics,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(17)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Xinjiang,O
"
",O
Medical,O
University,O
",",O
Wulumuqi,O
",",O
China,O
.,O
"
",O
(18)Department,O
of,O
Pediatrics,O
",",O
Nanchong,O
Central,O
Hospital,O
",",O
The,O
Second,O
Clinical,O
"
",O
Medical,O
College,O
",",O
North,O
Sichuan,O
Medical,O
College,O
",",O
Nanchong,O
",",O
China,O
.,O
"
",O
(19)Department,O
of,O
General,O
Pediatrics,O
",",O
Henan,O
Children,O
's,O
Hospital,O
Affiliated,O
to,O
"
",O
Zhengzhou,O
University,O
",",O
Zhengzhou,O
",",O
China,O
.,O
"
",O
(20)Department,O
of,O
Infectious,O
Diseases,O
",",O
Hunan,O
Children,O
's,O
Hospital,O
",",O
Changsha,O
",",O
"
",O
China,O
.,O
"
",O
(21)Department,O
of,O
Digestive,O
Infection,O
",",O
Gansu,O
Provincial,O
Maternity,O
and,O
Child,O
Care,O
"
",O
Hospital,O
",",O
Lanzhou,O
",",O
China,O
.,O
"
",O
(22)Department,O
of,O
Pharmacy,O
",",O
The,O
Fourth,O
Hospital,O
of,O
Baotou,O
",",O
Baotou,O
",",O
China,O
.,O
"
",O
(23)Department,O
of,O
Pharmacy,O
",",O
Nanchong,O
Central,O
Hospital,O
",",O
The,O
Second,O
Clinical,O
"
",O
Medical,O
College,O
",",O
North,O
Sichuan,O
Medical,O
College,O
",",O
Nanchong,O
",",O
China,O
.,O
"
",O
(24)Department,O
of,O
Infectious,O
Diseases,O
",",O
Children,O
's,O
Hospital,O
of,O
Fudan,O
University,O
",",O
"
",O
Shanghai,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
zengmeigao@aliyun.com,O
.,O
"

",O
OBJECTIVES,O
:,O
To,O
assess,O
clinical,O
indicationspecific,O
antibiotic,O
prescribing,O
in,O
"
",O
pediatric,O
practice,O
in,O
China,O
based,O
on,O
the,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
Access,O
",",O
"
",O
Watch,O
",",O
and,O
Reserve,O
(,O
AWaRe,O
),O
metrics,O
and,O
to,O
detect,O
potential,O
problem,O
areas,O
.,O
"
",O
STUDY,O
DESIGN,O
:,O
Pediatric,O
prescription,O
records,O
on,O
the,O
16th,O
of,O
each,O
month,O
during,O
"
",O
2018,O
were,O
sampled,O
for,O
all,O
encounters,O
at,O
outpatient,O
and,O
emergency,O
departments,O
of,O
"
",O
16,O
tertiary,O
care,O
hospitals,O
via,O
hospital,O
information,O
systems,O
.,O
Antibiotic,O
"
",O
prescribing,O
patterns,O
were,O
analyzed,O
across,O
and,O
within,O
diagnostic,O
conditions,O
"
",O
according,O
to,O
WHO,O
AWaRe,O
metrics,O
and,O
Anatomical,O
Therapeutic,O
Chemical,O
(,O
ATC,O
),O
"
",O
classification,O
.,O
"
",O
RESULTS,O
:,O
A,O
total,O
of,O
260,O
â€ˆ,O
1,O
pediatric,O
encounters,O
were,O
assessed,O
",",O
and,O
antibiotics,O
"
",O
were,O
prescribed,O
in,O
94,O
â€ˆ,O
453,O
(,O
36.3,O
%,O
),O
.,O
In,O
35,O
â€ˆ,O
167,O
encounters,O
(,O
37.2,O
%,O
),O
",",O
at,O
least,O
1,O
"
",O
intravenous,O
antibiotic,O
was,O
administered,O
.,O
WHO,O
Watch,O
group,O
antibiotics,O
accounted,O
"
",O
for,O
82.2,O
%,O
(,O
n,O
Â ,O
=,O
Â ,O
84,O
â€ˆ,O
176,O
),O
of,O
all,O
antibiotic,O
therapies,O
.,O
Azithromycin,O
(,O
n,O
Â ,O
=,O
Â ,O
15,O
â€ˆ,O
791,O
;,O
"
",O
15.4,O
%,O
),O
was,O
the,O
most,O
commonly,O
prescribed,O
antibiotic,O
",",O
and,O
thirdgeneration,O
"
",O
cephalosporins,O
(,O
n,O
Â ,O
=,O
Â ,O
44,O
â€ˆ,O
387,O
;,O
43.3,O
%,O
),O
were,O
the,O
most,O
commonly,O
prescribed,O
antibiotic,O
"
",O
class,O
.,O
In,O
at,O
least,O
66,O
â€ˆ,O
98,O
encounters,O
(,O
70,O
%,O
),O
",",O
antibiotics,O
were,O
prescribed,O
for,O
"
",O
respiratory,O
tract,O
conditions,O
",",O
mainly,O
for,O
bronchitis,O
bronchiolitis,O
(,O
n,O
Â ,O
=,O
Â ,O
25,O
â€ˆ,O
815,O
;,O
"
",O
27.3,O
%,O
),O
",",O
upper,O
respiratory,O
tract,O
infection,O
(,O
n,O
Â ,O
=,O
Â ,O
25,O
â€ˆ,O
184,O
;,O
26.7,O
%,O
),O
",",O
and,O
pneumonia,O
"
",O
(,O
n,O
Â ,O
=,O
Â ,O
13,O
â€ˆ,O
392,O
;,O
14.2,O
%,O
),O
.,O
"
",O
CONCLUSIONS,O
:,O
Overuse,O
and,O
misuse,O
of,O
WHO,O
Watch,O
group,O
antibiotics,O
for,O
respiratory,O
"
",O
tract,O
conditions,O
and,O
viral,O
infectious,O
diseases,O
is,O
common,O
in,O
pediatric,O
outpatients,O
"
",O
in,O
China,O
.,O
Pediatric,O
antimicrobial,O
stewardship,O
should,O
be,O
strengthened,O
using,O
WHO,O
"
",O
AWaRe,O
metrics,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jpeds.2020.01.044,O
"
",O
PMID,O
:,O
32093934,O
"


",O
552,O
.,O
Med,O
Clin,O
(,O
Barc,O
),O
.,O
2020,O
Mar,O
13;154(5):175177,O
.,O
doi,O
:,O
10.1016,O
j.medcli.2020.02.002,O
.,O
"
",O
Epub,O
2020,O
Feb,O
21,O
.,O
"

",O
One,O
world,O
",",O
one,O
health,O
:,O
The,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
COVID19,B-Disease_COVID-19
epidemic,O
.,O
"

",O
[,O
Article,O
in,O
English,O
",",O
Spanish,O
],O
"

",O
Trilla,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Hospital,O
ClÃ­nic,O
de,O
Barcelona,O
",",O
Universidad,O
de,O
Barcelona,O
",",O
ISGlobal,O
",",O
Barcelona,O
",",O
"
",O
EspaÃ±a,O
.,O
Electronic,O
address,O
:,O
atrilla@clinic.cat,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.medcli.2020.02.002,O
"
",O
PMID,O
:,O
32093921,O
"


",O
553,O
.,O
Psychiatry,O
Investig,O
.,O
2020,O
Feb;17(2):175176,O
.,O
doi,O
:,O
10.30773,O
pi.2020.0047,O
.,O
Epub,O
"
",O
2020,O
Feb,O
25,O
.,O
"

",O
A,O
Novel,O
Approach,O
of,O
Consultation,O
on,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(COVID19)Related,O
"
",O
Psychological,O
and,O
Mental,O
Problems,O
:,O
Structured,O
Letter,O
Therapy,O
.,O
"

",O
Xiao,O
C(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
National,O
Clinical,O
Research,O
Center,O
for,O
Mental,O
Disorder,O
&,O
Beijing,O
Key,O
"
",O
Laboratory,O
of,O
Mental,O
Disorders,O
",",O
Beijing,O
Anding,O
Hospital,O
",",O
Capital,O
Medical,O
"
",O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Advanced,O
Innovation,O
Center,O
for,O
Human,O
Brain,O
Protection,O
",",O
Capital,O
Medical,O
"
",O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.30773,O
pi.2020.0047,O
"
",O
PMCID,O
:,O
PMC7047000,O
"
",O
PMID,O
:,O
32093461,O
"


",O
554,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
20;9(2,O
),O
.,O
pii,O
:,O
E575,O
.,O
doi,O
:,O
10.339,O
jcm9020575,O
.,O
"

",O
Characteristics,O
of,O
and,O
Public,O
Health,O
Responses,O
to,O
the,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
"
",O
Outbreak,O
in,O
China,O
.,O
"

",O
Deng,O
SQ(1,O
),O
",",O
Peng,O
HJ(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pathogen,O
Biology,O
",",O
Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
"
",O
Tropical,O
Disease,O
Research,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Southern,O
Medical,O
University,O
",",O
"
",O
Guangzhou,O
510515,O
",",O
China,O
.,O
"

",O
In,O
December,O
2019,O
",",O
cases,O
of,O
unidentified,O
pneumonia,O
with,O
a,O
history,O
of,O
exposure,O
in,O
"
",O
the,O
Huanan,O
Seafood,O
Market,O
were,O
reported,O
in,O
Wuhan,O
",",O
Hubei,O
Province,O
.,O
A,O
novel,O
"
",O
coronavirus,O
",",O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
was,O
identified,O
to,O
be,O
accountable,O
for,O
this,O
disease,O
.,O
"
",O
Humantohuman,O
transmission,O
is,O
confirmed,O
",",O
and,O
this,O
disease,O
(,O
named,O
COVID19,B-Disease_COVID-19
by,O
"
",O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
),O
spread,O
rapidly,O
around,O
the,O
country,O
and,O
the,O
world,O
.,O
"
",O
As,O
of,O
18,O
February,O
2020,O
",",O
the,O
number,O
of,O
confirmed,O
cases,O
had,O
reached,O
75199,O
with,O
"
",O
2009,O
fatalities,O
.,O
The,O
COVID19,B-Disease_COVID-19
resulted,O
in,O
a,O
much,O
lower,O
casefatality,O
rate,O
(,O
about,O
"
",O
2.67,O
%,O
),O
among,O
the,O
confirmed,O
cases,O
",",O
compared,O
with,O
Severe,O
Acute,O
Respiratory,O
Syndrome,O
"
",O
(,O
SARS,O
),O
and,O
Middle,O
East,O
Respiratory,O
Syndrome,O
(,O
MERS,O
),O
.,O
Among,O
the,O
symptom,O
composition,O
"
",O
of,O
the,O
45,O
fatality,O
cases,O
collected,O
from,O
the,O
released,O
official,O
reports,O
",",O
the,O
top,O
"
",O
four,O
are,O
fever,O
",",O
cough,O
",",O
short,O
of,O
breath,O
",",O
and,O
chest,O
tightness,O
pain,O
.,O
The,O
major,O
"
",O
comorbidities,O
of,O
the,O
fatality,O
cases,O
include,O
hypertension,O
",",O
diabetes,O
",",O
coronary,O
"
",O
heart,O
disease,O
",",O
cerebral,O
infarction,O
",",O
and,O
chronic,O
bronchitis,O
.,O
The,O
source,O
of,O
the,O
"
",O
virus,O
and,O
the,O
pathogenesis,O
of,O
this,O
disease,O
are,O
still,O
unconfirmed,O
.,O
No,O
specific,O
"
",O
therapeutic,O
drug,O
has,O
been,O
found,O
.,O
The,O
Chinese,O
Government,O
has,O
initiated,O
a,O
level1,O
"
",O
public,O
health,O
response,O
to,O
prevent,O
the,O
spread,O
of,O
the,O
disease,O
.,O
Meanwhile,O
",",O
it,O
is,O
"
",O
also,O
crucial,O
to,O
speed,O
up,O
the,O
development,O
of,O
vaccines,O
and,O
drugs,O
for,O
treatment,O
",",O
"
",O
which,O
will,O
enable,O
us,O
to,O
defeat,O
COVID19,B-Disease_COVID-19
as,O
soon,O
as,O
possible,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9020575,O
"
",O
PMID,O
:,O
32093211,O
"


",O
555,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
19;9(2,O
),O
.,O
pii,O
:,O
E571,O
.,O
doi,O
:,O
10.339,O
jcm9020571,O
.,O
"

",O
Risk,O
Assessment,O
of,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
COVID19,B-Disease_COVID-19
Outbreaks,O
Outside,O
China,O
.,O
"

",O
Boldog,O
P(1,O
),O
",",O
Tekeli,O
T(1,O
),O
",",O
Vizi,O
Z(1,O
),O
",",O
DÃ©nes,O
A(1,O
),O
",",O
Bartha,O
FA(1,O
),O
",",O
RÃ¶st,O
G(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Bolyai,O
Institute,O
",",O
University,O
of,O
Szeged,O
",",O
H6720,O
Szeged,O
",",O
Hungary,O
.,O
"

",O
We,O
developed,O
a,O
computational,O
tool,O
to,O
assess,O
the,O
risks,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
outbreaks,O
outside,O
of,O
China,O
.,O
We,O
estimate,O
the,O
dependence,O
of,O
the,O
risk,O
of,O
a,O
major,O
"
",O
outbreak,O
in,O
a,O
country,O
from,O
imported,O
cases,O
on,O
key,O
parameters,O
such,O
as,O
:,O
(,O
i,O
),O
the,O
"
",O
evolution,O
of,O
the,O
cumulative,O
number,O
of,O
cases,O
in,O
mainland,O
China,O
outside,O
the,O
closed,O
"
",O
areas,O
;,O
(,O
ii,O
),O
the,O
connectivity,O
of,O
the,O
destination,O
country,O
with,O
China,O
",",O
including,O
"
",O
baseline,O
travel,O
frequencies,O
",",O
the,O
effect,O
of,O
travel,O
restrictions,O
",",O
and,O
the,O
efficacy,O
"
",O
of,O
entry,O
screening,O
at,O
destination,O
;,O
and,O
(,O
iii,O
),O
the,O
efficacy,O
of,O
control,O
measures,O
in,O
"
",O
the,O
destination,O
country,O
(,O
expressed,O
by,O
the,O
local,O
reproduction,O
number,O
R,O
loc,O
),O
.,O
We,O
"
",O
found,O
that,O
in,O
countries,O
with,O
low,O
connectivity,O
to,O
China,O
but,O
with,O
relatively,O
high,O
R,O
"
",O
loc,O
",",O
the,O
most,O
beneficial,O
control,O
measure,O
to,O
reduce,O
the,O
risk,O
of,O
outbreaks,O
is,O
a,O
"
",O
further,O
reduction,O
in,O
their,O
importation,O
number,O
either,O
by,O
entry,O
screening,O
or,O
travel,O
"
",O
restrictions,O
.,O
Countries,O
with,O
high,O
connectivity,O
but,O
low,O
R,O
loc,O
benefit,O
the,O
most,O
"
",O
from,O
policies,O
that,O
further,O
reduce,O
R,O
loc,O
.,O
Countries,O
in,O
the,O
middle,O
should,O
consider,O
"
",O
a,O
combination,O
of,O
such,O
policies,O
.,O
Risk,O
assessments,O
were,O
illustrated,O
for,O
selected,O
"
",O
groups,O
of,O
countries,O
from,O
America,O
",",O
Asia,O
",",O
and,O
Europe,O
.,O
We,O
investigated,O
how,O
their,O
"
",O
risks,O
depend,O
on,O
those,O
parameters,O
",",O
and,O
how,O
the,O
risk,O
is,O
increasing,O
in,O
time,O
as,O
the,O
"
",O
number,O
of,O
cases,O
in,O
China,O
is,O
growing,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9020571,O
"
",O
PMID,O
:,O
32093043,O
"


",O
556,O
.,O
Biomolecules,O
.,O
2020,O
Feb,O
19;10(2,O
),O
.,O
pii,O
:,O
E331,O
.,O
doi,O
:,O
10.339,O
biom10020331,O
.,O
"

",O
Rigidity,O
of,O
the,O
Outer,O
Shell,O
Predicted,O
by,O
a,O
Protein,O
Intrinsic,O
Disorder,O
Model,O
Sheds,O
"
",O
Light,O
on,O
the,O
COVID19,B-Disease_COVID-19
(,O
Wuhan2019nCoV,O
),O
Infectivity,O
.,O
"

",O
Goh,O
GK(1,O
),O
",",O
Dunker,O
AK(2,O
),O
",",O
Foster,O
JA(3)(4,O
),O
",",O
Uversky,O
VN(5)(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Goh,O
's,O
BioComputing,O
",",O
Singapore,O
548957,O
",",O
Singapore,O
.,O
"
",O
(2)Center,O
for,O
Computational,O
Biology,O
",",O
Indiana,O
and,O
Bioinformatics,O
",",O
Indiana,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Indianapolis,O
",",O
IN,O
46202,O
",",O
USA,O
.,O
"
",O
(3)Department,O
of,O
Biological,O
Sciences,O
",",O
University,O
of,O
Idaho,O
",",O
Moscow,O
",",O
ID,O
83844,O
",",O
USA,O
.,O
"
",O
(4)Institute,O
for,O
Bioinformatics,O
and,O
Evolutionary,O
Studies,O
",",O
University,O
of,O
Idaho,O
",",O
"
",O
Moscow,O
",",O
ID,O
83844,O
",",O
USA,O
.,O
"
",O
(5)Department,O
of,O
Molecular,O
Medicine,O
",",O
Morsani,O
College,O
of,O
Medicine,O
",",O
University,O
of,O
"
",O
South,O
Florida,O
",",O
Tampa,O
",",O
FL,O
33612,O
",",O
USA,O
.,O
"
",O
(6)Institute,O
for,O
Biological,O
Instrumentation,O
of,O
the,O
Russian,O
Academy,O
of,O
Sciences,O
",",O
"
",O
Federal,O
Research,O
Center,O
',O
Pushchino,O
Scientific,O
Center,O
for,O
Biological,O
Research,O
of,O
"
",O
the,O
Russian,O
Academy,O
of,O
Sciences,O
',O
",",O
Moscow,O
region,O
",",O
142290,O
Pushchino,O
",",O
Russia,O
.,O
"

",O
The,O
world,O
is,O
currently,O
witnessing,O
an,O
outbreak,O
of,O
a,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
spreading,O
"
",O
quickly,O
across,O
China,O
and,O
affecting,O
at,O
least,O
24,O
other,O
countries,O
.,O
With,O
almost,O
"
",O
65000,O
infected,O
",",O
a,O
worldwide,O
death,O
toll,O
of,O
at,O
least,O
1370,O
(,O
as,O
of,O
14,O
February,O
"
",O
2020,O
),O
",",O
and,O
with,O
the,O
potential,O
to,O
affect,O
up,O
to,O
twothirds,O
of,O
the,O
world,O
population,O
",",O
"
",O
COVID19,B-Disease_COVID-19
is,O
considered,O
by,O
the,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
to,O
be,O
a,O
global,O
"
",O
health,O
emergency,O
.,O
The,O
speed,O
of,O
spread,O
and,O
infectivity,O
of,O
COVID19,B-Disease_COVID-19
(,O
also,O
known,O
as,O
"
",O
Wuhan2019nCoV,O
),O
are,O
dramatically,O
exceeding,O
those,O
of,O
the,O
Middle,O
East,O
respiratory,O
"
",O
syndrome,O
coronavirus,O
(,O
MERSCoV,O
),O
and,O
severe,O
acute,O
respiratory,O
syndrome,O
coronavirus,O
"
",O
(,O
SARSCoV,O
),O
.,O
In,O
fact,O
",",O
since,O
September,O
2012,O
",",O
the,O
WHO,O
has,O
been,O
notified,O
of,O
2494,O
"
",O
laboratoryconfirmed,O
cases,O
of,O
infection,O
with,O
MERSCoV,O
",",O
whereas,O
the,O
20022003,O
"
",O
epidemic,O
of,O
SARS,O
affected,O
26,O
countries,O
and,O
resulted,O
in,O
more,O
than,O
8000,O
cases,O
.,O
"
",O
Therefore,O
",",O
although,O
SARS,O
",",O
MERS,O
",",O
and,O
COVID19,B-Disease_COVID-19
are,O
all,O
the,O
result,O
of,O
coronaviral,O
"
",O
infections,O
",",O
the,O
causes,O
of,O
the,O
coronaviruses,O
differ,O
dramatically,O
in,O
their,O
"
",O
transmissibility,O
.,O
It,O
is,O
likely,O
that,O
these,O
differences,O
in,O
infectivity,O
of,O
"
",O
coronaviruses,O
can,O
be,O
attributed,O
to,O
the,O
differences,O
in,O
the,O
rigidity,O
of,O
their,O
"
",O
shells,O
which,O
can,O
be,O
evaluated,O
using,O
computational,O
tools,O
for,O
predicting,O
intrinsic,O
"
",O
disorder,O
predisposition,O
of,O
the,O
corresponding,O
viral,O
proteins,O
.,O
"

",O
DOI,O
:,O
10.339,O
biom10020331,O
"
",O
PMID,O
:,O
32092911,O
"


",O
557,O
.,O
Biosci,O
Trends,O
.,O
2020,O
Feb,O
25,O
.,O
doi,O
:,O
10.5582,O
bst.2020.01056,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
:,O
Realtime,O
dissemination,O
of,O
scientific,O
information,O
to,O
fight,O
a,O
public,O
"
",O
health,O
emergency,O
of,O
international,O
concern,O
.,O
"

",O
Song,O
P(1,O
),O
",",O
Karako,O
T(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
for,O
Global,O
Health,O
Policy,O
Research,O
",",O
Bureau,O
of,O
International,O
Health,O
"
",O
Cooperation,O
",",O
National,O
Center,O
for,O
Global,O
Health,O
and,O
Medicine,O
",",O
Tokyo,O
",",O
Japan,O
.,O
"
",O
(2)International,O
Health,O
Care,O
Center,O
",",O
National,O
Center,O
for,O
Global,O
Health,O
and,O
"
",O
Medicine,O
",",O
Tokyo,O
",",O
Japan,O
.,O
"
",O
(3)Department,O
of,O
Surgery,O
",",O
the,O
University,O
of,O
Tokyo,O
Hospital,O
",",O
Tokyo,O
",",O
Japan,O
.,O
"

",O
Rapidly,O
sharing,O
scientific,O
information,O
is,O
an,O
effective,O
way,O
to,O
reduce,O
public,O
panic,O
"
",O
about,O
COVID19,B-Disease_COVID-19
",",O
and,O
doing,O
so,O
is,O
the,O
key,O
to,O
providing,O
realtime,O
guidance,O
to,O
"
",O
epidemiologists,O
working,O
to,O
contain,O
the,O
outbreak,O
",",O
clinicians,O
managing,O
patients,O
",",O
"
",O
and,O
modelers,O
helping,O
to,O
understand,O
future,O
developments,O
and,O
the,O
possible,O
"
",O
effectiveness,O
of,O
various,O
interventions,O
.,O
This,O
issue,O
has,O
rapidly,O
reviewed,O
and,O
"
",O
published,O
articles,O
describing,O
COVID19,B-Disease_COVID-19
",",O
including,O
the,O
drug,O
treatment,O
options,O
for,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
its,O
clinical,O
characteristics,O
",",O
and,O
therapies,O
involving,O
a,O
combination,O
"
",O
of,O
Chinese,O
and,O
Western,O
medicine,O
",",O
the,O
efficacy,O
of,O
chloroquine,O
phosphate,O
in,O
the,O
"
",O
treatment,O
of,O
COVID19,B-Disease_COVID-19
associated,O
pneumonia,O
according,O
to,O
clinical,O
studies,O
",",O
and,O
"
",O
reflections,O
on,O
the,O
system,O
of,O
reserve,O
medical,O
supplies,O
for,O
public,O
health,O
"
",O
emergencies,O
.,O
As,O
an,O
academic,O
journal,O
",",O
we,O
will,O
continue,O
to,O
quickly,O
and,O
"
",O
transparently,O
share,O
data,O
with,O
frontline,O
healthcare,O
workers,O
who,O
need,O
to,O
know,O
the,O
"
",O
epidemiological,O
and,O
clinical,O
features,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
DOI,O
:,O
10.5582,O
bst.2020.01056,O
"
",O
PMID,O
:,O
32092748,O
"


",O
558,O
.,O
Microbes,O
Infect,O
.,O
2020,O
Feb,O
22,O
.,O
pii,O
:,O
S12864579(20)300344,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.micinf.2020.02.006,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Is,O
COVID19,B-Disease_COVID-19
receiving,O
ADE,O
from,O
other,O
coronaviruses,O
?,O
"

",O
Tetro,O
JA(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)College,O
of,O
Biological,O
Sciences,O
",",O
University,O
of,O
Guelph,O
",",O
Guelph,O
",",O
Ontario,O
",",O
N1,O
G,O
"
",O
2W1,O
",",O
Canada,O
.,O
Electronic,O
address,O
:,O
jason@jasontetro.com,O
.,O
"

",O
One,O
of,O
the,O
most,O
perplexing,O
questions,O
regarding,O
the,O
current,O
COVID19,B-Disease_COVID-19
coronavirus,O
"
",O
epidemic,O
is,O
the,O
discrepancy,O
between,O
the,O
severity,O
of,O
cases,O
observed,O
in,O
the,O
Hubei,O
"
",O
province,O
of,O
China,O
and,O
those,O
occurring,O
elsewhere,O
in,O
the,O
world,O
.,O
One,O
possible,O
answer,O
"
",O
is,O
antibody,O
dependent,O
enhancement,O
(,O
ADE,O
),O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
due,O
to,O
prior,O
exposure,O
to,O
"
",O
other,O
coronaviruses,O
.,O
ADE,O
modulates,O
the,O
immune,O
response,O
and,O
can,O
elicit,O
sustained,O
"
",O
inflammation,O
",",O
lymphopenia,O
",",O
and,O
or,O
cytokine,O
storm,O
",",O
one,O
or,O
all,O
of,O
which,O
have,O
been,O
"
",O
documented,O
in,O
severe,O
cases,O
and,O
deaths,O
.,O
ADE,O
also,O
requires,O
prior,O
exposure,O
to,O
"
",O
similar,O
antigenic,O
epitopes,O
",",O
presumably,O
circulating,O
in,O
local,O
viruses,O
",",O
making,O
it,O
a,O
"
",O
possible,O
explanation,O
for,O
the,O
observed,O
geographic,O
limitation,O
of,O
severe,O
cases,O
and,O
"
",O
deaths,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Institut,O
Pasteur,O
.,O
Published,O
by,O
Elsevier,O
Masson,O
SAS,O
.,O
All,O
rights,O
"
",O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.micinf.2020.02.006,O
"
",O
PMID,O
:,O
32092539,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
None,O
declared,O
.,O
"


",O
559,O
.,O
Infect,O
Genet,O
Evol,O
.,O
2020,O
Feb,O
21;81:104260,O
.,O
doi,O
:,O
10.1016,O
j.meegid.2020.104260,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Genetic,O
diversity,O
and,O
evolution,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Phan,O
T(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Clinical,O
Microbiology,O
",",O
University,O
of,O
Pittsburgh,O
and,O
University,O
of,O
"
",O
Pittsburgh,O
Medical,O
Center,O
",",O
Pittsburgh,O
",",O
PA,O
",",O
USA,O
.,O
Electronic,O
address,O
:,O
"
",O
phantg@upmc.edu,O
.,O
"

",O
COVID19,B-Disease_COVID-19
is,O
a,O
viral,O
respiratory,O
illness,O
caused,O
by,O
a,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
called,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
The,O
World,O
Health,O
Organization,O
declared,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
outbreak,O
a,O
"
",O
global,O
public,O
health,O
emergency,O
.,O
We,O
performed,O
genetic,O
analyses,O
of,O
eightysix,O
"
",O
complete,O
or,O
nearcomplete,O
genomes,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
and,O
revealed,O
many,O
mutations,O
and,O
"
",O
deletions,O
on,O
coding,O
and,O
noncoding,O
regions,O
.,O
These,O
observations,O
provided,O
evidence,O
"
",O
of,O
the,O
genetic,O
diversity,O
and,O
rapid,O
evolution,O
of,O
this,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.meegid.2020.104260,O
"
",O
PMID,O
:,O
32092483,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
author,O
"
",O
declares,O
no,O
competing,O
financial,O
interests,O
.,O
"


",O
560,O
.,O
J,O
Infect,O
.,O
2020,O
Feb,O
21,O
.,O
pii,O
:,O
S01634453(20)300906,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.013,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Analysis,O
of,O
angiotensinconverting,O
enzyme,O
2,O
(,O
ACE2,O
),O
from,O
different,O
species,O
sheds,O
"
",O
some,O
light,O
on,O
crossspecies,O
receptor,O
usage,O
of,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2019nCoV.,O
"

",O
Li,O
R(1,O
),O
",",O
Qiao,O
S(1,O
),O
",",O
Zhang,O
G(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Animal,O
Immunology,O
of,O
the,O
Ministry,O
of,O
Agriculture,O
",",O
Henan,O
"
",O
Provincial,O
Key,O
Laboratory,O
of,O
Animal,O
Immunology,O
",",O
Henan,O
Academy,O
of,O
Agricultural,O
"
",O
Sciences,O
",",O
Zhengzhou,O
450002,O
",",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Animal,O
Immunology,O
of,O
the,O
Ministry,O
of,O
Agriculture,O
",",O
Henan,O
"
",O
Provincial,O
Key,O
Laboratory,O
of,O
Animal,O
Immunology,O
",",O
Henan,O
Academy,O
of,O
Agricultural,O
"
",O
Sciences,O
",",O
Zhengzhou,O
450002,O
",",O
China,O
;,O
College,O
of,O
Animal,O
Science,O
and,O
Veterinary,O
"
",O
Medicine,O
",",O
Henan,O
Agricultural,O
University,O
",",O
Zhengzhou,O
45002,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
zhanggaip@126.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.013,O
"
",O
PMID,O
:,O
32092392,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
561,O
.,O
J,O
Infect,O
.,O
2020,O
Feb,O
22,O
.,O
pii,O
:,O
S01634453(20)300840,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.002,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
cases,O
in,O
Hong,O
Kong,O
and,O
implications,O
for,O
further,O
"
",O
spread,O
.,O
"

",O
Kwok,O
KO(1,O
),O
",",O
Wong,O
V(2,O
),O
",",O
Wei,O
VWI(2,O
),O
",",O
Wong,O
SYS(2,O
),O
",",O
Tang,O
JW(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Jockey,O
Club,O
School,O
of,O
Public,O
Health,O
and,O
Primary,O
Care,O
",",O
The,O
Chinese,O
"
",O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
;,O
Stanley,O
Ho,O
Centre,O
for,O
Emerging,O
Infectious,O
"
",O
Diseases,O
",",O
The,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
Shatin,O
",",O
Hong,O
Kong,O
",",O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
;,O
Shenzhen,O
Research,O
Institute,O
of,O
The,O
Chinese,O
"
",O
University,O
of,O
Hong,O
Kong,O
",",O
Shenzhen,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
kkokwok@cuhk.edu.hk,O
.,O
"
",O
(2)The,O
Jockey,O
Club,O
School,O
of,O
Public,O
Health,O
and,O
Primary,O
Care,O
",",O
The,O
Chinese,O
"
",O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
.,O
"
",O
(3)Clinical,O
Microbiology,O
",",O
Â ,O
University,O
Hospitals,O
of,O
Leicester,O
NHS,O
Trust,O
",",O
Leicester,O
",",O
"
",O
UK,O
;,O
Respiratory,O
Sciences,O
",",O
University,O
of,O
Leicester,O
",",O
Leicester,O
",",O
United,O
Kingdom,O
.,O
"
",O
Electronic,O
address,O
:,O
julian.tang@uhltr.nhs.uk,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.002,O
"
",O
PMID,O
:,O
32092391,O
"


",O
562,O
.,O
J,O
Infect,O
.,O
2020,O
Feb,O
21,O
.,O
pii,O
:,O
S01634453(20)300827,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jinf.2020.02.011,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Chinese,O
medical,O
personnel,O
against,O
the,O
2019nCoV.,O
"

",O
Feng,O
ZH(1,O
),O
",",O
Cheng,O
YR(2,O
),O
",",O
Chen,O
J(3,O
),O
",",O
Ye,O
L(4,O
),O
",",O
Zhou,O
MY(5,O
),O
",",O
Wang,O
MW(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Neurology,O
",",O
Affiliated,O
Hospital,O
of,O
Guizhou,O
Medical,O
University,O
",",O
"
",O
Guiyang,O
",",O
China,O
.,O
"
",O
(2)Zhejiang,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Hangzhou,O
310012,O
",",O
China,O
;,O
Hangzhou,O
Medical,O
"
",O
College,O
",",O
Hangzhou,O
311300,O
",",O
China,O
.,O
"
",O
(3)Affiliated,O
Hospital,O
of,O
Hangzhou,O
Normal,O
University,O
",",O
Hangzhou,O
310015,O
",",O
China,O
.,O
"
",O
(4)Basic,O
Medical,O
College,O
",",O
Guizhou,O
Medical,O
University,O
",",O
Guizhou,O
550004,O
",",O
China,O
.,O
"
",O
(5)Hangzhou,O
Medical,O
College,O
",",O
Hangzhou,O
311300,O
",",O
China,O
.,O
"
",O
(6)Affiliated,O
Hospital,O
of,O
Hangzhou,O
Normal,O
University,O
",",O
Hangzhou,O
310015,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
wmw990556@163.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.02.011,O
"
",O
PMID,O
:,O
32092388,O
"


",O
563,O
.,O
J,O
Hosp,O
Infect,O
.,O
2020,O
Feb,O
21,O
.,O
pii,O
:,O
S01956701(20)30058X,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jhin.2020.02.010,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
noncontact,O
handheld,O
cutaneous,O
infrared,O
thermometer,O
for,O
fever,O
screening,O
"
",O
during,O
the,O
COVID19,B-Disease_COVID-19
global,O
emergency,O
.,O
"

",O
Aw,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Frontier,O
Medical,O
Group,O
",",O
Singapore,O
.,O
Electronic,O
address,O
:,O
med00114@yahoo.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jhin.2020.02.010,O
"
",O
PMID,O
:,O
32092368,O
"


",O
564,O
.,O
J,O
Am,O
Coll,O
Radiol,O
.,O
2020,O
Feb,O
19,O
.,O
pii,O
:,O
S15461440(20)301502,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jacr.2020.02.008,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Coronavirus,O
(,O
COVID19,B-Disease_COVID-19
),O
Outbreak,O
:,O
What,O
the,O
Department,O
of,O
Radiology,O
Should,O
Know,O
.,O
"

",O
Kooraki,O
S(1,O
),O
",",O
Hosseiny,O
M(2,O
),O
",",O
Myers,O
L(3,O
),O
",",O
Gholamrezanezhad,O
A(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Keck,O
School,O
of,O
Medicine,O
",",O
University,O
of,O
Southern,O
California,O
",",O
Los,O
Angeles,O
",",O
"
",O
California,O
.,O
"
",O
(2)Department,O
of,O
Radiological,O
Sciences,O
",",O
David,O
Geffen,O
School,O
of,O
Medicine,O
",",O
"
",O
University,O
of,O
California,O
at,O
Los,O
Angeles,O
",",O
Los,O
Angeles,O
",",O
California,O
.,O
"
",O
(3)Division,O
of,O
Emergency,O
Radiology,O
",",O
Department,O
of,O
Radiology,O
",",O
Keck,O
School,O
of,O
"
",O
Medicine,O
",",O
University,O
of,O
Sothern,O
California,O
",",O
Los,O
Angeles,O
",",O
California,O
.,O
"
",O
(4)Division,O
of,O
Emergency,O
Radiology,O
",",O
Department,O
of,O
Radiology,O
",",O
Keck,O
School,O
of,O
"
",O
Medicine,O
",",O
University,O
of,O
Sothern,O
California,O
",",O
Los,O
Angeles,O
",",O
California,O
.,O
Electronic,O
"
",O
address,O
:,O
ali.gholamrezanezhad@med.usc.edu,O
.,O
"

",O
In,O
December,O
2019,O
",",O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
pneumonia,O
emerged,O
in,O
Wuhan,O
",",O
"
",O
China,O
.,O
Since,O
then,O
",",O
this,O
highly,O
contagious,O
COVID19,B-Disease_COVID-19
has,O
been,O
spreading,O
worldwide,O
",",O
"
",O
with,O
a,O
rapid,O
rise,O
in,O
the,O
number,O
of,O
deaths,O
.,O
Novel,O
COVID19infected,O
pneumonia,O
"
",O
(,O
NCIP,O
),O
is,O
characterized,O
by,O
fever,O
",",O
fatigue,O
",",O
dry,O
cough,O
",",O
and,O
dyspnea,O
.,O
A,O
variety,O
of,O
"
",O
chest,O
imaging,O
features,O
have,O
been,O
reported,O
",",O
similar,O
to,O
those,O
found,O
in,O
other,O
types,O
"
",O
of,O
coronavirus,O
syndromes,O
.,O
The,O
purpose,O
of,O
the,O
present,O
review,O
is,O
to,O
briefly,O
discuss,O
"
",O
the,O
known,O
epidemiology,O
and,O
the,O
imaging,O
findings,O
of,O
coronavirus,O
syndromes,O
",",O
with,O
a,O
"
",O
focus,O
on,O
the,O
reported,O
imaging,O
findings,O
of,O
NCIP,O
.,O
Moreover,O
",",O
the,O
authors,O
review,O
"
",O
precautions,O
and,O
safety,O
measures,O
for,O
radiology,O
department,O
personnel,O
to,O
manage,O
"
",O
patients,O
with,O
known,O
or,O
suspected,O
NCIP,O
.,O
Implementation,O
of,O
a,O
robust,O
plan,O
in,O
the,O
"
",O
radiology,O
department,O
is,O
required,O
to,O
prevent,O
further,O
transmission,O
of,O
the,O
virus,O
to,O
"
",O
patients,O
and,O
department,O
staff,O
members,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
American,O
College,O
of,O
Radiology,O
.,O
Published,O
by,O
Elsevier,O
Inc.,O
All,O
"
",O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jacr.2020.02.008,O
"
",O
PMID,O
:,O
32092296,O
"


",O
565,O
.,O
JAMA,O
.,O
2020,O
Feb,O
24,O
.,O
doi,O
:,O
10.1001,O
jama.2020.2648,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Characteristics,O
of,O
and,O
Important,O
Lessons,O
From,O
the,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
Outbreak,O
in,O
China,O
:,O
Summary,O
of,O
a,O
Report,O
of,O
72,O
â€¯,O
314,O
Cases,O
From,O
the,O
"
",O
Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
.,O
"

",O
Wu,O
Z(1,O
),O
",",O
McGoogan,O
JM(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.2648,O
"
",O
PMID,O
:,O
32091533,O
"


",O
566,O
.,O
Invest,O
Radiol,O
.,O
2020,O
Feb,O
21,O
.,O
doi,O
:,O
10.1097,O
RLI.0000000000000670,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Chest,O
CT,O
Findings,O
in,O
Patients,O
with,O
Corona,B-Disease_COVID-19
Virus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
and,O
its,O
Relationship,O
"
",O
with,O
Clinical,O
Features,O
.,O
"

",O
Wu,O
J(1,O
),O
",",O
Wu,O
X(2,O
),O
",",O
Zeng,O
W(1,O
),O
",",O
Guo,O
D(2,O
),O
",",O
Fang,O
Z(2,O
),O
",",O
Chen,O
L(2,O
),O
",",O
Huang,O
H(3,O
),O
",",O
Li,O
C(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Chongqing,O
Three,O
Gorges,O
Central,O
Hospital,O
",",O
Chongqing,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
the,O
Second,O
Affiliated,O
Hospital,O
of,O
Chongqing,O
Medical,O
"
",O
University,O
",",O
Chongqing,O
",",O
China,O
.,O
"
",O
(3)Office,O
of,O
Academic,O
Research,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
Chongqing,O
"
",O
Medical,O
University,O
",",O
Chongqing,O
",",O
China,O
.,O
"

",O
OBJECTIVES,O
:,O
To,O
investigate,O
the,O
chest,O
computed,O
tomography,O
(,O
CT,O
),O
findings,O
in,O
"
",O
patients,O
with,O
confirmed,O
corona,B-Disease_COVID-19
virus,I-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
and,O
to,O
evaluate,O
its,O
"
",O
relationship,O
with,O
clinical,O
features,O
.,O
"
",O
MATERIALS,O
AND,O
METHODS,O
:,O
Study,O
sample,O
consisted,O
of,O
80,O
patients,O
diagnosed,O
as,O
"
",O
COVID19,B-Disease_COVID-19
from,O
January,O
to,O
February,O
2020,O
.,O
The,O
chest,O
CT,O
images,O
and,O
clinical,O
data,O
"
",O
were,O
reviewed,O
and,O
the,O
relationship,O
between,O
them,O
was,O
analyzed,O
.,O
"
",O
RESULTS,O
:,O
Totally,O
80,O
patients,O
diagnosed,O
with,O
COVID19,B-Disease_COVID-19
were,O
included,O
.,O
With,O
regards,O
"
",O
to,O
the,O
clinical,O
manifestations,O
",",O
58,O
80,O
(,O
73,O
%,O
),O
of,O
patients,O
had,O
cough,O
",",O
61,O
80,O
(,O
76,O
%,O
),O
of,O
"
",O
patients,O
had,O
high,O
temperature,O
levels,O
.,O
The,O
most,O
frequent,O
CT,O
abnormalities,O
observed,O
"
",O
were,O
ground,O
glass,O
opacity,O
(,O
GGO,O
),O
(,O
73,O
80,O
cases,O
",",O
91,O
%,O
),O
",",O
consolidation,O
(,O
50,O
80,O
cases,O
",",O
"
",O
63,O
%,O
),O
and,O
interlobular,O
septal,O
thickening,O
(,O
47,O
80,O
",",O
59,O
%,O
),O
.,O
Most,O
of,O
the,O
lesions,O
were,O
"
",O
multiple,O
",",O
with,O
an,O
average,O
of,O
12Â±6,O
lung,O
segments,O
involved,O
.,O
The,O
most,O
common,O
"
",O
involved,O
lung,O
segments,O
were,O
the,O
dorsal,O
segment,O
of,O
the,O
right,O
lower,O
lobe,O
(,O
69,O
80,O
",",O
"
",O
86,O
%,O
),O
",",O
the,O
posterior,O
basal,O
segment,O
of,O
the,O
right,O
lower,O
lobe,O
(,O
68,O
80,O
",",O
85,O
%,O
),O
",",O
the,O
"
",O
lateral,O
basal,O
segment,O
of,O
the,O
right,O
lower,O
lobe,O
(,O
64,O
80,O
",",O
80,O
%,O
),O
",",O
the,O
dorsal,O
segment,O
of,O
"
",O
the,O
left,O
lower,O
lobe,O
(,O
61,O
80,O
",",O
76,O
%,O
),O
and,O
the,O
posterior,O
basal,O
segment,O
of,O
the,O
left,O
"
",O
lower,O
lobe,O
(,O
65,O
80,O
",",O
81,O
%,O
),O
.,O
The,O
average,O
pulmonary,O
inflammation,O
index,O
(,O
PII,O
),O
value,O
was,O
"
",O
(,O
34%Â±20,O
%,O
),O
for,O
all,O
the,O
patients,O
.,O
Correlation,O
analysis,O
showed,O
that,O
the,O
PII,O
value,O
"
",O
was,O
significantly,O
correlated,O
with,O
the,O
values,O
of,O
lymphocyte,O
count,O
",",O
monocyte,O
count,O
",",O
"
",O
Creactive,O
protein,O
",",O
procalcitonin,O
",",O
days,O
from,O
illness,O
onset,O
and,O
body,O
temperature,O
"
",O
(,O
p<0.05,O
),O
.,O
"
",O
CONCLUSION,O
:,O
The,O
common,O
chest,O
CT,O
findings,O
of,O
COVID19,B-Disease_COVID-19
are,O
multiple,O
GGO,O
",",O
"
",O
consolidation,O
and,O
interlobular,O
septal,O
thickening,O
in,O
both,O
lungs,O
",",O
which,O
are,O
mostly,O
"
",O
distributed,O
under,O
the,O
pleura,O
.,O
There,O
are,O
significant,O
correlations,O
between,O
the,O
"
",O
degree,O
of,O
pulmonary,O
inflammation,O
and,O
the,O
main,O
clinical,O
symptoms,O
and,O
laboratory,O
"
",O
results,O
.,O
CT,O
plays,O
an,O
important,O
role,O
in,O
the,O
diagnosis,O
and,O
evaluation,O
of,O
this,O
"
",O
emerging,O
global,O
health,O
emergency,O
.,O
"

",O
DOI,O
:,O
10.1097,O
RLI.0000000000000670,O
"
",O
PMID,O
:,O
32091414,O
"


",O
567,O
.,O
Elife,O
.,O
2020,O
Feb,O
24;9,O
.,O
pii,O
:,O
e55570,O
.,O
doi,O
:,O
10.7554,O
eLife.55570,O
.,O
"

",O
Estimated,O
effectiveness,O
of,O
symptom,O
and,O
risk,O
screening,O
to,O
prevent,O
the,O
spread,O
of,O
"
",O
COVID19,B-Disease_COVID-19
.,O
"

",O
Gostic,O
K(1,O
),O
",",O
Gomez,O
AC(2,O
),O
",",O
Mummah,O
RO(2,O
),O
",",O
Kucharski,O
AJ(3,O
),O
",",O
LloydSmith,O
JO(2)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Ecology,O
and,O
Evolution,O
",",O
University,O
of,O
Chicago,O
",",O
Chicago,O
",",O
United,O
"
",O
States,O
.,O
"
",O
(2)Department,O
of,O
Ecology,O
and,O
Evolutionary,O
Biology,O
",",O
University,O
of,O
California,O
",",O
Los,O
"
",O
Angeles,O
",",O
Los,O
Angeles,O
",",O
United,O
States,O
.,O
"
",O
(3)Department,O
of,O
Infectious,O
Disease,O
Epidemiology,O
",",O
London,O
School,O
of,O
Tropical,O
"
",O
Hygiene,O
and,O
Medicine,O
",",O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
(4)Fogarty,O
International,O
Center,O
",",O
National,O
Institutes,O
of,O
Health,O
",",O
Bethesda,O
",",O
United,O
"
",O
States,O
.,O
"

",O
Traveller,O
screening,O
is,O
being,O
used,O
to,O
limit,O
further,O
spread,O
of,O
COVID19,B-Disease_COVID-19
following,O
"
",O
its,O
recent,O
emergence,O
",",O
and,O
symptom,O
screening,O
has,O
become,O
a,O
ubiquitous,O
tool,O
in,O
the,O
"
",O
global,O
response,O
.,O
Previously,O
",",O
we,O
developed,O
a,O
mathematical,O
model,O
to,O
understand,O
"
",O
factors,O
governing,O
the,O
effectiveness,O
of,O
traveller,O
screening,O
to,O
prevent,O
spread,O
of,O
"
",O
emerging,O
pathogens,O
(,O
Gostic,O
et,O
al.,O
",",O
2015,O
),O
.,O
Here,O
",",O
we,O
estimate,O
the,O
impact,O
of,O
"
",O
different,O
screening,O
programs,O
given,O
current,O
knowledge,O
of,O
key,O
COVID19,B-Disease_COVID-19
life,O
history,O
"
",O
and,O
epidemiological,O
parameters,O
.,O
Even,O
under,O
bestcase,O
assumptions,O
",",O
we,O
estimate,O
"
",O
that,O
screening,O
will,O
miss,O
more,O
than,O
half,O
of,O
infected,O
people,O
.,O
Breaking,O
down,O
the,O
"
",O
factors,O
leading,O
to,O
screening,O
successes,O
and,O
failures,O
",",O
we,O
find,O
that,O
most,O
cases,O
"
",O
missed,O
by,O
screening,O
are,O
fundamentally,O
undetectable,O
",",O
because,O
they,O
have,O
not,O
yet,O
"
",O
developed,O
symptoms,O
and,O
are,O
unaware,O
they,O
were,O
exposed,O
.,O
Our,O
work,O
underscores,O
the,O
"
",O
need,O
for,O
measures,O
to,O
limit,O
transmission,O
by,O
individuals,O
who,O
become,O
ill,O
after,O
being,O
"
",O
missed,O
by,O
a,O
screening,O
program,O
.,O
These,O
findings,O
can,O
support,O
evidencebased,O
policy,O
"
",O
to,O
combat,O
the,O
spread,O
of,O
COVID19,B-Disease_COVID-19
",",O
and,O
prospective,O
planning,O
to,O
mitigate,O
future,O
"
",O
emerging,O
pathogens,O
.,O
"

",O
Â©,O
2020,O
",",O
Gostic,O
et,O
al.,O
"

",O
DOI,O
:,O
10.7554,O
eLife.55570,O
"
",O
PMCID,O
:,O
PMC7060038,O
"
",O
PMID,O
:,O
32091395,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
KG,O
",",O
AG,O
",",O
RM,O
",",O
AK,O
",",O
JL,O
No,O
competing,O
interests,O
"
",O
declared,O
"


",O
568,O
.,O
Emerg,O
Infect,O
Dis,O
.,O
2020,O
May,O
17;26(5,O
),O
.,O
doi,O
:,O
10.3201,O
eid2605.200198,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Potential,O
Presymptomatic,O
Transmission,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
Zhejiang,O
Province,O
",",O
China,O
",",O
"
",O
2020,O
.,O
"

",O
Tong,O
ZD,O
",",O
Tang,O
A,O
",",O
Li,O
KF,O
",",O
Li,O
P,O
",",O
Wang,O
HL,O
",",O
Yi,O
JP,O
",",O
Zhang,O
YL,O
",",O
Yan,O
JB,O
.,O
"

",O
We,O
report,O
a,O
2family,O
cluster,O
of,O
persons,O
infected,O
with,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
coronavirus,O
2,O
in,O
the,O
city,O
of,O
Zhoushan,O
",",O
Zhejiang,O
Province,O
",",O
China,O
",",O
during,O
"
",O
January,O
2020,O
.,O
The,O
infections,O
resulted,O
from,O
contact,O
with,O
an,O
infected,O
but,O
"
",O
potentially,O
presymptomatic,O
traveler,O
from,O
the,O
city,O
of,O
Wuhan,O
in,O
Hubei,O
Province,O
.,O
"

",O
DOI,O
:,O
10.3201,O
eid2605.200198,O
"
",O
PMID,O
:,O
32091386,O
"


",O
569,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
24,O
.,O
doi,O
:,O
10.1002,O
jmv.25720,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Facing,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
:,O
What,O
should,O
we,O
know,O
and,O
what,O
could,O
we,O
do,O
?,O
"

",O
Yang,O
Y(1,O
),O
",",O
Shang,O
W(1,O
),O
",",O
Rao,O
X(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Microbial,O
Engineering,O
under,O
the,O
Educational,O
Committee,O
in,O
"
",O
Chongqing,O
",",O
Department,O
of,O
Microbiology,O
",",O
College,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Army,O
"
",O
Medical,O
University,O
(,O
Third,O
Military,O
Medical,O
University,O
),O
",",O
Chongqing,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25720,O
"
",O
PMID,O
:,O
32091134,O
"


",O
570,O
.,O
Biosens,O
Bioelectron,O
.,O
2020,O
Feb,O
15;155:112101,O
.,O
doi,O
:,O
10.1016,O
j.bios.2020.112101,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Differential,O
diagnosis,O
of,O
PRVinfected,O
versus,O
vaccinated,O
pigs,O
using,O
a,O
novel,O
"
",O
EuNPsvirus,O
antigen,O
probebased,O
blocking,O
fluorescent,O
lateral,O
flow,O
immunoassay,O
.,O
"

",O
Chen,O
H(1,O
),O
",",O
Zhang,O
X(1,O
),O
",",O
Jin,O
Z(1,O
),O
",",O
Huang,O
L(1,O
),O
",",O
Dan,O
H(2,O
),O
",",O
Xiao,O
W(1,O
),O
",",O
Liang,O
J(1,O
),O
",",O
Zou,O
"
",O
S(1,O
),O
",",O
Tang,O
Y(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Bioengineering,O
",",O
Guangdong,O
Province,O
Engineering,O
Research,O
Center,O
"
",O
of,O
Antibody,O
Drug,O
and,O
Immunoassay,O
",",O
Jinan,O
University,O
",",O
Guangzhou,O
",",O
510632,O
",",O
PR,O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
PR,O
China,O
;,O
Wuhan,O
Keqian,O
"
",O
Biology,O
Co.,O
",",O
Ltd,O
",",O
Wuhan,O
",",O
430000,O
",",O
PR,O
China,O
.,O
"
",O
(3)Department,O
of,O
Bioengineering,O
",",O
Guangdong,O
Province,O
Engineering,O
Research,O
Center,O
"
",O
of,O
Antibody,O
Drug,O
and,O
Immunoassay,O
",",O
Jinan,O
University,O
",",O
Guangzhou,O
",",O
510632,O
",",O
PR,O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
tyjaq7926@163.com,O
.,O
"

",O
A,O
novel,O
timeresolved,O
fluorescence,O
blocking,O
lateral,O
flow,O
immunoassay,O
(,O
TRFBLFIA,O
),O
"
",O
was,O
developed,O
for,O
onsite,O
differential,O
diagnosis,O
of,O
pseudorabies,O
virus,O
"
",O
(PRV)infected,O
and,O
vaccinated,O
pigs,O
using,O
europium,O
nanoparticles,O
(EuNPs)labeled,O
"
",O
virion,O
antigens,O
and,O
high,O
titer,O
PRV,O
gE,O
monoclonal,O
antibodies,O
(,O
PRV,O
gEmAb,O
),O
.,O
Upon,O
"
",O
application,O
of,O
a,O
positive,O
serum,O
sample,O
",",O
the,O
specific,O
epitopes,O
of,O
gE,O
protein,O
on,O
"
",O
the,O
EuNPsPRV,O
probe,O
were,O
blocked,O
",",O
inhibiting,O
binding,O
to,O
the,O
PRV,O
gEmAb,O
on,O
the,O
T,O
"
",O
line,O
",",O
resulting,O
in,O
low,O
or,O
negligible,O
fluorescence,O
signal,O
",",O
whereas,O
when,O
a,O
negative,O
"
",O
sample,O
was,O
applied,O
",",O
EuNPsPRV,O
probes,O
would,O
be,O
able,O
to,O
bind,O
the,O
antibody,O
at,O
the,O
T,O
"
",O
line,O
",",O
leading,O
to,O
high,O
fluorescence,O
signal,O
.,O
Under,O
optimized,O
conditions,O
",",O
TRFBLFIA,O
"
",O
provided,O
excellent,O
sensitivity,O
and,O
selectivity,O
.,O
When,O
testing,O
swine,O
clinical,O
"
",O
samples,O
(,O
n,O
Â ,O
=,O
Â ,O
356,O
),O
",",O
there,O
was,O
96.1,O
%,O
agreement,O
between,O
this,O
method,O
and,O
a,O
most,O
"
",O
widely,O
used,O
commercial,O
gEELISA,O
kit,O
.,O
Moreover,O
",",O
our,O
method,O
was,O
rapid,O
(,O
15,O
Â ,O
min,O
),O
",",O
"
",O
costefficient,O
and,O
easy,O
to,O
operate,O
with,O
simple,O
training,O
",",O
allowing,O
for,O
onsite,O
"
",O
detection,O
.,O
Thus,O
",",O
TRFBLFIA,O
could,O
be,O
a,O
practical,O
tool,O
to,O
differentially,O
diagnose,O
"
",O
PRVinfected,O
and,O
vaccinated,O
pigs,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.bios.2020.112101,O
"
",O
PMID,O
:,O
32090873,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
The,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
known,O
competing,O
financial,O
interests,O
or,O
personal,O
"
",O
relationships,O
that,O
could,O
have,O
appeared,O
to,O
influence,O
the,O
work,O
reported,O
in,O
this,O
"
",O
paper,O
.,O
"


",O
571,O
.,O
Am,O
J,O
Transplant,O
.,O
2020,O
Mar;20(3):889895,O
.,O
doi,O
:,O
10.1111,O
ajt.15805,O
.,O
"

",O
Initial,O
public,O
health,O
response,O
and,O
interim,O
clinical,O
guidance,O
for,O
the,O
2019,O
novel,O
"
",O
coronavirus,O
outbreak,O
 ,O
United,O
States,O
",",O
December,O
31,O
",",O
2019February,O
4,O
",",O
2020,O
.,O
"

",O
Patel,O
A(1,O
),O
",",O
Jernigan,O
DB(1,O
),O
;,O
2019nCoV,B-Virus_SARS-CoV-2
CDC,O
Response,O
Team,O
.,O
"

",O
Collaborators,O
:,O
Abdirizak,O
F,O
",",O
Abedi,O
G,O
",",O
Aggarwal,O
S,O
",",O
Albina,O
D,O
",",O
Allen,O
E,O
",",O
Andersen,O
L,O
",",O
"
",O
Anderson,O
J,O
",",O
Anderson,O
M,O
",",O
Anderson,O
T,O
",",O
Anderson,O
K,O
",",O
Bardossy,O
AC,O
",",O
Barry,O
V,O
",",O
Beer,O
K,O
",",O
"
",O
Bell,O
M,O
",",O
Berger,O
S,O
",",O
Bertulfo,O
J,O
",",O
Biggs,O
H,O
",",O
Bornemann,O
J,O
",",O
Bornstein,O
J,O
",",O
Bower,O
W,O
",",O
Bresee,O
"
",O
J,O
",",O
Brown,O
C,O
",",O
Budd,O
A,O
",",O
Buigut,O
J,O
",",O
Burke,O
S,O
",",O
Burke,O
R,O
",",O
Burns,O
E,O
",",O
Butler,O
J,O
",",O
Cantrell,O
R,O
",",O
"
",O
Cardemil,O
C,O
",",O
Cates,O
J,O
",",O
Cetron,O
M,O
",",O
ChathamStephens,O
K,O
",",O
ChathamStevens,O
K,O
",",O
Chea,O
N,O
",",O
"
",O
Christensen,O
B,O
",",O
Chu,O
V,O
",",O
Clarke,O
K,O
",",O
Cleveland,O
A,O
",",O
Cohen,O
N,O
",",O
Cohen,O
M,O
",",O
Cohn,O
A,O
",",O
Collins,O
J,O
",",O
"
",O
Conners,O
E,O
",",O
Curns,O
A,O
",",O
Dahl,O
R,O
",",O
Daley,O
W,O
",",O
Dasari,O
V,O
",",O
Davlantes,O
E,O
",",O
Dawson,O
P,O
",",O
Delaney,O
L,O
",",O
"
",O
Donahue,O
M,O
",",O
Dowell,O
C,O
",",O
Dyal,O
J,O
",",O
Edens,O
W,O
",",O
Eidex,O
R,O
",",O
Epstein,O
L,O
",",O
Evans,O
M,O
",",O
Fagan,O
R,O
",",O
"
",O
Farris,O
K,O
",",O
Feldstein,O
L,O
",",O
Fox,O
L,O
",",O
Frank,O
M,O
",",O
Freeman,O
B,O
",",O
Fry,O
A,O
",",O
Fuller,O
J,O
",",O
Galang,O
R,O
",",O
"
",O
Gerber,O
S,O
",",O
Gokhale,O
R,O
",",O
Goldstein,O
S,O
",",O
Gorman,O
S,O
",",O
Gregg,O
W,O
",",O
Greim,O
W,O
",",O
Grube,O
S,O
",",O
Hall,O
A,O
",",O
"
",O
Haynes,O
A,O
",",O
Hill,O
S,O
",",O
HornsbyMyers,O
J,O
",",O
Hunter,O
J,O
",",O
Ionta,O
C,O
",",O
Isenhour,O
C,O
",",O
Jacobs,O
M,O
",",O
"
",O
Jacobs,O
Slifka,O
K,O
",",O
Jernigan,O
D,O
",",O
Jhung,O
M,O
",",O
JonesWormley,O
J,O
",",O
Kambhampati,O
A,O
",",O
Kamili,O
S,O
",",O
"
",O
Kennedy,O
P,O
",",O
Kent,O
C,O
",",O
Killerby,O
M,O
",",O
Kim,O
L,O
",",O
Kirking,O
H,O
",",O
Koonin,O
L,O
",",O
Koppaka,O
R,O
",",O
Kosmos,O
C,O
",",O
"
",O
Kuhar,O
D,O
",",O
KuhnertTallman,O
W,O
",",O
Kujawski,O
S,O
",",O
Kumar,O
A,O
",",O
Landon,O
A,O
",",O
Lee,O
L,O
",",O
Leung,O
J,O
",",O
"
",O
Lindstrom,O
S,O
",",O
LinkGelles,O
R,O
",",O
Lively,O
J,O
",",O
Lu,O
X,O
",",O
Lynch,O
B,O
",",O
Malapati,O
L,O
",",O
Mandel,O
S,O
",",O
Manns,O
"
",O
B,O
",",O
Marano,O
N,O
",",O
Marlow,O
M,O
",",O
Marston,O
B,O
",",O
McClung,O
N,O
",",O
McClure,O
L,O
",",O
McDonald,O
E,O
",",O
McGovern,O
O,O
",",O
"
",O
Messonnier,O
N,O
",",O
Midgley,O
C,O
",",O
Moulia,O
D,O
",",O
Murray,O
J,O
",",O
Noelte,O
K,O
",",O
NoonanSmith,O
M,O
",",O
Nordlund,O
"
",O
K,O
",",O
Norton,O
E,O
",",O
Oliver,O
S,O
",",O
Pallansch,O
M,O
",",O
Parashar,O
U,O
",",O
Patel,O
A,O
",",O
Patel,O
M,O
",",O
Pettrone,O
K,O
",",O
"
",O
Pierce,O
T,O
",",O
Pietz,O
H,O
",",O
Pillai,O
S,O
",",O
Radonovich,O
L,O
",",O
ReaganSteiner,O
S,O
",",O
Reel,O
A,O
",",O
Reese,O
H,O
",",O
Rha,O
"
",O
B,O
",",O
Ricks,O
P,O
",",O
Rolfes,O
M,O
",",O
Roohi,O
S,O
",",O
Roper,O
L,O
",",O
Rotz,O
L,O
",",O
Routh,O
J,O
",",O
Sakthivel,O
SK,O
",",O
Sarmiento,O
"
",O
L,O
",",O
Schindelar,O
J,O
",",O
Schneider,O
E,O
",",O
Schuchat,O
A,O
",",O
Scott,O
S,O
",",O
Shetty,O
V,O
",",O
Shockey,O
C,O
",",O
Shugart,O
"
",O
J,O
",",O
Stenger,O
M,O
",",O
Stuckey,O
M,O
",",O
Sunshine,O
B,O
",",O
Sykes,O
T,O
",",O
Uyeki,O
T,O
",",O
Vahey,O
G,O
",",O
Valderrama,O
A,O
",",O
"
",O
Villanueva,O
J,O
",",O
Walker,O
T,O
",",O
Wallace,O
M,O
",",O
Wang,O
L,O
",",O
Watson,O
J,O
",",O
Weber,O
A,O
",",O
Weinbaum,O
C,O
",",O
Weldon,O
"
",O
W,O
",",O
Westnedge,O
C,O
",",O
Whitaker,O
B,O
",",O
Whitaker,O
M,O
",",O
Williams,O
A,O
",",O
Willams,O
I,O
",",O
Wong,O
K,O
",",O
Xie,O
A,O
",",O
"
",O
Yousef,O
A.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Incident,O
Manager,O
",",O
2019nCoV,B-Virus_SARS-CoV-2
CDC,O
Response,O
",",O
CDC,O
.,O
"

",O
DOI,O
:,O
10.1111,O
ajt.15805,O
"
",O
PMID,O
:,O
32090470,O
"


",O
572,O
.,O
Protein,O
Cell,O
.,O
2020,O
Feb,O
22,O
.,O
doi,O
:,O
10.1007,O
s1323802000693y,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Puzzle,O
of,O
highly,O
pathogenic,O
human,O
coronaviruses,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
"

",O
Li,O
J(1)(2,O
),O
",",O
Liu,O
W(3)(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)CAS,O
Key,O
Laboratory,O
of,O
Pathogenic,O
Microbiology,O
and,O
Immunology,O
",",O
Institute,O
of,O
"
",O
Microbiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100101,O
",",O
China,O
.,O
lj418@163.com,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100049,O
",",O
China,O
.,O
"
",O
lj418@163.com,O
.,O
"
",O
(3)CAS,O
Key,O
Laboratory,O
of,O
Pathogenic,O
Microbiology,O
and,O
Immunology,O
",",O
Institute,O
of,O
"
",O
Microbiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100101,O
",",O
China,O
.,O
"
",O
liuwj@im.ac.cn,O
.,O
"
",O
(4)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100049,O
",",O
China,O
.,O
"
",O
liuwj@im.ac.cn,O
.,O
"
",O
(5)Institute,O
of,O
Microbiology,O
",",O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
"
",O
of,O
Sciences,O
",",O
Beijing,O
",",O
100101,O
",",O
China,O
.,O
liuwj@im.ac.cn,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s1323802000693y,O
"
",O
PMID,O
:,O
32088858,O
"


",O
573,O
.,O
Eur,O
J,O
Nucl,O
Med,O
Mol,O
Imaging,O
.,O
2020,O
Feb,O
22,O
.,O
doi,O
:,O
10.1007,O
s0025902004734w,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
18FFDG,O
PET,O
CT,O
findings,O
of,O
COVID19,B-Disease_COVID-19
:,O
a,O
series,O
of,O
four,O
highly,O
suspected,O
cases,O
.,O
"

",O
Qin,O
C(1)(2,O
),O
",",O
Liu,O
F(1)(2,O
),O
",",O
Yen,O
TC(3,O
),O
",",O
Lan,O
X(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Nuclear,O
Medicine,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
No.,O
1277,O
Jiefang,O
Ave,O
",",O
Wuhan,O
",",O
"
",O
430022,O
",",O
China,O
.,O
"
",O
(2)Hubei,O
Province,O
Key,O
Laboratory,O
of,O
Molecular,O
Imaging,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Nuclear,O
Medicine,O
and,O
Molecular,O
Imaging,O
Center,O
",",O
Linkou,O
Chang,O
Gung,O
"
",O
Memorial,O
Hospital,O
and,O
Chang,O
Gung,O
University,O
",",O
Taoyuan,O
",",O
Taiwan,O
.,O
"
",O
yentc1110@gmail.com,O
.,O
"
",O
(4)Department,O
of,O
Nuclear,O
Medicine,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
No.,O
1277,O
Jiefang,O
Ave,O
",",O
Wuhan,O
",",O
"
",O
430022,O
",",O
China,O
.,O
xiaoli_lan@hust.edu.cn,O
.,O
"
",O
(5)Hubei,O
Province,O
Key,O
Laboratory,O
of,O
Molecular,O
Imaging,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
xiaoli_lan@hust.edu.cn,O
.,O
"

",O
PURPOSE,O
:,O
The,O
aim,O
of,O
this,O
case,O
series,O
is,O
to,O
illustrate,O
the,O
18FFDG,O
PET,O
CT,O
findings,O
"
",O
of,O
patients,O
with,O
acute,O
respiratory,O
disease,O
caused,O
by,O
COVID19,B-Disease_COVID-19
in,O
Wuhan,O
",",O
Hubei,O
"
",O
province,O
of,O
China,O
.,O
"
",O
METHODS,O
:,O
We,O
describe,O
the,O
18FFDG,O
PET,O
CT,O
results,O
from,O
four,O
patients,O
who,O
were,O
"
",O
admitted,O
to,O
the,O
hospital,O
with,O
respiratory,O
symptoms,O
and,O
fever,O
between,O
January,O
13,O
"
",O
and,O
January,O
20,O
",",O
2020,O
",",O
when,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
was,O
still,O
unrecognized,O
and,O
the,O
"
",O
virus,O
infectivity,O
was,O
unknown,O
.,O
A,O
retrospective,O
review,O
of,O
the,O
patients,O
',O
medical,O
"
",O
history,O
",",O
clinical,O
and,O
laboratory,O
data,O
",",O
as,O
well,O
as,O
imaging,O
findings,O
strongly,O
"
",O
suggested,O
a,O
diagnosis,O
of,O
COVID19,B-Disease_COVID-19
.,O
"
",O
RESULTS,O
:,O
All,O
patients,O
had,O
peripheral,O
groundglass,O
opacities,O
and,O
or,O
lung,O
"
",O
consolidations,O
in,O
more,O
than,O
two,O
pulmonary,O
lobes,O
.,O
Lung,O
lesions,O
were,O
characterized,O
"
",O
by,O
a,O
high,O
18FFDG,O
uptake,O
and,O
there,O
was,O
evidence,O
of,O
lymph,O
node,O
involvement,O
.,O
"
",O
Conversely,O
",",O
disseminated,O
disease,O
was,O
absent,O
",",O
a,O
finding,O
suggesting,O
that,O
COVID19,B-Disease_COVID-19
"
",O
has,O
pulmonary,O
tropism,O
.,O
"
",O
CONCLUSIONS,O
:,O
Although,O
18FFDG,O
PET,O
CT,O
can,O
not,O
be,O
routinely,O
used,O
in,O
an,O
emergency,O
"
",O
setting,O
and,O
is,O
generally,O
not,O
recommended,O
for,O
infectious,O
diseases,O
",",O
our,O
pilot,O
data,O
"
",O
shed,O
light,O
on,O
the,O
potential,O
clinical,O
utility,O
of,O
this,O
imaging,O
technique,O
in,O
the,O
"
",O
differential,O
diagnosis,O
of,O
complex,O
cases,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s0025902004734w,O
"
",O
PMID,O
:,O
32088847,O
"


",O
574,O
.,O
J,O
Infect,O
Dev,O
Ctries,O
.,O
2019,O
Dec,O
31;13(12):11351141,O
.,O
doi,O
:,O
10.3855,O
jidc.11549,O
.,O
"

",O
A,O
quite,O
sensitive,O
fluorescent,O
loopmediated,O
isothermal,O
amplification,O
for,O
rapid,O
"
",O
detection,O
of,O
respiratory,O
syncytial,O
virus,O
.,O
"

",O
Hu,O
Y(1,O
),O
",",O
Wan,O
Z(2,O
),O
",",O
Mu,O
Y(3,O
),O
",",O
Zhou,O
Y(4,O
),O
",",O
Liu,O
J(5,O
),O
",",O
Lan,O
K(6,O
),O
",",O
Zhang,O
C(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Pathogen,O
Discovery,O
and,O
Big,O
Data,O
Center,O
",",O
Institut,O
Pasteur,O
of,O
Shanghai,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
Shanghai,O
",",O
China,O
.,O
yhhu@ips.ac.cn,O
.,O
"
",O
(2)Medical,O
Laboratory,O
of,O
Taizhou,O
Fourth,O
People,O
's,O
Hospital,O
",",O
Taizhou,O
",",O
China,O
.,O
"
",O
wanlv@126.com,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Computational,O
Biology,O
",",O
Chinese,O
Academy,O
of,O
SciencesMax,O
"
",O
Planck,O
Partner,O
Institute,O
for,O
Computational,O
Biology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
"
",O
Shanghai,O
",",O
China,O
.,O
muyonglin@picb.ac.cn,O
.,O
"
",O
(4)Pathogen,O
Discovery,O
and,O
Big,O
Data,O
Center,O
",",O
Institut,O
Pasteur,O
of,O
Shanghai,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
Shanghai,O
",",O
China,O
.,O
yizhou@ips.ac.cn,O
.,O
"
",O
(5)Pathogen,O
Discovery,O
and,O
Big,O
Data,O
Center,O
",",O
Institut,O
Pasteur,O
of,O
Shanghai,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
Shanghai,O
",",O
China,O
.,O
liuj@yiruibio.com.cn,O
.,O
"
",O
(6)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Medical,O
Research,O
"
",O
Institute,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
klan@whu.edu.cn,O
.,O
"
",O
(7)Pathogen,O
Discovery,O
and,O
Big,O
Data,O
Center,O
",",O
Institut,O
Pasteur,O
of,O
Shanghai,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
Shanghai,O
",",O
China,O
.,O
zhangcy1999@ips.ac.cn,O
.,O
"

",O
INTRODUCTION,O
:,O
Human,O
respiratory,O
syncytial,O
virus,O
(,O
hRSV,O
),O
is,O
a,O
common,O
respiratory,O
"
",O
virus,O
closely,O
related,O
to,O
respiratory,O
tract,O
infection,O
(,O
RTI,O
),O
.,O
Rapid,O
and,O
accurate,O
"
",O
detection,O
of,O
hRSV,O
is,O
urgently,O
needed,O
to,O
reduce,O
the,O
high,O
morbidity,O
and,O
mortality,O
"
",O
due,O
to,O
hRSV,O
infection,O
.,O
"
",O
METHODOLOGY,O
:,O
Here,O
",",O
we,O
established,O
a,O
highly,O
sensitive,O
and,O
specific,O
"
",O
reversetranscription,O
loopmediated,O
isothermal,O
amplification,O
(,O
RTLAMP,O
),O
assay,O
for,O
"
",O
the,O
rapid,O
detection,O
of,O
A,O
and,O
B,O
group,O
hRSV,O
simultaneously,O
.,O
The,O
specific,O
primer,O
"
",O
sets,O
for,O
hRSV,O
A,O
and,O
B,O
groups,O
were,O
designed,O
in,O
the,O
M,O
and,O
M22,O
gene,O
",",O
respectively,O
.,O
"
",O
SYTO,O
9,O
was,O
used,O
as,O
the,O
fluorescent,O
dye,O
for,O
realtime,O
monitoring,O
of,O
the,O
"
",O
amplification,O
of,O
hRSV,O
RNA,O
without,O
cross,O
reaction,O
between,O
hRSV,O
A,O
and,O
B.,O
"
",O
RESULTS,O
:,O
The,O
limit,O
of,O
detection,O
(,O
LOD,O
),O
of,O
our,O
new,O
method,O
was,O
281.17,O
50,O
%,O
tissue,O
"
",O
culture,O
infective,O
doses,O
(,O
TCID50,O
),O
mL,O
for,O
hRSV,O
A,O
and,O
1.58,O
TCID50,O
mL,O
for,O
hRSV,O
B.,O
"
",O
Using,O
90,O
clinical,O
samples,O
",",O
a,O
comparison,O
to,O
traditional,O
RTPCR,O
was,O
performed,O
to,O
"
",O
validate,O
this,O
assay,O
.,O
The,O
positivity,O
rate,O
of,O
RTLAMP,O
and,O
RTPCR,O
were,O
67.8,O
%,O
and,O
"
",O
55.6,O
%,O
",",O
respectively,O
",",O
and,O
the,O
positivity,O
rate,O
of,O
RTLAMP,O
was,O
significantly,O
higher,O
"
",O
than,O
RTPCR,O
(,O
Ï‡2,O
test,O
",",O
P,O
<,O
0.01,O
),O
.,O
"
",O
CONCLUSIONS,O
:,O
Compared,O
with,O
traditional,O
RTPCR,O
method,O
",",O
the,O
newly,O
developed,O
"
",O
fluorescent,O
RTLAMP,O
combined,O
with,O
welldesigned,O
primers,O
and,O
SYTO,O
9,O
is,O
quite,O
"
",O
sensitive,O
",",O
specific,O
",",O
rapid,O
and,O
well,O
applicable,O
to,O
hRSV,O
clinical,O
diagnosis,O
.,O
"

",O
Copyright,O
(,O
c,O
),O
2019,O
Yihong,O
Hu,O
",",O
Zhenzhou,O
Wan,O
",",O
Yonglin,O
Mu,O
",",O
Yi,O
Zhou,O
",",O
Jia,O
Liu,O
",",O
Ke,O
Lan,O
",",O
"
",O
Chiyu,O
Zhang,O
.,O
"

",O
DOI,O
:,O
10.3855,O
jidc.11549,O
"
",O
PMID,O
:,O
32088701,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
No,O
Conflict,O
of,O
Interest,O
is,O
declared,O
"


",O
575,O
.,O
J,O
Infect,O
Dev,O
Ctries,O
.,O
2020,O
Jan,O
31;14(1):317,O
.,O
doi,O
:,O
10.3855,O
jidc.12425,O
.,O
"

",O
2019nCoV,B-Virus_SARS-CoV-2
(,O
Wuhan,B-Virus_SARS-CoV-2
virus,I-Virus_SARS-CoV-2
),O
",",O
a,O
novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
:,O
humantohuman,O
transmission,O
",",O
"
",O
travelrelated,O
cases,O
",",O
and,O
vaccine,O
readiness,O
.,O
"

",O
Ralph,O
R(1,O
),O
",",O
Lew,O
J(2,O
),O
",",O
Zeng,O
T(3,O
),O
",",O
Francis,O
M(4,O
),O
",",O
Xue,O
B(5,O
),O
",",O
Roux,O
M(6,O
),O
",",O
Toloue,O
"
",O
Ostadgavahi,O
A(7,O
),O
",",O
Rubino,O
S(8,O
),O
",",O
Dawe,O
NJ(9,O
),O
",",O
AlAhdal,O
MN(10,O
),O
",",O
Kelvin,O
DJ(11,O
),O
",",O
"
",O
Richardson,O
CD(12,O
),O
",",O
Kindrachuk,O
J(13,O
),O
",",O
Falzarano,O
D(14,O
),O
",",O
Kelvin,O
AA(15,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Vaccine,O
and,O
Infectious,O
Disease,O
Organization,O
 ,O
International,O
Vaccine,O
Centre,O
"
",O
(,O
VIDOInterVac,O
),O
",",O
Saskatoon,O
",",O
Saskatchewan,O
",",O
Canada,O
.,O
robyn.ralph@usask.ca,O
.,O
"
",O
(2)Vaccine,O
and,O
Infectious,O
Disease,O
Organization,O
 ,O
International,O
Vaccine,O
Centre,O
"
",O
(,O
VIDOInterVac,O
),O
",",O
Saskatoon,O
",",O
Saskatchewan,O
",",O
Canada,O
.,O
jocelyne.lew@usask.ca,O
.,O
"
",O
(3)International,O
Institute,O
of,O
Infection,O
and,O
Immunity,O
",",O
Shantou,O
University,O
Medical,O
"
",O
College,O
",",O
Shantou,O
",",O
Guangdong,O
",",O
China,O
.,O
allenzengts@126.com,O
.,O
"
",O
(4)Department,O
of,O
Microbiology,O
and,O
Immunology,O
",",O
Faculty,O
of,O
Medicine,O
",",O
Dalhousie,O
"
",O
University,O
",",O
Halifax,O
",",O
Nova,O
Scotia,O
",",O
Canada,O
.,O
m.francis@dal.ca,O
.,O
"
",O
(5)International,O
Institute,O
of,O
Infection,O
and,O
Immunity,O
",",O
Shantou,O
University,O
Medical,O
"
",O
College,O
",",O
Shantou,O
",",O
Guangdong,O
",",O
China,O
.,O
bz520251@dal.ca,O
.,O
"
",O
(6)Department,O
of,O
Microbiology,O
and,O
Immunology,O
",",O
Faculty,O
of,O
Medicine,O
",",O
Dalhousie,O
"
",O
University,O
",",O
Halifax,O
",",O
Nova,O
Scotia,O
",",O
Canada,O
.,O
melissa.rioux@dal.ca,O
.,O
"
",O
(7)Department,O
of,O
Microbiology,O
and,O
Immunology,O
",",O
Faculty,O
of,O
Medicine,O
",",O
Dalhousie,O
"
",O
University,O
",",O
Halifax,O
",",O
Nova,O
Scotia,O
",",O
Canada,O
.,O
Ali.Toloue@dal.ca,O
.,O
"
",O
(8)Sezione,O
di,O
Microbiologia,O
Sperimentale,O
e,O
Clinica,O
",",O
Dipartimento,O
di,O
Scienze,O
"
",O
Biomediche,O
",",O
UniversitÃ ,O
degli,O
Studi,O
di,O
Sassari,O
",",O
Sassari,O
",",O
Italy,O
.,O
rubino@uniss.it,O
.,O
"
",O
(9)Department,O
of,O
Microbiology,O
and,O
Immunology,O
",",O
Faculty,O
of,O
Medicine,O
",",O
Dalhousie,O
"
",O
University,O
",",O
Halifax,O
",",O
Nova,O
Scotia,O
",",O
Canada,O
.,O
nc350339@dal.ca,O
.,O
"
",O
(10)Department,O
of,O
Infection,O
and,O
Immunity,O
",",O
King,O
Faisal,O
Specialist,O
Hospital,O
and,O
"
",O
Research,O
Center,O
",",O
Riyadh,O
",",O
Saudi,O
Arabia,O
.,O
profahdal@gmail.com,O
.,O
"
",O
(11)International,O
Institute,O
of,O
Infection,O
and,O
Immunity,O
",",O
Shantou,O
University,O
Medical,O
"
",O
College,O
",",O
Shantou,O
",",O
Guangdong,O
",",O
China,O
.,O
dkelvin@jidc.org,O
.,O
"
",O
(12)Department,O
of,O
Microbiology,O
and,O
Immunology,O
",",O
Faculty,O
of,O
Medicine,O
",",O
Dalhousie,O
"
",O
University,O
",",O
Halifax,O
",",O
Nova,O
Scotia,O
",",O
Canada,O
.,O
chris.richardson@dal.ca,O
.,O
"
",O
(13)Laboratory,O
of,O
Emerging,O
and,O
ReEmerging,O
Viruses,O
",",O
Department,O
of,O
Medical,O
"
",O
Microbiology,O
",",O
University,O
of,O
Manitoba,O
",",O
Winnipeg,O
",",O
Manitoba,O
",",O
Canada,O
.,O
"
",O
kjk1642@gmail.com,O
.,O
"
",O
(14)Vaccine,O
and,O
Infectious,O
Disease,O
Organization,O
 ,O
International,O
Vaccine,O
Centre,O
"
",O
(,O
VIDOInterVac,O
),O
",",O
Saskatoon,O
",",O
Saskatchewan,O
",",O
Canada,O
.,O
darryl.falzarano@usask.ca,O
.,O
"
",O
(15)Department,O
of,O
Microbiology,O
and,O
Immunology,O
",",O
Faculty,O
of,O
Medicine,O
",",O
Dalhousie,O
"
",O
University,O
",",O
Halifax,O
",",O
Nova,O
Scotia,O
",",O
Canada,O
.,O
akelvin@jidc.org,O
.,O
"

",O
On,O
31,O
December,O
2019,O
the,O
Wuhan,O
Health,O
Commission,O
reported,O
a,O
cluster,O
of,O
atypical,O
"
",O
pneumonia,O
cases,O
that,O
was,O
linked,O
to,O
a,O
wet,O
market,O
in,O
the,O
city,O
of,O
Wuhan,O
",",O
China,O
.,O
The,O
"
",O
first,O
patients,O
began,O
experiencing,O
symptoms,O
of,O
illness,O
in,O
midDecember,O
2019,O
.,O
"
",O
Clinical,O
isolates,O
were,O
found,O
to,O
contain,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
with,O
similarity,O
to,O
"
",O
bat,O
coronaviruses,O
.,O
As,O
of,O
28,O
January,O
2020,O
",",O
there,O
are,O
in,O
excess,O
of,O
4500,O
"
",O
laboratoryconfirmed,O
cases,O
",",O
with,O
>,O
100,O
known,O
deaths,O
.,O
As,O
with,O
the,O
SARSCoV,O
",",O
"
",O
infections,O
in,O
children,O
appear,O
to,O
be,O
rare,O
.,O
Travelrelated,O
cases,O
have,O
been,O
"
",O
confirmed,O
in,O
multiple,O
countries,O
and,O
regions,O
outside,O
mainland,O
China,O
including,O
"
",O
Germany,O
",",O
France,O
",",O
Thailand,O
",",O
Japan,O
",",O
South,O
Korea,O
",",O
Vietnam,O
",",O
Canada,O
",",O
and,O
the,O
United,O
"
",O
States,O
",",O
as,O
well,O
as,O
Hong,O
Kong,O
and,O
Taiwan,O
.,O
Domestically,O
in,O
China,O
",",O
the,O
virus,O
has,O
"
",O
also,O
been,O
noted,O
in,O
several,O
cities,O
and,O
provinces,O
with,O
cases,O
in,O
all,O
but,O
one,O
"
",O
provinence,O
.,O
While,O
zoonotic,O
transmission,O
appears,O
to,O
be,O
the,O
original,O
source,O
of,O
"
",O
infections,O
",",O
the,O
most,O
alarming,O
development,O
is,O
that,O
humantohuman,O
transmission,O
is,O
"
",O
now,O
prevelant,O
.,O
Of,O
particular,O
concern,O
is,O
that,O
many,O
healthcare,O
workers,O
have,O
been,O
"
",O
infected,O
in,O
the,O
current,O
epidemic,O
.,O
There,O
are,O
several,O
critical,O
clinical,O
questions,O
"
",O
that,O
need,O
to,O
be,O
resolved,O
",",O
including,O
how,O
efficient,O
is,O
humantohuman,O
transmission,O
?,O
"
",O
What,O
is,O
the,O
animal,O
reservoir,O
?,O
Is,O
there,O
an,O
intermediate,O
animal,O
reservoir,O
?,O
Do,O
the,O
"
",O
vaccines,O
generated,O
to,O
the,O
SARSCoV,O
or,O
MERSCoV,O
or,O
their,O
proteins,O
offer,O
protection,O
"
",O
against,O
2019nCoV,B-Virus_SARS-CoV-2
?,O
We,O
offer,O
a,O
research,O
perspective,O
on,O
the,O
next,O
steps,O
for,O
the,O
"
",O
generation,O
of,O
vaccines,O
.,O
We,O
also,O
present,O
data,O
on,O
the,O
use,O
of,O
in,O
silico,O
docking,O
in,O
"
",O
gaining,O
insight,O
into,O
2019nCoV,B-Virus_SARS-CoV-2
Spikereceptor,O
binding,O
to,O
aid,O
in,O
therapeutic,O
"
",O
development,O
.,O
Diagnostic,O
PCR,O
protocols,O
can,O
be,O
found,O
at,O
"
",O
https,O
:,O
 ,O
www.who.int,O
healthtopics,O
coronavirus,O
laboratorydiagnosticsfornovelco,O
"
",O
ronavirus,O
.,O
"

",O
Copyright,O
(,O
c,O
),O
2020,O
Robyn,O
Ralph,O
",",O
Jocelyn,O
Lew,O
",",O
Tiansheng,O
Zeng,O
",",O
Magie,O
Francis,O
",",O
Bei,O
"
",O
Xue,O
",",O
Melissa,O
Roux,O
",",O
Ali,O
Toloue,O
Ostadgavahi,O
",",O
Salvatore,O
Rubino,O
",",O
Mohammed,O
N,O
AlAhdal,O
",",O
"
",O
David,O
J,O
Kelvin,O
",",O
Christopher,O
D,O
Richardson,O
",",O
Jason,O
Kindrachuk,O
",",O
Darryl,O
Falzarano,O
",",O
"
",O
Alyson,O
Anne,O
Kelvin,O
.,O
"

",O
DOI,O
:,O
10.3855,O
jidc.12425,O
"
",O
PMID,O
:,O
32088679,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
No,O
Conflict,O
of,O
Interest,O
is,O
declared,O
"


",O
576,O
.,O
J,O
Infect,O
Dev,O
Ctries,O
.,O
2020,O
Jan,O
31;14(1):12,O
.,O
doi,O
:,O
10.3855,O
jidc.12496,O
.,O
"

",O
Fear,O
of,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
.,O
"

",O
Kelvin,O
DJ(1,O
),O
",",O
Rubino,O
S(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)International,O
Institute,O
of,O
Infection,O
and,O
Immunity,O
",",O
Shantou,O
University,O
Medical,O
"
",O
College,O
",",O
Shantou,O
",",O
Guangdong,O
",",O
China,O
;,O
and,O
Department,O
of,O
Microbiology,O
and,O
"
",O
Immunology,O
",",O
Faculty,O
of,O
Medicine,O
",",O
Dalhousie,O
University,O
",",O
Halifax,O
",",O
Nova,O
Scotia,O
",",O
"
",O
Canada,O
.,O
Canadian,O
Centre,O
for,O
Vaccinology,O
",",O
IWK,O
Health,O
Centre,O
",",O
Halifax,O
",",O
Nova,O
Scotia,O
",",O
"
",O
Canada,O
.,O
Senior,O
editor,O
",",O
JIDC,O
.,O
dkelvin@jidc.org,O
.,O
"
",O
(2)Dipartimento,O
di,O
Scienze,O
Biomediche,O
",",O
Universita,O
',O
degli,O
Studi,O
di,O
Sassari,O
",",O
"
",O
Sassari,O
",",O
Italy,O
.,O
EditorinChief,O
",",O
JIDC,O
.,O
srubino@jidc.org,O
.,O
"

",O
DOI,O
:,O
10.3855,O
jidc.12496,O
"
",O
PMID,O
:,O
32088678,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
No,O
Conflict,O
of,O
Interest,O
is,O
declared,O
"


",O
577,O
.,O
Int,O
J,O
Hyg,O
Environ,O
Health,O
.,O
2020,O
Feb,O
20;226:113490,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ijheh.2020.113490,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
First,O
respiratory,O
transmitted,O
food,O
borne,O
outbreak,O
?,O
"

",O
Jalava,O
K(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Mathematics,O
and,O
Statistics,O
(,O
Faculty,O
of,O
Social,O
Sciences,O
),O
",",O
"
",O
University,O
of,O
Helsinki,O
",",O
Finland,O
;,O
Department,O
of,O
Food,O
Hygiene,O
and,O
Environmental,O
"
",O
Health,O
(,O
Faculty,O
of,O
Veterinary,O
Medicine,O
),O
",",O
University,O
of,O
Helsinki,O
",",O
Finland,O
.,O
"
",O
Electronic,O
address,O
:,O
katriyalava@gmail.com,O
.,O
"

",O
The,O
world,O
is,O
faced,O
with,O
a,O
remarkable,O
coronavirus,O
outbreak,O
with,O
epicentre,O
in,O
"
",O
Wuhan,O
",",O
China,O
.,O
Altogether,O
40554,O
cases,O
have,O
been,O
confirmed,O
globally,O
with,O
novel,O
"
",O
coronavirus,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
until,O
February,O
10,O
",",O
2020,O
.,O
Rigorous,O
surveillance,O
in,O
other,O
"
",O
countries,O
is,O
required,O
to,O
prevent,O
further,O
global,O
expansion,O
of,O
the,O
outbreak,O
",",O
but,O
"
",O
resolving,O
the,O
exact,O
mechanism,O
of,O
the,O
initial,O
transmission,O
events,O
is,O
crucial,O
.,O
Most,O
"
",O
initial,O
cases,O
had,O
visited,O
Huanan,O
South,O
Seafood,O
Market,O
in,O
Wuhan,O
selling,O
also,O
"
",O
various,O
exotic,O
live,O
animals,O
.,O
Based,O
on,O
the,O
limited,O
initial,O
humantohuman,O
"
",O
transmission,O
and,O
timely,O
clustering,O
of,O
cases,O
in,O
Huanan,O
market,O
among,O
elderly,O
men,O
",",O
"
",O
coupled,O
with,O
knowledge,O
that,O
coronaviruses,O
are,O
derived,O
from,O
animals,O
and,O
"
",O
relationship,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
to,O
bat,O
coronavirus,O
",",O
zoonotic,O
transmission,O
in,O
the,O
first,O
"
",O
instance,O
is,O
probable,O
.,O
To,O
target,O
the,O
actions,O
",",O
similar,O
epidemiological,O
actions,O
to,O
"
",O
human,O
cases,O
are,O
needed,O
with,O
animal,O
or,O
food,O
exposures,O
.,O
According,O
to,O
current,O
"
",O
information,O
",",O
an,O
exceptionally,O
wide,O
contamination,O
of,O
seafood,O
market,O
might,O
explain,O
"
",O
the,O
initiation,O
of,O
the,O
SARSCoV2,B-Virus_SARS-CoV-2
outbreak,O
.,O
Seafood,O
tanks,O
",",O
air,O
contamination,O
by,O
"
",O
live,O
animals,O
or,O
rodents,O
are,O
possibilities,O
",",O
but,O
sold,O
animals,O
normally,O
come,O
from,O
"
",O
various,O
sources,O
.,O
The,O
mode,O
of,O
transmission,O
may,O
become,O
clearer,O
in,O
future,O
:,O
usually,O
"
",O
in,O
outbreak,O
investigations,O
",",O
hindsight,O
is,O
easy,O
",",O
but,O
for,O
now,O
information,O
about,O
the,O
"
",O
initial,O
source,O
of,O
this,O
outbreak,O
is,O
limited,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
GmbH.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijheh.2020.113490,O
"
",O
PMID,O
:,O
32088598,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
None,O
.,O
"


",O
578,O
.,O
Anaesth,O
Crit,O
Care,O
Pain,O
Med,O
.,O
2020,O
Feb,O
20,O
.,O
pii,O
:,O
S23525568(20)300291,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.accpm.2020.02.002,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
:,O
A,O
critical,O
care,O
perspective,O
informed,O
by,O
lessons,O
learnt,O
from,O
other,O
viral,O
"
",O
epidemics,O
.,O
"

",O
Ling,O
L(1,O
),O
",",O
Joynt,O
GM(2,O
),O
",",O
Lipman,O
J(3,O
),O
",",O
Constantin,O
JM(4,O
),O
",",O
JoannesBoyau,O
O(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Anaesthesia,O
and,O
Intensive,O
Care,O
",",O
The,O
Chinese,O
University,O
of,O
Hong,O
"
",O
Kong,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Anaesthesia,O
and,O
Intensive,O
Care,O
",",O
The,O
Chinese,O
University,O
of,O
Hong,O
"
",O
Kong,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
gavinmjoynt@cuhk.edu.hk,O
.,O
"
",O
(3)Intensive,O
Care,O
Services,O
",",O
Royal,O
Brisbane,O
and,O
Women,O
's,O
Hospital,O
;,O
The,O
University,O
"
",O
of,O
Queensland,O
Centre,O
for,O
Clinical,O
Research,O
",",O
Brisbane,O
",",O
Australia,O
;,O
NÃ®mes,O
University,O
"
",O
Hospital,O
",",O
University,O
of,O
Montpellier,O
",",O
NÃ®mes,O
",",O
France,O
.,O
"
",O
(4)Medecine,O
SorbonneUniversitÃ©,O
",",O
DMU,O
DREAM,O
",",O
APHP,O
Sorbonne,O
UniversitÃ©,O
",",O
"
",O
PitiÃ©SalpÃªtriÃ¨re,O
Hospital,O
",",O
Paris,O
",",O
France,O
;,O
GRC,O
ARPE,O
",",O
Medecine,O
"
",O
SorbonneUniversitÃ©,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(5)Service,O
d'AnesthÃ©sieRÃ©animation,O
Sud,O
",",O
Centre,O
MÃ©dicoChirurgical,O
Magellan,O
",",O
"
",O
Centre,O
Hospitalier,O
Universitaire,O
(,O
CHU,O
),O
de,O
Bordeaux,O
",",O
33000,O
",",O
Bordeaux,O
",",O
France,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.accpm.2020.02.002,O
"
",O
PMID,O
:,O
32088344,O
"


",O
579,O
.,O
Int,O
J,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
20,O
.,O
pii,O
:,O
S12019712(20)300837,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ijid.2020.02.025,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
basic,O
reproduction,O
number,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
estimation,O
based,O
"
",O
on,O
exponential,O
growth,O
in,O
the,O
early,O
outbreak,O
in,O
China,O
from,O
2019,O
to,O
2020,O
:,O
A,O
reply,O
"
",O
to,O
Dhungana,O
.,O
"

",O
Zhao,O
S(1,O
),O
",",O
Lin,O
Q(2,O
),O
",",O
Ran,O
J(3,O
),O
",",O
Musa,O
SS(4,O
),O
",",O
Yang,O
G(5,O
),O
",",O
Wang,O
W(6,O
),O
",",O
Lou,O
Y(7,O
),O
",",O
Gao,O
"
",O
D(8,O
),O
",",O
Yang,O
L(9,O
),O
",",O
He,O
D(10,O
),O
",",O
Wang,O
MH(11,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)JC,O
School,O
of,O
Public,O
Health,O
and,O
Primary,O
Care,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
",",O
China,O
;,O
Shenzhen,O
Research,O
Institute,O
of,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Shenzhen,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
zhaoshi.cmsa@gmail.com,O
.,O
"
",O
(2)Michigan,O
Institute,O
for,O
Data,O
Science,O
",",O
University,O
of,O
Michigan,O
",",O
Ann,O
Arbor,O
",",O
"
",O
Michigan,O
",",O
USA,O
.,O
Electronic,O
address,O
:,O
qianying.lin@connect.polyu.hk,O
.,O
"
",O
(3)School,O
of,O
Public,O
Health,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Hong,O
"
",O
Kong,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
jimran@connect.hku.hk,O
.,O
"
",O
(4)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
salihusabiu.musa@connect.polyu.hk,O
.,O
"
",O
(5)Department,O
of,O
Orthopaedics,O
and,O
Traumatology,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
",",O
China,O
;,O
SH,O
Ho,O
Scoliosis,O
Research,O
Lab,O
",",O
Joint,O
Scoliosis,O
Research,O
Center,O
"
",O
of,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
and,O
Nanjing,O
University,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
kennethgpy@link.cuhk.edu.hk,O
.,O
"
",O
(6)School,O
of,O
Mathematics,O
and,O
Statistics,O
",",O
Huaiyin,O
Normal,O
University,O
",",O
Huaian,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
weimingwang2003@163.com,O
.,O
"
",O
(7)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
yijun.lou@polyu.edu.hk,O
.,O
"
",O
(8)Department,O
of,O
Mathematics,O
",",O
Shanghai,O
Normal,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
dzgao@shnu.edu.cn,O
.,O
"
",O
(9)School,O
of,O
Nursing,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
l.yang@polyu.edu.hk,O
.,O
"
",O
(10)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
daihai.he@polyu.edu.hk,O
.,O
"
",O
(11)JC,O
School,O
of,O
Public,O
Health,O
and,O
Primary,O
Care,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
",",O
China,O
;,O
Shenzhen,O
Research,O
Institute,O
of,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Shenzhen,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
maggiew@cuhk.edu.hk,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijid.2020.02.025,O
"
",O
PMID,O
:,O
32088339,O
"


",O
580,O
.,O
Int,O
J,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
20,O
.,O
pii,O
:,O
S12019712(20)300825,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ijid.2020.02.024,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Comments,O
on,O
"""",O
Preliminary,O
estimation,O
of,O
the,O
basic,O
reproduction,O
number,O
of,O
novel,O
"
",O
Coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
in,O
China,O
",",O
from,O
2019,O
to,O
2020,O
:,O
A,O
datadriven,O
Analysis,O
in,O
"
",O
the,O
early,O
phase,O
of,O
the,O
outbreak,O
"""",O
.,O
"

",O
Dhungana,O
HN(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Mathematical,O
Science,O
",",O
University,O
of,O
Technology,O
Sydney,O
.,O
Electronic,O
"
",O
address,O
:,O
homnath.dhungana@uts.edu.au,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijid.2020.02.024,O
"
",O
PMID,O
:,O
32088335,O
"


",O
581,O
.,O
Microbes,O
Infect,O
.,O
2020,O
Feb,O
20,O
.,O
pii,O
:,O
S12864579(20)300320,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.micinf.2020.02.004,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Lessons,O
learned,O
from,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
epidemic,O
on,O
prevention,O
of,O
future,O
infectious,O
"
",O
diseases,O
.,O
"

",O
Pan,O
X(1,O
),O
",",O
Ojcius,O
DM(2,O
),O
",",O
Gao,O
T(3,O
),O
",",O
Li,O
Z(4,O
),O
",",O
Pan,O
C(5,O
),O
",",O
Pan,O
C(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Human,O
Resources,O
",",O
Shanghai,O
University,O
of,O
Finance,O
and,O
Economics,O
",",O
"
",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Biomedical,O
Sciences,O
",",O
University,O
of,O
the,O
Pacific,O
",",O
School,O
of,O
"
",O
Dentistry,O
",",O
San,O
Francisco,O
",",O
USA,O
.,O
"
",O
(3)Earl,O
Haig,O
Secondary,O
School,O
",",O
North,O
York,O
",",O
Ontario,O
",",O
Canada,O
.,O
"
",O
(4)Guangdong,O
Haid,O
Institute,O
of,O
Animal,O
Husbandry,O
&,O
Veterinary,O
",",O
Guangdong,O
"
",O
Provincial,O
Key,O
Laboratory,O
of,O
Research,O
on,O
the,O
Technology,O
of,O
Pigbreeding,O
and,O
"
",O
Pigdisease,O
Prevention,O
",",O
Haid,O
Research,O
Institute,O
",",O
Guangdong,O
Haid,O
Group,O
Co.,O
",",O
Ltd,O
",",O
"
",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(5)The,O
1st,O
Ward,O
of,O
the,O
Medical,O
Department,O
",",O
Affiliated,O
Cancer,O
Hospital,O
and,O
"
",O
Institute,O
of,O
Guangzhou,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
chhpan@163.com,O
.,O
"
",O
(6)Guangdong,O
Haid,O
Institute,O
of,O
Animal,O
Husbandry,O
&,O
Veterinary,O
",",O
Guangdong,O
"
",O
Provincial,O
Key,O
Laboratory,O
of,O
Research,O
on,O
the,O
Technology,O
of,O
Pigbreeding,O
and,O
"
",O
Pigdisease,O
Prevention,O
",",O
Haid,O
Research,O
Institute,O
",",O
Guangdong,O
Haid,O
Group,O
Co.,O
",",O
Ltd,O
",",O
"
",O
Guangzhou,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
chungenp@163.com,O
.,O
"

",O
Only,O
a,O
month,O
after,O
the,O
outbreak,O
of,O
pneumonia,B-Disease_COVID-19
caused,I-Disease_COVID-19
by,I-Disease_COVID-19
2019nCoV,I-Disease_COVID-19
",",O
more,O
than,O
"
",O
fortythousand,O
people,O
were,O
infected,O
.,O
This,O
put,O
enormous,O
pressure,O
on,O
the,O
Chinese,O
"
",O
government,O
",",O
medical,O
healthcare,O
provider,O
",",O
and,O
the,O
general,O
public,O
",",O
but,O
also,O
made,O
"
",O
the,O
international,O
community,O
deeply,O
nervous,O
.,O
On,O
the,O
25th,O
day,O
after,O
the,O
outbreak,O
",",O
"
",O
the,O
Chinese,O
government,O
implemented,O
strict,O
traffic,O
restrictions,O
on,O
the,O
area,O
where,O
"
",O
the,O
2019nCoV,B-Virus_SARS-CoV-2
had,O
originatedHubei,O
province,O
",",O
whose,O
capital,O
city,O
is,O
Wuhan,O
.,O
Ten,O
"
",O
days,O
later,O
",",O
the,O
rate,O
of,O
increase,O
of,O
cases,O
in,O
Hubei,O
showed,O
a,O
significant,O
"
",O
difference,O
(,O
p,O
Â ,O
=,O
Â ,O
0.0001,O
),O
compared,O
with,O
the,O
total,O
rate,O
of,O
increase,O
in,O
other,O
"
",O
provinces,O
of,O
China,O
.,O
These,O
preliminary,O
data,O
suggest,O
the,O
effectiveness,O
of,O
a,O
traffic,O
"
",O
restriction,O
policy,O
for,O
this,O
pandemic,O
thus,O
far,O
.,O
At,O
the,O
same,O
time,O
",",O
solid,O
financial,O
"
",O
support,O
and,O
improved,O
research,O
ability,O
",",O
along,O
with,O
network,O
communication,O
"
",O
technology,O
",",O
also,O
greatly,O
facilitated,O
the,O
application,O
of,O
epidemic,O
prevention,O
"
",O
measures,O
.,O
These,O
measures,O
were,O
motivated,O
by,O
the,O
need,O
to,O
provide,O
effective,O
"
",O
treatment,O
of,O
patients,O
",",O
and,O
involved,O
consultation,O
with,O
three,O
major,O
groups,O
in,O
"
",O
policy,O
formulationpublic,O
health,O
experts,O
",",O
the,O
government,O
",",O
and,O
the,O
general,O
public,O
.,O
"
",O
It,O
was,O
also,O
aided,O
by,O
media,O
and,O
information,O
technology,O
",",O
as,O
well,O
as,O
international,O
"
",O
cooperation,O
.,O
This,O
experience,O
will,O
provide,O
China,O
and,O
other,O
countries,O
with,O
valuable,O
"
",O
lessons,O
for,O
quickly,O
coordinating,O
and,O
coping,O
with,O
future,O
public,O
health,O
"
",O
emergencies,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Institut,O
Pasteur,O
.,O
Published,O
by,O
Elsevier,O
Masson,O
SAS,O
.,O
All,O
rights,O
"
",O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.micinf.2020.02.004,O
"
",O
PMID,O
:,O
32088333,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
582,O
.,O
J,O
Ethnopharmacol,O
.,O
2020,O
Feb,O
20:112611,O
.,O
doi,O
:,O
10.1016,O
j.jep.2020.112611,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
The,O
Chinese,O
herbal,O
prescription,O
JZ1,O
induces,O
autophagy,O
to,O
protect,O
against,O
herpes,O
"
",O
simplex,O
Virus2,O
in,O
human,O
vaginal,O
epithelial,O
cells,O
by,O
inhibiting,O
the,O
PI3,O
K,O
Akt,O
mTOR,O
"
",O
pathway,O
.,O
"

",O
Shao,O
Q(1,O
),O
",",O
Liu,O
T(2,O
),O
",",O
Wang,O
W(3,O
),O
",",O
Duan,O
Q(4,O
),O
",",O
Liu,O
T(5,O
),O
",",O
Xu,O
L(6,O
),O
",",O
Huang,O
G(7,O
),O
",",O
Chen,O
"
",O
Z(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Integrated,O
Traditional,O
Chinese,O
and,O
Western,O
Medicine,O
",",O
Tongji,O
"
",O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
430030,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
18202734254@163.com,O
.,O
"
",O
(2)Institute,O
of,O
Integrated,O
Traditional,O
Chinese,O
and,O
Western,O
Medicine,O
",",O
Tongji,O
"
",O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
430030,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
1922108215@qq.com,O
.,O
"
",O
(3)Institute,O
of,O
Integrated,O
Traditional,O
Chinese,O
and,O
Western,O
Medicine,O
",",O
Tongji,O
"
",O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
430030,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
1098738840@qq.com,O
.,O
"
",O
(4)Institute,O
of,O
Integrated,O
Traditional,O
Chinese,O
and,O
Western,O
Medicine,O
",",O
Tongji,O
"
",O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
430030,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
540740962@qq.com,O
.,O
"
",O
(5)Institute,O
of,O
Integrated,O
Traditional,O
Chinese,O
and,O
Western,O
Medicine,O
",",O
Tongji,O
"
",O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
430030,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
18338981233@163.com,O
.,O
"
",O
(6)Institute,O
of,O
Integrated,O
Traditional,O
Chinese,O
and,O
Western,O
Medicine,O
",",O
Tongji,O
"
",O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
430030,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
979883165@qq.com,O
.,O
"
",O
(7)Department,O
of,O
Integrated,O
Traditional,O
Chinese,O
and,O
Western,O
Medicine,O
",",O
Tongji,O
"
",O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
430030,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
gyhuang@tjh.tjmu.edu.cn,O
.,O
"
",O
(8)Institute,O
of,O
Integrated,O
Traditional,O
Chinese,O
and,O
Western,O
Medicine,O
",",O
Tongji,O
"
",O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
430030,O
",",O
China,O
;,O
Department,O
of,O
Integrated,O
Traditional,O
Chinese,O
and,O
Western,O
"
",O
Medicine,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
"
",O
and,O
Technology,O
",",O
Wuhan,O
",",O
430030,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
chenz@tjh.tjmu.edu.cn,O
.,O
"

",O
ETHNOPHAMACOLOGICAL,O
RELEVANCE,O
:,O
The,O
Chinese,O
herbal,O
prescription,O
JieZe1,O
(,O
JZ1,O
),O
is,O
"
",O
based,O
on,O
the,O
modification,O
of,O
Yihuang,O
Tang,O
",",O
which,O
was,O
first,O
described,O
in,O
Fu,O
"
",O
Qingzhu,O
Nvke,O
by,O
the,O
famous,O
Qing,O
Dynasty,O
doctor,O
Shan,O
Fu,O
as,O
a,O
treatment,O
for,O
"
",O
leukorrheal,O
diseases,O
.,O
As,O
an,O
inhospital,O
preparation,O
",",O
JZ1,O
has,O
been,O
used,O
in,O
Tongji,O
"
",O
Hospital,O
for,O
many,O
years,O
to,O
treat,O
various,O
infectious,O
diseases,O
of,O
the,O
lower,O
female,O
"
",O
genital,O
tract,O
",",O
including,O
cervicitis,O
",",O
vaginitis,O
",",O
genital,O
herpes,O
and,O
condyloma,O
"
",O
acuminatum,O
.,O
Our,O
previous,O
studies,O
have,O
shown,O
that,O
JZ1,O
has,O
curative,O
effects,O
on,O
"
",O
Candida,O
albicans,O
",",O
Trichomonas,O
vaginalis,O
and,O
Ureaplasma,O
urealyticum,O
infections,O
.,O
"
",O
AIM,O
OF,O
THE,O
STUDY,O
:,O
Genital,O
herpes,O
is,O
among,O
the,O
most,O
common,O
sexually,O
transmitted,O
"
",O
diseases,O
(,O
STDs,O
),O
worldwide,O
and,O
is,O
mainly,O
caused,O
by,O
herpes,O
simplex,O
virus,O
type2,O
"
",O
(,O
HSV2,O
),O
.,O
Current,O
therapies,O
can,O
relieve,O
symptoms,O
in,O
patients,O
but,O
do,O
not,O
cure,O
or,O
"
",O
prevent,O
the,O
spread,O
of,O
the,O
virus,O
.,O
This,O
study,O
was,O
designed,O
to,O
investigate,O
the,O
"
",O
effect,O
of,O
JZ1,O
on,O
HSV2,O
infection,O
and,O
its,O
mechanism,O
",",O
which,O
is,O
based,O
on,O
autophagy,O
"
",O
induction,O
",",O
to,O
provide,O
new,O
ideas,O
and,O
a,O
basis,O
for,O
the,O
study,O
of,O
antiviral,O
drugs,O
.,O
"
",O
MATERIALS,O
AND,O
METHODS,O
:,O
Evaluation,O
of,O
the,O
antiviral,O
activity,O
of,O
JZ1,O
was,O
conducted,O
"
",O
by,O
MTT,O
assay,O
and,O
western,O
blotting,O
.,O
Then,O
",",O
Western,O
blot,O
and,O
immunofluorescence,O
"
",O
analyses,O
",",O
observations,O
through,O
transmission,O
electron,O
microscopy,O
and,O
experiments,O
"
",O
with,O
the,O
recombinant,O
lentivirus,O
vector,O
mRFPGFPLC3B,O
were,O
used,O
to,O
monitor,O
"
",O
autophagic,O
flux,O
in,O
VK2,O
E6E7,O
cells,O
.,O
To,O
explore,O
the,O
mechanism,O
by,O
which,O
JZ1,O
"
",O
regulates,O
autophagy,O
",",O
western,O
blotting,O
and,O
realtime,O
quantitative,O
PCR,O
(,O
qRTPCR,O
),O
"
",O
were,O
used,O
to,O
determine,O
the,O
expression,O
of,O
phosphoinositide,O
3kinase,O
"
",O
(,O
PI3,O
K,O
),O
Akt,O
mTOR,O
pathway,O
proteins,O
and,O
to,O
detect,O
changes,O
in,O
critical,O
molecules,O
in,O
"
",O
the,O
pathway,O
after,O
the,O
application,O
of,O
a,O
PI3,O
K,O
inhibitor,O
.,O
Additionally,O
",",O
the,O
mRNA,O
"
",O
expression,O
levels,O
of,O
inflammatory,O
cytokines,O
",",O
namely,O
",",O
IL6,O
",",O
IFNÎ±,O
",",O
IFNÎ²,O
and,O
"
",O
TNFÎ±,O
",",O
were,O
measured,O
with,O
qRTPCR,O
.,O
"
",O
RESULTS,O
:,O
HSV2,O
infection,O
inhibited,O
autophagy,O
in,O
the,O
VK2,O
E6E7,O
cells,O
.,O
Further,O
study,O
"
",O
revealed,O
that,O
the,O
activation,O
of,O
the,O
PI3,O
K,O
Akt,O
mTOR,O
pathway,O
induced,O
by,O
HSV2,O
"
",O
infection,O
may,O
result,O
in,O
the,O
blocked,O
autophagic,O
flux,O
and,O
inhibited,O
autophagosome,O
"
",O
and,O
autolysosome,O
formation,O
.,O
JZ1,O
exhibited,O
significant,O
antiviral,O
activity,O
in,O
the,O
"
",O
VK2,O
E6E7,O
cells,O
",",O
which,O
showed,O
increased,O
cell,O
vitality,O
and,O
reduced,O
viral,O
protein,O
"
",O
expression,O
",",O
namely,O
",",O
earliest,O
virusspecific,O
infected,O
cell,O
polypeptides,O
5,O
(,O
ICP5,O
),O
"
",O
and,O
glycoprotein,O
D,O
(,O
gD,O
),O
.,O
We,O
found,O
that,O
JZ1,O
treatment,O
inhibited,O
the,O
upregulation,O
"
",O
of,O
the,O
PI3,O
K,O
Akt,O
mTOR,O
pathway,O
proteins,O
and,O
promoted,O
autophagy,O
to,O
combat,O
HSV2,O
"
",O
infection,O
",",O
while,O
PI3,O
K,O
inhibitor,O
pretreatment,O
prevented,O
the,O
enhanced,O
autophagy,O
"
",O
induced,O
by,O
JZ1,O
.,O
Moreover,O
",",O
JZ1,O
attenuated,O
the,O
increase,O
in,O
inflammatory,O
cytokines,O
"
",O
that,O
had,O
been,O
induced,O
HSV2,O
infection,O
.,O
"
",O
CONCLUSION,O
:,O
Our,O
results,O
showed,O
that,O
JZ1,O
protects,O
against,O
HSV2,O
infection,O
",",O
and,O
"
",O
this,O
beneficial,O
effect,O
may,O
be,O
mediated,O
by,O
inducing,O
autophagy,O
via,O
inhibition,O
of,O
"
",O
the,O
PI3,O
K,O
Akt,O
mTOR,O
signaling,O
axis,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
B.V.,O
"

",O
DOI,O
:,O
10.1016,O
j.jep.2020.112611,O
"
",O
PMID,O
:,O
32088246,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
The,O
authors,O
"
",O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
583,O
.,O
Lancet,O
.,O
2020,O
Mar,O
14;395(10227):871877,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)304116,O
.,O
Epub,O
"
",O
2020,O
Feb,O
20,O
.,O
"

",O
Preparedness,O
and,O
vulnerability,O
of,O
African,O
countries,O
against,O
importations,O
of,O
"
",O
COVID19,B-Disease_COVID-19
:,O
a,O
modelling,O
study,O
.,O
"

",O
Gilbert,O
M(1,O
),O
",",O
Pullano,O
G(2,O
),O
",",O
Pinotti,O
F(3,O
),O
",",O
Valdano,O
E(4,O
),O
",",O
Poletto,O
C(3,O
),O
",",O
BoÃ«lle,O
"
",O
PY(3,O
),O
",",O
D'Ortenzio,O
E(5,O
),O
",",O
Yazdanpanah,O
Y(5,O
),O
",",O
Eholie,O
SP(6,O
),O
",",O
Altmann,O
M(7,O
),O
",",O
Gutierrez,O
"
",O
B(8,O
),O
",",O
Kraemer,O
MUG(9,O
),O
",",O
Colizza,O
V(10,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Spatial,O
Epidemiology,O
Laboratory,O
",",O
UniversitÃ©,O
Libre,O
de,O
Bruxelles,O
",",O
Brussels,O
",",O
"
",O
Belgium,O
;,O
Fonds,O
National,O
de,O
la,O
Recherche,O
Scientifiques,O
",",O
Brussels,O
",",O
Belgium,O
.,O
"
",O
(2)INSERM,O
",",O
Sorbonne,O
UniversitÃ©,O
",",O
Institut,O
Pierre,O
Louis,O
d'EpidÃ©miologie,O
et,O
de,O
SantÃ©,O
"
",O
Publique,O
",",O
Paris,O
",",O
France,O
;,O
Sociology,O
and,O
Economics,O
of,O
Networks,O
and,O
Services,O
"
",O
Laboratory,O
at,O
Orange,O
Experience,O
Design,O
Laboratory,O
Chatillion,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(3)INSERM,O
",",O
Sorbonne,O
UniversitÃ©,O
",",O
Institut,O
Pierre,O
Louis,O
d'EpidÃ©miologie,O
et,O
de,O
SantÃ©,O
"
",O
Publique,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(4)Center,O
for,O
Biomedical,O
Modeling,O
",",O
The,O
Semel,O
Institute,O
for,O
Neuroscience,O
and,O
Human,O
"
",O
Behavior,O
",",O
David,O
Geffen,O
School,O
of,O
Medicine,O
",",O
University,O
of,O
California,O
Los,O
Angeles,O
",",O
"
",O
LA,O
",",O
USA,O
.,O
"
",O
(5)Infection,O
",",O
Antimicrobials,O
",",O
Modelling,O
",",O
Evolution,O
",",O
INSERM,O
",",O
UniversitÃ©,O
de,O
Paris,O
",",O
"
",O
Paris,O
",",O
France,O
;,O
Bichat,O
Claude,O
Bernard,O
Hospital,O
",",O
Assistance,O
publiqueHÃ´pitaux,O
de,O
"
",O
Paris,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(6)Service,O
des,O
Maladies,O
Infectieuses,O
et,O
Tropicales,O
",",O
Centre,O
Hospitalier,O
"
",O
Universitaire,O
de,O
Treichville,O
",",O
Abidjan,O
",",O
CÃ´te,O
d'Ivoire,O
;,O
DÃ©partement,O
de,O
"
",O
DermatologieInfectiologie,O
",",O
UnitÃ©,O
de,O
Formation,O
et,O
de,O
Recherche,O
des,O
Sciences,O
"
",O
MÃ©dicales,O
",",O
UniversitÃ©,O
FÃ©lix,O
HouphouetBoigny,O
",",O
Abidjan,O
",",O
CÃ´te,O
d'Ivoire,O
.,O
"
",O
(7)IDLICMaladies,O
Infectieuses,O
Dans,O
Les,O
Pays,O
Ã ,O
Ressources,O
LimitÃ©es,O
",",O
INSERM,O
U1219,O
",",O
"
",O
Bordeaux,O
",",O
France,O
;,O
Bordeaux,O
Population,O
Health,O
",",O
University,O
of,O
Bordeaux,O
",",O
Bordeaux,O
",",O
"
",O
France,O
.,O
"
",O
(8)Department,O
of,O
Zoology,O
",",O
University,O
of,O
Oxford,O
",",O
Oxford,O
",",O
UK,O
.,O
"
",O
(9)Department,O
of,O
Zoology,O
",",O
University,O
of,O
Oxford,O
",",O
Oxford,O
",",O
UK,O
;,O
Harvard,O
Medical,O
"
",O
School,O
",",O
Harvard,O
University,O
",",O
Boston,O
",",O
MA,O
",",O
USA,O
;,O
Computational,O
Epidemiology,O
Group,O
",",O
"
",O
Boston,O
Children,O
's,O
Hospital,O
",",O
Boston,O
",",O
MA,O
",",O
USA,O
.,O
"
",O
(10)INSERM,O
",",O
Sorbonne,O
UniversitÃ©,O
",",O
Institut,O
Pierre,O
Louis,O
d'EpidÃ©miologie,O
et,O
de,O
"
",O
SantÃ©,O
Publique,O
",",O
Paris,O
",",O
France,O
.,O
Electronic,O
address,O
:,O
vittoria.colizza@inserm.fr,O
.,O
"

",O
BACKGROUND,O
:,O
The,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
2019,O
(,O
COVID19,B-Disease_COVID-19
),O
epidemic,O
has,O
spread,O
"
",O
from,O
China,O
to,O
25,O
countries,O
.,O
Local,O
cycles,O
of,O
transmission,O
have,O
already,O
occurred,O
in,O
"
",O
12,O
countries,O
after,O
case,O
importation,O
.,O
In,O
Africa,O
",",O
Egypt,O
has,O
so,O
far,O
confirmed,O
one,O
"
",O
case,O
.,O
The,O
management,O
and,O
control,O
of,O
COVID19,B-Disease_COVID-19
importations,O
heavily,O
rely,O
on,O
a,O
"
",O
country,O
's,O
health,O
capacity,O
.,O
Here,O
we,O
evaluate,O
the,O
preparedness,O
and,O
vulnerability,O
of,O
"
",O
African,O
countries,O
against,O
their,O
risk,O
of,O
importation,O
of,O
COVID19,B-Disease_COVID-19
.,O
"
",O
METHODS,O
:,O
We,O
used,O
data,O
on,O
the,O
volume,O
of,O
air,O
travel,O
departing,O
from,O
airports,O
in,O
the,O
"
",O
infected,O
provinces,O
in,O
China,O
and,O
directed,O
to,O
Africa,O
to,O
estimate,O
the,O
risk,O
of,O
"
",O
importation,O
per,O
country,O
.,O
We,O
determined,O
the,O
country,O
's,O
capacity,O
to,O
detect,O
and,O
"
",O
respond,O
to,O
cases,O
with,O
two,O
indicators,O
:,O
preparedness,O
",",O
using,O
the,O
WHO,O
International,O
"
",O
Health,O
Regulations,O
Monitoring,O
and,O
Evaluation,O
Framework,O
;,O
and,O
vulnerability,O
",",O
using,O
"
",O
the,O
Infectious,O
Disease,O
Vulnerability,O
Index,O
.,O
Countries,O
were,O
clustered,O
according,O
to,O
"
",O
the,O
Chinese,O
regions,O
contributing,O
most,O
to,O
their,O
risk,O
.,O
"
",O
FINDINGS,O
:,O
Countries,O
with,O
the,O
highest,O
importation,O
risk,O
(,O
ie,O
",",O
Egypt,O
",",O
Algeria,O
",",O
and,O
"
",O
South,O
Africa,O
),O
have,O
moderate,O
to,O
high,O
capacity,O
to,O
respond,O
to,O
outbreaks,O
.,O
Countries,O
"
",O
at,O
moderate,O
risk,O
(,O
ie,O
",",O
Nigeria,O
",",O
Ethiopia,O
",",O
Sudan,O
",",O
Angola,O
",",O
Tanzania,O
",",O
Ghana,O
",",O
and,O
"
",O
Kenya,O
),O
have,O
variable,O
capacity,O
and,O
high,O
vulnerability,O
.,O
We,O
identified,O
three,O
"
",O
clusters,O
of,O
countries,O
that,O
share,O
the,O
same,O
exposure,O
to,O
the,O
risk,O
originating,O
from,O
"
",O
the,O
provinces,O
of,O
Guangdong,O
",",O
Fujian,O
",",O
and,O
the,O
city,O
of,O
Beijing,O
",",O
respectively,O
.,O
"
",O
INTERPRETATION,O
:,O
Many,O
countries,O
in,O
Africa,O
are,O
stepping,O
up,O
their,O
preparedness,O
to,O
"
",O
detect,O
and,O
cope,O
with,O
COVID19,B-Disease_COVID-19
importations,O
.,O
Resources,O
",",O
intensified,O
surveillance,O
",",O
"
",O
and,O
capacity,O
building,O
should,O
be,O
urgently,O
prioritised,O
in,O
countries,O
with,O
moderate,O
"
",O
risk,O
that,O
might,O
be,O
illprepared,O
to,O
detect,O
imported,O
cases,O
and,O
to,O
limit,O
onward,O
"
",O
transmission,O
.,O
"
",O
FUNDING,O
:,O
EU,O
Framework,O
Programme,O
for,O
Research,O
and,O
Innovation,O
Horizon,O
2020,O
",",O
Agence,O
"
",O
Nationale,O
de,O
la,O
Recherche,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)304116,O
"
",O
PMID,O
:,O
32087820,O
"


",O
584,O
.,O
Lancet,O
.,O
2020,O
Feb,O
22;395(10224):537,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303792,O
.,O
"

",O
COVID19,B-Disease_COVID-19
:,O
fighting,O
panic,O
with,O
information,O
.,O
"

",O
The,O
Lancet,O
.,O
"

",O
Comment,O
on,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
29;395(10225):664666,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303792,O
"
",O
PMID,O
:,O
32087777,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
585,O
.,O
Microbes,O
Infect,O
.,O
2020,O
Feb,O
20,O
.,O
pii,O
:,O
S12864579(20)300307,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.micinf.2020.02.002,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
epidemic,O
of,O
2019novelcoronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
pneumonia,O
and,O
insights,O
for,O
"
",O
emerging,O
infectious,O
diseases,O
in,O
the,O
future,O
.,O
"

",O
Li,O
JY(1,O
),O
",",O
You,O
Z(2,O
),O
",",O
Wang,O
Q(3,O
),O
",",O
Zhou,O
ZJ(4,O
),O
",",O
Qiu,O
Y(5,O
),O
",",O
Luo,O
R(6,O
),O
",",O
Ge,O
XY(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Pathogen,O
Biology,O
and,O
Immunology,O
",",O
College,O
of,O
Biology,O
",",O
Hunan,O
"
",O
Provincial,O
Key,O
Laboratory,O
of,O
Medical,O
Virology,O
",",O
Hunan,O
University,O
",",O
Changsha,O
410082,O
",",O
"
",O
Hunan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
lijinyan@hnu.edu.cn,O
.,O
"
",O
(2)Institute,O
of,O
Pathogen,O
Biology,O
and,O
Immunology,O
",",O
College,O
of,O
Biology,O
",",O
Hunan,O
"
",O
Provincial,O
Key,O
Laboratory,O
of,O
Medical,O
Virology,O
",",O
Hunan,O
University,O
",",O
Changsha,O
410082,O
",",O
"
",O
Hunan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
YOUZHI@hnu.edu.cn,O
.,O
"
",O
(3)Institute,O
of,O
Pathogen,O
Biology,O
and,O
Immunology,O
",",O
College,O
of,O
Biology,O
",",O
Hunan,O
"
",O
Provincial,O
Key,O
Laboratory,O
of,O
Medical,O
Virology,O
",",O
Hunan,O
University,O
",",O
Changsha,O
410082,O
",",O
"
",O
Hunan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
qw@hnu.edu.cn,O
.,O
"
",O
(4)Institute,O
of,O
Pathogen,O
Biology,O
and,O
Immunology,O
",",O
College,O
of,O
Biology,O
",",O
Hunan,O
"
",O
Provincial,O
Key,O
Laboratory,O
of,O
Medical,O
Virology,O
",",O
Hunan,O
University,O
",",O
Changsha,O
410082,O
",",O
"
",O
Hunan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
zjzhou@hnu.edu.cn,O
.,O
"
",O
(5)Institute,O
of,O
Pathogen,O
Biology,O
and,O
Immunology,O
",",O
College,O
of,O
Biology,O
",",O
Hunan,O
"
",O
Provincial,O
Key,O
Laboratory,O
of,O
Medical,O
Virology,O
",",O
Hunan,O
University,O
",",O
Changsha,O
410082,O
",",O
"
",O
Hunan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
qiuye@hnu.edu.cn,O
.,O
"
",O
(6)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
China,O
;,O
Key,O
"
",O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
The,O
Cooperative,O
"
",O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
luorui@mail.hzau.edu.cn,O
.,O
"
",O
(7)Institute,O
of,O
Pathogen,O
Biology,O
and,O
Immunology,O
",",O
College,O
of,O
Biology,O
",",O
Hunan,O
"
",O
Provincial,O
Key,O
Laboratory,O
of,O
Medical,O
Virology,O
",",O
Hunan,O
University,O
",",O
Changsha,O
410082,O
",",O
"
",O
Hunan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
xyge@hnu.edu.cn,O
.,O
"

",O
At,O
the,O
end,O
of,O
December,O
2019,O
",",O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
2019nCoV,B-Virus_SARS-CoV-2
",",O
caused,O
an,O
outbreak,O
"
",O
of,O
pneumonia,O
spreading,O
from,O
Wuhan,O
",",O
Hubei,O
province,O
",",O
to,O
the,O
whole,O
country,O
of,O
China,O
",",O
"
",O
which,O
has,O
posed,O
great,O
threats,O
to,O
public,O
health,O
and,O
attracted,O
enormous,O
attention,O
"
",O
around,O
the,O
world,O
.,O
To,O
date,O
",",O
there,O
are,O
no,O
clinically,O
approved,O
vaccines,O
or,O
antiviral,O
"
",O
drugs,O
available,O
for,O
these,O
human,O
coronavirus,O
infections,O
.,O
Intensive,O
research,O
on,O
the,O
"
",O
novel,O
emerging,O
human,O
infectious,O
coronaviruses,O
is,O
urgently,O
needed,O
to,O
elucidate,O
"
",O
their,O
route,O
of,O
transmission,O
and,O
pathogenic,O
mechanisms,O
",",O
and,O
to,O
identify,O
potential,O
"
",O
drug,O
targets,O
",",O
which,O
would,O
promote,O
the,O
development,O
of,O
effective,O
preventive,O
and,O
"
",O
therapeutic,O
countermeasures,O
.,O
Herein,O
",",O
we,O
describe,O
the,O
epidemic,O
and,O
etiological,O
"
",O
characteristics,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
discuss,O
its,O
essential,O
biological,O
features,O
",",O
"
",O
including,O
tropism,O
and,O
receptor,O
usage,O
",",O
summarize,O
approaches,O
for,O
disease,O
prevention,O
"
",O
and,O
treatment,O
",",O
and,O
speculate,O
on,O
the,O
transmission,O
route,O
of,O
2019nCoV.,O
"

",O
Copyright,O
Â©,O
2020,O
Institut,O
Pasteur,O
.,O
Published,O
by,O
Elsevier,O
Masson,O
SAS,O
.,O
All,O
rights,O
"
",O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.micinf.2020.02.002,O
"
",O
PMID,O
:,O
32087334,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
586,O
.,O
Chest,O
.,O
2020,O
Feb,O
19,O
.,O
pii,O
:,O
S00123692(20)303238,O
.,O
doi,O
:,O
10.1016,O
j.chest.2020.02.014,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
A,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
Outbreak,O
:,O
A,O
Call,O
for,O
Action,O
.,O
"

",O
Zhang,O
Y(1,O
),O
",",O
Xu,O
J(2,O
),O
",",O
Li,O
H(1,O
),O
",",O
Cao,O
B(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Center,O
of,O
Respiratory,O
"
",O
Medicine,O
",",O
ChinaJapan,O
Friendship,O
Hospital,O
",",O
Beijing,O
",",O
China,O
;,O
National,O
Clinical,O
"
",O
Research,O
Center,O
for,O
Respiratory,O
Diseases,O
",",O
Beijing,O
",",O
China,O
;,O
Department,O
of,O
"
",O
Respiratory,O
Medicine,O
",",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Tsinghua,O
University,O
School,O
of,O
Medicine,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Center,O
of,O
Respiratory,O
"
",O
Medicine,O
",",O
ChinaJapan,O
Friendship,O
Hospital,O
",",O
Beijing,O
",",O
China,O
;,O
National,O
Clinical,O
"
",O
Research,O
Center,O
for,O
Respiratory,O
Diseases,O
",",O
Beijing,O
",",O
China,O
;,O
Department,O
of,O
"
",O
Respiratory,O
Medicine,O
",",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
caobin_ben@163.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.chest.2020.02.014,O
"
",O
PMID,O
:,O
32087216,O
"


",O
587,O
.,O
Lancet,O
.,O
2020,O
Feb,O
19,O
.,O
pii,O
:,O
S01406736(20)304190,O
.,O
doi,O
:,O
"
",O
10.1016,O
S01406736(20)304190,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
A,O
distinct,O
name,O
is,O
needed,O
for,O
the,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
.,O
"

",O
Jiang,O
S(1,O
),O
",",O
Shi,O
Z(2,O
),O
",",O
Shu,O
Y(3,O
),O
",",O
Song,O
J(4,O
),O
",",O
Gao,O
GF(4,O
),O
",",O
Tan,O
W(4,O
),O
",",O
Guo,O
D(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)School,O
of,O
Public,O
Health,O
(,O
Shenzhen,O
),O
",",O
Sun,O
Yatsen,O
University,O
",",O
Shenzhen,O
",",O
China,O
.,O
"
",O
(4)China,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)School,O
of,O
Medicine,O
",",O
Sun,O
Yatsen,O
University,O
",",O
Guangzhou,O
510080,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
guodeyin@mail.sysu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)304190,O
"
",O
PMID,O
:,O
32087125,O
"


",O
588,O
.,O
Lancet,O
.,O
2020,O
Mar,O
7;395(10226):e42e43,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)304189,O
.,O
Epub,O
"
",O
2020,O
Feb,O
19,O
.,O
"

",O
Statement,O
in,O
support,O
of,O
the,O
scientists,O
",",O
public,O
health,O
professionals,O
",",O
and,O
medical,O
"
",O
professionals,O
of,O
China,O
combatting,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Calisher,O
C(1,O
),O
",",O
Carroll,O
D(2,O
),O
",",O
Colwell,O
R(3,O
),O
",",O
Corley,O
RB(4,O
),O
",",O
Daszak,O
P(5,O
),O
",",O
Drosten,O
"
",O
C(6,O
),O
",",O
Enjuanes,O
L(7,O
),O
",",O
Farrar,O
J(8,O
),O
",",O
Field,O
H(9,O
),O
",",O
Golding,O
J(8,O
),O
",",O
Gorbalenya,O
A(10,O
),O
",",O
"
",O
Haagmans,O
B(11,O
),O
",",O
Hughes,O
JM(12,O
),O
",",O
Karesh,O
WB(13,O
),O
",",O
Keusch,O
GT(14,O
),O
",",O
Lam,O
SK(15,O
),O
",",O
Lubroth,O
"
",O
J(16,O
),O
",",O
Mackenzie,O
JS(17,O
),O
",",O
Madoff,O
L(18,O
),O
",",O
Mazet,O
J(19,O
),O
",",O
Palese,O
P(20,O
),O
",",O
Perlman,O
S(21,O
),O
",",O
"
",O
Poon,O
L(22,O
),O
",",O
Roizman,O
B(23,O
),O
",",O
Saif,O
L(24,O
),O
",",O
Subbarao,O
K(25,O
),O
",",O
Turner,O
M(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Colorado,O
State,O
University,O
",",O
Fort,O
Collins,O
",",O
CO,O
",",O
USA,O
.,O
Electronic,O
address,O
:,O
"
",O
COVID19statement@gmail.com,O
.,O
"
",O
(2)Scowcroft,O
Institute,O
of,O
International,O
Affairs,O
",",O
Texas,O
A&M,O
",",O
College,O
Station,O
",",O
TX,O
",",O
"
",O
USA,O
.,O
"
",O
(3)University,O
of,O
Maryland,O
",",O
College,O
Park,O
",",O
MD,O
",",O
USA,O
.,O
"
",O
(4)NEIDL,O
Institute,O
",",O
Boston,O
",",O
MA,O
",",O
USA,O
.,O
"
",O
(5)EcoHealth,O
Alliance,O
",",O
New,O
York,O
",",O
NY,O
",",O
USA,O
.,O
"
",O
(6)CharitÃ©,O
 ,O
Universitatsmedizin,O
Berlin,O
",",O
Berlin,O
",",O
Germany,O
.,O
"
",O
(7)National,O
Center,O
of,O
Biotechnology,O
",",O
Madrid,O
",",O
Spain,O
.,O
"
",O
(8)The,O
Wellcome,O
Trust,O
",",O
London,O
",",O
UK,O
.,O
"
",O
(9)School,O
of,O
Veterinary,O
Science,O
",",O
The,O
University,O
of,O
Queensland,O
",",O
Brisbane,O
",",O
QLD,O
",",O
"
",O
Australia,O
.,O
"
",O
(10)Leiden,O
University,O
Medical,O
Center,O
",",O
Leiden,O
",",O
Netherlands,O
.,O
"
",O
(11)Erasmus,O
Medical,O
Center,O
",",O
Rotterdam,O
",",O
Netherlands,O
.,O
"
",O
(12)Emory,O
University,O
",",O
Atlanta,O
",",O
GA,O
",",O
USA,O
.,O
"
",O
(13)World,O
Organization,O
for,O
Animal,O
Health,O
(,O
OIE,O
),O
Working,O
Group,O
on,O
Wildlife,O
",",O
New,O
"
",O
York,O
",",O
NY,O
",",O
USA,O
.,O
"
",O
(14)Boston,O
University,O
",",O
Boston,O
",",O
MA,O
",",O
USA,O
.,O
"
",O
(15)University,O
of,O
Malaya,O
",",O
Kuala,O
Lumpur,O
",",O
Malaysia,O
.,O
"
",O
(16)Food,O
and,O
Agriculture,O
Organization,O
of,O
the,O
United,O
Nations,O
",",O
Rome,O
",",O
Italy,O
.,O
"
",O
(17)Curtin,O
University,O
",",O
Perth,O
",",O
WA,O
",",O
Australia,O
.,O
"
",O
(18)Massachusetts,O
Medical,O
School,O
",",O
Worcester,O
",",O
MA,O
",",O
USA,O
.,O
"
",O
(19)University,O
of,O
California,O
at,O
Davis,O
",",O
Davis,O
",",O
CA,O
",",O
USA,O
.,O
"
",O
(20)Department,O
of,O
Microbiology,O
",",O
Icahn,O
School,O
of,O
Medicine,O
",",O
Mt,O
Sinai,O
Hospital,O
",",O
New,O
"
",O
York,O
",",O
NY,O
",",O
USA,O
.,O
"
",O
(21)University,O
of,O
Iowa,O
",",O
Roy,O
J,O
and,O
Lucille,O
A,O
Carver,O
College,O
of,O
Medicine,O
",",O
Iowa,O
"
",O
City,O
",",O
IA,O
",",O
USA,O
.,O
"
",O
(22)The,O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
.,O
"
",O
(23)University,O
of,O
Chicago,O
",",O
Chigaco,O
",",O
IL,O
",",O
USA,O
.,O
"
",O
(24)The,O
Ohio,O
State,O
University,O
",",O
Columbus,O
",",O
OH,O
",",O
USA,O
.,O
"
",O
(25)The,O
University,O
of,O
Melbourne,O
",",O
Melboune,O
",",O
VIC,O
",",O
Australia,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)304189,O
"
",O
PMID,O
:,O
32087122,O
"


",O
589,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
19,O
.,O
pii,O
:,O
S14733099(20)301146,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301146,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Asymptomatic,O
cases,O
in,O
a,O
family,O
cluster,O
with,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"

",O
Pan,O
X(1,O
),O
",",O
Chen,O
D(2,O
),O
",",O
Xia,O
Y(3,O
),O
",",O
Wu,O
X(4,O
),O
",",O
Li,O
T(5,O
),O
",",O
Ou,O
X(6,O
),O
",",O
Zhou,O
L(6,O
),O
",",O
Liu,O
J(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Diseases,O
",",O
Third,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
"
",O
Medical,O
University,O
",",O
Guangzhou,O
",",O
Guangdong,O
510150,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
panxf0125@163.com,O
.,O
"
",O
(2)Emergency,O
Department,O
",",O
Third,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
Medical,O
"
",O
University,O
",",O
Guangzhou,O
",",O
Guangdong,O
510150,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Clinical,O
Laboratory,O
",",O
Third,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
"
",O
Medical,O
University,O
",",O
Guangzhou,O
",",O
Guangdong,O
510150,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Microbiology,O
",",O
Guangzhou,O
Center,O
for,O
Disease,O
Control,O
and,O
"
",O
Prevention,O
",",O
Guangzhou,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Radiology,O
",",O
Third,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
Medical,O
"
",O
University,O
",",O
Guangzhou,O
",",O
Guangdong,O
510150,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Infectious,O
Diseases,O
",",O
Third,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
"
",O
Medical,O
University,O
",",O
Guangzhou,O
",",O
Guangdong,O
510150,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Gastroenterology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
Hubei,O
430071,O
",",O
China,O
;,O
Hubei,O
Clinical,O
Center,O
and,O
Key,O
Laboratory,O
of,O
Intestinal,O
and,O
"
",O
Colorectal,O
Diseases,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
liujing_GI@whu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301146,O
"
",O
PMID,O
:,O
32087116,O
"


",O
590,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
19,O
.,O
pii,O
:,O
S14733099(20)301195,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301195,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Open,O
access,O
epidemiological,O
data,O
from,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
.,O
"

",O
Xu,O
B(1,O
),O
",",O
Kraemer,O
MUG(2,O
),O
;,O
Open,O
COVID19,B-Disease_COVID-19
Data,O
Curation,O
Group,O
.,O
"

",O
Collaborators,O
:,O
Xu,O
B,O
",",O
Gutierrez,O
B,O
",",O
Mekaru,O
S,O
",",O
Sewalk,O
K,O
",",O
Loskill,O
A,O
",",O
Wang,O
L,O
",",O
Cohn,O
E,O
",",O
"
",O
Hill,O
S,O
",",O
Zarebski,O
A,O
",",O
Li,O
S,O
",",O
Wu,O
CH,O
",",O
Hulland,O
E,O
",",O
Morgan,O
J,O
",",O
Scarpino,O
S,O
",",O
Brownstein,O
J,O
",",O
"
",O
Pybus,O
O,O
",",O
Pigott,O
D,O
",",O
Kraemer,O
M.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Zoology,O
",",O
University,O
of,O
Oxford,O
",",O
Oxford,O
OX1,O
3SZ,O
",",O
UK,O
.,O
"
",O
(2)Department,O
of,O
Zoology,O
",",O
University,O
of,O
Oxford,O
",",O
Oxford,O
OX1,O
3SZ,O
",",O
UK,O
.,O
Electronic,O
"
",O
address,O
:,O
moritz.kraemer@zoo.ox.ac.uk,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301195,O
"
",O
PMID,O
:,O
32087115,O
"


",O
591,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
19,O
.,O
pii,O
:,O
S14733099(20)301201,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301201,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
An,O
interactive,O
webbased,O
dashboard,O
to,O
track,O
COVID19,B-Disease_COVID-19
in,O
real,O
time,O
.,O
"

",O
Dong,O
E(1,O
),O
",",O
Du,O
H(1,O
),O
",",O
Gardner,O
L(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Civil,O
and,O
Systems,O
Engineering,O
",",O
Johns,O
Hopkins,O
University,O
",",O
"
",O
Baltimore,O
",",O
MD,O
21218,O
",",O
USA,O
.,O
"
",O
(2)Department,O
of,O
Civil,O
and,O
Systems,O
Engineering,O
",",O
Johns,O
Hopkins,O
University,O
",",O
"
",O
Baltimore,O
",",O
MD,O
21218,O
",",O
USA,O
.,O
Electronic,O
address,O
:,O
l.gardner@jhu.edu,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301201,O
"
",O
PMID,O
:,O
32087114,O
"


",O
592,O
.,O
Lancet,O
Gastroenterol,O
Hepatol,O
.,O
2020,O
Apr;5(4):335337,O
.,O
doi,O
:,O
"
",O
10.1016,O
S24681253(20)300480,O
.,O
Epub,O
2020,O
Feb,O
20,O
.,O
"

",O
Enteric,O
involvement,O
of,O
coronaviruses,O
:,O
is,O
faecaloral,O
transmission,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
possible,O
?,O
"

",O
Yeo,O
C(1,O
),O
",",O
Kaushal,O
S(1,O
),O
",",O
Yeo,O
D(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
General,O
Surgery,O
",",O
Tan,O
Tock,O
Seng,O
Hospital,O
",",O
Singapore,O
308433,O
.,O
"
",O
(2)Department,O
of,O
General,O
Surgery,O
",",O
Tan,O
Tock,O
Seng,O
Hospital,O
",",O
Singapore,O
308433,O
.,O
"
",O
Electronic,O
address,O
:,O
danson_xw_yeo@ttsh.com.sg,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S24681253(20)300480,O
"
",O
PMID,O
:,O
32087098,O
"


",O
593,O
.,O
Int,O
J,O
Epidemiol,O
.,O
2020,O
Feb,O
22,O
.,O
pii,O
:,O
dyaa033,O
.,O
doi,O
:,O
10.1093,O
ije,O
dyaa033,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
The,O
SARS,O
",",O
MERS,O
and,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
epidemics,O
",",O
the,O
newest,O
and,O
biggest,O
"
",O
global,O
health,O
threats,O
:,O
what,O
lessons,O
have,O
we,O
learned,O
?,O
"

",O
Peeri,O
NC(1,O
),O
",",O
Shrestha,O
N(1,O
),O
",",O
Rahman,O
MS(2,O
),O
",",O
Zaki,O
R(3,O
),O
",",O
Tan,O
Z(1,O
),O
",",O
Bibi,O
S(4,O
),O
",",O
"
",O
Baghbanzadeh,O
M(5,O
),O
",",O
Aghamohammadi,O
N(6,O
),O
",",O
Zhang,O
W(7,O
),O
",",O
Haque,O
U(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Biostatistics,O
and,O
Epidemiology,O
",",O
University,O
of,O
North,O
Texas,O
Health,O
"
",O
Science,O
Center,O
",",O
Fort,O
Worth,O
",",O
TX,O
",",O
USA,O
.,O
"
",O
(2)Department,O
of,O
Statistics,O
",",O
Begum,O
Rokeya,O
University,O
",",O
Rangpur,O
",",O
Bangladesh,O
.,O
"
",O
(3)Centre,O
for,O
Epidemiology,O
and,O
Evidencebased,O
Practice,O
",",O
Department,O
of,O
Social,O
and,O
"
",O
Preventive,O
Medicine,O
",",O
University,O
of,O
Malaya,O
",",O
Kuala,O
Lumpur,O
",",O
Malaysia,O
.,O
"
",O
(4)Department,O
of,O
Biology,O
",",O
National,O
University,O
of,O
Medical,O
Sciences,O
",",O
Rawalpindi,O
",",O
"
",O
Pakistan,O
.,O
"
",O
(5)Department,O
of,O
Business,O
Development,O
",",O
Ofogh,O
Kourosh,O
Chain,O
Stores,O
",",O
Tehran,O
",",O
Iran,O
.,O
"
",O
(6)Centre,O
for,O
Occupational,O
and,O
Environmental,O
Health,O
",",O
Department,O
of,O
Social,O
and,O
"
",O
Preventive,O
Medicine,O
",",O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Malaya,O
",",O
Kuala,O
Lumpur,O
",",O
"
",O
Malaysia,O
.,O
"
",O
(7)Center,O
for,O
Disease,O
Surveillance,O
and,O
Research,O
",",O
Center,O
for,O
Disease,O
Control,O
and,O
"
",O
Prevention,O
of,O
PLA,O
",",O
Beijing,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"

",O
OBJECTIVES,O
:,O
To,O
provide,O
an,O
overview,O
of,O
the,O
three,O
major,O
deadly,O
coronaviruses,O
and,O
"
",O
identify,O
areas,O
for,O
improvement,O
of,O
future,O
preparedness,O
plans,O
",",O
as,O
well,O
as,O
provide,O
a,O
"
",O
critical,O
assessment,O
of,O
the,O
risk,O
factors,O
and,O
actionable,O
items,O
for,O
stopping,O
their,O
"
",O
spread,O
",",O
utilizing,O
lessons,O
learned,O
from,O
the,O
first,O
two,O
deadly,O
coronavirus,O
"
",O
outbreaks,O
",",O
as,O
well,O
as,O
initial,O
reports,O
from,O
the,O
current,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
epidemic,O
in,O
Wuhan,O
",",O
China,O
.,O
"
",O
METHODS,O
:,O
Utilizing,O
the,O
Centers,O
for,O
Disease,O
Control,O
and,O
Prevention,O
(,O
CDC,O
",",O
USA,O
),O
"
",O
website,O
",",O
and,O
a,O
comprehensive,O
review,O
of,O
PubMed,O
literature,O
",",O
we,O
obtained,O
information,O
"
",O
regarding,O
clinical,O
signs,O
and,O
symptoms,O
",",O
treatment,O
and,O
diagnosis,O
",",O
transmission,O
"
",O
methods,O
",",O
protection,O
methods,O
and,O
risk,O
factors,O
for,O
Middle,O
East,O
Respiratory,O
Syndrome,O
"
",O
(,O
MERS,O
),O
",",O
Severe,O
Acute,O
Respiratory,O
Syndrome,O
(,O
SARS,O
),O
and,O
COVID19,B-Disease_COVID-19
.,O
Comparisons,O
"
",O
between,O
the,O
viruses,O
were,O
made,O
.,O
"
",O
RESULTS,O
:,O
Inadequate,O
risk,O
assessment,O
regarding,O
the,O
urgency,O
of,O
the,O
situation,O
",",O
and,O
"
",O
limited,O
reporting,O
on,O
the,O
virus,O
within,O
China,O
has,O
",",O
in,O
part,O
",",O
led,O
to,O
the,O
rapid,O
spread,O
"
",O
of,O
COVID19,B-Disease_COVID-19
throughout,O
mainland,O
China,O
and,O
into,O
proximal,O
and,O
distant,O
countries,O
.,O
"
",O
Compared,O
with,O
SARS,O
and,O
MERS,O
",",O
COVID19,B-Disease_COVID-19
has,O
spread,O
more,O
rapidly,O
",",O
due,O
in,O
part,O
to,O
"
",O
increased,O
globalization,O
and,O
the,O
focus,O
of,O
the,O
epidemic,O
.,O
Wuhan,O
",",O
China,O
is,O
a,O
large,O
"
",O
hub,O
connecting,O
the,O
North,O
",",O
South,O
",",O
East,O
and,O
West,O
of,O
China,O
via,O
railways,O
and,O
a,O
major,O
"
",O
international,O
airport,O
.,O
The,O
availability,O
of,O
connecting,O
flights,O
",",O
the,O
timing,O
of,O
the,O
"
",O
outbreak,O
during,O
the,O
Chinese,O
(,O
Lunar,O
),O
New,O
Year,O
",",O
and,O
the,O
massive,O
rail,O
transit,O
hub,O
"
",O
located,O
in,O
Wuhan,O
has,O
enabled,O
the,O
virus,O
to,O
perforate,O
throughout,O
China,O
",",O
and,O
"
",O
eventually,O
",",O
globally,O
.,O
"
",O
CONCLUSIONS,O
:,O
We,O
conclude,O
that,O
we,O
did,O
not,O
learn,O
from,O
the,O
two,O
prior,O
epidemics,O
of,O
"
",O
coronavirus,O
and,O
were,O
illprepared,O
to,O
deal,O
with,O
the,O
challenges,O
the,O
COVID19,B-Disease_COVID-19
"
",O
epidemic,O
has,O
posed,O
.,O
Future,O
research,O
should,O
attempt,O
to,O
address,O
the,O
uses,O
and,O
"
",O
implications,O
of,O
internet,O
of,O
things,O
(,O
IoT,O
),O
technologies,O
for,O
mapping,O
the,O
spread,O
of,O
"
",O
infection,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
;,O
all,O
rights,O
reserved,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
"
",O
on,O
behalf,O
of,O
the,O
International,O
Epidemiological,O
Association,O
.,O
"

",O
DOI,O
:,O
10.1093,O
ije,O
dyaa033,O
"
",O
PMID,O
:,O
32086938,O
"


",O
594,O
.,O
Br,O
J,O
Ophthalmol,O
.,O
2020,O
Mar;104(3):297298,O
.,O
doi,O
:,O
10.1136,O
bjophthalmol2020315994,O
.,O
"

",O
Novel,B-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
2019,O
(,O
COVID19,B-Disease_COVID-19
),O
:,O
The,O
importance,O
of,O
recognising,O
possible,O
"
",O
early,O
ocular,O
manifestation,O
and,O
using,O
protective,O
eyewear,O
.,O
"

",O
Li,O
JO(1,O
),O
",",O
Lam,O
DSC(2)(3,O
),O
",",O
Chen,O
Y(4,O
),O
",",O
Ting,O
DSW(5)(6)(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Moorfields,O
Eye,O
Hospital,O
",",O
London,O
",",O
UK,O
.,O
"
",O
(2)CMER,O
Dennis,O
Lam,O
Eye,O
Center,O
",",O
CMer,O
International,O
Eye,O
Care,O
Group,O
Limited,O
",",O
Hong,O
"
",O
Kong,O
",",O
Hong,O
Kong,O
.,O
"
",O
(3)International,O
Eye,O
Research,O
Institute,O
of,O
the,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
"
",O
(,O
Shenzhen,O
),O
",",O
Shenzhen,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Ophthalmology,O
",",O
Peking,O
Union,O
Medical,O
College,O
Hospital,O
",",O
Beijing,O
",",O
"
",O
China,O
.,O
"
",O
(5)Moorfields,O
Eye,O
Hospital,O
",",O
London,O
",",O
UK,O
daniel.ting.s.w@singhealth.com.sg,O
.,O
"
",O
(6)Singapore,O
National,O
Eye,O
Center,O
",",O
Singapore,O
",",O
Singapore,O
.,O
"
",O
(7)State,O
Key,O
Laboratory,O
of,O
Ophthalmology,O
",",O
Zhongshan,O
Ophthalmic,O
Center,O
",",O
Guangzhou,O
",",O
"
",O
China,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bjophthalmol2020315994,O
"
",O
PMID,O
:,O
32086236,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interests,O
:,O
None,O
declared,O
.,O
"


",O
595,O
.,O
BMJ,O
.,O
2020,O
Feb,O
21;368:m707,O
.,O
doi,O
:,O
10.1136,O
bmj.m707,O
.,O
"

",O
Rules,O
on,O
isolation,O
rooms,O
for,O
suspected,O
covid19,B-Disease_COVID-19
cases,O
in,O
GP,O
surgeries,O
to,O
be,O
"
",O
relaxed,O
.,O
"

",O
Kmietowicz,O
Z(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m707,O
"
",O
PMID,O
:,O
32086235,O
"


",O
596,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
18,O
.,O
pii,O
:,O
S14733099(20)301109,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301109,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Initiation,O
of,O
a,O
new,O
infection,O
control,O
system,O
for,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
.,O
"

",O
Chen,O
X(1,O
),O
",",O
Tian,O
J(2,O
),O
",",O
Li,O
G(2,O
),O
",",O
Li,O
G(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Center,O
for,O
Clinical,O
Epidemiology,O
and,O
Methodology,O
",",O
Guangdong,O
Second,O
Provincial,O
"
",O
General,O
Hospital,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(2)Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Guangdong,O
Second,O
Provincial,O
General,O
"
",O
Hospital,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(3)Center,O
for,O
Clinical,O
Epidemiology,O
and,O
Methodology,O
",",O
Guangdong,O
Second,O
Provincial,O
"
",O
General,O
Hospital,O
",",O
Guangzhou,O
",",O
China,O
;,O
Department,O
of,O
Health,O
Research,O
Methods,O
",",O
"
",O
Evidence,O
",",O
and,O
Impact,O
",",O
McMaster,O
University,O
",",O
Hamilton,O
",",O
ON,O
",",O
Canada,O
.,O
Electronic,O
"
",O
address,O
:,O
lig28@mcmaster.ca,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301109,O
"
",O
PMID,O
:,O
32085850,O
"


",O
597,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
18,O
.,O
pii,O
:,O
S14733099(20)301110,O
.,O
doi,O
:,O
"
",O
10.1016,O
S14733099(20)301110,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
first,O
Vietnamese,O
case,O
of,O
COVID19,B-Disease_COVID-19
acquired,O
from,O
China,O
.,O
"

",O
Van,O
Cuong,O
L(1,O
),O
",",O
Giang,O
HTN(2,O
),O
",",O
Linh,O
LK(3,O
),O
",",O
Shah,O
J(4,O
),O
",",O
Van,O
Sy,O
L(1,O
),O
",",O
Hung,O
TH(5,O
),O
",",O
"
",O
Reda,O
A(6,O
),O
",",O
Truong,O
LN(7,O
),O
",",O
Tien,O
DX(1,O
),O
",",O
Huy,O
NT(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Thanh,O
Hoa,O
General,O
Hospital,O
",",O
Thanh,O
Hoa,O
",",O
Vietnam,O
.,O
"
",O
(2)University,O
of,O
Da,O
Nang,O
",",O
Da,O
Nang,O
",",O
Vietnam,O
.,O
"
",O
(3)College,O
of,O
Health,O
Sciences,O
",",O
VinUniversity,O
",",O
Hanoi,O
",",O
Vietnam,O
.,O
"
",O
(4)Drexel,O
University,O
College,O
of,O
Medicine,O
",",O
Drexel,O
University,O
",",O
Philadelphia,O
",",O
PA,O
",",O
"
",O
USA,O
.,O
"
",O
(5)Thanh,O
Hoa,O
Department,O
of,O
Health,O
",",O
Thanh,O
Hoa,O
",",O
Vietnam,O
.,O
"
",O
(6)Faculty,O
of,O
Medicine,O
",",O
AlAzhar,O
University,O
",",O
Cairo,O
",",O
Egypt,O
.,O
"
",O
(7)Thanh,O
Hoa,O
Provincial,O
Center,O
for,O
Disease,O
Control,O
",",O
Thanh,O
Hoa,O
",",O
Vietnam,O
.,O
"
",O
(8)Department,O
of,O
Clinical,O
Product,O
Development,O
",",O
Institute,O
of,O
Tropical,O
Medicine,O
",",O
"
",O
School,O
of,O
Tropical,O
Medicine,O
and,O
Global,O
Health,O
",",O
Nagasaki,O
University,O
",",O
Nagasaki,O
"
",O
8528523,O
",",O
Japan,O
.,O
Electronic,O
address,O
:,O
tienhuy@nagasakiu.ac.jp,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
24,O
;,O
:,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)301110,O
"
",O
PMID,O
:,O
32085849,O
"


",O
598,O
.,O
Lancet,O
Respir,O
Med,O
.,O
2020,O
Feb,O
18,O
.,O
pii,O
:,O
S22132600(20)30076X,O
.,O
doi,O
:,O
"
",O
10.1016,O
S22132600(20)30076X,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Pathological,O
findings,O
of,O
COVID19,B-Disease_COVID-19
associated,O
with,O
acute,O
respiratory,O
distress,O
"
",O
syndrome,O
.,O
"

",O
Xu,O
Z(1,O
),O
",",O
Shi,O
L(1,O
),O
",",O
Wang,O
Y(2,O
),O
",",O
Zhang,O
J(1,O
),O
",",O
Huang,O
L(1,O
),O
",",O
Zhang,O
C(1,O
),O
",",O
Liu,O
S(2,O
),O
",",O
Zhao,O
"
",O
P(1,O
),O
",",O
Liu,O
H(1,O
),O
",",O
Zhu,O
L(2,O
),O
",",O
Tai,O
Y(2,O
),O
",",O
Bai,O
C(3,O
),O
",",O
Gao,O
T(2,O
),O
",",O
Song,O
J(1,O
),O
",",O
Xia,O
P(1,O
),O
",",O
Dong,O
"
",O
J(4,O
),O
",",O
Zhao,O
J(5,O
),O
",",O
Wang,O
FS(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Treatment,O
and,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
The,O
Fifth,O
Medical,O
"
",O
Center,O
of,O
PLA,O
General,O
Hospital,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
"
",O
Diseases,O
",",O
Beijing,O
100039,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pathology,O
and,O
Hepatology,O
",",O
The,O
Fifth,O
Medical,O
Center,O
of,O
PLA,O
"
",O
General,O
Hospital,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
"
",O
Beijing,O
100039,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Respiration,O
",",O
The,O
Fifth,O
Medical,O
Center,O
of,O
PLA,O
General,O
Hospital,O
",",O
"
",O
National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
Beijing,O
100039,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Radiology,O
",",O
The,O
Fifth,O
Medical,O
Center,O
of,O
PLA,O
General,O
Hospital,O
",",O
"
",O
National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
Beijing,O
100039,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Pathology,O
and,O
Hepatology,O
",",O
The,O
Fifth,O
Medical,O
Center,O
of,O
PLA,O
"
",O
General,O
Hospital,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
"
",O
Beijing,O
100039,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
jmzhao302@163.com,O
.,O
"
",O
(6)Treatment,O
and,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
The,O
Fifth,O
Medical,O
"
",O
Center,O
of,O
PLA,O
General,O
Hospital,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
"
",O
Diseases,O
",",O
Beijing,O
100039,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
fswang302@163.com,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
Lancet,O
Respir,O
Med,O
.,O
2020,O
Feb,O
25,O
;,O
:,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22132600(20)30076X,O
"
",O
PMID,O
:,O
32085846,O
"


",O
599,O
.,O
Lancet,O
Psychiatry,O
.,O
2020,O
Feb,O
18,O
.,O
pii,O
:,O
S22150366(20)300791,O
.,O
doi,O
:,O
"
",O
10.1016,O
S22150366(20)300791,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Mental,O
health,O
services,O
for,O
older,O
adults,O
in,O
China,O
during,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
.,O
"

",O
Yang,O
Y(1,O
),O
",",O
Li,O
W(2,O
),O
",",O
Zhang,O
Q(3,O
),O
",",O
Zhang,O
L(3,O
),O
",",O
Cheung,O
T(4,O
),O
",",O
Xiang,O
YT(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Unit,O
of,O
Psychiatry,O
",",O
Institute,O
of,O
Translational,O
Medicine,O
",",O
Faculty,O
of,O
Health,O
"
",O
Sciences,O
",",O
University,O
of,O
Macau,O
",",O
Macau,O
Special,O
Administrative,O
Region,O
",",O
China,O
;,O
Center,O
"
",O
for,O
Cognition,O
and,O
Brain,O
Sciences,O
",",O
University,O
of,O
Macau,O
",",O
Macau,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
;,O
Department,O
of,O
Psychiatry,O
",",O
Southern,O
Medical,O
"
",O
University,O
Nanfang,O
Hospital,O
and,O
GuangdongHong,O
KongMacau,O
Greater,O
Bay,O
Area,O
Center,O
"
",O
for,O
Brian,O
Science,O
and,O
BrainInspired,O
Intelligence,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(2)Unit,O
of,O
Psychiatry,O
",",O
Institute,O
of,O
Translational,O
Medicine,O
",",O
Faculty,O
of,O
Health,O
"
",O
Sciences,O
",",O
University,O
of,O
Macau,O
",",O
Macau,O
Special,O
Administrative,O
Region,O
",",O
China,O
;,O
Center,O
"
",O
for,O
Cognition,O
and,O
Brain,O
Sciences,O
",",O
University,O
of,O
Macau,O
",",O
Macau,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(3)The,O
National,O
Clinical,O
Research,O
Center,O
for,O
Mental,O
Disorders,O
and,O
Beijing,O
Key,O
"
",O
Laboratory,O
of,O
Mental,O
Disorders,O
",",O
Beijing,O
Anding,O
Hospital,O
and,O
The,O
Advanced,O
"
",O
Innovation,O
Center,O
for,O
Human,O
Brain,O
Protection,O
",",O
Capital,O
Medical,O
University,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)School,O
of,O
Nursing,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
Kong,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(5)Unit,O
of,O
Psychiatry,O
",",O
Institute,O
of,O
Translational,O
Medicine,O
",",O
Faculty,O
of,O
Health,O
"
",O
Sciences,O
",",O
University,O
of,O
Macau,O
",",O
Macau,O
Special,O
Administrative,O
Region,O
",",O
China,O
;,O
Center,O
"
",O
for,O
Cognition,O
and,O
Brain,O
Sciences,O
",",O
University,O
of,O
Macau,O
",",O
Macau,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
ytxiang@um.edu.mo,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22150366(20)300791,O
"
",O
PMID,O
:,O
32085843,O
"


",O
600,O
.,O
Lancet,O
Psychiatry,O
.,O
2020,O
Feb,O
18,O
.,O
pii,O
:,O
S22150366(20)300766,O
.,O
doi,O
:,O
"
",O
10.1016,O
S22150366(20)300766,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
neglected,O
health,O
of,O
international,O
migrant,O
workers,O
in,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
.,O
"

",O
Liem,O
A(1,O
),O
",",O
Wang,O
C(2,O
),O
",",O
Wariyanti,O
Y(3,O
),O
",",O
Latkin,O
CA(4,O
),O
",",O
Hall,O
BJ(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Global,O
and,O
Community,O
Mental,O
Health,O
Research,O
Group,O
",",O
Department,O
of,O
Psychology,O
",",O
"
",O
University,O
of,O
Macau,O
",",O
Macau,O
Special,O
Administrative,O
Region,O
999078,O
",",O
China,O
.,O
"
",O
(2)Dermatology,O
Hospital,O
of,O
Southern,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
China,O
;,O
"
",O
Southern,O
Medical,O
University,O
Institute,O
for,O
Global,O
Health,O
and,O
Sexually,O
Transmitted,O
"
",O
Diseases,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(3)Indonesian,O
Migrant,O
Worker,O
's,O
Union,O
",",O
Macau,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Health,O
",",O
Behavior,O
and,O
Society,O
",",O
Johns,O
Hopkins,O
Bloomberg,O
School,O
of,O
"
",O
Public,O
Health,O
",",O
Baltimore,O
",",O
MD,O
",",O
USA,O
.,O
"
",O
(5)Global,O
and,O
Community,O
Mental,O
Health,O
Research,O
Group,O
",",O
Department,O
of,O
Psychology,O
",",O
"
",O
University,O
of,O
Macau,O
",",O
Macau,O
Special,O
Administrative,O
Region,O
999078,O
",",O
China,O
;,O
"
",O
Department,O
of,O
Health,O
",",O
Behavior,O
and,O
Society,O
",",O
Johns,O
Hopkins,O
Bloomberg,O
School,O
of,O
"
",O
Public,O
Health,O
",",O
Baltimore,O
",",O
MD,O
",",O
USA,O
.,O
Electronic,O
address,O
:,O
brianhall@um.edu.mo,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22150366(20)300766,O
"
",O
PMID,O
:,O
32085842,O
"


",O
601,O
.,O
Lancet,O
Psychiatry,O
.,O
2020,O
Feb,O
18,O
.,O
pii,O
:,O
S22150366(20)300778,O
.,O
doi,O
:,O
"
",O
10.1016,O
S22150366(20)300778,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Online,O
mental,O
health,O
services,O
in,O
China,O
during,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
.,O
"

",O
Liu,O
S(1,O
),O
",",O
Yang,O
L(2,O
),O
",",O
Zhang,O
C(2,O
),O
",",O
Xiang,O
YT(3,O
),O
",",O
Liu,O
Z(4,O
),O
",",O
Hu,O
S(5,O
),O
",",O
Zhang,O
B(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Psychiatry,O
",",O
Nanfang,O
Hospital,O
",",O
Southern,O
Medical,O
University,O
",",O
"
",O
Guangzhou,O
510515,O
",",O
China,O
;,O
GuangdongHong,O
KongMacao,O
Greater,O
Bay,O
Area,O
Center,O
for,O
"
",O
Brain,O
Science,O
and,O
BrainInspired,O
Intelligence,O
",",O
Southern,O
Medical,O
University,O
",",O
"
",O
Guangzhou,O
",",O
China,O
;,O
The,O
Third,O
People,O
's,O
Hospital,O
of,O
Qinghai,O
Province,O
",",O
Xining,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Psychiatry,O
",",O
Nanfang,O
Hospital,O
",",O
Southern,O
Medical,O
University,O
",",O
"
",O
Guangzhou,O
510515,O
",",O
China,O
;,O
GuangdongHong,O
KongMacao,O
Greater,O
Bay,O
Area,O
Center,O
for,O
"
",O
Brain,O
Science,O
and,O
BrainInspired,O
Intelligence,O
",",O
Southern,O
Medical,O
University,O
",",O
"
",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(3)Unit,O
of,O
Psychiatry,O
",",O
Institute,O
of,O
Translational,O
Medicine,O
",",O
Faculty,O
of,O
Health,O
"
",O
Sciences,O
",",O
University,O
of,O
Macau,O
",",O
Macau,O
Special,O
Administrative,O
Region,O
",",O
China,O
;,O
Center,O
"
",O
for,O
Cognition,O
and,O
Brain,O
Sciences,O
",",O
University,O
of,O
Macau,O
",",O
Macau,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Psychiatry,O
",",O
Renmin,O
Hospital,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Psychiatry,O
",",O
First,O
Affiliated,O
Hospital,O
",",O
Zhejiang,O
University,O
"
",O
School,O
of,O
Medicine,O
",",O
Hangzhou,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Psychiatry,O
",",O
Nanfang,O
Hospital,O
",",O
Southern,O
Medical,O
University,O
",",O
"
",O
Guangzhou,O
510515,O
",",O
China,O
;,O
GuangdongHong,O
KongMacao,O
Greater,O
Bay,O
Area,O
Center,O
for,O
"
",O
Brain,O
Science,O
and,O
BrainInspired,O
Intelligence,O
",",O
Southern,O
Medical,O
University,O
",",O
"
",O
Guangzhou,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
zhang73bin@hotmail.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22150366(20)300778,O
"
",O
PMID,O
:,O
32085841,O
"


",O
602,O
.,O
Lancet,O
Psychiatry,O
.,O
2020,O
Feb,O
18,O
.,O
pii,O
:,O
S22150366(20)300730,O
.,O
doi,O
:,O
"
",O
10.1016,O
S22150366(20)300730,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Psychological,O
interventions,O
for,O
people,O
affected,O
by,O
the,O
COVID19,B-Disease_COVID-19
epidemic,O
.,O
"

",O
Duan,O
L(1,O
),O
",",O
Zhu,O
G(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Psychiatry,O
",",O
the,O
First,O
Affiliated,O
Hospital,O
of,O
China,O
Medical,O
"
",O
University,O
",",O
Shenyang,O
110001,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Psychiatry,O
",",O
the,O
First,O
Affiliated,O
Hospital,O
of,O
China,O
Medical,O
"
",O
University,O
",",O
Shenyang,O
110001,O
",",O
China,O
;,O
Central,O
Laboratory,O
",",O
the,O
First,O
Affiliated,O
"
",O
Hospital,O
of,O
China,O
Medical,O
University,O
",",O
Shenyang,O
110001,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
gzhu@cmu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22150366(20)300730,O
"
",O
PMID,O
:,O
32085840,O
"


",O
603,O
.,O
Lancet,O
Psychiatry,O
.,O
2020,O
Feb,O
18,O
.,O
pii,O
:,O
S22150366(20)30078X,O
.,O
doi,O
:,O
"
",O
10.1016,O
S22150366(20)30078X,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Mental,O
health,O
care,O
for,O
medical,O
staff,O
in,O
China,O
during,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
.,O
"

",O
Chen,O
Q(1,O
),O
",",O
Liang,O
M(2,O
),O
",",O
Li,O
Y(1,O
),O
",",O
Guo,O
J(3,O
),O
",",O
Fei,O
D(4,O
),O
",",O
Wang,O
L(1,O
),O
",",O
He,O
L(1,O
),O
",",O
Sheng,O
"
",O
C(1,O
),O
",",O
Cai,O
Y(1,O
),O
",",O
Li,O
X(1,O
),O
",",O
Wang,O
J(1,O
),O
",",O
Zhang,O
Z(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Clinical,O
Nursing,O
Teaching,O
and,O
Research,O
Section,O
",",O
The,O
Second,O
Xiangya,O
Hospital,O
",",O
"
",O
Central,O
South,O
University,O
",",O
Changsha,O
410011,O
",",O
China,O
.,O
"
",O
(2)Clinical,O
Nursing,O
Teaching,O
and,O
Research,O
Section,O
",",O
The,O
Second,O
Xiangya,O
Hospital,O
",",O
"
",O
Central,O
South,O
University,O
",",O
Changsha,O
410011,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
liangmining@csu.edu.cn,O
.,O
"
",O
(3)Mental,O
Health,O
Institute,O
",",O
The,O
Second,O
Xiangya,O
Hospital,O
",",O
Central,O
South,O
"
",O
University,O
",",O
Changsha,O
410011,O
",",O
China,O
.,O
"
",O
(4)Clinical,O
Nursing,O
Teaching,O
and,O
Research,O
Section,O
",",O
The,O
Second,O
Xiangya,O
Hospital,O
",",O
"
",O
Central,O
South,O
University,O
",",O
Changsha,O
410011,O
",",O
China,O
;,O
Metabolism,O
and,O
Endocrinology,O
"
",O
Department,O
",",O
The,O
Second,O
Xiangya,O
Hospital,O
",",O
Central,O
South,O
University,O
",",O
Changsha,O
"
",O
410011,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22150366(20)30078X,O
"
",O
PMID,O
:,O
32085839,O
"


",O
604,O
.,O
Cells,O
.,O
2020,O
Feb,O
18;9(2,O
),O
.,O
pii,O
:,O
E457,O
.,O
doi,O
:,O
10.339,O
cells9020457,O
.,O
"

",O
Role,O
of,O
Angiopoietins,O
in,O
Development,O
of,O
Cancer,O
and,O
Neoplasia,O
Associated,O
with,O
"
",O
Viral,O
Infection,O
.,O
"

",O
Yu,O
X(1)(2,O
),O
",",O
Ye,O
F(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Biocatalysis,O
and,O
Enzyme,O
Engineering,O
",",O
College,O
of,O
Life,O
"
",O
Sciences,O
",",O
Hubei,O
University,O
",",O
Wuhan,O
430062,O
",",O
China,O
.,O
"
",O
(2)Hubei,O
Key,O
Laboratory,O
of,O
Industrial,O
Biotechnology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
"
",O
Hubei,O
University,O
",",O
Wuhan,O
430062,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Molecular,O
Biology,O
&,O
Microbiology,O
",",O
School,O
of,O
Medicine,O
",",O
Case,O
"
",O
Western,O
Reserve,O
University,O
",",O
10900,O
Euclid,O
Avenue,O
",",O
Cleveland,O
",",O
OH,O
44106,O
",",O
USA,O
.,O
"

",O
Angiopoietin,O
tyrosine,O
protein,O
kinase,O
receptor,O
Tie2,O
signaling,O
in,O
endothelial,O
"
",O
cells,O
plays,O
an,O
essential,O
role,O
in,O
angiogenesis,O
and,O
wound,O
healing,O
.,O
Angiopoietin1,O
"
",O
(,O
Ang1,O
),O
is,O
crucial,O
for,O
blood,O
vessel,O
maturation,O
while,O
angiopoietin2,O
(,O
Ang2,O
),O
",",O
in,O
"
",O
collaboration,O
with,O
vascular,O
endothelial,O
growth,O
factor,O
(,O
VEGF,O
),O
",",O
initiates,O
"
",O
angiogenesis,O
by,O
destabilizing,O
existing,O
blood,O
vessels,O
.,O
In,O
healthy,O
people,O
",",O
the,O
"
",O
Ang1,O
level,O
is,O
sustained,O
while,O
Ang2,O
expression,O
is,O
restricted,O
.,O
In,O
cancer,O
"
",O
patients,O
",",O
Ang2,O
level,O
is,O
elevated,O
",",O
which,O
correlates,O
with,O
poor,O
prognosis,O
.,O
Ang2,O
"
",O
not,O
only,O
drives,O
tumor,O
angiogenesis,O
but,O
also,O
attracts,O
infiltration,O
of,O
myeloid,O
"
",O
cells,O
.,O
The,O
latter,O
rapidly,O
differentiate,O
into,O
tumor,O
stromal,O
cells,O
that,O
foster,O
"
",O
tumor,O
angiogenesis,O
and,O
progression,O
",",O
and,O
weaken,O
the,O
host,O
's,O
antitumor,O
immunity,O
.,O
"
",O
Moreover,O
",",O
through,O
integrin,O
signaling,O
",",O
Ang2,O
induces,O
expression,O
of,O
matrix,O
"
",O
metallopeptidases,O
(,O
MMPs,O
),O
to,O
promote,O
tumor,O
cell,O
invasion,O
and,O
metastasis,O
.,O
Many,O
"
",O
oncogenic,O
viruses,O
induce,O
expression,O
of,O
Ang2,O
to,O
promote,O
development,O
of,O
neoplasia,O
"
",O
associated,O
with,O
viral,O
infection,O
.,O
Multiple,O
Ang2,O
inhibitors,O
exhibit,O
remarkable,O
"
",O
antitumor,O
activities,O
",",O
further,O
highlighting,O
the,O
importance,O
of,O
Ang2,O
in,O
cancer,O
"
",O
development,O
.,O
"

",O
DOI,O
:,O
10.339,O
cells9020457,O
"
",O
PMID,O
:,O
32085414,O
"


",O
605,O
.,O
Radiology,O
.,O
2020,O
Feb,O
21:200490,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200490,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
:,O
A,O
Perspective,O
from,O
China,O
.,O
"

",O
Zu,O
ZY(1,O
),O
",",O
Jiang,O
MD(1,O
),O
",",O
Xu,O
PP(1,O
),O
",",O
Chen,O
W(1,O
),O
",",O
Ni,O
QQ(1,O
),O
",",O
Lu,O
GM(1,O
),O
",",O
Zhang,O
LJ(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medical,O
Imaging,O
",",O
Jinling,O
Hospital,O
",",O
Medical,O
School,O
of,O
Nanjing,O
"
",O
University,O
",",O
Nanjing,O
",",O
Jiangsu,O
",",O
210002,O
",",O
China,O
(,O
Z.Y.Z.,O
",",O
M.D.J.,O
",",O
P.P.X.,O
",",O
Q.Q.N.,O
",",O
"
",O
G.M.L.,O
",",O
L.J.Z,O
),O
;,O
Department,O
of,O
Medical,O
Imaging,O
",",O
Taihe,O
Hospital,O
",",O
Shiyan,O
",",O
Hubei,O
",",O
"
",O
442000,O
",",O
China,O
(,O
W.C,O
),O
.,O
"

",O
In,O
December,O
2019,O
",",O
an,O
outbreak,O
of,O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
"
",O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
infection,O
occurred,O
in,O
Wuhan,O
",",O
Hubei,O
Province,O
",",O
China,O
and,O
spread,O
across,O
"
",O
China,O
and,O
beyond,O
.,O
On,O
February,O
12,O
",",O
2020,O
",",O
WHO,O
officially,O
named,O
the,O
disease,O
caused,O
"
",O
by,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
as,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
.,O
Since,O
most,O
"
",O
COVID19,B-Disease_COVID-19
infected,O
patients,O
were,O
diagnosed,O
with,O
pneumonia,O
and,O
characteristic,O
CT,O
"
",O
imaging,O
patterns,O
",",O
radiological,O
examinations,O
have,O
become,O
vital,O
in,O
early,O
diagnosis,O
"
",O
and,O
assessment,O
of,O
disease,O
course,O
.,O
To,O
date,O
",",O
CT,O
findings,O
have,O
been,O
recommended,O
as,O
"
",O
major,O
evidence,O
for,O
clinical,O
diagnosis,O
of,O
COVID19,B-Disease_COVID-19
in,O
Hubei,O
",",O
China,O
.,O
This,O
review,O
"
",O
focuses,O
on,O
the,O
etiology,O
",",O
epidemiology,O
",",O
and,O
clinical,O
symptoms,O
of,O
COVID19,B-Disease_COVID-19
",",O
while,O
"
",O
highlighting,O
the,O
role,O
of,O
chest,O
CT,O
in,O
prevention,O
and,O
disease,O
control,O
.,O
A,O
full,O
"
",O
translation,O
of,O
this,O
article,O
in,O
Chinese,O
is,O
available,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200490,O
"
",O
PMID,O
:,O
32083985,O
"


",O
606,O
.,O
Diagnosis,O
(,O
Berl,O
),O
.,O
2020,O
Jan,O
28,O
.,O
pii,O
:,O
"
 ",O
j,O
dx.aheadofprint,O
dx20200015,O
dx20200015.xml,O
.,O
doi,O
:,O
10.1515,O
dx20200015,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
outbreak,O
:,O
think,O
the,O
unthinkable,O
and,O
be,O
prepared,O
"
",O
to,O
face,O
the,O
challenge,O
.,O
"

",O
Lippi,O
G(1,O
),O
",",O
Plebani,O
M(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Associate,O
Editor,O
of,O
Diagnosis,O
",",O
Section,O
of,O
Clinical,O
Biochemistry,O
",",O
Department,O
of,O
"
",O
Neuroscience,O
",",O
Biomedicine,O
and,O
Movement,O
",",O
University,O
Hospital,O
of,O
Verona,O
",",O
Piazzale,O
"
",O
L.A.,O
Scuro,O
",",O
10,O
",",O
37134,O
Verona,O
",",O
Italy,O
.,O
"
",O
(2)EditorinChief,O
of,O
Diagnosis,O
",",O
Department,O
of,O
Laboratory,O
Medicine,O
",",O
University,O
"
",O
Hospital,O
of,O
Padova,O
",",O
Padova,O
",",O
Italy,O
.,O
"

",O
DOI,O
:,O
10.1515,O
dx20200015,O
"
",O
PMID,O
:,O
32083831,O
"


",O
607,O
.,O
Int,O
Nurs,O
Rev.,O
2020,O
Mar;67(1):46,O
.,O
doi,O
:,O
10.1111,O
inr.12578,O
.,O
"

",O
Global,O
challenges,O
in,O
health,O
and,O
health,O
care,O
for,O
nurses,O
and,O
midwives,O
everywhere,O
.,O
"

",O
Catton,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)International,O
Council,O
of,O
Nurses,O
",",O
Geneva,O
",",O
Switzerland,O
.,O
"

",O
The,O
next,O
decade,O
is,O
likely,O
to,O
produce,O
any,O
number,O
of,O
global,O
challenges,O
that,O
will,O
"
",O
affect,O
health,O
and,O
health,O
care,O
",",O
including,O
pannational,O
infections,O
such,O
as,O
the,O
new,O
"
",O
coronavirus,O
COVID19,B-Disease_COVID-19
and,O
others,O
that,O
will,O
be,O
related,O
to,O
global,O
warming,O
.,O
Nurses,O
"
",O
will,O
be,O
required,O
to,O
react,O
to,O
these,O
events,O
",",O
even,O
though,O
they,O
will,O
also,O
be,O
affected,O
"
",O
as,O
ordinary,O
citizens,O
.,O
The,O
future,O
resilience,O
of,O
healthcare,O
services,O
will,O
depend,O
on,O
"
",O
having,O
sufficient,O
numbers,O
of,O
nurses,O
who,O
are,O
adequately,O
resourced,O
to,O
face,O
the,O
"
",O
coming,O
challenges,O
.,O
"

",O
Â©,O
2020,O
International,O
Council,O
of,O
Nurses,O
.,O
"

",O
DOI,O
:,O
10.1111,O
inr.12578,O
"
",O
PMID,O
:,O
32083728,O
"


",O
608,O
.,O
JAMA,O
.,O
2020,O
Feb,O
21,O
.,O
doi,O
:,O
10.1001,O
jama.2020.2565,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Presumed,O
Asymptomatic,O
Carrier,O
Transmission,O
of,O
COVID19,B-Disease_COVID-19
.,O
"

",O
Bai,O
Y(1,O
),O
",",O
Yao,O
L(2,O
),O
",",O
Wei,O
T(3,O
),O
",",O
Tian,O
F(4,O
),O
",",O
Jin,O
DY(5,O
),O
",",O
Chen,O
L(1,O
),O
",",O
Wang,O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medical,O
Imaging,O
",",O
Henan,O
Provincial,O
People,O
's,O
Hospital,O
",",O
Zhengzhou,O
",",O
"
",O
Henan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
Anyang,O
Hospital,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
"
",O
Anyang,O
",",O
Henan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Radiology,O
and,O
Interventional,O
",",O
the,O
Fifth,O
People,O
's,O
Hospital,O
of,O
"
",O
Anyang,O
",",O
Anyang,O
",",O
Henan,O
",",O
China,O
.,O
"
",O
(4)Tianjin,O
Medical,O
University,O
Cancer,O
Institute,O
and,O
Hospital,O
",",O
Tianjin,O
",",O
China,O
.,O
"
",O
(5)Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
the,O
University,O
of,O
Hong,O
Kong,O
",",O
Pokfulam,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.2565,O
"
",O
PMCID,O
:,O
PMC7042844,O
[,O
Available,O
on,O
20200821,O
],O
"
",O
PMID,O
:,O
32083643,O
"


",O
609,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
21,O
.,O
doi,O
:,O
10.1002,O
jmv.25719,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID2019,O
:,O
The,O
role,O
of,O
the,O
nsp2,O
and,O
nsp3,O
in,O
its,O
pathogenesis,O
.,O
"

",O
Angeletti,O
S(1,O
),O
",",O
Benvenuto,O
D(2,O
),O
",",O
Bianchi,O
M(3,O
),O
",",O
Giovanetti,O
M(4,O
),O
",",O
Pascarella,O
S(3,O
),O
",",O
"
",O
Ciccozzi,O
M(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Unit,O
of,O
Clinical,O
Laboratory,O
Science,O
",",O
University,O
Campus,O
BioMedico,O
of,O
Rome,O
",",O
"
",O
Rome,O
",",O
Italy,O
.,O
"
",O
(2)Unit,O
of,O
Medical,O
Statistics,O
and,O
Molecular,O
Epidemiology,O
",",O
University,O
Campus,O
"
",O
BioMedico,O
of,O
Rome,O
",",O
Rome,O
",",O
Italy,O
.,O
"
",O
(3)Department,O
of,O
Biochemical,O
Sciences,O
"""",O
A.,O
Rossi,O
Fanelli,O
"""",O
",",O
University,O
of,O
Rome,O
"""",O
La,O
"
",O
Sapienza,O
"""",O
",",O
Rome,O
",",O
Italy,O
.,O
"
",O
(4)Flavivirus,O
Laboratory,O
",",O
Oswaldo,O
Cruz,O
Institute,O
",",O
Oswaldo,O
Cruz,O
Foundation,O
",",O
Rio,O
de,O
"
",O
Janeiro,O
",",O
Brazil,O
.,O
"

",O
Last,O
December,O
2019,O
",",O
a,O
new,O
virus,O
",",O
named,O
novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
COVID2019,O
),O
causing,O
"
",O
many,O
cases,O
of,O
severe,O
pneumonia,O
was,O
reported,O
in,O
Wuhan,O
",",O
China,O
.,O
The,O
virus,O
knowledge,O
"
",O
is,O
limited,O
and,O
especially,O
about,O
COVID2019,O
pathogenesis,O
.,O
The,O
Open,O
Reading,O
Frame,O
"
",O
1ab,O
(,O
ORF1ab,O
),O
of,O
COVID2019,O
has,O
been,O
analyzed,O
to,O
evidence,O
the,O
presence,O
of,O
mutation,O
"
",O
caused,O
by,O
selective,O
pressure,O
on,O
the,O
virus,O
.,O
For,O
selective,O
pressure,O
analysis,O
"
",O
fastunconstrained,O
Bayesian,O
approximation,O
(,O
FUBAR,O
),O
was,O
used,O
.,O
Homology,O
modelling,O
"
",O
has,O
been,O
performed,O
by,O
SwissModel,O
and,O
HHPred,O
servers,O
.,O
The,O
presence,O
of,O
"
",O
transmembrane,O
helical,O
segments,O
in,O
Coronavirus,O
ORF1ab,O
non,O
structural,O
protein,O
2,O
"
",O
(,O
nsp2,O
),O
and,O
nsp3,O
was,O
tested,O
by,O
TMHMM,O
",",O
MEMSAT,O
",",O
and,O
MEMPACK,O
tools,O
.,O
Threedimensional,O
"
",O
structures,O
have,O
been,O
analyzed,O
and,O
displayed,O
using,O
PyMOL,O
.,O
FUBAR,O
analysis,O
revealed,O
"
",O
the,O
presence,O
of,O
potential,O
sites,O
under,O
positive,O
selective,O
pressure,O
(,O
P,O
â€‰,O
<,O
â€‰,O
0.05,O
),O
.,O
"
",O
Position,O
723,O
in,O
the,O
COVID2019,O
has,O
a,O
serine,O
instead,O
a,O
glycine,O
residue,O
",",O
while,O
at,O
"
",O
aminoacidic,O
position,O
1010,O
a,O
proline,O
instead,O
an,O
isoleucine,O
.,O
Significant,O
(,O
P,O
â€‰,O
<,O
â€‰,O
0.05,O
),O
"
",O
pervasive,O
negative,O
selection,O
in,O
2416,O
sites,O
(,O
55,O
%,O
),O
was,O
found,O
.,O
The,O
positive,O
"
",O
selective,O
pressure,O
could,O
account,O
for,O
some,O
clinical,O
features,O
of,O
this,O
virus,O
"
",O
compared,O
with,O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
and,O
Bat,O
SARSlike,O
CoV.,O
The,O
"
",O
stabilizing,O
mutation,O
falling,O
in,O
the,O
endosomeassociatedproteinlike,O
domain,O
of,O
"
",O
the,O
nsp2,O
protein,O
could,O
account,O
for,O
COVID2019,O
high,O
ability,O
of,O
contagious,O
",",O
while,O
"
",O
the,O
destabilizing,O
mutation,O
in,O
nsp3,O
proteins,O
could,O
suggest,O
a,O
potential,O
mechanism,O
"
",O
differentiating,O
COVID2019,O
from,O
SARS,O
.,O
These,O
data,O
could,O
be,O
helpful,O
for,O
further,O
"
",O
investigation,O
aimed,O
to,O
identify,O
potential,O
therapeutic,O
targets,O
or,O
vaccine,O
"
",O
strategy,O
",",O
especially,O
in,O
the,O
actual,O
moment,O
when,O
the,O
epidemic,O
is,O
ongoing,O
and,O
the,O
"
",O
scientific,O
community,O
is,O
trying,O
to,O
enrich,O
knowledge,O
about,O
this,O
new,O
viral,O
pathogen,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25719,O
"
",O
PMID,O
:,O
32083328,O
"


",O
610,O
.,O
Biomed,O
Res,O
Int,O
.,O
2020,O
Jan,O
30;2020:4045204,O
.,O
doi,O
:,O
10.1155,O
2020,O
4045204,O
.,O
eCollection,O
"
",O
2020,O
.,O
"

",O
Global,O
Analysis,O
of,O
Alternative,O
Splicing,O
Difference,O
in,O
Peripheral,O
Immune,O
Organs,O
"
",O
between,O
Tongcheng,O
Pigs,O
and,O
Large,O
White,O
Pigs,O
Artificially,O
Infected,O
with,O
PRRSV,O
In,O
"
",O
Vivo,O
.,O
"

",O
Zhang,O
Y(1,O
),O
",",O
Xue,O
L(1,O
),O
",",O
Xu,O
H(1,O
),O
",",O
Liang,O
W(1,O
),O
",",O
Wu,O
Q(1,O
),O
",",O
Zhang,O
Q(2,O
),O
",",O
Zhou,O
X(1,O
),O
",",O
Liu,O
"
",O
B(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Agricultural,O
Animal,O
Genetics,O
",",O
Breeding,O
",",O
and,O
Reproduction,O
of,O
"
",O
Ministry,O
of,O
Education,O
",",O
College,O
of,O
Animal,O
Science,O
and,O
Technology,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(2)Laboratory,O
Animal,O
Centre,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
China,O
.,O
"

",O
Alternative,O
splicing,O
(,O
AS,O
),O
plays,O
a,O
significant,O
role,O
in,O
regulating,O
gene,O
expression,O
"
",O
at,O
the,O
transcriptional,O
level,O
in,O
eukaryotes,O
.,O
Flexibility,O
and,O
diversity,O
of,O
"
",O
transcriptome,O
and,O
proteome,O
can,O
be,O
significantly,O
increased,O
through,O
alternative,O
"
",O
splicing,O
of,O
genes,O
.,O
In,O
the,O
present,O
study,O
",",O
transcriptome,O
data,O
of,O
peripheral,O
immune,O
"
",O
organs,O
including,O
spleen,O
and,O
inguinal,O
lymph,O
nodes,O
(,O
ILN,O
),O
were,O
used,O
to,O
identify,O
AS,O
"
",O
difference,O
between,O
PRRSVresistant,O
Tongcheng,O
(,O
TC,O
),O
pigs,O
and,O
PRRSVsusceptible,O
"
",O
Large,O
White,O
(,O
LW,O
),O
pigs,O
artificially,O
infected,O
with,O
porcine,O
reproductive,O
and,O
"
",O
respiratory,O
syndrome,O
virus,O
(,O
PRRSV,O
),O
in,O
vivo,O
.,O
The,O
results,O
showed,O
that,O
PRRSV,O
"
",O
infection,O
induced,O
global,O
alternative,O
splicing,O
events,O
(,O
ASEs,O
),O
with,O
different,O
modes,O
.,O
"
",O
Among,O
them,O
",",O
373,O
genes,O
and,O
595,O
genes,O
in,O
the,O
spleen,O
and,O
ILN,O
of,O
TC,O
pigs,O
",",O
while,O
458,O
"
",O
genes,O
and,O
560,O
genes,O
in,O
the,O
spleen,O
and,O
ILN,O
of,O
LW,O
pigs,O
had,O
significantly,O
"
",O
differential,O
ASEs,O
.,O
Alternative,O
splicing,O
was,O
subject,O
to,O
tissuespecific,O
and,O
"
",O
lineagespecific,O
regulation,O
in,O
response,O
to,O
PRRSV,O
infection,O
.,O
Enriched,O
GO,O
terms,O
and,O
"
",O
pathways,O
showed,O
that,O
genes,O
with,O
differential,O
ASEs,O
played,O
important,O
roles,O
in,O
"
",O
transcriptional,O
regulation,O
",",O
immune,O
response,O
",",O
metabolism,O
",",O
and,O
apoptosis,O
.,O
"
",O
Furthermore,O
",",O
a,O
splicing,O
factor,O
associated,O
with,O
apoptosis,O
",",O
SRSF4,O
",",O
was,O
"
",O
significantly,O
upregulated,O
in,O
LW,O
pigs,O
.,O
Functional,O
analysis,O
on,O
apoptosis,O
associated,O
"
",O
genes,O
was,O
validated,O
by,O
RTPCR,O
and,O
DNA,O
sequencing,O
.,O
These,O
findings,O
revealed,O
"
",O
different,O
response,O
to,O
PRRSV,O
between,O
PRRSVresistant,O
TC,O
pigs,O
and,O
PRRSVsusceptible,O
"
",O
LW,O
pigs,O
at,O
the,O
level,O
of,O
alternative,O
splicing,O
",",O
suggesting,O
the,O
potential,O
"
",O
relationship,O
between,O
AS,O
and,O
disease,O
resistance,O
to,O
PRRSV,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Yu,O
Zhang,O
et,O
al.,O
"

",O
DOI,O
:,O
10.1155,O
2020,O
4045204,O
"
",O
PMCID,O
:,O
PMC7011390,O
"
",O
PMID,O
:,O
32083129,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
611,O
.,O
Front,O
Microbiol,O
.,O
2020,O
Jan,O
31;11:78,O
.,O
doi,O
:,O
10.3389,O
fmicb.2020.00078,O
.,O
eCollection,O
"
",O
2020,O
.,O
"

",O
HDAC6,O
",",O
A,O
Novel,O
Cargo,O
for,O
Autophagic,O
Clearance,O
of,O
Stress,O
Granules,O
",",O
Mediates,O
the,O
"
",O
Repression,O
of,O
the,O
Type,O
I,O
Interferon,O
Response,O
During,O
Coxsackievirus,O
A16,O
Infection,O
.,O
"

",O
Zheng,O
Y(1)(2,O
),O
",",O
Zhu,O
G(3,O
),O
",",O
Tang,O
Y(1)(2,O
),O
",",O
Yan,O
J(1)(2,O
),O
",",O
Han,O
S(1,O
),O
",",O
Yin,O
J(1,O
),O
",",O
Peng,O
"
",O
B(1,O
),O
",",O
He,O
X(1,O
),O
",",O
Liu,O
W(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Hubei,O
Province,O
Key,O
Laboratory,O
of,O
Allergy,O
and,O
Immunology,O
",",O
Department,O
of,O
"
",O
Immunology,O
",",O
School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Shenzhen,O
Research,O
Institute,O
",",O
Wuhan,O
University,O
",",O
Shenzhen,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Emergency,O
",",O
General,O
Hospital,O
of,O
Central,O
Theater,O
Command,O
of,O
"
",O
People,O
's,O
Liberation,O
Army,O
of,O
China,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
Autophagic,O
cargoes,O
ensure,O
selective,O
autophagy,O
for,O
the,O
recognition,O
and,O
removal,O
of,O
"
",O
various,O
cytosolic,O
aggregated,O
proteins,O
",",O
damaged,O
organelles,O
",",O
or,O
pathogens,O
.,O
Stress,O
"
",O
granules,O
(,O
SGs,O
),O
",",O
as,O
antiviral,O
immune,O
complexes,O
",",O
serve,O
a,O
positive,O
role,O
in,O
the,O
type,O
"
",O
I,O
interferon,O
(,O
IFN,O
),O
response,O
and,O
can,O
be,O
targeted,O
by,O
autophagy,O
(,O
termed,O
"
",O
granulophagy,O
),O
.,O
However,O
",",O
the,O
cargo,O
of,O
granulophagy,O
remains,O
elusive,O
",",O
and,O
it,O
is,O
"
",O
still,O
unknown,O
whether,O
granulophagy,O
plays,O
a,O
role,O
in,O
viral,O
infection,O
.,O
Here,O
",",O
we,O
"
",O
found,O
that,O
histone,O
deacetylase,O
6,O
(,O
HDAC6,O
),O
",",O
a,O
component,O
of,O
viral,O
RNAinduced,O
SGs,O
",",O
"
",O
is,O
a,O
novel,O
granulophagic,O
cargo,O
that,O
is,O
recognized,O
by,O
p62,O
Sequestosome,O
1,O
(,O
SQSTM1,O
),O
"
",O
and,O
mediates,O
the,O
degradation,O
of,O
SGs,O
in,O
coxsackievirus,O
A16,O
(CA16)infected,O
cells,O
.,O
"
",O
CA16,O
viral,O
RNA,O
activated,O
the,O
protein,O
kinase,O
RNAactivated,O
(,O
PKR,O
),O
eukaryotic,O
"
",O
translation,O
initiation,O
factor,O
2alpha,O
(,O
eIF2Î±,O
),O
pathway,O
to,O
promote,O
SG,O
assembly,O
.,O
The,O
"
",O
SGs,O
were,O
degraded,O
by,O
CA16triggered,O
autophagy,O
via,O
the,O
interaction,O
between,O
the,O
"
",O
ubiquitinassociated,O
(,O
UBA,O
),O
domain,O
of,O
p62,O
and,O
the,O
ubiquitinbinding,O
domain,O
(,O
UBD,O
),O
"
",O
of,O
HDAC6,O
",",O
which,O
was,O
bridged,O
by,O
a,O
polyubiquitin,O
chain,O
.,O
We,O
also,O
found,O
that,O
"
",O
granulophagy,O
repressed,O
the,O
type,O
I,O
interferon,O
response,O
and,O
facilitated,O
viral,O
"
",O
replication,O
.,O
These,O
results,O
suggest,O
that,O
HDAC6,O
might,O
be,O
the,O
first,O
identified,O
"
",O
granulophagic,O
cargo,O
and,O
granulophagy,O
could,O
be,O
a,O
strategy,O
that,O
viruses,O
apply,O
to,O
"
",O
repress,O
the,O
antiviral,O
immune,O
response,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Zheng,O
",",O
Zhu,O
",",O
Tang,O
",",O
Yan,O
",",O
Han,O
",",O
Yin,O
",",O
Peng,O
",",O
He,O
and,O
Liu,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fmicb.2020.00078,O
"
",O
PMCID,O
:,O
PMC7005486,O
"
",O
PMID,O
:,O
32082291,O
"


",O
612,O
.,O
Front,O
Microbiol,O
.,O
2020,O
Jan,O
30;10:3111,O
.,O
doi,O
:,O
10.3389,O
fmicb.2019.03111,O
.,O
eCollection,O
"
",O
2019,O
.,O
"

",O
Characterization,O
of,O
Ebinur,O
Lake,O
Virus,O
and,O
Its,O
Human,O
Seroprevalence,O
at,O
the,O
"
",O
ChinaKazakhstan,O
Border,O
.,O
"

",O
Xia,O
H(1,O
),O
",",O
Liu,O
R(2,O
),O
",",O
Zhao,O
L(1)(3,O
),O
",",O
Sun,O
X(4,O
),O
",",O
Zheng,O
Z(4,O
),O
",",O
Atoni,O
E(1)(3,O
),O
",",O
Hu,O
X(1,O
),O
",",O
"
",O
Zhang,O
B(1,O
),O
",",O
Zhang,O
G(4,O
),O
",",O
Yuan,O
Z(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Illumina,O
(,O
China,O
),O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
of,O
Xinjiang,O
Uygur,O
Autonomous,O
Region,O
",",O
"
",O
Urumqi,O
",",O
China,O
.,O
"

",O
In,O
recent,O
years,O
",",O
rapidly,O
increasing,O
trade,O
and,O
travel,O
across,O
the,O
ChinaKazakhstan,O
"
",O
border,O
has,O
increased,O
the,O
potential,O
risk,O
of,O
the,O
introduction,O
and,O
exportation,O
of,O
"
",O
vectors,O
and,O
their,O
related,O
diseases,O
.,O
The,O
Ebinur,O
Lake,O
Nature,O
Reserve,O
is,O
located,O
in,O
"
",O
Xinjiang,O
Uygur,O
Autonomous,O
Region,O
",",O
near,O
the,O
ChinaKazakhstan,O
border,O
",",O
with,O
a,O
"
",O
suitable,O
ecosystem,O
for,O
mosquito,O
breeding,O
.,O
In,O
our,O
previous,O
work,O
",",O
a,O
novel,O
"
",O
Orthobunyavirus,O
species,O
named,O
Ebinur,O
Lake,O
virus,O
(,O
EBIV,O
),O
was,O
isolated,O
in,O
the,O
"
",O
reserve,O
.,O
To,O
gain,O
insights,O
into,O
the,O
potential,O
risk,O
of,O
EBIV,O
in,O
this,O
region,O
",",O
we,O
"
",O
conducted,O
a,O
study,O
that,O
aimed,O
to,O
clearly,O
outline,O
EBIV,O
's,O
biological,O
characteristics,O
"
",O
and,O
its,O
human,O
seroprevalence,O
in,O
this,O
region,O
.,O
Phylogenetically,O
",",O
the,O
analysis,O
of,O
"
",O
all,O
three,O
segments,O
of,O
EBIV,O
demonstrated,O
that,O
it,O
belongs,O
to,O
the,O
genus,O
"
",O
Orthobunyavirus,O
",",O
which,O
is,O
clustered,O
in,O
the,O
Bunyamwera,O
serogroup,O
.,O
EBIV,O
replicated,O
"
",O
efficiently,O
and,O
caused,O
cytopathic,O
effects,O
(,O
CPEs,O
),O
in,O
vertebrate,O
cells,O
.,O
The,O
"
",O
survival,O
rates,O
of,O
the,O
EBIVchallenged,O
mice,O
were,O
0,O
and,O
20,O
%,O
when,O
inoculated,O
with,O
"
",O
viral,O
concentrations,O
â‰¥104,O
or,O
102,O
plaqueforming,O
units,O
",",O
respectively,O
.,O
For,O
"
",O
EBIVinfected,O
mice,O
",",O
internal,O
bleeding,O
and,O
pathological,O
changes,O
were,O
observed,O
.,O
In,O
"
",O
addition,O
",",O
the,O
overall,O
immunoglobulin,O
M,O
(,O
IgM,O
),O
antibody,O
[,O
0.044444444,O
by,O
immunofluorescence,O
"
",O
assay,O
(,O
IFA,O
),O
],O
",",O
immunoglobulin,O
G,O
(,O
IgG,O
),O
antibody,O
(,O
0.048611111,O
by,O
IFA,O
),O
",",O
and,O
neutralizing,O
"
",O
antibody,O
[,O
90,O
%,O
plaque,O
reduction,O
neutralization,O
test,O
(,O
PRNT,O
),O
],O
prevalence,O
was,O
8.05,O
",",O
"
",O
12.3,O
",",O
and,O
0.95,O
%,O
",",O
respectively,O
",",O
in,O
the,O
studied,O
residents,O
.,O
In,O
summary,O
",",O
EBIV,O
is,O
a,O
"
",O
new,O
member,O
of,O
the,O
Bunyamwera,O
serogroup,O
and,O
is,O
able,O
to,O
competently,O
infect,O
cells,O
"
",O
derived,O
from,O
mosquitoes,O
",",O
rodents,O
",",O
monkeys,O
",",O
or,O
humans,O
.,O
Furthermore,O
",",O
EBIV,O
caused,O
"
",O
severe,O
disease,O
and,O
even,O
death,O
in,O
challenged,O
Kunming,O
mice,O
",",O
and,O
the,O
antibodies,O
"
",O
against,O
EBIV,O
have,O
been,O
detected,O
in,O
local,O
residents,O
",",O
indicating,O
that,O
the,O
virus,O
is,O
"
",O
a,O
potential,O
animal,O
or,O
human,O
pathogen,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Xia,O
",",O
Liu,O
",",O
Zhao,O
",",O
Sun,O
",",O
Zheng,O
",",O
Atoni,O
",",O
Hu,O
",",O
Zhang,O
",",O
Zhang,O
and,O
Yuan,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fmicb.2019.03111,O
"
",O
PMCID,O
:,O
PMC7002386,O
"
",O
PMID,O
:,O
32082268,O
"


",O
613,O
.,O
J,O
Am,O
Acad,O
Dermatol,O
.,O
2020,O
Feb,O
17,O
.,O
pii,O
:,O
S01909622(20)302681,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jaad.2020.02.030,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
What,O
are,O
we,O
doing,O
in,O
the,O
dermatology,O
outpatient,O
department,O
amidst,O
the,O
raging,O
of,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
?,O
"

",O
Chen,O
Y,O
",",O
Pradhan,O
S,O
",",O
Xue,O
S.,O
"

",O
DOI,O
:,O
10.1016,O
j.jaad.2020.02.030,O
"
",O
PMID,O
:,O
32081700,O
"


",O
614,O
.,O
Int,O
J,O
Antimicrob,O
Agents,O
.,O
2020,O
Mar;55(3):105924,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ijantimicag.2020.105924,O
.,O
Epub,O
2020,O
Feb,O
17,O
.,O
"

",O
Severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
and,O
coronavirus,O
"
",O
disease2019,O
(,O
COVID19,B-Disease_COVID-19
),O
:,O
The,O
epidemic,O
and,O
the,O
challenges,O
.,O
"

",O
Lai,O
CC(1,O
),O
",",O
Shih,O
TP(2,O
),O
",",O
Ko,O
WC(3,O
),O
",",O
Tang,O
HJ(4,O
),O
",",O
Hsueh,O
PR(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Internal,O
Medicine,O
",",O
Kaohsiung,O
Veterans,O
General,O
Hospital,O
",",O
Tainan,O
"
",O
Branch,O
",",O
Tainan,O
",",O
Taiwan,O
.,O
"
",O
(2)Department,O
of,O
Family,O
Medicine,O
",",O
Kaohsiung,O
Veterans,O
General,O
Hospital,O
",",O
Tainan,O
"
",O
Branch,O
",",O
Tainan,O
",",O
Taiwan,O
.,O
"
",O
(3)Department,O
of,O
Medicine,O
",",O
College,O
of,O
Medicine,O
",",O
National,O
Cheng,O
Kung,O
University,O
",",O
"
",O
Tainan,O
",",O
Taiwan,O
.,O
"
",O
(4)Department,O
of,O
Medicine,O
",",O
Chi,O
Mei,O
Medical,O
Center,O
",",O
Tainan,O
71004,O
",",O
Taiwan,O
.,O
"
",O
(5)Department,O
of,O
Laboratory,O
Medicine,O
",",O
National,O
Taiwan,O
University,O
Hospital,O
",",O
"
",O
National,O
Taiwan,O
University,O
College,O
of,O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
;,O
Department,O
of,O
"
",O
Internal,O
Medicine,O
",",O
National,O
Taiwan,O
University,O
Hospital,O
",",O
National,O
Taiwan,O
"
",O
University,O
College,O
of,O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
.,O
Electronic,O
address,O
:,O
"
",O
hsporen@ntu.edu.tw,O
.,O
"

",O
The,O
emergence,O
of,O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
;,O
"
",O
previously,O
provisionally,O
named,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
or,O
2019nCoV,B-Virus_SARS-CoV-2
),O
disease,O
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
in,O
China,O
at,O
the,O
end,O
of,O
2019,O
has,O
caused,O
a,O
large,O
global,O
outbreak,O
and,O
is,O
"
",O
a,O
major,O
public,O
health,O
issue,O
.,O
As,O
of,O
11,O
February,O
2020,O
",",O
data,O
from,O
the,O
World,O
Health,O
"
",O
Organization,O
(,O
WHO,O
),O
have,O
shown,O
that,O
more,O
than,O
43,O
0,O
confirmed,O
cases,O
have,O
been,O
"
",O
identified,O
in,O
28,O
countries,O
regions,O
",",O
with,O
>,O
99,O
%,O
of,O
cases,O
being,O
detected,O
in,O
China,O
.,O
"
",O
On,O
30,O
January,O
2020,O
",",O
the,O
WHO,O
declared,O
COVID19,B-Disease_COVID-19
as,O
the,O
sixth,O
public,O
health,O
"
",O
emergency,O
of,O
international,O
concern,O
.,O
SARSCoV2,B-Virus_SARS-CoV-2
is,O
closely,O
related,O
to,O
two,O
"
",O
batderived,O
severe,O
acute,O
respiratory,O
syndromelike,O
coronaviruses,O
",",O
batSLCoVZC45,O
"
",O
and,O
batSLCoVZXC21,O
.,O
It,O
is,O
spread,O
by,O
humantohuman,O
transmission,O
via,O
droplets,O
or,O
"
",O
direct,O
contact,O
",",O
and,O
infection,O
has,O
been,O
estimated,O
to,O
have,O
mean,O
incubation,O
period,O
"
",O
of,O
6.4,O
days,O
and,O
a,O
basic,O
reproduction,O
number,O
of,O
2.243.58,O
.,O
Among,O
patients,O
with,O
"
",O
pneumonia,B-Disease_COVID-19
caused,I-Disease_COVID-19
by,I-Disease_COVID-19
SARSCoV2,I-Disease_COVID-19
(,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
or,O
Wuhan,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
),O
",",O
"
",O
fever,O
was,O
the,O
most,O
common,O
symptom,O
",",O
followed,O
by,O
cough,O
.,O
Bilateral,O
lung,O
involvement,O
"
",O
with,O
groundglass,O
opacity,O
was,O
the,O
most,O
common,O
finding,O
from,O
computed,O
tomography,O
"
",O
images,O
of,O
the,O
chest,O
.,O
The,O
one,O
case,O
of,O
SARSCoV2,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
in,O
the,O
USA,O
is,O
"
",O
responding,O
well,O
to,O
remdesivir,O
",",O
which,O
is,O
now,O
undergoing,O
a,O
clinical,O
trial,O
in,O
China,O
.,O
"
",O
Currently,O
",",O
controlling,O
infection,O
to,O
prevent,O
the,O
spread,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
is,O
the,O
"
",O
primary,O
intervention,O
being,O
used,O
.,O
However,O
",",O
public,O
health,O
authorities,O
should,O
keep,O
"
",O
monitoring,O
the,O
situation,O
closely,O
",",O
as,O
the,O
more,O
we,O
can,O
learn,O
about,O
this,O
novel,O
virus,O
"
",O
and,O
its,O
associated,O
outbreak,O
",",O
the,O
better,O
we,O
can,O
respond,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijantimicag.2020.105924,O
"
",O
PMID,O
:,O
32081636,O
"


",O
615,O
.,O
Res,O
Social,O
Adm,O
Pharm,O
.,O
2020,O
Feb,O
12,O
.,O
pii,O
:,O
S15517411(20)301182,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.sapharm.2020.02.003,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Community,O
pharmacist,O
in,O
public,O
health,O
emergencies,O
:,O
Quick,O
to,O
action,O
against,O
the,O
"
",O
coronavirus,O
2019nCoV,B-Virus_SARS-CoV-2
outbreak,O
.,O
"

",O
Ung,O
COL(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Quality,O
Research,O
in,O
Chinese,O
Medicine,O
",",O
Institute,O
of,O
"
",O
Chinese,O
Medical,O
Sciences,O
",",O
Room,O
",",O
2058,O
",",O
N22,O
Building,O
",",O
University,O
of,O
Macau,O
",",O
Taipa,O
",",O
"
",O
Macao,O
.,O
Electronic,O
address,O
:,O
carolinaung@um.edu.mo,O
.,O
"

",O
The,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
that,O
is,O
caused,O
by,O
a,O
novel,O
strain,O
of,O
coronavirus,O
was,O
first,O
"
",O
detected,O
in,O
China,O
in,O
the,O
end,O
of,O
December,O
2019,O
and,O
declared,O
a,O
public,O
health,O
"
",O
emergency,O
of,O
international,O
concern,O
by,O
the,O
World,O
Health,O
Organization,O
on,O
January,O
"
",O
30,O
",",O
2020,O
.,O
Community,O
pharmacists,O
in,O
one,O
of,O
the,O
first,O
areas,O
that,O
had,O
confirmed,O
"
",O
cases,O
of,O
the,O
viral,O
infection,O
",",O
Macau,O
",",O
joined,O
the,O
collaborative,O
force,O
in,O
supporting,O
"
",O
the,O
local,O
health,O
emergency,O
preparedness,O
and,O
response,O
arrangements,O
.,O
This,O
paper,O
"
",O
aimed,O
to,O
improve,O
the,O
understanding,O
of,O
community,O
pharmacists,O
',O
role,O
in,O
case,O
of,O
"
",O
2019CoV,O
outbreak,O
based,O
on,O
the,O
practical,O
experiences,O
in,O
consultation,O
with,O
the,O
"
",O
recommendations,O
made,O
by,O
the,O
International,O
Pharmaceutical,O
Federation,O
on,O
the,O
"
",O
Coronavirus,O
2019nCoV,B-Virus_SARS-CoV-2
outbreak,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.sapharm.2020.02.003,O
"
",O
PMID,O
:,O
32081569,O
"


",O
616,O
.,O
Biochem,O
Biophys,O
Res,O
Commun,O
.,O
2020,O
Feb,O
17,O
.,O
pii,O
:,O
S0006291X(20)303399,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.bbrc.2020.02.071,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Structure,O
analysis,O
of,O
the,O
receptor,O
binding,O
of,O
2019nCoV.,O
"

",O
Chen,O
Y(1,O
),O
",",O
Guo,O
Y(1,O
),O
",",O
Pan,O
Y(2,O
),O
",",O
Zhao,O
ZJ(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Edmond,O
H.,O
Fischer,O
Translational,O
Medical,O
Research,O
Laboratory,O
",",O
Precision,O
"
",O
Medicine,O
Center,O
",",O
The,O
Seventh,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
University,O
",",O
"
",O
Shenzhen,O
",",O
518107,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(2)Edmond,O
H.,O
Fischer,O
Translational,O
Medical,O
Research,O
Laboratory,O
",",O
Precision,O
"
",O
Medicine,O
Center,O
",",O
The,O
Seventh,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
University,O
",",O
"
",O
Shenzhen,O
",",O
518107,O
",",O
Guangdong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
yihang73@hotmail.com,O
.,O
"
",O
(3)Edmond,O
H.,O
Fischer,O
Translational,O
Medical,O
Research,O
Laboratory,O
",",O
Precision,O
"
",O
Medicine,O
Center,O
",",O
The,O
Seventh,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
University,O
",",O
"
",O
Shenzhen,O
",",O
518107,O
",",O
Guangdong,O
",",O
China,O
;,O
Department,O
of,O
Pathology,O
",",O
University,O
of,O
"
",O
Oklahoma,O
Health,O
Sciences,O
Center,O
",",O
940,O
Stanton,O
L.,O
Young,O
Blvd,O
",",O
Oklahoma,O
City,O
",",O
OK,O
",",O
"
",O
73104,O
",",O
USA,O
.,O
Electronic,O
address,O
:,O
joezhao@ouhsc.edu,O
.,O
"

",O
2019nCoV,B-Virus_SARS-CoV-2
is,O
a,O
newly,O
identified,O
coronavirus,O
with,O
high,O
similarity,O
to,O
SARSCoV.,O
We,O
"
",O
performed,O
a,O
structural,O
analysis,O
of,O
the,O
receptor,O
binding,O
domain,O
(,O
RBD,O
),O
of,O
spike,O
"
",O
glycoprotein,O
responsible,O
for,O
entry,O
of,O
coronaviruses,O
into,O
host,O
cells,O
.,O
The,O
RBDs,O
"
",O
from,O
the,O
two,O
viruses,O
share,O
72,O
%,O
identity,O
in,O
amino,O
acid,O
sequences,O
",",O
and,O
molecular,O
"
",O
simulation,O
reveals,O
highly,O
similar,O
ternary,O
structures,O
.,O
However,O
",",O
2019nCoV,B-Virus_SARS-CoV-2
has,O
a,O
"
",O
distinct,O
loop,O
with,O
flexible,O
glycyl,O
residues,O
replacing,O
rigid,O
prolyl,O
residues,O
in,O
"
",O
SARSCoV.,O
Molecular,O
modeling,O
revealed,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
RBD,O
has,O
a,O
stronger,O
"
",O
interaction,O
with,O
angiotensin,O
converting,O
enzyme,O
2,O
(,O
ACE2,O
),O
.,O
A,O
unique,O
phenylalanine,O
"
",O
F486,O
in,O
the,O
flexible,O
loop,O
likely,O
plays,O
a,O
major,O
role,O
because,O
its,O
penetration,O
into,O
"
",O
a,O
deep,O
hydrophobic,O
pocket,O
in,O
ACE2,O
.,O
ACE2,O
is,O
widely,O
expressed,O
with,O
conserved,O
"
",O
primary,O
structures,O
throughout,O
the,O
animal,O
kingdom,O
from,O
fish,O
",",O
amphibians,O
",",O
reptiles,O
",",O
"
",O
birds,O
",",O
to,O
mammals,O
.,O
Structural,O
analysis,O
suggests,O
that,O
ACE2,O
from,O
these,O
animals,O
can,O
"
",O
potentially,O
bind,O
RBD,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
making,O
them,O
all,O
possible,O
natural,O
hosts,O
for,O
the,O
"
",O
virus,O
.,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
thought,O
to,O
be,O
transmitted,O
through,O
respiratory,O
droplets,O
.,O
"
",O
However,O
",",O
since,O
ACE2,O
is,O
predominantly,O
expressed,O
in,O
intestines,O
",",O
testis,O
",",O
and,O
kidney,O
",",O
"
",O
fecaloral,O
and,O
other,O
routes,O
of,O
transmission,O
are,O
also,O
possible,O
.,O
Finally,O
",",O
"
",O
antibodies,O
and,O
small,O
molecular,O
inhibitors,O
that,O
can,O
block,O
the,O
interaction,O
of,O
ACE2,O
"
",O
with,O
RBD,O
should,O
be,O
developed,O
to,O
combat,O
the,O
virus,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Authors,O
.,O
Published,O
by,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.bbrc.2020.02.071,O
"
",O
PMID,O
:,O
32081428,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
The,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
known,O
competing,O
financial,O
interests,O
or,O
personal,O
"
",O
relationships,O
that,O
could,O
have,O
appeared,O
to,O
influence,O
the,O
work,O
reported,O
in,O
this,O
"
",O
paper,O
.,O
"


",O
617,O
.,O
Adv,O
Immunol,O
.,O
2020;145:136,O
.,O
doi,O
:,O
10.1016,O
bs.ai.2019.11.001,O
.,O
Epub,O
2019,O
Dec,O
3,O
.,O
"

",O
Deciphering,O
the,O
pathways,O
to,O
antiviral,O
innate,O
immunity,O
and,O
inflammation,O
.,O
"

",O
Yang,O
Q(1,O
),O
",",O
Shu,O
HB(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Diseases,O
",",O
Medical,O
Research,O
Institute,O
",",O
Zhongnan,O
"
",O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Infectious,O
Diseases,O
",",O
Medical,O
Research,O
Institute,O
",",O
Zhongnan,O
"
",O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
shuh@whu.edu.cn,O
.,O
"

",O
The,O
antiviral,O
innate,O
immune,O
and,O
inflammatory,O
responses,O
are,O
critical,O
for,O
host,O
"
",O
defense,O
against,O
viral,O
infection,O
.,O
How,O
these,O
antiviral,O
responses,O
are,O
initiated,O
and,O
"
",O
regulated,O
has,O
been,O
intensively,O
investigated,O
.,O
Viral,O
nucleic,O
acids,O
are,O
sensed,O
by,O
"
",O
patternrecognition,O
receptors,O
(,O
PRRs,O
),O
",",O
which,O
trigger,O
various,O
signaling,O
pathways,O
by,O
"
",O
utilizing,O
distinct,O
adaptor,O
proteins,O
",",O
kinases,O
and,O
regulatory,O
proteins,O
.,O
These,O
"
",O
pathways,O
lead,O
to,O
activation,O
of,O
the,O
transcriptional,O
factors,O
NFÎºB,O
and,O
IRF3,O
and,O
"
",O
ultimate,O
induction,O
of,O
antiviral,O
effector,O
proteins,O
including,O
type,O
I,O
interferons,O
"
",O
(,O
IFNs,O
),O
",",O
TNF,O
and,O
IL1Î²,O
",",O
which,O
are,O
critical,O
mediators,O
of,O
antiviral,O
innate,O
immune,O
"
",O
and,O
inflammatory,O
responses,O
.,O
For,O
the,O
past,O
20,O
years,O
",",O
our,O
groups,O
at,O
Peking,O
"
",O
University,O
and,O
Wuhan,O
University,O
have,O
made,O
restless,O
efforts,O
in,O
deciphering,O
the,O
"
",O
molecular,O
mechanisms,O
of,O
antiviral,O
innate,O
immune,O
and,O
inflammatory,O
responses,O
.,O
Here,O
",",O
"
",O
we,O
summarize,O
the,O
major,O
discoveries,O
from,O
our,O
groups,O
",",O
including,O
the,O
identifications,O
"
",O
of,O
the,O
critical,O
adaptors,O
VISA,O
MAVS,O
and,O
MITA,O
STING,O
",",O
regulatory,O
mechanisms,O
of,O
these,O
"
",O
adaptermediated,O
signaling,O
",",O
and,O
regulation,O
of,O
TNF,O
and,O
IL1Î²triggered,O
"
",O
inflammatory,O
responses,O
.,O
"

",O
Â©,O
2020,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
bs.ai.2019.11.001,O
"
",O
PMID,O
:,O
32081195,O
"


",O
618,O
.,O
J,O
Korean,O
Med,O
Sci,O
.,O
2020,O
Feb,O
24;35(7):e89,O
.,O
doi,O
:,O
10.3346,O
jkms.2020.35.e89,O
.,O
"

",O
The,O
Author,O
's,O
Response,O
:,O
Case,O
of,O
the,O
Index,O
Patient,O
Who,O
Caused,O
Tertiary,O
Transmission,O
"
",O
of,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
in,O
Korea,O
:,O
the,O
Application,O
of,O
Lopinavir,O
Ritonavir,O
for,O
"
",O
the,O
Treatment,O
of,O
COVID19,B-Disease_COVID-19
Pneumonia,O
Monitored,O
by,O
Quantitative,O
RTPCR,O
.,O
"

",O
Lim,O
J(1,O
),O
",",O
Jeon,O
S(2,O
),O
",",O
Shin,O
HY(3,O
),O
",",O
Kim,O
MJ(1,O
),O
",",O
Seong,O
YM(4,O
),O
",",O
Lee,O
WJ(5,O
),O
",",O
Choe,O
KW(6,O
),O
",",O
"
",O
Kang,O
YM(6,O
),O
",",O
Lee,O
B(7,O
),O
",",O
Park,O
SJ(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Laboratory,O
Medicine,O
",",O
Myongji,O
Hospital,O
",",O
Hanyang,O
University,O
"
",O
College,O
of,O
Medicine,O
",",O
Goyang,O
",",O
Korea,O
.,O
"
",O
(2)New,O
Horizon,O
Cancer,O
Institute,O
",",O
Myongji,O
Hospital,O
",",O
Goyang,O
",",O
Korea,O
.,O
"
",O
(3)Department,O
of,O
Family,O
Medicine,O
",",O
Myongji,O
Hospital,O
",",O
Hanyang,O
University,O
College,O
of,O
"
",O
Medicine,O
",",O
Goyang,O
",",O
Korea,O
.,O
"
",O
(4)Department,O
of,O
Internal,O
Medicine,O
",",O
Myongji,O
Hospital,O
",",O
Goyang,O
",",O
Korea,O
.,O
"
",O
(5)Office,O
of,O
Chief,O
Executive,O
Officer,O
and,O
Chairman,O
",",O
Department,O
of,O
General,O
Surgery,O
",",O
"
",O
Myongji,O
Hospital,O
",",O
Goyang,O
",",O
Korea,O
.,O
"
",O
(6)Department,O
of,O
Infectious,O
Diseases,O
",",O
Myongji,O
Hospital,O
",",O
Goyang,O
",",O
Korea,O
.,O
"
",O
(7)CancerROP,O
",",O
Seoul,O
",",O
Korea,O
.,O
baeckseung@gmail.com,O
.,O
"
",O
(8)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Myongji,O
Hospital,O
",",O
Goyang,O
",",O
"
",O
Korea,O
.,O
drjoseph@mjh.or.kr,O
.,O
"

",O
DOI,O
:,O
10.3346,O
jkms.2020.35.e89,O
"
",O
PMID,O
:,O
32080993,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
have,O
no,O
potential,O
conflicts,O
of,O
"
",O
interest,O
to,O
disclose,O
.,O
"


",O
619,O
.,O
J,O
Korean,O
Med,O
Sci,O
.,O
2020,O
Feb,O
24;35(7):e88,O
.,O
doi,O
:,O
10.3346,O
jkms.2020.35.e88,O
.,O
"

",O
Letter,O
to,O
the,O
Editor,O
:,O
Case,O
of,O
the,O
Index,O
Patient,O
Who,O
Caused,O
Tertiary,O
Transmission,O
"
",O
of,O
Coronavirus,B-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
in,O
Korea,O
:,O
the,O
Application,O
of,O
Lopinavir,O
Ritonavir,O
for,O
"
",O
the,O
Treatment,O
of,O
COVID19,B-Disease_COVID-19
Pneumonia,O
Monitored,O
by,O
Quantitative,O
RTPCR,O
.,O
"

",O
Kim,O
JY(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
Incheon,O
"
",O
Medical,O
Center,O
",",O
Incheon,O
",",O
Korea,O
.,O
kjykey@gmail.com,O
.,O
"

",O
Comment,O
on,O
"
    ",O
J,O
Korean,O
Med,O
Sci,O
.,O
2020,O
Feb,O
17;35(6):e79,O
.,O
"

",O
DOI,O
:,O
10.3346,O
jkms.2020.35.e88,O
"
",O
PMCID,O
:,O
PMC7036343,O
"
",O
PMID,O
:,O
32080992,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
author,O
has,O
no,O
potential,O
conflicts,O
of,O
interest,O
"
",O
to,O
disclose,O
.,O
"


",O
620,O
.,O
J,O
Korean,O
Med,O
Sci,O
.,O
2020,O
Feb,O
24;35(7):e86,O
.,O
doi,O
:,O
10.3346,O
jkms.2020.35.e86,O
.,O
"

",O
Viral,O
Load,O
Kinetics,O
of,O
SARSCoV2,B-Disease_COVID-19
Infection,I-Disease_COVID-19
in,O
First,O
Two,O
Patients,O
in,O
Korea,O
.,O
"

",O
Kim,O
JY(#)(1,O
),O
",",O
Ko,O
JH(#)(2,O
),O
",",O
Kim,O
Y(3,O
),O
",",O
Kim,O
YJ(4,O
),O
",",O
Kim,O
JM(5,O
),O
",",O
Chung,O
YS(5,O
),O
",",O
Kim,O
"
",O
HM(5,O
),O
",",O
Han,O
MG(5,O
),O
",",O
Kim,O
SY(6,O
),O
",",O
Chin,O
BS(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
Incheon,O
"
",O
Medical,O
Center,O
",",O
Incheon,O
",",O
Korea,O
.,O
"
",O
(2)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Medicine,O
",",O
Samsung,O
Medical,O
"
",O
Center,O
",",O
Sungkyunkwan,O
University,O
School,O
of,O
Medicine,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(3)Department,O
of,O
Internal,O
Medicine,O
",",O
National,O
Medical,O
Center,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(4)Department,O
of,O
Pediatrics,O
",",O
Samsung,O
Medical,O
Center,O
",",O
Sungkyunkwan,O
University,O
"
",O
School,O
of,O
Medicine,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(5)Division,O
of,O
Viral,O
Diseases,O
",",O
Center,O
for,O
Laboratory,O
Control,O
of,O
Infectious,O
"
",O
Diseases,O
",",O
Korea,O
Centers,O
for,O
Disease,O
Control,O
&,O
amp,O
;,O
Prevention,O
",",O
Cheongju,O
",",O
Korea,O
.,O
"
",O
(6)Department,O
of,O
Laboratory,O
Medicine,O
",",O
National,O
Medical,O
Center,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(7)Department,O
of,O
Internal,O
Medicine,O
",",O
National,O
Medical,O
Center,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
moberrer@nmc.or.kr,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
As,O
of,O
February,O
2020,O
",",O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
"
",O
outbreak,O
started,O
in,O
China,O
in,O
December,O
2019,O
has,O
been,O
spreading,O
in,O
many,O
countries,O
"
",O
in,O
the,O
world,O
.,O
With,O
the,O
numbers,O
of,O
confirmed,O
cases,O
are,O
increasing,O
",",O
information,O
on,O
"
",O
the,O
epidemiologic,O
investigation,O
and,O
clinical,O
manifestation,O
have,O
been,O
accumulated,O
.,O
"
",O
However,O
",",O
data,O
on,O
viral,O
load,O
kinetics,O
in,O
confirmed,O
cases,O
are,O
lacking,O
.,O
Here,O
",",O
we,O
"
",O
present,O
the,O
viral,O
load,O
kinetics,O
of,O
the,O
first,O
two,O
confirmed,O
patients,O
with,O
mild,O
to,O
"
",O
moderate,O
illnesses,O
in,O
Korea,O
in,O
whom,O
distinct,O
viral,O
load,O
kinetics,O
are,O
shown,O
.,O
This,O
"
",O
report,O
suggests,O
that,O
viral,O
load,O
kinetics,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
may,O
be,O
different,O
from,O
that,O
"
",O
of,O
previously,O
reported,O
other,O
coronavirus,O
infections,O
such,O
as,O
SARSCoV.,O
"

",O
Â©,O
2020,O
The,O
Korean,O
Academy,O
of,O
Medical,O
Sciences,O
.,O
"

",O
DOI,O
:,O
10.3346,O
jkms.2020.35.e86,O
"
",O
PMCID,O
:,O
PMC7036338,O
"
",O
PMID,O
:,O
32080991,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
have,O
no,O
potential,O
conflicts,O
of,O
"
",O
interest,O
to,O
disclose,O
.,O
"


",O
621,O
.,O
J,O
Korean,O
Med,O
Sci,O
.,O
2020,O
Feb,O
24;35(7):e84,O
.,O
doi,O
:,O
10.3346,O
jkms.2020.35.e84,O
.,O
"

",O
Virus,O
Isolation,O
from,O
the,O
First,O
Patient,O
with,O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
Korea,O
.,O
"

",O
Park,O
WB(#)(1)(2,O
),O
",",O
Kwon,O
NJ(#)(3,O
),O
",",O
Choi,O
SJ(2,O
),O
",",O
Kang,O
CK(1,O
),O
",",O
Choe,O
PG(1,O
),O
",",O
Kim,O
JY(4,O
),O
",",O
"
",O
Yun,O
J(3,O
),O
",",O
Lee,O
GW(3,O
),O
",",O
Seong,O
MW(5,O
),O
",",O
Kim,O
NJ(1)(2,O
),O
",",O
Seo,O
JS(3)(6,O
),O
",",O
Oh,O
MD(1)(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Internal,O
Medicine,O
",",O
Seoul,O
National,O
University,O
College,O
of,O
"
",O
Medicine,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(2)Laboratory,O
of,O
Infection,O
&,O
amp,O
;,O
Immunity,O
",",O
Seoul,O
National,O
University,O
Hospital,O
"
",O
Biomedical,O
Research,O
Institute,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(3)Macrogen,O
Inc.,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(4)Department,O
of,O
Internal,O
Medicine,O
",",O
Incheon,O
Medical,O
Center,O
",",O
Incheon,O
",",O
Korea,O
.,O
"
",O
(5)Department,O
of,O
Laboratory,O
Medicine,O
",",O
Seoul,O
National,O
University,O
College,O
of,O
"
",O
Medicine,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(6)Precision,O
Medicine,O
Center,O
",",O
Seoul,O
National,O
University,O
Bundang,O
Hospital,O
",",O
"
",O
Seongnam,O
",",O
Korea,O
.,O
"
",O
(7)Laboratory,O
of,O
Infection,O
&,O
amp,O
;,O
Immunity,O
",",O
Seoul,O
National,O
University,O
Hospital,O
"
",O
Biomedical,O
Research,O
Institute,O
",",O
Seoul,O
",",O
Korea,O
.,O
mdohmd@snu.ac.kr,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
Novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
is,O
found,O
to,O
cause,O
a,O
large,O
outbreak,O
started,O
from,O
"
",O
Wuhan,O
since,O
December,O
2019,O
in,O
China,O
and,O
SARSCoV2,B-Virus_SARS-CoV-2
infections,O
have,O
been,O
reported,O
"
",O
with,O
epidemiological,O
linkage,O
to,O
China,O
in,O
25,O
countries,O
until,O
now,O
.,O
We,O
isolated,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
from,O
the,O
oropharyngeal,O
sample,O
obtained,O
from,O
the,O
patient,O
with,O
the,O
first,O
"
",O
laboratoryconfirmed,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
in,O
Korea,O
.,O
Cytopathic,O
effects,O
of,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
the,O
Vero,O
cell,O
cultures,O
were,O
confluent,O
3,O
days,O
after,O
the,O
first,O
blind,O
"
",O
passage,O
of,O
the,O
sample,O
.,O
Coronavirus,O
was,O
confirmed,O
with,O
spherical,O
particle,O
having,O
a,O
"
",O
fringe,O
reminiscent,O
of,O
crown,O
on,O
transmission,O
electron,O
microscopy,O
.,O
Phylogenetic,O
"
",O
analyses,O
of,O
whole,O
genome,O
sequences,O
showed,O
that,O
it,O
clustered,O
with,O
other,O
SARSCoV2,B-Virus_SARS-CoV-2
"
",O
reported,O
from,O
Wuhan,O
.,O
"

",O
Â©,O
2020,O
The,O
Korean,O
Academy,O
of,O
Medical,O
Sciences,O
.,O
"

",O
DOI,O
:,O
10.3346,O
jkms.2020.35.e84,O
"
",O
PMCID,O
:,O
PMC7036342,O
"
",O
PMID,O
:,O
32080990,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
have,O
no,O
potential,O
conflicts,O
of,O
"
",O
interest,O
to,O
disclose,O
.,O
"


",O
622,O
.,O
J,O
Travel,O
Med,O
.,O
2020,O
Feb,O
20,O
.,O
pii,O
:,O
taaa022,O
.,O
doi,O
:,O
10.1093,O
jtm,O
taaa022,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Quantifying,O
the,O
association,O
between,O
domestic,O
travel,O
and,O
the,O
exportation,O
of,O
novel,O
"
",O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
cases,O
from,O
Wuhan,O
",",O
China,O
in,O
2020,O
:,O
A,O
correlational,O
"
",O
analysis,O
.,O
"

",O
Zhao,O
S(1)(2,O
),O
",",O
Zhuang,O
Z(3,O
),O
",",O
Cao,O
P(4,O
),O
",",O
Ran,O
J(5,O
),O
",",O
Gao,O
D(6,O
),O
",",O
Lou,O
Y(3,O
),O
",",O
Yang,O
L(7,O
),O
",",O
Cai,O
"
",O
Y(8,O
),O
",",O
Wang,O
W(8,O
),O
",",O
He,O
D(3,O
),O
",",O
Wang,O
MH(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)JC,O
School,O
of,O
Public,O
Health,O
and,O
Primary,O
Care,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(2)Shenzhen,O
Research,O
Institute,O
of,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
Shenzhen,O
",",O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
"
",O
(4)Clinical,O
Research,O
Centre,O
",",O
Zhujiang,O
Hospital,O
",",O
Southern,O
Medical,O
University,O
",",O
"
",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(5)School,O
of,O
Public,O
Health,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Hong,O
"
",O
Kong,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(6)Mathematics,O
and,O
Science,O
College,O
",",O
Shanghai,O
Normal,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(7)School,O
of,O
Nursing,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(8)Department,O
of,O
Mathematics,O
",",O
Huaiyin,O
Normal,O
University,O
",",O
Huai'an,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jtm,O
taaa022,O
"
",O
PMID,O
:,O
32080723,O
"


",O
623,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
17;9(2,O
),O
.,O
pii,O
:,O
E538,O
.,O
doi,O
:,O
10.339,O
jcm9020538,O
.,O
"

",O
Incubation,O
Period,O
and,O
Other,O
Epidemiological,O
Characteristics,O
of,O
2019,O
Novel,O
"
",O
Coronavirus,O
Infections,O
with,O
Right,O
Truncation,O
:,O
A,O
Statistical,O
Analysis,O
of,O
Publicly,O
"
",O
Available,O
Case,O
Data,O
.,O
"

",O
Linton,O
NM(1,O
),O
",",O
Kobayashi,O
T(1,O
),O
",",O
Yang,O
Y(1,O
),O
",",O
Hayashi,O
K(1,O
),O
",",O
Akhmetzhanov,O
AR(1,O
),O
",",O
Jung,O
"
",O
SM(1,O
),O
",",O
Yuan,O
B(1,O
),O
",",O
Kinoshita,O
R(1,O
),O
",",O
Nishiura,O
H(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Graduate,O
School,O
of,O
Medicine,O
",",O
Hokkaido,O
University,O
",",O
Kita,O
15,O
Jo,O
Nishi,O
7,O
Chome,O
",",O
"
",O
Kitaku,O
",",O
Sapporoshi,O
",",O
Hokkaido,O
608638,O
",",O
Japan,O
.,O
"
",O
(2)Core,O
Research,O
for,O
Evolutional,O
Science,O
and,O
Technology,O
(,O
CREST,O
),O
",",O
Japan,O
Science,O
"
",O
and,O
Technology,O
Agency,O
",",O
Honcho,O
418,O
",",O
Kawaguchi,O
",",O
Saitama,O
3320012,O
",",O
Japan,O
.,O
"

",O
The,O
geographic,O
spread,O
of,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
infections,O
from,O
the,O
"
",O
epicenter,O
of,O
Wuhan,O
",",O
China,O
",",O
has,O
provided,O
an,O
opportunity,O
to,O
study,O
the,O
natural,O
"
",O
history,O
of,O
the,O
recently,O
emerged,O
virus,O
.,O
Using,O
publicly,O
available,O
eventdate,O
data,O
"
",O
from,O
the,O
ongoing,O
epidemic,O
",",O
the,O
present,O
study,O
investigated,O
the,O
incubation,O
period,O
"
",O
and,O
other,O
time,O
intervals,O
that,O
govern,O
the,O
epidemiological,O
dynamics,O
of,O
COVID19,B-Disease_COVID-19
"
",O
infections,O
.,O
Our,O
results,O
show,O
that,O
the,O
incubation,O
period,O
falls,O
within,O
the,O
range,O
of,O
"
",O
214,O
days,O
with,O
95,O
%,O
confidence,O
and,O
has,O
a,O
mean,O
of,O
around,O
5,O
days,O
when,O
approximated,O
"
",O
using,O
the,O
bestfit,O
lognormal,O
distribution,O
.,O
The,O
mean,O
time,O
from,O
illness,O
onset,O
to,O
"
",O
hospital,O
admission,O
(,O
for,O
treatment,O
and,O
or,O
isolation,O
),O
was,O
estimated,O
at,O
34,O
days,O
"
",O
without,O
truncation,O
and,O
at,O
59,O
days,O
when,O
right,O
truncated,O
.,O
Based,O
on,O
the,O
95th,O
"
",O
percentile,O
estimate,O
of,O
the,O
incubation,O
period,O
",",O
we,O
recommend,O
that,O
the,O
length,O
of,O
"
",O
quarantine,O
should,O
be,O
at,O
least,O
14,O
days,O
.,O
The,O
median,O
time,O
delay,O
of,O
13,O
days,O
from,O
"
",O
illness,O
onset,O
to,O
death,O
(,O
17,O
days,O
with,O
right,O
truncation,O
),O
should,O
be,O
considered,O
when,O
"
",O
estimating,O
the,O
COVID19,B-Disease_COVID-19
case,O
fatality,O
risk,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9020538,O
"
",O
PMID,O
:,O
32079150,O
"


",O
624,O
.,O
J,O
Anxiety,O
Disord,O
.,O
2020,O
Mar;70:102196,O
.,O
doi,O
:,O
10.1016,O
j.janxdis.2020.102196,O
.,O
Epub,O
"
",O
2020,O
Feb,O
10,O
.,O
"

",O
Coronaphobia,O
:,O
Fear,O
and,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
outbreak,O
.,O
"

",O
Asmundson,O
GJG(1,O
),O
",",O
Taylor,O
S(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Psychology,O
",",O
University,O
of,O
Regina,O
",",O
Canada,O
.,O
Electronic,O
address,O
:,O
"
",O
gordon.asmundson@uregina.ca,O
.,O
"
",O
(2)Department,O
of,O
Psychiatry,O
",",O
University,O
of,O
British,O
Columbia,O
",",O
Canada,O
.,O
Electronic,O
"
",O
address,O
:,O
steven.taylor@ubc.ca,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.janxdis.2020.102196,O
"
",O
PMID,O
:,O
32078967,O
"


",O
625,O
.,O
Lancet,O
.,O
2020,O
Feb,O
29;395(10225):684685,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303755,O
.,O
Epub,O
"
",O
2020,O
Feb,O
17,O
.,O
"

",O
Timely,O
research,O
papers,O
about,O
COVID19,B-Disease_COVID-19
in,O
China,O
.,O
"

",O
Xiang,O
YT(1,O
),O
",",O
Li,O
W(2,O
),O
",",O
Zhang,O
Q(3,O
),O
",",O
Jin,O
Y(2,O
),O
",",O
Rao,O
WW(2,O
),O
",",O
Zeng,O
LN(4,O
),O
",",O
Lok,O
GKI(5,O
),O
",",O
"
",O
Chow,O
IHI(2,O
),O
",",O
Cheung,O
T(6,O
),O
",",O
Hall,O
BJ(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Unit,O
of,O
Psychiatry,O
",",O
Institute,O
of,O
Translational,O
Medicine,O
",",O
Faculty,O
of,O
Health,O
"
",O
Sciences,O
",",O
University,O
of,O
Macau,O
999078,O
",",O
Macau,O
SAR,O
",",O
China,O
;,O
Center,O
for,O
Cognition,O
and,O
"
",O
Brain,O
Sciences,O
",",O
University,O
of,O
Macau,O
",",O
Macao,O
SAR,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
xyutly@gmail.com,O
.,O
"
",O
(2)Unit,O
of,O
Psychiatry,O
",",O
Institute,O
of,O
Translational,O
Medicine,O
",",O
Faculty,O
of,O
Health,O
"
",O
Sciences,O
",",O
University,O
of,O
Macau,O
999078,O
",",O
Macau,O
SAR,O
",",O
China,O
;,O
Center,O
for,O
Cognition,O
and,O
"
",O
Brain,O
Sciences,O
",",O
University,O
of,O
Macau,O
",",O
Macao,O
SAR,O
",",O
China,O
.,O
"
",O
(3)The,O
National,O
Clinical,O
Research,O
Center,O
for,O
Mental,O
Disorders,O
&,O
Beijing,O
Key,O
"
",O
Laboratory,O
of,O
Mental,O
Disorders,O
",",O
Beijing,O
Anding,O
Hospital,O
&,O
the,O
Advanced,O
Innovation,O
"
",O
Center,O
for,O
Human,O
Brain,O
Protection,O
",",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)Unit,O
of,O
Psychiatry,O
",",O
Institute,O
of,O
Translational,O
Medicine,O
",",O
Faculty,O
of,O
Health,O
"
",O
Sciences,O
",",O
University,O
of,O
Macau,O
999078,O
",",O
Macau,O
SAR,O
",",O
China,O
;,O
Department,O
of,O
"
",O
Neurosurgery,O
",",O
The,O
Affiliated,O
Hospital,O
of,O
Southwest,O
Medical,O
University,O
",",O
Sichuan,O
",",O
"
",O
China,O
.,O
"
",O
(5)Unit,O
of,O
Psychiatry,O
",",O
Institute,O
of,O
Translational,O
Medicine,O
",",O
Faculty,O
of,O
Health,O
"
",O
Sciences,O
",",O
University,O
of,O
Macau,O
999078,O
",",O
Macau,O
SAR,O
",",O
China,O
;,O
Kiang,O
Wu,O
Nursing,O
College,O
"
",O
of,O
Macau,O
",",O
Macau,O
SAR,O
",",O
China,O
.,O
"
",O
(6)School,O
of,O
Nursing,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
Kong,O
SAR,O
",",O
China,O
.,O
"
",O
(7)Global,O
and,O
Community,O
Mental,O
Health,O
Research,O
Group,O
",",O
Department,O
of,O
Psychology,O
",",O
"
",O
University,O
of,O
Macau,O
999078,O
",",O
Macau,O
SAR,O
",",O
China,O
;,O
Health,O
",",O
Behavior,O
",",O
and,O
Society,O
",",O
"
",O
Johns,O
Hopkins,O
Bloomberg,O
School,O
of,O
Public,O
Health,O
",",O
Baltimore,O
",",O
MD,O
",",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303755,O
"
",O
PMID,O
:,O
32078803,O
"


",O
626,O
.,O
N,O
Z,O
Med,O
J.,O
2020,O
Feb,O
21;133(1510):1215,O
.,O
"

",O
COVID19,B-Disease_COVID-19
:,O
another,O
infectious,O
disease,O
emerging,O
at,O
the,O
animalhuman,O
interface,O
.,O
"

",O
Murdoch,O
DR(1,O
),O
",",O
French,O
NP(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Dean,O
and,O
Head,O
of,O
Campus,O
",",O
University,O
of,O
Otago,O
",",O
Christchurch,O
;,O
CoDirector,O
",",O
One,O
"
",O
Health,O
Aotearoa,O
.,O
"
",O
(2)Professor,O
of,O
Food,O
Safety,O
and,O
Veterinary,O
Public,O
Health,O
",",O
School,O
of,O
Veterinary,O
"
",O
Science,O
",",O
Massey,O
University,O
",",O
Palmerston,O
North,O
;,O
CoDirector,O
",",O
One,O
Health,O
Aotearoa,O
.,O
"


",O
PMID,O
:,O
32078596,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Nil,O
.,O
"


",O
627,O
.,O
N,O
Z,O
Med,O
J.,O
2020,O
Feb,O
21;133(1510):611,O
.,O
"

",O
SARSCoV2,B-Virus_SARS-CoV-2
:,O
a,O
novel,O
deadly,O
virus,O
in,O
a,O
globalised,O
world,O
.,O
"

",O
Dilcher,O
M(1,O
),O
",",O
Werno,O
A(1,O
),O
",",O
Jennings,O
LC(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Microbiology,O
Department,O
",",O
Canterbury,O
Health,O
Laboratories,O
",",O
Christchurch,O
.,O
"
",O
(2)Department,O
of,O
Pathology,O
and,O
Biomedical,O
Science,O
",",O
University,O
of,O
Otago,O
",",O
"
",O
Christchurch,O
.,O
"


",O
PMID,O
:,O
32078595,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Nil,O
.,O
"


",O
628,O
.,O
Clin,O
Transl,O
Med,O
.,O
2020,O
Feb,O
20;9(1):19,O
.,O
doi,O
:,O
10.1186,O
s4016902000271z,O
.,O
"

",O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
of,O
pneumonia,O
in,O
Wuhan,O
",",O
China,O
:,O
emerging,O
attack,O
and,O
"
",O
management,O
strategies,O
.,O
"

",O
She,O
J(1,O
),O
",",O
Jiang,O
J(1,O
),O
",",O
Ye,O
L(1,O
),O
",",O
Hu,O
L(1,O
),O
",",O
Bai,O
C(1,O
),O
",",O
Song,O
Y(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pulmonary,O
Medicine,O
",",O
Zhongshan,O
Hospital,O
",",O
Fudan,O
University,O
",",O
180,O
"
",O
Feng,O
Lin,O
Road,O
",",O
Shanghai,O
",",O
200032,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pulmonary,O
Medicine,O
",",O
Zhongshan,O
Hospital,O
",",O
Fudan,O
University,O
",",O
180,O
"
",O
Feng,O
Lin,O
Road,O
",",O
Shanghai,O
",",O
200032,O
",",O
China,O
.,O
song.yuanlin@zshospital.sh.cn,O
.,O
"

",O
An,O
ongoing,O
outbreak,O
of,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
was,O
first,O
identified,O
in,O
Wuhan,O
",",O
Hubei,O
"
",O
province,O
",",O
China,O
at,O
the,O
end,O
of,O
2019,O
.,O
With,O
the,O
spread,O
of,O
the,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
accelerating,O
",",O
persontoperson,O
transmission,O
in,O
family,O
homes,O
or,O
hospitals,O
",",O
and,O
"
",O
intercity,O
spread,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
occurred,O
.,O
At,O
least,O
40261,O
cases,O
confirmed,O
",",O
23589,O
"
",O
cases,O
suspected,O
",",O
909,O
cases,O
death,O
and,O
3444,O
cases,O
cured,O
in,O
China,O
and,O
worldwide,O
24,O
"
",O
countries,O
confirmed,O
383,O
cases,O
being,O
diagnosed,O
",",O
1,O
case,O
death,O
in,O
February,O
10th,O
",",O
"
",O
2020,O
.,O
At,O
present,O
",",O
the,O
mortality,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
China,O
is,O
2.3,O
%,O
",",O
compared,O
with,O
9.6,O
%,O
"
",O
of,O
SARS,O
and,O
34.4,O
%,O
of,O
MERS,O
reported,O
by,O
WHO,O
.,O
It,O
seems,O
the,O
new,O
virus,O
is,O
not,O
as,O
fatal,O
"
",O
as,O
many,O
people,O
thought,O
.,O
Chinese,O
authorities,O
improved,O
surveillance,O
network,O
",",O
made,O
"
",O
the,O
laboratory,O
be,O
able,O
to,O
recognize,O
the,O
outbreak,O
within,O
a,O
few,O
weeks,O
and,O
announced,O
"
",O
the,O
virus,O
genome,O
that,O
provide,O
efficient,O
epidemiological,O
control,O
.,O
More,O
"
",O
comprehensive,O
information,O
is,O
required,O
to,O
understand,O
2019nCoV,B-Virus_SARS-CoV-2
feature,O
",",O
the,O
"
",O
epidemiology,O
of,O
origin,O
and,O
spreading,O
",",O
and,O
the,O
clinical,O
phenomina,O
.,O
According,O
to,O
"
",O
the,O
current,O
status,O
",",O
blocking,O
transmission,O
",",O
isolation,O
",",O
protection,O
",",O
and,O
alternative,O
"
",O
medication,O
are,O
the,O
urgent,O
management,O
strategies,O
against,O
2019nCoV.,O
"

",O
DOI,O
:,O
10.1186,O
s4016902000271z,O
"
",O
PMCID,O
:,O
PMC7033263,O
"
",O
PMID,O
:,O
32078069,O
"


",O
629,O
.,O
Clin,O
Oral,O
Investig,O
.,O
2020,O
Feb,O
20,O
.,O
doi,O
:,O
10.1007,O
s0078402003248x,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Coronavirus,O
COVID19,B-Disease_COVID-19
impacts,O
to,O
dentistry,O
and,O
potential,O
salivary,O
diagnosis,O
.,O
"

",O
SabinoSilva,O
R(1)(2,O
),O
",",O
Jardim,O
ACG(3,O
),O
",",O
Siqueira,O
WL(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)College,O
of,O
Dentistry,O
",",O
University,O
of,O
Saskatchewan,O
",",O
Saskatoon,O
",",O
Saskatchewan,O
",",O
"
",O
Canada,O
.,O
"
",O
(2)Department,O
of,O
Physiology,O
",",O
Institute,O
of,O
Biomedical,O
Sciences,O
",",O
Federal,O
University,O
"
",O
of,O
Uberlandia,O
",",O
Uberlandia,O
",",O
Minas,O
Gerais,O
",",O
Brazil,O
.,O
"
",O
(3)Laboratory,O
of,O
Virology,O
",",O
Institute,O
of,O
Biomedical,O
Sciences,O
",",O
Federal,O
University,O
"
",O
of,O
Uberlandia,O
",",O
Uberlandia,O
",",O
Minas,O
Gerais,O
",",O
Brazil,O
.,O
"
",O
(4)College,O
of,O
Dentistry,O
",",O
University,O
of,O
Saskatchewan,O
",",O
Saskatoon,O
",",O
Saskatchewan,O
",",O
"
",O
Canada,O
.,O
walter.siqueira@usask.ca,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s0078402003248x,O
"
",O
PMID,O
:,O
32078048,O
"


",O
630,O
.,O
Intensive,O
Care,O
Med,O
.,O
2020,O
Feb,O
20,O
.,O
doi,O
:,O
10.1007,O
s0013402005966y,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Intensive,O
care,O
during,O
the,O
coronavirus,O
epidemic,O
.,O
"

",O
Qiu,O
H(1,O
),O
",",O
Tong,O
Z(2,O
),O
",",O
Ma,O
P(3,O
),O
",",O
Hu,O
M(4,O
),O
",",O
Peng,O
Z(5,O
),O
",",O
Wu,O
W(6,O
),O
",",O
Du,O
B(7,O
),O
;,O
China,O
"
",O
Critical,O
Care,O
Clinical,O
Trials,O
Group,O
(,O
CCCCTG,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Zhongda,O
Hospital,O
",",O
Southeast,O
University,O
",",O
"
",O
Nanjing,O
",",O
Jiangsu,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Beijing,O
Chaoyang,O
Hospital,O
",",O
"
",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Peking,O
University,O
Third,O
Hospital,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Wuhan,O
Pulmonary,O
Hospital,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
"
",O
China,O
.,O
"
",O
(5)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Wuhan,O
Jinyintan,O
Hospital,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
"
",O
China,O
.,O
"
",O
(7)Medical,O
ICU,O
",",O
Peking,O
Union,O
Medical,O
College,O
Hospital,O
",",O
1,O
Shuai,O
Fu,O
Yuan,O
",",O
Beijing,O
",",O
"
",O
100730,O
",",O
China,O
.,O
Dubin98@gmail.com,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s0013402005966y,O
"
",O
PMID,O
:,O
32077996,O
"


",O
631,O
.,O
Clin,O
Chem,O
.,O
2020,O
Feb,O
20,O
.,O
pii,O
:,O
hvaa071,O
.,O
doi,O
:,O
10.1093,O
clinchem,O
hvaa071,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Emergence,O
of,O
a,O
Novel,B-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
and,O
the,O
Importance,O
of,O
"
",O
Diagnostic,O
Testing,O
:,O
Why,O
Partnership,O
between,O
Clinical,O
Laboratories,O
",",O
Public,O
Health,O
"
",O
Agencies,O
",",O
and,O
Industry,O
Is,O
Essential,O
to,O
Control,O
the,O
Outbreak,O
.,O
"

",O
Binnicker,O
MJ(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Clinical,O
Microbiology,O
",",O
Department,O
of,O
Laboratory,O
Medicine,O
and,O
"
",O
Pathology,O
",",O
Mayo,O
Clinic,O
",",O
Rochester,O
",",O
MN,O
.,O
"

",O
DOI,O
:,O
10.1093,O
clinchem,O
hvaa071,O
"
",O
PMID,O
:,O
32077933,O
"


",O
632,O
.,O
JAMA,O
.,O
2020,O
Feb,O
20,O
.,O
doi,O
:,O
10.1001,O
jama.2020.2467,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
COVID19,B-Disease_COVID-19
in,O
SingaporeCurrent,O
Experience,O
:,O
Critical,O
Global,O
Issues,O
That,O
Require,O
"
",O
Attention,O
and,O
Action,O
.,O
"

",O
Wong,O
JEL(1,O
),O
",",O
Leo,O
YS(2,O
),O
",",O
Tan,O
CC(1)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
University,O
of,O
Singapore,O
",",O
Singapore,O
.,O
"
",O
(2)National,O
Centre,O
for,O
Infectious,O
Diseases,O
",",O
Singapore,O
.,O
"
",O
(3)Ministry,O
of,O
Health,O
",",O
Singapore,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.2467,O
"
",O
PMID,O
:,O
32077901,O
"


",O
633,O
.,O
Radiology,O
.,O
2020,O
Feb,O
20:200463,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200463,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Chest,O
CT,O
Findings,O
in,O
Coronavirus,B-Disease_COVID-19
Disease19,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
:,O
Relationship,O
to,O
Duration,O
"
",O
of,O
Infection,O
.,O
"

",O
Bernheim,O
A(1,O
),O
",",O
Mei,O
X(1,O
),O
",",O
Huang,O
M(1,O
),O
",",O
Yang,O
Y(1,O
),O
",",O
Fayad,O
ZA(1,O
),O
",",O
Zhang,O
N(1,O
),O
",",O
Diao,O
"
",O
K(1,O
),O
",",O
Lin,O
B(1,O
),O
",",O
Zhu,O
X(1,O
),O
",",O
Li,O
K(1,O
),O
",",O
Li,O
S(1,O
),O
",",O
Shan,O
H(1,O
),O
",",O
Jacobi,O
A(1,O
),O
",",O
Chung,O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Diagnostic,O
",",O
Molecular,O
and,O
Interventional,O
Radiology,O
",",O
Icahn,O
School,O
"
",O
of,O
Medicine,O
at,O
Mount,O
Sinai,O
",",O
New,O
York,O
",",O
NY,O
(,O
A.B.,O
",",O
M.H.,O
",",O
Y.Y.,O
",",O
A.J.,O
",",O
M.C,O
),O
;,O
"
",O
BioMedical,O
Engineering,O
and,O
Imaging,O
Institute,O
",",O
Icahn,O
School,O
of,O
Medicine,O
at,O
Mount,O
"
",O
Sinai,O
",",O
New,O
York,O
",",O
NY,O
(,O
X.M,O
),O
;,O
Department,O
of,O
Diagnostic,O
",",O
Molecular,O
and,O
Interventional,O
"
",O
Radiology,O
",",O
and,O
BioMedical,O
Engineering,O
and,O
Imaging,O
Institute,O
",",O
Icahn,O
School,O
of,O
"
",O
Medicine,O
at,O
Mount,O
Sinai,O
",",O
New,O
York,O
(,O
Z.A.F,O
),O
;,O
Department,O
of,O
Radiology,O
",",O
The,O
First,O
"
",O
Affiliated,O
Hospital,O
of,O
Nanchang,O
University,O
",",O
NanChang,O
",",O
JiangXi,O
",",O
China,O
(,O
N.Z,O
),O
;,O
"
",O
Department,O
of,O
Radiology,O
",",O
West,O
China,O
Hospital,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
"
",O
Sichuan,O
",",O
China,O
(,O
K.D,O
),O
;,O
Department,O
of,O
Radiology,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
"
",O
Zhejiang,O
University,O
School,O
Medicine,O
",",O
Hangzhou,O
",",O
China,O
(,O
B.L,O
),O
;,O
Department,O
of,O
"
",O
Radiology,O
",",O
Nanxishan,O
Hospital,O
",",O
Guangxi,O
Zhuang,O
Autonomous,O
Region,O
",",O
China,O
(,O
X.Z,O
),O
;,O
"
",O
Department,O
of,O
Radiology,O
",",O
The,O
Fifth,O
Affiliated,O
Hospital,O
",",O
Sun,O
Yatsen,O
University,O
",",O
"
",O
New,O
Xiangzhou,O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
",",O
China,O
(,O
K.L.,O
",",O
S.L.,O
",",O
H.S,O
),O
.,O
"

",O
In,O
this,O
retrospective,O
study,O
",",O
chest,O
CTs,O
of,O
121,O
symptomatic,O
patients,O
infected,O
with,O
"
",O
coronavirus,B-Disease_COVID-19
disease19,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
from,O
four,O
centers,O
in,O
China,O
from,O
January,O
18,O
",",O
"
",O
2020,O
to,O
February,O
2,O
",",O
2020,O
were,O
reviewed,O
for,O
common,O
CT,O
findings,O
in,O
relationship,O
to,O
"
",O
the,O
time,O
between,O
symptom,O
onset,O
and,O
the,O
initial,O
CT,O
scan,O
(,O
i.e.,O
early,O
",",O
2,O
days,O
(,O
36,O
"
",O
patients,O
),O
",",O
intermediate,O
35,O
days,O
(,O
33,O
patients,O
),O
",",O
late,O
612,O
days,O
(,O
25,O
patients,O
),O
),O
.,O
"
",O
The,O
hallmarks,O
of,O
COVID19,B-Disease_COVID-19
infection,O
on,O
imaging,O
were,O
bilateral,O
and,O
peripheral,O
"
",O
groundglass,O
and,O
consolidative,O
pulmonary,O
opacities,O
.,O
Notably,O
",",O
20,O
36,O
(,O
56,O
%,O
),O
of,O
early,O
"
",O
patients,O
had,O
a,O
normal,O
CT,O
.,O
With,O
a,O
longer,O
time,O
after,O
the,O
onset,O
of,O
symptoms,O
",",O
CT,O
"
",O
findings,O
were,O
more,O
frequent,O
",",O
including,O
consolidation,O
",",O
bilateral,O
and,O
peripheral,O
"
",O
disease,O
",",O
greater,O
total,O
lung,O
involvement,O
",",O
linear,O
opacities,O
",",O
"""",O
crazypaving,O
"""",O
pattern,O
"
",O
and,O
the,O
"""",O
reverse,O
halo,O
"""",O
sign,O
.,O
Bilateral,O
lung,O
involvement,O
was,O
observed,O
in,O
10,O
36,O
"
",O
early,O
patients,O
(,O
28,O
%,O
),O
",",O
25,O
33,O
intermediate,O
patients,O
(,O
76,O
%,O
),O
",",O
and,O
22,O
25,O
late,O
patients,O
"
",O
(,O
88,O
%,O
),O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200463,O
"
",O
PMID,O
:,O
32077789,O
"


",O
634,O
.,O
Small,O
.,O
2020,O
Feb,O
20:e1906206,O
.,O
doi,O
:,O
10.1002,O
smll.201906206,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
GlycyrrhizicAcidBased,O
Carbon,O
Dots,O
with,O
High,O
Antiviral,O
Activity,O
by,O
Multisite,O
"
",O
Inhibition,O
Mechanisms,O
.,O
"

",O
Tong,O
T(1,O
),O
",",O
Hu,O
H(1,O
),O
",",O
Zhou,O
J(2,O
),O
",",O
Deng,O
S(1,O
),O
",",O
Zhang,O
X(1,O
),O
",",O
Tang,O
W(1,O
),O
",",O
Fang,O
L(2,O
),O
",",O
Xiao,O
"
",O
S(2,O
),O
",",O
Liang,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)College,O
of,O
Resource,O
and,O
Environment,O
",",O
College,O
of,O
Science,O
",",O
State,O
Key,O
Laboratory,O
"
",O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
P.,O
"
",O
R.,O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Key,O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
The,O
"
",O
Cooperative,O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
P.,O
R.,O
China,O
.,O
"

",O
With,O
the,O
gradual,O
usage,O
of,O
carbon,O
dots,O
(,O
CDs,O
),O
in,O
the,O
area,O
of,O
antiviral,O
research,O
",",O
"
",O
attempts,O
have,O
been,O
stepped,O
up,O
to,O
develop,O
new,O
antiviral,O
CDs,O
with,O
high,O
"
",O
biocompatibility,O
and,O
antiviral,O
effects,O
.,O
In,O
this,O
study,O
",",O
a,O
kind,O
of,O
highly,O
"
",O
biocompatible,O
CDs,O
(,O
GlyCDs,O
),O
is,O
synthesized,O
from,O
active,O
ingredient,O
(,O
glycyrrhizic,O
"
",O
acid,O
),O
of,O
Chinese,O
herbal,O
medicine,O
by,O
a,O
hydrothermal,O
method,O
.,O
Using,O
the,O
porcine,O
"
",O
reproductive,O
and,O
respiratory,O
syndrome,O
virus,O
(,O
PRRSV,O
),O
as,O
a,O
model,O
",",O
it,O
is,O
found,O
that,O
"
",O
the,O
GlyCDs,O
inhibit,O
PRRSV,O
proliferation,O
by,O
up,O
to,O
5,O
orders,O
of,O
viral,O
titers,O
.,O
"
",O
Detailed,O
investigations,O
reveal,O
that,O
GlyCDs,O
can,O
inhibit,O
PRRSV,O
invasion,O
and,O
"
",O
replication,O
",",O
stimulate,O
antiviral,O
innate,O
immune,O
responses,O
",",O
and,O
inhibit,O
the,O
"
",O
accumulation,O
of,O
intracellular,O
reactive,O
oxygen,O
species,O
(,O
ROS,O
),O
caused,O
by,O
PRRSV,O
"
",O
infection,O
.,O
Proteomics,O
analysis,O
demonstrates,O
that,O
GlyCDs,O
can,O
stimulate,O
cells,O
to,O
"
",O
regulate,O
the,O
expression,O
of,O
some,O
host,O
restriction,O
factors,O
",",O
including,O
DDX53,O
and,O
"
",O
NOS3,O
",",O
which,O
are,O
directly,O
related,O
to,O
PRRSV,O
proliferation,O
.,O
Moreover,O
",",O
it,O
is,O
found,O
"
",O
that,O
GlyCDs,O
also,O
remarkably,O
suppress,O
the,O
propagation,O
of,O
other,O
viruses,O
",",O
such,O
as,O
"
",O
pseudorabies,O
virus,O
(,O
PRV,O
),O
and,O
porcine,O
epidemic,O
diarrhea,O
virus,O
(,O
PEDV,O
),O
",",O
suggesting,O
"
",O
the,O
broad,O
antiviral,O
activity,O
of,O
GlyCDs,O
.,O
The,O
integrated,O
results,O
demonstrate,O
that,O
"
",O
GlyCDs,O
possess,O
extraordinary,O
antiviral,O
activity,O
with,O
multisite,O
inhibition,O
"
",O
mechanisms,O
",",O
providing,O
a,O
promising,O
candidate,O
for,O
alternative,O
therapy,O
for,O
PRRSV,O
"
",O
infection,O
.,O
"

",O
Â©,O
2020,O
WILEYVCH,O
Verlag,O
GmbH,O
&,O
Co.,O
KGaA,O
",",O
Weinheim,O
.,O
"

",O
DOI,O
:,O
10.1002,O
smll.201906206,O
"
",O
PMID,O
:,O
32077621,O
"


",O
635,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
20,O
.,O
doi,O
:,O
10.1002,O
jmv.25718,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
GP73,O
facilitates,O
hepatitis,O
B,O
virus,O
replication,O
by,O
repressing,O
the,O
NFÎºB,O
signaling,O
"
",O
pathway,O
.,O
"

",O
Liu,O
L(1,O
),O
",",O
Zhu,O
J(1,O
),O
",",O
Yang,O
J(1,O
),O
",",O
Li,O
X(2,O
),O
",",O
Yuan,O
J(1,O
),O
",",O
Wu,O
J(3)(4,O
),O
",",O
Liu,O
Z(1)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Department,O
of,O
Respiratory,O
",",O
Department,O
of,O
"
",O
Infectious,O
Diseases,O
",",O
Renmin,O
Hospital,O
",",O
Hubei,O
University,O
of,O
Medicine,O
",",O
Shiyan,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Emergency,O
",",O
Dongfeng,O
Maojian,O
Hospital,O
",",O
Sinopharm,O
Group,O
"
",O
Corporation,O
",",O
Shiyan,O
",",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Virology,O
and,O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Institute,O
of,O
Medical,O
Microbiology,O
",",O
Jinan,O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"

",O
Hepatitis,O
B,O
virus,O
(,O
HBV,O
),O
chronically,O
infects,O
approximately,O
350,O
million,O
people,O
"
",O
worldwide,O
",",O
and,O
600,O
â€‰,O
0,O
deaths,O
are,O
caused,O
by,O
HBVrelated,O
hepatic,O
failure,O
.,O
Golgi,O
"
",O
protein,O
73,O
(,O
GP73,O
),O
is,O
a,O
serum,O
biomarker,O
for,O
liver,O
diseases,O
",",O
including,O
chronic,O
"
",O
hepatitis,O
B.,O
Here,O
",",O
we,O
determine,O
the,O
effect,O
of,O
HBV,O
infection,O
on,O
GP73,O
production,O
"
",O
and,O
characterized,O
the,O
role,O
of,O
GP73,O
in,O
HBV,O
replication,O
.,O
Initially,O
",",O
we,O
show,O
that,O
"
",O
GP73,O
is,O
highly,O
produced,O
in,O
the,O
sera,O
of,O
HBVpositive,O
patients,O
with,O
chronic,O
liver,O
"
",O
diseases,O
and,O
in,O
HBVstimulated,O
leukocytes,O
.,O
In,O
addition,O
",",O
HBV,O
stimulation,O
promotes,O
"
",O
GP73,O
production,O
in,O
peripheral,O
blood,O
mononuclear,O
cells,O
isolated,O
from,O
healthy,O
"
",O
donors,O
and,O
in,O
macrophages,O
derived,O
from,O
human,O
acute,O
monocytic,O
leukemia,O
cells,O
"
",O
(,O
THP1,O
),O
.,O
Notably,O
",",O
the,O
hepatitis,O
B,O
surface,O
antigen,O
(,O
HBsAg,O
),O
",",O
but,O
not,O
HBV,O
"
",O
replication,O
",",O
is,O
required,O
for,O
the,O
activation,O
of,O
GP73,O
expression,O
.,O
Moreover,O
",",O
in,O
"
",O
HepG2,O
cells,O
and,O
Huh7,O
cells,O
",",O
GP73,O
facilitates,O
HBV,O
replication,O
and,O
represses,O
"
",O
nuclear,O
factor,O
kappa,O
B,O
p50,O
expression,O
",",O
which,O
in,O
turn,O
represses,O
HBV,O
replication,O
"
",O
and,O
GP73,O
expression,O
.,O
Finally,O
",",O
we,O
demonstrate,O
that,O
GP73,O
facilitates,O
HBV,O
"
",O
replication,O
by,O
repressing,O
the,O
innate,O
immune,O
response,O
and,O
the,O
nuclear,O
factor,O
kappa,O
"
",O
B,O
signaling,O
pathway,O
.,O
Taken,O
together,O
",",O
we,O
revealed,O
a,O
distinct,O
positive,O
feedback,O
"
",O
mechanism,O
between,O
HBV,O
replication,O
and,O
GP73,O
production,O
and,O
suggest,O
that,O
GP73,O
acts,O
"
",O
as,O
a,O
potential,O
antiviral,O
target,O
for,O
HBV,O
infection,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25718,O
"
",O
PMID,O
:,O
32077512,O
"


",O
636,O
.,O
Allergy,O
.,O
2020,O
Feb,O
19,O
.,O
doi,O
:,O
10.1111,O
all.14238,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
characteristics,O
of,O
140,O
patients,O
infected,O
with,O
SARSCoV2,B-Virus_SARS-CoV-2
in,O
Wuhan,O
",",O
"
",O
China,O
.,O
"

",O
Zhang,O
JJ(1,O
),O
",",O
Dong,O
X(1,O
),O
",",O
Cao,O
YY(2,O
),O
",",O
Yuan,O
YD(3,O
),O
",",O
Yang,O
YB(4,O
),O
",",O
Yan,O
YQ(5,O
),O
",",O
Akdis,O
"
",O
CA(6,O
),O
",",O
Gao,O
YD(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Allergology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Second,O
Hospital,O
of,O
Hebei,O
"
",O
Medical,O
University,O
",",O
Shijiazhuang,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
"
",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Infectious,O
Disease,O
",",O
No.,O
7,O
Hospital,O
of,O
Wuhan,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(6)Swiss,O
Institute,O
of,O
Allergy,O
and,O
Asthma,O
Research,O
(,O
SIAF,O
),O
",",O
University,O
of,O
Zurich,O
",",O
"
",O
Davos,O
",",O
Switzerland,O
.,O
"

",O
BACKGROUND,O
:,O
Coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
caused,O
by,O
severe,O
acute,O
"
",O
respiratory,O
syndrome,O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
infection,O
has,O
been,O
widely,O
spread,O
.,O
"
",O
We,O
aim,O
to,O
investigate,O
the,O
clinical,O
characteristic,O
and,O
allergy,O
status,O
of,O
patients,O
"
",O
infected,O
with,O
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"
",O
METHODS,O
:,O
Electronic,O
medical,O
records,O
including,O
demographics,O
",",O
clinical,O
"
",O
manifestation,O
",",O
comorbidities,O
",",O
laboratory,O
data,O
",",O
and,O
radiological,O
materials,O
of,O
140,O
"
",O
hospitalized,O
COVID19,B-Disease_COVID-19
patients,O
",",O
with,O
confirmed,O
result,O
of,O
SARSCoV2,B-Virus_SARS-CoV-2
viral,O
"
",O
infection,O
",",O
were,O
extracted,O
and,O
analyzed,O
.,O
"
",O
RESULTS,O
:,O
An,O
approximately,O
0.042361111,O
ratio,O
of,O
male,O
(,O
50.7,O
%,O
),O
and,O
female,O
COVID19,B-Disease_COVID-19
patients,O
"
",O
was,O
found,O
",",O
with,O
an,O
overall,O
median,O
age,O
of,O
57,O
Â ,O
years,O
.,O
All,O
patients,O
were,O
"
",O
communityacquired,O
cases,O
.,O
Fever,O
(,O
91.7,O
%,O
),O
",",O
cough,O
(,O
75,O
%,O
),O
",",O
fatigue,O
(,O
75,O
%,O
),O
",",O
and,O
"
",O
gastrointestinal,O
symptoms,O
(,O
39.6,O
%,O
),O
were,O
the,O
most,O
common,O
clinical,O
manifestations,O
",",O
"
",O
whereas,O
hypertension,O
(,O
30,O
%,O
),O
and,O
diabetes,O
mellitus,O
(,O
12.1,O
%,O
),O
were,O
the,O
most,O
common,O
"
",O
comorbidities,O
.,O
Drug,O
hypersensitivity,O
(,O
11.4,O
%,O
),O
and,O
urticaria,O
(,O
1.4,O
%,O
),O
were,O
"
",O
selfreported,O
by,O
several,O
patients,O
.,O
Asthma,O
or,O
other,O
allergic,O
diseases,O
were,O
not,O
"
",O
reported,O
by,O
any,O
of,O
the,O
patients,O
.,O
Chronic,O
obstructive,O
pulmonary,O
disease,O
(,O
COPD,O
",",O
"
",O
1.4,O
%,O
),O
patients,O
and,O
current,O
smokers,O
(,O
1.4,O
%,O
),O
were,O
rare,O
.,O
Bilateral,O
groundglass,O
or,O
"
",O
patchy,O
opacity,O
(,O
89.6,O
%,O
),O
was,O
the,O
most,O
common,O
sign,O
of,O
radiological,O
finding,O
.,O
"
",O
Lymphopenia,O
(,O
75.4,O
%,O
),O
and,O
eosinopenia,O
(,O
52.9,O
%,O
),O
were,O
observed,O
in,O
most,O
patients,O
.,O
Blood,O
"
",O
eosinophil,O
counts,O
correlate,O
positively,O
with,O
lymphocyte,O
counts,O
in,O
severe,O
"
",O
(,O
r,O
Â ,O
=,O
Â ,O
0.486,O
",",O
P,O
Â ,O
<,O
Â ,O
0.001,O
),O
and,O
nonsevere,O
(,O
r,O
Â ,O
=,O
Â ,O
0.469,O
",",O
P,O
Â ,O
<,O
Â ,O
0.001,O
),O
patients,O
after,O
hospital,O
"
",O
admission,O
.,O
Significantly,O
higher,O
levels,O
of,O
Ddimer,O
",",O
Creactive,O
protein,O
",",O
and,O
"
",O
procalcitonin,O
were,O
associated,O
with,O
severe,O
patients,O
compared,O
to,O
nonsevere,O
patients,O
"
",O
(,O
all,O
P,O
Â ,O
<,O
Â ,O
0.001,O
),O
.,O
"
",O
CONCLUSION,O
:,O
Detailed,O
clinical,O
investigation,O
of,O
140,O
hospitalized,O
COVID19,B-Disease_COVID-19
cases,O
"
",O
suggests,O
eosinopenia,O
together,O
with,O
lymphopenia,O
may,O
be,O
a,O
potential,O
indicator,O
for,O
"
",O
diagnosis,O
.,O
Allergic,O
diseases,O
",",O
asthma,O
",",O
and,O
COPD,O
are,O
not,O
risk,O
factors,O
for,O
"
",O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
Older,O
age,O
",",O
high,O
number,O
of,O
comorbidities,O
",",O
and,O
more,O
prominent,O
"
",O
laboratory,O
abnormalities,O
were,O
associated,O
with,O
severe,O
patients,O
.,O
"

",O
Â©,O
2020,O
EAACI,O
and,O
John,O
Wiley,O
and,O
Sons,O
A,O
S.,O
Published,O
by,O
John,O
Wiley,O
and,O
Sons,O
Ltd.,O
"

",O
DOI,O
:,O
10.1111,O
all.14238,O
"
",O
PMID,O
:,O
32077115,O
"


",O
637,O
.,O
Sci,O
Adv,O
.,O
2020,O
Feb,O
5;6(6):eaax7989,O
.,O
doi,O
:,O
10.1126,O
sciadv.aax7989,O
.,O
eCollection,O
2020,O
"
",O
Feb.,O
"

",O
Flavivirus,O
induces,O
and,O
antagonizes,O
antiviral,O
RNA,O
interference,O
in,O
both,O
mammals,O
and,O
"
",O
mosquitoes,O
.,O
"

",O
Qiu,O
Y(1)(2,O
),O
",",O
Xu,O
YP(3,O
),O
",",O
Wang,O
M(1)(2,O
),O
",",O
Miao,O
M(1)(4,O
),O
",",O
Zhou,O
H(1)(4,O
),O
",",O
Xu,O
J(1)(2,O
),O
",",O
Kong,O
"
",O
J(1)(2,O
),O
",",O
Zheng,O
D(5,O
),O
",",O
Li,O
RT(3,O
),O
",",O
Zhang,O
RR(3,O
),O
",",O
Guo,O
Y(3,O
),O
",",O
Li,O
XF(3,O
),O
",",O
Cui,O
J(1)(2)(6,O
),O
",",O
"
",O
Qin,O
CF(3,O
),O
",",O
Zhou,O
X(1)(2)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
for,O
"
",O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
(,O
CAS,O
),O
",",O
Wuhan,O
430071,O
",",O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
100049,O
",",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Pathogen,O
and,O
Biosecurity,O
",",O
Beijing,O
Institute,O
of,O
"
",O
Microbiology,O
and,O
Epidemiology,O
",",O
Academy,O
of,O
Military,O
Medical,O
Sciences,O
(,O
AMMS,O
),O
",",O
"
",O
Beijing,O
100071,O
",",O
China,O
.,O
"
",O
(4)College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
430072,O
",",O
China,O
.,O
"
",O
(5)Beijing,O
Institute,O
of,O
Technology,O
",",O
Beijing,O
10081,O
",",O
China,O
.,O
"
",O
(6)CAS,O
Key,O
Laboratory,O
of,O
Molecular,O
Virology,O
and,O
Immunology,O
",",O
Institut,O
Pasteur,O
of,O
"
",O
Shanghai,O
",",O
CAS,O
",",O
Shanghai,O
200031,O
",",O
China,O
.,O
"

",O
Mosquitoborne,O
flaviviruses,O
infect,O
both,O
mammals,O
and,O
mosquitoes,O
.,O
RNA,O
interference,O
"
",O
(,O
RNAi,O
),O
has,O
been,O
demonstrated,O
as,O
an,O
antiflavivirus,O
mechanism,O
in,O
mosquitoes,O
;,O
"
",O
however,O
",",O
whether,O
and,O
how,O
flaviviruses,O
induce,O
and,O
antagonize,O
RNAimediated,O
"
",O
antiviral,O
immunity,O
in,O
mammals,O
remains,O
unknown,O
.,O
We,O
show,O
that,O
the,O
nonstructural,O
"
",O
protein,O
NS2A,O
of,O
dengue,O
virus2,O
(,O
DENV2,O
),O
act,O
as,O
a,O
viral,O
suppressor,O
of,O
RNAi,O
(,O
VSR,O
),O
.,O
"
",O
When,O
NS2Amediated,O
RNAi,O
suppression,O
was,O
disabled,O
",",O
the,O
resulting,O
mutant,O
DENV2,O
"
",O
induced,O
Dicerdependent,O
production,O
of,O
abundant,O
DENV2derived,O
siRNAs,O
in,O
"
",O
differentiated,O
mammalian,O
cells,O
.,O
VSRdisabled,O
DENV2,O
showed,O
severe,O
replication,O
"
",O
defects,O
in,O
mosquito,O
and,O
mammalian,O
cells,O
and,O
in,O
mice,O
that,O
were,O
rescued,O
by,O
RNAi,O
"
",O
deficiency,O
.,O
Moreover,O
",",O
NS2As,O
of,O
multiple,O
flaviviruses,O
act,O
as,O
VSRs,O
in,O
vitro,O
and,O
"
",O
during,O
viral,O
infection,O
in,O
both,O
organisms,O
.,O
Overall,O
",",O
our,O
findings,O
demonstrate,O
that,O
"
",O
antiviral,O
RNAi,O
can,O
be,O
induced,O
by,O
flavivirus,O
",",O
while,O
flavivirus,O
uses,O
NS2A,O
as,O
a,O
bona,O
"
",O
fide,O
VSR,O
to,O
evade,O
RNAi,O
in,O
mammals,O
and,O
mosquitoes,O
",",O
highlighting,O
the,O
importance,O
of,O
"
",O
RNAi,O
in,O
flaviviral,O
vectorhost,O
life,O
cycles,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Authors,O
",",O
some,O
rights,O
reserved,O
;,O
exclusive,O
licensee,O
American,O
"
",O
Association,O
for,O
the,O
Advancement,O
of,O
Science,O
.,O
No,O
claim,O
to,O
original,O
U.S.,O
Government,O
"
",O
Works,O
.,O
Distributed,O
under,O
a,O
Creative,O
Commons,O
Attribution,O
NonCommercial,O
License,O
4,O
"
",O
(,O
CC,O
BYNC,O
),O
.,O
"

",O
DOI,O
:,O
10.1126,O
sciadv.aax7989,O
"
",O
PMCID,O
:,O
PMC7002134,O
"
",O
PMID,O
:,O
32076641,O
"


",O
638,O
.,O
Science,O
.,O
2020,O
Mar,O
13;367(6483):12601263,O
.,O
doi,O
:,O
10.1126,O
science.abb2507,O
.,O
Epub,O
2020,O
"
",O
Feb,O
19,O
.,O
"

",O
CryoEM,O
structure,O
of,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
spike,O
in,O
the,O
prefusion,O
conformation,O
.,O
"

",O
Wrapp,O
D(#)(1,O
),O
",",O
Wang,O
N(#)(1,O
),O
",",O
Corbett,O
KS(2,O
),O
",",O
Goldsmith,O
JA(1,O
),O
",",O
Hsieh,O
CL(1,O
),O
",",O
Abiona,O
"
",O
O(2,O
),O
",",O
Graham,O
BS(2,O
),O
",",O
McLellan,O
JS(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Molecular,O
Biosciences,O
",",O
The,O
University,O
of,O
Texas,O
at,O
Austin,O
",",O
"
",O
Austin,O
",",O
TX,O
78712,O
",",O
USA,O
.,O
"
",O
(2)Vaccine,O
Research,O
Center,O
",",O
National,O
Institute,O
of,O
Allergy,O
and,O
Infectious,O
"
",O
Diseases,O
",",O
National,O
Institutes,O
of,O
Health,O
",",O
Bethesda,O
",",O
MD,O
20892,O
",",O
USA,O
.,O
"
",O
(3)Department,O
of,O
Molecular,O
Biosciences,O
",",O
The,O
University,O
of,O
Texas,O
at,O
Austin,O
",",O
"
",O
Austin,O
",",O
TX,O
78712,O
",",O
USA,O
.,O
jmclellan@austin.utexas.edu,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
The,O
outbreak,O
of,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
represents,O
a,O
pandemic,O
threat,O
that,O
"
",O
has,O
been,O
declared,O
a,O
public,O
health,O
emergency,O
of,O
international,O
concern,O
.,O
The,O
CoV,O
"
",O
spike,O
(,O
S,O
),O
glycoprotein,O
is,O
a,O
key,O
target,O
for,O
vaccines,O
",",O
therapeutic,O
antibodies,O
",",O
and,O
"
",O
diagnostics,O
.,O
To,O
facilitate,O
medical,O
countermeasure,O
development,O
",",O
we,O
determined,O
a,O
"
",O
3.5angstromresolution,O
cryoelectron,O
microscopy,O
structure,O
of,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
S,O
"
",O
trimer,O
in,O
the,O
prefusion,O
conformation,O
.,O
The,O
predominant,O
state,O
of,O
the,O
trimer,O
has,O
one,O
"
",O
of,O
the,O
three,O
receptorbinding,O
domains,O
(,O
RBDs,O
),O
rotated,O
up,O
in,O
a,O
receptoraccessible,O
"
",O
conformation,O
.,O
We,O
also,O
provide,O
biophysical,O
and,O
structural,O
evidence,O
that,O
the,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
S,O
protein,O
binds,O
angiotensinconverting,O
enzyme,O
2,O
(,O
ACE2,O
),O
with,O
higher,O
"
",O
affinity,O
than,O
does,O
severe,O
acute,O
respiratory,O
syndrome,O
(SARS)CoV,O
S.,O
Additionally,O
",",O
"
",O
we,O
tested,O
several,O
published,O
SARSCoV,O
RBDspecific,O
monoclonal,O
antibodies,O
and,O
found,O
"
",O
that,O
they,O
do,O
not,O
have,O
appreciable,O
binding,O
to,O
2019nCoV,B-Virus_SARS-CoV-2
S,O
",",O
suggesting,O
that,O
"
",O
antibody,O
crossreactivity,O
may,O
be,O
limited,O
between,O
the,O
two,O
RBDs,O
.,O
The,O
structure,O
of,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
S,O
should,O
enable,O
the,O
rapid,O
development,O
and,O
evaluation,O
of,O
medical,O
"
",O
countermeasures,O
to,O
address,O
the,O
ongoing,O
public,O
health,O
crisis,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Authors,O
",",O
some,O
rights,O
reserved,O
;,O
exclusive,O
licensee,O
American,O
"
",O
Association,O
for,O
the,O
Advancement,O
of,O
Science,O
.,O
No,O
claim,O
to,O
original,O
U.S.,O
Government,O
"
",O
Works,O
.,O
"

",O
DOI,O
:,O
10.1126,O
science.abb2507,O
"
",O
PMID,O
:,O
32075877,O
"


",O
639,O
.,O
BMJ,O
.,O
2020,O
Feb,O
19;368:m627,O
.,O
doi,O
:,O
10.1136,O
bmj.m627,O
.,O
"

",O
Covid19,B-Disease_COVID-19
:,O
a,O
puzzle,O
with,O
many,O
missing,O
pieces,O
.,O
"

",O
Vetter,O
P(1)(2,O
),O
",",O
Eckerle,O
I(3)(4,O
),O
",",O
Kaiser,O
L(3)(2)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Geneva,O
Centre,O
for,O
Emerging,O
Viral,O
Diseases,O
",",O
Geneva,O
University,O
Hospitals,O
",",O
1211,O
"
",O
Geneva,O
14,O
",",O
Switzerland,O
pauline.vetter@hcuge.ch,O
.,O
"
",O
(2)Division,O
of,O
Infectious,O
Diseases,O
",",O
Geneva,O
University,O
Hospitals,O
",",O
Geneva,O
",",O
"
",O
Switzerland,O
.,O
"
",O
(3)Geneva,O
Centre,O
for,O
Emerging,O
Viral,O
Diseases,O
",",O
Geneva,O
University,O
Hospitals,O
",",O
1211,O
"
",O
Geneva,O
14,O
",",O
Switzerland,O
.,O
"
",O
(4)University,O
of,O
Geneva,O
",",O
Faculty,O
of,O
Medicine,O
",",O
1205,O
Geneva,O
",",O
Switzerland,O
.,O
"

",O
Comment,O
on,O
"
    ",O
BMJ,O
.,O
2020,O
Feb,O
19;368:m606,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m627,O
"
",O
PMID,O
:,O
32075791,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interests,O
:,O
We,O
have,O
read,O
and,O
understood,O
"
",O
BMJ,O
policy,O
on,O
declaration,O
of,O
interests,O
and,O
declare,O
that,O
we,O
have,O
no,O
competing,O
"
",O
interests,O
.,O
"


",O
640,O
.,O
BMJ,O
.,O
2020,O
Feb,O
19;368:m606,O
.,O
doi,O
:,O
10.1136,O
bmj.m606,O
.,O
"

",O
Clinical,O
findings,O
in,O
a,O
group,O
of,O
patients,O
infected,O
with,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
SARSCov2,B-Virus_SARS-CoV-2
),O
outside,O
of,O
Wuhan,O
",",O
China,O
:,O
retrospective,O
case,O
series,O
.,O
"

",O
Xu,O
XW(1,O
),O
",",O
Wu,O
XX(1,O
),O
",",O
Jiang,O
XG(2,O
),O
",",O
Xu,O
KJ(1,O
),O
",",O
Ying,O
LJ(3,O
),O
",",O
Ma,O
CL(4,O
),O
",",O
Li,O
SB(5,O
),O
",",O
Wang,O
"
",O
HY(6,O
),O
",",O
Zhang,O
S(7,O
),O
",",O
Gao,O
HN(8,O
),O
",",O
Sheng,O
JF(1,O
),O
",",O
Cai,O
HL(1,O
),O
",",O
Qiu,O
YQ(1,O
),O
",",O
Li,O
LJ(9,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
for,O
Diagnosis,O
and,O
Treatment,O
of,O
Infectious,O
Diseases,O
",",O
"
",O
National,O
Clinical,O
Research,O
Centre,O
for,O
Infectious,O
Diseases,O
",",O
Collaborative,O
"
",O
Innovation,O
Centre,O
for,O
Diagnosis,O
and,O
Treatment,O
of,O
Infectious,O
Diseases,O
",",O
the,O
First,O
"
",O
Affiliated,O
Hospital,O
",",O
College,O
of,O
Medicine,O
",",O
Zhejiang,O
University,O
",",O
Hangzhou,O
",",O
Zhejiang,O
"
",O
Province,O
",",O
310003,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Infectious,O
Disease,O
",",O
Wenzhou,O
Central,O
Hospital,O
",",O
Wenzhou,O
",",O
Zhejiang,O
"
",O
Province,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Infectious,O
Disease,O
",",O
Taizhou,O
Enze,O
Medical,O
Centre,O
(,O
Group,O
),O
",",O
Enze,O
"
",O
Hospital,O
",",O
Taizhou,O
",",O
Zhejiang,O
Province,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Infectious,O
Disease,O
",",O
First,O
People,O
's,O
Hospital,O
of,O
Wenling,O
",",O
Wenling,O
",",O
"
",O
Zhejiang,O
Province,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Infectious,O
Disease,O
",",O
Affiliated,O
Zhoushan,O
Hospital,O
",",O
Wenzhou,O
"
",O
Medical,O
University,O
",",O
Zhoushan,O
",",O
Zhejiang,O
Province,O
",",O
China,O
ljli@zju.edu.cn,O
.,O
"
",O
(6)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Yinzhou,O
People,O
's,O
"
",O
Hospital,O
",",O
Affiliated,O
Yinzhou,O
Hospital,O
",",O
College,O
of,O
Medicine,O
",",O
Ningbo,O
University,O
",",O
"
",O
Ningbo,O
City,O
",",O
Zhejiang,O
Province,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Infectious,O
Disease,O
",",O
Taizhou,O
Hospital,O
",",O
Taizhou,O
",",O
Zhejiang,O
"
",O
Province,O
",",O
China,O
.,O
"
",O
(8)Department,O
of,O
Infectious,O
Disease,O
",",O
ShuLan,O
(,O
Hangzhou,O
),O
Hospital,O
affiliated,O
to,O
"
",O
Zhejiang,O
Shuren,O
University,O
Shulan,O
International,O
Medical,O
College,O
",",O
Hangzhou,O
",",O
"
",O
Zhejiang,O
Province,O
",",O
China,O
.,O
"
",O
(9)State,O
Key,O
Laboratory,O
for,O
Diagnosis,O
and,O
Treatment,O
of,O
Infectious,O
Diseases,O
",",O
"
",O
National,O
Clinical,O
Research,O
Centre,O
for,O
Infectious,O
Diseases,O
",",O
Collaborative,O
"
",O
Innovation,O
Centre,O
for,O
Diagnosis,O
and,O
Treatment,O
of,O
Infectious,O
Diseases,O
",",O
the,O
First,O
"
",O
Affiliated,O
Hospital,O
",",O
College,O
of,O
Medicine,O
",",O
Zhejiang,O
University,O
",",O
Hangzhou,O
",",O
Zhejiang,O
"
",O
Province,O
",",O
310003,O
",",O
China,O
ljli@zju.edu.cn,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
BMJ,O
.,O
2020,O
Feb,O
27;368:m792,O
.,O
"

",O
Comment,O
in,O
"
    ",O
BMJ,O
.,O
2020,O
Feb,O
19;368:m627,O
.,O
"

",O
OBJECTIVE,O
:,O
To,O
study,O
the,O
clinical,O
characteristics,O
of,O
patients,O
in,O
Zhejiang,O
"
",O
province,O
",",O
China,O
",",O
infected,O
with,O
the,O
2019,O
severe,O
acute,O
respiratory,O
syndrome,O
"
",O
coronavirus,O
2,O
(,O
SARSCov2,B-Virus_SARS-CoV-2
),O
responsible,O
for,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
covid2019,O
),O
.,O
"
",O
DESIGN,O
:,O
Retrospective,O
case,O
series,O
.,O
"
",O
SETTING,O
:,O
Seven,O
hospitals,O
in,O
Zhejiang,O
province,O
",",O
China,O
.,O
"
",O
PARTICIPANTS,O
:,O
62,O
patients,O
admitted,O
to,O
hospital,O
with,O
laboratory,O
confirmed,O
"
",O
SARSCov2,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
Data,O
were,O
collected,O
from,O
10,O
January,O
2020,O
to,O
26,O
January,O
"
",O
2020,O
.,O
"
",O
MAIN,O
OUTCOME,O
MEASURES,O
:,O
Clinical,O
data,O
",",O
collected,O
using,O
a,O
standardised,O
case,O
report,O
"
",O
form,O
",",O
such,O
as,O
temperature,O
",",O
history,O
of,O
exposure,O
",",O
incubation,O
period,O
.,O
If,O
information,O
"
",O
was,O
not,O
clear,O
",",O
the,O
working,O
group,O
in,O
Hangzhou,O
contacted,O
the,O
doctor,O
responsible,O
for,O
"
",O
treating,O
the,O
patient,O
for,O
clarification,O
.,O
"
",O
RESULTS,O
:,O
Of,O
the,O
62,O
patients,O
studied,O
(,O
median,O
age,O
41,O
years,O
),O
",",O
only,O
one,O
was,O
admitted,O
"
",O
to,O
an,O
intensive,O
care,O
unit,O
",",O
and,O
no,O
patients,O
died,O
during,O
the,O
study,O
.,O
According,O
to,O
"
",O
research,O
",",O
none,O
of,O
the,O
infected,O
patients,O
in,O
Zhejiang,O
province,O
were,O
ever,O
exposed,O
to,O
"
",O
the,O
Huanan,O
seafood,O
market,O
",",O
the,O
original,O
source,O
of,O
the,O
virus,O
;,O
all,O
studied,O
cases,O
"
",O
were,O
infected,O
by,O
human,O
to,O
human,O
transmission,O
.,O
The,O
most,O
common,O
symptoms,O
at,O
onset,O
"
",O
of,O
illness,O
were,O
fever,O
in,O
48,O
(,O
77,O
%,O
),O
patients,O
",",O
cough,O
in,O
50,O
(,O
81,O
%,O
),O
",",O
expectoration,O
in,O
"
",O
35,O
(,O
56,O
%,O
),O
",",O
headache,O
in,O
21,O
(,O
34,O
%,O
),O
",",O
myalgia,O
or,O
fatigue,O
in,O
32,O
(,O
52,O
%,O
),O
",",O
diarrhoea,O
in,O
3,O
"
",O
(,O
8,O
%,O
),O
",",O
and,O
haemoptysis,O
in,O
2,O
(,O
3,O
%,O
),O
.,O
Only,O
two,O
patients,O
(,O
3,O
%,O
),O
developed,O
shortness,O
of,O
"
",O
breath,O
on,O
admission,O
.,O
The,O
median,O
time,O
from,O
exposure,O
to,O
onset,O
of,O
illness,O
was,O
4,O
days,O
"
",O
(,O
interquartile,O
range,O
35,O
days,O
),O
",",O
and,O
from,O
onset,O
of,O
symptoms,O
to,O
first,O
hospital,O
"
",O
admission,O
was,O
2,O
(,O
14,O
),O
days,O
.,O
"
",O
CONCLUSION,O
:,O
As,O
of,O
early,O
February,O
2020,O
",",O
compared,O
with,O
patients,O
initially,O
infected,O
"
",O
with,O
SARSCov2,B-Virus_SARS-CoV-2
in,O
Wuhan,O
",",O
the,O
symptoms,O
of,O
patients,O
in,O
Zhejiang,O
province,O
are,O
"
",O
relatively,O
mild,O
.,O
"

",O
Published,O
by,O
the,O
BMJ,O
Publishing,O
Group,O
Limited,O
.,O
For,O
permission,O
to,O
use,O
(,O
where,O
not,O
"
",O
already,O
granted,O
under,O
a,O
licence,O
),O
please,O
go,O
to,O
"
",O
http,O
:,O
 ,O
group.bmj.com,O
group,O
rightslicensing,O
permissions,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m606,O
"
",O
PMID,O
:,O
32075786,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interests,O
:,O
All,O
authors,O
have,O
completed,O
"
",O
the,O
ICMJE,O
uniform,O
disclosure,O
form,O
at,O
www.icmje.org,O
coi_disclosure.pdf,O
and,O
"
",O
declare,O
:,O
no,O
support,O
from,O
any,O
organisation,O
for,O
the,O
submitted,O
work,O
;,O
no,O
financial,O
"
",O
relationships,O
with,O
any,O
organisations,O
that,O
might,O
have,O
an,O
interest,O
in,O
the,O
submitted,O
"
",O
work,O
in,O
the,O
previous,O
three,O
years,O
;,O
no,O
other,O
relationships,O
or,O
activities,O
that,O
could,O
"
",O
appear,O
to,O
have,O
influenced,O
the,O
submitted,O
work,O
.,O
"


",O
641,O
.,O
BMJ,O
.,O
2020,O
Feb,O
19;368:m643,O
.,O
doi,O
:,O
10.1136,O
bmj.m643,O
.,O
"

",O
Letter,O
from,O
China,O
:,O
covid19,B-Disease_COVID-19
on,O
the,O
grapevine,O
",",O
on,O
the,O
internet,O
",",O
and,O
in,O
commerce,O
.,O
"

",O
Mowbray,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Beijing,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m643,O
"
",O
PMID,O
:,O
32075783,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interests,O
:,O
I,O
have,O
read,O
and,O
understood,O
"
",O
BMJ,O
policy,O
on,O
declaration,O
of,O
interests,O
and,O
have,O
no,O
relevant,O
interests,O
to,O
declare,O
.,O
"


",O
642,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
14;9(2,O
),O
.,O
pii,O
:,O
E523,O
.,O
doi,O
:,O
10.339,O
jcm9020523,O
.,O
"

",O
RealTime,O
Estimation,O
of,O
the,O
Risk,O
of,O
Death,O
from,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
"
",O
Infection,O
:,O
Inference,O
Using,O
Exported,O
Cases,O
.,O
"

",O
Jung,O
SM(1,O
),O
",",O
Akhmetzhanov,O
AR(1,O
),O
",",O
Hayashi,O
K(1,O
),O
",",O
Linton,O
NM(1,O
),O
",",O
Yang,O
Y(1,O
),O
",",O
Yuan,O
B(1,O
),O
",",O
"
",O
Kobayashi,O
T(1,O
),O
",",O
Kinoshita,O
R(1,O
),O
",",O
Nishiura,O
H(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Graduate,O
School,O
of,O
Medicine,O
",",O
Hokkaido,O
University,O
",",O
Kita,O
15,O
Jo,O
Nishi,O
7,O
Chome,O
",",O
"
",O
Kitaku,O
",",O
Sapporoshi,O
",",O
Hokkaido,O
608638,O
",",O
Japan,O
.,O
"
",O
(2)Core,O
Research,O
for,O
Evolutional,O
Science,O
and,O
Technology,O
(,O
CREST,O
),O
",",O
Japan,O
Science,O
"
",O
and,O
Technology,O
Agency,O
",",O
Honcho,O
418,O
",",O
Kawaguchi,O
",",O
Saitama,O
3320012,O
",",O
Japan,O
.,O
"

",O
The,O
exported,O
cases,O
of,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
infection,O
that,O
were,O
"
",O
confirmed,O
outside,O
China,O
provide,O
an,O
opportunity,O
to,O
estimate,O
the,O
cumulative,O
"
",O
incidence,O
and,O
confirmed,O
case,O
fatality,O
risk,O
(,O
cCFR,O
),O
in,O
mainland,O
China,O
.,O
Knowledge,O
of,O
"
",O
the,O
cCFR,O
is,O
critical,O
to,O
characterize,O
the,O
severity,O
and,O
understand,O
the,O
pandemic,O
"
",O
potential,O
of,O
COVID19,B-Disease_COVID-19
in,O
the,O
early,O
stage,O
of,O
the,O
epidemic,O
.,O
Using,O
the,O
exponential,O
"
",O
growth,O
rate,O
of,O
the,O
incidence,O
",",O
the,O
present,O
study,O
statistically,O
estimated,O
the,O
cCFR,O
"
",O
and,O
the,O
basic,O
reproduction,O
numberthe,O
average,O
number,O
of,O
secondary,O
cases,O
generated,O
"
",O
by,O
a,O
single,O
primary,O
case,O
in,O
a,O
naÃ¯ve,O
population,O
.,O
We,O
modeled,O
epidemic,O
growth,O
either,O
"
",O
from,O
a,O
single,O
index,O
case,O
with,O
illness,O
onset,O
on,O
8,O
December,O
",",O
2019,O
(,O
Scenario,O
1,O
),O
",",O
or,O
"
",O
using,O
the,O
growth,O
rate,O
fitted,O
along,O
with,O
the,O
other,O
parameters,O
(,O
Scenario,O
2,O
),O
based,O
"
",O
on,O
data,O
from,O
20,O
exported,O
cases,O
reported,O
by,O
24,O
January,O
2020,O
.,O
The,O
cumulative,O
"
",O
incidence,O
in,O
China,O
by,O
24,O
January,O
was,O
estimated,O
at,O
6924,O
cases,O
(,O
95,O
%,O
confidence,O
"
",O
interval,O
[,O
CI,O
],O
:,O
4885,O
",",O
9211,O
),O
and,O
19289,O
cases,O
(,O
95,O
%,O
CI,O
:,O
10901,O
",",O
30158,O
),O
",",O
"
",O
respectively,O
.,O
The,O
latest,O
estimated,O
values,O
of,O
the,O
cCFR,O
were,O
5.3,O
%,O
(,O
95,O
%,O
CI,O
:,O
3.5,O
%,O
",",O
"
",O
7.5,O
%,O
),O
for,O
Scenario,O
1,O
and,O
8.4,O
%,O
(,O
95,O
%,O
CI,O
:,O
5.3,O
%,O
",",O
12.3,O
%,O
),O
for,O
Scenario,O
2,O
.,O
The,O
basic,O
"
",O
reproduction,O
number,O
was,O
estimated,O
to,O
be,O
2.1,O
(,O
95,O
%,O
CI,O
:,O
2,O
",",O
2.2,O
),O
and,O
3.2,O
(,O
95,O
%,O
CI,O
:,O
"
",O
2.7,O
",",O
3.7,O
),O
for,O
Scenarios,O
1,O
and,O
2,O
",",O
respectively,O
.,O
Based,O
on,O
these,O
results,O
",",O
we,O
argued,O
"
",O
that,O
the,O
current,O
COVID19,B-Disease_COVID-19
epidemic,O
has,O
a,O
substantial,O
potential,O
for,O
causing,O
a,O
"
",O
pandemic,O
.,O
The,O
proposed,O
approach,O
provides,O
insights,O
in,O
early,O
risk,O
assessment,O
using,O
"
",O
publicly,O
available,O
data,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9020523,O
"
",O
PMID,O
:,O
32075152,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
643,O
.,O
Biosci,O
Trends,O
.,O
2020,O
Feb,O
19,O
.,O
doi,O
:,O
10.5582,O
bst.2020.01047,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Breakthrough,O
:,O
Chloroquine,O
phosphate,O
has,O
shown,O
apparent,O
efficacy,O
in,O
treatment,O
of,O
"
",O
COVID19,B-Disease_COVID-19
associated,O
pneumonia,O
in,O
clinical,O
studies,O
.,O
"

",O
Gao,O
J(1,O
),O
",",O
Tian,O
Z(2,O
),O
",",O
Yang,O
X(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pharmacology,O
",",O
School,O
of,O
Pharmacy,O
",",O
Qingdao,O
University,O
",",O
Qingdao,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pharmacy,O
",",O
Qingdao,O
Municipal,O
Hospital,O
",",O
Qingdao,O
",",O
China,O
.,O
"

",O
The,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
virus,O
is,O
spreading,O
rapidly,O
",",O
and,O
"
",O
scientists,O
are,O
endeavoring,O
to,O
discover,O
drugs,O
for,O
its,O
efficacious,O
treatment,O
in,O
"
",O
China,O
.,O
Chloroquine,O
phosphate,O
",",O
an,O
old,O
drug,O
for,O
treatment,O
of,O
malaria,O
",",O
is,O
shown,O
to,O
"
",O
have,O
apparent,O
efficacy,O
and,O
acceptable,O
safety,O
against,O
COVID19,B-Disease_COVID-19
associated,O
"
",O
pneumonia,O
in,O
multicenter,O
clinical,O
trials,O
conducted,O
in,O
China,O
.,O
The,O
drug,O
is,O
"
",O
recommended,O
to,O
be,O
included,O
in,O
the,O
next,O
version,O
of,O
the,O
Guidelines,O
for,O
the,O
"
",O
Prevention,O
",",O
Diagnosis,O
",",O
and,O
Treatment,O
of,O
Pneumonia,O
Caused,O
by,O
COVID19,B-Disease_COVID-19
issued,O
by,O
"
",O
the,O
National,O
Health,O
Commission,O
of,O
the,O
People,O
's,O
Republic,O
of,O
China,O
for,O
treatment,O
of,O
"
",O
COVID19,B-Disease_COVID-19
infection,O
in,O
larger,O
populations,O
in,O
the,O
future,O
.,O
"

",O
DOI,O
:,O
10.5582,O
bst.2020.01047,O
"
",O
PMID,O
:,O
32074550,O
"


",O
644,O
.,O
Jpn,O
J,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
18,O
.,O
doi,O
:,O
10.7883,O
yoken,O
.,O
JJID.2020.061,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Development,O
of,O
Genetic,O
Diagnostic,O
Methods,O
for,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
2019,I-Virus_SARS-CoV-2
(,O
nCoV2019,O
),O
"
",O
in,O
Japan,O
.,O
"

",O
Shirato,O
K(1,O
),O
",",O
Nao,O
N(1,O
),O
",",O
Katano,O
H(2,O
),O
",",O
Takayama,O
I(3,O
),O
",",O
Saito,O
S(3,O
),O
",",O
Kato,O
F(1,O
),O
",",O
Katoh,O
"
",O
H(1,O
),O
",",O
Sakata,O
M(1,O
),O
",",O
Nakatsu,O
Y(1,O
),O
",",O
Mori,O
Y(1,O
),O
",",O
Kageyama,O
T(3,O
),O
",",O
Matsuyama,O
S(1,O
),O
",",O
Takeda,O
"
",O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Virology,O
III,O
",",O
National,O
Institute,O
of,O
Infectious,O
Disease,O
.,O
"
",O
(2)Department,O
of,O
Pathology,O
",",O
National,O
Institute,O
of,O
Infectious,O
Disease,O
.,O
"
",O
(3)Influenza,O
Virus,O
Research,O
Center,O
",",O
National,O
Institute,O
of,O
Infectious,O
Disease,O
.,O
"

",O
At,O
the,O
end,O
of,O
2019,O
",",O
pneumonia,B-Disease_COVID-19
caused,I-Disease_COVID-19
by,I-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
nCoV,O
),O
emerged,O
in,O
"
",O
Wuhan,O
city,O
",",O
China,O
.,O
Many,O
airline,O
travelers,O
moved,O
between,O
Wuhan,O
and,O
Japan,O
at,O
that,O
"
",O
time,O
",",O
suggesting,O
that,O
Japan,O
is,O
at,O
high,O
risk,O
of,O
invasion,O
by,O
the,O
virus,O
.,O
Diagnostic,O
"
",O
systems,O
for,O
2019nCoV,B-Virus_SARS-CoV-2
were,O
developed,O
with,O
urgency,O
.,O
Two,O
nested,O
RTPCR,O
assays,O
and,O
"
",O
two,O
realtime,O
RTPCR,O
assays,O
were,O
adapted,O
to,O
local,O
Japanese,O
conditions,O
.,O
As,O
of,O
8,O
"
",O
February,O
2020,O
",",O
the,O
assays,O
developed,O
have,O
successfully,O
detected,O
25,O
positive,O
cases,O
"
",O
of,O
infection,O
in,O
Japan,O
.,O
"

",O
DOI,O
:,O
10.7883,O
yoken,O
.,O
JJID.2020.061,O
"
",O
PMID,O
:,O
32074516,O
"


",O
645,O
.,O
Commun,O
Dis,O
Intell,O
(,O
2018,O
),O
.,O
2020,O
Feb,O
20;44,O
.,O
doi,O
:,O
10.33321,O
cdi.2020.44.15,O
.,O
"

",O
COVID19,B-Disease_COVID-19
",",O
Australia,O
:,O
Epidemiology,O
Report,O
3,O
(,O
Reporting,O
week,O
ending,O
0.791666667,O
AEDT,O
15,O
"
",O
February,O
2020,O
),O
.,O
"

",O
COVID19,B-Disease_COVID-19
National,O
Incident,O
Room,O
Surveillance,O
Team,O
.,O
"

",O
This,O
is,O
the,O
third,O
epidemiological,O
report,O
for,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
",",O
"
",O
previously,O
known,O
as,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
",",O
from,O
the,O
virus,O
now,O
known,O
as,O
"
",O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
reported,O
in,O
Australia,O
as,O
at,O
0.791666667,O
Australian,O
Eastern,O
Daylight,O
Time,O
"
",O
[,O
AEDT,O
],O
15,O
February,O
2020,O
.,O
It,O
includes,O
data,O
on,O
the,O
COVID19,B-Disease_COVID-19
Australian,O
cases,O
",",O
the,O
"
",O
international,O
situation,O
and,O
current,O
information,O
on,O
the,O
severity,O
",",O
transmission,O
and,O
"
",O
spread,O
.,O
"

",O
Â©,O
Commonwealth,O
of,O
Australia,O
CC,O
BYNCND,O
.,O
"

",O
DOI,O
:,O
10.33321,O
cdi.2020.44.15,O
"
",O
PMID,O
:,O
32074480,O
"


",O
646,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Feb,O
19,O
.,O
doi,O
:,O
10.1056,O
NEJMc2001737,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
SARSCoV2,B-Virus_SARS-CoV-2
Viral,O
Load,O
in,O
Upper,O
Respiratory,O
Specimens,O
of,O
Infected,O
Patients,O
.,O
"

",O
Zou,O
L(1,O
),O
",",O
Ruan,O
F(2,O
),O
",",O
Huang,O
M(3,O
),O
",",O
Liang,O
L(1,O
),O
",",O
Huang,O
H(2,O
),O
",",O
Hong,O
Z(3,O
),O
",",O
Yu,O
J(1,O
),O
",",O
Kang,O
"
",O
M(1,O
),O
",",O
Song,O
Y(1,O
),O
",",O
Xia,O
J(3,O
),O
",",O
Guo,O
Q(1,O
),O
",",O
Song,O
T(1,O
),O
",",O
He,O
J(1,O
),O
",",O
Yen,O
HL(4,O
),O
",",O
Peiris,O
M(4,O
),O
",",O
"
",O
Wu,O
J(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Guangdong,O
Provincial,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Guangzhou,O
",",O
"
",O
China,O
.,O
"
",O
(2)Zhuhai,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Zhuhai,O
",",O
China,O
.,O
"
",O
(3)Fifth,O
Affiliated,O
Hospital,O
of,O
Sun,O
YatSen,O
University,O
",",O
Zhuhai,O
",",O
China,O
.,O
"
",O
(4)University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(5)Guangdong,O
Provincial,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Guangzhou,O
",",O
"
",O
China,O
771276998@qq.com,O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMc2001737,O
"
",O
PMID,O
:,O
32074444,O
"


",O
647,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Feb,O
19,O
.,O
doi,O
:,O
10.1056,O
NEJMp2002125,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Defining,O
the,O
Epidemiology,O
of,O
Covid19,B-Disease_COVID-19
 ,O
Studies,O
Needed,O
.,O
"

",O
Lipsitch,O
M(1,O
),O
",",O
Swerdlow,O
DL(1,O
),O
",",O
Finelli,O
L(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Center,O
for,O
Communicable,O
Disease,O
Dynamics,O
",",O
Department,O
of,O
Epidemiology,O
",",O
"
",O
Harvard,O
T.H.,O
Chan,O
School,O
of,O
Public,O
Health,O
",",O
Boston,O
(,O
M.L.,O
),O
;,O
Medical,O
Development,O
and,O
"
",O
Scientific,O
Clinical,O
Affairs,O
",",O
Pfizer,O
Vaccines,O
",",O
Collegeville,O
",",O
PA,O
(,O
D.L.S.,O
),O
;,O
and,O
the,O
"
",O
Center,O
for,O
Observational,O
and,O
RealWorld,O
Evidence,O
",",O
Merck,O
",",O
Kenilworth,O
",",O
NJ,O
(,O
L.F.,O
),O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMp2002125,O
"
",O
PMID,O
:,O
32074416,O
"


",O
648,O
.,O
JAMA,O
.,O
2020,O
Feb,O
19,O
.,O
doi,O
:,O
10.1001,O
jama.2020.2342,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Preparing,O
for,O
the,O
Most,O
Critically,O
Ill,O
Patients,O
With,O
COVID19,B-Disease_COVID-19
:,O
The,O
Potential,O
Role,O
"
",O
of,O
Extracorporeal,O
Membrane,O
Oxygenation,O
.,O
"

",O
MacLaren,O
G(1,O
),O
",",O
Fisher,O
D(2)(3,O
),O
",",O
Brodie,O
D(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Cardiothoracic,O
Intensive,O
Care,O
Unit,O
",",O
National,O
University,O
Health,O
System,O
",",O
"
",O
Singapore,O
.,O
"
",O
(2)Division,O
of,O
Infectious,O
Diseases,O
",",O
University,O
Medicine,O
Cluster,O
",",O
National,O
"
",O
University,O
Health,O
Systems,O
",",O
Singapore,O
.,O
"
",O
(3)Department,O
of,O
Medicine,O
",",O
Yong,O
Loo,O
Lin,O
School,O
of,O
Medicine,O
",",O
National,O
University,O
"
",O
of,O
Singapore,O
",",O
Singapore,O
.,O
"
",O
(4)Division,O
of,O
Pulmonary,O
",",O
Allergy,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Columbia,O
University,O
"
",O
College,O
of,O
Physicians,O
and,O
Surgeons,O
New,O
YorkPresbyterian,O
Hospital,O
",",O
New,O
York,O
.,O
"
",O
(5)Center,O
for,O
Acute,O
Respiratory,O
Failure,O
",",O
New,O
YorkPresbyterian,O
Hospital,O
",",O
New,O
"
",O
York,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.2342,O
"
",O
PMID,O
:,O
32074258,O
"


",O
649,O
.,O
QJM,O
.,O
2020,O
Feb,O
19,O
.,O
pii,O
:,O
hcaa038,O
.,O
doi,O
:,O
10.1093,O
qjmed,O
hcaa038,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Changes,O
of,O
CT,O
Findings,O
in,O
a,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
pneumonia,O
patient,O
.,O
"

",O
Fang,O
X(1,O
),O
",",O
Zhao,O
M(2,O
),O
",",O
Li,O
S(1,O
),O
",",O
Yang,O
L(1,O
),O
",",O
Wu,O
B(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
West,O
China,O
Hospital,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Gastroenterology,O
and,O
Hepatology,O
",",O
West,O
China,O
Hospital,O
",",O
Sichuan,O
"
",O
University,O
",",O
Chengdu,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1093,O
qjmed,O
hcaa038,O
"
",O
PMID,O
:,O
32073631,O
"


",O
650,O
.,O
Radiology,O
.,O
2020,O
Feb,O
19:200432,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200432,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Sensitivity,O
of,O
Chest,O
CT,O
for,O
COVID19,B-Disease_COVID-19
:,O
Comparison,O
to,O
RTPCR,O
.,O
"

",O
Fang,O
Y(1,O
),O
",",O
Zhang,O
H(1,O
),O
",",O
Xie,O
J(1,O
),O
",",O
Lin,O
M(1,O
),O
",",O
Ying,O
L(1,O
),O
",",O
Pang,O
P(1,O
),O
",",O
Ji,O
W(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Department,O
of,O
Radiology,O
",",O
Affiliated,O
Taizhou,O
Hospital,O
of,O
Wenzhou,O
"
",O
Medical,O
University,O
",",O
150,O
Ximen,O
Street,O
",",O
Linhai,O
",",O
317000,O
",",O
Zhejiang,O
Province,O
",",O
China,O
"
",O
(,O
Y.F.,O
",",O
H.Z.,O
",",O
J.X.,O
",",O
M.L.,O
",",O
W.J.,O
),O
;,O
Taizhou,O
Enze,O
Medical,O
Center,O
(,O
Group,O
),O
Enze,O
"
",O
Hospital,O
",",O
Taizhou,O
",",O
318050,O
",",O
Zhejiang,O
Province,O
",",O
China,O
(,O
L.Y.,O
),O
;,O
GE,O
Healthcare,O
",",O
China,O
",",O
"
",O
Advanced,O
Application,O
Team,O
",",O
Shanghai,O
",",O
Shanghai,O
",",O
China,O
(,O
P.P.,O
),O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200432,O
"
",O
PMID,O
:,O
32073353,O
"


",O
651,O
.,O
J,O
Thromb,O
Haemost,O
.,O
2020,O
Feb,O
19,O
.,O
doi,O
:,O
10.1111,O
jth.14768,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Abnormal,O
coagulation,O
parameters,O
are,O
associated,O
with,O
poor,O
prognosis,O
in,O
patients,O
"
",O
with,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
.,O
"

",O
Tang,O
N(1,O
),O
",",O
Li,O
D(2,O
),O
",",O
Wang,O
X(1,O
),O
",",O
Sun,O
Z(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Clinical,O
Laboratory,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Hematology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
In,O
the,O
recent,O
outbreak,O
of,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
in,O
Wuhan,O
",",O
"
",O
China,O
",",O
significantly,O
abnormal,O
coagulation,O
parameters,O
in,O
severe,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
pneumonia,O
(,O
NCP,B-Disease_COVID-19
),O
cases,O
were,O
a,O
concern,O
.,O
"
",O
OBJECTIVES,O
:,O
To,O
describe,O
the,O
coagulation,O
feature,O
of,O
patients,O
with,O
NCP,B-Disease_COVID-19
.,O
"
",O
METHODS,O
:,O
Conventional,O
coagulation,O
results,O
and,O
outcomes,O
of,O
183,O
consecutive,O
"
",O
patients,O
with,O
confirmed,O
NCP,B-Disease_COVID-19
in,O
Tongji,O
hospital,O
were,O
retrospectively,O
analyzed,O
.,O
"
",O
RESULTS,O
:,O
The,O
overall,O
mortality,O
was,O
11.5,O
%,O
",",O
the,O
nonsurvivors,O
revealed,O
"
",O
significantly,O
higher,O
Ddimer,O
and,O
fibrin,O
degradation,O
product,O
(,O
FDP,O
),O
levels,O
",",O
longer,O
"
",O
prothrombin,O
time,O
and,O
activated,O
partial,O
thromboplastin,O
time,O
compared,O
to,O
survivors,O
"
",O
on,O
admission,O
(,O
P,O
Â ,O
<,O
Â ,O
0.05,O
),O
;,O
71.4,O
%,O
of,O
nonsurvivors,O
and,O
0.6,O
%,O
survivors,O
met,O
the,O
"
",O
criteria,O
of,O
disseminated,O
intravascular,O
coagulation,O
during,O
their,O
hospital,O
stay,O
.,O
"
",O
CONCLUSIONS,O
:,O
The,O
present,O
study,O
shows,O
that,O
abnormal,O
coagulation,O
results,O
",",O
"
",O
especially,O
markedly,O
elevated,O
Ddimer,O
and,O
FDP,O
are,O
common,O
in,O
deaths,O
with,O
NCP,B-Disease_COVID-19
.,O
"

",O
Â©,O
2020,O
International,O
Society,O
on,O
Thrombosis,O
and,O
Haemostasis,O
.,O
"

",O
DOI,O
:,O
10.1111,O
jth.14768,O
"
",O
PMID,O
:,O
32073213,O
"


",O
652,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
19,O
.,O
doi,O
:,O
10.1002,O
jmv.25711,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
course,O
of,O
clinical,O
diagnosis,O
and,O
treatment,O
of,O
a,O
case,O
infected,O
with,O
"
",O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
.,O
"

",O
Han,O
W(1,O
),O
",",O
Quan,O
B(2,O
),O
",",O
Guo,O
Y(3,O
),O
",",O
Zhang,O
J(4,O
),O
",",O
Lu,O
Y(5,O
),O
",",O
Feng,O
G(1,O
),O
",",O
Wu,O
Q(1,O
),O
",",O
Fang,O
"
",O
F(1,O
),O
",",O
Cheng,O
L(1,O
),O
",",O
Jiao,O
N(6,O
),O
",",O
Li,O
X(1,O
),O
",",O
Chen,O
Q(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Clinical,O
Laboratory,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Wanan,O
"
",O
Medical,O
College,O
",",O
Wuhu,O
",",O
Anhui,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Wanan,O
"
",O
Medical,O
College,O
",",O
Wuhu,O
",",O
Anhui,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Gynaecology,O
and,O
Obstetrics,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
"
",O
Wanan,O
Medical,O
College,O
",",O
Wuhu,O
",",O
Anhui,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Clinical,O
Blood,O
Laboratory,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
"
",O
Wanan,O
Medical,O
College,O
",",O
Wuhu,O
",",O
Anhui,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Medical,O
Laboratory,O
Science,O
",",O
School,O
of,O
Laboratory,O
Medicine,O
",",O
Wanan,O
"
",O
Medical,O
College,O
",",O
Wuhu,O
",",O
Anhui,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Pathology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Wanan,O
Medical,O
"
",O
College,O
",",O
Wuhu,O
",",O
Anhui,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Nuclear,O
Medicine,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Wanan,O
Medical,O
"
",O
College,O
",",O
Wuhu,O
",",O
Anhui,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25711,O
"
",O
PMID,O
:,O
32073161,O
"


",O
653,O
.,O
Infection,O
.,O
2020,O
Feb,O
18,O
.,O
doi,O
:,O
10.1007,O
s1501002001401y,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
:,O
where,O
we,O
are,O
and,O
what,O
we,O
know,O
.,O
"

",O
Cheng,O
ZJ(1)(2)(3,O
),O
",",O
Shan,O
J(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Allergy,O
and,O
Immunology,O
",",O
School,O
of,O
Medicine,O
",",O
Shenzhen,O
University,O
",",O
"
",O
Shenzhen,O
",",O
China,O
.,O
zche2025@uni.sydney.edu.au,O
.,O
"
",O
(2)Center,O
for,O
Applied,O
Genomics,O
",",O
The,O
Children,O
's,O
Hospital,O
of,O
Philadelphia,O
",",O
"
",O
Philadelphia,O
",",O
USA,O
.,O
zche2025@uni.sydney.edu.au,O
.,O
"
",O
(3)Institute,O
of,O
Medical,O
Physics,O
",",O
University,O
of,O
Sydney,O
",",O
Sydney,O
",",O
Australia,O
.,O
"
",O
zche2025@uni.sydney.edu.au,O
.,O
"
",O
(4)Discipline,O
of,O
Child,O
and,O
Adolescence,O
Health,O
",",O
The,O
Faculty,O
of,O
Medicine,O
and,O
"
",O
Health,O
",",O
University,O
of,O
Sydney,O
",",O
Sydney,O
",",O
Australia,O
.,O
"

",O
There,O
is,O
a,O
current,O
worldwide,O
outbreak,O
of,O
a,O
new,O
type,O
of,O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
",",O
"
",O
which,O
originated,O
from,O
Wuhan,O
in,O
China,O
and,O
has,O
now,O
spread,O
to,O
17,O
other,O
countries,O
.,O
"
",O
Governments,O
are,O
under,O
increased,O
pressure,O
to,O
stop,O
the,O
outbreak,O
spiraling,O
into,O
a,O
"
",O
global,O
health,O
emergency,O
.,O
At,O
this,O
stage,O
",",O
preparedness,O
",",O
transparency,O
",",O
and,O
sharing,O
"
",O
of,O
information,O
are,O
crucial,O
to,O
risk,O
assessments,O
and,O
beginning,O
outbreak,O
control,O
"
",O
activities,O
.,O
This,O
information,O
should,O
include,O
reports,O
from,O
outbreak,O
sites,O
and,O
from,O
"
",O
laboratories,O
supporting,O
the,O
investigation,O
.,O
This,O
paper,O
aggregates,O
and,O
consolidates,O
"
",O
the,O
virology,O
",",O
epidemiology,O
",",O
clinical,O
management,O
strategies,O
from,O
both,O
English,O
and,O
"
",O
Chinese,O
literature,O
",",O
official,O
news,O
channels,O
",",O
and,O
other,O
official,O
government,O
"
",O
documents,O
.,O
In,O
addition,O
",",O
by,O
fitting,O
the,O
number,O
of,O
infections,O
with,O
a,O
singleterm,O
"
",O
exponential,O
model,O
",",O
we,O
report,O
that,O
the,O
infection,O
is,O
spreading,O
at,O
an,O
exponential,O
"
",O
rate,O
",",O
with,O
a,O
doubling,O
period,O
of,O
1.8,O
Â ,O
days,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s1501002001401y,O
"
",O
PMID,O
:,O
32072569,O
"


",O
654,O
.,O
Eur,O
Radiol,O
.,O
2020,O
Feb,O
18,O
.,O
doi,O
:,O
10.1007,O
s00330020067482,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Outbreak,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
:,O
What,O
is,O
the,O
role,O
of,O
radiologists,O
?,O
"

",O
Kim,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Seoul,O
National,O
University,O
Hospital,O
",",O
101,O
",",O
Daehakro,O
",",O
"
",O
Jongnogu,O
",",O
Seoul,O
",",O
3080,O
",",O
South,O
Korea,O
.,O
khj.snuh@gmail.com,O
.,O
"

",O
KEY,O
POINTS,O
:,O
â€¢,O
Novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(COVID19)infected,O
pneumonia,O
usually,O
manifests,O
"
",O
as,O
bilateral,O
groundglass,O
opacities,O
in,O
the,O
lung,O
periphery,O
on,O
chest,O
CT,O
scans,O
.,O
â€¢,O
"
",O
Role,O
of,O
radiologists,O
includes,O
not,O
only,O
early,O
detection,O
of,O
lung,O
abnormality,O
",",O
but,O
"
",O
also,O
suggestion,O
of,O
disease,O
severity,O
",",O
potential,O
progression,O
to,O
acute,O
respiratory,O
"
",O
distress,O
syndrome,O
",",O
and,O
possible,O
bacterial,O
coinfection,O
in,O
hospitalized,O
patients,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00330020067482,O
"
",O
PMID,O
:,O
32072255,O
"


",O
655,O
.,O
Cell,O
Res,O
.,O
2020,O
Mar;30(3):189190,O
.,O
doi,O
:,O
10.1038,O
s4142202002900,O
.,O
"

",O
Virus,O
against,O
virus,O
:,O
a,O
potential,O
treatment,O
for,O
2019nCov,B-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
and,O
other,O
"
",O
RNA,O
viruses,O
.,O
"

",O
Nguyen,O
TM(1,O
),O
",",O
Zhang,O
Y(1,O
),O
",",O
Pandolfi,O
PP(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Cancer,O
Research,O
Institute,O
",",O
Beth,O
Israel,O
Deaconess,O
Medical,O
Center,O
",",O
Harvard,O
"
",O
Medical,O
School,O
",",O
Boston,O
",",O
MA,O
",",O
2115,O
",",O
USA,O
.,O
"
",O
(2)Cancer,O
Research,O
Institute,O
",",O
Beth,O
Israel,O
Deaconess,O
Medical,O
Center,O
",",O
Harvard,O
"
",O
Medical,O
School,O
",",O
Boston,O
",",O
MA,O
",",O
2115,O
",",O
USA,O
.,O
pierpaolo.pandolfiderinaldis@unito.it,O
.,O
"
",O
(3)MBC,O
",",O
Department,O
of,O
Molecular,O
Biotechnology,O
and,O
Health,O
Sciences,O
",",O
University,O
of,O
"
",O
Torino,O
",",O
Torino,O
",",O
TO,O
",",O
10126,O
",",O
Italy,O
.,O
pierpaolo.pandolfiderinaldis@unito.it,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s4142202002900,O
"
",O
PMCID,O
:,O
PMC7054296,O
[,O
Available,O
on,O
20210301,O
],O
"
",O
PMID,O
:,O
32071427,O
"


",O
656,O
.,O
BMJ,O
.,O
2020,O
Feb,O
18;368:m641,O
.,O
doi,O
:,O
10.1136,O
bmj.m641,O
.,O
"

",O
Coronavirus,O
covid19,B-Disease_COVID-19
has,O
killed,O
more,O
people,O
than,O
SARS,O
and,O
MERS,O
combined,O
",",O
despite,O
"
",O
lower,O
case,O
fatality,O
rate,O
.,O
"

",O
Mahase,O
E(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m641,O
"
",O
PMID,O
:,O
32071063,O
"


",O
657,O
.,O
Int,O
J,O
Antimicrob,O
Agents,O
.,O
2020,O
Mar;55(3):105923,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.ijantimicag.2020.105923,O
.,O
Epub,O
2020,O
Feb,O
15,O
.,O
"

",O
Chloroquine,O
for,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
SARSCoV2,B-Virus_SARS-CoV-2
.,O
"

",O
Colson,O
P(1,O
),O
",",O
Rolain,O
JM(1,O
),O
",",O
Raoult,O
D(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)AixMarseille,O
UniversitÃ©,O
",",O
Institut,O
de,O
Recherche,O
pour,O
le,O
DÃ©veloppement,O
(,O
IRD,O
),O
",",O
"
",O
Assistance,O
PubliqueHÃ´pitaux,O
de,O
Marseille,O
(,O
APHM,O
),O
",",O
MEPHI,O
",",O
27,O
boulevard,O
Jean,O
"
",O
Moulin,O
",",O
13005,O
Marseille,O
",",O
France,O
;,O
IHU,O
MÃ©diterranÃ©e,O
Infection,O
",",O
1921,O
boulevard,O
Jean,O
"
",O
Moulin,O
",",O
13005,O
Marseille,O
",",O
France,O
.,O
"
",O
(2)AixMarseille,O
UniversitÃ©,O
",",O
Institut,O
de,O
Recherche,O
pour,O
le,O
DÃ©veloppement,O
(,O
IRD,O
),O
",",O
"
",O
Assistance,O
PubliqueHÃ´pitaux,O
de,O
Marseille,O
(,O
APHM,O
),O
",",O
MEPHI,O
",",O
27,O
boulevard,O
Jean,O
"
",O
Moulin,O
",",O
13005,O
Marseille,O
",",O
France,O
;,O
IHU,O
MÃ©diterranÃ©e,O
Infection,O
",",O
1921,O
boulevard,O
Jean,O
"
",O
Moulin,O
",",O
13005,O
Marseille,O
",",O
France,O
.,O
Electronic,O
address,O
:,O
didier.raoult@gmail.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijantimicag.2020.105923,O
"
",O
PMID,O
:,O
32070753,O
"


",O
658,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Feb;25(6,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.6.2002131,O
.,O
"

",O
Latest,O
updates,O
on,O
COVID19,B-Disease_COVID-19
from,O
the,O
European,O
Centre,O
for,O
Disease,O
Prevention,O
and,O
"
",O
Control,O
.,O
"

",O
Eurosurveillance,O
Editorial,O
Team(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)European,O
Centre,O
for,O
Disease,O
Prevention,O
and,O
Control,O
(,O
ECDC,O
),O
",",O
Stockholm,O
",",O
Sweden,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.6.2002131,O
"
",O
PMCID,O
:,O
PMC7029450,O
"
",O
PMID,O
:,O
32070466,O
"


",O
659,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Feb;25(6,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.6.2000094,O
.,O
"

",O
First,O
cases,O
of,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
in,O
France,O
:,O
surveillance,O
",",O
"
",O
investigations,O
and,O
control,O
measures,O
",",O
January,O
2020,O
.,O
"

",O
Bernard,O
Stoecklin,O
S(1,O
),O
",",O
Rolland,O
P(2,O
),O
",",O
Silue,O
Y(3,O
),O
",",O
Mailles,O
A(1,O
),O
",",O
Campese,O
C(1,O
),O
",",O
"
",O
Simondon,O
A(4,O
),O
",",O
Mechain,O
M(5,O
),O
",",O
Meurice,O
L(6,O
),O
",",O
Nguyen,O
M(5,O
),O
",",O
Bassi,O
C(3,O
),O
",",O
Yamani,O
E(4,O
),O
",",O
"
",O
Behillil,O
S(7,O
),O
",",O
Ismael,O
S(8,O
),O
",",O
Nguyen,O
D(9,O
),O
",",O
Malvy,O
D(10)(9,O
),O
",",O
Lescure,O
FX(11)(8,O
),O
",",O
"
",O
Georges,O
S(1,O
),O
",",O
Lazarus,O
C(12,O
),O
",",O
TabaÃ¯,O
A(13,O
),O
",",O
Stempfelet,O
M(13,O
),O
",",O
Enouf,O
V(7,O
),O
",",O
Coignard,O
"
",O
B(1,O
),O
",",O
LevyBruhl,O
D(1,O
),O
",",O
Investigation,O
Team(14,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)SantÃ©,O
publique,O
France,O
",",O
Direction,O
des,O
maladies,O
infectieuses,O
",",O
SaintMaurice,O
",",O
"
",O
France,O
.,O
"
",O
(2)SantÃ©,O
publique,O
France,O
",",O
Direction,O
des,O
rÃ©gions,O
",",O
SaintMaurice,O
",",O
France,O
.,O
"
",O
(3)SantÃ©,O
publique,O
France,O
",",O
Direction,O
des,O
rÃ©gions,O
",",O
Cellule,O
RÃ©gionale,O
IledeFrance,O
",",O
"
",O
Paris,O
",",O
France,O
.,O
"
",O
(4)Agence,O
RÃ©gionale,O
de,O
SantÃ©,O
IledeFrance,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(5)Agence,O
RÃ©gionale,O
de,O
SantÃ©,O
NouvelleAquitaine,O
",",O
Bordeaux,O
",",O
France,O
.,O
"
",O
(6)SantÃ©,O
publique,O
France,O
",",O
Direction,O
des,O
rÃ©gions,O
",",O
Cellule,O
RÃ©gionale,O
"
",O
NouvelleAquitaine,O
",",O
Bordeaux,O
",",O
France,O
.,O
"
",O
(7)Centre,O
National,O
de,O
RÃ©fÃ©rence,O
des,O
virus,O
des,O
infections,O
respiratoires,O
",",O
do,O
nt,O
la,O
"
",O
grippe,O
",",O
Institut,O
Pasteur,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(8)APHP,O
",",O
HÃ´pital,O
Bichat,O
",",O
Service,O
des,O
maladies,O
infectieuses,O
et,O
tropicales,O
",",O
Paris,O
",",O
"
",O
France,O
.,O
"
",O
(9)Centre,O
Hospitalier,O
Universitaire,O
de,O
Bordeaux,O
",",O
Service,O
des,O
maladies,O
"
",O
infectieuses,O
et,O
tropicales,O
",",O
Bordeaux,O
GeoSentinel,O
Site,O
",",O
Bordeaux,O
",",O
France,O
.,O
"
",O
(10)UMR,O
1219,O
",",O
UniversitÃ©,O
de,O
Bordeaux,O
",",O
Bordeaux,O
",",O
France,O
.,O
"
",O
(11)UniversitÃ©,O
de,O
Paris,O
",",O
IAME,O
",",O
INSERM,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(12)Direction,O
GÃ©nÃ©rale,O
de,O
la,O
SantÃ©,O
",",O
MinistÃ¨re,O
des,O
solidaritÃ©s,O
et,O
de,O
la,O
santÃ©,O
",",O
"
",O
Centre,O
opÃ©rationnel,O
de,O
rÃ©ception,O
et,O
de,O
rÃ©gulation,O
des,O
urgences,O
sanitaires,O
et,O
"
",O
sociales,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(13)SantÃ©,O
publique,O
France,O
",",O
Direction,O
alerte,O
et,O
crise,O
",",O
SaintMaurice,O
",",O
France,O
.,O
"
",O
(14)The,O
members,O
of,O
the,O
investigation,O
team,O
are,O
listed,O
at,O
the,O
end,O
of,O
the,O
article,O
.,O
"

",O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
",",O
SARSCoV2,B-Virus_SARS-CoV-2
),O
"
",O
causing,O
a,O
cluster,O
of,O
respiratory,O
infections,O
(,O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
",",O
COVID19,B-Disease_COVID-19
),O
"
",O
in,O
Wuhan,O
",",O
China,O
",",O
was,O
identified,O
on,O
7,O
January,O
2020,O
.,O
The,O
epidemic,O
quickly,O
"
",O
disseminated,O
from,O
Wuhan,O
and,O
as,O
at,O
12,O
February,O
2020,O
",",O
45179,O
cases,O
have,O
been,O
"
",O
confirmed,O
in,O
25,O
countries,O
",",O
including,O
1116,O
deaths,O
.,O
Strengthened,O
surveillance,O
was,O
"
",O
implemented,O
in,O
France,O
on,O
10,O
January,O
2020,O
in,O
order,O
to,O
identify,O
imported,O
cases,O
"
",O
early,O
and,O
prevent,O
secondary,O
transmission,O
.,O
Three,O
categories,O
of,O
risk,O
exposure,O
and,O
"
",O
followup,O
procedure,O
were,O
defined,O
for,O
contacts,O
.,O
Three,O
cases,O
of,O
COVID19,B-Disease_COVID-19
were,O
"
",O
confirmed,O
on,O
24,O
January,O
",",O
the,O
first,O
cases,O
in,O
Europe,O
.,O
Contact,O
tracing,O
was,O
"
",O
immediately,O
initiated,O
.,O
Five,O
contacts,O
were,O
evaluated,O
as,O
at,O
low,O
risk,O
of,O
exposure,O
"
",O
and,O
18,O
at,O
moderate,O
high,O
risk,O
.,O
As,O
at,O
12,O
February,O
2020,O
",",O
two,O
cases,O
have,O
been,O
"
",O
discharged,O
and,O
the,O
third,O
one,O
remains,O
symptomatic,O
with,O
a,O
persistent,O
cough,O
",",O
and,O
no,O
"
",O
secondary,O
transmission,O
has,O
been,O
identified,O
.,O
Effective,O
collaboration,O
between,O
all,O
"
",O
parties,O
involved,O
in,O
the,O
surveillance,O
and,O
response,O
to,O
emerging,O
threats,O
is,O
required,O
"
",O
to,O
detect,O
imported,O
cases,O
early,O
and,O
to,O
implement,O
adequate,O
control,O
measures,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.6.2000094,O
"
",O
PMCID,O
:,O
PMC7029452,O
"
",O
PMID,O
:,O
32070465,O
"


",O
660,O
.,O
Crit,O
Care,O
.,O
2020,O
Feb,O
19;24(1):56,O
.,O
doi,O
:,O
10.1186,O
s130540202786x,O
.,O
"

",O
Critical,O
care,O
response,O
to,O
a,O
hospital,O
outbreak,O
of,O
the,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
in,O
"
",O
Shenzhen,O
",",O
China,O
.,O
"

",O
Liu,O
Y(1)(2,O
),O
",",O
Li,O
J(2)(3,O
),O
",",O
Feng,O
Y(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Shenzhen,O
Hospital,O
",",O
Southern,O
Medical,O
"
",O
University,O
",",O
Shenzhen,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(2)Expert,O
panel,O
of,O
Shenzhen,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
",",O
Shenzhen,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Shenzhen,O
Third,O
People,O
's,O
Hospital,O
",",O
"
",O
Shenzhen,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(4)Expert,O
panel,O
of,O
Shenzhen,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
",",O
Shenzhen,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
fengyongwensz@163.com,O
.,O
"
",O
(5)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Shenzhen,O
Second,O
People,O
's,O
hospital,O
",",O
No,O
"
",O
3002,O
",",O
Sungang,O
Road,O
",",O
Futian,O
District,O
",",O
Shenzhen,O
",",O
518028,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
fengyongwensz@163.com,O
.,O
"

",O
Comment,O
in,O
"
    ",O
Crit,O
Care,O
.,O
2020,O
Mar,O
9;24(1):83,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s130540202786x,O
"
",O
PMCID,O
:,O
PMC7029610,O
"
",O
PMID,O
:,O
32070391,O
"


",O
661,O
.,O
RNA,O
Biol,O
.,O
2020,O
Mar,O
0.577777778,O
.,O
doi,O
:,O
10.108,O
15476286.2020.1731664,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
G2quadruplex,O
in,O
the,O
3'UTR,O
of,O
IE180,O
regulates,O
Pseudorabies,O
virus,O
replication,O
by,O
"
",O
enhancing,O
gene,O
expression,O
.,O
"

",O
Zhang,O
Y(1)(2)(3,O
),O
",",O
Liu,O
S(1)(2,O
),O
",",O
Jiang,O
H(1)(4,O
),O
",",O
Deng,O
H(2,O
),O
",",O
Dong,O
C(2,O
),O
",",O
Shen,O
W(2,O
),O
",",O
"
",O
Chen,O
H(2,O
),O
",",O
Gao,O
C(1)(2)(3,O
),O
",",O
Xiao,O
S(1)(4,O
),O
",",O
Liu,O
ZF(1)(4,O
),O
",",O
Wei,O
D(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)College,O
of,O
Science,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)College,O
of,O
Plant,O
Science,O
and,O
Technology,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"

",O
RNA,O
secondary,O
structure,O
elements,O
in,O
the,O
mRNA,O
3'untranslated,O
regions,O
(,O
3'UTR,O
),O
play,O
"
",O
important,O
roles,O
in,O
posttranscriptional,O
regulation,O
.,O
RNA,O
structure,O
elements,O
in,O
the,O
"
",O
viral,O
RNA,O
provide,O
valuable,O
model,O
for,O
studying,O
diverse,O
regulation,O
mechanisms,O
.,O
"
",O
Herpesvirus,O
genomes,O
are,O
doublestranded,O
DNA,O
with,O
GCrich,O
sequences,O
",",O
which,O
can,O
be,O
"
",O
transcribed,O
into,O
abundant,O
GCrich,O
RNAs,O
.,O
It,O
is,O
valuable,O
to,O
explore,O
the,O
structures,O
"
",O
and,O
function,O
of,O
those,O
GCrich,O
RNAs,O
.,O
We,O
identified,O
a,O
G2quadruplexforming,O
"
",O
sequence,O
named,O
PQS181,O
in,O
the,O
3'UTR,O
of,O
the,O
unique,O
immediate,O
early,O
gene,O
of,O
"
",O
Pseudorabies,O
virus,O
(,O
PRV,O
),O
",",O
an,O
important,O
member,O
of,O
Alphaherpesvirinae,O
subfamily,O
.,O
"
",O
The,O
RNA,O
PQS181,O
was,O
folded,O
into,O
parallel,O
Gquadruplex,O
structure,O
",",O
enhancing,O
gene,O
"
",O
expression,O
.,O
Both,O
nonGquadruplex,O
mutant,O
and,O
G3quadruplex,O
mutant,O
in,O
the,O
3'UTR,O
"
",O
showed,O
lower,O
gene,O
expression,O
level,O
than,O
the,O
wildtype,O
G2quadruplex,O
.,O
TMPyP4,O
"
",O
destroyed,O
PQS181,O
Â ,O
G2quadruplex,O
and,O
suppressed,O
gene,O
expression,O
",",O
accordingly,O
"
",O
reducing,O
PRV,O
replication,O
by,O
one,O
titre,O
in,O
the,O
PK15,O
cells,O
at,O
24,O
Â ,O
h,O
post,O
infection,O
.,O
"
",O
Our,O
findings,O
indicated,O
that,O
the,O
RNA,O
G2quadruplex,O
in,O
3'UTR,O
was,O
essential,O
for,O
high,O
"
",O
expression,O
of,O
IE180,O
gene,O
",",O
and,O
it,O
could,O
be,O
a,O
specific,O
posttranscription,O
"
",O
regulation,O
element,O
in,O
response,O
to,O
small,O
molecules,O
or,O
other,O
macromolecules,O
.,O
This,O
"
",O
study,O
discovers,O
a,O
novel,O
RNA,O
G2quadruplex,O
in,O
the,O
3'UTR,O
of,O
an,O
immediate,O
early,O
gene,O
"
",O
of,O
alphaherpesvirus,O
and,O
provides,O
a,O
new,O
nucleic,O
acid,O
target,O
for,O
antivirus,O
drug,O
"
",O
design,O
.,O
"

",O
DOI,O
:,O
10.108,O
15476286.2020.1731664,O
"
",O
PMID,O
:,O
32070191,O
"


",O
662,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Feb,O
18,O
.,O
doi,O
:,O
10.1056,O
NEJMc2001899,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Evidence,O
of,O
SARSCoV2,B-Disease_COVID-19
Infection,I-Disease_COVID-19
in,O
Returning,O
Travelers,O
from,O
Wuhan,O
",",O
China,O
.,O
"

",O
Hoehl,O
S(1,O
),O
",",O
Berger,O
A(1,O
),O
",",O
Kortenbusch,O
M(1,O
),O
",",O
Cinatl,O
J(1,O
),O
",",O
Bojkova,O
D(1,O
),O
",",O
Rabenau,O
"
",O
H(1,O
),O
",",O
Behrens,O
P(2,O
),O
",",O
BÃ¶ddinghaus,O
B(2,O
),O
",",O
GÃ¶tsch,O
U(2,O
),O
",",O
Naujoks,O
F(2,O
),O
",",O
Neumann,O
P(2,O
),O
",",O
"
",O
Schork,O
J(2,O
),O
",",O
TiarksJungk,O
P(2,O
),O
",",O
Walczok,O
A(2,O
),O
",",O
Eickmann,O
M(3,O
),O
",",O
Vehreschild,O
MJGT(1,O
),O
",",O
"
",O
Kann,O
G(1,O
),O
",",O
Wolf,O
T(1,O
),O
",",O
Gottschalk,O
R(2,O
),O
",",O
Ciesek,O
S(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)University,O
Hospital,O
Frankfurt,O
",",O
Frankfurt,O
am,O
Main,O
",",O
Germany,O
.,O
"
",O
(2)Health,O
Protection,O
Authority,O
",",O
City,O
of,O
Frankfurt,O
",",O
Frankfurt,O
am,O
Main,O
",",O
Germany,O
.,O
"
",O
(3)Philipps,O
University,O
Marburg,O
",",O
Marburg,O
",",O
Germany,O
.,O
"
",O
(4)University,O
Hospital,O
Frankfurt,O
",",O
Frankfurt,O
am,O
Main,O
",",O
Germany,O
"
",O
sandra.ciesek@kgu.de,O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMc2001899,O
"
",O
PMID,O
:,O
32069388,O
"


",O
663,O
.,O
J,O
Hosp,O
Infect,O
.,O
2020,O
Feb,O
14,O
.,O
pii,O
:,O
S01956701(20)300517,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jhin.2020.02.005,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
emergency,O
in,O
Zhuhai,O
:,O
impact,O
and,O
challenges,O
.,O
"

",O
Jin,O
H(1,O
),O
",",O
Lu,O
L(2,O
),O
",",O
Liu,O
J(3,O
),O
",",O
Cui,O
M(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Second,O
Department,O
of,O
General,O
Surgery,O
",",O
Zhuhai,O
People,O
's,O
Hospital,O
(,O
Zhuhai,O
"
",O
Hospital,O
Affiliated,O
with,O
Jinan,O
University,O
),O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
519000,O
",",O
"
",O
China,O
.,O
"
",O
(2)Zhuhai,O
People,O
's,O
Hospital,O
(,O
Zhuhai,O
hospital,O
affiliated,O
with,O
Jinan,O
University,O
),O
",",O
"
",O
Zhuhai,O
",",O
Guangdong,O
Province,O
519000,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
2061923583@qq.com,O
.,O
"
",O
(3)Party,O
committee,O
of,O
the,O
Communist,O
Party,O
of,O
China,O
",",O
Zhuhai,O
People,O
's,O
Hospital,O
"
",O
(,O
Zhuhai,O
hospital,O
affiliated,O
with,O
Jinan,O
University,O
),O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
"
",O
519000,O
",",O
China,O
..,O
Electronic,O
address,O
:,O
andy19900324@163.com,O
.,O
"
",O
(4)The,O
Second,O
Department,O
of,O
General,O
Surgery,O
",",O
Zhuhai,O
People,O
's,O
Hospital,O
(,O
Zhuhai,O
"
",O
Hospital,O
Affiliated,O
with,O
Jinan,O
University,O
),O
",",O
Zhuhai,O
",",O
Guangdong,O
Province,O
519000,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
haodoctorjin@foxmail.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jhin.2020.02.005,O
"
",O
PMID,O
:,O
32068012,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflicts,O
of,O
interest,O
No,O
benefits,O
in,O
any,O
form,O
"
",O
have,O
been,O
received,O
or,O
will,O
be,O
received,O
from,O
a,O
commercial,O
party,O
related,O
directly,O
"
",O
or,O
indirectly,O
to,O
the,O
subject,O
of,O
this,O
article,O
.,O
There,O
is,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
664,O
.,O
J,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
18,O
.,O
pii,O
:,O
jiaa077,O
.,O
doi,O
:,O
10.1093,O
infdis,O
jiaa077,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
A,O
familial,O
cluster,O
of,O
infection,O
associated,O
with,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
indicating,O
potential,O
persontoperson,O
transmission,O
during,O
the,O
incubation,O
period,O
.,O
"

",O
Yu,O
P(1,O
),O
",",O
Zhu,O
J(2,O
),O
",",O
Zhang,O
Z(3,O
),O
",",O
Han,O
Y(3,O
),O
",",O
Huang,O
L(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Jingan,O
District,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Shanghai,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(3)Huangpu,O
District,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Biostatistics,O
",",O
Zhongshan,O
Hospital,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
"
",O
China,O
.,O
"

",O
An,O
ongoing,O
outbreak,O
of,O
pneumonia,O
associated,O
with,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
was,O
reported,O
in,O
China,O
.,O
It,O
is,O
unclear,O
if,O
the,O
infectivity,O
exists,O
during,O
"
",O
the,O
incubation,O
period,O
",",O
although,O
a,O
persontoperson,O
transmission,O
has,O
been,O
reported,O
"
",O
in,O
previous,O
studies,O
.,O
We,O
report,O
the,O
epidemiological,O
features,O
of,O
a,O
familial,O
cluster,O
"
",O
of,O
four,O
patients,O
in,O
Shanghai,O
",",O
of,O
which,O
one,O
was,O
88,O
years,O
old,O
man,O
with,O
moving,O
"
",O
difficulties,O
and,O
was,O
only,O
exposed,O
to,O
his,O
asymptomatic,O
family,O
members,O
who,O
"
",O
developed,O
symptoms,O
later,O
.,O
The,O
epidemiological,O
evidence,O
has,O
shown,O
a,O
potential,O
"
",O
transmission,O
of,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
during,O
the,O
incubation,O
period,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
infdis,O
jiaa077,O
"
",O
PMID,O
:,O
32067043,O
"


",O
665,O
.,O
J,O
Immunol,O
.,O
2020,O
Feb,O
17,O
.,O
pii,O
:,O
ji1900561,O
.,O
doi,O
:,O
10.4049,O
jimmunol.1900561,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Zebrafish,O
NIK,O
Mediates,O
IFN,O
Induction,O
by,O
Regulating,O
Activation,O
of,O
IRF3,O
and,O
NFÎºB.,O
"

",O
Chen,O
B(1)(2,O
),O
",",O
Li,O
C(1)(2,O
),O
",",O
Yao,O
J(1)(2,O
),O
",",O
Shi,O
L(1)(2,O
),O
",",O
Liu,O
W(1)(2,O
),O
",",O
Wang,O
F(1)(2,O
),O
",",O
"
",O
Huo,O
S(1)(2,O
),O
",",O
Zhang,O
Y(1)(2,O
),O
",",O
Lu,O
Y(3,O
),O
",",O
Ashraf,O
U(4,O
),O
",",O
Ye,O
J(5,O
),O
",",O
Liu,O
X(6)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)College,O
of,O
Fisheries,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
"
",O
China,O
.,O
"
",O
(2)Hubei,O
Engineering,O
Technology,O
Research,O
Center,O
for,O
Aquatic,O
Animal,O
Diseases,O
"
",O
Control,O
and,O
Prevention,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Public,O
Health,O
Sciences,O
",",O
University,O
of,O
Hawaii,O
at,O
Manoa,O
",",O
Honolulu,O
",",O
"
",O
Hawaii,O
96822,O
;,O
and,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(5)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
China,O
yej@mail.hzau.edu.cn,O
"
",O
xueqinliu@mail.hzau.edu.cn,O
.,O
"
",O
(6)College,O
of,O
Fisheries,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
"
",O
China,O
;,O
yej@mail.hzau.edu.cn,O
xueqinliu@mail.hzau.edu.cn,O
.,O
"

",O
Type,O
I,O
IFN,O
mediates,O
the,O
innate,O
immune,O
system,O
to,O
provide,O
defense,O
against,O
viral,O
"
",O
infections,O
.,O
NFÎºBinducing,O
kinase,O
(,O
NIK,O
),O
potentiates,O
the,O
basal,O
activation,O
of,O
"
",O
endogenous,O
STING,O
",",O
which,O
facilitates,O
the,O
recruitment,O
of,O
TBK1,O
with,O
the,O
ectopically,O
"
",O
expressed,O
IRF3,O
to,O
induce,O
IFN,O
production,O
.,O
Moreover,O
",",O
NIK,O
phosphorylates,O
IKKÎ±,O
and,O
"
",O
confers,O
its,O
ability,O
to,O
phosphorylate,O
p100,O
(,O
also,O
known,O
as,O
NFÎºB2,O
),O
in,O
mammals,O
.,O
Our,O
"
",O
study,O
demonstrated,O
that,O
NIK,O
plays,O
a,O
critical,O
role,O
in,O
IFN,O
production,O
in,O
teleost,O
"
",O
fish,O
.,O
It,O
was,O
found,O
that,O
NIK,O
interacts,O
with,O
IKKÎ±,O
in,O
the,O
cytoplasm,O
and,O
that,O
IKKÎ±,O
"
",O
phosphorylates,O
the,O
NIK,O
at,O
the,O
residue,O
Thr432,O
",",O
which,O
is,O
different,O
from,O
the,O
"
",O
mammals,O
.,O
Overexpression,O
of,O
NIK,O
caused,O
the,O
activation,O
of,O
IRF3,O
and,O
NFÎºB,O
",",O
which,O
in,O
"
",O
turn,O
led,O
to,O
the,O
production,O
of,O
IFN,O
and,O
IFNstimulated,O
genes,O
(,O
ISGs,O
),O
.,O
Furthermore,O
",",O
"
",O
the,O
ectopic,O
expression,O
of,O
NIK,O
was,O
observed,O
to,O
be,O
associated,O
with,O
a,O
reduced,O
"
",O
replication,O
of,O
the,O
fish,O
virus,O
",",O
whereas,O
silencing,O
of,O
endogenous,O
NIK,O
had,O
an,O
"
",O
opposite,O
effect,O
in,O
vitro,O
.,O
Furthermore,O
",",O
NIK,O
knockdown,O
significantly,O
reduced,O
the,O
"
",O
expression,O
of,O
IFN,O
and,O
key,O
ISGs,O
in,O
zebrafish,O
larvae,O
after,O
spring,O
viremia,O
of,O
carp,O
"
",O
virus,O
infection,O
.,O
Additionally,O
",",O
the,O
replication,O
of,O
spring,O
viremia,O
of,O
carp,O
virus,O
"
",O
was,O
enhanced,O
in,O
NIK,O
knockdown,O
zebrafish,O
larvae,O
",",O
leading,O
to,O
a,O
lower,O
survival,O
rate,O
.,O
"
",O
In,O
summary,O
",",O
our,O
findings,O
revealed,O
a,O
previously,O
undescribed,O
function,O
of,O
NIK,O
in,O
"
",O
activating,O
IFN,O
and,O
ISGs,O
as,O
a,O
host,O
antiviral,O
response,O
.,O
These,O
findings,O
may,O
"
",O
facilitate,O
the,O
establishment,O
of,O
antiviral,O
therapy,O
to,O
combat,O
fish,O
viruses,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
by,O
The,O
American,O
Association,O
of,O
Immunologists,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.4049,O
jimmunol.1900561,O
"
",O
PMID,O
:,O
32066597,O
"


",O
666,O
.,O
Lancet,O
Oncol,O
.,O
2020,O
Mar;21(3):335337,O
.,O
doi,O
:,O
10.1016,O
S14702045(20)300966,O
.,O
Epub,O
"
",O
2020,O
Feb,O
14,O
.,O
"

",O
Cancer,O
patients,O
in,O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
:,O
a,O
nationwide,O
analysis,O
in,O
China,O
.,O
"

",O
Liang,O
W(1,O
),O
",",O
Guan,O
W(2,O
),O
",",O
Chen,O
R(2,O
),O
",",O
Wang,O
W(1,O
),O
",",O
Li,O
J(1,O
),O
",",O
Xu,O
K(1,O
),O
",",O
Li,O
C(1,O
),O
",",O
Ai,O
Q(1,O
),O
",",O
"
",O
Lu,O
W(1,O
),O
",",O
Liang,O
H(1,O
),O
",",O
Li,O
S(2,O
),O
",",O
He,O
J(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Thoracic,O
Oncology,O
and,O
Surgery,O
",",O
China,O
State,O
Key,O
Laboratory,O
of,O
"
",O
Respiratory,O
Disease,O
and,O
National,O
Clinical,O
Research,O
Center,O
for,O
Respiratory,O
"
",O
Disease,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
Medical,O
University,O
",",O
Guangzhou,O
"
",O
510120,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Respiratory,O
Disease,O
",",O
China,O
State,O
Key,O
Laboratory,O
of,O
Respiratory,O
"
",O
Disease,O
and,O
National,O
Clinical,O
Research,O
Center,O
for,O
Respiratory,O
Disease,O
",",O
The,O
First,O
"
",O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
Medical,O
University,O
",",O
Guangzhou,O
510120,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Thoracic,O
Oncology,O
and,O
Surgery,O
",",O
China,O
State,O
Key,O
Laboratory,O
of,O
"
",O
Respiratory,O
Disease,O
and,O
National,O
Clinical,O
Research,O
Center,O
for,O
Respiratory,O
"
",O
Disease,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
Medical,O
University,O
",",O
Guangzhou,O
"
",O
510120,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
drjianxing.he@gmail.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14702045(20)300966,O
"
",O
PMID,O
:,O
32066541,O
"


",O
667,O
.,O
Lancet,O
.,O
2020,O
Feb,O
14,O
.,O
pii,O
:,O
S01406736(20)303718,O
.,O
doi,O
:,O
"
",O
10.1016,O
S01406736(20)303718,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Full,O
spectrum,O
of,O
COVID19,B-Disease_COVID-19
severity,O
still,O
being,O
depicted,O
 ,O
Authors,O
',O
reply,O
.,O
"

",O
Gu,O
X(1,O
),O
",",O
Cao,O
B(2,O
),O
",",O
Wang,O
J(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Clinical,O
Medical,O
Sciences,O
",",O
ChinaJapan,O
Friendship,O
Hospital,O
",",O
"
",O
Beijing,O
",",O
China,O
;,O
Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
National,O
"
",O
Clinical,O
Research,O
Center,O
of,O
Respiratory,O
Diseases,O
",",O
ChinaJapan,O
Friendship,O
"
",O
Hospital,O
",",O
Beijing,O
100029,O
",",O
China,O
;,O
Institute,O
of,O
Respiratory,O
Medicine,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Medical,O
Science,O
",",O
Beijing,O
100029,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
National,O
Clinical,O
Research,O
"
",O
Center,O
of,O
Respiratory,O
Diseases,O
",",O
ChinaJapan,O
Friendship,O
Hospital,O
",",O
Beijing,O
100029,O
",",O
"
",O
China,O
;,O
Institute,O
of,O
Respiratory,O
Medicine,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Science,O
",",O
"
",O
Beijing,O
100029,O
",",O
China,O
;,O
Department,O
of,O
Respiratory,O
Medicine,O
",",O
Capital,O
Medical,O
"
",O
University,O
",",O
Beijing,O
",",O
China,O
;,O
Tsinghua,O
UniversityPeking,O
University,O
Joint,O
Center,O
"
",O
for,O
Life,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
caobin_ben@163.com,O
.,O
"
",O
(3)NHC,O
Key,O
Laboratory,O
of,O
Systems,O
Biology,O
of,O
Pathogens,O
and,O
Christophe,O
Merieux,O
"
",O
Laboratory,O
",",O
Institute,O
of,O
Pathogen,O
Biology,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
&,O
"
",O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303718,O
"
",O
PMID,O
:,O
32066526,O
"


",O
668,O
.,O
Lancet,O
.,O
2020,O
Feb,O
14,O
.,O
pii,O
:,O
S01406736(20)303081,O
.,O
doi,O
:,O
"
",O
10.1016,O
S01406736(20)303081,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Full,O
spectrum,O
of,O
COVID19,B-Disease_COVID-19
severity,O
still,O
being,O
depicted,O
.,O
"

",O
Xu,O
Z(1,O
),O
",",O
Li,O
S(1,O
),O
",",O
Tian,O
S(1,O
),O
",",O
Li,O
H(1,O
),O
",",O
Kong,O
LQ(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Endocrine,O
and,O
Breast,O
Surgery,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
"
",O
Chongqing,O
Medical,O
University,O
",",O
Chongqing,O
400016,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Endocrine,O
and,O
Breast,O
Surgery,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
"
",O
Chongqing,O
Medical,O
University,O
",",O
Chongqing,O
400016,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
huihuikp@163.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303081,O
"
",O
PMID,O
:,O
32066525,O
"


",O
669,O
.,O
Neurosci,O
Bull,O
.,O
2020,O
Mar;36(3):199201,O
.,O
doi,O
:,O
10.1007,O
s1226402000472z,O
.,O
Epub,O
2020,O
"
",O
Feb,O
17,O
.,O
"

",O
Neuronal,O
Network,O
Dissection,O
with,O
Neurotropic,O
Virus,O
Tracing,O
.,O
"

",O
Rao,O
X(1,O
),O
",",O
Wang,O
J(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Center,O
of,O
Brain,O
Science,O
",",O
State,O
Key,O
Laboratory,O
of,O
Magnetic,O
Resonance,O
and,O
Atomic,O
"
",O
and,O
Molecular,O
Physics,O
",",O
National,O
Center,O
for,O
Magnetic,O
Resonance,O
in,O
Wuhan,O
",",O
Key,O
"
",O
Laboratory,O
of,O
Magnetic,O
Resonance,O
in,O
Biological,O
Systems,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Physics,O
and,O
Mathematics,O
",",O
Innovation,O
Academy,O
for,O
Precision,O
Measurement,O
Science,O
and,O
"
",O
Technology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(2)Center,O
of,O
Brain,O
Science,O
",",O
State,O
Key,O
Laboratory,O
of,O
Magnetic,O
Resonance,O
and,O
Atomic,O
"
",O
and,O
Molecular,O
Physics,O
",",O
National,O
Center,O
for,O
Magnetic,O
Resonance,O
in,O
Wuhan,O
",",O
Key,O
"
",O
Laboratory,O
of,O
Magnetic,O
Resonance,O
in,O
Biological,O
Systems,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Physics,O
and,O
Mathematics,O
",",O
Innovation,O
Academy,O
for,O
Precision,O
Measurement,O
Science,O
and,O
"
",O
Technology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
jie.wang@wipm.ac.cn,O
.,O
"
",O
(3)The,O
Second,O
Hospital,O
of,O
Shijiazhuang,O
",",O
Shijiazhuang,O
",",O
50051,O
",",O
China,O
.,O
"
",O
jie.wang@wipm.ac.cn,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s1226402000472z,O
"
",O
PMID,O
:,O
32065368,O
"


",O
670,O
.,O
Chin,O
J,O
Integr,O
Med,O
.,O
2020,O
Feb,O
17,O
.,O
doi,O
:,O
10.1007,O
s1165502031926,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Can,O
Chinese,O
Medicine,O
Be,O
Used,O
for,O
Prevention,O
of,O
Corona,B-Disease_COVID-19
Virus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
?,O
A,O
Review,O
of,O
Historical,O
Classics,O
",",O
Research,O
Evidence,O
and,O
Current,O
"
",O
Prevention,O
Programs,O
.,O
"

",O
Luo,O
H(1)(2,O
),O
",",O
Tang,O
QL(3,O
),O
",",O
Shang,O
YX(2)(3,O
),O
",",O
Liang,O
SB(2)(3,O
),O
",",O
Yang,O
M(2)(3,O
),O
",",O
Robinson,O
"
",O
N(2)(4,O
),O
",",O
Liu,O
JP(5)(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
for,O
Tibetan,O
Medicine,O
",",O
China,O
Tibetology,O
Research,O
Center,O
",",O
Beijing,O
",",O
"
",O
100101,O
",",O
China,O
.,O
"
",O
(2)Centre,O
for,O
EvidenceBased,O
Chinese,O
Medicine,O
",",O
Beijing,O
University,O
of,O
Chinese,O
"
",O
Medicine,O
",",O
Beijing,O
",",O
100029,O
",",O
China,O
.,O
"
",O
(3)School,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
Beijing,O
University,O
of,O
Chinese,O
"
",O
Medicine,O
",",O
Beijing,O
",",O
100029,O
",",O
China,O
.,O
"
",O
(4)School,O
of,O
Health,O
and,O
Social,O
Care,O
",",O
London,O
South,O
Bank,O
University,O
",",O
London,O
",",O
SE1,O
"
",O
0AA,O
",",O
UK,O
.,O
"
",O
(5)Centre,O
for,O
EvidenceBased,O
Chinese,O
Medicine,O
",",O
Beijing,O
University,O
of,O
Chinese,O
"
",O
Medicine,O
",",O
Beijing,O
",",O
100029,O
",",O
China,O
.,O
jianping_l@hotmail.com,O
.,O
"
",O
(6)Institute,O
of,O
Integrated,O
Traditional,O
Chinese,O
Medicine,O
and,O
Western,O
Medicine,O
",",O
"
",O
Guangzhou,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
510120,O
",",O
China,O
.,O
jianping_l@hotmail.com,O
.,O
"

",O
OBJECTIVE,O
:,O
Since,O
December,O
2019,O
",",O
an,O
outbreak,O
of,O
corona,B-Disease_COVID-19
virus,I-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
"
",O
(,O
COVID19,B-Disease_COVID-19
),O
occurred,O
in,O
Wuhan,O
",",O
and,O
rapidly,O
spread,O
to,O
almost,O
all,O
parts,O
of,O
China,O
.,O
"
",O
This,O
was,O
followed,O
by,O
prevention,O
programs,O
recommending,O
Chinese,O
medicine,O
(,O
CM,O
),O
for,O
"
",O
the,O
prevention,O
.,O
In,O
order,O
to,O
provide,O
evidence,O
for,O
CM,O
recommendations,O
",",O
we,O
reviewed,O
"
",O
ancient,O
classics,O
and,O
human,O
studies,O
.,O
"
",O
METHODS,O
:,O
Historical,O
records,O
on,O
prevention,O
and,O
treatment,O
of,O
infections,O
in,O
CM,O
"
",O
classics,O
",",O
clinical,O
evidence,O
of,O
CM,O
on,O
the,O
prevention,O
of,O
severe,O
acute,O
respiratory,O
"
",O
syndrome,O
(,O
SARS,O
),O
and,O
H1N1,O
influenza,O
",",O
and,O
CM,O
prevention,O
programs,O
issued,O
by,O
health,O
"
",O
authorities,O
in,O
China,O
since,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
were,O
retrieved,O
from,O
different,O
"
",O
databases,O
and,O
websites,O
till,O
12,O
February,O
",",O
2020,O
.,O
Research,O
evidence,O
included,O
data,O
"
",O
from,O
clinical,O
trials,O
",",O
cohort,O
or,O
other,O
population,O
studies,O
using,O
CM,O
for,O
preventing,O
"
",O
contagious,O
respiratory,O
virus,O
diseases,O
.,O
"
",O
RESULTS,O
:,O
The,O
use,O
of,O
CM,O
to,O
prevent,O
epidemics,O
of,O
infectious,O
diseases,O
was,O
traced,O
"
",O
back,O
to,O
ancient,O
Chinese,O
practice,O
cited,O
in,O
Huangdi,O
's,O
Internal,O
Classic,O
(,O
Huang,O
Di,O
"
",O
Nei,O
Jing,O
),O
where,O
preventive,O
effects,O
were,O
recorded,O
.,O
There,O
were,O
3,O
studies,O
using,O
CM,O
"
",O
for,O
prevention,O
of,O
SARS,O
and,O
4,O
studies,O
for,O
H1N1,O
influenza,O
.,O
None,O
of,O
the,O
participants,O
"
",O
who,O
took,O
CM,O
contracted,O
SARS,O
in,O
the,O
3,O
studies,O
.,O
The,O
infection,O
rate,O
of,O
H1N1,O
"
",O
influenza,O
in,O
the,O
CM,O
group,O
was,O
significantly,O
lower,O
than,O
the,O
nonCM,O
group,O
(,O
relative,O
"
",O
risk,O
0.36,O
",",O
95,O
%,O
confidence,O
interval,O
0.240.52,O
;,O
n=4,O
),O
.,O
For,O
prevention,O
of,O
COVID19,B-Disease_COVID-19
",",O
"
",O
23,O
provinces,O
in,O
China,O
issued,O
CM,O
programs,O
.,O
The,O
main,O
principles,O
of,O
CM,O
use,O
were,O
to,O
"
",O
tonify,O
qi,O
to,O
protect,O
from,O
external,O
pathogens,O
",",O
disperse,O
wind,O
and,O
discharge,O
heat,O
",",O
"
",O
and,O
resolve,O
dampness,O
.,O
The,O
most,O
frequently,O
used,O
herbs,O
included,O
Radix,O
astragali,O
"
",O
(,O
Huangqi,O
),O
",",O
Radix,O
glycyrrhizae,O
(,O
Gancao,O
),O
",",O
Radix,O
saposhnikoviae,O
(,O
Fangfeng,O
),O
",",O
Rhizoma,O
"
",O
Atractylodis,O
Macrocephalae,O
(,O
Baizhu,O
),O
",",O
Lonicerae,O
Japonicae,O
Flos,O
(,O
Jinyinhua,O
),O
",",O
and,O
"
",O
Fructus,O
forsythia,O
(,O
Lianqiao,O
),O
.,O
"
",O
CONCLUSIONS,O
:,O
Based,O
on,O
historical,O
records,O
and,O
human,O
evidence,O
of,O
SARS,O
and,O
H1N1,O
"
",O
influenza,O
prevention,O
",",O
Chinese,O
herbal,O
formula,O
could,O
be,O
an,O
alternative,O
approach,O
for,O
"
",O
prevention,O
of,O
COVID19,B-Disease_COVID-19
in,O
highrisk,O
population,O
.,O
Prospective,O
",",O
rigorous,O
population,O
"
",O
studies,O
are,O
warranted,O
to,O
confirm,O
the,O
potential,O
preventive,O
effect,O
of,O
CM,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s1165502031926,O
"
",O
PMID,O
:,O
32065348,O
"


",O
671,O
.,O
Arch,O
Virol,O
.,O
2020,O
Feb,O
17,O
.,O
doi,O
:,O
10.1007,O
s00705020045541,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Molecular,O
characterization,O
of,O
a,O
novel,O
fusarivirus,O
infecting,O
the,O
plantpathogenic,O
"
",O
fungus,O
Botryosphaeria,O
dothidea,O
.,O
"

",O
Liu,O
W(1)(2,O
),O
",",O
Hai,O
D(2,O
),O
",",O
Mu,O
F(2,O
),O
",",O
Yu,O
X(1,O
),O
",",O
Zhao,O
Y(1,O
),O
",",O
He,O
B(1,O
),O
",",O
Xie,O
J(2,O
),O
",",O
Jiang,O
"
",O
D(2,O
),O
",",O
Liu,O
H(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Shandong,O
Research,O
Center,O
for,O
Forestry,O
Harmful,O
Biological,O
Control,O
Engineering,O
"
",O
and,O
Technology,O
",",O
College,O
of,O
Plant,O
Protection,O
",",O
Shandong,O
Agricultural,O
University,O
",",O
"
",O
Tai'an,O
",",O
271018,O
",",O
Shandong,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
The,O
Provincial,O
Key,O
Lab,O
of,O
"
",O
Plant,O
Pathology,O
of,O
Hubei,O
Province,O
",",O
College,O
of,O
Plant,O
Science,O
and,O
Technology,O
",",O
"
",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
Hubei,O
",",O
People,O
's,O
Republic,O
of,O
"
",O
China,O
.,O
"
",O
(3)Shandong,O
Research,O
Center,O
for,O
Forestry,O
Harmful,O
Biological,O
Control,O
Engineering,O
"
",O
and,O
Technology,O
",",O
College,O
of,O
Plant,O
Protection,O
",",O
Shandong,O
Agricultural,O
University,O
",",O
"
",O
Tai'an,O
",",O
271018,O
",",O
Shandong,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
hxliu@sdau.edu.cn,O
.,O
"

",O
A,O
novel,O
virus,O
",",O
Botryosphaeria,O
dothidea,O
fusarivirus,O
1,O
(,O
BdFV1,O
),O
",",O
was,O
isolated,O
from,O
a,O
"
",O
fungal,O
strain,O
",",O
SDAU1186,O
of,O
Botryosphaeria,O
dothidea,O
",",O
and,O
its,O
complete,O
genome,O
"
",O
sequence,O
was,O
determined,O
.,O
BdFV1,O
has,O
a,O
singlestranded,O
positivesense,O
(,O
+,O
ssRNA,O
),O
"
",O
genome,O
with,O
6179,O
nucleotides,O
",",O
excluding,O
the,O
poly(A,O
),O
tail,O
.,O
The,O
genome,O
of,O
BdFV1,O
"
",O
contains,O
two,O
putative,O
open,O
reading,O
frames,O
(,O
ORFs,O
),O
.,O
The,O
first,O
ORF,O
encodes,O
a,O
large,O
"
",O
polyprotein,O
of,O
1544,O
amino,O
acids,O
(,O
aa,O
),O
with,O
conserved,O
RNAdependent,O
RNA,O
polymerase,O
"
",O
and,O
viral,O
helicase,O
domains,O
.,O
The,O
second,O
ORF,O
encodes,O
a,O
putative,O
481aa,O
protein,O
with,O
"
",O
unknown,O
function,O
.,O
Sequence,O
comparisons,O
and,O
phylogenetic,O
analysis,O
suggested,O
that,O
"
",O
BdFV1,O
is,O
a,O
novel,O
mycovirus,O
belonging,O
to,O
the,O
newly,O
proposed,O
family,O
"
",O
"""",O
Fusariviridae,O
"""",O
.,O
This,O
is,O
the,O
first,O
report,O
of,O
a,O
+,O
ssRNA,O
mycovirus,O
in,O
B.,O
dothidea,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00705020045541,O
"
",O
PMID,O
:,O
32065316,O
"


",O
672,O
.,O
Pathog,O
Dis,O
.,O
2019,O
Dec,O
1;77(9,O
),O
.,O
pii,O
:,O
ftaa006,O
.,O
doi,O
:,O
10.1093,O
femspd,O
ftaa006,O
.,O
"

",O
Coronaviruses,O
:,O
a,O
paradigm,O
of,O
new,O
emerging,O
zoonotic,O
diseases,O
.,O
"

",O
Salata,O
C(1,O
),O
",",O
Calistri,O
A(1,O
),O
",",O
Parolin,O
C(1,O
),O
",",O
PalÃ¹,O
G(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Molecular,O
Medicine,O
",",O
University,O
of,O
Padova,O
",",O
Via,O
Gabelli,O
63,O
",",O
35121,O
",",O
"
",O
Padova,O
",",O
Italy,O
.,O
"

",O
A,O
novel,O
type,O
of,O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
infecting,O
humans,O
appeared,O
in,O
Wuhan,O
",",O
"
",O
China,O
",",O
at,O
the,O
end,O
of,O
December,O
2019,O
.,O
Since,O
the,O
identification,O
of,O
the,O
outbreak,O
the,O
"
",O
infection,O
quickly,O
spread,O
involving,O
in,O
one,O
month,O
more,O
than,O
31000,O
confirmed,O
cases,O
"
",O
with,O
638,O
death,O
.,O
Molecular,O
analysis,O
suggest,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
could,O
be,O
originated,O
"
",O
from,O
bats,O
after,O
passaging,O
in,O
intermediate,O
hosts,O
",",O
highlighting,O
the,O
high,O
zoonotic,O
"
",O
potential,O
of,O
coronaviruses,O
.,O
"

",O
Â©,O
FEMS,O
2020,O
.,O
"

",O
DOI,O
:,O
10.1093,O
femspd,O
ftaa006,O
"
",O
PMID,O
:,O
32065221,O
"


",O
673,O
.,O
Emerg,O
Microbes,O
Infect,O
.,O
2020,O
Dec;9(1):386389,O
.,O
doi,O
:,O
10.108,O
22221751.2020.1729071,O
.,O
"

",O
Molecular,O
and,O
serological,O
investigation,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
infected,O
patients,O
:,O
"
",O
implication,O
of,O
multiple,O
shedding,O
routes,O
.,O
"

",O
Zhang,O
W(1,O
),O
",",O
Du,O
RH(2,O
),O
",",O
Li,O
B(1,O
),O
",",O
Zheng,O
XS(1,O
),O
",",O
Yang,O
XL(1,O
),O
",",O
Hu,O
B(1,O
),O
",",O
Wang,O
YY(1,O
),O
",",O
Xiao,O
"
",O
GF(1,O
),O
",",O
Yan,O
B(1,O
),O
",",O
Shi,O
ZL(1,O
),O
",",O
Zhou,O
P(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
"
",O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
People,O
's,O
Republic,O
"
",O
of,O
China,O
.,O
"
",O
(2)Wuhan,O
Pulmonary,O
Hospital,O
",",O
Wuhan,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"

",O
In,O
December,O
2019,O
",",O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
caused,O
an,O
outbreak,O
in,O
Wuhan,O
",",O
"
",O
China,O
",",O
and,O
soon,O
spread,O
to,O
other,O
parts,O
of,O
the,O
world,O
.,O
It,O
was,O
believed,O
that,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
was,O
transmitted,O
through,O
respiratory,O
tract,O
and,O
then,O
induced,O
pneumonia,O
",",O
"
",O
thus,O
molecular,O
diagnosis,O
based,O
on,O
oral,O
swabs,O
was,O
used,O
for,O
confirmation,O
of,O
this,O
"
",O
disease,O
.,O
Likewise,O
",",O
patient,O
will,O
be,O
released,O
upon,O
two,O
times,O
of,O
negative,O
detection,O
"
",O
from,O
oral,O
swabs,O
.,O
However,O
",",O
many,O
coronaviruses,O
can,O
also,O
be,O
transmitted,O
through,O
"
",O
oralfecal,O
route,O
by,O
infecting,O
intestines,O
.,O
Whether,O
2019nCoV,B-Virus_SARS-CoV-2
infected,O
patients,O
"
",O
also,O
carry,O
virus,O
in,O
other,O
organs,O
like,O
intestine,O
need,O
to,O
be,O
tested,O
.,O
We,O
conducted,O
"
",O
investigation,O
on,O
patients,O
in,O
a,O
local,O
hospital,O
who,O
were,O
infected,O
with,O
this,O
virus,O
.,O
"
",O
We,O
found,O
the,O
presence,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
anal,O
swabs,O
and,O
blood,O
as,O
well,O
",",O
and,O
more,O
anal,O
"
",O
swab,O
positives,O
than,O
oral,O
swab,O
positives,O
in,O
a,O
later,O
stage,O
of,O
infection,O
",",O
suggesting,O
"
",O
shedding,O
and,O
thereby,O
transmitted,O
through,O
oralfecal,O
route,O
.,O
We,O
also,O
showed,O
"
",O
serology,O
test,O
can,O
improve,O
detection,O
positive,O
rate,O
thus,O
should,O
be,O
used,O
in,O
future,O
"
",O
epidemiology,O
.,O
Our,O
report,O
provides,O
a,O
cautionary,O
warning,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
may,O
be,O
shed,O
"
",O
through,O
multiple,O
routes,O
.,O
"

",O
DOI,O
:,O
10.108,O
22221751.2020.1729071,O
"
",O
PMCID,O
:,O
PMC7048229,O
"
",O
PMID,O
:,O
32065057,O
"


",O
674,O
.,O
Emerg,O
Microbes,O
Infect,O
.,O
2020,O
Dec;9(1):382385,O
.,O
doi,O
:,O
10.108,O
22221751.2020.1729069,O
.,O
"

",O
Potent,O
binding,O
of,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
spike,O
protein,O
by,O
a,O
SARS,O
"
",O
coronavirusspecific,O
human,O
monoclonal,O
antibody,O
.,O
"

",O
Tian,O
X(1,O
),O
",",O
Li,O
C(1,O
),O
",",O
Huang,O
A(1,O
),O
",",O
Xia,O
S(1,O
),O
",",O
Lu,O
S(1,O
),O
",",O
Shi,O
Z(2,O
),O
",",O
Lu,O
L(1,O
),O
",",O
Jiang,O
S(1,O
),O
",",O
"
",O
Yang,O
Z(3,O
),O
",",O
Wu,O
Y(1,O
),O
",",O
Ying,O
T(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)MOE,O
NHC,O
CAMS,O
Key,O
Laboratory,O
of,O
Medical,O
Molecular,O
Virology,O
",",O
School,O
of,O
Basic,O
"
",O
Medical,O
Sciences,O
",",O
Shanghai,O
Medical,O
College,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
People,O
's,O
"
",O
Republic,O
of,O
China,O
.,O
"
",O
(2)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
"
",O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
People,O
's,O
Republic,O
"
",O
of,O
China,O
.,O
"
",O
(3)Department,O
of,O
Pulmonary,O
Medicine,O
",",O
Zhongshan,O
Hospital,O
",",O
Fudan,O
University,O
",",O
"
",O
Shanghai,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"

",O
The,O
newly,O
identified,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
has,O
caused,O
more,O
than,O
"
",O
11900,O
laboratoryconfirmed,O
human,O
infections,O
",",O
including,O
259,O
deaths,O
",",O
posing,O
a,O
"
",O
serious,O
threat,O
to,O
human,O
health,O
.,O
Currently,O
",",O
however,O
",",O
there,O
is,O
no,O
specific,O
"
",O
antiviral,O
treatment,O
or,O
vaccine,O
.,O
Considering,O
the,O
relatively,O
high,O
identity,O
of,O
"
",O
receptorbinding,O
domain,O
(,O
RBD,O
),O
in,O
2019nCoV,B-Virus_SARS-CoV-2
and,O
SARSCoV,O
",",O
it,O
is,O
urgent,O
to,O
assess,O
"
",O
the,O
crossreactivity,O
of,O
antiSARS,O
CoV,O
antibodies,O
with,O
2019nCoV,B-Virus_SARS-CoV-2
spike,O
protein,O
",",O
"
",O
which,O
could,O
have,O
important,O
implications,O
for,O
rapid,O
development,O
of,O
vaccines,O
and,O
"
",O
therapeutic,O
antibodies,O
against,O
2019nCoV.,O
Here,O
",",O
we,O
report,O
for,O
the,O
first,O
time,O
that,O
"
",O
a,O
SARSCoVspecific,O
human,O
monoclonal,O
antibody,O
",",O
CR3022,O
",",O
could,O
bind,O
potently,O
with,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
RBD,O
(,O
KD,O
of,O
6.3,O
nM,O
),O
.,O
The,O
epitope,O
of,O
CR3022,O
does,O
not,O
overlap,O
with,O
the,O
"
",O
ACE2,O
binding,O
site,O
within,O
2019nCoV,B-Virus_SARS-CoV-2
RBD,O
.,O
These,O
results,O
suggest,O
that,O
CR3022,O
may,O
"
",O
have,O
the,O
potential,O
to,O
be,O
developed,O
as,O
candidate,O
therapeutics,O
",",O
alone,O
or,O
in,O
"
",O
combination,O
with,O
other,O
neutralizing,O
antibodies,O
",",O
for,O
the,O
prevention,O
and,O
treatment,O
"
",O
of,O
2019nCoV,B-Virus_SARS-CoV-2
infections,O
.,O
Interestingly,O
",",O
some,O
of,O
the,O
most,O
potent,O
SARSCoVspecific,O
"
",O
neutralizing,O
antibodies,O
(,O
e.g.,O
m396,O
",",O
CR3014,O
),O
that,O
target,O
the,O
ACE2,O
binding,O
site,O
of,O
"
",O
SARSCoV,O
failed,O
to,O
bind,O
2019nCoV,B-Virus_SARS-CoV-2
spike,O
protein,O
",",O
implying,O
that,O
the,O
difference,O
in,O
"
",O
the,O
RBD,O
of,O
SARSCoV,O
and,O
2019nCoV,B-Virus_SARS-CoV-2
has,O
a,O
critical,O
impact,O
for,O
the,O
crossreactivity,O
"
",O
of,O
neutralizing,O
antibodies,O
",",O
and,O
that,O
it,O
is,O
still,O
necessary,O
to,O
develop,O
novel,O
"
",O
monoclonal,O
antibodies,O
that,O
could,O
bind,O
specifically,O
to,O
2019nCoV,B-Virus_SARS-CoV-2
RBD,O
.,O
"

",O
DOI,O
:,O
10.108,O
22221751.2020.1729069,O
"
",O
PMCID,O
:,O
PMC7048180,O
"
",O
PMID,O
:,O
32065055,O
"


",O
675,O
.,O
Front,O
Pharmacol,O
.,O
2020,O
Jan,O
29;10:1563,O
.,O
doi,O
:,O
10.3389,O
fphar.2019.01563,O
.,O
eCollection,O
"
",O
2019,O
.,O
"

",O
Epigallocatechin3Gallate,O
Toxicity,O
in,O
Children,O
:,O
A,O
Potential,O
and,O
Current,O
"
",O
Toxicological,O
Event,O
in,O
the,O
Differential,O
Diagnosis,O
With,O
VirusTriggered,O
Fulminant,O
"
",O
Hepatic,O
Failure,O
.,O
"

",O
Sergi,O
CM(1)(2)(3)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
"""",O
111,O
"""",O
Center,O
for,O
Cellular,O
Regulation,O
and,O
Molecular,O
Pharmaceutics,O
",",O
Key,O
"
",O
Laboratory,O
of,O
Fermentation,O
Engineering,O
",",O
Ministry,O
of,O
Education,O
",",O
Hubei,O
University,O
"
",O
of,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Stollery,O
Children,O
's,O
Hospital,O
",",O
University,O
Alberta,O
Hospital,O
",",O
Edmonton,O
",",O
AB,O
",",O
"
",O
Canada,O
.,O
"
",O
(3)Department,O
of,O
Laboratory,O
Medicine,O
and,O
Pathology,O
",",O
University,O
of,O
Alberta,O
",",O
"
",O
Edmonton,O
",",O
AB,O
",",O
Canada,O
.,O
"
",O
(4)Department,O
of,O
Orthopedics,O
",",O
Tianyou,O
Hospital,O
",",O
Wuhan,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
The,O
use,O
of,O
nutraceuticals,O
is,O
considerably,O
increasing,O
worldwide,O
with,O
a,O
demand,O
for,O
"
",O
organic,O
and,O
clean,O
foods,O
in,O
the,O
last,O
two,O
decades,O
",",O
which,O
is,O
probably,O
incomparable,O
"
",O
with,O
other,O
periods,O
of,O
our,O
civilization,O
.,O
The,O
consistent,O
application,O
of,O
"
",O
nutraceuticals,O
and,O
socalled,O
"""",O
superfood,O
"""",O
may,O
have,O
remarkable,O
effects,O
on,O
the,O
"
",O
prevention,O
of,O
several,O
chronic,O
diseases,O
",",O
including,O
cancer,O
.,O
Moreover,O
",",O
the,O
increased,O
"
",O
rate,O
of,O
overweight,O
and,O
obesity,O
in,O
Western,O
countries,O
does,O
not,O
spare,O
childhood,O
and,O
"
",O
youth,O
",",O
and,O
the,O
number,O
of,O
parents,O
using,O
natural,O
remedies,O
for,O
preventing,O
pediatric,O
"
",O
illness,O
is,O
vastly,O
increasing,O
worldwide,O
.,O
However,O
",",O
the,O
overwhelming,O
effects,O
on,O
"
",O
diseases,O
often,O
overshadow,O
the,O
side,O
effects,O
of,O
such,O
nutrition,O
",",O
particularly,O
in,O
"
",O
societies,O
without,O
millennial,O
experience,O
with,O
botanicals,O
and,O
natural,O
elements,O
.,O
"
",O
Thus,O
",",O
the,O
final,O
result,O
may,O
be,O
disastrous,O
for,O
some,O
individuals,O
.,O
The,O
liver,O
is,O
the,O
"
",O
most,O
important,O
and,O
conspicuous,O
target,O
organ,O
of,O
numerous,O
molecular,O
compounds,O
",",O
and,O
"
",O
the,O
cell,O
damage,O
is,O
particularly,O
striking,O
on,O
the,O
infantile,O
and,O
pediatric,O
liver,O
due,O
"
",O
to,O
the,O
immaturity,O
of,O
the,O
hepatocytes,O
.,O
Here,O
",",O
we,O
target,O
some,O
generic,O
data,O
on,O
"
",O
fulminant,O
hepatic,O
failure,O
",",O
the,O
benefits,O
",",O
and,O
toxicity,O
of,O
"
",O
epigallocatechin3gallate,O
",",O
which,O
is,O
one,O
of,O
the,O
major,O
components,O
of,O
green,O
tea,O
",",O
"
",O
and,O
the,O
histopathology,O
of,O
the,O
"""",O
"greentea""associated",O
liver,O
disease,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Sergi,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fphar.2019.01563,O
"
",O
PMCID,O
:,O
PMC7000546,O
"
",O
PMID,O
:,O
32063842,O
"


",O
676,O
.,O
Biosci,O
Trends,O
.,O
2020,O
Feb,O
17,O
.,O
doi,O
:,O
10.5582,O
bst.2020.01043,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Challenges,O
to,O
the,O
system,O
of,O
reserve,O
medical,O
supplies,O
for,O
public,O
health,O
"
",O
emergencies,O
:,O
reflections,O
on,O
the,O
outbreak,O
of,O
the,O
severe,O
acute,O
respiratory,O
syndrome,O
"
",O
coronavirus,O
2,O
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
epidemic,O
in,O
China,O
.,O
"

",O
Wang,O
X(1,O
),O
",",O
Zhang,O
X(1,O
),O
",",O
He,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Health,O
Policy,O
Research,O
",",O
Shanghai,O
Health,O
Development,O
Research,O
"
",O
Center,O
(,O
Shanghai,O
Medical,O
Information,O
Center,O
),O
",",O
Shanghai,O
",",O
China,O
.,O
"

",O
On,O
December,O
31,O
",",O
2019,O
",",O
the,O
Wuhan,O
Municipal,O
Health,O
Commission,O
announced,O
an,O
outbreak,O
"
",O
of,O
severe,B-Virus_SARS-CoV-2
acute,I-Virus_SARS-CoV-2
respiratory,I-Virus_SARS-CoV-2
syndrome,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
China,O
is,O
now,O
at,O
"
",O
a,O
critical,O
period,O
in,O
the,O
control,O
of,O
the,O
epidemic,O
.,O
The,O
Chinese,O
Government,O
has,O
been,O
"
",O
taking,O
a,O
series,O
of,O
rapid,O
",",O
comprehensive,O
",",O
and,O
effective,O
prevention,O
and,O
control,O
"
",O
measures,O
.,O
As,O
the,O
pandemic,O
has,O
developed,O
",",O
a,O
fact,O
has,O
become,O
apparent,O
:,O
there,O
is,O
a,O
"
",O
serious,O
dearth,O
of,O
emergency,O
medical,O
supplies,O
",",O
and,O
especially,O
an,O
extreme,O
shortage,O
"
",O
of,O
personal,O
protective,O
equipment,O
such,O
as,O
masks,O
and,O
medical,O
protective,O
clothing,O
.,O
"
",O
This,O
is,O
one,O
of,O
the,O
major,O
factors,O
affecting,O
the,O
progress,O
of,O
epidemic,O
prevention,O
"
",O
and,O
control,O
.,O
Although,O
China,O
has,O
made,O
great,O
efforts,O
to,O
strengthen,O
the,O
ability,O
to,O
"
",O
quickly,O
respond,O
to,O
public,O
health,O
emergencies,O
since,O
the,O
SARS,O
outbreak,O
in,O
2003,O
and,O
"
",O
it,O
has,O
clarified,O
requirements,O
for,O
emergency,O
supplies,O
through,O
legislation,O
",",O
the,O
"
",O
emergency,O
reserve,O
supplies,O
program,O
has,O
not,O
been,O
effectively,O
implemented,O
",",O
and,O
"
",O
there,O
are,O
also,O
deficiencies,O
in,O
the,O
types,O
",",O
quantity,O
",",O
and,O
availability,O
of,O
emergency,O
"
",O
medical,O
supplies,O
.,O
A,O
sound,O
system,O
of,O
emergency,O
reserve,O
supplies,O
is,O
crucial,O
to,O
the,O
"
",O
management,O
of,O
public,O
health,O
emergencies,O
.,O
Based,O
on,O
international,O
experiences,O
with,O
"
",O
pandemic,O
control,O
",",O
the,O
world,O
should,O
emphasize,O
improving,O
the,O
system,O
of,O
emergency,O
"
",O
reserve,O
medical,O
supplies,O
in,O
the,O
process,O
of,O
establishing,O
and,O
improving,O
public,O
"
",O
health,O
emergency,O
response,O
systems,O
",",O
and,O
it,O
should,O
promote,O
the,O
establishment,O
of,O
"
",O
international,O
cooperative,O
programs,O
to,O
jointly,O
deal,O
with,O
public,O
health,O
emergencies,O
"
",O
of,O
international,O
concern,O
in,O
the,O
future,O
.,O
"

",O
DOI,O
:,O
10.5582,O
bst.2020.01043,O
"
",O
PMID,O
:,O
32062645,O
"


",O
677,O
.,O
Lancet,O
Respir,O
Med,O
.,O
2020,O
Mar;8(3):e11e12,O
.,O
doi,O
:,O
10.1016,O
S22132600(20)300710,O
.,O
"
",O
Epub,O
2020,O
Feb,O
13,O
.,O
"

",O
Therapeutic,O
and,O
triage,O
strategies,O
for,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
disease,I-Disease_COVID-19
in,O
fever,O
"
",O
clinics,O
.,O
"

",O
Zhang,O
J(1,O
),O
",",O
Zhou,O
L(2,O
),O
",",O
Yang,O
Y(3,O
),O
",",O
Peng,O
W(4,O
),O
",",O
Wang,O
W(5,O
),O
",",O
Chen,O
X(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Emergency,O
Medicine,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
430022,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
zhangjnwhhb@163.com,O
.,O
"
",O
(2)First,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
Medical,O
University,O
",",O
National,O
Clinical,O
"
",O
Research,O
Center,O
for,O
Respiratory,O
Disease,O
",",O
Guangzhou,O
Institute,O
of,O
Respiratory,O
"
",O
Health,O
",",O
State,O
Key,O
Laboratory,O
of,O
Respiratory,O
Disease,O
",",O
Guangzhou,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
zhlx09@163.com,O
.,O
"
",O
(3)First,O
Affiliated,O
Hospital,O
of,O
Guangzhou,O
Medical,O
University,O
",",O
National,O
Clinical,O
"
",O
Research,O
Center,O
for,O
Respiratory,O
Disease,O
",",O
Guangzhou,O
Institute,O
of,O
Respiratory,O
"
",O
Health,O
",",O
State,O
Key,O
Laboratory,O
of,O
Respiratory,O
Disease,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(4)Division,O
of,O
ICU,O
and,O
Respiratory,O
Service,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
Salt,O
"
",O
Lake,O
Regional,O
Medical,O
Center,O
",",O
Heart,O
and,O
Lung,O
Institute,O
of,O
Utah,O
",",O
Salt,O
Lake,O
City,O
",",O
"
",O
UT,O
",",O
USA,O
.,O
"
",O
(5)Department,O
of,O
Emergency,O
Medicine,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
430022,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Gerontology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
430022,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22132600(20)300710,O
"
",O
PMID,O
:,O
32061335,O
"


",O
678,O
.,O
Lancet,O
.,O
2020,O
Feb,O
22;395(10224):542545,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303743,O
.,O
Epub,O
"
",O
2020,O
Feb,O
13,O
.,O
"

",O
COVID19,B-Disease_COVID-19
:,O
what,O
is,O
next,O
for,O
public,O
health,O
?,O
"

",O
Heymann,O
DL(1,O
),O
",",O
Shindo,O
N(2,O
),O
;,O
WHO,O
Scientific,O
and,O
Technical,O
Advisory,O
Group,O
for,O
"
",O
Infectious,O
Hazards,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Infectious,O
Disease,O
Epidemiology,O
",",O
London,O
School,O
of,O
Hygiene,O
&,O
Tropical,O
Medicine,O
",",O
"
",O
London,O
WC1E,O
7HT,O
",",O
UK,O
.,O
Electronic,O
address,O
:,O
david.heymann@lshtm.ac.uk,O
.,O
"
",O
(2)World,O
Health,O
Organization,O
",",O
Geneva,O
",",O
Switzerland,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303743,O
"
",O
PMID,O
:,O
32061313,O
"


",O
679,O
.,O
Lancet,O
.,O
2020,O
Feb,O
29;395(10225):664666,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303731,O
.,O
Epub,O
"
",O
2020,O
Feb,O
13,O
.,O
"

",O
Do,O
not,O
violate,O
the,O
International,O
Health,O
Regulations,O
during,O
the,O
COVID19,B-Disease_COVID-19
outbreak,O
.,O
"

",O
Habibi,O
R(1,O
),O
",",O
Burci,O
GL(2,O
),O
",",O
de,O
Campos,O
TC(3,O
),O
",",O
Chirwa,O
D(4,O
),O
",",O
CinÃ ,O
M(1,O
),O
",",O
Dagron,O
S(5,O
),O
",",O
"
",O
EcclestonTurner,O
M(6,O
),O
",",O
Forman,O
L(7,O
),O
",",O
Gostin,O
LO(8,O
),O
",",O
Meier,O
BM(9,O
),O
",",O
Negri,O
S(10,O
),O
",",O
Ooms,O
"
",O
G(11,O
),O
",",O
Sekalala,O
S(12,O
),O
",",O
Taylor,O
A(13,O
),O
",",O
Yamin,O
AE(14,O
),O
",",O
Hoffman,O
SJ(15,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Global,O
Strategy,O
Lab,O
",",O
York,O
University,O
",",O
Toronto,O
",",O
ON,O
M3J,O
1P3,O
",",O
Canada,O
.,O
"
",O
(2)Graduate,O
Institute,O
of,O
International,O
and,O
Development,O
Studies,O
",",O
Geneva,O
",",O
"
",O
Switzerland,O
.,O
"
",O
(3)Pontificia,O
Universidad,O
CatÃ³lica,O
de,O
Chile,O
",",O
Santiago,O
",",O
Chile,O
.,O
"
",O
(4)University,O
of,O
Cape,O
Town,O
",",O
Cape,O
Town,O
",",O
South,O
Africa,O
.,O
"
",O
(5)University,O
of,O
Geneva,O
",",O
Geneva,O
",",O
Switzerland,O
.,O
"
",O
(6)Keele,O
University,O
",",O
Keele,O
",",O
UK,O
.,O
"
",O
(7)University,O
of,O
Toronto,O
",",O
Toronto,O
",",O
ON,O
",",O
Canada,O
.,O
"
",O
(8)O'Neill,O
Institute,O
for,O
National,O
and,O
Global,O
Health,O
Law,O
",",O
Georgetown,O
University,O
"
",O
Law,O
Center,O
",",O
Washington,O
",",O
DC,O
",",O
USA,O
.,O
"
",O
(9)University,O
of,O
North,O
Carolina,O
at,O
Chapel,O
Hill,O
",",O
Chapel,O
Hill,O
",",O
NC,O
",",O
USA,O
.,O
"
",O
(10)University,O
of,O
Salerno,O
",",O
Fisciano,O
",",O
Italy,O
.,O
"
",O
(11)London,O
School,O
of,O
Hygiene,O
&,O
Tropical,O
Medicine,O
",",O
London,O
",",O
UK,O
.,O
"
",O
(12)Warwick,O
University,O
",",O
Coventry,O
",",O
UK,O
.,O
"
",O
(13)University,O
of,O
Washington,O
",",O
Seattle,O
",",O
WA,O
",",O
USA,O
.,O
"
",O
(14)Harvard,O
University,O
",",O
Cambridge,O
",",O
MA,O
",",O
USA,O
.,O
"
",O
(15)Global,O
Strategy,O
Lab,O
",",O
York,O
University,O
",",O
Toronto,O
",",O
ON,O
M3J,O
1P3,O
",",O
Canada,O
.,O
Electronic,O
"
",O
address,O
:,O
steven.hoffman@globalstrategylab.org,O
.,O
"

",O
Comment,O
in,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
22;395(10224):537,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303731,O
"
",O
PMID,O
:,O
32061311,O
"


",O
680,O
.,O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):483,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)30355X,O
.,O
"

",O
Africa,O
prepares,O
for,O
coronavirus,O
.,O
"

",O
Makoni,O
M.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)30355X,O
"
",O
PMID,O
:,O
32061284,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
681,O
.,O
Lett,O
Appl,O
Microbiol,O
.,O
2020,O
Feb,O
14,O
.,O
doi,O
:,O
10.1111,O
lam.13285,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
2019_nCoV,O
SARSCoV2,B-Virus_SARS-CoV-2
:,O
rapid,O
classification,O
of,O
betacoronaviruses,O
and,O
"
",O
identification,O
of,O
Traditional,O
Chinese,O
Medicine,O
as,O
potential,O
origin,O
of,O
zoonotic,O
"
",O
coronaviruses,O
.,O
"

",O
Wassenaar,O
TM(1,O
),O
",",O
Zou,O
Y(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Molecular,O
Microbiology,O
and,O
Genomics,O
Consultants,O
",",O
Zotzenheim,O
",",O
Germany,O
.,O
"
",O
(2)SciPaperEdit,O
",",O
Chuangkexing,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
The,O
current,O
outbreak,O
of,O
a,O
novel,O
severe,O
acute,O
respiratory,O
syndromelike,O
"
",O
coronavirus,O
",",O
2019_nCoV,O
Â ,O
(,O
now,O
named,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
",",O
illustrated,O
difficulties,O
in,O
"
",O
identifying,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
and,O
its,O
natural,O
host,O
",",O
as,O
the,O
coding,O
sequences,O
of,O
"
",O
various,O
Betacoronavirus,O
species,O
can,O
be,O
highly,O
diverse,O
.,O
By,O
means,O
of,O
wholegenome,O
"
",O
sequence,O
comparisons,O
",",O
we,O
demonstrate,O
that,O
the,O
noncoding,O
flanks,O
of,O
the,O
viral,O
"
",O
genome,O
can,O
be,O
used,O
to,O
correctly,O
separate,O
the,O
recognized,O
four,O
betacoronavirus,O
"
",O
subspecies,O
.,O
The,O
conservation,O
would,O
be,O
sufficient,O
to,O
define,O
target,O
sequences,O
that,O
"
",O
could,O
",",O
in,O
theory,O
",",O
classify,O
novel,O
virus,O
species,O
into,O
their,O
subspecies,O
.,O
Only,O
253,O
"
",O
upstream,O
noncoding,O
sequences,O
of,O
Sarbecovirus,O
are,O
sufficient,O
to,O
identify,O
genetic,O
"
",O
similarities,O
between,O
species,O
of,O
this,O
subgenus,O
.,O
Furthermore,O
",",O
it,O
was,O
investigated,O
"
",O
which,O
bat,O
species,O
have,O
commercial,O
value,O
in,O
China,O
",",O
and,O
would,O
thus,O
likely,O
be,O
"
",O
handled,O
for,O
trading,O
purposes,O
.,O
A,O
number,O
of,O
coronavirus,O
genomes,O
have,O
been,O
published,O
"
",O
that,O
were,O
obtained,O
from,O
such,O
bat,O
species,O
.,O
These,O
bats,O
are,O
used,O
in,O
Traditional,O
"
",O
Chinese,O
Medicine,O
",",O
and,O
their,O
handling,O
poses,O
a,O
potential,O
risk,O
to,O
cause,O
zoonotic,O
"
",O
coronavirus,O
epidemics,O
.,O
SIGNIFICANCE,O
AND,O
IMPACT,O
OF,O
THE,O
STUDY,O
:,O
The,O
noncoding,O
"
",O
upstream,O
and,O
downstream,O
flanks,O
of,O
coronavirus,O
genomes,O
allow,O
for,O
rapid,O
"
",O
classification,O
of,O
novel,O
Betacoronavirus,O
species,O
and,O
correct,O
identification,O
of,O
"
",O
genetic,O
relationships,O
.,O
Although,O
bats,O
are,O
the,O
likely,O
natural,O
host,O
of,O
2019_nCoV,O
",",O
"
",O
the,O
exact,O
bat,O
species,O
that,O
serves,O
as,O
the,O
natural,O
host,O
of,O
the,O
virus,O
remains,O
as,O
yet,O
"
",O
unknown,O
.,O
Chinese,O
bat,O
species,O
with,O
commercial,O
value,O
were,O
identified,O
as,O
natural,O
"
",O
reservoirs,O
of,O
coronaviruses,O
and,O
are,O
used,O
in,O
Traditional,O
Chinese,O
Medicine,O
.,O
Since,O
"
",O
their,O
trading,O
provides,O
a,O
potential,O
risk,O
for,O
spreading,O
zoonoses,O
",",O
a,O
change,O
in,O
these,O
"
",O
practices,O
is,O
highly,O
recommended,O
.,O
"

",O
Â©,O
2020,O
The,O
Authors,O
.,O
Letters,O
in,O
Applied,O
Microbiology,O
published,O
by,O
John,O
Wiley,O
&,O
"
",O
Sons,O
Ltd,O
on,O
behalf,O
of,O
Society,O
for,O
Applied,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1111,O
lam.13285,O
"
",O
PMID,O
:,O
32060933,O
"


",O
682,O
.,O
Virol,O
Sin,O
.,O
2020,O
Feb,O
14,O
.,O
doi,O
:,O
10.1007,O
s12250020002065,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
First,O
Disease,O
X,O
is,O
Caused,O
by,O
a,O
Highly,O
Transmissible,O
Acute,O
Respiratory,O
"
",O
Syndrome,O
Coronavirus,O
.,O
"

",O
Jiang,O
S(1)(2,O
),O
",",O
Shi,O
ZL(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Medical,O
Molecular,O
Virology,O
(,O
MOE,O
NHC,O
CAMS,O
),O
",",O
School,O
of,O
Basic,O
"
",O
Medical,O
Sciences,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
200032,O
",",O
China,O
.,O
"
",O
shibojiang@fudan.edu.cn,O
.,O
"
",O
(2)New,O
York,O
Blood,O
Center,O
",",O
The,O
Lindsley,O
F.,O
Kimball,O
Research,O
Institute,O
",",O
New,O
York,O
",",O
"
",O
NY,O
",",O
10065,O
",",O
USA,O
.,O
shibojiang@fudan.edu.cn,O
.,O
"
",O
(3)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
"
",O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"

",O
Based,O
on,O
the,O
announcement,O
of,O
the,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
in,O
2018,O
",",O
the,O
"
",O
Wuhan,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
caused,O
by,O
an,O
unknown,O
etiology,O
should,O
be,O
recognized,O
as,O
the,O
first,O
"
",O
Disease,O
X.,O
Later,O
",",O
the,O
pathogen,O
was,O
identified,O
to,O
be,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
denoted,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
",",O
which,O
has,O
79.5,O
%,O
and,O
96,O
%,O
whole,O
genome,O
sequence,O
identify,O
to,O
SARSCoV,O
and,O
"
",O
bat,O
SARSrelated,O
coronavirus,O
(,O
SARSrCoVRaTG13,O
),O
",",O
respectively,O
",",O
suggesting,O
its,O
"
",O
potential,O
bat,O
origin,O
.,O
With,O
high,O
humantohuman,O
transmission,O
rate,O
(,O
R0,O
),O
",",O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
has,O
quickly,O
spread,O
in,O
China,O
and,O
other,O
countries,O
",",O
resulting,O
in,O
34953,O
confirmed,O
"
",O
cases,O
and,O
725,O
deaths,O
as,O
of,O
8,O
February,O
2020,O
",",O
thus,O
calling,O
for,O
urgent,O
development,O
"
",O
of,O
therapeutics,O
and,O
prophylactics,O
.,O
Here,O
we,O
suggest,O
renaming,O
2019nCoV,B-Virus_SARS-CoV-2
as,O
"
",O
"""",O
transmissible,O
acute,O
respiratory,O
syndrome,O
coronavirus,O
(,O
TARSCoV,O
),O
"""",O
and,O
briefly,O
"
",O
review,O
the,O
advancement,O
of,O
research,O
and,O
development,O
of,O
neutralizing,O
antibodies,O
and,O
"
",O
vaccines,O
targeting,O
the,O
receptorbinding,O
domain,O
(,O
RBD,O
),O
and,O
viral,O
fusion,O
inhibitors,O
"
",O
targeting,O
the,O
heptad,O
repeat,O
1,O
(,O
HR1,O
),O
domain,O
in,O
spike,O
protein,O
of,O
2019nCoV.,O
"

",O
DOI,O
:,O
10.1007,O
s12250020002065,O
"
",O
PMID,O
:,O
32060789,O
"


",O
683,O
.,O
Lancet,O
.,O
2020,O
Feb,O
29;395(10225):685686,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303573,O
.,O
Epub,O
"
",O
2020,O
Feb,O
11,O
.,O
"

",O
2019nCoV,B-Virus_SARS-CoV-2
",",O
fake,O
news,O
",",O
and,O
racism,O
.,O
"

",O
Shimizu,O
K(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Faculty,O
of,O
Public,O
Health,O
and,O
Policy,O
",",O
London,O
School,O
of,O
Hygiene,O
&,O
Tropical,O
"
",O
Medicine,O
",",O
London,O
WC1E,O
7HT,O
",",O
UK,O
;,O
Department,O
of,O
Health,O
Policy,O
",",O
London,O
School,O
of,O
"
",O
Economics,O
&,O
Political,O
Science,O
",",O
London,O
",",O
UK,O
;,O
Department,O
of,O
Hygiene,O
",",O
Graduate,O
School,O
"
",O
of,O
Medicine,O
",",O
Hokkaido,O
University,O
",",O
Japan,O
.,O
Electronic,O
address,O
:,O
"
",O
k.shimizu1@lse.ac.uk,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303573,O
"
",O
PMID,O
:,O
32059801,O
"


",O
684,O
.,O
Lancet,O
.,O
2020,O
Feb,O
29;395(10225):685,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303597,O
.,O
Epub,O
2020,O
"
",O
Feb,O
11,O
.,O
"

",O
Minimise,O
nosocomial,O
spread,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
when,O
treating,O
acute,O
respiratory,O
failure,O
.,O
"

",O
Cabrini,O
L(1,O
),O
",",O
Landoni,O
G(2,O
),O
",",O
Zangrillo,O
A(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)UniversitÃ ,O
degli,O
Studi,O
dell'Insubria,O
",",O
Varese,O
",",O
Italy,O
;,O
Azienda,O
Ospedaliera,O
"
",O
Ospedale,O
di,O
Circolo,O
e,O
Fondazione,O
Macchi,O
",",O
Varese,O
",",O
Italy,O
.,O
"
",O
(2)VitaSalute,O
San,O
Raffaele,O
University,O
",",O
Milan,O
20132,O
",",O
Italy,O
;,O
IRCCS,O
San,O
Raffaele,O
"
",O
Scientific,O
Institute,O
",",O
Milan,O
",",O
Italy,O
.,O
Electronic,O
address,O
:,O
landoni.giovanni@hsr.it,O
.,O
"
",O
(3)VitaSalute,O
San,O
Raffaele,O
University,O
",",O
Milan,O
20132,O
",",O
Italy,O
;,O
IRCCS,O
San,O
Raffaele,O
"
",O
Scientific,O
Institute,O
",",O
Milan,O
",",O
Italy,O
.,O
"

",O
Comment,O
on,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):470473,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303597,O
"
",O
PMID,O
:,O
32059800,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
685,O
.,O
Lancet,O
.,O
2020,O
Feb,O
22;395(10224):e33e34,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303500,O
.,O
Epub,O
"
",O
2020,O
Feb,O
11,O
.,O
"

",O
From,O
Hendra,O
to,O
Wuhan,O
:,O
what,O
has,O
been,O
learned,O
in,O
responding,O
to,O
emerging,O
zoonotic,O
"
",O
viruses,O
.,O
"

",O
Wang,O
LF(1,O
),O
",",O
Anderson,O
DE(2,O
),O
",",O
Mackenzie,O
JS(3,O
),O
",",O
Merson,O
MH(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Programme,O
in,O
Emerging,O
Infections,O
Diseases,O
",",O
DukeNUS,O
Medical,O
School,O
",",O
Singapore,O
"
",O
169857,O
;,O
SingHealth,O
DukeNUS,O
Global,O
Health,O
Institute,O
",",O
Singapore,O
;,O
Duke,O
Global,O
"
",O
Health,O
Institute,O
",",O
Duke,O
University,O
",",O
Singapore,O
.,O
Electronic,O
address,O
:,O
"
",O
linfa.wang@dukenus.edu.sg,O
.,O
"
",O
(2)Programme,O
in,O
Emerging,O
Infections,O
Diseases,O
",",O
DukeNUS,O
Medical,O
School,O
",",O
Singapore,O
"
",O
169857,O
.,O
"
",O
(3)Curtin,O
University,O
",",O
Perth,O
",",O
WA,O
",",O
Australia,O
.,O
"
",O
(4)SingHealth,O
DukeNUS,O
Global,O
Health,O
Institute,O
",",O
Singapore,O
;,O
Duke,O
Global,O
Health,O
"
",O
Institute,O
",",O
Duke,O
University,O
",",O
Singapore,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303500,O
"
",O
PMID,O
:,O
32059799,O
"


",O
686,O
.,O
Lancet,O
.,O
2020,O
Feb,O
29;395(10225):687,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303561,O
.,O
Epub,O
2020,O
"
",O
Feb,O
11,O
.,O
"

",O
Early,O
lessons,O
from,O
the,O
frontline,O
of,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
outbreak,O
.,O
"

",O
Zhang,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Neurology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
430071,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
zhangh9@yahoo.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303561,O
"
",O
PMID,O
:,O
32059798,O
"


",O
687,O
.,O
JAMA,O
.,O
2020,O
Feb,O
14,O
.,O
doi,O
:,O
10.1001,O
jama.2020.2131,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Novel,B-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Infection,I-Disease_COVID-19
in,O
Hospitalized,O
Infants,O
Under,O
1,O
Year,O
of,O
Age,O
in,O
China,O
.,O
"

",O
Wei,O
M(1,O
),O
",",O
Yuan,O
J(1,O
),O
",",O
Liu,O
Y(2,O
),O
",",O
Fu,O
T(1,O
),O
",",O
Yu,O
X(3,O
),O
",",O
Zhang,O
ZJ(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)School,O
of,O
Management,O
",",O
Wuhan,O
Institute,O
of,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)School,O
of,O
Health,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.2131,O
"
",O
PMCID,O
:,O
PMC7042807,O
[,O
Available,O
on,O
20200814,O
],O
"
",O
PMID,O
:,O
32058570,O
"


",O
688,O
.,O
Clin,O
Microbiol,O
Infect,O
.,O
2020,O
Feb,O
11,O
.,O
pii,O
:,O
S1198743X(20)300847,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.cmi.2020.02.005,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
:,O
how,O
things,O
are,O
in,O
Wuhan,O
.,O
"

",O
Khan,O
S(1,O
),O
",",O
Nabi,O
G(2,O
),O
",",O
Han,O
G(3,O
),O
",",O
Siddique,O
R(4,O
),O
",",O
Lian,O
S(5,O
),O
",",O
Shi,O
H(6,O
),O
",",O
Bashir,O
N(7,O
),O
",",O
"
",O
Ali,O
A(8,O
),O
",",O
Shereen,O
MA(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Cerebrovascular,O
Diseases,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
"
",O
Zhengzhou,O
University,O
",",O
Zhengzhou,O
",",O
China,O
;,O
Henan,O
Medical,O
Key,O
Laboratory,O
of,O
"
",O
Translational,O
Cerebrovascular,O
Diseases,O
",",O
Zhengzhou,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
Suliman.khan18@mails.ucas.ac.cn,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Animal,O
Physiology,O
",",O
Biochemistry,O
and,O
Molecular,O
Biology,O
of,O
"
",O
Hebei,O
Province,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Hebei,O
Normal,O
University,O
",",O
Shijiazhuang,O
",",O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Radiation,O
Oncology,O
",",O
Hubei,O
Cancer,O
Hospital,O
",",O
Tongji,O
Medical,O
"
",O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Cerebrovascular,O
Diseases,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
"
",O
Zhengzhou,O
University,O
",",O
Zhengzhou,O
",",O
China,O
;,O
Henan,O
Medical,O
Key,O
Laboratory,O
of,O
"
",O
Translational,O
Cerebrovascular,O
Diseases,O
",",O
Zhengzhou,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Cerebrovascular,O
Diseases,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
"
",O
Zhengzhou,O
University,O
",",O
Zhengzhou,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Radiation,O
Oncology,O
",",O
Hubei,O
Cancer,O
Hospital,O
",",O
Tongji,O
Medical,O
"
",O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
;,O
Department,O
"
",O
of,O
Oncology,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(7)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(8)Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
Xiao,O
Hong,O
Shan,O
",",O
No.,O
"
",O
44,O
",",O
Wuhan,O
",",O
China,O
;,O
The,O
University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100049,O
",",O
"
",O
China,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.cmi.2020.02.005,O
"
",O
PMID,O
:,O
32058086,O
"


",O
689,O
.,O
Pharmacol,O
Res,O
.,O
2020,O
Feb,O
11;155:104690,O
.,O
doi,O
:,O
10.1016,O
j.phrs.2020.104690,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Berberinemediated,O
upregulation,O
of,O
surfactant,O
protein,O
D,O
facilitates,O
cartilage,O
"
",O
repair,O
by,O
modulating,O
immune,O
responses,O
via,O
the,O
inhibition,O
of,O
TLR4,O
NFÄ¸B,O
signaling,O
.,O
"

",O
Zhou,O
Y(1,O
),O
",",O
Ming,O
J(2,O
),O
",",O
Deng,O
M(3,O
),O
",",O
Li,O
Y(2,O
),O
",",O
Li,O
B(4,O
),O
",",O
Li,O
J(5,O
),O
",",O
Ma,O
Y(2,O
),O
",",O
Chen,O
Z(3,O
),O
",",O
"
",O
Liu,O
S(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Orthopedics,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
430060,O
Wuhan,O
",",O
"
",O
China,O
;,O
Central,O
Laboratory,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
430060,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
yanzhou0827@163.com,O
.,O
"
",O
(2)Department,O
of,O
Orthopedics,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
430060,O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(3)Central,O
Laboratory,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
430060,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Rehabilitation,O
",",O
Wuhan,O
Union,O
Hospital,O
",",O
Huazhong,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
430022,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(5)College,O
of,O
Acupuncture,O
and,O
Bone,O
Injury,O
",",O
Hubei,O
University,O
of,O
Traditional,O
"
",O
Chinese,O
Medicine,O
",",O
430061,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
The,O
innate,O
immune,O
system,O
drives,O
inflammatory,O
joint,O
damage,O
in,O
osteoarthritis,O
(,O
OA,O
),O
"
",O
and,O
regulates,O
cartilage,O
repair,O
.,O
Berberine,O
chloride,O
(,O
BBR,O
),O
is,O
an,O
isoquinoline,O
"
",O
alkaloid,O
that,O
shows,O
immunomodulatory,O
activity,O
in,O
a,O
variety,O
of,O
cell,O
lines,O
.,O
"
",O
However,O
",",O
the,O
immunomodulatory,O
mechanisms,O
of,O
BBR,O
in,O
chondrocytes,O
during,O
OA,O
are,O
"
",O
largely,O
unknown,O
.,O
Herein,O
",",O
we,O
assessed,O
the,O
ability,O
of,O
BBR,O
to,O
mediate,O
"
",O
chondroprotection,O
through,O
its,O
effects,O
on,O
innate,O
immunity,O
.,O
We,O
found,O
that,O
BBR,O
"
",O
upregulated,O
the,O
expression,O
of,O
surfactant,O
protein,O
D,O
(,O
SPD,O
),O
in,O
OA,O
cartilage,O
",",O
a,O
key,O
"
",O
regulator,O
of,O
inflammation,O
and,O
innate,O
immunity,O
both,O
in,O
the,O
airways,O
and,O
"
",O
extrapulmonary,O
tissues,O
",",O
including,O
joint,O
cartilage,O
.,O
To,O
further,O
explore,O
these,O
"
",O
findings,O
",",O
we,O
used,O
recombinant,O
adenoassociated,O
virus,O
(rAAV)mediated,O
knockdown,O
of,O
"
",O
SPD,O
.,O
Silencing,O
was,O
assessed,O
in,O
rat,O
model,O
of,O
surgicallyinduced,O
OA,O
in,O
the,O
"
",O
presence,O
or,O
absence,O
of,O
BBR,O
treatment,O
",",O
10,O
weeks,O
postsurgery,O
.,O
We,O
observed,O
a,O
clear,O
"
",O
improvement,O
in,O
histological,O
scores,O
of,O
BBRtreated,O
animals,O
compared,O
to,O
those,O
"
",O
treated,O
with,O
BBR,O
and,O
the,O
rAAVSPD,O
vector,O
.,O
In,O
addition,O
",",O
animals,O
cotreated,O
with,O
"
",O
BBR,O
+,O
recombinant,O
human,O
SPD,O
(,O
rhSPD,O
),O
exhibited,O
significantly,O
lower,O
histological,O
"
",O
scores,O
than,O
those,O
treated,O
with,O
BBR,O
alone,O
.,O
BBR,O
treatment,O
led,O
to,O
significantly,O
"
",O
reduced,O
immune,O
cell,O
infiltration,O
mediated,O
through,O
TLR4,O
",",O
F4,O
80,O
",",O
CD68,O
and,O
CD34,O
",",O
"
",O
whilst,O
SPD,O
silencing,O
reversed,O
this,O
improvement,O
.,O
In,O
contrast,O
",",O
rhSPD,O
treatment,O
"
",O
enhanced,O
the,O
protective,O
phenotype,O
.,O
We,O
further,O
explored,O
how,O
BBR,O
influences,O
SPD,O
"
",O
and,O
other,O
OAassociated,O
genes,O
in,O
vitro,O
.,O
We,O
observed,O
an,O
upregulation,O
of,O
SPD,O
and,O
"
",O
a,O
marked,O
decline,O
in,O
TRAF6,O
",",O
TLR4,O
",",O
MD2,O
and,O
MyD88,O
expression,O
",",O
as,O
well,O
as,O
NFÎºB,O
p65,O
"
",O
and,O
IÎºBÎ±,O
phosphorylation,O
in,O
chondrocytes,O
treated,O
with,O
sodium,O
nitroprusside,O
.,O
"
",O
siRNAs,O
specific,O
for,O
SPD,O
were,O
able,O
to,O
partially,O
reverse,O
this,O
phenotype,O
",",O
whilst,O
"
",O
both,O
rhSPD,O
and,O
the,O
TLR4,O
inhibitor,O
TAK242,O
enhanced,O
the,O
effects,O
.,O
Together,O
",",O
these,O
"
",O
results,O
are,O
consistent,O
with,O
a,O
model,O
wherein,O
SPD,O
has,O
therapeutic,O
potential,O
for,O
OA,O
"
",O
treatment,O
.,O
Concomitantly,O
",",O
BBR,O
modulates,O
immune,O
responses,O
and,O
decreases,O
cartilage,O
"
",O
degradation,O
.,O
These,O
findings,O
suggest,O
that,O
BBR,O
achieves,O
this,O
function,O
through,O
"
",O
releasing,O
SPD,O
from,O
MD2,O
SPD,O
complexes,O
and,O
through,O
the,O
inhibition,O
of,O
TLR4,O
NFÎºB,O
"
",O
signaling,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.phrs.2020.104690,O
"
",O
PMID,O
:,O
32057894,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
All,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
conflict,O
of,O
interests,O
concerning,O
this,O
article,O
.,O
"


",O
690,O
.,O
J,O
Hosp,O
Infect,O
.,O
2020,O
Feb,O
11,O
.,O
pii,O
:,O
S01956701(20)300487,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jhin.2020.02.002,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
poor,O
quarantine,O
",",O
and,O
the,O
risk,O
of,O
pandemic,O
.,O
"

",O
Khan,O
S(1,O
),O
",",O
Siddique,O
R(2,O
),O
",",O
Ali,O
A(3,O
),O
",",O
Xue,O
M(2,O
),O
",",O
Nabi,O
G(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Cerebrovascular,O
Diseases,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
"
",O
Zhengzhou,O
University,O
",",O
Zhengzhou,O
",",O
China,O
;,O
Henan,O
Medical,O
Key,O
Laboratory,O
of,O
"
",O
Translational,O
Cerebrovascular,O
Diseases,O
",",O
Zhengzhou,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
Suliman.khan18@mails.ucas.ac.cn,O
.,O
"
",O
(2)Department,O
of,O
Cerebrovascular,O
Diseases,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
"
",O
Zhengzhou,O
University,O
",",O
Zhengzhou,O
",",O
China,O
;,O
Henan,O
Medical,O
Key,O
Laboratory,O
of,O
"
",O
Translational,O
Cerebrovascular,O
Diseases,O
",",O
Zhengzhou,O
",",O
China,O
.,O
"
",O
(3)Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Xiao,O
Hong,O
Shan,O
No.,O
"
",O
44,O
",",O
Wuhan,O
",",O
China,O
;,O
University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)Key,O
Laboratory,O
of,O
Animal,O
Physiology,O
",",O
Biochemistry,O
and,O
Molecular,O
Biology,O
of,O
"
",O
Hebei,O
Province,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Hebei,O
Normal,O
University,O
",",O
Shijiazhuang,O
",",O
"
",O
China,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jhin.2020.02.002,O
"
",O
PMID,O
:,O
32057788,O
"


",O
691,O
.,O
Antiviral,O
Res,O
.,O
2020,O
Feb,O
10;176:104742,O
.,O
doi,O
:,O
10.1016,O
j.antiviral.2020.104742,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
spike,O
glycoprotein,O
of,O
the,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2019nCoV,B-Virus_SARS-CoV-2
contains,O
a,O
furinlike,O
"
",O
cleavage,O
site,O
absent,O
in,O
CoV,O
of,O
the,O
same,O
clade,O
.,O
"

",O
Coutard,O
B(1,O
),O
",",O
Valle,O
C(2,O
),O
",",O
de,O
Lamballerie,O
X(1,O
),O
",",O
Canard,O
B(2,O
),O
",",O
Seidah,O
NG(3,O
),O
",",O
Decroly,O
"
",O
E(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)UnitÃ©,O
des,O
Virus,O
Ã‰mergents,O
(,O
UVE,O
:,O
AixMarseille,O
Univ,O
 ,O
IRD,O
190,O
 ,O
Inserm,O
1207,O
"
",O
IHU,O
MÃ©diterranÃ©e,O
Infection,O
),O
",",O
Marseille,O
",",O
France,O
.,O
"
",O
(2)Aix,O
Marseille,O
UniversitÃ©,O
",",O
CNRS,O
",",O
AFMB,O
UMR,O
7257,O
",",O
Marseille,O
",",O
France,O
.,O
"
",O
(3)Laboratory,O
of,O
Biochemical,O
Neuroendocrinology,O
",",O
Montreal,O
Clinical,O
Research,O
"
",O
Institute,O
(,O
IRCM,O
",",O
Affiliated,O
to,O
the,O
University,O
of,O
Montreal,O
),O
",",O
110,O
Pine,O
Ave,O
West,O
",",O
"
",O
Montreal,O
",",O
QC,O
",",O
H2W1R7,O
",",O
Canada,O
.,O
"
",O
(4)Aix,O
Marseille,O
UniversitÃ©,O
",",O
CNRS,O
",",O
AFMB,O
UMR,O
7257,O
",",O
Marseille,O
",",O
France,O
.,O
Electronic,O
"
",O
address,O
:,O
etienne.decroly@afmb.univmrs.fr,O
.,O
"

",O
In,O
2019,O
",",O
a,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
infecting,O
Humans,O
has,O
emerged,O
in,O
Wuhan,O
",",O
"
",O
China,O
.,O
Its,O
genome,O
has,O
been,O
sequenced,O
and,O
the,O
genomic,O
information,O
promptly,O
"
",O
released,O
.,O
Despite,O
a,O
high,O
similarity,O
with,O
the,O
genome,O
sequence,O
of,O
SARSCoV,O
and,O
"
",O
SARSlike,O
CoVs,O
",",O
we,O
identified,O
a,O
peculiar,O
furinlike,O
cleavage,O
site,O
in,O
the,O
Spike,O
"
",O
protein,O
of,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
lacking,O
in,O
the,O
other,O
SARSlike,O
CoVs,O
.,O
In,O
this,O
article,O
",",O
"
",O
we,O
discuss,O
the,O
possible,O
functional,O
consequences,O
of,O
this,O
cleavage,O
site,O
in,O
the,O
"
",O
viral,O
cycle,O
",",O
pathogenicity,O
and,O
its,O
potential,O
implication,O
in,O
the,O
development,O
of,O
"
",O
antivirals,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.antiviral.2020.104742,O
"
",O
PMID,O
:,O
32057769,O
"


",O
692,O
.,O
Emerg,O
Microbes,O
Infect,O
.,O
2020,O
Dec;9(1):378381,O
.,O
doi,O
:,O
10.108,O
22221751.2020.1727299,O
.,O
"

",O
HIV1,O
did,O
not,O
contribute,O
to,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
genome,O
.,O
"

",O
Xiao,O
C(1,O
),O
",",O
Li,O
X(2,O
),O
",",O
Liu,O
S(3,O
),O
",",O
Sang,O
Y(4,O
),O
",",O
Gao,O
SJ(5,O
),O
",",O
Gao,O
F(2)(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Chemistry,O
and,O
Biochemistry,O
",",O
The,O
University,O
of,O
Texas,O
at,O
El,O
Paso,O
",",O
"
",O
El,O
Paso,O
",",O
TX,O
",",O
USA,O
.,O
"
",O
(2)Department,O
of,O
Medicine,O
",",O
Duke,O
University,O
Medical,O
Center,O
",",O
Durham,O
",",O
NC,O
",",O
USA,O
.,O
"
",O
(3)NA,O
BioTech,O
Corp,O
",",O
M2D2,O
Incubator,O
",",O
University,O
of,O
Massachusetts,O
Medical,O
School,O
",",O
"
",O
Worcester,O
",",O
MA,O
",",O
USA,O
.,O
"
",O
(4)Department,O
of,O
Agricultural,O
and,O
Environmental,O
Sciences,O
",",O
Tennessee,O
State,O
"
",O
University,O
",",O
Nashville,O
",",O
TN,O
",",O
USA,O
.,O
"
",O
(5)UPMC,O
Hillman,O
Cancer,O
Center,O
",",O
Department,O
of,O
Microbiology,O
and,O
Molecular,O
Genetics,O
",",O
"
",O
University,O
of,O
Pittsburgh,O
",",O
Pittsburgh,O
",",O
PA,O
",",O
USA,O
.,O
"
",O
(6)National,O
Engineering,O
Laboratory,O
for,O
AIDS,O
Vaccine,O
",",O
School,O
of,O
Life,O
Sciences,O
",",O
"
",O
Jilin,O
University,O
",",O
Changchun,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"

",O
DOI,O
:,O
10.108,O
22221751.2020.1727299,O
"
",O
PMCID,O
:,O
PMC7033698,O
"
",O
PMID,O
:,O
32056509,O
"


",O
693,O
.,O
J,O
Korean,O
Med,O
Sci,O
.,O
2020,O
Feb,O
17;35(6):e79,O
.,O
doi,O
:,O
10.3346,O
jkms.2020.35.e79,O
.,O
"

",O
Case,O
of,O
the,O
Index,O
Patient,O
Who,O
Caused,O
Tertiary,O
Transmission,O
of,O
COVID19,B-Disease_COVID-19
Infection,O
"
",O
in,O
Korea,O
:,O
the,O
Application,O
of,O
Lopinavir,O
Ritonavir,O
for,O
the,O
Treatment,O
of,O
COVID19,B-Disease_COVID-19
"
",O
Infected,O
Pneumonia,O
Monitored,O
by,O
Quantitative,O
RTPCR,O
.,O
"

",O
Lim,O
J(1,O
),O
",",O
Jeon,O
S(2,O
),O
",",O
Shin,O
HY(3,O
),O
",",O
Kim,O
MJ(1,O
),O
",",O
Seong,O
YM(4,O
),O
",",O
Lee,O
WJ(5,O
),O
",",O
Choe,O
KW(6,O
),O
",",O
"
",O
Kang,O
YM(6,O
),O
",",O
Lee,O
B(7,O
),O
",",O
Park,O
SJ(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Laboratory,O
Medicine,O
",",O
Myongji,O
Hospital,O
",",O
Hanyang,O
University,O
"
",O
College,O
of,O
Medicine,O
",",O
Goyang,O
",",O
Korea,O
.,O
"
",O
(2)New,O
Horizon,O
Cancer,O
Institute,O
",",O
Myongji,O
Hospital,O
",",O
Goyang,O
",",O
Korea,O
.,O
"
",O
(3)Department,O
of,O
Family,O
Medicine,O
",",O
Myongji,O
Hospital,O
",",O
Hanyang,O
University,O
College,O
of,O
"
",O
Medicine,O
",",O
Goyang,O
",",O
Korea,O
.,O
"
",O
(4)Department,O
of,O
Internal,O
Medicine,O
",",O
Myongji,O
Hospital,O
",",O
Goyang,O
",",O
Korea,O
.,O
"
",O
(5)Office,O
of,O
Chief,O
Executive,O
Officer,O
and,O
Chairman,O
",",O
Department,O
of,O
General,O
Surgery,O
",",O
"
",O
Myongji,O
Hospital,O
",",O
Goyang,O
",",O
Korea,O
.,O
"
",O
(6)Department,O
of,O
Infectious,O
Diseases,O
",",O
Myongji,O
Hospital,O
",",O
Goyang,O
",",O
Korea,O
.,O
"
",O
(7)CancerROP,O
",",O
Seoul,O
",",O
Korea,O
.,O
baeckseung@gmail.com,O
.,O
"
",O
(8)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Myongji,O
Hospital,O
",",O
Goyang,O
",",O
"
",O
Korea,O
.,O
drjoseph@mjh.or.kr,O
.,O
"

",O
Comment,O
in,O
"
    ",O
J,O
Korean,O
Med,O
Sci,O
.,O
2020,O
Feb,O
24;35(7):e88,O
.,O
"

",O
Since,O
midDecember,O
of,O
2019,O
",",O
coronavirus,B-Disease_COVID-19
disease,I-Disease_COVID-19
2019,I-Disease_COVID-19
(,O
COVID19,B-Disease_COVID-19
),O
infection,O
has,O
"
",O
been,O
spreading,O
from,O
Wuhan,O
",",O
China,O
.,O
The,O
confirmed,O
COVID19,B-Disease_COVID-19
patients,O
in,O
South,O
Korea,O
"
",O
are,O
those,O
who,O
came,O
from,O
or,O
visited,O
China,O
.,O
As,O
secondary,O
transmissions,O
have,O
"
",O
occurred,O
and,O
the,O
speed,O
of,O
transmission,O
is,O
accelerating,O
",",O
there,O
are,O
rising,O
concerns,O
"
",O
about,O
community,O
infections,O
.,O
The,O
54year,O
old,O
male,O
is,O
the,O
third,O
patient,O
diagnosed,O
"
",O
with,O
COVID19,B-Disease_COVID-19
infection,O
in,O
Korea,O
.,O
He,O
is,O
a,O
worker,O
for,O
a,O
clothing,O
business,O
and,O
had,O
"
",O
mild,O
respiratory,O
symptoms,O
and,O
intermittent,O
fever,O
in,O
the,O
beginning,O
of,O
"
",O
hospitalization,O
",",O
and,O
pneumonia,O
symptoms,O
on,O
chest,O
computerized,O
tomography,O
scan,O
on,O
"
",O
day,O
6,O
of,O
admission,O
.,O
This,O
patient,O
caused,O
one,O
case,O
of,O
secondary,O
transmission,O
and,O
"
",O
three,O
cases,O
of,O
tertiary,O
transmission,O
.,O
Hereby,O
",",O
we,O
report,O
the,O
clinical,O
findings,O
of,O
"
",O
the,O
index,O
patient,O
who,O
was,O
the,O
first,O
to,O
cause,O
tertiary,O
transmission,O
outside,O
China,O
.,O
"
",O
Interestingly,O
",",O
after,O
lopinavir,O
ritonavir,O
(,O
Kaletra,O
",",O
AbbVie,O
),O
was,O
administered,O
",",O
"
",O
Î²coronavirus,O
viral,O
loads,O
significantly,O
decreased,O
and,O
no,O
or,O
little,O
coronavirus,O
"
",O
titers,O
were,O
observed,O
.,O
"

",O
Â©,O
2020,O
The,O
Korean,O
Academy,O
of,O
Medical,O
Sciences,O
.,O
"

",O
DOI,O
:,O
10.3346,O
jkms.2020.35.e79,O
"
",O
PMCID,O
:,O
PMC7025910,O
"
",O
PMID,O
:,O
32056407,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
have,O
no,O
potential,O
conflicts,O
of,O
"
",O
interest,O
to,O
disclose,O
.,O
"


",O
694,O
.,O
Korean,O
J,O
Radiol,O
.,O
2020,O
Mar;21(3):365368,O
.,O
doi,O
:,O
10.3348,O
kjr.2020.0078,O
.,O
Epub,O
2020,O
"
",O
Feb,O
11,O
.,O
"

",O
Novel,B-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Pneumonia,I-Disease_COVID-19
Outbreak,O
in,O
2019,O
:,O
Computed,O
Tomographic,O
Findings,O
in,O
"
",O
Two,O
Cases,O
.,O
"

",O
Lin,O
X(1,O
),O
",",O
Gong,O
Z(2,O
),O
",",O
Xiao,O
Z(3,O
),O
",",O
Xiong,O
J(4,O
),O
",",O
Fan,O
B(5,O
),O
",",O
Liu,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Jiangxi,O
Provincial,O
People,O
's,O
Hospital,O
",",O
Jiangxi,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Prevention,O
and,O
Health,O
Care,O
",",O
Jiangxi,O
Provincial,O
People,O
's,O
"
",O
Hospital,O
",",O
Jiangxi,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Respiratory,O
",",O
Jiangxi,O
Provincial,O
People,O
's,O
Hospital,O
",",O
Jiangxi,O
",",O
"
",O
China,O
.,O
"
",O
(4)Department,O
of,O
Radiology,O
",",O
Jiangxi,O
Chest,O
Hospital,O
",",O
Jiangxi,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Radiology,O
",",O
Jiangxi,O
Provincial,O
People,O
's,O
Hospital,O
",",O
Jiangxi,O
",",O
China,O
.,O
"
",O
26171381@qq.com,O
.,O
"

",O
Since,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
or,O
officially,O
named,O
by,O
the,O
World,O
"
",O
Health,O
Organization,O
as,O
COVID19,B-Disease_COVID-19
),O
outbreak,O
in,O
Wuhan,O
",",O
Hubei,O
Province,O
",",O
China,O
in,O
"
",O
2019,O
",",O
there,O
have,O
been,O
a,O
few,O
reports,O
of,O
its,O
imaging,O
findings,O
.,O
Here,O
",",O
we,O
report,O
two,O
"
",O
confirmed,O
cases,O
of,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
with,O
chest,O
computed,O
tomography,O
findings,O
of,O
"
",O
multiple,O
regions,O
of,O
patchy,O
consolidation,O
and,O
groundglass,O
opacities,O
in,O
both,O
"
",O
lungs,O
.,O
These,O
findings,O
were,O
characteristically,O
located,O
along,O
the,O
bronchial,O
bundle,O
"
",O
or,O
subpleural,O
lungs,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Korean,O
Society,O
of,O
Radiology,O
.,O
"

",O
DOI,O
:,O
10.3348,O
kjr.2020.0078,O
"
",O
PMCID,O
:,O
PMC7039714,O
"
",O
PMID,O
:,O
32056397,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
have,O
no,O
potential,O
conflicts,O
of,O
"
",O
interest,O
to,O
disclose,O
.,O
"


",O
695,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
13,O
.,O
doi,O
:,O
10.1002,O
jmv.25709,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Overlapping,O
and,O
discrete,O
aspects,O
of,O
the,O
pathology,O
and,O
pathogenesis,O
of,O
the,O
"
",O
emerging,O
human,O
pathogenic,O
coronaviruses,O
SARSCoV,O
",",O
MERSCoV,O
",",O
and,O
2019nCoV.,O
"

",O
Liu,O
J(1)(2,O
),O
",",O
Zheng,O
X(1)(2,O
),O
",",O
Tong,O
Q(1,O
),O
",",O
Li,O
W(1,O
),O
",",O
Wang,O
B(1)(2,O
),O
",",O
Sutter,O
K(3)(2,O
),O
",",O
"
",O
Trilling,O
M(3)(2,O
),O
",",O
Lu,O
M(3)(2,O
),O
",",O
Dittmer,O
U(3)(2,O
),O
",",O
Yang,O
D(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infectious,O
Diseases,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(2)Joint,O
International,O
Laboratory,O
of,O
Infection,O
and,O
Immunity,O
",",O
Huazhong,O
University,O
"
",O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(3)Institute,O
for,O
Virology,O
",",O
University,O
Hospital,O
of,O
Essen,O
",",O
University,O
of,O
"
",O
DuisburgEssen,O
",",O
Essen,O
",",O
Germany,O
.,O
"

",O
First,O
reported,O
from,O
Wuhan,O
",",O
The,O
Â ,O
People,O
's,O
Republic,O
of,O
China,O
",",O
on,O
31,O
December,O
2019,O
",",O
"
",O
the,O
ongoing,O
outbreak,O
of,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
causes,O
great,O
global,O
"
",O
concerns,O
.,O
Based,O
on,O
the,O
advice,O
of,O
the,O
International,O
Health,O
Regulations,O
Emergency,O
"
",O
Committee,O
and,O
the,O
fact,O
that,O
to,O
date,O
24,O
other,O
countries,O
also,O
reported,O
cases,O
",",O
the,O
"
",O
WHO,O
DirectorGeneral,O
declared,O
that,O
the,O
outbreak,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
constitutes,O
a,O
Public,O
"
",O
Health,O
Emergency,O
of,O
International,O
Concern,O
on,O
30,O
January,O
2020,O
.,O
Together,O
with,O
the,O
"
",O
other,O
two,O
highly,O
pathogenic,O
coronaviruses,O
",",O
the,O
severe,O
acute,O
respiratory,O
syndrome,O
"
",O
coronavirus,O
(,O
SARSCoV,O
),O
and,O
Middle,O
East,O
respiratory,O
syndrome,O
coronavirus,O
"
",O
(,O
MERSCoV,O
),O
",",O
2019nCov,B-Virus_SARS-CoV-2
and,O
other,O
yet,O
to,O
be,O
identified,O
coronaviruses,O
pose,O
a,O
global,O
"
",O
threat,O
to,O
public,O
health,O
.,O
In,O
this,O
minireview,O
",",O
we,O
provide,O
a,O
brief,O
introduction,O
to,O
"
",O
the,O
pathology,O
and,O
pathogenesis,O
of,O
SARSCoV,O
and,O
MERSCoV,O
and,O
extrapolate,O
this,O
"
",O
knowledge,O
to,O
the,O
newly,O
identified,O
2019nCoV.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25709,O
"
",O
PMID,O
:,O
32056249,O
"


",O
696,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
13,O
.,O
doi,O
:,O
10.1002,O
jmv.25708,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Does,O
SARSCoV2,B-Virus_SARS-CoV-2
has,O
a,O
longer,O
incubation,O
period,O
than,O
SARS,O
and,O
MERS,O
?,O
"

",O
Jiang,O
X(1)(2,O
),O
",",O
Rayner,O
S(3)(4)(5,O
),O
",",O
Luo,O
MH(1)(2)(5)(6)(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Joint,O
Center,O
of,O
Translational,O
Precision,O
Medicine,O
Guangzhou,O
Institute,O
of,O
"
",O
Pediatrics,O
",",O
Guangzhou,O
Women,O
and,O
Children,O
Medical,O
Center,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(2)The,O
Joint,O
Center,O
of,O
Translational,O
Precision,O
Medicine,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Medical,O
Genetics,O
",",O
Oslo,O
University,O
Hospital,O
and,O
University,O
of,O
"
",O
Oslo,O
",",O
Oslo,O
",",O
Norway,O
.,O
"
",O
(4)Hybrid,O
Technology,O
HubCentre,O
of,O
Excellence,O
",",O
Institute,O
of,O
Basic,O
Medical,O
"
",O
Sciences,O
",",O
University,O
of,O
Oslo,O
",",O
Oslo,O
",",O
Norway,O
.,O
"
",O
(5)Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(6)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
CAS,O
Center,O
for,O
Excellence,O
in,O
Brain,O
Science,O
"
",O
and,O
Intelligence,O
Technology,O
(,O
CEBSIT,O
),O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(7)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
The,O
outbreak,O
of,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
since,O
December,O
2019,O
in,O
Wuhan,O
",",O
"
",O
the,O
major,O
transportation,O
hub,O
in,O
central,O
China,O
",",O
became,O
an,O
emergency,O
of,O
major,O
"
",O
international,O
concern,O
.,O
While,O
several,O
etiological,O
studies,O
have,O
begun,O
to,O
reveal,O
the,O
"
",O
specific,O
biological,O
features,O
of,O
this,O
virus,O
",",O
the,O
epidemic,O
characteristics,O
need,O
to,O
"
",O
be,O
elucidated,O
.,O
Notably,O
",",O
a,O
long,O
incubation,O
time,O
was,O
reported,O
to,O
be,O
associated,O
with,O
"
",O
SARSCoV2,B-Disease_COVID-19
infection,I-Disease_COVID-19
",",O
leading,O
to,O
adjustments,O
in,O
screening,O
and,O
control,O
policies,O
.,O
"
",O
To,O
avoid,O
the,O
risk,O
of,O
virus,O
spread,O
",",O
all,O
potentially,O
exposed,O
subjects,O
are,O
required,O
"
",O
to,O
be,O
isolated,O
for,O
14,O
days,O
",",O
which,O
is,O
the,O
longest,O
predicted,O
incubation,O
time,O
.,O
"
",O
However,O
",",O
based,O
on,O
our,O
analysis,O
of,O
a,O
larger,O
dataset,O
available,O
so,O
far,O
",",O
we,O
find,O
"
",O
there,O
is,O
no,O
observable,O
difference,O
between,O
the,O
incubation,O
time,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
"
",O
severe,O
acute,O
respiratory,O
syndrome,O
coronavirus,O
(,O
SARSCoV,O
),O
",",O
and,O
middle,O
east,O
"
",O
respiratory,O
syndrome,O
coronavirus,O
(,O
MERSCoV,O
),O
",",O
highlighting,O
the,O
need,O
for,O
larger,O
and,O
"
",O
wellannotated,O
datasets,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25708,O
"
",O
PMID,O
:,O
32056235,O
"


",O
697,O
.,O
Eur,O
Radiol,O
.,O
2020,O
Feb,O
13,O
.,O
doi,O
:,O
10.1007,O
s0033002006731x,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Initial,O
CT,O
findings,O
and,O
temporal,O
changes,O
in,O
patients,O
with,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
pneumonia,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
:,O
a,O
study,O
of,O
63,O
patients,O
in,O
Wuhan,O
",",O
China,O
.,O
"

",O
Pan,O
Y(1,O
),O
",",O
Guan,O
H(1,O
),O
",",O
Zhou,O
S(1,O
),O
",",O
Wang,O
Y(1,O
),O
",",O
Li,O
Q(1,O
),O
",",O
Zhu,O
T(1,O
),O
",",O
Hu,O
Q(2,O
),O
",",O
Xia,O
L(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
radiology,O
",",O
Tongji,O
hospital,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
",",O
430030,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)Department,O
of,O
radiology,O
",",O
Tongji,O
hospital,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
",",O
430030,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
qjhu@outlook.com,O
.,O
"
",O
(3)Department,O
of,O
radiology,O
",",O
Tongji,O
hospital,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
",",O
430030,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
lmxia@tjh.tjmu.edu.cn,O
.,O
"

",O
OBJECTIVES,O
:,O
The,O
purpose,O
of,O
this,O
study,O
was,O
to,O
observe,O
the,O
imaging,O
characteristics,O
"
",O
of,O
the,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
.,O
"
",O
METHODS,O
:,O
Sixtythree,O
confirmed,O
patients,O
were,O
enrolled,O
from,O
December,O
30,O
",",O
2019,O
to,O
"
",O
January,O
31,O
",",O
2020,O
.,O
Highresolution,O
CT,O
(,O
HRCT,O
),O
of,O
the,O
chest,O
was,O
performed,O
.,O
The,O
"
",O
number,O
of,O
affected,O
lobes,O
",",O
ground,O
glass,O
nodules,O
(,O
GGO,O
),O
",",O
patchy,O
punctate,O
ground,O
"
",O
glass,O
opacities,O
",",O
patchy,O
consolidation,O
",",O
fibrous,O
stripes,O
and,O
irregular,O
solid,O
"
",O
nodules,O
in,O
each,O
patient,O
's,O
chest,O
CT,O
image,O
were,O
recorded,O
.,O
Additionally,O
",",O
we,O
"
",O
performed,O
imaging,O
followup,O
of,O
these,O
patients,O
.,O
"
",O
RESULTS,O
:,O
CT,O
images,O
of,O
63,O
confirmed,O
patients,O
were,O
collected,O
.,O
M,O
F,O
ratio,O
:,O
33,O
30,O
.,O
The,O
"
",O
mean,O
age,O
was,O
44.9,O
Â±,O
15.2,O
years,O
.,O
The,O
mean,O
number,O
of,O
affected,O
lobes,O
was,O
3.3,O
Â±,O
1.8,O
.,O
"
",O
Nineteen,O
(,O
30.2,O
%,O
),O
patients,O
had,O
one,O
affected,O
lobe,O
",",O
five,O
(,O
7.9,O
%,O
),O
patients,O
had,O
two,O
"
",O
affected,O
lobes,O
",",O
four,O
(,O
6.3,O
%,O
),O
patients,O
had,O
three,O
affected,O
lobes,O
",",O
seven,O
(,O
11.1,O
%,O
),O
"
",O
patients,O
had,O
four,O
affected,O
lobes,O
while,O
28,O
(,O
44.4,O
%,O
),O
patients,O
had,O
5,O
affected,O
lobes,O
.,O
"
",O
Fiftyfour,O
(,O
85.7,O
%,O
),O
patients,O
had,O
patchy,O
punctate,O
ground,O
glass,O
opacities,O
",",O
14,O
"
",O
(,O
22.2,O
%,O
),O
patients,O
had,O
GGO,O
",",O
12,O
(,O
19,O
%,O
),O
patients,O
had,O
patchy,O
consolidation,O
",",O
11,O
"
",O
(,O
17.5,O
%,O
),O
patients,O
had,O
fibrous,O
stripes,O
and,O
8,O
(,O
12.7,O
%,O
),O
patients,O
had,O
irregular,O
solid,O
"
",O
nodules,O
.,O
Fiftyfour,O
(,O
85.7,O
%,O
),O
patients,O
progressed,O
",",O
including,O
single,O
GGO,O
increased,O
",",O
"
",O
enlarged,O
and,O
consolidated,O
;,O
fibrous,O
stripe,O
enlarged,O
",",O
while,O
solid,O
nodules,O
increased,O
"
",O
and,O
enlarged,O
.,O
"
",O
CONCLUSIONS,O
:,O
Imaging,O
changes,O
in,O
novel,O
viral,O
pneumonia,O
are,O
rapid,O
.,O
The,O
"
",O
manifestations,O
of,O
the,O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
are,O
diverse,O
.,O
Imaging,O
changes,O
of,O
"
",O
typical,O
viral,O
pneumonia,O
and,O
some,O
specific,O
imaging,O
features,O
were,O
observed,O
.,O
"
",O
Therefore,O
",",O
we,O
need,O
to,O
strengthen,O
the,O
recognition,O
of,O
image,O
changes,O
to,O
help,O
"
",O
clinicians,O
to,O
diagnose,O
quickly,O
and,O
accurately,O
.,O
"
",O
KEY,O
POINTS,O
:,O
â€¢,O
Highresolution,O
CT,O
(,O
HRCT,O
),O
of,O
the,O
chest,O
is,O
critical,O
for,O
early,O
"
",O
detection,O
",",O
evaluation,O
of,O
disease,O
severity,O
and,O
followup,O
of,O
patients,O
with,O
the,O
"
",O
novel,B-Disease_COVID-19
coronavirus,I-Disease_COVID-19
pneumonia,I-Disease_COVID-19
.,O
â€¢,O
The,O
manifestations,O
of,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
pneumonia,O
are,O
diverse,O
and,O
change,O
rapidly,O
.,O
â€¢,O
Radiologists,O
should,O
be,O
aware,O
of,O
the,O
"
",O
various,O
features,O
of,O
the,O
disease,O
and,O
temporal,O
changes,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s0033002006731x,O
"
",O
PMID,O
:,O
32055945,O
"


",O
698,O
.,O
Mol,O
Ther,O
Oncolytics,O
.,O
2020,O
Jan,O
11;16:158171,O
.,O
doi,O
:,O
10.1016,O
j.omto.2019.12.012,O
.,O
"
",O
eCollection,O
2020,O
Mar,O
27,O
.,O
"

",O
oHSV2,O
Can,O
Target,O
Murine,O
Colon,O
Carcinoma,O
by,O
Altering,O
the,O
Immune,O
Status,O
of,O
the,O
"
",O
Tumor,O
Microenvironment,O
and,O
Inducing,O
Antitumor,O
Immunity,O
.,O
"

",O
Zhang,O
W(1,O
),O
",",O
Hu,O
X(2,O
),O
",",O
Liang,O
J(3,O
),O
",",O
Zhu,O
Y(2,O
),O
",",O
Zeng,O
B(3,O
),O
",",O
Feng,O
L(2,O
),O
",",O
Zhao,O
C(4,O
),O
",",O
Liu,O
"
",O
S(3,O
),O
",",O
Liu,O
B(5,O
),O
",",O
Zhang,O
K(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Immunology,O
",",O
National,O
Cancer,O
Center,O
National,O
Clinical,O
Research,O
"
",O
Center,O
for,O
Cancer,O
Cancer,O
Hospital,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
and,O
Peking,O
"
",O
Union,O
Medical,O
College,O
",",O
Beijing,O
100021,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Molecular,O
Oncology,O
",",O
Department,O
of,O
Etiology,O
and,O
"
",O
Carcinogenesis,O
",",O
National,O
Cancer,O
Center,O
National,O
Clinical,O
Research,O
Center,O
for,O
"
",O
Cancer,O
Cancer,O
Hospital,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
and,O
Peking,O
Union,O
"
",O
Medical,O
College,O
",",O
Beijing,O
100021,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Pathology,O
",",O
National,O
Cancer,O
Center,O
National,O
Clinical,O
Research,O
"
",O
Center,O
for,O
Cancer,O
Cancer,O
Hospital,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
and,O
Peking,O
"
",O
Union,O
Medical,O
College,O
",",O
Beijing,O
100021,O
",",O
China,O
.,O
"
",O
(4)Chongqing,O
Deepexam,O
Bioltechnology,O
Co.,O
",",O
Ltd.,O
",",O
Chongqing,O
400020,O
",",O
China,O
.,O
"
",O
(5)Hubei,O
University,O
of,O
Technology,O
",",O
Nanhu,O
",",O
Wuchang,O
District,O
",",O
Wuhan,O
430068,O
",",O
China,O
.,O
"

",O
Oncolytic,O
viruses,O
are,O
promising,O
immunoreagents,O
.,O
Numerous,O
studies,O
have,O
shown,O
that,O
"
",O
oncolytic,O
virotherapy,O
is,O
effective,O
for,O
many,O
tumors,O
.,O
Herein,O
",",O
we,O
investigated,O
the,O
"
",O
therapeutic,O
effect,O
of,O
oHSV2,O
",",O
an,O
oncolytic,O
type,O
2,O
herpes,O
simplex,O
virus,O
",",O
on,O
mouse,O
"
",O
colon,O
carcinoma,O
.,O
The,O
in,O
Â ,O
vivo,O
antitumor,O
efficacy,O
of,O
oHSV2,O
was,O
observed,O
in,O
both,O
"
",O
unilateral,O
and,O
bilateral,O
colon,O
cancer,O
models,O
.,O
oHSV2,O
effectively,O
eliminated,O
tumors,O
"
",O
and,O
prolonged,O
the,O
survival,O
of,O
mice,O
without,O
side,O
effects,O
.,O
Additionally,O
",",O
treatment,O
"
",O
with,O
oHSV2,O
effectively,O
prevented,O
the,O
growth,O
of,O
rechallenged,O
tumors,O
and,O
distant,O
"
",O
implanted,O
tumors,O
.,O
The,O
specific,O
killing,O
ability,O
of,O
splenic,O
immune,O
cells,O
to,O
tumor,O
"
",O
cells,O
was,O
enhanced,O
.,O
oHSV2,O
treatment,O
effectively,O
reduced,O
the,O
content,O
of,O
inhibitory,O
"
",O
immune,O
cells,O
(,O
regulatory,O
T,O
Â ,O
cells,O
[,O
Tregs,O
],O
and,O
myeloidderived,O
suppressor,O
cells,O
"
",O
[,O
MDSCs,O
],O
),O
and,O
increased,O
the,O
content,O
of,O
positive,O
immune,O
cells,O
(,O
natural,O
killer,O
[,O
NK,O
],O
",",O
"
",O
CD8,O
+,O
T,O
",",O
and,O
dendritic,O
cells,O
[,O
DCs,O
],O
),O
in,O
the,O
spleen,O
.,O
Moreover,O
",",O
treatment,O
with,O
oHSV2,O
"
",O
remodeled,O
the,O
tumor,O
immune,O
microenvironment,O
.,O
In,O
summary,O
",",O
treatment,O
with,O
oHSV2,O
can,O
"
",O
effectively,O
eliminate,O
primary,O
tumors,O
",",O
generate,O
tumorspecific,O
immunity,O
",",O
and,O
"
",O
elicit,O
immune,O
memory,O
to,O
inhibit,O
tumor,O
recurrence,O
and,O
metastasis,O
.,O
Furthermore,O
",",O
"
",O
this,O
virotherapy,O
can,O
reshape,O
the,O
immune,O
status,O
of,O
the,O
spleen,O
and,O
tumor,O
"
",O
microenvironment,O
in,O
mice,O
",",O
which,O
can,O
further,O
improve,O
the,O
therapeutic,O
antitumor,O
"
",O
effect,O
.,O
"

",O
Â©,O
2020,O
The,O
Authors,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.omto.2019.12.012,O
"
",O
PMCID,O
:,O
PMC7011019,O
"
",O
PMID,O
:,O
32055679,O
"


",O
699,O
.,O
Sci,O
Rep.,O
2020,O
Feb,O
13;10(1):2541,O
.,O
doi,O
:,O
10.1038,O
s4159802059265z,O
.,O
"

",O
Effects,O
of,O
temperature,O
fluctuations,O
on,O
spatialtemporal,O
transmission,O
of,O
hand,O
",",O
"
",O
foot,O
",",O
and,O
mouth,O
disease,O
.,O
"

",O
Xu,O
C(1,O
),O
",",O
Zhang,O
X(1)(2,O
),O
",",O
Wang,O
L(1)(3)(4,O
),O
",",O
Zhou,O
Y(5,O
),O
",",O
Xiao,O
G(6,O
),O
",",O
Liao,O
J(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Resources,O
and,O
Environmental,O
Information,O
System,O
",",O
"
",O
Institute,O
of,O
Geographic,O
Sciences,O
and,O
Natural,O
Resources,O
Research,O
",",O
Chinese,O
Academy,O
"
",O
of,O
Sciences,O
",",O
Beijing,O
",",O
100101,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Earth,O
Surface,O
Processes,O
and,O
Resource,O
Ecology,O
",",O
Beijing,O
"
",O
Normal,O
University,O
",",O
Beijing,O
",",O
100875,O
",",O
China,O
.,O
"
",O
(3)College,O
of,O
Environment,O
and,O
Planning,O
",",O
Henan,O
University,O
",",O
KaiFeng,O
",",O
475001,O
",",O
China,O
.,O
"
",O
(4)Key,O
Laboratory,O
of,O
Geospatial,O
Technology,O
for,O
the,O
Middle,O
and,O
Lower,O
Yellow,O
River,O
"
",O
Regions,O
(,O
Henan,O
University,O
),O
",",O
Ministry,O
of,O
Education,O
",",O
Kai,O
Feng,O
",",O
475001,O
",",O
China,O
.,O
"
",O
(5)Key,O
Laboratory,O
of,O
Ecosystem,O
Network,O
Observation,O
and,O
Modeling,O
",",O
Institute,O
of,O
"
",O
Geographic,O
and,O
Nature,O
Resources,O
Research,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
"
",O
100101,O
",",O
China,O
.,O
"
",O
(6)China,O
National,O
Center,O
for,O
Food,O
Safety,O
Risk,O
Assessment,O
",",O
Beijing,O
",",O
100022,O
",",O
China,O
.,O
"
",O
biocomputer@126.com,O
.,O
"
",O
(7)School,O
of,O
Public,O
Health,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430074,O
",",O
China,O
.,O
ljq19861023@163.com,O
.,O
"

",O
Hand,O
",",O
foot,O
",",O
and,O
mouth,O
disease,O
(,O
HFMD,O
),O
",",O
predominantly,O
occurs,O
among,O
infants,O
and,O
"
",O
children,O
.,O
Previous,O
studies,O
have,O
shown,O
that,O
suitable,O
",",O
stable,O
temperatures,O
favor,O
"
",O
HFMD,O
virus,O
reproduction,O
;,O
however,O
",",O
temperature,O
fluctuations,O
also,O
affect,O
virus,O
"
",O
transmission,O
",",O
and,O
there,O
are,O
",",O
so,O
far,O
",",O
no,O
studies,O
concerning,O
the,O
association,O
"
",O
between,O
such,O
fluctuations,O
and,O
the,O
incidence,O
of,O
HFMD,O
.,O
The,O
objective,O
of,O
this,O
study,O
"
",O
was,O
to,O
map,O
the,O
spatialtemporal,O
distribution,O
of,O
HFMD,O
incidence,O
and,O
quantify,O
the,O
"
",O
longterm,O
effects,O
of,O
temperature,O
fluctuations,O
on,O
HFMD,O
incidence,O
in,O
children,O
.,O
HFMD,O
"
",O
cases,O
in,O
children,O
under,O
five,O
",",O
from,O
January,O
2009,O
to,O
December,O
2013,O
",",O
in,O
Beijing,O
",",O
"
",O
Tianjin,O
",",O
and,O
Hebei,O
provinces,O
of,O
China,O
",",O
were,O
used,O
in,O
this,O
study,O
.,O
The,O
GeoDetector,O
"
",O
and,O
Bayesian,O
spacetime,O
hierarchy,O
models,O
were,O
employed,O
to,O
explore,O
the,O
"
",O
spatialtemporal,O
association,O
between,O
temperature,O
fluctuations,O
and,O
HFMD,O
incidence,O
.,O
"
",O
The,O
results,O
indicate,O
that,O
HFMD,O
incidence,O
had,O
significant,O
spatial,O
stratified,O
"
",O
heterogeneity,O
(,O
GeoDetector,O
qstatistic,O
â€‰,O
=,O
â€‰,O
0.83,O
",",O
p,O
â€‰,O
<,O
â€‰,O
0.05,O
),O
",",O
and,O
that,O
areas,O
with,O
"
",O
higher,O
risk,O
mainly,O
appeared,O
in,O
metropolises,O
and,O
their,O
adjacent,O
regions,O
.,O
HFMD,O
"
",O
transmission,O
was,O
negatively,O
associated,O
with,O
temperature,O
fluctuations,O
.,O
A,O
1,O
â€‰,O
Â°,O
C,O
"
",O
increase,O
in,O
the,O
standard,O
deviation,O
of,O
maximum,O
and,O
minimum,O
temperatures,O
was,O
"
",O
associated,O
with,O
decreases,O
of,O
8.22,O
%,O
and,O
11.87,O
%,O
in,O
the,O
risk,O
of,O
HFMD,O
incidence,O
",",O
"
",O
respectively,O
.,O
The,O
study,O
suggests,O
that,O
large,O
temperature,O
fluctuations,O
affect,O
virus,O
"
",O
growth,O
or,O
multiplication,O
",",O
thereby,O
inhibiting,O
the,O
activity,O
of,O
the,O
virus,O
and,O
"
",O
potentially,O
even,O
leading,O
to,O
its,O
extinction,O
",",O
and,O
consequently,O
affecting,O
the,O
"
",O
spatialtemporal,O
distribution,O
of,O
HFMD,O
.,O
The,O
findings,O
can,O
serve,O
as,O
a,O
reference,O
for,O
"
",O
the,O
practical,O
control,O
of,O
this,O
disease,O
and,O
offer,O
help,O
in,O
the,O
rational,O
allocation,O
"
",O
of,O
medical,O
resources,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s4159802059265z,O
"
",O
PMCID,O
:,O
PMC7018740,O
"
",O
PMID,O
:,O
32054890,O
"


",O
700,O
.,O
Proc,O
Natl,O
Acad,O
Sci,O
U,O
S,O
A.,O
2020,O
Feb,O
13,O
.,O
pii,O
:,O
201922083,O
.,O
doi,O
:,O
"
",O
10.1073,O
pnas.1922083117,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Prophylactic,O
and,O
therapeutic,O
remdesivir,O
(,O
GS5734,O
),O
treatment,O
in,O
the,O
rhesus,O
macaque,O
"
",O
model,O
of,O
MERSCoV,O
infection,O
.,O
"

",O
de,O
Wit,O
E(1,O
),O
",",O
Feldmann,O
F(2,O
),O
",",O
Cronin,O
J(3,O
),O
",",O
Jordan,O
R(4,O
),O
",",O
Okumura,O
A(5,O
),O
",",O
Thomas,O
T(3,O
),O
",",O
"
",O
Scott,O
D(2,O
),O
",",O
Cihlar,O
T(4,O
),O
",",O
Feldmann,O
H(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Laboratory,O
of,O
Virology,O
",",O
National,O
Institute,O
of,O
Allergy,O
and,O
Infectious,O
Diseases,O
",",O
"
",O
NIH,O
",",O
Hamilton,O
",",O
MT,O
59840,O
;,O
Emmie.deWit@nih.gov,O
.,O
"
",O
(2)Rocky,O
Mountain,O
Veterinary,O
Branch,O
",",O
National,O
Institute,O
of,O
Allergy,O
and,O
Infectious,O
"
",O
Diseases,O
",",O
NIH,O
",",O
Hamilton,O
",",O
MT,O
59840,O
.,O
"
",O
(3)Laboratory,O
of,O
Virology,O
",",O
National,O
Institute,O
of,O
Allergy,O
and,O
Infectious,O
Diseases,O
",",O
"
",O
NIH,O
",",O
Hamilton,O
",",O
MT,O
59840,O
.,O
"
",O
(4)Biology,O
Department,O
",",O
Gilead,O
Sciences,O
",",O
Foster,O
City,O
",",O
CA,O
94404,O
.,O
"
",O
(5)Center,O
for,O
Infection,O
and,O
Immunity,O
",",O
Mailman,O
School,O
of,O
Public,O
Health,O
",",O
Columbia,O
"
",O
University,O
",",O
New,O
York,O
",",O
NY,O
10032,O
.,O
"

",O
The,O
continued,O
emergence,O
of,O
Middle,O
East,O
Respiratory,O
Syndrome,O
(,O
MERS,O
),O
cases,O
with,O
a,O
"
",O
high,O
case,O
fatality,O
rate,O
stresses,O
the,O
need,O
for,O
the,O
availability,O
of,O
effective,O
"
",O
antiviral,O
treatments,O
.,O
Remdesivir,O
(,O
GS5734,O
),O
effectively,O
inhibited,O
MERS,O
coronavirus,O
"
",O
(,O
MERSCoV,O
),O
replication,O
in,O
vitro,O
",",O
and,O
showed,O
efficacy,O
against,O
Severe,O
Acute,O
"
",O
Respiratory,O
Syndrome,O
(SARS)CoV,O
in,O
a,O
mouse,O
model,O
.,O
Here,O
",",O
we,O
tested,O
the,O
efficacy,O
of,O
"
",O
prophylactic,O
and,O
therapeutic,O
remdesivir,O
treatment,O
in,O
a,O
nonhuman,O
primate,O
model,O
of,O
"
",O
MERSCoV,O
infection,O
",",O
the,O
rhesus,O
macaque,O
.,O
Prophylactic,O
remdesivir,O
treatment,O
"
",O
initiated,O
24,O
h,O
prior,O
to,O
inoculation,O
completely,O
prevented,O
MERSCoVinduced,O
"
",O
clinical,O
disease,O
",",O
strongly,O
inhibited,O
MERSCoV,O
replication,O
in,O
respiratory,O
tissues,O
",",O
"
",O
and,O
prevented,O
the,O
formation,O
of,O
lung,O
lesions,O
.,O
Therapeutic,O
remdesivir,O
treatment,O
"
",O
initiated,O
12,O
h,O
postinoculation,O
also,O
provided,O
a,O
clear,O
clinical,O
benefit,O
",",O
with,O
a,O
"
",O
reduction,O
in,O
clinical,O
signs,O
",",O
reduced,O
virus,O
replication,O
in,O
the,O
lungs,O
",",O
and,O
"
",O
decreased,O
presence,O
and,O
severity,O
of,O
lung,O
lesions,O
.,O
The,O
data,O
presented,O
here,O
support,O
"
",O
testing,O
of,O
the,O
efficacy,O
of,O
remdesivir,O
treatment,O
in,O
the,O
context,O
of,O
a,O
MERS,O
clinical,O
"
",O
trial,O
.,O
It,O
may,O
also,O
be,O
considered,O
for,O
a,O
wider,O
range,O
of,O
coronaviruses,O
",",O
including,O
"
",O
the,O
currently,O
emerging,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2019nCoV.,O
"

",O
DOI,O
:,O
10.1073,O
pnas.1922083117,O
"
",O
PMID,O
:,O
32054787,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interest,O
statement,O
:,O
The,O
authors,O
"
",O
affiliated,O
with,O
Gilead,O
Sciences,O
are,O
employees,O
of,O
the,O
company,O
and,O
may,O
own,O
company,O
"
",O
stock,O
;,O
R.J.,O
holds,O
a,O
patent,O
on,O
the,O
use,O
of,O
remdesivir,O
to,O
treat,O
Filovirus,O
"
",O
infections,O
.,O
The,O
authors,O
affiliated,O
with,O
NIH,O
have,O
no,O
conflict,O
of,O
interest,O
to,O
"
",O
report,O
.,O
"


",O
701,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
11;9(2,O
),O
.,O
pii,O
:,O
E498,O
.,O
doi,O
:,O
10.339,O
jcm9020498,O
.,O
"

",O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
Outbreak,O
in,O
Wuhan,O
",",O
China,O
",",O
2020,O
:,O
Intense,O
Surveillance,O
Is,O
Vital,O
"
",O
for,O
Preventing,O
Sustained,O
Transmission,O
in,O
New,O
Locations,O
.,O
"

",O
Thompson,O
RN(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Mathematical,O
Institute,O
",",O
University,O
of,O
Oxford,O
",",O
Woodstock,O
Road,O
",",O
Oxford,O
OX2,O
6GG,O
",",O
"
",O
UK,O
.,O
"
",O
(2)Christ,O
Church,O
",",O
University,O
of,O
Oxford,O
",",O
St,O
Aldates,O
",",O
Oxford,O
OX1,O
1DP,O
",",O
UK,O
.,O
"

",O
The,O
outbreak,O
of,O
pneumonia,O
originating,O
in,O
Wuhan,O
",",O
China,O
",",O
has,O
generated,O
24500,O
"
",O
confirmed,O
cases,O
",",O
including,O
492,O
deaths,O
",",O
as,O
of,O
5,O
February,O
2020,O
.,O
The,O
virus,O
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
has,O
spread,O
elsewhere,O
in,O
China,O
and,O
to,O
24,O
countries,O
",",O
including,O
South,O
"
",O
Korea,O
",",O
Thailand,O
",",O
Japan,O
and,O
USA,O
.,O
Fortunately,O
",",O
there,O
has,O
only,O
been,O
limited,O
"
",O
humantohuman,O
transmission,O
outside,O
of,O
China,O
.,O
Here,O
",",O
we,O
assess,O
the,O
risk,O
of,O
"
",O
sustained,O
transmission,O
whenever,O
the,O
coronavirus,O
arrives,O
in,O
other,O
countries,O
.,O
Data,O
"
",O
describing,O
the,O
times,O
from,O
symptom,O
onset,O
to,O
hospitalisation,O
for,O
47,O
patients,O
"
",O
infected,O
early,O
in,O
the,O
current,O
outbreak,O
are,O
used,O
to,O
generate,O
an,O
estimate,O
for,O
the,O
"
",O
probability,O
that,O
an,O
imported,O
case,O
is,O
followed,O
by,O
sustained,O
humantohuman,O
"
",O
transmission,O
.,O
Under,O
the,O
assumptions,O
that,O
the,O
imported,O
case,O
is,O
representative,O
of,O
"
",O
the,O
patients,O
in,O
China,O
",",O
and,O
that,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
similarly,O
transmissible,O
to,O
the,O
"
",O
SARS,O
coronavirus,O
",",O
the,O
probability,O
that,O
an,O
imported,O
case,O
is,O
followed,O
by,O
sustained,O
"
",O
humantohuman,O
transmission,O
is,O
0.41,O
(,O
credible,O
interval,O
[,O
0.27,O
",",O
0.55,O
],O
),O
.,O
However,O
",",O
if,O
"
",O
the,O
mean,O
time,O
from,O
symptom,O
onset,O
to,O
hospitalisation,O
can,O
be,O
halved,O
by,O
intense,O
"
",O
surveillance,O
",",O
then,O
the,O
probability,O
that,O
an,O
imported,O
case,O
leads,O
to,O
sustained,O
"
",O
transmission,O
is,O
only,O
0.012,O
(,O
credible,O
interval,O
[,O
0,O
",",O
0.099,O
],O
),O
.,O
This,O
emphasises,O
the,O
"
",O
importance,O
of,O
current,O
surveillance,O
efforts,O
in,O
countries,O
around,O
the,O
world,O
",",O
to,O
"
",O
ensure,O
that,O
the,O
ongoing,O
outbreak,O
will,O
not,O
become,O
a,O
global,O
pandemic,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9020498,O
"
",O
PMID,O
:,O
32054124,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
There,O
are,O
no,O
competing,O
interests,O
.,O
"


",O
702,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
11;9(2,O
),O
.,O
pii,O
:,O
E488,O
.,O
doi,O
:,O
10.339,O
jcm9020488,O
.,O
"

",O
Initial,O
Cluster,O
of,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
Infections,O
in,O
Wuhan,O
",",O
China,O
Is,O
"
",O
Consistent,O
with,O
Substantial,O
HumantoHuman,O
Transmission,O
.,O
"

",O
Nishiura,O
H(1)(2,O
),O
",",O
Linton,O
NM(1,O
),O
",",O
Akhmetzhanov,O
AR(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Graduate,O
School,O
of,O
Medicine,O
",",O
Hokkaido,O
University,O
",",O
Kita,O
15,O
Jo,O
Nishi,O
7,O
Chome,O
",",O
"
",O
Kitaku,O
",",O
Sapporoshi,O
",",O
Hokkaido,O
608638,O
",",O
Japan,O
.,O
"
",O
(2)Core,O
Research,O
for,O
Evolutionary,O
Science,O
and,O
Technology,O
",",O
Japan,O
Science,O
and,O
"
",O
Technology,O
Agency,O
",",O
Honcho,O
418,O
",",O
Kawaguchi,O
",",O
Saitama,O
3320012,O
",",O
Japan,O
.,O
"

",O
Reanalysis,O
of,O
the,O
epidemic,O
curve,O
from,O
the,O
initial,O
cluster,O
of,O
cases,O
with,O
novel,O
"
",O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
in,O
December,O
2019,O
indicates,O
substantial,O
humantohuman,O
"
",O
transmission,O
.,O
It,O
is,O
possible,O
that,O
the,O
common,O
exposure,O
history,O
at,O
a,O
seafood,O
market,O
"
",O
in,O
Wuhan,O
originated,O
from,O
the,O
humantohuman,O
transmission,O
events,O
within,O
the,O
"
",O
market,O
",",O
and,O
the,O
early,O
",",O
strong,O
emphasis,O
that,O
market,O
exposure,O
indicated,O
"
",O
animaltohuman,O
transmission,O
was,O
potentially,O
the,O
result,O
of,O
observer,O
bias,O
.,O
To,O
"
",O
support,O
the,O
hypothesis,O
of,O
zoonotic,O
origin,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
stemming,O
from,O
the,O
Huanan,O
"
",O
seafood,O
market,O
",",O
the,O
index,O
case,O
should,O
have,O
had,O
exposure,O
history,O
related,O
to,O
the,O
"
",O
market,O
and,O
the,O
virus,O
should,O
have,O
been,O
identified,O
from,O
animals,O
sold,O
at,O
the,O
market,O
.,O
"
",O
As,O
these,O
requirements,O
remain,O
unmet,O
",",O
zoonotic,O
spillover,O
at,O
the,O
market,O
must,O
not,O
be,O
"
",O
overemphasized,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9020488,O
"
",O
PMID,O
:,O
32054045,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
703,O
.,O
MMWR,O
Morb,O
Mortal,O
Wkly,O
Rep.,O
2020,O
Feb,O
14;69(6):173,O
.,O
doi,O
:,O
10.15585,O
mmwr.mm6906a5,O
.,O
"

",O
Erratum,O
:,O
Vol,O
.,O
69,O
",",O
No.,O
5,O
.,O
"

",O
2019nCoV,B-Virus_SARS-CoV-2
CDC,O
Response,O
Team,O
.,O
"

",O
Collaborators,O
:,O
Ahmed,O
F(1,O
),O
",",O
Almendares,O
O(2,O
),O
",",O
Belludi,O
A(2,O
),O
",",O
Benowitz,O
I(1,O
),O
",",O
Braden,O
"
",O
C(1,O
),O
",",O
Carlson,O
C(3,O
),O
",",O
Chiou,O
H(4,O
),O
",",O
Clemmons,O
N(2,O
),O
",",O
Daigle,O
D(3,O
),O
",",O
Desai,O
M(3,O
),O
",",O
Duca,O
"
",O
L(5,O
),O
",",O
Fischer,O
M(1,O
),O
",",O
Ghinai,O
I(4,O
),O
",",O
Greene,O
C(2,O
),O
",",O
Grigg,O
C(1,O
),O
",",O
Grills,O
A(1,O
),O
",",O
Grusich,O
"
",O
K(2,O
),O
",",O
Hallowell,O
B(2,O
),O
",",O
Hoff,O
C(1,O
),O
",",O
Jacobs,O
J(4,O
),O
",",O
King,O
B(6,O
),O
",",O
MacArthur,O
J(3,O
),O
",",O
Mattison,O
"
",O
C(2,O
),O
",",O
McDonald,O
J(7,O
),O
",",O
McPherson,O
T(4,O
),O
",",O
Millman,O
A(2,O
),O
",",O
Novosad,O
S(1,O
),O
",",O
Pomeroy,O
M(1,O
),O
",",O
"
",O
Qualls,O
N(1,O
),O
",",O
Reynolds,O
M(1,O
),O
",",O
Rhodes,O
H(4,O
),O
",",O
Sharma,O
R(3,O
),O
",",O
Simmonds,O
R(3,O
),O
",",O
Stewart,O
"
",O
R(8,O
),O
",",O
Sunenshine,O
R(7,O
),O
",",O
Tenforde,O
M(2,O
),O
",",O
Uzicanin,O
A(1,O
),O
",",O
Verani,O
J(3,O
),O
",",O
Whitehill,O
F(9,O
),O
",",O
"
",O
Wilson,O
K(1,O
),O
",",O
Wortham,O
J(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Center,O
for,O
Emerging,O
and,O
Zoonotic,O
Infectious,O
Diseases,O
",",O
CDC,O
.,O
"
",O
(2)National,O
Center,O
for,O
Immunization,O
and,O
Respiratory,O
Diseases,O
",",O
CDC,O
.,O
"
",O
(3)Center,O
for,O
Global,O
Health,O
",",O
CDC,O
.,O
"
",O
(4)Center,O
for,O
Surveillance,O
",",O
Epidemiology,O
",",O
and,O
Laboratory,O
Services,O
",",O
CDC,O
.,O
"
",O
(5)National,O
Center,O
for,O
Chronic,O
Disease,O
Prevention,O
and,O
Health,O
Promotion,O
",",O
CDC,O
.,O
"
",O
(6)National,O
Institute,O
for,O
Occupational,O
Safety,O
and,O
Health,O
",",O
CDC,O
.,O
"
",O
(7)Center,O
for,O
Preparedness,O
and,O
Response,O
",",O
CDC,O
.,O
"
",O
(8)National,O
Center,O
for,O
HIV,O
AIDS,O
",",O
Viral,O
Hepatitis,O
",",O
STD,O
",",O
and,O
TB,O
Prevention,O
",",O
CDC,O
.,O
"
",O
(9)National,O
Center,O
on,O
Birth,O
Defects,O
and,O
Developmental,O
Disabilities,O
",",O
CDC,O
.,O
"

",O
Erratum,O
for,O
"
    ",O
MMWR,O
Morb,O
Mortal,O
Wkly,O
Rep.,O
2020,O
Feb,O
07;69(5):140146,O
.,O
"

",O
DOI,O
:,O
10.15585,O
mmwr.mm6906a5,O
"
",O
PMCID,O
:,O
PMC7017960,O
"
",O
PMID,O
:,O
32053580,O
"


",O
704,O
.,O
MMWR,O
Morb,O
Mortal,O
Wkly,O
Rep.,O
2020,O
Feb,O
14;69(6):166170,O
.,O
doi,O
:,O
"
",O
10.15585,O
mmwr.mm6906e1,O
.,O
"

",O
Persons,O
Evaluated,O
for,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
 ,O
United,O
States,O
",",O
January,O
2020,O
.,O
"

",O
Bajema,O
KL,O
",",O
Oster,O
AM,O
",",O
McGovern,O
OL,O
",",O
Lindstrom,O
S,O
",",O
Stenger,O
MR,O
",",O
Anderson,O
TC,O
",",O
Isenhour,O
"
",O
C,O
",",O
Clarke,O
KR,O
",",O
Evans,O
ME,O
",",O
Chu,O
VT,O
",",O
Biggs,O
HM,O
",",O
Kirking,O
HL,O
",",O
Gerber,O
SI,O
",",O
Hall,O
AJ,O
",",O
Fry,O
AM,O
",",O
"
",O
Oliver,O
SE,O
;,O
2019nCoV,B-Virus_SARS-CoV-2
Persons,O
Under,O
Investigation,O
Team,O
;,O
2019CoV,O
Persons,O
Under,O
"
",O
Investigation,O
Team,O
.,O
"

",O
Collaborators,O
:,O
Abedi,O
G(1,O
),O
",",O
Bower,O
W(2,O
),O
",",O
ChathamStephens,O
K(3,O
),O
",",O
Conklin,O
L(4,O
),O
",",O
"
",O
Cooley,O
L(5,O
),O
",",O
Cortese,O
M(1,O
),O
",",O
Curns,O
A(1,O
),O
",",O
Dooling,O
K(6,O
),O
",",O
Gokhale,O
R(2,O
),O
",",O
Gold,O
J(2,O
),O
",",O
"
",O
Grant,O
G(4,O
),O
",",O
Gutman,O
J(4,O
),O
",",O
Hesse,O
E(2,O
),O
",",O
Kamili,O
S(1,O
),O
",",O
Kim,O
L(1,O
),O
",",O
Kirkcaldy,O
R(5,O
),O
",",O
"
",O
Koumans,O
E(7,O
),O
",",O
Kujawski,O
S(1,O
),O
",",O
Langley,O
G(1,O
),O
",",O
Lively,O
J(1,O
),O
",",O
Lu,O
X(1,O
),O
",",O
Lynch,O
B(6,O
),O
",",O
Lyss,O
"
",O
S(5,O
),O
",",O
Malapati,O
L(1,O
),O
",",O
Martin,O
M(5,O
),O
",",O
Mbaeyi,O
S(1,O
),O
",",O
McClung,O
P(5,O
),O
",",O
Midgley,O
C(1,O
),O
",",O
Miller,O
"
",O
M(7,O
),O
",",O
Morales,O
M(4,O
),O
",",O
Murray,O
J(1,O
),O
",",O
Parker,O
Fiebelkorn,O
A(1,O
),O
",",O
Patel,O
M(1,O
),O
",",O
Peacock,O
"
",O
G(8,O
),O
",",O
Pierce,O
T(2,O
),O
",",O
Rha,O
B(1,O
),O
",",O
Sakthivel,O
S(1,O
),O
",",O
Schneider,O
E(1,O
),O
",",O
Siegel,O
DA(7,O
),O
",",O
"
",O
Sunshine,O
B(9,O
),O
",",O
Wallace,O
M(1,O
),O
",",O
Wang,O
L(1,O
),O
",",O
Watson,O
J(1,O
),O
",",O
Whitaker,O
B(1,O
),O
",",O
Yousaf,O
A(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Center,O
for,O
Immunization,O
and,O
Respiratory,O
Diseases,O
",",O
CDC,O
.,O
"
",O
(2)National,O
Center,O
for,O
Emerging,O
and,O
Zoonotic,O
Infectious,O
Diseases,O
",",O
CDC,O
.,O
"
",O
(3)National,O
Center,O
on,O
Birth,O
Defects,O
and,O
Developmental,O
Disabilities,O
",",O
CDC,O
.,O
"
",O
(4)Center,O
for,O
Global,O
Health,O
",",O
CDC,O
.,O
"
",O
(5)National,O
Center,O
for,O
HIV,O
AIDS,O
",",O
Viral,O
Hepatitis,O
",",O
STD,O
",",O
and,O
TB,O
Prevention,O
",",O
CDC,O
.,O
"
",O
(,O
6,O
),O
",",O
National,O
Center,O
for,O
Immunization,O
and,O
Respiratory,O
Diseases,O
",",O
CDC,O
.,O
"
",O
(7)National,O
Center,O
for,O
Chronic,O
Disease,O
Prevention,O
and,O
Health,O
Promotion,O
",",O
CDC,O
.,O
"
",O
(8)National,O
Center,O
for,O
Birth,O
Defects,O
and,O
Developmental,O
Disabilities,O
",",O
CDC,O
.,O
"
",O
(,O
9,O
),O
",",O
National,O
Center,O
for,O
Emerging,O
and,O
Zoonotic,O
Infectious,O
Diseases,O
",",O
CDC,O
.,O
"

",O
In,O
December,O
2019,O
",",O
a,O
cluster,O
of,O
cases,O
of,O
pneumonia,O
emerged,O
in,O
Wuhan,O
City,O
in,O
"
",O
central,O
China,O
's,O
Hubei,O
Province,O
.,O
Genetic,O
sequencing,O
of,O
isolates,O
obtained,O
from,O
"
",O
patients,O
with,O
pneumonia,O
identified,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
as,O
the,O
"
",O
etiology,O
(,O
1,O
),O
.,O
As,O
of,O
February,O
4,O
",",O
2020,O
",",O
approximately,O
20000,O
confirmed,O
cases,O
had,O
"
",O
been,O
identified,O
in,O
China,O
and,O
an,O
additional,O
159,O
confirmed,O
cases,O
in,O
23,O
other,O
"
",O
countries,O
",",O
including,O
11,O
in,O
the,O
United,O
States,O
(,O
"2,3",O
),O
.,O
On,O
January,O
17,O
",",O
CDC,O
and,O
the,O
"
",O
U.S.,O
Department,O
of,O
Homeland,O
Security,O
's,O
Customs,O
and,O
Border,O
Protection,O
began,O
health,O
"
",O
screenings,O
at,O
U.S.,O
airports,O
to,O
identify,O
ill,O
travelers,O
returning,O
from,O
Wuhan,O
City,O
"
",O
(,O
4,O
),O
.,O
CDC,O
activated,O
its,O
Emergency,O
Operations,O
Center,O
on,O
January,O
21,O
and,O
formalized,O
a,O
"
",O
process,O
for,O
inquiries,O
regarding,O
persons,O
suspected,O
of,O
having,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
"
",O
(,O
2,O
),O
.,O
As,O
of,O
January,O
31,O
",",O
2020,O
",",O
CDC,O
had,O
responded,O
to,O
clinical,O
inquiries,O
from,O
public,O
"
",O
health,O
officials,O
and,O
health,O
care,O
providers,O
to,O
assist,O
in,O
evaluating,O
approximately,O
"
",O
650,O
persons,O
thought,O
to,O
be,O
at,O
risk,O
for,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
Guided,O
by,O
CDC,O
criteria,O
"
",O
for,O
the,O
evaluation,O
of,O
persons,O
under,O
investigation,O
(,O
PUIs,O
),O
(,O
5,O
),O
",",O
210,O
symptomatic,O
"
",O
persons,O
were,O
tested,O
for,O
2019nCoV,B-Virus_SARS-CoV-2
;,O
among,O
these,O
persons,O
",",O
148,O
(,O
70,O
%,O
),O
had,O
"
",O
travelrelated,O
risk,O
only,O
",",O
42,O
(,O
20,O
%,O
),O
had,O
close,O
contact,O
with,O
an,O
ill,O
"
",O
laboratoryconfirmed,O
2019nCoV,B-Virus_SARS-CoV-2
patient,O
or,O
PUI,O
",",O
and,O
18,O
(,O
9,O
%,O
),O
had,O
both,O
travel,O
and,O
"
",O
contactrelated,O
risks,O
.,O
Eleven,O
of,O
these,O
persons,O
had,O
laboratoryconfirmed,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
infection,O
.,O
Recognizing,O
persons,O
at,O
risk,O
for,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
critical,O
to,O
identifying,O
"
",O
cases,O
and,O
preventing,O
further,O
transmission,O
.,O
Health,O
care,O
providers,O
should,O
remain,O
"
",O
vigilant,O
and,O
adhere,O
to,O
recommended,O
infection,O
prevention,O
and,O
control,O
practices,O
"
",O
when,O
evaluating,O
patients,O
for,O
possible,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
(,O
6,O
),O
.,O
Providers,O
should,O
"
",O
consult,O
with,O
their,O
local,O
and,O
state,O
health,O
departments,O
when,O
assessing,O
not,O
only,O
ill,O
"
",O
travelers,O
from,O
2019nCoVaffected,O
countries,O
but,O
also,O
ill,O
persons,O
who,O
have,O
been,O
in,O
"
",O
close,O
contact,O
with,O
patients,O
with,O
laboratoryconfirmed,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
in,O
the,O
"
",O
United,O
States,O
.,O
"

",O
DOI,O
:,O
10.15585,O
mmwr.mm6906e1,O
"
",O
PMCID,O
:,O
PMC7017962,O
"
",O
PMID,O
:,O
32053579,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
All,O
authors,O
have,O
completed,O
and,O
submitted,O
the,O
"
",O
International,O
Committee,O
of,O
Medical,O
Journal,O
Editors,O
form,O
for,O
disclosure,O
of,O
"
",O
potential,O
conflicts,O
of,O
interest,O
.,O
No,O
potential,O
conflicts,O
of,O
interest,O
were,O
"
",O
disclosed,O
.,O
"


",O
705,O
.,O
Emerg,O
Infect,O
Dis,O
.,O
2020,O
May,O
17;26(5,O
),O
.,O
doi,O
:,O
10.3201,O
eid2605.200146,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Risk,O
for,O
Transportation,O
of,O
2019,B-Disease_COVID-19
Novel,I-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Disease,I-Disease_COVID-19
from,O
Wuhan,O
to,O
Other,O
"
",O
Cities,O
in,O
China,O
.,O
"

",O
Du,O
Z,O
",",O
Wang,O
L,O
",",O
Cauchemez,O
S,O
",",O
Xu,O
X,O
",",O
Wang,O
X,O
",",O
Cowling,O
BJ,O
",",O
Meyers,O
LA,O
.,O
"

",O
On,O
January,O
23,O
",",O
2020,O
",",O
China,O
quarantined,O
Wuhan,O
to,O
contain,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
.,O
We,O
estimated,O
the,O
probability,O
of,O
transportation,O
of,O
COVID19,B-Disease_COVID-19
"
",O
from,O
Wuhan,O
to,O
369,O
other,O
cities,O
in,O
China,O
before,O
the,O
quarantine,O
.,O
Expected,O
COVID19,B-Disease_COVID-19
"
",O
risk,O
is,O
>,O
50,O
%,O
in,O
130,O
(,O
95,O
%,O
CI,O
89190,O
),O
cities,O
and,O
>,O
99,O
%,O
in,O
the,O
4,O
largest,O
metropolitan,O
"
",O
areas,O
.,O
"

",O
DOI,O
:,O
10.3201,O
eid2605.200146,O
"
",O
PMID,O
:,O
32053479,O
"


",O
706,O
.,O
Radiology,O
.,O
2020,O
Feb,O
13:200370,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200370,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Time,O
Course,O
of,O
Lung,O
Changes,O
On,O
Chest,O
CT,O
During,O
Recovery,O
From,O
2019,O
Novel,O
"
",O
Coronavirus,O
(,O
COVID19,B-Disease_COVID-19
),O
Pneumonia,O
.,O
"

",O
Pan,O
F(1,O
),O
",",O
Ye,O
T(1,O
),O
",",O
Sun,O
P(1,O
),O
",",O
Gui,O
S(1,O
),O
",",O
Liang,O
B(1,O
),O
",",O
Li,O
L(1,O
),O
",",O
Zheng,O
D(1,O
),O
",",O
Wang,O
"
",O
J(1,O
),O
",",O
Hesketh,O
RL(1,O
),O
",",O
Yang,O
L(1,O
),O
",",O
Zheng,O
C(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Department,O
of,O
Radiology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Jiefang,O
Avenue,O
#,O
1277,O
",",O
Wuhan,O
",",O
"
",O
430022,O
",",O
China,O
(,O
F.P.,O
",",O
T.Y.,O
",",O
S.G.,O
",",O
B.L.,O
",",O
L.L.,O
",",O
L.Y.,O
",",O
C.Z,O
),O
;,O
Department,O
of,O
Radiology,O
",",O
"
",O
Hubei,O
Province,O
Key,O
Laboratory,O
of,O
Molecular,O
Imaging,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
(,O
F.P.,O
",",O
"
",O
T.Y.,O
),O
;,O
Department,O
of,O
Emergency,O
Medicine,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Jiefang,O
Avenue,O
#,O
1277,O
",",O
Wuhan,O
",",O
"
",O
430022,O
",",O
China,O
(,O
P.S.,O
),O
;,O
Department,O
of,O
Radiology,O
",",O
MSC,O
Clinical,O
&,O
Technical,O
Solutions,O
",",O
"
",O
Philips,O
Healthcare,O
",",O
Beijing,O
",",O
100000,O
",",O
China,O
(,O
D.Z.,O
",",O
J.W.,O
),O
;,O
Department,O
of,O
Radiology,O
",",O
"
",O
University,O
College,O
London,O
Hospital,O
",",O
235,O
",",O
Euston,O
Road,O
",",O
London,O
",",O
NW1,O
2BU,O
",",O
UK,O
"
",O
(,O
R.L.H,O
),O
.,O
"

",O
Background,O
Chest,O
CT,O
is,O
used,O
to,O
assess,O
the,O
severity,O
of,O
lung,O
involvement,O
in,O
"
",O
COVID19,B-Disease_COVID-19
pneumonia,O
.,O
Purpose,O
To,O
determine,O
the,O
change,O
in,O
chest,O
CT,O
findings,O
"
",O
associated,O
with,O
COVID19,B-Disease_COVID-19
pneumonia,O
from,O
initial,O
diagnosis,O
until,O
patient,O
recovery,O
.,O
"
",O
Materials,O
and,O
Methods,O
This,O
retrospective,O
review,O
included,O
patients,O
with,O
RTPCR,O
"
",O
confirmed,O
COVID19,B-Disease_COVID-19
infection,O
presenting,O
between,O
12,O
January,O
2020,O
to,O
6,O
February,O
"
",O
2020,O
.,O
Patients,O
with,O
severe,O
respiratory,O
distress,O
and,O
 ,O
or,O
oxygen,O
requirement,O
at,O
any,O
"
",O
time,O
during,O
the,O
disease,O
course,O
were,O
excluded,O
.,O
Repeat,O
Chest,O
CT,O
was,O
obtained,O
at,O
"
",O
approximately,O
4,O
day,O
intervals,O
.,O
The,O
total,O
CT,O
score,O
was,O
the,O
sum,O
of,O
lung,O
involvement,O
"
",O
(,O
5,O
lobes,O
",",O
score,O
15,O
for,O
each,O
lobe,O
",",O
range,O
",",O
0,O
none,O
",",O
25,O
maximum,O
),O
was,O
determined,O
.,O
"
",O
Results,O
Twenty,O
one,O
patients,O
(,O
6,O
males,O
and,O
15,O
females,O
",",O
age,O
2563,O
years,O
),O
with,O
"
",O
confirmed,O
COVID19,B-Disease_COVID-19
pneumonia,O
were,O
evaluated,O
.,O
These,O
patients,O
under,O
went,O
a,O
total,O
of,O
"
",O
82,O
pulmonary,O
CT,O
scans,O
with,O
a,O
mean,O
interval,O
of,O
4Â±1,O
days,O
(,O
range,O
:,O
18,O
days,O
),O
.,O
All,O
"
",O
patients,O
were,O
discharged,O
after,O
a,O
mean,O
hospitalized,O
period,O
of,O
17Â±4,O
days,O
(,O
range,O
:,O
"
",O
1126,O
days,O
),O
.,O
Maximum,O
lung,O
involved,O
peaked,O
at,O
approximately,O
10,O
days,O
(,O
with,O
the,O
"
",O
calculated,O
total,O
CT,O
score,O
of,O
6,O
),O
from,O
the,O
onset,O
of,O
initial,O
symptoms,O
(,O
R2=0.25,O
),O
",",O
"
",O
p<0.001,O
),O
.,O
Based,O
on,O
quartiles,O
of,O
patients,O
from,O
day,O
0,O
to,O
day,O
26,O
involvement,O
",",O
4,O
"
",O
stages,O
of,O
lung,O
CT,O
were,O
defined,O
:,O
Stage,O
1,O
(,O
4,O
days,O
),O
:,O
ground,O
glass,O
opacities,O
(,O
GGO,O
),O
"
",O
in,O
18,O
24,O
(,O
75,O
%,O
),O
patients,O
with,O
the,O
total,O
CT,O
score,O
of,O
2Â±2,O
;,O
(2)Stage2,O
(,O
58d,O
days,O
),O
:,O
"
",O
increased,O
crazypaving,O
pattern,O
9,O
17,O
patients,O
(,O
53,O
%,O
),O
with,O
a,O
increase,O
in,O
total,O
CT,O
"
",O
score,O
(,O
6Â±4,O
",",O
p=0.002,O
),O
;,O
(,O
3,O
),O
Stage3,O
(,O
913days,O
),O
:,O
consolidation,O
19,O
21,O
(,O
91,O
%,O
),O
patients,O
"
",O
with,O
the,O
peak,O
of,O
total,O
CT,O
score,O
(,O
7Â±4,O
),O
;,O
(,O
4,O
),O
Stage4,O
(,O
â‰¥14,O
days,O
),O
:,O
gradual,O
resolution,O
"
",O
of,O
consolidation,O
15,O
20,O
(,O
75,O
%,O
),O
patients,O
with,O
a,O
decreased,O
total,O
CT,O
score,O
(,O
6Â±4,O
),O
"
",O
without,O
crazypaving,O
pattern,O
.,O
Conclusion,O
In,O
patients,O
recovering,O
from,O
COVID19,B-Disease_COVID-19
"
",O
pneumonia,O
(,O
without,O
severe,O
respiratory,O
distress,O
during,O
the,O
disease,O
course,O
),O
",",O
lung,O
"
",O
abnormalities,O
on,O
chest,O
CT,O
showed,O
greatest,O
severity,O
approximately,O
10,O
days,O
after,O
"
",O
initial,O
onset,O
of,O
symptoms,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200370,O
"
",O
PMID,O
:,O
32053470,O
"


",O
707,O
.,O
Br,O
J,O
Nurs,O
.,O
2020,O
Feb,O
13;29(3):166167,O
.,O
doi,O
:,O
10.12968,O
bjon.2020.29.3.166,O
.,O
"

",O
Infections,O
without,O
borders,O
:,O
a,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
in,O
Wuhan,O
",",O
China,O
.,O
"

",O
Wood,O
C(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Senior,O
Lecturer,O
",",O
Leadership,O
and,O
Management,O
:,O
Public,O
Health,O
",",O
Birmingham,O
City,O
"
",O
University,O
.,O
"

",O
DOI,O
:,O
10.12968,O
bjon.2020.29.3.166,O
"
",O
PMID,O
:,O
32053437,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
708,O
.,O
Am,O
J,O
Public,O
Health,O
.,O
2020,O
Feb,O
13:e1e2,O
.,O
doi,O
:,O
10.2105,O
AJPH.2020.305618,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Straining,O
the,O
System,O
:,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
and,O
Preparedness,O
for,O
"
",O
Concomitant,O
Disasters,O
.,O
"

",O
Smith,O
N(1,O
),O
",",O
Fraser,O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Nathaniel,O
Smith,O
is,O
the,O
Secretary,O
of,O
Health,O
",",O
Arkansas,O
Department,O
of,O
Health,O
",",O
"
",O
Little,O
Rock,O
",",O
and,O
President,O
",",O
Association,O
of,O
State,O
and,O
Territorial,O
Health,O
Officials,O
"
",O
(,O
ASTHO,O
),O
.,O
Michael,O
R.,O
Fraser,O
is,O
Chief,O
Executive,O
Officer,O
",",O
ASTHO,O
",",O
and,O
Affiliate,O
"
",O
Faculty,O
",",O
the,O
Department,O
of,O
Global,O
and,O
Community,O
Health,O
",",O
College,O
of,O
Health,O
and,O
"
",O
Human,O
Services,O
",",O
George,O
Mason,O
University,O
",",O
Fairfax,O
",",O
VA,O
.,O
"

",O
Just,O
a,O
few,O
weeks,O
before,O
the,O
first,O
confirmed,O
case,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
),O
"
",O
was,O
reported,O
in,O
the,O
United,O
States,O
",",O
the,O
US,O
Centers,O
for,O
Disease,O
Control,O
and,O
"
",O
Prevention,O
(,O
CDC,O
),O
issued,O
a,O
bold,O
promise,O
to,O
the,O
nation,O
:,O
the,O
agency,O
will,O
use,O
its,O
"
",O
scientific,O
expertise,O
to,O
bring,O
a,O
new,O
level,O
of,O
preparedness,O
in,O
the,O
United,O
States,O
"
",O
and,O
global,O
health,O
security,O
against,O
current,O
and,O
growing,O
threats,O
",",O
finally,O
eliminate,O
"
",O
certain,O
diseases,O
",",O
and,O
bring,O
an,O
end,O
to,O
the,O
devastation,O
of,O
epidemics.1,O
The,O
current,O
"
",O
outbreak,O
of,O
COVID19,B-Disease_COVID-19
reminds,O
us,O
how,O
urgent,O
this,O
promise,O
is,O
and,O
just,O
how,O
critical,O
"
",O
it,O
is,O
to,O
continue,O
to,O
sustain,O
and,O
strengthen,O
our,O
nation,O
's,O
public,O
health,O
"
",O
infrastructure,O
.,O
The,O
unprecedented,O
pace,O
of,O
the,O
public,O
health,O
response,O
to,O
COVID19,B-Disease_COVID-19
"
",O
has,O
only,O
been,O
possible,O
because,O
of,O
prior,O
investments,O
in,O
public,O
health,O
"
",O
preparedness,O
.,O
To,O
accelerate,O
our,O
pace,O
and,O
meet,O
the,O
challenges,O
of,O
current,O
and,O
"
",O
future,O
health,O
threats,O
",",O
we,O
must,O
advance,O
our,O
worldclass,O
data,O
and,O
analytics,O
"
",O
capabilities,O
;,O
maintain,O
and,O
expand,O
our,O
stateoftheart,O
public,O
health,O
laboratory,O
"
",O
capacity,O
;,O
continue,O
building,O
a,O
workforce,O
of,O
trusted,O
",",O
expert,O
",",O
public,O
health,O
"
",O
professionals,O
;,O
sustain,O
our,O
capacity,O
to,O
rapidly,O
respond,O
to,O
outbreaks,O
at,O
their,O
"
",O
source,O
;,O
and,O
assure,O
a,O
strong,O
global,O
and,O
domestic,O
preparedness,O
capacity,O
.,O
(,O
Am,O
J,O
"
",O
Public,O
Health,O
.,O
Published,O
online,O
ahead,O
of,O
print,O
February,O
13,O
",",O
2020,O
:,O
e1e2,O
.,O
"
",O
doi:10.2105,O
AJPH.2020.305618,O
),O
.,O
"

",O
DOI,O
:,O
10.2105,O
AJPH.2020.305618,O
"
",O
PMID,O
:,O
32053389,O
"


",O
709,O
.,O
Immunology,O
.,O
2020,O
Feb,O
13,O
.,O
doi,O
:,O
10.1111,O
imm.13181,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
HIV,O
infection,O
suppresses,O
TLR3,O
activationmediated,O
antiviral,O
immunity,O
in,O
microglia,O
"
",O
and,O
macrophages,O
.,O
"

",O
Liu,O
H(1,O
),O
",",O
Zhou,O
RH(1,O
),O
",",O
Liu,O
Y(1,O
),O
",",O
Guo,O
L(1,O
),O
",",O
Wang,O
X(2,O
),O
",",O
Hu,O
WH(2,O
),O
",",O
Ho,O
WZ(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
P.R.,O
China,O
.,O
"
",O
(2)Department,O
of,O
Pathology,O
and,O
Laboratory,O
Medicine,O
",",O
Temple,O
University,O
Lewis,O
Katz,O
"
",O
School,O
of,O
Medicine,O
",",O
Philadelphia,O
",",O
PA,O
",",O
USA,O
.,O
"

",O
Monocyticlineage,O
cells,O
in,O
the,O
central,O
nervous,O
system,O
(,O
CNS,O
),O
",",O
including,O
microglia,O
"
",O
and,O
brain,O
resident,O
macrophages,O
",",O
are,O
the,O
key,O
players,O
in,O
the,O
CNS,O
innate,O
immunity,O
"
",O
against,O
viral,O
infections,O
",",O
including,O
human,O
immunodeficiency,O
virus,O
(,O
HIV,O
),O
.,O
However,O
",",O
"
",O
these,O
cells,O
also,O
serve,O
as,O
the,O
major,O
targets,O
and,O
reservoirs,O
for,O
HIV,O
in,O
the,O
CNS,O
.,O
To,O
"
",O
address,O
the,O
question,O
of,O
how,O
HIV,O
can,O
establish,O
persistent,O
infection,O
in,O
the,O
target,O
"
",O
cells,O
in,O
the,O
CNS,O
",",O
we,O
examined,O
whether,O
HIV,O
has,O
the,O
ability,O
to,O
counteract,O
Tolllike,O
"
",O
receptor,O
3,O
(,O
TLR3,O
),O
activationmediated,O
antiviral,O
immunity,O
in,O
microglia,O
and,O
"
",O
macrophages,O
.,O
We,O
observed,O
that,O
HIV,O
latently,O
infected,O
microglial,O
cells,O
(,O
HC69.5,O
),O
"
",O
expressed,O
reduced,O
levels,O
of,O
TLR3,O
and,O
TLR3,O
activationmediated,O
interferons,O
"
",O
(,O
IFNÎ±,O
Î²,O
and,O
IFNÎ»,O
),O
as,O
compared,O
with,O
the,O
uninfected,O
control,O
cells,O
(,O
C20,O
),O
.,O
In,O
"
",O
addition,O
",",O
HIV,O
infection,O
of,O
primary,O
human,O
macrophages,O
suppressed,O
the,O
expression,O
of,O
"
",O
TLR3,O
and,O
the,O
IFNs,O
.,O
HIV,O
infection,O
also,O
inhibited,O
the,O
expression,O
of,O
the,O
antiviral,O
"
",O
ISGs,O
and,O
the,O
HIVrestriction,O
miRNAs,O
.,O
Mechanistically,O
",",O
HIV,O
infection,O
inhibited,O
the,O
"
",O
phosphorylation,O
of,O
IFN,O
regulatory,O
factors,O
(,O
IRF3,O
and,O
IRF7,O
),O
and,O
signal,O
transducer,O
"
",O
and,O
activator,O
of,O
transcription,O
proteins,O
(,O
STAT1,O
and,O
STAT3,O
),O
in,O
both,O
HIV,O
latently,O
"
",O
infected,O
microglia,O
and,O
acutely,O
infected,O
macrophages,O
.,O
These,O
findings,O
provide,O
"
",O
previously,O
unrecognized,O
and,O
sound,O
mechanisms,O
for,O
HIV,O
infection,O
and,O
persistence,O
in,O
"
",O
the,O
primary,O
target,O
and,O
reservoir,O
cells,O
in,O
the,O
brain,O
.,O
"

",O
This,O
article,O
is,O
protected,O
by,O
copyright,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1111,O
imm.13181,O
"
",O
PMID,O
:,O
32053234,O
"


",O
710,O
.,O
Am,O
J,O
Clin,O
Pathol,O
.,O
2020,O
Mar,O
9;153(4):420421,O
.,O
doi,O
:,O
10.1093,O
ajcp,O
aqaa029,O
.,O
"

",O
Three,O
Emerging,O
Coronaviruses,O
in,O
Two,O
Decades,O
.,O
"

",O
Guarner,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pathology,O
and,O
Laboratory,O
Medicine,O
",",O
Emory,O
University,O
",",O
Atlanta,O
GA,O
.,O
"

",O
DOI,O
:,O
10.1093,O
ajcp,O
aqaa029,O
"
",O
PMID,O
:,O
32053148,O
"


",O
711,O
.,O
J,O
Travel,O
Med,O
.,O
2020,O
Feb,O
13,O
.,O
pii,O
:,O
taaa021,O
.,O
doi,O
:,O
10.1093,O
jtm,O
taaa021,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
The,O
reproductive,O
number,O
of,O
COVID19,B-Disease_COVID-19
is,O
higher,O
compared,O
to,O
SARS,O
coronavirus,O
.,O
"

",O
Liu,O
Y(1,O
),O
",",O
Gayle,O
AA(2,O
),O
",",O
WilderSmith,O
A(2)(3,O
),O
",",O
RocklÃ¶v,O
J(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
International,O
Business,O
",",O
Xiamen,O
University,O
Tan,O
Kah,O
Kee,O
College,O
",",O
"
",O
Zhangzhou,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Public,O
Health,O
and,O
Clinical,O
Medicine,O
",",O
Section,O
of,O
Sustainable,O
"
",O
Health,O
",",O
UmeÃ¥,O
University,O
",",O
UmeÃ¥,O
",",O
Sweden,O
.,O
"
",O
(3)Heidelberg,O
Institute,O
of,O
Public,O
Health,O
",",O
Heidelberg,O
",",O
Germany,O
.,O
"

",O
Teaser,O
:,O
Our,O
review,O
found,O
the,O
average,O
R0,O
for,O
2019nCoV,B-Virus_SARS-CoV-2
to,O
be,O
3.28,O
",",O
which,O
exceeds,O
"
",O
WHO,O
estimates,O
of,O
1.4,O
to,O
2.5,O
.,O
"

",O
Â©,O
International,O
Society,O
of,O
Travel,O
Medicine,O
2020,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jtm,O
taaa021,O
"
",O
PMID,O
:,O
32052846,O
"


",O
712,O
.,O
J,O
Travel,O
Med,O
.,O
2020,O
Feb,O
13,O
.,O
pii,O
:,O
taaa020,O
.,O
doi,O
:,O
10.1093,O
jtm,O
taaa020,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Isolation,O
",",O
quarantine,O
",",O
social,O
distancing,O
and,O
community,O
containment,O
:,O
pivotal,O
role,O
"
",O
for,O
oldstyle,O
public,O
health,O
measures,O
in,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
"
",O
outbreak,O
.,O
"

",O
WilderSmith,O
A(1)(2,O
),O
",",O
Freedman,O
DO(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Disease,O
Control,O
",",O
London,O
School,O
of,O
Hygiene,O
and,O
Tropical,O
Medicine,O
",",O
"
",O
UK,O
.,O
"
",O
(2)Heidelberg,O
Institute,O
of,O
Global,O
Health,O
",",O
University,O
of,O
Heidelberg,O
",",O
Germany,O
.,O
"
",O
(3)University,O
of,O
Alabama,O
",",O
US,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jtm,O
taaa020,O
"
",O
PMID,O
:,O
32052841,O
"


",O
713,O
.,O
Trop,O
Med,O
Int,O
Health,O
.,O
2020,O
Mar;25(3):278280,O
.,O
doi,O
:,O
10.1111,O
tmi.13383,O
.,O
Epub,O
2020,O
"
",O
Feb,O
16,O
.,O
"

",O
The,O
COVID19,B-Disease_COVID-19
epidemic,O
.,O
"

",O
Velavan,O
TP(1)(2)(3,O
),O
",",O
Meyer,O
CG(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Tropical,O
Medicine,O
",",O
UniversitÃ¤tsklinikum,O
TÃ¼bingen,O
",",O
Germany,O
.,O
"
",O
(2)Vietnamese,O
German,O
Center,O
for,O
Medical,O
Research,O
",",O
Hanoi,O
",",O
Vietnam,O
.,O
"
",O
(3)Faculty,O
of,O
Medicine,O
",",O
Duy,O
Tan,O
University,O
",",O
Da,O
Nang,O
",",O
Vietnam,O
.,O
"

",O
DOI,O
:,O
10.1111,O
tmi.13383,O
"
",O
PMID,O
:,O
32052514,O
"


",O
714,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
13,O
.,O
doi,O
:,O
10.1002,O
jmv.25707,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Potential,O
interventions,O
for,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
in,O
China,O
:,O
A,O
systematic,O
review,O
.,O
"

",O
Zhang,O
L(1,O
),O
",",O
Liu,O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Neurosurgery,O
",",O
Shengjing,O
Hospital,O
of,O
China,O
Medical,O
University,O
",",O
"
",O
Shenyang,O
",",O
Liaoning,O
",",O
China,O
.,O
"

",O
An,O
outbreak,O
of,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
COVID19,B-Disease_COVID-19
or,O
2019CoV,O
),O
infection,O
has,O
posed,O
"
",O
significant,O
threats,O
to,O
international,O
health,O
and,O
the,O
economy,O
.,O
In,O
the,O
absence,O
of,O
"
",O
treatment,O
for,O
this,O
virus,O
",",O
there,O
is,O
an,O
urgent,O
need,O
to,O
find,O
alternative,O
methods,O
to,O
"
",O
control,O
the,O
spread,O
of,O
disease,O
.,O
Here,O
",",O
we,O
have,O
conducted,O
an,O
online,O
search,O
for,O
all,O
"
",O
treatment,O
options,O
related,O
to,O
coronavirus,O
infections,O
as,O
well,O
as,O
some,O
RNAvirus,O
"
",O
infection,O
and,O
we,O
have,O
found,O
that,O
general,O
treatments,O
",",O
coronavirusspecific,O
"
",O
treatments,O
",",O
and,O
antiviral,O
treatments,O
should,O
be,O
useful,O
in,O
fighting,O
COVID19,B-Disease_COVID-19
.,O
We,O
"
",O
suggest,O
that,O
the,O
nutritional,O
status,O
of,O
each,O
infected,O
patient,O
should,O
be,O
evaluated,O
"
",O
before,O
the,O
administration,O
of,O
general,O
treatments,O
and,O
the,O
current,O
children,O
's,O
"
",O
RNAvirus,O
vaccines,O
including,O
influenza,O
vaccine,O
should,O
be,O
immunized,O
for,O
uninfected,O
"
",O
people,O
and,O
health,O
care,O
workers,O
.,O
In,O
addition,O
",",O
convalescent,O
plasma,O
should,O
be,O
given,O
"
",O
to,O
COVID19,B-Disease_COVID-19
patients,O
if,O
it,O
is,O
available,O
.,O
In,O
conclusion,O
",",O
we,O
suggest,O
that,O
all,O
the,O
"
",O
potential,O
interventions,O
be,O
implemented,O
to,O
control,O
the,O
emerging,O
COVID19,B-Disease_COVID-19
if,O
the,O
"
",O
infection,O
is,O
uncontrollable,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25707,O
"
",O
PMID,O
:,O
32052466,O
"


",O
715,O
.,O
Can,O
J,O
Anaesth,O
.,O
2020,O
Feb,O
12,O
.,O
doi,O
:,O
10.1007,O
s1263002001591x,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Practical,O
recommendations,O
for,O
critical,O
care,O
and,O
anesthesiology,O
teams,O
caring,O
for,O
"
",O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
patients,O
.,O
"

",O
Wax,O
RS(1)(2)(3,O
),O
",",O
Christian,O
MD(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Faculty,O
of,O
Health,O
Sciences,O
",",O
Queen,O
's,O
"
",O
University,O
",",O
Kingston,O
",",O
ON,O
",",O
Canada,O
.,O
randy.wax@queensu.ca,O
.,O
"
",O
(2)Department,O
of,O
Medicine,O
",",O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Toronto,O
",",O
Toronto,O
",",O
"
",O
ON,O
",",O
Canada,O
.,O
randy.wax@queensu.ca,O
.,O
"
",O
(3)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Lakeridge,O
Health,O
",",O
1,O
Hospital,O
Court,O
",",O
"
",O
Oshawa,O
",",O
ON,O
",",O
L1,O
G,O
2B9,O
",",O
Canada,O
.,O
randy.wax@queensu.ca,O
.,O
"
",O
(4)London,O
's,O
Air,O
Ambulance,O
",",O
Royal,O
London,O
Hospital,O
",",O
Barts,O
Health,O
NHS,O
Trust,O
",",O
London,O
",",O
"
",O
England,O
",",O
UK,O
.,O
"

",O
A,O
global,O
health,O
emergency,O
has,O
been,O
declared,O
by,O
the,O
World,O
Health,O
Organization,O
as,O
"
",O
the,O
2019nCoV,B-Virus_SARS-CoV-2
outbreak,O
spreads,O
across,O
the,O
world,O
",",O
with,O
confirmed,O
patients,O
in,O
"
",O
Canada,O
.,O
Patients,O
infected,O
with,O
2019nCoV,B-Virus_SARS-CoV-2
are,O
at,O
risk,O
for,O
developing,O
respiratory,O
"
",O
failure,O
and,O
requiring,O
admission,O
to,O
critical,O
care,O
units,O
.,O
While,O
providing,O
optimal,O
"
",O
treatment,O
for,O
these,O
patients,O
",",O
careful,O
execution,O
of,O
infection,O
control,O
measures,O
is,O
"
",O
necessary,O
to,O
prevent,O
nosocomial,O
transmission,O
to,O
other,O
patients,O
and,O
to,O
healthcare,O
"
",O
workers,O
providing,O
care,O
.,O
Although,O
the,O
exact,O
mechanisms,O
of,O
transmission,O
are,O
"
",O
currently,O
unclear,O
",",O
humantohuman,O
transmission,O
can,O
occur,O
",",O
and,O
the,O
risk,O
of,O
"
",O
airborne,O
spread,O
during,O
aerosolgenerating,O
medical,O
procedures,O
remains,O
a,O
concern,O
in,O
"
",O
specific,O
circumstances,O
.,O
This,O
paper,O
summarizes,O
important,O
considerations,O
regarding,O
"
",O
patient,O
screening,O
",",O
environmental,O
controls,O
",",O
personal,O
protective,O
equipment,O
",",O
"
",O
resuscitation,O
measures,O
(,O
including,O
intubation,O
),O
",",O
and,O
critical,O
care,O
unit,O
operations,O
"
",O
planning,O
as,O
we,O
prepare,O
for,O
the,O
possibility,O
of,O
new,O
imported,O
cases,O
or,O
local,O
"
",O
outbreaks,O
of,O
2019nCoV.,O
Although,O
understanding,O
of,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
virus,O
is,O
"
",O
evolving,O
",",O
lessons,O
learned,O
from,O
prior,O
infectious,O
disease,O
challenges,O
such,O
as,O
Severe,O
"
",O
Acute,O
Respiratory,O
Syndrome,O
will,O
hopefully,O
improve,O
our,O
state,O
of,O
readiness,O
"
",O
regardless,O
of,O
the,O
number,O
of,O
cases,O
we,O
eventually,O
manage,O
in,O
Canada,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s1263002001591x,O
"
",O
PMID,O
:,O
32052373,O
"


",O
716,O
.,O
Singapore,O
Med,O
J.,O
2020,O
Feb;61(2):5557,O
.,O
doi,O
:,O
10.11622,O
smedj.2020018,O
.,O
Epub,O
2020,O
Feb,O
"
",O
13,O
.,O
"

",O
Outbreak,O
of,O
COVID19,B-Disease_COVID-19
 ,O
an,O
urgent,O
need,O
for,O
good,O
science,O
to,O
silence,O
our,O
fears,O
?,O
"

",O
Lum,O
LHW(1,O
),O
",",O
Tambyah,O
PA(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Medicine,O
",",O
National,O
University,O
"
",O
Health,O
System,O
",",O
Singapore,O
.,O
"

",O
DOI,O
:,O
10.11622,O
smedj.2020018,O
"
",O
PMCID,O
:,O
PMC7052000,O
"
",O
PMID,O
:,O
32052064,O
"


",O
717,O
.,O
Viruses,O
.,O
2020,O
Feb,O
10;12(2,O
),O
.,O
pii,O
:,O
E194,O
.,O
doi,O
:,O
10.339,O
v12020194,O
.,O
"

",O
Potential,O
Maternal,O
and,O
Infant,O
Outcomes,O
from,O
(,O
Wuhan,O
),O
Coronavirus,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
Infecting,O
Pregnant,O
Women,O
:,O
Lessons,O
from,O
SARS,O
",",O
MERS,O
",",O
and,O
Other,O
Human,O
Coronavirus,O
"
",O
Infections,O
.,O
"

",O
Schwartz,O
DA(1,O
),O
",",O
Graham,O
AL(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Medical,O
College,O
of,O
Georgia,O
",",O
Augusta,O
University,O
",",O
Augusta,O
",",O
GA,O
30912,O
",",O
USA,O
.,O
"
",O
(2)Department,O
of,O
Anthropology,O
",",O
University,O
of,O
Connecticut,O
",",O
Storrs,O
",",O
CT,O
6269,O
",",O
USA,O
.,O
"

",O
In,O
early,O
December,O
2019,O
a,O
cluster,O
of,O
cases,O
of,O
pneumonia,O
of,O
unknown,O
cause,O
was,O
"
",O
identified,O
in,O
Wuhan,O
",",O
a,O
city,O
of,O
11,O
million,O
persons,O
in,O
the,O
People,O
's,O
Republic,O
of,O
"
",O
China,O
.,O
Further,O
investigation,O
revealed,O
these,O
cases,O
to,O
result,O
from,O
infection,O
with,O
a,O
"
",O
newly,O
identified,O
coronavirus,O
",",O
termed,O
the,O
2019nCoV.,O
The,O
infection,O
moved,O
rapidly,O
"
",O
through,O
China,O
",",O
spread,O
to,O
Thailand,O
and,O
Japan,O
",",O
extended,O
into,O
adjacent,O
countries,O
"
",O
through,O
infected,O
persons,O
travelling,O
by,O
air,O
",",O
eventually,O
reaching,O
multiple,O
"
",O
countries,O
and,O
continents,O
.,O
Similar,O
to,O
such,O
other,O
coronaviruses,O
as,O
those,O
causing,O
"
",O
the,O
Middle,O
East,O
respiratory,O
syndrome,O
(,O
MERS,O
),O
and,O
severe,O
acute,O
respiratory,O
syndrome,O
"
",O
(,O
SARS,O
),O
",",O
the,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
was,O
reported,O
to,O
spread,O
via,O
natural,O
aerosols,O
from,O
"
",O
humantohuman,O
.,O
In,O
the,O
early,O
stages,O
of,O
this,O
epidemic,O
the,O
case,O
fatality,O
rate,O
is,O
"
",O
estimated,O
to,O
be,O
approximately,O
2,O
%,O
",",O
with,O
the,O
majority,O
of,O
deaths,O
occurring,O
in,O
"
",O
special,O
populations,O
.,O
Unfortunately,O
",",O
there,O
is,O
limited,O
experience,O
with,O
coronavirus,O
"
",O
infections,O
during,O
pregnancy,O
",",O
and,O
it,O
now,O
appears,O
certain,O
that,O
pregnant,O
women,O
have,O
"
",O
become,O
infected,O
during,O
the,O
present,O
2019nCoV,B-Virus_SARS-CoV-2
epidemic,O
.,O
In,O
order,O
to,O
assess,O
the,O
"
",O
potential,O
of,O
the,O
Wuhan,O
2019nCoV,B-Virus_SARS-CoV-2
to,O
cause,O
maternal,O
",",O
fetal,O
and,O
neonatal,O
morbidity,O
"
",O
and,O
other,O
poor,O
obstetrical,O
outcomes,O
",",O
this,O
communication,O
reviews,O
the,O
published,O
"
",O
data,O
addressing,O
the,O
epidemiological,O
and,O
clinical,O
effects,O
of,O
SARS,O
",",O
MERS,O
",",O
and,O
other,O
"
",O
coronavirus,O
infections,O
on,O
pregnant,O
women,O
and,O
their,O
infants,O
.,O
Recommendations,O
are,O
"
",O
also,O
made,O
for,O
the,O
consideration,O
of,O
pregnant,O
women,O
in,O
the,O
design,O
",",O
clinical,O
trials,O
",",O
"
",O
and,O
implementation,O
of,O
future,O
2019nCoV,B-Virus_SARS-CoV-2
vaccines,O
.,O
"

",O
DOI,O
:,O
10.339,O
v12020194,O
"
",O
PMID,O
:,O
32050635,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
718,O
.,O
Commun,O
Dis,O
Intell,O
(,O
2018,O
),O
.,O
2020,O
Feb,O
12;44,O
.,O
doi,O
:,O
10.33321,O
cdi.2020.44.14,O
.,O
"

",O
COVID19,B-Disease_COVID-19
",",O
Australia,O
:,O
Epidemiology,O
Report,O
2,O
(,O
Reporting,O
week,O
ending,O
0.791666667,O
AEDT,O
8,O
"
",O
February,O
2020,O
),O
.,O
"

",O
COVID19,B-Disease_COVID-19
National,O
Incident,O
Room,O
Surveillance,O
Team,O
.,O
"

",O
This,O
is,O
the,O
second,O
epidemiological,O
report,O
for,O
coronavirus,O
disease,O
(,O
COVID19,B-Disease_COVID-19
),O
",",O
"
",O
previously,O
known,O
as,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
",",O
reported,O
in,O
Australia,O
as,O
at,O
"
",O
0.791666667,O
Australian,O
Eastern,O
Daylight,O
Time,O
[,O
AEDT,O
],O
8,O
February,O
2020,O
.,O
It,O
includes,O
data,O
"
",O
on,O
Australian,O
cases,O
notified,O
during,O
the,O
week,O
ending,O
0.791666667,O
AEDT,O
8,O
February,O
2020,O
",",O
"
",O
the,O
international,O
situation,O
and,O
current,O
information,O
on,O
the,O
severity,O
",",O
transmission,O
"
",O
and,O
spread,O
of,O
the,O
COVID19,B-Disease_COVID-19
infection,O
.,O
"

",O
Â©,O
Commonwealth,O
of,O
Australia,O
CC,O
BYNCND,O
.,O
"

",O
DOI,O
:,O
10.33321,O
cdi.2020.44.14,O
"
",O
PMID,O
:,O
32050080,O
"


",O
719,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Mar,O
12;382(11):10701072,O
.,O
doi,O
:,O
10.1056,O
NEJMc2001573,O
.,O
Epub,O
2020,O
"
",O
Feb,O
12,O
.,O
"

",O
A,O
Locally,O
Transmitted,O
Case,O
of,O
SARSCoV2,B-Disease_COVID-19
Infection,I-Disease_COVID-19
in,O
Taiwan,O
.,O
"

",O
Liu,O
YC(1,O
),O
",",O
Liao,O
CH(1,O
),O
",",O
Chang,O
CF(1,O
),O
",",O
Chou,O
CC(1,O
),O
",",O
Lin,O
YR(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Changhua,O
Christian,O
Hospital,O
",",O
Changhua,O
City,O
",",O
Taiwan,O
h6213.lac@gmail.com,O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMc2001573,O
"
",O
PMID,O
:,O
32050059,O
"


",O
720,O
.,O
Medicine,O
(,O
Baltimore,O
),O
.,O
2020,O
Feb;99(7):e19095,O
.,O
doi,O
:,O
10.1097,O
MD.0000000000019095,O
.,O
"

",O
Effectiveness,O
",",O
immunogenicity,O
",",O
and,O
safety,O
of,O
influenza,O
vaccines,O
with,O
MF59,O
"
",O
adjuvant,O
in,O
healthy,O
people,O
of,O
different,O
age,O
groups,O
:,O
A,O
systematic,O
review,O
and,O
"
",O
metaanalysis,O
.,O
"

",O
Yang,O
J(1)(2,O
),O
",",O
Zhang,O
J(1)(2,O
),O
",",O
Han,O
T(1)(2,O
),O
",",O
Liu,O
C(1)(2,O
),O
",",O
Li,O
X(1)(2,O
),O
",",O
Yan,O
L(1)(2,O
),O
",",O
"
",O
Yang,O
B(1)(2,O
),O
",",O
Yang,O
X(1)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Institute,O
of,O
Engineering,O
Technology,O
Research,O
in,O
Combination,O
Vaccine,O
.,O
"
",O
(2)Wuhan,O
Institute,O
of,O
Biological,O
Products,O
Co.,O
",",O
Ltd.,O
",",O
Wuhan,O
",",O
Hubei,O
province,O
.,O
"
",O
(3)China,O
Biotechnology,O
Co.,O
",",O
Ltd.,O
",",O
Peking,O
China,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
Influenza,O
is,O
a,O
severe,O
disease,O
burden,O
among,O
all,O
age,O
groups,O
.,O
This,O
study,O
"
",O
aimed,O
to,O
review,O
the,O
efficacy,O
of,O
inactivated,O
influenza,O
vaccines,O
with,O
MF59,O
adjuvant,O
"
",O
and,O
nonadjuvanted,O
inactivated,O
influenza,O
vaccines,O
among,O
all,O
age,O
groups,O
against,O
"
",O
specific,O
influenza,O
vaccine,O
strains,O
.,O
"
",O
METHODS,O
:,O
Literature,O
search,O
of,O
PubMed,O
",",O
Embase,O
",",O
Medline,O
",",O
OVID,O
",",O
and,O
Cochrane,O
Library,O
"
",O
Trials,O
(,O
CENTRAL,O
),O
was,O
implemented,O
up,O
to,O
March,O
1,O
",",O
2019,O
.,O
Homogeneity,O
qualified,O
"
",O
studies,O
were,O
included,O
forData,O
were,O
extracted,O
such,O
as,O
study,O
country,O
location,O
",",O
"
",O
demographic,O
characteristics,O
",",O
and,O
measure,O
outcomes,O
",",O
and,O
were,O
analyzed,O
by,O
a,O
random,O
"
",O
effect,O
model,O
and,O
sensitivity,O
analyses,O
to,O
identify,O
heterogeneity,O
.,O
Risk,O
of,O
bias,O
was,O
"
",O
evaluated,O
using,O
the,O
Cochrane,O
Risk,O
of,O
Bias,O
Tool,O
.,O
"
",O
RESULTS,O
:,O
We,O
retrieved,O
1021,O
publications,O
and,O
selected,O
31,O
studies,O
for,O
full,O
review,O
",",O
"
",O
including,O
17,O
trials,O
for,O
metaanalysis,O
and,O
6,O
trials,O
for,O
qualitative,O
synthesis,O
.,O
"
",O
MF59adjuvanted,O
influenza,O
vaccines,O
demonstrated,O
better,O
immunogenicity,O
against,O
"
",O
specific,O
vaccine,O
virus,O
strains,O
compared,O
to,O
nonadjuvanted,O
influenza,O
vaccine,O
both,O
"
",O
in,O
healthy,O
adult,O
group,O
(,O
RR,O
â€Š,O
=,O
â€Š,O
2.1,O
;,O
95,O
%,O
CI,O
:,O
1.283.44,O
),O
and,O
the,O
healthy,O
aged,O
"
",O
(,O
RR,O
â€Š,O
=,O
â€Š,O
1.26,O
;,O
95,O
%,O
CI,O
:,O
1.101.44,O
),O
.,O
"
",O
CONCLUSION,O
:,O
The,O
quality,O
of,O
evidence,O
is,O
moderate,O
to,O
high,O
for,O
seroconversion,O
and,O
"
",O
seroprotection,O
rates,O
of,O
influenza,O
vaccine,O
.,O
MF59adjuvanted,O
influenza,O
vaccines,O
are,O
"
",O
superior,O
to,O
nonadjuvanted,O
influenza,O
vaccines,O
to,O
enhance,O
immune,O
responses,O
of,O
"
",O
vaccination,O
in,O
healthy,O
adults,O
and,O
older,O
adults,O
",",O
and,O
could,O
be,O
considered,O
for,O
"
",O
routine,O
use,O
especially,O
the,O
monovalent,O
prepandemic,O
influenza,O
vaccines,O
.,O
"

",O
DOI,O
:,O
10.1097,O
MD.0000000000019095,O
"
",O
PMCID,O
:,O
PMC7035094,O
"
",O
PMID,O
:,O
32049815,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
721,O
.,O
J,O
Chin,O
Med,O
Assoc,O
.,O
2020,O
Feb,O
11,O
.,O
doi,O
:,O
10.1097,O
JCMA.0000000000000270,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Overview,O
of,O
The,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
:,O
The,O
Pathogen,O
of,O
Severe,O
"
",O
Specific,O
Contagious,O
Pneumonia,O
(,O
SSCP,O
),O
.,O
"

",O
Wu,O
YC(1,O
),O
",",O
Chen,O
CS(1,O
),O
",",O
Chan,O
YJ(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Microbiology,O
",",O
Department,O
of,O
Pathology,O
and,O
Laboratory,O
Medicine,O
",",O
"
",O
Taipei,O
Veterans,O
General,O
Hospital,O
",",O
Taipei,O
",",O
Taiwan,O
",",O
ROC,O
.,O
"
",O
(2)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Medicine,O
",",O
Taipei,O
Veterans,O
"
",O
General,O
Hospital,O
",",O
Taipei,O
",",O
Taiwan,O
",",O
ROC,O
.,O
"
",O
(3)Institute,O
of,O
Public,O
Health,O
",",O
National,O
Yang,O
Ming,O
University,O
",",O
Taipei,O
",",O
Taiwan,O
",",O
"
",O
ROC,O
.,O
"

",O
In,O
late,O
December,O
2019,O
a,O
previous,O
unidentified,O
coronavirus,O
",",O
currently,O
named,O
as,O
the,O
"
",O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
",",O
emerged,O
from,O
Wuhan,O
",",O
China,O
and,O
resulted,O
in,O
a,O
"
",O
formidable,O
outbreak,O
in,O
many,O
cities,O
in,O
China,O
and,O
expanding,O
globally,O
",",O
including,O
"
",O
Thailand,O
",",O
Republic,O
of,O
Korea,O
",",O
Japan,O
",",O
USA,O
",",O
Philippines,O
",",O
Viet,O
Nam,O
",",O
and,O
our,O
country,O
"
",O
(,O
as,O
of,O
2,O
6,O
2020,O
at,O
least,O
25,O
countries,O
),O
.,O
The,O
disease,O
is,O
officially,O
named,O
as,O
the,O
"
",O
Severe,O
Specific,O
Contagious,O
Pneumonia,O
(,O
SSCP,O
),O
in,O
1,O
15,O
2019,O
and,O
is,O
a,O
notifiable,O
"
",O
communicable,O
disease,O
of,O
the,O
5,O
category,O
by,O
the,O
Taiwan,O
CDC,O
",",O
the,O
Ministry,O
of,O
Health,O
.,O
"
",O
SSCP,O
is,O
a,O
potential,O
zoonotic,O
disease,O
with,O
low,O
to,O
moderate,O
(,O
estimated,O
25,O
%,O
),O
"
",O
mortality,O
rate,O
.,O
Persontoperson,O
transmission,O
may,O
occur,O
through,O
droplet,O
or,O
"
",O
contact,O
transmission,O
and,O
jeopardized,O
firstline,O
healthcare,O
workers,O
if,O
lack,O
of,O
"
",O
stringent,O
infection,O
control,O
or,O
no,O
proper,O
personal,O
protective,O
equipment,O
available,O
.,O
"
",O
Currently,O
",",O
there,O
is,O
no,O
definite,O
treatment,O
for,O
SSCP,O
although,O
some,O
drugs,O
are,O
under,O
"
",O
investigation,O
.,O
To,O
promptly,O
identify,O
patients,O
and,O
prevent,O
further,O
spreading,O
",",O
"
",O
physicians,O
should,O
be,O
aware,O
of,O
travel,O
or,O
contact,O
history,O
for,O
patients,O
with,O
"
",O
compatible,O
symptoms,O
.,O
"

",O
DOI,O
:,O
10.1097,O
JCMA.0000000000000270,O
"
",O
PMID,O
:,O
32049687,O
"


",O
722,O
.,O
Radiology,O
.,O
2020,O
Feb,O
12:200323,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200323,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Pre,O
and,O
Posttreatment,O
Chest,O
CT,O
Findings,O
:,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
"
",O
Pneumonia,O
.,O
"

",O
Duan,O
YN(1,O
),O
",",O
Qin,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Department,O
of,O
Radiology,O
",",O
the,O
Third,O
Affiliated,O
Hospital,O
of,O
Sun,O
Yatsen,O
"
",O
University,O
",",O
600,O
Tianhe,O
Rd,O
",",O
Guangzhou,O
",",O
P.,O
R.,O
China,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200323,O
"
",O
PMID,O
:,O
32049602,O
"


",O
723,O
.,O
Radiology,O
.,O
2020,O
Feb,O
12:200343,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200343,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Chest,O
CT,O
for,O
Typical,O
2019nCoV,B-Disease_COVID-19
Pneumonia,I-Disease_COVID-19
:,O
Relationship,O
to,O
Negative,O
RTPCR,O
"
",O
Testing,O
.,O
"

",O
Xie,O
X(1,O
),O
",",O
Zhong,O
Z(1,O
),O
",",O
Zhao,O
W(1,O
),O
",",O
Zheng,O
C(1,O
),O
",",O
Wang,O
F(1,O
),O
",",O
Liu,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Department,O
of,O
Radiology,O
",",O
Second,O
Xiangya,O
Hospital,O
",",O
Central,O
South,O
"
",O
University,O
",",O
Changsha,O
",",O
Hunan,O
Province,O
",",O
410011,O
",",O
China,O
(,O
X.X.,O
",",O
W.Z.,O
",",O
J.L.,O
),O
;,O
"
",O
Department,O
of,O
Radiology,O
Quality,O
Control,O
Center,O
",",O
Changsha,O
",",O
Hunan,O
Province,O
",",O
410011,O
",",O
"
",O
China,O
(,O
J.L.,O
),O
;,O
Department,O
of,O
Radiology,O
",",O
First,O
hospital,O
of,O
Changsha,O
",",O
Hunan,O
"
",O
Province,O
",",O
410005,O
",",O
China,O
(,O
Z.Z.,O
),O
;,O
Changsha,O
public,O
health,O
treatment,O
center,O
",",O
Hunan,O
"
",O
Province,O
",",O
410153,O
",",O
China,O
(,O
Z.Z.,O
),O
;,O
Department,O
of,O
Radiology,O
",",O
The,O
first,O
people,O
's,O
"
",O
hospital,O
of,O
Changde,O
city,O
",",O
Hunan,O
"Province,415003,China",O
(,O
C.Z.,O
),O
;,O
and,O
Department,O
of,O
"
",O
Radiology,O
",",O
The,O
second,O
people,O
's,O
hospital,O
of,O
Changde,O
city,O
",",O
Hunan,O
"
",O
"Province,415001,China",O
(,O
F.W.,O
),O
.,O
"

",O
Some,O
patients,O
with,O
positive,O
chest,O
CT,O
findings,O
may,O
present,O
with,O
negative,O
results,O
"
",O
of,O
real,O
time,O
reversetranscriptionpolymerase,O
chain,O
reaction,O
(,O
RTPCR,O
),O
for,O
2019,O
"
",O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
In,O
this,O
report,O
",",O
we,O
present,O
chest,O
CT,O
findings,O
from,O
"
",O
five,O
patients,O
with,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
who,O
had,O
initial,O
negative,O
RTPCR,O
results,O
.,O
"
",O
All,O
five,O
patients,O
had,O
typical,O
imaging,O
findings,O
",",O
including,O
groundglass,O
opacity,O
"
",O
(,O
GGO,O
),O
(,O
5,O
patients,O
),O
and,O
or,O
mixed,O
GGO,O
and,O
mixed,O
consolidation,O
(,O
2,O
patients,O
),O
.,O
After,O
"
",O
isolation,O
for,O
presumed,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
",",O
all,O
patients,O
were,O
eventually,O
"
",O
confirmed,O
with,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
by,O
repeated,O
swab,O
tests,O
.,O
A,O
combination,O
of,O
"
",O
repeated,O
swab,O
tests,O
and,O
CT,O
scanning,O
may,O
be,O
helpful,O
when,O
for,O
individuals,O
with,O
high,O
"
",O
clinical,O
suspicion,O
of,O
nCoV,O
infection,O
but,O
negative,O
RTPCR,O
screening,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200343,O
"
",O
PMID,O
:,O
32049601,O
"


",O
724,O
.,O
Hum,O
Vaccin,O
Immunother,O
.,O
2020,O
Feb,O
0.509027778,O
.,O
doi,O
:,O
10.108,O
21645515.2020.1724000,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Are,O
we,O
ready,O
for,O
the,O
new,O
fatal,O
Coronavirus,O
:,O
scenario,O
of,O
Pakistan,O
?,O
"

",O
Ahmad,O
T(1)(2,O
),O
",",O
Khan,O
M(3,O
),O
",",O
Khan,O
FM(4,O
),O
",",O
Hui,O
J(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Epidemiology,O
and,O
Health,O
Statistics,O
",",O
School,O
of,O
Public,O
Health,O
",",O
"
",O
Southeast,O
University,O
",",O
Nanjing,O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Environmental,O
Medicine,O
Engineering,O
",",O
Ministry,O
of,O
Education,O
",",O
"
",O
School,O
of,O
Public,O
Health,O
",",O
Southeast,O
University,O
",",O
Nanjing,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Genetics,O
",",O
Centre,O
for,O
Human,O
Genetics,O
",",O
Hazara,O
University,O
Mansehra,O
",",O
"
",O
Khyber,O
Pakhtunkhwa,O
",",O
Islamic,O
Republic,O
of,O
Pakistan,O
.,O
"
",O
(4)Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Centre,O
for,O
Emerging,O
"
",O
Infectious,O
Diseases,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
"
",O
Wuhan,O
China,O
.,O
"

",O
DOI,O
:,O
10.108,O
21645515.2020.1724000,O
"
",O
PMID,O
:,O
32048891,O
"


",O
725,O
.,O
Vet,O
Ital,O
.,O
2020,O
Feb,O
12,O
.,O
doi,O
:,O
10.12834,O
VetIt.2173.11599.1,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
SARSCoV2,B-Virus_SARS-CoV-2
),O
epidemic,O
:,O
a,O
veterinary,O
perspective,O
.,O
"

",O
Lorusso,O
A(1,O
),O
",",O
Calistri,O
P(2,O
),O
",",O
Petrini,O
A(3,O
),O
",",O
Savini,O
G(4,O
),O
",",O
Decaro,O
N(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Istituto,O
Zooprofilattico,O
Sperimentale,O
dell'Abruzzo,O
e,O
del,O
Molise,O
',O
G.,O
Caporale,O
',O
",",O
"
",O
Teramo,O
",",O
Italy,O
.,O
a.lorusso@izs.it,O
.,O
"
",O
(2)Istituto,O
Zooprofilattico,O
Sperimentale,O
dell'Abruzzo,O
e,O
del,O
Molise,O
',O
G.,O
Caporale,O
',O
",",O
"
",O
Teramo,O
",",O
Italy,O
.,O
p.calistri@izs.it,O
.,O
"
",O
(3)Istituto,O
Zooprofilattico,O
Sperimentale,O
dell'Abruzzo,O
e,O
del,O
Molise,O
',O
G.,O
Caporale,O
',O
",",O
"
",O
Teramo,O
",",O
Italy,O
.,O
a.petrini@izs.it,O
.,O
"
",O
(4)Istituto,O
Zooprofilattico,O
Sperimentale,O
dell'Abruzzo,O
e,O
del,O
Molise,O
',O
G.,O
Caporale,O
',O
",",O
"
",O
Teramo,O
",",O
Italy,O
.,O
g.savini@izs.it,O
.,O
"
",O
(5)Dipartimento,O
di,O
Medicina,O
Veterinaria,O
",",O
UniversitÃ ,O
degli,O
Studi,O
di,O
Bari,O
",",O
"
",O
Valenzano,O
(,O
BA,O
),O
",",O
Italy,O
.,O
nicola.decaro@uniba.it,O
.,O
"

",O
DOI,O
:,O
10.12834,O
VetIt.2173.11599.1,O
"
",O
PMID,O
:,O
32048818,O
"


",O
726,O
.,O
J,O
Evid,O
Based,O
Med,O
.,O
2020,O
Feb;13(1):37,O
.,O
doi,O
:,O
10.1111,O
jebm.12376,O
.,O
Epub,O
2020,O
Feb,O
12,O
.,O
"

",O
Preliminary,O
prediction,O
of,O
the,O
basic,O
reproduction,O
number,O
of,O
the,O
Wuhan,O
novel,O
"
",O
coronavirus,O
2019nCoV.,O
"

",O
Zhou,O
T(1,O
),O
",",O
Liu,O
Q(2,O
),O
",",O
Yang,O
Z(3,O
),O
",",O
Liao,O
J(4,O
),O
",",O
Yang,O
K(2,O
),O
",",O
Bai,O
W(5,O
),O
",",O
Lu,O
X(6,O
),O
",",O
Zhang,O
"
",O
W(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Big,O
Data,O
Research,O
Center,O
",",O
University,O
of,O
Electronic,O
Science,O
and,O
Technology,O
of,O
"
",O
China,O
",",O
Chengdu,O
",",O
611731,O
",",O
China,O
.,O
"
",O
(2)College,O
of,O
Computer,O
Science,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
",",O
610065,O
",",O
China,O
.,O
"
",O
(3)Beijing,O
AiQiYi,O
Science,O
&,O
Technology,O
Co.,O
Ltd.,O
",",O
Beijing,O
",",O
100080,O
",",O
China,O
.,O
"
",O
(4)Shenzhen,O
International,O
Graduate,O
School,O
",",O
Tsinghua,O
University,O
",",O
Shenzhen,O
",",O
518055,O
",",O
"
",O
China,O
.,O
"
",O
(5)CompleX,O
Lab,O
",",O
University,O
of,O
Electronic,O
Science,O
and,O
Technology,O
of,O
China,O
",",O
"
",O
Chengdu,O
",",O
611731,O
",",O
China,O
.,O
"
",O
(6)College,O
of,O
Systems,O
Engineering,O
",",O
National,O
University,O
of,O
Defense,O
Technology,O
",",O
"
",O
Changsha,O
",",O
410073,O
",",O
China,O
.,O
"
",O
(7)West,O
China,O
Biomedical,O
Big,O
Data,O
Center,O
",",O
West,O
China,O
Hospital,O
",",O
Sichuan,O
"
",O
University,O
",",O
Chengdu,O
",",O
610047,O
",",O
China,O
.,O
"

",O
OBJECTIVES,O
:,O
To,O
estimate,O
the,O
basic,O
reproduction,O
number,O
of,O
the,O
Wuhan,O
novel,O
"
",O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
"
",O
METHODS,O
:,O
Based,O
on,O
the,O
susceptibleexposedinfectedremoved,O
(,O
SEIR,O
),O
compartment,O
"
",O
model,O
and,O
the,O
assumption,O
that,O
the,O
infectious,O
cases,O
with,O
symptoms,O
occurred,O
before,O
"
",O
26,O
January,O
",",O
2020,O
are,O
resulted,O
from,O
free,O
propagation,O
without,O
intervention,O
",",O
we,O
"
",O
estimate,O
the,O
basic,O
reproduction,O
number,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
according,O
to,O
the,O
reported,O
"
",O
confirmed,O
cases,O
and,O
suspected,O
cases,O
",",O
as,O
well,O
as,O
the,O
theoretical,O
estimated,O
number,O
"
",O
of,O
infected,O
cases,O
by,O
other,O
research,O
teams,O
",",O
together,O
with,O
some,O
epidemiological,O
"
",O
determinants,O
learned,O
from,O
the,O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
.,O
"
",O
RESULTS,O
:,O
The,O
basic,O
reproduction,O
number,O
fall,O
between,O
2.8,O
and,O
3.3,O
by,O
using,O
the,O
"
",O
realtime,O
reports,O
on,O
the,O
number,O
of,O
2019nCoVinfected,O
cases,O
from,O
People,O
's,O
Daily,O
"
",O
in,O
China,O
and,O
fall,O
between,O
3.2,O
and,O
3.9,O
on,O
the,O
basis,O
of,O
the,O
predicted,O
number,O
of,O
"
",O
infected,O
cases,O
from,O
international,O
colleagues,O
.,O
"
",O
CONCLUSIONS,O
:,O
The,O
early,O
transmission,O
ability,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
close,O
to,O
or,O
slightly,O
"
",O
higher,O
than,O
SARS,O
.,O
It,O
is,O
a,O
controllable,O
disease,O
with,O
moderate,O
to,O
high,O
"
",O
transmissibility,O
.,O
Timely,O
and,O
effective,O
control,O
measures,O
are,O
needed,O
to,O
prevent,O
the,O
"
",O
further,O
transmissions,O
.,O
"

",O
Â©,O
2020,O
Chinese,O
Cochrane,O
Center,O
",",O
West,O
China,O
Hospital,O
of,O
Sichuan,O
University,O
and,O
"
",O
John,O
Wiley,O
&,O
Sons,O
Australia,O
",",O
Ltd.,O
"

",O
DOI,O
:,O
10.1111,O
jebm.12376,O
"
",O
PMID,O
:,O
32048815,O
"


",O
727,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
12,O
.,O
doi,O
:,O
10.1002,O
jmv.25706,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Economic,O
impacts,O
of,O
Wuhan,O
2019nCoV,B-Virus_SARS-CoV-2
on,O
China,O
and,O
the,O
world,O
.,O
"

",O
Ayittey,O
FK(1,O
),O
",",O
Ayittey,O
MK(2,O
),O
",",O
Chiwero,O
NB(1,O
),O
",",O
Kamasah,O
JS(3,O
),O
",",O
Dzuvor,O
C(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Chemical,O
Engineering,O
",",O
Curtin,O
University,O
Malaysia,O
",",O
Miri,O
",",O
Sarawak,O
",",O
"
",O
Malaysia,O
.,O
"
",O
(2)Agricultural,O
Extension,O
Office,O
",",O
Ministry,O
of,O
Food,O
and,O
Agriculture,O
",",O
Adidome,O
",",O
"
",O
Ghana,O
.,O
"
",O
(3)Medical,O
Research,O
Assistant,O
",",O
Kumasi,O
Centre,O
for,O
Collaborative,O
Research,O
in,O
"
",O
Tropical,O
Medicine,O
",",O
Kumasi,O
",",O
Ghana,O
.,O
"
",O
(4)Department,O
of,O
Chemical,O
Engineering,O
",",O
Monash,O
University,O
",",O
Clayton,O
",",O
Victoria,O
",",O
"
",O
Australia,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25706,O
"
",O
PMID,O
:,O
32048740,O
"


",O
728,O
.,O
Pathog,O
Glob,O
Health,O
.,O
2020,O
Feb,O
0.509722222,O
.,O
doi,O
:,O
10.108,O
20477724.2020.1725339,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
The,O
global,O
spread,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
:,O
a,O
molecular,O
evolutionary,O
analysis,O
.,O
"

",O
Benvenuto,O
D(1,O
),O
",",O
Giovanetti,O
M(2,O
),O
",",O
Salemi,O
M(3)(4,O
),O
",",O
Prosperi,O
M(3)(4,O
),O
",",O
De,O
Flora,O
C(1,O
),O
",",O
"
",O
Junior,O
Alcantara,O
LC(2,O
),O
",",O
Angeletti,O
S(5,O
),O
",",O
Ciccozzi,O
M(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Unit,O
of,O
Medical,O
Statistics,O
and,O
Molecular,O
Epidemiology,O
",",O
University,O
Campus,O
"
",O
BioMedico,O
of,O
Rome,O
",",O
Italy,O
.,O
"
",O
(2)LaboratÃ³rio,O
de,O
FlavivÃ­rus,O
",",O
Instituto,O
Oswaldo,O
Cruz,O
",",O
FundaÃ§Ã£o,O
Oswaldo,O
Cruz,O
",",O
Rio,O
"
",O
de,O
Janeiro,O
",",O
Brazil,O
.,O
"
",O
(3)Department,O
of,O
Epidemiology,O
",",O
University,O
of,O
Florida,O
",",O
Gainesville,O
",",O
FL,O
",",O
USA,O
.,O
"
",O
(4)Emerging,O
Pathogens,O
Institute,O
",",O
University,O
of,O
Florida,O
",",O
Gainesville,O
",",O
FL,O
",",O
USA,O
.,O
"
",O
(5)Unit,O
of,O
Clinical,O
Laboratory,O
Science,O
",",O
University,O
Campus,O
BioMedico,O
of,O
Rome,O
",",O
"
",O
Italy,O
.,O
"

",O
The,O
global,O
spread,O
of,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
continuing,O
and,O
is,O
fast,O
moving,O
",",O
as,O
indicated,O
"
",O
by,O
the,O
WHO,O
raising,O
the,O
risk,O
assessment,O
to,O
high,O
.,O
In,O
this,O
article,O
",",O
we,O
provide,O
a,O
"
",O
preliminary,O
phylodynamic,O
and,O
phylogeographic,O
analysis,O
of,O
this,O
new,O
virus,O
.,O
A,O
"
",O
Maximum,O
Clade,O
Credibility,O
tree,O
has,O
been,O
built,O
using,O
the,O
29,O
available,O
whole,O
genome,O
"
",O
sequences,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
and,O
two,O
whole,O
genome,O
sequences,O
that,O
are,O
highly,O
similar,O
"
",O
sequences,O
from,O
Bat,O
SARSlike,O
Coronavirus,O
available,O
in,O
GeneBank,O
.,O
We,O
are,O
able,O
to,O
"
",O
clarify,O
the,O
mechanism,O
of,O
transmission,O
among,O
the,O
countries,O
which,O
have,O
provided,O
the,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
sequence,O
isolates,O
from,O
their,O
patients,O
.,O
The,O
Bayesian,O
phylogeographic,O
"
",O
reconstruction,O
shows,O
that,O
the,O
20192020,O
nCoV,O
most,O
probably,O
originated,O
from,O
the,O
"
",O
Bat,O
SARSlike,O
Coronavirus,O
circulating,O
in,O
the,O
Rhinolophus,O
bat,O
family,O
.,O
In,O
agreement,O
"
",O
with,O
epidemiological,O
observations,O
",",O
the,O
most,O
likely,O
geographic,O
origin,O
of,O
the,O
new,O
"
",O
outbreak,O
was,O
the,O
city,O
of,O
Wuhan,O
",",O
China,O
",",O
where,O
2019nCoV,B-Virus_SARS-CoV-2
time,O
of,O
the,O
most,O
recent,O
"
",O
common,O
ancestor,O
emerged,O
",",O
according,O
to,O
molecular,O
clock,O
analysis,O
",",O
around,O
November,O
"
",O
25th,O
",",O
2019,O
.,O
These,O
results,O
",",O
together,O
with,O
previously,O
recorded,O
epidemics,O
",",O
suggest,O
a,O
"
",O
recurring,O
pattern,O
of,O
periodical,O
epizootic,O
outbreaks,O
due,O
to,O
Betacoronavirus,O
.,O
"
",O
Moreover,O
",",O
our,O
study,O
describes,O
the,O
same,O
population,O
genetic,O
dynamic,O
underlying,O
the,O
"
",O
SARS,O
2003,O
epidemic,O
",",O
and,O
suggests,O
the,O
urgent,O
need,O
for,O
the,O
development,O
of,O
effective,O
"
",O
molecular,O
surveillance,O
strategies,O
of,O
Betacoronavirus,O
among,O
animals,O
and,O
"
",O
Rhinolophus,O
of,O
the,O
bat,O
family,O
.,O
"

",O
DOI,O
:,O
10.108,O
20477724.2020.1725339,O
"
",O
PMID,O
:,O
32048560,O
"


",O
729,O
.,O
Sci,O
China,O
Life,O
Sci,O
.,O
2020,O
Mar;63(3):364374,O
.,O
doi,O
:,O
10.1007,O
s1142702016438,O
.,O
Epub,O
"
",O
2020,O
Feb,O
9,O
.,O
"

",O
Clinical,O
and,O
biochemical,O
indexes,O
from,O
2019nCoV,B-Virus_SARS-CoV-2
infected,O
patients,O
linked,O
to,O
viral,O
"
",O
loads,O
and,O
lung,O
injury,O
.,O
"

",O
Liu,O
Y(1,O
),O
",",O
Yang,O
Y(2,O
),O
",",O
Zhang,O
C(3)(4,O
),O
",",O
Huang,O
F(4,O
),O
",",O
Wang,O
F(2,O
),O
",",O
Yuan,O
J(2,O
),O
",",O
Wang,O
Z(2,O
),O
",",O
"
",O
Li,O
J(2,O
),O
",",O
Li,O
J(2,O
),O
",",O
Feng,O
C(2,O
),O
",",O
Zhang,O
Z(2,O
),O
",",O
Wang,O
L(2,O
),O
",",O
Peng,O
L(2,O
),O
",",O
Chen,O
L(2,O
),O
",",O
Qin,O
"
",O
Y(4,O
),O
",",O
Zhao,O
D(4,O
),O
",",O
Tan,O
S(5,O
),O
",",O
Yin,O
L(6,O
),O
",",O
Xu,O
J(6,O
),O
",",O
Zhou,O
C(3,O
),O
",",O
Jiang,O
C(7,O
),O
",",O
Liu,O
L(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Shenzhen,O
Key,O
Laboratory,O
of,O
Pathogen,O
and,O
Immunity,O
",",O
National,O
Clinical,O
Research,O
"
",O
Center,O
for,O
Infectious,O
Disease,O
",",O
State,O
Key,O
Discipline,O
of,O
Infectious,O
Disease,O
",",O
"
",O
Shenzhen,O
Third,O
People,O
's,O
Hospital,O
",",O
Second,O
Hospital,O
Affiliated,O
to,O
Southern,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Shenzhen,O
",",O
518112,O
",",O
China,O
.,O
"
",O
yingxialiu@hotmail.com,O
.,O
"
",O
(2)Shenzhen,O
Key,O
Laboratory,O
of,O
Pathogen,O
and,O
Immunity,O
",",O
National,O
Clinical,O
Research,O
"
",O
Center,O
for,O
Infectious,O
Disease,O
",",O
State,O
Key,O
Discipline,O
of,O
Infectious,O
Disease,O
",",O
"
",O
Shenzhen,O
Third,O
People,O
's,O
Hospital,O
",",O
Second,O
Hospital,O
Affiliated,O
to,O
Southern,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Shenzhen,O
",",O
518112,O
",",O
China,O
.,O
"
",O
(3)Hefei,O
National,O
Laboratory,O
for,O
Physical,O
Sciences,O
at,O
the,O
Microscale,O
and,O
School,O
"
",O
of,O
Life,O
Sciences,O
",",O
University,O
of,O
Science,O
and,O
Technology,O
of,O
China,O
",",O
Hefei,O
",",O
230027,O
",",O
"
",O
China,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Medical,O
Molecular,O
Biology,O
",",O
Institute,O
of,O
Basic,O
Medical,O
"
",O
Sciences,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Department,O
of,O
Biochemistry,O
",",O
Peking,O
"
",O
Union,O
Medical,O
College,O
",",O
Beijing,O
",",O
100005,O
",",O
China,O
.,O
"
",O
(5)Institute,O
of,O
Microbiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100101,O
",",O
"
",O
China,O
.,O
"
",O
(6)Emergence,O
Department,O
Peking,O
Union,O
Medical,O
College,O
Hospital,O
",",O
Beijing,O
",",O
100731,O
",",O
"
",O
China,O
.,O
"
",O
(7)State,O
Key,O
Laboratory,O
of,O
Medical,O
Molecular,O
Biology,O
",",O
Institute,O
of,O
Basic,O
Medical,O
"
",O
Sciences,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Department,O
of,O
Biochemistry,O
",",O
Peking,O
"
",O
Union,O
Medical,O
College,O
",",O
Beijing,O
",",O
100005,O
",",O
China,O
.,O
jiang@pumc.edu.cn,O
.,O
"
",O
(8)Shenzhen,O
Key,O
Laboratory,O
of,O
Pathogen,O
and,O
Immunity,O
",",O
National,O
Clinical,O
Research,O
"
",O
Center,O
for,O
Infectious,O
Disease,O
",",O
State,O
Key,O
Discipline,O
of,O
Infectious,O
Disease,O
",",O
"
",O
Shenzhen,O
Third,O
People,O
's,O
Hospital,O
",",O
Second,O
Hospital,O
Affiliated,O
to,O
Southern,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Shenzhen,O
",",O
518112,O
",",O
China,O
.,O
"
",O
liulei3322@aliyun.com,O
.,O
"

",O
The,O
outbreak,O
of,O
the,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
began,O
in,O
December,O
2019,O
in,O
Wuhan,O
",",O
Hubei,O
"
",O
province,O
",",O
and,O
rapidly,O
spread,O
to,O
many,O
provinces,O
in,O
China,O
as,O
well,O
as,O
other,O
"
",O
countries,O
.,O
Here,O
we,O
report,O
the,O
epidemiological,O
",",O
clinical,O
",",O
laboratory,O
",",O
and,O
"
",O
radiological,O
characteristics,O
",",O
as,O
well,O
as,O
potential,O
biomarkers,O
for,O
predicting,O
"
",O
disease,O
severity,O
in,O
2019nCoVinfected,O
patients,O
in,O
Shenzhen,O
",",O
China,O
.,O
All,O
12,O
cases,O
"
",O
of,O
the,O
2019nCoVinfected,O
patients,O
developed,O
pneumonia,O
and,O
half,O
of,O
them,O
developed,O
"
",O
acute,O
respiratory,O
distress,O
syndrome,O
(,O
ARDS,O
),O
.,O
The,O
most,O
common,O
laboratory,O
"
",O
abnormalities,O
were,O
hypoalbuminemia,O
",",O
lymphopenia,O
",",O
decreased,O
percentage,O
of,O
"
",O
lymphocytes,O
(,O
LYM,O
),O
and,O
neutrophils,O
(,O
NEU,O
),O
",",O
elevated,O
Creactive,O
protein,O
(,O
CRP,O
),O
and,O
"
",O
lactate,O
dehydrogenase,O
(,O
LDH,O
),O
",",O
and,O
decreased,O
CD8,O
count,O
.,O
The,O
viral,O
load,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
detected,O
from,O
patient,O
respiratory,O
tracts,O
was,O
positively,O
linked,O
to,O
lung,O
disease,O
"
",O
severity,O
.,O
ALB,O
",",O
LYM,O
",",O
LYM,O
(,O
%,O
),O
",",O
LDH,O
",",O
NEU,O
(,O
%,O
),O
",",O
and,O
CRP,O
were,O
highly,O
correlated,O
to,O
the,O
"
",O
acute,O
lung,O
injury,O
.,O
Age,O
",",O
viral,O
load,O
",",O
lung,O
injury,O
score,O
",",O
and,O
blood,O
biochemistry,O
"
",O
indexes,O
",",O
albumin,O
(,O
ALB,O
),O
",",O
CRP,O
",",O
LDH,O
",",O
LYM,O
(,O
%,O
),O
",",O
LYM,O
",",O
and,O
NEU,O
(,O
%,O
),O
",",O
may,O
be,O
predictors,O
of,O
"
",O
disease,O
severity,O
.,O
Moreover,O
",",O
the,O
Angiotensin,O
II,O
level,O
in,O
the,O
plasma,O
sample,O
from,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
infected,O
patients,O
was,O
markedly,O
elevated,O
and,O
linearly,O
associated,O
to,O
"
",O
viral,O
load,O
and,O
lung,O
injury,O
.,O
Our,O
results,O
suggest,O
a,O
number,O
of,O
potential,O
diagnosis,O
"
",O
biomarkers,O
and,O
angiotensin,O
receptor,O
blocker,O
(,O
ARB,O
),O
drugs,O
for,O
potential,O
repurposing,O
"
",O
treatment,O
of,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"

",O
DOI,O
:,O
10.1007,O
s1142702016438,O
"
",O
PMID,O
:,O
32048163,O
"


",O
730,O
.,O
Clin,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
12,O
.,O
pii,O
:,O
ciaa149,O
.,O
doi,O
:,O
10.1093,O
cid,O
ciaa149,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Consistent,O
detection,O
of,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
in,O
saliva,O
.,O
"

",O
To,O
KK(1)(2)(3,O
),O
",",O
Tsang,O
OT(4,O
),O
",",O
ChikYan,O
Yip,O
C(1)(2,O
),O
",",O
Chan,O
KH(1,O
),O
",",O
Wu,O
TC(5,O
),O
",",O
Chan,O
"
",O
JMC(4,O
),O
",",O
Leung,O
WS(4,O
),O
",",O
Chik,O
TS(4,O
),O
",",O
Choi,O
CY(4,O
),O
",",O
Kandamby,O
DH(6,O
),O
",",O
Lung,O
DC(7,O
),O
",",O
Tam,O
"
",O
AR(8,O
),O
",",O
Poon,O
RW(1)(2,O
),O
",",O
Fung,O
AY(1,O
),O
",",O
Hung,O
IF(8,O
),O
",",O
Cheng,O
VC(1)(2,O
),O
",",O
Chan,O
JF(1)(2)(3,O
),O
",",O
"
",O
Yuen,O
KY(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
for,O
Emerging,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
"
",O
Microbiology,O
",",O
Carol,O
Yu,O
Centre,O
for,O
Infection,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
"
",O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Microbiology,O
",",O
Queen,O
Mary,O
Hospital,O
",",O
Hong,O
Kong,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Clinical,O
Microbiology,O
and,O
Infection,O
Control,O
",",O
The,O
University,O
of,O
"
",O
Hong,O
KongShenzhen,O
Hospital,O
",",O
Shenzhen,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Medicine,O
and,O
Geriatrics,O
",",O
Princess,O
Margaret,O
Hospital,O
",",O
Hong,O
Kong,O
"
",O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Medicine,O
",",O
Queen,O
Elizabeth,O
Hospital,O
",",O
Hong,O
Kong,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(6)Intensive,O
Care,O
Unit,O
",",O
Princess,O
Margaret,O
Hospital,O
",",O
Hong,O
Kong,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Pathology,O
",",O
Queen,O
Elizabeth,O
Hospital,O
",",O
Hong,O
Kong,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(8)Department,O
of,O
Medicine,O
",",O
Queen,O
Mary,O
Hospital,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
"
",O
Region,O
",",O
China,O
.,O
"

",O
The,O
2019novelcoronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
was,O
detected,O
in,O
the,O
selfcollected,O
saliva,O
"
",O
of,O
91.7,O
%,O
(,O
11,O
12,O
),O
of,O
patients,O
.,O
Serial,O
saliva,O
viral,O
load,O
monitoring,O
generally,O
"
",O
showed,O
a,O
declining,O
trend,O
.,O
Live,O
virus,O
was,O
detected,O
in,O
saliva,O
by,O
viral,O
culture,O
.,O
"
",O
Saliva,O
is,O
a,O
promising,O
noninvasive,O
specimen,O
for,O
diagnosis,O
",",O
monitoring,O
",",O
and,O
"
",O
infection,O
control,O
in,O
patients,O
with,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
for,O
the,O
Infectious,O
"
",O
Diseases,O
Society,O
of,O
America,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
permissions,O
",",O
email,O
:,O
"
",O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
cid,O
ciaa149,O
"
",O
PMID,O
:,O
32047895,O
"


",O
731,O
.,O
Cell,O
Mol,O
Immunol,O
.,O
2020,O
Feb,O
11,O
.,O
doi,O
:,O
10.1038,O
s4142302003742,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Fusion,O
mechanism,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
and,O
fusion,O
inhibitors,O
targeting,O
HR1,O
domain,O
in,O
spike,O
"
",O
protein,O
.,O
"

",O
Xia,O
S(1,O
),O
",",O
Zhu,O
Y(2,O
),O
",",O
Liu,O
M(3,O
),O
",",O
Lan,O
Q(1,O
),O
",",O
Xu,O
W(1,O
),O
",",O
Wu,O
Y(1,O
),O
",",O
Ying,O
T(1,O
),O
",",O
Liu,O
S(4,O
),O
",",O
"
",O
Shi,O
Z(3,O
),O
",",O
Jiang,O
S(5)(6,O
),O
",",O
Lu,O
L(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Medical,O
Molecular,O
Virology,O
(,O
MOE,O
NHC,O
CAMS,O
),O
",",O
School,O
of,O
Basic,O
"
",O
Medical,O
Sciences,O
",",O
FudanJinbo,O
Joint,O
Research,O
Center,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
"
",O
China,O
.,O
"
",O
(2)National,O
Laboratory,O
of,O
Biomacromolecules,O
",",O
Institute,O
of,O
Biophysics,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
New,O
Drug,O
Screening,O
",",O
Guangzhou,O
Key,O
"
",O
Laboratory,O
of,O
Drug,O
Research,O
for,O
Emerging,O
Virus,O
Prevention,O
and,O
Treatment,O
",",O
School,O
"
",O
of,O
Pharmaceutical,O
Sciences,O
",",O
Southern,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(5)Key,O
Laboratory,O
of,O
Medical,O
Molecular,O
Virology,O
(,O
MOE,O
NHC,O
CAMS,O
),O
",",O
School,O
of,O
Basic,O
"
",O
Medical,O
Sciences,O
",",O
FudanJinbo,O
Joint,O
Research,O
Center,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
"
",O
China,O
.,O
shibojiang@fudan.edu.cn,O
.,O
"
",O
(6)Lindsley,O
F.,O
Kimball,O
Research,O
Institute,O
",",O
New,O
York,O
Blood,O
Center,O
",",O
New,O
York,O
",",O
NY,O
",",O
"
",O
USA,O
.,O
shibojiang@fudan.edu.cn,O
.,O
"
",O
(7)Key,O
Laboratory,O
of,O
Medical,O
Molecular,O
Virology,O
(,O
MOE,O
NHC,O
CAMS,O
),O
",",O
School,O
of,O
Basic,O
"
",O
Medical,O
Sciences,O
",",O
FudanJinbo,O
Joint,O
Research,O
Center,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
"
",O
China,O
.,O
lul@fudan.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s4142302003742,O
"
",O
PMID,O
:,O
32047258,O
"


",O
732,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Feb;25(5,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.5.2000062,O
.,O
"

",O
Incubation,O
period,O
of,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
infections,O
among,O
"
",O
travellers,O
from,O
Wuhan,O
",",O
China,O
",",O
2028,O
January,O
2020,O
.,O
"

",O
Backer,O
JA(1,O
),O
",",O
Klinkenberg,O
D(1,O
),O
",",O
Wallinga,O
J(2)(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Centre,O
for,O
Infectious,O
Disease,O
Control,O
",",O
National,O
Institute,O
for,O
Public,O
Health,O
"
",O
and,O
the,O
Environment,O
(,O
RIVM,O
),O
",",O
Bilthoven,O
",",O
Netherlands,O
.,O
"
",O
(2)Department,O
of,O
Biomedical,O
Data,O
Sciences,O
",",O
Leiden,O
University,O
Medical,O
Center,O
",",O
"
",O
Leiden,O
",",O
Netherlands,O
.,O
"

",O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
is,O
causing,O
an,O
outbreak,O
of,O
viral,O
pneumonia,O
that,O
"
",O
started,O
in,O
Wuhan,O
",",O
China,O
.,O
Using,O
the,O
travel,O
history,O
and,O
symptom,O
onset,O
of,O
88,O
"
",O
confirmed,O
cases,O
that,O
were,O
detected,O
outside,O
Wuhan,O
in,O
the,O
early,O
outbreak,O
phase,O
",",O
we,O
"
",O
estimate,O
the,O
mean,O
incubation,O
period,O
to,O
be,O
6.4,O
days,O
(,O
95,O
%,O
credible,O
interval,O
:,O
"
",O
5.67.7,O
),O
",",O
ranging,O
from,O
2.1,O
to,O
11.1,O
days,O
(,O
2.5th,O
to,O
97.5th,O
percentile,O
),O
.,O
These,O
"
",O
values,O
should,O
help,O
inform,O
2019nCoV,B-Virus_SARS-CoV-2
case,O
definitions,O
and,O
appropriate,O
quarantine,O
"
",O
durations,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.5.2000062,O
"
",O
PMCID,O
:,O
PMC7014672,O
"
",O
PMID,O
:,O
32046819,O
"


",O
733,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Feb;25(5,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.5.2000080,O
.,O
"

",O
Effectiveness,O
of,O
airport,O
screening,O
at,O
detecting,O
travellers,O
infected,O
with,O
novel,O
"
",O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
"

",O
Quilty,O
BJ(1,O
),O
",",O
Clifford,O
S(1,O
),O
",",O
Flasche,O
S(2)(1,O
),O
",",O
Eggo,O
RM(2)(1,O
),O
;,O
CMMID,O
nCoV,O
working,O
"
",O
group(3,O
),O
.,O
"

",O
Collaborators,O
:,O
Liu,O
Y,O
",",O
Diamond,O
C,O
",",O
Edmunds,O
WJ,O
",",O
Funk,O
S,O
",",O
Gimma,O
A,O
",",O
Munday,O
JD,O
",",O
Gibbs,O
H,O
",",O
"
",O
Bosse,O
NI,O
",",O
Abbott,O
S,O
",",O
Russell,O
TW,O
",",O
Klepac,O
P,O
",",O
Jit,O
M,O
",",O
Hellewell,O
J.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Centre,O
for,O
the,O
Mathematical,O
Modelling,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
"
",O
Infectious,O
Disease,O
Epidemiology,O
",",O
London,O
School,O
of,O
Hygiene,O
and,O
Tropical,O
Medicine,O
",",O
"
",O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
(2)These,O
authors,O
contributed,O
equally,O
to,O
this,O
work,O
.,O
"
",O
(3)The,O
members,O
of,O
the,O
Centre,O
for,O
the,O
Mathematical,O
Modelling,O
of,O
Infectious,O
"
",O
Diseases,O
(,O
CMMID,O
),O
nCoV,O
working,O
group,O
are,O
listed,O
at,O
the,O
end,O
of,O
the,O
article,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
Euro,O
Surveill,O
.,O
2020,O
Feb;25(6,O
),O
:,O
.,O
"

",O
We,O
evaluated,O
effectiveness,O
of,O
thermal,O
passenger,O
screening,O
for,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
"
",O
at,O
airport,O
exit,O
and,O
entry,O
to,O
inform,O
public,O
health,O
decisionmaking,O
.,O
In,O
our,O
"
",O
baseline,O
scenario,O
",",O
we,O
estimated,O
that,O
46,O
%,O
(,O
95,O
%,O
confidence,O
interval,O
:,O
36,O
to,O
58,O
),O
of,O
"
",O
infected,O
travellers,O
would,O
not,O
be,O
detected,O
",",O
depending,O
on,O
incubation,O
period,O
",",O
"
",O
sensitivity,O
of,O
exit,O
and,O
entry,O
screening,O
",",O
and,O
proportion,O
of,O
asymptomatic,O
cases,O
.,O
"
",O
Airport,O
screening,O
is,O
unlikely,O
to,O
detect,O
a,O
sufficient,O
proportion,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
infected,O
travellers,O
to,O
avoid,O
entry,O
of,O
infected,O
travellers,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.5.2000080,O
"
",O
PMCID,O
:,O
PMC7014668,O
"
",O
PMID,O
:,O
32046816,O
"


",O
734,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Feb;25(6,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.6.2000082,O
.,O
Epub,O
"
",O
2020,O
Feb,O
11,O
.,O
"

",O
Laboratory,O
readiness,O
and,O
response,O
for,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
in,O
expert,O
"
",O
laboratories,O
in,O
30,O
EU,O
EEA,O
countries,O
",",O
January,O
2020,O
.,O
"

",O
Reusken,O
CBEM(1)(2,O
),O
",",O
Broberg,O
EK(3,O
),O
",",O
Haagmans,O
B(1,O
),O
",",O
Meijer,O
A(2,O
),O
",",O
Corman,O
VM(4)(5,O
),O
",",O
"
",O
Papa,O
A(6,O
),O
",",O
Charrel,O
R(7,O
),O
",",O
Drosten,O
C(4)(5,O
),O
",",O
Koopmans,O
M(1,O
),O
",",O
Leitmeyer,O
K(3,O
),O
",",O
On,O
"
",O
Behalf,O
Of,O
EvdLabNet,O
And,O
ErliNet(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Viroscience,O
department,O
",",O
Erasmus,O
MC,O
",",O
Rotterdam,O
",",O
the,O
Netherlands,O
.,O
"
",O
(2)Centre,O
for,O
Infectious,O
Disease,O
Control,O
",",O
National,O
Institute,O
for,O
Public,O
Health,O
"
",O
and,O
the,O
Environment,O
",",O
Bilthoven,O
",",O
the,O
Netherlands,O
.,O
"
",O
(3)European,O
Centre,O
for,O
Disease,O
Prevention,O
and,O
Control,O
",",O
Solna,O
",",O
Sweden,O
.,O
"
",O
(4)German,O
Centre,O
for,O
Infection,O
Research,O
(,O
DZIF,O
),O
",",O
Berlin,O
",",O
Germany,O
.,O
"
",O
(5)CharitÃ©,O
 ,O
UniversitÃ¤tsmedizin,O
Berlin,O
Institute,O
of,O
Virology,O
",",O
Berlin,O
",",O
Germany,O
.,O
"
",O
(6)Department,O
of,O
Microbiology,O
",",O
Medical,O
School,O
",",O
Aristotle,O
University,O
of,O
"
",O
Thessaloniki,O
",",O
Thessaloniki,O
",",O
Greece,O
.,O
"
",O
(7)UnitÃ©,O
des,O
Virus,O
Emergents,O
(,O
AixMarseille,O
UnivIRD,O
190Inserm,O
1207IHU,O
"
",O
MÃ©diterranÃ©e,O
Infection,O
),O
",",O
Marseille,O
",",O
France,O
.,O
"
",O
(8)The,O
participating,O
members,O
of,O
EVDLabNet,O
and,O
ERLINet,O
are,O
acknowledged,O
at,O
the,O
"
",O
end,O
of,O
the,O
article,O
.,O
"

",O
Timely,O
detection,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
infection,O
cases,O
is,O
crucial,O
to,O
"
",O
interrupt,O
the,O
spread,O
of,O
this,O
virus,O
.,O
We,O
assessed,O
the,O
required,O
expertise,O
and,O
"
",O
capacity,O
for,O
molecular,O
detection,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
specialised,O
laboratories,O
in,O
30,O
"
",O
European,O
Union,O
European,O
Economic,O
Area,O
(,O
EU,O
EEA,O
),O
countries,O
.,O
Thirtyeight,O
"
",O
laboratories,O
in,O
24,O
EU,O
EEA,O
countries,O
had,O
diagnostic,O
tests,O
available,O
by,O
29,O
January,O
"
",O
2020,O
.,O
A,O
coverage,O
of,O
all,O
EU,O
EEA,O
countries,O
was,O
expected,O
by,O
midFebruary,O
.,O
"
",O
Availability,O
of,O
primers,O
probes,O
",",O
positive,O
controls,O
and,O
personnel,O
were,O
main,O
"
",O
implementation,O
barriers,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.6.2000082,O
"
",O
PMCID,O
:,O
PMC7029448,O
"
",O
PMID,O
:,O
32046815,O
"


",O
735,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Feb;25(6,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.6.2000110,O
.,O
Epub,O
"
",O
2020,O
Feb,O
11,O
.,O
"

",O
Epidemiological,O
research,O
priorities,O
for,O
public,O
health,O
control,O
of,O
the,O
ongoing,O
"
",O
global,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
outbreak,O
.,O
"

",O
Cowling,O
BJ(1,O
),O
",",O
Leung,O
GM(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)WHO,O
Collaborating,O
Centre,O
for,O
Infectious,O
Disease,O
Epidemiology,O
and,O
Control,O
",",O
"
",O
School,O
of,O
Public,O
Health,O
",",O
The,O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
Special,O
"
",O
Administrative,O
Region,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.6.2000110,O
"
",O
PMCID,O
:,O
PMC7029449,O
"
",O
PMID,O
:,O
32046814,O
"


",O
736,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
7;9(2,O
),O
.,O
pii,O
:,O
E462,O
.,O
doi,O
:,O
10.339,O
jcm9020462,O
.,O
"

",O
Estimation,O
of,O
the,O
Transmission,O
Risk,O
of,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
and,O
Its,O
Implication,O
for,O
"
",O
Public,O
Health,O
Interventions,O
.,O
"

",O
Tang,O
B(1)(2,O
),O
",",O
Wang,O
X(3,O
),O
",",O
Li,O
Q(2)(4,O
),O
",",O
Bragazzi,O
NL(2,O
),O
",",O
Tang,O
S(3,O
),O
",",O
Xiao,O
Y(1)(4,O
),O
",",O
Wu,O
"
",O
J(1)(2)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Interdisciplinary,O
Research,O
Center,O
for,O
Mathematics,O
and,O
Life,O
Sciences,O
",",O
Xi'an,O
"
",O
Jiaotong,O
University,O
",",O
Xi'an,O
710049,O
",",O
China,O
.,O
"
",O
(2)Laboratory,O
for,O
Industrial,O
and,O
Applied,O
Mathematics,O
",",O
Department,O
of,O
Mathematics,O
"
",O
and,O
Statistics,O
",",O
York,O
University,O
",",O
Toronto,O
",",O
Ontario,O
M3J,O
1P3,O
",",O
Canada,O
.,O
"
",O
(3)School,O
of,O
Mathematics,O
and,O
Information,O
Science,O
",",O
Shaanxi,O
Normal,O
University,O
",",O
"
",O
Xi'an,O
710119,O
",",O
China,O
.,O
"
",O
(4)School,O
of,O
Mathematics,O
and,O
Statistics,O
",",O
Xi'an,O
Jiaotong,O
University,O
",",O
Xi'an,O
710049,O
",",O
"
",O
China,O
.,O
"
",O
(5)FieldsCQAM,O
Laboratory,O
of,O
Mathematics,O
for,O
Public,O
Health,O
",",O
York,O
University,O
",",O
"
",O
Toronto,O
",",O
Ontario,O
M3J,O
1P3,O
",",O
Canada,O
.,O
"

",O
Since,O
the,O
emergence,O
of,O
the,O
first,O
cases,O
in,O
Wuhan,O
",",O
China,O
",",O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
infection,O
has,O
been,O
quickly,O
spreading,O
out,O
to,O
other,O
provinces,O
and,O
"
",O
neighboring,O
countries,O
.,O
Estimation,O
of,O
the,O
basic,O
reproduction,O
number,O
by,O
means,O
of,O
"
",O
mathematical,O
modeling,O
can,O
be,O
helpful,O
for,O
determining,O
the,O
potential,O
and,O
severity,O
"
",O
of,O
an,O
outbreak,O
and,O
providing,O
critical,O
information,O
for,O
identifying,O
the,O
type,O
of,O
"
",O
disease,O
interventions,O
and,O
intensity,O
.,O
A,O
deterministic,O
compartmental,O
model,O
was,O
"
",O
devised,O
based,O
on,O
the,O
clinical,O
progression,O
of,O
the,O
disease,O
",",O
epidemiological,O
status,O
"
",O
of,O
the,O
individuals,O
",",O
and,O
intervention,O
measures,O
.,O
The,O
estimations,O
based,O
on,O
"
",O
likelihood,O
and,O
model,O
analysis,O
show,O
that,O
the,O
control,O
reproduction,O
number,O
may,O
be,O
as,O
"
",O
high,O
as,O
6.47,O
(,O
95,O
%,O
CI,O
5.717.23,O
),O
.,O
Sensitivity,O
analyses,O
show,O
that,O
interventions,O
",",O
"
",O
such,O
as,O
intensive,O
contact,O
tracing,O
followed,O
by,O
quarantine,O
and,O
isolation,O
",",O
can,O
"
",O
effectively,O
reduce,O
the,O
control,O
reproduction,O
number,O
and,O
transmission,O
risk,O
",",O
with,O
"
",O
the,O
effect,O
of,O
travel,O
restriction,O
adopted,O
by,O
Wuhan,O
on,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
in,O
"
",O
Beijing,O
being,O
almost,O
equivalent,O
to,O
increasing,O
quarantine,O
by,O
a,O
100,O
thousand,O
"
",O
baseline,O
value,O
.,O
It,O
is,O
essential,O
to,O
assess,O
how,O
the,O
expensive,O
",",O
resourceintensive,O
"
",O
measures,O
implemented,O
by,O
the,O
Chinese,O
authorities,O
can,O
contribute,O
to,O
the,O
prevention,O
"
",O
and,O
control,O
of,O
the,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
",",O
and,O
how,O
long,O
they,O
should,O
be,O
maintained,O
.,O
"
",O
Under,O
the,O
most,O
restrictive,O
measures,O
",",O
the,O
outbreak,O
is,O
expected,O
to,O
peak,O
within,O
two,O
"
",O
weeks,O
(,O
since,O
23,O
January,O
2020,O
),O
with,O
a,O
significant,O
low,O
peak,O
value,O
.,O
With,O
travel,O
"
",O
restriction,O
(,O
no,O
imported,O
exposed,O
individuals,O
to,O
Beijing,O
),O
",",O
the,O
number,O
of,O
infected,O
"
",O
individuals,O
in,O
seven,O
days,O
will,O
decrease,O
by,O
91.14,O
%,O
in,O
Beijing,O
",",O
compared,O
with,O
the,O
"
",O
scenario,O
of,O
no,O
travel,O
restriction,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9020462,O
"
",O
PMID,O
:,O
32046137,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
737,O
.,O
Exp,O
Neurol,O
.,O
2020,O
Feb,O
8;327:113240,O
.,O
doi,O
:,O
10.1016,O
j.expneurol.2020.113240,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Upregulation,O
of,O
transcription,O
factor,O
4,O
downregulates,O
NaV1.8,O
expression,O
in,O
DRG,O
"
",O
neurons,O
and,O
prevents,O
the,O
development,O
of,O
rat,O
inflammatory,O
and,O
neuropathic,O
"
",O
hypersensitivity,O
.,O
"

",O
Li,O
N(1,O
),O
",",O
Liu,O
B(2,O
),O
",",O
Wu,O
W(2,O
),O
",",O
Hong,O
Y(2,O
),O
",",O
Zhang,O
J(2,O
),O
",",O
Liu,O
Y(2,O
),O
",",O
Zhang,O
M(2,O
),O
",",O
Zhang,O
"
",O
X(3,O
),O
",",O
Duan,O
G(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Anesthesiology,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
",",O
Chongqing,O
"
",O
Medical,O
University,O
",",O
Chongqing,O
400010,O
",",O
China,O
.,O
;,O
Department,O
of,O
Anesthesiology,O
",",O
"
",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
430030,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Anesthesiology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
430030,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Anesthesiology,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
430030,O
",",O
China,O
..,O
Electronic,O
"
",O
address,O
:,O
ourpain@163.com,O
.,O
"
",O
(4)Department,O
of,O
Anesthesiology,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
",",O
Chongqing,O
"
",O
Medical,O
University,O
",",O
Chongqing,O
400010,O
",",O
China,O
..,O
Electronic,O
address,O
:,O
"
",O
dgy1986anesthesia@126.com,O
.,O
"

",O
The,O
voltage,O
sodium,O
channel,O
1.8,O
(,O
NaV1.8,O
),O
in,O
the,O
dorsal,O
root,O
ganglion,O
(,O
DRG,O
),O
neurons,O
"
",O
contributes,O
to,O
the,O
initiation,O
and,O
development,O
of,O
chronic,O
inflammatory,O
and,O
"
",O
neuropathic,O
pain,O
.,O
However,O
",",O
an,O
effective,O
intervention,O
on,O
NaV1.8,O
remains,O
to,O
be,O
"
",O
studied,O
in,O
preclinical,O
research,O
and,O
clinical,O
trials,O
.,O
In,O
this,O
study,O
",",O
we,O
aimed,O
to,O
"
",O
investigate,O
whether,O
transcription,O
factor,O
4,O
(,O
TCF4,O
),O
overexpression,O
represses,O
NaV1.8,O
"
",O
expression,O
in,O
DRG,O
neurons,O
",",O
thus,O
preventing,O
the,O
development,O
of,O
chronic,O
pain,O
.,O
Using,O
"
",O
chromatin,O
immunoprecipitation,O
(,O
CHIP,O
),O
",",O
we,O
verified,O
the,O
interaction,O
of,O
TCF4,O
and,O
"
",O
sodium,O
voltagegated,O
channel,O
alpha,O
subunit,O
10A,O
(,O
SCN10A,O
),O
enhancer,O
in,O
HEK293,O
cells,O
"
",O
and,O
rat,O
DRG,O
neurons,O
.,O
Using,O
a,O
dual,O
luciferase,O
reporter,O
assay,O
",",O
we,O
confirmed,O
the,O
"
",O
transcriptional,O
inhibition,O
of,O
TCF4,O
on,O
SCN10A,O
promoter,O
in,O
vitro,O
.,O
To,O
investigate,O
"
",O
the,O
regulation,O
of,O
TCF4,O
on,O
Nav1.8,O
",",O
we,O
then,O
upregulated,O
TCF4,O
expression,O
by,O
"
",O
intrathecally,O
delivering,O
an,O
overexpression,O
of,O
recombinant,O
adenoassociated,O
virus,O
"
",O
(,O
rAAV,O
),O
in,O
the,O
Complete,O
Freund,O
's,O
adjuvant,O
(CFA)induced,O
inflammatory,O
pain,O
model,O
"
",O
and,O
spared,O
nerve,O
injury,O
(SNI)induced,O
neuropathic,O
pain,O
model,O
.,O
By,O
using,O
a,O
"
",O
quantitative,O
polymerase,O
chain,O
reaction,O
(,O
qPCR,O
),O
",",O
western,O
blot,O
",",O
and,O
immunostaining,O
",",O
"
",O
we,O
evaluated,O
NaV1.8,O
expression,O
after,O
a,O
noxious,O
stimulation,O
and,O
the,O
application,O
of,O
"
",O
the,O
TCF4,O
overexpression,O
virus,O
.,O
We,O
showed,O
that,O
the,O
intrathecal,O
delivery,O
of,O
TCF4,O
"
",O
overexpression,O
virus,O
significantly,O
repressed,O
the,O
increase,O
of,O
NaV1.8,O
and,O
prevented,O
"
",O
the,O
development,O
of,O
hyperalgesia,O
in,O
rats,O
.,O
Moreover,O
",",O
we,O
confirmed,O
the,O
efficient,O
"
",O
role,O
of,O
an,O
overexpressed,O
TCF4,O
in,O
preventing,O
the,O
CFA,O
and,O
SNIinduced,O
neuronal,O
"
",O
hyperexcitability,O
by,O
calcium,O
imaging,O
.,O
Our,O
results,O
suggest,O
that,O
attenuating,O
the,O
"
",O
dysregulation,O
of,O
NaV1.8,O
by,O
targeting,O
TCF4,O
may,O
be,O
a,O
novel,O
therapeutic,O
strategy,O
for,O
"
",O
chronic,O
inflammatory,O
and,O
neuropathic,O
pain,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
Inc.,O
"

",O
DOI,O
:,O
10.1016,O
j.expneurol.2020.113240,O
"
",O
PMID,O
:,O
32045596,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
738,O
.,O
Chin,O
Med,O
J,O
(,O
Engl,O
),O
.,O
2020,O
Feb,O
7,O
.,O
doi,O
:,O
10.1097,O
CM9.0000000000000744,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Clinical,O
characteristics,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
cases,O
in,O
tertiary,O
hospitals,O
in,O
"
",O
Hubei,O
Province,O
.,O
"

",O
Liu,O
K(1,O
),O
",",O
Fang,O
YY(1,O
),O
",",O
Deng,O
Y(1,O
),O
",",O
Liu,O
W(2,O
),O
",",O
Wang,O
MF(3,O
),O
",",O
Ma,O
JP(4,O
),O
",",O
Xiao,O
W(5,O
),O
",",O
Wang,O
"
",O
YN(6,O
),O
",",O
Zhong,O
MH(7,O
),O
",",O
Li,O
CH(8,O
),O
",",O
Li,O
GC(9,O
),O
",",O
Liu,O
HG(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
"
",O
430030,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Central,O
Hospital,O
of,O
"
",O
Wuhan,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
Hubei,O
430030,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Taihe,O
Hospital,O
",",O
"
",O
Affiliated,O
Hospital,O
of,O
Hubei,O
University,O
of,O
Medicine,O
",",O
Shiyan,O
",",O
Hubei,O
442000,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Jingzhou,O
Central,O
"
",O
Hospital,O
",",O
Jingzhou,O
",",O
Hubei,O
434020,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
First,O
People,O
's,O
"
",O
Hospital,O
of,O
Jingzhou,O
",",O
Jingzhou,O
",",O
Hubei,O
434000,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
People,O
's,O
Hospital,O
of,O
"
",O
China,O
Three,O
Gorges,O
University,O
",",O
The,O
First,O
People,O
's,O
Hospital,O
of,O
Yichang,O
",",O
Yichang,O
",",O
"
",O
Hubei,O
443000,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Xiaogan,O
Hospital,O
"
",O
Affiliated,O
to,O
Wuhan,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
The,O
Central,O
Hospital,O
of,O
"
",O
Xiaogan,O
",",O
Xiaogan,O
",",O
Hubei,O
432100,O
",",O
China,O
.,O
"
",O
(8)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
Sixth,O
Hospital,O
of,O
"
",O
Wuhan,O
",",O
Jianghan,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
430015,O
",",O
China,O
.,O
"
",O
(9)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
Central,O
Hospital,O
of,O
"
",O
Enshi,O
Tujia,O
and,O
Miao,O
Autonmous,O
Prefecture,O
",",O
Enshi,O
Clinical,O
College,O
",",O
Wuhan,O
"
",O
University,O
",",O
Enshi,O
Tujia,O
and,O
Miao,O
Autonomous,O
Prefecture,O
",",O
Hubei,O
445000,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
causing,O
an,O
outbreak,O
of,O
pneumonia,O
in,O
"
",O
Wuhan,O
",",O
Hubei,O
province,O
of,O
China,O
was,O
isolated,O
in,O
January,O
2020,O
.,O
This,O
study,O
aims,O
to,O
"
",O
investigate,O
its,O
epidemiologic,O
history,O
",",O
and,O
analyze,O
the,O
clinical,O
characteristics,O
",",O
"
",O
treatment,O
regimens,O
",",O
and,O
prognosis,O
of,O
patients,O
infected,O
with,O
2019nCoV,B-Virus_SARS-CoV-2
during,O
this,O
"
",O
outbreak,O
.,O
"
",O
METHODS,O
:,O
Clinical,O
data,O
from,O
137,O
2019nCoVinfected,O
patients,O
admitted,O
to,O
the,O
"
",O
respiratory,O
departments,O
of,O
the,O
respiratory,O
departments,O
of,O
nine,O
tertiary,O
hospitals,O
"
",O
in,O
Hubei,O
province,O
from,O
December,O
30,O
",",O
2019,O
to,O
January,O
24,O
",",O
2020,O
were,O
retrospectively,O
"
",O
collected,O
",",O
including,O
general,O
status,O
",",O
clinical,O
manifestations,O
",",O
laboratory,O
test,O
"
",O
results,O
",",O
imaging,O
characteristics,O
",",O
and,O
treatment,O
regimens,O
.,O
"
",O
RESULTS,O
:,O
None,O
of,O
the,O
137,O
patients,O
(,O
61,O
males,O
",",O
76,O
females,O
",",O
aged,O
2083,O
years,O
",",O
median,O
"
",O
age,O
57,O
years,O
),O
had,O
a,O
definite,O
history,O
of,O
exposure,O
to,O
Huanan,O
Seafood,O
Wholesale,O
"
",O
Market,O
.,O
Major,O
initial,O
symptoms,O
included,O
fever,O
(,O
112,O
137,O
",",O
81.8,O
%,O
),O
",",O
coughing,O
(,O
66,O
137,O
",",O
"
",O
48.2,O
%,O
),O
",",O
and,O
muscle,O
pain,O
or,O
fatigue,O
(,O
44,O
137,O
",",O
32.1,O
%,O
),O
",",O
with,O
other,O
",",O
less,O
typical,O
"
",O
initial,O
symptoms,O
observed,O
at,O
low,O
frequency,O
",",O
including,O
heart,O
palpitations,O
",",O
"
",O
diarrhea,O
",",O
and,O
headache,O
.,O
Nearly,O
80,O
%,O
of,O
the,O
patients,O
had,O
normal,O
or,O
decreased,O
white,O
"
",O
blood,O
cell,O
counts,O
",",O
and,O
72.3,O
%,O
(,O
99,O
137,O
),O
had,O
lymphocytopenia,O
.,O
Lung,O
involvement,O
was,O
"
",O
present,O
in,O
all,O
cases,O
",",O
with,O
most,O
chest,O
computed,O
tomography,O
scans,O
showing,O
lesions,O
"
",O
in,O
multiple,O
lung,O
lobes,O
",",O
some,O
of,O
which,O
were,O
dense,O
;,O
groundglass,O
opacity,O
coexisted,O
"
",O
with,O
consolidation,O
shadows,O
or,O
cordlike,O
shadows,O
.,O
Given,O
the,O
lack,O
of,O
effective,O
"
",O
drugs,O
",",O
treatment,O
focused,O
on,O
symptomatic,O
and,O
respiratory,O
support,O
.,O
Immunoglobulin,O
G,O
"
",O
was,O
delivered,O
to,O
some,O
critically,O
ill,O
patients,O
according,O
to,O
their,O
conditions,O
.,O
"
",O
Systemic,O
corticosteroid,O
treatment,O
did,O
not,O
show,O
significant,O
benefits,O
.,O
Notably,O
",",O
"
",O
early,O
respiratory,O
support,O
facilitated,O
disease,O
recovery,O
and,O
improved,O
prognosis,O
.,O
"
",O
The,O
risk,O
of,O
death,O
was,O
primarily,O
associated,O
with,O
age,O
",",O
underlying,O
chronic,O
diseases,O
",",O
"
",O
and,O
median,O
interval,O
from,O
the,O
appearance,O
of,O
initial,O
symptoms,O
to,O
dyspnea,O
.,O
"
",O
CONCLUSIONS,O
:,O
The,O
majority,O
of,O
patients,O
with,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
present,O
with,O
fever,O
"
",O
as,O
the,O
first,O
symptom,O
",",O
and,O
most,O
of,O
them,O
still,O
showed,O
typical,O
manifestations,O
of,O
"
",O
viral,O
pneumonia,O
on,O
chest,O
imaging,O
.,O
Middleaged,O
and,O
elderly,O
patients,O
with,O
"
",O
underlying,O
comorbidities,O
are,O
susceptible,O
to,O
respiratory,O
failure,O
and,O
may,O
have,O
a,O
"
",O
poorer,O
prognosis,O
.,O
"

",O
DOI,O
:,O
10.1097,O
CM9.0000000000000744,O
"
",O
PMID,O
:,O
32044814,O
"


",O
739,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Jan,O
 ,O
Feb;33:101578,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.tmaid.2020.101578,O
.,O
Epub,O
2020,O
Feb,O
8,O
.,O
"

",O
Going,O
global,O
 ,O
Travel,O
and,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
.,O
"

",O
RodrÃ­guezMorales,O
AJ(1,O
),O
",",O
MacGregor,O
K(2,O
),O
",",O
Kanagarajah,O
S(2,O
),O
",",O
Patel,O
D(2,O
),O
",",O
"
",O
Schlagenhauf,O
P(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Public,O
Health,O
and,O
Infection,O
Research,O
Group,O
",",O
Faculty,O
of,O
Health,O
Sciences,O
",",O
"
",O
Universidad,O
TecnolÃ³gica,O
de,O
Pereira,O
",",O
Pereira,O
",",O
Risaralda,O
",",O
Colombia,O
;,O
Grupo,O
de,O
"
",O
InvestigaciÃ³n,O
Biomedicina,O
",",O
Faculty,O
of,O
Medicine,O
",",O
FundaciÃ³n,O
Universitaria,O
AutÃ³noma,O
"
",O
de,O
las,O
AmÃ©ricas,O
",",O
Pereira,O
",",O
Risaralda,O
",",O
660004,O
",",O
Colombia,O
.,O
Electronic,O
address,O
:,O
"
",O
arodriguezm@utp.edu.co,O
.,O
"
",O
(2)National,O
Travel,O
Health,O
Network,O
and,O
Centre,O
(,O
NaTHNaC,O
),O
",",O
UCLH,O
NHS,O
Foundation,O
"
",O
Trust,O
",",O
London,O
",",O
NW1,O
2PG,O
",",O
United,O
Kingdom,O
.,O
"
",O
(3)University,O
of,O
ZÃ¼rich,O
Centre,O
for,O
Travel,O
Medicine,O
",",O
WHO,O
Collaborating,O
Centre,O
for,O
"
",O
Travellers,O
',O
Health,O
",",O
Institute,O
for,O
Epidemiology,O
",",O
Biostatistics,O
and,O
Prevention,O
",",O
"
",O
Hirschengraben,O
84,O
",",O
8001,O
",",O
ZÃ¼rich,O
",",O
Switzerland,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101578,O
"
",O
PMID,O
:,O
32044389,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
None,O
.,O
"


",O
740,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
7:101577,O
.,O
doi,O
:,O
10.1016,O
j.tmaid.2020.101577,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Coronavirus,O
2019nCoV,B-Virus_SARS-CoV-2
:,O
Is,O
the,O
genie,O
already,O
out,O
of,O
the,O
bottle,O
?,O
"

",O
Hanscheid,O
T(1,O
),O
",",O
Valadas,O
E(2,O
),O
",",O
Grobusch,O
MP(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Instituto,O
de,O
Microbiologia,O
",",O
Faculdade,O
de,O
Medicina,O
",",O
Universidade,O
de,O
Lisboa,O
",",O
"
",O
Lisboa,O
",",O
Portugal,O
.,O
Electronic,O
address,O
:,O
t.hanscheid@medicina.ulisboa.pt,O
.,O
"
",O
(2)ClÃ­nica,O
DoenÃ§as,O
Infecciosas,O
e,O
ParasitÃ¡rias,O
",",O
Faculdade,O
de,O
Medicina,O
",",O
"
",O
Universidade,O
de,O
Lisboa,O
",",O
Lisboa,O
",",O
Portugal,O
.,O
"
",O
(3)Center,O
of,O
Tropical,O
Medicine,O
and,O
Travel,O
Medicine,O
",",O
Department,O
of,O
Infectious,O
"
",O
Diseases,O
",",O
Division,O
of,O
Internal,O
Medicine,O
",",O
Amsterdam,O
University,O
Medical,O
Centers,O
",",O
"
",O
University,O
of,O
Amsterdam,O
",",O
Amsterdam,O
",",O
the,O
Netherlands,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101577,O
"
",O
PMID,O
:,O
32044388,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
None,O
of,O
the,O
"
",O
authors,O
has,O
any,O
conflict,O
of,O
interest,O
to,O
declare,O
.,O
"


",O
741,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Jan,O
 ,O
Feb;33:101574,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.tmaid.2020.101574,O
.,O
Epub,O
2020,O
Feb,O
7,O
.,O
"

",O
Maps,O
",",O
masks,O
and,O
media,O
 ,O
Traveller,O
and,O
practitioner,O
resources,O
for,O
2019,O
novel,O
"
",O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
acute,O
respiratory,O
virus,O
.,O
"

",O
Chiodini,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Amersham,O
Vale,O
Practice,O
",",O
London,O
",",O
UK,O
.,O
Electronic,O
address,O
:,O
jane.chiodini@nhs.net,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101574,O
"
",O
PMID,O
:,O
32044387,O
"


",O
742,O
.,O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):473475,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303172,O
.,O
Epub,O
"
",O
2020,O
Feb,O
7,O
.,O
"

",O
Clinical,O
evidence,O
does,O
not,O
support,O
corticosteroid,O
treatment,O
for,O
2019nCoV,B-Virus_SARS-CoV-2
lung,O
"
",O
injury,O
.,O
"

",O
Russell,O
CD(1,O
),O
",",O
Millar,O
JE(2,O
),O
",",O
Baillie,O
JK(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)University,O
of,O
Edinburgh,O
Centre,O
for,O
Inflammation,O
Research,O
",",O
The,O
Queen,O
's,O
Medical,O
"
",O
Research,O
Institute,O
Edinburgh,O
",",O
Edinburgh,O
",",O
UK,O
.,O
"
",O
(2)Genetics,O
and,O
Genomics,O
",",O
Roslin,O
Institute,O
",",O
University,O
of,O
Edinburgh,O
",",O
Edinburgh,O
"
",O
EH25,O
9RG,O
",",O
UK,O
.,O
"
",O
(3)Genetics,O
and,O
Genomics,O
",",O
Roslin,O
Institute,O
",",O
University,O
of,O
Edinburgh,O
",",O
Edinburgh,O
"
",O
EH25,O
9RG,O
",",O
UK,O
.,O
Electronic,O
address,O
:,O
j.k.baillie@ed.ac.uk,O
.,O
"

",O
Comment,O
in,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
29;395(10225):683684,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303172,O
"
",O
PMID,O
:,O
32043983,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
743,O
.,O
Lancet,O
.,O
2020,O
Feb,O
22;395(10224):e37e38,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303093,O
.,O
Epub,O
"
",O
2020,O
Feb,O
7,O
.,O
"

",O
2019nCoV,B-Virus_SARS-CoV-2
epidemic,O
:,O
address,O
mental,O
health,O
care,O
to,O
empower,O
society,O
.,O
"

",O
Bao,O
Y(1,O
),O
",",O
Sun,O
Y(2,O
),O
",",O
Meng,O
S(1,O
),O
",",O
Shi,O
J(1,O
),O
",",O
Lu,O
L(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Peking,O
University,O
Health,O
Science,O
Center,O
",",O
Peking,O
University,O
",",O
Beijing,O
100191,O
",",O
"
",O
China,O
;,O
National,O
Institute,O
on,O
Drug,O
Dependence,O
",",O
Peking,O
University,O
",",O
Beijing,O
100191,O
",",O
"
",O
China,O
.,O
"
",O
(2)Institute,O
of,O
Mental,O
Health,O
",",O
Peking,O
University,O
",",O
Beijing,O
100191,O
",",O
China,O
;,O
National,O
"
",O
Clinical,O
Research,O
Center,O
for,O
Mental,O
Disorders,O
",",O
Peking,O
University,O
",",O
Beijing,O
100191,O
",",O
"
",O
China,O
;,O
Peking,O
University,O
Sixth,O
Hospital,O
",",O
Peking,O
University,O
",",O
Beijing,O
100191,O
",",O
"
",O
China,O
.,O
"
",O
(3)Peking,O
University,O
Health,O
Science,O
Center,O
",",O
Peking,O
University,O
",",O
Beijing,O
100191,O
",",O
"
",O
China,O
;,O
National,O
Institute,O
on,O
Drug,O
Dependence,O
",",O
Peking,O
University,O
",",O
Beijing,O
100191,O
",",O
"
",O
China,O
;,O
Institute,O
of,O
Mental,O
Health,O
",",O
Peking,O
University,O
",",O
Beijing,O
100191,O
",",O
China,O
;,O
"
",O
National,O
Clinical,O
Research,O
Center,O
for,O
Mental,O
Disorders,O
",",O
Peking,O
University,O
",",O
"
",O
Beijing,O
100191,O
",",O
China,O
;,O
Peking,O
University,O
Sixth,O
Hospital,O
",",O
Peking,O
University,O
",",O
"
",O
Beijing,O
100191,O
",",O
China,O
;,O
PekingTsinghua,O
Center,O
for,O
Life,O
Sciences,O
",",O
Peking,O
"
",O
University,O
",",O
Beijing,O
100191,O
",",O
China,O
;,O
PKUIDG,O
McGovern,O
Institute,O
for,O
Brain,O
Research,O
",",O
"
",O
Peking,O
University,O
",",O
Beijing,O
100191,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
linlu@bjmu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303093,O
"
",O
PMID,O
:,O
32043982,O
"


",O
744,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,O
Mar;20(3):280,O
.,O
doi,O
:,O
10.1016,O
S14733099(20)300682,O
.,O
Epub,O
"
",O
2020,O
Feb,O
7,O
.,O
"

",O
Pandemic,O
potential,O
of,O
2019nCoV.,O
"

",O
Thompson,O
R(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Christ,O
Church,O
",",O
University,O
of,O
Oxford,O
",",O
Oxford,O
OX1,O
1DP,O
",",O
UK,O
.,O
Electronic,O
address,O
:,O
"
",O
robin.thompson@chch.ox.ac.uk,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S14733099(20)300682,O
"
",O
PMID,O
:,O
32043978,O
"


",O
745,O
.,O
Intensive,O
Care,O
Med,O
.,O
2020,O
Feb;46(2):315328,O
.,O
doi,O
:,O
10.1007,O
s00134020059435,O
.,O
Epub,O
"
",O
2020,O
Feb,O
10,O
.,O
"

",O
Critical,O
care,O
management,O
of,O
adults,O
with,O
communityacquired,O
severe,O
respiratory,O
"
",O
viral,O
infection,O
.,O
"

",O
Arabi,O
YM(1)(2)(3,O
),O
",",O
Fowler,O
R(4)(5)(6,O
),O
",",O
Hayden,O
FG(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)College,O
of,O
Medicine,O
",",O
King,O
Saud,O
Bin,O
Abdulaziz,O
University,O
for,O
Health,O
Sciences,O
",",O
"
",O
Riyadh,O
",",O
Saudi,O
Arabia,O
.,O
Arabi@ngha.med.sa,O
.,O
"
",O
(2)King,O
Abdullah,O
International,O
Medical,O
Research,O
Center,O
",",O
Riyadh,O
",",O
Saudi,O
Arabia,O
.,O
"
",O
Arabi@ngha.med.sa,O
.,O
"
",O
(3)Intensive,O
Care,O
Department,O
",",O
King,O
Abdulaziz,O
Medical,O
City,O
",",O
P.O.,O
Box,O
22490,O
",",O
"
",O
Riyadh,O
",",O
11426,O
",",O
Saudi,O
Arabia,O
.,O
Arabi@ngha.med.sa,O
.,O
"
",O
(4)Institute,O
of,O
Health,O
Policy,O
Management,O
and,O
Evaluation,O
",",O
University,O
of,O
Toronto,O
",",O
"
",O
Toronto,O
",",O
Canada,O
.,O
"
",O
(5)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Sunnybrook,O
Hospital,O
",",O
Toronto,O
",",O
Canada,O
.,O
"
",O
(6)Department,O
of,O
Medicine,O
",",O
Sunnybrook,O
Hospital,O
",",O
Toronto,O
",",O
Canada,O
.,O
"
",O
(7)Department,O
of,O
Medicine,O
",",O
Division,O
of,O
Infectious,O
Diseases,O
and,O
International,O
"
",O
Health,O
",",O
University,O
of,O
Virginia,O
School,O
of,O
Medicine,O
",",O
Charlottesville,O
",",O
VA,O
",",O
USA,O
.,O
"

",O
With,O
the,O
expanding,O
use,O
of,O
molecular,O
assays,O
",",O
viral,O
pathogens,O
are,O
increasingly,O
"
",O
recognized,O
among,O
critically,O
ill,O
adult,O
patients,O
with,O
communityacquired,O
severe,O
"
",O
respiratory,O
illness,O
;,O
studies,O
have,O
detected,O
respiratory,O
viral,O
infections,O
(,O
RVIs,O
),O
in,O
"
",O
1753,O
%,O
of,O
such,O
patients,O
.,O
In,O
addition,O
",",O
novel,O
pathogens,O
including,O
zoonotic,O
"
",O
coronaviruses,O
like,O
the,O
agents,O
causing,O
Severe,O
Acute,O
Respiratory,O
Syndrome,O
(,O
SARS,O
),O
",",O
"
",O
Middle,O
East,O
Respiratory,O
Syndrome,O
(,O
MERS,O
),O
and,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019,O
"
",O
nCoV,O
),O
are,O
still,O
being,O
identified,O
.,O
Patients,O
with,O
severe,O
RVIs,O
requiring,O
ICU,O
care,O
"
",O
present,O
typically,O
with,O
hypoxemic,O
respiratory,O
failure,O
.,O
Oseltamivir,O
is,O
the,O
most,O
"
",O
widely,O
used,O
neuraminidase,O
inhibitor,O
for,O
treatment,O
of,O
influenza,O
;,O
data,O
suggest,O
that,O
"
",O
early,O
use,O
is,O
associated,O
with,O
reduced,O
mortality,O
in,O
critically,O
ill,O
patients,O
with,O
"
",O
influenza,O
.,O
At,O
present,O
",",O
there,O
are,O
no,O
antiviral,O
therapies,O
of,O
proven,O
efficacy,O
for,O
"
",O
other,O
severe,O
RVIs,O
.,O
Several,O
adjunctive,O
pharmacologic,O
interventions,O
have,O
been,O
"
",O
studied,O
for,O
their,O
immunomodulatory,O
effects,O
",",O
including,O
macrolides,O
",",O
"
",O
corticosteroids,O
",",O
cyclooxygenase2,O
inhibitors,O
",",O
sirolimus,O
",",O
statins,O
",",O
antiinfluenza,O
"
",O
immune,O
plasma,O
",",O
and,O
vitamin,O
C,O
",",O
but,O
none,O
is,O
recommended,O
at,O
present,O
in,O
severe,O
RVIs,O
.,O
"
",O
Evidencebased,O
supportive,O
care,O
is,O
the,O
mainstay,O
for,O
management,O
of,O
severe,O
"
",O
respiratory,O
viral,O
infection,O
.,O
Noninvasive,O
ventilation,O
in,O
patients,O
with,O
severe,O
RVI,O
"
",O
causing,O
acute,O
hypoxemic,O
respiratory,O
failure,O
and,O
pneumonia,O
is,O
associated,O
with,O
a,O
"
",O
high,O
likelihood,O
of,O
transition,O
to,O
invasive,O
ventilation,O
.,O
Limited,O
existing,O
knowledge,O
"
",O
highlights,O
the,O
need,O
for,O
data,O
regarding,O
supportive,O
care,O
and,O
adjunctive,O
"
",O
pharmacologic,O
therapy,O
that,O
is,O
specific,O
for,O
critically,O
ill,O
patients,O
with,O
severe,O
"
",O
RVI,O
.,O
There,O
is,O
a,O
need,O
for,O
more,O
pragmatic,O
and,O
efficient,O
designs,O
to,O
test,O
different,O
"
",O
therapeutics,O
both,O
individually,O
and,O
in,O
combination,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00134020059435,O
"
",O
PMID,O
:,O
32040667,O
"


",O
746,O
.,O
Int,O
Health,O
.,O
2020,O
Feb,O
12;12(2):7785,O
.,O
doi,O
:,O
10.1093,O
inthealth,O
ihaa001,O
.,O
"

",O
A,O
qualitative,O
study,O
of,O
zoonotic,O
risk,O
factors,O
among,O
rural,O
communities,O
in,O
southern,O
"
",O
China,O
.,O
"

",O
Li,O
HY(1,O
),O
",",O
Zhu,O
GJ(1,O
),O
",",O
Zhang,O
YZ(2,O
),O
",",O
Zhang,O
LB(3,O
),O
",",O
Hagan,O
EA(1,O
),O
",",O
Martinez,O
S(1,O
),O
",",O
Chmura,O
"
",O
AA(1,O
),O
",",O
Francisco,O
L(4,O
),O
",",O
Tai,O
H(5,O
),O
",",O
Miller,O
M(6,O
),O
",",O
Daszak,O
P(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)EcoHealth,O
Alliance,O
",",O
460,O
West,O
34th,O
Street,O
",",O
New,O
York,O
",",O
NY,O
10001,O
",",O
USA,O
.,O
"
",O
(2)Institute,O
of,O
Preventive,O
Medicine,O
",",O
Dali,O
University,O
",",O
Dali,O
",",O
671000,O
",",O
China,O
.,O
"
",O
(3)Guangdong,O
Institute,O
of,O
Applied,O
Biological,O
Resources,O
",",O
Guangdong,O
Academy,O
of,O
"
",O
Sciences,O
",",O
#,O
105,O
Xingang,O
Road,O
West,O
",",O
Guangzhou,O
",",O
510260,O
",",O
China,O
.,O
"
",O
(4)Henry,O
M,O
Jackson,O
Foundation,O
for,O
the,O
Advancement,O
of,O
Military,O
Medicine,O
",",O
Bethesda,O
",",O
"
",O
MD,O
20817,O
",",O
USA,O
.,O
"
",O
(5)School,O
of,O
Medicine,O
",",O
St.,O
George,O
's,O
University,O
",",O
Great,O
River,O
",",O
NY,O
11739,O
",",O
USA,O
.,O
"
",O
(6)Mailman,O
School,O
of,O
Public,O
Health,O
",",O
Columbia,O
University,O
",",O
New,O
York,O
",",O
NY,O
10032,O
",",O
USA,O
.,O
"

",O
BACKGROUND,O
:,O
Strategies,O
are,O
urgently,O
needed,O
to,O
mitigate,O
the,O
risk,O
of,O
zoonotic,O
"
",O
disease,O
emergence,O
in,O
southern,O
China,O
",",O
where,O
pathogens,O
with,O
zoonotic,O
potential,O
are,O
"
",O
known,O
to,O
circulate,O
in,O
wild,O
animal,O
populations,O
.,O
However,O
",",O
the,O
risk,O
factors,O
leading,O
"
",O
to,O
emergence,O
are,O
poorly,O
understood,O
",",O
which,O
presents,O
a,O
challenge,O
in,O
developing,O
"
",O
appropriate,O
mitigation,O
strategies,O
for,O
local,O
communities,O
.,O
"
",O
METHODS,O
:,O
Residents,O
in,O
rural,O
communities,O
of,O
Yunnan,O
",",O
Guangxi,O
and,O
Guangdong,O
"
",O
provinces,O
were,O
recruited,O
and,O
enrolled,O
in,O
this,O
study,O
.,O
Data,O
were,O
collected,O
through,O
"
",O
ethnographic,O
interviews,O
and,O
field,O
observations,O
",",O
and,O
thematically,O
coded,O
and,O
"
",O
analysed,O
to,O
identify,O
both,O
risk,O
and,O
protective,O
factors,O
for,O
zoonotic,O
disease,O
"
",O
emergence,O
at,O
the,O
individual,O
",",O
community,O
and,O
policy,O
levels,O
.,O
"
",O
RESULTS,O
:,O
Eightyeight,O
ethnographic,O
interviews,O
and,O
55,O
field,O
observations,O
were,O
"
",O
conducted,O
at,O
nine,O
selected,O
sites,O
.,O
Frequent,O
humananimal,O
interactions,O
and,O
low,O
"
",O
levels,O
of,O
environmental,O
biosecurity,O
in,O
local,O
communities,O
were,O
identified,O
as,O
risks,O
"
",O
for,O
zoonotic,O
disease,O
emergence,O
.,O
Policies,O
and,O
programmes,O
existing,O
in,O
the,O
"
",O
communities,O
provide,O
opportunities,O
for,O
zoonotic,O
risk,O
mitigation,O
.,O
"
",O
CONCLUSIONS,O
:,O
This,O
study,O
explored,O
the,O
relationship,O
among,O
zoonotic,O
risk,O
and,O
human,O
"
",O
behaviour,O
",",O
environment,O
and,O
policies,O
in,O
rural,O
communities,O
in,O
southern,O
China,O
.,O
It,O
"
",O
identifies,O
key,O
behavioural,O
risk,O
factors,O
that,O
can,O
be,O
targeted,O
for,O
development,O
of,O
"
",O
tailored,O
riskmitigation,O
strategies,O
to,O
reduce,O
the,O
threat,O
of,O
novel,O
zoonoses,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
.,O
"

",O
DOI,O
:,O
10.1093,O
inthealth,O
ihaa001,O
"
",O
PMCID,O
:,O
PMC7017878,O
"
",O
PMID,O
:,O
32040190,O
"


",O
747,O
.,O
Biosci,O
Rep.,O
2020,O
Feb,O
10,O
.,O
pii,O
:,O
BSR20192424,O
.,O
doi,O
:,O
10.1042,O
BSR20192424,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Comparison,O
of,O
diagnostic,O
accuracy,O
of,O
Midkine,O
and,O
AFP,O
for,O
detecting,O
hepatocellular,O
"
",O
carcinoma,O
:,O
a,O
systematic,O
review,O
and,O
metaanalysis,O
.,O
"

",O
Lu,O
Q(1,O
),O
",",O
Li,O
J(1,O
),O
",",O
Cao,O
H(1,O
),O
",",O
Lv,O
C(1,O
),O
",",O
Wang,O
X(1,O
),O
",",O
Cao,O
S(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Gastroenterology,O
",",O
Liyuan,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
OBJECTIVE,O
:,O
Midkine,O
(,O
MDK,O
),O
has,O
been,O
proposed,O
as,O
one,O
of,O
the,O
most,O
promising,O
markers,O
"
",O
for,O
hepatocellular,O
carcinoma,O
(,O
HCC,O
),O
.,O
This,O
metaanalysis,O
was,O
conducted,O
to,O
compare,O
"
",O
the,O
diagnostic,O
accuracy,O
of,O
Midkine,O
and,O
AFP,O
for,O
HCC,O
.,O
"
",O
METHODS,O
:,O
We,O
systematically,O
searched,O
PubMed,O
MEDLINE,O
",",O
Ovid,O
EMBASE,O
",",O
and,O
the,O
Cochrane,O
"
",O
Library,O
for,O
all,O
relevant,O
studies,O
up,O
to,O
May,O
18,O
",",O
2019,O
.,O
The,O
Revised,O
Quality,O
"
",O
Assessment,O
for,O
Studies,O
of,O
Diagnostic,O
Accuracy,O
tool,O
(,O
QUADAS2,O
),O
was,O
used,O
to,O
assess,O
"
",O
the,O
methodological,O
quality,O
of,O
the,O
included,O
studies,O
.,O
The,O
sensitivity,O
",",O
specificity,O
",",O
"
",O
and,O
the,O
area,O
under,O
the,O
curve,O
(,O
AUC,O
),O
of,O
MDK,O
and,O
AFP,O
for,O
detecting,O
HCC,O
were,O
pooled,O
"
",O
using,O
random,O
effects,O
model,O
.,O
"
",O
RESULTS,O
:,O
17,O
studies,O
from,O
5,O
articles,O
with,O
a,O
total,O
of,O
1122,O
HCC,O
patients,O
and,O
2483,O
"
",O
controls,O
were,O
included,O
.,O
The,O
summary,O
estimates,O
using,O
MDK,O
and,O
AFP,O
for,O
detecting,O
HCC,O
"
",O
as,O
follows,O
:,O
sensitivity,O
",",O
85,O
%,O
vs,O
52,O
%,O
",",O
specificity,O
",",O
82,O
%,O
vs,O
94,O
%,O
",",O
and,O
AUC,O
",",O
0.9,O
vs,O
"
",O
0.83,O
.,O
The,O
summary,O
estimates,O
using,O
MDK,O
and,O
AFP,O
for,O
detecting,O
hepatitis,O
"
",O
virusrelated,O
HCC,O
as,O
follows,O
:,O
sensitivity,O
",",O
93,O
%,O
vs,O
74,O
%,O
",",O
specificity,O
",",O
85,O
%,O
vs,O
97,O
%,O
",",O
"
",O
and,O
AUC,O
",",O
0.95,O
vs,O
0.97,O
.,O
The,O
summary,O
estimates,O
using,O
MDK,O
and,O
AFP,O
for,O
detecting,O
"
",O
earlystage,O
HCC,O
as,O
follows,O
:,O
sensitivity,O
",",O
83.5,O
%,O
vs,O
44.4,O
%,O
",",O
specificity,O
",",O
81.7,O
%,O
vs,O
"
",O
84.8,O
%,O
",",O
and,O
AUC,O
",",O
0.87,O
vs,O
0.52,O
.,O
The,O
summary,O
estimates,O
using,O
MDK,O
for,O
detecting,O
"
",O
AFPnegative,O
HCC,O
as,O
follows,O
:,O
sensitivity,O
",",O
88.5,O
%,O
",",O
specificity,O
",",O
83.9,O
%,O
",",O
and,O
AUC,O
",",O
"
",O
0.91,O
.,O
"
",O
CONCLUSION,O
:,O
MDK,O
is,O
more,O
accurate,O
than,O
AFP,O
in,O
diagnosing,O
HCC,O
",",O
especially,O
for,O
"
",O
earlystage,O
HCC,O
and,O
AFPnegative,O
HCC,O
.,O
Both,O
of,O
MDK,O
and,O
AFP,O
had,O
excellent,O
"
",O
diagnostic,O
performance,O
for,O
hepatitis,O
virusrelated,O
HCC,O
.,O
"

",O
Copyright,O
2020,O
The,O
Author(s,O
),O
.,O
"

",O
DOI,O
:,O
10.1042,O
BSR20192424,O
"
",O
PMID,O
:,O
32039435,O
"


",O
748,O
.,O
Front,O
Vet,O
Sci,O
.,O
2020,O
Jan,O
21;6:511,O
.,O
doi,O
:,O
10.3389,O
fvets.2019.00511,O
.,O
eCollection,O
"
",O
2019,O
.,O
"

",O
Retrospect,O
and,O
Risk,O
Analysis,O
of,O
FootandMouth,O
Disease,O
in,O
China,O
Based,O
on,O
"
",O
Integrated,O
Surveillance,O
and,O
Spatial,O
Analysis,O
Tools,O
.,O
"

",O
Chen,O
J(1,O
),O
",",O
Wang,O
J(1,O
),O
",",O
Wang,O
M(1,O
),O
",",O
Liang,O
R(1,O
),O
",",O
Lu,O
Y(1,O
),O
",",O
Zhang,O
Q(2,O
),O
",",O
Chen,O
Q(1,O
),O
",",O
Niu,O
"
",O
B(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Shanghai,O
Key,O
Laboratory,O
of,O
BioEnergy,O
Crops,O
",",O
School,O
of,O
Life,O
Sciences,O
",",O
Shanghai,O
"
",O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Tech,O
Ctr,O
Anim,O
Plant,O
&,O
Food,O
Inspect,O
&,O
Quarantine,O
",",O
Shanghai,O
Customs,O
",",O
Shanghai,O
",",O
"
",O
China,O
.,O
"

",O
Footandmouth,O
disease,O
(,O
FMD,O
),O
is,O
a,O
highly,O
contagious,O
disease,O
of,O
livestock,O
and,O
"
",O
seriously,O
affects,O
the,O
development,O
of,O
animal,O
husbandry,O
.,O
It,O
is,O
necessary,O
to,O
defend,O
"
",O
the,O
spread,O
of,O
FMD,O
.,O
To,O
explore,O
the,O
distribution,O
characteristics,O
and,O
transmission,O
"
",O
of,O
FMD,O
between,O
2010,O
and,O
2017,O
in,O
China,O
",",O
Global,O
Moran,O
's,O
I,O
test,O
and,O
GetisOrd,O
Gi,O
"
",O
index,O
were,O
used,O
to,O
analyze,O
the,O
spatial,O
cluster,O
.,O
A,O
spacetime,O
permutation,O
scan,O
"
",O
statistic,O
was,O
applied,O
to,O
analyze,O
the,O
spatiotemporal,O
pattern,O
.,O
GISbased,O
method,O
"
",O
was,O
employed,O
to,O
create,O
a,O
map,O
representing,O
the,O
distribution,O
pattern,O
",",O
directional,O
"
",O
trend,O
",",O
and,O
hotspots,O
for,O
each,O
outbreak,O
.,O
The,O
number,O
of,O
cases,O
was,O
defined,O
as,O
the,O
"
",O
number,O
of,O
animals,O
with,O
FMD,O
for,O
the,O
above,O
analysis,O
.,O
We,O
also,O
constructed,O
a,O
"
",O
phylogenetic,O
tree,O
to,O
compare,O
the,O
homology,O
and,O
variation,O
of,O
FMD,O
virus,O
(,O
FMDV,O
),O
to,O
"
",O
provide,O
a,O
clue,O
for,O
the,O
potential,O
development,O
of,O
an,O
effective,O
vaccine,O
.,O
The,O
results,O
"
",O
indicated,O
that,O
the,O
FMD,O
outbreaks,O
in,O
China,O
had,O
obvious,O
time,O
patterns,O
and,O
clusters,O
"
",O
in,O
space,O
and,O
spacetime,O
",",O
with,O
the,O
outbreaks,O
concentrated,O
in,O
the,O
first,O
half,O
of,O
"
",O
each,O
year,O
.,O
The,O
outbreaks,O
of,O
FMD,O
decreased,O
each,O
year,O
from,O
2010,O
with,O
an,O
obvious,O
"
",O
downward,O
trend,O
of,O
hotspots,O
.,O
Spatial,O
analysis,O
revealed,O
that,O
the,O
distribution,O
of,O
"
",O
FMD,O
outbreaks,O
in,O
2010,O
",",O
2015,O
",",O
and,O
2017,O
exhibited,O
a,O
clustered,O
pattern,O
.,O
Spacetime,O
"
",O
scanning,O
revealed,O
that,O
the,O
spatiotemporal,O
clusters,O
were,O
centered,O
in,O
Guangdong,O
",",O
"
",O
Tibet,O
and,O
the,O
junction,O
of,O
Wuhan,O
",",O
Jiangxi,O
",",O
Anhui,O
.,O
Comparison,O
of,O
the,O
spatial,O
"
",O
analysis,O
and,O
spacetime,O
analysis,O
of,O
FMD,O
outbreaks,O
revealed,O
that,O
Guangdong,O
was,O
the,O
"
",O
same,O
cluster,O
of,O
the,O
two,O
in,O
2010,O
.,O
In,O
addition,O
",",O
the,O
directional,O
trend,O
analysis,O
"
",O
indicated,O
that,O
the,O
FMD,O
transmission,O
was,O
oriented,O
northwestsoutheast,O
.,O
The,O
"
",O
findings,O
demonstrated,O
that,O
FMDV,O
in,O
China,O
can,O
be,O
divided,O
into,O
three,O
pedigrees,O
and,O
"
",O
the,O
homology,O
of,O
these,O
strains,O
is,O
very,O
high,O
while,O
comparing,O
the,O
first,O
FMDV,O
strain,O
"
",O
with,O
the,O
others,O
.,O
The,O
data,O
provide,O
a,O
basis,O
for,O
the,O
effective,O
monitoring,O
and,O
"
",O
prevention,O
of,O
FMD,O
",",O
and,O
for,O
the,O
development,O
of,O
an,O
FMD,O
vaccine,O
in,O
China,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Chen,O
",",O
Wang,O
",",O
Wang,O
",",O
Liang,O
",",O
Lu,O
",",O
Zhang,O
",",O
Chen,O
and,O
Niu,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fvets.2019.00511,O
"
",O
PMCID,O
:,O
PMC6986238,O
"
",O
PMID,O
:,O
32039251,O
"


",O
749,O
.,O
Front,O
Cell,O
Infect,O
Microbiol,O
.,O
2020,O
Jan,O
22;9:456,O
.,O
doi,O
:,O
10.3389,O
fcimb.2019.00456,O
.,O
"
",O
eCollection,O
2019,O
.,O
"

",O
Editorial,O
:,O
Frontiers,O
in,O
Fungal,O
Virus,O
Research,O
.,O
"

",O
Sun,O
L(1,O
),O
",",O
Suzuki,O
N(2,O
),O
",",O
Jiang,O
D(3,O
),O
",",O
Turina,O
M(4,O
),O
",",O
Xie,O
J(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Crop,O
Stress,O
Biology,O
for,O
Arid,O
Areas,O
",",O
College,O
of,O
Plant,O
"
",O
Protection,O
",",O
Northwest,O
Agriculture,O
and,O
Forestry,O
University,O
",",O
Yangling,O
",",O
China,O
.,O
"
",O
(2)Institute,O
of,O
Plant,O
Science,O
and,O
Resources,O
",",O
Okayama,O
University,O
",",O
Okayama,O
",",O
Japan,O
.,O
"
",O
(3)The,O
State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Institute,O
for,O
Sustainable,O
Plant,O
Protection,O
",",O
Italian,O
National,O
Research,O
Council,O
",",O
"
",O
Rome,O
",",O
Italy,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fcimb.2019.00456,O
"
",O
PMCID,O
:,O
PMC6987040,O
"
",O
PMID,O
:,O
32039042,O
"


",O
750,O
.,O
Front,O
Microbiol,O
.,O
2020,O
Jan,O
21;10:3085,O
.,O
doi,O
:,O
10.3389,O
fmicb.2019.03085,O
.,O
eCollection,O
"
",O
2019,O
.,O
"

",O
Transmissible,O
Gastroenteritis,O
Virus,O
Infection,O
UpRegulates,O
FcRn,O
Expression,O
via,O
"
",O
Nucleocapsid,O
Protein,O
and,O
Secretion,O
of,O
TGFÎ²,O
in,O
Porcine,O
Intestinal,O
Epithelial,O
"
",O
Cells,O
.,O
"

",O
Qian,O
S(1,O
),O
",",O
Gao,O
Z(1,O
),O
",",O
Cao,O
R(1,O
),O
",",O
Yang,O
K(1,O
),O
",",O
Cui,O
Y(1,O
),O
",",O
Li,O
S(1)(2)(3,O
),O
",",O
Meng,O
"
",O
X(1)(2)(3,O
),O
",",O
He,O
Q(1)(2)(3,O
),O
",",O
Li,O
Z(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
The,O
"
",O
Cooperative,O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Development,O
of,O
Veterinary,O
Diagnostic,O
Products,O
",",O
Ministry,O
of,O
"
",O
Agriculture,O
of,O
the,O
People,O
's,O
Republic,O
of,O
China,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
Transmissible,O
gastroenteritis,O
virus,O
(,O
TGEV,O
),O
is,O
a,O
porcine,O
intestinal,O
coronavirus,O
"
",O
that,O
causes,O
fatal,O
severe,O
watery,O
diarrhea,O
in,O
piglets,O
.,O
The,O
neonatal,O
Fc,O
receptor,O
"
",O
(,O
FcRn,O
),O
is,O
the,O
only,O
IgG,O
transport,O
receptor,O
",",O
its,O
expression,O
on,O
mucosal,O
surfaces,O
is,O
"
",O
triggered,O
upon,O
viral,O
stimulation,O
",",O
which,O
significantly,O
enhances,O
mucosal,O
immunity,O
.,O
"
",O
We,O
utilized,O
TGEV,O
as,O
a,O
model,O
pathogen,O
to,O
explore,O
the,O
role,O
of,O
FcRn,O
in,O
resisting,O
"
",O
viral,O
invasion,O
in,O
overall,O
intestinal,O
mucosal,O
immunity,O
.,O
TGEV,O
induced,O
FcRn,O
"
",O
expression,O
by,O
activating,O
NFÎºB,O
signaling,O
in,O
porcine,O
small,O
intestinal,O
epithelial,O
"
",O
(,O
IPECJ2,O
),O
cells,O
",",O
however,O
",",O
the,O
underlying,O
mechanisms,O
are,O
unclear,O
.,O
First,O
",",O
using,O
"
",O
small,O
interfering,O
RNAs,O
",",O
we,O
found,O
that,O
TGEV,O
upregulated,O
FcRn,O
expression,O
via,O
TLR3,O
",",O
"
",O
TLR9,O
and,O
RIGI,O
.,O
Moreover,O
",",O
TGEV,O
induced,O
IL1Î²,O
",",O
IL6,O
",",O
IL8,O
",",O
TGFÎ²,O
",",O
and,O
TNFÎ±,O
"
",O
production,O
.,O
TGFÎ²stimulated,O
IPECJ2,O
cells,O
highly,O
upregulated,O
FcRn,O
expression,O
",",O
"
",O
while,O
treatment,O
with,O
a,O
JNKspecific,O
inhibitor,O
downregulated,O
the,O
expression,O
.,O
TGEV,O
"
",O
nucleocapsid,O
(,O
N,O
),O
protein,O
also,O
enhanced,O
FcRn,O
promoter,O
activity,O
via,O
the,O
NFÎºB,O
"
",O
signaling,O
pathway,O
and,O
its,O
central,O
region,O
(,O
aa,O
128252,O
),O
was,O
essential,O
for,O
FcRn,O
"
",O
activation,O
.,O
Additionally,O
",",O
N,O
proteinmediated,O
FcRn,O
upregulation,O
promotes,O
IgG,O
"
",O
transcytosis,O
.,O
Thus,O
",",O
TGEV,O
N,O
protein,O
and,O
TGFÎ²,O
upregulated,O
FcRn,O
expression,O
",",O
"
",O
further,O
clarifying,O
the,O
molecular,O
mechanism,O
of,O
upregulation,O
of,O
FcRn,O
expression,O
by,O
"
",O
TGEV,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Qian,O
",",O
Gao,O
",",O
Cao,O
",",O
Yang,O
",",O
Cui,O
",",O
Li,O
",",O
Meng,O
",",O
He,O
and,O
Li,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fmicb.2019.03085,O
"
",O
PMCID,O
:,O
PMC6990134,O
"
",O
PMID,O
:,O
32038538,O
"


",O
751,O
.,O
Front,O
Mol,O
Neurosci,O
.,O
2020,O
Jan,O
24;13:2,O
.,O
doi,O
:,O
10.3389,O
fnmol.2020.00002,O
.,O
eCollection,O
"
",O
2020,O
.,O
"

",O
Herpes,O
Simplex,O
Virus,O
1Induced,O
BloodBrain,O
Barrier,O
Damage,O
Involves,O
Apoptosis,O
"
",O
Associated,O
With,O
GM130Mediated,O
Golgi,O
Stress,O
.,O
"

",O
He,O
Q(1,O
),O
",",O
Liu,O
H(1,O
),O
",",O
Huang,O
C(1,O
),O
",",O
Wang,O
R(2,O
),O
",",O
Luo,O
M(3,O
),O
",",O
Lu,O
W(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Neurology,O
",",O
The,O
Second,O
Xiangya,O
Hospital,O
",",O
Central,O
South,O
"
",O
University,O
",",O
Changsha,O
",",O
China,O
.,O
"
",O
(2)The,O
Second,O
Clinical,O
Medicine,O
School,O
",",O
Lanzhou,O
University,O
",",O
Lanzhou,O
",",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
CAS,O
Center,O
for,O
Excellence,O
in,O
Brain,O
Science,O
"
",O
and,O
Intelligence,O
Technology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
"
",O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
Herpes,O
simplex,O
encephalitis,O
(,O
HSE,O
),O
caused,O
by,O
herpes,O
simplex,O
virus,O
1,O
(,O
HSV1,O
),O
"
",O
infection,O
can,O
lead,O
to,O
a,O
high,O
mortality,O
rate,O
and,O
severe,O
neurological,O
sequelae,O
.,O
The,O
"
",O
destruction,O
of,O
the,O
bloodbrain,O
barrier,O
(,O
BBB,O
),O
is,O
an,O
important,O
pathological,O
"
",O
mechanism,O
for,O
the,O
development,O
of,O
HSE,O
.,O
However,O
",",O
the,O
specific,O
mechanism,O
underlying,O
"
",O
the,O
BBB,O
destruction,O
remains,O
unclear,O
.,O
Our,O
previous,O
study,O
found,O
that,O
the,O
Golgi,O
"
",O
apparatus,O
(,O
GA,O
),O
plays,O
a,O
crucial,O
role,O
in,O
maintaining,O
the,O
integrity,O
of,O
the,O
BBB,O
.,O
"
",O
Therefore,O
",",O
this,O
present,O
study,O
aimed,O
to,O
investigate,O
the,O
role,O
of,O
the,O
GA,O
in,O
the,O
"
",O
destruction,O
of,O
the,O
BBB,O
and,O
its,O
underlying,O
mechanisms,O
.,O
Mouse,O
brain,O
endothelial,O
"
",O
cells,O
(,O
Bend.3,O
),O
were,O
cultured,O
to,O
establish,O
a,O
BBB,O
model,O
in,O
vitro,O
",",O
and,O
then,O
infected,O
"
",O
with,O
HSV1,O
.,O
The,O
results,O
showed,O
that,O
HSV1,O
infection,O
caused,O
downregulation,O
of,O
the,O
"
",O
Golgiassociated,O
protein,O
GM130,O
",",O
accompanied,O
by,O
Golgi,O
fragmentation,O
",",O
cell,O
"
",O
apoptosis,O
",",O
and,O
downregulation,O
of,O
tight,O
junction,O
proteins,O
occludin,O
and,O
claudin,O
5,O
.,O
"
",O
Knockdown,O
of,O
GM130,O
with,O
small,O
interfering,O
RNA,O
in,O
uninfected,O
Bend.3,O
cells,O
"
",O
triggered,O
Golgi,O
fragmentation,O
",",O
apoptosis,O
",",O
and,O
downregulation,O
of,O
occludin,O
and,O
"
",O
claudin,O
5,O
.,O
However,O
",",O
overexpression,O
of,O
GM130,O
in,O
HSV1,O
infected,O
Bend.3,O
cells,O
by,O
"
",O
transient,O
transfection,O
partially,O
attenuated,O
the,O
aforementioned,O
damage,O
caused,O
by,O
"
",O
HSV1,O
infection,O
.,O
When,O
the,O
pancaspase,O
inhibitor,O
ZVADfmk,O
was,O
used,O
after,O
HSV1,O
"
",O
infection,O
to,O
inhibit,O
apoptosis,O
",",O
the,O
protein,O
levels,O
of,O
GM130,O
",",O
occludin,O
and,O
claudin,O
"
",O
5,O
were,O
partially,O
restored,O
.,O
Taken,O
together,O
",",O
these,O
observations,O
indicate,O
that,O
HSV1,O
"
",O
infection,O
of,O
Bend.3,O
cells,O
triggers,O
a,O
GM130mediated,O
Golgi,O
stress,O
response,O
that,O
is,O
"
",O
involved,O
in,O
apoptosis,O
",",O
which,O
in,O
turn,O
results,O
in,O
downregulation,O
of,O
occludin,O
and,O
"
",O
claudin,O
5,O
protein,O
levels,O
.,O
Meanwhile,O
",",O
GM130,O
downregulation,O
is,O
partially,O
due,O
to,O
"
",O
apoptosis,O
triggered,O
by,O
HSV1,O
infection,O
.,O
Our,O
findings,O
reveal,O
an,O
association,O
"
",O
between,O
the,O
GA,O
and,O
the,O
BBB,O
during,O
HSV1,O
infection,O
and,O
identify,O
potentially,O
novel,O
"
",O
targets,O
for,O
protecting,O
the,O
BBB,O
and,O
therapeutic,O
approaches,O
for,O
patients,O
with,O
HSE,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
He,O
",",O
Liu,O
",",O
Huang,O
",",O
Wang,O
",",O
Luo,O
and,O
Lu,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fnmol.2020.00002,O
"
",O
PMCID,O
:,O
PMC6992570,O
"
",O
PMID,O
:,O
32038167,O
"


",O
752,O
.,O
Biosci,O
Trends,O
.,O
2020,O
Feb,O
9,O
.,O
doi,O
:,O
10.5582,O
bst.2020.01030,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
characteristics,O
and,O
therapeutic,O
procedure,O
for,O
four,O
cases,O
with,O
2019,O
novel,O
"
",O
coronavirus,O
pneumonia,O
receiving,O
combined,O
Chinese,O
and,O
Western,O
medicine,O
treatment,O
.,O
"

",O
Wang,O
Z(1,O
),O
",",O
Chen,O
X(2,O
),O
",",O
Lu,O
Y(2,O
),O
",",O
Chen,O
F(3,O
),O
",",O
Zhang,O
W(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Respiratory,O
Disease,O
",",O
Yueyang,O
Hospital,O
of,O
Integrated,O
Traditional,O
"
",O
Chinese,O
and,O
Western,O
Medicine,O
",",O
Shanghai,O
University,O
of,O
Traditional,O
Chinese,O
"
",O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
Shanghai,O
Public,O
Health,O
Clinical,O
"
",O
Center,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Respiratory,O
Disease,O
",",O
Shuguang,O
Hospital,O
Affiliated,O
to,O
Shanghai,O
"
",O
University,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"

",O
Pneumonia,O
associated,O
with,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
is,O
continuously,O
"
",O
and,O
rapidly,O
circulating,O
at,O
present,O
.,O
No,O
effective,O
antiviral,O
treatment,O
has,O
been,O
"
",O
verified,O
thus,O
far,O
.,O
We,O
report,O
here,O
the,O
clinical,O
characteristics,O
and,O
therapeutic,O
"
",O
procedure,O
for,O
four,O
patients,O
with,O
mild,O
or,O
severe,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
admitted,O
to,O
"
",O
Shanghai,O
Public,O
Health,O
Clinical,O
Center,O
.,O
All,O
the,O
patients,O
were,O
given,O
antiviral,O
"
",O
treatment,O
including,O
lopinavir,O
ritonavir,O
(,O
Kaletra,O
Â®,O
),O
",",O
arbidol,O
",",O
and,O
Shufeng,O
Jiedu,O
"
",O
Capsule,O
(,O
SFJDC,O
",",O
a,O
traditional,O
Chinese,O
medicine,O
),O
and,O
other,O
necessary,O
support,O
care,O
.,O
"
",O
After,O
treatment,O
",",O
three,O
patients,O
gained,O
significant,O
improvement,O
in,O
pneumonia,O
"
",O
associated,O
symptoms,O
",",O
two,O
of,O
whom,O
were,O
confirmed,O
2019nCoV,B-Virus_SARS-CoV-2
negative,O
and,O
"
",O
discharged,O
",",O
and,O
one,O
of,O
whom,O
was,O
virus,O
negative,O
at,O
the,O
first,O
test,O
.,O
The,O
remaining,O
"
",O
patient,O
with,O
severe,O
pneumonia,O
had,O
shown,O
signs,O
of,O
improvement,O
by,O
the,O
cutoff,O
date,O
"
",O
for,O
data,O
collection,O
.,O
Results,O
obtained,O
in,O
the,O
current,O
study,O
may,O
provide,O
clues,O
for,O
"
",O
treatment,O
of,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
.,O
The,O
efficacy,O
of,O
antiviral,O
treatment,O
including,O
"
",O
lopinavir,O
ritonavir,O
",",O
arbidol,O
",",O
and,O
SFJDC,O
warrants,O
further,O
verification,O
in,O
future,O
"
",O
study,O
.,O
"

",O
DOI,O
:,O
10.5582,O
bst.2020.01030,O
"
",O
PMID,O
:,O
32037389,O
"


",O
753,O
.,O
Vet,O
Q.,O
2020,O
Dec;40(1):6876,O
.,O
doi,O
:,O
10.108,O
01652176.2020.1727993,O
.,O
"

",O
Emerging,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(2019nCoV)current,O
scenario,O
",",O
evolutionary,O
perspective,O
"
",O
based,O
on,O
genome,O
analysis,O
and,O
recent,O
developments,O
.,O
"

",O
Malik,O
YS(1,O
),O
",",O
Sircar,O
S(1,O
),O
",",O
Bhat,O
S(1,O
),O
",",O
Sharun,O
K(2,O
),O
",",O
Dhama,O
K(3,O
),O
",",O
Dadar,O
M(4,O
),O
",",O
Tiwari,O
"
",O
R(5,O
),O
",",O
Chaicumpa,O
W(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Biological,O
Standardization,O
",",O
ICARIndian,O
Veterinary,O
Research,O
"
",O
Institute,O
",",O
Bareilly,O
",",O
Uttar,O
Pradesh,O
",",O
India,O
.,O
"
",O
(2)Division,O
of,O
Surgery,O
",",O
ICARIndian,O
Veterinary,O
Research,O
Institute,O
",",O
Bareilly,O
",",O
"
",O
Uttar,O
Pradesh,O
",",O
India,O
.,O
"
",O
(3)Division,O
of,O
Pathology,O
",",O
ICARIndian,O
Veterinary,O
Research,O
Institute,O
",",O
Bareilly,O
",",O
"
",O
Uttar,O
Pradesh,O
",",O
India,O
.,O
"
",O
(4)Razi,O
Vaccine,O
and,O
Serum,O
Research,O
Institute,O
",",O
Agricultural,O
Research,O
",",O
Education,O
"
",O
and,O
Extension,O
Organization,O
(,O
AREEO,O
),O
",",O
Karaj,O
",",O
Iran,O
.,O
"
",O
(5)Department,O
of,O
Veterinary,O
Microbiology,O
and,O
Immunology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Sciences,O
",",O
Deen,O
Dayal,O
Upadhayay,O
Pashu,O
Chikitsa,O
Vigyan,O
Vishwavidyalay,O
Evum,O
"
",O
GoAnusandhan,O
Sansthan,O
(,O
DUVASU,O
),O
",",O
Mathura,O
",",O
India,O
.,O
"
",O
(6)Center,O
of,O
Research,O
Excellence,O
on,O
Therapeutic,O
Proteins,O
and,O
Antibody,O
"
",O
Engineering,O
",",O
Department,O
of,O
Parasitology,O
",",O
Faculty,O
of,O
Medicine,O
Siriraj,O
Hospital,O
",",O
"
",O
Mahidol,O
University,O
",",O
Bangkok,O
",",O
Thailand,O
.,O
"

",O
Coronaviruses,O
are,O
the,O
wellknown,O
cause,O
of,O
severe,O
respiratory,O
",",O
enteric,O
and,O
"
",O
systemic,O
infections,O
in,O
a,O
wide,O
range,O
of,O
hosts,O
including,O
man,O
",",O
mammals,O
",",O
fish,O
",",O
and,O
"
",O
avian,O
.,O
The,O
scientific,O
interest,O
on,O
coronaviruses,O
increased,O
after,O
the,O
emergence,O
of,O
"
",O
Severe,O
Acute,O
Respiratory,O
Syndrome,O
coronavirus,O
(,O
SARSCoV,O
),O
outbreaks,O
in,O
20022003,O
"
",O
followed,O
by,O
Middle,O
East,O
Respiratory,O
Syndrome,O
CoV,O
(,O
MERSCoV,O
),O
.,O
This,O
decade,O
's,O
first,O
"
",O
CoV,O
",",O
named,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
emerged,O
from,O
Wuhan,O
",",O
China,O
",",O
and,O
declared,O
as,O
',O
Public,O
Health,O
"
",O
Emergency,O
of,O
International,O
Concern,O
',O
on,O
January,O
30th,O
",",O
2020,O
by,O
the,O
World,O
Health,O
"
",O
Organization,O
(,O
WHO,O
),O
.,O
As,O
on,O
February,O
4,O
",",O
2020,O
",",O
425,O
deaths,O
reported,O
in,O
China,O
only,O
and,O
"
",O
one,O
death,O
outside,O
China,O
(,O
Philippines,O
),O
.,O
In,O
a,O
short,O
span,O
of,O
time,O
",",O
the,O
virus,O
spread,O
"
",O
has,O
been,O
noted,O
in,O
24,O
countries,O
.,O
The,O
zoonotic,O
transmission,O
(,O
animaltohuman,O
),O
is,O
"
",O
suspected,O
as,O
the,O
route,O
of,O
disease,O
origin,O
.,O
The,O
genetic,O
analyses,O
predict,O
bats,O
as,O
"
",O
the,O
most,O
probable,O
source,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
though,O
further,O
investigations,O
needed,O
to,O
"
",O
confirm,O
the,O
origin,O
of,O
the,O
novel,O
virus,O
.,O
The,O
ongoing,O
nCoV,O
outbreak,O
highlights,O
the,O
"
",O
hidden,O
wild,O
animal,O
reservoir,O
of,O
the,O
deadly,O
viruses,O
and,O
possible,O
threat,O
of,O
"
",O
spillover,O
zoonoses,O
as,O
well,O
.,O
The,O
successful,O
virus,O
isolation,O
attempts,O
have,O
made,O
"
",O
doors,O
open,O
for,O
developing,O
better,O
diagnostics,O
and,O
effective,O
vaccines,O
helping,O
in,O
"
",O
combating,O
the,O
spread,O
of,O
the,O
virus,O
to,O
newer,O
areas,O
.,O
"

",O
DOI,O
:,O
10.108,O
01652176.2020.1727993,O
"
",O
PMCID,O
:,O
PMC7054940,O
"
",O
PMID,O
:,O
32036774,O
"


",O
754,O
.,O
J,O
Hosp,O
Infect,O
.,O
2020,O
Mar;104(3):246251,O
.,O
doi,O
:,O
10.1016,O
j.jhin.2020.01.022,O
.,O
Epub,O
"
",O
2020,O
Feb,O
6,O
.,O
"

",O
Persistence,O
of,O
coronaviruses,O
on,O
inanimate,O
surfaces,O
and,O
their,O
inactivation,O
with,O
"
",O
biocidal,O
agents,O
.,O
"

",O
Kampf,O
G(1,O
),O
",",O
Todt,O
D(2,O
),O
",",O
Pfaender,O
S(2,O
),O
",",O
Steinmann,O
E(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)University,O
Medicine,O
Greifswald,O
",",O
Institute,O
for,O
Hygiene,O
and,O
Environmental,O
"
",O
Medicine,O
",",O
FerdinandSauerbruchStraÃŸe,O
",",O
17475,O
Greifswald,O
",",O
Germany,O
.,O
Electronic,O
"
",O
address,O
:,O
guenter.kampf@unigreifswald.de,O
.,O
"
",O
(2)Department,O
of,O
Molecular,O
and,O
Medical,O
Virology,O
",",O
Ruhr,O
University,O
Bochum,O
",",O
"
",O
UniversitÃ¤tsstrasse,O
50,O
",",O
44801,O
Bochum,O
",",O
Germany,O
.,O
"

",O
Currently,O
",",O
the,O
emergence,O
of,O
a,O
novel,O
human,O
coronavirus,O
",",O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
has,O
become,O
a,O
"
",O
global,O
health,O
concern,O
causing,O
severe,O
respiratory,O
tract,O
infections,O
in,O
humans,O
.,O
"
",O
Humantohuman,O
transmissions,O
have,O
been,O
described,O
with,O
incubation,O
times,O
between,O
"
",O
210,O
days,O
",",O
facilitating,O
its,O
spread,O
via,O
droplets,O
",",O
contaminated,O
hands,O
or,O
surfaces,O
.,O
"
",O
We,O
therefore,O
reviewed,O
the,O
literature,O
on,O
all,O
available,O
information,O
about,O
the,O
"
",O
persistence,O
of,O
human,O
and,O
veterinary,O
coronaviruses,O
on,O
inanimate,O
surfaces,O
as,O
well,O
"
",O
as,O
inactivation,O
strategies,O
with,O
biocidal,O
agents,O
used,O
for,O
chemical,O
disinfection,O
",",O
"
",O
e.g.,O
in,O
healthcare,O
facilities,O
.,O
The,O
analysis,O
of,O
22,O
studies,O
reveals,O
that,O
human,O
"
",O
coronaviruses,O
such,O
as,O
Severe,O
Acute,O
Respiratory,O
Syndrome,O
(,O
SARS,O
),O
coronavirus,O
",",O
"
",O
Middle,O
East,O
Respiratory,O
Syndrome,O
(,O
MERS,O
),O
coronavirus,O
or,O
endemic,O
human,O
"
",O
coronaviruses,O
(,O
HCoV,O
),O
can,O
persist,O
on,O
inanimate,O
surfaces,O
like,O
metal,O
",",O
glass,O
or,O
"
",O
plastic,O
for,O
up,O
to,O
9,O
days,O
",",O
but,O
can,O
be,O
efficiently,O
inactivated,O
by,O
surface,O
"
",O
disinfection,O
procedures,O
with,O
6271,O
%,O
ethanol,O
",",O
0.5,O
%,O
hydrogen,O
peroxide,O
or,O
0.1,O
%,O
"
",O
sodium,O
hypochlorite,O
within,O
1,O
minute,O
.,O
Other,O
biocidal,O
agents,O
such,O
as,O
0.050.2,O
%,O
"
",O
benzalkonium,O
chloride,O
or,O
0.02,O
%,O
chlorhexidine,O
digluconate,O
are,O
less,O
effective,O
.,O
As,O
"
",O
no,O
specific,O
therapies,O
are,O
available,O
for,O
SARSCoV2,B-Virus_SARS-CoV-2
",",O
early,O
containment,O
and,O
"
",O
prevention,O
of,O
further,O
spread,O
will,O
be,O
crucial,O
to,O
stop,O
the,O
ongoing,O
outbreak,O
and,O
to,O
"
",O
control,O
this,O
novel,O
infectious,O
thread,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Healthcare,O
Infection,O
Society,O
.,O
Published,O
by,O
Elsevier,O
Ltd.,O
All,O
"
",O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jhin.2020.01.022,O
"
",O
PMID,O
:,O
32035997,O
"


",O
755,O
.,O
Int,O
J,O
Biol,O
Macromol,O
.,O
2020,O
Feb,O
6;151:1926,O
.,O
doi,O
:,O
10.1016,O
j.ijbiomac.2020.02.038,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Nglycoproteomic,O
analysis,O
of,O
duck,O
egg,O
yolk,O
proteins,O
:,O
Implications,O
for,O
"
",O
biofunctions,O
and,O
evolution,O
.,O
"

",O
Meng,O
Y(1,O
),O
",",O
Qiu,O
N(2,O
),O
",",O
Geng,O
F(3,O
),O
",",O
Keast,O
R(4,O
),O
",",O
Li,O
B(1,O
),O
",",O
Zheng,O
X(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Environment,O
Correlative,O
Dietology,O
",",O
Ministry,O
of,O
Education,O
",",O
"
",O
National,O
Research,O
and,O
Development,O
Center,O
for,O
Egg,O
Processing,O
",",O
College,O
of,O
Food,O
"
",O
Science,O
and,O
Technology,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
PR,O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Environment,O
Correlative,O
Dietology,O
",",O
Ministry,O
of,O
Education,O
",",O
"
",O
National,O
Research,O
and,O
Development,O
Center,O
for,O
Egg,O
Processing,O
",",O
College,O
of,O
Food,O
"
",O
Science,O
and,O
Technology,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
PR,O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
qiuning@mail.hzau.edu.cn,O
.,O
"
",O
(3)Meat,O
Processing,O
Key,O
Laboratory,O
of,O
Sichuan,O
Province,O
",",O
College,O
of,O
Pharmacy,O
and,O
"
",O
Biological,O
Engineering,O
",",O
Chengdu,O
University,O
",",O
No.,O
2025,O
Chengluo,O
Avenue,O
",",O
Chengdu,O
"
",O
610106,O
",",O
PR,O
China,O
.,O
"
",O
(4)Centre,O
for,O
Advanced,O
Sensory,O
Science,O
",",O
School,O
of,O
Exercise,O
and,O
Nutrition,O
"
",O
Sciences,O
",",O
Deakin,O
University,O
",",O
Burwood,O
",",O
Victoria,O
3125,O
",",O
Australia,O
.,O
"

",O
Egg,O
yolk,O
contains,O
multifunctional,O
glycoproteins,O
",",O
which,O
modulate,O
embryogenesis,O
and,O
"
",O
indicate,O
speciesspecific,O
adaptation,O
.,O
Here,O
",",O
we,O
conducted,O
an,O
Nglycoproteomic,O
"
",O
study,O
of,O
duck,O
egg,O
yolk,O
(,O
DEY,O
),O
and,O
identified,O
359,O
Nglycosites,O
corresponding,O
to,O
113,O
"
",O
glycoproteins,O
.,O
The,O
comparison,O
of,O
DEY,O
Nglycoproteins,O
with,O
those,O
of,O
chicken,O
egg,O
"
",O
yolk,O
(,O
CEY,O
),O
revealed,O
a,O
higher,O
Nglycosylation,O
level,O
in,O
DEY,O
proteins,O
",",O
suggesting,O
a,O
"
",O
biological,O
adaption,O
to,O
meet,O
the,O
requirements,O
for,O
embryo,O
development,O
by,O
modulating,O
"
",O
protein,O
structure,O
and,O
binding,O
ability,O
",",O
including,O
immune,O
response,O
and,O
ligand,O
"
",O
transport,O
.,O
This,O
variation,O
may,O
be,O
correlated,O
to,O
the,O
strong,O
resistance,O
to,O
the,O
"
",O
influenza,O
virus,O
disease,O
of,O
duck,O
.,O
A,O
large,O
set,O
of,O
corresponding,O
glycoproteins,O
"
",O
between,O
DEY,O
and,O
CEY,O
were,O
detected,O
with,O
similar,O
molecular,O
functions,O
",",O
which,O
"
",O
suggested,O
a,O
relatively,O
lower,O
evolution,O
speed,O
of,O
avian,O
egg,O
yolk,O
proteins,O
than,O
that,O
"
",O
of,O
egg,O
white,O
proteins,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijbiomac.2020.02.038,O
"
",O
PMID,O
:,O
32035964,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
The,O
authors,O
"
",O
declare,O
no,O
competing,O
financial,O
interests,O
.,O
"


",O
756,O
.,O
J,O
Microbiol,O
Immunol,O
Infect,O
.,O
2020,O
Feb,O
4,O
.,O
pii,O
:,O
S16841182(20)300116,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.jmii.2020.02.001,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Emerging,O
threats,O
from,O
zoonotic,O
coronavirusesfrom,O
SARS,O
and,O
MERS,O
to,O
2019nCoV.,O
"

",O
Lee,O
PI(1,O
),O
",",O
Hsueh,O
PR(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pediatrics,O
",",O
National,O
Taiwan,O
University,O
Children,O
's,O
Hospital,O
and,O
"
",O
National,O
Taiwan,O
University,O
College,O
of,O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
.,O
Electronic,O
"
",O
address,O
:,O
pinging@ntu.edu.tw,O
.,O
"
",O
(2)Department,O
of,O
Laboratory,O
Medicine,O
",",O
National,O
Taiwan,O
University,O
Hospital,O
",",O
"
",O
National,O
Taiwan,O
University,O
College,O
of,O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
;,O
Department,O
of,O
"
",O
Internal,O
Medicine,O
",",O
National,O
Taiwan,O
University,O
Hospital,O
",",O
National,O
Taiwan,O
"
",O
University,O
College,O
of,O
Medicine,O
",",O
Taipei,O
",",O
Taiwan,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jmii.2020.02.001,O
"
",O
PMID,O
:,O
32035811,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declares,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
757,O
.,O
Lancet,O
.,O
2020,O
Feb,O
8;395(10222):401,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)302920,O
.,O
"

",O
What,O
next,O
for,O
the,O
coronavirus,O
response,O
?,O
"

",O
Zarocostas,O
J.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)302920,O
"
",O
PMID,O
:,O
32035538,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
758,O
.,O
Lancet,O
.,O
2020,O
Feb,O
8;395(10222):400,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)302993,O
.,O
"

",O
Offline,O
:,O
"2019nCoV""A",O
desperate,O
plea,O
"""",O
.,O
"

",O
Horton,O
R.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)302993,O
"
",O
PMID,O
:,O
32035537,O
"


",O
759,O
.,O
Lancet,O
.,O
2020,O
Feb,O
8;395(10222):391393,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303007,O
.,O
"

",O
What,O
to,O
do,O
next,O
to,O
control,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
epidemic,O
?,O
"

",O
Wang,O
FS(1,O
),O
",",O
Zhang,O
C(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Treatment,O
and,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
The,O
Fifth,O
Medical,O
"
",O
Center,O
of,O
PLA,O
General,O
Hospital,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
"
",O
Diseases,O
",",O
Beijing,O
100039,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
fswang302@163.com,O
.,O
"
",O
(2)Treatment,O
and,O
Research,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
The,O
Fifth,O
Medical,O
"
",O
Center,O
of,O
PLA,O
General,O
Hospital,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Infectious,O
"
",O
Diseases,O
",",O
Beijing,O
100039,O
",",O
China,O
.,O
"

",O
Comment,O
on,O
"
    ",O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Jan,O
24;:null,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303007,O
"
",O
PMID,O
:,O
32035533,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
760,O
.,O
Lancet,O
.,O
2020,O
Feb,O
22;395(10224):e40,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303111,O
.,O
Epub,O
2020,O
"
",O
Feb,O
6,O
.,O
"

",O
2019nCoV,B-Virus_SARS-CoV-2
epidemic,O
:,O
what,O
about,O
pregnancies,O
?,O
"

",O
Favre,O
G(1,O
),O
",",O
Pomar,O
L(1,O
),O
",",O
Musso,O
D(2,O
),O
",",O
Baud,O
D(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Maternofetal,O
and,O
Obstetrics,O
Research,O
Unit,O
",",O
Department,O
WomanMotherChild,O
",",O
"
",O
Lausanne,O
University,O
Hospital,O
",",O
1011,O
Lausanne,O
",",O
Switzerland,O
.,O
"
",O
(2)Laboratoire,O
Eurofins,O
Labazur,O
Guyane,O
",",O
French,O
Guiana,O
;,O
Aix,O
Marseille,O
UniversitÃ©,O
",",O
"
",O
IRD,O
",",O
APHM,O
",",O
SSA,O
",",O
VITROME,O
",",O
IHUMÃ©diterranÃ©e,O
infection,O
",",O
Marseille,O
",",O
France,O
.,O
"
",O
(3)Maternofetal,O
and,O
Obstetrics,O
Research,O
Unit,O
",",O
Department,O
WomanMotherChild,O
",",O
"
",O
Lausanne,O
University,O
Hospital,O
",",O
1011,O
Lausanne,O
",",O
Switzerland,O
.,O
Electronic,O
address,O
:,O
"
",O
david.baud@chuv.ch,O
.,O
"

",O
Comment,O
on,O
"
    ",O
J,O
Microbiol,O
Immunol,O
Infect,O
.,O
2019,O
Jun;52(3):501503,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303111,O
"
",O
PMID,O
:,O
32035511,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
761,O
.,O
Lancet,O
.,O
2020,O
Feb,O
22;395(10224):e39,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303135,O
.,O
Epub,O
2020,O
"
",O
Feb,O
6,O
.,O
"

",O
2019nCoV,B-Virus_SARS-CoV-2
transmission,O
through,O
the,O
ocular,O
surface,O
must,O
not,O
be,O
ignored,O
.,O
"

",O
Lu,O
CW(1,O
),O
",",O
Liu,O
XF(2,O
),O
",",O
Jia,O
ZF(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Opthalmology,O
",",O
First,O
Hospital,O
of,O
Jilin,O
University,O
",",O
Changchun,O
"
",O
130021,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
lcwchina800@sina.com,O
.,O
"
",O
(2)Department,O
of,O
Opthalmology,O
",",O
First,O
Hospital,O
of,O
Jilin,O
University,O
",",O
Changchun,O
"
",O
130021,O
",",O
China,O
.,O
"
",O
(3)Division,O
of,O
Clinical,O
Research,O
",",O
First,O
Hospital,O
of,O
Jilin,O
University,O
",",O
Changchun,O
"
",O
130021,O
",",O
China,O
.,O
"

",O
Comment,O
on,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):497506,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303135,O
"
",O
PMID,O
:,O
32035510,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
762,O
.,O
Lancet,O
Planet,O
Health,O
.,O
2020,O
Feb,O
6,O
.,O
pii,O
:,O
S25425196(20)300358,O
.,O
doi,O
:,O
"
",O
10.1016,O
S25425196(20)300358,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
2019nCoV,B-Virus_SARS-CoV-2
in,O
context,O
:,O
lessons,O
learned,O
?,O
"

",O
Kock,O
RA(1,O
),O
",",O
Karesh,O
WB(2,O
),O
",",O
Veas,O
F(3,O
),O
",",O
Velavan,O
TP(4,O
),O
",",O
Simons,O
D(5,O
),O
",",O
Mboera,O
LEG(6,O
),O
",",O
"
",O
Dar,O
O(7,O
),O
",",O
Arruda,O
LB(8,O
),O
",",O
Zumla,O
A(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pathobiology,O
and,O
Population,O
Science,O
",",O
Royal,O
Veterinary,O
College,O
",",O
"
",O
North,O
Mymms,O
",",O
Hatfield,O
",",O
AL9,O
7TA,O
",",O
UK,O
.,O
Electronic,O
address,O
:,O
Rkock@rvc.ac.uk,O
.,O
"
",O
(2)EcoHealth,O
Alliance,O
",",O
New,O
York,O
",",O
NY,O
",",O
USA,O
.,O
"
",O
(3)IRD,O
",",O
UMR5569,O
",",O
Faculty,O
of,O
Pharmacy,O
",",O
Montpellier,O
University,O
",",O
Montpellier,O
",",O
"
",O
France,O
.,O
"
",O
(4)Institute,O
of,O
Tropical,O
Medicine,O
",",O
UniversitÃ¤tsklinikum,O
TÃ¼bingen,O
",",O
TÃ¼bingen,O
",",O
"
",O
Germany,O
;,O
VietnameseGerman,O
Center,O
for,O
Medical,O
Research,O
(,O
VGCARE,O
),O
",",O
Hanoi,O
",",O
Vietnam,O
;,O
"
",O
Faculty,O
of,O
Medicine,O
",",O
Duy,O
Tan,O
University,O
",",O
Da,O
Nang,O
",",O
Vietnam,O
.,O
"
",O
(5)Department,O
of,O
Pathobiology,O
and,O
Population,O
Science,O
",",O
Royal,O
Veterinary,O
College,O
",",O
"
",O
North,O
Mymms,O
",",O
Hatfield,O
",",O
AL9,O
7TA,O
",",O
UK,O
.,O
"
",O
(6)SACIDS,O
Foundation,O
for,O
One,O
Health,O
",",O
Sokoine,O
University,O
of,O
Agriculture,O
",",O
Chuo,O
"
",O
Kikuu,O
",",O
Morogoro,O
",",O
Tanzania,O
.,O
"
",O
(7)Chatham,O
House,O
Centre,O
on,O
Global,O
Health,O
Security,O
",",O
Royal,O
Institute,O
of,O
"
",O
International,O
Affairs,O
",",O
London,O
",",O
UK,O
.,O
"
",O
(8)Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
University,O
College,O
London,O
",",O
and,O
UCL,O
"
",O
Hospitals,O
NIHR,O
Biomedical,O
Research,O
Centre,O
London,O
",",O
London,O
",",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S25425196(20)300358,O
"
",O
PMID,O
:,O
32035507,O
"


",O
763,O
.,O
Epidemiol,O
Health,O
.,O
2020,O
Feb,O
9:e2020007,O
.,O
doi,O
:,O
10.4178,O
epih.e2020007,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Epidemiologic,O
characteristics,O
of,O
early,O
cases,O
with,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
disease,O
in,O
Republic,O
of,O
Korea,O
.,O
"

",O
Ki,O
M(1,O
),O
",",O
nCoV,O
TFF(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Cancer,O
Control,O
and,O
Population,O
Health,O
",",O
Graduate,O
School,O
of,O
Cancer,O
"
",O
Science,O
and,O
Policy,O
",",O
National,O
Cancer,O
Center,O
",",O
Goyang,O
",",O
Korea,O
.,O
"
",O
(2)The,O
Korean,O
Society,O
for,O
Preventive,O
Medicine,O
&,O
Korean,O
Society,O
of,O
Epidemiology,O
.,O
"

",O
Since,O
the,O
first,O
case,O
of,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
in,O
South,O
Korea,O
was,O
"
",O
confirmed,O
on,O
January,O
20,O
",",O
2020,O
",",O
there,O
have,O
been,O
24,O
confirmed,O
cases,O
of,O
2019nCoV.,O
"
",O
The,O
majority,O
of,O
these,O
cases,O
(,O
58.3,O
%,O
;,O
n=14,O
),O
were,O
male,O
",",O
with,O
a,O
median,O
age,O
of,O
42,O
"
",O
years,O
(,O
range,O
",",O
2162,O
years,O
),O
.,O
Of,O
the,O
confirmed,O
cases,O
",",O
15,O
were,O
index,O
cases,O
(,O
63,O
%,O
),O
",",O
"
",O
six,O
were,O
firstgeneration,O
patients,O
(,O
24,O
%,O
),O
",",O
and,O
three,O
were,O
secondgeneration,O
"
",O
patients,O
(,O
12.5,O
%,O
),O
.,O
All,O
the,O
first,O
and,O
secondgeneration,O
patients,O
were,O
family,O
"
",O
members,O
or,O
close,O
acquaintances,O
of,O
index,O
cases,O
.,O
All,O
the,O
index,O
cases,O
entered,O
the,O
"
",O
South,O
Korea,O
from,O
January,O
19,O
to,O
24,O
",",O
2020,O
.,O
The,O
average,O
incubation,O
period,O
was,O
3.6,O
"
",O
days,O
(,O
median,O
",",O
4,O
days,O
),O
and,O
the,O
reproduction,O
number,O
(,O
R0,O
),O
was,O
calculated,O
as,O
0.5,O
.,O
Two,O
"
",O
of,O
the,O
confirmed,O
cases,O
were,O
asymptomatic,O
.,O
As,O
of,O
February,O
8,O
",",O
22,O
patients,O
with,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
are,O
hospitalized,O
in,O
South,O
Korea,O
",",O
and,O
2,O
have,O
been,O
discharged,O
from,O
the,O
"
",O
hospital,O
.,O
The,O
epidemiological,O
indicators,O
will,O
be,O
revised,O
as,O
new,O
information,O
"
",O
becomes,O
available,O
in,O
the,O
future,O
.,O
Sharing,O
epidemiological,O
information,O
among,O
"
",O
researchers,O
around,O
the,O
world,O
is,O
essential,O
for,O
efficient,O
preparations,O
and,O
"
",O
responses,O
to,O
new,O
infectious,O
diseases,O
.,O
"

",O
DOI,O
:,O
10.4178,O
epih.e2020007,O
"
",O
PMID,O
:,O
32035431,O
"


",O
764,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Jan,O
 ,O
Feb;33:101572,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.tmaid.2020.101572,O
.,O
Epub,O
2020,O
Feb,O
5,O
.,O
"

",O
What,O
goes,O
on,O
board,O
aircraft,O
?,O
Passengers,O
include,O
Aedes,O
",",O
Anopheles,O
",",O
2019nCoV,B-Virus_SARS-CoV-2
",",O
"
",O
dengue,O
",",O
Salmonella,O
",",O
Zika,O
",",O
et,O
al.,O
"

",O
Wilson,O
ME(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Clinical,O
Professor,O
of,O
Epidemiology,O
and,O
Biostatistics,O
",",O
School,O
of,O
Medicine,O
",",O
"
",O
University,O
of,O
California,O
",",O
San,O
Francisco,O
",",O
USA,O
;,O
Adjunct,O
Professor,O
of,O
Global,O
Health,O
"
",O
and,O
Population,O
",",O
Harvard,O
T.H.,O
Chan,O
School,O
of,O
Public,O
Health,O
",",O
Boston,O
",",O
MA,O
",",O
USA,O
.,O
"
",O
Electronic,O
address,O
:,O
mewilson@hsph.harvard.edu,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101572,O
"
",O
PMID,O
:,O
32035269,O
"


",O
765,O
.,O
Lancet,O
Psychiatry,O
.,O
2020,O
Mar;7(3):e14,O
.,O
doi,O
:,O
10.1016,O
S22150366(20)30047X,O
.,O
Epub,O
"
",O
2020,O
Feb,O
5,O
.,O
"

",O
The,O
mental,O
health,O
of,O
medical,O
workers,O
in,O
Wuhan,O
",",O
China,O
dealing,O
with,O
the,O
2019,O
novel,O
"
",O
coronavirus,O
.,O
"

",O
Kang,O
L(1,O
),O
",",O
Li,O
Y(2,O
),O
",",O
Hu,O
S(3,O
),O
",",O
Chen,O
M(4,O
),O
",",O
Yang,O
C(1,O
),O
",",O
Yang,O
BX(5,O
),O
",",O
Wang,O
Y(1,O
),O
",",O
Hu,O
"
",O
J(3,O
),O
",",O
Lai,O
J(3,O
),O
",",O
Ma,O
X(6,O
),O
",",O
Chen,O
J(7,O
),O
",",O
Guan,O
L(8,O
),O
",",O
Wang,O
G(1,O
),O
",",O
Ma,O
H(8,O
),O
",",O
Liu,O
Z(9,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Psychiatry,O
",",O
RenMin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
430060,O
",",O
"
",O
China,O
.,O
"
",O
(2)Wuhan,O
Mental,O
Health,O
Center,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Psychiatry,O
",",O
First,O
Affiliated,O
Hospital,O
",",O
Zhejiang,O
University,O
"
",O
School,O
of,O
Medicine,O
",",O
Hangzhou,O
",",O
China,O
.,O
"
",O
(4)The,O
School,O
of,O
Computer,O
Science,O
and,O
Technology,O
",",O
Huazhong,O
University,O
of,O
Science,O
"
",O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(5)School,O
of,O
Health,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Psychiatry,O
",",O
First,O
Affiliated,O
Hospital,O
of,O
Xi'an,O
Jiaotong,O
"
",O
University,O
",",O
Xi'an,O
",",O
China,O
.,O
"
",O
(7)Shanghai,O
Mental,O
Health,O
Center,O
",",O
Shanghai,O
Jiao,O
Tong,O
University,O
School,O
of,O
"
",O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(8)Peking,O
University,O
Sixth,O
Hospital,O
",",O
Peking,O
University,O
Institute,O
of,O
Mental,O
"
",O
Health,O
",",O
NHC,O
Key,O
Laboratory,O
of,O
Mental,O
Health,O
(,O
Peking,O
University,O
),O
",",O
National,O
"
",O
Clinical,O
Research,O
Center,O
for,O
Mental,O
Disorders,O
(,O
Peking,O
University,O
Sixth,O
Hospital,O
),O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(9)Department,O
of,O
Psychiatry,O
",",O
RenMin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
430060,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
zcliu6@whu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S22150366(20)30047X,O
"
",O
PMID,O
:,O
32035030,O
"


",O
766,O
.,O
Cell,O
Host,O
Microbe,O
.,O
2020,O
Mar,O
11;27(3):325328,O
.,O
doi,O
:,O
10.1016,O
j.chom.2020.02.001,O
.,O
"
",O
Epub,O
2020,O
Feb,O
7,O
.,O
"

",O
Genome,O
Composition,O
and,O
Divergence,O
of,O
the,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
"
",O
Originating,O
in,O
China,O
.,O
"

",O
Wu,O
A(1,O
),O
",",O
Peng,O
Y(2,O
),O
",",O
Huang,O
B(3,O
),O
",",O
Ding,O
X(1,O
),O
",",O
Wang,O
X(1,O
),O
",",O
Niu,O
P(3,O
),O
",",O
Meng,O
J(1,O
),O
",",O
Zhu,O
"
",O
Z(2,O
),O
",",O
Zhang,O
Z(2,O
),O
",",O
Wang,O
J(1,O
),O
",",O
Sheng,O
J(1,O
),O
",",O
Quan,O
L(4,O
),O
",",O
Xia,O
Z(5,O
),O
",",O
Tan,O
W(6,O
),O
",",O
Cheng,O
"
",O
G(7,O
),O
",",O
Jiang,O
T(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Center,O
for,O
Systems,O
Medicine,O
",",O
Institute,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Medical,O
Sciences,O
&,O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
100005,O
",",O
"
",O
China,O
;,O
Suzhou,O
Institute,O
of,O
Systems,O
Medicine,O
",",O
Suzhou,O
",",O
Jiangsu,O
215123,O
",",O
China,O
.,O
"
",O
(2)College,O
of,O
Biology,O
",",O
Hunan,O
Provincial,O
Key,O
Laboratory,O
of,O
Medical,O
Virology,O
",",O
Hunan,O
"
",O
University,O
",",O
Changsha,O
410082,O
",",O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Medical,O
Virology,O
",",O
National,O
Health,O
and,O
Family,O
Planning,O
"
",O
Commission,O
",",O
National,O
Institute,O
for,O
Viral,O
Disease,O
Control,O
and,O
Prevention,O
",",O
China,O
"
",O
CDC,O
",",O
Beijing,O
102206,O
",",O
China,O
.,O
"
",O
(4)School,O
of,O
Computer,O
Science,O
and,O
Technology,O
",",O
Soochow,O
University,O
",",O
Suzhou,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Cell,O
Biology,O
",",O
School,O
of,O
Life,O
Science,O
",",O
Central,O
South,O
University,O
",",O
"
",O
Changsha,O
410013,O
",",O
China,O
;,O
Hunan,O
Key,O
Laboratory,O
of,O
Animal,O
Models,O
for,O
Human,O
Diseases,O
",",O
"
",O
Hunan,O
Key,O
Laboratory,O
of,O
Medical,O
Genetics,O
&,O
Center,O
for,O
Medical,O
Genetics,O
",",O
School,O
of,O
"
",O
Life,O
Science,O
",",O
Central,O
South,O
University,O
",",O
Changsha,O
410013,O
",",O
China,O
.,O
"
",O
(6)Key,O
Laboratory,O
of,O
Medical,O
Virology,O
",",O
National,O
Health,O
and,O
Family,O
Planning,O
"
",O
Commission,O
",",O
National,O
Institute,O
for,O
Viral,O
Disease,O
Control,O
and,O
Prevention,O
",",O
China,O
"
",O
CDC,O
",",O
Beijing,O
102206,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
tanwj@ivdc.chinacdc.cn,O
.,O
"
",O
(7)Department,O
of,O
Microbiology,O
",",O
Immunology,O
and,O
Molecular,O
Genetics,O
",",O
University,O
of,O
"
",O
California,O
",",O
Los,O
Angeles,O
",",O
Los,O
Angeles,O
",",O
USA,O
.,O
Electronic,O
address,O
:,O
"
",O
gcheng@mednet.ucla.edu,O
.,O
"
",O
(8)Center,O
for,O
Systems,O
Medicine,O
",",O
Institute,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Medical,O
Sciences,O
&,O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
100005,O
",",O
"
",O
China,O
;,O
Suzhou,O
Institute,O
of,O
Systems,O
Medicine,O
",",O
Suzhou,O
",",O
Jiangsu,O
215123,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
taijiao@ibms.pumc.edu.cn,O
.,O
"

",O
An,O
indepth,O
annotation,O
of,O
the,O
newly,O
discovered,O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
genome,O
has,O
"
",O
revealed,O
differences,O
between,O
2019nCoV,B-Virus_SARS-CoV-2
and,O
severe,O
acute,O
respiratory,O
syndrome,O
"
",O
(,O
SARS,O
),O
or,O
SARSlike,O
coronaviruses,O
.,O
A,O
systematic,O
comparison,O
identified,O
380,O
amino,O
"
",O
acid,O
substitutions,O
between,O
these,O
coronaviruses,O
",",O
which,O
may,O
have,O
caused,O
functional,O
"
",O
and,O
pathogenic,O
divergence,O
of,O
2019nCoV.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.chom.2020.02.001,O
"
",O
PMID,O
:,O
32035028,O
"


",O
767,O
.,O
Lancet,O
.,O
2020,O
Feb,O
22;395(10224):e35e36,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303056,O
.,O
Epub,O
"
",O
2020,O
Feb,O
5,O
.,O
"

",O
Reducing,O
mortality,O
from,O
2019nCoV,B-Virus_SARS-CoV-2
:,O
hostdirected,O
therapies,O
should,O
be,O
an,O
option,O
.,O
"

",O
Zumla,O
A(1,O
),O
",",O
Hui,O
DS(2,O
),O
",",O
Azhar,O
EI(3,O
),O
",",O
Memish,O
ZA(4,O
),O
",",O
Maeurer,O
M(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Infection,O
",",O
Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
University,O
"
",O
College,O
London,O
",",O
London,O
",",O
UK,O
;,O
National,O
Institute,O
for,O
Health,O
Research,O
Biomedical,O
"
",O
Research,O
Centre,O
",",O
University,O
College,O
London,O
Hospitals,O
NHS,O
Foundation,O
Trust,O
",",O
"
",O
London,O
",",O
UK,O
.,O
"
",O
(2)Department,O
of,O
Medicine,O
&,O
Therapeutics,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
Prince,O
"
",O
of,O
Wales,O
Hospital,O
",",O
Shatin,O
",",O
New,O
Territories,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(3)Special,O
Infectious,O
Agents,O
Unit,O
",",O
King,O
Fahd,O
Medical,O
Research,O
Center,O
and,O
"
",O
Department,O
of,O
Medical,O
Laboratory,O
Technology,O
",",O
Faculty,O
of,O
Applied,O
Medical,O
Sciences,O
",",O
"
",O
King,O
Abdulaziz,O
University,O
",",O
Jeddah,O
",",O
Saudi,O
Arabia,O
.,O
"
",O
(4)Infectious,O
Diseases,O
Division,O
",",O
Department,O
of,O
Medicine,O
and,O
Research,O
Department,O
",",O
"
",O
Prince,O
Mohamed,O
Bin,O
Abdulaziz,O
Hospital,O
",",O
Ministry,O
of,O
Health,O
",",O
Riyadh,O
",",O
Saudi,O
Arabia,O
;,O
"
",O
College,O
of,O
Medicine,O
",",O
Alfaisal,O
University,O
",",O
Riyadh,O
",",O
Saudi,O
Arabia,O
.,O
"
",O
(5)Immunotherapy,O
Programme,O
",",O
Champalimaud,O
Centre,O
for,O
the,O
Unknown,O
",",O
1400038,O
Lisbon,O
",",O
"
",O
Portugal,O
;,O
I,O
Med,O
Clinic,O
",",O
University,O
of,O
Mainz,O
",",O
Mainz,O
",",O
Germany,O
.,O
Electronic,O
address,O
:,O
"
",O
markus.maeurer@fundacaochampalimaud.pt,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303056,O
"
",O
PMID,O
:,O
32035018,O
"


",O
768,O
.,O
Psychiatry,O
Clin,O
Neurosci,O
.,O
2020,O
Feb,O
8,O
.,O
doi,O
:,O
10.1111,O
pcn.12988,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Public,O
responses,O
to,O
the,O
novel,O
2019,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
in,O
Japan,O
:,O
Mental,O
"
",O
health,O
consequences,O
and,O
target,O
populations,O
.,O
"

",O
Shigemura,O
J(1,O
),O
",",O
Ursano,O
RJ(2,O
),O
",",O
Morganstein,O
JC(2,O
),O
",",O
Kurosawa,O
M(1)(3,O
),O
",",O
Benedek,O
DM(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Psychiatry,O
",",O
School,O
of,O
Medicine,O
",",O
National,O
Defense,O
Medical,O
"
",O
College,O
",",O
Tokorozawa,O
",",O
Japan,O
.,O
"
",O
(2)Center,O
for,O
the,O
Study,O
of,O
Traumatic,O
Stress,O
",",O
Department,O
of,O
Psychiatry,O
",",O
Uniformed,O
"
",O
Services,O
University,O
of,O
the,O
Health,O
Sciences,O
",",O
Bethesda,O
",",O
USA,O
.,O
"
",O
(3)Musashino,O
University,O
Creating,O
Happiness,O
Incubation,O
",",O
Musashino,O
University,O
",",O
"
",O
Tokyo,O
",",O
Japan,O
.,O
"

",O
DOI,O
:,O
10.1111,O
pcn.12988,O
"
",O
PMID,O
:,O
32034840,O
"


",O
769,O
.,O
World,O
J,O
Pediatr,O
.,O
2020,O
Feb,O
7,O
.,O
doi,O
:,O
10.1007,O
s12519020003437,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Diagnosis,O
",",O
treatment,O
",",O
and,O
prevention,O
of,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
in,O
"
",O
children,O
:,O
experts,O
',O
consensus,O
statement,O
.,O
"

",O
Shen,O
K(1,O
),O
",",O
Yang,O
Y(2,O
),O
",",O
Wang,O
T(3,O
),O
",",O
Zhao,O
D(4,O
),O
",",O
Jiang,O
Y(5,O
),O
",",O
Jin,O
R(6,O
),O
",",O
Zheng,O
Y(7,O
),O
",",O
Xu,O
"
",O
B(8,O
),O
",",O
Xie,O
Z(9,O
),O
",",O
Lin,O
L(10,O
),O
",",O
Shang,O
Y(11,O
),O
",",O
Lu,O
X(12,O
),O
",",O
Shu,O
S(13,O
),O
",",O
Bai,O
Y(6,O
),O
",",O
Deng,O
"
",O
J(14,O
),O
",",O
Lu,O
M(15,O
),O
",",O
Ye,O
L(16,O
),O
",",O
Wang,O
X(17,O
),O
",",O
Wang,O
Y(18,O
),O
",",O
Gao,O
L(8,O
),O
;,O
China,O
National,O
"
",O
Clinical,O
Research,O
Center,O
for,O
Respiratory,O
Diseases,O
;,O
National,O
Center,O
for,O
Children,O
â€™s,O
"
",O
Health,O
",",O
Beijing,O
",",O
China,O
;,O
Group,O
of,O
Respirology,O
",",O
Chinese,O
Pediatric,O
Society,O
",",O
Chinese,O
"
",O
Medical,O
Association,O
;,O
Chinese,O
Medical,O
Doctor,O
Association,O
Committee,O
on,O
Respirology,O
"
",O
Pediatrics,O
;,O
China,O
Medicine,O
Education,O
Association,O
Committee,O
on,O
Pediatrics,O
;,O
Chinese,O
"
",O
Research,O
Hospital,O
Association,O
Committee,O
on,O
Pediatrics,O
;,O
Chinese,O
Nongovernment,O
"
",O
Medical,O
Institutions,O
Association,O
Committee,O
on,O
Pediatrics,O
;,O
China,O
Association,O
of,O
"
",O
Traditional,O
Chinese,O
Medicine,O
",",O
Committee,O
on,O
Children,O
â€™s,O
Health,O
and,O
Medicine,O
"
",O
Research,O
;,O
China,O
News,O
of,O
Drug,O
Information,O
Association,O
",",O
Committee,O
on,O
Children,O
â€™s,O
"
",O
Safety,O
Medication,O
;,O
Global,O
Pediatric,O
Pulmonology,O
Alliance,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Beijing,O
Children,O
's,O
Hospital,O
",",O
Capital,O
"
",O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
kunlingshen1717@163.com,O
.,O
"
",O
(2)Beijing,O
Pediatric,O
Research,O
Institute,O
",",O
Beijing,O
Children,O
's,O
Hospital,O
",",O
Capital,O
"
",O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
yyh628628@sina.com,O
.,O
"
",O
(3)Center,O
of,O
Hematologic,O
Oncology,O
",",O
Beijing,O
Children,O
's,O
Hospital,O
",",O
Capital,O
Medical,O
"
",O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Pediatrics,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
zhao_wh2004@hotmail.com,O
.,O
"
",O
(5)Department,O
of,O
Pediatrics,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Pediatrics,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Shenzhen,O
Children,O
's,O
Hospital,O
",",O
Shenzhen,O
",",O
"
",O
China,O
.,O
"
",O
(8)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Beijing,O
Children,O
's,O
Hospital,O
",",O
Capital,O
"
",O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(9)Beijing,O
Pediatric,O
Research,O
Institute,O
",",O
Beijing,O
Children,O
's,O
Hospital,O
",",O
Capital,O
"
",O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(10)Hospital,O
Management,O
Institute,O
of,O
Wuhan,O
University,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(11)Department,O
of,O
Pediatric,O
Respiratory,O
",",O
Shengjing,O
Hospital,O
of,O
China,O
Medical,O
"
",O
University,O
",",O
Shenyang,O
",",O
China,O
.,O
"
",O
(12)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Wuhan,O
Children,O
's,O
Hospital,O
",",O
Tongji,O
Medical,O
"
",O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(13)Department,O
of,O
Pediatrics,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(14)Department,O
of,O
Infectious,O
Disease,O
",",O
Shenzhen,O
Children,O
's,O
Hospital,O
",",O
Shenzhen,O
",",O
"
",O
China,O
.,O
"
",O
(15)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Children,O
's,O
Hospital,O
of,O
Shanghai,O
",",O
"
",O
Shanghai,O
",",O
China,O
.,O
"
",O
(16)Department,O
of,O
Pediatrics,O
",",O
Peking,O
University,O
First,O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(17)Department,O
of,O
Pediatrics,O
",",O
Affiliated,O
Hospital,O
of,O
Liaoning,O
University,O
of,O
"
",O
Traditional,O
Chinese,O
Medicine,O
",",O
Shenyang,O
",",O
China,O
.,O
"
",O
(18)Institute,O
of,O
Basic,O
Research,O
in,O
Clinical,O
Medicine,O
",",O
China,O
Academy,O
of,O
Chinese,O
"
",O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
Since,O
the,O
outbreak,O
of,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
in,O
Wuhan,O
City,O
",",O
"
",O
China,O
",",O
by,O
January,O
30,O
",",O
2020,O
",",O
a,O
total,O
of,O
9692,O
confirmed,O
cases,O
and,O
15238,O
suspected,O
"
",O
cases,O
have,O
been,O
reported,O
around,O
31,O
provinces,O
or,O
cities,O
in,O
China,O
.,O
Among,O
the,O
"
",O
confirmed,O
cases,O
",",O
1527,O
were,O
severe,O
cases,O
",",O
171,O
had,O
recovered,O
and,O
been,O
discharged,O
at,O
"
",O
home,O
",",O
and,O
213,O
died,O
.,O
And,O
among,O
these,O
cases,O
",",O
a,O
Â ,O
total,O
of,O
28,O
children,O
aged,O
from,O
"
",O
1,O
Â ,O
month,O
to,O
17,O
Â ,O
years,O
have,O
been,O
reported,O
in,O
China,O
.,O
For,O
standardizing,O
prevention,O
and,O
"
",O
management,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
infections,O
in,O
children,O
",",O
we,O
called,O
up,O
an,O
experts,O
',O
"
",O
committee,O
to,O
formulate,O
this,O
experts,O
',O
consensus,O
statement,O
.,O
This,O
statement,O
is,O
based,O
"
",O
on,O
the,O
Novel,B-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Infection,I-Disease_COVID-19
Pneumonia,O
Diagnosis,O
and,O
Treatment,O
Standards,O
"
",O
(,O
the,O
fourth,O
edition,O
),O
(,O
National,O
Health,O
Committee,O
),O
and,O
other,O
previous,O
diagnosis,O
and,O
"
",O
treatment,O
strategies,O
for,O
pediatric,O
virus,O
infections,O
.,O
The,O
present,O
consensus,O
"
",O
statement,O
summarizes,O
current,O
strategies,O
on,O
diagnosis,O
",",O
treatment,O
",",O
and,O
prevention,O
"
",O
of,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
in,O
children,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12519020003437,O
"
",O
PMID,O
:,O
32034659,O
"


",O
770,O
.,O
Virol,O
Sin,O
.,O
2020,O
Feb,O
7,O
.,O
doi,O
:,O
10.1007,O
s12250020002056,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Compensation,O
of,O
ACE2,O
Function,O
for,O
Possible,O
Clinical,O
Management,O
of,O
"
",O
2019nCoVInduced,O
Acute,O
Lung,O
Injury,O
.,O
"

",O
Wu,O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Center,O
for,O
Biodefense,O
and,O
Infectious,O
Diseases,O
",",O
School,O
of,O
Systems,O
"
",O
Biology,O
",",O
George,O
Mason,O
University,O
",",O
Manassas,O
",",O
VA,O
",",O
20110,O
",",O
USA,O
.,O
ywu8@gmu.edu,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12250020002056,O
"
",O
PMID,O
:,O
32034638,O
"


",O
771,O
.,O
Virol,O
Sin,O
.,O
2020,O
Feb,O
7,O
.,O
doi,O
:,O
10.1007,O
s12250020002038,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
Features,O
and,O
Treatment,O
of,O
2019nCov,B-Disease_COVID-19
Pneumonia,I-Disease_COVID-19
Patients,O
in,O
Wuhan,O
:,O
Report,O
"
",O
of,O
A,O
Couple,O
Cases,O
.,O
"

",O
Zhang,O
Z(1,O
),O
",",O
Li,O
X(2,O
),O
",",O
Zhang,O
W(3,O
),O
",",O
Shi,O
ZL(3,O
),O
",",O
Zheng,O
Z(2,O
),O
",",O
Wang,O
T(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Respiratory,O
Disease,O
and,O
Intensive,O
Care,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
",",O
430060,O
",",O
China,O
.,O
doctorzhang2003@163.com,O
.,O
"
",O
(2)Department,O
of,O
Respiratory,O
Disease,O
and,O
Intensive,O
Care,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
",",O
430060,O
",",O
China,O
.,O
"
",O
(3)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
"
",O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12250020002038,O
"
",O
PMID,O
:,O
32034637,O
"


",O
772,O
.,O
BMJ,O
.,O
2020,O
Feb,O
7;368:m516,O
.,O
doi,O
:,O
10.1136,O
bmj.m516,O
.,O
"

",O
In,O
Beijing,O
",",O
coronavirus,O
2019nCoV,B-Virus_SARS-CoV-2
has,O
created,O
a,O
siege,O
mentality,O
.,O
"

",O
Mowbray,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Beijing,O
.,O
"

",O
Comment,O
in,O
"
    ",O
BMJ,O
.,O
2020,O
Mar,O
2;368:m764,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m516,O
"
",O
PMID,O
:,O
32033967,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interests,O
:,O
I,O
have,O
read,O
and,O
understood,O
"
",O
BMJ,O
policy,O
on,O
declaration,O
of,O
interests,O
and,O
have,O
no,O
relevant,O
interests,O
to,O
declare,O
.,O
"


",O
773,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
4;9(2,O
),O
.,O
pii,O
:,O
E419,O
.,O
doi,O
:,O
10.339,O
jcm9020419,O
.,O
"

",O
The,O
Rate,O
of,O
Underascertainment,O
of,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
Infection,O
:,O
"
",O
Estimation,O
Using,O
Japanese,O
Passengers,O
Data,O
on,O
Evacuation,O
Flights,O
.,O
"

",O
Nishiura,O
H(1)(2,O
),O
",",O
Kobayashi,O
T(1,O
),O
",",O
Yang,O
Y(1,O
),O
",",O
Hayashi,O
K(1,O
),O
",",O
Miyama,O
T(3,O
),O
",",O
Kinoshita,O
"
",O
R(1,O
),O
",",O
Linton,O
NM(1,O
),O
",",O
Jung,O
SM(1,O
),O
",",O
Yuan,O
B(1,O
),O
",",O
Suzuki,O
A(1,O
),O
",",O
Akhmetzhanov,O
AR(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Graduate,O
School,O
of,O
Medicine,O
",",O
Hokkaido,O
University,O
",",O
Kita,O
15,O
Jo,O
Nishi,O
7,O
Chome,O
",",O
"
",O
Kitaku,O
",",O
Sapporoshi,O
",",O
Hokkaido,O
608638,O
",",O
Japan,O
.,O
"
",O
(2)Core,O
Research,O
for,O
Evolutionary,O
Science,O
and,O
Technology,O
",",O
Japan,O
Science,O
and,O
"
",O
Technology,O
Agency,O
",",O
Honcho,O
418,O
",",O
Kawaguchi,O
",",O
Saitama,O
3320012,O
",",O
Japan,O
.,O
"
",O
(3)Osaka,O
Institute,O
of,O
Public,O
Health,O
",",O
Nakamichi,O
1369,O
",",O
Higashinari,O
",",O
Osaka,O
"
",O
5370025,O
",",O
Japan,O
.,O
"

",O
From,O
29,O
to,O
31,O
January,O
2020,O
",",O
a,O
total,O
of,O
565,O
Japanese,O
citizens,O
were,O
evacuated,O
from,O
"
",O
Wuhan,O
",",O
China,O
on,O
three,O
chartered,O
flights,O
.,O
All,O
passengers,O
were,O
screened,O
upon,O
"
",O
arrival,O
in,O
Japan,O
for,O
symptoms,O
consistent,O
with,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
"
",O
infection,O
and,O
tested,O
for,O
presence,O
of,O
the,O
virus,O
.,O
Assuming,O
that,O
the,O
mean,O
detection,O
"
",O
window,O
of,O
the,O
virus,O
can,O
be,O
informed,O
by,O
the,O
mean,O
serial,O
interval,O
(,O
estimated,O
at,O
7.5,O
"
",O
days,O
),O
",",O
the,O
ascertainment,O
rate,O
of,O
infection,O
was,O
estimated,O
at,O
9.2,O
%,O
(,O
95,O
%,O
confidence,O
"
",O
interval,O
:,O
5,O
",",O
20,O
),O
.,O
This,O
indicates,O
that,O
the,O
incidence,O
of,O
infection,O
in,O
Wuhan,O
can,O
"
",O
be,O
estimated,O
at,O
20767,O
infected,O
individuals,O
",",O
including,O
those,O
with,O
asymptomatic,O
"
",O
and,O
mildly,O
symptomatic,O
infections,O
.,O
The,O
infection,O
fatality,O
risk,O
(IFR)the,O
actual,O
"
",O
risk,O
of,O
death,O
among,O
all,O
infected,O
individualsis,O
therefore,O
0.3,O
%,O
to,O
0.6,O
%,O
",",O
which,O
may,O
"
",O
be,O
comparable,O
to,O
Asian,O
influenza,O
pandemic,O
of,O
19571958,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9020419,O
"
",O
PMID,O
:,O
32033064,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
774,O
.,O
Microbes,O
Infect,O
.,O
2020,O
Feb,O
4,O
.,O
pii,O
:,O
S12864579(20)300265,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.micinf.2020.01.004,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Pathogenicity,O
and,O
transmissibility,O
of,O
2019nCoVA,O
quick,O
overview,O
and,O
comparison,O
"
",O
with,O
other,O
emerging,O
viruses,O
.,O
"

",O
Chen,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Medical,O
Molecular,O
Virology,O
(,O
MOE,O
NHC,O
CAMS,O
),O
",",O
School,O
of,O
Basic,O
"
",O
Medical,O
Sciences,O
",",O
Shanghai,O
Medical,O
College,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
jieliangchen@fudan.edu.cn,O
.,O
"

",O
A,O
zoonotic,O
coronavirus,O
",",O
tentatively,O
labeled,O
as,O
2019nCoV,B-Virus_SARS-CoV-2
by,O
the,O
World,O
Health,O
"
",O
Organization,O
(,O
WHO,O
),O
",",O
has,O
been,O
identified,O
as,O
the,O
causative,O
agent,O
of,O
the,O
viral,O
"
",O
pneumonia,O
outbreak,O
in,O
Wuhan,O
",",O
China,O
",",O
at,O
the,O
end,O
of,O
2019,O
.,O
Although,O
2019nCoV,B-Virus_SARS-CoV-2
can,O
"
",O
cause,O
a,O
severe,O
respiratory,O
illness,O
like,O
SARS,O
and,O
MERS,O
",",O
evidence,O
from,O
clinics,O
"
",O
suggested,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
generally,O
less,O
pathogenic,O
than,O
SARSCoV,O
",",O
and,O
much,O
"
",O
less,O
than,O
MERSCoV.,O
The,O
transmissibility,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
still,O
debated,O
and,O
needs,O
"
",O
to,O
be,O
further,O
assessed,O
.,O
To,O
avoid,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
outbreak,O
turning,O
into,O
an,O
epidemic,O
"
",O
or,O
even,O
a,O
pandemic,O
and,O
to,O
minimize,O
the,O
mortality,O
rate,O
",",O
China,O
activated,O
emergency,O
"
",O
response,O
procedures,O
",",O
but,O
much,O
remains,O
to,O
be,O
learned,O
about,O
the,O
features,O
of,O
the,O
"
",O
virus,O
to,O
refine,O
the,O
risk,O
assessment,O
and,O
response,O
.,O
Here,O
",",O
the,O
current,O
knowledge,O
in,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
pathogenicity,O
and,O
transmissibility,O
is,O
summarized,O
in,O
comparison,O
with,O
"
",O
several,O
commonly,O
known,O
emerging,O
viruses,O
",",O
and,O
information,O
urgently,O
needed,O
for,O
a,O
"
",O
better,O
control,O
of,O
the,O
disease,O
is,O
highlighted,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Author(s,O
),O
.,O
Published,O
by,O
Elsevier,O
Masson,O
SAS,O
..,O
All,O
rights,O
"
",O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.micinf.2020.01.004,O
"
",O
PMID,O
:,O
32032682,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
author,O
"
",O
declared,O
no,O
competing,O
interests,O
.,O
"


",O
775,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Feb,O
4:101571,O
.,O
doi,O
:,O
10.1016,O
j.tmaid.2020.101571,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Outbreak,O
of,O
novel,B-Virus_SARS-CoV-2
Corona,I-Virus_SARS-CoV-2
virus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
;,O
implications,O
for,O
travelers,O
to,O
"
",O
Pakistan,O
.,O
"

",O
Rahman,O
Qureshi,O
UU(1,O
),O
",",O
Saleem,O
S(2,O
),O
",",O
Khan,O
A(2,O
),O
",",O
Afzal,O
MS(3,O
),O
",",O
Ali,O
MS(4,O
),O
",",O
Ahmed,O
H(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Health,O
Sciences,O
",",O
Firat,O
University,O
Elazig,O
",",O
Turkey,O
.,O
"
",O
(2)Department,O
of,O
Biosciences,O
",",O
COMSATS,O
University,O
Islamabad,O
(,O
CUI,O
),O
",",O
Islamabad,O
",",O
"
",O
Pakistan,O
.,O
"
",O
(3)Department,O
of,O
Life,O
Sciences,O
",",O
University,O
of,O
Management,O
&,O
Technology,O
(,O
UMT,O
),O
",",O
"
",O
Lahore,O
",",O
Pakistan,O
.,O
"
",O
(4)Department,O
of,O
Wildlife,O
&,O
Fisheries,O
",",O
University,O
of,O
Veterinary,O
and,O
Animal,O
"
",O
Sciences,O
(,O
UVAS,O
),O
",",O
Lahore,O
",",O
Pakistan,O
.,O
"
",O
(5)Department,O
of,O
Biosciences,O
",",O
COMSATS,O
University,O
Islamabad,O
(,O
CUI,O
),O
",",O
Islamabad,O
",",O
"
",O
Pakistan,O
.,O
Electronic,O
address,O
:,O
haroonahmed@comsats.edu.pk,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101571,O
"
",O
PMID,O
:,O
32032674,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
The,O
authors,O
"
",O
declare,O
that,O
there,O
is,O
no,O
conflict,O
of,O
interest,O
or,O
financial,O
disclosure,O
about,O
this,O
"
",O
publication,O
.,O
"


",O
776,O
.,O
J,O
Hosp,O
Infect,O
.,O
2020,O
Mar;104(3):252253,O
.,O
doi,O
:,O
10.1016,O
j.jhin.2020.01.019,O
.,O
Epub,O
"
",O
2020,O
Feb,O
4,O
.,O
"

",O
Novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
is,O
putting,O
the,O
whole,O
world,O
on,O
alert,O
.,O
"

",O
Khan,O
S(1,O
),O
",",O
Ali,O
A(2,O
),O
",",O
Siddique,O
R(3,O
),O
",",O
Nabi,O
G(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Cerebrovascular,O
Diseases,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
"
",O
Zhengzhou,O
University,O
",",O
Zhengzhou,O
",",O
China,O
;,O
Henan,O
Medical,O
Key,O
Laboratory,O
of,O
"
",O
Translational,O
Cerebrovascular,O
Diseases,O
",",O
Zhengzhou,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
Suliman.khan18@mails.ucas.ac.cn,O
.,O
"
",O
(2)Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
;,O
"
",O
University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Cerebrovascular,O
Diseases,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
"
",O
Zhengzhou,O
University,O
",",O
Zhengzhou,O
",",O
China,O
;,O
Henan,O
Medical,O
Key,O
Laboratory,O
of,O
"
",O
Translational,O
Cerebrovascular,O
Diseases,O
",",O
Zhengzhou,O
",",O
China,O
.,O
"
",O
(4)Key,O
Laboratory,O
of,O
Animal,O
Physiology,O
",",O
Biochemistry,O
and,O
Molecular,O
Biology,O
of,O
"
",O
Hebei,O
Province,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Hebei,O
Normal,O
University,O
",",O
Shijiazhuang,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
ghulamnabiqau@gmail.com,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jhin.2020.01.019,O
"
",O
PMID,O
:,O
32032614,O
"


",O
777,O
.,O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):e30e31,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)303044,O
.,O
Epub,O
"
",O
2020,O
Feb,O
4,O
.,O
"

",O
Baricitinib,O
as,O
potential,O
treatment,O
for,O
2019nCoV,B-Disease_COVID-19
acute,I-Disease_COVID-19
respiratory,I-Disease_COVID-19
disease,I-Disease_COVID-19
.,O
"

",O
Richardson,O
P(1,O
),O
",",O
Griffin,O
I(1,O
),O
",",O
Tucker,O
C(1,O
),O
",",O
Smith,O
D(1,O
),O
",",O
Oechsle,O
O(1,O
),O
",",O
Phelan,O
"
",O
A(1,O
),O
",",O
Stebbing,O
J(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)BenevolentAI,O
",",O
London,O
",",O
UK,O
.,O
"
",O
(2)Department,O
of,O
Surgery,O
and,O
Cancer,O
",",O
Imperial,O
College,O
London,O
",",O
London,O
SW7,O
2AZ,O
",",O
UK,O
.,O
"
",O
Electronic,O
address,O
:,O
j.stebbing@imperial.ac.uk,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)303044,O
"
",O
PMID,O
:,O
32032529,O
"


",O
778,O
.,O
Radiology,O
.,O
2020,O
Feb,O
7:200269,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200269,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Evolution,O
of,O
CT,O
Manifestations,O
in,O
a,O
Patient,O
Recovered,O
from,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
Pneumonia,O
in,O
Wuhan,O
",",O
China,O
.,O
"

",O
Shi,O
H(1,O
),O
",",O
Han,O
X(1,O
),O
",",O
Zheng,O
C(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Department,O
of,O
Radiology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
1277,O
Jiefang,O
Rd,O
",",O
Wuhan,O
",",O
Hubei,O
"
",O
Province,O
430022,O
",",O
The,O
People,O
's,O
Republic,O
of,O
China,O
;,O
and,O
Hubei,O
Province,O
Key,O
"
",O
Laboratory,O
of,O
Molecular,O
Imaging,O
",",O
Wuhan,O
",",O
The,O
People,O
's,O
Republic,O
of,O
China,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200269,O
"
",O
PMID,O
:,O
32032497,O
"


",O
779,O
.,O
Clin,O
Chem,O
.,O
2020,O
Feb,O
7,O
.,O
pii,O
:,O
hvaa038,O
.,O
doi,O
:,O
10.1093,O
clinchem,O
hvaa038,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Racing,O
towards,O
the,O
development,O
of,O
diagnostics,O
for,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
"

",O
Dennis,O
Lo,O
YM(1,O
),O
",",O
Chiu,O
RWK(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Li,O
Ka,O
Shing,O
Institute,O
of,O
Health,O
Sciences,O
and,O
Department,O
of,O
Chemical,O
Pathology,O
",",O
"
",O
The,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
Prince,O
of,O
Wales,O
Hospital,O
",",O
Shatin,O
",",O
New,O
"
",O
Territories,O
",",O
Hong,O
Kong,O
SAR,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1093,O
clinchem,O
hvaa038,O
"
",O
PMID,O
:,O
32031590,O
"


",O
780,O
.,O
Clin,O
Chem,O
.,O
2020,O
Jan,O
31,O
.,O
pii,O
:,O
hvaa029,O
.,O
doi,O
:,O
10.1093,O
clinchem,O
hvaa029,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Molecular,O
Diagnosis,O
of,O
a,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
Causing,O
an,O
Outbreak,O
of,O
"
",O
Pneumonia,O
.,O
"

",O
Chu,O
DKW(1,O
),O
",",O
Pan,O
Y(2)(3)(4,O
),O
",",O
Cheng,O
SMS(1,O
),O
",",O
Hui,O
KPY(1,O
),O
",",O
Krishnan,O
P(1,O
),O
",",O
Liu,O
Y(1,O
),O
",",O
Ng,O
"
",O
DYM(1,O
),O
",",O
Wan,O
CKC(1,O
),O
",",O
Yang,O
P(2)(3)(4,O
),O
",",O
Wang,O
Q(2)(3,O
),O
",",O
Peiris,O
M(1,O
),O
",",O
Poon,O
LLM(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Public,O
Health,O
",",O
LKS,O
Faculty,O
of,O
Medicine,O
",",O
The,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
.,O
"
",O
(2)Beijing,O
Center,O
for,O
Disease,O
Prevention,O
and,O
Control,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Beijing,O
Research,O
Center,O
for,O
Preventive,O
Medicine,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)School,O
of,O
Public,O
Health,O
",",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
of,O
zoonotic,O
origin,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
has,O
recently,O
been,O
"
",O
identified,O
in,O
patients,O
with,O
acute,O
respiratory,O
disease,O
.,O
This,O
virus,O
is,O
genetically,O
"
",O
similar,O
to,O
SARS,O
coronavirus,O
and,O
bat,O
SARSlike,O
coronaviruses,O
.,O
The,O
outbreak,O
was,O
"
",O
initially,O
detected,O
in,O
Wuhan,O
",",O
a,O
major,O
city,O
of,O
China,O
",",O
but,O
has,O
subsequently,O
been,O
"
",O
detected,O
in,O
other,O
provinces,O
of,O
China,O
.,O
Travelassociated,O
cases,O
have,O
also,O
been,O
"
",O
reported,O
in,O
a,O
few,O
other,O
countries,O
.,O
Outbreaks,O
in,O
health,O
care,O
workers,O
indicate,O
"
",O
humantohuman,O
transmission,O
.,O
Molecular,O
tests,O
for,O
rapid,O
detection,O
of,O
this,O
virus,O
"
",O
are,O
urgently,O
needed,O
for,O
early,O
identification,O
of,O
infected,O
patients,O
.,O
"
",O
METHODS,O
:,O
We,O
developed,O
two,O
1step,O
quantitative,O
realtime,O
reversetranscription,O
PCR,O
"
",O
assays,O
to,O
detect,O
two,O
different,O
regions,O
(,O
ORF1b,O
and,O
N,O
),O
of,O
the,O
viral,O
genome,O
.,O
The,O
"
",O
primer,O
and,O
probe,O
sets,O
were,O
designed,O
to,O
react,O
with,O
this,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
and,O
its,O
"
",O
closely,O
related,O
viruses,O
",",O
such,O
as,O
SARS,O
coronavirus,O
.,O
These,O
assays,O
were,O
evaluated,O
"
",O
using,O
a,O
panel,O
of,O
positive,O
and,O
negative,O
controls,O
.,O
In,O
addition,O
",",O
respiratory,O
"
",O
specimens,O
from,O
two,O
2019nCoVinfected,O
patients,O
were,O
tested,O
.,O
"
",O
RESULTS,O
:,O
Using,O
RNA,O
extracted,O
from,O
cells,O
infected,O
by,O
SARS,O
coronavirus,O
as,O
a,O
"
",O
positive,O
control,O
",",O
these,O
assays,O
were,O
shown,O
to,O
have,O
a,O
dynamic,O
range,O
of,O
at,O
least,O
"
",O
seven,O
orders,O
of,O
magnitude,O
(,O
2x1042000,O
TCID50,O
reaction,O
),O
.,O
Using,O
DNA,O
plasmids,O
as,O
"
",O
positive,O
standards,O
",",O
the,O
detection,O
limits,O
of,O
these,O
assays,O
were,O
found,O
to,O
be,O
below,O
"
",O
10,O
copies,O
per,O
reaction,O
.,O
All,O
negative,O
control,O
samples,O
were,O
negative,O
in,O
the,O
assays,O
.,O
"
",O
Samples,O
from,O
two,O
2019nCoVinfected,O
patients,O
were,O
positive,O
in,O
the,O
tests,O
.,O
"
",O
CONCLUSIONS,O
:,O
The,O
established,O
assays,O
can,O
achieve,O
a,O
rapid,O
detection,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
"
",O
human,O
samples,O
",",O
thereby,O
allowing,O
early,O
identification,O
of,O
patients,O
.,O
"

",O
Â©,O
American,O
Association,O
for,O
Clinical,O
Chemistry,O
2020,O
.,O
All,O
rights,O
reserved,O
.,O
For,O
"
",O
permissions,O
",",O
please,O
email,O
:,O
journals.permissions@oup.com,O
.,O
"

",O
DOI,O
:,O
10.1093,O
clinchem,O
hvaa029,O
"
",O
PMID,O
:,O
32031583,O
"


",O
781,O
.,O
JAMA,O
.,O
2020,O
Feb,O
7,O
.,O
doi,O
:,O
10.1001,O
jama.2020.1585,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Clinical,O
Characteristics,O
of,O
138,O
Hospitalized,O
Patients,O
With,O
2019,O
Novel,O
"
",O
CoronavirusInfected,O
Pneumonia,O
in,O
Wuhan,O
",",O
China,O
.,O
"

",O
Wang,O
D(1,O
),O
",",O
Hu,O
B(1,O
),O
",",O
Hu,O
C(1,O
),O
",",O
Zhu,O
F(1,O
),O
",",O
Liu,O
X(1,O
),O
",",O
Zhang,O
J(1,O
),O
",",O
Wang,O
B(1,O
),O
",",O
Xiang,O
"
",O
H(1,O
),O
",",O
Cheng,O
Z(2,O
),O
",",O
Xiong,O
Y(3,O
),O
",",O
Zhao,O
Y(4,O
),O
",",O
Li,O
Y(5,O
),O
",",O
Wang,O
X(6,O
),O
",",O
Peng,O
Z(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pulmonary,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Infectious,O
Disease,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Emergency,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Laboratory,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Urology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
"
",O
China,O
.,O
"

",O
Importance,O
:,O
In,O
December,O
2019,O
",",O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(2019nCoV)infected,O
pneumonia,O
"
",O
(,O
NCIP,O
),O
occurred,O
in,O
Wuhan,O
",",O
China,O
.,O
The,O
number,O
of,O
cases,O
has,O
increased,O
rapidly,O
but,O
"
",O
information,O
on,O
the,O
clinical,O
characteristics,O
of,O
affected,O
patients,O
is,O
limited,O
.,O
"
",O
Objective,O
:,O
To,O
describe,O
the,O
epidemiological,O
and,O
clinical,O
characteristics,O
of,O
NCIP,O
.,O
"
",O
Design,O
",",O
Setting,O
",",O
and,O
Participants,O
:,O
Retrospective,O
",",O
singlecenter,O
case,O
series,O
of,O
"
",O
the,O
138,O
consecutive,O
hospitalized,O
patients,O
with,O
confirmed,O
NCIP,O
at,O
Zhongnan,O
"
",O
Hospital,O
of,O
Wuhan,O
University,O
in,O
Wuhan,O
",",O
China,O
",",O
from,O
January,O
1,O
to,O
January,O
28,O
",",O
2020,O
;,O
"
",O
final,O
date,O
of,O
followup,O
was,O
February,O
3,O
",",O
2020,O
.,O
"
",O
Exposures,O
:,O
Documented,O
NCIP,O
.,O
"
",O
Main,O
Outcomes,O
and,O
Measures,O
:,O
Epidemiological,O
",",O
demographic,O
",",O
clinical,O
",",O
laboratory,O
",",O
"
",O
radiological,O
",",O
and,O
treatment,O
data,O
were,O
collected,O
and,O
analyzed,O
.,O
Outcomes,O
of,O
"
",O
critically,O
ill,O
patients,O
and,O
noncritically,O
ill,O
patients,O
were,O
compared,O
.,O
Presumed,O
"
",O
hospitalrelated,O
transmission,O
was,O
suspected,O
if,O
a,O
cluster,O
of,O
health,O
professionals,O
"
",O
or,O
hospitalized,O
patients,O
in,O
the,O
same,O
wards,O
became,O
infected,O
and,O
a,O
possible,O
source,O
"
",O
of,O
infection,O
could,O
be,O
tracked,O
.,O
"
",O
Results,O
:,O
Of,O
138,O
hospitalized,O
patients,O
with,O
NCIP,O
",",O
the,O
median,O
age,O
was,O
56,O
years,O
"
",O
(,O
interquartile,O
range,O
",",O
4268,O
;,O
range,O
",",O
2292,O
years,O
),O
and,O
75,O
(,O
54.3,O
%,O
),O
were,O
men,O
.,O
"
",O
Hospitalassociated,O
transmission,O
was,O
suspected,O
as,O
the,O
presumed,O
mechanism,O
of,O
"
",O
infection,O
for,O
affected,O
health,O
professionals,O
(,O
40,O
[,O
29,O
%,O
],O
),O
and,O
hospitalized,O
patients,O
"
",O
(,O
17,O
[,O
12.3,O
%,O
],O
),O
.,O
Common,O
symptoms,O
included,O
fever,O
(,O
136,O
[,O
98.6,O
%,O
],O
),O
",",O
fatigue,O
(,O
96,O
[,O
69.6,O
%,O
],O
),O
",",O
"
",O
and,O
dry,O
cough,O
(,O
82,O
[,O
59.4,O
%,O
],O
),O
.,O
Lymphopenia,O
(,O
lymphocyte,O
count,O
",",O
0.8,O
â€‰,O
Ã—,O
â€‰,O
109,O
L,O
"
",O
[,O
interquartile,O
range,O
{,O
IQR,O
},O
",",O
0.61.1,O
],O
),O
occurred,O
in,O
97,O
patients,O
(,O
70.3,O
%,O
),O
",",O
prolonged,O
"
",O
prothrombin,O
time,O
(,O
13,O
seconds,O
[,O
IQR,O
",",O
12.313.7,O
],O
),O
in,O
80,O
patients,O
(,O
58,O
%,O
),O
",",O
and,O
"
",O
elevated,O
lactate,O
dehydrogenase,O
(,O
261,O
U,O
L,O
[,O
IQR,O
",",O
182403,O
],O
),O
in,O
55,O
patients,O
(,O
39.9,O
%,O
),O
.,O
"
",O
Chest,O
computed,O
tomographic,O
scans,O
showed,O
bilateral,O
patchy,O
shadows,O
or,O
ground,O
glass,O
"
",O
opacity,O
in,O
the,O
lungs,O
of,O
all,O
patients,O
.,O
Most,O
patients,O
received,O
antiviral,O
therapy,O
"
",O
(,O
oseltamivir,O
",",O
124,O
[,O
89.9,O
%,O
],O
),O
",",O
and,O
many,O
received,O
antibacterial,O
therapy,O
"
",O
(,O
moxifloxacin,O
",",O
89,O
[,O
64.4,O
%,O
],O
;,O
ceftriaxone,O
",",O
34,O
[,O
24.6,O
%,O
],O
;,O
azithromycin,O
",",O
25,O
[,O
18.1,O
%,O
],O
),O
and,O
"
",O
glucocorticoid,O
therapy,O
(,O
62,O
[,O
44.9,O
%,O
],O
),O
.,O
Thirtysix,O
patients,O
(,O
26.1,O
%,O
),O
were,O
transferred,O
"
",O
to,O
the,O
intensive,O
care,O
unit,O
(,O
ICU,O
),O
because,O
of,O
complications,O
",",O
including,O
acute,O
"
",O
respiratory,O
distress,O
syndrome,O
(,O
22,O
[,O
61.1,O
%,O
],O
),O
",",O
arrhythmia,O
(,O
16,O
[,O
44.4,O
%,O
],O
),O
",",O
and,O
shock,O
"
",O
(,O
11,O
[,O
30.6,O
%,O
],O
),O
.,O
The,O
median,O
time,O
from,O
first,O
symptom,O
to,O
dyspnea,O
was,O
5,O
days,O
",",O
to,O
"
",O
hospital,O
admission,O
was,O
7,O
days,O
",",O
and,O
to,O
ARDS,O
was,O
8,O
days,O
.,O
Patients,O
treated,O
in,O
"
",O
the,O
ICU,O
(,O
n,O
â€‰,O
=,O
â€‰,O
36,O
),O
",",O
compared,O
with,O
patients,O
not,O
treated,O
in,O
the,O
ICU,O
(,O
n,O
â€‰,O
=,O
â€‰,O
102,O
),O
",",O
were,O
"
",O
older,O
(,O
median,O
age,O
",",O
66,O
years,O
vs,O
51,O
years,O
),O
",",O
were,O
more,O
likely,O
to,O
have,O
underlying,O
"
",O
comorbidities,O
(,O
26,O
[,O
72.2,O
%,O
],O
vs,O
38,O
[,O
37.3,O
%,O
],O
),O
",",O
and,O
were,O
more,O
likely,O
to,O
have,O
dyspnea,O
"
",O
(,O
23,O
[,O
63.9,O
%,O
],O
vs,O
20,O
[,O
19.6,O
%,O
],O
),O
",",O
and,O
anorexia,O
(,O
24,O
[,O
66.7,O
%,O
],O
vs,O
31,O
[,O
30.4,O
%,O
],O
),O
.,O
Of,O
the,O
36,O
"
",O
cases,O
in,O
the,O
ICU,O
",",O
4,O
(,O
11.1,O
%,O
),O
received,O
highflow,O
oxygen,O
therapy,O
",",O
15,O
(,O
41.7,O
%,O
),O
"
",O
received,O
noninvasive,O
ventilation,O
",",O
and,O
17,O
(,O
47.2,O
%,O
),O
received,O
invasive,O
ventilation,O
(,O
4,O
"
",O
were,O
switched,O
to,O
extracorporeal,O
membrane,O
oxygenation,O
),O
.,O
As,O
of,O
February,O
3,O
",",O
47,O
"
",O
patients,O
(,O
34.1,O
%,O
),O
were,O
discharged,O
and,O
6,O
died,O
(,O
overall,O
mortality,O
",",O
4.3,O
%,O
),O
",",O
but,O
the,O
"
",O
remaining,O
patients,O
are,O
still,O
hospitalized,O
.,O
Among,O
those,O
discharged,O
alive,O
(,O
n,O
â€‰,O
=,O
â€‰,O
47,O
),O
",",O
"
",O
the,O
median,O
hospital,O
stay,O
was,O
10,O
days,O
(,O
IQR,O
",",O
7.014.0,O
),O
.,O
"
",O
Conclusions,O
and,O
Relevance,O
:,O
In,O
this,O
singlecenter,O
case,O
series,O
of,O
138,O
hospitalized,O
"
",O
patients,O
with,O
confirmed,O
NCIP,O
in,O
Wuhan,O
",",O
China,O
",",O
presumed,O
hospitalrelated,O
"
",O
transmission,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
was,O
suspected,O
in,O
41,O
%,O
of,O
patients,O
",",O
26,O
%,O
of,O
patients,O
"
",O
received,O
ICU,O
care,O
",",O
and,O
mortality,O
was,O
4.3,O
%,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.1585,O
"
",O
PMCID,O
:,O
PMC7042881,O
[,O
Available,O
on,O
20200807,O
],O
"
",O
PMID,O
:,O
32031570,O
"


",O
782,O
.,O
JAMA,O
.,O
2020,O
Feb,O
7,O
.,O
doi,O
:,O
10.1001,O
jama.2020.1623,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Epidemiologic,O
and,O
Clinical,O
Characteristics,O
of,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
Infections,O
"
",O
Involving,O
13,O
Patients,O
Outside,O
Wuhan,O
",",O
China,O
.,O
"

",O
Chang(1,O
),O
",",O
Lin,O
M(2,O
),O
",",O
Wei,O
L(3,O
),O
",",O
Xie,O
L(1,O
),O
",",O
Zhu,O
G(4,O
),O
",",O
Dela,O
Cruz,O
CS(5,O
),O
",",O
Sharma,O
L(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)College,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Chinese,O
PLA,O
General,O
"
",O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Beijing,O
Tsinghua,O
Changgung,O
Hospital,O
",",O
Tsinghua,O
University,O
School,O
of,O
Medicine,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Institute,O
for,O
Precision,O
Medicine,O
",",O
Tsinghua,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Infectious,O
Diseases,O
",",O
Beijing,O
Anzhen,O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)Section,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
and,O
Sleep,O
Medicine,O
",",O
Yale,O
University,O
"
",O
School,O
of,O
Medicine,O
",",O
New,O
Haven,O
",",O
Connecticut,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.1623,O
"
",O
PMCID,O
:,O
PMC7042871,O
[,O
Available,O
on,O
20200807,O
],O
"
",O
PMID,O
:,O
32031568,O
"


",O
783,O
.,O
Radiology,O
.,O
2020,O
Feb,O
7:200280,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200280,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
CT,O
Manifestations,O
of,O
Two,O
Cases,O
of,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
Pneumonia,O
.,O
"

",O
Fang,O
Y(1,O
),O
",",O
Zhang,O
H(1,O
),O
",",O
Xu,O
Y(1,O
),O
",",O
Xie,O
J(1,O
),O
",",O
Pang,O
P(1,O
),O
",",O
Ji,O
W(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
Investigating,O
and,O
Research,O
Team,O
",",O
Department,O
of,O
Radiology,O
",",O
"
",O
Affiliated,O
Taizhou,O
Hospital,O
of,O
Wenzhou,O
Medical,O
University,O
",",O
150,O
Ximen,O
Street,O
",",O
"
",O
Linhai,O
",",O
317000,O
",",O
Zhejiang,O
Province,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200280,O
"
",O
PMID,O
:,O
32031481,O
"


",O
784,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
7,O
.,O
doi,O
:,O
10.1002,O
jmv.25702,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Evolving,O
status,O
of,O
the,O
2019,B-Disease_COVID-19
novel,I-Disease_COVID-19
coronavirus,I-Disease_COVID-19
infection,I-Disease_COVID-19
:,O
Proposal,O
of,O
conventional,O
"
",O
serologic,O
assays,O
for,O
disease,O
diagnosis,O
and,O
infection,O
monitoring,O
.,O
"

",O
Xiao,O
SY(1)(2,O
),O
",",O
Wu,O
Y(1,O
),O
",",O
Liu,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pathology,O
",",O
Wuhan,O
University,O
Zhongnan,O
Hospital,O
",",O
Wuhan,O
University,O
"
",O
Center,O
for,O
Pathology,O
and,O
Molecular,O
Diagnostics,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pathology,O
",",O
University,O
of,O
Chicago,O
Medicine,O
",",O
Chicago,O
",",O
Illinois,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25702,O
"
",O
PMID,O
:,O
32031264,O
"


",O
785,O
.,O
Swiss,O
Med,O
Wkly,O
.,O
2020,O
Feb,O
7;150:w20203,O
.,O
doi,O
:,O
10.4414,O
smw.2020.20203,O
.,O
eCollection,O
"
",O
2020,O
Jan,O
27,O
.,O
"

",O
2019novel,O
Coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
:,O
estimating,O
the,O
case,O
fatality,O
rate,O
 ,O
a,O
word,O
of,O
"
",O
caution,O
.,O
"

",O
Battegay,O
M(1,O
),O
",",O
Kuehl,O
R(1,O
),O
",",O
TschudinSutter,O
S(1,O
),O
",",O
Hirsch,O
HH(2,O
),O
",",O
Widmer,O
AF(1,O
),O
",",O
"
",O
Neher,O
RA(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infectious,O
Diseases,O
&,O
Hospital,O
Epidemiology,O
",",O
University,O
Hospital,O
"
",O
Basel,O
",",O
Basel,O
",",O
Switzerland,O
.,O
"
",O
(2)Division,O
of,O
Infectious,O
Diseases,O
&,O
Hospital,O
Epidemiology,O
",",O
University,O
Hospital,O
"
",O
Basel,O
",",O
Basel,O
",",O
Switzerland,O
;,O
Clinical,O
Virology,O
",",O
Laboratory,O
Medicine,O
",",O
University,O
"
",O
Hospital,O
Basel,O
",",O
Switzerland,O
;,O
Transplantation,O
and,O
Clinical,O
Virology,O
",",O
Department,O
"
",O
Biomedicine,O
",",O
University,O
of,O
Basel,O
",",O
Switzerland,O
.,O
"
",O
(3)Biozentrum,O
",",O
University,O
of,O
Basel,O
",",O
Switzerland,O
.,O
"

",O
DOI,O
:,O
10.4414,O
smw.2020.20203,O
"
",O
PMID,O
:,O
32031234,O
"


",O
786,O
.,O
J,O
Korean,O
Med,O
Sci,O
.,O
2020,O
Feb,O
10;35(5):e61,O
.,O
doi,O
:,O
10.3346,O
jkms.2020.35.e61,O
.,O
"

",O
The,O
First,O
Case,O
of,O
2019,B-Disease_COVID-19
Novel,I-Disease_COVID-19
Coronavirus,I-Disease_COVID-19
Pneumonia,I-Disease_COVID-19
Imported,O
into,O
Korea,O
from,O
"
",O
Wuhan,O
",",O
China,O
:,O
Implication,O
for,O
Infection,O
Prevention,O
and,O
Control,O
Measures,O
.,O
"

",O
Kim,O
JY(#)(1)(2)(3,O
),O
",",O
Choe,O
PG(#)(4,O
),O
",",O
Oh,O
Y(1,O
),O
",",O
Oh,O
KJ(5,O
),O
",",O
Kim,O
J(2,O
),O
",",O
Park,O
SJ(2,O
),O
",",O
Park,O
"
",O
JH(2,O
),O
",",O
Na,O
HK(3,O
),O
",",O
Oh,O
MD(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Internal,O
Medicine,O
",",O
Incheon,O
Medical,O
Center,O
",",O
Incheon,O
",",O
Korea,O
.,O
"
",O
(2)Infection,O
Control,O
Office,O
",",O
Incheon,O
Medical,O
Center,O
",",O
Incheon,O
",",O
Korea,O
.,O
"
",O
(3)Designated,O
Isolation,O
Unit,O
",",O
Incheon,O
Medical,O
Center,O
",",O
Incheon,O
",",O
Korea,O
.,O
"
",O
(4)Department,O
of,O
Internal,O
Medicine,O
",",O
Seoul,O
National,O
University,O
College,O
of,O
"
",O
Medicine,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(5)Department,O
of,O
Radiology,O
",",O
Incheon,O
Medical,O
Center,O
",",O
Incheon,O
",",O
Korea,O
.,O
"
",O
(6)Department,O
of,O
Internal,O
Medicine,O
",",O
Seoul,O
National,O
University,O
College,O
of,O
"
",O
Medicine,O
",",O
Seoul,O
",",O
Korea,O
.,O
mdohmd@snu.ac.kr,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
In,O
December,O
2019,O
",",O
a,O
viral,O
pneumonia,O
outbreak,O
caused,O
by,O
a,O
novel,O
betacoronavirus,O
",",O
"
",O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
",",O
began,O
in,O
Wuhan,O
",",O
China,O
.,O
We,O
report,O
the,O
"
",O
epidemiological,O
and,O
clinical,O
features,O
of,O
the,O
first,O
patient,O
with,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
pneumonia,O
imported,O
into,O
Korea,O
from,O
Wuhan,O
.,O
This,O
report,O
suggests,O
that,O
in,O
the,O
early,O
"
",O
phase,O
of,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
",",O
chest,O
radiography,O
would,O
miss,O
patients,O
with,O
"
",O
pneumonia,O
and,O
highlights,O
taking,O
travel,O
history,O
is,O
of,O
paramount,O
importance,O
for,O
"
",O
early,O
detection,O
and,O
isolation,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
cases,O
.,O
"

",O
Â©,O
2020,O
The,O
Korean,O
Academy,O
of,O
Medical,O
Sciences,O
.,O
"

",O
DOI,O
:,O
10.3346,O
jkms.2020.35.e61,O
"
",O
PMCID,O
:,O
PMC7008073,O
"
",O
PMID,O
:,O
32030925,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
have,O
no,O
potential,O
conflicts,O
of,O
"
",O
interest,O
to,O
disclose,O
.,O
"


",O
787,O
.,O
Mil,O
Med,O
Res,O
.,O
2020,O
Feb,O
6;7(1):4,O
.,O
doi,O
:,O
10.1186,O
s4077902002336,O
.,O
"

",O
A,O
rapid,O
advice,O
guideline,O
for,O
the,O
diagnosis,O
and,O
treatment,O
of,O
2019,O
novel,O
"
",O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
infected,O
pneumonia,O
(,O
standard,O
version,O
),O
.,O
"

",O
Jin,O
YH(1,O
),O
",",O
Cai,O
L(2,O
),O
",",O
Cheng,O
ZS(3,O
),O
",",O
Cheng,O
H(4,O
),O
",",O
Deng,O
T(1)(5,O
),O
",",O
Fan,O
YP(6)(7,O
),O
",",O
Fang,O
"
",O
C(1,O
),O
",",O
Huang,O
D(1,O
),O
",",O
Huang,O
LQ(6)(7,O
),O
",",O
Huang,O
Q(1,O
),O
",",O
Han,O
Y(2,O
),O
",",O
Hu,O
B(8,O
),O
",",O
Hu,O
F(8,O
),O
",",O
Li,O
"
",O
BH(1)(5,O
),O
",",O
Li,O
YR(9,O
),O
",",O
Liang,O
K(10,O
),O
",",O
Lin,O
LK(2,O
),O
",",O
Luo,O
LS(1,O
),O
",",O
Ma,O
J(8,O
),O
",",O
Ma,O
LL(1,O
),O
",",O
Peng,O
"
",O
ZY(8,O
),O
",",O
Pan,O
YB(9,O
),O
",",O
Pan,O
ZY(11,O
),O
",",O
Ren,O
XQ(5,O
),O
",",O
Sun,O
HM(12,O
),O
",",O
Wang,O
Y(13,O
),O
",",O
Wang,O
YY(1,O
),O
",",O
Weng,O
"
",O
H(1,O
),O
",",O
Wei,O
CJ(3,O
),O
",",O
Wu,O
DF(4,O
),O
",",O
Xia,O
J(14,O
),O
",",O
Xiong,O
Y(10,O
),O
",",O
Xu,O
HB(15,O
),O
",",O
Yao,O
XM(16,O
),O
",",O
Yuan,O
"
",O
YF(2,O
),O
",",O
Ye,O
TS(17,O
),O
",",O
Zhang,O
XC(15,O
),O
",",O
Zhang,O
YW(17,O
),O
",",O
Zhang,O
YG(2,O
),O
",",O
Zhang,O
HM(6)(7,O
),O
",",O
Zhao,O
"
",O
Y(14,O
),O
",",O
Zhao,O
MJ(1,O
),O
",",O
Zi,O
H(1)(5,O
),O
",",O
Zeng,O
XT(18)(19,O
),O
",",O
Wang,O
YY(20)(21,O
),O
",",O
Wang,O
XH(22)(23,O
),O
;,O
"
",O
",",O
for,O
the,O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
Management,O
and,O
"
",O
Research,O
Team,O
",",O
EvidenceBased,O
Medicine,O
Chapter,O
of,O
China,O
International,O
Exchange,O
"
",O
and,O
Promotive,O
Association,O
for,O
Medical,O
and,O
Health,O
Care,O
(,O
CPAM,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Center,O
for,O
EvidenceBased,O
and,O
Translational,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
"
",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(2)Institute,O
of,O
Hospital,O
Management,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Pharmacy,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430071,O
",",O
"
",O
China,O
.,O
"
",O
(5)Institute,O
of,O
EvidenceBased,O
Medicine,O
and,O
Knowledge,O
Translation,O
",",O
Henan,O
"
",O
University,O
",",O
Kaifeng,O
",",O
475000,O
",",O
China,O
.,O
"
",O
(6)China,O
Academy,O
of,O
Chinese,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
100700,O
",",O
China,O
.,O
"
",O
(7)China,O
Center,O
for,O
Evidence,O
Based,O
Traditional,O
Chinese,O
Medicine,O
(,O
CCEBTCM,O
),O
",",O
"
",O
Beijing,O
",",O
100700,O
",",O
China,O
.,O
"
",O
(8)Department,O
of,O
Critical,O
Care,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(9)Department,O
of,O
Clinical,O
Laboratory,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(10)Department,O
of,O
Infectious,O
Diseases,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(11)Division,O
of,O
Medical,O
Affairs,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
430071,O
",",O
China,O
.,O
"
",O
(12)Division,O
of,O
Nursing,O
Affairs,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
430071,O
",",O
China,O
.,O
"
",O
(13)Office,O
of,O
Nosocomial,O
Infection,O
Control,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(14)Emergency,O
Center,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430071,O
",",O
"
",O
China,O
.,O
"
",O
(15)Department,O
of,O
Radiology,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
430071,O
",",O
China,O
.,O
"
",O
(16)Department,O
of,O
Health,O
Research,O
Methods,O
",",O
Evidence,O
",",O
and,O
Impact,O
",",O
McMaster,O
"
",O
University,O
",",O
Hamilton,O
",",O
ON,O
",",O
L8S,O
4L8,O
",",O
Canada,O
.,O
"
",O
(17)Department,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(18)Center,O
for,O
EvidenceBased,O
and,O
Translational,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
"
",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
zengxiantao1128@163.com,O
.,O
"
",O
(19)Global,O
Health,O
Institute,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430072,O
",",O
China,O
.,O
"
",O
zengxiantao1128@163.com,O
.,O
"
",O
(20)China,O
Academy,O
of,O
Chinese,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
100700,O
",",O
China,O
.,O
"
",O
wangyyanpublic@bta.net.cn,O
.,O
"
",O
(21)China,O
Center,O
for,O
Evidence,O
Based,O
Traditional,O
Chinese,O
Medicine,O
(,O
CCEBTCM,O
),O
",",O
"
",O
Beijing,O
",",O
100700,O
",",O
China,O
.,O
wangyyanpublic@bta.net.cn,O
.,O
"
",O
(22)Center,O
for,O
EvidenceBased,O
and,O
Translational,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
"
",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
wangxinghuan1965@163.com,O
.,O
"
",O
(23)Institute,O
of,O
Hospital,O
Management,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
wangxinghuan1965@163.com,O
.,O
"

",O
In,O
December,O
2019,O
",",O
a,O
new,O
type,O
viral,O
pneumonia,O
cases,O
occurred,O
in,O
Wuhan,O
",",O
Hubei,O
"
",O
Province,O
;,O
and,O
then,O
named,O
"""",O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
"""",O
by,O
the,O
World,O
Health,O
"
",O
Organization,O
(,O
WHO,O
),O
on,O
12,O
January,O
2020,O
.,O
For,O
it,O
is,O
a,O
never,O
been,O
experienced,O
"
",O
respiratory,O
disease,O
before,O
and,O
with,O
infection,O
ability,O
widely,O
and,O
quickly,O
",",O
it,O
"
",O
attracted,O
the,O
world,O
's,O
attention,O
but,O
without,O
treatment,O
and,O
control,O
manual,O
.,O
For,O
the,O
"
",O
request,O
from,O
frontline,O
clinicians,O
and,O
public,O
health,O
professionals,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
infected,O
pneumonia,O
management,O
",",O
an,O
evidencebased,O
guideline,O
urgently,O
needs,O
to,O
be,O
"
",O
developed,O
.,O
Therefore,O
",",O
we,O
drafted,O
this,O
guideline,O
according,O
to,O
the,O
rapid,O
advice,O
"
",O
guidelines,O
methodology,O
and,O
general,O
rules,O
of,O
WHO,O
guideline,O
development,O
;,O
we,O
also,O
"
",O
added,O
the,O
firsthand,O
management,O
data,O
of,O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
.,O
"
",O
This,O
guideline,O
includes,O
the,O
guideline,O
methodology,O
",",O
epidemiological,O
"
",O
characteristics,O
",",O
disease,O
screening,O
and,O
population,O
prevention,O
",",O
diagnosis,O
",",O
"
",O
treatment,O
and,O
control,O
(,O
including,O
traditional,O
Chinese,O
Medicine,O
),O
",",O
nosocomial,O
"
",O
infection,O
prevention,O
and,O
control,O
",",O
and,O
disease,O
nursing,O
of,O
the,O
2019nCoV.,O
Moreover,O
",",O
"
",O
we,O
also,O
provide,O
a,O
whole,O
process,O
of,O
a,O
successful,O
treatment,O
case,O
of,O
the,O
severe,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
infected,O
pneumonia,O
and,O
experience,O
and,O
lessons,O
of,O
hospital,O
rescue,O
for,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
infections,O
.,O
This,O
rapid,O
advice,O
guideline,O
is,O
suitable,O
for,O
the,O
first,O
"
",O
frontline,O
doctors,O
and,O
nurses,O
",",O
managers,O
of,O
hospitals,O
and,O
healthcare,O
sections,O
",",O
"
",O
community,O
residents,O
",",O
public,O
health,O
persons,O
",",O
relevant,O
researchers,O
",",O
and,O
all,O
person,O
"
",O
who,O
are,O
interested,O
in,O
the,O
2019nCoV.,O
"

",O
DOI,O
:,O
10.1186,O
s4077902002336,O
"
",O
PMCID,O
:,O
PMC7003341,O
"
",O
PMID,O
:,O
32029004,O
"


",O
788,O
.,O
Biomed,O
Pharmacother,O
.,O
2020,O
Feb,O
3;125:109900,O
.,O
doi,O
:,O
10.1016,O
j.biopha.2020.109900,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Data,O
mining,O
and,O
systematic,O
pharmacology,O
to,O
reveal,O
the,O
mechanisms,O
of,O
traditional,O
"
",O
Chinese,O
medicine,O
in,O
Mycoplasma,O
pneumoniae,O
pneumonia,O
treatment,O
.,O
"

",O
Sun,O
JH(1,O
),O
",",O
Sun,O
F(2,O
),O
",",O
Yan,O
B(3,O
),O
",",O
Li,O
JY(4,O
),O
",",O
Xin,O
L(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Tropical,O
Medicine,O
Research,O
Institute,O
",",O
Beijing,O
Friendship,O
Hospital,O
",",O
Capital,O
"
",O
Medical,O
University,O
",",O
Beijing,O
",",O
"100050,China",O
.,O
Electronic,O
address,O
:,O
1260798143@qq.com,O
.,O
"
",O
(2)The,O
Center,O
for,O
Biomedical,O
Research,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
phil_sunfei@163.com,O
.,O
"
",O
(3)Department,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
Peking,O
Union,O
Medical,O
College,O
"
",O
Hospital,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
100730,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
545020728@qq.com,O
.,O
"
",O
(4)Department,O
of,O
Integrated,O
Traditional,O
Chinese,O
and,O
Western,O
Medicine,O
",",O
Union,O
"
",O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
lijunyi19901990@163.com,O
.,O
"
",O
(5)Tropical,O
Medicine,O
Research,O
Institute,O
",",O
Beijing,O
Friendship,O
Hospital,O
",",O
Capital,O
"
",O
Medical,O
University,O
",",O
Beijing,O
",",O
"100050,China",O
.,O
Electronic,O
address,O
:,O
xindl48@126.com,O
.,O
"

",O
Traditional,O
Chinese,O
Medicine,O
(,O
TCM,O
),O
is,O
widely,O
used,O
in,O
the,O
treatment,O
of,O
Mycoplasma,O
"
",O
pneumoniae,O
Pneumonia,O
(,O
MPP,O
),O
in,O
East,O
Asia,O
.,O
However,O
",",O
our,O
current,O
understanding,O
of,O
"
",O
the,O
underlying,O
molecular,O
mechanism,O
remains,O
dispersive,O
and,O
promiscuous,O
.,O
In,O
this,O
"
",O
study,O
",",O
a,O
systematic,O
pharmacological,O
approach,O
combined,O
with,O
literature,O
data,O
mining,O
"
",O
was,O
applied,O
for,O
drug,O
similarity,O
evaluation,O
",",O
drug,O
halflife,O
evaluation,O
",",O
oral,O
"
",O
bioavailability,O
prediction,O
",",O
drug,O
target,O
exploration,O
",",O
Gene,O
Ontology,O
(,O
GO,O
),O
analysis,O
",",O
"
",O
KEGG,O
pathway,O
enrichment,O
and,O
network,O
construction,O
",",O
thus,O
providing,O
the,O
rationale,O
"
",O
for,O
its,O
clinical,O
performance,O
.,O
Five,O
mostly,O
studied,O
herbs,O
",",O
including,O
Ephedra,O
Herba,O
",",O
"
",O
Amygdalus,O
communis,O
Vas,O
",",O
Platycodon,O
grandiforus,O
",",O
Licorice,O
and,O
Scutellariae,O
Radix,O
",",O
"
",O
were,O
selected,O
from,O
the,O
literature,O
.,O
Total,O
ninetythree,O
active,O
ingredients,O
",",O
which,O
"
",O
are,O
expected,O
to,O
be,O
the,O
effective,O
components,O
for,O
MPP,O
treatment,O
",",O
were,O
screened,O
out,O
.,O
"
",O
Interrelationship,O
between,O
active,O
compounds,O
",",O
drug,O
targets,O
and,O
signaling,O
pathways,O
"
",O
were,O
analyzed,O
to,O
reveal,O
the,O
therapeutic,O
effect,O
of,O
TCM,O
in,O
detail,O
.,O
Of,O
importance,O
",",O
"
",O
we,O
found,O
that,O
TNF,O
",",O
Î²2AR,O
and,O
PTGS2,O
play,O
pivotal,O
role,O
in,O
TCM,O
mediated,O
MPP,O
"
",O
inhibition,O
.,O
And,O
mechanistically,O
",",O
epithelial,O
apoptosis,O
(,O
defensive,O
barrier,O
"
",O
function,O
),O
",",O
GPCR,O
signaling,O
(,O
symptom,O
amelioration,O
),O
and,O
immune,O
pathways,O
(,O
innate,O
"
",O
signaling,O
and,O
adaptive,O
Th17,O
response,O
),O
are,O
critically,O
involved,O
.,O
Our,O
work,O
",",O
achieved,O
"
",O
through,O
systematic,O
pharmacology,O
and,O
data,O
mining,O
",",O
enlarges,O
the,O
knowledge,O
of,O
TCM,O
in,O
"
",O
MPP,O
therapy,O
",",O
and,O
could,O
provide,O
valuable,O
insights,O
for,O
further,O
drug,O
discovery,O
"
",O
studies,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
Masson,O
SAS,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.biopha.2020.109900,O
"
",O
PMID,O
:,O
32028237,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
789,O
.,O
Commun,O
Dis,O
Intell,O
(,O
2018,O
),O
.,O
2020,O
Feb,O
6;44,O
.,O
doi,O
:,O
10.33321,O
cdi.2019.44.13,O
.,O
"

",O
2019nCoV,B-Disease_COVID-19
acute,I-Disease_COVID-19
respiratory,I-Disease_COVID-19
disease,I-Disease_COVID-19
",",O
Australia,O
:,O
Epidemiology,O
Report,O
1,O
(,O
Reporting,O
"
",O
week,O
26,O
January,O
 ,O
1,O
February,O
2020,O
),O
.,O
"

",O
2019nCoV,B-Virus_SARS-CoV-2
National,O
Incident,O
Room,O
Surveillance,O
Team,O
.,O
"

",O
This,O
is,O
the,O
first,O
epidemiological,O
report,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
acute,O
"
",O
respiratory,O
disease,O
infections,O
reported,O
in,O
Australia,O
at,O
0.791666667,O
Australian,O
Eastern,O
"
",O
Daylight,O
Time,O
[,O
AEDT,O
],O
1,O
February,O
2020,O
.,O
It,O
includes,O
data,O
on,O
Australian,O
cases,O
"
",O
notified,O
during,O
the,O
week,O
26,O
January,O
to,O
1,O
February,O
2020,O
and,O
in,O
the,O
previous,O
week,O
"
",O
(,O
19,O
to,O
25,O
January,O
2020,O
),O
",",O
the,O
international,O
situation,O
and,O
current,O
information,O
on,O
"
",O
the,O
severity,O
",",O
transmission,O
and,O
spread,O
of,O
the,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"

",O
Â©,O
Commonwealth,O
of,O
Australia,O
CC,O
BYNCND,O
.,O
"

",O
DOI,O
:,O
10.33321,O
cdi.2020.44.13,O
"
",O
PMID,O
:,O
32027812,O
"


",O
790,O
.,O
MMWR,O
Morb,O
Mortal,O
Wkly,O
Rep.,O
2020,O
Feb,O
7;69(5):140146,O
.,O
doi,O
:,O
10.15585,O
mmwr.mm6905e1,O
.,O
"

",O
Initial,O
Public,O
Health,O
Response,O
and,O
Interim,O
Clinical,O
Guidance,O
for,O
the,O
2019,O
Novel,O
"
",O
Coronavirus,O
Outbreak,O
 ,O
United,O
States,O
",",O
December,O
31,O
",",O
2019February,O
4,O
",",O
2020,O
.,O
"

",O
Patel,O
A(1,O
),O
",",O
Jernigan,O
DB(1,O
),O
;,O
2019nCoV,B-Virus_SARS-CoV-2
CDC,O
Response,O
Team,O
.,O
"

",O
Collaborators,O
:,O
Abdirizak,O
F(2,O
),O
",",O
Abedi,O
G(2,O
),O
",",O
Aggarwal,O
S(2,O
),O
",",O
Albina,O
D(3,O
),O
",",O
Allen,O
"
",O
E(3,O
),O
",",O
Andersen,O
L(3,O
),O
",",O
Anderson,O
J(4,O
),O
",",O
Anderson,O
M(4,O
),O
",",O
Anderson,O
T(5,O
),O
",",O
Anderson,O
K(6,O
),O
",",O
"
",O
Bardossy,O
AC(3,O
),O
",",O
Barry,O
V(7,O
),O
",",O
Beer,O
K(3,O
),O
",",O
Bell,O
M(3,O
),O
",",O
Berger,O
S(8,O
),O
",",O
Bertulfo,O
J(8,O
),O
",",O
"
",O
Biggs,O
H(2,O
),O
",",O
Bornemann,O
J(8,O
),O
",",O
Bornstein,O
J(8,O
),O
",",O
Bower,O
W(3,O
),O
",",O
Bresee,O
J(2,O
),O
",",O
Brown,O
C(3,O
),O
",",O
"
",O
Budd,O
A(2,O
),O
",",O
Buigut,O
J(3,O
),O
",",O
Burke,O
S(2,O
),O
",",O
Burke,O
R(2,O
),O
",",O
Burns,O
E(2,O
),O
",",O
Butler,O
J(9,O
),O
",",O
Cantrell,O
"
",O
R(5,O
),O
",",O
Cardemil,O
C(2,O
),O
",",O
Cates,O
J(2,O
),O
",",O
Cetron,O
M(3,O
),O
",",O
ChathamStephens,O
K(6,O
),O
",",O
"
",O
ChathamStevens,O
K(6,O
),O
",",O
Chea,O
N(3,O
),O
",",O
Christensen,O
B(3,O
),O
",",O
Chu,O
V(2,O
),O
",",O
Clarke,O
K(10,O
),O
",",O
"
",O
Cleveland,O
A(2,O
),O
",",O
Cohen,O
N(3,O
),O
",",O
Cohen,O
M(5,O
),O
",",O
Cohn,O
A(2,O
),O
",",O
Collins,O
J(11,O
),O
",",O
Dahl,O
R(2,O
),O
",",O
"
",O
Daley,O
W(4,O
),O
",",O
Dasari,O
V(5,O
),O
",",O
Davlantes,O
E(5,O
),O
",",O
Dawson,O
P(3,O
),O
",",O
Delaney,O
L(12,O
),O
",",O
Donahue,O
"
",O
M(5,O
),O
",",O
Dowell,O
C(12,O
),O
",",O
Dyal,O
J(2,O
),O
",",O
Edens,O
W(2,O
),O
",",O
Eidex,O
R(13,O
),O
",",O
Epstein,O
L(3,O
),O
",",O
Evans,O
M(7,O
),O
",",O
"
",O
Fagan,O
R(3,O
),O
",",O
Farris,O
K(2,O
),O
",",O
Feldstein,O
L(2,O
),O
",",O
Fox,O
L(2,O
),O
",",O
Frank,O
M(4,O
),O
",",O
Freeman,O
B(2,O
),O
",",O
Fry,O
"
",O
A(2,O
),O
",",O
Fuller,O
J(10,O
),O
",",O
Galang,O
R(14,O
),O
",",O
Gerber,O
S(2,O
),O
",",O
Gokhale,O
R(3,O
),O
",",O
Goldstein,O
S(2,O
),O
",",O
"
",O
Gorman,O
S(4,O
),O
",",O
Gregg,O
W(2,O
),O
",",O
Greim,O
W(3,O
),O
",",O
Grube,O
S(8,O
),O
",",O
Hall,O
A(2,O
),O
",",O
Haynes,O
A(2,O
),O
",",O
Hill,O
"
",O
S(2,O
),O
",",O
HornsbyMyers,O
J(12,O
),O
",",O
Hunter,O
J(13,O
),O
",",O
Ionta,O
C(2,O
),O
",",O
Isenhour,O
C(2,O
),O
",",O
Jacobs,O
M(5,O
),O
",",O
"
",O
Slifka,O
KJ(3,O
),O
",",O
Jernigan,O
D(2,O
),O
",",O
Jhung,O
M(3,O
),O
",",O
JonesWormley,O
J(4,O
),O
",",O
Kambhampati,O
A(2,O
),O
",",O
"
",O
Kamili,O
S(2,O
),O
",",O
Kennedy,O
P(2,O
),O
",",O
Kent,O
C(15,O
),O
",",O
Killerby,O
M(2,O
),O
",",O
Kim,O
L(2,O
),O
",",O
Kirking,O
H(2,O
),O
",",O
"
",O
Koonin,O
L(2,O
),O
",",O
Koppaka,O
R(2,O
),O
",",O
Kosmos,O
C(4,O
),O
",",O
Kuhar,O
D(3,O
),O
",",O
KuhnertTallman,O
W(16,O
),O
",",O
"
",O
Kujawski,O
S(2,O
),O
",",O
Kumar,O
A(17,O
),O
",",O
Landon,O
A(8,O
),O
",",O
Lee,O
L(2,O
),O
",",O
Leung,O
J(2,O
),O
",",O
Lindstrom,O
S(2,O
),O
",",O
"
",O
LinkGelles,O
R(2,O
),O
",",O
Lively,O
J(2,O
),O
",",O
Lu,O
X(2,O
),O
",",O
Lynch,O
B(2,O
),O
",",O
Malapati,O
L(2,O
),O
",",O
Mandel,O
S(2,O
),O
",",O
"
",O
Manns,O
B(2,O
),O
",",O
Marano,O
N(3,O
),O
",",O
Marlow,O
M(2,O
),O
",",O
Marston,O
B(10,O
),O
",",O
McClung,O
N(2,O
),O
",",O
McClure,O
L(10,O
),O
",",O
"
",O
McDonald,O
E(3,O
),O
",",O
McGovern,O
O(2,O
),O
",",O
Messonnier,O
N(2,O
),O
",",O
Midgley,O
C(2,O
),O
",",O
Moulia,O
D(2,O
),O
",",O
Murray,O
"
",O
J(2,O
),O
",",O
Noelte,O
K(4,O
),O
",",O
NoonanSmith,O
M(8,O
),O
",",O
Nordlund,O
K(2,O
),O
",",O
Norton,O
E(12,O
),O
",",O
Oliver,O
S(2,O
),O
",",O
"
",O
Pallansch,O
M(2,O
),O
",",O
Parashar,O
U(2,O
),O
",",O
Patel,O
A(2,O
),O
",",O
Patel,O
M(2,O
),O
",",O
Pettrone,O
K(18,O
),O
",",O
Pierce,O
"
",O
T(3,O
),O
",",O
Pietz,O
H(4,O
),O
",",O
Pillai,O
S(3,O
),O
",",O
Radonovich,O
L(12,O
),O
",",O
ReaganSteiner,O
S(3,O
),O
",",O
Reel,O
A(2,O
),O
",",O
"
",O
Reese,O
H(2,O
),O
",",O
Rha,O
B(2,O
),O
",",O
Ricks,O
P(10,O
),O
",",O
Rolfes,O
M(2,O
),O
",",O
Roohi,O
S(3,O
),O
",",O
Roper,O
L(2,O
),O
",",O
Rotz,O
"
",O
L(3,O
),O
",",O
Routh,O
J(2,O
),O
",",O
Sakthivel,O
SK(2,O
),O
",",O
Sarmiento,O
L(12,O
),O
",",O
Schindelar,O
J(3,O
),O
",",O
Schneider,O
"
",O
E(2,O
),O
",",O
Schuchat,O
A(8,O
),O
",",O
Scott,O
S(5,O
),O
",",O
Shetty,O
V(5,O
),O
",",O
Shockey,O
C(3,O
),O
",",O
Shugart,O
J(12,O
),O
",",O
"
",O
Stenger,O
M(19,O
),O
",",O
Stuckey,O
M(3,O
),O
",",O
Sunshine,O
B(3,O
),O
",",O
Sykes,O
T(8,O
),O
",",O
Trapp,O
J(8,O
),O
",",O
Uyeki,O
T(2,O
),O
",",O
"
",O
Vahey,O
G(3,O
),O
",",O
Valderrama,O
A(3,O
),O
",",O
Villanueva,O
J(3,O
),O
",",O
Walker,O
T(4,O
),O
",",O
Wallace,O
M(2,O
),O
",",O
Wang,O
"
",O
L(2,O
),O
",",O
Watson,O
J(2,O
),O
",",O
Weber,O
A(12,O
),O
",",O
Weinbaum,O
C(2,O
),O
",",O
Weldon,O
W(2,O
),O
",",O
Westnedge,O
C(2,O
),O
",",O
"
",O
Whitaker,O
B(2,O
),O
",",O
Whitaker,O
M(2,O
),O
",",O
Williams,O
A(8,O
),O
",",O
Williams,O
H(8,O
),O
",",O
Willams,O
I(3,O
),O
",",O
Wong,O
"
",O
K(15,O
),O
",",O
Xie,O
A(5,O
),O
",",O
Yousef,O
A(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Incident,O
Manager,O
",",O
2019nCoV,B-Virus_SARS-CoV-2
CDC,O
Response,O
",",O
CDC,O
.,O
"
",O
(2)National,O
Center,O
for,O
Immunization,O
and,O
Respiratory,O
Diseases,O
",",O
CDC,O
.,O
"
",O
(3)National,O
Center,O
for,O
Emerging,O
and,O
Zoonotic,O
Infectious,O
Diseases,O
",",O
CDC,O
.,O
"
",O
(4)Center,O
for,O
Preparedness,O
and,O
Response,O
",",O
CDC,O
.,O
"
",O
(5)Center,O
for,O
State,O
",",O
Tribal,O
",",O
Local,O
and,O
Territorial,O
Support,O
",",O
CDC,O
.,O
"
",O
(6)National,O
Center,O
on,O
Birth,O
Defects,O
and,O
Developmental,O
Disabilities,O
",",O
CDC,O
.,O
"
",O
(7)National,O
Center,O
for,O
Injury,O
Prevention,O
and,O
Control,O
",",O
CDC,O
.,O
"
",O
(8)Office,O
of,O
the,O
Director,O
",",O
CDC,O
.,O
"
",O
(9)Office,O
of,O
the,O
Deputy,O
Director,O
of,O
Infectious,O
Disease,O
",",O
CDC,O
.,O
"
",O
(10)Center,O
for,O
Global,O
Health,O
",",O
CDC,O
.,O
"
",O
(11)National,O
Center,O
for,O
Emerging,O
and,O
Zoonotic,O
Infectious,O
Diseases,O
",",O
CDC,O
;,O
Erin,O
"
",O
Conners,O
",",O
National,O
Center,O
for,O
Emerging,O
and,O
Zoonotic,O
Infectious,O
Diseases,O
",",O
CDC,O
;,O
"
",O
Aaron,O
Curns,O
",",O
National,O
Center,O
for,O
Immunization,O
and,O
Respiratory,O
Diseases,O
",",O
CDC,O
.,O
"
",O
(12)National,O
Institute,O
for,O
Occupational,O
Safety,O
and,O
Health,O
",",O
CDC,O
.,O
"
",O
(,O
13,O
),O
",",O
National,O
Center,O
for,O
Emerging,O
and,O
Zoonotic,O
Infectious,O
Diseases,O
",",O
CDC,O
.,O
"
",O
(14)National,O
Center,O
for,O
Chronic,O
Disease,O
Prevention,O
and,O
Promotion,O
",",O
CDC,O
.,O
"
",O
(15)Center,O
for,O
Surveillance,O
",",O
Epidemiology,O
and,O
Laboratory,O
Services,O
",",O
CDC,O
.,O
"
",O
(16)Deputy,O
Director,O
for,O
Infectious,O
Diseases,O
",",O
CDC,O
.,O
"
",O
(,O
17,O
),O
",",O
National,O
Center,O
for,O
Immunization,O
and,O
Respiratory,O
Diseases,O
",",O
CDC,O
.,O
"
",O
(18)National,O
Center,O
for,O
Health,O
Statistics,O
",",O
CDC,O
.,O
"
",O
(19)National,O
Center,O
for,O
HIV,O
AIDS,O
",",O
Viral,O
Hepatitis,O
",",O
STD,O
",",O
and,O
TB,O
Prevention,O
",",O
CDC,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
MMWR,O
Morb,O
Mortal,O
Wkly,O
Rep.,O
2020,O
Feb,O
14;69(6):173,O
.,O
"

",O
On,O
December,O
31,O
",",O
2019,O
",",O
Chinese,O
health,O
officials,O
reported,O
a,O
cluster,O
of,O
cases,O
of,O
"
",O
acute,O
respiratory,O
illness,O
in,O
persons,O
associated,O
with,O
the,O
Hunan,O
seafood,O
and,O
animal,O
"
",O
market,O
in,O
the,O
city,O
of,O
Wuhan,O
",",O
Hubei,O
Province,O
",",O
in,O
central,O
China,O
.,O
On,O
January,O
7,O
",",O
"
",O
2020,O
",",O
Chinese,O
health,O
officials,O
confirmed,O
that,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
was,O
"
",O
associated,O
with,O
this,O
initial,O
cluster,O
(,O
1,O
),O
.,O
As,O
of,O
February,O
4,O
",",O
2020,O
",",O
a,O
total,O
of,O
"
",O
20471,O
confirmed,O
cases,O
",",O
including,O
2788,O
(,O
13.6,O
%,O
),O
with,O
severe,O
illness,O
",",O
*,O
and,O
425,O
"
",O
deaths,O
(,O
2.1,O
%,O
),O
had,O
been,O
reported,O
by,O
the,O
National,O
Health,O
Commission,O
of,O
China,O
(,O
2,O
),O
.,O
"
",O
Cases,O
have,O
also,O
been,O
reported,O
in,O
26,O
locations,O
outside,O
of,O
mainland,O
China,O
",",O
"
",O
including,O
documentation,O
of,O
some,O
persontoperson,O
transmission,O
and,O
one,O
death,O
(,O
2,O
),O
.,O
"
",O
As,O
of,O
February,O
4,O
",",O
11,O
cases,O
had,O
been,O
reported,O
in,O
the,O
United,O
States,O
.,O
On,O
January,O
30,O
",",O
"
",O
the,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
DirectorGeneral,O
declared,O
that,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
outbreak,O
constitutes,O
a,O
Public,O
Health,O
Emergency,O
of,O
International,O
Concern.â€ ,O
On,O
"
",O
January,O
31,O
",",O
the,O
U.S.,O
Department,O
of,O
Health,O
and,O
Human,O
Services,O
(,O
HHS,O
),O
Secretary,O
"
",O
declared,O
a,O
U.S.,O
public,O
health,O
emergency,O
to,O
respond,O
to,O
2019nCoV.Â§,O
Also,O
on,O
January,O
"
",O
31,O
",",O
the,O
president,O
of,O
the,O
United,O
States,O
signed,O
a,O
"""",O
Proclamation,O
on,O
Suspension,O
of,O
"
",O
Entry,O
as,O
Immigrants,O
and,O
Nonimmigrants,O
of,O
Persons,O
who,O
Pose,O
a,O
Risk,O
of,O
Transmitting,O
"
",O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
",",O
"""",O
which,O
limits,O
entry,O
into,O
the,O
United,O
States,O
of,O
persons,O
who,O
"
",O
traveled,O
to,O
mainland,O
China,O
to,O
U.S.,O
citizens,O
and,O
lawful,O
permanent,O
residents,O
and,O
"
",O
their,O
families,O
(,O
3,O
),O
.,O
CDC,O
",",O
multiple,O
other,O
federal,O
agencies,O
",",O
state,O
and,O
local,O
health,O
"
",O
departments,O
",",O
and,O
other,O
partners,O
are,O
implementing,O
aggressive,O
measures,O
to,O
slow,O
"
",O
transmission,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
the,O
United,O
States,O
(,O
"4,5",O
),O
.,O
These,O
measures,O
require,O
the,O
"
",O
identification,O
of,O
cases,O
and,O
their,O
contacts,O
in,O
the,O
United,O
States,O
and,O
the,O
"
",O
appropriate,O
assessment,O
and,O
care,O
of,O
travelers,O
arriving,O
from,O
mainland,O
China,O
to,O
the,O
"
",O
United,O
States,O
.,O
These,O
measures,O
are,O
being,O
implemented,O
in,O
anticipation,O
of,O
additional,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
cases,O
in,O
the,O
United,O
States,O
.,O
Although,O
these,O
measures,O
might,O
not,O
prevent,O
"
",O
the,O
eventual,O
establishment,O
of,O
ongoing,O
",",O
widespread,O
transmission,O
of,O
the,O
virus,O
in,O
"
",O
the,O
United,O
States,O
",",O
they,O
are,O
being,O
implemented,O
to,O
1,O
),O
slow,O
the,O
spread,O
of,O
illness,O
;,O
"
",O
2,O
),O
provide,O
time,O
to,O
better,O
prepare,O
health,O
care,O
systems,O
and,O
the,O
general,O
public,O
to,O
"
",O
be,O
ready,O
if,O
widespread,O
transmission,O
with,O
substantial,O
associated,O
illness,O
occurs,O
;,O
"
",O
and,O
3,O
),O
better,O
characterize,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
to,O
guide,O
public,O
health,O
"
",O
recommendations,O
and,O
the,O
development,O
of,O
medical,O
countermeasures,O
including,O
"
",O
diagnostics,O
",",O
therapeutics,O
",",O
and,O
vaccines,O
.,O
Public,O
health,O
authorities,O
are,O
monitoring,O
"
",O
the,O
situation,O
closely,O
.,O
As,O
more,O
is,O
learned,O
about,O
this,O
novel,O
virus,O
and,O
this,O
"
",O
outbreak,O
",",O
CDC,O
will,O
rapidly,O
incorporate,O
new,O
knowledge,O
into,O
guidance,O
for,O
action,O
by,O
"
",O
CDC,O
and,O
state,O
and,O
local,O
health,O
departments,O
.,O
"

",O
DOI,O
:,O
10.15585,O
mmwr.mm6905e1,O
"
",O
PMCID,O
:,O
PMC7004396,O
"
",O
PMID,O
:,O
32027631,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
All,O
authors,O
have,O
completed,O
and,O
submitted,O
the,O
"
",O
International,O
Committee,O
of,O
Medical,O
Journal,O
Editors,O
form,O
for,O
disclosure,O
of,O
"
",O
potential,O
conflicts,O
of,O
interest,O
.,O
No,O
potential,O
conflicts,O
of,O
interest,O
were,O
"
",O
disclosed,O
.,O
"


",O
791,O
.,O
Radiology,O
.,O
2020,O
Feb,O
6:200274,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200274,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Emerging,O
Coronavirus,O
2019nCoV,B-Disease_COVID-19
Pneumonia,I-Disease_COVID-19
.,O
"

",O
Song,O
F(1,O
),O
",",O
Shi,O
N(1,O
),O
",",O
Shan,O
F(1,O
),O
",",O
Zhang,O
Z(1,O
),O
",",O
Shen,O
J(1,O
),O
",",O
Lu,O
H(1,O
),O
",",O
Ling,O
Y(1,O
),O
",",O
Jiang,O
"
",O
Y(1,O
),O
",",O
Shi,O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Department,O
of,O
Radiology,O
",",O
Shanghai,O
Public,O
Health,O
Clinical,O
Center,O
",",O
"
",O
Shanghai,O
201508,O
",",O
China,O
(,O
F.S.,O
",",O
N.S.,O
",",O
F.S.,O
",",O
J.S.,O
",",O
Y.S.,O
),O
;,O
Fudan,O
University,O
",",O
"
",O
Shanghai,O
",",O
200433,O
",",O
China,O
(,O
Z.Z.,O
),O
;,O
Department,O
of,O
Infectious,O
Disease,O
",",O
Shanghai,O
Public,O
"
",O
Health,O
Clinical,O
Center,O
",",O
Shanghai,O
201508,O
",",O
China,O
(,O
H.L.,O
),O
;,O
Cancer,O
Center,O
",",O
University,O
"
",O
of,O
Michigan,O
",",O
Ann,O
Arbor,O
",",O
Michigan,O
(,O
Y.J.,O
),O
;,O
Shanghai,O
Key,O
Laboratory,O
of,O
Molecular,O
"
",O
Imaging,O
",",O
Shanghai,O
201318,O
",",O
China,O
(,O
Y.S.,O
),O
.,O
"

",O
Background,O
The,O
chest,O
CT,O
findings,O
of,O
patients,O
with,O
coronavirus,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
"
",O
have,O
not,O
previously,O
been,O
described,O
in,O
detail,O
.,O
Purpose,O
To,O
investigate,O
the,O
"
",O
clinical,O
",",O
laboratory,O
",",O
and,O
imaging,O
findings,O
of,O
emerging,O
coronavirus,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
pneumonia,O
in,O
humans,O
.,O
Materials,O
and,O
Methods,O
Fiftyone,O
patients,O
(,O
25,O
men,O
and,O
26,O
"
",O
women,O
",",O
1676,O
years,O
old,O
),O
with,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
confirmed,O
with,O
the,O
positive,O
new,O
"
",O
coronavirus,O
nucleic,O
acid,O
antibody,O
underwent,O
thinsection,O
CT,O
.,O
The,O
imaging,O
"
",O
findings,O
",",O
clinical,O
and,O
laboratory,O
data,O
were,O
evaluated,O
.,O
Results,O
Fifty,O
of,O
51,O
"
",O
patients,O
(,O
98,O
%,O
),O
had,O
a,O
history,O
of,O
the,O
endemic,O
center,O
Wuhan,O
contact,O
.,O
Fever,O
(,O
49,O
51,O
",",O
"
",O
96,O
%,O
),O
and,O
cough,O
(,O
24,O
51,O
",",O
47,O
%,O
),O
were,O
the,O
most,O
common,O
symptoms,O
.,O
Most,O
patients,O
had,O
a,O
"
",O
normal,O
white,O
blood,O
cell,O
count,O
(,O
37,O
51,O
",",O
73,O
%,O
),O
",",O
neutrophil,O
count,O
(,O
44,O
51,O
",",O
86.3,O
%,O
),O
and,O
"
",O
normal,O
(,O
17,O
51,O
",",O
35.3,O
%,O
),O
or,O
reduced,O
(,O
33,O
51,O
",",O
64.7,O
%,O
),O
lymphocyte,O
count,O
.,O
CT,O
images,O
"
",O
showed,O
pure,O
ground,O
grass,O
opacity,O
(,O
GGO,O
),O
in,O
39,O
51,O
(,O
77,O
%,O
),O
patients,O
",",O
GGO,O
with,O
"
",O
reticular,O
and,O
or,O
interlobular,O
septal,O
thickening,O
in,O
38,O
51,O
(,O
75,O
%,O
),O
patients,O
.,O
GGO,O
with,O
"
",O
consolidation,O
was,O
present,O
in,O
30,O
51,O
(,O
59,O
%,O
),O
and,O
pure,O
consolidation,O
in,O
28,O
51,O
(,O
55,O
%,O
),O
"
",O
patients,O
.,O
44,O
51,O
(,O
86,O
%,O
),O
patients,O
had,O
bilateral,O
lung,O
involvement,O
",",O
while,O
41,O
51,O
(,O
80,O
%,O
),O
"
",O
involved,O
the,O
posterior,O
part,O
of,O
the,O
lungs,O
and,O
44,O
51,O
(,O
86,O
%,O
),O
were,O
peripheral,O
.,O
There,O
"
",O
were,O
more,O
consolidated,O
lung,O
lesions,O
in,O
patients,O
5,O
or,O
more,O
days,O
from,O
disease,O
onset,O
"
",O
to,O
CT,O
scan,O
versus,O
4,O
or,O
fewer,O
days,O
(,O
431,O
712,O
lesions,O
vs.,O
129,O
612,O
lesions,O
",",O
p,O
<,O
"
",O
0.001,O
),O
.,O
Patients,O
more,O
than,O
50,O
years,O
old,O
had,O
more,O
consolidated,O
lung,O
lesions,O
than,O
"
",O
those,O
50,O
years,O
or,O
younger,O
(,O
212,O
470,O
vs.,O
198,O
854,O
",",O
p,O
<,O
0.001,O
),O
.,O
Follow,O
up,O
CT,O
in,O
13,O
"
",O
patients,O
showed,O
improvement,O
in,O
7,O
(,O
54,O
%,O
),O
patients,O
and,O
progression,O
in,O
4,O
(,O
31,O
%,O
),O
"
",O
patients,O
.,O
Conclusions,O
Patients,O
with,O
fever,O
and,O
or,O
cough,O
and,O
with,O
conspicuous,O
"
",O
ground,O
grass,O
opacity,O
lesions,O
in,O
the,O
peripheral,O
and,O
posterior,O
lungs,O
on,O
CT,O
images,O
"
",O
combined,O
with,O
normal,O
or,O
decreased,O
white,O
blood,O
cells,O
and,O
a,O
history,O
of,O
epidemic,O
"
",O
exposure,O
are,O
highly,O
suspected,O
of,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200274,O
"
",O
PMID,O
:,O
32027573,O
"


",O
792,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
6,O
.,O
doi,O
:,O
10.1002,O
jmv.25700,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Genomic,O
variance,O
of,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
coronavirus,O
.,O
"

",O
Ceraolo,O
C(1,O
),O
",",O
Giorgi,O
FM(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pharmacy,O
and,O
Biotechnology,O
",",O
University,O
of,O
Bologna,O
",",O
Bologna,O
",",O
"
",O
Italy,O
.,O
"

",O
There,O
is,O
a,O
rising,O
global,O
concern,O
for,O
the,O
recently,O
emerged,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
Full,O
genomic,O
sequences,O
have,O
been,O
released,O
by,O
the,O
worldwide,O
"
",O
scientific,O
community,O
in,O
the,O
last,O
few,O
weeks,O
to,O
understand,O
the,O
evolutionary,O
origin,O
"
",O
and,O
molecular,O
characteristics,O
of,O
this,O
virus,O
.,O
Taking,O
advantage,O
of,O
all,O
the,O
genomic,O
"
",O
information,O
currently,O
available,O
",",O
we,O
constructed,O
a,O
phylogenetic,O
tree,O
including,O
"
",O
also,O
representatives,O
of,O
other,O
coronaviridae,O
",",O
such,O
as,O
Bat,O
coronavirus,O
(,O
BCoV,O
),O
and,O
"
",O
severe,O
acute,O
respiratory,O
syndrome,O
.,O
We,O
confirm,O
high,O
sequence,O
similarity,O
(,O
>,O
99,O
%,O
),O
"
",O
between,O
all,O
sequenced,O
2019nCoVs,O
genomes,O
available,O
",",O
with,O
the,O
closest,O
BCoV,O
"
",O
sequence,O
sharing,O
96.2,O
%,O
sequence,O
identity,O
",",O
confirming,O
the,O
notion,O
of,O
a,O
zoonotic,O
"
",O
origin,O
of,O
2019nCoV.,O
Despite,O
the,O
low,O
heterogeneity,O
of,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
genomes,O
",",O
we,O
"
",O
could,O
identify,O
at,O
least,O
two,O
hypervariable,O
genomic,O
hotspots,O
",",O
one,O
of,O
which,O
is,O
"
",O
responsible,O
for,O
a,O
Serine,O
Leucine,O
variation,O
in,O
the,O
viral,O
ORF8encoded,O
protein,O
.,O
"
",O
Finally,O
",",O
we,O
perform,O
a,O
full,O
proteomic,O
comparison,O
with,O
other,O
coronaviridae,O
",",O
"
",O
identifying,O
key,O
aminoacidic,O
differences,O
to,O
be,O
considered,O
for,O
antiviral,O
strategies,O
"
",O
deriving,O
from,O
previous,O
anticoronavirus,O
approaches,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25700,O
"
",O
PMID,O
:,O
32027036,O
"


",O
793,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
6,O
.,O
doi,O
:,O
10.1002,O
jmv.25701,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Transmission,O
dynamics,O
and,O
evolutionary,O
history,O
of,O
2019nCoV.,O
"

",O
Li,O
X(1,O
),O
",",O
Wang,O
W(2,O
),O
",",O
Zhao,O
X(3,O
),O
",",O
Zai,O
J(4,O
),O
",",O
Zhao,O
Q(5,O
),O
",",O
Li,O
Y(1,O
),O
",",O
Chaillon,O
A(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Hubei,O
Engineering,O
Research,O
Center,O
of,O
Viral,O
Vector,O
",",O
Wuhan,O
University,O
of,O
"
",O
Bioengineering,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Spleen,O
and,O
Stomach,O
Diseases,O
",",O
First,O
Affiliated,O
Hospital,O
of,O
"
",O
Guangxi,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Nanning,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Science,O
and,O
Technology,O
",",O
Ruikang,O
Hospital,O
Affiliated,O
to,O
Guangxi,O
"
",O
University,O
of,O
Chinese,O
Medicine,O
",",O
Nanning,O
",",O
China,O
.,O
"
",O
(4)Immunology,O
Innovation,O
Team,O
",",O
School,O
of,O
Medicine,O
",",O
Ningbo,O
University,O
",",O
Ningbo,O
",",O
"
",O
China,O
.,O
"
",O
(5)Precision,O
Cancer,O
Center,O
Airport,O
Center,O
",",O
Tianjin,O
Cancer,O
Hospital,O
Airport,O
"
",O
Hospital,O
",",O
Tianjin,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Medicine,O
",",O
University,O
of,O
California,O
San,O
Diego,O
",",O
La,O
Jolla,O
",",O
"
",O
California,O
.,O
"

",O
To,O
investigate,O
the,O
time,O
origin,O
",",O
genetic,O
diversity,O
",",O
and,O
transmission,O
dynamics,O
of,O
"
",O
the,O
recent,O
2019nCoV,B-Virus_SARS-CoV-2
outbreak,O
in,O
China,O
and,O
beyond,O
",",O
a,O
total,O
of,O
32,O
genomes,O
of,O
virus,O
"
",O
strains,O
sampled,O
from,O
China,O
",",O
Thailand,O
",",O
and,O
the,O
USA,O
with,O
sampling,O
dates,O
between,O
24,O
"
",O
December,O
2019,O
and,O
23,O
January,O
2020,O
were,O
analyzed,O
.,O
Phylogenetic,O
",",O
transmission,O
"
",O
network,O
",",O
and,O
likelihoodmapping,O
analyses,O
of,O
the,O
genome,O
sequences,O
were,O
performed,O
.,O
"
",O
On,O
the,O
basis,O
of,O
the,O
likelihoodmapping,O
analysis,O
",",O
the,O
increasing,O
treelike,O
signals,O
"
",O
(,O
from,O
0,O
%,O
to,O
8.2,O
%,O
",",O
18.2,O
%,O
",",O
and,O
25.4,O
%,O
),O
over,O
time,O
may,O
be,O
indicative,O
of,O
increasing,O
"
",O
genetic,O
diversity,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
human,O
hosts,O
.,O
We,O
identified,O
three,O
phylogenetic,O
"
",O
clusters,O
using,O
the,O
Bayesian,O
inference,O
framework,O
and,O
three,O
transmission,O
clusters,O
"
",O
using,O
transmission,O
network,O
analysis,O
",",O
with,O
only,O
one,O
cluster,O
identified,O
by,O
both,O
"
",O
methods,O
using,O
the,O
above,O
genome,O
sequences,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
strains,O
.,O
The,O
estimated,O
mean,O
"
",O
evolutionary,O
rate,O
for,O
2019nCoV,B-Virus_SARS-CoV-2
ranged,O
from,O
1.7926,O
Ã—,O
â€‰,O
103,O
to,O
1.8266,O
â€‰,O
Ã—,O
â€‰,O
103,O
"
",O
substitutions,O
per,O
site,O
per,O
year,O
.,O
On,O
the,O
basis,O
of,O
our,O
study,O
",",O
undertaking,O
"
",O
epidemiological,O
investigations,O
and,O
genomic,O
data,O
surveillance,O
could,O
positively,O
"
",O
impact,O
public,O
health,O
in,O
terms,O
of,O
guiding,O
prevention,O
efforts,O
to,O
reduce,O
2019nCOV,B-Virus_SARS-CoV-2
"
",O
transmission,O
in,O
realtime,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25701,O
"
",O
PMID,O
:,O
32027035,O
"


",O
794,O
.,O
World,O
J,O
Pediatr,O
.,O
2020,O
Feb,O
5,O
.,O
doi,O
:,O
10.1007,O
s12519020003455,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Diagnosis,O
and,O
treatment,O
recommendations,O
for,O
pediatric,O
respiratory,O
infection,O
"
",O
caused,O
by,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
.,O
"

",O
Chen,O
ZM(1,O
),O
",",O
Fu,O
JF(2,O
),O
",",O
Shu,O
Q(3,O
),O
",",O
Chen,O
YH(1,O
),O
",",O
Hua,O
CZ(1,O
),O
",",O
Li,O
FB(1,O
),O
",",O
Lin,O
R(1,O
),O
",",O
Tang,O
"
",O
LF(1,O
),O
",",O
Wang,O
TL(1,O
),O
",",O
Wang,O
W(1,O
),O
",",O
Wang,O
YS(1,O
),O
",",O
Xu,O
WZ(1,O
),O
",",O
Yang,O
ZH(1,O
),O
",",O
Ye,O
S(1,O
),O
",",O
Yuan,O
"
",O
TM(1,O
),O
",",O
Zhang,O
CM(1,O
),O
",",O
Zhang,O
YY(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Children,O
's,O
Hospital,O
",",O
Zhejiang,O
University,O
School,O
of,O
Medicine,O
",",O
National,O
Clinical,O
"
",O
Research,O
Center,O
for,O
Child,O
Health,O
",",O
National,O
Children,O
's,O
Regional,O
Medical,O
Center,O
",",O
"
",O
Hangzhou,O
",",O
310052,O
",",O
China,O
.,O
"
",O
(2)Children,O
's,O
Hospital,O
",",O
Zhejiang,O
University,O
School,O
of,O
Medicine,O
",",O
National,O
Clinical,O
"
",O
Research,O
Center,O
for,O
Child,O
Health,O
",",O
National,O
Children,O
's,O
Regional,O
Medical,O
Center,O
",",O
"
",O
Hangzhou,O
",",O
310052,O
",",O
China,O
.,O
fjf68@zju.edu.cn,O
.,O
"
",O
(3)Children,O
's,O
Hospital,O
",",O
Zhejiang,O
University,O
School,O
of,O
Medicine,O
",",O
National,O
Clinical,O
"
",O
Research,O
Center,O
for,O
Child,O
Health,O
",",O
National,O
Children,O
's,O
Regional,O
Medical,O
Center,O
",",O
"
",O
Hangzhou,O
",",O
310052,O
",",O
China,O
.,O
shuqiang@zju.edu.cn,O
.,O
"

",O
Since,O
December,O
2019,O
",",O
an,O
epidemic,O
caused,O
by,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
"
",O
infection,O
has,O
occurred,O
unexpectedly,O
in,O
China,O
.,O
As,O
of,O
8,O
pm,O
",",O
31,O
January,O
2020,O
",",O
more,O
"
",O
than,O
20,O
pediatric,O
cases,O
have,O
been,O
reported,O
in,O
China,O
.,O
Of,O
these,O
cases,O
",",O
Â ,O
ten,O
patients,O
"
",O
were,O
identified,O
in,O
Zhejiang,O
Province,O
",",O
with,O
an,O
age,O
of,O
onset,O
ranging,O
from,O
112,O
Â ,O
days,O
"
",O
to,O
17,O
Â ,O
years,O
.,O
Following,O
the,O
latest,O
National,O
recommendations,O
for,O
diagnosis,O
and,O
"
",O
treatment,O
of,O
pneumonia,B-Disease_COVID-19
caused,I-Disease_COVID-19
by,I-Disease_COVID-19
2019nCoV,I-Disease_COVID-19
(,O
the,O
4th,O
edition,O
),O
and,O
current,O
status,O
"
",O
of,O
clinical,O
practice,O
in,O
Zhejiang,O
Province,O
",",O
recommendations,O
for,O
the,O
diagnosis,O
and,O
"
",O
treatment,O
of,O
respiratory,O
infection,B-Disease_COVID-19
caused,I-Disease_COVID-19
by,I-Disease_COVID-19
2019nCoV,I-Disease_COVID-19
for,O
children,O
were,O
drafted,O
"
",O
by,O
the,O
National,O
Clinical,O
Research,O
Center,O
for,O
Child,O
Health,O
",",O
the,O
Â ,O
National,O
"
",O
Children,O
's,O
Regional,O
Medical,O
Center,O
",",O
Children,O
's,O
Hospital,O
",",O
Zhejiang,O
University,O
"
",O
School,O
of,O
Medicine,O
to,O
further,O
standardize,O
the,O
protocol,O
for,O
diagnosis,O
and,O
"
",O
treatment,O
of,O
respiratory,O
infection,O
in,O
children,O
caused,O
by,O
2019nCoV.,O
"

",O
DOI,O
:,O
10.1007,O
s12519020003455,O
"
",O
PMID,O
:,O
32026148,O
"


",O
795,O
.,O
Eur,O
Radiol,O
.,O
2020,O
Feb,O
6,O
.,O
doi,O
:,O
10.1007,O
s0033002006713z,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Imaging,O
changes,O
in,O
patients,O
with,O
2019nCov,B-Virus_SARS-CoV-2
.,O
"

",O
Pan,O
Y(1,O
),O
",",O
Guan,O
H(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Radiology,O
",",O
Tongji,O
Hospital,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
",",O
430030,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)Department,O
of,O
Radiology,O
",",O
Tongji,O
Hospital,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
",",O
430030,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
hxguan@tjh.tjmu.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s0033002006713z,O
"
",O
PMID,O
:,O
32025790,O
"


",O
796,O
.,O
PeerJ.,O
2020,O
Jan,O
28;8:e8394,O
.,O
doi,O
:,O
10.7717,O
peerj.8394,O
.,O
eCollection,O
2020,O
.,O
"

",O
LINC00844,O
promotes,O
proliferation,O
and,O
migration,O
of,O
hepatocellular,O
carcinoma,O
by,O
"
",O
regulating,O
NDRG1,O
expression,O
.,O
"

",O
Zhou,O
W(1,O
),O
",",O
Huang,O
K(1,O
),O
",",O
Zhang,O
Q(1,O
),O
",",O
Ye,O
S(1,O
),O
",",O
Zhong,O
Z(1,O
),O
",",O
Zeng,O
C(1,O
),O
",",O
Peng,O
G(1,O
),O
",",O
Li,O
"
",O
L(1,O
),O
",",O
Ye,O
Q(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Institute,O
of,O
Hepatobiliary,O
Diseases,O
of,O
"
",O
Wuhan,O
University,O
",",O
Transplant,O
Center,O
of,O
Wuhan,O
University,O
",",O
Hubei,O
Key,O
Laboratory,O
of,O
"
",O
Medical,O
Technology,O
on,O
Transplantation,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)The,O
3rd,O
Xiangya,O
Hospital,O
of,O
Central,O
South,O
University,O
",",O
Research,O
Center,O
of,O
"
",O
National,O
Health,O
Ministry,O
on,O
Transplantation,O
Medicine,O
Engineering,O
and,O
Technology,O
",",O
"
",O
Changsha,O
",",O
China,O
.,O
"

",O
Background,O
:,O
Aberrant,O
expression,O
of,O
long,O
noncoding,O
RNAs,O
are,O
implicated,O
in,O
the,O
"
",O
pathogenesis,O
of,O
human,O
malignancies,O
.,O
LINC00844,O
expression,O
is,O
dramatically,O
"
",O
downregulated,O
in,O
prostate,O
cancer,O
",",O
and,O
functional,O
studies,O
have,O
revealed,O
the,O
"
",O
association,O
between,O
the,O
aberrant,O
expression,O
of,O
LINC00844,O
and,O
prostate,O
cancer,O
cell,O
"
",O
invasion,O
and,O
metastasis,O
.,O
However,O
",",O
the,O
function,O
and,O
mechanism,O
of,O
action,O
of,O
"
",O
LINC00844,O
in,O
the,O
pathogenesis,O
of,O
hepatocellular,O
carcinoma,O
(,O
HCC,O
),O
are,O
poorly,O
"
",O
understood,O
.,O
"
",O
Methods,O
:,O
LINC00844,O
and,O
NMyc,O
downstreamregulated,O
1,O
(,O
NDRG1,O
),O
expression,O
in,O
HCC,O
"
",O
tissues,O
and,O
cell,O
lines,O
was,O
detected,O
with,O
realtime,O
quantitative,O
polymerase,O
chain,O
"
",O
reaction,O
(,O
RTqPCR,O
),O
and,O
western,O
blot,O
analysis,O
.,O
Correlations,O
between,O
LINC00844,O
"
",O
expression,O
level,O
and,O
clinicopathological,O
features,O
were,O
investigated,O
using,O
the,O
"
",O
original,O
data,O
from,O
The,O
Cancer,O
Genome,O
Atlas,O
(,O
TCGA,O
),O
database,O
.,O
HepG2,O
and,O
HCCLM9,O
cell,O
"
",O
lines,O
were,O
transfected,O
with,O
LvLIN00844,O
virus,O
to,O
obtain,O
LINC00844overexpressing,O
"
",O
cell,O
lines,O
.,O
Cell,O
proliferation,O
and,O
cell,O
invasion,O
and,O
migration,O
were,O
examined,O
with,O
"
",O
the,O
cell,O
counting,O
kit8,O
(,O
CCK8,O
),O
and,O
transwell,O
assay,O
",",O
respectively,O
.,O
Furthermore,O
",",O
"
",O
the,O
correlation,O
between,O
LINC00844,O
and,O
NDRG1,O
expression,O
was,O
analysed,O
using,O
"
",O
Pearson,O
's,O
correlation,O
analysis,O
.,O
"
",O
Results,O
:,O
LINC00844,O
expression,O
was,O
significantly,O
downregulatedin,O
HCC,O
tissues,O
and,O
"
",O
cell,O
lines,O
",",O
and,O
a,O
statistical,O
correlation,O
was,O
detected,O
between,O
low,O
LINC00844,O
"
",O
expression,O
and,O
sex,O
(,O
Female,O
),O
",",O
advanced,O
American,O
Joint,O
Committee,O
on,O
Cancer,O
(,O
AJCC,O
),O
"
",O
stage,O
(,O
III,O
+,O
IV,O
),O
",",O
histological,O
grade,O
(,O
G3,O
+,O
G4,O
),O
",",O
and,O
vascular,O
invasion,O
(,O
Micro,O
and,O
"
",O
Macro,O
),O
.,O
In,O
vitro,O
experiments,O
showed,O
that,O
LINC00844,O
overexpression,O
significantly,O
"
",O
repressed,O
the,O
proliferation,O
",",O
migration,O
",",O
and,O
invasion,O
of,O
HCC,O
cells,O
.,O
NDRG1,O
"
",O
expression,O
was,O
higher,O
in,O
HCC,O
tissues,O
and,O
LINC00844,O
could,O
partly,O
inhibit,O
the,O
"
",O
expression,O
of,O
NDRG1,O
.,O
"

",O
Â©,O
2020,O
Zhou,O
et,O
al.,O
"

",O
DOI,O
:,O
10.7717,O
peerj.8394,O
"
",O
PMCID,O
:,O
PMC6993750,O
"
",O
PMID,O
:,O
32025371,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
there,O
are,O
no,O
competing,O
"
",O
interests,O
.,O
"


",O
797,O
.,O
Hortic,O
Res,O
.,O
2020,O
Feb,O
1;7:18,O
.,O
doi,O
:,O
10.1038,O
s4143802002405,O
.,O
eCollection,O
2020,O
.,O
"

",O
A,O
chromosomescale,O
genome,O
assembly,O
of,O
Isatis,O
indigotica,O
",",O
an,O
important,O
medicinal,O
"
",O
plant,O
used,O
in,O
traditional,O
Chinese,O
medicine,O
:,O
An,O
Isatis,O
genome,O
.,O
"

",O
Kang,O
M(1,O
),O
",",O
Wu,O
H(1,O
),O
",",O
Yang,O
Q(1,O
),O
",",O
Huang,O
L(1,O
),O
",",O
Hu,O
Q(1,O
),O
",",O
Ma,O
T(1,O
),O
",",O
Li,O
Z(2)(1,O
),O
",",O
Liu,O
"
",O
J(1)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)1Key,O
Laboratory,O
of,O
BioResource,O
and,O
EcoEnvironment,O
of,O
Ministry,O
of,O
Education,O
&,O
"
",O
State,O
Key,O
Laboratory,O
of,O
Hydraulics,O
&,O
Mountain,O
River,O
Engineering,O
",",O
College,O
of,O
Life,O
"
",O
Sciences,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
",",O
610065,O
China,O
.,O
"
",O
(2)2National,O
Key,O
Laboratory,O
of,O
Crop,O
Genetic,O
Improvement,O
",",O
National,O
Center,O
of,O
Oil,O
"
",O
Crop,O
Improvement,O
(,O
Wuhan,O
),O
",",O
College,O
of,O
Plant,O
Science,O
and,O
Technology,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)3State,O
Key,O
Laboratory,O
of,O
Grassland,O
AgroEcosystem,O
",",O
Institute,O
of,O
Innovation,O
"
",O
Ecology,O
",",O
Lanzhou,O
University,O
",",O
Lanzhou,O
",",O
730000,O
China,O
.,O
"

",O
Isatis,O
indigotica,O
(,O
2n,O
â€‰,O
=,O
â€‰,O
14,O
),O
is,O
an,O
important,O
medicinal,O
plant,O
in,O
China,O
.,O
Its,O
dried,O
"
",O
leaves,O
and,O
roots,O
(,O
called,O
Isatidis,O
Folium,O
and,O
Isatidis,O
Radix,O
",",O
respectively,O
),O
are,O
"
",O
broadly,O
used,O
in,O
traditional,O
Chinese,O
medicine,O
for,O
curing,O
diseases,O
caused,O
by,O
"
",O
bacteria,O
and,O
viruses,O
such,O
as,O
influenza,O
and,O
viral,O
pneumonia,O
.,O
Various,O
classes,O
of,O
"
",O
compounds,O
isolated,O
from,O
this,O
species,O
have,O
been,O
identified,O
as,O
effective,O
"
",O
ingredients,O
.,O
Previous,O
studies,O
based,O
on,O
transcriptomes,O
revealed,O
only,O
a,O
few,O
"
",O
candidate,O
genes,O
for,O
the,O
biosynthesis,O
of,O
these,O
active,O
compounds,O
in,O
this,O
medicinal,O
"
",O
plant,O
.,O
Here,O
",",O
we,O
report,O
a,O
highquality,O
chromosomescale,O
genome,O
assembly,O
of,O
I.,O
"
",O
indigotica,O
with,O
a,O
total,O
size,O
of,O
293.88,O
â€‰,O
Mb,O
and,O
scaffold,O
N50,O
â€‰,O
=,O
â€‰,O
36.16,O
â€‰,O
Mb,O
using,O
"
",O
singlemolecule,O
realtime,O
long,O
reads,O
and,O
highthroughput,O
chromosome,O
conformation,O
"
",O
capture,O
techniques,O
.,O
We,O
annotated,O
30323,O
highconfidence,O
proteincoding,O
genes,O
.,O
"
",O
Based,O
on,O
homolog,O
searching,O
and,O
functional,O
annotations,O
",",O
we,O
identified,O
many,O
"
",O
candidate,O
genes,O
involved,O
in,O
the,O
biosynthesis,O
of,O
main,O
active,O
components,O
such,O
as,O
"
",O
indoles,O
",",O
terpenoids,O
",",O
and,O
phenylpropanoids,O
.,O
In,O
addition,O
",",O
we,O
found,O
that,O
some,O
key,O
"
",O
enzymecoding,O
gene,O
families,O
related,O
to,O
the,O
biosynthesis,O
of,O
these,O
components,O
were,O
"
",O
expanded,O
due,O
to,O
tandem,O
duplications,O
",",O
which,O
likely,O
drove,O
the,O
production,O
of,O
these,O
"
",O
major,O
active,O
compounds,O
and,O
explained,O
why,O
I.,O
indigotica,O
has,O
excellent,O
"
",O
antibacterial,O
and,O
antiviral,O
activities,O
.,O
Our,O
results,O
highlighted,O
the,O
importance,O
of,O
"
",O
genome,O
sequencing,O
in,O
identifying,O
candidate,O
genes,O
for,O
metabolite,O
synthesis,O
in,O
"
",O
medicinal,O
plants,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s4143802002405,O
"
",O
PMCID,O
:,O
PMC6994597,O
"
",O
PMID,O
:,O
32025321,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflict,O
of,O
interestThe,O
authors,O
declare,O
that,O
they,O
"
",O
have,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
798,O
.,O
Plant,O
Methods,O
.,O
2020,O
Feb,O
3;16:9,O
.,O
doi,O
:,O
10.1186,O
s1300702005603,O
.,O
eCollection,O
2020,O
.,O
"

",O
A,O
cucumber,O
green,O
mottle,O
mosaic,O
virus,O
vector,O
for,O
virusinduced,O
gene,O
silencing,O
in,O
"
",O
cucurbit,O
plants,O
.,O
"

",O
Liu,O
M(1)(2,O
),O
",",O
Liang,O
Z(1,O
),O
",",O
Aranda,O
MA(3,O
),O
",",O
Hong,O
N(2,O
),O
",",O
Liu,O
L(1,O
),O
",",O
Kang,O
B(1,O
),O
",",O
Gu,O
Q(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)1Zhengzhou,O
Fruit,O
Research,O
Institute,O
",",O
Chinese,O
Academy,O
of,O
Agricultural,O
Sciences,O
",",O
"
",O
Zhengzhou,O
",",O
450009,O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)2Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(3)3Centro,O
de,O
Edafologia,O
y,O
Biologia,O
Aplicada,O
del,O
Segura,O
(CEBAS)CSIC,O
",",O
Apdo,O
.,O
"
",O
Correos,O
164,O
",",O
Espinardo,O
",",O
30100,O
Murcia,O
",",O
Spain,O
.,O
"

",O
Background,O
:,O
Cucurbits,O
produce,O
fruits,O
or,O
vegetables,O
that,O
have,O
great,O
dietary,O
"
",O
importance,O
and,O
economic,O
significance,O
worldwide,O
.,O
The,O
published,O
genomes,O
of,O
at,O
least,O
"
",O
11,O
cucurbit,O
species,O
are,O
boosting,O
gene,O
mining,O
and,O
novel,O
breeding,O
strategies,O
",",O
"
",O
however,O
genetic,O
transformation,O
in,O
cucurbits,O
is,O
impractical,O
as,O
a,O
tool,O
for,O
gene,O
"
",O
function,O
validation,O
due,O
to,O
low,O
transformation,O
efficiency,O
.,O
Virusinduced,O
gene,O
"
",O
silencing,O
(,O
VIGS,O
),O
is,O
a,O
potential,O
alternative,O
tool,O
.,O
So,O
far,O
",",O
very,O
few,O
ideal,O
VIGS,O
"
",O
vectors,O
are,O
available,O
for,O
cucurbits,O
.,O
"
",O
Results,O
:,O
Here,O
",",O
we,O
describe,O
a,O
new,O
VIGS,O
vector,O
derived,O
from,O
cucumber,O
green,O
mottle,O
"
",O
mosaic,O
virus,O
(,O
CGMMV,O
),O
",",O
a,O
monopartite,O
virus,O
that,O
infects,O
cucurbits,O
naturally,O
.,O
We,O
"
",O
show,O
that,O
the,O
CGMMV,O
vector,O
is,O
competent,O
to,O
induce,O
efficient,O
silencing,O
of,O
the,O
"
",O
phytoene,O
desaturase,O
(,O
PDS,O
),O
gene,O
in,O
the,O
model,O
plant,O
Nicotiana,O
benthamiana,O
and,O
in,O
"
",O
cucurbits,O
",",O
including,O
watermelon,O
",",O
melon,O
",",O
cucumber,O
and,O
bottle,O
gourd,O
.,O
Infection,O
with,O
"
",O
the,O
CGMMV,O
vector,O
harboring,O
PDS,O
sequences,O
of,O
69300,O
Â ,O
bp,O
in,O
length,O
in,O
the,O
form,O
of,O
"
",O
senseoriented,O
or,O
hairpin,O
cDNAs,O
resulted,O
in,O
photobleaching,O
phenotypes,O
in,O
N.,O
"
",O
benthamiana,O
and,O
cucurbits,O
by,O
PDS,O
silencing,O
.,O
Additional,O
results,O
reflect,O
that,O
"
",O
silencing,O
of,O
the,O
PDS,O
gene,O
could,O
persist,O
for,O
over,O
two,O
months,O
and,O
the,O
silencing,O
"
",O
effect,O
of,O
CGMMVbased,O
vectors,O
could,O
be,O
passaged,O
.,O
"
",O
Conclusions,O
:,O
These,O
results,O
demonstrate,O
that,O
CGMMV,O
vector,O
could,O
serve,O
as,O
a,O
"
",O
powerful,O
and,O
easytouse,O
tool,O
for,O
characterizing,O
gene,O
function,O
",",O
controlling,O
viral,O
"
",O
pathogens,O
or,O
even,O
performing,O
resistance,O
breeding,O
in,O
cucurbits,O
.,O
Moreover,O
",",O
this,O
"
",O
study,O
will,O
possess,O
considerable,O
important,O
reference,O
value,O
for,O
developing,O
"
",O
different,O
viral,O
vectors,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s1300702005603,O
"
",O
PMCID,O
:,O
PMC6996188,O
"
",O
PMID,O
:,O
32025236,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
interestsThe,O
authors,O
declare,O
that,O
they,O
"
",O
have,O
no,O
competing,O
interests,O
.,O
"


",O
799,O
.,O
Cell,O
Mol,O
Immunol,O
.,O
2020,O
Feb,O
5,O
.,O
doi,O
:,O
10.1038,O
s4142302003724,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
causing,O
pneumoniaassociated,O
respiratory,O
"
",O
syndrome,O
.,O
"

",O
Jiang,O
S(1,O
),O
",",O
Xia,O
S(2,O
),O
",",O
Ying,O
T(2,O
),O
",",O
Lu,O
L(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Fudan,O
University,O
",",O
131,O
Dong,O
An,O
Road,O
",",O
Fuxing,O
"
",O
Building,O
",",O
Xuhui,O
District,O
",",O
Shanghai,O
",",O
200032,O
",",O
China,O
.,O
shibojiang@fudan.edu.cn,O
.,O
"
",O
(2)School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Fudan,O
University,O
",",O
131,O
Dong,O
An,O
Road,O
",",O
Fuxing,O
"
",O
Building,O
",",O
Xuhui,O
District,O
",",O
Shanghai,O
",",O
200032,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s4142302003724,O
"
",O
PMID,O
:,O
32024976,O
"


",O
800,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Feb,O
1;9(2,O
),O
.,O
pii,O
:,O
E388,O
.,O
doi,O
:,O
10.339,O
jcm9020388,O
.,O
"

",O
Estimating,O
the,O
Unreported,O
Number,O
of,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
Cases,O
in,O
China,O
"
",O
in,O
the,O
First,O
Half,O
of,O
January,O
2020,O
:,O
A,O
DataDriven,O
Modelling,O
Analysis,O
of,O
the,O
Early,O
"
",O
Outbreak,O
.,O
"

",O
Zhao,O
S(1)(2,O
),O
",",O
Musa,O
SS(3,O
),O
",",O
Lin,O
Q(4,O
),O
",",O
Ran,O
J(5,O
),O
",",O
Yang,O
G(6)(7,O
),O
",",O
Wang,O
W(8,O
),O
",",O
Lou,O
Y(3,O
),O
",",O
"
",O
Yang,O
L(9,O
),O
",",O
Gao,O
D(10,O
),O
",",O
He,O
D(3,O
),O
",",O
Wang,O
MH(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)JC,O
School,O
of,O
Public,O
Health,O
and,O
Primary,O
Care,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
999077,O
",",O
China,O
.,O
"
",O
(2)Shenzhen,O
Research,O
Institute,O
of,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
Shenzhen,O
"
",O
518060,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
Kong,O
"
",O
999077,O
",",O
China,O
.,O
"
",O
(4)Michigan,O
Institute,O
for,O
Data,O
Science,O
",",O
University,O
of,O
Michigan,O
",",O
Ann,O
Arbor,O
",",O
"
",O
Michigan,O
",",O
MI,O
48104,O
",",O
USA,O
.,O
"
",O
(5)School,O
of,O
Public,O
Health,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Hong,O
"
",O
Kong,O
",",O
Hong,O
Kong,O
999077,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Orthopaedics,O
and,O
Traumatology,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
999077,O
",",O
China,O
.,O
"
",O
(7)SH,O
Ho,O
Scoliosis,O
Research,O
Lab,O
",",O
Joint,O
Scoliosis,O
Research,O
Center,O
of,O
Chinese,O
"
",O
University,O
of,O
Hong,O
Kong,O
and,O
Nanjing,O
University,O
",",O
Hong,O
Kong,O
999077,O
",",O
China,O
.,O
"
",O
(8)School,O
of,O
Mathematics,O
and,O
Statistics,O
",",O
Huaiyin,O
Normal,O
University,O
",",O
Huaian,O
"
",O
223300,O
",",O
China,O
.,O
"
",O
(9)School,O
of,O
Nursing,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
Kong,O
999077,O
",",O
China,O
.,O
"
",O
(10)Department,O
of,O
Mathematics,O
",",O
Shanghai,O
Normal,O
University,O
",",O
Shanghai,O
200234,O
",",O
"
",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
In,O
December,O
2019,O
",",O
an,O
outbreak,O
of,O
respiratory,O
illness,O
caused,O
by,O
a,O
"
",O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
emerged,O
in,O
Wuhan,O
",",O
China,O
and,O
has,O
swiftly,O
spread,O
to,O
"
",O
other,O
parts,O
of,O
China,O
and,O
a,O
number,O
of,O
foreign,O
countries,O
.,O
The,O
2019nCoV,B-Virus_SARS-CoV-2
cases,O
might,O
"
",O
have,O
been,O
underreported,O
roughly,O
from,O
1,O
to,O
15,O
January,O
2020,O
",",O
and,O
thus,O
we,O
estimated,O
"
",O
the,O
number,O
of,O
unreported,O
cases,O
and,O
the,O
basic,O
reproduction,O
number,O
",",O
R0,O
",",O
of,O
"
",O
2019nCoV.,O
"
",O
METHODS,O
:,O
We,O
modelled,O
the,O
epidemic,O
curve,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
cases,O
",",O
in,O
mainland,O
China,O
"
",O
from,O
1,O
December,O
2019,O
to,O
24,O
January,O
2020,O
through,O
the,O
exponential,O
growth,O
.,O
The,O
"
",O
number,O
of,O
unreported,O
cases,O
was,O
determined,O
by,O
the,O
maximum,O
likelihood,O
estimation,O
.,O
"
",O
We,O
used,O
the,O
serial,O
intervals,O
(,O
SI,O
),O
of,O
infection,O
caused,O
by,O
two,O
other,O
wellknown,O
"
",O
coronaviruses,O
(,O
CoV,O
),O
",",O
Severe,O
Acute,O
Respiratory,O
Syndrome,O
(,O
SARS,O
),O
and,O
Middle,O
East,O
"
",O
Respiratory,O
Syndrome,O
(,O
MERS,O
),O
CoVs,O
",",O
as,O
approximations,O
of,O
the,O
unknown,O
SI,O
for,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
to,O
estimate,O
R0,O
.,O
"
",O
RESULTS,O
:,O
We,O
confirmed,O
that,O
the,O
initial,O
growth,O
phase,O
followed,O
an,O
exponential,O
"
",O
growth,O
pattern,O
.,O
The,O
underreporting,O
was,O
likely,O
to,O
have,O
resulted,O
in,O
469,O
(,O
95,O
%,O
CI,O
:,O
"
",O
403540,O
),O
unreported,O
cases,O
from,O
1,O
to,O
15,O
January,O
2020,O
.,O
The,O
reporting,O
rate,O
after,O
17,O
"
",O
January,O
2020,O
was,O
likely,O
to,O
have,O
increased,O
21fold,O
(,O
95,O
%,O
CI,O
:,O
1825,O
),O
in,O
comparison,O
"
",O
to,O
the,O
situation,O
from,O
1,O
to,O
17,O
January,O
2020,O
on,O
average,O
.,O
We,O
estimated,O
the,O
R0,O
of,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
at,O
2.56,O
(,O
95,O
%,O
CI,O
:,O
2.492.63,O
),O
.,O
"
",O
CONCLUSION,O
:,O
The,O
underreporting,O
was,O
likely,O
to,O
have,O
occurred,O
during,O
the,O
first,O
half,O
"
",O
of,O
January,O
2020,O
and,O
should,O
be,O
considered,O
in,O
future,O
investigation,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9020388,O
"
",O
PMID,O
:,O
32024089,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
801,O
.,O
Epidemiol,O
Health,O
.,O
2020;42:e2020006,O
.,O
doi,O
:,O
10.4178,O
epih.e2020006,O
.,O
Epub,O
2020,O
Feb,O
6,O
.,O
"

",O
An,O
interim,O
review,O
of,O
the,O
epidemiological,O
characteristics,O
of,O
2019,O
novel,O
"
",O
coronavirus,O
.,O
"

",O
Ryu,O
S(1,O
),O
",",O
Chun,O
BC(2,O
),O
;,O
Korean,O
Society,O
of,O
Epidemiology,O
2019nCoV,B-Virus_SARS-CoV-2
Task,O
Force,O
"
",O
Team(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Preventive,O
Medicine,O
",",O
Konyang,O
University,O
College,O
of,O
Medicine,O
",",O
"
",O
Daejeon,O
",",O
Korea,O
.,O
"
",O
(2)Department,O
of,O
Preventive,O
Medicine,O
",",O
Korea,O
University,O
College,O
of,O
Medicine,O
",",O
"
",O
Seoul,O
",",O
Korea,O
.,O
"

",O
OBJECTIVES,O
:,O
The,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
from,O
Wuhan,O
",",O
China,O
is,O
currently,O
"
",O
recognized,O
as,O
a,O
public,O
health,O
emergency,O
of,O
global,O
concern,O
.,O
"
",O
METHODS,O
:,O
We,O
reviewed,O
the,O
currently,O
available,O
literature,O
to,O
provide,O
uptodate,O
"
",O
guidance,O
on,O
control,O
measures,O
to,O
be,O
implemented,O
by,O
public,O
health,O
authorities,O
.,O
"
",O
RESULTS,O
:,O
Some,O
of,O
the,O
epidemiological,O
characteristics,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
have,O
been,O
"
",O
identified,O
.,O
However,O
",",O
there,O
remain,O
considerable,O
uncertainties,O
",",O
which,O
should,O
be,O
"
",O
considered,O
when,O
providing,O
guidance,O
to,O
public,O
health,O
authorities,O
on,O
control,O
"
",O
measures,O
.,O
"
",O
CONCLUSIONS,O
:,O
Additional,O
studies,O
incorporating,O
more,O
detailed,O
information,O
from,O
"
",O
confirmed,O
cases,O
would,O
be,O
valuable,O
.,O
"

",O
DOI,O
:,O
10.4178,O
epih.e2020006,O
"
",O
PMCID,O
:,O
PMC7011107,O
"
",O
PMID,O
:,O
32023775,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
802,O
.,O
Acta,O
Med,O
Port,O
.,O
2020,O
Feb,O
5,O
.,O
doi,O
:,O
10.20344,O
amp.13547,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
:,O
Novel,O
Virus,O
",",O
Old,O
Challenges,O
.,O
"

",O
Duarte,O
R(1,O
),O
",",O
Furtado,O
I(2,O
),O
",",O
Sousa,O
L(3,O
),O
",",O
Carvalho,O
CFA(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)ServiÃ§o,O
de,O
Pneumologia,O
.,O
Centro,O
Hospitalar,O
de,O
Vila,O
Nova,O
de,O
Gaia,O
Espinho,O
.,O
Vila,O
"
",O
Nova,O
de,O
Gaia,O
;,O
Departamento,O
de,O
Epidemiologia,O
.,O
Faculdade,O
de,O
Medicina,O
.,O
Universidade,O
"
",O
do,O
Porto,O
.,O
Porto,O
;,O
Instituto,O
de,O
SaÃºde,O
PÃºblica,O
.,O
Universidade,O
do,O
Porto,O
.,O
Porto,O
.,O
"
",O
Portugal,O
.,O
"
",O
(2)ServiÃ§o,O
de,O
Infeciologia,O
.,O
Centro,O
Hospitalar,O
UniversitÃ¡rio,O
do,O
Porto,O
.,O
Porto,O
.,O
"
",O
Portugal,O
.,O
"
",O
(3)Departamento,O
de,O
SaÃºde,O
PÃºblica,O
.,O
AdministraÃ§Ã£o,O
Regional,O
de,O
SaÃºde,O
do,O
Norte,O
.,O
"
",O
Porto,O
.,O
Infectious,O
Disease,O
Epidemiology,O
and,O
Preparedness,O
Department,O
.,O
Statens,O
Serum,O
"
",O
Institut,O
.,O
Copenhaga,O
.,O
Dinamarca,O
.,O
Portugal,O
.,O
"
",O
(4)Departamento,O
de,O
SaÃºde,O
PÃºblica,O
.,O
AdministraÃ§Ã£o,O
Regional,O
de,O
SaÃºde,O
do,O
Norte,O
.,O
"
",O
Porto,O
.,O
Unidade,O
Multidisciplinar,O
de,O
InvestigaÃ§Ã£o,O
BiomÃ©dica,O
(,O
UMIB,O
),O
.,O
Instituto,O
de,O
"
",O
CiÃªncias,O
BiomÃ©dicas,O
Abel,O
Salazar,O
.,O
Universidade,O
do,O
Porto,O
.,O
Porto,O
.,O
Portugal,O
.,O
"

",O
DOI,O
:,O
10.20344,O
amp.13547,O
"
",O
PMID,O
:,O
32023427,O
"


",O
803,O
.,O
Ann,O
Intern,O
Med,O
.,O
2020,O
Feb,O
5,O
.,O
doi,O
:,O
10.7326,O
M200358,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Reporting,O
",",O
Epidemic,O
Growth,O
",",O
and,O
Reproduction,O
Numbers,O
for,O
the,O
2019,O
Novel,O
"
",O
Coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
Epidemic,O
.,O
"

",O
Tuite,O
AR(1,O
),O
",",O
Fisman,O
DN(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Dalla,O
Lana,O
School,O
of,O
Public,O
Health,O
",",O
University,O
of,O
Toronto,O
",",O
Toronto,O
",",O
Ontario,O
",",O
"
",O
Canada,O
(,O
A.R.T.,O
",",O
D.N.F.,O
),O
.,O
"

",O
DOI,O
:,O
10.7326,O
M200358,O
"
",O
PMID,O
:,O
32023340,O
"


",O
804,O
.,O
Chembiochem,O
.,O
2020,O
Mar,O
2;21(5):730738,O
.,O
doi,O
:,O
10.1002,O
cbic.202000047,O
.,O
Epub,O
2020,O
Feb,O
"
",O
25,O
.,O
"

",O
Learning,O
from,O
the,O
Past,O
:,O
Possible,O
Urgent,O
Prevention,O
and,O
Treatment,O
Options,O
for,O
"
",O
Severe,O
Acute,O
Respiratory,O
Infections,O
Caused,O
by,O
2019nCoV.,O
"

",O
Morse,O
JS(1,O
),O
",",O
Lalonde,O
T(1,O
),O
",",O
Xu,O
S(1,O
),O
",",O
Liu,O
WR(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Texas,O
A&M,O
Drug,O
Discovery,O
Laboratory,O
",",O
Department,O
of,O
Chemistry,O
",",O
Texas,O
A&M,O
"
",O
University,O
",",O
College,O
Station,O
",",O
TX,O
",",O
77843,O
",",O
USA,O
.,O
"

",O
With,O
the,O
current,O
trajectory,O
of,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
outbreak,O
unknown,O
",",O
public,O
health,O
and,O
"
",O
medicinal,O
measures,O
will,O
both,O
be,O
needed,O
to,O
contain,O
spreading,O
of,O
the,O
virus,O
and,O
to,O
"
",O
optimize,O
patient,O
outcomes,O
.,O
Although,O
little,O
is,O
known,O
about,O
the,O
virus,O
",",O
an,O
"
",O
examination,O
of,O
the,O
genome,O
sequence,O
shows,O
strong,O
homology,O
with,O
its,O
betterstudied,O
"
",O
cousin,O
",",O
SARSCoV.,O
The,O
spike,O
protein,O
used,O
for,O
host,O
cell,O
infection,O
shows,O
key,O
"
",O
nonsynonymous,O
mutations,O
that,O
might,O
hamper,O
the,O
efficacy,O
of,O
previously,O
developed,O
"
",O
therapeutics,O
but,O
remains,O
a,O
viable,O
target,O
for,O
the,O
development,O
of,O
biologics,O
and,O
"
",O
macrocyclic,O
peptides,O
.,O
Other,O
key,O
drug,O
targets,O
",",O
including,O
RNAdependent,O
RNA,O
"
",O
polymerase,O
and,O
coronavirus,O
main,O
proteinase,O
(,O
3CLpro,O
),O
",",O
share,O
a,O
strikingly,O
high,O
"
",O
(,O
>,O
95,O
â€‰,O
%,O
),O
homology,O
to,O
SARSCoV.,O
Herein,O
",",O
we,O
suggest,O
four,O
potential,O
drug,O
candidates,O
"
",O
(,O
an,O
ACE2based,O
peptide,O
",",O
remdesivir,O
",",O
3CLpro1,O
and,O
a,O
novel,O
vinylsulfone,O
protease,O
"
",O
inhibitor,O
),O
that,O
could,O
be,O
used,O
to,O
treat,O
patients,O
suffering,O
with,O
the,O
2019nCoV.,O
We,O
"
",O
also,O
summarize,O
previous,O
efforts,O
into,O
drugging,O
these,O
targets,O
and,O
hope,O
to,O
help,O
in,O
"
",O
the,O
development,O
of,O
broadspectrum,O
anticoronaviral,O
agents,O
for,O
future,O
epidemics,O
.,O
"

",O
Â©,O
2020,O
WileyVCH,O
Verlag,O
GmbH,O
&,O
Co.,O
KGaA,O
",",O
Weinheim,O
.,O
"

",O
DOI,O
:,O
10.1002,O
cbic.202000047,O
"
",O
PMID,O
:,O
32022370,O
"


",O
805,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
5,O
.,O
doi,O
:,O
10.1002,O
jmv.25698,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Immunoinformaticsaided,O
identification,O
of,O
T,O
cell,O
and,O
B,O
cell,O
epitopes,O
in,O
the,O
"
",O
surface,O
glycoprotein,O
of,O
2019nCoV.,O
"

",O
Baruah,O
V(1,O
),O
",",O
Bose,O
S(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Biotechnology,O
",",O
Gauhati,O
University,O
",",O
Guwahati,O
",",O
Assam,O
",",O
India,O
.,O
"

",O
The,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
outbreak,O
has,O
caused,O
a,O
large,O
number,O
of,O
"
",O
deaths,O
with,O
thousands,O
of,O
confirmed,O
cases,O
worldwide,O
",",O
especially,O
in,O
East,O
Asia,O
.,O
This,O
"
",O
study,O
took,O
an,O
immunoinformatics,O
approach,O
to,O
identify,O
significant,O
cytotoxic,O
T,O
"
",O
lymphocyte,O
(,O
CTL,O
),O
and,O
B,O
cell,O
epitopes,O
in,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
surface,O
glycoprotein,O
.,O
Also,O
",",O
"
",O
interactions,O
between,O
identified,O
CTL,O
epitopes,O
and,O
their,O
corresponding,O
major,O
"
",O
histocompatibility,O
complex,O
(,O
MHC,O
),O
class,O
I,O
supertype,O
representatives,O
prevalent,O
in,O
"
",O
China,O
were,O
studied,O
by,O
molecular,O
dynamics,O
simulations,O
.,O
We,O
identified,O
five,O
CTL,O
"
",O
epitopes,O
",",O
three,O
sequential,O
B,O
cell,O
epitopes,O
and,O
five,O
discontinuous,O
B,O
cell,O
epitopes,O
"
",O
in,O
the,O
viral,O
surface,O
glycoprotein,O
.,O
Also,O
",",O
during,O
simulations,O
",",O
the,O
CTL,O
epitopes,O
"
",O
were,O
observed,O
to,O
be,O
binding,O
MHC,O
class,O
I,O
peptidebinding,O
grooves,O
via,O
multiple,O
"
",O
contacts,O
",",O
with,O
continuous,O
hydrogen,O
bonds,O
and,O
salt,O
bridge,O
anchors,O
",",O
indicating,O
"
",O
their,O
potential,O
in,O
generating,O
immune,O
responses,O
.,O
Some,O
of,O
these,O
identified,O
epitopes,O
"
",O
can,O
be,O
potential,O
candidates,O
for,O
the,O
development,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
vaccines,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25698,O
"
",O
PMID,O
:,O
32022276,O
"


",O
806,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Feb,O
5,O
.,O
doi,O
:,O
10.1002,O
jmv.25699,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
first,O
two,O
cases,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
Italy,O
:,O
Where,O
they,O
come,O
from,O
?,O
"

",O
Giovanetti,O
M(1,O
),O
",",O
Benvenuto,O
D(2,O
),O
",",O
Angeletti,O
S(3,O
),O
",",O
Ciccozzi,O
M(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)LaboratÃ³rio,O
de,O
FlavivÃ­rus,O
",",O
Instituto,O
Oswaldo,O
Cruz,O
",",O
FundaÃ§Ã£o,O
Oswaldo,O
Cruz,O
",",O
Rio,O
"
",O
de,O
Janeiro,O
",",O
Brazil,O
.,O
"
",O
(2)Unit,O
of,O
Medical,O
Statistics,O
and,O
Molecular,O
Epidemiology,O
",",O
University,O
Campus,O
"
",O
BioMedico,O
of,O
Rome,O
",",O
Rome,O
",",O
Italy,O
.,O
"
",O
(3)Unit,O
of,O
Clinical,O
Laboratory,O
Science,O
",",O
University,O
Campus,O
BioMedico,O
of,O
Rome,O
",",O
"
",O
Rome,O
",",O
Italy,O
.,O
"

",O
A,O
novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
",",O
2019nCoV,B-Virus_SARS-CoV-2
",",O
has,O
been,O
identified,O
as,O
the,O
causal,O
pathogen,O
of,O
an,O
"
",O
ongoing,O
epidemic,O
",",O
with,O
the,O
first,O
cases,O
reported,O
in,O
Wuhan,O
",",O
China,O
",",O
last,O
December,O
"
",O
2019,O
",",O
and,O
has,O
since,O
spread,O
to,O
other,O
countries,O
worldwide,O
",",O
included,O
Europe,O
and,O
very,O
"
",O
recently,O
Italy,O
.,O
In,O
this,O
short,O
report,O
",",O
phylogenetic,O
reconstruction,O
was,O
used,O
to,O
"
",O
better,O
understand,O
the,O
transmission,O
dynamics,O
of,O
the,O
virus,O
from,O
its,O
first,O
"
",O
introduction,O
in,O
China,O
focusing,O
on,O
the,O
more,O
recent,O
evidence,O
of,O
infection,O
in,O
a,O
"
",O
couple,O
of,O
Chinese,O
tourists,O
arrived,O
in,O
Italy,O
on,O
23rd,O
January,O
2020,O
and,O
labeled,O
as,O
"
",O
Coronavirus,O
Italian,O
cases,O
.,O
A,O
maximum,O
clade,O
credibility,O
tree,O
has,O
been,O
built,O
using,O
"
",O
a,O
dataset,O
of,O
54,O
genome,O
sequences,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
plus,O
two,O
closely,O
related,O
bat,O
"
",O
strains,O
(,O
SARSlike,O
CoV,O
),O
available,O
in,O
GenBank,O
.,O
Bayesian,O
timescaled,O
phylogenetic,O
"
",O
analysis,O
was,O
implemented,O
in,O
BEAST,O
1.10.4,O
.,O
The,O
Bayesian,O
phylogenetic,O
"
",O
reconstruction,O
showed,O
that,O
Â ,O
20192020,O
nCoV,O
firstly,O
introduced,O
in,O
Wuhan,O
on,O
25,O
"
",O
November,O
2019,O
",",O
started,O
epidemic,O
transmission,O
reaching,O
many,O
countries,O
worldwide,O
",",O
"
",O
including,O
Europe,O
and,O
Italy,O
where,O
the,O
two,O
strains,O
isolated,O
dated,O
back,O
19,O
January,O
"
",O
2020,O
",",O
the,O
same,O
that,O
the,O
Chinese,O
tourists,O
arrived,O
in,O
Italy,O
.,O
Strains,O
isolated,O
"
",O
outside,O
China,O
were,O
intermixed,O
with,O
strains,O
isolated,O
in,O
China,O
as,O
evidence,O
of,O
"
",O
likely,O
imported,O
cases,O
in,O
Rome,O
",",O
Italy,O
",",O
and,O
Europe,O
",",O
as,O
well,O
.,O
In,O
conclusion,O
",",O
this,O
"
",O
report,O
suggests,O
that,O
further,O
spread,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
epidemic,O
was,O
supported,O
by,O
human,O
"
",O
mobility,O
and,O
that,O
quarantine,O
of,O
suspected,O
or,O
diagnosed,O
cases,O
is,O
useful,O
to,O
prevent,O
"
",O
further,O
transmission,O
.,O
Viral,O
genome,O
phylogenetic,O
analysis,O
represents,O
a,O
useful,O
tool,O
"
",O
for,O
the,O
evaluation,O
of,O
transmission,O
dynamics,O
and,O
preventive,O
action,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25699,O
"
",O
PMID,O
:,O
32022275,O
"


",O
807,O
.,O
Onco,O
Targets,O
Ther,O
.,O
2019,O
Dec,O
31;12:1162311635,O
.,O
doi,O
:,O
10.2147,O
OTT.S218308,O
.,O
"
",O
eCollection,O
2019,O
.,O
"

",O
Long,O
NonCoding,O
RNA,O
EGOT,O
Promotes,O
the,O
Malignant,O
Phenotypes,O
of,O
Hepatocellular,O
"
",O
Carcinoma,O
Cells,O
and,O
Increases,O
the,O
Expression,O
of,O
HMGA2,O
via,O
DownRegulating,O
"
",O
miR33a5p,O
.,O
"

",O
Wu,O
S(1,O
),O
",",O
Ai,O
H(2,O
),O
",",O
Zhang,O
K(3)(4,O
),O
",",O
Yun,O
H(3)(4,O
),O
",",O
Xie,O
F(3)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Center,O
for,O
Clinical,O
Laboratory,O
",",O
General,O
Hospital,O
of,O
the,O
Yangtze,O
River,O
"
",O
Shipping,O
",",O
Wuhan,O
Brain,O
Hospital,O
",",O
Wuhan,O
430030,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)Center,O
for,O
Clinical,O
Laboratory,O
",",O
Wuhan,O
Kangjian,O
Maternal,O
and,O
Infant,O
Hospital,O
",",O
"
",O
Wuhan,O
430050,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(3)Wuhan,O
Center,O
for,O
Clinical,O
Laboratory,O
",",O
Wuhan,O
Fourth,O
Hospital,O
",",O
Wuhan,O
430030,O
",",O
"
",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(4)Puai,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
430032,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"

",O
Background,O
:,O
Chronic,O
hepatitis,O
C,O
virus,O
(,O
HCV,O
),O
infection,O
is,O
an,O
important,O
risk,O
factor,O
"
",O
for,O
hepatocellular,O
carcinoma,O
(,O
HCC,O
),O
.,O
EGOT,O
is,O
a,O
long,O
noncoding,O
RNA,O
(,O
lncRNA,O
),O
"
",O
induced,O
after,O
HCV,O
infection,O
that,O
increases,O
viral,O
replication,O
by,O
antagonizing,O
the,O
"
",O
antiviral,O
response,O
.,O
Interestingly,O
",",O
EGOT,O
also,O
acts,O
as,O
a,O
crucial,O
regulator,O
in,O
"
",O
multiple,O
cancers,O
.,O
However,O
",",O
its,O
role,O
in,O
HCC,O
remains,O
unclear,O
.,O
"
",O
Methods,O
:,O
Realtime,O
PCR,O
(,O
RTPCR,O
),O
was,O
used,O
to,O
detect,O
the,O
expression,O
of,O
EGOT,O
in,O
HCC,O
"
",O
samples,O
and,O
cell,O
lines,O
.,O
CCK8,O
assay,O
and,O
colony,O
formation,O
assay,O
were,O
performed,O
to,O
"
",O
evaluate,O
the,O
effect,O
of,O
EGOT,O
on,O
proliferation,O
.,O
Scratch,O
healing,O
assay,O
and,O
transwell,O
"
",O
assay,O
were,O
used,O
to,O
detect,O
the,O
changes,O
of,O
migration,O
and,O
invasion,O
.,O
Flow,O
cytometry,O
"
",O
was,O
used,O
to,O
detect,O
the,O
effect,O
of,O
EGOT,O
on,O
apoptosis,O
.,O
Interaction,O
between,O
EGOT,O
and,O
"
",O
miR33a5p,O
was,O
determined,O
by,O
bioinformatics,O
analysis,O
",",O
RTPCR,O
",",O
and,O
dualluciferase,O
"
",O
reporter,O
assay,O
.,O
Western,O
blot,O
was,O
used,O
to,O
confirm,O
that,O
high,O
mobility,O
group,O
protein,O
"
",O
A2,O
(,O
HMGA2,O
),O
could,O
be,O
modulated,O
by,O
EGOT,O
.,O
"
",O
Results,O
:,O
Compared,O
with,O
normal,O
liver,O
tissues,O
",",O
the,O
expression,O
level,O
of,O
EGOT,O
in,O
HCC,O
"
",O
tissues,O
was,O
significantly,O
upregulated,O
.,O
EGOT,O
markedly,O
regulated,O
viability,O
",",O
"
",O
migration,O
and,O
invasion,O
of,O
HCC,O
cells,O
.,O
The,O
expression,O
level,O
of,O
EGOT,O
was,O
negatively,O
"
",O
correlated,O
the,O
expression,O
level,O
of,O
miR33a5p,O
.,O
It,O
is,O
also,O
confirmed,O
that,O
EGOT,O
"
",O
could,O
specifically,O
bind,O
to,O
miR33a5p,O
and,O
could,O
reduce,O
its,O
expression,O
",",O
in,O
turn,O
",",O
"
",O
upregulate,O
the,O
expression,O
of,O
HMGA2,O
.,O
"
",O
Conclusion,O
:,O
Our,O
data,O
imply,O
that,O
EGOT,O
may,O
be,O
a,O
novel,O
therapeutic,O
target,O
for,O
HCC,O
",",O
"
",O
and,O
highlights,O
the,O
key,O
role,O
of,O
EGOT,O
miR33a5p,O
HMGA2,O
in,O
the,O
progression,O
of,O
this,O
"
",O
deadly,O
disease,O
.,O
"

",O
Â©,O
2019,O
Wu,O
et,O
al.,O
"

",O
DOI,O
:,O
10.2147,O
OTT.S218308,O
"
",O
PMCID,O
:,O
PMC6942514,O
"
",O
PMID,O
:,O
32021242,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
report,O
no,O
conflicts,O
of,O
interest,O
in,O
"
",O
this,O
work,O
.,O
"


",O
808,O
.,O
Int,O
J,O
Occup,O
Environ,O
Med,O
.,O
2020,O
Feb,O
5;11(2):6571,O
.,O
doi,O
:,O
10.15171,O
ijoem.2020.1921,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
:,O
A,O
Bird,O
's,O
Eye,O
View,O
.,O
"

",O
Habibzadeh,O
P,O
",",O
Stoneman,O
EK(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infectious,O
Diseases,O
and,O
Department,O
of,O
Infection,O
Prevention,O
and,O
"
",O
Epidemiology,O
",",O
University,O
of,O
Michigan,O
",",O
Ann,O
Arbor,O
",",O
USA,O
.,O
emilyks@umich.edu,O
.,O
"

",O
The,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
outbreak,O
",",O
which,O
initially,O
began,O
in,O
China,O
",",O
has,O
"
",O
spread,O
to,O
many,O
countries,O
around,O
the,O
globe,O
",",O
with,O
the,O
number,O
of,O
confirmed,O
cases,O
"
",O
increasing,O
every,O
day,O
.,O
With,O
a,O
death,O
toll,O
exceeding,O
that,O
of,O
the,O
SARSCoV,O
outbreak,O
"
",O
back,O
in,O
2002,O
and,O
2003,O
in,O
China,O
",",O
2019nCoV,B-Virus_SARS-CoV-2
has,O
led,O
to,O
a,O
public,O
health,O
emergency,O
of,O
"
",O
international,O
concern,O
",",O
putting,O
all,O
health,O
organizations,O
on,O
high,O
alert,O
.,O
Herein,O
",",O
we,O
"
",O
present,O
on,O
an,O
overview,O
of,O
the,O
currently,O
available,O
information,O
on,O
the,O
"
",O
pathogenesis,O
",",O
epidemiology,O
",",O
clinical,O
presentation,O
",",O
diagnosis,O
",",O
and,O
treatment,O
of,O
"
",O
this,O
virus,O
.,O
"

",O
DOI,O
:,O
10.15171,O
ijoem.2020.1921,O
"
",O
PMID,O
:,O
32020915,O
"


",O
809,O
.,O
Emerg,O
Microbes,O
Infect,O
.,O
2020,O
Dec;9(1):313319,O
.,O
doi,O
:,O
10.108,O
22221751.2020.1725399,O
.,O
"

",O
RNA,O
based,O
mNGS,O
approach,O
identifies,O
a,O
novel,O
human,O
coronavirus,O
from,O
two,O
individual,O
"
",O
pneumonia,O
cases,O
in,O
2019,O
Wuhan,O
outbreak,O
.,O
"

",O
Chen,O
L(1)(2,O
),O
",",O
Liu,O
W(3,O
),O
",",O
Zhang,O
Q(1,O
),O
",",O
Xu,O
K(1,O
),O
",",O
Ye,O
G(2,O
),O
",",O
Wu,O
W(4,O
),O
",",O
Sun,O
Z(3,O
),O
",",O
Liu,O
"
",O
F(1,O
),O
",",O
Wu,O
K(1,O
),O
",",O
Zhong,O
B(1,O
),O
",",O
Mei,O
Y(1,O
),O
",",O
Zhang,O
W(1,O
),O
",",O
Chen,O
Y(1,O
),O
",",O
Li,O
Y(2,O
),O
",",O
Shi,O
M(4,O
),O
",",O
"
",O
Lan,O
K(1,O
),O
",",O
Liu,O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Modern,O
Virology,O
Research,O
Center,O
",",O
College,O
of,O
"
",O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)Department,O
of,O
Laboratory,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(3)Department,O
of,O
Laboratory,O
Medicine,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(4)School,O
of,O
Medicine,O
",",O
Sun,O
yatSen,O
University,O
",",O
Guangzhou,O
",",O
People,O
's,O
Republic,O
of,O
"
",O
China,O
.,O
"

",O
From,O
December,O
2019,O
",",O
an,O
outbreak,O
of,O
unusual,O
pneumonia,O
was,O
reported,O
in,O
Wuhan,O
with,O
"
",O
many,O
cases,O
linked,O
to,O
Huanan,O
Seafood,O
Market,O
that,O
sells,O
seafood,O
as,O
well,O
as,O
live,O
"
",O
exotic,O
animals,O
.,O
We,O
investigated,O
two,O
patients,O
who,O
developed,O
acute,O
respiratory,O
"
",O
syndromes,O
after,O
independent,O
contact,O
history,O
with,O
this,O
market,O
.,O
The,O
two,O
patients,O
"
",O
shared,O
common,O
clinical,O
features,O
including,O
fever,O
",",O
cough,O
",",O
and,O
multiple,O
groundglass,O
"
",O
opacities,O
in,O
the,O
bilateral,O
lung,O
field,O
with,O
patchy,O
infiltration,O
.,O
Here,O
",",O
we,O
"
",O
highlight,O
the,O
use,O
of,O
a,O
lowinput,O
metagenomic,O
nextgeneration,O
sequencing,O
(,O
mNGS,O
),O
"
",O
approach,O
on,O
RNA,O
extracted,O
from,O
bronchoalveolar,O
lavage,O
fluid,O
(,O
BALF,O
),O
.,O
It,O
rapidly,O
"
",O
identified,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
named,O
2019nCoV,B-Virus_SARS-CoV-2
according,O
to,O
World,O
Health,O
"
",O
Organization,O
announcement,O
),O
which,O
was,O
the,O
sole,O
pathogens,O
in,O
the,O
sample,O
with,O
very,O
"
",O
high,O
abundance,O
level,O
(,O
1.5,O
%,O
and,O
0.62,O
%,O
of,O
total,O
RNA,O
sequenced,O
),O
.,O
The,O
entire,O
viral,O
"
",O
genome,O
is,O
29881,O
â€…,O
nt,O
in,O
length,O
(,O
GenBank,O
MN988668,O
and,O
MN988669,O
",",O
Sequence,O
Read,O
"
",O
Archive,O
database,O
Bioproject,O
accession,O
PRJNA601736,O
),O
and,O
is,O
classified,O
into,O
"
",O
Î²coronavirus,O
genus,O
.,O
Phylogenetic,O
analysis,O
indicates,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
close,O
to,O
"
",O
coronaviruses,O
(,O
CoVs,O
),O
circulating,O
in,O
Rhinolophus,O
(,O
Horseshoe,O
bats,O
),O
",",O
such,O
as,O
98.7,O
%,O
"
",O
nucleotide,O
identity,O
to,O
partial,O
RdRp,O
gene,O
of,O
bat,O
coronavirus,O
strain,O
BtCoV,O
4991,O
"
",O
(,O
GenBank,O
KP876546,O
",",O
370,O
â€…,O
nt,O
sequence,O
of,O
RdRp,O
and,O
lack,O
of,O
other,O
genome,O
sequence,O
),O
and,O
"
",O
87.9,O
%,O
nucleotide,O
identity,O
to,O
bat,O
coronavirus,O
strain,O
batSLCoVZC45,O
and,O
"
",O
batSLCoVZXC21,O
.,O
Evolutionary,O
analysis,O
based,O
on,O
ORF1a,O
1b,O
",",O
S,O
",",O
and,O
N,O
genes,O
also,O
"
",O
suggests,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
more,O
likely,O
a,O
novel,O
CoV,O
independently,O
introduced,O
from,O
"
",O
animals,O
to,O
humans,O
.,O
"

",O
DOI,O
:,O
10.108,O
22221751.2020.1725399,O
"
",O
PMCID,O
:,O
PMC7033720,O
"
",O
PMID,O
:,O
32020836,O
"


",O
810,O
.,O
Cell,O
Res,O
.,O
2020,O
Mar;30(3):269271,O
.,O
doi,O
:,O
10.1038,O
s4142202002820,O
.,O
Epub,O
2020,O
Feb,O
"
",O
4,O
.,O
"

",O
Remdesivir,O
and,O
chloroquine,O
effectively,O
inhibit,O
the,O
recently,O
emerged,O
novel,O
"
",O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
in,O
vitro,O
.,O
"

",O
Wang,O
M(1,O
),O
",",O
Cao,O
R(2,O
),O
",",O
Zhang,O
L(1,O
),O
",",O
Yang,O
X(1,O
),O
",",O
Liu,O
J(1,O
),O
",",O
Xu,O
M(1,O
),O
",",O
Shi,O
Z(1,O
),O
",",O
Hu,O
Z(3,O
),O
",",O
"
",O
Zhong,O
W(4,O
),O
",",O
Xiao,O
G(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
for,O
"
",O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
430071,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)National,O
Engineering,O
Research,O
Center,O
for,O
the,O
Emergency,O
Drug,O
",",O
Beijing,O
Institute,O
"
",O
of,O
Pharmacology,O
and,O
Toxicology,O
",",O
100850,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
for,O
"
",O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
430071,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
huzh@wh.iov.cn,O
.,O
"
",O
(4)National,O
Engineering,O
Research,O
Center,O
for,O
the,O
Emergency,O
Drug,O
",",O
Beijing,O
Institute,O
"
",O
of,O
Pharmacology,O
and,O
Toxicology,O
",",O
100850,O
",",O
Beijing,O
",",O
China,O
.,O
zhongwu@bmi.ac.cn,O
.,O
"
",O
(5)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
for,O
"
",O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
430071,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
xiaogf@wh.iov.cn,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s4142202002820,O
"
",O
PMCID,O
:,O
PMC7054408,O
"
",O
PMID,O
:,O
32020029,O
"


",O
811,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Jan;25(4,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.4.2000058,O
.,O
"

",O
Pattern,O
of,O
early,O
humantohuman,O
transmission,O
of,O
Wuhan,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
",",O
December,O
2019,O
to,O
January,O
2020,O
.,O
"

",O
Riou,O
J(1,O
),O
",",O
Althaus,O
CL(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Social,O
and,O
Preventive,O
Medicine,O
",",O
University,O
of,O
Bern,O
",",O
Bern,O
",",O
"
",O
Switzerland,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
Euro,O
Surveill,O
.,O
2020,O
Feb;25(7,O
),O
:,O
.,O
"

",O
Since,O
December,O
2019,O
",",O
China,O
has,O
been,O
experiencing,O
a,O
large,O
outbreak,O
of,O
a,O
novel,O
"
",O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
which,O
can,O
cause,O
respiratory,O
disease,O
and,O
severe,O
pneumonia,O
.,O
"
",O
We,O
estimated,O
the,O
basic,O
reproduction,O
number,O
R0,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
to,O
be,O
around,O
2.2,O
(,O
90,O
%,O
"
",O
high,O
density,O
interval,O
:,O
1.43.8,O
),O
",",O
indicating,O
the,O
potential,O
for,O
sustained,O
"
",O
humantohuman,O
transmission,O
.,O
Transmission,O
characteristics,O
appear,O
to,O
be,O
of,O
similar,O
"
",O
magnitude,O
to,O
severe,O
acute,O
respiratory,O
syndromerelated,O
coronavirus,O
(,O
SARSCoV,O
),O
and,O
"
",O
pandemic,O
influenza,O
",",O
indicating,O
a,O
risk,O
of,O
global,O
spread,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.4.2000058,O
"
",O
PMCID,O
:,O
PMC7001239,O
"
",O
PMID,O
:,O
32019669,O
"


",O
812,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Jan;25(4,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.4.2000057,O
.,O
"

",O
Novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
earlystage,O
importation,O
risk,O
to,O
Europe,O
",",O
January,O
"
",O
2020,O
.,O
"

",O
Pullano,O
G(1,O
),O
",",O
Pinotti,O
F(1,O
),O
",",O
Valdano,O
E(2,O
),O
",",O
BoÃ«lle,O
PY(1,O
),O
",",O
Poletto,O
C(1,O
),O
",",O
Colizza,O
"
",O
V(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)INSERM,O
",",O
Sorbonne,O
UniversitÃ©,O
",",O
Institut,O
Pierre,O
Louis,O
d'EpidÃ©miologie,O
et,O
de,O
SantÃ©,O
"
",O
Publique,O
",",O
IPLESP,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(2)Center,O
for,O
Biomedical,O
Modeling,O
",",O
The,O
Semel,O
Institute,O
for,O
Neuroscience,O
and,O
Human,O
"
",O
Behavior,O
",",O
David,O
Geffen,O
School,O
of,O
Medicine,O
",",O
University,O
of,O
California,O
Los,O
Angeles,O
",",O
"
",O
Los,O
Angeles,O
",",O
United,O
States,O
.,O
"

",O
As,O
at,O
27,O
January,O
2020,O
",",O
42,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
cases,O
were,O
confirmed,O
"
",O
outside,O
China,O
.,O
We,O
estimate,O
the,O
risk,O
of,O
case,O
importation,O
to,O
Europe,O
from,O
affected,O
"
",O
areas,O
in,O
China,O
via,O
air,O
travel,O
.,O
We,O
consider,O
travel,O
restrictions,O
in,O
place,O
",",O
three,O
"
",O
reported,O
cases,O
in,O
France,O
",",O
one,O
in,O
Germany,O
.,O
Estimated,O
risk,O
in,O
Europe,O
remains,O
high,O
.,O
"
",O
The,O
United,O
Kingdom,O
",",O
Germany,O
and,O
France,O
are,O
at,O
highest,O
risk,O
.,O
Importation,O
from,O
"
",O
Beijing,O
and,O
Shanghai,O
would,O
lead,O
to,O
higher,O
and,O
widespread,O
risk,O
for,O
Europe,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.4.2000057,O
"
",O
PMCID,O
:,O
PMC7001240,O
"
",O
PMID,O
:,O
32019667,O
"


",O
813,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Feb;25(5,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.5.200131e,O
.,O
Epub,O
"
",O
2020,O
Jan,O
31,O
.,O
"

",O
Note,O
from,O
the,O
editors,O
:,O
World,O
Health,O
Organization,O
declares,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
sixth,O
public,O
health,O
emergency,O
of,O
international,O
concern,O
.,O
"

",O
Eurosurveillance,O
Editorial,O
Team(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)European,O
Centre,O
for,O
Disease,O
Prevention,O
and,O
Control,O
(,O
ECDC,O
),O
",",O
Stockholm,O
",",O
Sweden,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.5.200131e,O
"
",O
PMCID,O
:,O
PMC7014669,O
"
",O
PMID,O
:,O
32019636,O
"


",O
814,O
.,O
Microbes,O
Infect,O
.,O
2020,O
Feb,O
1,O
.,O
pii,O
:,O
S12864579(20)300253,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.micinf.2020.01.003,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Measures,O
for,O
diagnosing,O
and,O
treating,O
infections,O
by,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
responsible,O
for,O
a,O
pneumonia,O
outbreak,O
originating,O
in,O
Wuhan,O
",",O
China,O
.,O
"

",O
Yu,O
F(1,O
),O
",",O
Du,O
L(2,O
),O
",",O
Ojcius,O
DM(3,O
),O
",",O
Pan,O
C(4,O
),O
",",O
Jiang,O
S(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
College,O
of,O
Life,O
and,O
Sciences,O
",",O
Hebei,O
Agricultural,O
University,O
",",O
Bao,O
Ding,O
",",O
"
",O
China,O
.,O
"
",O
(2)Lindsley,O
F.,O
Kimball,O
Research,O
Institute,O
",",O
New,O
York,O
Blood,O
Center,O
",",O
New,O
York,O
",",O
NY,O
",",O
"
",O
USA,O
.,O
"
",O
(3)Department,O
of,O
Biomedical,O
Sciences,O
",",O
University,O
of,O
the,O
Pacific,O
",",O
School,O
of,O
"
",O
Dentistry,O
",",O
San,O
Francisco,O
",",O
USA,O
.,O
"
",O
(4)Guangdong,O
Haid,O
Institute,O
of,O
Animal,O
Husbandry,O
&,O
Veterinary,O
",",O
Haid,O
Research,O
"
",O
Institute,O
",",O
Guangdong,O
Haid,O
Group,O
Co.,O
",",O
Ltd,O
",",O
Guangzhou,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
chungenp@163.com,O
.,O
"
",O
(5)Lindsley,O
F.,O
Kimball,O
Research,O
Institute,O
",",O
New,O
York,O
Blood,O
Center,O
",",O
New,O
York,O
",",O
NY,O
",",O
"
",O
USA,O
;,O
Key,O
Laboratory,O
of,O
Medical,O
Molecular,O
Virology,O
(,O
MOE,O
NHC,O
CAMS,O
),O
",",O
School,O
of,O
Basic,O
"
",O
Medical,O
Sciences,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
shibojiang@fudan.edu.cn,O
.,O
"

",O
On,O
10,O
January,O
2020,O
",",O
a,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
causing,O
a,O
pneumonia,O
outbreak,O
in,O
Wuhan,O
City,O
"
",O
in,O
central,O
China,O
was,O
denoted,O
as,O
2019nCoV,B-Virus_SARS-CoV-2
by,O
the,O
World,O
Health,O
Organization,O
(,O
WHO,O
),O
.,O
"
",O
As,O
of,O
24,O
January,O
2020,O
",",O
there,O
were,O
887,O
confirmed,O
cases,O
of,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
",",O
"
",O
including,O
26,O
deaths,O
",",O
reported,O
in,O
China,O
and,O
other,O
countries,O
.,O
Therefore,O
",",O
combating,O
"
",O
this,O
new,O
virus,O
and,O
stopping,O
the,O
epidemic,O
is,O
a,O
matter,O
of,O
urgency,O
.,O
Here,O
",",O
we,O
focus,O
"
",O
on,O
advances,O
in,O
research,O
and,O
development,O
of,O
fast,O
diagnosis,O
methods,O
",",O
as,O
well,O
as,O
"
",O
potential,O
prophylactics,O
and,O
therapeutics,O
to,O
prevent,O
or,O
treat,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"

",O
Copyright,O
Â©,O
2020,O
Institut,O
Pasteur,O
.,O
Published,O
by,O
Elsevier,O
Masson,O
SAS,O
.,O
All,O
rights,O
"
",O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.micinf.2020.01.003,O
"
",O
PMID,O
:,O
32017984,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
815,O
.,O
Radiology,O
.,O
2020,O
Feb,O
4:200241,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200241,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Chest,O
CT,O
Findings,O
in,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
Infections,O
from,O
Wuhan,O
",",O
"
",O
China,O
:,O
Key,O
Points,O
for,O
the,O
Radiologist,O
.,O
"

",O
Kanne,O
JP(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Department,O
of,O
Radiology,O
",",O
University,O
of,O
WisconsinMadison,O
School,O
of,O
"
",O
Medicine,O
and,O
Public,O
Health,O
",",O
600,O
Highland,O
Ave,O
",",O
Madison,O
",",O
WI,O
53792,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200241,O
"
",O
PMID,O
:,O
32017662,O
"


",O
816,O
.,O
Radiology,O
.,O
2020,O
Feb,O
4:200230,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200230,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
CT,O
Imaging,O
Features,O
of,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
"

",O
Chung,O
M(1,O
),O
",",O
Bernheim,O
A(1,O
),O
",",O
Mei,O
X(1,O
),O
",",O
Zhang,O
N(1,O
),O
",",O
Huang,O
M(1,O
),O
",",O
Zeng,O
X(1,O
),O
",",O
Cui,O
J(1,O
),O
",",O
"
",O
Xu,O
W(1,O
),O
",",O
Yang,O
Y(1,O
),O
",",O
Fayad,O
ZA(1,O
),O
",",O
Jacobi,O
A(1,O
),O
",",O
Li,O
K(1,O
),O
",",O
Li,O
S(1,O
),O
",",O
Shan,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Department,O
of,O
Diagnostic,O
",",O
Molecular,O
",",O
and,O
Interventional,O
Radiology,O
"
",O
(,O
M.C.,O
",",O
A.B.,O
",",O
M.H.,O
",",O
Z.A.F.,O
",",O
A.J.,O
),O
and,O
BioMedical,O
Engineering,O
and,O
Imaging,O
Institute,O
"
",O
(,O
X.M.,O
",",O
Y.Y.,O
",",O
Z.A.F.,O
),O
",",O
Icahn,O
School,O
of,O
Medicine,O
at,O
Mount,O
Sinai,O
",",O
New,O
York,O
",",O
NY,O
;,O
"
",O
Department,O
of,O
Radiology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Nanchang,O
University,O
",",O
"
",O
Nanchang,O
",",O
China,O
(,O
N.Z.,O
",",O
X.Z.,O
),O
;,O
Department,O
of,O
Radiology,O
",",O
The,O
Affiliated,O
Hospital,O
of,O
"
",O
Qingdao,O
University,O
",",O
Qingdao,O
",",O
China,O
(,O
J.C.,O
",",O
W.X.,O
),O
;,O
and,O
Guangdong,O
Provincial,O
Key,O
"
",O
Laboratory,O
of,O
Biomedical,O
Imaging,O
",",O
Department,O
of,O
Radiology,O
",",O
The,O
Fifth,O
Affiliated,O
"
",O
Hospital,O
",",O
Sun,O
Yatsen,O
University,O
",",O
52,O
East,O
Meihua,O
Rd,O
",",O
New,O
Xiangzhou,O
",",O
Zhuhai,O
",",O
"
",O
Guangdong,O
Province,O
",",O
China,O
",",O
519000,O
(,O
K.L.,O
",",O
S.L.,O
",",O
H.S.,O
),O
.,O
"

",O
In,O
this,O
retrospective,O
case,O
series,O
",",O
chest,O
CT,O
scans,O
of,O
21,O
symptomatic,O
patients,O
from,O
"
",O
China,O
infected,O
with,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
were,O
reviewed,O
",",O
with,O
"
",O
emphasis,O
on,O
identifying,O
and,O
characterizing,O
the,O
most,O
common,O
findings,O
.,O
Typical,O
CT,O
"
",O
findings,O
included,O
bilateral,O
pulmonary,O
parenchymal,O
groundglass,O
and,O
consolidative,O
"
",O
pulmonary,O
opacities,O
",",O
sometimes,O
with,O
a,O
rounded,O
morphology,O
and,O
a,O
peripheral,O
lung,O
"
",O
distribution,O
.,O
Notably,O
",",O
lung,O
cavitation,O
",",O
discrete,O
pulmonary,O
nodules,O
",",O
pleural,O
"
",O
effusions,O
",",O
and,O
lymphadenopathy,O
were,O
absent,O
.,O
Followup,O
imaging,O
in,O
a,O
subset,O
of,O
"
",O
patients,O
during,O
the,O
study,O
time,O
window,O
often,O
demonstrated,O
mild,O
or,O
moderate,O
"
",O
progression,O
of,O
disease,O
",",O
as,O
manifested,O
by,O
increasing,O
extent,O
and,O
density,O
of,O
lung,O
"
",O
opacities,O
.,O
"

",O
Â©,O
RSNA,O
",",O
2020,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200230,O
"
",O
PMID,O
:,O
32017661,O
"


",O
817,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Apr;92(4):403407,O
.,O
doi,O
:,O
10.1002,O
jmv.25695,O
.,O
Epub,O
2020,O
Feb,O
10,O
.,O
"

",O
Updates,O
on,O
Wuhan,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
epidemic,O
.,O
"

",O
Kofi,O
Ayittey,O
F(1,O
),O
",",O
Dzuvor,O
C(2,O
),O
",",O
Kormla,O
Ayittey,O
M(3,O
),O
",",O
Bennita,O
Chiwero,O
N(1,O
),O
",",O
Habib,O
"
",O
A(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Chemical,O
Engineering,O
",",O
Curtin,O
University,O
Malaysia,O
",",O
Sarawak,O
",",O
"
",O
Malaysia,O
.,O
"
",O
(2)Department,O
of,O
Chemical,O
Engineering,O
",",O
Monash,O
University,O
",",O
Clayton,O
",",O
Victoria,O
",",O
"
",O
Australia,O
.,O
"
",O
(3)Agricultural,O
Extension,O
Office,O
",",O
Ministry,O
of,O
Food,O
and,O
Agriculture,O
",",O
Adidome,O
",",O
"
",O
Ghana,O
.,O
"
",O
(4)Urological,O
Division,O
",",O
Ghana,O
Health,O
Service,O
",",O
Sogakope,O
",",O
Ghana,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25695,O
"
",O
PMID,O
:,O
32017153,O
"


",O
818,O
.,O
Int,O
J,O
Biol,O
Sci,O
.,O
2020,O
Jan,O
1;16(3):374387,O
.,O
doi,O
:,O
10.715,O
ijbs.39551,O
.,O
eCollection,O
"
",O
2020,O
.,O
"

",O
DHA,O
Sensor,O
GPR120,O
in,O
Host,O
Defense,O
Exhibits,O
the,O
Dual,O
Characteristics,O
of,O
Regulating,O
"
",O
Dendritic,O
Cell,O
Function,O
and,O
Skewing,O
the,O
Balance,O
of,O
Th17,O
Tregs,O
.,O
"

",O
Zhao,O
C(1,O
),O
",",O
Zhou,O
J(1,O
),O
",",O
Meng,O
Y(1,O
),O
",",O
Shi,O
N(2,O
),O
",",O
Wang,O
X(1,O
),O
",",O
Zhou,O
M(3,O
),O
",",O
Li,O
G(1,O
),O
",",O
Yang,O
"
",O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
State,O
Key,O
Laboratory,O
of,O
Reproductive,O
Regulation,O
and,O
Breeding,O
of,O
Grassland,O
"
",O
Livestock,O
",",O
School,O
of,O
Life,O
Sciences,O
",",O
Inner,O
Mongolia,O
University,O
",",O
Hohhot,O
",",O
10070,O
",",O
"
",O
China,O
.,O
"
",O
(2)Inner,O
Mongolia,O
People,O
's,O
Hospital,O
",",O
Hohhot,O
",",O
Inner,O
Mongolia,O
",",O
CN,O
10017,O
.,O
"
",O
(3)The,O
State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"

",O
In,O
addition,O
to,O
functioning,O
as,O
an,O
antioxidant,O
",",O
antiinflammatory,O
and,O
agedefying,O
"
",O
cellular,O
component,O
",",O
DHA,O
impacts,O
the,O
immune,O
system,O
by,O
facilitating,O
the,O
pathogen,O
"
",O
invasion,O
.,O
The,O
mechanism,O
through,O
which,O
DHA,O
regulates,O
immune,O
suppression,O
remains,O
"
",O
obscure,O
.,O
In,O
our,O
study,O
",",O
we,O
postulated,O
that,O
DHA,O
might,O
interact,O
with,O
GPR120,O
to,O
shape,O
"
",O
the,O
dendritic,O
cell,O
(,O
DC,O
),O
differentiation,O
and,O
subsequently,O
drive,O
T,O
cell,O
"
",O
proliferation,O
during,O
the,O
virus,O
infection,O
.,O
In,O
vitro,O
",",O
the,O
proportion,O
of,O
"
",O
costimulatory,O
molecules,O
and,O
HLADR,O
on,O
DC,O
that,O
generated,O
from,O
exogenous,O
and,O
"
",O
endogenous,O
(,O
fad3b,O
expression,O
),O
DHA,O
supplemented,O
mice,O
were,O
significantly,O
lower,O
than,O
"
",O
wildtype,O
mice,O
.,O
Given,O
the,O
importance,O
of,O
FAs,O
",",O
DHA,O
is,O
not,O
only,O
a,O
critical,O
cellular,O
"
",O
constituent,O
but,O
also,O
a,O
cell,O
signaling,O
molecule,O
and,O
FA,O
deficiency,O
reduces,O
DC,O
"
",O
generation,O
;,O
we,O
used,O
GPR120,O
 ,O
mice,O
to,O
determine,O
whether,O
DHA,O
receptor,O
deficiency,O
"
",O
disorders,O
DC,O
maturation,O
processing,O
.,O
Novelty,O
",",O
the,O
expression,O
of,O
GPR120,O
on,O
DC,O
from,O
"
",O
wildtype,O
(,O
WT,O
),O
mice,O
was,O
inversely,O
related,O
to,O
DC,O
activation,O
and,O
DC,O
from,O
the,O
"
",O
GPR120,O
 ,O
mice,O
maintained,O
a,O
spontaneous,O
maturation,O
status,O
.,O
In,O
vivo,O
",",O
both,O
the,O
"
",O
excessive,O
activation,O
of,O
GPR120,O
by,O
DHA,O
and,O
the,O
deletion,O
of,O
GPR120,O
effectively,O
"
",O
skewed,O
the,O
balance,O
of,O
Th17,O
Tregs,O
and,O
reduced,O
the,O
production,O
of,O
VNA,O
and,O
protection,O
"
",O
of,O
vaccination,O
.,O
Overall,O
",",O
our,O
results,O
revealed,O
a,O
mechanism,O
that,O
the,O
GPR120,O
"
",O
selfregulation,O
plays,O
a,O
crucial,O
role,O
in,O
sensing,O
DHA,O
variation,O
",",O
which,O
provides,O
a,O
"
",O
new,O
prospect,O
for,O
therapeutic,O
manipulation,O
in,O
autoimmune,O
diseases,O
and,O
the,O
design,O
"
",O
of,O
a,O
vaccine,O
adjuvant,O
.,O
"

",O
Â©,O
The,O
author(s,O
),O
.,O
"

",O
DOI,O
:,O
10.715,O
ijbs.39551,O
"
",O
PMCID,O
:,O
PMC6990895,O
"
",O
PMID,O
:,O
32015675,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Competing,O
Interests,O
:,O
The,O
authors,O
have,O
declared,O
"
",O
that,O
no,O
competing,O
interest,O
exists,O
.,O
"


",O
819,O
.,O
Nature,O
.,O
2020,O
Mar;579(7798):265269,O
.,O
doi,O
:,O
10.1038,O
s4158602020083,O
.,O
Epub,O
2020,O
Feb,O
"
",O
3,O
.,O
"

",O
A,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
associated,O
with,O
human,O
respiratory,O
disease,O
in,O
China,O
.,O
"

",O
Wu,O
F(1,O
),O
",",O
Zhao,O
S(2,O
),O
",",O
Yu,O
B(3,O
),O
",",O
Chen,O
YM(1,O
),O
",",O
Wang,O
W(4,O
),O
",",O
Song,O
ZG(1,O
),O
",",O
Hu,O
Y(2,O
),O
",",O
Tao,O
"
",O
ZW(2,O
),O
",",O
Tian,O
JH(3,O
),O
",",O
Pei,O
YY(1,O
),O
",",O
Yuan,O
ML(2,O
),O
",",O
Zhang,O
YL(1,O
),O
",",O
Dai,O
FH(1,O
),O
",",O
Liu,O
Y(1,O
),O
",",O
Wang,O
"
",O
QM(1,O
),O
",",O
Zheng,O
JJ(1,O
),O
",",O
Xu,O
L(1,O
),O
",",O
Holmes,O
EC(1)(5,O
),O
",",O
Zhang,O
YZ(6)(7)(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Shanghai,O
Public,O
Health,O
Clinical,O
Center,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
Central,O
Hospital,O
of,O
"
",O
Wuhan,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Wuhan,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Zoonosis,O
",",O
National,O
Institute,O
for,O
Communicable,O
Disease,O
Control,O
"
",O
and,O
Prevention,O
",",O
China,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)Marie,O
Bashir,O
Institute,O
for,O
Infectious,O
Diseases,O
and,O
Biosecurity,O
",",O
School,O
of,O
Life,O
"
",O
and,O
Environmental,O
Sciences,O
and,O
School,O
of,O
Medical,O
Sciences,O
",",O
The,O
University,O
of,O
"
",O
Sydney,O
",",O
Sydney,O
",",O
New,O
South,O
Wales,O
",",O
Australia,O
.,O
"
",O
(6)Shanghai,O
Public,O
Health,O
Clinical,O
Center,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
zhangyongzhen@shphc.org.cn,O
.,O
"
",O
(7)Department,O
of,O
Zoonosis,O
",",O
National,O
Institute,O
for,O
Communicable,O
Disease,O
Control,O
"
",O
and,O
Prevention,O
",",O
China,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
zhangyongzhen@shphc.org.cn,O
.,O
"
",O
(8)School,O
of,O
Public,O
Health,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
zhangyongzhen@shphc.org.cn,O
.,O
"

",O
Comment,O
in,O
"
    ",O
Nature,O
.,O
2020,O
Feb;578(7793):7,O
.,O
"

",O
Emerging,O
infectious,O
diseases,O
",",O
such,O
as,O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
"
",O
and,O
Zika,O
virus,O
disease,O
",",O
present,O
a,O
major,O
threat,O
to,O
public,O
health13,O
.,O
Despite,O
"
",O
intense,O
research,O
efforts,O
",",O
how,O
",",O
when,O
and,O
where,O
new,O
diseases,O
appear,O
are,O
still,O
a,O
"
",O
source,O
of,O
considerable,O
uncertainty,O
.,O
A,O
severe,O
respiratory,O
disease,O
was,O
recently,O
"
",O
reported,O
in,O
Wuhan,O
",",O
Hubei,O
province,O
",",O
China,O
.,O
As,O
of,O
25,O
January,O
2020,O
",",O
at,O
least,O
"
",O
1975,O
Â ,O
cases,O
had,O
been,O
reported,O
since,O
the,O
first,O
patient,O
was,O
hospitalized,O
on,O
12,O
"
",O
December,O
2019,O
.,O
Epidemiological,O
investigations,O
have,O
suggested,O
that,O
the,O
outbreak,O
"
",O
was,O
associated,O
with,O
a,O
seafood,O
market,O
in,O
Wuhan,O
.,O
Here,O
we,O
study,O
a,O
single,O
patient,O
who,O
"
",O
was,O
a,O
worker,O
at,O
the,O
market,O
and,O
who,O
was,O
admitted,O
to,O
the,O
Central,O
Hospital,O
of,O
Wuhan,O
"
",O
on,O
26,O
December,O
2019,O
while,O
experiencing,O
a,O
severe,O
respiratory,O
syndrome,O
that,O
"
",O
included,O
fever,O
",",O
dizziness,O
and,O
a,O
cough,O
.,O
Metagenomic,O
RNA,O
sequencing4,O
of,O
a,O
sample,O
of,O
"
",O
bronchoalveolar,O
lavage,O
fluid,O
from,O
the,O
patient,O
identified,O
a,O
new,O
RNA,O
virus,O
strain,O
"
",O
from,O
the,O
family,O
Coronaviridae,O
",",O
which,O
is,O
designated,O
here,O
',O
WHHuman,O
1,O
',O
coronavirus,O
"
",O
(,O
and,O
has,O
also,O
been,O
referred,O
to,O
as,O
',O
2019nCoV,B-Virus_SARS-CoV-2
',O
),O
.,O
Phylogenetic,O
analysis,O
of,O
the,O
"
",O
complete,O
viral,O
genome,O
(,O
29903,O
Â ,O
nucleotides,O
),O
revealed,O
that,O
the,O
virus,O
was,O
most,O
"
",O
closely,O
related,O
(,O
89.1,O
%,O
nucleotide,O
similarity,O
),O
to,O
a,O
group,O
of,O
SARSlike,O
"
",O
coronaviruses,O
(,O
genus,O
Betacoronavirus,O
",",O
subgenus,O
Sarbecovirus,O
),O
that,O
had,O
previously,O
"
",O
been,O
found,O
in,O
bats,O
in,O
China5,O
.,O
This,O
outbreak,O
highlights,O
the,O
ongoing,O
ability,O
of,O
"
",O
viral,O
spillover,O
from,O
animals,O
to,O
cause,O
severe,O
disease,O
in,O
humans,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s4158602020083,O
"
",O
PMID,O
:,O
32015508,O
"


",O
820,O
.,O
Nature,O
.,O
2020,O
Mar;579(7798):270273,O
.,O
doi,O
:,O
10.1038,O
s4158602020127,O
.,O
Epub,O
2020,O
Feb,O
"
",O
3,O
.,O
"

",O
A,O
pneumonia,O
outbreak,O
associated,O
with,O
a,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
of,O
probable,O
bat,O
origin,O
.,O
"

",O
Zhou,O
P(1,O
),O
",",O
Yang,O
XL(1,O
),O
",",O
Wang,O
XG(2,O
),O
",",O
Hu,O
B(1,O
),O
",",O
Zhang,O
L(1,O
),O
",",O
Zhang,O
W(1,O
),O
",",O
Si,O
HR(1)(3,O
),O
",",O
"
",O
Zhu,O
Y(1,O
),O
",",O
Li,O
B(1,O
),O
",",O
Huang,O
CL(2,O
),O
",",O
Chen,O
HD(2,O
),O
",",O
Chen,O
J(1)(3,O
),O
",",O
Luo,O
Y(1)(3,O
),O
",",O
Guo,O
"
",O
H(1)(3,O
),O
",",O
Jiang,O
RD(1)(3,O
),O
",",O
Liu,O
MQ(1)(3,O
),O
",",O
Chen,O
Y(1)(3,O
),O
",",O
Shen,O
XR(1)(3,O
),O
",",O
Wang,O
X(1)(3,O
),O
",",O
"
",O
Zheng,O
XS(1)(3,O
),O
",",O
Zhao,O
K(1)(3,O
),O
",",O
Chen,O
QJ(1,O
),O
",",O
Deng,O
F(1,O
),O
",",O
Liu,O
LL(4,O
),O
",",O
Yan,O
B(1,O
),O
",",O
Zhan,O
"
",O
FX(4,O
),O
",",O
Wang,O
YY(1,O
),O
",",O
Xiao,O
GF(1,O
),O
",",O
Shi,O
ZL(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
"
",O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Wuhan,O
Jin,O
YinTan,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)Hubei,O
Provincial,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(5)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
"
",O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
zlshi@wh.iov.cn,O
.,O
"

",O
Comment,O
in,O
"
    ",O
Nature,O
.,O
2020,O
Feb;578(7793):7,O
.,O
"

",O
Since,O
the,O
outbreak,O
of,O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
18,O
Â ,O
years,O
ago,O
",",O
a,O
"
",O
large,O
number,O
of,O
SARSrelated,O
coronaviruses,O
(,O
SARSrCoVs,O
),O
have,O
been,O
discovered,O
in,O
"
",O
their,O
natural,O
reservoir,O
host,O
",",O
bats14,O
.,O
Previous,O
studies,O
have,O
shown,O
that,O
some,O
bat,O
"
",O
SARSrCoVs,O
have,O
the,O
potential,O
to,O
infect,O
humans57,O
.,O
Here,O
we,O
report,O
the,O
"
",O
identification,O
and,O
characterization,O
of,O
a,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
",",O
which,O
"
",O
caused,O
an,O
epidemic,O
of,O
acute,O
respiratory,O
syndrome,O
in,O
humans,O
in,O
Wuhan,O
",",O
China,O
.,O
The,O
"
",O
epidemic,O
",",O
which,O
started,O
on,O
12,O
December,O
2019,O
",",O
had,O
caused,O
2794,O
"
",O
laboratoryconfirmed,O
infections,O
including,O
80,O
deaths,O
by,O
26,O
January,O
2020,O
.,O
"
",O
Fulllength,O
genome,O
sequences,O
were,O
obtained,O
from,O
five,O
patients,O
at,O
an,O
early,O
stage,O
"
",O
of,O
the,O
outbreak,O
.,O
The,O
sequences,O
are,O
almost,O
identical,O
and,O
share,O
79.6,O
%,O
sequence,O
"
",O
identity,O
to,O
SARSCoV.,O
Furthermore,O
",",O
we,O
show,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
96,O
%,O
identical,O
at,O
the,O
"
",O
wholegenome,O
level,O
to,O
a,O
bat,O
coronavirus,O
.,O
Pairwise,O
protein,O
sequence,O
analysis,O
of,O
"
",O
seven,O
conserved,O
nonstructural,O
proteins,O
domains,O
show,O
that,O
this,O
virus,O
belongs,O
to,O
"
",O
the,O
species,O
of,O
SARSrCoV.,O
In,O
addition,O
",",O
2019nCoV,B-Virus_SARS-CoV-2
virus,O
isolated,O
from,O
the,O
"
",O
bronchoalveolar,O
lavage,O
fluid,O
of,O
a,O
critically,O
ill,O
patient,O
could,O
be,O
neutralized,O
by,O
"
",O
sera,O
from,O
several,O
patients,O
.,O
Notably,O
",",O
we,O
confirmed,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
uses,O
the,O
same,O
"
",O
cell,O
entry,O
receptorangiotensin,O
converting,O
enzyme,O
II,O
(ACE2)as,O
SARSCoV.,O
"

",O
DOI,O
:,O
10.1038,O
s4158602020127,O
"
",O
PMID,O
:,O
32015507,O
"


",O
821,O
.,O
Antiviral,O
Res,O
.,O
2020,O
Jan,O
31;176:104730,O
.,O
doi,O
:,O
10.1016,O
j.antiviral.2020.104730,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
epigenetic,O
landscapes,O
of,O
histone,O
modifications,O
on,O
HSV1,O
genome,O
in,O
human,O
THP1,O
"
",O
cells,O
.,O
"

",O
Gao,O
C(1,O
),O
",",O
Chen,O
L(1,O
),O
",",O
Tang,O
SB(1,O
),O
",",O
Long,O
QY(1,O
),O
",",O
He,O
JL(1,O
),O
",",O
Zhang,O
NA(2,O
),O
",",O
Shu,O
HB(3,O
),O
",",O
"
",O
Chen,O
ZX(2,O
),O
",",O
Wu,O
M(4,O
),O
",",O
Li,O
LY(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Hubei,O
Key,O
Laboratory,O
of,O
Cell,O
Homeostasis,O
",",O
Hubei,O
Key,O
Laboratory,O
of,O
"
",O
Developmentally,O
Originated,O
Disease,O
",",O
Hubei,O
Key,O
Laboratory,O
of,O
Enteropathy,O
",",O
College,O
"
",O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
430072,O
",",O
China,O
.,O
"
",O
(2)College,O
of,O
Life,O
Sciences,O
and,O
Technology,O
",",O
Huazhong,O
Agriculture,O
University,O
",",O
"
",O
Wuhan,O
",",O
Hubei,O
",",O
430070,O
",",O
China,O
.,O
"
",O
(3)Medical,O
Research,O
Institute,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
Hubei,O
",",O
430072,O
",",O
China,O
.,O
"
",O
(4)Hubei,O
Key,O
Laboratory,O
of,O
Cell,O
Homeostasis,O
",",O
Hubei,O
Key,O
Laboratory,O
of,O
"
",O
Developmentally,O
Originated,O
Disease,O
",",O
Hubei,O
Key,O
Laboratory,O
of,O
Enteropathy,O
",",O
College,O
"
",O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
430072,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
wumin@whu.edu.cn,O
.,O
"
",O
(5)Hubei,O
Key,O
Laboratory,O
of,O
Cell,O
Homeostasis,O
",",O
Hubei,O
Key,O
Laboratory,O
of,O
"
",O
Developmentally,O
Originated,O
Disease,O
",",O
Hubei,O
Key,O
Laboratory,O
of,O
Enteropathy,O
",",O
College,O
"
",O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
430072,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
lilianyun@whu.edu.cn,O
.,O
"

",O
Histone,O
positioning,O
and,O
modifications,O
on,O
viral,O
genomes,O
are,O
important,O
factors,O
"
",O
regulating,O
virus,O
replication,O
.,O
To,O
investigate,O
the,O
dynamics,O
of,O
modified,O
histones,O
on,O
"
",O
the,O
viral,O
genome,O
and,O
their,O
potential,O
roles,O
in,O
antiviral,O
response,O
",",O
we,O
studied,O
the,O
"
",O
dynamic,O
changes,O
of,O
histone,O
modifications,O
across,O
the,O
HSV1,O
genome,O
in,O
THP1,O
Â ,O
cells,O
.,O
"
",O
Histone,O
modifications,O
were,O
detected,O
on,O
the,O
HSV1,O
genome,O
soon,O
after,O
infection,O
",",O
"
",O
including,O
H3K9me3,O
",",O
H3K27me3,O
",",O
H3K4me3,O
and,O
H3K27ac,O
.,O
These,O
modifications,O
emerged,O
on,O
"
",O
the,O
viral,O
genome,O
soon,O
after,O
infection,O
and,O
changed,O
rapidly,O
along,O
with,O
virus,O
life,O
"
",O
cycle,O
progression,O
.,O
The,O
transcription,O
repression,O
marks,O
",",O
H3K9me3,O
and,O
H3K27me3,O
",",O
"
",O
decreased,O
on,O
the,O
viral,O
genome,O
during,O
the,O
infection,O
process,O
;,O
the,O
transcription,O
"
",O
activation,O
mark,O
H3K27ac,O
increased,O
.,O
Treatment,O
with,O
C646,O
",",O
an,O
inhibitor,O
of,O
H3K27ac,O
"
",O
transferase,O
p300,O
",",O
significantly,O
repressed,O
virus,O
replication,O
and,O
viral,O
gene,O
"
",O
expression,O
.,O
Our,O
study,O
reveals,O
the,O
relationship,O
between,O
histone,O
modifications,O
and,O
"
",O
viral,O
gene,O
expression,O
and,O
provides,O
potential,O
novel,O
strategies,O
for,O
antiviral,O
"
",O
treatment,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.antiviral.2020.104730,O
"
",O
PMID,O
:,O
32014498,O
"


",O
822,O
.,O
Lancet,O
.,O
2020,O
Feb,O
29;395(10225):689697,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)302609,O
.,O
Epub,O
"
",O
2020,O
Jan,O
31,O
.,O
"

",O
Nowcasting,O
and,O
forecasting,O
the,O
potential,O
domestic,O
and,O
international,O
spread,O
of,O
the,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
outbreak,O
originating,O
in,O
Wuhan,O
",",O
China,O
:,O
a,O
modelling,O
study,O
.,O
"

",O
Wu,O
JT(1,O
),O
",",O
Leung,O
K(2,O
),O
",",O
Leung,O
GM(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)WHO,O
Collaborating,O
Centre,O
for,O
Infectious,O
Disease,O
Epidemiology,O
and,O
Control,O
",",O
"
",O
School,O
of,O
Public,O
Health,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Hong,O
"
",O
Kong,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
joewu@hku.hk,O
.,O
"
",O
(2)WHO,O
Collaborating,O
Centre,O
for,O
Infectious,O
Disease,O
Epidemiology,O
and,O
Control,O
",",O
"
",O
School,O
of,O
Public,O
Health,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Hong,O
"
",O
Kong,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
4,O
;,O
:,O
.,O
"

",O
BACKGROUND,O
:,O
Since,O
Dec,O
31,O
",",O
2019,O
",",O
the,O
Chinese,O
city,O
of,O
Wuhan,O
has,O
reported,O
an,O
"
",O
outbreak,O
of,O
atypical,O
pneumonia,O
caused,O
by,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
"
",O
Cases,O
have,O
been,O
exported,O
to,O
other,O
Chinese,O
cities,O
",",O
as,O
well,O
as,O
internationally,O
",",O
"
",O
threatening,O
to,O
trigger,O
a,O
global,O
outbreak,O
.,O
Here,O
",",O
we,O
provide,O
an,O
estimate,O
of,O
the,O
"
",O
size,O
of,O
the,O
epidemic,O
in,O
Wuhan,O
on,O
the,O
basis,O
of,O
the,O
number,O
of,O
cases,O
exported,O
from,O
"
",O
Wuhan,O
to,O
cities,O
outside,O
mainland,O
China,O
and,O
forecast,O
the,O
extent,O
of,O
the,O
domestic,O
"
",O
and,O
global,O
public,O
health,O
risks,O
of,O
epidemics,O
",",O
accounting,O
for,O
social,O
and,O
"
",O
nonpharmaceutical,O
prevention,O
interventions,O
.,O
"
",O
METHODS,O
:,O
We,O
used,O
data,O
from,O
Dec,O
31,O
",",O
2019,O
",",O
to,O
Jan,O
28,O
",",O
2020,O
",",O
on,O
the,O
number,O
of,O
cases,O
"
",O
exported,O
from,O
Wuhan,O
internationally,O
(,O
known,O
days,O
of,O
symptom,O
onset,O
from,O
Dec,O
25,O
",",O
"
",O
2019,O
",",O
to,O
Jan,O
19,O
",",O
2020,O
),O
to,O
infer,O
the,O
number,O
of,O
infections,O
in,O
Wuhan,O
from,O
Dec,O
1,O
",",O
"
",O
2019,O
",",O
to,O
Jan,O
25,O
",",O
2020,O
.,O
Cases,O
exported,O
domestically,O
were,O
then,O
estimated,O
.,O
We,O
"
",O
forecasted,O
the,O
national,O
and,O
global,O
spread,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
accounting,O
for,O
the,O
effect,O
"
",O
of,O
the,O
metropolitanwide,O
quarantine,O
of,O
Wuhan,O
and,O
surrounding,O
cities,O
",",O
which,O
began,O
"
",O
Jan,O
2324,O
",",O
2020,O
.,O
We,O
used,O
data,O
on,O
monthly,O
flight,O
bookings,O
from,O
the,O
Official,O
"
",O
Aviation,O
Guide,O
and,O
data,O
on,O
human,O
mobility,O
across,O
more,O
than,O
300,O
prefecturelevel,O
"
",O
cities,O
in,O
mainland,O
China,O
from,O
the,O
Tencent,O
database,O
.,O
Data,O
on,O
confirmed,O
cases,O
were,O
"
",O
obtained,O
from,O
the,O
reports,O
published,O
by,O
the,O
Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
"
",O
Prevention,O
.,O
Serial,O
interval,O
estimates,O
were,O
based,O
on,O
previous,O
studies,O
of,O
severe,O
"
",O
acute,O
respiratory,O
syndrome,O
coronavirus,O
(,O
SARSCoV,O
),O
.,O
A,O
"
",O
susceptibleexposedinfectiousrecovered,O
metapopulation,O
model,O
was,O
used,O
to,O
"
",O
simulate,O
the,O
epidemics,O
across,O
all,O
major,O
cities,O
in,O
China,O
.,O
The,O
basic,O
reproductive,O
"
",O
number,O
was,O
estimated,O
using,O
Markov,O
Chain,O
Monte,O
Carlo,O
methods,O
and,O
presented,O
using,O
"
",O
the,O
resulting,O
posterior,O
mean,O
and,O
95,O
%,O
credibile,O
interval,O
(,O
CrI,O
),O
.,O
"
",O
FINDINGS,O
:,O
In,O
our,O
baseline,O
scenario,O
",",O
we,O
estimated,O
that,O
the,O
basic,O
reproductive,O
"
",O
number,O
for,O
2019nCoV,B-Virus_SARS-CoV-2
was,O
2Â·68,O
(,O
95,O
%,O
CrI,O
2Â·472Â·86,O
),O
and,O
that,O
75,O
â€ˆ,O
815,O
individuals,O
"
",O
(,O
95,O
%,O
CrI,O
37,O
â€ˆ,O
304130,O
â€ˆ,O
330,O
),O
have,O
been,O
infected,O
in,O
Wuhan,O
as,O
of,O
Jan,O
25,O
",",O
2020,O
.,O
The,O
"
",O
epidemic,O
doubling,O
time,O
was,O
6Â·4,O
days,O
(,O
95,O
%,O
CrI,O
5Â·87Â·1,O
),O
.,O
We,O
estimated,O
that,O
in,O
the,O
"
",O
baseline,O
scenario,O
",",O
Chongqing,O
",",O
Beijing,O
",",O
Shanghai,O
",",O
Guangzhou,O
",",O
and,O
Shenzhen,O
had,O
"
",O
imported,O
461,O
(,O
95,O
%,O
CrI,O
227805,O
),O
",",O
113,O
(,O
57193,O
),O
",",O
98,O
(,O
49168,O
),O
",",O
111,O
(,O
56191,O
),O
",",O
and,O
80,O
"
",O
(,O
40139,O
),O
infections,O
from,O
Wuhan,O
",",O
respectively,O
.,O
If,O
the,O
transmissibility,O
of,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
were,O
similar,O
everywhere,O
domestically,O
and,O
over,O
time,O
",",O
we,O
inferred,O
that,O
"
",O
epidemics,O
are,O
already,O
growing,O
exponentially,O
in,O
multiple,O
major,O
cities,O
of,O
China,O
"
",O
with,O
a,O
lag,O
time,O
behind,O
the,O
Wuhan,O
outbreak,O
of,O
about,O
12,O
weeks,O
.,O
"
",O
INTERPRETATION,O
:,O
Given,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
no,O
longer,O
contained,O
within,O
Wuhan,O
",",O
other,O
"
",O
major,O
Chinese,O
cities,O
are,O
probably,O
sustaining,O
localised,O
outbreaks,O
.,O
Large,O
cities,O
"
",O
overseas,O
with,O
close,O
transport,O
links,O
to,O
China,O
could,O
also,O
become,O
outbreak,O
"
",O
epicentres,O
",",O
unless,O
substantial,O
public,O
health,O
interventions,O
at,O
both,O
the,O
population,O
"
",O
and,O
personal,O
levels,O
are,O
implemented,O
immediately,O
.,O
Independent,O
selfsustaining,O
"
",O
outbreaks,O
in,O
major,O
cities,O
globally,O
could,O
become,O
inevitable,O
because,O
of,O
substantial,O
"
",O
exportation,O
of,O
presymptomatic,O
cases,O
and,O
in,O
the,O
absence,O
of,O
largescale,O
public,O
"
",O
health,O
interventions,O
.,O
Preparedness,O
plans,O
and,O
mitigation,O
interventions,O
should,O
be,O
"
",O
readied,O
for,O
quick,O
deployment,O
globally,O
.,O
"
",O
FUNDING,O
:,O
Health,O
and,O
Medical,O
Research,O
Fund,O
(,O
Hong,O
Kong,O
",",O
China,O
),O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)302609,O
"
",O
PMID,O
:,O
32014114,O
"


",O
823,O
.,O
Virol,O
J.,O
2020,O
Feb,O
3;17(1):18,O
.,O
doi,O
:,O
10.1186,O
s1298502012884,O
.,O
"

",O
Porcine,O
Î²defensin,O
2,O
inhibits,O
proliferation,O
of,O
pseudorabies,O
virus,O
in,O
vitro,O
and,O
in,O
"
",O
transgenic,O
mice,O
.,O
"

",O
Huang,O
J(1)(2,O
),O
",",O
Qi,O
Y(1)(2,O
),O
",",O
Wang,O
A(1)(2,O
),O
",",O
Huang,O
C(1)(2,O
),O
",",O
Liu,O
X(1)(2,O
),O
",",O
Yang,O
"
",O
X(1)(3,O
),O
",",O
Li,O
L(4)(5)(6)(7,O
),O
",",O
Zhou,O
R(8)(9)(10)(11,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
"
",O
Cooperative,O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Wuhan,O
",",O
430070,O
",",O
"
",O
China,O
.,O
"
",O
(3)Chongqing,O
Academy,O
of,O
Animal,O
Sciences,O
",",O
Chongqing,O
",",O
402460,O
",",O
China,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"
",O
lilu@mail.hzau.edu.cn,O
.,O
"
",O
(5)Key,O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
"
",O
Cooperative,O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Wuhan,O
",",O
430070,O
",",O
"
",O
China,O
.,O
lilu@mail.hzau.edu.cn,O
.,O
"
",O
(6)Key,O
Laboratory,O
of,O
Development,O
of,O
Veterinary,O
Diagnostic,O
Products,O
",",O
Ministry,O
of,O
"
",O
Agriculture,O
and,O
Rural,O
Affairs,O
of,O
the,O
People,O
's,O
Republic,O
of,O
China,O
",",O
Wuhan,O
",",O
430070,O
",",O
"
",O
China,O
.,O
lilu@mail.hzau.edu.cn,O
.,O
"
",O
(7)International,O
Research,O
Center,O
for,O
Animal,O
Disease,O
",",O
Ministry,O
of,O
Science,O
and,O
"
",O
Technology,O
of,O
the,O
People,O
's,O
Republic,O
of,O
China,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"
",O
lilu@mail.hzau.edu.cn,O
.,O
"
",O
(8)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"
",O
rzhou@mail.hzau.edu.cn,O
.,O
"
",O
(9)Key,O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
"
",O
Cooperative,O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Wuhan,O
",",O
430070,O
",",O
"
",O
China,O
.,O
rzhou@mail.hzau.edu.cn,O
.,O
"
",O
(10)Key,O
Laboratory,O
of,O
Development,O
of,O
Veterinary,O
Diagnostic,O
Products,O
",",O
Ministry,O
of,O
"
",O
Agriculture,O
and,O
Rural,O
Affairs,O
of,O
the,O
People,O
's,O
Republic,O
of,O
China,O
",",O
Wuhan,O
",",O
430070,O
",",O
"
",O
China,O
.,O
rzhou@mail.hzau.edu.cn,O
.,O
"
",O
(11)International,O
Research,O
Center,O
for,O
Animal,O
Disease,O
",",O
Ministry,O
of,O
Science,O
and,O
"
",O
Technology,O
of,O
the,O
People,O
's,O
Republic,O
of,O
China,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"
",O
rzhou@mail.hzau.edu.cn,O
.,O
"

",O
BACKGROUND,O
:,O
Porcine,O
Î²defensin,O
2,O
(,O
PBD2,O
),O
",",O
produced,O
by,O
host,O
cells,O
",",O
is,O
an,O
"
",O
antimicrobial,O
cysteinerich,O
cationic,O
peptide,O
with,O
multifunctions,O
.,O
Previous,O
"
",O
studies,O
have,O
demonstrated,O
that,O
PBD2,O
can,O
kill,O
various,O
bacteria,O
",",O
regulate,O
host,O
"
",O
immune,O
responses,O
and,O
promote,O
growth,O
of,O
piglets,O
.,O
However,O
",",O
the,O
antiviral,O
role,O
of,O
"
",O
PBD2,O
is,O
rarely,O
investigated,O
.,O
This,O
study,O
aimed,O
to,O
reveal,O
the,O
antiviral,O
ability,O
of,O
"
",O
PBD2,O
against,O
pseudorabies,O
virus,O
(,O
PRV,O
),O
",",O
the,O
causative,O
pathogen,O
of,O
Aujeszky,O
's,O
"
",O
disease,O
",",O
in,O
PK15,O
cells,O
and,O
in,O
a,O
PBD2,O
expressing,O
transgenic,O
(,O
TG,O
),O
mouse,O
model,O
.,O
"
",O
METHODS,O
:,O
In,O
this,O
study,O
",",O
the,O
cytotoxicity,O
of,O
PBD2,O
on,O
PK15,O
cells,O
was,O
measured,O
by,O
"
",O
CCK8,O
assay,O
.,O
PK15,O
cells,O
were,O
incubated,O
with,O
PRV,O
pretreated,O
with,O
different,O
"
",O
concentrations,O
of,O
PBD2,O
and,O
PRV,O
titers,O
in,O
cell,O
culture,O
supernatants,O
were,O
"
",O
determined,O
by,O
realtime,O
quantitative,O
PCR,O
(,O
RTqPCR,O
),O
.,O
TG,O
mice,O
and,O
wildtype,O
(,O
WT,O
),O
"
",O
mice,O
were,O
intraperitoneally,O
injected,O
with,O
PRV,O
and,O
the,O
survival,O
rate,O
was,O
recorded,O
"
",O
for,O
10,O
â€‰,O
days,O
.,O
Meanwhile,O
",",O
tissue,O
lesions,O
in,O
brain,O
",",O
spleen,O
and,O
liver,O
of,O
infected,O
"
",O
mice,O
were,O
observed,O
and,O
the,O
viral,O
loads,O
of,O
PRV,O
in,O
brain,O
",",O
liver,O
and,O
lung,O
were,O
"
",O
analyzed,O
by,O
RTqPCR,O
.,O
"
",O
RESULTS,O
:,O
PBD2,O
at,O
a,O
maximum,O
concentration,O
of,O
80,O
â€‰,O
Î¼g,O
mL,O
displayed,O
no,O
significant,O
"
",O
cytotoxicity,O
on,O
PK15,O
cells,O
.,O
A,O
threshold,O
concentration,O
of,O
PBD2,O
at,O
40,O
â€‰,O
Î¼g,O
mL,O
was,O
"
",O
required,O
to,O
inhibit,O
PRV,O
proliferation,O
in,O
PK15,O
cells,O
.,O
The,O
survival,O
rate,O
in,O
PBD2,O
"
",O
TG,O
mice,O
was,O
50,O
%,O
higher,O
than,O
that,O
of,O
WT,O
mice,O
.,O
In,O
addition,O
",",O
TG,O
mice,O
showed,O
"
",O
alleviated,O
tissue,O
lesions,O
in,O
brain,O
",",O
spleen,O
and,O
liver,O
compared,O
with,O
their,O
WT,O
"
",O
littermates,O
after,O
PRV,O
challenge,O
",",O
while,O
viral,O
loads,O
of,O
PRV,O
in,O
brain,O
",",O
liver,O
and,O
"
",O
lung,O
of,O
TG,O
mice,O
were,O
significantly,O
lower,O
than,O
that,O
of,O
WT,O
mice,O
.,O
"
",O
CONCLUSIONS,O
:,O
PBD2,O
could,O
inhibit,O
PRV,O
proliferation,O
in,O
PK15,O
cells,O
and,O
protect,O
"
",O
mice,O
from,O
PRV,O
infection,O
",",O
which,O
confirmed,O
the,O
antiviral,O
ability,O
of,O
PBD2,O
both,O
in,O
"
",O
vitro,O
and,O
in,O
vivo,O
.,O
The,O
application,O
of,O
PBD2,O
in,O
developing,O
antiviral,O
drugs,O
or,O
"
",O
diseaseresistant,O
animals,O
can,O
be,O
further,O
investigated,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s1298502012884,O
"
",O
PMCID,O
:,O
PMC6998849,O
"
",O
PMID,O
:,O
32014007,O
"


",O
824,O
.,O
Radiology,O
.,O
2020,O
Feb,O
4:200257,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200257,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
Pneumonia,O
.,O
"

",O
Liu,O
P(1,O
),O
",",O
Tan,O
XZ(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Department,O
of,O
Radiology,O
",",O
Hunan,O
Provincial,O
People,O
's,O
Hospital,O
",",O
First,O
"
",O
Affiliated,O
Hospital,O
of,O
Hunan,O
Normal,O
University,O
",",O
Changsha,O
410005,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200257,O
"
",O
PMID,O
:,O
32013795,O
"


",O
825,O
.,O
Autophagy,O
.,O
2020,O
Feb,O
0.538888889,O
.,O
doi,O
:,O
10.108,O
15548627.2020.1725375,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Influenza,O
A,O
virus,O
protein,O
PB1F2,O
impairs,O
innate,O
immunity,O
by,O
inducing,O
mitophagy,O
.,O
"

",O
Wang,O
R(1)(2,O
),O
",",O
Zhu,O
Y(1)(2,O
),O
",",O
Ren,O
C(1)(2,O
),O
",",O
Yang,O
S(1)(2,O
),O
",",O
Tian,O
S(1)(2,O
),O
",",O
Chen,O
H(1)(2,O
),O
",",O
"
",O
Jin,O
M(1)(2,O
),O
",",O
Zhou,O
H(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
The,O
"
",O
Cooperative,O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
Influenza,O
A,O
virus,O
(,O
IAV,O
),O
infection,O
induces,O
mitophagy,O
",",O
which,O
is,O
essential,O
for,O
the,O
"
",O
clearance,O
of,O
damaged,O
mitochondria,O
.,O
Dysfunctional,O
mitochondria,O
can,O
be,O
selectively,O
"
",O
targeted,O
by,O
PINK1,O
",",O
which,O
recruits,O
PRKN,O
PARK2,O
and,O
leads,O
to,O
subsequent,O
"
",O
mitochondrial,O
sequestration,O
within,O
autophagosomes,O
.,O
The,O
IAV,O
PB1F2,O
protein,O
"
",O
translocates,O
to,O
mitochondria,O
",",O
accelerates,O
the,O
mitochondrial,O
fragmentation,O
and,O
"
",O
impairs,O
the,O
innate,O
immunity,O
.,O
However,O
",",O
whether,O
PB1F2,O
mediates,O
IAVinduced,O
"
",O
mitophagy,O
and,O
the,O
relation,O
between,O
mitophagy,O
and,O
PB1F2attenuated,O
innate,O
"
",O
immunity,O
remain,O
obscure,O
.,O
Here,O
",",O
we,O
showed,O
that,O
PB1F2,O
translocated,O
to,O
mitochondria,O
"
",O
by,O
interacting,O
and,O
colocalizing,O
with,O
TUFM,O
(,O
Tu,O
translation,O
elongation,O
factor,O
",",O
"
",O
mitochondrial,O
),O
.,O
Further,O
studies,O
revealed,O
that,O
PB1F2,O
induced,O
complete,O
mitophagy,O
",",O
"
",O
which,O
required,O
the,O
interactions,O
of,O
PB1F2,O
with,O
both,O
TUFM,O
and,O
MAP1LC3B,O
LC3B,O
that,O
"
",O
mediated,O
the,O
autophagosome,O
formation,O
.,O
PB1F2induced,O
mitophagy,O
was,O
critical,O
for,O
"
",O
the,O
MAVS,O
(,O
mitochondrial,O
antiviral,O
signaling,O
protein,O
),O
degradation,O
and,O
led,O
to,O
its,O
"
",O
suppression,O
of,O
the,O
type,O
I,O
IFN,O
production,O
.,O
Importantly,O
",",O
the,O
Cterminal,O
LIR,O
motif,O
"
",O
of,O
PB1F2,O
protein,O
was,O
demonstrated,O
to,O
be,O
essential,O
for,O
its,O
mitophagy,O
induction,O
"
",O
and,O
attenuated,O
innate,O
immunity,O
.,O
In,O
conclusion,O
",",O
PB1F2induced,O
mitophagy,O
strongly,O
"
",O
correlates,O
with,O
impaired,O
cellular,O
innate,O
immunity,O
",",O
revealing,O
it,O
is,O
a,O
potential,O
"
",O
therapeutic,O
target,O
.,O
Abbreviations,O
:,O
BCL2L13,O
:,O
BCL2,O
like,O
13,O
;,O
BECN1,O
:,O
beclin,O
1,O
;,O
"
",O
BNIP3L,O
Nix,O
:,O
BCL2,O
interacting,O
protein,O
3,O
like,O
;,O
CQ,O
:,O
chloroquine,O
;,O
DDX58,O
:,O
DExD,O
Hbox,O
"
",O
helicase,O
58,O
;,O
eGFP,O
:,O
enhanced,O
green,O
fluorescent,O
protein,O
;,O
hpi,O
:,O
hours,O
post,O
infection,O
;,O
"
",O
IAV,O
:,O
influenza,O
A,O
virus,O
;,O
IFN,O
:,O
interferon,O
;,O
IP,O
:,O
immunoprecipitation,O
;,O
LIR,O
:,O
"
",O
LC3interacting,O
region,O
;,O
MAP1LC3B,O
LC3B,O
:,O
microtubule,O
associated,O
protein,O
1,O
light,O
"
",O
chain,O
3,O
beta,O
;,O
MAVS,O
:,O
mitochondrial,O
antiviral,O
signaling,O
protein,O
;,O
MMP,O
:,O
mitochondrial,O
"
",O
membrane,O
potential,O
;,O
MOI,O
",",O
multiplicity,O
of,O
infection,O
;,O
mRFP,O
:,O
monomeric,O
red,O
"
",O
fluorescent,O
protein,O
;,O
NBR1,O
:,O
NBR1,O
autophagy,O
cargo,O
receptor,O
;,O
NC,O
:,O
negative,O
control,O
;,O
"
",O
NLRP3,O
:,O
NLR,O
family,O
pyrin,O
domain,O
containing,O
3,O
;,O
PINK1,O
:,O
PTEN,O
induced,O
kinase,O
1,O
;,O
"
",O
PRKN,O
PARK2,O
:,O
parkin,O
RBR,O
E3,O
ubiquitin,O
protein,O
ligase,O
;,O
RLR,O
:,O
RIGIlikereceptor,O
;,O
"
",O
ROS,O
:,O
reactive,O
oxygen,O
species,O
;,O
SEV,O
:,O
sendai,O
virus,O
;,O
SQSTM1,O
p62,O
:,O
sequestosome,O
1,O
;,O
"
",O
TAX1BP1,O
:,O
Tax1,O
binding,O
protein,O
1,O
;,O
TM,O
:,O
transmembrane,O
;,O
TOMM20,O
40,O
:,O
translocase,O
of,O
"
",O
outer,O
mitochondrial,O
membrane,O
20,O
40,O
;,O
TUFM,O
:,O
Tu,O
translation,O
elongation,O
factor,O
",",O
"
",O
mitochondrial,O
.,O
"

",O
DOI,O
:,O
10.108,O
15548627.2020.1725375,O
"
",O
PMID,O
:,O
32013669,O
"


",O
826,O
.,O
J,O
Travel,O
Med,O
.,O
2020,O
Feb,O
3,O
.,O
pii,O
:,O
taaa015,O
.,O
doi,O
:,O
10.1093,O
jtm,O
taaa015,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Travelers,O
Give,O
Wings,O
to,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
"

",O
Wilson,O
ME(1,O
),O
",",O
Chen,O
LH(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Clinical,O
Professor,O
of,O
Epidemiology,O
and,O
Biostatistics,O
",",O
School,O
of,O
Medicine,O
",",O
"
",O
University,O
of,O
California,O
",",O
San,O
Francisco,O
",",O
Adjunct,O
Professor,O
of,O
Global,O
Health,O
and,O
"
",O
Population,O
",",O
Harvard,O
T.H.,O
Chan,O
School,O
of,O
Public,O
Health,O
",",O
Boston,O
",",O
Massachusetts,O
.,O
"
",O
(2)Travel,O
Medicine,O
Center,O
",",O
Mount,O
Auburn,O
Hospital,O
",",O
Cambridge,O
",",O
Massachusetts,O
",",O
and,O
"
",O
Associate,O
Professor,O
of,O
Medicine,O
",",O
Harvard,O
Medical,O
School,O
",",O
Boston,O
",",O
Massachusetts,O
",",O
"
",O
USA,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jtm,O
taaa015,O
"
",O
PMID,O
:,O
32010938,O
"


",O
827,O
.,O
Sci,O
China,O
Life,O
Sci,O
.,O
2020,O
Mar;63(3):457460,O
.,O
doi,O
:,O
10.1007,O
s1142702016375,O
.,O
Epub,O
"
",O
2020,O
Jan,O
21,O
.,O
"

",O
Evolution,O
of,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
from,O
the,O
ongoing,O
Wuhan,O
outbreak,O
and,O
modeling,O
"
",O
of,O
its,O
spike,O
protein,O
for,O
risk,O
of,O
human,O
transmission,O
.,O
"

",O
Xu,O
X(1,O
),O
",",O
Chen,O
P(2)(3,O
),O
",",O
Wang,O
J(4,O
),O
",",O
Feng,O
J(5,O
),O
",",O
Zhou,O
H(2,O
),O
",",O
Li,O
X(6,O
),O
",",O
Zhong,O
W(7,O
),O
",",O
Hao,O
"
",O
P(8)(9)(10,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Molecular,O
Virology,O
and,O
Immunology,O
",",O
Institut,O
Pasteur,O
of,O
"
",O
Shanghai,O
",",O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
"
",O
Shanghai,O
",",O
200031,O
",",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Synthetic,O
Biology,O
",",O
CAS,O
Center,O
for,O
Excellence,O
in,O
Molecular,O
"
",O
Plant,O
Sciences,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Shanghai,O
",",O
200032,O
",",O
China,O
.,O
"
",O
(3)The,O
Joint,O
Program,O
in,O
Infection,O
and,O
Immunity,O
:,O
Guangzhou,O
Women,O
and,O
Children,O
's,O
"
",O
Medical,O
Center,O
",",O
Guangzhou,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
510623,O
",",O
China,O
.,O
"
",O
(4)Key,O
Laboratory,O
of,O
Systems,O
Biomedicine,O
",",O
Ministry,O
of,O
Education,O
",",O
Shanghai,O
Center,O
"
",O
for,O
Systems,O
Biomedicine,O
",",O
Shanghai,O
Jiao,O
Tong,O
University,O
",",O
Shanghai,O
",",O
200240,O
",",O
China,O
.,O
"
",O
(5)National,O
Engineering,O
Research,O
Center,O
for,O
the,O
Emergence,O
Drugs,O
",",O
Beijing,O
"
",O
Institute,O
of,O
Pharmacology,O
and,O
Toxicology,O
",",O
Beijing,O
",",O
100850,O
",",O
China,O
.,O
"
",O
(6)Key,O
Laboratory,O
of,O
Synthetic,O
Biology,O
",",O
CAS,O
Center,O
for,O
Excellence,O
in,O
Molecular,O
"
",O
Plant,O
Sciences,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Shanghai,O
",",O
200032,O
",",O
China,O
.,O
"
",O
lixuan@sippe.ac.cn,O
.,O
"
",O
(7)National,O
Engineering,O
Research,O
Center,O
for,O
the,O
Emergence,O
Drugs,O
",",O
Beijing,O
"
",O
Institute,O
of,O
Pharmacology,O
and,O
Toxicology,O
",",O
Beijing,O
",",O
100850,O
",",O
China,O
.,O
"
",O
zhongwu@bmi.ac.cn,O
.,O
"
",O
(8)Key,O
Laboratory,O
of,O
Molecular,O
Virology,O
and,O
Immunology,O
",",O
Institut,O
Pasteur,O
of,O
"
",O
Shanghai,O
",",O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
"
",O
Shanghai,O
",",O
200031,O
",",O
China,O
.,O
phao@ips.ac.cn,O
.,O
"
",O
(9)The,O
Joint,O
Program,O
in,O
Infection,O
and,O
Immunity,O
:,O
Guangzhou,O
Women,O
and,O
Children,O
's,O
"
",O
Medical,O
Center,O
",",O
Guangzhou,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
510623,O
",",O
China,O
.,O
"
",O
phao@ips.ac.cn,O
.,O
"
",O
(10)The,O
Joint,O
Program,O
in,O
Infection,O
and,O
Immunity,O
:,O
Institute,O
Pasteur,O
of,O
Shanghai,O
",",O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Shanghai,O
",",O
200031,O
",",O
China,O
.,O
phao@ips.ac.cn,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s1142702016375,O
"
",O
PMID,O
:,O
32009228,O
"


",O
828,O
.,O
Infez,O
Med,O
.,O
2020,O
Mar,O
1;28(1):35,O
.,O
"

",O
History,O
is,O
repeating,O
itself,O
:,O
Probable,O
zoonotic,O
spillover,O
as,O
the,O
cause,O
of,O
the,O
2019,O
"
",O
novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
Epidemic,O
"

",O
RodriguezMorales,O
AJ(1,O
),O
",",O
BonillaAldana,O
DK(2,O
),O
",",O
BalbinRamon,O
GJ(3,O
),O
",",O
Rabaan,O
AA(4,O
),O
",",O
"
",O
Sah,O
R(5,O
),O
",",O
PanizMondolfi,O
A(6,O
),O
",",O
Pagliano,O
P(7,O
),O
",",O
Esposito,O
S(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Public,O
Health,O
and,O
Infection,O
Research,O
Group,O
",",O
Faculty,O
of,O
Health,O
Sciences,O
",",O
"
",O
Universidad,O
Tecnologica,O
de,O
Pereira,O
",",O
Pereira,O
",",O
Colombia,O
;,O
Grupo,O
de,O
Investigacion,O
"
",O
Biomedicina,O
",",O
Faculty,O
of,O
Medicine,O
",",O
Fundacion,O
Universitaria,O
Autonoma,O
de,O
las,O
"
",O
Americas,O
",",O
Pereira,O
",",O
Risaralda,O
",",O
Colombia,O
;,O
Master,O
in,O
Clinical,O
Epidemiology,O
and,O
"
",O
Biostatistics,O
",",O
Universidad,O
Cientifica,O
del,O
Sur,O
",",O
Lima,O
",",O
Peru,O
.,O
"
",O
(2)Public,O
Health,O
and,O
Infection,O
Research,O
Group,O
",",O
Faculty,O
of,O
Health,O
Sciences,O
",",O
"
",O
Universidad,O
Tecnologica,O
de,O
Pereira,O
",",O
Pereira,O
",",O
Colombia,O
;,O
Incubator,O
in,O
Zoonosis,O
"
",O
(,O
SIZOO,O
),O
",",O
Biodiversity,O
and,O
Ecosystem,O
Conservation,O
Research,O
Group,O
(,O
BIOECOS,O
),O
",",O
"
",O
Fundacion,O
Universitaria,O
Autonoma,O
de,O
las,O
Americas,O
",",O
Sede,O
Pereira,O
",",O
Pereira,O
",",O
"
",O
Risaralda,O
",",O
Colombia,O
.,O
"
",O
(3)Master,O
in,O
Clinical,O
Epidemiology,O
and,O
Biostatistics,O
",",O
Universidad,O
Cientifica,O
del,O
"
",O
Sur,O
",",O
Lima,O
",",O
Peru,O
;,O
Hospital,O
de,O
Emergencias,O
Jose,O
Casimo,O
Ulloa,O
",",O
Lima,O
",",O
Peru,O
.,O
"
",O
(4)Molecular,O
Diagnostic,O
Laboratory,O
",",O
Johns,O
Hopkins,O
Aramco,O
Healthcare,O
",",O
Dhahran,O
",",O
"
",O
Saudi,O
Arabia,O
.,O
"
",O
(5)Department,O
of,O
Microbiology,O
",",O
Tribhuvan,O
University,O
Teaching,O
Hospital,O
",",O
Institute,O
"
",O
of,O
Medicine,O
",",O
Kathmandu,O
",",O
Nepal,O
.,O
"
",O
(6)Laboratory,O
of,O
Medical,O
Microbiology,O
",",O
Department,O
of,O
Pathology,O
",",O
Molecular,O
and,O
"
",O
Cellbased,O
Medicine,O
",",O
The,O
Mount,O
Sinai,O
HospitalIcahn,O
School,O
of,O
Medicine,O
at,O
Mount,O
"
",O
Sinai,O
",",O
New,O
York,O
",",O
USA,O
;,O
Instituto,O
de,O
Investigaciones,O
Biomedicas,O
IDB,O
  ,O
Incubadora,O
"
",O
Venezolana,O
de,O
la,O
Ciencia,O
",",O
Cabudare,O
",",O
Lara,O
",",O
Venezuela,O
;,O
Academia,O
Nacional,O
de,O
"
",O
Medicina,O
",",O
Caracas,O
",",O
Venezuela,O
.,O
"
",O
(7)Department,O
of,O
Infectious,O
Diseases,O
",",O
University,O
of,O
Salerno,O
",",O
Salerno,O
",",O
Italy,O
.,O
"

",O
Pathogen,O
transmission,O
from,O
a,O
vertebrate,O
animal,O
to,O
a,O
human,O
",",O
also,O
known,O
as,O
zoonotic,O
"
",O
spillover,O
",",O
represents,O
a,O
global,O
public,O
health,O
burden,O
",",O
which,O
while,O
associated,O
with,O
"
",O
multiple,O
outbreaks,O
",",O
still,O
remains,O
a,O
poorly,O
understood,O
phenomenon,O
.,O
Coronaviruses,O
",",O
"
",O
like,O
influenza,O
viruses,O
",",O
circulate,O
in,O
nature,O
in,O
various,O
animal,O
species,O
.,O
"
",O
Alphacoronaviruses,O
and,O
betacoronaviruses,O
can,O
infect,O
mammals,O
and,O
"
",O
gammacoronaviruses,O
and,O
deltacoronaviruses,O
tend,O
to,O
infect,O
birds,O
",",O
but,O
some,O
of,O
"
",O
them,O
can,O
also,O
be,O
transmitted,O
to,O
mammals,O
.,O
Although,O
still,O
preliminary,O
",",O
current,O
data,O
"
",O
suggest,O
that,O
bats,O
are,O
the,O
most,O
probable,O
initial,O
source,O
of,O
the,O
current,O
2019,O
novel,O
"
",O
CoV,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
outbreak,O
",",O
that,O
begun,O
on,O
December,O
2019,O
in,O
Wuhan,O
",",O
China,O
",",O
apparently,O
"
",O
spreading,O
from,O
a,O
"""",O
wet,O
market,O
"""",O
to,O
multiple,O
cities,O
and,O
provinces,O
in,O
China,O
.,O
This,O
"
",O
epidemic,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
already,O
reaching,O
more,O
than,O
6000,O
cases,O
today,O
(,O
end,O
of,O
"
",O
January,O
2020,O
),O
(,O
>,O
90,O
%,O
in,O
China,O
),O
",",O
will,O
not,O
be,O
the,O
last,O
one,O
linked,O
to,O
zoonotic,O
"
",O
spillover,O
events,O
.,O
"


",O
PMID,O
:,O
32009128,O
"


",O
829,O
.,O
Int,O
J,O
Infect,O
Dis,O
.,O
2020,O
Mar;92:214217,O
.,O
doi,O
:,O
10.1016,O
j.ijid.2020.01.050,O
.,O
Epub,O
2020,O
"
",O
Jan,O
30,O
.,O
"

",O
Preliminary,O
estimation,O
of,O
the,O
basic,O
reproduction,O
number,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
in,O
China,O
",",O
from,O
2019,O
to,O
2020,O
:,O
A,O
datadriven,O
analysis,O
in,O
the,O
early,O
"
",O
phase,O
of,O
the,O
outbreak,O
.,O
"

",O
Zhao,O
S(1,O
),O
",",O
Lin,O
Q(2,O
),O
",",O
Ran,O
J(3,O
),O
",",O
Musa,O
SS(4,O
),O
",",O
Yang,O
G(5,O
),O
",",O
Wang,O
W(6,O
),O
",",O
Lou,O
Y(7,O
),O
",",O
Gao,O
"
",O
D(8,O
),O
",",O
Yang,O
L(9,O
),O
",",O
He,O
D(10,O
),O
",",O
Wang,O
MH(11,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)JC,O
School,O
of,O
Public,O
Health,O
and,O
Primary,O
Care,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
",",O
China,O
;,O
Shenzhen,O
Research,O
Institute,O
of,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Shenzhen,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
shi.zhao@link.cuhk.edu.hk,O
.,O
"
",O
(2)Michigan,O
Institute,O
for,O
Data,O
Science,O
",",O
University,O
of,O
Michigan,O
",",O
Ann,O
Arbor,O
",",O
MI,O
",",O
"
",O
USA,O
.,O
Electronic,O
address,O
:,O
qianying.lin@connect.polyu.hk,O
.,O
"
",O
(3)School,O
of,O
Public,O
Health,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Hong,O
"
",O
Kong,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
jimran@connect.hku.hk,O
.,O
"
",O
(4)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
salihusabiu.musa@connect.polyu.hk,O
.,O
"
",O
(5)Department,O
of,O
Orthopaedics,O
and,O
Traumatology,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
",",O
China,O
;,O
SH,O
Ho,O
Scoliosis,O
Research,O
Lab,O
",",O
Joint,O
Scoliosis,O
Research,O
Center,O
"
",O
of,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
and,O
Nanjing,O
University,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
kennethgpy@link.cuhk.edu.hk,O
.,O
"
",O
(6)School,O
of,O
Mathematics,O
and,O
Statistics,O
",",O
Huaiyin,O
Normal,O
University,O
",",O
Huaian,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
weimingwang2003@163.com,O
.,O
"
",O
(7)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
yijun.lou@polyu.edu.hk,O
.,O
"
",O
(8)Department,O
of,O
Mathematics,O
",",O
Shanghai,O
Normal,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
dzgao@shnu.edu.cn,O
.,O
"
",O
(9)School,O
of,O
Nursing,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
l.yang@polyu.edu.hk,O
.,O
"
",O
(10)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
daihai.he@polyu.edu.hk,O
.,O
"
",O
(11)JC,O
School,O
of,O
Public,O
Health,O
and,O
Primary,O
Care,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
",",O
China,O
;,O
Shenzhen,O
Research,O
Institute,O
of,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Shenzhen,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
maggiew@cuhk.edu.hk,O
.,O
"

",O
BACKGROUNDS,O
:,O
An,O
ongoing,O
outbreak,O
of,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
pneumonia,O
hit,O
"
",O
a,O
major,O
city,O
in,O
China,O
",",O
Wuhan,O
",",O
December,O
2019,O
and,O
subsequently,O
reached,O
other,O
"
",O
provinces,O
regions,O
of,O
China,O
and,O
other,O
countries,O
.,O
We,O
present,O
estimates,O
of,O
the,O
basic,O
"
",O
reproduction,O
number,O
",",O
R0,O
",",O
of,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
the,O
early,O
phase,O
of,O
the,O
outbreak,O
.,O
"
",O
METHODS,O
:,O
Accounting,O
for,O
the,O
impact,O
of,O
the,O
variations,O
in,O
disease,O
reporting,O
rate,O
",",O
"
",O
we,O
modelled,O
the,O
epidemic,O
curve,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
cases,O
time,O
series,O
",",O
in,O
mainland,O
China,O
"
",O
from,O
January,O
10,O
to,O
January,O
24,O
",",O
2020,O
",",O
through,O
the,O
exponential,O
growth,O
.,O
With,O
the,O
"
",O
estimated,O
intrinsic,O
growth,O
rate,O
(,O
Î³,O
),O
",",O
we,O
estimated,O
R0,O
by,O
using,O
the,O
serial,O
"
",O
intervals,O
(,O
SI,O
),O
of,O
two,O
other,O
wellknown,O
coronavirus,O
diseases,O
",",O
MERS,O
and,O
SARS,O
",",O
as,O
"
",O
approximations,O
for,O
the,O
TRUE,O
unknown,O
SI,O
.,O
"
",O
FINDINGS,O
:,O
The,O
early,O
outbreak,O
data,O
largely,O
follows,O
the,O
exponential,O
growth,O
.,O
We,O
"
",O
estimated,O
that,O
the,O
mean,O
R0,O
ranges,O
from,O
2.24,O
(,O
95%CI,O
:,O
1.962.55,O
),O
to,O
3.58,O
(,O
95%CI,O
:,O
"
",O
2.894.39,O
),O
associated,O
with,O
8fold,O
to,O
2fold,O
increase,O
in,O
the,O
reporting,O
rate,O
.,O
We,O
"
",O
demonstrated,O
that,O
changes,O
in,O
reporting,O
rate,O
substantially,O
affect,O
estimates,O
of,O
R0,O
.,O
"
",O
CONCLUSION,O
:,O
The,O
mean,O
estimate,O
of,O
R0,O
for,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
ranges,O
from,O
2.24,O
to,O
3.58,O
",",O
"
",O
and,O
is,O
significantly,O
larger,O
than,O
1,O
.,O
Our,O
findings,O
indicate,O
the,O
potential,O
of,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
to,O
cause,O
outbreaks,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Author(s,O
),O
.,O
Published,O
by,O
Elsevier,O
Ltd,O
..,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijid.2020.01.050,O
"
",O
PMID,O
:,O
32007643,O
"


",O
830,O
.,O
Infect,O
Genet,O
Evol,O
.,O
2020,O
Apr;79:104211,O
.,O
doi,O
:,O
10.1016,O
j.meegid.2020.104211,O
.,O
Epub,O
"
",O
2020,O
Jan,O
30,O
.,O
"

",O
Novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
:,O
From,O
discovery,O
to,O
clinical,O
diagnostics,O
.,O
"

",O
Phan,O
T(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Clinical,O
Microbiology,O
",",O
University,O
of,O
Pittsburgh,O
and,O
University,O
of,O
"
",O
Pittsburgh,O
Medical,O
Center,O
",",O
Pittsburgh,O
",",O
PA,O
",",O
USA,O
.,O
Electronic,O
address,O
:,O
"
",O
phantg@upmc.edu,O
.,O
"

",O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
designated,O
as,O
2019nCoV,B-Virus_SARS-CoV-2
first,O
appeared,O
in,O
Wuhan,O
",",O
China,O
in,O
"
",O
late,O
December,O
2019,O
.,O
Dozens,O
of,O
people,O
died,O
in,O
China,O
",",O
and,O
thousands,O
of,O
people,O
"
",O
infected,O
as,O
2019nCoV,B-Virus_SARS-CoV-2
continues,O
to,O
spread,O
around,O
the,O
world,O
.,O
We,O
have,O
described,O
the,O
"
",O
discovery,O
",",O
emergence,O
",",O
genomic,O
characteristics,O
",",O
and,O
clinical,O
diagnostics,O
of,O
"
",O
2019nCoV.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.meegid.2020.104211,O
"
",O
PMID,O
:,O
32007627,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
author,O
"
",O
declares,O
no,O
competing,O
financial,O
interests,O
.,O
"


",O
831,O
.,O
Lancet,O
.,O
2020,O
Feb,O
1;395(10221):322,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)302129,O
.,O
"

",O
Offline,O
:,O
2019nCoV,B-Virus_SARS-CoV-2
outbreakearly,O
lessons,O
.,O
"

",O
Horton,O
R.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)302129,O
"
",O
PMID,O
:,O
32007152,O
"


",O
832,O
.,O
Lancet,O
.,O
2020,O
Feb,O
22;395(10224):565574,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)302518,O
.,O
Epub,O
"
",O
2020,O
Jan,O
30,O
.,O
"

",O
Genomic,O
characterisation,O
and,O
epidemiology,O
of,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
:,O
implications,O
"
",O
for,O
virus,O
origins,O
and,O
receptor,O
binding,O
.,O
"

",O
Lu,O
R(1,O
),O
",",O
Zhao,O
X(1,O
),O
",",O
Li,O
J(2,O
),O
",",O
Niu,O
P(1,O
),O
",",O
Yang,O
B(3,O
),O
",",O
Wu,O
H(4,O
),O
",",O
Wang,O
W(1,O
),O
",",O
Song,O
H(5,O
),O
",",O
"
",O
Huang,O
B(1,O
),O
",",O
Zhu,O
N(1,O
),O
",",O
Bi,O
Y(6,O
),O
",",O
Ma,O
X(1,O
),O
",",O
Zhan,O
F(3,O
),O
",",O
Wang,O
L(6,O
),O
",",O
Hu,O
T(2,O
),O
",",O
Zhou,O
H(2,O
),O
",",O
"
",O
Hu,O
Z(7,O
),O
",",O
Zhou,O
W(1,O
),O
",",O
Zhao,O
L(1,O
),O
",",O
Chen,O
J(8,O
),O
",",O
Meng,O
Y(1,O
),O
",",O
Wang,O
J(1,O
),O
",",O
Lin,O
Y(4,O
),O
",",O
Yuan,O
"
",O
J(4,O
),O
",",O
Xie,O
Z(4,O
),O
",",O
Ma,O
J(4,O
),O
",",O
Liu,O
WJ(1,O
),O
",",O
Wang,O
D(1,O
),O
",",O
Xu,O
W(1,O
),O
",",O
Holmes,O
EC(9,O
),O
",",O
Gao,O
GF(10,O
),O
",",O
"
",O
Wu,O
G(1,O
),O
",",O
Chen,O
W(4,O
),O
",",O
Shi,O
W(11,O
),O
",",O
Tan,O
W(12,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)NHC,O
Key,O
Laboratory,O
of,O
Biosafety,O
",",O
National,O
Institute,O
for,O
Viral,O
Disease,O
Control,O
"
",O
and,O
Prevention,O
",",O
Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Beijing,O
",",O
"
",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Etiology,O
and,O
Epidemiology,O
of,O
Emerging,O
Infectious,O
Diseases,O
in,O
"
",O
Universities,O
of,O
Shandong,O
",",O
Shandong,O
First,O
Medical,O
University,O
and,O
Shandong,O
Academy,O
"
",O
of,O
Medical,O
Sciences,O
",",O
Tai'an,O
",",O
China,O
.,O
"
",O
(3)Division,O
for,O
Viral,O
Disease,O
Detection,O
",",O
Hubei,O
Provincial,O
Center,O
for,O
Disease,O
"
",O
Control,O
and,O
Prevention,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)BGI,O
PathoGenesis,O
Pharmaceutical,O
Technology,O
",",O
Shenzhen,O
",",O
China,O
.,O
"
",O
(5)Research,O
Network,O
of,O
Immunity,O
and,O
Health,O
(,O
RNIH,O
),O
",",O
Beijing,O
Institutes,O
of,O
Life,O
"
",O
Science,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(6)Chinese,O
Academy,O
of,O
Sciences,O
Key,O
Laboratory,O
of,O
Pathogenic,O
Microbiology,O
and,O
"
",O
Immunology,O
",",O
Institute,O
of,O
Microbiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
"
",O
China,O
;,O
Center,O
for,O
Influenza,O
Research,O
and,O
Earlywarning,O
(,O
CASCIRE,O
),O
",",O
CASTWAS,O
Center,O
"
",O
of,O
Excellence,O
for,O
Emerging,O
Infectious,O
Diseases,O
(,O
CEEID,O
),O
",",O
Chinese,O
Academy,O
of,O
"
",O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(7)Central,O
Theater,O
",",O
People,O
's,O
Liberation,O
Army,O
General,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(8)Key,O
Laboratory,O
of,O
Laboratory,O
Medicine,O
",",O
Ministry,O
of,O
Education,O
",",O
and,O
Zhejiang,O
"
",O
Provincial,O
Key,O
Laboratory,O
of,O
Medical,O
Genetics,O
",",O
Institute,O
of,O
Medical,O
Virology,O
",",O
"
",O
School,O
of,O
Laboratory,O
Medicine,O
and,O
Life,O
Sciences,O
",",O
Wenzhou,O
Medical,O
University,O
",",O
"
",O
Wenzhou,O
",",O
China,O
.,O
"
",O
(9)Marie,O
Bashir,O
Institute,O
for,O
Infectious,O
Diseases,O
and,O
Biosecurity,O
",",O
School,O
of,O
Life,O
"
",O
and,O
Environmental,O
Sciences,O
and,O
School,O
of,O
Medical,O
Sciences,O
",",O
University,O
of,O
Sydney,O
",",O
"
",O
Sydney,O
",",O
NSW,O
",",O
Australia,O
.,O
"
",O
(10)NHC,O
Key,O
Laboratory,O
of,O
Biosafety,O
",",O
National,O
Institute,O
for,O
Viral,O
Disease,O
Control,O
"
",O
and,O
Prevention,O
",",O
Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Beijing,O
",",O
"
",O
China,O
;,O
Chinese,O
Academy,O
of,O
Sciences,O
Key,O
Laboratory,O
of,O
Pathogenic,O
Microbiology,O
and,O
"
",O
Immunology,O
",",O
Institute,O
of,O
Microbiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
"
",O
China,O
;,O
Center,O
for,O
Influenza,O
Research,O
and,O
Earlywarning,O
(,O
CASCIRE,O
),O
",",O
CASTWAS,O
Center,O
"
",O
of,O
Excellence,O
for,O
Emerging,O
Infectious,O
Diseases,O
(,O
CEEID,O
),O
",",O
Chinese,O
Academy,O
of,O
"
",O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(11)Key,O
Laboratory,O
of,O
Etiology,O
and,O
Epidemiology,O
of,O
Emerging,O
Infectious,O
Diseases,O
"
",O
in,O
Universities,O
of,O
Shandong,O
",",O
Shandong,O
First,O
Medical,O
University,O
and,O
Shandong,O
"
",O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Tai'an,O
",",O
China,O
;,O
The,O
First,O
Affiliated,O
Hospital,O
of,O
"
",O
Shandong,O
First,O
Medical,O
University,O
(,O
Shandong,O
Provincial,O
Qianfoshan,O
Hospital,O
),O
",",O
"
",O
Jinan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
wfshi@sdfmu.edu.cn,O
.,O
"
",O
(12)NHC,O
Key,O
Laboratory,O
of,O
Biosafety,O
",",O
National,O
Institute,O
for,O
Viral,O
Disease,O
Control,O
"
",O
and,O
Prevention,O
",",O
Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Beijing,O
",",O
"
",O
China,O
;,O
Central,O
Theater,O
",",O
People,O
's,O
Liberation,O
Army,O
General,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
;,O
"
",O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
tanwj@ivdc.chinacdc.cn,O
.,O
"

",O
BACKGROUND,O
:,O
In,O
late,O
December,O
",",O
2019,O
",",O
patients,O
presenting,O
with,O
viral,O
pneumonia,O
due,O
"
",O
to,O
an,O
unidentified,O
microbial,O
agent,O
were,O
reported,O
in,O
Wuhan,O
",",O
China,O
.,O
A,O
novel,O
"
",O
coronavirus,O
was,O
subsequently,O
identified,O
as,O
the,O
causative,O
pathogen,O
",",O
provisionally,O
"
",O
named,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
As,O
of,O
Jan,O
26,O
",",O
2020,O
",",O
more,O
than,O
2000,O
"
",O
cases,O
of,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
have,O
been,O
confirmed,O
",",O
most,O
of,O
which,O
involved,O
people,O
"
",O
living,O
in,O
or,O
visiting,O
Wuhan,O
",",O
and,O
humantohuman,O
transmission,O
has,O
been,O
confirmed,O
.,O
"
",O
METHODS,O
:,O
We,O
did,O
nextgeneration,O
sequencing,O
of,O
samples,O
from,O
bronchoalveolar,O
lavage,O
"
",O
fluid,O
and,O
cultured,O
isolates,O
from,O
nine,O
inpatients,O
",",O
eight,O
of,O
whom,O
had,O
visited,O
the,O
"
",O
Huanan,O
seafood,O
market,O
in,O
Wuhan,O
.,O
Complete,O
and,O
partial,O
2019nCoV,B-Virus_SARS-CoV-2
genome,O
sequences,O
"
",O
were,O
obtained,O
from,O
these,O
individuals,O
.,O
Viral,O
contigs,O
were,O
connected,O
using,O
Sanger,O
"
",O
sequencing,O
to,O
obtain,O
the,O
fulllength,O
genomes,O
",",O
with,O
the,O
terminal,O
regions,O
"
",O
determined,O
by,O
rapid,O
amplification,O
of,O
cDNA,O
ends,O
.,O
Phylogenetic,O
analysis,O
of,O
these,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
genomes,O
and,O
those,O
of,O
other,O
coronaviruses,O
was,O
used,O
to,O
determine,O
the,O
"
",O
evolutionary,O
history,O
of,O
the,O
virus,O
and,O
help,O
infer,O
its,O
likely,O
origin,O
.,O
Homology,O
"
",O
modelling,O
was,O
done,O
to,O
explore,O
the,O
likely,O
receptorbinding,O
properties,O
of,O
the,O
"
",O
virus,O
.,O
"
",O
FINDINGS,O
:,O
The,O
ten,O
genome,O
sequences,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
obtained,O
from,O
the,O
nine,O
patients,O
"
",O
were,O
extremely,O
similar,O
",",O
exhibiting,O
more,O
than,O
99Â·98,O
%,O
sequence,O
identity,O
.,O
Notably,O
",",O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
was,O
closely,O
related,O
(,O
with,O
88,O
%,O
identity,O
),O
to,O
two,O
batderived,O
severe,O
acute,O
"
",O
respiratory,O
syndrome,O
(SARS)like,O
coronaviruses,O
",",O
batSLCoVZC45,O
and,O
"
",O
batSLCoVZXC21,O
",",O
collected,O
in,O
2018,O
in,O
Zhoushan,O
",",O
eastern,O
China,O
",",O
but,O
were,O
more,O
"
",O
distant,O
from,O
SARSCoV,O
(,O
about,O
79,O
%,O
),O
and,O
MERSCoV,O
(,O
about,O
50,O
%,O
),O
.,O
Phylogenetic,O
analysis,O
"
",O
revealed,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
fell,O
within,O
the,O
subgenus,O
Sarbecovirus,O
of,O
the,O
genus,O
"
",O
Betacoronavirus,O
",",O
with,O
a,O
relatively,O
long,O
branch,O
length,O
to,O
its,O
closest,O
relatives,O
"
",O
batSLCoVZC45,O
and,O
batSLCoVZXC21,O
",",O
and,O
was,O
genetically,O
distinct,O
from,O
SARSCoV.,O
"
",O
Notably,O
",",O
homology,O
modelling,O
revealed,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
had,O
a,O
similar,O
"
",O
receptorbinding,O
domain,O
structure,O
to,O
that,O
of,O
SARSCoV,O
",",O
despite,O
amino,O
acid,O
"
",O
variation,O
at,O
some,O
key,O
residues,O
.,O
"
",O
INTERPRETATION,O
:,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
sufficiently,O
divergent,O
from,O
SARSCoV,O
to,O
be,O
"
",O
considered,O
a,O
new,O
humaninfecting,O
betacoronavirus,O
.,O
Although,O
our,O
phylogenetic,O
"
",O
analysis,O
suggests,O
that,O
bats,O
might,O
be,O
the,O
original,O
host,O
of,O
this,O
virus,O
",",O
an,O
animal,O
"
",O
sold,O
at,O
the,O
seafood,O
market,O
in,O
Wuhan,O
might,O
represent,O
an,O
intermediate,O
host,O
"
",O
facilitating,O
the,O
emergence,O
of,O
the,O
virus,O
in,O
humans,O
.,O
Importantly,O
",",O
structural,O
"
",O
analysis,O
suggests,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
might,O
be,O
able,O
to,O
bind,O
to,O
the,O
"
",O
angiotensinconverting,O
enzyme,O
2,O
receptor,O
in,O
humans,O
.,O
The,O
future,O
evolution,O
",",O
"
",O
adaptation,O
",",O
and,O
spread,O
of,O
this,O
virus,O
warrant,O
urgent,O
investigation,O
.,O
"
",O
FUNDING,O
:,O
National,O
Key,O
Research,O
and,O
Development,O
Program,O
of,O
China,O
",",O
National,O
Major,O
"
",O
Project,O
for,O
Control,O
and,O
Prevention,O
of,O
Infectious,O
Disease,O
in,O
China,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
Shandong,O
First,O
Medical,O
University,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)302518,O
"
",O
PMID,O
:,O
32007145,O
"


",O
833,O
.,O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):507513,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)302117,O
.,O
Epub,O
"
",O
2020,O
Jan,O
30,O
.,O
"

",O
Epidemiological,O
and,O
clinical,O
characteristics,O
of,O
99,O
cases,O
of,O
2019,O
novel,O
"
",O
coronavirus,O
pneumonia,O
in,O
Wuhan,O
",",O
China,O
:,O
a,O
descriptive,O
study,O
.,O
"

",O
Chen,O
N(1,O
),O
",",O
Zhou,O
M(2,O
),O
",",O
Dong,O
X(1,O
),O
",",O
Qu,O
J(2,O
),O
",",O
Gong,O
F(3,O
),O
",",O
Han,O
Y(4,O
),O
",",O
Qiu,O
Y(5,O
),O
",",O
Wang,O
"
",O
J(3,O
),O
",",O
Liu,O
Y(6,O
),O
",",O
Wei,O
Y(1,O
),O
",",O
Xia,O
J(1,O
),O
",",O
Yu,O
T(1,O
),O
",",O
Zhang,O
X(7,O
),O
",",O
Zhang,O
L(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Tuberculosis,O
and,O
Respiratory,O
Department,O
",",O
Wuhan,O
Jinyintan,O
Hospital,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Respiratory,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Ruijin,O
Hospital,O
",",O
"
",O
Shanghai,O
Jiaotong,O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
;,O
Institute,O
of,O
"
",O
Respiratory,O
Diseases,O
",",O
Shanghai,O
Jiaotong,O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
"
",O
China,O
.,O
"
",O
(3)Infection,O
Disease,O
Department,O
",",O
Wuhan,O
Jinyintan,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Science,O
and,O
Education,O
Department,O
",",O
Wuhan,O
Jinyintan,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
;,O
"
",O
State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
for,O
"
",O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(5)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
for,O
"
",O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(6)The,O
Office,O
of,O
Drug,O
Clinical,O
Trial,O
Institution,O
",",O
Wuhan,O
Jinyintan,O
Hospital,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(7)Research,O
Laboratory,O
of,O
Clinical,O
Virology,O
",",O
Ruijin,O
Hospital,O
and,O
Ruijin,O
Hospital,O
"
",O
North,O
",",O
Shanghai,O
Jiaotong,O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
;,O
Clinical,O
"
",O
Research,O
Center,O
",",O
Ruijin,O
Hospital,O
North,O
",",O
Shanghai,O
Jiaotong,O
University,O
School,O
of,O
"
",O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
zhangx@shsmu.edu.cn,O
.,O
"
",O
(8)Tuberculosis,O
and,O
Respiratory,O
Department,O
",",O
Wuhan,O
Jinyintan,O
Hospital,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
zhangli080806@163.com,O
.,O
"

",O
BACKGROUND,O
:,O
In,O
December,O
",",O
2019,O
",",O
a,O
pneumonia,O
associated,O
with,O
the,O
2019,O
novel,O
"
",O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
emerged,O
in,O
Wuhan,O
",",O
China,O
.,O
We,O
aimed,O
to,O
further,O
clarify,O
the,O
"
",O
epidemiological,O
and,O
clinical,O
characteristics,O
of,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
.,O
"
",O
METHODS,O
:,O
In,O
this,O
retrospective,O
",",O
singlecentre,O
study,O
",",O
we,O
included,O
all,O
confirmed,O
"
",O
cases,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
Wuhan,O
Jinyintan,O
Hospital,O
from,O
Jan,O
1,O
to,O
Jan,O
20,O
",",O
2020,O
.,O
Cases,O
"
",O
were,O
confirmed,O
by,O
realtime,O
RTPCR,O
and,O
were,O
analysed,O
for,O
epidemiological,O
",",O
"
",O
demographic,O
",",O
clinical,O
",",O
and,O
radiological,O
features,O
and,O
laboratory,O
data,O
.,O
Outcomes,O
"
",O
were,O
followed,O
up,O
until,O
Jan,O
25,O
",",O
2020,O
.,O
"
",O
FINDINGS,O
:,O
Of,O
the,O
99,O
patients,O
with,O
2019nCoV,B-Disease_COVID-19
pneumonia,I-Disease_COVID-19
",",O
49,O
(,O
49,O
%,O
),O
had,O
a,O
history,O
of,O
"
",O
exposure,O
to,O
the,O
Huanan,O
seafood,O
market,O
.,O
The,O
average,O
age,O
of,O
the,O
patients,O
was,O
55Â·5,O
"
",O
years,O
(,O
SD,O
13Â·1,O
),O
",",O
including,O
67,O
men,O
and,O
32,O
women,O
.,O
2019nCoV,B-Virus_SARS-CoV-2
was,O
detected,O
in,O
all,O
"
",O
patients,O
by,O
realtime,O
RTPCR,O
.,O
50,O
(,O
51,O
%,O
),O
patients,O
had,O
chronic,O
diseases,O
.,O
Patients,O
"
",O
had,O
clinical,O
manifestations,O
of,O
fever,O
(,O
82,O
[,O
83,O
%,O
],O
patients,O
),O
",",O
cough,O
(,O
81,O
[,O
82,O
%,O
],O
"
",O
patients,O
),O
",",O
shortness,O
of,O
breath,O
(,O
31,O
[,O
31,O
%,O
],O
patients,O
),O
",",O
muscle,O
ache,O
(,O
11,O
[,O
11,O
%,O
],O
"
",O
patients,O
),O
",",O
confusion,O
(,O
nine,O
[,O
9,O
%,O
],O
patients,O
),O
",",O
headache,O
(,O
eight,O
[,O
8,O
%,O
],O
patients,O
),O
",",O
sore,O
"
",O
throat,O
(,O
five,O
[,O
5,O
%,O
],O
patients,O
),O
",",O
rhinorrhoea,O
(,O
four,O
[,O
4,O
%,O
],O
patients,O
),O
",",O
chest,O
pain,O
(,O
two,O
"
",O
[,O
2,O
%,O
],O
patients,O
),O
",",O
diarrhoea,O
(,O
two,O
[,O
2,O
%,O
],O
patients,O
),O
",",O
and,O
nausea,O
and,O
vomiting,O
(,O
one,O
[,O
1,O
%,O
],O
"
",O
patient,O
),O
.,O
According,O
to,O
imaging,O
examination,O
",",O
74,O
(,O
75,O
%,O
),O
patients,O
showed,O
bilateral,O
"
",O
pneumonia,O
",",O
14,O
(,O
14,O
%,O
),O
patients,O
showed,O
multiple,O
mottling,O
and,O
groundglass,O
opacity,O
",",O
"
",O
and,O
one,O
(,O
1,O
%,O
),O
patient,O
had,O
pneumothorax,O
.,O
17,O
(,O
17,O
%,O
),O
patients,O
developed,O
acute,O
"
",O
respiratory,O
distress,O
syndrome,O
and,O
",",O
among,O
them,O
",",O
11,O
(,O
11,O
%,O
),O
patients,O
worsened,O
in,O
a,O
"
",O
short,O
period,O
of,O
time,O
and,O
died,O
of,O
multiple,O
organ,O
failure,O
.,O
"
",O
INTERPRETATION,O
:,O
The,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
was,O
of,O
clustering,O
onset,O
",",O
is,O
more,O
likely,O
"
",O
to,O
affect,O
older,O
males,O
with,O
comorbidities,O
",",O
and,O
can,O
result,O
in,O
severe,O
and,O
even,O
fatal,O
"
",O
respiratory,O
diseases,O
such,O
as,O
acute,O
respiratory,O
distress,O
syndrome,O
.,O
In,O
general,O
",",O
"
",O
characteristics,O
of,O
patients,O
who,O
died,O
were,O
in,O
line,O
with,O
the,O
MuLBSTA,O
score,O
",",O
an,O
"
",O
early,O
warning,O
model,O
for,O
predicting,O
mortality,O
in,O
viral,O
pneumonia,O
.,O
Further,O
"
",O
investigation,O
is,O
needed,O
to,O
explore,O
the,O
applicability,O
of,O
the,O
MuLBSTA,O
score,O
in,O
"
",O
predicting,O
the,O
risk,O
of,O
mortality,O
in,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
"
",O
FUNDING,O
:,O
National,O
Key,O
R&D,O
Program,O
of,O
China,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)302117,O
"
",O
PMID,O
:,O
32007143,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
834,O
.,O
Lancet,O
Planet,O
Health,O
.,O
2020,O
Jan,O
30,O
.,O
pii,O
:,O
S25425196(20)300322,O
.,O
doi,O
:,O
"
",O
10.1016,O
S25425196(20)300322,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Origins,O
of,O
MERSCoV,O
",",O
and,O
lessons,O
for,O
2019nCoV.,O
"

",O
Ji,O
JS(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Environmental,O
Research,O
Center,O
",",O
Duke,O
Kunshan,O
University,O
",",O
Kunshan,O
215316,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
john.ji@dukekunshan.edu.cn,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S25425196(20)300322,O
"
",O
PMID,O
:,O
32007135,O
"


",O
835,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Jan,O
 ,O
Feb;33:101567,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.tmaid.2020.101567,O
.,O
Epub,O
2020,O
Jan,O
30,O
.,O
"

",O
The,O
next,O
big,O
threat,O
to,O
global,O
health,O
?,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
:,O
What,O
"
",O
advice,O
can,O
we,O
give,O
to,O
travellers,O
?,O
 ,O
Interim,O
recommendations,O
January,O
2020,O
",",O
from,O
"
",O
the,O
LatinAmerican,O
society,O
for,O
Travel,O
Medicine,O
(,O
SLAMVI,O
),O
.,O
"

",O
Biscayart,O
C(1,O
),O
",",O
Angeleri,O
P(2,O
),O
",",O
Lloveras,O
S(3,O
),O
",",O
Chaves,O
TDSS(4,O
),O
",",O
Schlagenhauf,O
P(5,O
),O
",",O
"
",O
RodrÃ­guezMorales,O
AJ(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)FundaciÃ³n,O
Centro,O
de,O
Estudios,O
InfectolÃ³gicos,O
(,O
FUNCEI,O
),O
",",O
Buenos,O
Aires,O
",",O
Argentina,O
;,O
"
",O
Panel,O
of,O
Scientific,O
Publications,O
and,O
Teaching,O
",",O
Latin,O
American,O
Society,O
for,O
Travel,O
"
",O
Medicine,O
(,O
SLAMVI,O
),O
",",O
Buenos,O
Aires,O
",",O
Argentina,O
.,O
"
",O
(2)Hospital,O
General,O
de,O
Agudos,O
P.,O
PiÃ±ero,O
",",O
Buenos,O
Aires,O
",",O
Argentina,O
.,O
"
",O
(3)Panel,O
of,O
Scientific,O
Publications,O
and,O
Teaching,O
",",O
Latin,O
American,O
Society,O
for,O
"
",O
Travel,O
Medicine,O
(,O
SLAMVI,O
),O
",",O
Buenos,O
Aires,O
",",O
Argentina,O
;,O
Panel,O
of,O
Sports,O
and,O
Travel,O
",",O
"
",O
Latin,O
American,O
Society,O
for,O
Travel,O
Medicine,O
(,O
SLAMVI,O
),O
",",O
Buenos,O
Aires,O
",",O
Argentina,O
;,O
"
",O
Hospital,O
de,O
Enfermedades,O
Infecciosas,O
Francisco,O
J.,O
MuÃ±iz,O
",",O
Buenos,O
Aires,O
",",O
Argentina,O
.,O
"
",O
(4)Evandro,O
Chagas,O
Institute,O
",",O
Health,O
of,O
Ministry,O
of,O
Brazil,O
",",O
Rodovia,O
BR,O
316,O
Km,O
7,O
",",O
"
",O
S,O
N,O
",",O
CEP,O
67030000,O
",",O
Ananindeua,O
",",O
ParÃ¡,O
",",O
Brazil,O
;,O
Faculdade,O
de,O
Medicina,O
da,O
"
",O
Universidade,O
Federal,O
Do,O
ParÃ¡,O
",",O
ParÃ¡,O
",",O
Brazil,O
;,O
Centro,O
UniversitÃ¡rio,O
Do,O
"
",O
ParÃ¡,O
Medicina,O
",",O
ParÃ¡,O
",",O
Brazil,O
;,O
Panel,O
of,O
Vaccines,O
in,O
Travelers,O
",",O
Latin,O
American,O
"
",O
Society,O
for,O
Travel,O
Medicine,O
(,O
SLAMVI,O
),O
",",O
ParÃ¡,O
",",O
Brazil,O
.,O
"
",O
(5)University,O
of,O
ZÃ¼rich,O
Centre,O
for,O
Travel,O
Medicine,O
",",O
WHO,O
Collaborating,O
Centre,O
for,O
"
",O
Travellers,O
',O
Health,O
",",O
Institute,O
for,O
Epidemiology,O
",",O
Biostatistics,O
and,O
Prevention,O
",",O
"
",O
Hirschengraben,O
84,O
",",O
8001,O
",",O
ZÃ¼rich,O
",",O
Switzerland,O
.,O
"
",O
(6)Panel,O
of,O
Scientific,O
Publications,O
and,O
Teaching,O
",",O
Latin,O
American,O
Society,O
for,O
"
",O
Travel,O
Medicine,O
(,O
SLAMVI,O
),O
",",O
Buenos,O
Aires,O
",",O
Argentina,O
;,O
Public,O
Health,O
and,O
Infection,O
"
",O
Research,O
Group,O
",",O
Faculty,O
of,O
Health,O
Sciences,O
",",O
Universidad,O
TecnolÃ³gica,O
de,O
Pereira,O
",",O
"
",O
Pereira,O
",",O
Risaralda,O
",",O
Colombia,O
;,O
Grupo,O
de,O
InvestigaciÃ³n,O
Biomedicina,O
",",O
Faculty,O
of,O
"
",O
Medicine,O
",",O
FundaciÃ³n,O
Universitaria,O
AutÃ³noma,O
de,O
Las,O
AmÃ©ricas,O
",",O
Pereira,O
",",O
Risaralda,O
",",O
"
",O
660004,O
",",O
Colombia,O
.,O
Electronic,O
address,O
:,O
arodriguezm@utp.edu.co,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101567,O
"
",O
PMID,O
:,O
32006657,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
None,O
.,O
"


",O
836,O
.,O
Travel,O
Med,O
Infect,O
Dis,O
.,O
2020,O
Jan,O
 ,O
Feb;33:101568,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.tmaid.2020.101568,O
.,O
Epub,O
2020,O
Jan,O
30,O
.,O
"

",O
The,O
association,O
between,O
domestic,O
train,O
transportation,O
and,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
outbreak,O
in,O
China,O
from,O
2019,O
to,O
2020,O
:,O
A,O
datadriven,O
correlational,O
"
",O
report,O
.,O
"

",O
Zhao,O
S(1,O
),O
",",O
Zhuang,O
Z(2,O
),O
",",O
Ran,O
J(3,O
),O
",",O
Lin,O
J(4,O
),O
",",O
Yang,O
G(5,O
),O
",",O
Yang,O
L(6,O
),O
",",O
He,O
D(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)JC,O
School,O
of,O
Public,O
Health,O
and,O
Primary,O
Care,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
",",O
China,O
;,O
Shenzhen,O
Research,O
Institute,O
of,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Shenzhen,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
shi.zhao@link.cuhk.edu.hk,O
.,O
"
",O
(2)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
larry.zhuang@polyu.edu.hk,O
.,O
"
",O
(3)School,O
of,O
Public,O
Health,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
University,O
of,O
Hong,O
"
",O
Kong,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
jimran@connect.hku.hk,O
.,O
"
",O
(4)JC,O
School,O
of,O
Public,O
Health,O
and,O
Primary,O
Care,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
JiaerLIN@link.cuhk.edu.hk,O
.,O
"
",O
(5)Department,O
of,O
Orthopaedics,O
and,O
Traumatology,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
",",O
China,O
;,O
SH,O
Ho,O
Scoliosis,O
Research,O
Lab,O
",",O
Joint,O
Scoliosis,O
Research,O
Center,O
"
",O
of,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
and,O
Nanjing,O
University,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
kennethgpy@link.cuhk.edu.hk,O
.,O
"
",O
(6)School,O
of,O
Nursing,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
l.yang@polyu.edu.hk,O
.,O
"
",O
(7)Department,O
of,O
Applied,O
Mathematics,O
",",O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
Hong,O
"
",O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
daihai.he@polyu.edu.hk,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tmaid.2020.101568,O
"
",O
PMID,O
:,O
32006656,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
The,O
authors,O
"
",O
declared,O
no,O
competing,O
interests,O
.,O
"


",O
837,O
.,O
Life,O
Sci,O
.,O
2020,O
Mar,O
15;245:117386,O
.,O
doi,O
:,O
10.1016,O
j.lfs.2020.117386,O
.,O
Epub,O
2020,O
Jan,O
"
",O
30,O
.,O
"

",O
Inhibition,O
of,O
steroid,O
receptor,O
coactivator1,O
in,O
the,O
hippocampus,O
impairs,O
the,O
"
",O
consolidation,O
and,O
reconsolidation,O
of,O
contextual,O
fear,O
memory,O
in,O
mice,O
.,O
"

",O
Chen,O
X(1,O
),O
",",O
Tian,O
Y(1,O
),O
",",O
Zhu,O
H(2,O
),O
",",O
Bian,O
C(3,O
),O
",",O
Li,O
M(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Military,O
Psychology,O
",",O
College,O
of,O
Psychology,O
",",O
Army,O
Medical,O
"
",O
University,O
",",O
Chongqing,O
400038,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Neurology,O
",",O
Airborne,O
Military,O
Hospital,O
",",O
Chinese,O
People,O
's,O
"
",O
Liberation,O
Army,O
",",O
Wuhan,O
430014,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Military,O
Psychology,O
",",O
College,O
of,O
Psychology,O
",",O
Army,O
Medical,O
"
",O
University,O
",",O
Chongqing,O
400038,O
",",O
China,O
;,O
Department,O
of,O
Developmental,O
Psychology,O
of,O
"
",O
Army,O
man,O
",",O
College,O
of,O
Psychology,O
",",O
Army,O
Medical,O
University,O
",",O
Chongqing,O
400038,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
bc818@163.com,O
.,O
"
",O
(4)Department,O
of,O
Military,O
Psychology,O
",",O
College,O
of,O
Psychology,O
",",O
Army,O
Medical,O
"
",O
University,O
",",O
Chongqing,O
400038,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
limin52267@tmmu.edu.cn,O
.,O
"

",O
AIMS,O
:,O
Steroid,O
receptor,O
coactivator1,O
(,O
SRC1,O
),O
is,O
a,O
key,O
coactivator,O
for,O
the,O
"
",O
efficient,O
transcriptional,O
activity,O
of,O
steroids,O
in,O
the,O
regulation,O
of,O
hippocampal,O
"
",O
functions,O
.,O
However,O
",",O
the,O
effect,O
of,O
SRC1,O
on,O
hippocampal,O
memory,O
processes,O
remains,O
"
",O
unknown,O
.,O
Our,O
aim,O
was,O
to,O
investigate,O
the,O
roles,O
of,O
hippocampal,O
SRC1,O
in,O
the,O
"
",O
consolidation,O
and,O
reconsolidation,O
of,O
contextual,O
fear,O
memory,O
in,O
mice,O
.,O
"
",O
MAIN,O
METHODS,O
:,O
Contextual,O
fear,O
conditioning,O
paradigm,O
was,O
constructed,O
in,O
adult,O
male,O
"
",O
C57BL,O
6,O
mice,O
to,O
examine,O
the,O
fear,O
learning,O
and,O
memory,O
processes,O
.,O
Adenoassociated,O
"
",O
virus,O
(,O
AAV,O
),O
vectormediated,O
RNA,O
interference,O
(,O
RNAi,O
),O
was,O
infused,O
into,O
hippocampus,O
"
",O
to,O
block,O
hippocampal,O
SRC1,O
level,O
.,O
Immunofluorescent,O
staining,O
was,O
used,O
to,O
detect,O
"
",O
the,O
efficiency,O
of,O
transfection,O
.,O
High,O
plus,O
maze,O
and,O
open,O
field,O
test,O
were,O
used,O
to,O
"
",O
determine,O
anxiety,O
and,O
locomotor,O
activity,O
.,O
Western,O
blot,O
analyses,O
were,O
used,O
to,O
"
",O
detect,O
the,O
expression,O
of,O
SRC1,O
and,O
synaptic,O
proteins,O
in,O
the,O
hippocampus,O
.,O
"
",O
KEY,O
FINDINGS,O
:,O
We,O
first,O
showed,O
that,O
the,O
expression,O
of,O
SRC1,O
was,O
regulated,O
by,O
fear,O
"
",O
conditioning,O
training,O
in,O
a,O
timedependent,O
manner,O
",",O
and,O
knockdown,O
of,O
SRC1,O
impaired,O
"
",O
contextual,O
fear,O
memory,O
consolidation,O
without,O
affecting,O
innate,O
anxiety,O
or,O
"
",O
locomotor,O
activity,O
.,O
In,O
addition,O
",",O
hippocampal,O
SRC1,O
was,O
also,O
regulated,O
by,O
the,O
"
",O
retrieval,O
of,O
contextual,O
fear,O
memory,O
",",O
and,O
downregulation,O
of,O
SRC1,O
disrupted,O
fear,O
"
",O
memory,O
reconsolidation,O
.,O
Moreover,O
",",O
knockdown,O
of,O
SRC1,O
reversed,O
the,O
increased,O
GluR1,O
"
",O
and,O
PSD95,O
levels,O
induced,O
by,O
contextual,O
fear,O
memory,O
retrieval,O
.,O
"
",O
SIGNIFICANCE,O
:,O
Our,O
data,O
indicate,O
that,O
hippocampal,O
SRC1,O
is,O
required,O
for,O
the,O
"
",O
consolidation,O
and,O
reconsolidation,O
of,O
contextual,O
fear,O
memory,O
",",O
and,O
SRC1,O
may,O
be,O
a,O
"
",O
potential,O
therapeutic,O
target,O
for,O
mental,O
disorders,O
that,O
are,O
involved,O
in,O
"
",O
hippocampal,O
memory,O
dysfunction,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.lfs.2020.117386,O
"
",O
PMID,O
:,O
32006528,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
The,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
838,O
.,O
Plant,O
Sci,O
.,O
2020,O
Mar;292:110374,O
.,O
doi,O
:,O
10.1016,O
j.plantsci.2019.110374,O
.,O
Epub,O
2019,O
"
",O
Dec,O
13,O
.,O
"

",O
GbMPK3,O
overexpression,O
increases,O
cotton,O
sensitivity,O
to,O
Verticillium,O
dahliae,O
by,O
"
",O
regulating,O
salicylic,O
acid,O
signaling,O
.,O
"

",O
Long,O
L(1,O
),O
",",O
Xu,O
FC(2,O
),O
",",O
Zhao,O
JR(2,O
),O
",",O
Li,O
B(2,O
),O
",",O
Xu,O
L(3,O
),O
",",O
Gao,O
W(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Cotton,O
Biology,O
",",O
School,O
of,O
Life,O
Science,O
",",O
Henan,O
"
",O
University,O
",",O
Kaifeng,O
",",O
Henan,O
",",O
PR,O
China,O
;,O
State,O
Key,O
Laboratory,O
of,O
Crop,O
Stress,O
"
",O
Adaptation,O
and,O
Improvement,O
",",O
Henan,O
University,O
",",O
Kaifeng,O
",",O
Henan,O
",",O
PR,O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Cotton,O
Biology,O
",",O
School,O
of,O
Life,O
Science,O
",",O
Henan,O
"
",O
University,O
",",O
Kaifeng,O
",",O
Henan,O
",",O
PR,O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Biology,O
and,O
Genetic,O
Improvement,O
of,O
Oil,O
Crops,O
",",O
Oil,O
Crops,O
"
",O
Research,O
Institute,O
",",O
Chinese,O
Academy,O
of,O
Agricultural,O
Sciences,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
"
",O
430062,O
",",O
PR,O
China,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Cotton,O
Biology,O
",",O
School,O
of,O
Life,O
Science,O
",",O
Henan,O
"
",O
University,O
",",O
Kaifeng,O
",",O
Henan,O
",",O
PR,O
China,O
;,O
State,O
Key,O
Laboratory,O
of,O
Crop,O
Stress,O
"
",O
Adaptation,O
and,O
Improvement,O
",",O
Henan,O
University,O
",",O
Kaifeng,O
",",O
Henan,O
",",O
PR,O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
gaowei021@163.com,O
.,O
"

",O
The,O
soilborn,O
vascular,O
disease,O
Verticillium,O
wilt,O
",",O
which,O
is,O
caused,O
by,O
fungal,O
"
",O
pathogen,O
Verticillium,O
dahliae,O
",",O
is,O
a,O
devastating,O
disease,O
of,O
cotton,O
worldwide,O
.,O
In,O
"
",O
the,O
last,O
decade,O
",",O
a,O
large,O
number,O
of,O
genes,O
have,O
been,O
found,O
to,O
participate,O
in,O
"
",O
cottonV.,O
dahliae,O
interactions,O
",",O
but,O
the,O
detailed,O
mechanisms,O
of,O
cotton,O
resistance,O
"
",O
to,O
V.,O
dahliae,O
remain,O
unclear,O
.,O
Here,O
",",O
we,O
functionally,O
characterized,O
MPK3,O
",",O
a,O
MAPK,O
"
",O
gene,O
from,O
cotton,O
.,O
MPK3,O
was,O
induced,O
in,O
the,O
roots,O
of,O
both,O
resistant,O
and,O
susceptible,O
"
",O
cotton,O
cultivars,O
by,O
V.,O
dahliae,O
inoculation,O
.,O
Transgenic,O
cotton,O
and,O
tobacco,O
with,O
"
",O
constitutively,O
higher,O
GbMPK3,O
expression,O
conferred,O
higher,O
V.,O
dahliae,O
"
",O
susceptibility,O
",",O
while,O
MPK3,O
knockdown,O
in,O
cotton,O
has,O
limited,O
effect,O
on,O
cotton,O
"
",O
resistance,O
to,O
V.,O
dahliae,O
.,O
Expression,O
profiling,O
revealed,O
that,O
SAmediated,O
defense,O
"
",O
pathway,O
genes,O
(,O
WRKY70,O
",",O
PR1,O
",",O
and,O
PR5,O
),O
accumulated,O
after,O
V.,O
dahliae,O
inoculation,O
in,O
"
",O
roots,O
of,O
both,O
wildtype,O
and,O
transgenic,O
cotton,O
",",O
and,O
the,O
expression,O
levels,O
of,O
these,O
"
",O
genes,O
were,O
higher,O
in,O
GbMPK3overexpressing,O
plants,O
than,O
in,O
wildtype,O
plants,O
",",O
"
",O
indicating,O
that,O
GbMPK3,O
upregulation,O
may,O
reduce,O
plant,O
resistance,O
to,O
V.,O
dahliae,O
"
",O
through,O
regulating,O
salicylic,O
acid,O
signaling,O
transduction,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.plantsci.2019.110374,O
"
",O
PMID,O
:,O
32005380,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
All,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
839,O
.,O
Emerg,O
Microbes,O
Infect,O
.,O
2020,O
Dec;9(1):275277,O
.,O
doi,O
:,O
10.108,O
22221751.2020.1723441,O
.,O
"

",O
An,O
emerging,O
coronavirus,O
causing,O
pneumonia,O
outbreak,O
in,O
Wuhan,O
",",O
China,O
:,O
calling,O
for,O
"
",O
developing,O
therapeutic,O
and,O
prophylactic,O
strategies,O
.,O
"

",O
Jiang,O
S(1)(2,O
),O
",",O
Du,O
L(2,O
),O
",",O
Shi,O
Z(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Medical,O
Molecular,O
Virology,O
(,O
MOE,O
NHC,O
CAMS,O
),O
",",O
School,O
of,O
Basic,O
"
",O
Medical,O
Sciences,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)Lindsley,O
F.,O
Kimball,O
Research,O
Institute,O
",",O
New,O
York,O
Blood,O
Center,O
",",O
New,O
York,O
",",O
NY,O
",",O
"
",O
USA,O
.,O
"
",O
(3)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
Emerg,O
Microbes,O
Infect,O
.,O
2020,O
Dec;9(1):539,O
.,O
"

",O
DOI,O
:,O
10.108,O
22221751.2020.1723441,O
"
",O
PMCID,O
:,O
PMC7033706,O
"
",O
PMID,O
:,O
32005086,O
"


",O
840,O
.,O
Infect,O
Genet,O
Evol,O
.,O
2020,O
Apr;79:104212,O
.,O
doi,O
:,O
10.1016,O
j.meegid.2020.104212,O
.,O
Epub,O
"
",O
2020,O
Jan,O
29,O
.,O
"

",O
Fullgenome,O
evolutionary,O
analysis,O
of,O
the,O
novel,B-Virus_SARS-CoV-2
corona,I-Virus_SARS-CoV-2
virus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
rejects,O
"
",O
the,O
hypothesis,O
of,O
emergence,O
as,O
a,O
result,O
of,O
a,O
recent,O
recombination,O
event,O
.,O
"

",O
Paraskevis,O
D(1,O
),O
",",O
Kostaki,O
EG(2,O
),O
",",O
Magiorkinis,O
G(2,O
),O
",",O
Panayiotakopoulos,O
G(3,O
),O
",",O
"
",O
Sourvinos,O
G(4,O
),O
",",O
Tsiodras,O
S(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Hygiene,O
Epidemiology,O
and,O
Medical,O
Statistics,O
",",O
Medical,O
School,O
",",O
"
",O
National,O
and,O
Kapodistrian,O
University,O
of,O
Athens,O
",",O
Athens,O
",",O
Greece,O
.,O
Electronic,O
"
",O
address,O
:,O
dparask@med.uoa.gr,O
.,O
"
",O
(2)Department,O
of,O
Hygiene,O
Epidemiology,O
and,O
Medical,O
Statistics,O
",",O
Medical,O
School,O
",",O
"
",O
National,O
and,O
Kapodistrian,O
University,O
of,O
Athens,O
",",O
Athens,O
",",O
Greece,O
.,O
"
",O
(3)National,O
Public,O
Health,O
Organization,O
(,O
NPHO,O
),O
",",O
Athens,O
",",O
Greece,O
.,O
"
",O
(4)Laboratory,O
of,O
Clinical,O
Virology,O
",",O
School,O
of,O
Medicine,O
",",O
University,O
of,O
Crete,O
",",O
"
",O
Heraklion,O
",",O
Greece,O
.,O
"
",O
(5)Medical,O
School,O
",",O
National,O
and,O
Kapodistrian,O
University,O
of,O
Athens,O
",",O
Athens,O
",",O
"
",O
Greece,O
.,O
"

",O
BACKGROUND,O
:,O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
associated,O
with,O
human,O
to,O
human,O
"
",O
transmission,O
and,O
severe,O
human,O
infection,O
has,O
been,O
recently,O
reported,O
from,O
the,O
city,O
"
",O
of,O
Wuhan,O
in,O
China,O
.,O
Our,O
objectives,O
were,O
to,O
characterize,O
the,O
genetic,O
relationships,O
"
",O
of,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
and,O
to,O
search,O
for,O
putative,O
recombination,O
within,O
the,O
subgenus,O
of,O
"
",O
sarbecovirus,O
.,O
"
",O
METHODS,O
:,O
Putative,O
recombination,O
was,O
investigated,O
by,O
RDP4,O
and,O
Simplot,O
v3.5.1,O
and,O
"
",O
discordant,O
phylogenetic,O
clustering,O
in,O
individual,O
genomic,O
fragments,O
was,O
confirmed,O
"
",O
by,O
phylogenetic,O
analysis,O
using,O
maximum,O
likelihood,O
and,O
Bayesian,O
methods,O
.,O
"
",O
RESULTS,O
:,O
Our,O
analysis,O
suggests,O
that,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
although,O
closely,O
related,O
to,O
"
",O
BatCoV,O
RaTG13,O
sequence,O
throughout,O
the,O
genome,O
(,O
sequence,O
similarity,O
96.3,O
%,O
),O
",",O
shows,O
"
",O
discordant,O
clustering,O
with,O
the,O
Bat_SARSlike,O
coronavirus,O
sequences,O
.,O
Specifically,O
",",O
"
",O
in,O
the,O
5'part,O
spanning,O
the,O
first,O
11498,O
nucleotides,O
and,O
the,O
last,O
3'part,O
"
",O
spanning,O
2434130696,O
positions,O
",",O
2019nCoV,B-Virus_SARS-CoV-2
and,O
RaTG13,O
formed,O
a,O
single,O
cluster,O
"
",O
with,O
Bat_SARSlike,O
coronavirus,O
sequences,O
",",O
whereas,O
in,O
the,O
middle,O
region,O
spanning,O
"
",O
the,O
3'end,O
of,O
ORF1a,O
",",O
the,O
ORF1b,O
and,O
almost,O
half,O
of,O
the,O
spike,O
regions,O
",",O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
and,O
RaTG13,O
grouped,O
in,O
a,O
separate,O
distant,O
lineage,O
within,O
the,O
sarbecovirus,O
branch,O
.,O
"
",O
CONCLUSIONS,O
:,O
The,O
levels,O
of,O
genetic,O
similarity,O
between,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
and,O
RaTG13,O
"
",O
suggest,O
that,O
the,O
latter,O
does,O
not,O
provide,O
the,O
exact,O
variant,O
that,O
caused,O
the,O
"
",O
outbreak,O
in,O
humans,O
",",O
but,O
the,O
hypothesis,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
has,O
originated,O
from,O
bats,O
is,O
"
",O
very,O
likely,O
.,O
We,O
show,O
evidence,O
that,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCov,B-Virus_SARS-CoV-2
),O
is,O
"
",O
notmosaic,O
consisting,O
in,O
almost,O
half,O
of,O
its,O
genome,O
of,O
a,O
distinct,O
lineage,O
within,O
"
",O
the,O
betacoronavirus,O
.,O
These,O
genomic,O
features,O
and,O
their,O
potential,O
association,O
with,O
"
",O
virus,O
characteristics,O
and,O
virulence,O
in,O
humans,O
need,O
further,O
attention,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.meegid.2020.104212,O
"
",O
PMID,O
:,O
32004758,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
All,O
authors,O
"
",O
report,O
no,O
conflict,O
of,O
interest,O
related,O
to,O
the,O
submitted,O
work,O
.,O
"


",O
841,O
.,O
Infect,O
Genet,O
Evol,O
.,O
2020,O
Jan,O
28;81:104210,O
.,O
doi,O
:,O
10.1016,O
j.meegid.2020.104210,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Acarbose,O
",",O
as,O
a,O
potential,O
drug,O
",",O
effectively,O
blocked,O
the,O
dynamic,O
metastasis,O
of,O
EV71,O
"
",O
from,O
the,O
intestine,O
to,O
the,O
whole,O
body,O
.,O
"

",O
Feng,O
Q(1,O
),O
",",O
Zhou,O
H(2,O
),O
",",O
Zhang,O
X(3,O
),O
",",O
Liu,O
X(2,O
),O
",",O
Wang,O
J(2,O
),O
",",O
Zhang,O
C(2,O
),O
",",O
Ma,O
X(2,O
),O
",",O
Quan,O
"
",O
C(2,O
),O
",",O
Zheng,O
Z(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Otorhinolaryngology,O
Head,O
and,O
Neck,O
Surgery,O
",",O
The,O
First,O
Affiliated,O
"
",O
Hospital,O
of,O
Guangxi,O
Medical,O
University,O
",",O
Nanning,O
",",O
Guangxi,O
530021,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
430072,O
",",O
China,O
.,O
"
",O
(3)China,O
Animal,O
Health,O
and,O
Epidemiology,O
Center,O
",",O
Qingdao,O
",",O
Shandong,O
266032,O
",",O
China,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
430072,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
biochem@whu.edu.cn,O
.,O
"

",O
Enterovirus,O
71,O
(,O
EV71,O
),O
is,O
one,O
of,O
the,O
main,O
pathogens,O
causing,O
handfootandmouth,O
"
",O
disease,O
(,O
HFMD,O
),O
.,O
The,O
nose,O
and,O
mouth,O
are,O
usually,O
the,O
main,O
infection,O
entries,O
of,O
EV71,O
"
",O
virus,O
.,O
However,O
",",O
its,O
dynamic,O
transport,O
pathway,O
from,O
mouth,O
to,O
the,O
whole,O
body,O
"
",O
remains,O
unknown,O
.,O
The,O
reveal,O
of,O
this,O
physiological,O
mechanism,O
in,O
vivo,O
will,O
help,O
to,O
"
",O
understand,O
its,O
transport,O
direction,O
",",O
find,O
its,O
key,O
proliferation,O
nodes,O
",",O
and,O
develop,O
"
",O
new,O
preventive,O
strategies,O
.,O
We,O
trained,O
a,O
new,O
strain,O
of,O
GFPEV71,O
virus,O
to,O
be,O
"
",O
susceptible,O
to,O
mice,O
brain,O
by,O
intracranial,O
injection,O
of,O
mice,O
.,O
The,O
adapted,O
virus,O
"
",O
was,O
oraladministrated,O
to,O
suckling,O
mice,O
.,O
Then,O
",",O
the,O
dynamic,O
distributions,O
of,O
the,O
"
",O
virus,O
in,O
vivo,O
were,O
detected,O
by,O
living,O
image,O
system,O
and,O
fluorescence,O
quantitation,O
"
",O
polymerase,O
chain,O
reaction,O
(,O
qPCR,O
),O
.,O
We,O
figured,O
out,O
the,O
dynamic,O
pathway,O
of,O
EV71,O
"
",O
transport,O
in,O
vivo,O
from,O
intestine,O
to,O
peripheral,O
tissue,O
",",O
then,O
to,O
the,O
other,O
organs,O
.,O
"
",O
Small,O
intestine,O
was,O
identified,O
as,O
a,O
gateway,O
for,O
EV71,O
infection,O
in,O
vivo,O
.,O
Ileum,O
was,O
"
",O
proved,O
to,O
be,O
the,O
main,O
part,O
of,O
proliferation,O
and,O
transport,O
of,O
EV71,O
in,O
small,O
"
",O
intestine,O
of,O
mice,O
.,O
EV71,O
was,O
verified,O
to,O
enter,O
small,O
intestinal,O
villus,O
of,O
mice,O
"
",O
through,O
the,O
infection,O
of,O
small,O
intestinal,O
epithelial,O
cell,O
.,O
Acarbose,O
displayed,O
a,O
"
",O
good,O
preventive,O
effect,O
on,O
EV71,O
infection,O
both,O
in,O
vivo,O
and,O
in,O
vitro,O
.,O
Acarbose,O
"
",O
possibly,O
decreased,O
the,O
intestinal,O
infection,O
of,O
EV71,O
by,O
blocking,O
the,O
"
",O
receptorbinding,O
sites,O
on,O
the,O
surface,O
of,O
EV71,O
virion,O
or,O
by,O
inhibiting,O
various,O
"
",O
glycolic,O
receptors,O
on,O
the,O
cell,O
surface,O
.,O
Thus,O
",",O
acarbose,O
and,O
its,O
analogue,O
may,O
be,O
"
",O
the,O
potential,O
medicines,O
to,O
prevent,O
EV71,O
infection,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.meegid.2020.104210,O
"
",O
PMID,O
:,O
32004757,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
competing,O
interests,O
.,O
"


",O
842,O
.,O
Monoclon,O
Antib,O
Immunodiagn,O
Immunother,O
.,O
2020,O
Feb;39(1):1216,O
.,O
doi,O
:,O
"
",O
10.1089,O
mab.2019.0044,O
.,O
Epub,O
2020,O
Jan,O
31,O
.,O
"

",O
Production,O
and,O
Characterization,O
of,O
Monoclonal,O
Antibodies,O
Against,O
Gp,O
Protein,O
of,O
"
",O
Ebola,O
Virus,O
.,O
"

",O
Yu,O
M(1)(2,O
),O
",",O
Ye,O
J(1)(2,O
),O
",",O
Cao,O
S(1)(2,O
),O
",",O
Liu,O
X(3,O
),O
",",O
Chen,O
Z(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Aquatic,O
Animal,O
Medicine,O
",",O
College,O
of,O
Fisheries,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
The,O
DNA,O
fragment,O
encoding,O
predicted,O
main,O
antigenic,O
region,O
",",O
aa,O
1300,O
on,O
Gp,O
protein,O
"
",O
of,O
Ebola,O
virus,O
(,O
EBOV,O
),O
was,O
cloned,O
into,O
the,O
vector,O
pGEXKG,O
.,O
The,O
recombinant,O
"
",O
GSTtagged,O
Gp300,O
was,O
expressed,O
in,O
Escherichia,O
coli,O
BL21,O
(,O
DE3,O
),O
by,O
induction,O
with,O
"
",O
1,O
â€‰,O
mM,O
isopropyl1thiobdgalactoside,O
and,O
purified,O
by,O
dialysis,O
.,O
Four,O
monoclonal,O
"
",O
antibodies,O
(,O
mAbs,O
),O
named,O
1C4,O
",",O
2A3,O
",",O
2G7,O
",",O
and,O
2H9,O
against,O
Gp,O
protein,O
were,O
generated,O
"
",O
by,O
fusing,O
mouse,O
myeloma,O
cell,O
line,O
SP2,O
0,O
with,O
spleen,O
lymphocytes,O
from,O
Gp300,O
"
",O
proteinimmunized,O
mice,O
.,O
The,O
activity,O
of,O
the,O
mAbs,O
was,O
then,O
characterized,O
by,O
"
",O
enzymelinked,O
immunosorbent,O
assay,O
",",O
indirect,O
immunofluorescent,O
assays,O
(,O
IFA,O
),O
",",O
and,O
"
",O
western,O
blot,O
analysis,O
.,O
The,O
results,O
demonstrated,O
that,O
all,O
the,O
mAbs,O
showed,O
high,O
"
",O
specificity,O
and,O
sensitivity,O
in,O
IFA,O
and,O
in,O
western,O
blot,O
analysis,O
",",O
which,O
indicated,O
"
",O
that,O
these,O
mAbs,O
against,O
Gp,O
protein,O
of,O
EBOV,O
may,O
be,O
used,O
as,O
valuable,O
tools,O
for,O
"
",O
analysis,O
of,O
the,O
protein,O
functions,O
and,O
pathogenesis,O
of,O
EBOV,O
.,O
"

",O
DOI,O
:,O
10.1089,O
mab.2019.0044,O
"
",O
PMID,O
:,O
32004438,O
"


",O
843,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Mar,O
5;382(10):929936,O
.,O
doi,O
:,O
10.1056,O
NEJMoa2001191,O
.,O
Epub,O
2020,O
"
",O
Jan,O
31,O
.,O
"

",O
First,O
Case,O
of,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
in,O
the,O
United,O
States,O
.,O
"

",O
Holshue,O
ML(1,O
),O
",",O
DeBolt,O
C(1,O
),O
",",O
Lindquist,O
S(1,O
),O
",",O
Lofy,O
KH(1,O
),O
",",O
Wiesman,O
J(1,O
),O
",",O
Bruce,O
H(1,O
),O
",",O
"
",O
Spitters,O
C(1,O
),O
",",O
Ericson,O
K(1,O
),O
",",O
Wilkerson,O
S(1,O
),O
",",O
Tural,O
A(1,O
),O
",",O
Diaz,O
G(1,O
),O
",",O
Cohn,O
A(1,O
),O
",",O
"
",O
Fox,O
L(1,O
),O
",",O
Patel,O
A(1,O
),O
",",O
Gerber,O
SI(1,O
),O
",",O
Kim,O
L(1,O
),O
",",O
Tong,O
S(1,O
),O
",",O
Lu,O
X(1,O
),O
",",O
Lindstrom,O
S(1,O
),O
",",O
"
",O
Pallansch,O
MA(1,O
),O
",",O
Weldon,O
WC(1,O
),O
",",O
Biggs,O
HM(1,O
),O
",",O
Uyeki,O
TM(1,O
),O
",",O
Pillai,O
SK(1,O
),O
;,O
Washington,O
"
",O
State,O
2019nCoV,B-Virus_SARS-CoV-2
Case,O
Investigation,O
Team,O
.,O
"

",O
Collaborators,O
:,O
Harry,O
C,O
",",O
Boysun,O
M,O
",",O
Matheson,O
J,O
",",O
Russell,O
D,O
",",O
Hiatt,O
B,O
",",O
Podczervinski,O
"
",O
S,O
",",O
Lewis,O
L,O
",",O
Montgomery,O
P,O
",",O
Turnberg,O
W,O
",",O
Graff,O
NR,O
",",O
Dostal,O
TKH,O
",",O
Lam,O
EW,O
",",O
Chan,O
M,O
",",O
"
",O
Hawkins,O
V,O
",",O
Zimmerman,O
M,O
",",O
Wickersham,O
K,O
",",O
deGrauw,O
X,O
",",O
Peifer,O
K,O
",",O
Bevers,O
E,O
",",O
Fairfortune,O
"
",O
T,O
",",O
Midgley,O
CM,O
",",O
Kujawski,O
S,O
",",O
Schneider,O
E,O
",",O
Watson,O
JT,O
",",O
Hunter,O
J,O
",",O
Killerby,O
ME,O
",",O
Rha,O
B,O
",",O
"
",O
Oliver,O
S,O
",",O
Rolfes,O
M,O
",",O
Hall,O
A,O
",",O
Fry,O
A,O
",",O
Jernigan,O
D,O
",",O
Chu,O
V,O
",",O
Kirking,O
H,O
",",O
Queen,O
K,O
",",O
Tao,O
Y,O
",",O
"
",O
Li,O
Y,O
",",O
Paden,O
CR,O
",",O
Zhang,O
J.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Epidemic,O
Intelligence,O
Service,O
(,O
M.L.H.,O
),O
",",O
the,O
National,O
Center,O
for,O
"
",O
Immunizations,O
and,O
Respiratory,O
Diseases,O
(,O
A.C.,O
",",O
L.F.,O
",",O
A.P.,O
),O
",",O
the,O
Division,O
of,O
Viral,O
"
",O
Diseases,O
(,O
S.I.G.,O
",",O
L.K.,O
",",O
S.T.,O
",",O
X.L.,O
",",O
S.,O
Lindstrom,O
",",O
M.A.P.,O
",",O
W.C.W.,O
",",O
H.M.B.,O
),O
",",O
the,O
"
",O
Influenza,O
Division,O
(,O
T.M.U.,O
),O
",",O
and,O
the,O
Division,O
of,O
Preparedness,O
and,O
Emerging,O
"
",O
Infections,O
(,O
S.K.P.,O
),O
",",O
Centers,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Atlanta,O
;,O
and,O
the,O
"
",O
Washington,O
State,O
Department,O
of,O
Health,O
",",O
Shoreline,O
(,O
M.L.H.,O
",",O
C.D.,O
",",O
S.,O
Lindquist,O
",",O
"
",O
K.H.L.,O
",",O
J.W.,O
),O
",",O
Snohomish,O
Health,O
District,O
(,O
H.B.,O
",",O
C.S.,O
),O
",",O
Providence,O
Medical,O
Group,O
"
",O
(,O
K.E.,O
),O
",",O
and,O
Providence,O
Regional,O
Medical,O
Center,O
(,O
S.W.,O
",",O
A.T.,O
",",O
G.D.,O
),O
",",O
Everett,O
",",O
and,O
"
",O
Department,O
of,O
Medicine,O
",",O
University,O
of,O
Washington,O
School,O
of,O
Medicine,O
",",O
Seattle,O
"
",O
(,O
C.S.,O
),O
 ,O
all,O
in,O
Washington,O
.,O
"

",O
An,O
outbreak,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
that,O
began,O
in,O
Wuhan,O
",",O
China,O
",",O
has,O
"
",O
spread,O
rapidly,O
",",O
with,O
cases,O
now,O
confirmed,O
in,O
multiple,O
countries,O
.,O
We,O
report,O
the,O
"
",O
first,O
case,O
of,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
confirmed,O
in,O
the,O
United,O
States,O
and,O
describe,O
the,O
"
",O
identification,O
",",O
diagnosis,O
",",O
clinical,O
course,O
",",O
and,O
management,O
of,O
the,O
case,O
",",O
including,O
"
",O
the,O
patient,O
's,O
initial,O
mild,O
symptoms,O
at,O
presentation,O
with,O
progression,O
to,O
pneumonia,O
"
",O
on,O
day,O
9,O
of,O
illness,O
.,O
This,O
case,O
highlights,O
the,O
importance,O
of,O
close,O
coordination,O
"
",O
between,O
clinicians,O
and,O
public,O
health,O
authorities,O
at,O
the,O
local,O
",",O
state,O
",",O
and,O
federal,O
"
",O
levels,O
",",O
as,O
well,O
as,O
the,O
need,O
for,O
rapid,O
dissemination,O
of,O
clinical,O
information,O
"
",O
related,O
to,O
the,O
care,O
of,O
patients,O
with,O
this,O
emerging,O
infection,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Massachusetts,O
Medical,O
Society,O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMoa2001191,O
"
",O
PMID,O
:,O
32004427,O
"


",O
844,O
.,O
Chin,O
Med,O
J,O
(,O
Engl,O
),O
.,O
2020,O
Feb,O
11,O
.,O
doi,O
:,O
10.1097,O
CM9.0000000000000722,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Identification,O
of,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
causing,O
severe,O
pneumonia,O
in,O
human,O
:,O
a,O
"
",O
descriptive,O
study,O
.,O
"

",O
Ren,O
LL(1,O
),O
",",O
Wang,O
YM(2)(3,O
),O
",",O
Wu,O
ZQ(4,O
),O
",",O
Xiang,O
ZC(1,O
),O
",",O
Guo,O
L(1,O
),O
",",O
Xu,O
T(5,O
),O
",",O
Jiang,O
YZ(6,O
),O
",",O
"
",O
Xiong,O
Y(7,O
),O
",",O
Li,O
YJ(5,O
),O
",",O
Li,O
XW(8,O
),O
",",O
Li,O
H(9,O
),O
",",O
Fan,O
GH(2)(3)(9,O
),O
",",O
Gu,O
XY(2)(3)(9,O
),O
",",O
Xiao,O
"
",O
Y(1,O
),O
",",O
Gao,O
H(10,O
),O
",",O
Xu,O
JY(11,O
),O
",",O
Yang,O
F(4,O
),O
",",O
Wang,O
XM(1,O
),O
",",O
Wu,O
C(1,O
),O
",",O
Chen,O
L(1,O
),O
",",O
Liu,O
YW(1,O
),O
",",O
"
",O
Liu,O
B(4,O
),O
",",O
Yang,O
J(4,O
),O
",",O
Wang,O
XR(5,O
),O
",",O
Dong,O
J(4,O
),O
",",O
Li,O
L(4,O
),O
",",O
Huang,O
CL(12,O
),O
",",O
Zhao,O
JP(13,O
),O
",",O
"
",O
Hu,O
Y(14,O
),O
",",O
Cheng,O
ZS(15,O
),O
",",O
Liu,O
LL(6,O
),O
",",O
Qian,O
ZH(4,O
),O
",",O
Qin,O
C(10,O
),O
",",O
Jin,O
Q(4,O
),O
",",O
Cao,O
B(2)(3,O
),O
",",O
"
",O
Wang,O
JW(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Health,O
Commission,O
of,O
the,O
People,O
's,O
Republic,O
of,O
China,O
Key,O
Laboratory,O
of,O
"
",O
Systems,O
Biology,O
of,O
Pathogens,O
and,O
Christophe,O
MÃ©rieux,O
Laboratory,O
",",O
Institute,O
of,O
"
",O
Pathogen,O
Biology,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
&,O
Peking,O
Union,O
Medical,O
"
",O
College,O
",",O
Beijing,O
100730,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Center,O
of,O
Respiratory,O
"
",O
Medicine,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Respiratory,O
Diseases,O
",",O
ChinaJapan,O
"
",O
Friendship,O
Hospital,O
",",O
Beijing,O
100029,O
",",O
China,O
.,O
"
",O
(3)Institute,O
of,O
Respiratory,O
Medicine,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Peking,O
"
",O
Union,O
Medical,O
College,O
",",O
Beijing,O
100029,O
",",O
China,O
.,O
"
",O
(4)National,O
Health,O
Commission,O
of,O
the,O
People,O
's,O
Republic,O
of,O
China,O
Key,O
Laboratory,O
of,O
"
",O
Systems,O
Biology,O
of,O
Pathogens,O
",",O
Institute,O
of,O
Pathogen,O
Biology,O
",",O
Chinese,O
Academy,O
of,O
"
",O
Medical,O
Sciences,O
&,O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
100730,O
",",O
China,O
.,O
"
",O
(5)Vision,O
Medicals,O
Co.,O
",",O
Ltd,O
",",O
Guangzhou,O
",",O
Guangdong,O
510000,O
",",O
China,O
.,O
"
",O
(6)Hubei,O
Provincial,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Wuhan,O
",",O
Hubei,O
"
",O
430079,O
",",O
China,O
.,O
"
",O
(7)Wuhan,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Wuhan,O
",",O
Hubei,O
430022,O
",",O
China,O
.,O
"
",O
(8)Clinical,O
and,O
Research,O
Center,O
of,O
Infectious,O
Diseases,O
",",O
Beijing,O
Ditan,O
Hospital,O
",",O
"
",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
100015,O
",",O
China,O
.,O
"
",O
(9)Institute,O
of,O
Clinical,O
Medical,O
Sciences,O
",",O
ChinaJapan,O
Friendship,O
Hospital,O
",",O
"
",O
Beijing,O
100029,O
",",O
China,O
.,O
"
",O
(10)Institute,O
of,O
Laboratory,O
Animal,O
Science,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
&,O
"
",O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
100021,O
",",O
China,O
.,O
"
",O
(11)Department,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Tsinghua,O
University,O
School,O
of,O
Medicine,O
",",O
"
",O
Beijing,O
",",O
100084,O
",",O
China,O
.,O
"
",O
(12)Jin,O
Yintan,O
Hospital,O
of,O
Wuhan,O
",",O
Wuhan,O
",",O
Hubei,O
430022,O
",",O
China,O
.,O
"
",O
(13)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Sciences,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
"
",O
430030,O
",",O
China,O
.,O
"
",O
(14)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
Central,O
Hospital,O
of,O
"
",O
Wuhan,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
Hubei,O
430014,O
",",O
China,O
.,O
"
",O
(15)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
Hubei,O
430071,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
Human,O
infections,O
with,O
zoonotic,O
coronaviruses,O
(,O
CoVs,O
),O
",",O
including,O
severe,O
"
",O
acute,O
respiratory,O
syndrome,O
(SARS)CoV,O
and,O
Middle,O
East,O
respiratory,O
syndrome,O
"
",O
(MERS)CoV,O
",",O
have,O
raised,O
great,O
public,O
health,O
concern,O
globally,O
.,O
Here,O
",",O
we,O
report,O
a,O
"
",O
novel,O
batorigin,O
CoV,O
causing,O
severe,O
and,O
fatal,O
pneumonia,O
in,O
humans,O
.,O
"
",O
METHODS,O
:,O
We,O
collected,O
clinical,O
data,O
and,O
bronchoalveolar,O
lavage,O
(,O
BAL,O
),O
specimens,O
"
",O
from,O
five,O
patients,O
with,O
severe,O
pneumonia,O
from,O
Jin,O
Yintan,O
Hospital,O
of,O
Wuhan,O
",",O
"
",O
Hubei,O
province,O
",",O
China,O
.,O
Nucleic,O
acids,O
of,O
the,O
BAL,O
were,O
extracted,O
and,O
subjected,O
to,O
"
",O
nextgeneration,O
sequencing,O
.,O
Virus,O
isolation,O
was,O
carried,O
out,O
",",O
and,O
"
",O
maximumlikelihood,O
phylogenetic,O
trees,O
were,O
constructed,O
.,O
"
",O
RESULTS,O
:,O
Five,O
patients,O
hospitalized,O
from,O
December,O
18,O
to,O
December,O
29,O
",",O
2019,O
"
",O
presented,O
with,O
fever,O
",",O
cough,O
",",O
and,O
dyspnea,O
accompanied,O
by,O
complications,O
of,O
acute,O
"
",O
respiratory,O
distress,O
syndrome,O
.,O
Chest,O
radiography,O
revealed,O
diffuse,O
opacities,O
and,O
"
",O
consolidation,O
.,O
One,O
of,O
these,O
patients,O
died,O
.,O
Sequence,O
results,O
revealed,O
the,O
presence,O
"
",O
of,O
a,O
previously,O
unknown,O
Î²CoV,O
strain,O
in,O
all,O
five,O
patients,O
",",O
with,O
99.8,O
%,O
to,O
99.9,O
%,O
"
",O
nucleotide,O
identities,O
among,O
the,O
isolates,O
.,O
These,O
isolates,O
showed,O
79,O
%,O
nucleotide,O
"
",O
identity,O
with,O
the,O
sequence,O
of,O
SARSCoV,O
(,O
GenBank,O
NC_004718,O
),O
and,O
51.8,O
%,O
identity,O
"
",O
with,O
the,O
sequence,O
of,O
MERSCoV,O
(,O
GenBank,O
NC_019843,O
),O
.,O
The,O
virus,O
is,O
phylogenetically,O
"
",O
closest,O
to,O
a,O
bat,O
SARSlike,O
CoV,O
(,O
SLZC45,O
",",O
GenBank,O
MG772933,O
),O
with,O
87.6,O
%,O
to,O
87.7,O
%,O
"
",O
nucleotide,O
identity,O
",",O
but,O
is,O
in,O
a,O
separate,O
clade,O
.,O
Moreover,O
",",O
these,O
viruses,O
have,O
a,O
"
",O
single,O
intact,O
open,O
reading,O
frame,O
gene,O
8,O
",",O
as,O
a,O
further,O
indicator,O
of,O
batorigin,O
"
",O
CoVs,O
.,O
However,O
",",O
the,O
amino,O
acid,O
sequence,O
of,O
the,O
tentative,O
receptorbinding,O
domain,O
"
",O
resembles,O
that,O
of,O
SARSCoV,O
",",O
indicating,O
that,O
these,O
viruses,O
might,O
use,O
the,O
same,O
"
",O
receptor,O
.,O
"
",O
CONCLUSION,O
:,O
A,O
novel,O
batborne,O
CoV,O
was,O
identified,O
that,O
is,O
associated,O
with,O
severe,O
"
",O
and,O
fatal,O
respiratory,O
disease,O
in,O
humans,O
.,O
"

",O
DOI,O
:,O
10.1097,O
CM9.0000000000000722,O
"
",O
PMID,O
:,O
32004165,O
"


",O
845,O
.,O
Am,O
J,O
Respir,O
Crit,O
Care,O
Med,O
.,O
2020,O
Feb,O
15;201(4):P7P8,O
.,O
doi,O
:,O
10.1164,O
rccm.2014P7,O
.,O
"

",O
Novel,O
Wuhan,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
Coronavirus,O
.,O
"

",O
Carlos,O
WG,O
",",O
Dela,O
Cruz,O
CS,O
",",O
Cao,O
B,O
",",O
Pasnick,O
S,O
",",O
Jamil,O
S.,O
"

",O
DOI,O
:,O
10.1164,O
rccm.2014P7,O
"
",O
PMID,O
:,O
32004066,O
"


",O
846,O
.,O
Radiology,O
.,O
2020,O
Jan,O
31:200236,O
.,O
doi,O
:,O
10.1148,O
radiol.2020200236,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
CT,O
Imaging,O
of,O
the,O
2019,B-Virus_SARS-CoV-2
Novel,I-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
Pneumonia,O
.,O
"

",O
Lei,O
J(1,O
),O
",",O
Li,O
J(1,O
),O
",",O
Li,O
X(1,O
),O
",",O
Qi,O
X(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
Investigating,O
and,O
Research,O
Team,O
",",O
The,O
First,O
Hospital,O
of,O
"
",O
Lanzhou,O
University,O
",",O
1,O
Donggang,O
West,O
Rd,O
",",O
Lanzhou,O
730000,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1148,O
radiol.2020200236,O
"
",O
PMID,O
:,O
32003646,O
"


",O
847,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Mar,O
5;382(10):970971,O
.,O
doi,O
:,O
10.1056,O
NEJMc2001468,O
.,O
Epub,O
2020,O
"
",O
Jan,O
30,O
.,O
"

",O
Transmission,O
of,O
2019nCoV,B-Disease_COVID-19
Infection,I-Disease_COVID-19
from,O
an,O
Asymptomatic,O
Contact,O
in,O
Germany,O
.,O
"

",O
Rothe,O
C(1,O
),O
",",O
Schunk,O
M(1,O
),O
",",O
Sothmann,O
P(1,O
),O
",",O
Bretzel,O
G(1,O
),O
",",O
Froeschl,O
G(1,O
),O
",",O
Wallrauch,O
"
",O
C(1,O
),O
",",O
Zimmer,O
T(1,O
),O
",",O
Thiel,O
V(1,O
),O
",",O
Janke,O
C(1,O
),O
",",O
Guggemos,O
W(2,O
),O
",",O
Seilmaier,O
M(2,O
),O
",",O
Drosten,O
"
",O
C(3,O
),O
",",O
Vollmar,O
P(4,O
),O
",",O
Zwirglmaier,O
K(4,O
),O
",",O
Zange,O
S(4,O
),O
",",O
WÃ¶lfel,O
R(4,O
),O
",",O
Hoelscher,O
M(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)University,O
Hospital,O
LMU,O
Munich,O
",",O
Munich,O
",",O
Germany,O
rothe@lrz.unimuenchen.de,O
.,O
"
",O
(2)Klinikum,O
MÃ¼nchenSchwabing,O
",",O
Munich,O
",",O
Germany,O
.,O
"
",O
(3)CharitÃ©,O
UniversitÃ¤tsmedizin,O
Berlin,O
",",O
Berlin,O
",",O
Germany,O
.,O
"
",O
(4)Bundeswehr,O
Institute,O
of,O
Microbiology,O
",",O
Munich,O
",",O
Germany,O
.,O
"
",O
(5)University,O
Hospital,O
LMU,O
Munich,O
",",O
Munich,O
",",O
Germany,O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMc2001468,O
"
",O
PMID,O
:,O
32003551,O
"


",O
848,O
.,O
J,O
Recept,O
Signal,O
Transduct,O
Res,O
.,O
2020,O
Apr;40(2):126132,O
.,O
doi,O
:,O
"
",O
10.108,O
10799893.2020.1719416,O
.,O
Epub,O
2020,O
Jan,O
31,O
.,O
"

",O
ERK1,O
2PPARÎ³,O
pathway,O
is,O
involved,O
in,O
Chlamydia,O
pneumoniainduced,O
human,O
umbilical,O
"
",O
vein,O
endothelial,O
cell,O
apoptosis,O
through,O
increased,O
LOX1,O
expression,O
.,O
"

",O
Sun,O
S(1,O
),O
",",O
Duan,O
X(1,O
),O
",",O
Wu,O
Q(1,O
),O
",",O
He,O
Y(1,O
),O
",",O
Bu,O
X(1,O
),O
",",O
Ming,O
X(1,O
),O
",",O
Yan,O
F(1,O
),O
",",O
Zhu,O
H(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)General,O
Medicine,O
",",O
The,O
Central,O
Hospital,O
of,O
Wuhan,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"

",O
Chlamydia,O
pneumonia,O
(,O
C.pn,O
),O
is,O
a,O
common,O
respiratory,O
pathogen,O
that,O
is,O
involved,O
in,O
"
",O
human,O
cardiovascular,O
diseases,O
and,O
promotes,O
the,O
development,O
of,O
atherosclerosis,O
in,O
"
",O
hyperlipidemic,O
animal,O
models,O
.,O
C.pn,O
reportedly,O
upregulated,O
lectinlike,O
oxidized,O
"
",O
lowdensity,O
lipoprotein,O
receptor1,O
(,O
LOX1,O
),O
in,O
endothelial,O
cells,O
.,O
Recently,O
",",O
the,O
"
",O
antiatherosclerotic,O
activity,O
of,O
peroxisome,O
proliferatoractivated,O
receptor,O
Î³,O
"
",O
(,O
PPARÎ³,O
),O
has,O
been,O
documented,O
.,O
In,O
the,O
present,O
study,O
",",O
we,O
investigated,O
the,O
effect,O
of,O
"
",O
C.pn,O
on,O
LOX1,O
expression,O
in,O
human,O
umbilical,O
vein,O
endothelial,O
cells,O
(,O
HUVECs,O
),O
and,O
"
",O
identified,O
the,O
involvement,O
of,O
the,O
PPARÎ³,O
signaling,O
pathway,O
therein,O
.,O
The,O
results,O
"
",O
showed,O
that,O
C.pn,O
increased,O
the,O
expression,O
of,O
LOX1,O
in,O
HUVECs,O
in,O
a,O
dose,O
and,O
"
",O
timedependent,O
manner,O
.,O
C.pninduced,O
upregulation,O
of,O
LOX1,O
was,O
mediated,O
by,O
"
",O
ERK1,O
2,O
",",O
whereas,O
p38,O
MAPK,O
and,O
JNK,O
had,O
no,O
effect,O
on,O
this,O
process,O
.,O
C.pn,O
induced,O
"
",O
apoptosis,O
",",O
inhibited,O
cell,O
proliferation,O
",",O
and,O
decreased,O
the,O
expression,O
PPARÎ³,O
in,O
"
",O
HUVECs,O
.,O
Additionally,O
",",O
LOX1,O
activity,O
and,O
cell,O
injury,O
caused,O
by,O
C.pn,O
through,O
"
",O
activation,O
of,O
ERK1,O
2,O
was,O
completely,O
inhibited,O
by,O
rosiglitazone,O
",",O
a,O
PPARÎ³,O
agonist,O
.,O
"
",O
In,O
conclusion,O
",",O
we,O
inferred,O
that,O
activation,O
of,O
PPARÎ³,O
in,O
HUVECs,O
suppressed,O
"
",O
C.pninduced,O
LOX1,O
expression,O
and,O
cell,O
damage,O
by,O
inhibiting,O
ERK1,O
2,O
signaling,O
.,O
"

",O
DOI,O
:,O
10.108,O
10799893.2020.1719416,O
"
",O
PMID,O
:,O
32003295,O
"


",O
849,O
.,O
Eur,O
J,O
Clin,O
Invest,O
.,O
2020,O
Mar;50(3):e13209,O
.,O
doi,O
:,O
10.1111,O
eci.13209,O
.,O
Epub,O
2020,O
Feb,O
"
",O
5,O
.,O
"

",O
The,O
novel,O
Chinese,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
infections,O
:,O
Challenges,O
for,O
fighting,O
the,O
"
",O
storm,O
.,O
"

",O
Bassetti,O
M(1)(2,O
),O
",",O
Vena,O
A(1)(2,O
),O
",",O
Giacobbe,O
DR(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Health,O
Sciences,O
",",O
University,O
of,O
Genoa,O
",",O
Genoa,O
",",O
Italy,O
.,O
"
",O
(2)Clinica,O
Malattie,O
Infettive,O
",",O
Ospedale,O
Policlinico,O
San,O
MartinoIRCCS,O
",",O
Genoa,O
",",O
"
",O
Italy,O
.,O
"

",O
DOI,O
:,O
10.1111,O
eci.13209,O
"
",O
PMID,O
:,O
32003000,O
"


",O
850,O
.,O
Cell,O
Mol,O
Life,O
Sci,O
.,O
2020,O
Jan,O
30,O
.,O
doi,O
:,O
10.1007,O
s00018020034537,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Infection,O
and,O
atherosclerosis,O
:,O
TLRdependent,O
pathways,O
.,O
"

",O
Li,O
B(1,O
),O
",",O
Xia,O
Y(2,O
),O
",",O
Hu,O
B(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Neurology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Neurology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
xiayuanpeng@hust.edu.cn,O
.,O
"
",O
(3)Department,O
of,O
Neurology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
hubo@hust.edu.cn,O
.,O
"

",O
Atherosclerotic,O
vascular,O
disease,O
(,O
ASVD,O
),O
is,O
a,O
chronic,O
process,O
",",O
with,O
a,O
progressive,O
"
",O
course,O
over,O
many,O
years,O
",",O
but,O
it,O
can,O
cause,O
acute,O
clinical,O
events,O
",",O
including,O
acute,O
"
",O
coronary,O
syndromes,O
(,O
ACS,O
),O
",",O
myocardial,O
infarction,O
(,O
MI,O
),O
and,O
stroke,O
.,O
In,O
addition,O
to,O
a,O
"
",O
series,O
of,O
typical,O
risk,O
factors,O
for,O
atherosclerosis,O
",",O
like,O
hyperlipidemia,O
",",O
"
",O
hypertension,O
",",O
smoking,O
and,O
obesity,O
",",O
emerging,O
evidence,O
suggests,O
that,O
"
",O
atherosclerosis,O
is,O
a,O
chronic,O
inflammatory,O
disease,O
",",O
suggesting,O
that,O
chronic,O
"
",O
infection,O
plays,O
an,O
important,O
role,O
in,O
the,O
development,O
of,O
atherosclerosis,O
.,O
"
",O
Tolllike,O
receptors,O
(,O
TLRs,O
),O
are,O
the,O
most,O
characteristic,O
members,O
of,O
pattern,O
"
",O
recognition,O
receptors,O
(,O
PRRs,O
),O
",",O
which,O
play,O
an,O
important,O
role,O
in,O
innate,O
immune,O
"
",O
mechanism,O
.,O
TLRs,O
play,O
different,O
roles,O
in,O
different,O
stages,O
of,O
infection,O
of,O
"
",O
atherosclerosisrelated,O
pathogens,O
such,O
as,O
Chlamydia,O
pneumoniae,O
(,O
C.,O
pneumoniae,O
),O
",",O
"
",O
periodontal,O
pathogens,O
including,O
Porphyromonas,O
gingivalis,O
(,O
P.,O
gingivalis,O
),O
",",O
"
",O
Helicobacter,O
pylori,O
(,O
H.,O
pylori,O
),O
and,O
human,O
immunodeficiency,O
virus,O
(,O
HIV,O
),O
.,O
Overall,O
",",O
"
",O
activation,O
of,O
TLR2,O
and,O
4,O
seems,O
to,O
have,O
a,O
profound,O
impact,O
on,O
infectionrelated,O
"
",O
atherosclerosis,O
.,O
This,O
article,O
reviews,O
the,O
role,O
of,O
TLRs,O
in,O
the,O
process,O
of,O
"
",O
atherosclerosis,O
after,O
C.,O
pneumoniae,O
and,O
other,O
infections,O
and,O
the,O
current,O
status,O
"
",O
of,O
treatment,O
",",O
with,O
a,O
view,O
to,O
providing,O
a,O
new,O
direction,O
and,O
potential,O
therapeutic,O
"
",O
targets,O
for,O
the,O
study,O
of,O
ASVD,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00018020034537,O
"
",O
PMID,O
:,O
32002588,O
"


",O
851,O
.,O
J,O
Infect,O
.,O
2020,O
Mar;80(3):350371,O
.,O
doi,O
:,O
10.1016,O
j.jinf.2020.01.014,O
.,O
Epub,O
2020,O
Jan,O
"
",O
28,O
.,O
"

",O
Emergence,O
of,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
causing,O
respiratory,O
illness,O
from,O
Wuhan,O
",",O
China,O
.,O
"

",O
Tang,O
JW(1,O
),O
",",O
Tambyah,O
PA(2,O
),O
",",O
Hui,O
DSC(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Clinical,O
Microbiology,O
",",O
University,O
Hospitals,O
of,O
Leicester,O
NHS,O
Trust,O
",",O
Leicester,O
",",O
"
",O
United,O
Kingdom,O
;,O
Respiratory,O
Sciences,O
",",O
University,O
of,O
Leicester,O
",",O
Leicester,O
",",O
United,O
"
",O
Kingdom,O
.,O
Electronic,O
address,O
:,O
julian.tang@uhltr.nhs.uk,O
.,O
"
",O
(2)Department,O
of,O
Medicine,O
",",O
National,O
University,O
of,O
Singapore,O
",",O
Singapore,O
.,O
"
",O
(3)Department,O
of,O
Medicine,O
and,O
Therapeutics,O
",",O
The,O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
"
",O
Hong,O
Kong,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.jinf.2020.01.014,O
"
",O
PMID,O
:,O
32001309,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
the,O
following,O
financial,O
interests,O
personal,O
relationships,O
which,O
may,O
be,O
"
",O
considered,O
as,O
potential,O
competing,O
interests,O
.,O
"


",O
852,O
.,O
Biochim,O
Biophys,O
Acta,O
Biomembr,O
.,O
2020,O
May,O
1;1862(5):183205,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.bbamem.2020.183205,O
.,O
Epub,O
2020,O
Jan,O
28,O
.,O
"

",O
Idiopathic,O
pulmonary,O
fibrosis,O
is,O
associated,O
with,O
tight,O
junction,O
protein,O
"
",O
alterations,O
.,O
"

",O
Zou,O
J(1,O
),O
",",O
Li,O
Y(2,O
),O
",",O
Yu,O
J(3,O
),O
",",O
Dong,O
L(4,O
),O
",",O
Husain,O
AN(2,O
),O
",",O
Shen,O
L(5,O
),O
",",O
Weber,O
CR(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
"
",O
University,O
",",O
99,O
Zhangzhidong,O
Road,O
",",O
Wuhan,O
",",O
Hubei,O
430060,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pathology,O
",",O
University,O
of,O
Chicago,O
",",O
5841,O
S.,O
Maryland,O
Ave,O
.,O
",",O
"
",O
Chicago,O
",",O
IL,O
60637,O
",",O
United,O
States,O
of,O
America,O
.,O
"
",O
(3)Ningbo,O
College,O
of,O
Health,O
Sciences,O
",",O
Zhejiang,O
315100,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Animal,O
Nutrition,O
and,O
Feed,O
Science,O
",",O
College,O
of,O
Animal,O
Science,O
and,O
"
",O
Technology,O
",",O
Yangzhou,O
University,O
",",O
Jiangsu,O
Province,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Surgery,O
",",O
University,O
of,O
Chicago,O
",",O
5841,O
S.,O
Maryland,O
Ave,O
.,O
",",O
Chicago,O
",",O
"
",O
IL,O
60637,O
",",O
United,O
States,O
of,O
America,O
.,O
Electronic,O
address,O
:,O
leshen@uchospitals.edu,O
.,O
"
",O
(6)Department,O
of,O
Pathology,O
",",O
University,O
of,O
Chicago,O
",",O
5841,O
S.,O
Maryland,O
Ave,O
.,O
",",O
"
",O
Chicago,O
",",O
IL,O
60637,O
",",O
United,O
States,O
of,O
America,O
.,O
Electronic,O
address,O
:,O
"
",O
cweber@bsd.uchicago.edu,O
.,O
"

",O
Idiopathic,O
pulmonary,O
fibrosis,O
(,O
IPF,O
),O
is,O
a,O
chronic,O
disease,O
characterized,O
by,O
an,O
"
",O
abnormal,O
healing,O
response,O
to,O
injury,O
of,O
the,O
alveolar,O
epithelium,O
.,O
Tight,O
junctions,O
"
",O
provide,O
a,O
physical,O
barrier,O
at,O
the,O
apical,O
intercellular,O
space,O
between,O
epithelial,O
"
",O
cells,O
and,O
regulate,O
paracellular,O
flux,O
.,O
While,O
tight,O
junction,O
alterations,O
are,O
known,O
"
",O
to,O
contribute,O
to,O
barrier,O
dysfunction,O
in,O
a,O
number,O
of,O
disease,O
states,O
",",O
the,O
role,O
of,O
"
",O
tight,O
junction,O
proteins,O
in,O
IPF,O
is,O
poorly,O
defined,O
.,O
To,O
determine,O
a,O
potential,O
role,O
"
",O
for,O
tight,O
junction,O
protein,O
alterations,O
in,O
IPF,O
",",O
we,O
performed,O
immunohistochemical,O
"
",O
staining,O
for,O
tight,O
junction,O
proteins,O
ZO1,O
",",O
occludin,O
",",O
claudin2,O
",",O
claudin3,O
",",O
"
",O
claudin4,O
",",O
claudin5,O
",",O
and,O
claudin18,O
.,O
Staining,O
intensity,O
and,O
localization,O
were,O
"
",O
compared,O
between,O
IPF,O
and,O
control,O
lung,O
tissues,O
.,O
IPF,O
was,O
associated,O
with,O
type,O
II,O
"
",O
pneumocyte,O
hyperplasia,O
and,O
altered,O
tight,O
junction,O
protein,O
expression,O
.,O
While,O
there,O
"
",O
was,O
no,O
difference,O
in,O
the,O
expression,O
of,O
ZO1,O
",",O
claudin3,O
",",O
or,O
claudin5,O
",",O
between,O
IPF,O
"
",O
and,O
normal,O
control,O
",",O
there,O
was,O
an,O
overall,O
increase,O
in,O
claudin2,O
expression,O
in,O
"
",O
bronchiolar,O
and,O
alveolar,O
epithelium,O
and,O
a,O
decrease,O
in,O
claudin4,O
expression,O
in,O
"
",O
type,O
II,O
pneumocytes,O
.,O
There,O
was,O
also,O
increased,O
occludin,O
and,O
decreased,O
claudin18,O
"
",O
expression,O
in,O
pneumocytes,O
overlying,O
fibroblastic,O
foci,O
.,O
These,O
findings,O
suggest,O
"
",O
that,O
epithelial,O
barrier,O
alterations,O
may,O
be,O
important,O
to,O
the,O
pathogenesis,O
of,O
IPF,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.bbamem.2020.183205,O
"
",O
PMID,O
:,O
32001212,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
We,O
have,O
no,O
"
",O
conflicts,O
of,O
interest,O
.,O
"


",O
853,O
.,O
JAMA,O
.,O
2020,O
Jan,O
30,O
.,O
doi,O
:,O
10.1001,O
jama.2020.1097,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
Originating,O
in,O
Wuhan,O
",",O
China,O
:,O
Challenges,O
for,O
Global,O
Health,O
"
",O
Governance,O
.,O
"

",O
Phelan,O
AL(1)(2,O
),O
",",O
Katz,O
R(1,O
),O
",",O
Gostin,O
LO(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Center,O
for,O
Global,O
Health,O
Science,O
and,O
Security,O
",",O
Georgetown,O
University,O
",",O
"
",O
Washington,O
",",O
DC,O
.,O
"
",O
(2)O'Neill,O
Institute,O
for,O
National,O
and,O
Global,O
Health,O
Law,O
",",O
Georgetown,O
University,O
"
",O
Law,O
Center,O
",",O
Washington,O
",",O
DC,O
.,O
"

",O
DOI,O
:,O
10.1001,O
jama.2020.1097,O
"
",O
PMID,O
:,O
31999307,O
"


",O
854,O
.,O
J,O
Korean,O
Med,O
Sci,O
.,O
2020,O
Feb,O
3;35(4):e56,O
.,O
doi,O
:,O
10.3346,O
jkms.2020.35.e56,O
.,O
"

",O
The,O
Fight,O
against,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
Outbreak,O
:,O
an,O
Arduous,O
March,O
Has,O
Just,O
Begun,O
.,O
"

",O
Yoo,O
JH(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
College,O
of,O
"
",O
Medicine,O
",",O
The,O
Catholic,O
University,O
of,O
Korea,O
",",O
Seoul,O
",",O
Korea,O
.,O
"
",O
(2)Division,O
of,O
Infectious,O
Diseases,O
",",O
Department,O
of,O
Internal,O
Medicine,O
",",O
Bucheon,O
St.,O
"
",O
Mary,O
's,O
Hospital,O
",",O
Bucheon,O
",",O
Korea,O
.,O
jhyoo@catholic.ac.kr,O
.,O
"

",O
DOI,O
:,O
10.3346,O
jkms.2020.35.e56,O
"
",O
PMCID,O
:,O
PMC6995816,O
"
",O
PMID,O
:,O
31997618,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
author,O
has,O
no,O
potential,O
conflicts,O
of,O
interest,O
"
",O
to,O
disclose,O
.,O
"


",O
855,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Apr;92(4):448454,O
.,O
doi,O
:,O
10.1002,O
jmv.25693,O
.,O
Epub,O
2020,O
Feb,O
14,O
.,O
"

",O
Potential,O
of,O
large,O
"""",O
first,O
generation,O
"""",O
humantohuman,O
transmission,O
of,O
2019nCoV.,O
"

",O
Li,O
X(1,O
),O
",",O
Zai,O
J(2,O
),O
",",O
Wang,O
X(1,O
),O
",",O
Li,O
Y(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Hubei,O
Engineering,O
Research,O
Center,O
of,O
Viral,O
Vector,O
",",O
Wuhan,O
University,O
of,O
"
",O
Bioengineering,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Immunology,O
Innovation,O
Team,O
",",O
School,O
of,O
Medicine,O
",",O
Ningbo,O
University,O
",",O
Ningbo,O
",",O
"
",O
China,O
.,O
"

",O
To,O
investigate,O
the,O
genetic,O
diversity,O
",",O
time,O
origin,O
",",O
and,O
evolutionary,O
history,O
of,O
"
",O
the,O
2019nCoV,B-Virus_SARS-CoV-2
outbreak,O
in,O
China,O
and,O
Thailand,O
",",O
a,O
total,O
of,O
12,O
genome,O
sequences,O
of,O
"
",O
the,O
virus,O
with,O
known,O
sampling,O
date,O
(,O
24,O
December,O
2019,O
and,O
13,O
January,O
2020,O
),O
and,O
"
",O
geographic,O
location,O
(,O
primarily,O
Wuhan,O
city,O
",",O
Hubei,O
Province,O
",",O
China,O
",",O
but,O
also,O
"
",O
Bangkok,O
",",O
Thailand,O
),O
were,O
analyzed,O
.,O
Phylogenetic,O
and,O
likelihoodmapping,O
analyses,O
of,O
"
",O
these,O
genome,O
sequences,O
were,O
performed,O
.,O
On,O
the,O
basis,O
of,O
our,O
results,O
",",O
the,O
starlike,O
"
",O
signal,O
and,O
topology,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
may,O
be,O
indicative,O
of,O
potentially,O
large,O
"""",O
first,O
"
",O
generation,O
"""",O
humantohuman,O
virus,O
transmission,O
.,O
We,O
estimated,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
likely,O
"
",O
originated,O
in,O
Wuhan,O
on,O
9,O
November,O
2019,O
(,O
95,O
%,O
credible,O
interval,O
:,O
25,O
September,O
2019,O
"
",O
and,O
19,O
December,O
2019,O
),O
",",O
and,O
that,O
Wuhan,O
is,O
the,O
major,O
hub,O
for,O
the,O
spread,O
of,O
the,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
outbreak,O
in,O
China,O
and,O
elsewhere,O
.,O
Our,O
results,O
could,O
be,O
useful,O
for,O
"
",O
designing,O
effective,O
prevention,O
strategies,O
for,O
2019nCoV,B-Virus_SARS-CoV-2
in,O
China,O
and,O
beyond,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25693,O
"
",O
PMID,O
:,O
31997390,O
"


",O
856,O
.,O
Biosci,O
Trends,O
.,O
2020,O
Jan,O
28,O
.,O
doi,O
:,O
10.5582,O
bst.2020.01020,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Drug,O
treatment,O
options,O
for,O
the,O
2019new,O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
"

",O
Lu,O
H(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Scientific,O
Research,O
Center,O
",",O
Shanghai,O
Public,O
Health,O
Clinical,O
Center,O
",",O
Fudan,O
"
",O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Infectious,O
Diseases,O
",",O
Shanghai,O
Public,O
Health,O
Clinical,O
Center,O
",",O
"
",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Infectious,O
Disease,O
",",O
Huashan,O
Hospital,O
Affiliated,O
to,O
Fudan,O
"
",O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"

",O
As,O
of,O
January,O
22,O
",",O
2020,O
",",O
a,O
total,O
of,O
571,O
cases,O
of,O
the,O
2019new,O
coronavirus,O
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
have,O
been,O
reported,O
in,O
25,O
provinces,O
(,O
districts,O
and,O
cities,O
),O
in,O
China,O
.,O
"
",O
At,O
present,O
",",O
there,O
is,O
no,O
vaccine,O
or,O
antiviral,O
treatment,O
for,O
human,O
and,O
animal,O
"
",O
coronavirus,O
",",O
so,O
that,O
identifying,O
the,O
drug,O
treatment,O
options,O
as,O
soon,O
as,O
possible,O
"
",O
is,O
critical,O
for,O
the,O
response,O
to,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
outbreak,O
.,O
Three,O
general,O
methods,O
",",O
"
",O
which,O
include,O
existing,O
broadspectrum,O
antiviral,O
drugs,O
using,O
standard,O
assays,O
",",O
"
",O
screening,O
of,O
a,O
chemical,O
library,O
containing,O
many,O
existing,O
compounds,O
or,O
databases,O
",",O
"
",O
and,O
the,O
redevelopment,O
of,O
new,O
specific,O
drugs,O
based,O
on,O
the,O
genome,O
and,O
biophysical,O
"
",O
understanding,O
of,O
individual,O
coronaviruses,O
",",O
are,O
used,O
to,O
discover,O
the,O
potential,O
"
",O
antiviral,O
treatment,O
of,O
human,O
pathogen,O
coronavirus,O
.,O
Lopinavir,O
 ,O
Ritonavir,O
",",O
"
",O
Nucleoside,O
analogues,O
",",O
Neuraminidase,O
inhibitors,O
",",O
Remdesivir,O
",",O
peptide,O
(,O
EK1,O
),O
",",O
"
",O
arbidol,O
",",O
RNA,O
synthesis,O
inhibitors,O
(,O
such,O
as,O
TDF,O
",",O
3TC,O
),O
",",O
antiinflammatory,O
drugs,O
"
",O
(,O
such,O
as,O
hormones,O
and,O
other,O
molecules,O
),O
",",O
Chinese,O
traditional,O
medicine,O
",",O
such,O
"
",O
ShuFengJieDu,O
Capsules,O
and,O
Lianhuaqingwen,O
Capsule,O
",",O
could,O
be,O
the,O
drug,O
treatment,O
"
",O
options,O
for,O
2019nCoV.,O
However,O
",",O
the,O
efficacy,O
and,O
safety,O
of,O
these,O
drugs,O
for,O
2019,O
"
",O
nCoV,O
still,O
need,O
to,O
be,O
further,O
confirmed,O
by,O
clinical,O
experiments,O
.,O
"

",O
DOI,O
:,O
10.5582,O
bst.2020.01020,O
"
",O
PMID,O
:,O
31996494,O
"


",O
857,O
.,O
J,O
Immunol,O
.,O
2020,O
Mar,O
1;204(5):12871298,O
.,O
doi,O
:,O
10.4049,O
jimmunol.1900946,O
.,O
Epub,O
2020,O
"
",O
Jan,O
29,O
.,O
"

",O
The,O
Japanese,O
Encephalitis,O
Virus,O
NS1,O
',O
Protein,O
Inhibits,O
Type,O
I,O
IFN,O
Production,O
by,O
"
",O
Targeting,O
MAVS,O
.,O
"

",O
Zhou,O
D(1)(2)(3,O
),O
",",O
Li,O
Q(1)(2)(3,O
),O
",",O
Jia,O
F(4,O
),O
",",O
Zhang,O
L(1)(2)(3,O
),O
",",O
Wan,O
S(1)(2)(3,O
),O
",",O
Li,O
"
",O
Y(1)(2)(3,O
),O
",",O
Song,O
Y(1)(2)(3,O
),O
",",O
Chen,O
H(1)(2)(3,O
),O
",",O
Cao,O
S(1)(2)(3,O
),O
",",O
Ye,O
J(5)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)Laboratory,O
of,O
Animal,O
Virology,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(3)The,O
Cooperative,O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
People,O
's,O
Republic,O
of,O
China,O
;,O
and,O
.,O
"
",O
(4)Wuhan,O
Institute,O
of,O
Physics,O
and,O
Mathematics,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
"
",O
430070,O
",",O
Hubei,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(5)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
People,O
's,O
Republic,O
of,O
China,O
;,O
"
",O
yej@mail.hzau.edu.cn,O
.,O
"

",O
Japanese,O
encephalitis,O
virus,O
(,O
JEV,O
),O
is,O
a,O
mosquitoborne,O
Flavivirus,O
that,O
causes,O
"
",O
severe,O
neurologic,O
disease,O
in,O
humans,O
.,O
NS1,O
',O
is,O
a,O
NS1related,O
protein,O
only,O
reported,O
"
",O
in,O
the,O
Japanese,O
encephalitis,O
serogroup,O
members,O
of,O
Flavivirus,O
It,O
is,O
produced,O
"
",O
through,O
programmed,O
1,O
ribosomal,O
frameshift,O
in,O
NS2A,O
.,O
Our,O
previous,O
study,O
"
",O
demonstrated,O
that,O
JEV,O
NS1,O
',O
could,O
antagonize,O
type,O
I,O
IFN,O
(,O
IFNI,O
),O
production,O
",",O
but,O
"
",O
the,O
mechanism,O
is,O
still,O
unclear,O
.,O
In,O
the,O
current,O
study,O
",",O
we,O
found,O
that,O
JEV,O
NS1,O
',O
"
",O
inhibits,O
the,O
expression,O
of,O
MAVS,O
",",O
and,O
knockdown,O
of,O
MAVS,O
hampers,O
inhibition,O
of,O
"
",O
IFNÎ²,O
induction,O
by,O
NS1,O
',O
",",O
suggesting,O
that,O
JEV,O
NS1,O
',O
inhibits,O
IFNI,O
production,O
by,O
"
",O
targeting,O
MAVS,O
.,O
This,O
finding,O
is,O
further,O
supported,O
by,O
the,O
result,O
of,O
the,O
in,O
vivo,O
"
",O
assay,O
that,O
showed,O
the,O
similar,O
mortality,O
caused,O
by,O
NS1'deficient,O
virus,O
and,O
its,O
"
",O
wild,O
type,O
virus,O
in,O
MAVSdeficient,O
mice,O
.,O
Based,O
on,O
our,O
previous,O
sequencing,O
results,O
"
",O
of,O
noncoding,O
RNA,O
in,O
JEVinfected,O
cells,O
",",O
microRNA22,O
(,O
miR22,O
),O
was,O
identified,O
to,O
be,O
"
",O
a,O
key,O
regulator,O
for,O
MAVS,O
expression,O
during,O
JEV,O
infection,O
.,O
Furthermore,O
",",O
we,O
"
",O
demonstrated,O
that,O
JEV,O
NS1,O
',O
could,O
induce,O
the,O
expression,O
of,O
miR22,O
by,O
increasing,O
"
",O
the,O
binding,O
of,O
transcriptional,O
factors,O
",",O
CREB,O
and,O
cRel,O
",",O
to,O
the,O
promoter,O
elements,O
"
",O
of,O
miR22,O
.,O
Taken,O
together,O
",",O
our,O
results,O
reveal,O
a,O
novel,O
mechanism,O
by,O
which,O
JEV,O
NS1,O
',O
"
",O
antagonizes,O
host,O
MAVS,O
by,O
regulating,O
miR22,O
",",O
thereby,O
inhibiting,O
the,O
IFNI,O
"
",O
production,O
and,O
facilitating,O
viral,O
replication,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
by,O
The,O
American,O
Association,O
of,O
Immunologists,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.4049,O
jimmunol.1900946,O
"
",O
PMID,O
:,O
31996459,O
"


",O
858,O
.,O
J,O
Virol,O
.,O
2020,O
Jan,O
29,O
.,O
pii,O
:,O
JVI.0012720,O
.,O
doi,O
:,O
10.1128,O
JVI.0012720,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Receptor,O
recognition,O
by,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
from,O
Wuhan,O
:,O
An,O
analysis,O
based,O
on,O
"
",O
decadelong,O
structural,O
studies,O
of,O
SARS,O
.,O
"

",O
Wan,O
Y(1,O
),O
",",O
Shang,O
J(1,O
),O
",",O
Graham,O
R(2,O
),O
",",O
Baric,O
RS(2,O
),O
",",O
Li,O
F(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Veterinary,O
and,O
Biomedical,O
Sciences,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
University,O
of,O
Minnesota,O
",",O
Saint,O
Paul,O
",",O
MN,O
",",O
USA,O
.,O
"
",O
(2)Department,O
of,O
Epidemiology,O
",",O
University,O
of,O
North,O
Carolina,O
",",O
Chapel,O
Hill,O
",",O
NC,O
",",O
"
",O
USA,O
.,O
"
",O
(3)Department,O
of,O
Veterinary,O
and,O
Biomedical,O
Sciences,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
University,O
of,O
Minnesota,O
",",O
Saint,O
Paul,O
",",O
MN,O
",",O
USA,O
lifang@umn.edu,O
.,O
"

",O
Recently,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
has,O
emerged,O
from,O
Wuhan,O
",",O
China,O
",",O
causing,O
"
",O
symptoms,O
in,O
humans,O
similar,O
to,O
those,O
caused,O
by,O
SARS,O
coronavirus,O
(,O
SARSCoV,O
),O
.,O
Since,O
"
",O
SARSCoV,O
outbreak,O
in,O
2002,O
",",O
extensive,O
structural,O
analyses,O
have,O
revealed,O
key,O
"
",O
atomiclevel,O
interactions,O
between,O
SARSCoV,O
spike,O
protein,O
receptorbinding,O
domain,O
"
",O
(,O
RBD,O
),O
and,O
its,O
host,O
receptor,O
angiotensinconverting,O
enzyme,O
2,O
(,O
ACE2,O
),O
",",O
which,O
"
",O
regulate,O
both,O
the,O
crossspecies,O
and,O
humantohuman,O
transmissions,O
of,O
SARSCoV.,O
"
",O
Here,O
we,O
analyzed,O
the,O
potential,O
receptor,O
usage,O
by,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
based,O
on,O
the,O
rich,O
"
",O
knowledge,O
about,O
SARSCoV,O
and,O
the,O
newly,O
released,O
sequence,O
of,O
2019nCoV.,O
First,O
",",O
the,O
"
",O
sequence,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
RBD,O
",",O
including,O
its,O
receptorbinding,O
motif,O
(,O
RBM,O
),O
that,O
"
",O
directly,O
contacts,O
ACE2,O
",",O
is,O
similar,O
to,O
that,O
of,O
SARSCoV,O
",",O
strongly,O
suggesting,O
that,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
uses,O
ACE2,O
as,O
its,O
receptor,O
.,O
Second,O
",",O
several,O
critical,O
residues,O
in,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
RBM,O
(,O
particularly,O
Gln493,O
),O
provide,O
favorable,O
interactions,O
with,O
human,O
"
",O
ACE2,O
",",O
consistent,O
with,O
2019nCoV,B-Virus_SARS-CoV-2
's,O
capacity,O
for,O
human,O
cell,O
infection,O
.,O
Third,O
",",O
"
",O
several,O
other,O
critical,O
residues,O
in,O
2019nCoV,B-Virus_SARS-CoV-2
RBM,O
(,O
particularly,O
Asn501,O
),O
are,O
"
",O
compatible,O
with,O
",",O
but,O
not,O
ideal,O
for,O
",",O
binding,O
human,O
ACE2,O
",",O
suggesting,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
has,O
acquired,O
some,O
capacity,O
for,O
humantohuman,O
transmission,O
.,O
Last,O
",",O
while,O
"
",O
phylogenetic,O
analysis,O
indicates,O
a,O
bat,O
origin,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
2019nCoV,B-Virus_SARS-CoV-2
also,O
"
",O
potentially,O
recognizes,O
ACE2,O
from,O
a,O
diversity,O
of,O
animal,O
species,O
(,O
except,O
mice,O
and,O
"
",O
rats,O
),O
",",O
implicating,O
these,O
animal,O
species,O
as,O
possible,O
intermediate,O
hosts,O
or,O
animal,O
"
",O
models,O
for,O
2019nCoV,B-Virus_SARS-CoV-2
infections,O
.,O
These,O
analyses,O
provide,O
insights,O
into,O
the,O
"
",O
receptor,O
usage,O
",",O
cell,O
entry,O
",",O
host,O
cell,O
infectivity,O
and,O
animal,O
origin,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
"
",O
and,O
may,O
help,O
epidemic,O
surveillance,O
and,O
preventive,O
measures,O
against,O
"
",O
2019nCoV.SignificanceThe,O
recent,O
emergence,O
of,O
Wuhan,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
puts,O
"
",O
the,O
world,O
on,O
alert,O
.,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
reminiscent,O
of,O
the,O
SARSCoV,O
outbreak,O
in,O
"
",O
20022003,O
.,O
Our,O
decadelong,O
structural,O
studies,O
on,O
the,O
receptor,O
recognition,O
by,O
"
",O
SARSCoV,O
have,O
identified,O
key,O
interactions,O
between,O
SARSCoV,O
spike,O
protein,O
and,O
its,O
"
",O
host,O
receptor,O
angiotensinconverting,O
enzyme,O
2,O
(,O
ACE2,O
),O
",",O
which,O
regulate,O
both,O
the,O
"
",O
crossspecies,O
and,O
humantohuman,O
transmissions,O
of,O
SARSCoV.,O
One,O
of,O
the,O
goals,O
of,O
"
",O
SARSCoV,O
research,O
was,O
to,O
build,O
an,O
atomiclevel,O
iterative,O
framework,O
of,O
"
",O
virusreceptor,O
interactions,O
to,O
facilitate,O
epidemic,O
surveillance,O
",",O
predict,O
"
",O
speciesspecific,O
receptor,O
usage,O
",",O
and,O
identify,O
potential,O
animal,O
hosts,O
and,O
animal,O
"
",O
models,O
of,O
viruses,O
.,O
Based,O
on,O
the,O
sequence,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
spike,O
protein,O
",",O
we,O
apply,O
"
",O
this,O
predictive,O
framework,O
to,O
provide,O
novel,O
insights,O
into,O
the,O
receptor,O
usage,O
and,O
"
",O
likely,O
host,O
range,O
of,O
2019nCoV.,O
This,O
study,O
provides,O
a,O
robust,O
test,O
of,O
this,O
"
",O
reiterative,O
framework,O
",",O
providing,O
the,O
basic,O
",",O
translational,O
and,O
public,O
health,O
"
",O
research,O
communities,O
with,O
predictive,O
insights,O
that,O
may,O
help,O
study,O
and,O
battle,O
this,O
"
",O
novel,O
2019nCoV.,O
"

",O
Copyright,O
Â©,O
2020,O
American,O
Society,O
for,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1128,O
JVI.0012720,O
"
",O
PMID,O
:,O
31996437,O
"


",O
859,O
.,O
mSphere,O
.,O
2020,O
Jan,O
29;5(1,O
),O
.,O
pii,O
:,O
e0080719,O
.,O
doi,O
:,O
10.1128,O
mSphere.0080719,O
.,O
"

",O
Discovery,O
of,O
Bat,O
Coronaviruses,O
through,O
Surveillance,O
and,O
Probe,O
CaptureBased,O
"
",O
NextGeneration,O
Sequencing,O
.,O
"

",O
Li,O
B(#)(1,O
),O
",",O
Si,O
HR(#)(1)(2,O
),O
",",O
Zhu,O
Y(1,O
),O
",",O
Yang,O
XL(1,O
),O
",",O
Anderson,O
DE(3,O
),O
",",O
Shi,O
ZL(1,O
),O
",",O
Wang,O
"
",O
LF(4,O
),O
",",O
Zhou,O
P(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
"
",O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Programme,O
in,O
Emerging,O
Infectious,O
Diseases,O
",",O
DukeNUS,O
Medical,O
School,O
",",O
Singapore,O
",",O
"
",O
Singapore,O
.,O
"
",O
(4)Programme,O
in,O
Emerging,O
Infectious,O
Diseases,O
",",O
DukeNUS,O
Medical,O
School,O
",",O
Singapore,O
",",O
"
",O
Singapore,O
linfa.wang@dukenus.edu.sg,O
peng.zhou@wh.iov.cn,O
.,O
"
",O
(5)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
"
",O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
"
",O
linfa.wang@dukenus.edu.sg,O
peng.zhou@wh.iov.cn,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
Coronaviruses,O
(,O
CoVs,O
),O
of,O
bat,O
origin,O
have,O
caused,O
two,O
pandemics,O
in,O
this,O
century,O
.,O
"
",O
Severe,O
acute,O
respiratory,O
syndrome,O
(SARS)CoV,O
and,O
Middle,O
East,O
respiratory,O
syndrome,O
"
",O
(MERS)CoV,O
both,O
originated,O
from,O
bats,O
",",O
and,O
it,O
is,O
highly,O
likely,O
that,O
bat,O
"
",O
coronaviruses,O
will,O
cause,O
future,O
outbreaks,O
.,O
Active,O
surveillance,O
is,O
both,O
urgent,O
and,O
"
",O
essential,O
to,O
predict,O
and,O
mitigate,O
the,O
emergence,O
of,O
these,O
viruses,O
in,O
humans,O
.,O
"
",O
Nextgeneration,O
sequencing,O
(,O
NGS,O
),O
is,O
currently,O
the,O
preferred,O
methodology,O
for,O
virus,O
"
",O
discovery,O
to,O
ensure,O
unbiased,O
sequencing,O
of,O
bat,O
CoVs,O
",",O
considering,O
their,O
high,O
"
",O
genetic,O
diversity,O
.,O
However,O
",",O
unbiased,O
NGS,O
is,O
an,O
expensive,O
methodology,O
and,O
is,O
prone,O
"
",O
to,O
missing,O
lowabundance,O
CoV,O
sequences,O
due,O
to,O
the,O
high,O
background,O
level,O
of,O
"
",O
nonviral,O
sequences,O
present,O
in,O
surveillance,O
field,O
samples,O
.,O
Here,O
",",O
we,O
employ,O
a,O
"
",O
capturebased,O
NGS,O
approach,O
using,O
baits,O
targeting,O
most,O
of,O
the,O
CoV,O
species,O
.,O
Using,O
"
",O
this,O
technology,O
",",O
we,O
effectively,O
reduced,O
sequencing,O
costs,O
by,O
increasing,O
the,O
"
",O
sensitivity,O
of,O
detection,O
.,O
We,O
discovered,O
nine,O
full,O
genomes,O
of,O
bat,O
CoVs,O
in,O
this,O
"
",O
study,O
and,O
revealed,O
great,O
genetic,O
diversity,O
for,O
eight,O
of,O
them,O
.,O
IMPORTANCE,O
Active,O
"
",O
surveillance,O
is,O
both,O
urgent,O
and,O
essential,O
to,O
predict,O
and,O
mitigate,O
the,O
emergence,O
"
",O
of,O
batorigin,O
CoV,O
in,O
humans,O
and,O
livestock,O
.,O
However,O
",",O
great,O
genetic,O
diversity,O
"
",O
increases,O
the,O
chance,O
of,O
homologous,O
recombination,O
among,O
CoVs,O
.,O
Performing,O
targeted,O
"
",O
PCR,O
",",O
a,O
common,O
practice,O
for,O
many,O
surveillance,O
studies,O
",",O
would,O
not,O
reflect,O
this,O
"
",O
diversity,O
.,O
NGS,O
",",O
on,O
the,O
other,O
hand,O
",",O
is,O
an,O
expensive,O
methodology,O
and,O
is,O
prone,O
to,O
"
",O
missing,O
lowabundance,O
CoV,O
sequences,O
.,O
Here,O
",",O
we,O
employ,O
a,O
capturebased,O
NGS,O
approach,O
"
",O
using,O
baits,O
targeting,O
all,O
CoVs,O
.,O
Our,O
work,O
demonstrates,O
that,O
targeted,O
",",O
"
",O
costeffective,O
",",O
largescale,O
",",O
genomelevel,O
surveillance,O
of,O
bat,O
CoVs,O
is,O
now,O
highly,O
"
",O
feasible,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Li,O
et,O
al.,O
"

",O
DOI,O
:,O
10.1128,O
mSphere.0080719,O
"
",O
PMCID,O
:,O
PMC6992374,O
"
",O
PMID,O
:,O
31996413,O
"


",O
860,O
.,O
BMJ,O
.,O
2020,O
Jan,O
29;368:m351,O
.,O
doi,O
:,O
10.1136,O
bmj.m351,O
.,O
"

",O
Wuhan,O
:,O
Britons,O
to,O
be,O
evacuated,O
as,O
scientists,O
estimate,O
44,O
0,O
cases,O
of,O
2019nCOV,B-Virus_SARS-CoV-2
"
",O
in,O
the,O
city,O
.,O
"

",O
Parry,O
J(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Hamilton,O
",",O
Canada,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m351,O
"
",O
PMID,O
:,O
31996342,O
"


",O
861,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Jan,O
29,O
.,O
doi,O
:,O
10.1056,O
NEJMoa2001316,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Early,O
Transmission,O
Dynamics,O
in,O
Wuhan,O
",",O
China,O
",",O
of,O
Novel,O
CoronavirusInfected,O
"
",O
Pneumonia,O
.,O
"

",O
Li,O
Q(1,O
),O
",",O
Guan,O
X(1,O
),O
",",O
Wu,O
P(1,O
),O
",",O
Wang,O
X(1,O
),O
",",O
Zhou,O
L(1,O
),O
",",O
Tong,O
Y(1,O
),O
",",O
Ren,O
R(1,O
),O
",",O
Leung,O
"
",O
KSM(1,O
),O
",",O
Lau,O
EHY(1,O
),O
",",O
Wong,O
JY(1,O
),O
",",O
Xing,O
X(1,O
),O
",",O
Xiang,O
N(1,O
),O
",",O
Wu,O
Y(1,O
),O
",",O
Li,O
C(1,O
),O
",",O
Chen,O
"
",O
Q(1,O
),O
",",O
Li,O
D(1,O
),O
",",O
Liu,O
T(1,O
),O
",",O
Zhao,O
J(1,O
),O
",",O
Li,O
M(1,O
),O
",",O
Tu,O
W(1,O
),O
",",O
Chen,O
C(1,O
),O
",",O
Jin,O
L(1,O
),O
",",O
Yang,O
"
",O
R(1,O
),O
",",O
Wang,O
Q(1,O
),O
",",O
Zhou,O
S(1,O
),O
",",O
Wang,O
R(1,O
),O
",",O
Liu,O
H(1,O
),O
",",O
Luo,O
Y(1,O
),O
",",O
Liu,O
Y(1,O
),O
",",O
Shao,O
G(1,O
),O
",",O
"
",O
Li,O
H(1,O
),O
",",O
Tao,O
Z(1,O
),O
",",O
Yang,O
Y(1,O
),O
",",O
Deng,O
Z(1,O
),O
",",O
Liu,O
B(1,O
),O
",",O
Ma,O
Z(1,O
),O
",",O
Zhang,O
Y(1,O
),O
",",O
Shi,O
G(1,O
),O
",",O
"
",O
Lam,O
TTY(1,O
),O
",",O
Wu,O
JTK(1,O
),O
",",O
Gao,O
GF(1,O
),O
",",O
Cowling,O
BJ(1,O
),O
",",O
Yang,O
B(1,O
),O
",",O
Leung,O
GM(1,O
),O
",",O
Feng,O
"
",O
Z(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Beijing,O
(,O
Q.L.,O
",",O
"
",O
X.W.,O
",",O
L.Z.,O
",",O
R.R.,O
",",O
N.X.,O
",",O
C.L.,O
",",O
D.L.,O
",",O
J.Z.,O
",",O
W.T.,O
",",O
L.J.,O
",",O
Q.W.,O
",",O
R.W.,O
",",O
Y.Z.,O
",",O
G.,O
Shi,O
",",O
"
",O
G.F.G.,O
",",O
Z.F.,O
),O
",",O
the,O
Hubei,O
Provincial,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
"
",O
Wuhan,O
",",O
Hubei,O
(,O
X.G.,O
",",O
Y.T.,O
",",O
X.X.,O
",",O
Y.W.,O
",",O
Q.C.,O
",",O
M.L.,O
",",O
C.C.,O
",",O
R.Y.,O
",",O
S.Z.,O
",",O
Y.,O
Luo,O
",",O
"
",O
B.Y.,O
),O
",",O
the,O
World,O
Health,O
Organization,O
Collaborating,O
Centre,O
for,O
Infectious,O
Disease,O
"
",O
Epidemiology,O
and,O
Control,O
",",O
School,O
of,O
Public,O
Health,O
",",O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
"
",O
Kong,O
(,O
P.W.,O
",",O
K.S.M.L.,O
",",O
E.H.Y.L.,O
",",O
J.Y.W.,O
",",O
T.T.Y.L.,O
",",O
J.T.K.W.,O
",",O
B.J.C.,O
",",O
G.M.L.,O
),O
",",O
the,O
"
",O
Chinese,O
Field,O
Epidemiology,O
Training,O
Program,O
",",O
Chinese,O
Center,O
for,O
Disease,O
Control,O
"
",O
and,O
Prevention,O
",",O
Beijing,O
(,O
T.L.,O
",",O
R.Y.,O
",",O
S.Z.,O
",",O
H.,O
Liu,O
",",O
Y.,O
Liu,O
",",O
G.,O
Shao,O
",",O
H.,O
Li,O
",",O
Z.T.,O
),O
",",O
"
",O
the,O
Jingzhou,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Jingzhou,O
",",O
Hubei,O
(,O
T.L.,O
),O
",",O
"
",O
the,O
Chengdu,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Chengdu,O
",",O
Sichuan,O
(,O
H.,O
Liu,O
),O
;,O
"
",O
the,O
Hunan,O
Provincial,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Changsha,O
",",O
Hunan,O
"
",O
(,O
Y.,O
Liu,O
),O
",",O
the,O
Anyang,O
Municipal,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Anyang,O
",",O
"
",O
Henan,O
(,O
G.,O
Shao,O
),O
",",O
the,O
Panjin,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Panjin,O
",",O
"
",O
Liaoning,O
(,O
H.,O
Li,O
),O
",",O
the,O
Guizhou,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Guiyang,O
",",O
"
",O
Guizhou,O
(,O
Z.T.,O
),O
",",O
the,O
Jiading,O
District,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
"
",O
Shanghai,O
(,O
Y.Y.,O
),O
",",O
the,O
Nanchang,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
"
",O
Nanchang,O
",",O
Jiangxi,O
(,O
Z.D.,O
),O
",",O
the,O
Inner,O
Mongolia,O
Comprehensive,O
Center,O
for,O
Disease,O
"
",O
Control,O
and,O
Prevention,O
",",O
Hohhot,O
",",O
Inner,O
Mongolia,O
(,O
B.L.,O
),O
",",O
and,O
the,O
Baoshan,O
District,O
"
",O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Shanghai,O
(,O
Z.M.,O
),O
 ,O
all,O
in,O
China,O
.,O
"

",O
BACKGROUND,O
:,O
The,O
initial,O
cases,O
of,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(2019nCoV)infected,O
pneumonia,O
"
",O
(,O
NCIP,O
),O
occurred,O
in,O
Wuhan,O
",",O
Hubei,O
Province,O
",",O
China,O
",",O
in,O
December,O
2019,O
and,O
January,O
"
",O
2020,O
.,O
We,O
analyzed,O
data,O
on,O
the,O
first,O
425,O
confirmed,O
cases,O
in,O
Wuhan,O
to,O
determine,O
the,O
"
",O
epidemiologic,O
characteristics,O
of,O
NCIP,O
.,O
"
",O
METHODS,O
:,O
We,O
collected,O
information,O
on,O
demographic,O
characteristics,O
",",O
exposure,O
"
",O
history,O
",",O
and,O
illness,O
timelines,O
of,O
laboratoryconfirmed,O
cases,O
of,O
NCIP,O
that,O
had,O
"
",O
been,O
reported,O
by,O
January,O
22,O
",",O
2020,O
.,O
We,O
described,O
characteristics,O
of,O
the,O
cases,O
and,O
"
",O
estimated,O
the,O
key,O
epidemiologic,O
timedelay,O
distributions,O
.,O
In,O
the,O
early,O
period,O
of,O
"
",O
exponential,O
growth,O
",",O
we,O
estimated,O
the,O
epidemic,O
doubling,O
time,O
and,O
the,O
basic,O
"
",O
reproductive,O
number,O
.,O
"
",O
RESULTS,O
:,O
Among,O
the,O
first,O
425,O
patients,O
with,O
confirmed,O
NCIP,O
",",O
the,O
median,O
age,O
was,O
59,O
"
",O
years,O
and,O
56,O
%,O
were,O
male,O
.,O
The,O
majority,O
of,O
cases,O
(,O
55,O
%,O
),O
with,O
onset,O
before,O
January,O
1,O
",",O
"
",O
2020,O
",",O
were,O
linked,O
to,O
the,O
Huanan,O
Seafood,O
Wholesale,O
Market,O
",",O
as,O
compared,O
with,O
8.6,O
%,O
"
",O
of,O
the,O
subsequent,O
cases,O
.,O
The,O
mean,O
incubation,O
period,O
was,O
5.2,O
days,O
(,O
95,O
%,O
confidence,O
"
",O
interval,O
[,O
CI,O
],O
",",O
4.1,O
to,O
7,O
),O
",",O
with,O
the,O
95th,O
percentile,O
of,O
the,O
distribution,O
at,O
12.5,O
"
",O
days,O
.,O
In,O
its,O
early,O
stages,O
",",O
the,O
epidemic,O
doubled,O
in,O
size,O
every,O
7.4,O
days,O
.,O
With,O
a,O
"
",O
mean,O
serial,O
interval,O
of,O
7.5,O
days,O
(,O
95,O
%,O
CI,O
",",O
5.3,O
to,O
19,O
),O
",",O
the,O
basic,O
reproductive,O
"
",O
number,O
was,O
estimated,O
to,O
be,O
2.2,O
(,O
95,O
%,O
CI,O
",",O
1.4,O
to,O
3.9,O
),O
.,O
"
",O
CONCLUSIONS,O
:,O
On,O
the,O
basis,O
of,O
this,O
information,O
",",O
there,O
is,O
evidence,O
that,O
"
",O
humantohuman,O
transmission,O
has,O
occurred,O
among,O
close,O
contacts,O
since,O
the,O
middle,O
of,O
"
",O
December,O
2019,O
.,O
Considerable,O
efforts,O
to,O
reduce,O
transmission,O
will,O
be,O
required,O
to,O
"
",O
control,O
outbreaks,O
if,O
similar,O
dynamics,O
apply,O
elsewhere,O
.,O
Measures,O
to,O
prevent,O
or,O
"
",O
reduce,O
transmission,O
should,O
be,O
implemented,O
in,O
populations,O
at,O
risk,O
.,O
(,O
Funded,O
by,O
the,O
"
",O
Ministry,O
of,O
Science,O
and,O
Technology,O
of,O
China,O
and,O
others,O
.,O
),O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Massachusetts,O
Medical,O
Society,O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMoa2001316,O
"
",O
PMID,O
:,O
31995857,O
"


",O
862,O
.,O
Cell,O
Rep.,O
2020,O
Jan,O
28;30(4):10131026.e7,O
.,O
doi,O
:,O
10.1016,O
j.celrep.2019.12.023,O
.,O
"

",O
Chronic,O
Viral,O
Infection,O
Promotes,O
Efficient,O
Germinal,O
Center,O
B,O
Cell,O
Responses,O
.,O
"

",O
Fallet,O
B(1,O
),O
",",O
Hao,O
Y(2,O
),O
",",O
Florova,O
M(1,O
),O
",",O
Cornille,O
K(1,O
),O
",",O
de,O
Los,O
Aires,O
AV(3,O
),O
",",O
Girelli,O
"
",O
Zubani,O
G(3,O
),O
",",O
Ertuna,O
YI(1,O
),O
",",O
Greiff,O
V(4,O
),O
",",O
Menzel,O
U(5,O
),O
",",O
Hammad,O
K(6,O
),O
",",O
Merkler,O
D(6,O
),O
",",O
"
",O
Reddy,O
ST(5,O
),O
",",O
Weill,O
JC(3,O
),O
",",O
Reynaud,O
CA(3,O
),O
",",O
Pinschewer,O
DD(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Biomedicine,O
",",O
Division,O
of,O
Experimental,O
Virology,O
",",O
University,O
of,O
"
",O
Basel,O
",",O
Haus,O
Petersplatz,O
",",O
4009,O
Basel,O
",",O
Switzerland,O
.,O
"
",O
(2)Development,O
of,O
the,O
Immune,O
System,O
",",O
Institut,O
NeckerEnfants,O
Malades,O
",",O
Institut,O
"
",O
National,O
de,O
la,O
SantÃ©,O
et,O
de,O
la,O
Recherche,O
MÃ©dicale,O
",",O
U1151Centre,O
National,O
de,O
la,O
"
",O
Recherche,O
Scientifique,O
",",O
UMR,O
8253,O
",",O
FacultÃ©,O
de,O
MÃ©decine,O
Paris,O
Descartes,O
",",O
UniversitÃ©,O
"
",O
Paris,O
Descartes,O
",",O
Sorbonne,O
Paris,O
CitÃ©,O
",",O
Paris,O
",",O
France,O
;,O
Department,O
of,O
Pathogen,O
"
",O
Biology,O
",",O
School,O
of,O
Basic,O
Medicine,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Development,O
of,O
the,O
Immune,O
System,O
",",O
Institut,O
NeckerEnfants,O
Malades,O
",",O
Institut,O
"
",O
National,O
de,O
la,O
SantÃ©,O
et,O
de,O
la,O
Recherche,O
MÃ©dicale,O
",",O
U1151Centre,O
National,O
de,O
la,O
"
",O
Recherche,O
Scientifique,O
",",O
UMR,O
8253,O
",",O
FacultÃ©,O
de,O
MÃ©decine,O
Paris,O
Descartes,O
",",O
UniversitÃ©,O
"
",O
Paris,O
Descartes,O
",",O
Sorbonne,O
Paris,O
CitÃ©,O
",",O
Paris,O
",",O
France,O
.,O
"
",O
(4)Department,O
of,O
Biosystems,O
Science,O
and,O
Engineering,O
",",O
ETH,O
ZÃ¼rich,O
",",O
Basel,O
",",O
"
",O
Switzerland,O
;,O
Department,O
of,O
Immunology,O
",",O
University,O
of,O
Oslo,O
",",O
Oslo,O
",",O
Norway,O
.,O
"
",O
(5)Department,O
of,O
Biosystems,O
Science,O
and,O
Engineering,O
",",O
ETH,O
ZÃ¼rich,O
",",O
Basel,O
",",O
"
",O
Switzerland,O
.,O
"
",O
(6)Department,O
of,O
Pathology,O
and,O
Immunology,O
",",O
Division,O
of,O
Clinical,O
Pathology,O
",",O
"
",O
University,O
&,O
University,O
Hospital,O
of,O
Geneva,O
",",O
Geneva,O
",",O
Switzerland,O
.,O
"
",O
(7)Department,O
of,O
Biomedicine,O
",",O
Division,O
of,O
Experimental,O
Virology,O
",",O
University,O
of,O
"
",O
Basel,O
",",O
Haus,O
Petersplatz,O
",",O
4009,O
Basel,O
",",O
Switzerland,O
.,O
Electronic,O
address,O
:,O
"
",O
daniel.pinschewer@unibas.ch,O
.,O
"

",O
Persistent,O
viral,O
infections,O
subvert,O
key,O
elements,O
of,O
adaptive,O
immunity,O
.,O
To,O
compare,O
"
",O
germinal,O
center,O
(,O
GC,O
),O
B,O
cell,O
responses,O
in,O
chronic,O
and,O
acute,O
lymphocytic,O
"
",O
choriomeningitis,O
virus,O
infection,O
",",O
we,O
exploit,O
activationinduced,O
deaminase,O
(,O
AID,O
),O
"
",O
fatereporter,O
mice,O
and,O
perform,O
adoptive,O
B,O
cell,O
transfer,O
experiments,O
.,O
Chronic,O
"
",O
infection,O
yields,O
GC,O
B,O
cell,O
responses,O
of,O
higher,O
cellularity,O
than,O
acute,O
infections,O
"
",O
do,O
",",O
higher,O
memory,O
B,O
cell,O
and,O
antibody,O
secreting,O
cell,O
output,O
for,O
longer,O
periods,O
of,O
"
",O
time,O
",",O
a,O
better,O
representation,O
of,O
the,O
late,O
B,O
cell,O
repertoire,O
in,O
serum,O
"
",O
immunoglobulin,O
",",O
and,O
higher,O
titers,O
of,O
protective,O
neutralizing,O
antibodies,O
.,O
GC,O
B,O
"
",O
cells,O
of,O
chronically,O
infected,O
mice,O
are,O
similarly,O
hypermutated,O
as,O
those,O
emerging,O
"
",O
from,O
acute,O
infection,O
.,O
They,O
efficiently,O
adapt,O
to,O
viral,O
escape,O
variants,O
and,O
even,O
in,O
"
",O
hypermutationimpaired,O
AID,O
mutant,O
mice,O
",",O
chronic,O
infection,O
selects,O
for,O
GC,O
B,O
cells,O
"
",O
with,O
hypermutated,O
B,O
cell,O
receptors,O
(,O
BCRs,O
),O
and,O
neutralizing,O
antibody,O
formation,O
.,O
"
",O
These,O
findings,O
demonstrate,O
that,O
",",O
unlike,O
for,O
CD8,O
+,O
T,O
Â ,O
cells,O
",",O
chronic,O
viral,O
infection,O
"
",O
drives,O
a,O
functional,O
",",O
productive,O
",",O
and,O
protective,O
GC,O
B,O
cell,O
response,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
The,O
Authors,O
.,O
Published,O
by,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.celrep.2019.12.023,O
"
",O
PMCID,O
:,O
PMC6996002,O
"
",O
PMID,O
:,O
31995746,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Interests,O
D.D.P.,O
is,O
a,O
founder,O
",",O
"
",O
shareholder,O
",",O
and,O
consultant,O
and,O
serves,O
as,O
chief,O
scientific,O
officer,O
of,O
Hookipa,O
"
",O
Pharma,O
Inc.,O
",",O
which,O
is,O
commercializing,O
arenavirusbased,O
vector,O
technology,O
.,O
D.M.,O
"
",O
and,O
D.D.P.,O
are,O
inventors,O
on,O
patents,O
describing,O
arenavirusbased,O
vector,O
"
",O
technology,O
.,O
The,O
remaining,O
authors,O
declare,O
no,O
competing,O
interests,O
.,O
"


",O
863,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Apr;92(4):441447,O
.,O
doi,O
:,O
10.1002,O
jmv.25689,O
.,O
Epub,O
2020,O
Feb,O
12,O
.,O
"

",O
Updated,O
understanding,O
of,O
the,O
outbreak,O
of,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
in,O
"
",O
Wuhan,O
",",O
China,O
.,O
"

",O
Wang,O
W(1)(2,O
),O
",",O
Tang,O
J(3,O
),O
",",O
Wei,O
F(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Hepatobiliary,O
and,O
Pancreatic,O
Surgery,O
",",O
Zhejiang,O
Provincial,O
"
",O
People,O
's,O
Hospital,O
",",O
Hangzhou,O
Medical,O
College,O
",",O
Hangzhou,O
",",O
Zhejiang,O
",",O
China,O
.,O
"
",O
(2)Second,O
Clinical,O
Medical,O
College,O
",",O
Zhejiang,O
Chinese,O
Medical,O
University,O
",",O
"
",O
Hangzhou,O
",",O
Zhejiang,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Radiation,O
Oncology,O
",",O
Zhejiang,O
Provincial,O
People,O
's,O
Hospital,O
",",O
"
",O
Hangzhou,O
Medical,O
College,O
",",O
Hangzhou,O
",",O
Zhejiang,O
",",O
China,O
.,O
"

",O
To,O
help,O
health,O
workers,O
and,O
the,O
public,O
recognize,O
and,O
deal,O
with,O
the,O
2019,O
novel,O
"
",O
coronavirus,O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
quickly,O
",",O
effectively,O
",",O
and,O
calmly,O
with,O
an,O
updated,O
"
",O
understanding,O
.,O
A,O
comprehensive,O
search,O
from,O
Chinese,O
and,O
worldwide,O
official,O
"
",O
websites,O
and,O
announcements,O
was,O
performed,O
between,O
1,O
December,O
2019,O
and,O
0.395833333,O
am,O
26,O
"
",O
January,O
2020,O
(,O
Beijing,O
time,O
),O
.,O
A,O
latest,O
summary,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
and,O
the,O
current,O
"
",O
outbreak,O
was,O
drawn,O
.,O
Up,O
to,O
24,O
pm,O
",",O
25,O
January,O
2020,O
",",O
a,O
total,O
of,O
1975,O
cases,O
of,O
"
",O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
were,O
confirmed,O
in,O
mainland,O
China,O
with,O
a,O
total,O
of,O
56,O
deaths,O
"
",O
having,O
occurred,O
.,O
The,O
latest,O
mortality,O
was,O
approximately,O
2.84,O
%,O
with,O
a,O
total,O
of,O
"
",O
2684,O
cases,O
still,O
suspected,O
.,O
The,O
China,O
National,O
Health,O
Commission,O
reported,O
the,O
"
",O
details,O
of,O
the,O
first,O
17,O
deaths,O
up,O
to,O
24,O
pm,O
",",O
22,O
January,O
2020,O
.,O
The,O
deaths,O
included,O
"
",O
13,O
males,O
and,O
4,O
females,O
.,O
The,O
median,O
age,O
of,O
the,O
people,O
who,O
died,O
was,O
75,O
(,O
range,O
"
",O
4889,O
),O
years,O
.,O
Fever,O
(,O
64.7,O
%,O
),O
and,O
cough,O
(,O
52.9,O
%,O
),O
were,O
the,O
most,O
common,O
first,O
symptoms,O
"
",O
among,O
those,O
who,O
died,O
.,O
The,O
median,O
number,O
of,O
days,O
from,O
the,O
occurence,O
of,O
the,O
first,O
"
",O
symptom,O
to,O
death,O
was,O
14,O
(,O
range,O
641,O
),O
days,O
",",O
and,O
it,O
tended,O
to,O
be,O
shorter,O
among,O
"
",O
people,O
aged,O
70,O
years,O
or,O
more,O
(,O
11.5,O
[,O
range,O
619,O
],O
days,O
),O
than,O
those,O
aged,O
less,O
than,O
"
",O
70,O
years,O
(,O
20,O
[,O
range,O
1041,O
],O
days,O
;,O
P,O
â€‰,O
=,O
â€‰,O
0.033,O
),O
.,O
The,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
is,O
spreading,O
"
",O
and,O
its,O
incidence,O
is,O
increasing,O
nationwide,O
.,O
The,O
first,O
deaths,O
occurred,O
mostly,O
in,O
"
",O
elderly,O
people,O
",",O
among,O
whom,O
the,O
disease,O
might,O
progress,O
faster,O
.,O
The,O
public,O
should,O
"
",O
still,O
be,O
cautious,O
in,O
dealing,O
with,O
the,O
virus,O
and,O
pay,O
more,O
attention,O
to,O
protecting,O
"
",O
the,O
elderly,O
people,O
from,O
the,O
virus,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25689,O
"
",O
PMID,O
:,O
31994742,O
"


",O
864,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Jan,O
29,O
.,O
doi,O
:,O
10.1002,O
jmv.25691,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
The,O
construction,O
of,O
a,O
new,O
oncolytic,O
herpes,O
simplex,O
virus,O
expressing,O
murine,O
"
",O
interleukin15,O
with,O
geneediting,O
technology,O
.,O
"

",O
Cai,O
L(1,O
),O
",",O
Hu,O
H(1,O
),O
",",O
Duan,O
H(1,O
),O
",",O
Li,O
Y(1,O
),O
",",O
Zou,O
Z(1,O
),O
",",O
Luo,O
K(1,O
),O
",",O
Zhang,O
Z(1,O
),O
",",O
Yang,O
J(1,O
),O
",",O
"
",O
Jin,O
J(1,O
),O
",",O
Chen,O
Y(2,O
),O
",",O
Ke,O
Z(3,O
),O
",",O
Fang,O
Z(3,O
),O
",",O
Liu,O
Q(2,O
),O
",",O
Hong,O
X(2,O
),O
",",O
Hu,O
S(4)(5,O
),O
",",O
Liu,O
"
",O
B(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
"""",O
111,O
"""",O
Center,O
for,O
Cellular,O
Regulation,O
and,O
Molecular,O
Pharmaceutics,O
",",O
Key,O
"
",O
Laboratory,O
of,O
Fermentation,O
Engineering,O
(,O
Ministry,O
of,O
Education,O
),O
",",O
Hubei,O
Provincial,O
"
",O
Cooperative,O
Innovation,O
Center,O
of,O
Industrial,O
Fermentation,O
",",O
College,O
of,O
"
",O
Bioengineering,O
",",O
Hubei,O
University,O
of,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Wuhan,O
Binhui,O
Biotechnology,O
Co.,O
Ltd.,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Hubei,O
University,O
of,O
Science,O
and,O
Technology,O
Xianning,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(4)Hubei,O
Cancer,O
Hospital,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(5)Huazhong,O
Agricultural,O
University,O
(,O
HZAU,O
),O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
The,O
treatment,O
of,O
tumors,O
with,O
oncolytic,O
viruses,O
is,O
an,O
important,O
cancer,O
"
",O
immunotherapy,O
strategy,O
.,O
Interleukin15,O
(,O
IL15,O
),O
can,O
enhance,O
the,O
antitumor,O
effect,O
"
",O
of,O
natural,O
killer,O
cells,O
and,O
T,O
cells,O
.,O
An,O
oncolytic,O
herpes,O
simplex,O
type,O
II,O
virus,O
"
",O
(,O
oHSV2mIL15CherryFP,O
),O
expressing,O
mouse,O
IL15,O
was,O
constructed,O
using,O
the,O
"
",O
CRISPR,O
Cas9,O
system,O
",",O
and,O
its,O
antitumor,O
activity,O
in,O
vitro,O
and,O
in,O
vivo,O
was,O
"
",O
evaluated,O
.,O
In,O
vitro,O
",",O
the,O
mouse,O
interleukin15,O
(,O
mIL15,O
),O
present,O
in,O
the,O
culture,O
"
",O
supernatant,O
expressed,O
by,O
oHSV2mIL15CherryFP,O
was,O
able,O
to,O
enhance,O
the,O
killing,O
of,O
"
",O
CT26GFP,O
tumor,O
cells,O
by,O
T,O
cells,O
.,O
In,O
addition,O
",",O
the,O
intratumoral,O
injection,O
of,O
"
",O
oHSV2mIL15CherryFP,O
inhibited,O
tumor,O
growth,O
in,O
the,O
CT26iRFP,O
and,O
BGC823iRFP,O
"
",O
model,O
.,O
These,O
results,O
indicate,O
that,O
the,O
use,O
of,O
oncolytic,O
herpes,O
simplex,O
virus,O
"
",O
expressing,O
IL15,O
may,O
be,O
a,O
potential,O
therapeutic,O
strategy,O
in,O
tumor,O
immunotherapy,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25691,O
"
",O
PMID,O
:,O
31994741,O
"


",O
865,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Apr;92(4):455459,O
.,O
doi,O
:,O
10.1002,O
jmv.25688,O
.,O
Epub,O
2020,O
Feb,O
7,O
.,O
"

",O
The,O
2019new,O
coronavirus,O
epidemic,O
:,O
Evidence,O
for,O
virus,O
evolution,O
.,O
"

",O
Benvenuto,O
D(1,O
),O
",",O
Giovanetti,O
M(2,O
),O
",",O
Ciccozzi,O
A(1,O
),O
",",O
Spoto,O
S(3,O
),O
",",O
Angeletti,O
S(4,O
),O
",",O
"
",O
Ciccozzi,O
M(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Unit,O
of,O
Medical,O
Statistics,O
and,O
Molecular,O
Epidemiology,O
",",O
University,O
Campus,O
"
",O
BioMedico,O
of,O
Rome,O
",",O
Rome,O
",",O
Italy,O
.,O
"
",O
(2)LaboratÃ³rio,O
de,O
FlavivÃ­rus,O
",",O
Instituto,O
Oswaldo,O
Cruz,O
",",O
FundaÃ§Ã£o,O
Oswaldo,O
Cruz,O
",",O
Rio,O
"
",O
de,O
Janeiro,O
",",O
Brazil,O
.,O
"
",O
(3)Internal,O
Medicine,O
Unit,O
",",O
University,O
Campus,O
BioMedico,O
of,O
Rome,O
",",O
Rome,O
",",O
Italy,O
.,O
"
",O
(4)Unit,O
of,O
Clinical,O
Laboratory,O
Science,O
",",O
University,O
Campus,O
BioMedico,O
of,O
Rome,O
",",O
"
",O
Rome,O
",",O
Italy,O
.,O
"

",O
There,O
is,O
a,O
worldwide,O
concern,O
about,O
the,O
new,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
2019nCoV,B-Virus_SARS-CoV-2
as,O
a,O
global,O
"
",O
public,O
health,O
threat,O
.,O
In,O
this,O
article,O
",",O
we,O
provide,O
a,O
preliminary,O
evolutionary,O
and,O
"
",O
molecular,O
epidemiological,O
analysis,O
of,O
this,O
new,O
virus,O
.,O
A,O
phylogenetic,O
tree,O
has,O
"
",O
been,O
built,O
using,O
the,O
15,O
available,O
whole,O
genome,O
sequences,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
12,O
whole,O
"
",O
genome,O
sequences,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
and,O
12,O
highly,O
similar,O
whole,O
genome,O
sequences,O
"
",O
available,O
in,O
gene,O
bank,O
(,O
five,O
from,O
the,O
severe,O
acute,O
respiratory,O
syndrome,O
",",O
two,O
from,O
"
",O
Middle,O
East,O
respiratory,O
syndrome,O
",",O
and,O
five,O
from,O
bat,O
SARSlike,O
coronavirus,O
),O
.,O
Fast,O
"
",O
unconstrained,O
Bayesian,O
approximation,O
analysis,O
shows,O
that,O
the,O
nucleocapsid,O
and,O
the,O
"
",O
spike,O
glycoprotein,O
have,O
some,O
sites,O
under,O
positive,O
pressure,O
",",O
whereas,O
homology,O
"
",O
modeling,O
revealed,O
some,O
molecular,O
and,O
structural,O
differences,O
between,O
the,O
viruses,O
.,O
"
",O
The,O
phylogenetic,O
tree,O
showed,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
significantly,O
clustered,O
with,O
bat,O
"
",O
SARSlike,O
coronavirus,O
sequence,O
isolated,O
in,O
2015,O
",",O
whereas,O
structural,O
analysis,O
"
",O
revealed,O
mutation,O
in,O
Spike,O
Glycoprotein,O
and,O
nucleocapsid,O
protein,O
.,O
From,O
these,O
"
",O
results,O
",",O
the,O
new,O
2019nCoV,B-Virus_SARS-CoV-2
is,O
distinct,O
from,O
SARS,O
virus,O
",",O
probably,O
trasmitted,O
from,O
"
",O
bats,O
after,O
mutation,O
conferring,O
ability,O
to,O
infect,O
humans,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25688,O
"
",O
PMID,O
:,O
31994738,O
"


",O
866,O
.,O
Nature,O
.,O
2020,O
Jan;577(7792):607,O
.,O
doi,O
:,O
10.1038,O
d41586020001906,O
.,O
"

",O
This,O
scientist,O
hopes,O
to,O
test,O
coronavirus,O
drugs,O
on,O
animals,O
in,O
lockeddown,O
Wuhan,O
.,O
"

",O
Cyranoski,O
D.,O
"

",O
DOI,O
:,O
10.1038,O
d41586020001906,O
"
",O
PMID,O
:,O
31992886,O
"


",O
867,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Jan;25(3,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.3.2001231,O
.,O
"

",O
Note,O
from,O
the,O
editors,O
:,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
"

",O
Eurosurveillance,O
Editorial,O
Team(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)European,O
Centre,O
for,O
Disease,O
Prevention,O
and,O
Control,O
(,O
ECDC,O
),O
",",O
Stockholm,O
",",O
Sweden,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.3.2001231,O
"
",O
PMCID,O
:,O
PMC6988271,O
"
",O
PMID,O
:,O
31992390,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
868,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Jan;25(3,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.3.2000044,O
.,O
"

",O
Realtime,O
tentative,O
assessment,O
of,O
the,O
epidemiological,O
characteristics,O
of,O
novel,O
"
",O
coronavirus,O
infections,O
in,O
Wuhan,O
",",O
China,O
",",O
as,O
at,O
22,O
January,O
2020,O
.,O
"

",O
Wu,O
P(1,O
),O
",",O
Hao,O
X(1,O
),O
",",O
Lau,O
EHY(1,O
),O
",",O
Wong,O
JY(1,O
),O
",",O
Leung,O
KSM(1,O
),O
",",O
Wu,O
JT(1,O
),O
",",O
Cowling,O
"
",O
BJ(2)(1,O
),O
",",O
Leung,O
GM(2)(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)World,O
Health,O
Organization,O
(,O
WHO,O
),O
Collaborating,O
Centre,O
for,O
Infectious,O
Disease,O
"
",O
Epidemiology,O
and,O
Control,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
"
",O
Medicine,O
",",O
The,O
University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
"
",O
China,O
.,O
"
",O
(2)These,O
authors,O
are,O
joint,O
senior,O
authors,O
with,O
equal,O
contribution,O
.,O
"

",O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
causing,O
severe,O
acute,O
respiratory,O
disease,O
emerged,O
"
",O
recently,O
in,O
Wuhan,O
",",O
China,O
.,O
Information,O
on,O
reported,O
cases,O
strongly,O
indicates,O
"
",O
humantohuman,O
spread,O
",",O
and,O
the,O
most,O
recent,O
information,O
is,O
increasingly,O
indicative,O
"
",O
of,O
sustained,O
humantohuman,O
transmission,O
.,O
While,O
the,O
overall,O
severity,O
profile,O
"
",O
among,O
cases,O
may,O
change,O
as,O
more,O
mild,O
cases,O
are,O
identified,O
",",O
we,O
estimate,O
a,O
risk,O
of,O
"
",O
fatality,O
among,O
hospitalised,O
cases,O
at,O
14,O
%,O
(,O
95,O
%,O
confidence,O
interval,O
:,O
3.932,O
%,O
),O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.3.2000044,O
"
",O
PMCID,O
:,O
PMC6988272,O
"
",O
PMID,O
:,O
31992388,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
869,O
.,O
Euro,O
Surveill,O
.,O
2020,O
Jan;25(3,O
),O
.,O
doi,O
:,O
10.2807,O
15607917.ES.2020.25.3.2000045,O
.,O
"

",O
Detection,O
of,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
by,O
realtime,O
RTPCR,O
.,O
"

",O
Corman,O
VM(1,O
),O
",",O
Landt,O
O(2,O
),O
",",O
Kaiser,O
M(2,O
),O
",",O
Molenkamp,O
R(3,O
),O
",",O
Meijer,O
A(4,O
),O
",",O
Chu,O
DKW(5,O
),O
",",O
"
",O
Bleicker,O
T(1,O
),O
",",O
BrÃ¼nink,O
S(1,O
),O
",",O
Schneider,O
J(1,O
),O
",",O
Schmidt,O
ML(1,O
),O
",",O
Mulders,O
DGJC(3,O
),O
",",O
"
",O
Haagmans,O
BL(3,O
),O
",",O
van,O
der,O
Veer,O
B(4,O
),O
",",O
van,O
den,O
Brink,O
S(4,O
),O
",",O
Wijsman,O
L(4,O
),O
",",O
Goderski,O
"
",O
G(4,O
),O
",",O
Romette,O
JL(6,O
),O
",",O
Ellis,O
J(7,O
),O
",",O
Zambon,O
M(7,O
),O
",",O
Peiris,O
M(5,O
),O
",",O
Goossens,O
H(8,O
),O
",",O
Reusken,O
"
",O
C(4,O
),O
",",O
Koopmans,O
MPG(3,O
),O
",",O
Drosten,O
C(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)CharitÃ©,O
 ,O
UniversitÃ¤tsmedizin,O
Berlin,O
Institute,O
of,O
Virology,O
",",O
Berlin,O
",",O
Germany,O
"
",O
and,O
German,O
Centre,O
for,O
Infection,O
Research,O
(,O
DZIF,O
),O
",",O
Berlin,O
",",O
Germany,O
.,O
"
",O
(2)TibMolbiol,O
",",O
Berlin,O
",",O
Germany,O
.,O
"
",O
(3)Department,O
of,O
Viroscience,O
",",O
Erasmus,O
MC,O
",",O
Rotterdam,O
",",O
the,O
Netherlands,O
.,O
"
",O
(4)National,O
Institute,O
for,O
Public,O
Health,O
and,O
the,O
Environment,O
(,O
RIVM,O
),O
",",O
Bilthoven,O
",",O
"
",O
the,O
Netherlands,O
.,O
"
",O
(5)University,O
of,O
Hong,O
Kong,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(6)Universite,O
d,O
AixMarseille,O
",",O
Marseille,O
",",O
France,O
.,O
"
",O
(7)Public,O
Health,O
England,O
",",O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
(8)Department,O
of,O
Medical,O
Microbiology,O
",",O
Vaccine,O
and,O
Infectious,O
Diseases,O
Institute,O
",",O
"
",O
University,O
of,O
Antwerp,O
",",O
Antwerp,O
",",O
Belgium,O
.,O
"

",O
BACKGROUND,O
:,O
The,O
ongoing,O
outbreak,O
of,O
the,O
recently,O
emerged,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
poses,O
a,O
challenge,O
for,O
public,O
health,O
laboratories,O
as,O
virus,O
isolates,O
"
",O
are,O
unavailable,O
while,O
there,O
is,O
growing,O
evidence,O
that,O
the,O
outbreak,O
is,O
more,O
"
",O
widespread,O
than,O
initially,O
thought,O
",",O
and,O
international,O
spread,O
through,O
travellers,O
"
",O
does,O
already,O
occur,O
.,O
"
",O
AIM,O
:,O
We,O
aimed,O
to,O
develop,O
and,O
deploy,O
robust,O
diagnostic,O
methodology,O
for,O
use,O
in,O
"
",O
public,O
health,O
laboratory,O
settings,O
without,O
having,O
virus,O
material,O
available,O
.,O
"
",O
METHODS,O
:,O
Here,O
we,O
present,O
a,O
validated,O
diagnostic,O
workflow,O
for,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
its,O
"
",O
design,O
relying,O
on,O
close,O
genetic,O
relatedness,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
with,O
SARS,O
coronavirus,O
",",O
"
",O
making,O
use,O
of,O
synthetic,O
nucleic,O
acid,O
technology,O
.,O
"
",O
RESULTS,O
:,O
The,O
workflow,O
reliably,O
detects,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
and,O
further,O
discriminates,O
"
",O
2019nCoV,B-Virus_SARS-CoV-2
from,O
SARSCoV.,O
Through,O
coordination,O
between,O
academic,O
and,O
public,O
"
",O
laboratories,O
",",O
we,O
confirmed,O
assay,O
exclusivity,O
based,O
on,O
297,O
original,O
clinical,O
"
",O
specimens,O
containing,O
a,O
full,O
spectrum,O
of,O
human,O
respiratory,O
viruses,O
.,O
Control,O
"
",O
material,O
is,O
made,O
available,O
through,O
European,O
Virus,O
Archive,O
 ,O
Global,O
(,O
EVAg,O
),O
",",O
a,O
"
",O
European,O
Union,O
infrastructure,O
project,O
.,O
"
",O
CONCLUSION,O
:,O
The,O
present,O
study,O
demonstrates,O
the,O
enormous,O
response,O
capacity,O
"
",O
achieved,O
through,O
coordination,O
of,O
academic,O
and,O
public,O
laboratories,O
in,O
national,O
and,O
"
",O
European,O
research,O
networks,O
.,O
"

",O
DOI,O
:,O
10.2807,O
15607917.ES.2020.25.3.2000045,O
"
",O
PMCID,O
:,O
PMC6988269,O
"
",O
PMID,O
:,O
31992387,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
870,O
.,O
J,O
Clin,O
Med,O
.,O
2020,O
Jan,O
24;9(2,O
),O
.,O
pii,O
:,O
E330,O
.,O
doi,O
:,O
10.339,O
jcm9020330,O
.,O
"

",O
The,O
Extent,O
of,O
Transmission,O
of,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
in,O
Wuhan,O
",",O
China,O
",",O
2020,O
.,O
"

",O
Nishiura,O
H(1)(2,O
),O
",",O
Jung,O
SM(1,O
),O
",",O
Linton,O
NM(1,O
),O
",",O
Kinoshita,O
R(1,O
),O
",",O
Yang,O
Y(1,O
),O
",",O
Hayashi,O
"
",O
K(1,O
),O
",",O
Kobayashi,O
T(1,O
),O
",",O
Yuan,O
B(1,O
),O
",",O
Akhmetzhanov,O
AR(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Graduate,O
School,O
of,O
Medicine,O
",",O
Hokkaido,O
University,O
",",O
Kita,O
15,O
Jo,O
Nishi,O
7,O
Chome,O
",",O
"
",O
Kitaku,O
",",O
Sapporoshi,O
",",O
Hokkaido,O
608638,O
",",O
Japan,O
.,O
"
",O
(2)CREST,O
",",O
Japan,O
Science,O
and,O
Technology,O
Agency,O
",",O
Honcho,O
418,O
",",O
Kawaguchi,O
",",O
Saitama,O
"
",O
3320012,O
",",O
Japan,O
.,O
"

",O
A,O
cluster,O
of,O
pneumonia,O
cases,O
linked,O
to,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
was,O
"
",O
reported,O
by,O
China,O
in,O
late,O
December,O
2019,O
.,O
Reported,O
case,O
incidence,O
has,O
now,O
reached,O
"
",O
the,O
hundreds,O
",",O
but,O
this,O
is,O
likely,O
an,O
underestimate,O
.,O
As,O
of,O
24,O
January,O
2020,O
",",O
with,O
"
",O
reports,O
of,O
thirteen,O
exportation,O
events,O
",",O
we,O
estimate,O
the,O
cumulative,O
incidence,O
in,O
"
",O
China,O
at,O
5502,O
cases,O
(,O
95,O
%,O
confidence,O
interval,O
:,O
3027,O
",",O
9057,O
),O
.,O
The,O
most,O
plausible,O
"
",O
number,O
of,O
infections,O
is,O
in,O
the,O
order,O
of,O
thousands,O
",",O
rather,O
than,O
hundreds,O
",",O
and,O
"
",O
there,O
is,O
a,O
strong,O
indication,O
that,O
untraced,O
exposures,O
other,O
than,O
the,O
one,O
in,O
the,O
"
",O
epidemiologically,O
linked,O
seafood,O
market,O
in,O
Wuhan,O
have,O
occurred,O
.,O
"

",O
DOI,O
:,O
10.339,O
jcm9020330,O
"
",O
PMID,O
:,O
31991628,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
871,O
.,O
Viruses,O
.,O
2020,O
Jan,O
24;12(2,O
),O
.,O
pii,O
:,O
E135,O
.,O
doi,O
:,O
10.339,O
v12020135,O
.,O
"

",O
Return,O
of,O
the,O
Coronavirus,O
:,O
2019nCoV.,O
"

",O
Gralinski,O
LE(1,O
),O
",",O
Menachery,O
VD(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Epidemiology,O
",",O
Gillings,O
School,O
of,O
Global,O
Public,O
Health,O
",",O
"
",O
University,O
of,O
North,O
Carolina,O
",",O
Chapel,O
Hill,O
",",O
NC,O
27514,O
",",O
USA,O
.,O
"
",O
(2)Department,O
of,O
Microbiology,O
and,O
Immunology,O
",",O
University,O
of,O
Texas,O
Medical,O
Branch,O
",",O
"
",O
Galveston,O
",",O
TX,O
77555,O
",",O
USA,O
.,O
"
",O
(3)Institute,O
for,O
Human,O
Infections,O
and,O
Immunity,O
",",O
University,O
of,O
Texas,O
Medical,O
"
",O
Branch,O
",",O
Galveston,O
",",O
TX,O
77555,O
",",O
USA,O
.,O
"

",O
The,O
emergence,O
of,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
has,O
awakened,O
the,O
echoes,O
of,O
"
",O
SARSCoV,O
from,O
nearly,O
two,O
decades,O
ago,O
.,O
Yet,O
",",O
with,O
technological,O
advances,O
and,O
"
",O
important,O
lessons,O
gained,O
from,O
previous,O
outbreaks,O
",",O
perhaps,O
the,O
world,O
is,O
better,O
"
",O
equipped,O
to,O
deal,O
with,O
the,O
most,O
recent,O
emergent,O
group,O
2B,O
coronavirus,O
.,O
"

",O
DOI,O
:,O
10.339,O
v12020135,O
"
",O
PMID,O
:,O
31991541,O
"


",O
872,O
.,O
Environ,O
Int,O
.,O
2020,O
Mar;136:105498,O
.,O
doi,O
:,O
10.1016,O
j.envint.2020.105498,O
.,O
Epub,O
2020,O
"
",O
Jan,O
25,O
.,O
"

",O
The,O
impact,O
of,O
ambient,O
ozone,O
pollution,O
on,O
pneumonia,O
:,O
A,O
nationwide,O
timeseries,O
"
",O
analysis,O
.,O
"

",O
Tian,O
Y(1,O
),O
",",O
Wu,O
Y(2,O
),O
",",O
Liu,O
H(3,O
),O
",",O
Si,O
Y(4,O
),O
",",O
Wu,O
Y(2,O
),O
",",O
Wang,O
X(2,O
),O
",",O
Wang,O
M(2,O
),O
",",O
Wu,O
J(2,O
),O
",",O
"
",O
Chen,O
L(5,O
),O
",",O
Wei,O
C(5,O
),O
",",O
Wu,O
T(2,O
),O
",",O
Gao,O
P(6,O
),O
",",O
Hu,O
Y(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Maternal,O
and,O
Child,O
Health,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
No.,O
13,O
Hangkong,O
"
",O
Road,O
",",O
430030,O
Wuhan,O
",",O
China,O
;,O
Ministry,O
of,O
Education,O
Key,O
Laboratory,O
of,O
Environment,O
"
",O
and,O
Health,O
",",O
and,O
State,O
Key,O
Laboratory,O
of,O
Environmental,O
Health,O
(,O
Incubating,O
),O
",",O
School,O
"
",O
of,O
Public,O
Health,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
No.,O
13,O
Hangkong,O
Road,O
",",O
430030,O
Wuhan,O
",",O
China,O
;,O
Department,O
of,O
Epidemiology,O
"
",O
and,O
Biostatistics,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Peking,O
University,O
",",O
No.,O
38,O
Xueyuan,O
"
",O
Road,O
",",O
100191,O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Epidemiology,O
and,O
Biostatistics,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Peking,O
"
",O
University,O
",",O
No.,O
38,O
Xueyuan,O
Road,O
",",O
100191,O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Epidemiology,O
and,O
Biostatistics,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Peking,O
"
",O
University,O
",",O
No.,O
38,O
Xueyuan,O
Road,O
",",O
100191,O
Beijing,O
",",O
China,O
;,O
Medical,O
Informatics,O
"
",O
Center,O
",",O
Peking,O
University,O
",",O
No.,O
38,O
Xueyuan,O
Road,O
",",O
100191,O
Beijing,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Epidemiology,O
and,O
Biostatistics,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Peking,O
"
",O
University,O
",",O
No.,O
38,O
Xueyuan,O
Road,O
",",O
100191,O
Beijing,O
",",O
China,O
;,O
Beijing,O
HealthCom,O
Data,O
"
",O
Technology,O
Co.,O
Ltd,O
",",O
No.,O
18,O
Fengtai,O
North,O
Road,O
",",O
10,O
F,O
Hengtai,O
Plaza,O
Block,O
C,O
",",O
100071,O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)Beijing,O
HealthCom,O
Data,O
Technology,O
Co.,O
Ltd,O
",",O
No.,O
18,O
Fengtai,O
North,O
Road,O
",",O
10,O
F,O
"
",O
Hengtai,O
Plaza,O
Block,O
C,O
",",O
100071,O
Beijing,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Epidemiology,O
and,O
Biostatistics,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Peking,O
"
",O
University,O
",",O
No.,O
38,O
Xueyuan,O
Road,O
",",O
100191,O
Beijing,O
",",O
China,O
;,O
Key,O
Laboratory,O
of,O
"
",O
Molecular,O
Cardiovascular,O
(,O
Peking,O
University,O
),O
",",O
Ministry,O
of,O
Education,O
",",O
Beijing,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
peigao@bjmu.edu.cn,O
.,O
"
",O
(7)Department,O
of,O
Epidemiology,O
and,O
Biostatistics,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Peking,O
"
",O
University,O
",",O
No.,O
38,O
Xueyuan,O
Road,O
",",O
100191,O
Beijing,O
",",O
China,O
;,O
Medical,O
Informatics,O
"
",O
Center,O
",",O
Peking,O
University,O
",",O
No.,O
38,O
Xueyuan,O
Road,O
",",O
100191,O
Beijing,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
yhhu@bjmu.edu.cn,O
.,O
"

",O
Few,O
large,O
multicity,O
studies,O
have,O
assessed,O
acute,O
effect,O
of,O
tropospheric,O
ozone,O
"
",O
pollution,O
on,O
pneumonia,O
risk,O
.,O
We,O
aimed,O
to,O
examine,O
the,O
relation,O
between,O
daytoday,O
"
",O
changes,O
in,O
ozone,O
concentrations,O
and,O
hospital,O
admissions,O
for,O
pneumonia,O
in,O
China,O
.,O
"
",O
We,O
conducted,O
a,O
national,O
timeseries,O
study,O
in,O
184,O
major,O
Chinese,O
cities,O
from,O
2014,O
"
",O
to,O
2017,O
.,O
Cityspecific,O
relation,O
between,O
ozone,O
concentrations,O
and,O
pneumonia,O
"
",O
admissions,O
was,O
evaluated,O
using,O
an,O
overdispersed,O
generalized,O
additive,O
model,O
.,O
"
",O
Randomeffects,O
metaanalysis,O
was,O
conducted,O
to,O
pool,O
the,O
cityspecific,O
estimates,O
.,O
"
",O
Twopollutant,O
models,O
were,O
fitted,O
to,O
test,O
the,O
robustness,O
of,O
the,O
relations,O
.,O
We,O
also,O
"
",O
investigated,O
potential,O
effect,O
modifiers,O
.,O
Overall,O
",",O
we,O
observed,O
increased,O
"
",O
admissions,O
for,O
pneumonia,O
associated,O
with,O
ozone,O
exposure,O
.,O
The,O
nationalaverage,O
"
",O
estimates,O
per,O
10Î¼g,O
m3,O
increase,O
in,O
ozone,O
were,O
0.14,O
%,O
(,O
95,O
%,O
CI,O
:,O
0.03%0.25,O
%,O
),O
at,O
lag,O
"
",O
0,O
Â ,O
day,O
in,O
the,O
whole,O
year,O
",",O
0.3,O
%,O
(,O
95,O
%,O
CI,O
:,O
0.17%0.43,O
%,O
),O
at,O
lag,O
0,O
Â ,O
day,O
in,O
the,O
warm,O
"
",O
season,O
",",O
and,O
0.2,O
%,O
(,O
95,O
%,O
CI,O
:,O
0.05%0.34,O
%,O
),O
at,O
lag,O
1,O
Â ,O
day,O
in,O
the,O
cool,O
season,O
.,O
"
",O
Twopollutant,O
models,O
indicated,O
that,O
the,O
ozone,O
effects,O
were,O
not,O
confounded,O
by,O
"
",O
PM2.5,O
",",O
SO2,O
",",O
NO2,O
or,O
CO,O
.,O
The,O
association,O
between,O
ozone,O
and,O
pneumonia,O
was,O
stronger,O
"
",O
in,O
the,O
elderly,O
.,O
Ozone,O
levels,O
and,O
gross,O
domestic,O
product,O
per,O
capita,O
reduced,O
the,O
"
",O
effects,O
of,O
ozone,O
",",O
and,O
smoking,O
enhanced,O
the,O
effects,O
of,O
ozone,O
.,O
In,O
conclusion,O
",",O
we,O
"
",O
estimated,O
an,O
increase,O
in,O
daily,O
pneumonia,O
admissions,O
associated,O
with,O
ozone,O
"
",O
exposure,O
in,O
China,O
.,O
As,O
the,O
first,O
national,O
study,O
in,O
China,O
to,O
report,O
acute,O
effect,O
of,O
"
",O
ozone,O
on,O
pneumonia,O
hospitalizations,O
",",O
our,O
findings,O
are,O
incredibly,O
meaningful,O
in,O
"
",O
terms,O
of,O
both,O
ozone,O
pollution,O
related,O
policy,O
development,O
and,O
pneumonia,O
"
",O
prevention,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
The,O
Authors,O
.,O
Published,O
by,O
Elsevier,O
Ltd,O
..,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.envint.2020.105498,O
"
",O
PMID,O
:,O
31991238,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
known,O
competing,O
financial,O
interests,O
or,O
personal,O
"
",O
relationships,O
that,O
could,O
have,O
appeared,O
to,O
influence,O
the,O
work,O
reported,O
in,O
this,O
"
",O
paper,O
.,O
"


",O
873,O
.,O
Free,O
Radic,O
Biol,O
Med,O
.,O
2020,O
Jan,O
25,O
.,O
pii,O
:,O
S08915849(19)32372X,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.freeradbiomed.2020.01.178,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
CTRP1,O
prevents,O
sepsisinduced,O
cardiomyopathy,O
via,O
Sirt1dependent,O
pathways,O
.,O
"

",O
Jiang,O
W(1,O
),O
",",O
Li,O
W(2,O
),O
",",O
Hu,O
X(3,O
),O
",",O
Hu,O
R(4,O
),O
",",O
Li,O
B(4,O
),O
",",O
Lan,O
L(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Thoracic,O
Surgery,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
430060,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Emergency,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430060,O
",",O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Cardiovascular,O
Surgery,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
430060,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
xiaoping8205@whu.edu.cn,O
.,O
"
",O
(4)Department,O
of,O
Cardiovascular,O
Surgery,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
430060,O
",",O
China,O
.,O
"

",O
C1q,O
tumor,O
necrosis,O
factorrelated,O
protein,O
1,O
(,O
CTRP1,O
),O
has,O
recently,O
been,O
identified,O
"
",O
as,O
a,O
key,O
regulator,O
of,O
cardiometabolic,O
diseases,O
.,O
It,O
has,O
been,O
reported,O
that,O
CTRP1,O
"
",O
could,O
inhibit,O
the,O
hypertrophic,O
response,O
in,O
mice,O
.,O
However,O
",",O
the,O
effect,O
of,O
CTRP1,O
on,O
"
",O
sepsisinduced,O
cardiomyopathy,O
remains,O
completely,O
unknown,O
.,O
Cardiomyocytespecific,O
"
",O
CTRP1,O
overexpression,O
was,O
achieved,O
using,O
an,O
adeno,O
associated,O
virus,O
system,O
in,O
mice,O
.,O
"
",O
CTRP1,O
deficiency,O
mice,O
were,O
also,O
subjected,O
to,O
lipopolysaccharide,O
(,O
LPS,O
),O
injection,O
.,O
"
",O
We,O
found,O
that,O
CTRP1,O
overexpression,O
improved,O
survival,O
rate,O
and,O
cardiac,O
function,O
",",O
"
",O
and,O
suppressed,O
myocardial,O
inflammation,O
",",O
oxidative,O
damage,O
and,O
apoptosis,O
without,O
"
",O
affecting,O
metabolic,O
disturbance,O
in,O
LPStreated,O
mice,O
.,O
CTRP1,O
depletion,O
further,O
"
",O
decreased,O
survival,O
rate,O
and,O
cardiac,O
function,O
",",O
and,O
promoting,O
myocardial,O
"
",O
inflammation,O
",",O
oxidative,O
damage,O
and,O
apoptosis,O
in,O
sepsis,O
mice,O
.,O
In,O
addition,O
",",O
we,O
"
",O
showed,O
that,O
CTRP1,O
provided,O
protection,O
against,O
LPSinduced,O
cell,O
injury,O
in,O
vitro,O
.,O
"
",O
CTRP1,O
activated,O
sirtuin,O
1,O
(,O
Sirt1,O
),O
signaling,O
pathway,O
",",O
and,O
Sirt1,O
inhibition,O
or,O
"
",O
deficiency,O
blocked,O
CTRP1mediated,O
cardioprotective,O
effects,O
in,O
vivo,O
and,O
in,O
vitro,O
.,O
"
",O
More,O
importantly,O
",",O
our,O
study,O
found,O
that,O
recombinant,O
human,O
globular,O
domain,O
of,O
CTRP1,O
"
",O
infusion,O
was,O
also,O
capable,O
of,O
blocking,O
sepsisinduced,O
cardiomyopathy,O
in,O
mice,O
.,O
In,O
"
",O
conclusion,O
",",O
CTRP1,O
improved,O
survival,O
rate,O
and,O
attenuated,O
LPSinduced,O
cardiac,O
"
",O
injury,O
via,O
activating,O
Sirt1,O
signaling,O
pathway,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.freeradbiomed.2020.01.178,O
"
",O
PMID,O
:,O
31991227,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
None,O
.,O
"


",O
874,O
.,O
Sci,O
Rep.,O
2020,O
Jan,O
27;10(1):1210,O
.,O
doi,O
:,O
10.1038,O
s4159802057737w,O
.,O
"

",O
Porcine,O
CXCR1,O
2,O
antagonist,O
CXCL8(372)G31P,O
inhibits,O
lung,O
inflammation,O
in,O
"
",O
LPSchallenged,O
mice,O
.,O
"

",O
Wang,O
X(1,O
),O
",",O
Li,O
Y(1,O
),O
",",O
Li,O
L(1,O
),O
",",O
Jiao,O
Z(1,O
),O
",",O
Liu,O
X(1,O
),O
",",O
Cheng,O
G(1,O
),O
",",O
Gu,O
C(1,O
),O
",",O
Hu,O
X(1,O
),O
",",O
"
",O
Zhang,O
W(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Collage,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
"
",O
Hubei,O
",",O
430070,O
",",O
China,O
.,O
"
",O
(2)Collage,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
"
",O
Hubei,O
",",O
430070,O
",",O
China,O
.,O
zwp@mail.hzau.edu.cn,O
.,O
"

",O
Swine,O
pneumonia,O
is,O
a,O
great,O
threat,O
for,O
pig,O
industry,O
around,O
the,O
world,O
",",O
which,O
is,O
"
",O
usually,O
accompanied,O
with,O
neutrophils,O
infiltration,O
in,O
the,O
airway,O
.,O
Although,O
"
",O
interleukin8,O
(,O
CXCL8,O
),O
and,O
its,O
receptors,O
",",O
CXC,O
chemokine,O
receptor,O
1,O
and,O
2,O
(,O
CXCR1,O
2,O
),O
"
",O
in,O
human,O
have,O
been,O
well,O
documented,O
",",O
the,O
expression,O
and,O
function,O
of,O
CXCR1,O
2,O
is,O
"
",O
still,O
unknown,O
in,O
swine,O
.,O
To,O
explore,O
the,O
feasibility,O
to,O
develop,O
new,O
veterinary,O
"
",O
antiinflammatory,O
drugs,O
targeting,O
porcine,O
CXCR1,O
2,O
",",O
we,O
detected,O
CXCR1,O
2,O
expression,O
"
",O
in,O
swine,O
pneumonia,O
through,O
RealTime,O
PCR,O
and,O
immunohistochemistry,O
for,O
the,O
first,O
"
",O
time,O
.,O
Two,O
porcine,O
CXCR1,O
2,O
antagonists,O
",",O
CXCL8(372)N11R,O
G31P,O
(,O
pN11R,O
),O
and,O
"
",O
CXCL8(372)G31P,O
(,O
pG31P,O
),O
were,O
prepared,O
and,O
their,O
antiinflammatory,O
effects,O
were,O
"
",O
evaluated,O
using,O
cell,O
chemotaxis,O
assays,O
and,O
animal,O
experiments,O
.,O
Our,O
data,O
showed,O
"
",O
that,O
CXCR1,O
2,O
expression,O
",",O
which,O
was,O
closely,O
related,O
to,O
neutrophil,O
infiltration,O
in,O
"
",O
the,O
lung,O
",",O
was,O
significantly,O
upregulated,O
in,O
swine,O
pneumonia,O
.,O
The,O
pN11R,O
and,O
pG31P,O
"
",O
could,O
effectively,O
inhibit,O
the,O
directional,O
migration,O
of,O
neutrophils,O
in,O
vitro,O
.,O
In,O
"
",O
vivo,O
data,O
also,O
indicated,O
that,O
both,O
pN11R,O
and,O
pG31P,O
significantly,O
relieved,O
"
",O
LPSinduced,O
pneumonia,O
in,O
mice,O
through,O
decreasing,O
the,O
expression,O
of,O
TNFÎ±,O
",",O
CXCL8,O
",",O
"
",O
and,O
IL1Î²,O
",",O
and,O
inhibiting,O
neutrophil,O
influx,O
into,O
the,O
lung,O
.,O
pG31P,O
was,O
more,O
"
",O
efficient,O
.,O
Our,O
study,O
suggested,O
that,O
it,O
is,O
possible,O
to,O
develop,O
new,O
veterinary,O
"
",O
antiinflammatory,O
drugs,O
targeting,O
porcine,O
CXCR1,O
2,O
",",O
and,O
pG31P,O
is,O
a,O
promising,O
"
",O
candidate,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s4159802057737w,O
"
",O
PMCID,O
:,O
PMC6985246,O
"
",O
PMID,O
:,O
31988368,O
"


",O
875,O
.,O
Emerg,O
Microbes,O
Infect,O
.,O
2020,O
Dec;9(1):221236,O
.,O
doi,O
:,O
10.108,O
22221751.2020.1719902,O
.,O
"

",O
Genomic,O
characterization,O
of,O
the,O
2019,O
novel,O
humanpathogenic,O
coronavirus,O
isolated,O
"
",O
from,O
a,O
patient,O
with,O
atypical,O
pneumonia,O
after,O
visiting,O
Wuhan,O
.,O
"

",O
Chan,O
JF(1)(2)(3)(4,O
),O
",",O
Kok,O
KH(1)(3)(4,O
),O
",",O
Zhu,O
Z(3,O
),O
",",O
Chu,O
H(1)(3)(4,O
),O
",",O
To,O
"
",O
KK(1)(2)(3)(4,O
),O
",",O
Yuan,O
S(1)(3)(4,O
),O
",",O
Yuen,O
KY(2)(3)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Emerging,O
Infectious,O
Diseases,O
",",O
The,O
University,O
of,O
Hong,O
"
",O
Kong,O
",",O
Pokfulam,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Clinical,O
Microbiology,O
and,O
Infection,O
Control,O
",",O
The,O
University,O
of,O
"
",O
Hong,O
KongShenzhen,O
Hospital,O
",",O
Shenzhen,O
",",O
Guangdong,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(3)Department,O
of,O
Microbiology,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
University,O
of,O
"
",O
Hong,O
Kong,O
",",O
Pokfulam,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"
",O
(4)Carol,O
Yu,O
Centre,O
for,O
Infection,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
University,O
"
",O
of,O
Hong,O
Kong,O
",",O
Pokfulam,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
China,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
Emerg,O
Microbes,O
Infect,O
.,O
2020,O
Dec;9(1):540,O
.,O
"

",O
A,O
mysterious,O
outbreak,O
of,O
atypical,O
pneumonia,O
in,O
late,O
2019,O
was,O
traced,O
to,O
a,O
seafood,O
"
",O
wholesale,O
market,O
in,O
Wuhan,O
of,O
China,O
.,O
Within,O
a,O
few,O
weeks,O
",",O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
tentatively,O
named,O
as,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
was,O
announced,O
by,O
the,O
"
",O
World,O
Health,O
Organization,O
.,O
We,O
performed,O
bioinformatics,O
analysis,O
on,O
a,O
virus,O
genome,O
"
",O
from,O
a,O
patient,O
with,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
and,O
compared,O
it,O
with,O
other,O
related,O
"
",O
coronavirus,O
genomes,O
.,O
Overall,O
",",O
the,O
genome,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
has,O
89,O
%,O
nucleotide,O
identity,O
"
",O
with,O
bat,O
SARSlikeCoVZXC21,O
and,O
82,O
%,O
with,O
that,O
of,O
human,O
SARSCoV.,O
The,O
phylogenetic,O
"
",O
trees,O
of,O
their,O
orf1a,O
b,O
",",O
Spike,O
",",O
Envelope,O
",",O
Membrane,O
and,O
Nucleoprotein,O
also,O
"
",O
clustered,O
closely,O
with,O
those,O
of,O
the,O
bat,O
",",O
civet,O
and,O
human,O
SARS,O
coronaviruses,O
.,O
"
",O
However,O
",",O
the,O
external,O
subdomain,O
of,O
Spike,O
's,O
receptor,O
binding,O
domain,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
"
",O
shares,O
only,O
40,O
%,O
amino,O
acid,O
identity,O
with,O
other,O
SARSrelated,O
coronaviruses,O
.,O
"
",O
Remarkably,O
",",O
its,O
orf3b,O
encodes,O
a,O
completely,O
novel,O
short,O
protein,O
.,O
Furthermore,O
",",O
its,O
"
",O
new,O
orf8,O
likely,O
encodes,O
a,O
secreted,O
protein,O
with,O
an,O
alphahelix,O
",",O
following,O
with,O
a,O
"
",O
betasheet(s,O
),O
containing,O
six,O
strands,O
.,O
Learning,O
from,O
the,O
roles,O
of,O
civet,O
in,O
SARS,O
"
",O
and,O
camel,O
in,O
MERS,O
",",O
hunting,O
for,O
the,O
animal,O
source,O
of,O
2019nCoV,B-Virus_SARS-CoV-2
and,O
its,O
more,O
"
",O
ancestral,O
virus,O
would,O
be,O
important,O
for,O
understanding,O
the,O
origin,O
and,O
evolution,O
of,O
"
",O
this,O
novel,O
lineage,O
B,O
betacoronavirus,O
.,O
These,O
findings,O
provide,O
the,O
basis,O
for,O
"
",O
starting,O
further,O
studies,O
on,O
the,O
pathogenesis,O
",",O
and,O
optimizing,O
the,O
design,O
of,O
"
",O
diagnostic,O
",",O
antiviral,O
and,O
vaccination,O
strategies,O
for,O
this,O
emerging,O
infection,O
.,O
"

",O
DOI,O
:,O
10.108,O
22221751.2020.1719902,O
"
",O
PMID,O
:,O
31987001,O
"


",O
876,O
.,O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):497506,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)301835,O
.,O
Epub,O
"
",O
2020,O
Jan,O
24,O
.,O
"

",O
Clinical,O
features,O
of,O
patients,O
infected,O
with,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
in,O
Wuhan,O
",",O
"
",O
China,O
.,O
"

",O
Huang,O
C(1,O
),O
",",O
Wang,O
Y(2,O
),O
",",O
Li,O
X(3,O
),O
",",O
Ren,O
L(4,O
),O
",",O
Zhao,O
J(5,O
),O
",",O
Hu,O
Y(6,O
),O
",",O
Zhang,O
L(1,O
),O
",",O
Fan,O
"
",O
G(7,O
),O
",",O
Xu,O
J(8,O
),O
",",O
Gu,O
X(7,O
),O
",",O
Cheng,O
Z(9,O
),O
",",O
Yu,O
T(1,O
),O
",",O
Xia,O
J(1,O
),O
",",O
Wei,O
Y(1,O
),O
",",O
Wu,O
W(1,O
),O
",",O
Xie,O
"
",O
X(1,O
),O
",",O
Yin,O
W(6,O
),O
",",O
Li,O
H(2,O
),O
",",O
Liu,O
M(10,O
),O
",",O
Xiao,O
Y(4,O
),O
",",O
Gao,O
H(11,O
),O
",",O
Guo,O
L(4,O
),O
",",O
Xie,O
J(5,O
),O
",",O
"
",O
Wang,O
G(12,O
),O
",",O
Jiang,O
R(3,O
),O
",",O
Gao,O
Z(13,O
),O
",",O
Jin,O
Q(4,O
),O
",",O
Wang,O
J(14,O
),O
",",O
Cao,O
B(15,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Jin,O
Yintan,O
Hospital,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Center,O
of,O
Respiratory,O
"
",O
Medicine,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Respiratory,O
Diseases,O
",",O
ChinaJapan,O
"
",O
Friendship,O
Hospital,O
",",O
Beijing,O
",",O
China,O
;,O
Institute,O
of,O
Respiratory,O
Medicine,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
",",O
China,O
;,O
"
",O
Department,O
of,O
Respiratory,O
Medicine,O
",",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Clinical,O
and,O
Research,O
Center,O
of,O
Infectious,O
Diseases,O
",",O
Beijing,O
Ditan,O
Hospital,O
",",O
"
",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)NHC,O
Key,O
Laboratory,O
of,O
Systems,O
Biology,O
of,O
Pathogens,O
and,O
Christophe,O
Merieux,O
"
",O
Laboratory,O
",",O
Institute,O
of,O
Pathogen,O
Biology,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
"
",O
and,O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
The,O
Central,O
Hospital,O
of,O
"
",O
Wuhan,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Center,O
of,O
Respiratory,O
"
",O
Medicine,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Respiratory,O
Diseases,O
",",O
ChinaJapan,O
"
",O
Friendship,O
Hospital,O
",",O
Beijing,O
",",O
China,O
;,O
Institute,O
of,O
Clinical,O
Medical,O
Sciences,O
",",O
"
",O
ChinaJapan,O
Friendship,O
Hospital,O
",",O
Beijing,O
",",O
China,O
;,O
Institute,O
of,O
Respiratory,O
"
",O
Medicine,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Peking,O
Union,O
Medical,O
College,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(8)Tsinghua,O
University,O
School,O
of,O
Medicine,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(9)Department,O
of,O
Respiratory,O
medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(10)Department,O
of,O
Radiology,O
",",O
ChinaJapan,O
Friendship,O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(11)Institute,O
of,O
Laboratory,O
Animal,O
Science,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
"
",O
and,O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(12)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Peking,O
University,O
First,O
"
",O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(13)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Peking,O
University,O
"
",O
People,O
's,O
Hospital,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(14)NHC,O
Key,O
Laboratory,O
of,O
Systems,O
Biology,O
of,O
Pathogens,O
and,O
Christophe,O
Merieux,O
"
",O
Laboratory,O
",",O
Institute,O
of,O
Pathogen,O
Biology,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
"
",O
and,O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
wangjw28@163.com,O
.,O
"
",O
(15)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Center,O
of,O
Respiratory,O
"
",O
Medicine,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Respiratory,O
Diseases,O
",",O
ChinaJapan,O
"
",O
Friendship,O
Hospital,O
",",O
Beijing,O
",",O
China,O
;,O
Institute,O
of,O
Respiratory,O
Medicine,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
",",O
China,O
;,O
"
",O
Department,O
of,O
Respiratory,O
Medicine,O
",",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
;,O
"
",O
Tsinghua,O
UniversityPeking,O
University,O
Joint,O
Center,O
for,O
Life,O
Sciences,O
",",O
Beijing,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
caobin_ben@163.com,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
Lancet,O
.,O
2020,O
Jan,O
30,O
;,O
:,O
.,O
"

",O
Comment,O
in,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):470473,O
.,O
"
    ",O
Lancet,O
.,O
2020,O
Jan,O
24;:null,O
.,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
22;395(10224):e39,O
.,O
"

",O
BACKGROUND,O
:,O
A,O
recent,O
cluster,O
of,O
pneumonia,O
cases,O
in,O
Wuhan,O
",",O
China,O
",",O
was,O
caused,O
by,O
a,O
"
",O
novel,O
betacoronavirus,O
",",O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
.,O
We,O
report,O
the,O
"
",O
epidemiological,O
",",O
clinical,O
",",O
laboratory,O
",",O
and,O
radiological,O
characteristics,O
and,O
"
",O
treatment,O
and,O
clinical,O
outcomes,O
of,O
these,O
patients,O
.,O
"
",O
METHODS,O
:,O
All,O
patients,O
with,O
suspected,O
2019nCoV,B-Virus_SARS-CoV-2
were,O
admitted,O
to,O
a,O
designated,O
"
",O
hospital,O
in,O
Wuhan,O
.,O
We,O
prospectively,O
collected,O
and,O
analysed,O
data,O
on,O
patients,O
with,O
"
",O
laboratoryconfirmed,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
by,O
realtime,O
RTPCR,O
and,O
nextgeneration,O
"
",O
sequencing,O
.,O
Data,O
were,O
obtained,O
with,O
standardised,O
data,O
collection,O
forms,O
shared,O
by,O
"
",O
WHO,O
and,O
the,O
International,O
Severe,O
Acute,O
Respiratory,O
and,O
Emerging,O
Infection,O
"
",O
Consortium,O
from,O
electronic,O
medical,O
records,O
.,O
Researchers,O
also,O
directly,O
"
",O
communicated,O
with,O
patients,O
or,O
their,O
families,O
to,O
ascertain,O
epidemiological,O
and,O
"
",O
symptom,O
data,O
.,O
Outcomes,O
were,O
also,O
compared,O
between,O
patients,O
who,O
had,O
been,O
admitted,O
"
",O
to,O
the,O
intensive,O
care,O
unit,O
(,O
ICU,O
),O
and,O
those,O
who,O
had,O
not,O
.,O
"
",O
FINDINGS,O
:,O
By,O
Jan,O
2,O
",",O
2020,O
",",O
41,O
admitted,O
hospital,O
patients,O
had,O
been,O
identified,O
as,O
"
",O
having,O
laboratoryconfirmed,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
.,O
Most,O
of,O
the,O
infected,O
patients,O
"
",O
were,O
men,O
(,O
30,O
[,O
73,O
%,O
],O
of,O
41,O
),O
;,O
less,O
than,O
half,O
had,O
underlying,O
diseases,O
(,O
13,O
[,O
32,O
%,O
],O
),O
",",O
"
",O
including,O
diabetes,O
(,O
eight,O
[,O
20,O
%,O
],O
),O
",",O
hypertension,O
(,O
six,O
[,O
15,O
%,O
],O
),O
",",O
and,O
cardiovascular,O
"
",O
disease,O
(,O
six,O
[,O
15,O
%,O
],O
),O
.,O
Median,O
age,O
was,O
49Â·0,O
years,O
(,O
IQR,O
41Â·058Â·0,O
),O
.,O
27,O
(,O
66,O
%,O
),O
of,O
41,O
"
",O
patients,O
had,O
been,O
exposed,O
to,O
Huanan,O
seafood,O
market,O
.,O
One,O
family,O
cluster,O
was,O
found,O
.,O
"
",O
Common,O
symptoms,O
at,O
onset,O
of,O
illness,O
were,O
fever,O
(,O
40,O
[,O
98,O
%,O
],O
of,O
41,O
patients,O
),O
",",O
cough,O
"
",O
(,O
31,O
[,O
76,O
%,O
],O
),O
",",O
and,O
myalgia,O
or,O
fatigue,O
(,O
18,O
[,O
44,O
%,O
],O
),O
;,O
less,O
common,O
symptoms,O
were,O
sputum,O
"
",O
production,O
(,O
11,O
[,O
28,O
%,O
],O
of,O
39,O
),O
",",O
headache,O
(,O
three,O
[,O
8,O
%,O
],O
of,O
38,O
),O
",",O
haemoptysis,O
(,O
two,O
[,O
5,O
%,O
],O
"
",O
of,O
39,O
),O
",",O
and,O
diarrhoea,O
(,O
one,O
[,O
3,O
%,O
],O
of,O
38,O
),O
.,O
Dyspnoea,O
developed,O
in,O
22,O
(,O
55,O
%,O
),O
of,O
40,O
"
",O
patients,O
(,O
median,O
time,O
from,O
illness,O
onset,O
to,O
dyspnoea,O
8Â·0,O
days,O
[,O
IQR,O
5Â·013Â·0,O
],O
),O
.,O
26,O
"
",O
(,O
63,O
%,O
),O
of,O
41,O
patients,O
had,O
lymphopenia,O
.,O
All,O
41,O
patients,O
had,O
pneumonia,O
with,O
abnormal,O
"
",O
findings,O
on,O
chest,O
CT,O
.,O
Complications,O
included,O
acute,O
respiratory,O
distress,O
syndrome,O
"
",O
(,O
12,O
[,O
29,O
%,O
],O
),O
",",O
RNAaemia,O
(,O
six,O
[,O
15,O
%,O
],O
),O
",",O
acute,O
cardiac,O
injury,O
(,O
five,O
[,O
12,O
%,O
],O
),O
and,O
secondary,O
"
",O
infection,O
(,O
four,O
[,O
10,O
%,O
],O
),O
.,O
13,O
(,O
32,O
%,O
),O
patients,O
were,O
admitted,O
to,O
an,O
ICU,O
and,O
six,O
(,O
15,O
%,O
),O
"
",O
died,O
.,O
Compared,O
with,O
nonICU,O
patients,O
",",O
ICU,O
patients,O
had,O
higher,O
plasma,O
levels,O
of,O
"
",O
IL2,O
",",O
IL7,O
",",O
IL10,O
",",O
GSCF,O
",",O
IP10,O
",",O
MCP1,O
",",O
MIP1A,O
",",O
and,O
TNFÎ±,O
.,O
"
",O
INTERPRETATION,O
:,O
The,O
2019nCoV,B-Disease_COVID-19
infection,I-Disease_COVID-19
caused,O
clusters,O
of,O
severe,O
respiratory,O
"
",O
illness,O
similar,O
to,O
severe,O
acute,O
respiratory,O
syndrome,O
coronavirus,O
and,O
was,O
"
",O
associated,O
with,O
ICU,O
admission,O
and,O
high,O
mortality,O
.,O
Major,O
gaps,O
in,O
our,O
knowledge,O
of,O
"
",O
the,O
origin,O
",",O
epidemiology,O
",",O
duration,O
of,O
human,O
transmission,O
",",O
and,O
clinical,O
spectrum,O
"
",O
of,O
disease,O
need,O
fulfilment,O
by,O
future,O
studies,O
.,O
"
",O
FUNDING,O
:,O
Ministry,O
of,O
Science,O
and,O
Technology,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
"
",O
National,O
Natural,O
Science,O
Foundation,O
of,O
China,O
",",O
and,O
Beijing,O
Municipal,O
Science,O
and,O
"
",O
Technology,O
Commission,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)301835,O
"
",O
PMID,O
:,O
31986264,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
877,O
.,O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):514523,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)301549,O
.,O
Epub,O
"
",O
2020,O
Jan,O
24,O
.,O
"

",O
A,O
familial,O
cluster,O
of,O
pneumonia,O
associated,O
with,O
the,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
indicating,O
persontoperson,O
transmission,O
:,O
a,O
study,O
of,O
a,O
family,O
cluster,O
.,O
"

",O
Chan,O
JF(1,O
),O
",",O
Yuan,O
S(2,O
),O
",",O
Kok,O
KH(2,O
),O
",",O
To,O
KK(1,O
),O
",",O
Chu,O
H(2,O
),O
",",O
Yang,O
J(3,O
),O
",",O
Xing,O
F(3,O
),O
",",O
Liu,O
"
",O
J(3,O
),O
",",O
Yip,O
CC(2,O
),O
",",O
Poon,O
RW(2,O
),O
",",O
Tsoi,O
HW(2,O
),O
",",O
Lo,O
SK(3,O
),O
",",O
Chan,O
KH(2,O
),O
",",O
Poon,O
VK(2,O
),O
",",O
Chan,O
"
",O
WM(2,O
),O
",",O
Ip,O
JD(2,O
),O
",",O
Cai,O
JP(2,O
),O
",",O
Cheng,O
VC(2,O
),O
",",O
Chen,O
H(1,O
),O
",",O
Hui,O
CK(4,O
),O
",",O
Yuen,O
KY(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Emerging,O
Infectious,O
Diseases,O
",",O
Carol,O
Yu,O
Centre,O
for,O
"
",O
Infection,O
",",O
Department,O
of,O
Microbiology,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
"
",O
University,O
of,O
Hong,O
Kong,O
",",O
Pokfulam,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
"
",O
China,O
;,O
Department,O
of,O
Clinical,O
Microbiology,O
and,O
Infection,O
Control,O
",",O
The,O
University,O
"
",O
of,O
Hong,O
KongShenzhen,O
Hospital,O
",",O
Shenzhen,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Emerging,O
Infectious,O
Diseases,O
",",O
Carol,O
Yu,O
Centre,O
for,O
"
",O
Infection,O
",",O
Department,O
of,O
Microbiology,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
"
",O
University,O
of,O
Hong,O
Kong,O
",",O
Pokfulam,O
",",O
Hong,O
Kong,O
Special,O
Administrative,O
Region,O
",",O
"
",O
China,O
.,O
"
",O
(3)Department,O
of,O
Clinical,O
Microbiology,O
and,O
Infection,O
Control,O
",",O
The,O
University,O
of,O
"
",O
Hong,O
KongShenzhen,O
Hospital,O
",",O
Shenzhen,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Medicine,O
",",O
The,O
University,O
of,O
Hong,O
KongShenzhen,O
Hospital,O
",",O
"
",O
Shenzhen,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Clinical,O
Microbiology,O
and,O
Infection,O
Control,O
",",O
The,O
University,O
of,O
"
",O
Hong,O
KongShenzhen,O
Hospital,O
",",O
Shenzhen,O
",",O
Guangdong,O
Province,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
kyyuen@hku.hk,O
.,O
"

",O
Comment,O
in,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):470473,O
.,O
"
    ",O
Lancet,O
.,O
2020,O
Jan,O
24;:null,O
.,O
"

",O
BACKGROUND,O
:,O
An,O
ongoing,O
outbreak,O
of,O
pneumonia,O
associated,O
with,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
"
",O
was,O
reported,O
in,O
Wuhan,O
city,O
",",O
Hubei,O
province,O
",",O
China,O
.,O
Affected,O
patients,O
were,O
"
",O
geographically,O
linked,O
with,O
a,O
local,O
wet,O
market,O
as,O
a,O
potential,O
source,O
.,O
No,O
data,O
on,O
"
",O
persontoperson,O
or,O
nosocomial,O
transmission,O
have,O
been,O
published,O
to,O
date,O
.,O
"
",O
METHODS,O
:,O
In,O
this,O
study,O
",",O
we,O
report,O
the,O
epidemiological,O
",",O
clinical,O
",",O
laboratory,O
",",O
"
",O
radiological,O
",",O
and,O
microbiological,O
findings,O
of,O
five,O
patients,O
in,O
a,O
family,O
cluster,O
"
",O
who,O
presented,O
with,O
unexplained,O
pneumonia,O
after,O
returning,O
to,O
Shenzhen,O
",",O
Guangdong,O
"
",O
province,O
",",O
China,O
",",O
after,O
a,O
visit,O
to,O
Wuhan,O
",",O
and,O
an,O
additional,O
family,O
member,O
who,O
did,O
"
",O
not,O
travel,O
to,O
Wuhan,O
.,O
Phylogenetic,O
analysis,O
of,O
genetic,O
sequences,O
from,O
these,O
"
",O
patients,O
were,O
done,O
.,O
"
",O
FINDINGS,O
:,O
From,O
Jan,O
10,O
",",O
2020,O
",",O
we,O
enrolled,O
a,O
family,O
of,O
six,O
patients,O
who,O
travelled,O
"
",O
to,O
Wuhan,O
from,O
Shenzhen,O
between,O
Dec,O
29,O
",",O
2019,O
and,O
Jan,O
4,O
",",O
2020,O
.,O
Of,O
six,O
family,O
"
",O
members,O
who,O
travelled,O
to,O
Wuhan,O
",",O
five,O
were,O
identified,O
as,O
infected,O
with,O
the,O
novel,O
"
",O
coronavirus,O
.,O
Additionally,O
",",O
one,O
family,O
member,O
",",O
who,O
did,O
not,O
travel,O
to,O
Wuhan,O
",",O
became,O
"
",O
infected,O
with,O
the,O
virus,O
after,O
several,O
days,O
of,O
contact,O
with,O
four,O
of,O
the,O
family,O
"
",O
members,O
.,O
None,O
of,O
the,O
family,O
members,O
had,O
contacts,O
with,O
Wuhan,O
markets,O
or,O
animals,O
",",O
"
",O
although,O
two,O
had,O
visited,O
a,O
Wuhan,O
hospital,O
.,O
Five,O
family,O
members,O
(,O
aged,O
3666,O
years,O
),O
"
",O
presented,O
with,O
fever,O
",",O
upper,O
or,O
lower,O
respiratory,O
tract,O
symptoms,O
",",O
or,O
diarrhoea,O
",",O
or,O
"
",O
a,O
combination,O
of,O
these,O
36,O
days,O
after,O
exposure,O
.,O
They,O
presented,O
to,O
our,O
hospital,O
"
",O
(,O
The,O
University,O
of,O
Hong,O
KongShenzhen,O
Hospital,O
",",O
Shenzhen,O
),O
610,O
days,O
after,O
symptom,O
"
",O
onset,O
.,O
They,O
and,O
one,O
asymptomatic,O
child,O
(,O
aged,O
10,O
years,O
),O
had,O
radiological,O
"
",O
groundglass,O
lung,O
opacities,O
.,O
Older,O
patients,O
(,O
aged,O
>,O
60,O
years,O
),O
had,O
more,O
systemic,O
"
",O
symptoms,O
",",O
extensive,O
radiological,O
groundglass,O
lung,O
changes,O
",",O
lymphopenia,O
",",O
"
",O
thrombocytopenia,O
",",O
and,O
increased,O
Creactive,O
protein,O
and,O
lactate,O
dehydrogenase,O
"
",O
levels,O
.,O
The,O
nasopharyngeal,O
or,O
throat,O
swabs,O
of,O
these,O
six,O
patients,O
were,O
negative,O
"
",O
for,O
known,O
respiratory,O
microbes,O
by,O
pointofcare,O
multiplex,O
RTPCR,O
",",O
but,O
five,O
"
",O
patients,O
(,O
four,O
adults,O
and,O
the,O
child,O
),O
were,O
RTPCR,O
positive,O
for,O
genes,O
encoding,O
the,O
"
",O
internal,O
RNAdependent,O
RNA,O
polymerase,O
and,O
surface,O
Spike,O
protein,O
of,O
this,O
novel,O
"
",O
coronavirus,O
",",O
which,O
were,O
confirmed,O
by,O
Sanger,O
sequencing,O
.,O
Phylogenetic,O
analysis,O
of,O
"
",O
these,O
five,O
patients,O
',O
RTPCR,O
amplicons,O
and,O
two,O
full,O
genomes,O
by,O
nextgeneration,O
"
",O
sequencing,O
showed,O
that,O
this,O
is,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
which,O
is,O
closest,O
to,O
the,O
bat,O
"
",O
severe,O
acute,O
respiatory,O
syndrome,O
(SARS)related,O
coronaviruses,O
found,O
in,O
Chinese,O
"
",O
horseshoe,O
bats,O
.,O
"
",O
INTERPRETATION,O
:,O
Our,O
findings,O
are,O
consistent,O
with,O
persontoperson,O
transmission,O
of,O
"
",O
this,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
in,O
hospital,O
and,O
family,O
settings,O
",",O
and,O
the,O
reports,O
of,O
"
",O
infected,O
travellers,O
in,O
other,O
geographical,O
regions,O
.,O
"
",O
FUNDING,O
:,O
The,O
Shaw,O
Foundation,O
Hong,O
Kong,O
",",O
Michael,O
SeakKan,O
Tong,O
",",O
Respiratory,O
Viral,O
"
",O
Research,O
Foundation,O
Limited,O
",",O
Hui,O
Ming,O
",",O
Hui,O
Hoy,O
and,O
Chow,O
Sin,O
Lan,O
Charity,O
Fund,O
"
",O
Limited,O
",",O
Marina,O
ManWai,O
Lee,O
",",O
the,O
Hong,O
Kong,O
Hainan,O
Commercial,O
Association,O
South,O
"
",O
China,O
Microbiology,O
Research,O
Fund,O
",",O
Sanming,O
Project,O
of,O
Medicine,O
(,O
Shenzhen,O
),O
",",O
and,O
"
",O
High,O
LevelHospital,O
Program,O
(,O
Guangdong,O
Health,O
Commission,O
),O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)301549,O
"
",O
PMID,O
:,O
31986261,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
878,O
.,O
Lancet,O
.,O
2020,O
Feb,O
1;395(10221):311,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)301860,O
.,O
Epub,O
2020,O
"
",O
Jan,O
24,O
.,O
"

",O
Emerging,O
understandings,O
of,O
2019nCoV.,O
"

",O
The,O
Lancet,O
.,O
"

",O
Comment,O
on,O
"
    ",O
Lancet,O
.,O
2020,O
Jan,O
24;:null,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)301860,O
"
",O
PMID,O
:,O
31986259,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
879,O
.,O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):469470,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)301847,O
.,O
Epub,O
"
",O
2020,O
Jan,O
24,O
.,O
"

",O
Data,O
sharing,O
and,O
outbreaks,O
:,O
best,O
practice,O
exemplified,O
.,O
"

",O
Heymann,O
DL(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Infectious,O
Disease,O
Epidemiology,O
",",O
London,O
School,O
of,O
Hygiene,O
&,O
Tropical,O
Medicine,O
",",O
"
",O
London,O
WC1E,O
7HT,O
",",O
UK,O
.,O
Electronic,O
address,O
:,O
david.heymann@lshtm.ac.uk,O
.,O
"

",O
Comment,O
in,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
1;395(10221):311,O
.,O
"

",O
Comment,O
on,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):514523,O
.,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):497506,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)301847,O
"
",O
PMID,O
:,O
31986258,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
880,O
.,O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):470473,O
.,O
doi,O
:,O
10.1016,O
S01406736(20)301859,O
.,O
Epub,O
"
",O
2020,O
Jan,O
24,O
.,O
"

",O
A,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
outbreak,O
of,O
global,O
health,O
concern,O
.,O
"

",O
Wang,O
C(1,O
),O
",",O
Horby,O
PW(2,O
),O
",",O
Hayden,O
FG(3,O
),O
",",O
Gao,O
GF(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pulmonary,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Center,O
of,O
Respiratory,O
"
",O
Medicine,O
",",O
ChinaJapan,O
Friendship,O
Hospital,O
",",O
Beijing,O
100029,O
",",O
China,O
;,O
National,O
"
",O
Clinical,O
Research,O
Center,O
for,O
Respiratory,O
Diseases,O
",",O
Beijing,O
",",O
China,O
;,O
Chinese,O
"
",O
Academy,O
of,O
Medical,O
Sciences,O
and,O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
",",O
China,O
;,O
"
",O
Institute,O
of,O
Respiratory,O
Medicine,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
"
",O
China,O
;,O
Department,O
of,O
Respiratory,O
Medicine,O
",",O
Capital,O
Medical,O
University,O
",",O
Beijing,O
",",O
"
",O
China,O
.,O
Electronic,O
address,O
:,O
cyhbirm@263.net,O
.,O
"
",O
(2)Centre,O
for,O
Tropical,O
Medicine,O
and,O
Global,O
Health,O
",",O
University,O
of,O
Oxford,O
",",O
Oxford,O
",",O
"
",O
UK,O
.,O
"
",O
(3)Department,O
of,O
Medicine,O
",",O
University,O
of,O
Virginia,O
School,O
of,O
Medicine,O
",",O
"
",O
Charlottesville,O
",",O
VA,O
",",O
USA,O
.,O
"
",O
(4)National,O
Institute,O
for,O
Viral,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Chinese,O
Center,O
"
",O
for,O
Disease,O
Control,O
and,O
Prevention,O
(,O
China,O
CDC,O
),O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
Erratum,O
in,O
"
    ",O
Lancet,O
.,O
2020,O
Jan,O
29,O
;,O
:,O
.,O
"

",O
Comment,O
in,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
29;395(10225):685,O
.,O
"

",O
Comment,O
on,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):514523,O
.,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
15;395(10223):497506,O
.,O
"

",O
DOI,O
:,O
10.1016,O
S01406736(20)301859,O
"
",O
PMID,O
:,O
31986257,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
881,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Feb,O
27;382(9):866,O
.,O
doi,O
:,O
10.1056,O
NEJMe2001329,O
.,O
Epub,O
2020,O
Jan,O
"
",O
27,O
.,O
"

",O
Medical,O
Journals,O
and,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
Outbreak,O
.,O
"

",O
Rubin,O
EJ,O
",",O
Baden,O
LR,O
",",O
Morrissey,O
S,O
",",O
Campion,O
EW,O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMe2001329,O
"
",O
PMID,O
:,O
31986242,O
"


",O
882,O
.,O
J,O
Travel,O
Med,O
.,O
2020,O
Jan,O
27,O
.,O
pii,O
:,O
taaa011,O
.,O
doi,O
:,O
10.1093,O
jtm,O
taaa011,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Potential,O
for,O
global,O
spread,O
of,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
from,O
China,O
.,O
"

",O
Bogoch,O
II(1)(2,O
),O
",",O
Watts,O
A(3)(4,O
),O
",",O
ThomasBachli,O
A(3)(4,O
),O
",",O
Huber,O
C(3)(4,O
),O
",",O
Kraemer,O
"
",O
MUG(5)(6,O
),O
",",O
Khan,O
K(1)(3)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medicine,O
",",O
University,O
of,O
Toronto,O
",",O
Toronto,O
",",O
Canada,O
.,O
"
",O
(2)Divisions,O
of,O
General,O
Internal,O
Medicine,O
and,O
Infectious,O
Diseases,O
",",O
University,O
"
",O
Health,O
Network,O
",",O
Toronto,O
",",O
Canada,O
.,O
"
",O
(3)Li,O
Ka,O
Shing,O
Knowledge,O
Institute,O
",",O
St.,O
Michael,O
's,O
Hospital,O
",",O
Toronto,O
",",O
Canada,O
.,O
"
",O
(4)BlueDot,O
",",O
Toronto,O
",",O
Canada,O
.,O
"
",O
(5)Department,O
of,O
Zoology,O
",",O
University,O
of,O
Oxford,O
",",O
Oxford,O
",",O
UK,O
.,O
"
",O
(6)Centre,O
for,O
the,O
Mathematical,O
Modelling,O
of,O
Infectious,O
Diseases,O
",",O
London,O
School,O
of,O
"
",O
Hygiene,O
&,O
Tropical,O
Medicine,O
",",O
London,O
",",O
UK,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jtm,O
taaa011,O
"
",O
PMID,O
:,O
31985790,O
"


",O
883,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Apr;92(4):424432,O
.,O
doi,O
:,O
10.1002,O
jmv.25685,O
.,O
Epub,O
2020,O
Feb,O
7,O
.,O
"

",O
Coronavirus,O
infections,O
and,O
immune,O
responses,O
.,O
"

",O
Li,O
G(1)(2,O
),O
",",O
Fan,O
Y(3,O
),O
",",O
Lai,O
Y(3,O
),O
",",O
Han,O
T(3,O
),O
",",O
Li,O
Z(2,O
),O
",",O
Zhou,O
P(1,O
),O
",",O
Pan,O
P(2,O
),O
",",O
Wang,O
"
",O
W(1,O
),O
",",O
Hu,O
D(4,O
),O
",",O
Liu,O
X(5,O
),O
",",O
Zhang,O
Q(1)(6,O
),O
",",O
Wu,O
J(1)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Guangdong,O
Provincial,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Institute,O
of,O
Medical,O
"
",O
Microbiology,O
",",O
Jinan,O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(2)Laboratory,O
Animal,O
Center,O
",",O
Guangzhou,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Guangzhou,O
",",O
"
",O
China,O
.,O
"
",O
(3)The,O
First,O
Clinical,O
Medical,O
College,O
",",O
Guangzhou,O
University,O
of,O
Chinese,O
Medicine,O
",",O
"
",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(5)The,O
First,O
Affiliated,O
Hospital,O
",",O
Guangzhou,O
University,O
of,O
Chinese,O
Medicine,O
",",O
"
",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(6)School,O
of,O
Pubic,O
Health,O
",",O
Southern,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"

",O
Coronaviruses,O
(,O
CoVs,O
),O
are,O
by,O
far,O
the,O
largest,O
group,O
of,O
known,O
positivesense,O
RNA,O
"
",O
viruses,O
having,O
an,O
extensive,O
range,O
of,O
natural,O
hosts,O
.,O
In,O
the,O
past,O
few,O
decades,O
",",O
"
",O
newly,O
evolved,O
Coronaviruses,O
have,O
posed,O
a,O
global,O
threat,O
to,O
public,O
health,O
.,O
The,O
"
",O
immune,O
response,O
is,O
essential,O
to,O
control,O
and,O
eliminate,O
CoV,O
infections,O
",",O
however,O
",",O
"
",O
maladjusted,O
immune,O
responses,O
may,O
result,O
in,O
immunopathology,O
and,O
impaired,O
pulmonary,O
"
",O
gas,O
exchange,O
.,O
Gaining,O
a,O
deeper,O
understanding,O
of,O
the,O
interaction,O
between,O
"
",O
Coronaviruses,O
and,O
the,O
innate,O
immune,O
systems,O
of,O
the,O
hosts,O
may,O
shed,O
light,O
on,O
the,O
"
",O
development,O
and,O
persistence,O
of,O
inflammation,O
in,O
the,O
lungs,O
and,O
hopefully,O
can,O
reduce,O
"
",O
the,O
risk,O
of,O
lung,O
inflammation,O
caused,O
by,O
CoVs,O
.,O
In,O
this,O
review,O
",",O
we,O
provide,O
an,O
"
",O
update,O
on,O
CoV,O
infections,O
and,O
relevant,O
diseases,O
",",O
particularly,O
the,O
host,O
defense,O
"
",O
against,O
CoVinduced,O
inflammation,O
of,O
lung,O
tissue,O
",",O
as,O
well,O
as,O
the,O
role,O
of,O
the,O
"
",O
innate,O
immune,O
system,O
in,O
the,O
pathogenesis,O
and,O
clinical,O
treatment,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25685,O
"
",O
PMID,O
:,O
31981224,O
"


",O
884,O
.,O
Arch,O
Virol,O
.,O
2020,O
Mar;165(3):785788,O
.,O
doi,O
:,O
10.1007,O
s00705020045309,O
.,O
Epub,O
2020,O
"
",O
Jan,O
24,O
.,O
"

",O
Molecular,O
characterization,O
of,O
a,O
novel,O
botoulivirus,O
from,O
the,O
phytopathogenic,O
"
",O
fungus,O
Sclerotinia,O
minor,O
.,O
"

",O
Liang,O
N(1,O
),O
",",O
Yang,O
D(2,O
),O
",",O
Wu,O
M(1,O
),O
",",O
Zhang,O
J(1,O
),O
",",O
Li,O
G(1,O
),O
",",O
Yang,O
L(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
and,O
Hubei,O
Key,O
Laboratory,O
"
",O
of,O
Plant,O
Pathology,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"
",O
(2)Hubei,O
Biopesticide,O
Engineering,O
Research,O
Center,O
",",O
Wuhan,O
",",O
430064,O
",",O
China,O
.,O
"
",O
(3)The,O
State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
and,O
Hubei,O
Key,O
Laboratory,O
"
",O
of,O
Plant,O
Pathology,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"
",O
yanglong@mail.hzau.edu.cn,O
.,O
"

",O
In,O
this,O
study,O
",",O
the,O
complete,O
genomic,O
sequence,O
of,O
a,O
novel,O
botoulivirus,O
(,O
Sclerotinia,O
"
",O
minor,O
botoulivirus,O
1,O
",",O
SmBV1,O
),O
from,O
the,O
phytopathogenic,O
fungus,O
Sclerotinia,O
minor,O
"
",O
strain,O
LC45,O
was,O
determined,O
.,O
The,O
genome,O
of,O
SmBV1,O
is,O
2882,O
nucleotides,O
in,O
length,O
"
",O
and,O
contains,O
a,O
single,O
large,O
open,O
reading,O
frame,O
(,O
ORF,O
),O
encoding,O
a,O
putative,O
"
",O
RNAdependent,O
RNA,O
polymerase,O
(,O
RdRp,O
),O
.,O
Phylogenetic,O
analysis,O
showed,O
that,O
SmBV1,O
"
",O
clustered,O
with,O
the,O
botoulivirus,O
clade,O
within,O
the,O
family,O
Botourmiaviridae,O
.,O
This,O
is,O
"
",O
the,O
first,O
report,O
of,O
a,O
botoulivirus,O
in,O
S.,O
minor,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00705020045309,O
"
",O
PMID,O
:,O
31980938,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
885,O
.,O
Viruses,O
.,O
2020,O
Jan,O
22;12(2,O
),O
.,O
pii,O
:,O
E130,O
.,O
doi,O
:,O
10.339,O
v12020130,O
.,O
"

",O
Emerging,O
Viruses,O
without,O
Borders,O
:,O
The,O
Wuhan,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
.,O
"

",O
Liu,O
SL(1)(2)(3)(4,O
),O
",",O
Saif,O
L(4)(5)(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Center,O
for,O
Retrovirus,O
Research,O
",",O
The,O
Ohio,O
State,O
University,O
",",O
Columbus,O
",",O
OH,O
43210,O
",",O
"
",O
USA,O
.,O
"
",O
(2)Department,O
of,O
Veterinary,O
Biosciences,O
",",O
The,O
Ohio,O
State,O
University,O
",",O
Columbus,O
",",O
OH,O
"
",O
43210,O
",",O
USA,O
.,O
"
",O
(3)Department,O
of,O
Microbial,O
Infection,O
and,O
Immunity,O
",",O
The,O
Ohio,O
State,O
University,O
",",O
"
",O
Columbus,O
",",O
OH,O
43210,O
",",O
USA,O
.,O
"
",O
(4)Viruses,O
and,O
Emerging,O
Pathogens,O
Program,O
",",O
Infectious,O
Diseases,O
Institute,O
",",O
The,O
"
",O
Ohio,O
State,O
University,O
",",O
Columbus,O
",",O
OH,O
43210,O
",",O
USA,O
.,O
"
",O
(5)Food,O
Animal,O
Health,O
Research,O
Program,O
",",O
The,O
Ohio,O
Agricultural,O
Research,O
and,O
"
",O
Development,O
Center,O
",",O
College,O
of,O
Food,O
",",O
Agriculture,O
and,O
Environmental,O
Sciences,O
",",O
The,O
"
",O
Ohio,O
State,O
University,O
",",O
Wooster,O
",",O
OH,O
43210,O
",",O
USA,O
.,O
"
",O
(6)Department,O
of,O
Veterinary,O
Preventive,O
Medicine,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
"
",O
The,O
Ohio,O
State,O
University,O
",",O
Wooster,O
",",O
OH,O
43210,O
",",O
USA,O
.,O
"

",O
The,O
recently,O
emerged,O
coronavirus,O
in,O
Wuhan,O
",",O
China,O
has,O
claimed,O
at,O
least,O
two,O
lives,O
"
",O
as,O
of,O
January,O
17,O
and,O
infected,O
hundreds,O
if,O
not,O
thousands,O
of,O
individuals,O
.,O
The,O
"
",O
situation,O
has,O
drawn,O
international,O
attention,O
",",O
including,O
from,O
the,O
virology,O
"
",O
community,O
.,O
We,O
applaud,O
the,O
rapid,O
release,O
to,O
the,O
public,O
of,O
the,O
genome,O
sequence,O
of,O
"
",O
the,O
new,O
virus,O
by,O
Chinese,O
virologists,O
",",O
but,O
we,O
also,O
believe,O
that,O
increased,O
"
",O
transparency,O
on,O
disease,O
reporting,O
and,O
data,O
sharing,O
with,O
international,O
colleagues,O
"
",O
are,O
crucial,O
for,O
curbing,O
the,O
spread,O
of,O
this,O
newly,O
emerging,O
virus,O
to,O
other,O
parts,O
of,O
"
",O
the,O
world,O
.,O
"

",O
DOI,O
:,O
10.339,O
v12020130,O
"
",O
PMID,O
:,O
31979013,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Drs,O
.,O
ShanLu,O
Liu,O
and,O
Linda,O
Saif,O
are,O
codirectors,O
"
",O
of,O
the,O
Emerging,O
Pathogens,O
Program,O
within,O
the,O
Infectious,O
Diseases,O
Institute,O
at,O
The,O
"
",O
Ohio,O
State,O
University,O
.,O
Dr.,O
ShanLu,O
Liu,O
is,O
the,O
founding,O
President,O
of,O
the,O
"
",O
Association,O
of,O
Chinese,O
Virologists,O
in,O
America,O
(,O
ACVA,O
),O
",",O
a,O
Division,O
of,O
the,O
Society,O
"
",O
of,O
Chinese,O
Bioscientists,O
in,O
America,O
(,O
SCBA,O
),O
.,O
The,O
authors,O
declare,O
no,O
conflict,O
of,O
"
",O
interest,O
.,O
"


",O
886,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Feb,O
20;382(8):727733,O
.,O
doi,O
:,O
10.1056,O
NEJMoa2001017,O
.,O
Epub,O
2020,O
"
",O
Jan,O
24,O
.,O
"

",O
A,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
from,O
Patients,O
with,O
Pneumonia,O
in,O
China,O
",",O
2019,O
.,O
"

",O
Zhu,O
N(1,O
),O
",",O
Zhang,O
D(1,O
),O
",",O
Wang,O
W(1,O
),O
",",O
Li,O
X(1,O
),O
",",O
Yang,O
B(1,O
),O
",",O
Song,O
J(1,O
),O
",",O
Zhao,O
X(1,O
),O
",",O
Huang,O
"
",O
B(1,O
),O
",",O
Shi,O
W(1,O
),O
",",O
Lu,O
R(1,O
),O
",",O
Niu,O
P(1,O
),O
",",O
Zhan,O
F(1,O
),O
",",O
Ma,O
X(1,O
),O
",",O
Wang,O
D(1,O
),O
",",O
Xu,O
W(1,O
),O
",",O
Wu,O
"
",O
G(1,O
),O
",",O
Gao,O
GF(1,O
),O
",",O
Tan,O
W(1,O
),O
;,O
China,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
Investigating,O
and,O
Research,O
"
",O
Team,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
NHC,O
Key,O
Laboratory,O
of,O
Biosafety,O
",",O
National,O
Institute,O
for,O
Viral,O
Disease,O
"
",O
Control,O
and,O
Prevention,O
",",O
Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
(,O
N.Z.,O
",",O
"
",O
W.W.,O
",",O
J.S.,O
",",O
X.Z.,O
",",O
B.H.,O
",",O
R.L.,O
",",O
P.N.,O
",",O
X.M.,O
",",O
D.W.,O
",",O
W.X.,O
",",O
G.W.,O
",",O
G.F.G.,O
",",O
W.T.,O
),O
",",O
and,O
"
",O
the,O
Department,O
of,O
Infectious,O
Diseases,O
",",O
Beijing,O
Ditan,O
Hospital,O
",",O
Capital,O
Medical,O
"
",O
University,O
(,O
X.L.,O
),O
 ,O
both,O
in,O
Beijing,O
;,O
Wuhan,O
Jinyintan,O
Hospital,O
(,O
D.Z.,O
),O
",",O
the,O
"
",O
Division,O
for,O
Viral,O
Disease,O
Detection,O
",",O
Hubei,O
Provincial,O
Center,O
for,O
Disease,O
Control,O
"
",O
and,O
Prevention,O
(,O
B.Y.,O
",",O
F.Z.,O
),O
",",O
and,O
the,O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
(,O
W.T.,O
),O
 ,O
all,O
in,O
Wuhan,O
;,O
and,O
the,O
Shandong,O
First,O
Medical,O
"
",O
University,O
and,O
Shandong,O
Academy,O
of,O
Medical,O
Sciences,O
",",O
Jinan,O
",",O
China,O
(,O
W.S.,O
),O
.,O
"

",O
Comment,O
in,O
"
    ",O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Feb,O
20;382(8):760762,O
.,O
"
    ",O
Lancet,O
.,O
2020,O
Feb,O
8;395(10222):391393,O
.,O
"

",O
In,O
December,O
2019,O
",",O
a,O
cluster,O
of,O
patients,O
with,O
pneumonia,O
of,O
unknown,O
cause,O
was,O
"
",O
linked,O
to,O
a,O
seafood,O
wholesale,O
market,O
in,O
Wuhan,O
",",O
China,O
.,O
A,O
previously,O
unknown,O
"
",O
betacoronavirus,O
was,O
discovered,O
through,O
the,O
use,O
of,O
unbiased,O
sequencing,O
in,O
samples,O
"
",O
from,O
patients,O
with,O
pneumonia,O
.,O
Human,O
airway,O
epithelial,O
cells,O
were,O
used,O
to,O
isolate,O
"
",O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
named,O
2019nCoV,B-Virus_SARS-CoV-2
",",O
which,O
formed,O
a,O
clade,O
within,O
the,O
subgenus,O
"
",O
sarbecovirus,O
",",O
Orthocoronavirinae,O
subfamily,O
.,O
Different,O
from,O
both,O
MERSCoV,O
and,O
"
",O
SARSCoV,O
",",O
2019nCoV,B-Virus_SARS-CoV-2
is,O
the,O
seventh,O
member,O
of,O
the,O
family,O
of,O
coronaviruses,O
that,O
"
",O
infect,O
humans,O
.,O
Enhanced,O
surveillance,O
and,O
further,O
investigation,O
are,O
ongoing,O
.,O
"
",O
(,O
Funded,O
by,O
the,O
National,O
Key,O
Research,O
and,O
Development,O
Program,O
of,O
China,O
and,O
the,O
"
",O
National,O
Major,O
Project,O
for,O
Control,O
and,O
Prevention,O
of,O
Infectious,O
Disease,O
in,O
"
",O
China,O
.,O
),O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Massachusetts,O
Medical,O
Society,O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMoa2001017,O
"
",O
PMID,O
:,O
31978945,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
887,O
.,O
N,O
Engl,O
J,O
Med,O
.,O
2020,O
Feb,O
20;382(8):692694,O
.,O
doi,O
:,O
10.1056,O
NEJMp2000929,O
.,O
Epub,O
2020,O
"
",O
Jan,O
24,O
.,O
"

",O
A,O
Novel,B-Virus_SARS-CoV-2
Coronavirus,I-Virus_SARS-CoV-2
Emerging,O
in,O
China,O
 ,O
Key,O
Questions,O
for,O
Impact,O
Assessment,O
.,O
"

",O
Munster,O
VJ(1,O
),O
",",O
Koopmans,O
M(1,O
),O
",",O
van,O
Doremalen,O
N(1,O
),O
",",O
van,O
Riel,O
D(1,O
),O
",",O
de,O
Wit,O
E(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)From,O
the,O
Laboratory,O
of,O
Virology,O
",",O
National,O
Institute,O
of,O
Allergy,O
and,O
Infectious,O
"
",O
Diseases,O
",",O
National,O
Institutes,O
of,O
Health,O
",",O
Hamilton,O
",",O
MT,O
(,O
V.J.M.,O
",",O
N.D.,O
",",O
E.W.,O
),O
;,O
and,O
"
",O
the,O
Department,O
of,O
Viroscience,O
",",O
Erasmus,O
Medical,O
Center,O
",",O
Rotterdam,O
",",O
the,O
Netherlands,O
"
",O
(,O
M.K.,O
",",O
D.R.,O
),O
.,O
"

",O
DOI,O
:,O
10.1056,O
NEJMp2000929,O
"
",O
PMID,O
:,O
31978293,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
888,O
.,O
Trends,O
Pharmacol,O
Sci,O
.,O
2020,O
Feb;41(2):123138,O
.,O
doi,O
:,O
10.1016,O
j.tips.2019.12.003,O
.,O
"
",O
Epub,O
2020,O
Jan,O
21,O
.,O
"

",O
Immunotherapy,O
for,O
Malignant,O
Glioma,O
:,O
Current,O
Status,O
and,O
Future,O
Directions,O
.,O
"

",O
Wang,O
H(1,O
),O
",",O
Xu,O
T(1,O
),O
",",O
Huang,O
Q(2,O
),O
",",O
Jin,O
W(3,O
),O
",",O
Chen,O
J(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Neurosurgery,O
",",O
Shanghai,O
Institute,O
of,O
Neurosurgery,O
",",O
Changzheng,O
"
",O
Hospital,O
",",O
Second,O
Military,O
Medical,O
University,O
",",O
Shanghai,O
200003,O
",",O
PR,O
China,O
.,O
"
",O
(2)Department,O
of,O
Neurosurgery,O
",",O
Shanghai,O
Institute,O
of,O
Neurosurgery,O
",",O
Changzheng,O
"
",O
Hospital,O
",",O
Second,O
Military,O
Medical,O
University,O
",",O
Shanghai,O
200003,O
",",O
PR,O
China,O
;,O
"
",O
Department,O
of,O
Neurosurgery,O
",",O
General,O
Hospital,O
of,O
Central,O
Theater,O
Command,O
of,O
"
",O
Chinese,O
People,O
's,O
Liberation,O
Army,O
",",O
Wuhan,O
430070,O
",",O
PR,O
China,O
.,O
"
",O
(3)Institute,O
of,O
Nano,O
Biomedicine,O
and,O
Engineering,O
",",O
Department,O
of,O
Instrument,O
"
",O
Science,O
and,O
Engineering,O
",",O
Key,O
Laboratory,O
for,O
Thin,O
Film,O
and,O
Microfabrication,O
"
",O
Technology,O
of,O
Ministry,O
of,O
Education,O
",",O
School,O
of,O
Electronic,O
Information,O
and,O
"
",O
Electronic,O
Engineering,O
",",O
Shanghai,O
Jiao,O
Tong,O
University,O
",",O
Shanghai,O
200240,O
",",O
PR,O
China,O
;,O
"
",O
Center,O
for,O
Translational,O
Medicine,O
",",O
The,O
Affiliated,O
Hospital,O
of,O
Guilin,O
Medical,O
"
",O
University,O
",",O
Guilin,O
541004,O
",",O
PR,O
China,O
.,O
Electronic,O
address,O
:,O
weilinjin@sjtu.edu.cn,O
.,O
"
",O
(4)Department,O
of,O
Neurosurgery,O
",",O
Shanghai,O
Institute,O
of,O
Neurosurgery,O
",",O
Changzheng,O
"
",O
Hospital,O
",",O
Second,O
Military,O
Medical,O
University,O
",",O
Shanghai,O
200003,O
",",O
PR,O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
juxiangchen@smmu.edu.cn,O
.,O
"

",O
Glioma,O
is,O
the,O
most,O
common,O
intracranial,O
primary,O
malignancy,O
",",O
with,O
limited,O
treatment,O
"
",O
options,O
and,O
a,O
poor,O
overall,O
survival,O
(,O
OS,O
),O
.,O
Immunotherapy,O
has,O
been,O
used,O
"
",O
successfully,O
in,O
various,O
cancers,O
",",O
leading,O
to,O
the,O
development,O
of,O
similar,O
therapies,O
"
",O
that,O
activate,O
the,O
patient,O
's,O
immune,O
system,O
to,O
eliminate,O
glioma,O
.,O
In,O
this,O
review,O
",",O
we,O
"
",O
introduce,O
the,O
diverse,O
immunotherapeutic,O
approaches,O
available,O
for,O
treating,O
glioma,O
",",O
"
",O
highlighting,O
the,O
successes,O
and,O
challenges,O
resulting,O
from,O
current,O
clinical,O
trials,O
.,O
"
",O
Additionally,O
",",O
we,O
emphasize,O
the,O
effect,O
of,O
multiple,O
clinical,O
factors,O
on,O
"
",O
immunotherapy,O
to,O
help,O
optimize,O
individualized,O
treatment,O
regimens,O
.,O
Finally,O
",",O
we,O
"
",O
also,O
highlight,O
several,O
novel,O
concepts,O
and,O
technologies,O
that,O
could,O
be,O
used,O
to,O
"
",O
design,O
new,O
and,O
or,O
improve,O
existing,O
immunotherapies,O
.,O
Such,O
approaches,O
will,O
"
",O
delineate,O
a,O
new,O
blueprint,O
for,O
glioma,O
treatment,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.tips.2019.12.003,O
"
",O
PMID,O
:,O
31973881,O
"


",O
889,O
.,O
ACS,O
Chem,O
Biol,O
.,O
2020,O
Feb,O
3,O
.,O
doi,O
:,O
10.1021,O
acschembio.9b00912,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Identification,O
of,O
Interferon,O
Receptor,O
IFNAR2,O
As,O
a,O
Novel,O
HCV,O
Entry,O
Factor,O
by,O
Using,O
"
",O
Chemical,O
Probes,O
.,O
"

",O
Qing,O
J(1)(2,O
),O
",",O
Wu,O
M(2,O
),O
",",O
Luo,O
R(3,O
),O
",",O
Chen,O
J(4,O
),O
",",O
Cao,O
L(5,O
),O
",",O
Zeng,O
D(6,O
),O
",",O
Shang,O
L(6,O
),O
",",O
Nong,O
"
",O
J(3,O
),O
",",O
Wu,O
Q(7,O
),O
",",O
Ding,O
BS(8,O
),O
",",O
Chen,O
X(4,O
),O
",",O
Rao,O
Z(3,O
),O
",",O
Liu,O
L(2,O
),O
",",O
Lou,O
Z(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Research,O
Center,O
of,O
Integrated,O
Traditional,O
Chinese,O
and,O
Western,O
Medicine,O
",",O
"
",O
Affiliated,O
Traditional,O
Medicine,O
Hospital,O
",",O
Southwest,O
Medical,O
University,O
",",O
Luzhou,O
"
",O
646000,O
",",O
China,O
.,O
"
",O
(2)MOE,O
Key,O
Laboratory,O
of,O
Bioorganic,O
Phosphorus,O
Chemistry,O
and,O
Chemical,O
Biology,O
",",O
"
",O
Department,O
of,O
Chemistry,O
",",O
Tsinghua,O
University,O
",",O
Beijing,O
100084,O
",",O
China,O
.,O
"
",O
(3)MOE,O
Key,O
Laboratory,O
of,O
Protein,O
Science,O
and,O
Collaborative,O
Innovation,O
Center,O
for,O
"
",O
Biotherapy,O
",",O
School,O
of,O
Medicine,O
",",O
Tsinghua,O
University,O
",",O
Beijing,O
",",O
100084,O
",",O
China,O
.,O
"
",O
(4)Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430071,O
",",O
"
",O
China,O
.,O
"
",O
(5)State,O
Key,O
Laboratory,O
of,O
Medicinal,O
Chemical,O
Biology,O
",",O
Nankai,O
University,O
",",O
"
",O
Tianjin,O
300350,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(6)College,O
of,O
Pharmacy,O
and,O
State,O
Key,O
Laboratory,O
of,O
ElementoOrganic,O
Chemistry,O
",",O
"
",O
Nankai,O
University,O
",",O
Tianjin,O
300071,O
",",O
China,O
.,O
"
",O
(7)School,O
of,O
Life,O
Science,O
",",O
Sichuan,O
University,O
",",O
Chengdu,O
610064,O
",",O
China,O
.,O
"
",O
(8)Division,O
of,O
Regenerative,O
Medicine,O
",",O
Department,O
of,O
Medicine,O
",",O
Ansary,O
Stem,O
Cell,O
"
",O
Institute,O
",",O
Weill,O
Cornell,O
Medicine,O
",",O
New,O
York,O
",",O
New,O
York,O
10065,O
",",O
United,O
States,O
.,O
"

",O
Upon,O
sensing,O
pathogenassociated,O
patterns,O
and,O
secreting,O
interferons,O
(,O
IFNs,O
),O
into,O
"
",O
the,O
environment,O
",",O
host,O
cells,O
perceive,O
extracellular,O
type,O
I,O
IFNs,O
by,O
the,O
IFNÎ±,O
Î²,O
"
",O
receptors,O
IFNAR1,O
and,O
IFNAR2,O
to,O
stimulate,O
downstream,O
innate,O
immune,O
signaling,O
"
",O
cascades,O
.,O
Through,O
the,O
use,O
of,O
chemical,O
probes,O
",",O
we,O
demonstrated,O
that,O
IFNAR2,O
"
",O
facilitates,O
hepatitis,O
C,O
virus,O
(,O
HCV,O
),O
entry,O
.,O
Silencing,O
of,O
IFNAR2,O
significantly,O
"
",O
attenuated,O
HCV,O
proliferation,O
.,O
IFNAR2,O
binds,O
infectious,O
HCV,O
virions,O
through,O
a,O
"
",O
direct,O
interaction,O
of,O
its,O
D2,O
domain,O
with,O
the,O
Cterminal,O
end,O
of,O
apolipoprotein,O
E,O
"
",O
(,O
apoE,O
),O
on,O
the,O
viral,O
envelope,O
and,O
facilitates,O
virus,O
entry,O
into,O
host,O
cells,O
.,O
The,O
"
",O
antibody,O
against,O
the,O
IFNAR2,O
D2,O
domain,O
attenuates,O
IFNAR2apoE,O
interaction,O
and,O
"
",O
impairs,O
HCV,O
infection,O
.,O
The,O
recombinant,O
IFNAR2,O
protein,O
and,O
the,O
chemical,O
probe,O
"
",O
potently,O
inhibit,O
major,O
HCV,O
genotypes,O
in,O
various,O
human,O
liver,O
cells,O
in,O
vitro,O
.,O
"
",O
Moreover,O
",",O
the,O
impact,O
of,O
a,O
chemical,O
probe,O
on,O
HCV,O
genotype,O
2a,O
is,O
also,O
documented,O
in,O
"
",O
immunecompromised,O
humanized,O
transgenic,O
mice,O
.,O
Our,O
results,O
not,O
only,O
expand,O
the,O
"
",O
understanding,O
of,O
the,O
biology,O
of,O
HCV,O
entry,O
and,O
the,O
virushost,O
relationship,O
but,O
"
",O
also,O
reveal,O
a,O
new,O
target,O
for,O
the,O
development,O
of,O
antiHCV,O
entry,O
inhibitors,O
.,O
"

",O
DOI,O
:,O
10.1021,O
acschembio.9b00912,O
"
",O
PMID,O
:,O
31972076,O
"


",O
890,O
.,O
World,O
J,O
Clin,O
Cases,O
.,O
2020,O
Jan,O
6;8(1):149156,O
.,O
doi,O
:,O
10.12998,O
wjcc.v8.i1.149,O
.,O
"

",O
Large,O
pelvic,O
mass,O
arising,O
from,O
the,O
cervical,O
stump,O
:,O
A,O
case,O
report,O
.,O
"

",O
Zhang,O
K(1,O
),O
",",O
Jiang,O
JH(2,O
),O
",",O
Hu,O
JL(1,O
),O
",",O
Liu,O
YL(1,O
),O
",",O
Zhang,O
XH(1,O
),O
",",O
Wang,O
YM(1,O
),O
",",O
Xue,O
FX,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Obstetrics,O
and,O
Gynecology,O
",",O
Tianjin,O
Medical,O
University,O
General,O
"
",O
Hospital,O
",",O
Tianjin,O
300052,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Obstetrics,O
and,O
Gynecology,O
",",O
Zhongnan,O
Hospital,O
",",O
Wuhan,O
430060,O
",",O
"
",O
Hubei,O
Province,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
A,O
large,O
cervical,O
cyst,O
with,O
a,O
cervical,O
highgrade,O
squamous,O
"
",O
intraepithelial,O
lesion,O
arising,O
from,O
the,O
cervical,O
stump,O
is,O
rare,O
.,O
After,O
"
",O
supracervical,O
hysterectomy,O
",",O
there,O
is,O
a,O
risk,O
of,O
various,O
lesions,O
occurring,O
in,O
the,O
"
",O
cervical,O
stump,O
.,O
We,O
review,O
the,O
types,O
and,O
characteristics,O
of,O
cervical,O
stump,O
lesions,O
"
",O
and,O
compare,O
total,O
hysterectomy,O
with,O
subtotal,O
hysterectomy,O
.,O
Gynecologists,O
should,O
"
",O
choose,O
the,O
most,O
suitable,O
surgical,O
method,O
based,O
on,O
both,O
the,O
patient,O
's,O
condition,O
"
",O
and,O
wishes,O
.,O
If,O
the,O
cervix,O
is,O
retained,O
",",O
patients,O
require,O
a,O
close,O
followup,O
.,O
"
",O
CASE,O
SUMMARY,O
:,O
A,O
57yearold,O
woman,O
was,O
admitted,O
to,O
the,O
Gynecology,O
Department,O
for,O
a,O
"
",O
large,O
pelvic,O
mass,O
.,O
Her,O
chief,O
complaint,O
was,O
abdominal,O
distention,O
for,O
two,O
months,O
.,O
"
",O
She,O
had,O
undergone,O
subtotal,O
supracervical,O
hysterectomy,O
for,O
leiomyoma,O
14,O
years,O
"
",O
prior,O
.,O
Abdominal,O
ultrasonography,O
detected,O
a,O
9.1,O
cm,O
Ã—,O
8.5,O
cm,O
Ã—,O
8.4,O
cm,O
anechoic,O
"
",O
mass,O
with,O
silvery,O
fluid,O
in,O
the,O
pelvic,O
cavity,O
and,O
highrisk,O
human,O
papilloma,O
virus,O
"
",O
53,O
(,O
HPV53,O
),O
was,O
positive,O
.,O
The,O
admission,O
diagnosis,O
we,O
first,O
considered,O
was,O
a,O
pelvic,O
"
",O
mass,O
mimicking,O
carcinoma,O
of,O
the,O
cervical,O
stump,O
.,O
We,O
performed,O
a,O
laparotomy,O
and,O
a,O
"
",O
rapid,O
frozen,O
biopsy,O
was,O
suggestive,O
of,O
a,O
fibrous,O
cyst,O
wall,O
coated,O
with,O
a,O
high,O
"
",O
squamous,O
intraepithelial,O
lesion,O
.,O
The,O
pelvic,O
mass,O
was,O
removed,O
",",O
and,O
a,O
bilateral,O
"
",O
adnexectomy,O
was,O
implemented,O
.,O
Final,O
pathology,O
confirmed,O
that,O
the,O
pelvic,O
mass,O
was,O
a,O
"
",O
large,O
inflammatory,O
cyst,O
with,O
a,O
cervical,O
highgrade,O
squamous,O
intraepithelial,O
"
",O
lesion,O
.,O
After,O
successful,O
intervention,O
",",O
the,O
patient,O
was,O
discharged,O
one,O
week,O
after,O
"
",O
surgery,O
and,O
there,O
was,O
no,O
recurrence,O
of,O
the,O
vaginal,O
stump,O
at,O
43,O
mo,O
.,O
"
",O
CONCLUSION,O
:,O
When,O
addressing,O
benign,O
uterine,O
diseases,O
",",O
gynecologists,O
should,O
pay,O
"
",O
adequate,O
attention,O
to,O
retaining,O
the,O
cervix,O
.,O
If,O
the,O
cervix,O
is,O
retained,O
",",O
patients,O
"
",O
require,O
a,O
close,O
followup,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
Published,O
by,O
Baishideng,O
Publishing,O
Group,O
Inc.,O
All,O
rights,O
"
",O
reserved,O
.,O
"

",O
DOI,O
:,O
10.12998,O
wjcc.v8.i1.149,O
"
",O
PMCID,O
:,O
PMC6962062,O
"
",O
PMID,O
:,O
31970181,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflictofinterest,O
statement,O
:,O
The,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
891,O
.,O
Cell,O
Discov,O
.,O
2020,O
Jan,O
14;6:2,O
.,O
doi,O
:,O
10.1038,O
s4142101901346,O
.,O
eCollection,O
2020,O
.,O
"

",O
Biphasic,O
exocytosis,O
of,O
herpesvirus,O
from,O
hippocampal,O
neurons,O
and,O
mechanistic,O
"
",O
implication,O
to,O
membrane,O
fusion,O
.,O
"

",O
Liu,O
YT(#)(1)(2)(3,O
),O
",",O
Shivakoti,O
S(#)(1)(2)(3,O
),O
",",O
Jia,O
F(4)(5,O
),O
",",O
Tao,O
CL(1)(6,O
),O
",",O
Zhang,O
"
",O
B(6,O
),O
",",O
Xu,O
F(4)(5)(7,O
),O
",",O
Lau,O
P(6,O
),O
",",O
Bi,O
GQ(1)(6)(7,O
),O
",",O
Zhou,O
ZH(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)1Center,O
for,O
Integrative,O
Imaging,O
",",O
Hefei,O
National,O
Laboratory,O
for,O
Physical,O
"
",O
Sciences,O
at,O
the,O
Microscale,O
",",O
and,O
School,O
of,O
Life,O
Sciences,O
",",O
University,O
of,O
Science,O
"
",O
and,O
Technology,O
of,O
China,O
",",O
Hefei,O
",",O
Anhui,O
230026,O
China,O
.,O
"
",O
(2)2California,O
NanoSystems,O
Institute,O
",",O
University,O
of,O
California,O
",",O
Los,O
Angeles,O
"
",O
(,O
UCLA,O
),O
",",O
Los,O
Angeles,O
",",O
CA,O
900957227,O
USA,O
.,O
"
",O
(3)3Department,O
of,O
Microbiology,O
",",O
Immunology,O
and,O
Molecular,O
Genetics,O
",",O
UCLA,O
",",O
Los,O
"
",O
Angeles,O
",",O
CA,O
900957364,O
USA,O
.,O
"
",O
(4)4State,O
Key,O
Laboratory,O
of,O
Magnetic,O
Resonance,O
and,O
Atomic,O
and,O
Molecular,O
Physics,O
",",O
"
",O
Key,O
Laboratory,O
of,O
Magnetic,O
Resonance,O
in,O
Biological,O
Systems,O
",",O
Brain,O
Research,O
"
",O
Center,O
",",O
Wuhan,O
Institute,O
of,O
Physics,O
and,O
Mathematics,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
"
",O
Wuhan,O
",",O
430071,O
China,O
.,O
"
",O
(5)5University,O
of,O
the,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100049,O
China,O
.,O
"
",O
(6)6CAS,O
Key,O
Laboratory,O
of,O
Brain,O
Function,O
and,O
Disease,O
",",O
and,O
School,O
of,O
Life,O
"
",O
Sciences,O
",",O
University,O
of,O
Science,O
and,O
Technology,O
of,O
China,O
",",O
Hefei,O
",",O
Anhui,O
230026,O
"
",O
China,O
.,O
"
",O
(7)7Center,O
for,O
Excellence,O
in,O
Brain,O
Science,O
and,O
Intelligence,O
Technology,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
Shanghai,O
",",O
200031,O
China,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
Exocytosis,O
is,O
a,O
crucial,O
cellular,O
process,O
involved,O
in,O
the,O
release,O
of,O
neural,O
"
",O
transmitters,O
or,O
signaling,O
hormones,O
",",O
and,O
disposal,O
of,O
waste,O
or,O
toxic,O
materials,O
.,O
The,O
"
",O
relationship,O
between,O
structural,O
transition,O
and,O
temporal,O
progression,O
of,O
this,O
"
",O
process,O
is,O
poorly,O
understood,O
",",O
partly,O
due,O
to,O
lack,O
of,O
adequate,O
tools,O
to,O
resolve,O
"
",O
such,O
dynamic,O
structures,O
at,O
sufficient,O
resolution,O
in,O
3D,O
.,O
Exocytosis,O
can,O
be,O
"
",O
hijacked,O
by,O
some,O
viruses,O
",",O
exemplified,O
by,O
the,O
widely,O
used,O
model,O
Î±herpesvirus,O
"
",O
pseudorabies,O
virus,O
(,O
PRV,O
),O
",",O
which,O
relies,O
on,O
exocytosis,O
for,O
transsynaptic,O
spread,O
"
",O
across,O
neurons,O
.,O
Here,O
",",O
we,O
have,O
used,O
cryo,O
electron,O
tomography,O
(,O
cryoET,O
),O
to,O
capture,O
"
",O
199,O
events,O
of,O
PRV,O
exocytosis,O
from,O
cultured,O
hippocampal,O
neurons,O
.,O
We,O
established,O
"
",O
cumulative,O
frequency,O
analysis,O
to,O
estimate,O
the,O
relative,O
duration,O
of,O
an,O
exocytosis,O
"
",O
stage,O
based,O
on,O
the,O
frequency,O
of,O
observed,O
viral,O
particles,O
at,O
that,O
stage,O
.,O
This,O
"
",O
analysis,O
revealed,O
that,O
PRV,O
exocytosis,O
is,O
biphasic,O
",",O
including,O
a,O
fast,O
",",O
"""",O
release,O
"
",O
phase,O
"""",O
driven,O
by,O
fusion,O
proteins,O
and,O
fused,O
membranes,O
",",O
and,O
a,O
slow,O
",",O
"""",O
recovery,O
"
",O
phase,O
"""",O
driven,O
by,O
flattening,O
of,O
curved,O
membranes,O
.,O
The,O
biphasic,O
property,O
of,O
"
",O
exocytosis,O
discovered,O
here,O
appears,O
to,O
be,O
conserved,O
for,O
membrane,O
fusion,O
during,O
"
",O
viral,O
entry,O
",",O
and,O
our,O
approach,O
of,O
cumulative,O
frequency,O
analysis,O
should,O
have,O
"
",O
general,O
utility,O
for,O
characterizing,O
other,O
membrane,O
fusion,O
events,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2020,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s4142101901346,O
"
",O
PMCID,O
:,O
PMC6957672,O
"
",O
PMID,O
:,O
31969988,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflict,O
of,O
interestThe,O
authors,O
declare,O
that,O
they,O
"
",O
have,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
892,O
.,O
J,O
Virol,O
.,O
2020,O
Jan,O
22,O
.,O
pii,O
:,O
JVI.0195719,O
.,O
doi,O
:,O
10.1128,O
JVI.0195719,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Anterograde,O
Viral,O
Tracer,O
HSV1,O
Strain,O
H129,O
Transports,O
Primarily,O
as,O
Capsids,O
in,O
"
",O
Cortical,O
Neuron,O
Axons,O
.,O
"

",O
Dong,O
X(1,O
),O
",",O
Zhou,O
J(1)(2,O
),O
",",O
Qin,O
HB(1)(2,O
),O
",",O
Xin,O
B(3,O
),O
",",O
Huang,O
ZL(3,O
),O
",",O
Li,O
YY(4,O
),O
",",O
Xu,O
X(5,O
),O
",",O
"
",O
Zhao,O
F(6,O
),O
",",O
Zhao,O
C(7,O
),O
",",O
Liu,O
JJ(8)(9,O
),O
",",O
Luo,O
MH(1)(2,O
),O
",",O
Zeng,O
WB(10,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
CAS,O
Center,O
for,O
Excellence,O
in,O
Brain,O
Science,O
"
",O
and,O
Intelligence,O
Technology,O
",",O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Wuhan,O
Institute,O
"
",O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Britton,O
Chance,O
Center,O
for,O
Biomedical,O
Photonics,O
",",O
Wuhan,O
National,O
Laboratory,O
for,O
"
",O
Optoelectronics,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)School,O
of,O
systems,O
science,O
",",O
Beijing,O
Normal,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Anatomy,O
and,O
Neurobiology,O
",",O
School,O
of,O
Medicine,O
",",O
University,O
of,O
"
",O
California,O
",",O
Irvine,O
",",O
CA,O
",",O
USA,O
.,O
"
",O
(6)Chinese,O
Institute,O
for,O
Brain,O
Research,O
;,O
School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
"
",O
Capital,O
Medical,O
"University,,Beijing",O
",",O
China,O
.,O
"
",O
(7)School,O
of,O
Ophthalmology,O
",",O
Central,O
South,O
University,O
",",O
Changsha,O
",",O
China,O
Aier,O
Eye,O
"
",O
Institute,O
",",O
Changsha,O
",",O
China,O
.,O
"
",O
(8)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
jjliu@genetics.ac.cn,O
zengwb@wh.iov.cn,O
.,O
"
",O
(9)State,O
Key,O
Laboratory,O
of,O
Molecular,O
Developmental,O
Biology,O
",",O
CAS,O
Center,O
for,O
"
",O
Excellence,O
in,O
Brain,O
Science,O
and,O
Intelligence,O
Technology,O
",",O
Institute,O
of,O
Genetics,O
"
",O
and,O
Developmental,O
Biology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(10)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
CAS,O
Center,O
for,O
Excellence,O
in,O
Brain,O
Science,O
"
",O
and,O
Intelligence,O
Technology,O
",",O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Wuhan,O
Institute,O
"
",O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
jjliu@genetics.ac.cn,O
"
",O
zengwb@wh.iov.cn,O
.,O
"

",O
The,O
features,O
of,O
HSV1,O
strain,O
129,O
(,O
H129,O
),O
",",O
including,O
natural,O
neurotropism,O
and,O
"
",O
anterograde,O
transneuronal,O
trafficking,O
",",O
make,O
it,O
a,O
potential,O
tool,O
for,O
anterograde,O
"
",O
neural,O
circuitry,O
tracing,O
.,O
Recently,O
anterograde,O
polysynaptic,O
and,O
monosynaptic,O
"
",O
tracers,O
were,O
developed,O
from,O
H129,O
",",O
and,O
have,O
been,O
applied,O
for,O
identification,O
of,O
"
",O
novel,O
connections,O
and,O
functions,O
of,O
different,O
neural,O
circuitries,O
.,O
However,O
",",O
how,O
"
",O
H129,O
viral,O
particles,O
are,O
transported,O
in,O
neurons,O
",",O
especially,O
those,O
of,O
the,O
central,O
"
",O
nervous,O
system,O
remains,O
unclear,O
.,O
In,O
this,O
study,O
",",O
we,O
constructed,O
recombinant,O
H129,O
"
",O
variants,O
with,O
mCherrylabeled,O
capsids,O
and,O
or,O
GFPlabeled,O
envelopes,O
and,O
infected,O
"
",O
the,O
cortical,O
neurons,O
to,O
study,O
axonal,O
transport,O
of,O
H129,O
viral,O
particles,O
.,O
We,O
found,O
"
",O
that,O
different,O
types,O
of,O
viral,O
particles,O
were,O
unevenly,O
distributed,O
in,O
the,O
nucleus,O
",",O
"
",O
cytoplasm,O
of,O
the,O
cell,O
body,O
and,O
axon,O
.,O
Most,O
H129,O
progeny,O
particles,O
were,O
unenveloped,O
"
",O
capsids,O
and,O
transported,O
as,O
capsids,O
rather,O
than,O
virions,O
in,O
the,O
axon,O
.,O
Notably,O
",",O
"
",O
capsids,O
acquired,O
envelopes,O
at,O
axonal,O
varicosities,O
and,O
terminals,O
where,O
are,O
the,O
"
",O
sites,O
forming,O
synapse,O
connected,O
with,O
other,O
neurons,O
.,O
Moreover,O
",",O
viral,O
capsids,O
moved,O
"
",O
more,O
frequently,O
in,O
the,O
anterograde,O
direction,O
in,O
axons,O
",",O
with,O
an,O
average,O
velocity,O
"
",O
of,O
0.62,O
Â±,O
0.18,O
Î¼m,O
s,O
and,O
maximal,O
velocity,O
of,O
1.8,O
Â±,O
0.15,O
Î¼m,O
s.,O
We,O
also,O
provided,O
"
",O
evidence,O
that,O
axonal,O
transport,O
of,O
capsids,O
requires,O
the,O
kinesin1,O
molecular,O
motor,O
.,O
"
",O
These,O
findings,O
support,O
that,O
H129derived,O
tracers,O
mapping,O
neural,O
circuit,O
"
",O
anterogradely,O
and,O
possibly,O
transsynaptically,O
.,O
These,O
data,O
will,O
guide,O
future,O
"
",O
modifications,O
and,O
improvements,O
of,O
the,O
H129based,O
anterograde,O
viral,O
"
",O
tracers,O
.,O
IMPORTANCE,O
Anterograde,O
transneuronal,O
tracers,O
derived,O
from,O
H129,O
virus,O
are,O
"
",O
important,O
tools,O
for,O
mapping,O
neural,O
circuit,O
anatomic,O
and,O
functional,O
connections,O
.,O
"
",O
It,O
is,O
therefore,O
critical,O
to,O
elucidate,O
the,O
transport,O
pattern,O
of,O
H129,O
virus,O
within,O
"
",O
neuron,O
and,O
between,O
neurons,O
.,O
We,O
constructed,O
recombinant,O
H129,O
variants,O
with,O
"
",O
genetically,O
encoded,O
fluorescence,O
labeled,O
capsid,O
protein,O
and,O
or,O
glycoprotein,O
to,O
"
",O
visualize,O
viral,O
particle,O
movement,O
in,O
neurons,O
.,O
Both,O
electron,O
microscopy,O
and,O
light,O
"
",O
microscopy,O
data,O
show,O
that,O
H129,O
capsids,O
and,O
envelopes,O
move,O
separately,O
",",O
and,O
notably,O
"
",O
capsids,O
are,O
enveloped,O
at,O
axonal,O
varicosity,O
and,O
terminal,O
which,O
are,O
the,O
sites,O
"
",O
forming,O
synapse,O
to,O
connect,O
with,O
other,O
neurons,O
.,O
Superresolution,O
microscopybased,O
"
",O
colocalization,O
analysis,O
and,O
inhibition,O
of,O
H129,O
particle,O
movement,O
by,O
inhibitors,O
of,O
"
",O
molecular,O
motors,O
support,O
that,O
kinesin1,O
contributes,O
to,O
the,O
anterograde,O
transport,O
"
",O
of,O
capsids,O
.,O
These,O
results,O
shed,O
light,O
into,O
mechanisms,O
for,O
anterograde,O
transport,O
of,O
"
",O
H129derived,O
tracers,O
',O
transport,O
in,O
axon,O
",",O
and,O
transmission,O
between,O
neurons,O
via,O
"
",O
synapses,O
",",O
explaining,O
the,O
anterograde,O
labeling,O
of,O
neural,O
circuits,O
by,O
H129derived,O
"
",O
tracers,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
American,O
Society,O
for,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1128,O
JVI.0195719,O
"
",O
PMID,O
:,O
31969440,O
"


",O
893,O
.,O
J,O
Virol,O
.,O
2020,O
Jan,O
22,O
.,O
pii,O
:,O
JVI.0171919,O
.,O
doi,O
:,O
10.1128,O
JVI.0171919,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
The,O
late,O
domain,O
of,O
prototype,O
foamy,O
virus,O
Gag,O
facilitates,O
autophagic,O
clearance,O
of,O
"
",O
stress,O
granules,O
by,O
promoting,O
amphisome,O
formation,O
.,O
"

",O
Zheng,O
Y(1)(2,O
),O
",",O
Zhu,O
G(3,O
),O
",",O
Yan,O
J(1)(2,O
),O
",",O
Tang,O
Y(1)(2,O
),O
",",O
Han,O
S(1,O
),O
",",O
Yin,O
J(1,O
),O
",",O
Peng,O
"
",O
B(1,O
),O
",",O
He,O
X(1,O
),O
",",O
Liu,O
W(4)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Hubei,O
Province,O
Key,O
Laboratory,O
of,O
Allergy,O
and,O
Immunology,O
",",O
Department,O
of,O
"
",O
Immunology,O
",",O
School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Shenzhen,O
Research,O
Institute,O
",",O
Wuhan,O
University,O
",",O
Shenzhen,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Emergency,O
",",O
General,O
Hospital,O
of,O
Central,O
Theater,O
Command,O
of,O
"
",O
People,O
's,O
Liberation,O
Army,O
of,O
China,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Hubei,O
Province,O
Key,O
Laboratory,O
of,O
Allergy,O
and,O
Immunology,O
",",O
Department,O
of,O
"
",O
Immunology,O
",",O
School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
liuwanhong@whu.edu.cn,O
.,O
"

",O
Prototype,O
foamy,O
virus,O
(,O
PFV,O
),O
",",O
a,O
complex,O
retrovirus,O
belonging,O
to,O
Spumaretrovirinae,O
",",O
"
",O
maintains,O
lifelong,O
latent,O
infection,O
.,O
The,O
maintenance,O
of,O
lifelong,O
latent,O
infection,O
"
",O
by,O
viruses,O
relies,O
on,O
the,O
repression,O
of,O
the,O
type,O
I,O
interferon,O
(,O
IFN,O
),O
response,O
.,O
"
",O
However,O
",",O
the,O
mechanism,O
involving,O
PFV,O
latency,O
",",O
especially,O
regarding,O
the,O
"
",O
suppression,O
of,O
the,O
IFN,O
response,O
",",O
is,O
poorly,O
understood,O
.,O
Our,O
previous,O
study,O
showed,O
"
",O
that,O
PFV,O
promotes,O
autophagic,O
flux,O
.,O
However,O
",",O
the,O
underlying,O
mechanism,O
and,O
the,O
role,O
"
",O
of,O
PFVinduced,O
autophagy,O
in,O
latent,O
infection,O
have,O
not,O
been,O
clarified,O
.,O
Here,O
",",O
we,O
"
",O
report,O
that,O
the,O
PFV,O
viral,O
structural,O
protein,O
Gag,O
induced,O
amphisome,O
formation,O
and,O
"
",O
triggered,O
autophagic,O
clearance,O
of,O
stress,O
granules,O
(,O
SGs,O
),O
to,O
attenuate,O
type,O
I,O
IFN,O
"
",O
production,O
.,O
Moreover,O
",",O
the,O
late,O
domain,O
(,O
Ldomain,O
),O
of,O
Gag,O
played,O
a,O
central,O
role,O
in,O
"
",O
Alix,O
recruitment,O
",",O
which,O
promoted,O
endosomal,O
sorting,O
complex,O
required,O
for,O
transport,O
"
",O
I,O
(,O
ESCRTI,O
),O
formation,O
and,O
amphisome,O
accumulation,O
by,O
facilitating,O
late,O
endosome,O
"
",O
formation,O
.,O
Our,O
data,O
suggest,O
that,O
PFV,O
Gag,O
represses,O
the,O
host,O
IFN,O
response,O
through,O
"
",O
autophagic,O
clearance,O
of,O
SGs,O
by,O
activating,O
the,O
endosomeautophagy,O
pathway,O
.,O
More,O
"
",O
importantly,O
",",O
we,O
found,O
a,O
novel,O
mechanism,O
by,O
which,O
a,O
retrovirus,O
inhibits,O
the,O
SG,O
"
",O
response,O
to,O
repress,O
the,O
type,O
I,O
IFN,O
response,O
.,O
IMPORTANCE,O
Maintenance,O
of,O
lifelong,O
"
",O
latent,O
infection,O
for,O
viruses,O
relies,O
on,O
the,O
repression,O
of,O
type,O
I,O
IFN,O
response,O
.,O
"
",O
Autophagy,O
plays,O
a,O
double,O
edge,O
sword,O
in,O
antiviral,O
immunity,O
.,O
However,O
",",O
the,O
role,O
of,O
"
",O
autophagy,O
in,O
the,O
regulation,O
of,O
type,O
I,O
IFN,O
response,O
and,O
the,O
mechanism,O
involving,O
"
",O
viruses,O
promote,O
autophagy,O
have,O
not,O
been,O
fully,O
elucidated,O
.,O
SG,O
is,O
an,O
immune,O
complex,O
"
",O
associated,O
with,O
antiviral,O
immune,O
response,O
and,O
is,O
critical,O
for,O
type,O
I,O
IFN,O
"
",O
production,O
.,O
Autophagic,O
clearance,O
of,O
SGs,O
is,O
one,O
degradation,O
way,O
of,O
SGs,O
and,O
is,O
"
",O
associated,O
with,O
regulation,O
of,O
immunity,O
",",O
but,O
the,O
detailed,O
mechanism,O
remains,O
"
",O
unclear,O
.,O
In,O
this,O
article,O
",",O
we,O
demonstrate,O
that,O
PFV,O
Gag,O
recruits,O
ESCRTI,O
to,O
"
",O
facilitate,O
amphisome,O
formation,O
.,O
Our,O
data,O
also,O
suggested,O
that,O
amphisome,O
formation,O
"
",O
is,O
critical,O
event,O
for,O
autophagic,O
clearance,O
of,O
SGs,O
and,O
repression,O
of,O
the,O
type,O
I,O
"
",O
IFN,O
response,O
.,O
More,O
importantly,O
",",O
we,O
found,O
a,O
novel,O
mechanism,O
by,O
which,O
a,O
retrovirus,O
"
",O
inhibits,O
the,O
SG,O
response,O
to,O
repress,O
the,O
type,O
I,O
IFN,O
response,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
American,O
Society,O
for,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1128,O
JVI.0171919,O
"
",O
PMID,O
:,O
31969431,O
"


",O
894,O
.,O
BMJ,O
.,O
2020,O
Jan,O
22;368:m265,O
.,O
doi,O
:,O
10.1136,O
bmj.m265,O
.,O
"

",O
Coronavirus,O
:,O
UK,O
screens,O
direct,O
flights,O
from,O
Wuhan,O
after,O
US,O
case,O
.,O
"

",O
Mahase,O
E(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
BMJ,O
.,O
"

",O
DOI,O
:,O
10.1136,O
bmj.m265,O
"
",O
PMID,O
:,O
31969317,O
"


",O
895,O
.,O
PLoS,O
Pathog,O
.,O
2020,O
Jan,O
22;16(1):e1008178,O
.,O
doi,O
:,O
10.1371,O
journal.ppat.1008178,O
.,O
"
",O
eCollection,O
2020,O
Jan.,O
"

",O
USP44,O
positively,O
regulates,O
innate,O
immune,O
response,O
to,O
DNA,O
viruses,O
through,O
"
",O
deubiquitinating,O
MITA,O
.,O
"

",O
Zhang,O
HY(1)(2,O
),O
",",O
Liao,O
BW(1)(2,O
),O
",",O
Xu,O
ZS(1,O
),O
",",O
Ran,O
Y(1,O
),O
",",O
Wang,O
DP(1)(2,O
),O
",",O
Yang,O
Y(1,O
),O
",",O
Luo,O
"
",O
WW(1,O
),O
",",O
Wang,O
YY(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
Mediator,O
of,O
IRF3,O
activation,O
(,O
MITA,O
",",O
also,O
known,O
as,O
stimulator,O
of,O
interferon,O
genes,O
",",O
"
",O
STING,O
),O
senses,O
the,O
second,O
messenger,O
cyclic,O
GMPAMP,O
(,O
cGAMP,O
),O
which,O
is,O
synthesized,O
"
",O
upon,O
DNA,O
virus,O
infection,O
and,O
activates,O
innate,O
antiviral,O
immune,O
response,O
.,O
It,O
has,O
"
",O
been,O
demonstrated,O
that,O
the,O
activity,O
of,O
MITA,O
is,O
delicately,O
regulated,O
by,O
various,O
"
",O
posttranslational,O
modifications,O
including,O
polyubiquitination,O
.,O
In,O
this,O
study,O
",",O
we,O
"
",O
identified,O
the,O
deubiquitinating,O
enzyme,O
USP44,O
as,O
a,O
positive,O
regulator,O
of,O
MITA,O
.,O
"
",O
USP44,O
is,O
recruited,O
to,O
MITA,O
following,O
DNA,O
virus,O
infection,O
and,O
removes,O
K48linked,O
"
",O
polyubiquitin,O
moieties,O
from,O
MITA,O
at,O
K236,O
",",O
therefore,O
prevents,O
MITA,O
from,O
proteasome,O
"
",O
mediated,O
degradation,O
.,O
USP44deficiency,O
results,O
in,O
acceleration,O
of,O
HSV1induced,O
"
",O
degradation,O
of,O
MITA,O
and,O
reduced,O
induction,O
of,O
type,O
I,O
interferons,O
(,O
IFNs,O
),O
and,O
"
",O
proinflammatory,O
cytokines,O
.,O
Consistently,O
",",O
Usp44,O
 ,O
mice,O
are,O
more,O
susceptible,O
to,O
"
",O
HSV1,O
infection,O
as,O
indicated,O
by,O
higher,O
tissue,O
viral,O
titers,O
",",O
greater,O
tissue,O
damage,O
"
",O
and,O
lower,O
survival,O
rate,O
.,O
These,O
findings,O
suggest,O
that,O
USP44,O
plays,O
a,O
specific,O
and,O
"
",O
critical,O
role,O
in,O
the,O
regulation,O
of,O
innate,O
immune,O
response,O
against,O
DNA,O
viruses,O
.,O
"

",O
DOI,O
:,O
10.1371,O
journal.ppat.1008178,O
"
",O
PMCID,O
:,O
PMC6975528,O
"
",O
PMID,O
:,O
31968013,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
have,O
declared,O
that,O
no,O
competing,O
"
",O
interests,O
exist,O
.,O
"


",O
896,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Apr;92(4):418423,O
.,O
doi,O
:,O
10.1002,O
jmv.25681,O
.,O
Epub,O
2020,O
Feb,O
7,O
.,O
"

",O
Emerging,O
coronaviruses,O
:,O
Genome,O
structure,O
",",O
replication,O
",",O
and,O
pathogenesis,O
.,O
"

",O
Chen,O
Y(1,O
),O
",",O
Liu,O
Q(1,O
),O
",",O
Guo,O
D(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Modern,O
Virology,O
Research,O
Center,O
",",O
College,O
of,O
"
",O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Center,O
for,O
Infection,O
and,O
Immunity,O
Study,O
",",O
School,O
of,O
Medicine,O
",",O
Sun,O
Yatsen,O
"
",O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"

",O
The,O
recent,O
emergence,O
of,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
(,O
2019nCoV,B-Virus_SARS-CoV-2
),O
",",O
which,O
is,O
causing,O
an,O
"
",O
outbreak,O
of,O
unusual,O
viral,O
pneumonia,O
in,O
patients,O
in,O
Wuhan,O
",",O
a,O
central,O
city,O
in,O
"
",O
China,O
",",O
is,O
another,O
warning,O
of,O
the,O
risk,O
of,O
CoVs,O
posed,O
to,O
public,O
health,O
.,O
In,O
this,O
"
",O
minireview,O
",",O
we,O
provide,O
a,O
brief,O
introduction,O
of,O
the,O
general,O
features,O
of,O
CoVs,O
and,O
"
",O
describe,O
diseases,O
caused,O
by,O
different,O
CoVs,O
in,O
humans,O
and,O
animals,O
.,O
This,O
review,O
"
",O
will,O
help,O
understand,O
the,O
biology,O
and,O
potential,O
risk,O
of,O
CoVs,O
that,O
exist,O
in,O
"
",O
richness,O
in,O
wildlife,O
such,O
as,O
bats,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25681,O
"
",O
PMID,O
:,O
31967327,O
"


",O
897,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Apr;92(4):433440,O
.,O
doi,O
:,O
10.1002,O
jmv.25682,O
.,O
"

",O
Crossspecies,O
transmission,O
of,O
the,O
newly,O
identified,O
coronavirus,O
2019nCoV.,O
"

",O
Ji,O
W(1,O
),O
",",O
Wang,O
W(2,O
),O
",",O
Zhao,O
X(3,O
),O
",",O
Zai,O
J(4,O
),O
",",O
Li,O
X(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Microbiology,O
",",O
Peking,O
University,O
Health,O
Science,O
Center,O
School,O
of,O
"
",O
Basic,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Spleen,O
and,O
Stomach,O
Diseases,O
",",O
The,O
First,O
affiliated,O
Hospital,O
of,O
"
",O
Guangxi,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Nanning,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Science,O
and,O
Technology,O
",",O
Ruikang,O
Hospital,O
Affiliated,O
to,O
Guangxi,O
"
",O
University,O
of,O
Chinese,O
Medicine,O
",",O
Nanning,O
",",O
China,O
.,O
"
",O
(4)Immunology,O
Innovation,O
Team,O
",",O
School,O
of,O
Medicine,O
",",O
Ningbo,O
University,O
",",O
Ningbo,O
",",O
"
",O
China,O
.,O
"
",O
(5)Hubei,O
Engineering,O
Research,O
Center,O
of,O
Viral,O
Vector,O
",",O
Wuhan,O
University,O
of,O
"
",O
Bioengineering,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
The,O
current,O
outbreak,O
of,O
viral,O
pneumonia,O
in,O
the,O
city,O
of,O
Wuhan,O
",",O
China,O
",",O
was,O
caused,O
"
",O
by,O
a,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
designated,O
2019nCoV,B-Virus_SARS-CoV-2
by,O
the,O
World,O
Health,O
Organization,O
",",O
as,O
"
",O
determined,O
by,O
sequencing,O
the,O
viral,O
RNA,O
genome,O
.,O
Many,O
initial,O
patients,O
were,O
exposed,O
"
",O
to,O
wildlife,O
animals,O
at,O
the,O
Huanan,O
seafood,O
wholesale,O
market,O
",",O
where,O
poultry,O
",",O
snake,O
",",O
"
",O
bats,O
",",O
and,O
other,O
farm,O
animals,O
were,O
also,O
sold,O
.,O
To,O
investigate,O
possible,O
virus,O
"
",O
reservoir,O
",",O
we,O
have,O
carried,O
out,O
comprehensive,O
sequence,O
analysis,O
and,O
comparison,O
in,O
"
",O
conjunction,O
with,O
relative,O
synonymous,O
codon,O
usage,O
(,O
RSCU,O
),O
bias,O
among,O
different,O
"
",O
animal,O
species,O
based,O
on,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
sequence,O
.,O
Results,O
obtained,O
from,O
our,O
"
",O
analyses,O
suggest,O
that,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
may,O
appear,O
to,O
be,O
a,O
recombinant,O
virus,O
between,O
"
",O
the,O
bat,O
coronavirus,O
and,O
an,O
originunknown,O
coronavirus,O
.,O
The,O
recombination,O
may,O
"
",O
occurred,O
within,O
the,O
viral,O
spike,O
glycoprotein,O
",",O
which,O
recognizes,O
a,O
cell,O
surface,O
"
",O
receptor,O
.,O
Additionally,O
",",O
our,O
findings,O
suggest,O
that,O
2019nCoV,B-Virus_SARS-CoV-2
has,O
most,O
similar,O
"
",O
genetic,O
information,O
with,O
bat,O
coronovirus,O
and,O
most,O
similar,O
codon,O
usage,O
bias,O
with,O
"
",O
snake,O
.,O
Taken,O
together,O
",",O
our,O
results,O
suggest,O
that,O
homologous,O
recombination,O
may,O
"
",O
occur,O
and,O
contribute,O
to,O
the,O
2019nCoV,B-Virus_SARS-CoV-2
crossspecies,O
transmission,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25682,O
"
",O
PMID,O
:,O
31967321,O
"


",O
898,O
.,O
Nature,O
.,O
2020,O
Jan;577(7791):450,O
.,O
doi,O
:,O
10.1038,O
d4158602000153x,O
.,O
"

",O
Stop,O
the,O
Wuhan,B-Virus_SARS-CoV-2
virus,I-Virus_SARS-CoV-2
.,O
"

",O
[,O
No,O
authors,O
listed,O
],O
"

",O
DOI,O
:,O
10.1038,O
d4158602000153x,O
"
",O
PMID,O
:,O
31965110,O
"


",O
899,O
.,O
Antibiotics,O
(,O
Basel,O
),O
.,O
2020,O
Jan,O
17;9(1,O
),O
.,O
pii,O
:,O
E33,O
.,O
doi,O
:,O
10.339,O
antibiotics9010033,O
.,O
"

",O
Inhibitory,O
Activity,O
of,O
a,O
Scorpion,O
Defensin,O
BmKDfsin3,O
against,O
Hepatitis,O
C,O
Virus,O
.,O
"

",O
Cheng,O
Y(1,O
),O
",",O
Sun,O
F(1,O
),O
",",O
Li,O
S(1,O
),O
",",O
Gao,O
M(1,O
),O
",",O
Wang,O
L(1,O
),O
",",O
Sarhan,O
M(2,O
),O
",",O
AbdelRahman,O
"
",O
MA(3,O
),O
",",O
Li,O
W(1,O
),O
",",O
Kwok,O
HF(4,O
),O
",",O
Wu,O
Y(1,O
),O
",",O
Cao,O
Z(1)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Modern,O
Virology,O
Research,O
Center,O
",",O
College,O
of,O
"
",O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
430072,O
",",O
China,O
.,O
"
",O
(2)Zoology,O
Department,O
",",O
AlAzhar,O
University,O
",",O
Assuit,O
71524,O
",",O
Egypt,O
.,O
"
",O
(3)Zoology,O
Department,O
",",O
Faculty,O
of,O
Science,O
",",O
Suez,O
Canal,O
University,O
",",O
Ismailia,O
41522,O
",",O
"
",O
Egypt,O
.,O
"
",O
(4)Institute,O
of,O
Translational,O
Medicine,O
",",O
Faculty,O
of,O
Health,O
Sciences,O
",",O
University,O
of,O
"
",O
Macau,O
",",O
Avenida,O
de,O
Universidade,O
",",O
Taipa,O
",",O
Macau,O
999078,O
",",O
China,O
.,O
"
",O
(5)Hubei,O
Province,O
Engineering,O
and,O
Technology,O
Research,O
",",O
Center,O
for,O
Fluorinated,O
"
",O
Pharmaceuticals,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
430072,O
",",O
China,O
.,O
"

",O
Hepatitis,O
C,O
virus,O
(,O
HCV,O
),O
infection,O
is,O
a,O
major,O
worldwide,O
health,O
problem,O
which,O
can,O
"
",O
cause,O
chronic,O
hepatitis,O
",",O
liver,O
fibrosis,O
and,O
hepatocellular,O
carcinoma,O
(,O
HCC,O
),O
.,O
There,O
"
",O
is,O
still,O
no,O
vaccine,O
to,O
prevent,O
HCV,O
infection,O
.,O
Currently,O
",",O
the,O
clinical,O
treatment,O
"
",O
of,O
HCV,O
infection,O
mainly,O
relies,O
on,O
the,O
use,O
of,O
directacting,O
antivirals,O
(,O
DAAs,O
),O
"
",O
which,O
are,O
expensive,O
and,O
have,O
side,O
effects,O
.,O
Here,O
",",O
BmKDfsin3,O
",",O
a,O
scorpion,O
defensin,O
"
",O
from,O
the,O
venom,O
of,O
Mesobuthus,O
martensii,O
Karsch,O
",",O
is,O
found,O
to,O
dosedependently,O
"
",O
inhibit,O
HCV,O
infection,O
at,O
noncytotoxic,O
concentrations,O
and,O
affect,O
viral,O
attachment,O
"
",O
and,O
postentry,O
in,O
HCV,O
life,O
cycle,O
.,O
Further,O
experimental,O
results,O
show,O
that,O
"
",O
BmKDfsin3,O
not,O
only,O
suppresses,O
p38,O
mitogenactivated,O
protein,O
kinase,O
(,O
MAPK,O
),O
"
",O
activation,O
of,O
HCVinfected,O
Huh7.5.1,O
cells,O
",",O
but,O
also,O
inhibits,O
p38,O
activation,O
of,O
"
",O
Huh7.5.1,O
cells,O
stimulated,O
by,O
tumor,O
necrosis,O
factorÎ±,O
(,O
TNFÎ±,O
),O
",",O
interleukin1Î²,O
"
",O
(,O
IL1Î²,O
),O
or,O
lipopolysaccharide,O
(,O
LPS,O
),O
.,O
BmKDfsin3,O
is,O
also,O
revealed,O
to,O
enter,O
into,O
"
",O
cells,O
.,O
Using,O
an,O
upstream,O
MyD88,O
dimerization,O
inhibitor,O
ST2345,O
or,O
kinase,O
IRAK1,O
4,O
"
",O
inhibitor,O
I,O
",",O
the,O
inhibition,O
of,O
p38,O
activation,O
represses,O
HCV,O
replication,O
in,O
vitro,O
.,O
"
",O
Taken,O
together,O
",",O
a,O
scorpion,O
defensin,O
BmKDfsin3,O
inhibits,O
HCV,O
replication,O
",",O
related,O
"
",O
to,O
regulated,O
p38,O
MAPK,O
activation,O
.,O
"

",O
DOI,O
:,O
10.339,O
antibiotics9010033,O
"
",O
PMID,O
:,O
31963532,O
"


",O
900,O
.,O
Chemosphere,O
.,O
2020,O
Jan,O
13;247:125913,O
.,O
doi,O
:,O
10.1016,O
j.chemosphere.2020.125913,O
.,O
"
",O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Fine,O
particulate,O
matter,O
and,O
causespecific,O
mortality,O
in,O
the,O
Hong,O
Kong,O
elder,O
"
",O
patients,O
with,O
chronic,O
kidney,O
disease,O
.,O
"

",O
Ran,O
J(1,O
),O
",",O
Sun,O
S(2,O
),O
",",O
Han,O
L(3,O
),O
",",O
Zhao,O
S(4,O
),O
",",O
Chen,O
D(5,O
),O
",",O
Guo,O
F(1,O
),O
",",O
Li,O
J(1,O
),O
",",O
Qiu,O
H(6,O
),O
",",O
"
",O
Lei,O
Y(7,O
),O
",",O
Tian,O
L(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Public,O
Health,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
University,O
of,O
"
",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Epidemiology,O
",",O
Brown,O
University,O
School,O
of,O
Public,O
Health,O
",",O
"
",O
Providence,O
",",O
RI,O
",",O
2912,O
",",O
USA,O
.,O
"
",O
(3)School,O
of,O
Nursing,O
",",O
The,O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Applied,O
Mathematics,O
",",O
The,O
Hong,O
Kong,O
Polytechnic,O
University,O
",",O
"
",O
China,O
.,O
"
",O
(5)Department,O
of,O
Global,O
Health,O
",",O
School,O
of,O
Health,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(6)Institute,O
of,O
Environment,O
",",O
Energy,O
and,O
Sustainability,O
",",O
The,O
Chinese,O
University,O
of,O
"
",O
Hong,O
Kong,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Thoracic,O
Surgery,O
I,O
",",O
The,O
Third,O
Affiliated,O
Hospital,O
of,O
Kunming,O
"
",O
Medical,O
University,O
",",O
Yunnan,O
Cancer,O
Hospital,O
",",O
Kunming,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
13888952499@139.com,O
.,O
"
",O
(8)School,O
of,O
Public,O
Health,O
",",O
Li,O
Ka,O
Shing,O
Faculty,O
of,O
Medicine,O
",",O
The,O
University,O
of,O
"
",O
Hong,O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
linweit@hku.hk,O
.,O
"

",O
Emerging,O
epidemiologic,O
studies,O
suggested,O
that,O
particulate,O
matter,O
(,O
PM,O
),O
was,O
a,O
risk,O
"
",O
factor,O
for,O
the,O
incidence,O
of,O
chronic,O
kidney,O
disease,O
(,O
CKD,O
),O
.,O
However,O
",",O
few,O
studies,O
"
",O
were,O
conducted,O
to,O
examine,O
whether,O
PM,O
was,O
associated,O
with,O
causespecific,O
deaths,O
in,O
"
",O
the,O
CKD,O
progression,O
.,O
This,O
study,O
aimed,O
to,O
estimate,O
the,O
association,O
between,O
fine,O
"
",O
particulate,O
matter,O
(,O
PM2.5,O
),O
and,O
a,O
spectrum,O
of,O
deaths,O
among,O
CKD,O
patients,O
.,O
We,O
took,O
"
",O
leverage,O
of,O
the,O
Elderly,O
Health,O
Service,O
cohort,O
(,O
n,O
Â ,O
=,O
Â ,O
66820,O
),O
",",O
a,O
large,O
Hong,O
Kong,O
"
",O
elderly,O
cohort,O
followed,O
up,O
till,O
2010,O
.,O
A,O
total,O
of,O
902,O
CKD,O
incident,O
patients,O
in,O
the,O
"
",O
cohort,O
were,O
identified,O
during,O
the,O
followup,O
period,O
.,O
We,O
estimated,O
yearly,O
PM2.5,O
at,O
"
",O
the,O
residential,O
address,O
for,O
each,O
CKD,O
patient,O
based,O
on,O
a,O
satellitebased,O
"
",O
spatiotemporal,O
model,O
.,O
We,O
used,O
Cox,O
proportional,O
hazards,O
models,O
with,O
attained,O
age,O
"
",O
as,O
the,O
underlying,O
timescale,O
to,O
assess,O
the,O
association,O
between,O
longterm,O
exposure,O
"
",O
to,O
PM2.5,O
and,O
causespecific,O
mortality,O
among,O
CKD,O
patients,O
.,O
A,O
total,O
of,O
496,O
patients,O
"
",O
died,O
during,O
the,O
followup,O
",",O
where,O
147,O
died,O
from,O
cardiovascular,O
disease,O
",",O
61,O
from,O
"
",O
respiratory,O
disease,O
and,O
154,O
from,O
renal,O
failure,O
.,O
The,O
mortality,O
hazard,O
ratio,O
(,O
HR,O
),O
"
",O
per,O
interquartilerange,O
increase,O
in,O
PM2.5,O
(,O
4,O
Â ,O
Î¼g,O
m3,O
),O
was,O
1.97,O
(,O
95,O
%,O
confidence,O
"
",O
interval,O
(,O
CI,O
),O
:,O
1.34,O
to,O
2.91,O
),O
for,O
ischemic,O
heart,O
disease,O
(,O
IHD,O
),O
among,O
CKD,O
patients,O
",",O
"
",O
and,O
was,O
1.42,O
(,O
95%CI,O
:,O
1.05,O
to,O
1.93,O
),O
for,O
CKD,O
among,O
those,O
patients,O
concomitantly,O
"
",O
with,O
hypertension,O
.,O
Associations,O
were,O
not,O
of,O
statistical,O
significance,O
between,O
"
",O
PM2.5,O
and,O
mortality,O
hazard,O
ratios,O
of,O
allcause,O
",",O
stroke,O
",",O
and,O
pneumonia,O
among,O
CKD,O
"
",O
patients,O
.,O
Our,O
findings,O
suggest,O
that,O
longterm,O
exposure,O
to,O
PM2.5,O
may,O
contribute,O
to,O
"
",O
the,O
CKD,O
progression,O
into,O
ischemic,O
heart,O
diseases,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.chemosphere.2020.125913,O
"
",O
PMID,O
:,O
31962222,O
"


",O
901,O
.,O
Am,O
J,O
Physiol,O
Endocrinol,O
Metab,O
.,O
2020,O
Mar,O
1;318(3):E318E329,O
.,O
doi,O
:,O
"
",O
10.1152,O
ajpendo.00424.2019,O
.,O
Epub,O
2020,O
Jan,O
21,O
.,O
"

",O
Enoyl,O
coenzyme,O
A,O
hydratase,O
1,O
combats,O
obesity,O
and,O
related,O
metabolic,O
disorders,O
by,O
"
",O
promoting,O
adipose,O
tissue,O
browning,O
.,O
"

",O
Mao,O
X(1)(2,O
),O
",",O
Huang,O
D(1)(2,O
),O
",",O
Rao,O
C(3,O
),O
",",O
Du,O
M(1)(2,O
),O
",",O
Liang,O
M(2,O
),O
",",O
Li,O
F(4,O
),O
",",O
Liu,O
B(4,O
),O
",",O
"
",O
Huang,O
K(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Cardiology,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Clinic,O
Center,O
of,O
Human,O
Gene,O
Research,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Geriatrics,O
",",O
Tongji,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Cardiovascular,O
Surgery,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
Browning,O
of,O
white,O
adipose,O
tissue,O
(,O
WAT,O
),O
has,O
been,O
recognized,O
as,O
an,O
important,O
"
",O
strategy,O
for,O
the,O
treatment,O
of,O
obesity,O
",",O
insulin,O
resistance,O
",",O
and,O
diabetes,O
.,O
Enoyl,O
"
",O
coenzyme,O
A,O
hydratase,O
1,O
(,O
ECH1,O
),O
is,O
a,O
widely,O
known,O
enzyme,O
involved,O
in,O
lipid,O
"
",O
metabolism,O
.,O
However,O
",",O
whether,O
and,O
how,O
ECH1,O
is,O
implicated,O
in,O
browning,O
of,O
WAT,O
remain,O
"
",O
obscure,O
.,O
Adenoassociated,O
",",O
virusmediated,O
genetic,O
engineering,O
of,O
ECH1,O
in,O
adipose,O
"
",O
tissue,O
was,O
used,O
in,O
investigations,O
in,O
mouse,O
models,O
of,O
obesity,O
induced,O
by,O
a,O
"
",O
highfat,O
diet,O
(,O
HFD,O
),O
or,O
browning,O
induced,O
by,O
cold,O
exposure,O
.,O
Metabolic,O
parameters,O
"
",O
showed,O
that,O
ECH1,O
overexpression,O
decreased,O
weight,O
gain,O
and,O
improved,O
insulin,O
"
",O
sensitivity,O
and,O
lipid,O
profile,O
after,O
8,O
wk,O
of,O
an,O
HFD,O
.,O
Further,O
work,O
revealed,O
that,O
"
",O
these,O
changes,O
were,O
associated,O
with,O
enhanced,O
energy,O
expenditure,O
and,O
increased,O
"
",O
appearance,O
of,O
brownlike,O
adipocytes,O
in,O
inguinal,O
WAT,O
",",O
as,O
verified,O
by,O
a,O
remarkable,O
"
",O
increase,O
in,O
uncoupling,O
protein,O
1,O
and,O
thermogenic,O
gene,O
expression,O
.,O
In,O
vitro,O
",",O
ECH1,O
"
",O
induced,O
brown,O
fatrelated,O
gene,O
expression,O
in,O
adipocytes,O
differentiated,O
from,O
"
",O
primary,O
stromal,O
vascular,O
fractions,O
",",O
whereas,O
knockdown,O
of,O
ECH1,O
reversed,O
this,O
"
",O
effect,O
.,O
Mechanistically,O
",",O
ECH1,O
regulated,O
the,O
thermogenic,O
program,O
by,O
inhibiting,O
"
",O
mammalian,O
target,O
of,O
rapamycin,O
signaling,O
",",O
which,O
may,O
partially,O
explain,O
the,O
"
",O
potential,O
mechanism,O
for,O
ECH1,O
regulating,O
adipose,O
browning,O
.,O
In,O
summary,O
",",O
ECH1,O
may,O
"
",O
participate,O
in,O
the,O
pathology,O
of,O
obesity,O
by,O
regulating,O
browning,O
of,O
WAT,O
",",O
which,O
"
",O
probably,O
provides,O
us,O
with,O
a,O
new,O
therapeutic,O
strategy,O
for,O
combating,O
obesity,O
.,O
"

",O
DOI,O
:,O
10.1152,O
ajpendo.00424.2019,O
"
",O
PMID,O
:,O
31961704,O
"


",O
902,O
.,O
J,O
Gen,O
Virol,O
.,O
2020,O
Feb;101(2):143144,O
.,O
doi,O
:,O
10.1099,O
jgv.0.001383,O
.,O
"

",O
ICTV,O
Virus,O
Taxonomy,O
Profile,O
:,O
Chrysoviridae,O
.,O
"

",O
KottaLoizou,O
I(1,O
),O
",",O
CastÃ³n,O
JR(2,O
),O
",",O
Coutts,O
RHA(3,O
),O
",",O
Hillman,O
BI(4,O
),O
",",O
Jiang,O
D(5,O
),O
",",O
Kim,O
"
",O
DH(6,O
),O
",",O
Moriyama,O
H(7,O
),O
",",O
Suzuki,O
N(8,O
),O
",",O
Ictv,O
Report,O
Consortium,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Imperial,O
College,O
London,O
",",O
London,O
",",O
SW7,O
2AZ,O
",",O
UK,O
.,O
"
",O
(2)Centro,O
Nacional,O
BiotecnologÃ­a,O
CSIC,O
",",O
28049,O
Madrid,O
",",O
Spain,O
.,O
"
",O
(3)University,O
of,O
Hertfordshire,O
",",O
Hatfield,O
",",O
AL10,O
9AB,O
",",O
UK,O
.,O
"
",O
(4)Rutgers,O
",",O
The,O
State,O
University,O
of,O
New,O
Jersey,O
",",O
New,O
Brunswick,O
",",O
NJ,O
",",O
USA,O
.,O
"
",O
(5)Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
PR,O
China,O
.,O
"
",O
(6)Chonbuk,O
National,O
University,O
",",O
Chonbuk,O
561756,O
",",O
Republic,O
of,O
Korea,O
.,O
"
",O
(7)Tokyo,O
University,O
of,O
Agriculture,O
and,O
Technology,O
",",O
Tokyo,O
1838509,O
",",O
Japan,O
.,O
"
",O
(8)Okayama,O
University,O
",",O
Kurashiki,O
",",O
Japan,O
.,O
"

",O
Members,O
of,O
the,O
family,O
Chrysoviridae,O
are,O
isometric,O
",",O
nonenveloped,O
viruses,O
with,O
"
",O
segmented,O
",",O
linear,O
",",O
dsRNA,O
genomes,O
.,O
There,O
are,O
37,O
genomic,O
segments,O
",",O
each,O
of,O
which,O
"
",O
is,O
individually,O
encapsidated,O
.,O
Chrysoviruses,O
infect,O
fungi,O
",",O
plants,O
and,O
possibly,O
"
",O
insects,O
",",O
and,O
may,O
cause,O
hypovirulence,O
in,O
their,O
fungal,O
hosts,O
.,O
Chrysoviruses,O
have,O
no,O
"
",O
known,O
vectors,O
and,O
lack,O
an,O
extracellular,O
phase,O
to,O
their,O
replication,O
cycle,O
;,O
they,O
"
",O
are,O
transmitted,O
via,O
intracellular,O
routes,O
within,O
an,O
individual,O
during,O
hyphal,O
"
",O
growth,O
",",O
in,O
asexual,O
or,O
sexual,O
spores,O
",",O
or,O
between,O
individuals,O
via,O
hyphal,O
"
",O
anastomosis,O
.,O
This,O
is,O
a,O
summary,O
of,O
the,O
International,O
Committee,O
on,O
Taxonomy,O
of,O
"
",O
Viruses,O
(,O
ICTV,O
),O
Report,O
on,O
the,O
taxonomy,O
of,O
the,O
family,O
Chrysoviridae,O
",",O
which,O
is,O
"
",O
available,O
at,O
ictv.global,O
report,O
chrysoviridae,O
.,O
"

",O
DOI,O
:,O
10.1099,O
jgv.0.001383,O
"
",O
PMID,O
:,O
31958044,O
"


",O
903,O
.,O
Virulence,O
.,O
2020,O
Dec;11(1):113131,O
.,O
doi,O
:,O
10.108,O
21505594.2020.1715189,O
.,O
"

",O
Zika,O
virus,O
promotes,O
CCN1,O
expression,O
via,O
the,O
CaMKIIÎ±CREB,O
pathway,O
in,O
astrocytes,O
.,O
"

",O
Sun,O
J(1)(2,O
),O
",",O
Zhang,O
W(3,O
),O
",",O
Tan,O
Z(1,O
),O
",",O
Zheng,O
C(1,O
),O
",",O
Tang,O
Y(1,O
),O
",",O
Ke,O
X(1,O
),O
",",O
Zhang,O
Y(1,O
),O
",",O
"
",O
Liu,O
Y(1,O
),O
",",O
Li,O
P(1,O
),O
",",O
Hu,O
Q(4,O
),O
",",O
Wang,O
H(1,O
),O
",",O
Mao,O
P(5,O
),O
",",O
Zheng,O
Z(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Center,O
for,O
Emerging,O
"
",O
Infectious,O
Diseases,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)College,O
of,O
life,O
sciences,O
and,O
health,O
",",O
Wuhan,O
university,O
of,O
science,O
and,O
"
",O
technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
"
",O
of,O
Sciences,O
",",O
Wuhan,O
",",O
P.R.,O
China,O
.,O
"
",O
(5)Beijing,O
Institute,O
of,O
Infectious,O
Diseases,O
",",O
Military,O
Hospital,O
of,O
China,O
",",O
Beijing,O
",",O
"
",O
P.R.,O
China,O
.,O
"

",O
Zika,O
virus,O
(,O
ZIKV,O
),O
infection,O
in,O
the,O
human,O
central,O
nervous,O
system,O
(,O
CNS,O
),O
causes,O
"
",O
GuillainBarre,O
syndrome,O
",",O
cerebellum,O
deformity,O
",",O
and,O
other,O
diseases,O
.,O
Astrocytes,O
are,O
"
",O
immune,O
response,O
cells,O
in,O
the,O
CNS,O
and,O
an,O
important,O
component,O
of,O
the,O
bloodbrain,O
"
",O
barrier,O
.,O
Consequently,O
",",O
any,O
damage,O
to,O
astrocytes,O
facilitates,O
the,O
spread,O
of,O
ZIKV,O
in,O
"
",O
the,O
CNS,O
.,O
Connective,O
tissue,O
growth,O
factor,O
Nephroblastoma,O
overexpressed,O
gene,O
family,O
"
",O
1,O
(,O
CCN1,O
),O
",",O
an,O
important,O
inflammatory,O
factor,O
secreted,O
by,O
astrocytes,O
",",O
is,O
reported,O
to,O
"
",O
regulate,O
innate,O
immunity,O
and,O
viral,O
infection,O
.,O
However,O
",",O
the,O
mechanism,O
by,O
which,O
"
",O
astrocyte,O
viral,O
infection,O
affects,O
CCN1,O
expression,O
remains,O
undefined,O
.,O
In,O
this,O
"
",O
study,O
",",O
we,O
demonstrate,O
that,O
ZIKV,O
infection,O
upregulates,O
CCN1,O
expression,O
in,O
"
",O
astrocytes,O
",",O
thus,O
promoting,O
intracellular,O
viral,O
replication,O
.,O
Other,O
studies,O
"
",O
revealed,O
that,O
the,O
cAMP,O
response,O
element,O
(,O
CRE,O
),O
in,O
the,O
CCN1,O
promoter,O
is,O
activated,O
"
",O
by,O
the,O
ZIKV,O
NS3,O
protein,O
.,O
The,O
cAMPresponsive,O
elementbinding,O
protein,O
(,O
CREB,O
),O
",",O
a,O
"
",O
transacting,O
factor,O
of,O
the,O
CRE,O
",",O
is,O
also,O
activated,O
by,O
NS3,O
or,O
ZIKV,O
.,O
Furthermore,O
",",O
a,O
"
",O
specific,O
inhibitor,O
of,O
CREB,O
",",O
i.e.,O
SGCCBP30,O
",",O
reduced,O
ZIKVinduced,O
CCN1,O
"
",O
upregulation,O
and,O
ZIKV,O
replication,O
.,O
Moreover,O
",",O
coimmunoprecipitation,O
",",O
"
",O
overexpression,O
",",O
and,O
knockdown,O
studies,O
confirmed,O
that,O
the,O
interaction,O
between,O
NS3,O
"
",O
and,O
the,O
regulatory,O
domain,O
of,O
CaMKIIÎ±,O
could,O
activate,O
the,O
CREB,O
pathway,O
",",O
thus,O
"
",O
resulting,O
in,O
the,O
upregulation,O
of,O
CCN1,O
expression,O
and,O
enhancement,O
of,O
virus,O
"
",O
replication,O
.,O
In,O
conclusion,O
",",O
the,O
findings,O
of,O
our,O
investigations,O
on,O
the,O
"
",O
NS3CaMKIIÎ±CREBCCN1,O
pathway,O
provide,O
a,O
foundation,O
for,O
understanding,O
the,O
"
",O
infection,O
mechanism,O
of,O
ZIKV,O
in,O
the,O
CNS,O
.,O
"

",O
DOI,O
:,O
10.108,O
21505594.2020.1715189,O
"
",O
PMCID,O
:,O
PMC6984649,O
"
",O
PMID,O
:,O
31957543,O
"


",O
904,O
.,O
Neurosci,O
Bull,O
.,O
2020,O
Jan,O
19,O
.,O
doi,O
:,O
10.1007,O
s12264019004586,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
A,O
Wholebrain,O
Map,O
of,O
Longrange,O
Inputs,O
to,O
GABAergic,O
Interneurons,O
in,O
the,O
Mouse,O
"
",O
Caudal,O
Forelimb,O
Area,O
.,O
"

",O
Duan,O
Z(1)(2,O
),O
",",O
Li,O
A(1)(2)(3,O
),O
",",O
Gong,O
H(1)(2)(3,O
),O
",",O
Li,O
X(4)(5)(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Britton,O
Chance,O
Center,O
for,O
Biomedical,O
Photonics,O
",",O
Wuhan,O
National,O
Laboratory,O
for,O
"
",O
OptoelectronicsHuazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430074,O
",",O
"
",O
China,O
.,O
"
",O
(2)Ministry,O
of,O
Education,O
Key,O
Laboratory,O
for,O
Biomedical,O
Photonics,O
",",O
School,O
of,O
"
",O
Engineering,O
Sciences,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
"
",O
430074,O
",",O
China,O
.,O
"
",O
(3)Huazhong,O
University,O
of,O
Science,O
and,O
TechnologySuzhou,O
Institute,O
for,O
"
",O
Brainsmatics,O
",",O
Suzhou,O
",",O
215125,O
",",O
China,O
.,O
"
",O
(4)Britton,O
Chance,O
Center,O
for,O
Biomedical,O
Photonics,O
",",O
Wuhan,O
National,O
Laboratory,O
for,O
"
",O
OptoelectronicsHuazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430074,O
",",O
"
",O
China,O
.,O
lixiangning@mail.hust.edu.cn,O
.,O
"
",O
(5)Ministry,O
of,O
Education,O
Key,O
Laboratory,O
for,O
Biomedical,O
Photonics,O
",",O
School,O
of,O
"
",O
Engineering,O
Sciences,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
"
",O
430074,O
",",O
China,O
.,O
lixiangning@mail.hust.edu.cn,O
.,O
"
",O
(6)Huazhong,O
University,O
of,O
Science,O
and,O
TechnologySuzhou,O
Institute,O
for,O
"
",O
Brainsmatics,O
",",O
Suzhou,O
",",O
215125,O
",",O
China,O
.,O
lixiangning@mail.hust.edu.cn,O
.,O
"

",O
The,O
caudal,O
forelimb,O
area,O
(,O
CFA,O
),O
of,O
the,O
mouse,O
cortex,O
is,O
essential,O
in,O
many,O
forelimb,O
"
",O
movements,O
",",O
and,O
diverse,O
types,O
of,O
GABAergic,O
interneuron,O
in,O
the,O
CFA,O
are,O
distinct,O
in,O
"
",O
the,O
mediation,O
of,O
cortical,O
inhibition,O
in,O
motor,O
information,O
processing,O
.,O
However,O
",",O
"
",O
their,O
longrange,O
inputs,O
remain,O
unclear,O
.,O
In,O
the,O
present,O
study,O
",",O
we,O
combined,O
the,O
"
",O
monosynaptic,O
rabies,O
virus,O
system,O
with,O
Cre,O
driver,O
mouse,O
lines,O
to,O
generate,O
a,O
"
",O
wholebrain,O
map,O
of,O
the,O
inputs,O
to,O
three,O
major,O
inhibitory,O
interneuron,O
types,O
in,O
the,O
"
",O
CFA,O
.,O
We,O
discovered,O
that,O
each,O
type,O
was,O
innervated,O
by,O
the,O
same,O
upstream,O
areas,O
",",O
but,O
"
",O
there,O
were,O
quantitative,O
differences,O
in,O
the,O
inputs,O
from,O
the,O
cortex,O
",",O
thalamus,O
",",O
and,O
"
",O
pallidum,O
.,O
Comparing,O
the,O
locations,O
of,O
the,O
interneurons,O
in,O
two,O
subregions,O
of,O
the,O
"
",O
CFA,O
",",O
we,O
discovered,O
that,O
their,O
longrange,O
inputs,O
were,O
remarkably,O
different,O
in,O
"
",O
distribution,O
and,O
proportion,O
.,O
This,O
wholebrain,O
mapping,O
indicates,O
the,O
existence,O
of,O
"
",O
parallel,O
pathway,O
organization,O
in,O
the,O
forelimb,O
subnetwork,O
and,O
provides,O
insight,O
"
",O
into,O
the,O
inhibitory,O
processes,O
in,O
forelimb,O
movement,O
to,O
reveal,O
the,O
structural,O
"
",O
architecture,O
underlying,O
the,O
functions,O
of,O
the,O
CFA,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12264019004586,O
"
",O
PMID,O
:,O
31956963,O
"


",O
905,O
.,O
Mol,O
Immunol,O
.,O
2020,O
Mar;119:1826,O
.,O
doi,O
:,O
10.1016,O
j.molimm.2020.01.004,O
.,O
Epub,O
2020,O
Jan,O
"
",O
15,O
.,O
"

",O
Function,O
characterization,O
and,O
expression,O
regulation,O
of,O
two,O
differentsized,O
3,O
',O
"
",O
untranslated,O
regioncontaining,O
interferon,O
genes,O
from,O
clone,O
F,O
of,O
gibel,O
carp,O
"
",O
Carassius,O
auratus,O
gibelio,O
.,O
"

",O
Zang,O
ZX(1,O
),O
",",O
Dan,O
C(2,O
),O
",",O
Zhou,O
L(3,O
),O
",",O
Zhang,O
QY(4,O
),O
",",O
Gui,O
JF(3,O
),O
",",O
Zhang,O
YB(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
;,O
University,O
of,O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
10049,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
;,O
University,O
of,O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
10049,O
",",O
China,O
;,O
The,O
Innovation,O
Academy,O
of,O
Seed,O
"
",O
Design,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
;,O
University,O
of,O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
10049,O
",",O
China,O
;,O
The,O
Innovation,O
Academy,O
of,O
Seed,O
"
",O
Design,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
;,O
Key,O
Laboratory,O
of,O
"
",O
Aquaculture,O
Disease,O
Control,O
of,O
Ministry,O
of,O
Agriculture,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
.,O
"
",O
(5)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
;,O
University,O
of,O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
10049,O
",",O
China,O
;,O
The,O
Innovation,O
Academy,O
of,O
Seed,O
"
",O
Design,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
;,O
Key,O
Laboratory,O
of,O
"
",O
Aquaculture,O
Disease,O
Control,O
of,O
Ministry,O
of,O
Agriculture,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
ybzhang@ihb.ac.cn,O
.,O
"

",O
Fish,O
interferon,O
(IFN)mediated,O
antiviral,O
innate,O
immunity,O
is,O
the,O
first,O
line,O
of,O
"
",O
defense,O
against,O
virus,O
invasion,O
.,O
In,O
the,O
present,O
study,O
",",O
we,O
identify,O
two,O
fish,O
IFN,O
"
",O
genes,O
(,O
here,O
tentatively,O
named,O
IFNa,O
and,O
IFNc,O
),O
with,O
differentsized,O
3,O
',O
UTRs,O
from,O
"
",O
clone,O
F,O
strain,O
of,O
gibel,O
carp,O
Carassius,O
auratus,O
gibelio,O
.,O
Carp,O
IFNa,O
has,O
a,O
"
",O
relatively,O
short,O
3'UTR,O
without,O
AUrich,O
elements,O
(,O
AREs,O
),O
but,O
IFNc,O
has,O
a,O
long,O
one,O
"
",O
with,O
9,O
AREs,O
.,O
Functionally,O
",",O
carp,O
IFNa,O
and,O
IFNc,O
display,O
significantly,O
antiviral,O
"
",O
potential,O
to,O
viral,O
infection,O
",",O
likely,O
through,O
induction,O
of,O
downstream,O
"
",O
IFNstimulated,O
genes,O
(,O
ISGs,O
),O
.,O
Both,O
carp,O
IFN,O
genes,O
are,O
induced,O
by,O
viral,O
infection,O
",",O
"
",O
poly(I,O
:,O
C,O
),O
treatment,O
and,O
IRF3,O
7,O
",",O
which,O
are,O
ascribed,O
to,O
the,O
IFNsensitive,O
response,O
"
",O
elements,O
(,O
ISRE,O
),O
within,O
their,O
promoters,O
.,O
Carp,O
IFN,O
genes,O
are,O
also,O
induced,O
by,O
each,O
"
",O
other,O
and,O
by,O
themselves,O
",",O
indicating,O
existence,O
of,O
a,O
positive,O
feedback,O
loop,O
in,O
fish,O
"
",O
IFNmediated,O
antiviral,O
immune,O
response,O
.,O
Comparative,O
analyses,O
of,O
3'UTRmediated,O
"
",O
expression,O
regulation,O
at,O
mRNA,O
and,O
protein,O
levels,O
show,O
that,O
the,O
AREcontaining,O
"
",O
3'UTR,O
of,O
carp,O
IFNc,O
rather,O
than,O
the,O
short,O
3'UTR,O
of,O
carp,O
IFNa,O
promotes,O
mRNA,O
decay,O
"
",O
but,O
instead,O
results,O
in,O
highlevel,O
protein,O
expression,O
",",O
indicating,O
that,O
3'UTR,O
of,O
"
",O
fish,O
IFN,O
mRNAs,O
might,O
be,O
a,O
potential,O
factor,O
for,O
regulation,O
of,O
IFNmediated,O
"
",O
antiviral,O
immune,O
response,O
.,O
Considering,O
a,O
fact,O
that,O
a,O
given,O
protein,O
function,O
is,O
"
",O
largely,O
related,O
to,O
its,O
protein,O
level,O
",",O
these,O
results,O
suggest,O
that,O
both,O
promoter,O
"
",O
and,O
3'UTR,O
contribute,O
to,O
the,O
transcription,O
and,O
translation,O
of,O
fish,O
IFN,O
genes,O
",",O
thus,O
"
",O
shaping,O
their,O
eventually,O
antiviral,O
potential,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.molimm.2020.01.004,O
"
",O
PMID,O
:,O
31954283,O
"


",O
906,O
.,O
Int,O
J,O
Infect,O
Dis,O
.,O
2020,O
Feb;91:264266,O
.,O
doi,O
:,O
10.1016,O
j.ijid.2020.01.009,O
.,O
Epub,O
2020,O
"
",O
Jan,O
14,O
.,O
"

",O
The,O
continuing,O
2019nCoV,B-Virus_SARS-CoV-2
epidemic,O
threat,O
of,O
novel,O
coronaviruses,O
to,O
global,O
health,O
"
 ",O
The,O
latest,O
2019,B-Virus_SARS-CoV-2
novel,I-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
outbreak,O
in,O
Wuhan,O
",",O
China,O
.,O
"

",O
Hui,O
DS(1,O
),O
",",O
I,O
Azhar,O
E(2,O
),O
",",O
Madani,O
TA(3,O
),O
",",O
Ntoumi,O
F(4,O
),O
",",O
Kock,O
R(5,O
),O
",",O
Dar,O
O(6,O
),O
",",O
Ippolito,O
"
",O
G(7,O
),O
",",O
Mchugh,O
TD(8,O
),O
",",O
Memish,O
ZA(9,O
),O
",",O
Drosten,O
C(10,O
),O
",",O
Zumla,O
A(11,O
),O
",",O
Petersen,O
E(12,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medicine,O
&,O
Therapeutics,O
",",O
Chinese,O
University,O
of,O
Hong,O
Kong,O
",",O
Prince,O
"
",O
of,O
Wales,O
Hospital,O
",",O
Shatin,O
",",O
New,O
Territories,O
",",O
Hong,O
Kong,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
dschui@cuhk.edu.hk,O
.,O
"
",O
(2)Special,O
Infectious,O
Agents,O
Unit,O
",",O
King,O
Fahd,O
Medical,O
Research,O
Center,O
and,O
",",O
"
",O
Department,O
of,O
Medical,O
Laboratory,O
Technology,O
",",O
Faculty,O
of,O
Applied,O
Medical,O
Sciences,O
",",O
"
",O
King,O
Abdulaziz,O
University,O
",",O
Jeddah,O
",",O
Saudi,O
Arabia,O
.,O
"
",O
(3)Department,O
of,O
Medicine,O
",",O
Faculty,O
of,O
Medicine,O
",",O
King,O
Abdulaziz,O
University,O
",",O
"
",O
Jeddah,O
",",O
Saudi,O
Arabia,O
.,O
"
",O
(4)Fondation,O
Congolaise,O
pour,O
la,O
Recherche,O
MÃ©dicale,O
",",O
Brazzaville,O
",",O
Republic,O
of,O
"
",O
Congo,O
.,O
"
",O
(5)The,O
Royal,O
Veterinary,O
College,O
",",O
University,O
of,O
London,O
",",O
Hawkshead,O
Lane,O
",",O
North,O
"
",O
Mymms,O
",",O
Hatfield,O
",",O
Hertfordshire,O
",",O
UK,O
.,O
"
",O
(6)Chatham,O
House,O
Centre,O
on,O
Global,O
Health,O
Security,O
",",O
Royal,O
Institute,O
of,O
"
",O
International,O
Affairs,O
",",O
London,O
",",O
UK,O
.,O
"
",O
(7)Lazzaro,O
Spallanzani,O
",",O
National,O
Institute,O
for,O
Infectious,O
Diseases,O
 ,O
IRCCS,O
",",O
Rome,O
",",O
"
",O
Italy,O
.,O
"
",O
(8)Center,O
for,O
Clinical,O
Microbiology,O
",",O
Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
"
",O
University,O
College,O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
(9)Research,O
CentreKing,O
Saud,O
Medical,O
City,O
",",O
Ministry,O
of,O
Health,O
",",O
Riyadh,O
",",O
Saudi,O
"
",O
Arabia,O
;,O
College,O
of,O
Medicine,O
",",O
Alfaisal,O
University,O
",",O
Riyadh,O
",",O
Saudi,O
Arabia,O
;,O
Hubert,O
"
",O
Department,O
of,O
Global,O
Health,O
",",O
Rollins,O
School,O
of,O
Public,O
Health,O
",",O
Emory,O
University,O
",",O
"
",O
Atlanta,O
",",O
GA,O
",",O
USA,O
.,O
"
",O
(10)CharitÃ©UniversitÃ¤tsmedizin,O
Berlin,O
",",O
Corporate,O
Member,O
of,O
Freie,O
UniversitÃ¤t,O
"
",O
Berlin,O
",",O
HumboldtUniversitÃ¤t,O
zu,O
Berlin,O
",",O
Germany,O
;,O
Berlin,O
Institute,O
of,O
Health,O
",",O
"
",O
Institute,O
of,O
Virology,O
",",O
Berlin,O
",",O
Germany,O
;,O
German,O
Centre,O
for,O
Infection,O
Research,O
",",O
"
",O
associated,O
partner,O
CharitÃ©,O
",",O
Berlin,O
",",O
Germany,O
.,O
"
",O
(11)Center,O
for,O
Clinical,O
Microbiology,O
",",O
Division,O
of,O
Infection,O
and,O
Immunity,O
",",O
"
",O
University,O
College,O
London,O
",",O
and,O
NIHR,O
Biomedical,O
Research,O
Centre,O
",",O
UCL,O
Hospitals,O
NHS,O
"
",O
Foundation,O
Trust,O
",",O
London,O
",",O
United,O
Kingdom,O
.,O
"
",O
(12)Directorate,O
General,O
for,O
Disease,O
Surveillance,O
and,O
Control,O
",",O
Ministry,O
of,O
Health,O
",",O
"
",O
Muscat,O
",",O
Oman,O
;,O
Institute,O
for,O
Clinical,O
Medicine,O
",",O
Faculty,O
of,O
Health,O
Science,O
",",O
"
",O
University,O
of,O
Aarhus,O
",",O
Aarhus,O
",",O
Denmark,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.ijid.2020.01.009,O
"
",O
PMID,O
:,O
31953166,O
"


",O
907,O
.,O
Chem,O
Rev.,O
2020,O
Feb,O
12;120(3):19361979,O
.,O
doi,O
:,O
10.1021,O
acs.chemrev.9b00692,O
.,O
Epub,O
"
",O
2020,O
Jan,O
17,O
.,O
"

",O
SingleVirus,O
Tracking,O
:,O
From,O
Imaging,O
Methodologies,O
to,O
Virological,O
Applications,O
.,O
"

",O
Liu,O
SL(1)(2,O
),O
",",O
Wang,O
ZG(1,O
),O
",",O
Xie,O
HY(3,O
),O
",",O
Liu,O
AA(1,O
),O
",",O
Lamb,O
DC(4,O
),O
",",O
Pang,O
DW(1)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Medicinal,O
Chemical,O
Biology,O
",",O
Tianjin,O
Key,O
Laboratory,O
of,O
"
",O
Biosensing,O
and,O
Molecular,O
Recognition,O
",",O
Research,O
Center,O
for,O
Analytical,O
Sciences,O
",",O
"
",O
College,O
of,O
Chemistry,O
",",O
and,O
School,O
of,O
Medicine,O
",",O
Nankai,O
University,O
",",O
Tianjin,O
300071,O
"
",O
",",O
P.,O
R.,O
China,O
.,O
"
",O
(2)Engineering,O
Research,O
Center,O
of,O
NanoGeomaterials,O
of,O
Ministry,O
of,O
Education,O
",",O
"
",O
Faculty,O
of,O
Materials,O
Science,O
and,O
Chemistry,O
",",O
China,O
University,O
of,O
Geosciences,O
",",O
"
",O
Wuhan,O
430074,O
",",O
P.,O
R.,O
China,O
.,O
"
",O
(3)School,O
of,O
Life,O
Science,O
",",O
Beijing,O
Institute,O
of,O
Technology,O
",",O
Beijing,O
100081,O
",",O
P.,O
"
",O
R.,O
China,O
.,O
"
",O
(4)Physical,O
Chemistry,O
",",O
Department,O
of,O
Chemistry,O
",",O
Center,O
for,O
Nanoscience,O
(,O
CeNS,O
),O
",",O
"
",O
and,O
Center,O
for,O
Integrated,O
Protein,O
Science,O
Munich,O
(,O
CIPSM,O
),O
and,O
Nanosystems,O
"
",O
Initiative,O
Munich,O
(,O
NIM,O
),O
",",O
LudwigMaximiliansUniversitÃ¤t,O
",",O
MÃ¼nchen,O
",",O
81377,O
",",O
"
",O
Germany,O
.,O
"
",O
(5)College,O
of,O
Chemistry,O
and,O
Molecular,O
Sciences,O
",",O
State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
"
",O
The,O
Institute,O
for,O
Advanced,O
Studies,O
",",O
and,O
Wuhan,O
Institute,O
of,O
Biotechnology,O
",",O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
430072,O
",",O
P.,O
R.,O
China,O
.,O
"

",O
Uncovering,O
the,O
mechanisms,O
of,O
virus,O
infection,O
and,O
assembly,O
is,O
crucial,O
for,O
"
",O
preventing,O
the,O
spread,O
of,O
viruses,O
and,O
treating,O
viral,O
disease,O
.,O
The,O
technique,O
of,O
"
",O
singlevirus,O
tracking,O
(,O
SVT,O
),O
",",O
also,O
known,O
as,O
singlevirus,O
tracing,O
",",O
allows,O
one,O
to,O
"
",O
follow,O
individual,O
viruses,O
at,O
different,O
parts,O
of,O
their,O
life,O
cycle,O
and,O
thereby,O
"
",O
provides,O
dynamic,O
insights,O
into,O
fundamental,O
processes,O
of,O
viruses,O
occurring,O
in,O
live,O
"
",O
cells,O
.,O
SVT,O
is,O
typically,O
based,O
on,O
fluorescence,O
imaging,O
and,O
reveals,O
insights,O
into,O
"
",O
previously,O
unreported,O
infection,O
mechanisms,O
.,O
In,O
this,O
review,O
article,O
",",O
we,O
provide,O
"
",O
the,O
readers,O
a,O
broad,O
overview,O
of,O
the,O
SVT,O
technique,O
.,O
We,O
first,O
summarize,O
recent,O
"
",O
advances,O
in,O
SVT,O
",",O
from,O
the,O
choice,O
of,O
fluorescent,O
labels,O
and,O
labeling,O
strategies,O
to,O
"
",O
imaging,O
implementation,O
and,O
analytical,O
methodologies,O
.,O
We,O
then,O
describe,O
"
",O
representative,O
applications,O
in,O
detail,O
to,O
elucidate,O
how,O
SVT,O
serves,O
as,O
a,O
valuable,O
"
",O
tool,O
in,O
virological,O
research,O
.,O
Finally,O
",",O
we,O
present,O
our,O
perspectives,O
regarding,O
the,O
"
",O
future,O
possibilities,O
and,O
challenges,O
of,O
SVT,O
.,O
"

",O
DOI,O
:,O
10.1021,O
acs.chemrev.9b00692,O
"
",O
PMID,O
:,O
31951121,O
"


",O
908,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Apr;92(4):401402,O
.,O
doi,O
:,O
10.1002,O
jmv.25678,O
.,O
Epub,O
2020,O
Feb,O
12,O
.,O
"

",O
Outbreak,O
of,O
pneumonia,O
of,O
unknown,O
etiology,O
in,O
Wuhan,O
",",O
China,O
:,O
The,O
mystery,O
and,O
the,O
"
",O
miracle,O
.,O
"

",O
Lu,O
H(1,O
),O
",",O
Stratton,O
CW(2,O
),O
",",O
Tang,O
YW(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Shanghai,O
Public,O
Health,O
Clinical,O
Center,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Pathology,O
",",O
Microbiology,O
",",O
and,O
Immunology,O
",",O
Vanderbilt,O
University,O
"
",O
Medical,O
Center,O
",",O
Nashville,O
",",O
Tennessee,O
.,O
"
",O
(3)Cepheid,O
",",O
Danaher,O
Diagnostic,O
Platform,O
",",O
Shanghai,O
",",O
China,O
.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25678,O
"
",O
PMID,O
:,O
31950516,O
"


",O
909,O
.,O
J,O
Med,O
Virol,O
.,O
2020,O
Apr;92(4):408417,O
.,O
doi,O
:,O
10.1002,O
jmv.25674,O
.,O
Epub,O
2020,O
Feb,O
4,O
.,O
"

",O
Recent,O
advances,O
in,O
the,O
detection,O
of,O
respiratory,O
virus,O
infection,O
in,O
humans,O
.,O
"

",O
Zhang,O
N(1,O
),O
",",O
Wang,O
L(2,O
),O
",",O
Deng,O
X(3,O
),O
",",O
Liang,O
R(3,O
),O
",",O
Su,O
M(3,O
),O
",",O
He,O
C(3,O
),O
",",O
Hu,O
L(3,O
),O
",",O
Su,O
Y(3,O
),O
",",O
"
",O
Ren,O
J(3,O
),O
",",O
Yu,O
F(3,O
),O
",",O
Du,O
L(4,O
),O
",",O
Jiang,O
S(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Clinical,O
Medicine,O
",",O
School,O
of,O
Medicine,O
",",O
Zhejiang,O
University,O
City,O
"
",O
College,O
",",O
Hangzhou,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
North,O
China,O
Crop,O
Improvement,O
and,O
Regulation,O
",",O
Research,O
"
",O
Center,O
of,O
Chinese,O
Jujube,O
",",O
Hebei,O
Agricultural,O
University,O
",",O
Baoding,O
",",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
North,O
China,O
Crop,O
Improvement,O
and,O
Regulation,O
",",O
College,O
"
",O
of,O
Life,O
and,O
Science,O
",",O
Hebei,O
Agricultural,O
University,O
",",O
Baoding,O
",",O
China,O
.,O
"
",O
(4)Lindsley,O
F.,O
Kimball,O
Research,O
Institute,O
",",O
New,O
York,O
Blood,O
Center,O
",",O
New,O
York,O
",",O
New,O
"
",O
York,O
.,O
"
",O
(5)Key,O
Laboratory,O
of,O
Medical,O
Molecular,O
Virology,O
(,O
MOE,O
NHC,O
CAMS,O
),O
",",O
School,O
of,O
Basic,O
"
",O
Medical,O
Sciences,O
",",O
Shanghai,O
Medical,O
College,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"

",O
Respiratory,O
tract,O
viral,O
infection,O
caused,O
by,O
viruses,O
or,O
bacteria,O
is,O
one,O
of,O
the,O
"
",O
most,O
common,O
diseases,O
in,O
human,O
worldwide,O
",",O
while,O
those,O
caused,O
by,O
emerging,O
viruses,O
",",O
"
",O
such,O
as,O
the,O
novel,B-Virus_SARS-CoV-2
coronavirus,I-Virus_SARS-CoV-2
",",O
2019nCoV,B-Virus_SARS-CoV-2
that,O
caused,O
the,O
pneumonia,O
outbreak,O
in,O
"
",O
Wuhan,O
",",O
China,O
most,O
recently,O
",",O
have,O
posed,O
great,O
threats,O
to,O
global,O
public,O
health,O
.,O
"
",O
Identification,O
of,O
the,O
causative,O
viral,O
pathogens,O
of,O
respiratory,O
tract,O
viral,O
"
",O
infections,O
is,O
important,O
to,O
select,O
an,O
appropriate,O
treatment,O
",",O
save,O
people,O
's,O
lives,O
",",O
"
",O
stop,O
the,O
epidemics,O
",",O
and,O
avoid,O
unnecessary,O
use,O
of,O
antibiotics,O
.,O
Conventional,O
"
",O
diagnostic,O
tests,O
",",O
such,O
as,O
the,O
assays,O
for,O
rapid,O
detection,O
of,O
antiviral,O
antibodies,O
"
",O
or,O
viral,O
antigens,O
",",O
are,O
widely,O
used,O
in,O
many,O
clinical,O
laboratories,O
.,O
With,O
the,O
"
",O
development,O
of,O
modern,O
technologies,O
",",O
new,O
diagnostic,O
strategies,O
",",O
including,O
"
",O
multiplex,O
nucleic,O
acid,O
amplification,O
and,O
microarraybased,O
assays,O
",",O
are,O
emerging,O
.,O
"
",O
This,O
review,O
summarizes,O
currently,O
available,O
and,O
novel,O
emerging,O
diagnostic,O
methods,O
"
",O
for,O
the,O
detection,O
of,O
common,O
respiratory,O
viruses,O
",",O
such,O
as,O
influenza,O
virus,O
",",O
human,O
"
",O
respiratory,O
syncytial,O
virus,O
",",O
coronavirus,O
",",O
human,O
adenovirus,O
",",O
and,O
human,O
rhinovirus,O
.,O
"
",O
Multiplex,O
assays,O
for,O
simultaneous,O
detection,O
of,O
multiple,O
respiratory,O
viruses,O
are,O
"
",O
also,O
described,O
.,O
It,O
is,O
anticipated,O
that,O
such,O
data,O
will,O
assist,O
researchers,O
and,O
"
",O
clinicians,O
to,O
develop,O
appropriate,O
diagnostic,O
strategies,O
for,O
timely,O
and,O
effective,O
"
",O
detection,O
of,O
respiratory,O
virus,O
infections,O
.,O
"

",O
Â©,O
2020,O
Wiley,O
Periodicals,O
",",O
Inc.,O
"

",O
DOI,O
:,O
10.1002,O
jmv.25674,O
"
",O
PMID,O
:,O
31944312,O
"


",O
910,O
.,O
Angew,O
Chem,O
Int,O
Ed,O
Engl,O
.,O
2020,O
Jan,O
15,O
.,O
doi,O
:,O
10.1002,O
anie.201913708,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Amphiphilic,O
Polyphenylene,O
Dendron,O
Conjugates,O
for,O
Surface,O
Remodeling,O
of,O
"
",O
Adenovirus,O
â€…,O
5,O
.,O
"

",O
Wagner,O
J(1)(2,O
),O
",",O
Li,O
L(3,O
),O
",",O
Simon,O
J(1)(4,O
),O
",",O
Krutzke,O
L(5,O
),O
",",O
Landfester,O
K(1,O
),O
",",O
MailÃ¤nder,O
"
",O
V(1)(4,O
),O
",",O
MÃ¼llen,O
K(1,O
),O
",",O
Ng,O
DYW(1,O
),O
",",O
Wu,O
Y(1)(3,O
),O
",",O
Weil,O
T(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Max,O
Planck,O
Institute,O
for,O
Polymer,O
Research,O
",",O
Ackermannweg,O
10,O
",",O
55128,O
",",O
Mainz,O
",",O
"
",O
Germany,O
.,O
"
",O
(2)Graduate,O
School,O
Materials,O
Science,O
in,O
Mainz,O
",",O
Staudingerweg,O
9,O
",",O
55128,O
",",O
Mainz,O
",",O
"
",O
Germany,O
.,O
"
",O
(3)Hubei,O
Key,O
Laboratory,O
of,O
Bioinorganic,O
Chemistry,O
and,O
Materia,O
Medica,O
",",O
School,O
of,O
"
",O
Chemistry,O
and,O
Chemical,O
Engineering,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
1037,O
Luoyu,O
Road,O
",",O
430074,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Dermatology,O
",",O
University,O
Medical,O
Center,O
of,O
the,O
Johannes,O
"
",O
GutenbergUniversity,O
Mainz,O
",",O
Langenbeckstr,O
.,O
1,O
",",O
55131,O
",",O
Mainz,O
",",O
Germany,O
.,O
"
",O
(5)University,O
Ulinic,O
",",O
Department,O
of,O
Gene,O
Therapy,O
",",O
Helmholtzstr,O
.,O
8,O
1,O
",",O
89081,O
",",O
Ulm,O
",",O
"
",O
Germany,O
.,O
"

",O
Amphiphilic,O
surface,O
groups,O
play,O
an,O
important,O
role,O
in,O
many,O
biological,O
processes,O
.,O
"
",O
The,O
synthesis,O
of,O
amphiphilic,O
polyphenylene,O
dendrimer,O
branches,O
(,O
dendrons,O
),O
",",O
"
",O
providing,O
alternating,O
hydrophilic,O
and,O
lipophilic,O
surface,O
groups,O
and,O
one,O
reactive,O
"
",O
ethynyl,O
group,O
at,O
the,O
core,O
is,O
reported,O
.,O
The,O
amphiphilic,O
surface,O
groups,O
serve,O
as,O
"
",O
biorecognition,O
units,O
that,O
bind,O
to,O
the,O
surface,O
of,O
adenovirus,O
â€…,O
5,O
(,O
Ad5,O
),O
",",O
which,O
is,O
a,O
"
",O
common,O
vector,O
in,O
gene,O
therapy,O
.,O
The,O
Ad5,O
dendron,O
complexes,O
showed,O
high,O
gene,O
"
",O
transduction,O
efficiencies,O
in,O
coxsackieadenovirus,O
receptor,O
(CAR)negative,O
cells,O
.,O
"
",O
Moreover,O
",",O
the,O
dendrons,O
offer,O
incorporation,O
of,O
new,O
functions,O
at,O
the,O
dendron,O
core,O
"
",O
by,O
in,O
situ,O
postmodifications,O
",",O
even,O
when,O
bound,O
to,O
the,O
Ad5,O
surface,O
.,O
Surfaces,O
"
",O
coated,O
with,O
these,O
dendrons,O
were,O
analyzed,O
for,O
their,O
bloodprotein,O
binding,O
"
",O
capacity,O
",",O
which,O
is,O
essential,O
to,O
predict,O
their,O
performance,O
in,O
the,O
blood,O
stream,O
.,O
A,O
"
",O
new,O
platform,O
for,O
introducing,O
bioactive,O
groups,O
to,O
the,O
Ad5,O
surface,O
without,O
"
",O
chemically,O
modifying,O
the,O
virus,O
particles,O
is,O
provided,O
.,O
"

",O
Â©,O
2020,O
The,O
Authors,O
.,O
Published,O
by,O
WileyVCH,O
Verlag,O
GmbH,O
&,O
Co.,O
KGaA.,O
"

",O
DOI,O
:,O
10.1002,O
anie.201913708,O
"
",O
PMID,O
:,O
31943635,O
"


",O
911,O
.,O
J,O
Travel,O
Med,O
.,O
2020,O
Jan,O
14,O
.,O
pii,O
:,O
taaa008,O
.,O
doi,O
:,O
10.1093,O
jtm,O
taaa008,O
.,O
[,O
Epub,O
ahead,O
of,O
"
",O
print,O
],O
"

",O
Pneumonia,O
of,O
Unknown,O
Etiology,O
in,O
Wuhan,O
",",O
China,O
:,O
Potential,O
for,O
International,O
Spread,O
"
",O
Via,O
Commercial,O
Air,O
Travel,O
.,O
"

",O
Bogoch,O
II(1)(2,O
),O
",",O
Watts,O
A(3)(4,O
),O
",",O
ThomasBachli,O
A(3)(4,O
),O
",",O
Huber,O
C(3)(4,O
),O
",",O
Kraemer,O
"
",O
MUG(5)(6,O
),O
",",O
Khan,O
K(1)(3)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Medicine,O
",",O
University,O
of,O
Toronto,O
",",O
Toronto,O
",",O
Canada,O
.,O
"
",O
(2)Divisions,O
of,O
General,O
Internal,O
Medicine,O
and,O
Infectious,O
Diseases,O
",",O
University,O
"
",O
Health,O
Network,O
",",O
Toronto,O
",",O
Canada,O
.,O
"
",O
(3)Li,O
Ka,O
Shing,O
Knowledge,O
Institute,O
",",O
St.,O
Michael,O
's,O
Hospital,O
",",O
Toronto,O
",",O
Canada,O
.,O
"
",O
(4)BlueDot,O
",",O
Toronto,O
",",O
Canada,O
.,O
"
",O
(5)Department,O
of,O
Zoology,O
",",O
University,O
of,O
Oxford,O
",",O
Oxford,O
",",O
UK,O
.,O
"
",O
(6)Centre,O
for,O
the,O
Mathematical,O
Modelling,O
of,O
Infectious,O
Diseases,O
",",O
London,O
School,O
of,O
"
",O
Hygiene,O
&,O
Tropical,O
Medicine,O
",",O
London,O
",",O
UK,O
.,O
"

",O
There,O
is,O
currently,O
an,O
outbreak,O
of,O
a,O
pneumonia,O
of,O
unknown,O
etiology,O
in,O
Wuhan,O
",",O
"
",O
China,O
.,O
While,O
there,O
are,O
still,O
several,O
unanswered,O
questions,O
",",O
we,O
evaluate,O
the,O
"
",O
potential,O
for,O
international,O
dissemination,O
of,O
this,O
disease,O
via,O
commercial,O
air,O
"
",O
travel,O
should,O
the,O
outbreak,O
continue,O
.,O
"

",O
Published,O
by,O
Oxford,O
University,O
Press,O
2020,O
.,O
"

",O
DOI,O
:,O
10.1093,O
jtm,O
taaa008,O
"
",O
PMID,O
:,O
31943059,O
"


",O
912,O
.,O
Vaccine,O
.,O
2020,O
Feb,O
11;38(7):16901699,O
.,O
doi,O
:,O
10.1016,O
j.vaccine.2019.12.054,O
.,O
Epub,O
"
",O
2020,O
Jan,O
11,O
.,O
"

",O
Characterization,O
of,O
thermostable,O
Newcastle,O
disease,O
virus,O
recombinants,O
expressing,O
"
",O
the,O
hemagglutinin,O
of,O
H5N1,O
avian,O
influenza,O
virus,O
as,O
bivalent,O
vaccine,O
candidates,O
.,O
"

",O
Xu,O
L(1,O
),O
",",O
Qin,O
Z(1,O
),O
",",O
Qiao,O
L(1,O
),O
",",O
Wen,O
J(1,O
),O
",",O
Shao,O
H(2,O
),O
",",O
Wen,O
G(3,O
),O
",",O
Pan,O
Z(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
430072,O
",",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Prevention,O
and,O
Control,O
Agents,O
for,O
Animal,O
Bacteriosis,O
"
",O
(,O
Ministry,O
of,O
Agriculture,O
),O
",",O
Institute,O
of,O
Animal,O
Husbandry,O
and,O
Veterinary,O
Sciences,O
",",O
"
",O
Hubei,O
Academy,O
of,O
Agricultural,O
Sciences,O
",",O
Wuhan,O
430064,O
",",O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Prevention,O
and,O
Control,O
Agents,O
for,O
Animal,O
Bacteriosis,O
"
",O
(,O
Ministry,O
of,O
Agriculture,O
),O
",",O
Institute,O
of,O
Animal,O
Husbandry,O
and,O
Veterinary,O
Sciences,O
",",O
"
",O
Hubei,O
Academy,O
of,O
Agricultural,O
Sciences,O
",",O
Wuhan,O
430064,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
wgy_524@163.com,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
430072,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
zspan@whu.edu.cn,O
.,O
"

",O
Newcastle,O
disease,O
virus,O
(,O
NDV,O
),O
has,O
been,O
used,O
as,O
a,O
vector,O
in,O
the,O
development,O
of,O
"
",O
vaccines,O
and,O
gene,O
delivery,O
.,O
In,O
the,O
present,O
study,O
",",O
we,O
generated,O
the,O
thermostable,O
"
",O
recombinant,O
NDV,O
(,O
rNDV,O
),O
expressing,O
the,O
different,O
forms,O
of,O
hemagglutinin,O
(,O
HA,O
),O
of,O
"
",O
highly,O
pathogenic,O
avian,O
influenza,O
virus,O
(,O
HPAIV,O
),O
H5N1,O
based,O
on,O
the,O
fulllength,O
"
",O
cDNA,O
clone,O
of,O
thermostable,O
TS09C,O
strain,O
.,O
The,O
recombinant,O
thermostable,O
Newcastle,O
"
",O
disease,O
viruses,O
",",O
rTSHA,O
",",O
rTSHA1,O
and,O
rTStPAs,O
HA1,O
",",O
expressed,O
the,O
HA,O
",",O
HA1,O
or,O
"
",O
modified,O
HA1,O
protein,O
with,O
the,O
tissue,O
plasminogen,O
activator,O
signal,O
sequence,O
"
",O
(,O
tPAs,O
),O
",",O
respectively,O
.,O
The,O
rNDVs,O
displayed,O
similar,O
thermostability,O
",",O
growth,O
"
",O
kinetics,O
and,O
pathogenicity,O
compared,O
with,O
the,O
parental,O
TS09C,O
virus,O
.,O
The,O
tPAs,O
"
",O
facilitated,O
the,O
expression,O
and,O
secretion,O
of,O
HA1,O
protein,O
in,O
cells,O
infected,O
with,O
"
",O
rNDV,O
.,O
Animal,O
studies,O
demonstrated,O
that,O
immunization,O
with,O
rNDVs,O
elicited,O
effective,O
"
",O
H5N1,O
and,O
NDVspecific,O
antibody,O
responses,O
and,O
conferred,O
immune,O
protection,O
against,O
"
",O
lethal,O
H5N1,O
and,O
NDV,O
challenges,O
in,O
chickens,O
and,O
mice,O
.,O
Importantly,O
",",O
vaccination,O
of,O
"
",O
rTStPAs,O
HA1,O
resulted,O
in,O
enhanced,O
protective,O
immunity,O
in,O
chickens,O
and,O
mice,O
.,O
Our,O
"
",O
study,O
thus,O
provides,O
a,O
novel,O
thermostable,O
NDVvectored,O
vaccine,O
candidate,O
"
",O
expressing,O
a,O
soluble,O
form,O
of,O
a,O
heterologous,O
viral,O
protein,O
",",O
which,O
will,O
greatly,O
aid,O
"
",O
the,O
poultry,O
industry,O
in,O
developing,O
countries,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.vaccine.2019.12.054,O
"
",O
PMID,O
:,O
31937412,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
that,O
they,O
have,O
no,O
known,O
competing,O
financial,O
interests,O
or,O
personal,O
"
",O
relationships,O
that,O
could,O
have,O
appeared,O
to,O
influence,O
the,O
work,O
reported,O
in,O
this,O
"
",O
paper,O
.,O
"


",O
913,O
.,O
BMC,O
Pregnancy,O
Childbirth,O
.,O
2020,O
Jan,O
14;20(1):38,O
.,O
doi,O
:,O
10.1186,O
s1288402027291,O
.,O
"

",O
Maternal,O
age,O
and,O
educational,O
level,O
modify,O
the,O
association,O
between,O
chronic,O
"
",O
hepatitis,O
B,O
infection,O
and,O
preterm,O
labor,O
.,O
"

",O
Peng,O
S(1,O
),O
",",O
Chen,O
H(2,O
),O
",",O
Li,O
X(2,O
),O
",",O
Du,O
Y(3,O
),O
",",O
Gan,O
Y(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Maternal,O
and,O
Child,O
Health,O
",",O
Xiangya,O
School,O
of,O
Public,O
Health,O
",",O
"
",O
Central,O
South,O
University,O
",",O
Changsha,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Maternal,O
and,O
Child,O
Health,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
13th,O
Hangkong,O
"
",O
Road,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Maternal,O
and,O
Child,O
Health,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
13th,O
Hangkong,O
"
",O
Road,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
1978020507@hust.edu.cn,O
.,O
"
",O
(4)Department,O
of,O
Social,O
Medicine,O
and,O
Health,O
Management,O
",",O
School,O
of,O
Public,O
Health,O
",",O
"
",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
No.,O
13,O
"
",O
Hangkong,O
Road,O
",",O
Wuhan,O
",",O
430030,O
",",O
China,O
.,O
scswj2008@163.com,O
.,O
"

",O
BACKGROUND,O
:,O
Few,O
studies,O
have,O
investigated,O
whether,O
maternal,O
age,O
and,O
education,O
"
",O
level,O
modify,O
the,O
association,O
of,O
chronic,O
hepatitis,O
B,O
virus,O
(,O
HBV,O
),O
infection,O
with,O
"
",O
preterm,O
labor,O
.,O
We,O
hypothesized,O
that,O
the,O
association,O
of,O
HBV,O
infection,O
with,O
preterm,O
"
",O
labor,O
is,O
modified,O
by,O
maternal,O
age,O
and,O
education,O
level,O
.,O
"
",O
METHODS,O
:,O
A,O
retrospective,O
cohort,O
study,O
was,O
conducted,O
on,O
the,O
HBsAgpositive,O
and,O
"
",O
HBsAgnegative,O
pregnant,O
women,O
delivered,O
from,O
June,O
2012,O
to,O
August,O
2017,O
at,O
Wuhan,O
"
",O
Medical,O
Care,O
Center,O
for,O
Women,O
and,O
Children,O
",",O
Wuhan,O
",",O
China,O
.,O
A,O
multivariate,O
"
",O
regression,O
model,O
was,O
used,O
in,O
this,O
study,O
.,O
"
",O
RESULTS,O
:,O
This,O
study,O
included,O
2050,O
HBsAgpositive,O
pregnant,O
women,O
and,O
2050,O
HBsAg,O
"
",O
negative,O
women,O
.,O
In,O
the,O
stratified,O
analyses,O
",",O
positive,O
HBsAg,O
status,O
was,O
associated,O
"
",O
with,O
the,O
increased,O
risk,O
of,O
preterm,O
labor,O
in,O
women,O
aged,O
<,O
â€‰,O
30,O
â€‰,O
years,O
",",O
having,O
low,O
"
",O
educational,O
level,O
",",O
with,O
an,O
odds,O
ratio,O
of,O
1.65(95,O
%,O
CI,O
1.072.54,O
),O
and,O
2.59(95,O
%,O
CI,O
"
",O
1.414.76,O
),O
",",O
respectively,O
.,O
BreslowDay,O
test,O
showed,O
that,O
there,O
existed,O
significant,O
"
",O
differences,O
in,O
the,O
ORs,O
for,O
HBsAg,O
carriage,O
across,O
each,O
stratum,O
of,O
maternal,O
age,O
"
",O
(,O
p,O
â€‰,O
=,O
â€‰,O
0.023,O
),O
",",O
educational,O
level,O
(,O
p,O
â€‰,O
=,O
â€‰,O
0.002,O
),O
.,O
After,O
adjusting,O
other,O
covariables,O
",",O
"
",O
we,O
observed,O
maternal,O
HBV,O
infection,O
(,O
OR,O
1.6,O
",",O
95,O
%,O
CI,O
1.032.49,O
),O
was,O
still,O
"
",O
associated,O
with,O
risk,O
of,O
preterm,O
labor,O
in,O
pregnancy,O
women,O
with,O
age,O
â€‰,O
<,O
â€‰,O
30,O
.,O
"
",O
Similarly,O
",",O
the,O
significant,O
association,O
of,O
HBV,O
infection,O
(,O
OR,O
2.49,O
",",O
95,O
%,O
CI,O
"
",O
1.344.63,O
),O
with,O
preterm,O
labor,O
remained,O
in,O
low,O
educated,O
women,O
.,O
"
",O
CONCLUSIONS,O
:,O
Our,O
results,O
indicated,O
that,O
HBV,O
infection,O
was,O
associated,O
with,O
high,O
"
",O
risk,O
of,O
preterm,O
labor,O
",",O
but,O
maternal,O
age,O
and,O
educational,O
level,O
could,O
modify,O
the,O
"
",O
association,O
between,O
HBV,O
infection,O
and,O
preterm,O
labor,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s1288402027291,O
"
",O
PMCID,O
:,O
PMC6961340,O
"
",O
PMID,O
:,O
31937269,O
"


",O
914,O
.,O
Viruses,O
.,O
2020,O
Jan,O
9;12(1,O
),O
.,O
pii,O
:,O
E79,O
.,O
doi,O
:,O
10.339,O
v12010079,O
.,O
"

",O
Isolation,O
and,O
Identification,O
of,O
Porcine,O
Deltacoronavirus,O
and,O
Alteration,O
of,O
"
",O
Immunoglobulin,O
Transport,O
Receptors,O
in,O
the,O
Intestinal,O
Mucosa,O
of,O
PDCoVInfected,O
"
",O
Piglets,O
.,O
"

",O
Qian,O
S(1,O
),O
",",O
Jia,O
X(1,O
),O
",",O
Gao,O
Z(1,O
),O
",",O
Zhang,O
W(1,O
),O
",",O
Xu,O
Q(1)(2)(3,O
),O
",",O
Li,O
Z(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
Wuhan,O
"
",O
430070,O
",",O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Development,O
of,O
Veterinary,O
Diagnostic,O
Products,O
",",O
Ministry,O
of,O
"
",O
Agriculture,O
of,O
the,O
People,O
's,O
Republic,O
of,O
China,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"

",O
Porcine,O
deltacoronavirus,O
(,O
PDCoV,O
),O
is,O
a,O
porcine,O
enteropathogenic,O
coronavirus,O
that,O
"
",O
causes,O
watery,O
diarrhea,O
",",O
vomiting,O
",",O
and,O
frequently,O
death,O
in,O
piglets,O
",",O
causing,O
"
",O
serious,O
economic,O
losses,O
to,O
the,O
pig,O
industry,O
.,O
The,O
strain,O
CHNJS2017,O
was,O
isolated,O
"
",O
and,O
identified,O
by,O
cytopathology,O
",",O
immunofluorescence,O
assays,O
",",O
transmission,O
electron,O
"
",O
microscopy,O
",",O
and,O
sequence,O
analysis,O
.,O
A,O
nucleotide,O
sequence,O
alignment,O
showed,O
that,O
"
",O
the,O
whole,O
genome,O
of,O
CHNJS2017,O
is,O
97.4%99.6,O
%,O
identical,O
to,O
other,O
PDCoV,O
strains,O
.,O
"
",O
The,O
pathogenicity,O
of,O
the,O
CHNJS2017,O
strain,O
was,O
investigated,O
in,O
orally,O
inoculated,O
"
",O
fivedayold,O
piglets,O
;,O
the,O
piglets,O
developed,O
acute,O
",",O
watery,O
diarrhea,O
",",O
but,O
all,O
"
",O
recovered,O
and,O
survived,O
.,O
CHNJS2017,O
infectioninduced,O
microscopic,O
lesions,O
were,O
"
",O
observed,O
",",O
and,O
viral,O
antigens,O
were,O
detected,O
mainly,O
by,O
immunohistochemical,O
staining,O
"
",O
in,O
the,O
small,O
intestine,O
.,O
The,O
neonatal,O
Fc,O
receptor,O
(,O
FcRn,O
),O
and,O
polymeric,O
"
",O
immunoglobulin,O
receptor,O
(,O
pIgR,O
),O
are,O
crucial,O
immunoglobulin,O
(,O
Ig,O
),O
receptors,O
for,O
the,O
"
",O
transcytosis,O
ofimmunoglobulin,O
G,O
(,O
IgG,O
),O
",",O
IgA,O
",",O
or,O
IgM.,O
Importantly,O
",",O
CHNJS2017,O
"
",O
infected,O
fivedayold,O
piglets,O
could,O
significantly,O
downregulate,O
the,O
expression,O
of,O
"
",O
FcRn,O
",",O
pIgR,O
",",O
and,O
nuclear,O
factorkappa,O
B,O
(NFÎºB)in,O
the,O
intestinal,O
mucosa,O
.,O
Note,O
that,O
"
",O
the,O
level,O
of,O
FcRn,O
mRNA,O
in,O
the,O
intestinal,O
mucosa,O
of,O
normal,O
piglets,O
is,O
positively,O
"
",O
correlated,O
with,O
pIgR,O
and,O
NFÎºB.,O
At,O
the,O
same,O
time,O
",",O
the,O
expressions,O
of,O
FcRn,O
",",O
pIgR,O
",",O
"
",O
and,O
NFÎºB,O
mRNA,O
are,O
also,O
positively,O
correlated,O
in,O
infected,O
piglets,O
.,O
These,O
results,O
"
",O
may,O
help,O
explain,O
the,O
immunological,O
and,O
pathological,O
changes,O
associated,O
with,O
"
",O
porcine,O
deltacorononirus,O
infection,O
.,O
"

",O
DOI,O
:,O
10.339,O
v12010079,O
"
",O
PMCID,O
:,O
PMC7019308,O
"
",O
PMID,O
:,O
31936476,O
"


",O
915,O
.,O
J,O
Gen,O
Virol,O
.,O
2020,O
Jan,O
14,O
.,O
doi,O
:,O
10.1099,O
jgv.0.001375,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Feedback,O
inhibition,O
of,O
bovine,O
herpesvirus,O
5,O
replication,O
by,O
dualcopy,O
"
",O
bhv5miRB103p,O
.,O
"

",O
Liu,O
J(1,O
),O
",",O
Song,O
XR(2)(1,O
),O
",",O
Zheng,O
K(1,O
),O
",",O
Zhang,O
WJ(1,O
),O
",",O
Chen,O
HC(1,O
),O
",",O
Liu,O
ZF(3)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
PR,O
China,O
.,O
"
",O
(2)Hubei,O
Vocational,O
College,O
of,O
BioTechnology,O
",",O
Wuhan,O
430070,O
",",O
PR,O
China,O
.,O
"
",O
(3)Present,O
address,O
:,O
State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
"
",O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
PR,O
China,O
.,O
"

",O
Bovine,O
herpesvirus,O
5,O
(,O
BoHV5,O
),O
is,O
a,O
pathogen,O
of,O
cattle,O
responsible,O
for,O
fatal,O
"
",O
meningoencephalitis,O
.,O
Like,O
alpha,O
herpesvirus,O
subfamily,O
members,O
",",O
BoHV5,O
also,O
"
",O
encodes,O
microRNA,O
in,O
lytic,O
infections,O
of,O
epithelial,O
cells,O
.,O
BoHV5miRB10,O
was,O
the,O
"
",O
most,O
abundant,O
miRNA,O
detected,O
in,O
a,O
highthroughput,O
sequencing,O
study,O
.,O
Here,O
",",O
we,O
"
",O
evaluated,O
the,O
kinetics,O
of,O
miRB10,O
expression,O
after,O
BoHV5,O
productive,O
infection,O
by,O
"
",O
stemloop,O
realtime,O
quantitative,O
PCR,O
.,O
miRB10,O
candidate,O
target,O
sites,O
in,O
the,O
virus,O
"
",O
were,O
predicted,O
",",O
and,O
BoHV5,O
UL39,O
was,O
confirmed,O
as,O
a,O
target,O
gene,O
by,O
dualluciferase,O
"
",O
assay,O
with,O
the,O
design,O
of,O
an,O
miRB10,O
tough,O
decoy,O
(,O
TuD,O
),O
.,O
The,O
UL39,O
gene,O
encoding,O
"
",O
ribonucleotide,O
reductase,O
(,O
RR,O
),O
large,O
subunit,O
plays,O
an,O
important,O
role,O
in,O
the,O
early,O
"
",O
stage,O
of,O
BoHV5,O
lytic,O
infection,O
.,O
As,O
BoHV5miRB10,O
is,O
located,O
in,O
internal,O
and,O
"
",O
terminal,O
repeat,O
regions,O
",",O
we,O
generated,O
a,O
TuD,O
geneintegrated,O
BoHV5,O
strain,O
",",O
which,O
"
",O
effectively,O
downregulated,O
miRB103p,O
.,O
Strikingly,O
",",O
the,O
suppression,O
of,O
miRB103p,O
"
",O
significantly,O
improved,O
BoHV5,O
replication,O
.,O
Taking,O
these,O
findings,O
together,O
",",O
our,O
"
",O
study,O
established,O
an,O
efficient,O
method,O
to,O
deliver,O
and,O
express,O
TuD,O
RNA,O
for,O
viral,O
"
",O
miRNA,O
suppression,O
",",O
and,O
demonstrated,O
that,O
virusencoded,O
miRNA,O
suppresses,O
"
",O
viralgenome,O
biogenesis,O
with,O
a,O
feedback,O
mode,O
",",O
which,O
might,O
serve,O
as,O
a,O
brake,O
for,O
"
",O
viral,O
replication,O
.,O
Herpesviruses,O
infect,O
humans,O
and,O
a,O
variety,O
of,O
animals,O
.,O
Almost,O
"
",O
all,O
herpesviruses,O
can,O
encode,O
miRNAs,O
",",O
but,O
the,O
functions,O
of,O
these,O
miRNAs,O
remain,O
to,O
"
",O
be,O
elucidated,O
.,O
Most,O
herpesvirusencoded,O
miRNA,O
harbours,O
dual,O
copies,O
",",O
which,O
is,O
"
",O
difficult,O
to,O
be,O
deleted,O
by,O
current,O
genetic,O
modulation,O
.,O
Here,O
",",O
we,O
developed,O
an,O
"
",O
efficient,O
method,O
to,O
deliver,O
and,O
express,O
TuD,O
RNA,O
to,O
efficiently,O
suppress,O
viral,O
"
",O
miRNA,O
with,O
multiple,O
copies,O
.,O
Using,O
this,O
method,O
",",O
we,O
demonstrated,O
for,O
the,O
first,O
time,O
"
",O
that,O
viral,O
miRNA,O
feedback,O
regulates,O
viral,O
replication,O
by,O
suppressing,O
the,O
"
",O
expression,O
of,O
RR,O
.,O
"

",O
DOI,O
:,O
10.1099,O
jgv.0.001375,O
"
",O
PMID,O
:,O
31935178,O
"


",O
916,O
.,O
Mol,O
Brain,O
.,O
2020,O
Jan,O
13;13(1):5,O
.,O
doi,O
:,O
10.1186,O
s1304102005442,O
.,O
"

",O
Highbrightness,O
anterograde,O
transneuronal,O
HSV1,O
H129,O
tracer,O
modified,O
using,O
a,O
"
",O
Trojan,O
horselike,O
strategy,O
.,O
"

",O
Su,O
P(1)(2,O
),O
",",O
Ying,O
M(2)(3,O
),O
",",O
Han,O
Z(2)(3,O
),O
",",O
Xia,O
J(2,O
),O
",",O
Jin,O
S(2)(4,O
),O
",",O
Li,O
Y(2,O
),O
",",O
Wang,O
"
",O
H(5)(6)(7,O
),O
",",O
Xu,O
F(8)(9)(10)(11)(12,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Wuhan,O
National,O
Laboratory,O
for,O
Optoelectronics,O
",",O
Huazhong,O
University,O
of,O
Science,O
"
",O
and,O
Technology,O
",",O
Wuhan,O
",",O
430074,O
",",O
China,O
.,O
"
",O
(2)Center,O
for,O
Brain,O
Science,O
",",O
State,O
Key,O
Laboratory,O
of,O
Magnetic,O
Resonance,O
and,O
"
",O
Atomic,O
and,O
Molecular,O
Physics,O
",",O
Key,O
Laboratory,O
of,O
Magnetic,O
Resonance,O
in,O
Biological,O
"
",O
Systems,O
",",O
Wuhan,O
Center,O
for,O
Magnetic,O
Resonance,O
",",O
Wuhan,O
Institute,O
of,O
Physics,O
and,O
"
",O
Mathematics,O
",",O
Innovation,O
Academy,O
for,O
Precision,O
Measurement,O
Science,O
and,O
Technology,O
",",O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(3)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100049,O
",",O
China,O
.,O
"
",O
(4)Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
(HUST)Suzhou,O
Institute,O
for,O
"
",O
Brainsmatics,O
",",O
JITRI,O
Institute,O
for,O
Brainsmatics,O
",",O
Suzhou,O
",",O
215125,O
",",O
China,O
.,O
"
",O
(5)Center,O
for,O
Brain,O
Science,O
",",O
State,O
Key,O
Laboratory,O
of,O
Magnetic,O
Resonance,O
and,O
"
",O
Atomic,O
and,O
Molecular,O
Physics,O
",",O
Key,O
Laboratory,O
of,O
Magnetic,O
Resonance,O
in,O
Biological,O
"
",O
Systems,O
",",O
Wuhan,O
Center,O
for,O
Magnetic,O
Resonance,O
",",O
Wuhan,O
Institute,O
of,O
Physics,O
and,O
"
",O
Mathematics,O
",",O
Innovation,O
Academy,O
for,O
Precision,O
Measurement,O
Science,O
and,O
Technology,O
",",O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
hdwang@wipm.ac.cn,O
.,O
"
",O
(6)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100049,O
",",O
China,O
.,O
"
",O
hdwang@wipm.ac.cn,O
.,O
"
",O
(7)Shenzhen,O
Key,O
Lab,O
of,O
Neuropsychiatric,O
Modulation,O
",",O
Guangdong,O
Provincial,O
Key,O
"
",O
Laboratory,O
of,O
Brain,O
Connectome,O
and,O
Behavior,O
",",O
CAS,O
Key,O
Laboratory,O
of,O
Brain,O
"
",O
Connectome,O
and,O
Manipulation,O
",",O
The,O
Brain,O
Cognition,O
and,O
Brain,O
Disease,O
Institute,O
"
",O
(,O
BCBDI,O
),O
",",O
Shenzhen,O
Institutes,O
of,O
Advanced,O
Technology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
;,O
"
",O
ShenzhenHong,O
Kong,O
Institute,O
of,O
Brain,O
ScienceShenzhen,O
Fundamental,O
Research,O
"
",O
Institutions,O
",",O
Shenzhen,O
",",O
518055,O
",",O
China,O
.,O
hdwang@wipm.ac.cn,O
.,O
"
",O
(8)Wuhan,O
National,O
Laboratory,O
for,O
Optoelectronics,O
",",O
Huazhong,O
University,O
of,O
Science,O
"
",O
and,O
Technology,O
",",O
Wuhan,O
",",O
430074,O
",",O
China,O
.,O
fuqiang.xu@wipm.ac.cn,O
.,O
"
",O
(9)Center,O
for,O
Brain,O
Science,O
",",O
State,O
Key,O
Laboratory,O
of,O
Magnetic,O
Resonance,O
and,O
"
",O
Atomic,O
and,O
Molecular,O
Physics,O
",",O
Key,O
Laboratory,O
of,O
Magnetic,O
Resonance,O
in,O
Biological,O
"
",O
Systems,O
",",O
Wuhan,O
Center,O
for,O
Magnetic,O
Resonance,O
",",O
Wuhan,O
Institute,O
of,O
Physics,O
and,O
"
",O
Mathematics,O
",",O
Innovation,O
Academy,O
for,O
Precision,O
Measurement,O
Science,O
and,O
Technology,O
",",O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
fuqiang.xu@wipm.ac.cn,O
.,O
"
",O
(10)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100049,O
",",O
China,O
.,O
"
",O
fuqiang.xu@wipm.ac.cn,O
.,O
"
",O
(11)Shenzhen,O
Key,O
Lab,O
of,O
Neuropsychiatric,O
Modulation,O
",",O
Guangdong,O
Provincial,O
Key,O
"
",O
Laboratory,O
of,O
Brain,O
Connectome,O
and,O
Behavior,O
",",O
CAS,O
Key,O
Laboratory,O
of,O
Brain,O
"
",O
Connectome,O
and,O
Manipulation,O
",",O
The,O
Brain,O
Cognition,O
and,O
Brain,O
Disease,O
Institute,O
"
",O
(,O
BCBDI,O
),O
",",O
Shenzhen,O
Institutes,O
of,O
Advanced,O
Technology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
;,O
"
",O
ShenzhenHong,O
Kong,O
Institute,O
of,O
Brain,O
ScienceShenzhen,O
Fundamental,O
Research,O
"
",O
Institutions,O
",",O
Shenzhen,O
",",O
518055,O
",",O
China,O
.,O
fuqiang.xu@wipm.ac.cn,O
.,O
"
",O
(12)Center,O
for,O
Excellence,O
in,O
Brain,O
Science,O
and,O
Intelligence,O
Technology,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
Shanghai,O
",",O
200031,O
",",O
China,O
.,O
fuqiang.xu@wipm.ac.cn,O
.,O
"

",O
Neurotropic,O
viral,O
transsynaptic,O
tracing,O
is,O
an,O
increasingly,O
powerful,O
technique,O
for,O
"
",O
dissecting,O
the,O
structure,O
and,O
function,O
of,O
neural,O
circuits,O
.,O
Herpes,O
simplex,O
virus,O
"
",O
type,O
1,O
strain,O
H129,O
has,O
been,O
widely,O
used,O
as,O
an,O
anterograde,O
tracer,O
.,O
However,O
",",O
HSV,O
"
",O
tracers,O
still,O
have,O
several,O
shortcomings,O
",",O
including,O
high,O
toxicity,O
",",O
low,O
sensitivity,O
"
",O
and,O
nonspecific,O
retrograde,O
labeling,O
.,O
Here,O
",",O
we,O
aimed,O
to,O
construct,O
highbrightness,O
"
",O
HSV,O
anterograde,O
tracers,O
by,O
increasing,O
the,O
expression,O
of,O
exogenous,O
genes,O
carried,O
"
",O
by,O
H129,O
viruses,O
.,O
Using,O
a,O
Trojan,O
horselike,O
strategy,O
",",O
a,O
HSV,O
AAV,O
(,O
adenoassociated,O
"
",O
virus,O
),O
chimaera,O
termed,O
H8,O
was,O
generated,O
to,O
enhance,O
the,O
expression,O
of,O
a,O
"
",O
fluorescent,O
marker,O
.,O
In,O
vitro,O
and,O
in,O
vivo,O
assays,O
showed,O
that,O
the,O
exogenous,O
gene,O
"
",O
was,O
efficiently,O
replicated,O
and,O
amplified,O
by,O
the,O
synergism,O
of,O
the,O
HSV,O
vector,O
and,O
"
",O
introduced,O
AAV,O
replication,O
system,O
.,O
H8,O
reporting,O
fluorescence,O
was,O
brighter,O
than,O
"
",O
that,O
of,O
currently,O
available,O
H129,O
tracers,O
",",O
and,O
H8,O
could,O
be,O
used,O
for,O
fast,O
and,O
"
",O
effective,O
anterograde,O
tracing,O
without,O
additional,O
immunostaining,O
.,O
These,O
results,O
"
",O
indicated,O
that,O
foreign,O
gene,O
expression,O
in,O
HSV,O
tracers,O
could,O
be,O
enhanced,O
by,O
"
",O
integrating,O
HSV,O
with,O
AAV,O
replication,O
system,O
.,O
This,O
approach,O
may,O
be,O
useful,O
as,O
a,O
"
",O
general,O
enhanced,O
expression,O
strategy,O
for,O
HSVbased,O
tracing,O
tools,O
or,O
gene,O
delivery,O
"
",O
vectors,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s1304102005442,O
"
",O
PMCID,O
:,O
PMC6958791,O
"
",O
PMID,O
:,O
31931837,O
"


",O
917,O
.,O
Vet,O
Microbiol,O
.,O
2020,O
Feb;241:108563,O
.,O
doi,O
:,O
10.1016,O
j.vetmic.2019.108563,O
.,O
Epub,O
2019,O
"
",O
Dec,O
23,O
.,O
"

",O
Porcine,O
reproductive,O
and,O
respiratory,O
syndrome,O
virus,O
infection,O
promotes,O
C1QBP,O
"
",O
secretion,O
to,O
enhance,O
inflammatory,O
responses,O
.,O
"

",O
Li,O
Y(1,O
),O
",",O
Wei,O
Y(1,O
),O
",",O
Hao,O
W(1,O
),O
",",O
Zhao,O
W(1,O
),O
",",O
Zhou,O
Y(1,O
),O
",",O
Wang,O
D(1,O
),O
",",O
Xiao,O
S(1,O
),O
",",O
Fang,O
"
",O
L(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
;,O
The,O
Key,O
"
",O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
Cooperative,O
"
",O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
;,O
The,O
Key,O
"
",O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
Cooperative,O
"
",O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
fanglr@mail.hzau.edu.cn,O
.,O
"

",O
Complement,O
component,O
1,O
",",O
q,O
subcomponent,O
binding,O
protein,O
(,O
C1QBP,O
),O
is,O
a,O
receptor,O
for,O
"
",O
the,O
globular,O
heads,O
of,O
C1q,O
and,O
modulates,O
various,O
biological,O
processes,O
including,O
"
",O
infection,O
",",O
inflammation,O
",",O
autoimmunity,O
",",O
and,O
cancer,O
.,O
In,O
our,O
previous,O
study,O
to,O
"
",O
identify,O
differentially,O
expressed,O
secretory,O
proteins,O
in,O
Marc145,O
cells,O
infected,O
"
",O
with,O
porcine,O
reproductive,O
and,O
respiratory,O
syndrome,O
virus,O
(,O
PRRSV,O
),O
",",O
mass,O
spectrum,O
"
",O
data,O
showed,O
that,O
C1QBP,O
was,O
secreted,O
after,O
PRRSV,O
infection,O
.,O
However,O
",",O
the,O
"
",O
biological,O
significance,O
of,O
secreted,O
C1QBP,O
remains,O
unclear,O
.,O
In,O
this,O
study,O
",",O
we,O
"
",O
confirmed,O
that,O
PRRSV,O
infection,O
promoted,O
C1QBP,O
secretion,O
in,O
Marc145,O
cells,O
and,O
"
",O
porcine,O
alveolar,O
macrophages,O
(,O
PAMs,O
),O
",",O
the,O
target,O
cells,O
of,O
PRRSV,O
in,O
vivo,O
.,O
Knockdown,O
"
",O
of,O
endogenous,O
C1QBP,O
decreased,O
PRRSVinduced,O
inflammatory,O
responses,O
.,O
The,O
purified,O
"
",O
recombinant,O
porcine,O
C1QBP,O
(,O
poC1QBP,O
),O
had,O
proinflammatory,O
effects,O
.,O
The,O
exogenous,O
"
",O
addition,O
of,O
poC1QBP,O
significantly,O
enhanced,O
PRRSVinduced,O
inflammatory,O
responses,O
"
",O
and,O
abolished,O
the,O
inhibitory,O
effects,O
mediated,O
by,O
poC1QBPknockdown,O
.,O
Taken,O
"
",O
together,O
",",O
these,O
results,O
demonstrate,O
that,O
PRRSV,O
infection,O
promotes,O
poC1QBP,O
"
",O
secretion,O
that,O
enhances,O
inflammatory,O
responses,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.vetmic.2019.108563,O
"
",O
PMID,O
:,O
31928703,O
"


",O
918,O
.,O
Plant,O
Sci,O
.,O
2020,O
Feb;291:110320,O
.,O
doi,O
:,O
10.1016,O
j.plantsci.2019.110320,O
.,O
Epub,O
2019,O
"
",O
Nov,O
9,O
.,O
"

",O
PtrCDPK10,O
of,O
Poncirus,O
trifoliata,O
functions,O
in,O
dehydration,O
and,O
drought,O
tolerance,O
"
",O
by,O
reducing,O
ROS,O
accumulation,O
via,O
phosphorylating,O
PtrAPX,O
.,O
"

",O
Meng,O
L(1,O
),O
",",O
Zhang,O
Q(1,O
),O
",",O
Yang,O
J(2,O
),O
",",O
Xie,O
G(2,O
),O
",",O
Liu,O
JH(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Horticultural,O
Plant,O
Biology,O
",",O
College,O
of,O
Horticulture,O
and,O
"
",O
Forestry,O
Sciences,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"
",O
(2)MOA,O
Key,O
Laboratory,O
of,O
Crop,O
Ecophysiology,O
and,O
Farming,O
System,O
in,O
the,O
Middle,O
"
",O
Reaches,O
of,O
the,O
Yangtze,O
River,O
",",O
College,O
of,O
Plant,O
Sciences,O
and,O
Technology,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
"Wuhan,430070",O
",",O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Horticultural,O
Plant,O
Biology,O
",",O
College,O
of,O
Horticulture,O
and,O
"
",O
Forestry,O
Sciences,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
liujihong@mail.hzau.edu.cn,O
.,O
"

",O
Calciumdependent,O
protein,O
kinases,O
(,O
CDPKs,O
),O
are,O
important,O
calcium,O
signaling,O
"
",O
components,O
that,O
have,O
been,O
shown,O
to,O
play,O
crucial,O
roles,O
in,O
modulating,O
plant,O
abiotic,O
"
",O
stress,O
responses,O
.,O
However,O
",",O
the,O
physiological,O
and,O
regulatory,O
roles,O
of,O
most,O
CDPKs,O
"
",O
are,O
still,O
poorly,O
understood,O
.,O
Here,O
",",O
we,O
report,O
the,O
functional,O
characterization,O
of,O
"
",O
PtrCDPK10,O
from,O
trifoliate,O
orange,O
(,O
Poncirus,O
trifoliata,O
(,O
L.,O
),O
Raf,O
.,O
),O
in,O
dehydration,O
"
",O
and,O
drought,O
stress,O
tolerance,O
.,O
PtrCDPK10,O
",",O
categorized,O
in,O
the,O
Type,O
III,O
subgroup,O
of,O
"
",O
the,O
CDPK,O
family,O
",",O
was,O
localized,O
to,O
the,O
nucleus,O
and,O
plasma,O
membrane,O
.,O
Transcript,O
"
",O
levels,O
of,O
PtrCDPK10,O
were,O
upregulated,O
by,O
dehydration,O
",",O
salt,O
and,O
ABA,O
treatments,O
.,O
"
",O
Transgenic,O
trifoliate,O
orange,O
plants,O
overexpressing,O
PtrCDPK10,O
showed,O
enhanced,O
"
",O
dehydration,O
tolerance,O
compared,O
with,O
the,O
wild,O
type,O
(,O
WT,O
),O
",",O
whereas,O
VIGS,O
"
",O
(,O
virusinduced,O
gene,O
silencing)mediated,O
knockdown,O
of,O
PtrCDPK10,O
resulted,O
in,O
"
",O
elevated,O
susceptibility,O
to,O
dehydration,O
and,O
drought,O
stresses,O
.,O
Yeast,O
twohybrid,O
"
",O
screening,O
identified,O
several,O
proteins,O
that,O
interacted,O
with,O
PtrCDPK10,O
",",O
including,O
"
",O
an,O
ascorbate,O
peroxidase,O
(,O
PtrAPX,O
),O
.,O
PtrCDPK10,O
was,O
shown,O
to,O
phosphorylate,O
PtrAPX,O
"
",O
based,O
on,O
an,O
in,O
vitro,O
kinase,O
assay,O
.,O
PtrCDPK10overexpressing,O
transgenic,O
lines,O
"
",O
exhibited,O
higher,O
PtrAPX,O
mRNA,O
abundance,O
and,O
APX,O
activity,O
and,O
accumulated,O
"
",O
dramatically,O
less,O
ROS,O
in,O
comparison,O
with,O
the,O
WT,O
",",O
while,O
PtrCDPK10silenced,O
VIGS,O
"
",O
lines,O
showed,O
decreased,O
PtrAPX,O
expression,O
and,O
increased,O
ROS,O
level,O
.,O
Taken,O
together,O
",",O
"
",O
these,O
results,O
demonstrate,O
that,O
PtrCDPK10,O
promotes,O
dehydration,O
and,O
drought,O
"
",O
tolerance,O
by,O
",",O
at,O
least,O
in,O
part,O
",",O
phosphorylating,O
APX,O
to,O
modulate,O
ROS,O
homeostasis,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.plantsci.2019.110320,O
"
",O
PMID,O
:,O
31928664,O
"


",O
919,O
.,O
Immunol,O
Invest,O
.,O
2020,O
Jan,O
0.36875,O
.,O
doi,O
:,O
10.108,O
08820139.2019.1708384,O
.,O
[,O
Epub,O
ahead,O
"
",O
of,O
print,O
],O
"

",O
Genetic,O
Variation,O
on,O
TNF,O
LTA,O
and,O
TNFRSF1A,O
Genes,O
is,O
Associated,O
with,O
Outcomes,O
of,O
"
",O
Hepatitis,O
C,O
Virus,O
Infection,O
.,O
"

",O
Yue,O
M(1)(2,O
),O
",",O
Huang,O
P(3,O
),O
",",O
Wang,O
C(4,O
),O
",",O
Fan,O
H(5,O
),O
",",O
Tian,O
T(6,O
),O
",",O
Wu,O
J(3,O
),O
",",O
Luo,O
F(1,O
),O
",",O
Fu,O
"
",O
Z(3,O
),O
",",O
Xia,O
X(7,O
),O
",",O
Zhu,O
P(8,O
),O
",",O
Li,O
J(2,O
),O
",",O
Han,O
Y(2,O
),O
",",O
Zhang,O
Y(3)(4,O
),O
",",O
Hou,O
W(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Wuhan,O
"
",O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Nanjing,O
"
",O
Medical,O
University,O
",",O
Nanjing,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Epidemiology,O
and,O
Biostatistics,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Nanjing,O
"
",O
Medical,O
University,O
",",O
Nanjing,O
",",O
China,O
.,O
"
",O
(4)Institute,O
of,O
Epidemiology,O
and,O
Microbiology,O
",",O
Eastern,O
Theater,O
Command,O
Centers,O
"
",O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Nanjing,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Information,O
Technology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Nanjing,O
"
",O
Medical,O
University,O
",",O
Nanjing,O
",",O
China,O
.,O
"
",O
(6)Institute,O
of,O
Food,O
Safety,O
and,O
Assessment,O
",",O
Jiangsu,O
Provincial,O
Center,O
for,O
Disease,O
"
",O
Control,O
and,O
Prevention,O
",",O
Nanjing,O
",",O
China,O
.,O
"
",O
(7)Faculty,O
of,O
Life,O
Science,O
and,O
Technology,O
",",O
Kunming,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Kunming,O
",",O
China,O
.,O
"
",O
(8)Department,O
of,O
Medical,O
Affairs,O
",",O
the,O
First,O
Affiliated,O
Hospital,O
of,O
Nanjing,O
"
",O
Medical,O
University,O
",",O
Nanjing,O
",",O
China,O
.,O
"

",O
Hepatitis,O
C,O
virus,O
(,O
HCV,O
),O
infections,O
are,O
a,O
serious,O
globalscaled,O
public,O
health,O
"
",O
problem,O
.,O
Tumor,O
necrosis,O
factor,O
(,O
TNF,O
),O
lymphotoxin,O
alpha,O
(,O
LTA,O
),O
has,O
been,O
found,O
to,O
"
",O
play,O
a,O
crucial,O
role,O
in,O
relation,O
to,O
the,O
outcomes,O
of,O
HCV,O
infection,O
after,O
it,O
binds,O
"
",O
to,O
TNF,O
receptor,O
superfamily,O
member,O
1A,O
(,O
TNFRSF1A,O
),O
.,O
Thus,O
",",O
we,O
investigated,O
whether,O
"
",O
or,O
not,O
the,O
TNF,O
LTA,O
gene,O
cluster,O
and,O
TNFRSF1A,O
gene,O
polymorphisms,O
were,O
associated,O
"
",O
with,O
the,O
outcomes,O
of,O
HCV,O
infection,O
.,O
1103,O
control,O
participants,O
without,O
HCV,O
"
",O
infection,O
",",O
497,O
patients,O
with,O
spontaneous,O
clearance,O
of,O
HCV,O
infection,O
",",O
and,O
713,O
"
",O
patients,O
with,O
persistent,O
HCV,O
infection,O
were,O
enrolled,O
.,O
Rs2229094,O
",",O
rs1041981,O
",",O
"
",O
rs1799964,O
",",O
and,O
rs767455,O
were,O
genotyped,O
using,O
the,O
ABI,O
TaqMan,O
allelic,O
"
",O
discrimination,O
assay,O
.,O
After,O
adjusting,O
for,O
age,O
",",O
gender,O
",",O
and,O
after,O
determining,O
a,O
"
",O
highrisk,O
population,O
",",O
we,O
used,O
logistic,O
regression,O
analyses,O
for,O
which,O
results,O
"
",O
indicated,O
that,O
the,O
rs767455C,O
allele,O
was,O
associated,O
with,O
a,O
reduced,O
risk,O
of,O
HCV,O
"
",O
infection,O
compared,O
to,O
respective,O
results,O
for,O
the,O
wildtype,O
T,O
allele,O
(,O
dominant,O
"
",O
model,O
:,O
adjusted,O
OR,O
Â ,O
=,O
Â ,O
0.74,O
",",O
95,O
%,O
CI,O
Â ,O
=,O
Â ,O
0.600.92,O
",",O
P,O
=,O
Â ,O
0.006,O
;,O
additive,O
model,O
:,O
adjusted,O
"
",O
OR,O
Â ,O
=,O
Â ,O
0.76,O
",",O
95,O
%,O
CI,O
Â ,O
=,O
Â ,O
0.620.91,O
",",O
P,O
=,O
Â ,O
0.004,O
),O
.,O
Results,O
also,O
indicated,O
that,O
the,O
"
",O
rs1041981A,O
allele,O
was,O
associated,O
with,O
a,O
decreased,O
risk,O
of,O
persistent,O
HCV,O
"
",O
infection,O
compared,O
to,O
respective,O
results,O
for,O
the,O
wildtype,O
C,O
allele,O
(,O
additive,O
"
",O
model,O
:,O
adjusted,O
OR,O
Â ,O
=,O
Â ,O
0.81,O
",",O
95,O
%,O
CI,O
Â ,O
=,O
Â ,O
0.680.96,O
",",O
P,O
=,O
Â ,O
0.017,O
),O
.,O
Genetic,O
polymorphisms,O
"
",O
in,O
the,O
LTA,O
and,O
TNFRSF1A,O
genes,O
were,O
found,O
to,O
have,O
been,O
potentially,O
important,O
in,O
"
",O
relation,O
to,O
the,O
susceptibility,O
and,O
chronicity,O
of,O
HCV,O
infection,O
among,O
Chinese,O
Han,O
"
",O
population,O
.,O
"

",O
DOI,O
:,O
10.108,O
08820139.2019.1708384,O
"
",O
PMID,O
:,O
31928491,O
"


",O
920,O
.,O
Inflammation,O
.,O
2020,O
Jan,O
11,O
.,O
doi,O
:,O
10.1007,O
s1075301901169w,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Protective,O
Effect,O
of,O
Dexmedetomidine,O
on,O
Acute,O
Lung,O
Injury,O
via,O
the,O
Upregulation,O
of,O
"
",O
Tumour,O
Necrosis,O
FactorÎ±Induced,O
Protein8like,O
2,O
in,O
Septic,O
Mice,O
.,O
"

",O
Kong,O
Q(1,O
),O
",",O
Wu,O
X(1,O
),O
",",O
Qiu,O
Z(1,O
),O
",",O
Huang,O
Q(1,O
),O
",",O
Xia,O
Z(2,O
),O
",",O
Song,O
X(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Anesthesiology,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
430060,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Anesthesiology,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
"
",O
430060,O
",",O
Hubei,O
",",O
China,O
.,O
xiazhongyuan2005@aliyun.com,O
.,O
"
",O
(3)Department,O
of,O
Anesthesiology,O
and,O
Critical,O
Care,O
Medicine,O
",",O
Zhongnan,O
Hospital,O
of,O
"
",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430071,O
",",O
Hubei,O
",",O
China,O
.,O
sxmcl1018@163.com,O
.,O
"

",O
The,O
aim,O
of,O
the,O
present,O
study,O
was,O
to,O
investigate,O
whether,O
TIPE2,O
participates,O
in,O
the,O
"
",O
protective,O
actions,O
of,O
dexmedetomidine,O
(,O
DEX,O
),O
in,O
a,O
mouse,O
model,O
of,O
sepsisinduced,O
"
",O
acute,O
lung,O
injury,O
(,O
ALI,O
),O
.,O
We,O
administered,O
TIPE2,O
adenoassociated,O
virus,O
(,O
AAVTIPE2,O
),O
"
",O
intratracheally,O
into,O
the,O
lungs,O
of,O
mice,O
.,O
Control,O
mice,O
were,O
infected,O
with,O
an,O
"
",O
adenoassociated,O
virus,O
expressing,O
no,O
transgene,O
.,O
Three,O
weeks,O
later,O
",",O
an,O
animal,O
"
",O
model,O
of,O
caecal,O
ligationperforation,O
(CLP)induced,O
sepsis,O
was,O
established,O
.,O
DEX,O
"
",O
was,O
administered,O
intravenously,O
30,O
Â ,O
min,O
after,O
CLP,O
.,O
Twentyfour,O
hours,O
after,O
sepsis,O
",",O
"
",O
lung,O
injury,O
was,O
assayed,O
by,O
lung,O
histology,O
",",O
the,O
ratio,O
of,O
polymorphonuclear,O
"
",O
leukocytes,O
(,O
PMNs,O
),O
to,O
total,O
cells,O
in,O
the,O
bronchoalveolar,O
lavage,O
fluid,O
(,O
BALF,O
),O
",",O
"
",O
myeloperoxidase,O
(,O
MPO,O
),O
activity,O
",",O
BALF,O
protein,O
content,O
and,O
the,O
lung,O
wettodry,O
"
",O
(,O
W,O
D,O
),O
weight,O
ratio,O
.,O
Proinflammatory,O
factor,O
levels,O
in,O
the,O
BALF,O
of,O
mice,O
were,O
"
",O
measured,O
.,O
The,O
protein,O
expression,O
levels,O
in,O
lung,O
tissues,O
were,O
analysed,O
by,O
Western,O
"
",O
blotting,O
.,O
The,O
results,O
showed,O
that,O
DEX,O
treatment,O
markedly,O
mitigated,O
sepsisinduced,O
"
",O
lung,O
injury,O
",",O
which,O
was,O
characterized,O
by,O
the,O
deterioration,O
of,O
histopathology,O
",",O
"
",O
histologic,O
scores,O
",",O
the,O
W,O
D,O
weight,O
ratio,O
and,O
total,O
protein,O
levels,O
in,O
the,O
BALF,O
.,O
"
",O
Moreover,O
",",O
DEX,O
markedly,O
attenuated,O
sepsisinduced,O
lung,O
inflammation,O
",",O
as,O
evidenced,O
"
",O
by,O
the,O
decrease,O
in,O
the,O
number,O
of,O
PMNs,O
in,O
the,O
BALF,O
",",O
lung,O
MPO,O
activity,O
and,O
"
",O
proinflammatory,O
cytokines,O
in,O
the,O
BALF,O
.,O
In,O
addition,O
",",O
DEX,O
dramatically,O
prevented,O
"
",O
sepsisinduced,O
pulmonary,O
cell,O
apoptosis,O
in,O
mice,O
",",O
as,O
reflected,O
by,O
decreases,O
in,O
the,O
"
",O
number,O
of,O
TUNELpositive,O
cells,O
",",O
the,O
protein,O
expression,O
of,O
cleaved,O
caspase9,O
and,O
"
",O
cleaved,O
caspase,O
3,O
and,O
the,O
Bax,O
Bcl2,O
ratio,O
.,O
In,O
addition,O
",",O
evaluation,O
of,O
protein,O
"
",O
expression,O
showed,O
that,O
DEX,O
blocked,O
sepsisactivated,O
JNK,O
phosphorylation,O
and,O
NFÎºB,O
"
",O
p65,O
nuclear,O
translocation,O
.,O
Similar,O
results,O
were,O
also,O
observed,O
in,O
the,O
TIPE2,O
"
",O
overexpression,O
group,O
.,O
Our,O
study,O
demonstrated,O
that,O
DEX,O
inhibits,O
acute,O
inflammation,O
"
",O
and,O
apoptosis,O
in,O
a,O
murine,O
model,O
of,O
sepsisstimulated,O
ALI,O
via,O
the,O
upregulation,O
of,O
"
",O
TIPE2,O
and,O
the,O
suppression,O
of,O
the,O
activation,O
of,O
the,O
NFÎºB,O
and,O
JNK,O
signalling,O
"
",O
pathways,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s1075301901169w,O
"
",O
PMID,O
:,O
31927655,O
"


",O
921,O
.,O
Front,O
Oncol,O
.,O
2019,O
Dec,O
18;9:1437,O
.,O
doi,O
:,O
10.3389,O
fonc.2019.01437,O
.,O
eCollection,O
2019,O
.,O
"

",O
Severe,O
ImmuneRelated,O
Pneumonitis,O
With,O
PD1,O
Inhibitor,O
After,O
Progression,O
on,O
"
",O
Previous,O
PDL1,O
Inhibitor,O
in,O
Small,O
Cell,O
Lung,O
Cancer,O
:,O
A,O
Case,O
Report,O
and,O
Review,O
of,O
"
",O
the,O
Literature,O
.,O
"

",O
Liang,O
X(1,O
),O
",",O
Guan,O
Y(2,O
),O
",",O
Zhang,O
B(3,O
),O
",",O
Liang,O
J(4,O
),O
",",O
Wang,O
B(1,O
),O
",",O
Li,O
Y(4,O
),O
",",O
Wang,O
J(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Oncology,O
",",O
No.,O
960,O
Hospital,O
",",O
The,O
People,O
's,O
Liberation,O
Army,O
",",O
Jinan,O
",",O
"
",O
China,O
.,O
"
",O
(2)Department,O
of,O
Respiratory,O
Medicine,O
",",O
Shandong,O
Thoracic,O
Diseases,O
Hospital,O
",",O
"
",O
Jinan,O
",",O
China,O
.,O
"
",O
(3)Cancer,O
Center,O
",",O
Renmin,O
Hospital,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Oncology,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Shandong,O
First,O
"
",O
Medical,O
University,O
",",O
Jinan,O
",",O
China,O
.,O
"
",O
(5)Shandong,O
Provincial,O
Qianfoshan,O
Hospital,O
",",O
Shandong,O
University,O
",",O
Jinan,O
",",O
China,O
.,O
"

",O
Objective,O
:,O
Combination,O
therapy,O
with,O
programmed,O
cell,O
death,O
protein1,O
(,O
PD1,O
),O
and,O
"
",O
programmed,O
cell,O
death,O
ligand1,O
(,O
PDL1,O
),O
inhibitors,O
might,O
be,O
viewed,O
as,O
a,O
promising,O
"
",O
therapeutic,O
strategy,O
for,O
resistant,O
lung,O
cancer,O
",",O
and,O
it,O
is,O
becoming,O
common,O
that,O
a,O
"
",O
second,O
PD1,O
PDL1,O
inhibitor,O
might,O
be,O
used,O
following,O
progression,O
on,O
previous,O
"
",O
PD1,O
PDL1,O
inhibitor,O
.,O
However,O
",",O
a,O
subgroup,O
of,O
patients,O
will,O
experience,O
various,O
"
",O
autoimmune,O
toxicities,O
",",O
termed,O
as,O
immunerelated,O
adverse,O
events,O
(,O
irAEs,O
),O
",",O
that,O
"
",O
occur,O
as,O
a,O
result,O
of,O
ontarget,O
and,O
offtumor,O
inflammation,O
.,O
Materials,O
and,O
Methods,O
:,O
"
",O
In,O
this,O
report,O
",",O
we,O
presented,O
a,O
patient,O
with,O
small,O
cell,O
lung,O
cancer,O
who,O
received,O
"
",O
different,O
PD1,O
PDL1,O
inhibitors,O
during,O
the,O
course,O
of,O
disease,O
progression,O
.,O
This,O
"
",O
patient,O
experienced,O
radiationrelated,O
pneumonitis,O
",",O
immunerelated,O
pneumonitis,O
",",O
as,O
"
",O
well,O
as,O
concomitant,O
bacterial,O
pneumonia,O
.,O
Results,O
:,O
In,O
particular,O
",",O
this,O
patient,O
"
",O
developed,O
immunerelated,O
pneumonitis,O
with,O
a,O
second,O
PD1,O
inhibitor,O
when,O
she,O
had,O
a,O
"
",O
progressive,O
disease,O
on,O
previous,O
PDL1,O
inhibitor,O
.,O
This,O
patient,O
was,O
initially,O
"
",O
responsive,O
to,O
steroid,O
treatment,O
",",O
but,O
rapidly,O
develop,O
more,O
severe,O
pneumonitis,O
and,O
"
",O
concomitant,O
bacterial,O
pneumonia,O
with,O
no,O
response,O
to,O
antibiotics,O
and,O
steroid,O
"
",O
treatment,O
.,O
Finally,O
",",O
this,O
patient,O
got,O
a,O
good,O
clinical,O
response,O
when,O
receiving,O
"
",O
additional,O
immunosuppressive,O
medications,O
infliximab,O
and,O
mycophenolate,O
mofetil,O
.,O
"
",O
Conclusions,O
:,O
Patients,O
with,O
a,O
history,O
of,O
radiationinduced,O
pneumonitis,O
and,O
treated,O
"
",O
with,O
sequential,O
different,O
PD1,O
PDL1,O
inhibitors,O
have,O
a,O
relative,O
high,O
risk,O
to,O
"
",O
develop,O
highgrade,O
or,O
steroidresistant,O
pneumonitis,O
",",O
and,O
additional,O
"
",O
immunosuppressive,O
medications,O
should,O
be,O
used,O
earlier,O
when,O
severe,O
pulmonary,O
"
",O
toxicity,O
occurs,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Liang,O
",",O
Guan,O
",",O
Zhang,O
",",O
Liang,O
",",O
Wang,O
",",O
Li,O
and,O
Wang,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fonc.2019.01437,O
"
",O
PMCID,O
:,O
PMC6930180,O
"
",O
PMID,O
:,O
31921686,O
"


",O
922,O
.,O
Front,O
Immunol,O
.,O
2019,O
Dec,O
18;10:2878,O
.,O
doi,O
:,O
10.3389,O
fimmu.2019.02878,O
.,O
eCollection,O
"
",O
2019,O
.,O
"

",O
ViralInfected,O
Change,O
of,O
the,O
Digestive,O
Tract,O
Microbiota,O
Associated,O
With,O
Mucosal,O
"
",O
Immunity,O
in,O
Teleost,O
Fish,O
.,O
"

",O
Dong,O
S(1,O
),O
",",O
Ding,O
LG(1,O
),O
",",O
Cao,O
JF(1,O
),O
",",O
Liu,O
X(1,O
),O
",",O
Xu,O
HY(1,O
),O
",",O
Meng,O
KF(1,O
),O
",",O
Yu,O
YY(1,O
),O
",",O
Wang,O
"
",O
Q(1,O
),O
",",O
Xu,O
Z(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Aquatic,O
Animal,O
Medicine,O
",",O
College,O
of,O
Fisheries,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Laboratory,O
for,O
Marine,O
Biology,O
and,O
Biotechnology,O
",",O
Qingdao,O
National,O
Laboratory,O
"
",O
for,O
Marine,O
Science,O
and,O
Technology,O
",",O
Qingdao,O
",",O
China,O
.,O
"

",O
The,O
digestive,O
tract,O
is,O
a,O
unique,O
series,O
of,O
organs,O
that,O
is,O
inhabited,O
by,O
a,O
range,O
of,O
"
",O
commensal,O
microbes,O
while,O
also,O
exposed,O
to,O
an,O
overwhelming,O
load,O
of,O
dietary,O
"
",O
antigens,O
.,O
It,O
is,O
widely,O
known,O
that,O
mammals,O
have,O
evolved,O
complex,O
and,O
efficient,O
"
",O
immune,O
strategies,O
to,O
protect,O
the,O
mucosa,O
of,O
the,O
digestive,O
tract,O
.,O
However,O
",",O
in,O
the,O
"
",O
early,O
vertebrates,O
",",O
the,O
roles,O
of,O
mucosal,O
immune,O
defense,O
and,O
microbial,O
communities,O
"
",O
in,O
the,O
different,O
segments,O
of,O
the,O
digestive,O
tract,O
are,O
not,O
wellunderstood,O
.,O
Here,O
",",O
"
",O
we,O
constructed,O
a,O
bath,O
infection,O
model,O
with,O
infectious,O
hematopoietic,O
necrosis,O
"
",O
virus,O
(,O
IHNV,O
),O
in,O
rainbow,O
trout,O
(,O
Oncorhynchus,O
mykiss,O
),O
.,O
Importantly,O
",",O
following,O
viral,O
"
",O
infection,O
",",O
we,O
found,O
that,O
the,O
IHNV,O
distribution,O
and,O
the,O
reactions,O
of,O
"
",O
immunerelated,O
genes,O
had,O
similar,O
trends,O
that,O
decreased,O
across,O
the,O
digestive,O
"
",O
tract,O
.,O
Hematoxylin,O
and,O
eosin,O
(,O
H,O
&,O
E,O
),O
and,O
alcian,O
blue,O
(,O
A,O
&,O
B,O
),O
staining,O
of,O
the,O
"
",O
trout,O
digestive,O
tract,O
showed,O
that,O
the,O
pathological,O
changes,O
only,O
occurred,O
in,O
the,O
"
",O
buccal,O
and,O
pharyngeal,O
mucosal,O
tissues,O
.,O
Moreover,O
",",O
the,O
increased,O
diversity,O
of,O
the,O
"
",O
microbial,O
community,O
was,O
only,O
detected,O
in,O
the,O
buccal,O
mucosa,O
through,O
16S,O
rRNA,O
gene,O
"
",O
sequencing,O
",",O
suggesting,O
that,O
the,O
magnitude,O
of,O
the,O
immune,O
response,O
and,O
microbial,O
"
",O
community,O
changes,O
are,O
related,O
to,O
the,O
IHNV,O
load,O
and,O
the,O
original,O
microbial,O
"
",O
diversity,O
.,O
In,O
addition,O
",",O
the,O
loss,O
of,O
digestive,O
tract,O
dominant,O
species,O
and,O
"
",O
increased,O
colonization,O
of,O
opportunistic,O
bacteria,O
were,O
discovered,O
in,O
the,O
buccal,O
"
",O
mucosal,O
surface,O
indicating,O
that,O
a,O
secondary,O
bacterial,O
infection,O
occurred,O
in,O
this,O
"
",O
mucosal,O
tissue,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Dong,O
",",O
Ding,O
",",O
Cao,O
",",O
Liu,O
",",O
Xu,O
",",O
Meng,O
",",O
Yu,O
",",O
Wang,O
and,O
Xu,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fimmu.2019.02878,O
"
",O
PMCID,O
:,O
PMC6930168,O
"
",O
PMID,O
:,O
31921142,O
"


",O
923,O
.,O
Biomed,O
Environ,O
Sci,O
.,O
2019,O
Dec;32(12):926929,O
.,O
doi,O
:,O
10.3967,O
bes2019.116,O
.,O
"

",O
Development,O
of,O
an,O
Internally,O
Controlled,O
Reverse,O
Transcription,O
Recombinaseaided,O
"
",O
Amplification,O
Assay,O
for,O
the,O
Rapid,O
and,O
Visual,O
Detection,O
of,O
West,O
Nile,O
Virus,O
.,O
"

",O
Fan,O
GH(1,O
),O
",",O
Shen,O
XX(2,O
),O
",",O
Li,O
F(3,O
),O
",",O
Li,O
XN(2,O
),O
",",O
Bai,O
XD(2,O
),O
",",O
Zhang,O
RQ(2,O
),O
",",O
Wang,O
RH(2,O
),O
",",O
Lei,O
"
",O
WW(3,O
),O
",",O
Wang,O
HY(3,O
),O
",",O
Ma,O
XJ(4,O
),O
",",O
Wu,O
GZ(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Core,O
Facility,O
",",O
Ministry,O
of,O
Health,O
Key,O
Laboratory,O
of,O
Disease,O
"
",O
Control,O
and,O
Prevention,O
",",O
Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
"
",O
Beijing,O
102206,O
",",O
China,O
;,O
Biosafety,O
3,O
Laboratory,O
",",O
Chinese,O
Center,O
for,O
Disease,O
Control,O
"
",O
and,O
Prevention,O
",",O
Beijing,O
102206,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Core,O
Facility,O
",",O
Ministry,O
of,O
Health,O
Key,O
Laboratory,O
of,O
Disease,O
"
",O
Control,O
and,O
Prevention,O
",",O
Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
"
",O
Beijing,O
102206,O
",",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Infectious,O
Disease,O
Prevention,O
and,O
Control,O
",",O
Chinese,O
"
",O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Beijing,O
102206,O
",",O
China,O
;,O
Department,O
of,O
"
",O
Viral,O
Encephalitis,O
",",O
NHC,O
Key,O
Laboratory,O
of,O
Biosafety,O
",",O
National,O
Institute,O
for,O
Viral,O
"
",O
Disease,O
Control,O
and,O
Prevention,O
",",O
Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
"
",O
Prevention,O
",",O
Beijing,O
102206,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Core,O
Facility,O
",",O
Ministry,O
of,O
Health,O
Key,O
Laboratory,O
of,O
Disease,O
"
",O
Control,O
and,O
Prevention,O
",",O
Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
"
",O
Beijing,O
102206,O
",",O
China,O
;,O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
"
",O
Sciences,O
",",O
Wuhan,O
430071,O
",",O
China,O
.,O
"
",O
(5)Biosafety,O
3,O
Laboratory,O
",",O
Chinese,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
"
",O
Beijing,O
102206,O
",",O
China,O
.,O
"

",O
West,O
Nile,O
virus,O
(,O
WNV,O
),O
causes,O
West,O
Nile,O
fever,O
and,O
West,O
Nile,O
encephalitis,O
.,O
Because,O
"
",O
infection,O
by,O
WNV,O
creates,O
serious,O
public,O
health,O
problems,O
",",O
its,O
simple,O
",",O
rapid,O
",",O
and,O
"
",O
visual,O
detection,O
is,O
very,O
important,O
in,O
clinical,O
practice,O
",",O
especially,O
in,O
"
",O
resourcelimited,O
laboratories,O
.,O
We,O
have,O
developed,O
a,O
rapid,O
",",O
specific,O
",",O
and,O
highly,O
"
",O
sensitive,O
internally,O
controlled,O
reverse,O
transcription,O
recombinaseaided,O
"
",O
amplification,O
(,O
RTRAA,O
),O
assay,O
to,O
detect,O
WNV,O
",",O
using,O
both,O
realtime,O
fluorescence,O
and,O
"
",O
the,O
lateral,O
flow,O
dipstick,O
(,O
LFD,O
),O
at,O
39,O
Â°,O
C,O
for,O
30,O
min,O
.,O
The,O
analytical,O
sensitivity,O
"
",O
of,O
the,O
RTRAA,O
assay,O
was,O
10,O
plasmid,O
copies,O
and,O
1.6,O
pfu,O
per,O
reaction,O
with,O
realtime,O
"
",O
fluorescence,O
",",O
and,O
1000,O
plasmid,O
copies,O
per,O
reaction,O
with,O
the,O
LFD,O
.,O
No,O
"
",O
crossreaction,O
with,O
other,O
control,O
viruses,O
was,O
observed,O
.,O
Compared,O
with,O
the,O
RTqPCR,O
"
",O
assay,O
",",O
the,O
RTRAA,O
assay,O
demonstrated,O
100,O
%,O
sensitivity,O
and,O
100,O
%,O
specificity,O
for,O
"
",O
WNV,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
The,O
Editorial,O
Board,O
of,O
Biomedical,O
and,O
Environmental,O
Sciences,O
.,O
"
",O
Published,O
by,O
China,O
CDC,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.3967,O
bes2019.116,O
"
",O
PMID,O
:,O
31918798,O
"


",O
924,O
.,O
Virol,O
Sin,O
.,O
2020,O
Jan,O
8,O
.,O
doi,O
:,O
10.1007,O
s1225001900188z,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
MetaTranscriptome,O
Profiling,O
of,O
Novel,O
Invasive,O
Pest,O
Spodoptera,O
frugiperda,O
in,O
"
",O
Yunnan,O
",",O
China,O
.,O
"

",O
Shi,O
J(1)(2,O
),O
",",O
Li,O
W(3)(4,O
),O
",",O
Wang,O
Y(3)(4,O
),O
",",O
Chen,O
Q(3,O
),O
",",O
Deng,O
F(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
and,O
National,O
Viruses,O
Resource,O
Center,O
",",O
Wuhan,O
"
",O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100049,O
",",O
China,O
.,O
"
",O
(3)Kunming,O
Institute,O
of,O
Zoology,O
",",O
Chinese,O
Academy,O
Sciences,O
",",O
Kunming,O
",",O
650223,O
",",O
"
",O
China,O
.,O
"
",O
(4)Yunnan,O
Agricultural,O
University,O
",",O
Kunming,O
",",O
650201,O
",",O
China,O
.,O
"
",O
(5)State,O
Key,O
Laboratory,O
of,O
Virology,O
and,O
National,O
Viruses,O
Resource,O
Center,O
",",O
Wuhan,O
"
",O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
df@wh.iov.cn,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s1225001900188z,O
"
",O
PMID,O
:,O
31916023,O
"


",O
925,O
.,O
Virol,O
Sin,O
.,O
2020,O
Feb;35(1):113,O
.,O
doi,O
:,O
10.1007,O
s12250019001905,O
.,O
Epub,O
2020,O
Jan,O
8,O
.,O
"

",O
CryoEM,O
Studies,O
of,O
VirusAntibody,O
Immune,O
Complexes,O
.,O
"

",O
Li,O
N(1)(2)(3,O
),O
",",O
Li,O
Z(1)(2)(3,O
),O
",",O
Fu,O
Y(1)(2,O
),O
",",O
Cao,O
S(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(2)Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
"
",O
China,O
.,O
"
",O
(3)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100049,O
",",O
China,O
.,O
"
",O
(4)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
caosheng@wh.iov.cn,O
.,O
"
",O
(5)Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
"
",O
China,O
.,O
caosheng@wh.iov.cn,O
.,O
"

",O
Antibodies,O
play,O
critical,O
roles,O
in,O
neutralizing,O
viral,O
infections,O
and,O
are,O
"
",O
increasingly,O
used,O
as,O
therapeutic,O
drugs,O
and,O
diagnostic,O
tools,O
.,O
Structural,O
studies,O
"
",O
on,O
virusantibody,O
immune,O
complexes,O
are,O
important,O
for,O
better,O
understanding,O
the,O
"
",O
molecular,O
mechanisms,O
of,O
antibodymediated,O
neutralization,O
and,O
also,O
provide,O
"
",O
valuable,O
information,O
for,O
structurebased,O
vaccine,O
design,O
.,O
Cryoelectron,O
microscopy,O
"
",O
(,O
cryoEM,O
),O
has,O
recently,O
matured,O
as,O
a,O
powerful,O
structural,O
technique,O
for,O
studying,O
"
",O
biomacromolecular,O
complexes,O
.,O
When,O
combined,O
with,O
Xray,O
crystallography,O
",",O
cryoEM,O
"
",O
provides,O
a,O
routine,O
approach,O
for,O
structurally,O
characterizing,O
the,O
immune,O
complexes,O
"
",O
formed,O
between,O
icosahedral,O
viruses,O
and,O
their,O
antibodies,O
.,O
In,O
this,O
review,O
",",O
recent,O
"
",O
advances,O
in,O
the,O
structural,O
understanding,O
of,O
virusantibody,O
interactions,O
are,O
"
",O
outlined,O
for,O
whole,O
virions,O
with,O
icosahedral,O
T,O
â€‰,O
=,O
â€‰,O
pseudo,O
3,O
(,O
picornaviruses,O
),O
and,O
"
",O
T,O
â€‰,O
=,O
â€‰,O
3,O
(,O
flaviviruses,O
),O
architectures,O
",",O
focusing,O
on,O
the,O
dynamic,O
nature,O
of,O
viral,O
"
",O
shells,O
in,O
different,O
functional,O
states,O
.,O
Glycoprotein,O
complexes,O
from,O
pleomorphic,O
"
",O
enveloped,O
viruses,O
are,O
also,O
discussed,O
as,O
immune,O
complex,O
antigens,O
.,O
Improving,O
our,O
"
",O
understanding,O
of,O
viral,O
epitope,O
structures,O
using,O
virusbased,O
platforms,O
would,O
"
",O
provide,O
a,O
fundamental,O
road,O
map,O
for,O
future,O
vaccine,O
development,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12250019001905,O
"
",O
PMCID,O
:,O
PMC7035235,O
"
",O
PMID,O
:,O
31916022,O
"


",O
926,O
.,O
J,O
Clin,O
Transl,O
Hepatol,O
.,O
2019,O
Dec,O
28;7(4):322328,O
.,O
doi,O
:,O
10.14218,O
JCTH.2019.00052,O
.,O
"
",O
Epub,O
2019,O
Dec,O
20,O
.,O
"

",O
Baseline,O
Characteristics,O
and,O
Treatment,O
Patterns,O
of,O
the,O
Patients,O
Recruited,O
to,O
the,O
"
",O
China,O
Registry,O
of,O
Hepatitis,O
B.,O
"

",O
Shan,O
S(1,O
),O
",",O
You,O
H(1,O
),O
",",O
Niu,O
J(2,O
),O
",",O
Shang,O
J(3,O
),O
",",O
Xie,O
W(4,O
),O
",",O
Zhang,O
Y(5,O
),O
",",O
Li,O
X(6,O
),O
",",O
Ren,O
"
",O
H(7,O
),O
",",O
Tang,O
H(8,O
),O
",",O
Ding,O
H(9,O
),O
",",O
Wang,O
X(10,O
),O
",",O
Nan,O
Y(11,O
),O
",",O
Dou,O
X(12,O
),O
",",O
Han,O
T(13,O
),O
",",O
Zhang,O
"
",O
L(14,O
),O
",",O
Liu,O
X(15,O
),O
",",O
Deng,O
C(16,O
),O
",",O
Cheng,O
J(17,O
),O
",",O
Wang,O
X(18,O
),O
",",O
Xie,O
Q(19,O
),O
",",O
Lin,O
S(20,O
),O
",",O
"
",O
Huang,O
Y(21,O
),O
",",O
Xu,O
Y(22,O
),O
",",O
Xiong,O
Y(23,O
),O
",",O
Li,O
W(24,O
),O
",",O
Yan,O
X(25,O
),O
",",O
Piao,O
H(26,O
),O
",",O
Huang,O
W(27,O
),O
",",O
"
",O
Lu,O
Q(28,O
),O
",",O
Gong,O
W(29,O
),O
",",O
Li,O
S(30,O
),O
",",O
Hu,O
X(31,O
),O
",",O
Zhang,O
X(32,O
),O
",",O
Liu,O
S(33,O
),O
",",O
Li,O
Y(34,O
),O
",",O
Yang,O
"
",O
D(35,O
),O
",",O
Li,O
H(36,O
),O
",",O
Yang,O
C(37,O
),O
",",O
Cheng,O
M(38,O
),O
",",O
Zhang,O
L(39,O
),O
",",O
Zheng,O
H(40,O
),O
",",O
Luo,O
X(41,O
),O
",",O
"
",O
Lin,O
F(42,O
),O
",",O
Wang,O
L(43,O
),O
",",O
Xu,O
G(44,O
),O
",",O
Xu,O
X(45,O
),O
",",O
Wei,O
L(46,O
),O
",",O
Hou,O
J(47,O
),O
",",O
Duan,O
Z(48,O
),O
",",O
"
",O
Zhuang,O
H(49,O
),O
",",O
Yang,O
X(50,O
),O
",",O
Kong,O
Y(51,O
),O
",",O
Jia,O
J(1,O
),O
;,O
CRHepB,O
study,O
group,O
",",O
Beijing,O
",",O
"
",O
China,O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Liver,O
Research,O
Center,O
",",O
Beijing,O
Friendship,O
Hospital,O
",",O
Capital,O
Medical,O
"
",O
University,O
",",O
Beijing,O
Key,O
Laboratory,O
of,O
Translational,O
Medicine,O
on,O
Liver,O
Cirrhosis,O
",",O
"
",O
National,O
Clinical,O
Research,O
Center,O
for,O
Digestive,O
Diseases,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Hepatology,O
",",O
First,O
Hospital,O
of,O
Jilin,O
University,O
",",O
Changchun,O
",",O
"
",O
Jilin,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Infectious,O
Diseases,O
",",O
Henan,O
Provincial,O
People,O
's,O
Hospital,O
",",O
"
",O
Zhengzhou,O
",",O
Henan,O
",",O
China,O
.,O
"
",O
(4)Center,O
of,O
Liver,O
Diseases,O
",",O
Beijing,O
Ditan,O
Hospital,O
",",O
Capital,O
Medical,O
University,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Infectious,O
Diseases,O
",",O
First,O
Affiliated,O
Hospital,O
of,O
Xinjiang,O
"
",O
Medical,O
University,O
",",O
Urumqi,O
",",O
Xinjiang,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
General,O
Surgery,O
",",O
The,O
First,O
Hospital,O
of,O
Lanzhou,O
University,O
",",O
"
",O
Lanzhou,O
",",O
Gansu,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
of,O
Chongqing,O
"
",O
Medical,O
University,O
",",O
Chongqing,O
",",O
China,O
.,O
"
",O
(8)Center,O
of,O
Infectious,O
Diseases,O
",",O
West,O
China,O
Hospital,O
of,O
Sichuan,O
University,O
",",O
"
",O
Chengdu,O
",",O
Sichuan,O
",",O
China,O
.,O
"
",O
(9)Department,O
of,O
Gastroenterology,O
and,O
Hepatology,O
",",O
Beijing,O
Youan,O
Hospital,O
",",O
Capital,O
"
",O
Medical,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(10)Center,O
of,O
Infectious,O
Diseases,O
",",O
The,O
Third,O
People,O
's,O
Hospital,O
of,O
Taiyuan,O
",",O
"
",O
Taiyuan,O
",",O
Shanxi,O
",",O
China,O
.,O
"
",O
(11)Department,O
of,O
Traditional,O
and,O
Western,O
Medical,O
Hepatology,O
",",O
The,O
Third,O
Hospital,O
"
",O
of,O
Hebei,O
Medical,O
University,O
",",O
Shijiazhuang,O
",",O
Hebei,O
",",O
China,O
.,O
"
",O
(12)Department,O
of,O
Infectious,O
Diseases,O
",",O
Shengjing,O
Hospital,O
of,O
China,O
Medical,O
"
",O
University,O
",",O
Shenyang,O
",",O
Liaoning,O
",",O
China,O
.,O
"
",O
(13)Department,O
of,O
Hepatology,O
",",O
Tianjin,O
Third,O
Central,O
Hospital,O
",",O
Tianjin,O
Medical,O
"
",O
University,O
",",O
Tianjin,O
",",O
China,O
.,O
"
",O
(14)Department,O
of,O
Hepatology,O
",",O
Lanzhou,O
University,O
Second,O
Hospital,O
",",O
Lanzhou,O
",",O
Gansu,O
",",O
"
",O
China,O
.,O
"
",O
(15)Department,O
of,O
Infectious,O
Diseases,O
",",O
Peking,O
Union,O
Medical,O
College,O
Hospital,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(16)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
Affiliated,O
Hospital,O
of,O
Southwest,O
"
",O
Medical,O
University,O
",",O
Luzhou,O
",",O
Gansu,O
",",O
China,O
.,O
"
",O
(17)Department,O
of,O
Gastroenterology,O
",",O
Shanghai,O
Public,O
Health,O
Clinical,O
Center,O
",",O
"
",O
Shanghai,O
",",O
China,O
.,O
"
",O
(18)Department,O
of,O
Hepatology,O
",",O
Xinjiang,O
Uygur,O
Autonomous,O
Region,O
Traditional,O
"
",O
Chinese,O
Medicine,O
Hospital,O
",",O
Urumqi,O
",",O
Xinjiang,O
",",O
China,O
.,O
"
",O
(19)Department,O
of,O
Infectious,O
Diseases,O
",",O
Shanghai,O
Ruijin,O
Hospital,O
",",O
Jiao,O
Tong,O
"
",O
University,O
School,O
of,O
Medicine,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(20)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Xian,O
Jiao,O
"
",O
Tong,O
University,O
",",O
Xi'an,O
",",O
Shaanxi,O
",",O
China,O
.,O
"
",O
(21)Department,O
of,O
Infectious,O
Diseases,O
",",O
Xiangya,O
Hospital,O
Central,O
South,O
University,O
",",O
"
",O
Changsha,O
",",O
Hunan,O
",",O
China,O
.,O
"
",O
(22)Department,O
of,O
Digestive,O
System,O
",",O
Beijing,O
Tiantan,O
Hospital,O
",",O
Capital,O
Medical,O
"
",O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(23)Department,O
of,O
Infectious,O
Diseases,O
",",O
Zhongnan,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(24)Department,O
of,O
Infectious,O
Diseases,O
",",O
First,O
Affiliated,O
Hospital,O
of,O
Kunming,O
"
",O
Medical,O
University,O
",",O
Kunming,O
",",O
Yunnan,O
",",O
China,O
.,O
"
",O
(25)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
Affiliated,O
Hospital,O
of,O
Xuzhou,O
Medical,O
"
",O
University,O
",",O
Xuzhou,O
",",O
Henan,O
",",O
China,O
.,O
"
",O
(26)Department,O
of,O
Infectious,O
Diseases,O
",",O
Yanbian,O
University,O
Hospital,O
",",O
Yanji,O
",",O
Jilin,O
",",O
"
",O
China,O
.,O
"
",O
(27)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Chongqing,O
"
",O
Medical,O
University,O
",",O
Chongqing,O
",",O
China,O
.,O
"
",O
(28)Department,O
of,O
Hepatology,O
",",O
The,O
Fourth,O
People,O
's,O
Hospital,O
of,O
Qinghai,O
Province,O
",",O
"
",O
Xining,O
",",O
Qinghai,O
",",O
China,O
.,O
"
",O
(29)Department,O
of,O
Infectious,O
Diseases,O
",",O
Xinjiang,O
Changji,O
Prefecture,O
People,O
's,O
"
",O
Hospital,O
",",O
Changji,O
",",O
Xinjiang,O
",",O
China,O
.,O
"
",O
(30)Department,O
of,O
Hepatopancreatobiliary,O
Surgery,O
",",O
Affiliated,O
Hospital,O
of,O
Weifang,O
"
",O
Medical,O
University,O
",",O
Weifang,O
",",O
Shandong,O
",",O
China,O
.,O
"
",O
(31)Department,O
of,O
Hepatology,O
",",O
Hunan,O
Provincial,O
People,O
's,O
Hospital,O
",",O
Changsha,O
",",O
"
",O
Hunan,O
",",O
China,O
.,O
"
",O
(32)Department,O
of,O
Gastroenterology,O
",",O
The,O
Second,O
Hospital,O
of,O
Hebei,O
Medical,O
"
",O
University,O
",",O
Shijiazhuang,O
",",O
Hebei,O
",",O
China,O
.,O
"
",O
(33)Department,O
of,O
Hepatology,O
",",O
Xixi,O
Hospital,O
of,O
Hangzhou,O
",",O
Hangzhou,O
",",O
Zhejiang,O
",",O
"
",O
China,O
.,O
"
",O
(34)Department,O
of,O
Infectious,O
Diseases,O
",",O
General,O
Hospital,O
of,O
Ningxia,O
Medical,O
"
",O
University,O
",",O
Yinchuan,O
",",O
Ningxia,O
",",O
China,O
.,O
"
",O
(35)Department,O
of,O
Infectious,O
Diseases,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
of,O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(36)Department,O
of,O
Hepatopancreatobiliary,O
and,O
Splenic,O
Medicine,O
",",O
The,O
Affiliated,O
"
",O
Hospital,O
",",O
Logistics,O
University,O
of,O
People,O
's,O
Armed,O
Police,O
Force,O
",",O
Tianjin,O
",",O
China,O
.,O
"
",O
(37)Department,O
of,O
Infectious,O
Diseases,O
",",O
Infectious,O
Disease,O
Hospital,O
of,O
Wuhai,O
",",O
"
",O
Wuhai,O
",",O
Inner,O
Mongolia,O
",",O
China,O
.,O
"
",O
(38)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
Affiliated,O
Hospital,O
of,O
Guizhou,O
Medical,O
"
",O
University,O
",",O
Guiyang,O
",",O
Guizhou,O
",",O
China,O
.,O
"
",O
(39)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Shanxi,O
"
",O
Medical,O
University,O
",",O
Taiyuan,O
",",O
Shanxi,O
",",O
China,O
.,O
"
",O
(40)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
Fifth,O
Hospital,O
of,O
Shijiazhuang,O
",",O
"
",O
Shijiazhuang,O
",",O
Hebei,O
",",O
China,O
.,O
"
",O
(41)Department,O
of,O
Infectious,O
Diseases,O
",",O
Guizhou,O
Provincial,O
People,O
's,O
Hospital,O
",",O
"
",O
Guiyang,O
",",O
Guizhou,O
",",O
China,O
.,O
"
",O
(42)Department,O
of,O
Infectious,O
Diseases,O
",",O
Hainan,O
General,O
Hospital,O
",",O
Haikou,O
",",O
Hainan,O
",",O
"
",O
China,O
.,O
"
",O
(43)Department,O
of,O
Infectious,O
Diseases,O
",",O
The,O
Second,O
Hospital,O
of,O
Shandong,O
"
",O
University,O
",",O
Jinan,O
",",O
Shandong,O
",",O
China,O
.,O
"
",O
(44)Department,O
of,O
Infectious,O
Diseases,O
",",O
Yanan,O
University,O
Affiliated,O
Hospital,O
",",O
"
",O
Yan'an,O
",",O
Shaanxi,O
",",O
China,O
.,O
"
",O
(45)Department,O
of,O
Infectious,O
Diseases,O
",",O
Peking,O
University,O
First,O
Hospital,O
",",O
Beijing,O
",",O
"
",O
China,O
.,O
"
",O
(46)Peking,O
University,O
Hepatology,O
Institute,O
",",O
Peking,O
University,O
People,O
's,O
Hospital,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(47)Institute,O
of,O
Hepatology,O
and,O
Department,O
of,O
Infectious,O
Disease,O
",",O
Nanfang,O
"
",O
Hospital,O
",",O
Southern,O
Medical,O
University,O
",",O
Guangzhou,O
",",O
Guangdong,O
",",O
China,O
.,O
"
",O
(48)Artificial,O
Liver,O
Center,O
",",O
Beijing,O
Youan,O
Hospital,O
",",O
Capital,O
Medical,O
University,O
",",O
"
",O
Beijing,O
",",O
China,O
.,O
"
",O
(49)Department,O
of,O
Microbiology,O
and,O
Infectious,O
Disease,O
Center,O
",",O
Peking,O
University,O
"
",O
Health,O
Science,O
Center,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(50)The,O
China,O
Foundation,O
of,O
Hepatitis,O
Prevention,O
and,O
Control,O
",",O
Beijing,O
China,O
.,O
"
",O
(51)Center,O
for,O
Clinical,O
Epidemiology,O
and,O
EBM,O
",",O
Beijing,O
Friendship,O
Hospital,O
",",O
"
",O
Capital,O
Medical,O
University,O
",",O
National,O
Clinical,O
Research,O
Center,O
for,O
Digestive,O
"
",O
Diseases,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
Background,O
and,O
Aims,O
:,O
Chronic,O
hepatitis,O
B,O
virus,O
(,O
HBV,O
),O
infection,O
remains,O
a,O
major,O
"
",O
public,O
health,O
problem,O
globally,O
.,O
Here,O
",",O
we,O
describe,O
the,O
baseline,O
characteristics,O
"
",O
and,O
treatment,O
profiles,O
of,O
HBVinfected,O
patients,O
recruited,O
to,O
the,O
China,O
Registry,O
"
",O
of,O
Hepatitis,O
B.,O
Methods,O
:,O
Inclusion,O
criteria,O
were,O
patients,O
with,O
different,O
stages,O
"
",O
of,O
chronic,O
HBV,O
infection,O
and,O
complete,O
key,O
data,O
.,O
Exclusion,O
criteria,O
were,O
patients,O
"
",O
with,O
hepatocellular,O
carcinoma,O
.,O
The,O
baseline,O
clinical,O
",",O
laboratory,O
and,O
treatment,O
"
",O
profiles,O
were,O
analyzed,O
.,O
Results,O
:,O
Finally,O
",",O
40431,O
patients,O
were,O
included,O
.,O
The,O
"
",O
median,O
age,O
was,O
43,O
years,O
",",O
with,O
65.2,O
%,O
being,O
men,O
and,O
51.3,O
%,O
being,O
positive,O
for,O
"
",O
hepatitis,O
B,O
e,O
antigen,O
(,O
HBeAg,O
),O
.,O
The,O
most,O
common,O
initial,O
diagnosis,O
was,O
chronic,O
"
",O
hepatitis,O
B,O
(,O
81,O
%,O
),O
",",O
followed,O
by,O
cirrhosis,O
(,O
9.3,O
%,O
),O
",",O
inactive,O
carrier,O
of,O
hepatitis,O
"
",O
B,O
surface,O
antigen,O
(,O
HBsAg,O
),O
(,O
6.7,O
%,O
),O
",",O
and,O
immune,O
tolerant,O
phase,O
of,O
hepatitis,O
B,O
"
",O
infection,O
(,O
3,O
%,O
),O
.,O
Among,O
the,O
21228,O
patients,O
who,O
were,O
on,O
treatment,O
",",O
88,O
%,O
",",O
10,O
%,O
"
",O
and,O
2,O
%,O
received,O
nucleos(t)ide,O
analogues,O
(,O
NAs,O
),O
",",O
interferon,O
or,O
combination,O
of,O
NAs,O
"
",O
and,O
interferon,O
",",O
respectively,O
.,O
The,O
proportion,O
of,O
patients,O
who,O
received,O
preferred,O
"
",O
NAs,O
(,O
entecavir,O
or,O
tenofovir,O
disoproxil,O
fumarate,O
),O
had,O
increased,O
from,O
13.5,O
%,O
in,O
2003,O
"
",O
to,O
79.7,O
%,O
in,O
2016,O
.,O
Conclusions,O
:,O
We,O
concluded,O
that,O
middleaged,O
men,O
accounted,O
for,O
"
",O
most,O
of,O
the,O
patients,O
with,O
chronic,O
hepatitis,O
B,O
in,O
this,O
crosssectional,O
study,O
.,O
"
",O
About,O
half,O
of,O
the,O
patients,O
were,O
HBeAgpositive,O
.,O
NAs,O
were,O
the,O
most,O
commonly,O
used,O
"
",O
therapy,O
",",O
and,O
use,O
of,O
the,O
preferred,O
NAs,O
had,O
steadily,O
increased,O
in,O
the,O
past,O
decade,O
.,O
"

",O
Â©,O
2019,O
Authors,O
.,O
"

",O
DOI,O
:,O
10.14218,O
JCTH.2019.00052,O
"
",O
PMCID,O
:,O
PMC6943209,O
"
",O
PMID,O
:,O
31915601,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
have,O
no,O
conflict,O
of,O
interests,O
related,O
"
",O
to,O
this,O
publication,O
.,O
"


",O
927,O
.,O
FASEB,O
J.,O
2020,O
Jan;34(1):9881000,O
.,O
doi,O
:,O
10.1096,O
fj.201902219R,O
.,O
Epub,O
2019,O
Nov,O
28,O
.,O
"

",O
Zebrafish,O
prmt7,O
negatively,O
regulates,O
antiviral,O
responses,O
by,O
suppressing,O
the,O
"
",O
retinoic,O
acidinducible,O
geneIlike,O
receptor,O
signaling,O
.,O
"

",O
Zhu,O
J(1)(2,O
),O
",",O
Liu,O
X(1)(3)(4,O
),O
",",O
Cai,O
X(1)(2,O
),O
",",O
Ouyang,O
G(1)(3)(4,O
),O
",",O
Fan,O
S(1)(2,O
),O
",",O
Wang,O
"
",O
J(1)(3)(4,O
),O
",",O
Xiao,O
W(1)(2)(3)(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
P.R.,O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
P.R.,O
China,O
.,O
"
",O
(3)The,O
Key,O
laboratory,O
of,O
Aquaculture,O
Disease,O
Control,O
",",O
Ministry,O
of,O
Agriculture,O
",",O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
P.R.,O
China,O
.,O
"
",O
(4)The,O
Innovation,O
of,O
Seed,O
Design,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
P.R.,O
China,O
.,O
"
",O
(5)The,O
Key,O
Laboratory,O
of,O
Aquatic,O
Biodiversity,O
and,O
Conservation,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
P.R.,O
China,O
.,O
"

",O
Arginine,O
methylation,O
is,O
a,O
posttranslational,O
modification,O
in,O
histone,O
and,O
"
",O
nonhistone,O
proteins,O
that,O
can,O
affect,O
numerous,O
cellular,O
activities,O
.,O
Protein,O
"
",O
arginine,O
methyltransferase,O
7,O
(,O
Prmt7,O
),O
",",O
a,O
type,O
III,O
arginine,O
methyltransferase,O
",",O
"
",O
catalyzes,O
the,O
formation,O
of,O
stable,O
monomethylarginines,O
of,O
histones,O
.,O
The,O
role,O
of,O
"
",O
PRMT7,O
in,O
virusinduced,O
innate,O
immunity,O
signaling,O
",",O
however,O
",",O
remains,O
largely,O
"
",O
unknown,O
.,O
We,O
demonstrate,O
that,O
zebrafish,O
prmt7,O
could,O
be,O
inhibited,O
by,O
spring,O
viremia,O
"
",O
of,O
carp,O
virus,O
(,O
SVCV,O
),O
and,O
grass,O
carp,O
reovirus,O
(,O
GCRV,O
),O
infection,O
.,O
The,O
overexpression,O
"
",O
of,O
prmt7,O
suppresses,O
cellular,O
antiviral,O
responses,O
that,O
are,O
partially,O
dependent,O
on,O
"
",O
the,O
arginine,O
methyltransferase,O
activity,O
of,O
prmt7,O
.,O
Consistently,O
",",O
prmt7null,O
"
",O
zebrafish,O
were,O
more,O
resistant,O
to,O
SVCV,O
or,O
GCRV,O
infection,O
",",O
exhibiting,O
enhanced,O
"
",O
expression,O
of,O
key,O
antiviral,O
genes,O
and,O
fewer,O
necrotic,O
cells,O
in,O
the,O
liver,O
and,O
"
",O
kidney,O
upon,O
viral,O
infection,O
.,O
Furthermore,O
",",O
we,O
established,O
a,O
zebrafish,O
model,O
to,O
"
",O
investigate,O
grass,O
carp,O
hemorrhagic,O
disease,O
.,O
Our,O
findings,O
suggest,O
that,O
by,O
"
",O
suppressing,O
the,O
RIGIlike,O
receptors,O
signaling,O
",",O
zebrafish,O
prmt7,O
negatively,O
"
",O
regulates,O
antiviral,O
responses,O
",",O
indicating,O
the,O
vital,O
role,O
of,O
prmt7,O
and,O
its,O
"
",O
arginine,O
methyltransferase,O
activity,O
in,O
innate,O
immunity,O
.,O
"

",O
Â©,O
2019,O
Federation,O
of,O
American,O
Societies,O
for,O
Experimental,O
Biology,O
.,O
"

",O
DOI,O
:,O
10.1096,O
fj.201902219R,O
"
",O
PMID,O
:,O
31914680,O
"


",O
928,O
.,O
Aging,O
(,O
Albany,O
NY,O
),O
.,O
2020,O
Jan,O
6;12(1):340358,O
.,O
doi,O
:,O
10.18632,O
aging.102618,O
.,O
Epub,O
"
",O
2020,O
Jan,O
6,O
.,O
"

",O
Downregulation,O
of,O
ABI2,O
expression,O
by,O
EBVmiRBART133p,O
induces,O
"
",O
epithelialmesenchymal,O
transition,O
of,O
nasopharyngeal,O
carcinoma,O
cells,O
through,O
"
",O
upregulation,O
of,O
cJUN,O
SLUG,O
signaling,O
.,O
"

",O
Huang,O
J(1,O
),O
",",O
Qin,O
Y(1,O
),O
",",O
Yang,O
C(1,O
),O
",",O
Wan,O
C(1,O
),O
",",O
Dai,O
X(1,O
),O
",",O
Sun,O
Y(1,O
),O
",",O
Meng,O
J(1,O
),O
",",O
Lu,O
"
",O
Y(1,O
),O
",",O
Li,O
Y(1,O
),O
",",O
Zhang,O
Z(1,O
),O
",",O
Wu,O
B(1,O
),O
",",O
Xu,O
S(1,O
),O
",",O
Jin,O
H(1,O
),O
",",O
Yang,O
K(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Cancer,O
Center,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
Wuhan,O
430022,O
",",O
China,O
.,O
"

",O
Existing,O
evidence,O
has,O
shown,O
that,O
circulating,O
EpsteinBarr,O
virus,O
"
",O
(EBV)miRBART133p,O
is,O
highly,O
expressed,O
in,O
plasma,O
of,O
nasopharyngeal,O
carcinoma,O
"
",O
(,O
NPC,O
),O
patients,O
",",O
especially,O
among,O
patients,O
with,O
advanced,O
diseases,O
.,O
However,O
",",O
the,O
"
",O
exact,O
role,O
that,O
EBVmiRBART133p,O
plays,O
in,O
the,O
development,O
of,O
NPC,O
remains,O
poorly,O
"
",O
understood,O
.,O
Here,O
we,O
show,O
that,O
upregulated,O
expression,O
of,O
EBVmiRBART133p,O
leads,O
"
",O
to,O
increased,O
capacity,O
in,O
migration,O
and,O
invasion,O
of,O
NPC,O
cells,O
in,O
vitro,O
and,O
causes,O
"
",O
tumor,O
metastasis,O
in,O
vivo,O
.,O
Furthermore,O
",",O
we,O
find,O
that,O
EBVmiRBART133p,O
directly,O
"
",O
targets,O
ABI2,O
",",O
known,O
as,O
a,O
tumor,O
suppressor,O
and,O
a,O
cell,O
migration,O
inhibitor,O
",",O
drives,O
"
",O
epithelialmesenchymal,O
transition,O
(,O
EMT,O
),O
by,O
activating,O
cJUN,O
SLUG,O
signaling,O
"
",O
pathway,O
.,O
Silencing,O
ABI2,O
shows,O
similar,O
effects,O
to,O
overexpression,O
of,O
"
",O
EBVmiRBART133p,O
",",O
whereas,O
reconstitution,O
of,O
ABI2,O
resulted,O
in,O
a,O
phenotypic,O
"
",O
reversion,O
",",O
highlighting,O
the,O
role,O
of,O
ABI2,O
in,O
EBVmiRBART133pdriven,O
metastasis,O
"
",O
in,O
NPC,O
.,O
Besides,O
",",O
expression,O
levels,O
of,O
ABI2,O
in,O
NPC,O
tissue,O
samples,O
correlate,O
with,O
N,O
"
",O
stages,O
of,O
NPC,O
patients,O
.,O
Taken,O
together,O
",",O
these,O
results,O
suggest,O
a,O
novel,O
mechanism,O
"
",O
by,O
which,O
ABI2,O
downregulation,O
by,O
EBVmiRBART133p,O
promotes,O
EMT,O
and,O
metastasis,O
of,O
"
",O
NPC,O
via,O
upregulating,O
cJUN,O
SLUG,O
signaling,O
pathway,O
.,O
"

",O
DOI,O
:,O
10.18632,O
aging.102618,O
"
",O
PMCID,O
:,O
PMC6977665,O
"
",O
PMID,O
:,O
31907338,O
"


",O
929,O
.,O
Pathogens,O
.,O
2020,O
Jan,O
2;9(1,O
),O
.,O
pii,O
:,O
E39,O
.,O
doi,O
:,O
10.339,O
pathogens9010039,O
.,O
"

",O
Comparison,O
of,O
the,O
Pathogenicity,O
of,O
Two,O
Different,O
Branches,O
of,O
Senecavirus,O
a,O
Strain,O
"
",O
in,O
China,O
.,O
"

",O
Zhang,O
H(1)(2,O
),O
",",O
Chen,O
P(2,O
),O
",",O
Hao,O
G(1)(2,O
),O
",",O
Liu,O
W(1)(2,O
),O
",",O
Chen,O
H(1)(2)(3)(4,O
),O
",",O
Qian,O
"
",O
P(1)(2)(3)(4,O
),O
",",O
Li,O
X(1)(2)(3)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"
",O
(2)Laboratory,O
of,O
Animal,O
Virology,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Development,O
of,O
Veterinary,O
Diagnostic,O
Products,O
",",O
Ministry,O
of,O
"
",O
Agriculture,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"
",O
(4)Key,O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
The,O
"
",O
Cooperative,O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Wuhan,O
430070,O
",",O
"
",O
China,O
.,O
"

",O
Senecavirus,O
A,O
(,O
SVA,O
),O
",",O
an,O
emerging,O
infectious,O
disease,O
",",O
is,O
associated,O
with,O
the,O
"
",O
porcine,O
idiopathic,O
vesicular,O
disease,O
.,O
Here,O
",",O
the,O
pathogenesis,O
of,O
different,O
strains,O
"
",O
of,O
SVA,O
was,O
investigated,O
in,O
growingfinishing,O
pigs,O
.,O
We,O
aimed,O
to,O
evaluate,O
the,O
"
",O
replication,O
characteristics,O
",",O
virus,O
particle,O
morphology,O
",",O
clinical,O
signs,O
",",O
and,O
"
",O
vesicular,O
lesions,O
in,O
comparison,O
with,O
two,O
different,O
strains,O
of,O
SVA,O
.,O
The,O
animals,O
"
",O
were,O
infected,O
with,O
SVA,O
HBCH2016,O
or,O
CH,O
AH02,O
2017,O
by,O
intranasal,O
routes,O
(,O
3,O
mL,O
",",O
"
",O
109TCID50,O
mL,O
),O
and,O
monitored,O
daily,O
for,O
14,O
days,O
postinoculation,O
(,O
dpi,O
),O
for,O
clinical,O
"
",O
signs,O
and,O
vesicular,O
lesions,O
.,O
Viremia,O
or,O
viral,O
shedding,O
was,O
detected,O
in,O
the,O
blood,O
",",O
"
",O
fecal,O
swab,O
",",O
and,O
nasal,O
swab,O
samples,O
.,O
Results,O
showed,O
no,O
distinct,O
differences,O
in,O
"
",O
plaque,O
size,O
",",O
replication,O
ability,O
",",O
and,O
characteristic,O
virions,O
between,O
SVA,O
"
",O
HBCH2016,O
and,O
CH,O
AH02,O
2017,O
strains,O
.,O
Animal,O
experimental,O
results,O
showed,O
that,O
"
",O
both,O
SVA,O
CH,O
AH02,O
2017,O
and,O
SVA,O
HBCH2016,O
could,O
infect,O
pigs,O
.,O
However,O
",",O
an,O
obvious,O
"
",O
difference,O
in,O
the,O
pathogenicity,O
and,O
dynamics,O
of,O
infection,O
was,O
observed,O
between,O
"
",O
SVA,O
HBCH2016,O
and,O
CH,O
AH02,O
2017,O
strains,O
.,O
The,O
pathogenesis,O
of,O
SVA,O
CH,O
AH02,O
2017,O
"
",O
was,O
similar,O
to,O
that,O
of,O
published,O
results,O
of,O
USA,O
strains,O
",",O
whereas,O
the,O
SVA,O
"
",O
HBCH2016,O
strain,O
had,O
low,O
pathogenicity,O
to,O
pigs,O
.,O
Clinical,O
signs,O
and,O
vesicular,O
"
",O
lesions,O
were,O
observed,O
in,O
SVA,O
CH,O
AH02,O
2017infected,O
pigs,O
.,O
Additionally,O
",",O
the,O
"
",O
different,O
branches,O
of,O
SVA,O
should,O
be,O
capable,O
of,O
inducing,O
broad,O
crossreactive,O
"
",O
neutralizing,O
antibodies,O
",",O
which,O
play,O
an,O
important,O
role,O
in,O
clearing,O
the,O
SVA,O
virus,O
.,O
"
",O
This,O
study,O
of,O
animal,O
models,O
for,O
SVA,O
infection,O
will,O
be,O
beneficial,O
to,O
develop,O
"
",O
vaccines,O
and,O
antivirals,O
.,O
"

",O
DOI,O
:,O
10.339,O
pathogens9010039,O
"
",O
PMID,O
:,O
31906571,O
"


",O
930,O
.,O
Mol,O
Cell,O
Probes,O
.,O
2020,O
Apr;50:101505,O
.,O
doi,O
:,O
10.1016,O
j.mcp.2019.101505,O
.,O
Epub,O
2020,O
"
",O
Jan,O
2,O
.,O
"

",O
Rapid,O
and,O
sensitive,O
detection,O
of,O
potato,O
virus,O
Y,O
by,O
isothermal,O
reverse,O
"
",O
transcriptionrecombinase,O
polymerase,O
amplification,O
assay,O
in,O
potato,O
.,O
"

",O
Wang,O
Y(1,O
),O
",",O
Chen,O
R(1,O
),O
",",O
Nie,O
X(2,O
),O
",",O
Zhong,O
Z(1,O
),O
",",O
Li,O
C(1,O
),O
",",O
Li,O
K(1,O
),O
",",O
Huang,O
W(1,O
),O
",",O
Fu,O
"
",O
X(1,O
),O
",",O
Liu,O
J(1,O
),O
",",O
Nie,O
B(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)National,O
Center,O
for,O
Vegetable,O
Improvement,O
(,O
Central,O
China,O
),O
",",O
Key,O
Laboratory,O
of,O
"
",O
Potato,O
Biology,O
and,O
Biotechnology,O
",",O
Ministry,O
of,O
Agriculture,O
and,O
Rural,O
Affairs,O
",",O
"
",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"
",O
(2)Fredericton,O
Research,O
and,O
Development,O
Center,O
",",O
Agriculture,O
and,O
AgriFood,O
Canada,O
",",O
"
",O
850,O
Lincoln,O
Road,O
",",O
P.,O
O.,O
Box,O
20280,O
",",O
Fredericton,O
",",O
New,O
Brunswick,O
",",O
E3B4Z7,O
",",O
Canada,O
.,O
"
",O
(3)National,O
Center,O
for,O
Vegetable,O
Improvement,O
(,O
Central,O
China,O
),O
",",O
Key,O
Laboratory,O
of,O
"
",O
Potato,O
Biology,O
and,O
Biotechnology,O
",",O
Ministry,O
of,O
Agriculture,O
and,O
Rural,O
Affairs,O
",",O
"
",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
nbihua@mail.hzau.edu.cn,O
.,O
"

",O
In,O
this,O
study,O
",",O
an,O
isothermal,O
reverse,O
transcriptionrecombinase,O
polymerase,O
"
",O
amplification,O
(,O
RTRPA,O
),O
assay,O
was,O
developed,O
for,O
the,O
efficient,O
and,O
accurate,O
"
",O
detection,O
of,O
potato,O
virus,O
Y,O
(,O
PVY,O
),O
under,O
isothermal,O
conditions,O
.,O
This,O
RTRPA,O
assay,O
"
",O
was,O
more,O
efficient,O
than,O
the,O
conventional,O
reverse,O
transcriptionpolymerase,O
chain,O
"
",O
reaction,O
(,O
RTPCR,O
),O
assay,O
as,O
the,O
amplification,O
reaction,O
can,O
be,O
completed,O
in,O
less,O
"
",O
than,O
20,O
Â ,O
min,O
.,O
Moreover,O
",",O
unlike,O
PCR,O
that,O
requires,O
a,O
thermocycler,O
to,O
carry,O
out,O
the,O
"
",O
DNA,O
amplification,O
through,O
specific,O
temperature,O
phases,O
",",O
RPA,O
assay,O
could,O
be,O
"
",O
performed,O
under,O
an,O
isothermal,O
condition,O
at,O
a,O
temperature,O
ranging,O
from,O
25,O
to,O
"
",O
40,O
Â ,O
Â°,O
C,O
.,O
A,O
simple,O
instrumentation,O
such,O
as,O
a,O
heating,O
block,O
or,O
a,O
water,O
bath,O
or,O
even,O
"
",O
anoninstrumental,O
condition,O
such,O
as,O
human,O
hands,O
or,O
a,O
benchtop,O
inside,O
outside,O
a,O
"
",O
room,O
during,O
the,O
summer,O
could,O
satisfy,O
the,O
temperature,O
requirement,O
of,O
RPA,O
.,O
The,O
"
",O
sensitivity,O
of,O
this,O
assay,O
was,O
equivalent,O
to,O
that,O
of,O
the,O
conventional,O
RTPCR,O
",",O
and,O
"
",O
the,O
virus,O
can,O
be,O
detected,O
in,O
a,O
minimum,O
of,O
2,O
Â ,O
pg,O
of,O
total,O
RNA,O
extracted,O
from,O
the,O
"
",O
PVY,O
infected,O
potato,O
leaf,O
tissues,O
.,O
The,O
efficacy,O
of,O
the,O
newly,O
developed,O
RTRPA,O
was,O
"
",O
then,O
evaluated,O
using,O
field,O
potato,O
leaf,O
and,O
dormancybroken,O
sprout,O
samples,O
upon,O
"
",O
enzymelinked,O
immunosorbent,O
assay,O
(,O
ELISA,O
),O
screening,O
.,O
Of,O
the,O
164,O
"
",O
PVYELISApositive,O
samples,O
",",O
RTRPA,O
detected,O
157,O
whereas,O
simplex,O
RTPCR,O
detected,O
"
",O
160,O
and,O
multiplex,O
RTPCR,O
detected,O
154,O
.,O
Of,O
the,O
74,O
randomly,O
selected,O
"
",O
PVYELISAnegative,O
samples,O
",",O
RTRPA,O
",",O
simplex,O
RTPCR,O
and,O
multiplex,O
RTPCR,O
led,O
to,O
1,O
",",O
"
",O
1,O
and,O
0,O
positive,O
detections,O
",",O
receptively,O
.,O
Overall,O
",",O
RTRPA,O
and,O
the,O
two,O
RTPCR,O
"
",O
assays,O
as,O
well,O
as,O
ELISA,O
exhibited,O
an,O
agreement,O
of,O
96.698.7,O
%,O
",",O
thus,O
demonstrating,O
"
",O
the,O
suitability,O
of,O
RTRPA,O
for,O
large,O
scale,O
detection,O
of,O
PVY,O
",",O
irrespective,O
of,O
the,O
"
",O
strain,O
type,O
of,O
the,O
virus,O
.,O
"

",O
Crown,O
Copyright,O
Â©,O
2020,O
.,O
Published,O
by,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.mcp.2019.101505,O
"
",O
PMID,O
:,O
31904418,O
"


",O
931,O
.,O
Biomed,O
Pharmacother,O
.,O
2020,O
Mar;123:109800,O
.,O
doi,O
:,O
10.1016,O
j.biopha.2019.109800,O
.,O
Epub,O
"
",O
2020,O
Jan,O
2,O
.,O
"

",O
Preliminary,O
functional,O
and,O
phylogeographic,O
analyses,O
of,O
the,O
72,O
nucleotide,O
"
",O
duplication,O
region,O
in,O
the,O
emerging,O
human,O
respiratory,O
syncytial,O
virus,O
ON1,O
strain,O
"
",O
attachment,O
glycoprotein,O
gene,O
.,O
"

",O
Cui,O
G(1,O
),O
",",O
Liu,O
H(2,O
),O
",",O
Li,O
X(3,O
),O
",",O
Ming,O
L(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Clinical,O
Laboratory,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Zhengzhou,O
"
",O
University,O
",",O
Zhengzhou,O
",",O
Henan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
cglsun@163.com,O
.,O
"
",O
(2)Department,O
of,O
Clinical,O
Laboratory,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Zhengzhou,O
"
",O
University,O
",",O
Zhengzhou,O
",",O
Henan,O
",",O
China,O
.,O
"
",O
(3)Hubei,O
Engineering,O
Research,O
Center,O
of,O
Viral,O
Vector,O
",",O
Wuhan,O
University,O
of,O
"
",O
Bioengineering,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Clinical,O
Laboratory,O
",",O
The,O
First,O
Affiliated,O
Hospital,O
of,O
Zhengzhou,O
"
",O
University,O
",",O
Zhengzhou,O
",",O
Henan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
mingliang_zzu@163.com,O
.,O
"

",O
The,O
emerging,O
human,O
respiratory,O
syncytial,O
virus,O
(,O
hRSV,O
),O
ON1,O
strain,O
",",O
which,O
is,O
"
",O
characterized,O
by,O
a,O
72nt,O
duplication,O
in,O
the,O
attachment,O
glycoprotein,O
(,O
G,O
),O
gene,O
",",O
has,O
"
",O
replaced,O
other,O
prevailing,O
global,O
genotypes,O
since,O
its,O
discovery,O
in,O
2012,O
.,O
In,O
this,O
"
",O
study,O
",",O
we,O
used,O
the,O
pseudotype,O
lentiviral,O
system,O
to,O
directly,O
address,O
the,O
effect,O
of,O
"
",O
the,O
duplication,O
on,O
hRSV,O
infection,O
.,O
In,O
addition,O
",",O
representative,O
199,O
ON1,O
sequences,O
"
",O
selected,O
from,O
2599,O
ON1,O
sequences,O
that,O
were,O
downloaded,O
from,O
GenBank,O
were,O
used,O
to,O
"
",O
perform,O
Bayesian,O
skyline,O
and,O
phylogeographic,O
analyses,O
.,O
Our,O
results,O
showed,O
that,O
"
",O
lentiviral,O
pseudoparticles,O
mimicked,O
the,O
key,O
functions,O
of,O
the,O
Gprotein,O
on,O
hRSV,O
"
",O
cell,O
entry,O
.,O
Further,O
",",O
we,O
showed,O
that,O
deletion,O
of,O
the,O
Gprotein,O
duplication,O
"
",O
decreased,O
the,O
efficiency,O
of,O
pLV,O
infection,O
.,O
The,O
mean,O
substitution,O
rate,O
of,O
the,O
"
",O
second,O
mucinlike,O
highly,O
variable,O
region,O
for,O
the,O
ON1,O
Gprotein,O
gene,O
was,O
"
",O
2.14,O
â€¯,O
Ã—,O
â€¯,O
103,O
(,O
95,O
%,O
HPD,O
:,O
1.23,O
â€¯,O
Ã—,O
â€¯,O
103,O
",",O
3.08,O
â€¯,O
Ã—,O
â€¯,O
103,O
),O
nucleotide,O
substitutions,O
per,O
"
",O
site,O
per,O
year,O
.,O
Phylogeographic,O
analyses,O
showed,O
that,O
the,O
ON1,O
isolates,O
might,O
"
",O
originate,O
from,O
Europe,O
at,O
the,O
time,O
of,O
MRCA,O
(,O
i.e.,O
",",O
the,O
most,O
recent,O
common,O
"
",O
ancestors,O
),O
",",O
which,O
dated,O
back,O
to,O
1998.3,O
(,O
95,O
%,O
HPD,O
:,O
1989.2,O
",",O
2005.2,O
),O
.,O
These,O
"
",O
preliminary,O
findings,O
revealed,O
the,O
enhanced,O
attachment,O
function,O
of,O
the,O
duplication,O
"
",O
region,O
in,O
the,O
ON1,O
G,O
gene,O
and,O
highlighted,O
the,O
importance,O
of,O
ongoing,O
surveillance,O
"
",O
of,O
ON1,O
to,O
better,O
understand,O
the,O
molecular,O
epidemiology,O
of,O
hRSV,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
The,O
Authors,O
.,O
Published,O
by,O
Elsevier,O
Masson,O
SAS,O
..,O
All,O
rights,O
"
",O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.biopha.2019.109800,O
"
",O
PMID,O
:,O
31901716,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
Competing,O
Interest,O
The,O
authors,O
"
",O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
932,O
.,O
Dev,O
Comp,O
Immunol,O
.,O
2020,O
Apr;105:103604,O
.,O
doi,O
:,O
10.1016,O
j.dci.2019.103604,O
.,O
Epub,O
2019,O
"
",O
Dec,O
30,O
.,O
"

",O
Myxovirus,O
resistance,O
(,O
Mx,O
),O
gene,O
and,O
its,O
differential,O
expression,O
regulated,O
by,O
three,O
"
",O
type,O
I,O
and,O
two,O
type,O
II,O
IFNs,O
in,O
mandarin,O
fish,O
",",O
Siniperca,O
chuatsi,O
.,O
"

",O
Li,O
L(1,O
),O
",",O
Chen,O
SN(2,O
),O
",",O
Laghari,O
ZA(2,O
),O
",",O
Huo,O
HJ(3,O
),O
",",O
Hou,O
J(2,O
),O
",",O
Huang,O
L(2,O
),O
",",O
Li,O
N(2,O
),O
",",O
Nie,O
"
",O
P(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Marine,O
Science,O
and,O
Engineering,O
",",O
Qingdao,O
Agricultural,O
University,O
",",O
"
",O
Qingdao,O
",",O
Shandong,O
Province,O
",",O
266109,O
",",O
China,O
;,O
State,O
Key,O
Laboratory,O
of,O
Freshwater,O
"
",O
Ecology,O
and,O
Biotechnology,O
",",O
Key,O
Laboratory,O
of,O
Aquaculture,O
Disease,O
Control,O
",",O
"
",O
Institute,O
of,O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
Hubei,O
Province,O
",",O
"
",O
430072,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Key,O
Laboratory,O
"
",O
of,O
Aquaculture,O
Disease,O
Control,O
",",O
Institute,O
of,O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
"
",O
Sciences,O
",",O
Wuhan,O
",",O
Hubei,O
Province,O
",",O
430072,O
",",O
China,O
.,O
"
",O
(3)School,O
of,O
Marine,O
Science,O
and,O
Engineering,O
",",O
Qingdao,O
Agricultural,O
University,O
",",O
"
",O
Qingdao,O
",",O
Shandong,O
Province,O
",",O
266109,O
",",O
China,O
.,O
"
",O
(4)School,O
of,O
Marine,O
Science,O
and,O
Engineering,O
",",O
Qingdao,O
Agricultural,O
University,O
",",O
"
",O
Qingdao,O
",",O
Shandong,O
Province,O
",",O
266109,O
",",O
China,O
;,O
State,O
Key,O
Laboratory,O
of,O
Freshwater,O
"
",O
Ecology,O
and,O
Biotechnology,O
",",O
Key,O
Laboratory,O
of,O
Aquaculture,O
Disease,O
Control,O
",",O
"
",O
Institute,O
of,O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
Hubei,O
Province,O
",",O
"
",O
430072,O
",",O
China,O
;,O
Laboratory,O
for,O
Marine,O
Biology,O
and,O
Biotechnology,O
",",O
Pilot,O
National,O
"
",O
Laboratory,O
for,O
Marine,O
Science,O
and,O
Technology,O
(,O
Qingdao,O
),O
",",O
Qingdao,O
",",O
Shandong,O
"
",O
Province,O
",",O
266237,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
pinnie@qau.edu.cn,O
.,O
"

",O
Interferons,O
(,O
IFNs,O
),O
can,O
induce,O
the,O
expression,O
of,O
IFNstimulated,O
genes,O
(,O
ISGs,O
),O
",",O
such,O
"
",O
as,O
myxovirus,O
resistance,O
(,O
Mx,O
),O
protein,O
",",O
to,O
inhibit,O
virus,O
replication,O
.,O
In,O
this,O
"
",O
study,O
",",O
the,O
expression,O
of,O
Mx,O
gene,O
in,O
mandarin,O
fish,O
",",O
and,O
the,O
IFNsensitive,O
response,O
"
",O
elements,O
(,O
ISREs,O
),O
and,O
gammainterferon,O
activated,O
sites,O
(,O
GASs,O
),O
in,O
the,O
promoter,O
of,O
"
",O
Mx,O
gene,O
were,O
analyzed,O
in,O
relation,O
to,O
the,O
stimulation,O
of,O
three,O
distinct,O
type,O
I,O
"
",O
IFNs,O
",",O
IFNc,O
",",O
IFNd,O
and,O
IFNh,O
",",O
and,O
two,O
type,O
II,O
IFNs,O
",",O
IFNÎ³,O
and,O
IFNÎ³,O
related,O
molecule,O
"
",O
(,O
IFNÎ³rel,O
),O
.,O
A,O
single,O
Mx,O
gene,O
was,O
found,O
in,O
mandarin,O
fish,O
",",O
and,O
its,O
expression,O
was,O
"
",O
highly,O
and,O
constitutively,O
observed,O
in,O
all,O
organs,O
tissues,O
examined,O
.,O
The,O
Mx,O
gene,O
"
",O
was,O
significantly,O
induced,O
in,O
vivo,O
for,O
120,O
Â ,O
h,O
following,O
infectious,O
spleen,O
and,O
"
",O
kidney,O
necrosis,O
virus,O
(,O
ISKNV,O
),O
infection,O
.,O
Furthermore,O
",",O
the,O
overexpression,O
and,O
"
",O
recombinant,O
of,O
IFNh,O
",",O
IFNc,O
",",O
as,O
well,O
as,O
IFNÎ³,O
can,O
significantly,O
induce,O
Mx,O
"
",O
expression,O
in,O
MFF1,O
Â ,O
cells,O
at,O
transcript,O
and,O
protein,O
levels,O
",",O
although,O
all,O
the,O
"
",O
three,O
type,O
I,O
IFNs,O
and,O
the,O
two,O
type,O
II,O
IFNs,O
can,O
activate,O
the,O
Mx,O
promoter,O
.,O
In,O
"
",O
addition,O
",",O
ISRE1,O
which,O
is,O
the,O
proximal,O
one,O
among,O
the,O
three,O
predicted,O
ISREs,O
seems,O
"
",O
to,O
be,O
the,O
important,O
ISRE,O
for,O
the,O
higher,O
and,O
efficient,O
activation,O
of,O
the,O
Mx,O
"
",O
promoter,O
.,O
However,O
",",O
the,O
possible,O
interaction,O
between,O
the,O
GASs,O
and,O
type,O
II,O
IFN,O
"
",O
signalling,O
molecules,O
require,O
further,O
study,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.dci.2019.103604,O
"
",O
PMID,O
:,O
31899304,O
"


",O
933,O
.,O
Virus,O
Genes,O
.,O
2020,O
Jan,O
2,O
.,O
doi,O
:,O
10.1007,O
s11262019017254,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Integration,O
of,O
hepatitis,O
B,O
virus,O
DNA,O
into,O
p21activated,O
kinase,O
3,O
(,O
PAK3,O
),O
gene,O
in,O
"
",O
HepG2.2.15,O
cells,O
.,O
"

",O
Ruan,O
P(1)(2)(3,O
),O
",",O
Dai,O
X(4,O
),O
",",O
Sun,O
J(5,O
),O
",",O
He,O
C(5,O
),O
",",O
Huang,O
C(5,O
),O
",",O
Zhou,O
R(5,O
),O
",",O
Chemin,O
I(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Gastroenterology,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
238,O
"
",O
Jiefang,O
Road,O
",",O
Wuhan,O
",",O
430060,O
",",O
Hubei,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
ruanpeng1973@163.com,O
.,O
"
",O
(2)Department,O
of,O
Breast,O
Surgery,O
",",O
Renmin,O
Hospital,O
",",O
Hubei,O
University,O
of,O
Medicine,O
",",O
"
",O
Shiyan,O
",",O
442000,O
",",O
Hubei,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
ruanpeng1973@163.com,O
.,O
"
",O
(3)INSERM,O
U1052,O
",",O
CNRS,O
UMR5286,O
",",O
Centre,O
de,O
Recherche,O
en,O
CancÃ©rologie,O
",",O
UniversitÃ©,O
"
",O
Claude,O
Bernard,O
",",O
Lyon,O
",",O
France,O
.,O
ruanpeng1973@163.com,O
.,O
"
",O
(4)Department,O
of,O
Breast,O
Surgery,O
",",O
Renmin,O
Hospital,O
",",O
Hubei,O
University,O
of,O
Medicine,O
",",O
"
",O
Shiyan,O
",",O
442000,O
",",O
Hubei,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(5)Department,O
of,O
Gastroenterology,O
",",O
Renmin,O
Hospital,O
of,O
Wuhan,O
University,O
",",O
238,O
"
",O
Jiefang,O
Road,O
",",O
Wuhan,O
",",O
430060,O
",",O
Hubei,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(6)INSERM,O
U1052,O
",",O
CNRS,O
UMR5286,O
",",O
Centre,O
de,O
Recherche,O
en,O
CancÃ©rologie,O
",",O
UniversitÃ©,O
"
",O
Claude,O
Bernard,O
",",O
Lyon,O
",",O
France,O
.,O
Isabelle.chemin@inserm.fr,O
.,O
"

",O
Integration,O
of,O
HBV,O
DNA,O
into,O
host,O
chromosomes,O
was,O
found,O
in,O
most,O
of,O
the,O
patients,O
"
",O
with,O
chronic,O
hepatitis,O
B,O
(,O
CHB,O
),O
.,O
In,O
this,O
study,O
",",O
using,O
inverse,O
nested,O
PCR,O
(,O
invPCR,O
),O
",",O
"
",O
we,O
found,O
the,O
integration,O
site,O
chrX,O
:,O
111009033,O
",",O
which,O
inserted,O
into,O
the,O
"
",O
p21activated,O
kinase,O
3,O
(,O
PAK3,O
),O
gene,O
in,O
HepG2.2.15,O
cells,O
.,O
The,O
viralhuman,O
chimeric,O
"
",O
transcripts,O
were,O
also,O
observed,O
and,O
",",O
significant,O
differences,O
of,O
the,O
copy,O
numbers,O
"
",O
of,O
integration,O
site,O
chrX,O
:,O
111009033,O
(,O
P,O
â€‰,O
=,O
â€‰,O
0.012,O
),O
and,O
intracell,O
HBV,O
DNA,O
levels,O
"
",O
(,O
P,O
â€‰,O
=,O
â€‰,O
0.027,O
),O
were,O
found,O
between,O
the,O
cells,O
with,O
and,O
without,O
H2O2,O
treatment,O
",",O
"
",O
respectively,O
.,O
This,O
study,O
may,O
provide,O
a,O
novel,O
insight,O
into,O
the,O
elucidation,O
of,O
"
",O
etiology,O
of,O
HBV,O
integration,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s11262019017254,O
"
",O
PMID,O
:,O
31897927,O
"


",O
934,O
.,O
J,O
Virol,O
.,O
2020,O
Feb,O
28;94(6,O
),O
.,O
pii,O
:,O
e0167419,O
.,O
doi,O
:,O
10.1128,O
JVI.0167419,O
.,O
Print,O
2020,O
"
",O
Feb,O
28,O
.,O
"

",O
Host,O
AAA+,O
ATPase,O
TER94,O
Plays,O
Critical,O
Roles,O
in,O
Building,O
the,O
Baculovirus,O
Viral,O
"
",O
Replication,O
Factory,O
and,O
Virion,O
Morphogenesis,O
.,O
"

",O
Li,O
Y(1,O
),O
",",O
Hu,O
L(1,O
),O
",",O
Chen,O
T(1)(2,O
),O
",",O
Chang,O
M(1)(2,O
),O
",",O
Deng,O
F(1,O
),O
",",O
Hu,O
Z(1,O
),O
",",O
Wang,O
H(3,O
),O
",",O
"
",O
Wang,O
M(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
"
",O
of,O
Sciences,O
",",O
Wuhan,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
People,O
's,O
Republic,O
of,O
"
",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
"
",O
of,O
Sciences,O
",",O
Wuhan,O
",",O
People,O
's,O
Republic,O
of,O
China,O
h.wang@wh.iov.cn,O
wangml@wh.iov.cn,O
.,O
"

",O
TER94,O
is,O
a,O
multifunctional,O
AAA+,O
ATPase,O
crucial,O
for,O
diverse,O
cellular,O
processes,O
",",O
"
",O
especially,O
protein,O
quality,O
control,O
and,O
chromatin,O
dynamics,O
in,O
eukaryotic,O
"
",O
organisms,O
.,O
Many,O
viruses,O
",",O
including,O
coronavirus,O
",",O
herpesvirus,O
",",O
and,O
retrovirus,O
",",O
"
",O
coopt,O
host,O
cellular,O
TER94,O
for,O
optimal,O
viral,O
invasion,O
and,O
replication,O
.,O
Previous,O
"
",O
proteomics,O
analysis,O
identified,O
the,O
association,O
of,O
TER94,O
with,O
the,O
budded,O
virions,O
"
",O
(,O
BVs,O
),O
of,O
baculovirus,O
",",O
an,O
enveloped,O
insect,O
large,O
DNA,O
virus,O
.,O
Here,O
",",O
the,O
role,O
of,O
"
",O
TER94,O
in,O
the,O
prototypic,O
baculovirus,O
Autographa,O
californica,O
multiple,O
"
",O
nucleopolyhedrovirus,O
(,O
AcMNPV,O
),O
life,O
cycle,O
was,O
investigated,O
.,O
In,O
virusinfected,O
"
",O
cells,O
",",O
TER94,O
accumulated,O
in,O
virogenic,O
stroma,O
(,O
VS,O
),O
at,O
the,O
early,O
stage,O
of,O
infection,O
"
",O
and,O
subsequently,O
partially,O
rearranged,O
in,O
the,O
ring,O
zone,O
region,O
.,O
In,O
the,O
virions,O
",",O
"
",O
TER94,O
was,O
associated,O
with,O
the,O
nucleocapsids,O
of,O
both,O
BV,O
and,O
occlusionderived,O
"
",O
virus,O
(,O
ODV,O
),O
.,O
Inhibition,O
of,O
TER94,O
ATPase,O
activity,O
significantly,O
reduced,O
viral,O
DNA,O
"
",O
replication,O
and,O
BV,O
production,O
.,O
Electron,O
immunoelectron,O
microscopy,O
revealed,O
that,O
"
",O
inhibition,O
of,O
TER94,O
resulted,O
in,O
the,O
trapping,O
of,O
nucleocapsids,O
within,O
cytoplasmic,O
"
",O
vacuoles,O
at,O
the,O
nuclear,O
periphery,O
for,O
BV,O
formation,O
and,O
blockage,O
of,O
ODV,O
"
",O
envelopment,O
at,O
a,O
premature,O
stage,O
within,O
infected,O
nuclei,O
",",O
which,O
appeared,O
highly,O
"
",O
consistent,O
with,O
its,O
pivotal,O
function,O
in,O
membrane,O
biogenesis,O
.,O
Further,O
analyses,O
"
",O
showed,O
that,O
TER94,O
was,O
recruited,O
to,O
the,O
VS,O
or,O
subnuclear,O
structures,O
through,O
"
",O
interaction,O
with,O
viral,O
early,O
proteins,O
LEF3,O
and,O
helicase,O
",",O
whereas,O
inhibition,O
of,O
"
",O
TER94,O
activity,O
blocked,O
the,O
proper,O
localization,O
of,O
replicationrelated,O
viral,O
"
",O
proteins,O
and,O
morphogenesis,O
of,O
VS,O
",",O
providing,O
an,O
explanation,O
for,O
its,O
role,O
in,O
viral,O
"
",O
DNA,O
replication,O
.,O
Taken,O
together,O
",",O
these,O
data,O
indicated,O
the,O
crucial,O
functions,O
of,O
"
",O
TER94,O
at,O
multiple,O
steps,O
of,O
the,O
baculovirus,O
life,O
cycle,O
",",O
including,O
genome,O
"
",O
replication,O
",",O
BV,O
formation,O
",",O
and,O
ODV,O
morphogenesis,O
.,O
IMPORTANCE,O
TER94,O
constitutes,O
an,O
"
",O
important,O
AAA+,O
ATPase,O
that,O
associates,O
with,O
diverse,O
cellular,O
processes,O
",",O
including,O
"
",O
protein,O
quality,O
control,O
",",O
membrane,O
fusion,O
of,O
the,O
Golgi,O
apparatus,O
and,O
endoplasmic,O
"
",O
reticulum,O
network,O
",",O
nuclear,O
envelope,O
reformation,O
",",O
and,O
DNA,O
replication,O
.,O
To,O
date,O
",",O
"
",O
little,O
is,O
known,O
regarding,O
the,O
role(s,O
),O
of,O
TER94,O
in,O
the,O
baculovirus,O
life,O
cycle,O
.,O
In,O
"
",O
this,O
study,O
",",O
TER94,O
was,O
found,O
to,O
play,O
a,O
crucial,O
role,O
in,O
multiple,O
steps,O
of,O
"
",O
baculovirus,O
infection,O
",",O
including,O
viral,O
DNA,O
replication,O
and,O
BV,O
and,O
ODV,O
formation,O
.,O
"
",O
Further,O
evidence,O
showed,O
that,O
the,O
membrane,O
fission,O
fusion,O
function,O
of,O
TER94,O
is,O
"
",O
likely,O
to,O
be,O
exploited,O
by,O
baculovirus,O
for,O
virion,O
morphogenesis,O
.,O
Moreover,O
",",O
TER94,O
"
",O
could,O
interact,O
with,O
the,O
viral,O
early,O
proteins,O
LEF3,O
and,O
helicase,O
to,O
transport,O
and,O
"
",O
further,O
recruit,O
viral,O
replicationrelated,O
proteins,O
to,O
establish,O
viral,O
replication,O
"
",O
factories,O
.,O
This,O
study,O
highlights,O
the,O
critical,O
roles,O
of,O
TER94,O
as,O
an,O
"
",O
energysupplying,O
chaperon,O
in,O
the,O
baculovirus,O
life,O
cycle,O
and,O
enriches,O
our,O
"
",O
knowledge,O
regarding,O
the,O
biological,O
function,O
of,O
this,O
important,O
host,O
factor,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
American,O
Society,O
for,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1128,O
JVI.0167419,O
"
",O
PMID,O
:,O
31896597,O
"


",O
935,O
.,O
J,O
Virol,O
.,O
2020,O
Feb,O
28;94(6,O
),O
.,O
pii,O
:,O
e0117519,O
.,O
doi,O
:,O
10.1128,O
JVI.0117519,O
.,O
Print,O
2020,O
"
",O
Feb,O
28,O
.,O
"

",O
Short,O
Direct,O
Repeats,O
in,O
the,O
3,O
',O
Untranslated,O
Region,O
Are,O
Involved,O
in,O
Subgenomic,O
"
",O
Flaviviral,O
RNA,O
Production,O
.,O
"

",O
Zhang,O
QY(#)(1,O
),O
",",O
Li,O
XF(#)(2,O
),O
",",O
Niu,O
X(3,O
),O
",",O
Li,O
N(1,O
),O
",",O
Wang,O
HJ(2,O
),O
",",O
Deng,O
CL(1,O
),O
",",O
Ye,O
HQ(1,O
),O
",",O
"
",O
Huang,O
XY(2,O
),O
",",O
Chen,O
Q(2,O
),O
",",O
Xu,O
YP(2,O
),O
",",O
Dong,O
HL(2,O
),O
",",O
Li,O
XD(4,O
),O
",",O
Zhao,O
H(2,O
),O
",",O
Shi,O
PY(5,O
),O
",",O
"
",O
Yuan,O
ZM(1,O
),O
",",O
Gong,O
P(1,O
),O
",",O
Fang,O
X(3,O
),O
",",O
Qin,O
CF(6,O
),O
",",O
Zhang,O
B(7)(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Pathogen,O
and,O
Biosecurity,O
",",O
Beijing,O
Institute,O
of,O
"
",O
Microbiology,O
and,O
Epidemiology,O
",",O
Academy,O
of,O
Military,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
"
",O
China,O
.,O
"
",O
(3)Beijing,O
Advanced,O
Innovation,O
Center,O
for,O
Structural,O
Biology,O
",",O
School,O
of,O
Life,O
"
",O
Sciences,O
",",O
Tsinghua,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)School,O
of,O
Medicine,O
",",O
Hunan,O
Normal,O
University,O
",",O
Changsha,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Biochemistry,O
and,O
Molecular,O
Biology,O
",",O
University,O
of,O
Texas,O
Medical,O
"
",O
Branch,O
",",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
"
",O
(6)State,O
Key,O
Laboratory,O
of,O
Pathogen,O
and,O
Biosecurity,O
",",O
Beijing,O
Institute,O
of,O
"
",O
Microbiology,O
and,O
Epidemiology,O
",",O
Academy,O
of,O
Military,O
Medical,O
Sciences,O
",",O
Beijing,O
",",O
"
",O
China,O
qincf@bmi.ac.cn,O
zhangbo@wh.iov.cn,O
.,O
"
",O
(7)Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
"
",O
China,O
qincf@bmi.ac.cn,O
zhangbo@wh.iov.cn,O
.,O
"
",O
(8)Drug,O
Discovery,O
Center,O
for,O
Infectious,O
Disease,O
",",O
Nankai,O
University,O
",",O
Tianjin,O
",",O
"
",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
Mosquitoborne,O
flaviviruses,O
consist,O
of,O
a,O
positivesense,O
genome,O
RNA,O
flanked,O
by,O
the,O
"
",O
untranslated,O
regions,O
(,O
UTRs,O
),O
.,O
There,O
is,O
a,O
panel,O
of,O
highly,O
complex,O
RNA,O
structures,O
in,O
"
",O
the,O
UTRs,O
with,O
critical,O
functions,O
.,O
For,O
instance,O
",",O
Xrn1resistant,O
RNAs,O
(,O
xrRNAs,O
),O
halt,O
"
",O
Xrn1,O
digestion,O
",",O
leading,O
to,O
the,O
production,O
of,O
subgenomic,O
flaviviral,O
RNA,O
(,O
sfRNA,O
),O
.,O
"
",O
Conserved,O
short,O
direct,O
repeats,O
(,O
DRs,O
),O
",",O
also,O
known,O
as,O
conserved,O
sequences,O
(,O
CS,O
),O
and,O
"
",O
repeated,O
conserved,O
sequences,O
(,O
RCS,O
),O
",",O
have,O
been,O
identified,O
as,O
being,O
among,O
the,O
RNA,O
"
",O
elements,O
locating,O
downstream,O
of,O
xrRNAs,O
",",O
but,O
their,O
biological,O
function,O
remains,O
"
",O
unknown,O
.,O
In,O
this,O
study,O
",",O
we,O
revealed,O
that,O
the,O
specific,O
DRs,O
are,O
involved,O
in,O
the,O
"
",O
production,O
of,O
specific,O
sfRNAs,O
in,O
both,O
mammalian,O
and,O
mosquito,O
cells,O
.,O
Biochemical,O
"
",O
assays,O
and,O
structural,O
remodeling,O
demonstrate,O
that,O
the,O
base,O
pairings,O
in,O
the,O
stem,O
"
",O
of,O
these,O
DRs,O
control,O
sfRNA,O
formation,O
by,O
maintaining,O
the,O
binding,O
affinity,O
of,O
the,O
"
",O
corresponding,O
xrRNAs,O
to,O
Xrn1,O
.,O
On,O
the,O
basis,O
of,O
these,O
findings,O
",",O
we,O
propose,O
that,O
DRs,O
"
",O
functions,O
like,O
a,O
bracket,O
holding,O
the,O
Xrn1xrRNA,O
complex,O
for,O
sfRNA,O
"
",O
formation,O
.,O
IMPORTANCE,O
Flaviviruses,O
include,O
many,O
important,O
human,O
pathogens,O
.,O
The,O
"
",O
production,O
of,O
subgenomic,O
flaviviral,O
RNAs,O
(,O
sfRNAs,O
),O
is,O
important,O
for,O
viral,O
"
",O
pathogenicity,O
as,O
a,O
common,O
feature,O
of,O
flaviviruses,O
.,O
sfRNAs,O
are,O
formed,O
through,O
the,O
"
",O
incomplete,O
degradation,O
of,O
viral,O
genomic,O
RNA,O
by,O
the,O
cytoplasmic,O
5'3,O
',O
"
",O
exoribonuclease,O
Xrn1,O
halted,O
at,O
the,O
Xrn1resistant,O
RNA,O
(,O
xrRNA,O
),O
structures,O
within,O
"
",O
the,O
3'UTR,O
.,O
The,O
3'UTRs,O
of,O
the,O
flavivirus,O
genome,O
also,O
contain,O
distinct,O
short,O
"
",O
direct,O
repeats,O
(,O
DRs,O
),O
",",O
such,O
as,O
RCS3,O
",",O
CS3,O
",",O
RCS2,O
",",O
and,O
CS2,O
.,O
However,O
",",O
the,O
biological,O
"
",O
functions,O
of,O
these,O
ancient,O
primary,O
DR,O
sequences,O
remain,O
largely,O
unknown,O
.,O
Here,O
",",O
we,O
"
",O
found,O
that,O
DR,O
sequences,O
are,O
involved,O
in,O
sfRNA,O
formation,O
and,O
viral,O
virulence,O
and,O
"
",O
provide,O
novel,O
targets,O
for,O
the,O
rational,O
design,O
of,O
live,O
attenuated,O
flavivirus,O
"
",O
vaccine,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
American,O
Society,O
for,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1128,O
JVI.0117519,O
"
",O
PMID,O
:,O
31896596,O
"


",O
936,O
.,O
J,O
Virol,O
.,O
2020,O
Feb,O
28;94(6,O
),O
.,O
pii,O
:,O
e0181319,O
.,O
doi,O
:,O
10.1128,O
JVI.0181319,O
.,O
Print,O
2020,O
"
",O
Feb,O
28,O
.,O
"

",O
Phylogenetics,O
",",O
Genomic,O
Recombination,O
",",O
and,O
NSP2,O
Polymorphic,O
Patterns,O
of,O
Porcine,O
"
",O
Reproductive,O
and,O
Respiratory,O
Syndrome,O
Virus,O
in,O
China,O
and,O
the,O
United,O
States,O
in,O
"
",O
20142018,O
.,O
"

",O
Yu,O
F(#)(1,O
),O
",",O
Yan,O
Y(#)(2)(3)(4,O
),O
",",O
Shi,O
M(5)(6,O
),O
",",O
Liu,O
HZ(2)(3,O
),O
",",O
Zhang,O
HL(1,O
),O
",",O
Yang,O
"
",O
YB(1,O
),O
",",O
Huang,O
XY(1,O
),O
",",O
Gauger,O
PC(7,O
),O
",",O
Zhang,O
J(7,O
),O
",",O
Zhang,O
YH(1,O
),O
",",O
Tong,O
GZ(8,O
),O
",",O
Tian,O
"
",O
ZJ(1,O
),O
",",O
Chen,O
JJ(2)(3,O
),O
",",O
Cai,O
XH(#)(1,O
),O
",",O
Liu,O
D(#)(2)(3)(4)(9,O
),O
",",O
Li,O
G(#)(10,O
),O
",",O
An,O
"
",O
TQ(#)(11,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Veterinary,O
Biotechnology,O
",",O
Harbin,O
Veterinary,O
Research,O
"
",O
Institute,O
",",O
Chinese,O
Academy,O
of,O
Agricultural,O
Sciences,O
",",O
Harbin,O
",",O
China,O
.,O
"
",O
(2)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Computational,O
Virology,O
Group,O
",",O
Center,O
for,O
Bacteria,O
and,O
Viruses,O
Resources,O
and,O
"
",O
Bioinformation,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(4)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)School,O
of,O
Medicine,O
",",O
Sun,O
Yatsen,O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(6)Marie,O
Bashir,O
Institute,O
for,O
Infectious,O
Diseases,O
and,O
Biosecurity,O
",",O
Charles,O
"
",O
Perkins,O
Centre,O
",",O
School,O
of,O
Biological,O
Sciences,O
and,O
Sydney,O
Medical,O
School,O
",",O
The,O
"
",O
University,O
of,O
Sydney,O
",",O
Sydney,O
",",O
Australia,O
.,O
"
",O
(7)Department,O
of,O
Veterinary,O
Diagnostic,O
and,O
Production,O
Animal,O
Medicine,O
",",O
College,O
of,O
"
",O
Veterinary,O
Medicine,O
",",O
Iowa,O
State,O
University,O
",",O
Ames,O
",",O
Iowa,O
",",O
USA,O
.,O
"
",O
(8)Shanghai,O
Veterinary,O
Research,O
Institute,O
",",O
Chinese,O
Academy,O
of,O
Agricultural,O
"
",O
Sciences,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(9)First,O
Affiliated,O
Hospital,O
of,O
Xinjiang,O
Medical,O
University,O
",",O
Urumqi,O
",",O
China,O
.,O
"
",O
(10)Department,O
of,O
Veterinary,O
Diagnostic,O
and,O
Production,O
Animal,O
Medicine,O
",",O
College,O
"
",O
of,O
Veterinary,O
Medicine,O
",",O
Iowa,O
State,O
University,O
",",O
Ames,O
",",O
Iowa,O
",",O
USA,O
"
",O
liganwu@iastate.edu,O
antongqing@caas.cn,O
.,O
"
",O
(11)State,O
Key,O
Laboratory,O
of,O
Veterinary,O
Biotechnology,O
",",O
Harbin,O
Veterinary,O
Research,O
"
",O
Institute,O
",",O
Chinese,O
Academy,O
of,O
Agricultural,O
Sciences,O
",",O
Harbin,O
",",O
China,O
"
",O
liganwu@iastate.edu,O
antongqing@caas.cn,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
Porcine,O
reproductive,O
and,O
respiratory,O
syndrome,O
virus,O
(,O
PRRSV,O
),O
",",O
an,O
important,O
"
",O
pathogen,O
that,O
affects,O
the,O
pig,O
industry,O
",",O
is,O
a,O
highly,O
genetically,O
diverse,O
RNA,O
"
",O
virus,O
.,O
However,O
",",O
the,O
phylogenetic,O
and,O
genomic,O
recombination,O
properties,O
of,O
this,O
"
",O
virus,O
have,O
not,O
been,O
completely,O
elucidated,O
.,O
In,O
this,O
study,O
",",O
comparative,O
analyses,O
of,O
"
",O
all,O
available,O
genomic,O
sequences,O
of,O
North,O
American,O
(NA)type,O
PRRSVs,O
(,O
n,O
â€‰,O
=,O
â€‰,O
355,O
",",O
"
",O
including,O
138,O
PRRSV,O
genomes,O
sequenced,O
in,O
this,O
study,O
),O
in,O
China,O
and,O
the,O
United,O
"
",O
States,O
during,O
20142018,O
revealed,O
a,O
high,O
frequency,O
of,O
interlineage,O
recombination,O
"
",O
hot,O
spots,O
in,O
nonstructural,O
protein,O
9,O
(,O
NSP9,O
),O
and,O
the,O
GP2,O
to,O
GP3,O
regions,O
.,O
Lineage,O
1,O
"
",O
(,O
L1,O
),O
PRRSV,O
was,O
found,O
to,O
be,O
susceptible,O
to,O
recombination,O
among,O
PRRSVs,O
both,O
in,O
"
",O
China,O
and,O
the,O
United,O
States,O
.,O
The,O
recombinant,O
major,O
parent,O
between,O
the,O
19912013,O
"
",O
data,O
and,O
the,O
20142018,O
data,O
showed,O
a,O
trend,O
from,O
complex,O
to,O
simple,O
.,O
The,O
major,O
"
",O
recombination,O
pattern,O
changed,O
from,O
an,O
L8,O
to,O
L1,O
backbone,O
during,O
20142018,O
for,O
"
",O
Chinese,O
PRRSVs,O
",",O
whereas,O
L1,O
was,O
always,O
the,O
major,O
backbone,O
for,O
US,O
PRRSVs,O
.,O
"
",O
Intralineage,O
recombination,O
hot,O
spots,O
were,O
not,O
as,O
concentrated,O
as,O
interlineage,O
"
",O
recombination,O
hot,O
spots,O
.,O
In,O
the,O
two,O
main,O
clades,O
with,O
differential,O
diversity,O
in,O
"
",O
L1,O
",",O
NADC30like,O
PRRSVs,O
are,O
undergoing,O
a,O
decrease,O
in,O
population,O
genetic,O
diversity,O
",",O
"
",O
NADC34like,O
PRRSVs,O
have,O
been,O
relatively,O
stable,O
in,O
population,O
genetic,O
diversity,O
"
",O
for,O
years,O
.,O
Systematic,O
analyses,O
of,O
insertion,O
and,O
deletion,O
(,O
indel,O
),O
polymorphisms,O
of,O
"
",O
NSP2,O
divided,O
PRRSVs,O
into,O
25,O
patterns,O
",",O
which,O
could,O
generate,O
novel,O
references,O
for,O
"
",O
the,O
classification,O
of,O
PRRSVs,O
.,O
The,O
results,O
of,O
this,O
study,O
contribute,O
to,O
a,O
deeper,O
"
",O
understanding,O
of,O
the,O
recombination,O
of,O
PRRSVs,O
and,O
indicate,O
the,O
need,O
for,O
"
",O
coordinated,O
epidemiological,O
investigations,O
among,O
countries,O
.,O
IMPORTANCE,O
Porcine,O
"
",O
reproductive,O
and,O
respiratory,O
syndrome,O
(,O
PRRS,O
),O
is,O
one,O
of,O
the,O
most,O
significant,O
swine,O
"
",O
diseases,O
.,O
However,O
",",O
the,O
phylogenetic,O
and,O
genomic,O
recombination,O
properties,O
of,O
the,O
"
",O
PRRS,O
virus,O
(,O
PRRSV,O
),O
have,O
not,O
been,O
completely,O
elucidated,O
.,O
In,O
this,O
study,O
",",O
we,O
"
",O
systematically,O
compared,O
differences,O
in,O
the,O
lineage,O
distribution,O
",",O
recombination,O
",",O
"
",O
NSP2,O
polymorphisms,O
",",O
and,O
evolutionary,O
dynamics,O
between,O
North,O
American,O
(NA)type,O
"
",O
PRRSVs,O
in,O
China,O
and,O
in,O
the,O
United,O
States,O
.,O
Strikingly,O
",",O
we,O
found,O
high,O
frequency,O
of,O
"
",O
interlineage,O
recombination,O
hot,O
spots,O
in,O
nonstructural,O
protein,O
9,O
(,O
NSP9,O
),O
and,O
in,O
the,O
"
",O
GP2,O
to,O
GP3,O
region,O
.,O
Also,O
",",O
intralineage,O
recombination,O
hot,O
spots,O
were,O
scattered,O
"
",O
across,O
the,O
genome,O
between,O
Chinese,O
and,O
US,O
strains,O
.,O
Furthermore,O
",",O
we,O
proposed,O
novel,O
"
",O
methods,O
based,O
on,O
NSP2,O
indel,O
patterns,O
for,O
the,O
classification,O
of,O
PRRSVs,O
.,O
"
",O
Evolutionary,O
dynamics,O
analysis,O
revealed,O
that,O
NADC30like,O
PRRSVs,O
are,O
undergoing,O
a,O
"
",O
decrease,O
in,O
population,O
genetic,O
diversity,O
",",O
suggesting,O
that,O
a,O
dominant,O
population,O
"
",O
may,O
occur,O
and,O
cause,O
an,O
outbreak,O
.,O
Our,O
findings,O
offer,O
important,O
insights,O
into,O
the,O
"
",O
recombination,O
of,O
PRRSVs,O
and,O
suggest,O
the,O
need,O
for,O
coordinated,O
international,O
"
",O
epidemiological,O
investigations,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
American,O
Society,O
for,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1128,O
JVI.0181319,O
"
",O
PMID,O
:,O
31896589,O
"


",O
937,O
.,O
Leg,O
Med,O
(,O
Tokyo,O
),O
.,O
2020,O
Feb;42:101662,O
.,O
doi,O
:,O
10.1016,O
j.legalmed.2019.101662,O
.,O
Epub,O
"
",O
2019,O
Dec,O
12,O
.,O
"

",O
Acute,O
myocardial,O
infarction,O
in,O
a,O
young,O
woman,O
:,O
Unexpected,O
findings,O
of,O
a,O
coronary,O
"
",O
occlusion,O
.,O
"

",O
Zhao,O
S(1,O
),O
",",O
Zhu,O
L(1,O
),O
",",O
Tinzin,O
L(1,O
),O
",",O
Huang,O
F(1,O
),O
",",O
Ma,O
L(1,O
),O
",",O
Zhou,O
Y(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Forensic,O
Medicine,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
"
",O
of,O
Science,O
and,O
Technology,O
",",O
No.,O
13,O
Hangkong,O
Road,O
",",O
Wuhan,O
430030,O
",",O
PR,O
China,O
.,O
"
",O
(2)Department,O
of,O
Forensic,O
Medicine,O
",",O
Tongji,O
Medical,O
College,O
",",O
Huazhong,O
University,O
"
",O
of,O
Science,O
and,O
Technology,O
",",O
No.,O
13,O
Hangkong,O
Road,O
",",O
Wuhan,O
430030,O
",",O
PR,O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
zhouyiwu@outlook.com,O
.,O
"

",O
In,O
clinical,O
and,O
forensic,O
practice,O
",",O
the,O
cause,O
of,O
death,O
is,O
often,O
attributed,O
to,O
"
",O
acute,O
myocardial,O
infarction,O
",",O
among,O
which,O
the,O
coronary,O
atherosclerosis,O
being,O
the,O
"
",O
Captain,O
of,O
the,O
Men,O
of,O
Death,O
.,O
However,O
",",O
other,O
reasons,O
such,O
as,O
coronary,O
septic,O
"
",O
embolization,O
with,O
neutrophilic,O
granulocyte,O
myocarditis,O
although,O
rare,O
",",O
can,O
also,O
"
",O
cause,O
sudden,O
unexpected,O
death,O
.,O
This,O
paper,O
reports,O
a,O
case,O
with,O
this,O
rare,O
causea,O
"
",O
21yearold,O
woman,O
diagnosed,O
with,O
"""",O
acute,O
gastroenteritis,O
"""",O
who,O
died,O
4,O
Â ,O
days,O
later,O
.,O
A,O
"
",O
forensic,O
autopsy,O
revealed,O
an,O
inflammatory,O
polypous,O
embolic,O
located,O
at,O
1,O
Â ,O
cm,O
from,O
"
",O
the,O
left,O
anterior,O
descending,O
branch,O
(,O
LAD,O
),O
with,O
serve,O
neutrophilic,O
granulocyte,O
"
",O
myocarditis,O
",",O
which,O
resulted,O
in,O
embolic,O
at,O
the,O
opening,O
of,O
the,O
left,O
main,O
coronary,O
"
",O
artery,O
",",O
acute,O
myocardial,O
infarction,O
and,O
eventually,O
leading,O
to,O
her,O
death,O
.,O
"
",O
Histopathological,O
examination,O
showed,O
large,O
amounts,O
of,O
neutrophilic,O
granulocyte,O
"
",O
infiltration,O
in,O
the,O
arterial,O
layer,O
forming,O
the,O
septic,O
embolic,O
and,O
eventually,O
"
",O
resulting,O
in,O
coronary,O
occlusion,O
.,O
To,O
find,O
the,O
real,O
cause,O
of,O
septic,O
embolic,O
",",O
"
",O
myocarditis,O
",",O
bacterial,O
",",O
fungal,O
",",O
protozoan,O
and,O
virus,O
detection,O
was,O
performed,O
"
",O
through,O
RTPCR,O
",",O
with,O
negative,O
findings,O
.,O
Septic,O
embolic,O
leading,O
coronary,O
occlusion,O
"
",O
in,O
left,O
main,O
coronary,O
artery,O
and,O
LAD,O
is,O
rarely,O
reported,O
in,O
forensic,O
practice,O
",",O
we,O
"
",O
hope,O
this,O
report,O
can,O
pave,O
the,O
way,O
on,O
understanding,O
this,O
rare,O
disease,O
to,O
make,O
"
",O
correct,O
diagnosis,O
in,O
medical,O
practice,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.legalmed.2019.101662,O
"
",O
PMID,O
:,O
31896072,O
"


",O
938,O
.,O
PLoS,O
Med,O
.,O
2019,O
Dec,O
31;16(12):e1003010,O
.,O
doi,O
:,O
10.1371,O
journal.pmed.1003010,O
.,O
"
",O
eCollection,O
2019,O
Dec.,O
"

",O
Ambient,O
particulate,O
matter,O
pollution,O
and,O
adult,O
hospital,O
admissions,O
for,O
pneumonia,O
"
",O
in,O
urban,O
China,O
:,O
A,O
national,O
time,O
series,O
analysis,O
for,O
2014,O
through,O
2017,O
.,O
"

",O
Tian,O
Y(1)(2)(3,O
),O
",",O
Liu,O
H(3)(4,O
),O
",",O
Wu,O
Y(3,O
),O
",",O
Si,O
Y(5,O
),O
",",O
Li,O
M(3,O
),O
",",O
Wu,O
Y(3,O
),O
",",O
Wang,O
X(3,O
),O
",",O
Wang,O
"
",O
M(3,O
),O
",",O
Chen,O
L(5,O
),O
",",O
Wei,O
C(5,O
),O
",",O
Wu,O
T(3,O
),O
",",O
Gao,O
P(3)(6,O
),O
",",O
Hu,O
Y(3)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Maternal,O
and,O
Child,O
Health,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Ministry,O
of,O
Education,O
Key,O
Laboratory,O
of,O
Environment,O
and,O
Health,O
",",O
and,O
State,O
Key,O
"
",O
Laboratory,O
of,O
Environmental,O
Health,O
(,O
Incubating,O
),O
",",O
School,O
of,O
Public,O
Health,O
",",O
Tongji,O
"
",O
Medical,O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Epidemiology,O
and,O
Biostatistics,O
",",O
School,O
of,O
Public,O
Health,O
",",O
Peking,O
"
",O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(4)Medical,O
Informatics,O
Center,O
",",O
Peking,O
University,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)Beijing,O
HealthCom,O
Data,O
Technology,O
Co.,O
Ltd,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(6)Key,O
Laboratory,O
of,O
Molecular,O
Cardiovascular,O
(,O
Peking,O
University,O
),O
",",O
Ministry,O
of,O
"
",O
Education,O
",",O
Beijing,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
The,O
effects,O
of,O
ambient,O
particulate,O
matter,O
(,O
PM,O
),O
pollution,O
on,O
pneumonia,O
"
",O
in,O
adults,O
are,O
inconclusive,O
",",O
and,O
few,O
scientific,O
data,O
on,O
a,O
national,O
scale,O
have,O
been,O
"
",O
generated,O
in,O
low,O
or,O
middleincome,O
countries,O
",",O
despite,O
their,O
much,O
higher,O
PM,O
"
",O
concentrations,O
.,O
We,O
aimed,O
to,O
examine,O
the,O
association,O
between,O
PM,O
levels,O
and,O
"
",O
hospital,O
admissions,O
for,O
pneumonia,O
in,O
Chinese,O
adults,O
.,O
"
",O
METHODS,O
AND,O
FINDINGS,O
:,O
A,O
nationwide,O
time,O
series,O
study,O
was,O
conducted,O
in,O
China,O
"
",O
between,O
2014,O
and,O
2017,O
.,O
Information,O
on,O
daily,O
hospital,O
admissions,O
for,O
pneumonia,O
for,O
"
",O
20142017,O
was,O
collected,O
from,O
the,O
database,O
of,O
Urban,O
Employee,O
Basic,O
Medical,O
"
",O
Insurance,O
(,O
UEBMI,O
),O
",",O
which,O
covers,O
282.93,O
million,O
adults,O
.,O
Associations,O
of,O
PM,O
"
",O
concentrations,O
and,O
hospital,O
admissions,O
for,O
pneumonia,O
were,O
estimated,O
for,O
each,O
city,O
"
",O
using,O
a,O
quasiPoisson,O
regression,O
model,O
controlling,O
for,O
time,O
trend,O
",",O
temperature,O
",",O
"
",O
relative,O
humidity,O
",",O
day,O
of,O
the,O
week,O
",",O
and,O
public,O
holiday,O
and,O
then,O
pooled,O
by,O
"
",O
randomeffects,O
metaanalysis,O
.,O
Metaregression,O
models,O
were,O
used,O
to,O
investigate,O
"
",O
potential,O
effect,O
modifiers,O
",",O
including,O
cities,O
',O
annualaverage,O
air,O
pollutants,O
"
",O
concentrations,O
",",O
temperature,O
",",O
relative,O
humidity,O
",",O
gross,O
domestic,O
product,O
(,O
GDP,O
),O
per,O
"
",O
capita,O
",",O
and,O
coverage,O
rates,O
by,O
the,O
UEBMI,O
.,O
More,O
than,O
4.2,O
million,O
pneumonia,O
"
",O
admissions,O
were,O
identified,O
in,O
184,O
Chinese,O
cities,O
during,O
the,O
study,O
period,O
.,O
"
",O
Shortterm,O
elevations,O
in,O
PM,O
concentrations,O
were,O
associated,O
with,O
increased,O
"
",O
pneumonia,O
admissions,O
.,O
At,O
the,O
national,O
level,O
",",O
a,O
10Î¼g,O
m3,O
increase,O
in,O
3day,O
moving,O
"
",O
average,O
(,O
lag,O
2,O
),O
concentrations,O
of,O
PM2.5,O
(,O
PM,O
â‰¤2.5,O
Î¼m,O
in,O
aerodynamic,O
diameter,O
),O
"
",O
and,O
PM10,O
(,O
PM,O
â‰¤10,O
Î¼m,O
in,O
aerodynamic,O
diameter,O
),O
was,O
associated,O
with,O
0.31,O
%,O
(,O
95,O
%,O
"
",O
confidence,O
interval,O
[,O
CI,O
],O
0.15%0.46,O
%,O
",",O
P,O
<,O
0.001,O
),O
and,O
0.19,O
%,O
(,O
0.11%0.30,O
%,O
",",O
P,O
<,O
"
",O
0.001,O
),O
increases,O
in,O
hospital,O
admissions,O
for,O
pneumonia,O
",",O
respectively,O
.,O
The,O
effects,O
"
",O
of,O
PM10,O
were,O
stronger,O
in,O
cities,O
with,O
higher,O
temperatures,O
(,O
percentage,O
increase,O
",",O
"
",O
0.031,O
%,O
;,O
95,O
%,O
CI,O
0.003%0.058,O
%,O
;,O
P,O
=,O
0.026,O
),O
and,O
relative,O
humidity,O
(,O
percentage,O
"
",O
increase,O
",",O
0.011,O
%,O
;,O
95,O
%,O
CI,O
0%0.022,O
%,O
;,O
P,O
=,O
0.045,O
),O
",",O
as,O
well,O
as,O
in,O
the,O
elderly,O
"
",O
(,O
percentage,O
increase,O
",",O
0.1,O
%,O
[,O
95,O
%,O
CI,O
0.02%0.19,O
%,O
],O
for,O
people,O
aged,O
1864,O
years,O
"
",O
versus,O
0.32,O
%,O
[,O
95,O
%,O
CI,O
0.22%0.39,O
%,O
],O
for,O
people,O
aged,O
â‰¥75,O
years,O
;,O
P,O
<,O
0.001,O
),O
.,O
The,O
main,O
"
",O
limitation,O
of,O
the,O
present,O
study,O
was,O
the,O
unavailability,O
of,O
data,O
on,O
individual,O
"
",O
exposure,O
to,O
PM,O
pollution,O
.,O
"
",O
CONCLUSIONS,O
:,O
Our,O
findings,O
suggest,O
that,O
there,O
are,O
significant,O
shortterm,O
"
",O
associations,O
between,O
ambient,O
PM,O
levels,O
and,O
increased,O
hospital,O
admissions,O
for,O
"
",O
pneumonia,O
in,O
Chinese,O
adults,O
.,O
These,O
findings,O
support,O
the,O
rationale,O
that,O
further,O
"
",O
limiting,O
PM,O
concentrations,O
in,O
China,O
may,O
be,O
an,O
effective,O
strategy,O
to,O
reduce,O
"
",O
pneumoniarelated,O
hospital,O
admissions,O
.,O
"

",O
DOI,O
:,O
10.1371,O
journal.pmed.1003010,O
"
",O
PMCID,O
:,O
PMC6938337,O
"
",O
PMID,O
:,O
31891579,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
have,O
declared,O
that,O
no,O
competing,O
"
",O
interests,O
exist,O
.,O
"


",O
939,O
.,O
Mol,O
Ther,O
Methods,O
Clin,O
Dev,O
.,O
2019,O
Nov,O
21;17:2133,O
.,O
doi,O
:,O
10.1016,O
j.omtm.2019.11.006,O
.,O
"
",O
eCollection,O
2020,O
Jun,O
12,O
.,O
"

",O
rAAV2Retro,O
Enables,O
Extensive,O
and,O
HighEfficient,O
Transduction,O
of,O
Lower,O
Motor,O
"
",O
Neurons,O
following,O
Intramuscular,O
Injection,O
.,O
"

",O
Chen,O
Z(1)(2,O
),O
",",O
Fan,O
G(1)(2,O
),O
",",O
Li,O
A(1)(2,O
),O
",",O
Yuan,O
J(1)(2,O
),O
",",O
Xu,O
T(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Britton,O
Chance,O
Center,O
for,O
Biomedical,O
Photonics,O
",",O
Wuhan,O
National,O
Laboratory,O
for,O
"
",O
Optoelectronics,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)MoE,O
Key,O
Laboratory,O
for,O
Biomedical,O
Photonics,O
",",O
Collaborative,O
Innovation,O
Center,O
"
",O
for,O
Biomedical,O
Engineering,O
",",O
School,O
of,O
Engineering,O
Sciences,O
",",O
Huazhong,O
University,O
"
",O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Institute,O
of,O
Life,O
Sciences,O
",",O
Nanchang,O
University,O
",",O
Nanchang,O
",",O
China,O
.,O
"

",O
The,O
motor,O
system,O
controls,O
muscle,O
movement,O
through,O
lower,O
motor,O
neurons,O
in,O
the,O
"
",O
spinal,O
cord,O
and,O
brainstem,O
.,O
Lower,O
motor,O
neurons,O
are,O
efferent,O
neurons,O
in,O
the,O
"
",O
central,O
nervous,O
system,O
(,O
CNS,O
),O
characterized,O
by,O
axonal,O
projections,O
that,O
reach,O
"
",O
specific,O
targets,O
in,O
the,O
periphery,O
.,O
Lower,O
motor,O
neuron,O
lesions,O
result,O
in,O
the,O
"
",O
denervation,O
and,O
dysfunction,O
of,O
peripheral,O
skeletal,O
muscle,O
.,O
Great,O
progress,O
has,O
"
",O
been,O
made,O
to,O
develop,O
therapeutic,O
strategies,O
to,O
transduce,O
lower,O
motor,O
neurons,O
with,O
"
",O
genes,O
.,O
However,O
",",O
the,O
widespread,O
distribution,O
of,O
lower,O
motor,O
neurons,O
makes,O
their,O
"
",O
specific,O
",",O
extensive,O
",",O
and,O
efficient,O
transduction,O
a,O
challenge,O
.,O
In,O
this,O
study,O
",",O
we,O
"
",O
demonstrated,O
that,O
",",O
compared,O
to,O
the,O
other,O
tested,O
recombinant,O
adenoassociated,O
"
",O
virus,O
(,O
rAAV,O
),O
serotypes,O
",",O
rAAV2retro,O
mediated,O
the,O
most,O
efficient,O
retrograde,O
"
",O
transduction,O
of,O
lower,O
motor,O
neurons,O
in,O
the,O
spinal,O
cord,O
following,O
intramuscular,O
"
",O
injection,O
in,O
neonatal,O
mice,O
.,O
A,O
single,O
injection,O
of,O
rAAV2retro,O
in,O
a,O
single,O
muscle,O
"
",O
enabled,O
the,O
efficient,O
and,O
extensive,O
transduction,O
of,O
lower,O
motor,O
neurons,O
in,O
the,O
"
",O
spinal,O
cord,O
and,O
brainstem,O
rather,O
than,O
transducing,O
only,O
the,O
lower,O
motor,O
neurons,O
"
",O
connected,O
to,O
the,O
injected,O
muscle,O
.,O
rAAV2retro,O
achieved,O
the,O
extensive,O
transduction,O
"
",O
of,O
lower,O
motor,O
neurons,O
by,O
the,O
cerebrospinal,O
fluid,O
pathway,O
.,O
Our,O
work,O
suggests,O
that,O
"
",O
gene,O
delivery,O
via,O
the,O
intramuscular,O
injection,O
of,O
rAAV2retro,O
represents,O
a,O
"
",O
promising,O
tool,O
in,O
the,O
development,O
of,O
gene,O
therapy,O
strategies,O
for,O
motor,O
neuron,O
"
",O
diseases,O
.,O
"

",O
Â©,O
2019,O
The,O
Authors,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.omtm.2019.11.006,O
"
",O
PMCID,O
:,O
PMC6926343,O
"
",O
PMID,O
:,O
31890738,O
"


",O
940,O
.,O
Saudi,O
J,O
Biol,O
Sci,O
.,O
2019,O
Dec;26(8):19781981,O
.,O
doi,O
:,O
10.1016,O
j.sjbs.2019.08.020,O
.,O
Epub,O
"
",O
2019,O
Aug,O
27,O
.,O
"

",O
Observation,O
of,O
the,O
effect,O
of,O
the,O
pregnancy,O
complicated,O
with,O
the,O
hepatitis,O
B,O
"
",O
infection,O
on,O
the,O
lyingin,O
women,O
and,O
neonates,O
.,O
"

",O
Xiao,O
B(1,O
),O
",",O
Liu,O
A(2,O
),O
",",O
Zhang,O
M(3,O
),O
",",O
Xue,O
H(4,O
),O
",",O
Zhu,O
Y(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Obstetrics,O
",",O
Hanyang,O
Hospital,O
Affiliated,O
to,O
Wuhan,O
University,O
of,O
"
",O
Science,O
and,O
Technology,O
",",O
Wuhan,O
430053,O
",",O
China,O
.,O
"
",O
(2)Clinical,O
Laboratory,O
",",O
The,O
People,O
's,O
Hospital,O
of,O
Longhua,O
District,O
of,O
Shenzhen,O
",",O
"
",O
Shenzhen,O
518109,O
",",O
China,O
.,O
"
",O
(3)Clinical,O
Laboratory,O
",",O
Zhucheng,O
Maternal,O
and,O
Child,O
Health,O
Hospital,O
",",O
Zhucheng,O
"
",O
262200,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Gynecology,O
",",O
The,O
Qingdao,O
Hiser,O
Hospital,O
",",O
Qingdao,O
266000,O
",",O
China,O
.,O
"
",O
(5)Hospital,O
Infection,O
Management,O
Office,O
",",O
The,O
Hospital,O
of,O
Xinjiang,O
Production,O
and,O
"
",O
Construction,O
Corps,O
",",O
Urumqi,O
830002,O
",",O
China,O
.,O
"

",O
Objective,O
:,O
To,O
investigate,O
the,O
effect,O
of,O
pregnancy,O
complicated,O
with,O
the,O
hepatitis,O
"
",O
B,O
infection,O
on,O
the,O
pregnancy,O
outcome,O
",",O
immunological,O
factors,O
and,O
the,O
subgroup,O
of,O
"
",O
lymphocytes,O
in,O
neonates,O
.,O
"
",O
Methods,O
:,O
Subjects,O
admitting,O
to,O
this,O
hospital,O
between,O
January,O
1,O
",",O
2016,O
and,O
January,O
"
",O
1,O
",",O
2018,O
in,O
this,O
study,O
were,O
divided,O
into,O
two,O
groups,O
according,O
to,O
the,O
hepatitis,O
B,O
"
",O
infection,O
",",O
i.e.,O
the,O
observation,O
group,O
(,O
infection,O
),O
and,O
the,O
control,O
group,O
"
",O
(,O
healthy,O
),O
",",O
with,O
60,O
subjects,O
in,O
each,O
group,O
.,O
Pregnancy,O
complications,O
and,O
the,O
"
",O
neonatal,O
complications,O
were,O
all,O
recorded,O
",",O
and,O
furthermore,O
",",O
the,O
subgroups,O
of,O
"
",O
lymphocytes,O
and,O
the,O
levels,O
of,O
immunoglobin,O
in,O
the,O
umbilical,O
cord,O
blood,O
were,O
"
",O
measured,O
.,O
"
",O
Results,O
:,O
The,O
incidence,O
rates,O
of,O
the,O
premature,O
rupture,O
of,O
fetal,O
membranes,O
",",O
"
",O
premature,O
delivery,O
",",O
postpartum,O
hemorrhage,O
and,O
pregnancyinduced,O
hypertension,O
"
",O
syndrome,O
in,O
the,O
observation,O
group,O
were,O
all,O
higher,O
than,O
those,O
in,O
the,O
control,O
"
",O
group,O
",",O
and,O
the,O
differences,O
had,O
statistical,O
significance,O
.,O
In,O
the,O
observation,O
"
",O
group,O
",",O
the,O
incidence,O
rates,O
of,O
the,O
neonatal,O
distress,O
and,O
asphyxia,O
",",O
and,O
the,O
levels,O
"
",O
of,O
neonatal,O
CD3ï¼‹,O
",",O
CD4ï¼‹,O
",",O
CD19ï¼‹,O
",",O
IgA,O
and,O
IgM,O
varied,O
significantly,O
from,O
those,O
in,O
the,O
"
",O
control,O
group,O
",",O
and,O
the,O
differences,O
showed,O
statistical,O
significance,O
.,O
However,O
",",O
no,O
"
",O
significant,O
differences,O
were,O
identified,O
in,O
comparison,O
of,O
the,O
incidence,O
rate,O
of,O
"
",O
the,O
cesarean,O
delivery,O
",",O
neonatal,O
deformity,O
",",O
neonatal,O
death,O
",",O
or,O
levels,O
of,O
neonatal,O
"
",O
CD8,O
+,O
and,O
IgG.,O
"
",O
Conclusion,O
:,O
During,O
pregnancy,O
",",O
complications,O
of,O
hepatitis,O
B,O
infection,O
results,O
in,O
"
",O
the,O
increases,O
in,O
the,O
incidence,O
rates,O
of,O
the,O
premature,O
rupture,O
of,O
fetal,O
membranes,O
"
",O
and,O
neonatal,O
asphyxia,O
",",O
with,O
influences,O
on,O
the,O
levels,O
of,O
immunological,O
factors,O
and,O
"
",O
lymphocyte,O
subgroups,O
in,O
the,O
umbilical,O
cord,O
blood,O
.,O
"

",O
Â©,O
2019,O
Production,O
and,O
hosting,O
by,O
Elsevier,O
B.V.,O
on,O
behalf,O
of,O
King,O
Saud,O
University,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.sjbs.2019.08.020,O
"
",O
PMCID,O
:,O
PMC6923461,O
"
",O
PMID,O
:,O
31889781,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
There,O
is,O
no,O
conflict,O
of,O
interest,O
.,O
"


",O
941,O
.,O
Int,O
J,O
Mol,O
Sci,O
.,O
2019,O
Dec,O
16;20(24,O
),O
.,O
pii,O
:,O
E6335,O
.,O
doi,O
:,O
10.339,O
ijms20246335,O
.,O
"

",O
Inducible,O
Nitric,O
Oxide,O
Synthase,O
(,O
iNOS,O
),O
Mediates,O
Vascular,O
Endothelial,O
Cell,O
"
",O
Apoptosis,O
in,O
Grass,O
Carp,O
Reovirus,O
(GCRV)Induced,O
Hemorrhage,O
.,O
"

",O
Liang,O
B(1)(2,O
),O
",",O
Su,O
J(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Aquatic,O
Animal,O
Medicine,O
",",O
College,O
of,O
Fisheries,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"
",O
(2)Laboratory,O
for,O
Marine,O
Biology,O
and,O
Biotechnology,O
",",O
Pilot,O
National,O
Laboratory,O
for,O
"
",O
Marine,O
Science,O
and,O
Technology,O
",",O
Qingdao,O
266237,O
",",O
China,O
.,O
"

",O
Hemorrhage,O
is,O
one,O
of,O
the,O
most,O
obvious,O
pathological,O
phenomena,O
in,O
grass,O
carp,O
"
",O
reovirus,O
(,O
GCRV,O
),O
infection,O
.,O
The,O
etiology,O
of,O
GCRVinduced,O
hemorrhage,O
is,O
unclear,O
.,O
We,O
"
",O
found,O
inducible,O
nitric,O
oxide,O
synthase,O
(,O
iNOS,O
),O
may,O
relate,O
to,O
viral,O
hemorrhage,O
"
",O
according,O
to,O
the,O
previous,O
studies,O
",",O
which,O
is,O
expressed,O
at,O
high,O
levels,O
after,O
GCRV,O
"
",O
infection,O
and,O
is,O
related,O
to,O
apoptosis,O
.,O
In,O
this,O
study,O
",",O
we,O
aimed,O
to,O
investigate,O
the,O
"
",O
mechanism,O
of,O
iNOS,O
on,O
apoptosis,O
and,O
hemorrhage,O
at,O
the,O
cell,O
level,O
and,O
individual,O
"
",O
level,O
on,O
subjects,O
who,O
were,O
infected,O
with,O
GCRV,O
and,O
treated,O
with,O
"
",O
Smethylisothiourea,O
sulfate,O
(,O
SMT,O
),O
",",O
an,O
iNOS,O
inhibitor,O
.,O
Cell,O
structure,O
",",O
apoptosis,O
"
",O
rate,O
",",O
and,O
hemorrhage,O
were,O
evaluated,O
through,O
fluorescence,O
microscopy,O
",",O
Annexin,O
"
",O
VFITC,O
staining,O
",",O
and,O
H&E,O
staining,O
",",O
respectively,O
.,O
Cell,O
samples,O
and,O
muscle,O
tissues,O
"
",O
were,O
collected,O
for,O
Western,O
blotting,O
",",O
NO,O
concentration,O
measure,O
",",O
caspase,O
activity,O
"
",O
assay,O
",",O
and,O
qRTPCR,O
.,O
iNOSinduced,O
cell,O
apoptosis,O
and,O
H&E,O
staining,O
showed,O
that,O
the,O
"
",O
vascular,O
wall,O
was,O
broken,O
after,O
GCRV,O
infection,O
in,O
vivo,O
.,O
When,O
the,O
function,O
of,O
iNOS,O
"
",O
was,O
inhibited,O
",",O
NO,O
content,O
",",O
apoptosis,O
rate,O
",",O
caspase,O
activity,O
",",O
and,O
hemorrhage,O
were,O
"
",O
reduced,O
.,O
Collectively,O
",",O
these,O
results,O
suggested,O
iNOS,O
plays,O
a,O
key,O
role,O
in,O
apoptosis,O
"
",O
of,O
vascular,O
endothelial,O
cells,O
in,O
GCRVinduced,O
hemorrhage,O
.,O
This,O
study,O
is,O
the,O
first,O
"
",O
to,O
elucidate,O
the,O
relationship,O
between,O
iNOSinduced,O
cell,O
apoptosis,O
and,O
"
",O
GCRVinduced,O
hemorrhage,O
",",O
which,O
lays,O
the,O
foundation,O
for,O
further,O
mechanistic,O
"
",O
research,O
of,O
virusinduced,O
hemorrhage,O
.,O
"

",O
DOI,O
:,O
10.339,O
ijms20246335,O
"
",O
PMCID,O
:,O
PMC6941106,O
"
",O
PMID,O
:,O
31888180,O
"


",O
942,O
.,O
Virulence,O
.,O
2020,O
Dec;11(1):3238,O
.,O
doi,O
:,O
10.108,O
21505594.2019.1705022,O
.,O
"

",O
Exosomes,O
cloak,O
the,O
virion,O
to,O
transmit,O
Enterovirus,O
71,O
nonlytically,O
.,O
"

",O
Gu,O
J(1)(2,O
),O
",",O
Wu,O
J(1)(2,O
),O
",",O
Fang,O
D(3,O
),O
",",O
Qiu,O
Y(4,O
),O
",",O
Zou,O
X(1)(2,O
),O
",",O
Jia,O
X(1)(2,O
),O
",",O
Yin,O
"
",O
Y(1)(2,O
),O
",",O
Shen,O
L(5,O
),O
",",O
Mao,O
L(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Laboratory,O
Medicine,O
",",O
The,O
Affiliated,O
People,O
's,O
Hospital,O
",",O
Jiangsu,O
"
",O
University,O
",",O
Zhenjiang,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Immunology,O
",",O
Jiangsu,O
Key,O
Laboratory,O
of,O
Laboratory,O
Medicine,O
",",O
"
",O
School,O
of,O
Medicine,O
",",O
Jiangsu,O
University,O
",",O
Zhenjiang,O
",",O
China,O
.,O
"
",O
(3)Clinical,O
Laboratory,O
",",O
Xuzhou,O
children,O
's,O
hospital,O
",",O
Xuzhou,O
",",O
China,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
for,O
"
",O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(5)Clinical,O
Laboratory,O
",",O
Zhenjiang,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
"
",O
Jiangsu,O
",",O
China,O
.,O
"

",O
Enterovirus,O
71,O
(,O
EV71,O
),O
is,O
a,O
nonenveloped,O
virus,O
and,O
it,O
can,O
be,O
released,O
from,O
host,O
"
",O
cells,O
through,O
a,O
traditional,O
cytolytic,O
manner,O
.,O
Now,O
",",O
we,O
showed,O
EV71,O
could,O
be,O
spread,O
"
",O
nonlytically,O
between,O
cells,O
during,O
early,O
viral,O
infection,O
.,O
In,O
order,O
to,O
explain,O
"
",O
this,O
phenomenon,O
",",O
we,O
separated,O
supernatant,O
fluids,O
of,O
rhabdomyosarcoma,O
(,O
RD,O
),O
cells,O
"
",O
cultures,O
infected,O
with,O
EV71,O
by,O
isopycnic,O
gradient,O
centrifugation,O
.,O
Two,O
populations,O
"
",O
of,O
virus,O
particles,O
were,O
morphology,O
indistinguishable,O
by,O
transmission,O
electron,O
"
",O
microscope,O
(,O
TEM,O
),O
.,O
It,O
showed,O
that,O
some,O
EV71,O
particles,O
were,O
wrapped,O
inside,O
"
",O
extracellular,O
vesicles,O
which,O
were,O
verified,O
to,O
be,O
exosomes,O
by,O
immunoassay,O
and,O
"
",O
morphologic,O
analysis,O
.,O
In,O
addition,O
",",O
exosomes,O
containing,O
viral,O
RNA,O
were,O
shed,O
in,O
"
",O
plasma,O
of,O
EV71infected,O
encephalitis,O
in,O
children,O
.,O
Our,O
findings,O
indicate,O
that,O
the,O
"
",O
"""",O
nonenveloped,O
"""",O
Â ,O
EV71,O
virions,O
could,O
be,O
wrapped,O
within,O
exosomes,O
which,O
promote,O
their,O
"
",O
spread,O
in,O
the,O
absence,O
of,O
cell,O
lysis,O
.,O
Abbreviation,O
:,O
EV71,O
:,O
enterovirus,O
71,O
;,O
EXO,O
:,O
"
",O
exosome,O
;,O
RD,O
:,O
rhabdomyosarcoma,O
;,O
TEM,O
:,O
transmission,O
electron,O
microscope,O
;,O
HFMD,O
:,O
hand,O
",",O
"
",O
foot,O
",",O
and,O
mouth,O
disease,O
;,O
HIV,O
:,O
immunodeficiency,O
virus,O
;,O
HCV,O
:,O
hepatitis,O
C,O
virus,O
;,O
"
",O
HTLV,O
:,O
Human,O
Tcell,O
lymphotropic,O
virus,O
;,O
HAV,O
:,O
hepatitis,O
A,O
virus,O
;,O
MOI,O
:,O
multiplicity,O
"
",O
of,O
infection,O
;,O
EVs,O
:,O
extracellular,O
vesicles,O
;,O
VP1,O
:,O
viral,O
capsid,O
protein,O
1,O
;,O
NTA,O
:,O
"
",O
nanoparticle,O
tracking,O
analysis,O
;,O
CNS,O
:,O
central,O
nervous,O
system,O
.,O
"

",O
DOI,O
:,O
10.108,O
21505594.2019.1705022,O
"
",O
PMCID,O
:,O
PMC6961726,O
"
",O
PMID,O
:,O
31885311,O
"


",O
943,O
.,O
EMBO,O
Rep.,O
2020,O
Feb,O
5;21(2):e49473,O
.,O
doi,O
:,O
10.15252,O
embr.201949473,O
.,O
Epub,O
2019,O
Dec,O
"
",O
29,O
.,O
"

",O
DOCK5,O
regulates,O
energy,O
balance,O
and,O
hepatic,O
insulin,O
sensitivity,O
by,O
targeting,O
"
",O
mTORC1,O
signaling,O
.,O
"

",O
Lai,O
Y(1,O
),O
",",O
Zhao,O
A(2,O
),O
",",O
Tan,O
M(1,O
),O
",",O
Yang,O
M(1)(3,O
),O
",",O
Lin,O
Y(2,O
),O
",",O
Li,O
S(1,O
),O
",",O
Song,O
J(4,O
),O
",",O
Zheng,O
"
",O
H(5,O
),O
",",O
Zhu,O
Z(6,O
),O
",",O
Liu,O
D(1,O
),O
",",O
Liu,O
C(7,O
),O
",",O
Li,O
L(1,O
),O
",",O
Yang,O
G(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Endocrinology,O
",",O
The,O
Second,O
Affiliated,O
Hospital,O
",",O
Chongqing,O
Medical,O
"
",O
University,O
",",O
Chongqing,O
",",O
China,O
.,O
"
",O
(2)The,O
Key,O
Laboratory,O
of,O
Laboratory,O
Medical,O
Diagnostics,O
in,O
the,O
Ministry,O
of,O
"
",O
Education,O
and,O
Department,O
of,O
Clinical,O
Biochemistry,O
",",O
College,O
of,O
Laboratory,O
"
",O
Medicine,O
",",O
Chongqing,O
Medical,O
University,O
",",O
Chongqing,O
",",O
China,O
.,O
"
",O
(3)School,O
of,O
Biomedical,O
Sciences,O
",",O
The,O
University,O
of,O
Queensland,O
",",O
Brisbane,O
",",O
Qld,O
",",O
"
",O
Australia,O
.,O
"
",O
(4)Chongqing,O
Key,O
Laboratory,O
for,O
oral,O
Diseases,O
and,O
Biomedical,O
Science,O
",",O
College,O
of,O
"
",O
Stomatology,O
",",O
Chongqing,O
Medical,O
University,O
",",O
Chongqing,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Endocrinology,O
",",O
Xinqiao,O
Hospital,O
",",O
Third,O
Military,O
Medical,O
"
",O
University,O
",",O
Chongqing,O
",",O
China,O
.,O
"
",O
(6)Department,O
of,O
Hypertension,O
and,O
Endocrinology,O
",",O
Daping,O
Hospital,O
",",O
Chongqing,O
"
",O
Institute,O
of,O
Hypertension,O
",",O
Third,O
Military,O
Medical,O
University,O
",",O
Chongqing,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Pathogen,O
Biology,O
",",O
School,O
of,O
Basic,O
Medicine,O
",",O
Huazhong,O
University,O
"
",O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
The,O
dedicator,O
of,O
cytokinesis,O
5,O
(,O
DOCK5,O
),O
is,O
associated,O
with,O
obesity,O
.,O
However,O
",",O
the,O
"
",O
mechanism,O
by,O
which,O
DOCK5,O
contributes,O
to,O
obesity,O
remains,O
completely,O
unknown,O
.,O
Here,O
",",O
"
",O
we,O
show,O
that,O
hepatic,O
DOCK5,O
expression,O
significantly,O
decreases,O
at,O
a,O
state,O
of,O
"
",O
insulin,O
resistance,O
(,O
IR,O
),O
.,O
Deletion,O
of,O
DOCK5,O
in,O
mice,O
reduces,O
energy,O
expenditure,O
",",O
"
",O
promotes,O
obesity,O
",",O
augments,O
IR,O
",",O
dysregulates,O
glucose,O
metabolism,O
",",O
and,O
activates,O
the,O
"
",O
mTOR,O
(,O
Raptor,O
),O
S6K1,O
pathway,O
under,O
a,O
highfat,O
diet,O
(,O
HFD,O
),O
.,O
The,O
overexpression,O
of,O
"
",O
DOCK5,O
in,O
hepatocytes,O
inhibits,O
gluconeogenic,O
gene,O
expression,O
and,O
increases,O
the,O
"
",O
level,O
of,O
insulin,O
receptor,O
(,O
InsR,O
),O
and,O
Akt,O
phosphorylation,O
.,O
DOCK5,O
overexpression,O
"
",O
also,O
inhibits,O
mTOR,O
S6K1,O
phosphorylation,O
and,O
decreases,O
the,O
level,O
of,O
raptor,O
protein,O
"
",O
expression,O
.,O
The,O
opposite,O
effects,O
were,O
observed,O
in,O
DOCK5deficient,O
hepatocytes,O
.,O
"
",O
Importantly,O
",",O
in,O
liverspecific,O
Raptor,O
knockout,O
mice,O
and,O
associated,O
hepatocytes,O
",",O
"
",O
the,O
effects,O
of,O
an,O
adenoassociated,O
virus,O
(,O
AAV8,O
),O
or,O
adenovirusmediated,O
DOCK5,O
"
",O
knockdown,O
on,O
glucose,O
metabolism,O
and,O
insulin,O
signaling,O
are,O
largely,O
eliminated,O
.,O
"
",O
Additionally,O
",",O
DOCK5Raptor,O
interaction,O
is,O
indispensable,O
for,O
the,O
DOCK5mediated,O
"
",O
regulation,O
of,O
hepatic,O
glucose,O
production,O
(,O
HGP,O
),O
.,O
Therefore,O
",",O
DOCK5,O
acts,O
as,O
a,O
"
",O
regulator,O
of,O
Raptor,O
to,O
control,O
hepatic,O
insulin,O
activity,O
and,O
glucose,O
homeostasis,O
.,O
"

",O
Â©,O
2019,O
The,O
Authors,O
.,O
"

",O
DOI,O
:,O
10.15252,O
embr.201949473,O
"
",O
PMCID,O
:,O
PMC7001503,O
[,O
Available,O
on,O
20210205,O
],O
"
",O
PMID,O
:,O
31885214,O
"


",O
944,O
.,O
Anal,O
Chim,O
Acta,O
.,O
2020,O
Feb,O
1;1096:1825,O
.,O
doi,O
:,O
10.1016,O
j.aca.2019.10.063,O
.,O
Epub,O
2019,O
"
",O
Oct,O
31,O
.,O
"

",O
Dualmode,O
detection,O
of,O
avian,O
influenza,O
virions,O
(,O
H9N2,O
),O
by,O
ICPMS,O
and,O
fluorescence,O
"
",O
after,O
quantum,O
dot,O
labeling,O
with,O
immunorolling,O
circle,O
amplification,O
.,O
"

",O
Xiao,O
G(1,O
),O
",",O
Chen,O
B(1,O
),O
",",O
He,O
M(1,O
),O
",",O
Hu,O
B(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Analytical,O
Chemistry,O
for,O
Biology,O
and,O
Medicine,O
(,O
Ministry,O
of,O
"
",O
Education,O
),O
",",O
Department,O
of,O
Chemistry,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430072,O
",",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Analytical,O
Chemistry,O
for,O
Biology,O
and,O
Medicine,O
(,O
Ministry,O
of,O
"
",O
Education,O
),O
",",O
Department,O
of,O
Chemistry,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
",",O
430072,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
binhu@whu.edu.cn,O
.,O
"

",O
Avian,O
influenza,O
virus,O
(,O
AIVs,O
),O
",",O
hosted,O
in,O
poultry,O
",",O
are,O
the,O
pathogens,O
of,O
many,O
"
",O
poultry,O
diseases,O
and,O
human,O
infections,O
",",O
which,O
bring,O
huge,O
losses,O
to,O
the,O
poultry,O
"
",O
breeding,O
industry,O
and,O
huge,O
panic,O
to,O
society,O
.,O
Therefore,O
",",O
it,O
is,O
of,O
great,O
"
",O
significance,O
to,O
establish,O
accurate,O
and,O
sensitive,O
detection,O
methods,O
for,O
AIVs,O
.,O
In,O
"
",O
this,O
work,O
",",O
a,O
dualmode,O
detection,O
method,O
based,O
on,O
immunorolling,O
circle,O
"
",O
amplification,O
(,O
immunoRCA,O
),O
and,O
quantum,O
dots,O
(,O
QDs,O
),O
labeling,O
for,O
inductively,O
"
",O
coupled,O
plasma,O
mass,O
spectrometry,O
(,O
ICPMS,O
),O
and,O
fluorescence,O
detection,O
of,O
H9N2,O
AIV,O
"
",O
was,O
developed,O
.,O
The,O
dualmode,O
detection,O
of,O
the,O
QDs,O
by,O
ICPMS,O
and,O
fluorescence,O
is,O
"
",O
used,O
to,O
achieve,O
mutual,O
verification,O
within,O
the,O
analysis,O
results,O
",",O
thus,O
improving,O
"
",O
the,O
accuracy,O
of,O
the,O
method,O
.,O
With,O
the,O
immunoRCA,O
",",O
the,O
sensitivity,O
of,O
the,O
method,O
"
",O
was,O
increased,O
by,O
two,O
orders,O
of,O
magnitude,O
.,O
The,O
limit,O
of,O
detection,O
of,O
the,O
proposed,O
"
",O
method,O
is,O
17,O
â€¯,O
ng,O
â€¯,O
L1,O
and,O
61,O
â€¯,O
ng,O
â€¯,O
L1,O
",",O
and,O
the,O
linear,O
range,O
of,O
the,O
proposed,O
method,O
is,O
"
",O
0.055,O
â€¯,O
ng,O
â€¯,O
mL1,O
and,O
0.15,O
â€¯,O
ng,O
â€¯,O
mL1,O
with,O
ICPMS,O
and,O
fluorescence,O
detection,O
",",O
"
",O
respectively,O
.,O
The,O
relative,O
standard,O
deviation,O
(,O
n,O
â€¯,O
=,O
â€¯,O
7,O
),O
is,O
4.9,O
%,O
with,O
ICPMS,O
"
",O
detection,O
and,O
3.1,O
%,O
with,O
fluorescence,O
detection,O
.,O
Furthermore,O
",",O
the,O
proposed,O
method,O
"
",O
was,O
applied,O
to,O
the,O
analysis,O
of,O
chicken,O
serum,O
samples,O
",",O
no,O
significant,O
different,O
"
",O
was,O
found,O
for,O
two,O
modes,O
detection,O
and,O
the,O
recoveries,O
of,O
the,O
spiking,O
experiments,O
"
",O
are,O
acceptable,O
",",O
indicating,O
that,O
the,O
method,O
has,O
good,O
practical,O
potential,O
for,O
real,O
"
",O
sample,O
analysis,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.aca.2019.10.063,O
"
",O
PMID,O
:,O
31883585,O
"


",O
945,O
.,O
Immunity,O
.,O
2020,O
Jan,O
14;52(1):109122.e6,O
.,O
doi,O
:,O
10.1016,O
j.immuni.2019.11.015,O
.,O
Epub,O
"
",O
2019,O
Dec,O
24,O
.,O
"

",O
Targeting,O
7Dehydrocholesterol,O
Reductase,O
Integrates,O
Cholesterol,O
Metabolism,O
and,O
"
",O
IRF3,O
Activation,O
to,O
Eliminate,O
Infection,O
.,O
"

",O
Xiao,O
J(1,O
),O
",",O
Li,O
W(1,O
),O
",",O
Zheng,O
X(1,O
),O
",",O
Qi,O
L(2,O
),O
",",O
Wang,O
H(3,O
),O
",",O
Zhang,O
C(1,O
),O
",",O
Wan,O
X(4,O
),O
",",O
Zheng,O
"
",O
Y(1,O
),O
",",O
Zhong,O
R(1,O
),O
",",O
Zhou,O
X(1,O
),O
",",O
Lu,O
Y(1,O
),O
",",O
Li,O
Z(5,O
),O
",",O
Qiu,O
Y(1,O
),O
",",O
Liu,O
C(1,O
),O
",",O
Zhang,O
F(2,O
),O
",",O
"
",O
Zhang,O
Y(6,O
),O
",",O
Xu,O
X(7,O
),O
",",O
Yang,O
Z(8,O
),O
",",O
Chen,O
H(4,O
),O
",",O
Zhai,O
Q(3,O
),O
",",O
Wei,O
B(9,O
),O
",",O
Wang,O
H(10,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Cell,O
Biology,O
",",O
Key,O
Laboratory,O
of,O
Systems,O
Biology,O
",",O
CAS,O
"
",O
Center,O
for,O
Excellence,O
in,O
Molecular,O
Cell,O
Science,O
",",O
Shanghai,O
Institute,O
of,O
"
",O
Biochemistry,O
and,O
Cell,O
Biology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
University,O
of,O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
Innovation,O
Center,O
for,O
Cell,O
Signaling,O
Network,O
",",O
Shanghai,O
",",O
"
",O
200031,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Wuhan,O
",",O
China,O
;,O
"
",O
School,O
of,O
Life,O
Sciences,O
",",O
Shanghai,O
University,O
",",O
Shangda,O
Road,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(3)CAS,O
Key,O
Laboratory,O
of,O
Nutrition,O
",",O
Metabolism,O
and,O
Food,O
Safety,O
",",O
CAS,O
Center,O
for,O
"
",O
Excellence,O
in,O
Molecular,O
Cell,O
Sciences,O
",",O
Shanghai,O
Institute,O
of,O
Nutrition,O
and,O
"
",O
Health,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Veterinary,O
Biotechnology,O
",",O
Harbin,O
Veterinary,O
Research,O
"
",O
Institute,O
",",O
Chinese,O
Academy,O
of,O
Agricultural,O
Sciences,O
",",O
Harbin,O
",",O
China,O
.,O
"
",O
(5)Huashan,O
Hospital,O
",",O
Fudan,O
University,O
",",O
Shanghai,O
",",O
China,O
.,O
"
",O
(6)State,O
Key,O
Laboratory,O
of,O
Cell,O
Biology,O
",",O
Key,O
Laboratory,O
of,O
Systems,O
Biology,O
",",O
CAS,O
"
",O
Center,O
for,O
Excellence,O
in,O
Molecular,O
Cell,O
Science,O
",",O
Shanghai,O
Institute,O
of,O
"
",O
Biochemistry,O
and,O
Cell,O
Biology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
University,O
of,O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
Innovation,O
Center,O
for,O
Cell,O
Signaling,O
Network,O
",",O
Shanghai,O
",",O
"
",O
200031,O
",",O
China,O
;,O
Division,O
of,O
Immunology,O
",",O
Department,O
of,O
Microbiology,O
and,O
"
",O
Immunobiology,O
",",O
Harvard,O
Medical,O
School,O
",",O
77,O
Avenue,O
Louis,O
Pasteur,O
",",O
Boston,O
",",O
MA,O
2115,O
",",O
"
",O
USA,O
.,O
"
",O
(7)State,O
Key,O
Laboratory,O
of,O
Cell,O
Biology,O
",",O
Key,O
Laboratory,O
of,O
Systems,O
Biology,O
",",O
CAS,O
"
",O
Center,O
for,O
Excellence,O
in,O
Molecular,O
Cell,O
Science,O
",",O
Shanghai,O
Institute,O
of,O
"
",O
Biochemistry,O
and,O
Cell,O
Biology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
University,O
of,O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
Innovation,O
Center,O
for,O
Cell,O
Signaling,O
Network,O
",",O
Shanghai,O
",",O
"
",O
200031,O
",",O
China,O
;,O
Experimental,O
Immunology,O
Branch,O
",",O
National,O
Cancer,O
Institute,O
",",O
US,O
"
",O
National,O
Institutes,O
of,O
Health,O
",",O
Bethesda,O
",",O
Maryland,O
",",O
USA,O
.,O
"
",O
(8)State,O
Key,O
Laboratory,O
of,O
Pharmaceutical,O
Biotechnology,O
and,O
MOE,O
Key,O
Laboratory,O
of,O
"
",O
Model,O
Animal,O
for,O
Disease,O
Study,O
",",O
Model,O
Animal,O
Research,O
Center,O
",",O
Nanjing,O
Biomedical,O
"
",O
Research,O
Institute,O
",",O
Nanjing,O
University,O
",",O
Nanjing,O
210061,O
",",O
China,O
.,O
"
",O
(9)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Wuhan,O
",",O
China,O
;,O
"
",O
School,O
of,O
Life,O
Sciences,O
",",O
Shanghai,O
University,O
",",O
Shangda,O
Road,O
",",O
Shanghai,O
",",O
China,O
;,O
"
",O
Cancer,O
Center,O
",",O
Shanghai,O
Tenth,O
People,O
's,O
Hospital,O
",",O
Tongji,O
University,O
",",O
School,O
of,O
"
",O
Medicine,O
",",O
Shanghai,O
200072,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
weibinwhy@shu.edu.cn,O
.,O
"
",O
(10)State,O
Key,O
Laboratory,O
of,O
Cell,O
Biology,O
",",O
Key,O
Laboratory,O
of,O
Systems,O
Biology,O
",",O
CAS,O
"
",O
Center,O
for,O
Excellence,O
in,O
Molecular,O
Cell,O
Science,O
",",O
Shanghai,O
Institute,O
of,O
"
",O
Biochemistry,O
and,O
Cell,O
Biology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
University,O
of,O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
Innovation,O
Center,O
for,O
Cell,O
Signaling,O
Network,O
",",O
Shanghai,O
",",O
"
",O
200031,O
",",O
China,O
;,O
Cancer,O
Center,O
",",O
Shanghai,O
Tenth,O
People,O
's,O
Hospital,O
",",O
Tongji,O
"
",O
University,O
",",O
School,O
of,O
Medicine,O
",",O
Shanghai,O
200072,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
"
",O
hongyanwang@sibcb.ac.cn,O
.,O
"

",O
Comment,O
in,O
"
    ",O
Immunity,O
.,O
2020,O
Jan,O
14;52(1):46,O
.,O
"

",O
Recent,O
work,O
suggests,O
that,O
cholesterol,O
metabolism,O
impacts,O
innate,O
immune,O
responses,O
"
",O
against,O
infection,O
.,O
However,O
",",O
the,O
key,O
enzymes,O
or,O
the,O
natural,O
products,O
and,O
"
",O
mechanisms,O
involved,O
are,O
not,O
well,O
elucidated,O
.,O
Here,O
",",O
we,O
have,O
shown,O
that,O
upon,O
DNA,O
"
",O
and,O
RNA,O
viral,O
infection,O
",",O
macrophages,O
reduced,O
7dehydrocholesterol,O
reductase,O
"
",O
(,O
DHCR7,O
),O
expression,O
.,O
DHCR7,O
deficiency,O
or,O
treatment,O
with,O
the,O
natural,O
product,O
"
",O
7dehydrocholesterol,O
(,O
7DHC,O
),O
could,O
specifically,O
promote,O
phosphorylation,O
of,O
IRF3,O
"
",O
(,O
not,O
TBK1,O
),O
and,O
enhance,O
type,O
I,O
interferon,O
(,O
IFNI,O
),O
production,O
in,O
macrophages,O
.,O
We,O
"
",O
further,O
elucidated,O
that,O
viral,O
infection,O
or,O
7DHC,O
treatment,O
enhanced,O
AKT3,O
"
",O
expression,O
and,O
activation,O
.,O
AKT3,O
directly,O
bound,O
and,O
phosphorylated,O
IRF3,O
at,O
Ser385,O
",",O
"
",O
together,O
with,O
TBK1induced,O
phosphorylation,O
of,O
IRF3,O
Ser386,O
",",O
to,O
achieve,O
IRF3,O
"
",O
dimerization,O
.,O
Deletion,O
of,O
DHCR7,O
and,O
Â ,O
the,O
DHCR7,O
inhibitors,O
including,O
AY9944,O
and,O
the,O
"
",O
chemotherapy,O
drug,O
tamoxifen,O
promoted,O
clearance,O
of,O
Zika,O
virus,O
and,O
multiple,O
viruses,O
"
",O
in,O
Â ,O
vitro,O
or,O
in,O
Â ,O
vivo,O
.,O
Taken,O
together,O
",",O
we,O
propose,O
that,O
the,O
DHCR7,O
inhibitors,O
and,O
"
",O
7DHC,O
are,O
potential,O
therapeutics,O
against,O
emerging,O
or,O
highly,O
pathogenic,O
viruses,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Elsevier,O
Inc.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.immuni.2019.11.015,O
"
",O
PMID,O
:,O
31882361,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
946,O
.,O
Fish,O
Shellfish,O
Immunol,O
.,O
2020,O
Feb;97:523530,O
.,O
doi,O
:,O
10.1016,O
j.fsi.2019.12.075,O
.,O
Epub,O
"
",O
2019,O
Dec,O
24,O
.,O
"

",O
Infectious,O
hematopoietic,O
necrosis,O
virus,O
N,O
protein,O
suppresses,O
fish,O
IFN1,O
production,O
"
",O
by,O
targeting,O
the,O
MITA,O
.,O
"

",O
Wang,O
ZX(1,O
),O
",",O
Zhou,O
Y(2,O
),O
",",O
Lu,O
LF(3,O
),O
",",O
Lu,O
XB(3,O
),O
",",O
Ni,O
B(4,O
),O
",",O
Liu,O
MX(5,O
),O
",",O
Guan,O
HX(6,O
),O
",",O
Li,O
"
",O
S(3,O
),O
",",O
Zhang,O
YA(7,O
),O
",",O
Ouyang,O
S(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
;,O
"
",O
Provincial,O
University,O
Key,O
Laboratory,O
of,O
Cellular,O
Stress,O
Response,O
and,O
Metabolic,O
"
",O
Regulation,O
",",O
The,O
Key,O
Laboratory,O
of,O
Innate,O
Immune,O
Biology,O
of,O
Fujian,O
Province,O
",",O
"
",O
Biomedical,O
Research,O
Center,O
of,O
South,O
China,O
",",O
Key,O
Laboratory,O
of,O
OptoElectronic,O
"
",O
Science,O
and,O
Technology,O
for,O
Medicine,O
of,O
the,O
Ministry,O
of,O
Education,O
",",O
College,O
of,O
Life,O
"
",O
Sciences,O
",",O
Fujian,O
Normal,O
University,O
",",O
Fuzhou,O
",",O
350117,O
",",O
China,O
;,O
University,O
of,O
Chinese,O
"
",O
Academy,O
of,O
Science,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(2)Institute,O
of,O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
;,O
"
",O
University,O
of,O
Chinese,O
Academy,O
of,O
Science,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Institute,O
of,O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Provincial,O
University,O
Key,O
Laboratory,O
of,O
Cellular,O
Stress,O
Response,O
and,O
Metabolic,O
"
",O
Regulation,O
",",O
The,O
Key,O
Laboratory,O
of,O
Innate,O
Immune,O
Biology,O
of,O
Fujian,O
Province,O
",",O
"
",O
Biomedical,O
Research,O
Center,O
of,O
South,O
China,O
",",O
Key,O
Laboratory,O
of,O
OptoElectronic,O
"
",O
Science,O
and,O
Technology,O
for,O
Medicine,O
of,O
the,O
Ministry,O
of,O
Education,O
",",O
College,O
of,O
Life,O
"
",O
Sciences,O
",",O
Fujian,O
Normal,O
University,O
",",O
Fuzhou,O
",",O
350117,O
",",O
China,O
;,O
The,O
Public,O
Service,O
"
",O
Platform,O
for,O
Industrialization,O
Development,O
Technology,O
of,O
Marine,O
Biological,O
"
",O
Medicine,O
and,O
Product,O
of,O
State,O
Oceanic,O
Administration,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
"
",O
Fujian,O
Normal,O
University,O
",",O
Fuzhou,O
",",O
350117,O
",",O
China,O
.,O
"
",O
(5)Provincial,O
University,O
Key,O
Laboratory,O
of,O
Cellular,O
Stress,O
Response,O
and,O
Metabolic,O
"
",O
Regulation,O
",",O
The,O
Key,O
Laboratory,O
of,O
Innate,O
Immune,O
Biology,O
of,O
Fujian,O
Province,O
",",O
"
",O
Biomedical,O
Research,O
Center,O
of,O
South,O
China,O
",",O
Key,O
Laboratory,O
of,O
OptoElectronic,O
"
",O
Science,O
and,O
Technology,O
for,O
Medicine,O
of,O
the,O
Ministry,O
of,O
Education,O
",",O
College,O
of,O
Life,O
"
",O
Sciences,O
",",O
Fujian,O
Normal,O
University,O
",",O
Fuzhou,O
",",O
350117,O
",",O
China,O
;,O
Fujian,O
Key,O
Laboratory,O
"
",O
of,O
Special,O
Marine,O
Bioresources,O
Sustainable,O
Utilization,O
",",O
Fujian,O
Normal,O
"
",O
University,O
",",O
Fuzhou,O
",",O
350117,O
",",O
China,O
.,O
"
",O
(6)Provincial,O
University,O
Key,O
Laboratory,O
of,O
Cellular,O
Stress,O
Response,O
and,O
Metabolic,O
"
",O
Regulation,O
",",O
The,O
Key,O
Laboratory,O
of,O
Innate,O
Immune,O
Biology,O
of,O
Fujian,O
Province,O
",",O
"
",O
Biomedical,O
Research,O
Center,O
of,O
South,O
China,O
",",O
Key,O
Laboratory,O
of,O
OptoElectronic,O
"
",O
Science,O
and,O
Technology,O
for,O
Medicine,O
of,O
the,O
Ministry,O
of,O
Education,O
",",O
College,O
of,O
Life,O
"
",O
Sciences,O
",",O
Fujian,O
Normal,O
University,O
",",O
Fuzhou,O
",",O
350117,O
",",O
China,O
;,O
The,O
Public,O
Service,O
"
",O
Platform,O
for,O
Industrialization,O
Development,O
Technology,O
of,O
Marine,O
Biological,O
"
",O
Medicine,O
and,O
Product,O
of,O
State,O
Oceanic,O
Administration,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
"
",O
Fujian,O
Normal,O
University,O
",",O
Fuzhou,O
",",O
350117,O
",",O
China,O
;,O
Fujian,O
Key,O
Laboratory,O
of,O
Special,O
"
",O
Marine,O
Bioresources,O
Sustainable,O
Utilization,O
",",O
Fujian,O
Normal,O
University,O
",",O
Fuzhou,O
",",O
"
",O
350117,O
",",O
China,O
.,O
"
",O
(7)Institute,O
of,O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
;,O
"
",O
Laboratory,O
for,O
Marine,O
Biology,O
and,O
Biotechnology,O
",",O
Pilot,O
National,O
Laboratory,O
for,O
"
",O
Marine,O
Science,O
and,O
Technology,O
(,O
Qingdao,O
),O
",",O
266337,O
",",O
China,O
;,O
State,O
Key,O
Laboratory,O
of,O
"
",O
Aquaculture,O
Microbiology,O
",",O
College,O
of,O
Fisheries,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
yonganzhang@mail.hzau.edu.cn,O
.,O
"
",O
(8)Laboratory,O
for,O
Marine,O
Biology,O
and,O
Biotechnology,O
",",O
Pilot,O
National,O
Laboratory,O
for,O
"
",O
Marine,O
Science,O
and,O
Technology,O
(,O
Qingdao,O
),O
",",O
266337,O
",",O
China,O
;,O
Provincial,O
University,O
Key,O
"
",O
Laboratory,O
of,O
Cellular,O
Stress,O
Response,O
and,O
Metabolic,O
Regulation,O
",",O
The,O
Key,O
"
",O
Laboratory,O
of,O
Innate,O
Immune,O
Biology,O
of,O
Fujian,O
Province,O
",",O
Biomedical,O
Research,O
"
",O
Center,O
of,O
South,O
China,O
",",O
Key,O
Laboratory,O
of,O
OptoElectronic,O
Science,O
and,O
Technology,O
"
",O
for,O
Medicine,O
of,O
the,O
Ministry,O
of,O
Education,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Fujian,O
"
",O
Normal,O
University,O
",",O
Fuzhou,O
",",O
350117,O
",",O
China,O
;,O
The,O
Public,O
Service,O
Platform,O
for,O
"
",O
Industrialization,O
Development,O
Technology,O
of,O
Marine,O
Biological,O
Medicine,O
and,O
"
",O
Product,O
of,O
State,O
Oceanic,O
Administration,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Fujian,O
Normal,O
"
",O
University,O
",",O
Fuzhou,O
",",O
350117,O
",",O
China,O
;,O
Fujian,O
Key,O
Laboratory,O
of,O
Special,O
Marine,O
"
",O
Bioresources,O
Sustainable,O
Utilization,O
",",O
Fujian,O
Normal,O
University,O
",",O
Fuzhou,O
",",O
350117,O
",",O
"
",O
China,O
.,O
"

",O
Interferon,O
(,O
IFN,O
),O
is,O
a,O
vital,O
antiviral,O
factor,O
in,O
host,O
in,O
the,O
early,O
stages,O
after,O
"
",O
the,O
viral,O
invasion,O
.,O
Meanwhile,O
",",O
viruses,O
have,O
to,O
survive,O
by,O
taking,O
advantage,O
of,O
the,O
"
",O
cellular,O
machinery,O
and,O
complete,O
their,O
replication,O
.,O
As,O
a,O
result,O
",",O
viruses,O
evolved,O
"
",O
several,O
immune,O
escape,O
mechanisms,O
to,O
inhibit,O
host,O
IFN,O
expression,O
.,O
However,O
",",O
the,O
"
",O
mechanisms,O
used,O
to,O
escape,O
the,O
host,O
's,O
IFN,O
system,O
are,O
still,O
unclear,O
for,O
infectious,O
"
",O
hematopoietic,O
necrosis,O
virus,O
(,O
IHNV,O
),O
.,O
In,O
this,O
study,O
",",O
we,O
report,O
that,O
the,O
N,O
protein,O
"
",O
of,O
IHNV,O
inhibits,O
IFN1,O
production,O
in,O
rainbow,O
trout,O
by,O
degrading,O
the,O
MITA,O
.,O
Firstly,O
",",O
"
",O
the,O
upregulation,O
of,O
IFN1,O
promoter,O
activity,O
stimulated,O
by,O
poly,O
I,O
:,O
C,O
was,O
suppressed,O
"
",O
by,O
IHNV,O
infection,O
.,O
Consistent,O
with,O
this,O
result,O
",",O
the,O
overexpression,O
of,O
the,O
N,O
"
",O
protein,O
of,O
IHNV,O
blocked,O
the,O
IFN1,O
transcription,O
that,O
was,O
activated,O
by,O
poly,O
I,O
:,O
C,O
and,O
"
",O
MITA,O
.,O
Secondly,O
",",O
MITA,O
was,O
remarkably,O
decreased,O
by,O
the,O
overexpression,O
of,O
N,O
protein,O
"
",O
at,O
the,O
protein,O
level,O
.,O
Further,O
analysis,O
demonstrated,O
that,O
the,O
N,O
protein,O
targeted,O
"
",O
MITA,O
and,O
promoted,O
the,O
ubiquitination,O
of,O
MITA,O
.,O
Taken,O
together,O
",",O
these,O
data,O
"
",O
suggested,O
that,O
the,O
production,O
of,O
rainbow,O
trout,O
IFN1,O
could,O
be,O
suppressed,O
by,O
the,O
N,O
"
",O
protein,O
of,O
IHNV,O
via,O
degrading,O
MITA,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.fsi.2019.12.075,O
"
",O
PMID,O
:,O
31881328,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
The,O
authors,O
"
",O
have,O
no,O
conflicting,O
commercial,O
or,O
financial,O
interest,O
in,O
publishing,O
this,O
paper,O
.,O
"


",O
947,O
.,O
Viruses,O
.,O
2019,O
Dec,O
23;12(1,O
),O
.,O
pii,O
:,O
E22,O
.,O
doi,O
:,O
10.339,O
v12010022,O
.,O
"

",O
Enterovirus,O
71,O
Represses,O
Interleukin,O
EnhancerBinding,O
Factor,O
2,O
Production,O
and,O
"
",O
Nucleus,O
Translocation,O
to,O
Antagonize,O
ILF2,O
Antiviral,O
Effects,O
.,O
"

",O
Jin,O
J(1,O
),O
",",O
Wang,O
W(2,O
),O
",",O
Ai,O
S(1,O
),O
",",O
Liu,O
W(1,O
),O
",",O
Song,O
Y(1,O
),O
",",O
Luo,O
Z(2,O
),O
",",O
Zhang,O
Q(1,O
),O
",",O
Wu,O
K(1,O
),O
",",O
"
",O
Liu,O
Y(1)(2,O
),O
",",O
Wu,O
J(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
430072,O
",",O
China,O
.,O
"
",O
(2)Guangdong,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Institute,O
of,O
Medical,O
Microbiology,O
",",O
Jinan,O
"
",O
University,O
",",O
Guangzhou,O
510632,O
",",O
China,O
.,O
"

",O
Enterovirus,O
71,O
(,O
EV71,O
),O
infection,O
causes,O
handfootmouth,O
disease,O
(,O
HFMD,O
),O
",",O
"
",O
meningoencephalitis,O
",",O
neonatal,O
sepsis,O
",",O
and,O
even,O
fatal,O
encephalitis,O
in,O
children,O
",",O
"
",O
thereby,O
presenting,O
a,O
serious,O
risk,O
to,O
public,O
health,O
.,O
It,O
is,O
important,O
to,O
determine,O
"
",O
the,O
mechanisms,O
underlying,O
the,O
regulation,O
of,O
EV71,O
infection,O
.,O
In,O
this,O
study,O
",",O
we,O
"
",O
initially,O
show,O
that,O
the,O
interleukin,O
enhancerbinding,O
factor,O
2,O
(,O
ILF2,O
),O
reduces,O
EV71,O
"
",O
50,O
%,O
tissue,O
culture,O
infective,O
dose,O
(,O
TCID50,O
),O
and,O
attenuates,O
EV71,O
plaqueformation,O
"
",O
unit,O
(,O
PFU,O
),O
",",O
thereby,O
repressing,O
EV71,O
infection,O
.,O
Microarray,O
data,O
analyses,O
show,O
that,O
"
",O
ILF2,O
mRNA,O
is,O
reduced,O
upon,O
EV71,O
infection,O
.,O
Cellular,O
studies,O
indicate,O
that,O
EV71,O
"
",O
infection,O
represses,O
ILF2,O
mRNA,O
expression,O
and,O
protein,O
production,O
in,O
human,O
leukemic,O
"
",O
monocytes,O
(,O
THP1,O
),O
differentiated,O
macrophages,O
and,O
human,O
rhabdomyosarcoma,O
(,O
RD,O
),O
"
",O
cells,O
.,O
In,O
addition,O
",",O
EV71,O
nonstructural,O
protein,O
2B,O
interacts,O
with,O
ILF2,O
in,O
human,O
"
",O
embryonic,O
kidney,O
(,O
HEK293,O
T,O
),O
cells,O
.,O
Interestingly,O
",",O
in,O
the,O
presence,O
of,O
EV71,O
2B,O
",",O
ILF2,O
"
",O
is,O
translocated,O
from,O
the,O
nucleus,O
to,O
the,O
cytoplasm,O
",",O
and,O
it,O
colocalizes,O
with,O
2B,O
in,O
"
",O
the,O
cytoplasm,O
.,O
Therefore,O
",",O
we,O
present,O
a,O
distinct,O
mechanism,O
by,O
which,O
EV71,O
"
",O
antagonizes,O
ILF2mediated,O
antiviral,O
effects,O
by,O
inhibiting,O
ILF2,O
expression,O
and,O
"
",O
promoting,O
ILF2,O
translocation,O
from,O
the,O
nucleus,O
to,O
the,O
cytoplasm,O
through,O
its,O
2B,O
"
",O
protein,O
.,O
"

",O
DOI,O
:,O
10.339,O
v12010022,O
"
",O
PMCID,O
:,O
PMC7019514,O
"
",O
PMID,O
:,O
31878072,O
"


",O
948,O
.,O
Cell,O
Microbiol,O
.,O
2019,O
Dec,O
26:e13150,O
.,O
doi,O
:,O
10.1111,O
cmi.13150,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Human,O
microRNA30,O
inhibits,O
influenza,O
virus,O
infection,O
by,O
suppressing,O
the,O
"
",O
expression,O
of,O
SOCS1,O
",",O
SOCS3,O
",",O
and,O
NEDD4,O
.,O
"

",O
Lin,O
X(1)(2)(3,O
),O
",",O
Yu,O
S(1)(2,O
),O
",",O
Ren,O
P(1)(2,O
),O
",",O
Sun,O
X(1)(2,O
),O
",",O
Jin,O
M(1)(2)(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Preventive,O
Veterinary,O
Medicine,O
",",O
College,O
of,O
Animal,O
Medicine,O
",",O
"
",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Biotechnology,O
",",O
College,O
of,O
Life,O
Science,O
and,O
Technology,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(4)Key,O
Laboratory,O
of,O
Development,O
of,O
Veterinary,O
Diagnostic,O
Products,O
",",O
Ministry,O
of,O
"
",O
Agriculture,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(5)The,O
Cooperative,O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"

",O
Influenza,O
A,O
virus,O
(,O
IAV,O
),O
has,O
evolved,O
multiple,O
mechanisms,O
to,O
compromise,O
type,O
I,O
"
",O
interferon,O
(,O
IFN,O
),O
responses,O
.,O
The,O
antiviral,O
function,O
of,O
IFN,O
is,O
mainly,O
exerted,O
by,O
"
",O
activating,O
the,O
JAK,O
STAT,O
signalling,O
and,O
subsequently,O
inducing,O
IFNstimulated,O
gene,O
"
",O
(,O
ISG,O
),O
production,O
.,O
However,O
",",O
the,O
mechanism,O
by,O
which,O
IAV,O
combat,O
the,O
type,O
I,O
IFN,O
"
",O
signalling,O
pathway,O
is,O
not,O
fully,O
elucidated,O
.,O
In,O
this,O
study,O
",",O
we,O
explored,O
the,O
roles,O
"
",O
of,O
human,O
microRNAs,O
modulated,O
by,O
IAV,O
infection,O
in,O
type,O
I,O
IFN,O
responses,O
.,O
We,O
"
",O
demonstrated,O
that,O
microRNA30,O
(,O
miR30,O
),O
family,O
members,O
were,O
downregulated,O
by,O
IAV,O
"
",O
infection,O
.,O
Our,O
data,O
showed,O
that,O
the,O
forced,O
expression,O
of,O
miR30,O
family,O
members,O
"
",O
inhibited,O
IAV,O
proliferation,O
",",O
while,O
miR30,O
family,O
member,O
inhibitors,O
promoted,O
IAV,O
"
",O
proliferation,O
.,O
Mechanistically,O
",",O
we,O
found,O
that,O
miR30,O
family,O
members,O
targeted,O
and,O
"
",O
reduced,O
SOCS1,O
and,O
SOCS3,O
expression,O
",",O
and,O
thus,O
relieved,O
their,O
inhibiting,O
effects,O
on,O
"
",O
IFN,O
JAK,O
STAT,O
signalling,O
pathway,O
.,O
In,O
addition,O
",",O
miR30,O
family,O
members,O
inhibited,O
the,O
"
",O
expression,O
of,O
NEDD4,O
",",O
a,O
negative,O
regulator,O
of,O
IFITM3,O
",",O
which,O
is,O
important,O
for,O
host,O
"
",O
defence,O
against,O
influenza,O
viruses,O
.,O
Our,O
findings,O
suggest,O
that,O
IAV,O
utilises,O
a,O
novel,O
"
",O
strategy,O
to,O
restrain,O
host,O
type,O
I,O
IFNmediated,O
antiviral,O
immune,O
responses,O
by,O
"
",O
decreasing,O
the,O
expression,O
of,O
miR30,O
family,O
members,O
",",O
and,O
add,O
a,O
new,O
way,O
to,O
"
",O
understand,O
the,O
mechanism,O
of,O
immune,O
escape,O
caused,O
by,O
influenza,O
viruses,O
.,O
"

",O
Â©,O
2019,O
John,O
Wiley,O
&,O
Sons,O
Ltd.,O
"

",O
DOI,O
:,O
10.1111,O
cmi.13150,O
"
",O
PMID,O
:,O
31876380,O
"


",O
949,O
.,O
Sci,O
Rep.,O
2019,O
Dec,O
24;9(1):19734,O
.,O
doi,O
:,O
10.1038,O
s41598019561226,O
.,O
"

",O
Adaptive,O
amino,O
acid,O
substitutions,O
enable,O
transmission,O
of,O
an,O
H9N2,O
avian,O
influenza,O
"
",O
virus,O
in,O
guinea,O
pigs,O
.,O
"

",O
Lina,O
L(1,O
),O
",",O
Saijuan,O
C(2,O
),O
",",O
Chengyu,O
W(3,O
),O
",",O
Yuefeng,O
L(1,O
),O
",",O
Shishan,O
D(2,O
),O
",",O
Ligong,O
C(2,O
),O
",",O
"
",O
Kangkang,O
G(2,O
),O
",",O
Zhendong,O
G(3,O
),O
",",O
Jiakai,O
L(1,O
),O
",",O
Jianhui,O
Z(1,O
),O
",",O
Qingping,O
L(1,O
),O
",",O
Wenting,O
"
",O
Z(1,O
),O
",",O
Yu,O
S(1,O
),O
",",O
Honglin,O
W(1,O
),O
",",O
Tengfei,O
Z(1,O
),O
",",O
Guoyuan,O
W(1,O
),O
",",O
Jiping,O
Z(4,O
),O
",",O
Chunmao,O
"
",O
Z(3,O
),O
",",O
Meilin,O
J(5,O
),O
",",O
Yuwei,O
G(6,O
),O
",",O
Huabin,O
S(7,O
),O
",",O
Zongzheng,O
Z(8)(9,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Animal,O
Husbandry,O
and,O
Veterinary,O
Sciences,O
",",O
Hubei,O
Academy,O
of,O
"
",O
Agricultural,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Institute,O
of,O
Mountainous,O
Area,O
Research,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Hebei,O
"
",O
Agricultural,O
University,O
",",O
Baoding,O
",",O
71001,O
",",O
Hebei,O
",",O
China,O
.,O
"
",O
(3)Institute,O
of,O
Military,O
Veterinary,O
",",O
Academy,O
of,O
Military,O
Medical,O
Sciences,O
",",O
666,O
"
",O
West,O
Liuying,O
Road,O
",",O
Changchun,O
",",O
130122,O
",",O
Jilin,O
",",O
China,O
.,O
"
",O
(4)Hubei,O
Engineering,O
Research,O
Center,O
of,O
Viral,O
Vector,O
",",O
Wuhan,O
university,O
of,O
"
",O
Bioengineering,O
",",O
430415,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(5)College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(6)Institute,O
of,O
Military,O
Veterinary,O
",",O
Academy,O
of,O
Military,O
Medical,O
Sciences,O
",",O
666,O
"
",O
West,O
Liuying,O
Road,O
",",O
Changchun,O
",",O
130122,O
",",O
Jilin,O
",",O
China,O
.,O
gaoyuwei@gmail.com,O
.,O
"
",O
(7)Institute,O
of,O
Animal,O
Husbandry,O
and,O
Veterinary,O
Sciences,O
",",O
Hubei,O
Academy,O
of,O
"
",O
Agricultural,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
shhb1961@163.com,O
.,O
"
",O
(8)Institute,O
of,O
Animal,O
Husbandry,O
and,O
Veterinary,O
Sciences,O
",",O
Hubei,O
Academy,O
of,O
"
",O
Agricultural,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
329517286@qq.com,O
.,O
"
",O
(9)Institute,O
of,O
Military,O
Veterinary,O
",",O
Academy,O
of,O
Military,O
Medical,O
Sciences,O
",",O
666,O
"
",O
West,O
Liuying,O
Road,O
",",O
Changchun,O
",",O
130122,O
",",O
Jilin,O
",",O
China,O
.,O
329517286@qq.com,O
.,O
"

",O
H9N2,O
is,O
the,O
most,O
prevalent,O
low,O
pathogenic,O
avian,O
influenza,O
virus,O
(,O
LPAIV,O
),O
in,O
"
",O
domestic,O
poultry,O
in,O
the,O
world,O
.,O
Two,O
distinct,O
H9N2,O
poultry,O
lineages,O
",",O
G1like,O
"
",O
(,O
A,O
quail,O
Hong,O
Kong,O
G1,O
97,O
),O
and,O
Y280like,O
(,O
A,O
Duck,O
Hong,O
Kong,O
Y280,O
1997,O
),O
viruses,O
",",O
are,O
"
",O
usually,O
associated,O
with,O
binding,O
affinity,O
for,O
both,O
Î±,O
"2,3",O
and,O
Î±,O
"2,6",O
sialic,O
acid,O
"
",O
receptors,O
(,O
avian,O
and,O
human,O
receptors,O
),O
",",O
raising,O
concern,O
whether,O
these,O
viruses,O
"
",O
possess,O
pandemic,O
potential,O
.,O
To,O
explore,O
the,O
impact,O
of,O
mouse,O
adaptation,O
on,O
the,O
"
",O
transmissibility,O
of,O
a,O
Y280like,O
virus,O
A,O
Chicken,O
Hubei,O
214,O
2017(H9N2,O
),O
(,O
abbreviated,O
"
",O
as,O
WT,O
),O
",",O
we,O
performed,O
serial,O
lungtolung,O
passages,O
of,O
the,O
WT,O
virus,O
in,O
mice,O
.,O
The,O
"
",O
mouseadapted,O
variant,O
(,O
MA,O
),O
exhibited,O
enhanced,O
pathogenicity,O
and,O
advantaged,O
"
",O
transmissibility,O
after,O
passaging,O
in,O
mice,O
.,O
Sequence,O
analysis,O
of,O
the,O
complete,O
"
",O
genomes,O
of,O
the,O
MA,O
virus,O
revealed,O
a,O
total,O
of,O
16,O
amino,O
acid,O
substitutions,O
.,O
These,O
"
",O
mutations,O
distributed,O
across,O
7,O
segments,O
including,O
PB2,O
",",O
PB1,O
",",O
PA,O
",",O
NP,O
",",O
HA,O
",",O
NA,O
and,O
"
",O
NS1,O
genes,O
.,O
Furthermore,O
",",O
we,O
generated,O
a,O
panel,O
of,O
recombinant,O
or,O
mutant,O
H9N2,O
"
",O
viruses,O
using,O
reverse,O
genetics,O
technology,O
and,O
confirmed,O
that,O
the,O
PB2,O
gene,O
"
",O
governing,O
the,O
increased,O
pathogenicity,O
and,O
transmissibility,O
.,O
The,O
combinations,O
of,O
"
",O
340,O
â€‰,O
K,O
and,O
588,O
â€‰,O
V,O
in,O
PB2,O
were,O
important,O
in,O
determining,O
the,O
altered,O
features,O
.,O
Our,O
"
",O
findings,O
elucidate,O
the,O
specific,O
mutations,O
in,O
PB2,O
contribute,O
to,O
the,O
phenotype,O
"
",O
differences,O
and,O
emphasize,O
the,O
importance,O
of,O
monitoring,O
the,O
identified,O
amino,O
acid,O
"
",O
substitutions,O
due,O
to,O
their,O
potential,O
threat,O
to,O
human,O
health,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s41598019561226,O
"
",O
PMCID,O
:,O
PMC6930279,O
"
",O
PMID,O
:,O
31875046,O
"


",O
950,O
.,O
Sci,O
Rep.,O
2019,O
Dec,O
24;9(1):19798,O
.,O
doi,O
:,O
10.1038,O
s41598019563911,O
.,O
"

",O
Microarray,O
analysis,O
reveals,O
the,O
inhibition,O
of,O
intestinal,O
expression,O
of,O
nutrient,O
"
",O
transporters,O
in,O
piglets,O
infected,O
with,O
porcine,O
epidemic,O
diarrhea,O
virus,O
.,O
"

",O
Zhang,O
J(1,O
),O
",",O
Zhao,O
D(1,O
),O
",",O
Yi,O
D(1,O
),O
",",O
Wu,O
M(1,O
),O
",",O
Chen,O
H(1,O
),O
",",O
Wu,O
T(1,O
),O
",",O
Zhou,O
J(1,O
),O
",",O
Li,O
P(1,O
),O
",",O
"
",O
Hou,O
Y(2,O
),O
",",O
Wu,O
G(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Hubei,O
Key,O
Laboratory,O
of,O
Animal,O
Nutrition,O
and,O
Feed,O
Science,O
",",O
Wuhan,O
Polytechnic,O
"
",O
University,O
",",O
Wuhan,O
",",O
430023,O
",",O
China,O
.,O
"
",O
(2)Hubei,O
Key,O
Laboratory,O
of,O
Animal,O
Nutrition,O
and,O
Feed,O
Science,O
",",O
Wuhan,O
Polytechnic,O
"
",O
University,O
",",O
Wuhan,O
",",O
430023,O
",",O
China,O
.,O
houyq@aliyun.com,O
.,O
"
",O
(3)Department,O
of,O
Animal,O
Science,O
",",O
Texas,O
A&M,O
University,O
",",O
College,O
Station,O
",",O
Texas,O
",",O
"
",O
77843,O
",",O
USA,O
.,O
"

",O
Porcine,O
epidemic,O
diarrhea,O
virus,O
(,O
PEDV,O
),O
infection,O
can,O
induce,O
intestinal,O
"
",O
dysfunction,O
",",O
resulting,O
in,O
severe,O
diarrhea,O
and,O
even,O
death,O
",",O
but,O
the,O
mode,O
of,O
action,O
"
",O
underlying,O
these,O
viral,O
effects,O
remains,O
unclear,O
.,O
This,O
study,O
determined,O
the,O
effects,O
"
",O
of,O
PEDV,O
infection,O
on,O
intestinal,O
absorption,O
and,O
the,O
expression,O
of,O
genes,O
for,O
"
",O
nutrient,O
transporters,O
via,O
biochemical,O
tests,O
and,O
microarray,O
analysis,O
.,O
Sixteen,O
"
",O
7dayold,O
healthy,O
piglets,O
fed,O
a,O
milk,O
replacer,O
were,O
randomly,O
allocated,O
to,O
one,O
of,O
"
",O
two,O
groups,O
.,O
After,O
5day,O
adaption,O
",",O
piglets,O
(,O
n,O
â€‰,O
=,O
â€‰,O
8,O
group,O
),O
were,O
orally,O
administrated,O
"
",O
with,O
either,O
sterile,O
saline,O
or,O
PEDV,O
(,O
the,O
strain,O
from,O
Yunnan,O
province,O
),O
at,O
104.5,O
"
",O
TCID50,O
(,O
50,O
%,O
tissue,O
culture,O
infectious,O
dose,O
),O
per,O
pig,O
.,O
All,O
pigs,O
were,O
orally,O
infused,O
"
",O
Dxylose,O
(,O
0.1,O
â€‰,O
g,O
kg,O
BW,O
),O
on,O
day,O
5,O
post,O
PEDV,O
or,O
saline,O
administration,O
.,O
One,O
hour,O
"
",O
later,O
",",O
jugular,O
vein,O
blood,O
samples,O
as,O
well,O
as,O
intestinal,O
samples,O
were,O
collected,O
"
",O
for,O
further,O
analysis,O
.,O
In,O
comparison,O
with,O
the,O
control,O
group,O
",",O
PEDV,O
infection,O
"
",O
increased,O
diarrhea,O
incidence,O
",",O
blood,O
diamine,O
oxidase,O
activity,O
",",O
and,O
iFABP,O
level,O
",",O
"
",O
while,O
reducing,O
growth,O
and,O
plasma,O
Dxylose,O
concentration,O
in,O
piglets,O
.,O
Moreover,O
",",O
"
",O
PEDV,O
infection,O
altered,O
plasma,O
and,O
jejunal,O
amino,O
acid,O
profiles,O
",",O
and,O
decreased,O
the,O
"
",O
expression,O
of,O
aquaporins,O
and,O
amino,O
acid,O
transporters,O
(,O
Ltype,O
amino,O
acid,O
"
",O
transporter,O
1,O
",",O
sodiumindependent,O
amino,O
acid,O
transporter,O
",",O
B(,O
Â°,O
",+)type",O
amino,O
acid,O
"
",O
transport,O
protein,O
",",O
sodiumdependent,O
neutral,O
amino,O
acid,O
transporter,O
1,O
",",O
"
",O
sodiumdependent,O
glutamate,O
aspartate,O
transporter,O
3,O
",",O
and,O
peptide,O
transporter,O
(,O
1,O
),O
",",O
"
",O
lipid,O
transport,O
and,O
metabolismrelated,O
genes,O
(,O
lipoprotein,O
lipase,O
",",O
apolipoprotein,O
"
",O
A1,O
",",O
apolipoprotein,O
A4,O
",",O
apolipoprotein,O
C2,O
",",O
solute,O
carrier,O
family,O
27,O
member,O
2,O
",",O
"
",O
solute,O
carrier,O
family,O
27,O
member,O
4,O
",",O
fatty,O
acid,O
synthase,O
",",O
and,O
longchain,O
acylCoA,O
"
",O
synthetase,O
(,O
3,O
),O
",",O
and,O
glucose,O
transport,O
genes,O
(,O
glucose,O
transporter2,O
and,O
insulin,O
"
",O
receptor,O
),O
in,O
the,O
jejunum,O
.,O
However,O
",",O
PEDV,O
administration,O
increased,O
mRNA,O
levels,O
for,O
"
",O
phosphoenolpyruvate,O
carboxykinase,O
1,O
",",O
argininosuccinate,O
synthase,O
1,O
",",O
sodium,O
glucose,O
"
",O
cotransporter1,O
",",O
and,O
cystic,O
fibrosis,O
transmembrane,O
conductance,O
regulator,O
in,O
the,O
"
",O
jejunum,O
.,O
Collectively,O
",",O
these,O
comprehensive,O
results,O
indicate,O
that,O
PEDV,O
infection,O
"
",O
induces,O
intestinal,O
injury,O
and,O
inhibits,O
the,O
expression,O
of,O
genes,O
encoding,O
for,O
"
",O
nutrient,O
transporters,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s41598019563911,O
"
",O
PMCID,O
:,O
PMC6930262,O
"
",O
PMID,O
:,O
31875021,O
"


",O
951,O
.,O
Fish,O
Shellfish,O
Immunol,O
.,O
2020,O
Feb;97:375381,O
.,O
doi,O
:,O
10.1016,O
j.fsi.2019.12.067,O
.,O
Epub,O
"
",O
2019,O
Dec,O
23,O
.,O
"

",O
Autophagy,O
induced,O
by,O
infectious,O
pancreatic,O
necrosis,O
virus,O
promotes,O
its,O
"
",O
multiplication,O
in,O
the,O
Chinook,O
salmon,O
embryo,O
cell,O
line,O
CHSE214,O
.,O
"

",O
Dong,O
Y(1,O
),O
",",O
Zhao,O
J(2,O
),O
",",O
Chen,O
X(3,O
),O
",",O
Liu,O
M(4,O
),O
",",O
Ren,O
G(5,O
),O
",",O
Lu,O
T(6,O
),O
",",O
Shao,O
Y(7,O
),O
",",O
Xu,O
L(8,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Laboratory,O
of,O
Fish,O
Diseases,O
",",O
Department,O
of,O
Aquaculture,O
",",O
Heilongjiang,O
River,O
"
",O
Fisheries,O
Research,O
Institute,O
",",O
Chinese,O
Academy,O
of,O
Fishery,O
Sciences,O
",",O
Harbin,O
",",O
"
",O
150070,O
",",O
PR,O
China,O
;,O
National,O
Demonstration,O
Center,O
for,O
Experimental,O
Fisheries,O
"
",O
Sciences,O
Education,O
",",O
Shanghai,O
Ocean,O
University,O
",",O
Shanghai,O
",",O
201306,O
",",O
PR,O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
1909662504@qq.com,O
.,O
"
",O
(2)Laboratory,O
of,O
Fish,O
Diseases,O
",",O
Department,O
of,O
Aquaculture,O
",",O
Heilongjiang,O
River,O
"
",O
Fisheries,O
Research,O
Institute,O
",",O
Chinese,O
Academy,O
of,O
Fishery,O
Sciences,O
",",O
Harbin,O
",",O
"
",O
150070,O
",",O
PR,O
China,O
.,O
Electronic,O
address,O
:,O
zhaojingzhuang@hrfri.ac.cn,O
.,O
"
",O
(3)Technology,O
Center,O
of,O
Wuhan,O
Customs,O
",",O
Wuhan,O
",",O
430050,O
",",O
PR,O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
xychen@126.com,O
.,O
"
",O
(4)Laboratory,O
of,O
Fish,O
Diseases,O
",",O
Department,O
of,O
Aquaculture,O
",",O
Heilongjiang,O
River,O
"
",O
Fisheries,O
Research,O
Institute,O
",",O
Chinese,O
Academy,O
of,O
Fishery,O
Sciences,O
",",O
Harbin,O
",",O
"
",O
150070,O
",",O
PR,O
China,O
.,O
Electronic,O
address,O
:,O
446048847@qq.com,O
.,O
"
",O
(5)Laboratory,O
of,O
Fish,O
Diseases,O
",",O
Department,O
of,O
Aquaculture,O
",",O
Heilongjiang,O
River,O
"
",O
Fisheries,O
Research,O
Institute,O
",",O
Chinese,O
Academy,O
of,O
Fishery,O
Sciences,O
",",O
Harbin,O
",",O
"
",O
150070,O
",",O
PR,O
China,O
.,O
Electronic,O
address,O
:,O
renguangming@hrfri.ac.cn,O
.,O
"
",O
(6)Laboratory,O
of,O
Fish,O
Diseases,O
",",O
Department,O
of,O
Aquaculture,O
",",O
Heilongjiang,O
River,O
"
",O
Fisheries,O
Research,O
Institute,O
",",O
Chinese,O
Academy,O
of,O
Fishery,O
Sciences,O
",",O
Harbin,O
",",O
"
",O
150070,O
",",O
PR,O
China,O
.,O
Electronic,O
address,O
:,O
lutongyan@hotmail.com,O
.,O
"
",O
(7)Laboratory,O
of,O
Fish,O
Diseases,O
",",O
Department,O
of,O
Aquaculture,O
",",O
Heilongjiang,O
River,O
"
",O
Fisheries,O
Research,O
Institute,O
",",O
Chinese,O
Academy,O
of,O
Fishery,O
Sciences,O
",",O
Harbin,O
",",O
"
",O
150070,O
",",O
PR,O
China,O
.,O
Electronic,O
address,O
:,O
shaoyizhi@hrfri.ac.cn,O
.,O
"
",O
(8)Laboratory,O
of,O
Fish,O
Diseases,O
",",O
Department,O
of,O
Aquaculture,O
",",O
Heilongjiang,O
River,O
"
",O
Fisheries,O
Research,O
Institute,O
",",O
Chinese,O
Academy,O
of,O
Fishery,O
Sciences,O
",",O
Harbin,O
",",O
"
",O
150070,O
",",O
PR,O
China,O
.,O
Electronic,O
address,O
:,O
xuliming@hrfri.ac.cn,O
.,O
"

",O
Infectious,O
pancreatic,O
necrosis,O
virus,O
(,O
IPNV,O
),O
is,O
a,O
common,O
pathogen,O
that,O
causes,O
huge,O
"
",O
economic,O
losses,O
for,O
the,O
salmonid,O
aquaculture,O
industry,O
.,O
Autophagy,O
plays,O
an,O
"
",O
important,O
regulatory,O
role,O
in,O
the,O
invasion,O
of,O
pathogenic,O
microorganisms,O
.,O
In,O
this,O
"
",O
study,O
",",O
we,O
explored,O
the,O
relationship,O
between,O
IPNV,O
infection,O
and,O
autophagy,O
in,O
"
",O
Chinook,O
salmon,O
embryo,O
(,O
CHSE214,O
),O
cells,O
using,O
standard,O
methods,O
.,O
Transmission,O
"
",O
electron,O
microscopy,O
showed,O
that,O
IPNV,O
infection,O
produced,O
typical,O
structures,O
of,O
"
",O
autophagosomes,O
in,O
CHSE214,O
Â ,O
cells,O
.,O
Transformation,O
of,O
microtubuleassociated,O
"
",O
protein,O
1,O
light,O
chain,O
3,O
(LC3)I,O
to,O
LC3II,O
protein,O
",",O
a,O
marker,O
of,O
autophagy,O
",",O
was,O
"
",O
observed,O
in,O
IPNVinfected,O
cells,O
using,O
confocal,O
fluorescence,O
microscopy,O
and,O
"
",O
western,O
blot,O
analysis,O
.,O
Western,O
blotting,O
also,O
showed,O
that,O
expression,O
of,O
the,O
"
",O
autophagy,O
substrate,O
p62,O
was,O
significantly,O
decreased,O
in,O
IPNVinfected,O
cells,O
.,O
The,O
"
",O
influence,O
of,O
autophagy,O
on,O
IPNV,O
multiplication,O
was,O
further,O
clarified,O
with,O
cell,O
"
",O
culture,O
experiments,O
using,O
autophagy,O
inducer,O
rapamycin,O
and,O
autophagy,O
inhibitor,O
"
",O
3methyladenine,O
.,O
Rapamycin,O
promoted,O
IPNV,O
multiplication,O
at,O
both,O
the,O
nucleic,O
acid,O
"
",O
and,O
protein,O
levels,O
",",O
which,O
led,O
to,O
higher,O
IPNV,O
yields,O
;,O
3methyladenine,O
treatment,O
"
",O
had,O
the,O
opposite,O
effect,O
.,O
This,O
study,O
has,O
demonstrated,O
that,O
IPNV,O
can,O
induce,O
"
",O
autophagy,O
",",O
and,O
that,O
autophagy,O
promotes,O
the,O
multiplication,O
of,O
IPNV,O
in,O
"
",O
CHSE214,O
Â ,O
cells,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.fsi.2019.12.067,O
"
",O
PMID,O
:,O
31874298,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Declaration,O
of,O
competing,O
interest,O
All,O
authors,O
"
",O
declare,O
that,O
no,O
conflicts,O
of,O
interest,O
exist,O
.,O
"


",O
952,O
.,O
Antimicrob,O
Agents,O
Chemother,O
.,O
2020,O
Feb,O
21;64(3,O
),O
.,O
pii,O
:,O
e0237319,O
.,O
doi,O
:,O
"
",O
10.1128,O
AAC.0237319,O
.,O
Print,O
2020,O
Feb,O
21,O
.,O
"

",O
Screening,O
of,O
Natural,O
Extracts,O
for,O
Inhibitors,O
against,O
Japanese,O
Encephalitis,O
Virus,O
"
",O
Infection,O
.,O
"

",O
Guo,O
J(1)(2,O
),O
",",O
Jia,O
X(1)(2,O
),O
",",O
Liu,O
Y(1,O
),O
",",O
Wang,O
S(1)(2,O
),O
",",O
Cao,O
J(1)(2,O
),O
",",O
Zhang,O
B(1)(2,O
),O
",",O
"
",O
Xiao,O
G(3)(2,O
),O
",",O
Wang,O
W(3)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
for,O
"
",O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)University,O
of,O
the,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
for,O
"
",O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
"
",O
xiaogf@wh.iov.cn,O
wangwei@wh.iov.cn,O
.,O
"

",O
The,O
mosquitoborne,O
Japanese,O
encephalitis,O
virus,O
(,O
JEV,O
),O
causes,O
serious,O
illness,O
"
",O
worldwide,O
that,O
is,O
associated,O
with,O
high,O
morbidity,O
and,O
mortality,O
.,O
Currently,O
",",O
there,O
"
",O
are,O
no,O
effective,O
drugs,O
approved,O
for,O
the,O
treatment,O
of,O
JEV,O
infection,O
.,O
"
",O
Drugrepurposing,O
screening,O
is,O
an,O
alternative,O
approach,O
to,O
discover,O
potential,O
"
",O
antiviral,O
agents,O
.,O
In,O
this,O
study,O
",",O
highcontent,O
screening,O
(,O
HCS,O
),O
of,O
a,O
natural,O
"
",O
extracts,O
library,O
was,O
performed,O
",",O
and,O
two,O
hit,O
FDAapproved,O
Na+,O
K+ATPase,O
"
",O
inhibitors,O
",",O
ouabain,O
and,O
digoxin,O
",",O
were,O
identified,O
as,O
having,O
robust,O
efficiency,O
"
",O
against,O
JEV,O
infection,O
with,O
the,O
selectivity,O
indexes,O
over,O
1000,O
.,O
The,O
results,O
"
",O
indicated,O
that,O
ouabain,O
and,O
digoxin,O
blocked,O
the,O
JEV,O
infection,O
at,O
the,O
replication,O
"
",O
stage,O
by,O
targeting,O
the,O
Na+,O
K+ATPase,O
.,O
Furthermore,O
",",O
it,O
was,O
proven,O
that,O
ouabain,O
"
",O
significantly,O
reduced,O
the,O
morbidity,O
and,O
mortality,O
caused,O
by,O
JEV,O
in,O
a,O
BALB,O
c,O
mouse,O
"
",O
model,O
.,O
This,O
work,O
demonstrated,O
that,O
Na+,O
K+ATPase,O
could,O
serve,O
as,O
the,O
target,O
of,O
"
",O
treatment,O
of,O
JEV,O
infection,O
",",O
and,O
ouabain,O
has,O
the,O
potential,O
to,O
be,O
developed,O
as,O
an,O
"
",O
effective,O
antiJEV,O
drug,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
Guo,O
et,O
al.,O
"

",O
DOI,O
:,O
10.1128,O
AAC.0237319,O
"
",O
PMCID,O
:,O
PMC7038234,O
"
",O
PMID,O
:,O
31871089,O
"


",O
953,O
.,O
J,O
Am,O
Heart,O
Assoc,O
.,O
2020,O
Jan,O
7;9(1):e014358,O
.,O
doi,O
:,O
10.1161,O
JAHA.119.014358,O
.,O
Epub,O
"
",O
2019,O
Dec,O
24,O
.,O
"

",O
Vaccine,O
Against,O
PCSK9,O
Improved,O
Renal,O
Fibrosis,O
by,O
Regulating,O
Fatty,O
Acid,O
"
",O
Î²Oxidation,O
.,O
"

",O
Wu,O
D(1)(2)(3,O
),O
",",O
Zhou,O
Y(1)(2)(3,O
),O
",",O
Pan,O
Y(1)(2)(3,O
),O
",",O
Li,O
C(1)(2)(3,O
),O
",",O
Wang,O
Y(1)(2)(3,O
),O
",",O
"
",O
Chen,O
F(1)(2)(3,O
),O
",",O
Chen,O
X(1)(2)(3,O
),O
",",O
Yang,O
S(1)(2)(3,O
),O
",",O
Zhou,O
Z(1)(2)(3,O
),O
",",O
Liao,O
"
",O
Y(1)(2)(3,O
),O
",",O
Qiu,O
Z(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Cardiology,O
Union,O
Hospital,O
Tongji,O
Medical,O
College,O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
Wuhan,O
China,O
.,O
"
",O
(2)Institute,O
of,O
Cardiology,O
Union,O
Hospital,O
Tongji,O
Medical,O
College,O
Huazhong,O
"
",O
University,O
of,O
Science,O
and,O
Technology,O
Wuhan,O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Molecular,O
Biological,O
Targeted,O
Therapies,O
of,O
the,O
Ministry,O
of,O
"
",O
Education,O
Union,O
Hospital,O
Tongji,O
Medical,O
College,O
Huazhong,O
University,O
of,O
Science,O
"
",O
and,O
Technology,O
Wuhan,O
China,O
.,O
"

",O
Background,O
Defects,O
in,O
the,O
renal,O
fatty,O
acid,O
Î²oxidation,O
pathway,O
have,O
been,O
"
",O
implicated,O
in,O
the,O
development,O
of,O
renal,O
fibrosis,O
.,O
Our,O
group,O
has,O
developed,O
a,O
"
",O
therapeutic,O
vaccine,O
targeting,O
PCSK9,O
(,O
proprotein,O
convertase,O
subtilisin,O
kexin,O
type,O
"
",O
9,O
),O
",",O
named,O
PCSK9QÎ²003,O
.,O
In,O
this,O
study,O
",",O
we,O
investigated,O
the,O
potential,O
effectiveness,O
"
",O
of,O
the,O
PCSK9QÎ²003,O
vaccine,O
on,O
hypercholesterolemia,O
with,O
renal,O
fibrosis,O
.,O
Methods,O
"
",O
and,O
Results,O
The,O
lowdensity,O
lipoprotein,O
receptor+,O
 ,O
male,O
mice,O
fed,O
with,O
a,O
"
",O
highcholesterol,O
(,O
1,O
%,O
),O
Western,O
diet,O
were,O
randomly,O
assigned,O
into,O
4,O
groups,O
:,O
the,O
sham,O
"
",O
group,O
(,O
or,O
the,O
control,O
group,O
),O
",",O
the,O
phosphatebuffered,O
saline,O
group,O
",",O
the,O
QÎ²,O
"
",O
viruslike,O
particles,O
group,O
and,O
the,O
PCSK9QÎ²003,O
vaccine,O
group,O
.,O
Mice,O
of,O
the,O
"
",O
PCSK9QÎ²003,O
group,O
were,O
injected,O
with,O
the,O
PCSK9QÎ²003,O
vaccine,O
(,O
100,O
Â ,O
Î¼g,O
time,O
),O
every,O
"
",O
2,O
or,O
4,O
Â ,O
weeks,O
.,O
The,O
mice,O
were,O
administered,O
with,O
either,O
unilateral,O
ureteral,O
"
",O
obstruction,O
for,O
2,O
Â ,O
weeks,O
or,O
Nnitrolarginine,O
methyl,O
ester,O
(,O
50,O
Â ,O
mg,O
kg,O
per,O
day,O
),O
for,O
"
",O
6,O
Â ,O
weeks,O
to,O
establish,O
a,O
renal,O
fibrosis,O
model,O
.,O
Compared,O
with,O
the,O
other,O
3,O
groups,O
",",O
"
",O
the,O
PCSK9QÎ²003,O
vaccine,O
obviously,O
decreased,O
total,O
cholesterol,O
and,O
lowdensity,O
"
",O
lipoprotein,O
cholesterol,O
in,O
lowdensity,O
lipoprotein,O
receptor+,O
 ,O
mice,O
with,O
"
",O
hypercholesterolemia,O
.,O
Compared,O
with,O
the,O
phosphatebuffered,O
saline,O
and,O
QÎ²,O
"
",O
viruslike,O
particles,O
groups,O
",",O
the,O
PCSK9QÎ²003,O
vaccine,O
improved,O
hepatic,O
steatosis,O
"
",O
and,O
renal,O
function,O
.,O
Histology,O
analysis,O
showed,O
that,O
the,O
PCSK9QÎ²003,O
vaccine,O
"
",O
significantly,O
ameliorated,O
renal,O
lipid,O
accumulation,O
and,O
renal,O
fibrosis,O
.,O
Moreover,O
",",O
"
",O
the,O
PCSK9QÎ²003,O
vaccine,O
obviously,O
upregulated,O
the,O
expression,O
of,O
lowdensity,O
"
",O
lipoprotein,O
receptor,O
",",O
verylowdensity,O
lipoprotein,O
receptor,O
",",O
sterolregulatory,O
"
",O
element,O
binding,O
protein,O
2,O
",",O
and,O
fatty,O
acid,O
Î²oxidationrelated,O
factors,O
",",O
and,O
"
",O
ameliorated,O
renal,O
fibrosisrelated,O
molecules,O
both,O
in,O
the,O
unilateral,O
ureteral,O
"
",O
obstruction,O
and,O
Nnitrolarginine,O
methyl,O
ester,O
models,O
.,O
Conclusions,O
This,O
study,O
"
",O
suggested,O
that,O
the,O
PCSK9QÎ²003,O
vaccine,O
improved,O
renal,O
lipid,O
accumulation,O
and,O
"
",O
renal,O
fibrosis,O
by,O
regulating,O
fatty,O
acid,O
Î²oxidation,O
",",O
which,O
may,O
provide,O
a,O
"
",O
promising,O
method,O
for,O
treating,O
hypercholesterolemia,O
with,O
renal,O
fibrosis,O
.,O
"

",O
DOI,O
:,O
10.1161,O
JAHA.119.014358,O
"
",O
PMCID,O
:,O
PMC6988173,O
"
",O
PMID,O
:,O
31870234,O
"


",O
954,O
.,O
BMC,O
Infect,O
Dis,O
.,O
2019,O
Dec,O
21;19(1):1076,O
.,O
doi,O
:,O
10.1186,O
s1287901947010,O
.,O
"

",O
Factors,O
affecting,O
HIV,O
counselling,O
and,O
testing,O
among,O
Ethiopian,O
women,O
aged,O
1549,O
.,O
"

",O
Erena,O
AN(1)(2,O
),O
",",O
Shen,O
G(3,O
),O
",",O
Lei,O
P(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Immunology,O
",",O
School,O
of,O
Basic,O
Medicine,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
asfneg@yahoo.com,O
.,O
"
",O
(2)Madawalabu,O
University,O
",",O
College,O
of,O
Medicine,O
and,O
Health,O
Sciences,O
",",O
Bale,O
Goba,O
",",O
"
",O
Ethiopia,O
.,O
asfneg@yahoo.com,O
.,O
"
",O
(3)Department,O
of,O
Immunology,O
",",O
School,O
of,O
Basic,O
Medicine,O
",",O
Tongji,O
Medical,O
College,O
",",O
"
",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
China,O
.,O
"

",O
BACKGROUND,O
:,O
HIV,O
voluntary,O
counseling,O
and,O
testing,O
(,O
VCT,O
),O
is,O
a,O
crucial,O
gateway,O
to,O
"
",O
all,O
strategies,O
related,O
to,O
care,O
",",O
prevention,O
and,O
treatment,O
of,O
human,O
"
",O
immunodeficiency,O
virus,O
(,O
HIV,O
),O
infection,O
.,O
Nevertheless,O
",",O
utilization,O
of,O
voluntary,O
"
",O
counselling,O
and,O
testing,O
(,O
VCT,O
),O
service,O
among,O
adults,O
is,O
very,O
low,O
in,O
Ethiopia,O
.,O
The,O
"
",O
objective,O
of,O
this,O
study,O
is,O
to,O
identify,O
determinants,O
associated,O
with,O
VCT,O
"
",O
utilization,O
among,O
adult,O
women,O
aged,O
1549,O
in,O
Ethiopia,O
.,O
"
",O
METHODS,O
:,O
A,O
crosssectional,O
study,O
was,O
conducted,O
based,O
on,O
data,O
taken,O
from,O
the,O
"
",O
Ethiopian,O
Demographic,O
Health,O
Survey,O
(,O
EDHS,O
),O
2016,O
.,O
Using,O
cluster,O
sampling,O
",",O
14369,O
"
",O
women,O
aged,O
1549,O
â€‰,O
years,O
were,O
selected,O
from,O
all,O
the,O
nine,O
administrative,O
regions,O
and,O
"
",O
two,O
city,O
administrations,O
.,O
Logistic,O
regression,O
was,O
used,O
to,O
analyze,O
factors,O
"
",O
associated,O
with,O
HIV,O
VCT,O
utilization,O
.,O
"
",O
RESULTS,O
:,O
Overall,O
prevalence,O
of,O
ever,O
tested,O
for,O
HIV,O
was,O
53,O
%,O
(,O
95,O
%,O
CI,O
",",O
52,O
",",O
54,O
),O
.,O
Aged,O
"
",O
2044,O
",",O
ever,O
married,O
",",O
being,O
at,O
higher,O
socio,O
economic,O
position,O
(,O
SEP,O
),O
and,O
having,O
"
",O
risky,O
sexual,O
behavior,O
were,O
factors,O
which,O
are,O
positively,O
associated,O
with,O
VCT,O
"
",O
utilization,O
.,O
Being,O
Muslims,O
in,O
urban,O
and,O
protestants,O
in,O
rural,O
were,O
factors,O
"
",O
significantly,O
and,O
negatively,O
associated,O
with,O
VCT,O
utilization,O
.,O
Those,O
who,O
had,O
"
",O
stigmatizing,O
attitude,O
both,O
in,O
urban,O
and,O
rural,O
and,O
who,O
had,O
comprehensive,O
knowledge,O
"
",O
in,O
rural,O
were,O
less,O
likely,O
to,O
utilize,O
VCT,O
service,O
.,O
"
",O
CONCLUSION,O
:,O
VCT,O
utilization,O
among,O
women,O
in,O
Ethiopia,O
is,O
demonstrating,O
better,O
"
",O
improvement,O
in,O
recent,O
years,O
.,O
However,O
",",O
stigmatizing,O
attitude,O
continued,O
to,O
be,O
among,O
"
",O
the,O
major,O
factors,O
",",O
which,O
are,O
negatively,O
affecting,O
VCT,O
uptake,O
among,O
women,O
in,O
"
",O
Ethiopia,O
.,O
Concerted,O
efforts,O
should,O
be,O
made,O
by,O
all,O
stakeholders,O
to,O
mitigate,O
"
",O
stigma,O
",",O
improve,O
socio,O
economic,O
inequities,O
and,O
increase,O
awareness,O
on,O
the,O
benefit,O
"
",O
of,O
VCT,O
in,O
controlling,O
HIV,O
in,O
the,O
society,O
.,O
In,O
this,O
aspect,O
",",O
the,O
role,O
of,O
religious,O
"
",O
leader,O
",",O
schools,O
",",O
health,O
extension,O
workers,O
and,O
community,O
leaders,O
should,O
not,O
be,O
"
",O
undermined,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s1287901947010,O
"
",O
PMCID,O
:,O
PMC6925845,O
"
",O
PMID,O
:,O
31864297,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
955,O
.,O
Nucleic,O
Acids,O
Res,O
.,O
2020,O
Feb,O
20;48(3):13921405,O
.,O
doi,O
:,O
10.1093,O
nar,O
gkz1170,O
.,O
"

",O
A,O
nucleobasebinding,O
pocket,O
in,O
a,O
viral,O
RNAdependent,O
RNA,O
polymerase,O
contributes,O
"
",O
to,O
elongation,O
complex,O
stability,O
.,O
"

",O
Shi,O
W(1)(2,O
),O
",",O
Ye,O
HQ(1,O
),O
",",O
Deng,O
CL(1,O
),O
",",O
Li,O
R(1)(2,O
),O
",",O
Zhang,O
B(1,O
),O
",",O
Gong,O
P(1)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
No.44,O
"
",O
Xiao,O
Hong,O
Shan,O
",",O
Wuhan,O
",",O
Hubei,O
Â ,O
430071,O
",",O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
Â ,O
100049,O
",",O
China,O
.,O
"
",O
(3)Drug,O
Discovery,O
Center,O
for,O
Infectious,O
Diseases,O
",",O
Nankai,O
University,O
",",O
Tianjin,O
"
",O
300350,O
",",O
China,O
.,O
"

",O
The,O
enterovirus,O
71,O
(,O
EV71,O
),O
3Dpol,O
is,O
an,O
RNAdependent,O
RNA,O
polymerase,O
(,O
RdRP,O
),O
that,O
"
",O
plays,O
the,O
central,O
role,O
in,O
the,O
viral,O
genome,O
replication,O
",",O
and,O
is,O
an,O
important,O
"
",O
target,O
in,O
antiviral,O
studies,O
.,O
Here,O
",",O
we,O
report,O
a,O
crystal,O
structure,O
of,O
EV71,O
3Dpol,O
"
",O
elongation,O
complex,O
(,O
EC,O
),O
at,O
1.8,O
Ã…,O
resolution,O
.,O
The,O
structure,O
reveals,O
that,O
the,O
"
",O
5'end,O
guanosine,O
of,O
the,O
downstream,O
RNA,O
template,O
interacts,O
with,O
a,O
fingers,O
domain,O
"
",O
pocket,O
",",O
with,O
the,O
base,O
sandwiched,O
by,O
H44,O
and,O
R277,O
side,O
chains,O
through,O
hydrophobic,O
"
",O
stacking,O
interactions,O
",",O
and,O
these,O
interactions,O
are,O
still,O
maintained,O
after,O
one,O
"
",O
incrystal,O
translocation,O
event,O
induced,O
by,O
nucleotide,O
incorporation,O
",",O
implying,O
that,O
"
",O
the,O
pocket,O
could,O
regulate,O
the,O
functional,O
properties,O
of,O
the,O
polymerase,O
by,O
"
",O
interacting,O
with,O
RNA,O
.,O
When,O
mutated,O
",",O
residue,O
R277,O
showed,O
an,O
impact,O
on,O
virus,O
"
",O
proliferation,O
in,O
virological,O
studies,O
with,O
residue,O
H44,O
having,O
a,O
synergistic,O
"
",O
effect,O
.,O
In,O
vitro,O
biochemical,O
data,O
further,O
suggest,O
that,O
mutations,O
at,O
these,O
two,O
"
",O
sites,O
affect,O
RNA,O
binding,O
",",O
EC,O
stability,O
",",O
but,O
not,O
polymerase,O
catalytic,O
rate,O
(,O
kcat,O
),O
"
",O
and,O
apparent,O
NTP,O
affinity,O
(,O
KM,O
",",O
NTP,O
),O
.,O
We,O
propose,O
that,O
",",O
although,O
rarely,O
captured,O
by,O
"
",O
crystallography,O
",",O
similar,O
surface,O
pocket,O
interaction,O
with,O
nucleobase,O
may,O
commonly,O
"
",O
exist,O
in,O
nucleic,O
acid,O
motor,O
enzymes,O
to,O
facilitate,O
their,O
processivity,O
.,O
Potential,O
"
",O
applications,O
in,O
antiviral,O
drug,O
and,O
vaccine,O
development,O
are,O
also,O
discussed,O
.,O
"

",O
Â©,O
The,O
Author(s,O
),O
2019,O
.,O
Published,O
by,O
Oxford,O
University,O
Press,O
on,O
behalf,O
of,O
Nucleic,O
"
",O
Acids,O
Research,O
.,O
"

",O
DOI,O
:,O
10.1093,O
nar,O
gkz1170,O
"
",O
PMCID,O
:,O
PMC7026628,O
"
",O
PMID,O
:,O
31863580,O
"


",O
956,O
.,O
J,O
Gen,O
Virol,O
.,O
2019,O
Dec,O
20,O
.,O
doi,O
:,O
10.1099,O
jgv.0.001376,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Nuclear,O
localization,O
of,O
Zika,O
virus,O
NS5,O
contributes,O
to,O
suppression,O
of,O
type,O
I,O
"
",O
interferon,O
production,O
and,O
response,O
.,O
"

",O
Zhao,O
Z(1)(2)(3,O
),O
",",O
Tao,O
M(1)(2)(3,O
),O
",",O
Han,O
W(2,O
),O
",",O
Fan,O
Z(1)(2)(3,O
),O
",",O
Imran,O
M(1)(2)(3,O
),O
",",O
Cao,O
"
",O
S(1)(2)(3,O
),O
",",O
Ye,O
J(1)(3)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)The,O
Cooperative,O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
PR,O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
College,O
of,O
"
",O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
PR,O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
430070,O
",",O
PR,O
China,O
.,O
"

",O
Zika,O
virus,O
(,O
ZIKV,O
),O
is,O
an,O
emerging,O
mosquitoborne,O
flavivirus,O
",",O
which,O
caused,O
an,O
"
",O
unprecedented,O
epidemic,O
in,O
Latin,O
America,O
.,O
Among,O
all,O
viral,O
nonstructural,O
proteins,O
"
",O
in,O
flavivirus,O
",",O
NS5,O
is,O
the,O
most,O
highly,O
conserved,O
and,O
has,O
multiple,O
crucial,O
"
",O
functions,O
",",O
including,O
participating,O
in,O
viral,O
RNA,O
replication,O
and,O
suppressing,O
host,O
"
",O
innate,O
immunity,O
.,O
Although,O
ZIKV,O
NS5,O
prominently,O
localizes,O
in,O
the,O
nucleus,O
during,O
"
",O
infection,O
",",O
its,O
specific,O
nuclear,O
localization,O
signal,O
(,O
NLS,O
),O
",",O
and,O
its,O
role,O
in,O
viral,O
"
",O
replication,O
and,O
pathogenesis,O
remain,O
controversial,O
.,O
Here,O
",",O
we,O
identified,O
aa,O
1190,O
"
",O
and,O
aa,O
370406,O
regions,O
that,O
contain,O
NLSs,O
",",O
which,O
are,O
critical,O
for,O
nuclear,O
"
",O
localization,O
of,O
ZIKV,O
NS5,O
.,O
Further,O
experiments,O
demonstrated,O
that,O
nuclear,O
"
",O
localization,O
of,O
ZIKV,O
NS5,O
predominantly,O
participates,O
in,O
suppression,O
of,O
interferon,O
"
",O
regulatory,O
factor,O
3,O
(IRF3)mediated,O
activation,O
of,O
type,O
I,O
IFN,O
(,O
IFNI,O
),O
"
",O
transcription,O
and,O
inhibition,O
of,O
IFNI,O
downstream,O
response,O
independent,O
of,O
its,O
"
",O
effect,O
on,O
signal,O
transducers,O
and,O
activators,O
of,O
transcription,O
2,O
(,O
STAT2,O
),O
"
",O
degradation,O
.,O
These,O
results,O
suggest,O
that,O
subcellular,O
localization,O
of,O
NS5,O
is,O
"
",O
important,O
for,O
its,O
function,O
on,O
innate,O
immune,O
suppression,O
",",O
which,O
provides,O
new,O
"
",O
insight,O
into,O
ZIKV,O
pathogenesis,O
.,O
"

",O
DOI,O
:,O
10.1099,O
jgv.0.001376,O
"
",O
PMID,O
:,O
31859616,O
"


",O
957,O
.,O
Emerg,O
Microbes,O
Infect,O
.,O
2020,O
Dec;9(1):2031,O
.,O
doi,O
:,O
10.108,O
22221751.2019.1701391,O
.,O
"

",O
Genetic,O
manipulation,O
of,O
porcine,O
deltacoronavirus,O
reveals,O
insights,O
into,O
NS6,O
and,O
"
",O
NS7,O
functions,O
:,O
a,O
novel,O
strategy,O
for,O
vaccine,O
design,O
.,O
"

",O
Zhang,O
M(1)(2,O
),O
",",O
Li,O
W(1)(2,O
),O
",",O
Zhou,O
P(1)(2,O
),O
",",O
Liu,O
D(1)(2,O
),O
",",O
Luo,O
R(1)(2,O
),O
",",O
"
",O
Jongkaewwattana,O
A(3,O
),O
",",O
He,O
Q(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
the,O
"
",O
Cooperative,O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Wuhan,O
",",O
People,O
's,O
"
",O
Republic,O
of,O
China,O
.,O
"
",O
(3)Virology,O
and,O
Cell,O
Technology,O
Laboratory,O
",",O
National,O
Center,O
for,O
Genetic,O
"
",O
Engineering,O
and,O
Biotechnology,O
(,O
BIOTEC,O
),O
",",O
National,O
Science,O
and,O
Technology,O
"
",O
Development,O
Agency,O
(,O
NSTDA,O
),O
",",O
Pathum,O
Thani,O
",",O
Thailand,O
.,O
"

",O
Porcine,O
deltacoronavirus,O
(,O
PDCoV,O
),O
is,O
an,O
emerging,O
swine,O
coronavirus,O
that,O
causes,O
"
",O
severe,O
diarrhea,O
",",O
resulting,O
in,O
high,O
mortality,O
in,O
neonatal,O
piglets,O
.,O
Despite,O
"
",O
widespread,O
outbreaks,O
in,O
many,O
countries,O
",",O
no,O
effective,O
PDCoV,O
vaccines,O
are,O
currently,O
"
",O
available,O
.,O
Here,O
",",O
we,O
generated,O
",",O
for,O
the,O
first,O
time,O
",",O
a,O
fulllength,O
infectious,O
cDNA,O
"
",O
clone,O
of,O
PDCoV.,O
We,O
further,O
manipulated,O
the,O
infectious,O
clone,O
by,O
replacing,O
the,O
NS6,O
"
",O
gene,O
with,O
a,O
green,O
fluorescent,O
protein,O
(,O
GFP,O
),O
to,O
generate,O
rPDCoVÎ”NS6GFP,O
;,O
"
",O
likewise,O
",",O
rPDCoVÎ”NS7,O
was,O
constructed,O
by,O
removing,O
the,O
ATG,O
start,O
codons,O
of,O
the,O
NS7,O
"
",O
gene,O
.,O
Growth,O
kinetics,O
studies,O
suggest,O
that,O
rPDCoVÎ”NS7,O
could,O
replicate,O
similarly,O
"
",O
to,O
that,O
of,O
the,O
wildtype,O
PDCoV,O
",",O
whereas,O
rPDCoVÎ”NS6GFP,O
exhibited,O
a,O
substantial,O
"
",O
reduction,O
of,O
viral,O
titer,O
in,O
vitro,O
and,O
in,O
vivo,O
.,O
Piglets,O
inoculated,O
with,O
"
",O
rPDCoVÎ”NS7,O
or,O
wildtype,O
PDCoV,O
showed,O
similar,O
diarrheic,O
scores,O
and,O
pathological,O
"
",O
injury,O
.,O
In,O
contrast,O
",",O
rPDCoVÎ”NS6GFPinfected,O
piglets,O
did,O
not,O
show,O
any,O
clinical,O
"
",O
signs,O
",",O
indicating,O
that,O
the,O
NS6,O
protein,O
is,O
an,O
important,O
virulence,O
factor,O
of,O
PDCoV,O
"
",O
and,O
that,O
the,O
NS6deficient,O
mutant,O
virus,O
might,O
be,O
a,O
promising,O
liveattenuated,O
"
",O
vaccine,O
candidate,O
.,O
Taken,O
together,O
",",O
the,O
reverse,O
genetics,O
platform,O
described,O
here,O
"
",O
not,O
only,O
provides,O
more,O
insights,O
into,O
the,O
role,O
of,O
PDCoV,O
accessory,O
proteins,O
in,O
"
",O
viral,O
replication,O
and,O
pathogenesis,O
",",O
but,O
also,O
allows,O
the,O
development,O
of,O
novel,O
"
",O
vaccines,O
against,O
PDCoV,O
infection,O
.,O
"

",O
DOI,O
:,O
10.108,O
22221751.2019.1701391,O
"
",O
PMCID,O
:,O
PMC6968670,O
"
",O
PMID,O
:,O
31859605,O
"


",O
958,O
.,O
Arch,O
Virol,O
.,O
2020,O
Feb;165(2):509514,O
.,O
doi,O
:,O
10.1007,O
s00705019044972,O
.,O
Epub,O
2019,O
"
",O
Dec,O
16,O
.,O
"

",O
Complete,O
genome,O
sequence,O
of,O
a,O
novel,O
victorivirus,O
isolated,O
from,O
the,O
sesame,O
"
",O
charcoal,O
rot,O
fungus,O
Macrophomina,O
phaseolina,O
.,O
"

",O
Wang,O
J(1)(2,O
),O
",",O
Xiao,O
Y(2,O
),O
",",O
Liu,O
X(1,O
),O
",",O
Ni,O
Y(1,O
),O
",",O
Zhao,O
H(1,O
),O
",",O
Zhao,O
X(1,O
),O
",",O
Liu,O
H(3,O
),O
",",O
Xiao,O
"
",O
X(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Institute,O
of,O
Plant,O
Protection,O
",",O
Henan,O
Academy,O
of,O
Agricultural,O
Sciences,O
",",O
"
",O
Zhengzhou,O
",",O
450002,O
",",O
Henan,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(2)The,O
Provincial,O
Key,O
Lab,O
of,O
Plant,O
Pathology,O
of,O
Hubei,O
Province,O
",",O
College,O
of,O
Plant,O
"
",O
Science,O
and,O
Technology,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
Hubei,O
",",O
"
",O
People,O
's,O
Republic,O
of,O
China,O
.,O
"
",O
(3)Institute,O
of,O
Plant,O
Protection,O
",",O
Henan,O
Academy,O
of,O
Agricultural,O
Sciences,O
",",O
"
",O
Zhengzhou,O
",",O
450002,O
",",O
Henan,O
",",O
People,O
's,O
Republic,O
of,O
China,O
.,O
liuhy1219@163.com,O
.,O
"
",O
(4)The,O
Provincial,O
Key,O
Lab,O
of,O
Plant,O
Pathology,O
of,O
Hubei,O
Province,O
",",O
College,O
of,O
Plant,O
"
",O
Science,O
and,O
Technology,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
Hubei,O
",",O
"
",O
People,O
's,O
Republic,O
of,O
China,O
.,O
xueqiongxiao@mail.hzau.edu.cn,O
.,O
"

",O
Macrophomina,O
phaseolina,O
is,O
an,O
important,O
phytopathogenic,O
fungus,O
with,O
a,O
broad,O
host,O
"
",O
range,O
.,O
Here,O
",",O
the,O
complete,O
genome,O
sequence,O
of,O
a,O
novel,O
victorivirus,O
",",O
tentatively,O
"
",O
named,O
Macrophomina,O
phaseolina,O
victorivirus,O
1,O
(,O
MpV1,O
),O
",",O
was,O
identified,O
from,O
strain,O
"
",O
2012019,O
of,O
M.,O
phaseolina,O
.,O
The,O
MpV1,O
genome,O
is,O
5128,O
nucleotides,O
long,O
with,O
a,O
"
",O
predicted,O
GC,O
content,O
of,O
62,O
%,O
.,O
Sequence,O
analysis,O
indicated,O
that,O
two,O
open,O
reading,O
"
",O
frames,O
(,O
ORF,O
1,O
and,O
2,O
),O
overlap,O
at,O
a,O
tetranucleotide,O
AUGA,O
sequence,O
.,O
Proteins,O
encoded,O
"
",O
by,O
ORF1,O
and,O
ORF2,O
showed,O
significant,O
sequence,O
similarity,O
to,O
coat,O
proteins,O
and,O
the,O
"
",O
RNAdependent,O
RNA,O
polymerases,O
",",O
respectively,O
",",O
of,O
members,O
of,O
the,O
family,O
"
",O
Totiviridae,O
.,O
Analysis,O
of,O
the,O
genomic,O
structure,O
of,O
MpV1,O
",",O
homolog,O
searches,O
of,O
the,O
"
",O
deduced,O
amino,O
acid,O
sequences,O
",",O
and,O
phylogenetic,O
analysis,O
indicated,O
that,O
MpV1,O
is,O
a,O
"
",O
new,O
member,O
of,O
the,O
genus,O
Victorivirus,O
.,O
As,O
far,O
as,O
we,O
know,O
",",O
this,O
is,O
the,O
first,O
report,O
"
",O
of,O
the,O
fulllength,O
nucleotide,O
sequence,O
of,O
the,O
genome,O
of,O
a,O
novel,O
victorivirus,O
that,O
"
",O
infects,O
M.,O
phaseolina,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00705019044972,O
"
",O
PMID,O
:,O
31845152,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
959,O
.,O
J,O
Gastroenterol,O
.,O
2020,O
Feb;55(2):142158,O
.,O
doi,O
:,O
10.1007,O
s00535019016498,O
.,O
Epub,O
"
",O
2019,O
Dec,O
16,O
.,O
"

",O
Intestinal,O
microbiome,O
and,O
NAFLD,O
:,O
molecular,O
insights,O
and,O
therapeutic,O
perspectives,O
.,O
"

",O
Hu,O
H(1,O
),O
",",O
Lin,O
A(2,O
),O
",",O
Kong,O
M(1,O
),O
",",O
Yao,O
X(1,O
),O
",",O
Yin,O
M(1,O
),O
",",O
Xia,O
H(1,O
),O
",",O
Ma,O
J(3,O
),O
",",O
Liu,O
H(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Hubei,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(2)Hubei,O
Provincial,O
Hospital,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
"
",O
China,O
.,O
"
",O
(3)Hubei,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
mj1964@163.com,O
.,O
"
",O
(4)Hubei,O
University,O
of,O
Chinese,O
Medicine,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
hongtaoliu@hbtcm.edu.cn,O
.,O
"

",O
Nonalcoholic,O
fatty,O
liver,O
disease,O
(,O
NAFLD,O
),O
is,O
the,O
hepatic,O
manifestation,O
of,O
"
",O
dysregulated,O
lipid,O
and,O
glucose,O
metabolism,O
",",O
which,O
is,O
often,O
associated,O
with,O
"
",O
obesity,O
",",O
dyslipidemia,O
and,O
insulin,O
resistance,O
.,O
In,O
view,O
of,O
the,O
high,O
morbidity,O
and,O
"
",O
health,O
risks,O
of,O
NAFLD,O
",",O
the,O
lack,O
of,O
effective,O
cure,O
has,O
drawn,O
great,O
attention,O
.,O
In,O
"
",O
recent,O
years,O
",",O
a,O
line,O
of,O
evidence,O
has,O
suggested,O
a,O
close,O
linkage,O
between,O
the,O
"
",O
intestine,O
and,O
liver,O
diseases,O
such,O
as,O
NAFLD,O
.,O
We,O
summarized,O
the,O
composition,O
and,O
"
",O
characteristics,O
of,O
intestinal,O
microbes,O
and,O
reviewed,O
molecular,O
insights,O
into,O
the,O
"
",O
intestinal,O
microbiome,O
in,O
development,O
and,O
progression,O
of,O
NAFLD,O
.,O
Intestinal,O
"
",O
microbes,O
mainly,O
include,O
bacteria,O
",",O
archaea,O
",",O
viruses,O
and,O
fungi,O
",",O
and,O
the,O
crosstalk,O
"
",O
between,O
nonbacterial,O
intestinal,O
microbes,O
and,O
human,O
liver,O
diseases,O
should,O
be,O
paid,O
"
",O
more,O
attention,O
.,O
Intestinal,O
microbiota,O
imbalance,O
may,O
not,O
only,O
increase,O
the,O
"
",O
intestinal,O
permeability,O
to,O
gut,O
microbes,O
but,O
also,O
lead,O
to,O
liver,O
exposure,O
to,O
"
",O
harmful,O
substances,O
that,O
promote,O
hepatic,O
lipogenesis,O
and,O
fibrosis,O
.,O
Furthermore,O
",",O
we,O
"
",O
focused,O
on,O
reviewing,O
the,O
latest,O
"""",O
gutliver,O
"axis""targeting",O
treatment,O
",",O
including,O
"
",O
the,O
application,O
of,O
antibiotics,O
",",O
probiotics,O
",",O
prebiotics,O
",",O
synbiotics,O
",",O
farnesoid,O
X,O
"
",O
receptor,O
agonists,O
",",O
bile,O
acid,O
sequestrants,O
",",O
gutderived,O
hormones,O
",",O
adsorbents,O
and,O
"
",O
fecal,O
microbiota,O
transplantation,O
for,O
NAFLD,O
.,O
In,O
this,O
review,O
",",O
we,O
also,O
discussed,O
the,O
"
",O
potential,O
mechanisms,O
of,O
"""",O
gutliver,O
axis,O
"""",O
manipulation,O
and,O
efficacy,O
of,O
these,O
"
",O
therapeutic,O
strategies,O
for,O
NAFLD,O
treatment,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s00535019016498,O
"
",O
PMCID,O
:,O
PMC6981320,O
"
",O
PMID,O
:,O
31845054,O
"


",O
960,O
.,O
Cells,O
.,O
2019,O
Dec,O
10;8(12,O
),O
.,O
pii,O
:,O
E1604,O
.,O
doi,O
:,O
10.339,O
cells8121604,O
.,O
"

",O
KRABZinc,O
Finger,O
Protein,O
ZNF268a,O
Deficiency,O
Attenuates,O
the,O
VirusInduced,O
"
",O
ProInflammatory,O
Response,O
by,O
Preventing,O
IKK,O
Complex,O
Assembly,O
.,O
"

",O
Liu,O
Y(1,O
),O
",",O
Yin,O
W(1,O
),O
",",O
Wang,O
J(2,O
),O
",",O
Lei,O
Y(1,O
),O
",",O
Sun,O
G(2)(3,O
),O
",",O
Li,O
W(1,O
),O
",",O
Huang,O
Z(1,O
),O
",",O
Guo,O
"
",O
M(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Hubei,O
Key,O
Laboratory,O
of,O
Cell,O
Homeostasis,O
&,O
State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
"
",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
430072,O
",",O
China,O
.,O
"
",O
(2)School,O
of,O
Basic,O
Medical,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
430071,O
",",O
China,O
.,O
"
",O
(3)Hubei,O
Provincial,O
Key,O
Laboratory,O
of,O
Allergy,O
and,O
Immunology,O
",",O
Wuhan,O
430071,O
",",O
"
",O
China,O
.,O
"

",O
Despite,O
progress,O
in,O
understanding,O
how,O
virusinduced,O
",",O
NFÎºBdependent,O
"
",O
proinflammatory,O
cytokines,O
are,O
regulated,O
",",O
there,O
are,O
still,O
factors,O
and,O
mechanisms,O
"
",O
that,O
remain,O
to,O
be,O
explored,O
.,O
We,O
aimed,O
to,O
uncover,O
the,O
relationship,O
between,O
"
",O
KRABzinc,O
finger,O
protein,O
ZNF268a,O
and,O
NFÎºBmediated,O
cytokine,O
production,O
in,O
"
",O
response,O
to,O
viral,O
infection,O
.,O
To,O
this,O
end,O
",",O
we,O
established,O
a,O
ZNF268aknockout,O
cell,O
"
",O
line,O
using,O
a,O
pair,O
of,O
sgRNAs,O
that,O
simultaneously,O
target,O
exon,O
3,O
in,O
the,O
coding,O
"
",O
sequence,O
of,O
the,O
ZNF268,O
gene,O
in,O
HEK293,O
T,O
.,O
HEK293,O
T,O
cells,O
lacking,O
ZNF268a,O
showed,O
less,O
"
",O
cytokine,O
expression,O
at,O
the,O
transcription,O
and,O
protein,O
levels,O
in,O
response,O
to,O
Sendai,O
"
",O
virus,O
vesicular,O
stomatitis,O
virus,O
(,O
SeV,O
VSV,O
),O
infection,O
than,O
wildtype,O
cells,O
.,O
"
",O
Consistent,O
with,O
HEK293,O
T,O
",",O
knockdown,O
of,O
ZNF268a,O
by,O
siRNAs,O
in,O
THP1,O
cells,O
"
",O
significantly,O
dampened,O
the,O
inflammatory,O
response,O
.,O
Mechanistically,O
",",O
ZNF268a,O
"
",O
facilitated,O
NFÎºB,O
activation,O
by,O
targeting,O
IKKÎ±,O
",",O
helping,O
to,O
maintain,O
the,O
IKK,O
"
",O
signaling,O
complex,O
and,O
thus,O
enabling,O
proper,O
p65,O
phosphorylation,O
and,O
nuclear,O
"
",O
translocation,O
.,O
Taken,O
together,O
",",O
our,O
data,O
suggest,O
that,O
ZNF268a,O
plays,O
a,O
positive,O
"
",O
role,O
in,O
the,O
regulation,O
of,O
virusinduced,O
proinflammatory,O
cytokine,O
production,O
.,O
By,O
"
",O
interacting,O
with,O
IKKÎ±,O
",",O
ZNF268a,O
promotes,O
NFÎºB,O
signal,O
transduction,O
upon,O
viral,O
"
",O
infection,O
by,O
helping,O
to,O
maintain,O
the,O
association,O
between,O
IKK,O
complex,O
subunits,O
.,O
"

",O
DOI,O
:,O
10.339,O
cells8121604,O
"
",O
PMCID,O
:,O
PMC6953056,O
"
",O
PMID,O
:,O
31835635,O
"


",O
961,O
.,O
Viruses,O
.,O
2019,O
Dec,O
10;11(12,O
),O
.,O
pii,O
:,O
E1145,O
.,O
doi,O
:,O
10.339,O
v11121145,O
.,O
"

",O
Fatty,O
Acids,O
Regulate,O
Porcine,O
Reproductive,O
and,O
Respiratory,O
Syndrome,O
Virus,O
"
",O
Infection,O
via,O
the,O
AMPKACC1,O
Signaling,O
Pathway,O
.,O
"

",O
Long,O
S(1)(2,O
),O
",",O
Zhou,O
Y(1)(2,O
),O
",",O
Bai,O
D(1)(2,O
),O
",",O
Hao,O
W(1)(2,O
),O
",",O
Zheng,O
B(1)(2,O
),O
",",O
Xiao,O
"
",O
S(1)(2,O
),O
",",O
Fang,O
L(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"
",O
(2)The,O
Key,O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
"
",O
Cooperative,O
Innovation,O
Center,O
for,O
Sustainable,O
Pig,O
Production,O
",",O
Wuhan,O
430070,O
",",O
"
",O
China,O
.,O
"
",O
(3)Laboratory,O
of,O
Animal,O
Virology,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
1,O
Shizishan,O
Street,O
",",O
Wuhan,O
430070,O
",",O
Hubei,O
",",O
China,O
.,O
"

",O
Lipids,O
play,O
a,O
crucial,O
role,O
in,O
the,O
replication,O
of,O
porcine,O
reproductive,O
and,O
"
",O
respiratory,O
syndrome,O
virus,O
(,O
PRRSV,O
),O
",",O
a,O
porcine,O
virus,O
that,O
is,O
endemic,O
throughout,O
"
",O
the,O
world,O
.,O
However,O
",",O
little,O
is,O
known,O
about,O
the,O
effect,O
of,O
fatty,O
acids,O
(,O
FAs,O
),O
",",O
a,O
type,O
"
",O
of,O
vital,O
lipid,O
",",O
on,O
PRRSV,O
infection,O
.,O
In,O
this,O
study,O
",",O
we,O
found,O
that,O
treatment,O
with,O
a,O
"
",O
FA,O
biosynthetic,O
inhibitor,O
significantly,O
inhibited,O
PRRSV,O
propagation,O
",",O
indicating,O
"
",O
the,O
necessity,O
of,O
FAs,O
for,O
optimal,O
replication,O
of,O
PRRSV,O
.,O
Further,O
study,O
revealed,O
"
",O
that,O
5'adenosine,O
monophosphate,O
(AMP)activated,O
protein,O
kinase,O
(,O
AMPK,O
),O
",",O
a,O
key,O
"
",O
kinase,O
antagonizing,O
FA,O
biosynthesis,O
",",O
was,O
strongly,O
activated,O
by,O
PRRSV,O
and,O
the,O
"
",O
pharmacological,O
activator,O
of,O
AMPK,O
exhibited,O
antiPRRSV,O
activity,O
.,O
Additionally,O
",",O
we,O
"
",O
found,O
that,O
acetylCoA,O
carboxylase,O
1,O
(,O
ACC1,O
),O
",",O
the,O
first,O
ratelimiting,O
enzyme,O
in,O
the,O
"
",O
FA,O
biosynthesis,O
pathway,O
",",O
was,O
phosphorylated,O
(,O
inactive,O
form,O
),O
by,O
PRRSVactivated,O
"
",O
AMPK,O
",",O
and,O
active,O
ACC1,O
was,O
required,O
for,O
PRRSV,O
proliferation,O
",",O
suggesting,O
that,O
the,O
"
",O
PRRSV,O
infection,O
induced,O
the,O
activation,O
of,O
the,O
AMPKACC1,O
pathway,O
",",O
which,O
was,O
not,O
"
",O
conducive,O
to,O
PRRSV,O
replication,O
.,O
This,O
work,O
provides,O
new,O
evidence,O
about,O
the,O
"
",O
mechanisms,O
involved,O
in,O
host,O
lipid,O
metabolism,O
during,O
PRRSV,O
infection,O
and,O
"
",O
identifies,O
novel,O
potential,O
antiviral,O
targets,O
for,O
PRRSV,O
.,O
"

",O
DOI,O
:,O
10.339,O
v11121145,O
"
",O
PMCID,O
:,O
PMC6950460,O
"
",O
PMID,O
:,O
31835577,O
"


",O
962,O
.,O
Nat,O
Commun,O
.,O
2019,O
Dec,O
12;10(1):5677,O
.,O
doi,O
:,O
10.1038,O
s41467019135891,O
.,O
"

",O
Maternal,O
vaccination,O
and,O
protective,O
immunity,O
against,O
Zika,O
virus,O
vertical,O
"
",O
transmission,O
.,O
"

",O
Shan,O
C(1)(2,O
),O
",",O
Xie,O
X(1,O
),O
",",O
Luo,O
H(3,O
),O
",",O
Muruato,O
AE(3,O
),O
",",O
Liu,O
Y(1,O
),O
",",O
Wakamiya,O
M(1,O
),O
",",O
La,O
"
",O
JH(4,O
),O
",",O
Chung,O
JM(4,O
),O
",",O
Weaver,O
SC(3)(5)(6)(7)(8)(9)(10,O
),O
",",O
Wang,O
T(3)(7)(11,O
),O
",",O
Shi,O
"
",O
PY(12)(13)(14)(15)(16)(17)(18,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Biochemistry,O
&,O
Molecular,O
Biology,O
",",O
University,O
of,O
Texas,O
Medical,O
"
",O
Branch,O
",",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
"
",O
(2)Wuhan,O
National,O
Biosafety,O
Laboratory,O
",",O
MegaScience,O
Center,O
for,O
BioSafety,O
"
",O
Research,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Microbiology,O
&,O
Immunology,O
",",O
University,O
of,O
Texas,O
Medical,O
Branch,O
",",O
"
",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
"
",O
(4)Department,O
of,O
Neuroscience,O
",",O
Cell,O
Biology,O
",",O
&,O
Anatomy,O
",",O
University,O
of,O
Texas,O
"
",O
Medical,O
Branch,O
",",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
"
",O
(5)Institute,O
for,O
Human,O
Infections,O
&,O
Immunity,O
",",O
University,O
of,O
Texas,O
Medical,O
Branch,O
",",O
"
",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
"
",O
(6)Institute,O
for,O
Translational,O
Sciences,O
",",O
University,O
of,O
Texas,O
Medical,O
Branch,O
",",O
"
",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
"
",O
(7)Sealy,O
Institute,O
for,O
Vaccine,O
Sciences,O
",",O
University,O
of,O
Texas,O
Medical,O
Branch,O
",",O
"
",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
"
",O
(8)Sealy,O
Center,O
for,O
Structural,O
Biology,O
&,O
Molecular,O
Biophysics,O
",",O
University,O
of,O
"
",O
Texas,O
Medical,O
Branch,O
",",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
"
",O
(9)Center,O
for,O
Biodefense,O
&,O
Emerging,O
Infectious,O
Diseases,O
",",O
University,O
of,O
Texas,O
"
",O
Medical,O
Branch,O
",",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
"
",O
(10)World,O
Reference,O
Center,O
for,O
Emerging,O
Viruses,O
and,O
Arboviruses,O
",",O
University,O
of,O
"
",O
Texas,O
Medical,O
Branch,O
",",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
"
",O
(11)Department,O
of,O
Pathology,O
",",O
University,O
of,O
Texas,O
Medical,O
Branch,O
",",O
Galveston,O
",",O
"
",O
Texas,O
",",O
USA,O
.,O
"
",O
(12)Department,O
of,O
Biochemistry,O
&,O
Molecular,O
Biology,O
",",O
University,O
of,O
Texas,O
Medical,O
"
",O
Branch,O
",",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
peshi@utmb.edu,O
.,O
"
",O
(13)Institute,O
for,O
Human,O
Infections,O
&,O
Immunity,O
",",O
University,O
of,O
Texas,O
Medical,O
"
",O
Branch,O
",",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
peshi@utmb.edu,O
.,O
"
",O
(14)Institute,O
for,O
Translational,O
Sciences,O
",",O
University,O
of,O
Texas,O
Medical,O
Branch,O
",",O
"
",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
peshi@utmb.edu,O
.,O
"
",O
(15)Sealy,O
Institute,O
for,O
Vaccine,O
Sciences,O
",",O
University,O
of,O
Texas,O
Medical,O
Branch,O
",",O
"
",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
peshi@utmb.edu,O
.,O
"
",O
(16)Sealy,O
Center,O
for,O
Structural,O
Biology,O
&,O
Molecular,O
Biophysics,O
",",O
University,O
of,O
"
",O
Texas,O
Medical,O
Branch,O
",",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
peshi@utmb.edu,O
.,O
"
",O
(17)Department,O
of,O
Pathology,O
",",O
University,O
of,O
Texas,O
Medical,O
Branch,O
",",O
Galveston,O
",",O
"
",O
Texas,O
",",O
USA,O
.,O
peshi@utmb.edu,O
.,O
"
",O
(18)Department,O
of,O
Phamarcology,O
&,O
Toxicology,O
",",O
University,O
of,O
Texas,O
Medical,O
Branch,O
",",O
"
",O
Galveston,O
",",O
Texas,O
",",O
USA,O
.,O
peshi@utmb.edu,O
.,O
"

",O
An,O
important,O
goal,O
of,O
the,O
Â ,O
Zika,O
virus,O
(,O
ZIKV,O
),O
vaccine,O
is,O
to,O
prevent,O
Â ,O
a,O
congenital,O
"
",O
syndrome,O
in,O
fetuses,O
of,O
pregnant,O
women,O
",",O
but,O
studies,O
directly,O
evaluating,O
maternal,O
"
",O
vaccination,O
for,O
ZIKV,O
are,O
lacking,O
.,O
Here,O
we,O
report,O
maternal,O
vaccination,O
using,O
a,O
"
",O
liveattenuated,O
ZIKV,O
vaccine,O
(,O
3'UTRâˆ†10LAV,O
),O
in,O
a,O
pregnant,O
mouse,O
model,O
.,O
Maternal,O
"
",O
immunization,O
with,O
3'UTRâˆ†10LAV,O
does,O
not,O
cause,O
any,O
adverse,O
effects,O
on,O
pregnancy,O
",",O
"
",O
fetal,O
development,O
",",O
or,O
offspring,O
behavior,O
.,O
One,O
maternal,O
immunization,O
fully,O
"
",O
protects,O
dams,O
against,O
ZIKV,O
infection,O
and,O
in,O
utero,O
transmission,O
.,O
Although,O
"
",O
neutralizing,O
antibody,O
alone,O
is,O
sufficient,O
to,O
prevent,O
in,O
utero,O
transmission,O
",",O
a,O
"
",O
higher,O
neutralizing,O
titer,O
is,O
required,O
to,O
protect,O
pregnant,O
mice,O
against,O
in,O
utero,O
"
",O
transmission,O
than,O
that,O
required,O
to,O
protect,O
nonpregnant,O
mice,O
against,O
viral,O
"
",O
infection,O
.,O
The,O
immunized,O
dams,O
transfer,O
maternal,O
antibodies,O
to,O
pups,O
",",O
which,O
protect,O
"
",O
neonates,O
against,O
ZIKV,O
infection,O
.,O
Notably,O
",",O
pregnancy,O
weakens,O
maternal,O
T,O
cell,O
"
",O
response,O
to,O
3'UTRâˆ†10LAV,O
vaccination,O
.,O
Our,O
results,O
suggest,O
that,O
",",O
besides,O
"
",O
vaccinating,O
nonpregnant,O
individuals,O
",",O
3'UTRâˆ†10LAV,O
may,O
also,O
be,O
considered,O
for,O
"
",O
maternal,O
vaccination,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s41467019135891,O
"
",O
PMCID,O
:,O
PMC6908683,O
"
",O
PMID,O
:,O
31831806,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
963,O
.,O
J,O
Neuroimmune,O
Pharmacol,O
.,O
2019,O
Dec,O
11,O
.,O
doi,O
:,O
10.1007,O
s11481019098929,O
.,O
[,O
Epub,O
"
",O
ahead,O
of,O
print,O
],O
"

",O
Heroin,O
Abuse,O
and,O
or,O
HIV,O
Infection,O
Dysregulate,O
Plasma,O
Exosomal,O
miRNAs,O
.,O
"

",O
Wang,O
X(1,O
),O
",",O
Sun,O
L(1)(2,O
),O
",",O
Zhou,O
Y(1)(3,O
),O
",",O
Su,O
QJ(4,O
),O
",",O
Li,O
JL(1,O
),O
",",O
Ye,O
L(5,O
),O
",",O
Liu,O
MQ(6,O
),O
",",O
"
",O
Zhou,O
W(6,O
),O
",",O
Ho,O
WZ(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pathology,O
and,O
Laboratory,O
Medicine,O
",",O
Temple,O
University,O
Lewis,O
Katz,O
"
",O
School,O
of,O
Medicine,O
",",O
Philadelphia,O
",",O
PA,O
",",O
19140,O
",",O
USA,O
.,O
"
",O
(2)Xinjiang,O
Uygur,O
Pharmaceutical,O
Co.,O
",",O
Ltd,O
",",O
Wulumuqi,O
",",O
830000,O
",",O
China,O
.,O
"
",O
(3)Eternity,O
Bioscience,O
Inc.,O
",",O
6,O
Cedarbrook,O
Drive,O
",",O
Cranbury,O
",",O
NJ,O
",",O
8512,O
",",O
USA,O
.,O
"
",O
(4)Ruikang,O
Hospital,O
Affiliated,O
to,O
Guangxi,O
University,O
of,O
Chinese,O
Medicine,O
",",O
"
",O
Nanning,O
",",O
530021,O
",",O
China,O
.,O
"
",O
(5)Guangxi,O
Key,O
Laboratory,O
of,O
AIDS,O
Prevention,O
and,O
Treatment,O
",",O
School,O
of,O
Public,O
"
",O
Health,O
",",O
Guangxi,O
Medical,O
University,O
",",O
Nanning,O
",",O
530021,O
",",O
China,O
.,O
"
",O
(6)Wuhan,O
Centers,O
for,O
Disease,O
Prevention,O
&,O
Control,O
",",O
Wuhan,O
",",O
430024,O
",",O
China,O
.,O
"
",O
(7)Department,O
of,O
Pathology,O
and,O
Laboratory,O
Medicine,O
",",O
Temple,O
University,O
Lewis,O
Katz,O
"
",O
School,O
of,O
Medicine,O
",",O
Philadelphia,O
",",O
PA,O
",",O
19140,O
",",O
USA,O
.,O
wenzheho@temple.edu,O
.,O
"

",O
Exosomes,O
play,O
an,O
important,O
role,O
in,O
celltocell,O
communication,O
as,O
they,O
can,O
"
",O
transfer,O
functional,O
molecules,O
such,O
as,O
microRNAs,O
(,O
miRNAs,O
),O
from,O
one,O
cell,O
to,O
"
",O
another,O
",",O
exerting,O
biological,O
and,O
immunological,O
functions,O
.,O
Here,O
",",O
we,O
investigated,O
"
",O
the,O
impact,O
of,O
HIV,O
infection,O
and,O
or,O
heroin,O
use,O
on,O
the,O
expression,O
of,O
the,O
miRNAs,O
in,O
"
",O
plasma,O
exosomes,O
.,O
We,O
found,O
that,O
HIV,O
infection,O
or,O
heroin,O
use,O
upregulated,O
the,O
"
",O
majority,O
(,O
98,O
%,O
),O
of,O
a,O
panel,O
of,O
plasma,O
exosomal,O
miRNAs,O
associated,O
with,O
immune,O
"
",O
regulation,O
and,O
inflammation,O
.,O
We,O
also,O
observed,O
the,O
enhanced,O
effect,O
of,O
HIV,O
"
",O
infection,O
and,O
heroin,O
use,O
on,O
some,O
of,O
these,O
upregulated,O
miRNAs,O
.,O
Our,O
further,O
"
",O
investigation,O
showed,O
that,O
the,O
levels,O
of,O
four,O
of,O
neuroinflammationrelated,O
miRNAs,O
"
",O
(,O
146a,O
",",O
126,O
",",O
21,O
",",O
and,O
let7a,O
),O
were,O
higher,O
in,O
HIVinfected,O
heroin,O
users,O
as,O
compared,O
"
",O
with,O
the,O
control,O
subjects,O
.,O
These,O
findings,O
indicate,O
that,O
the,O
dysregulations,O
of,O
the,O
"
",O
plasma,O
exosomal,O
miRNAs,O
support,O
further,O
studies,O
to,O
determine,O
the,O
role,O
of,O
the,O
"
",O
miRNAs,O
in,O
HIV,O
and,O
or,O
heroin,O
usemediated,O
immune,O
modulation,O
and,O
"
",O
neuroinflammation,O
.,O
Graphical,O
abstract,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s11481019098929,O
"
",O
PMID,O
:,O
31828734,O
"


",O
964,O
.,O
Virol,O
Sin,O
.,O
2019,O
Dec,O
11,O
.,O
doi,O
:,O
10.1007,O
s12250019001736,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
PanGenomic,O
Analysis,O
of,O
African,O
Swine,O
Fever,O
Virus,O
.,O
"

",O
Wang,O
Z(1)(2)(3,O
),O
",",O
Jia,O
L(1)(2)(3,O
),O
",",O
Li,O
J(3)(4,O
),O
",",O
Liu,O
H(2,O
),O
",",O
Liu,O
D(5)(6)(7)(8)(9,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(2)Computational,O
Virology,O
Group,O
",",O
Center,O
for,O
Bacteria,O
and,O
Virus,O
Resources,O
and,O
"
",O
Bioinformation,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
"
",O
430071,O
",",O
China,O
.,O
"
",O
(3)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100049,O
",",O
China,O
.,O
"
",O
(4)CAS,O
Key,O
Laboratory,O
of,O
Pathogenic,O
Microbiology,O
and,O
Immunology,O
",",O
Institute,O
of,O
"
",O
Microbiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100101,O
",",O
China,O
.,O
"
",O
(5)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
liud@wh.iov.cn,O
.,O
"
",O
(6)Computational,O
Virology,O
Group,O
",",O
Center,O
for,O
Bacteria,O
and,O
Virus,O
Resources,O
and,O
"
",O
Bioinformation,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
"
",O
430071,O
",",O
China,O
.,O
liud@wh.iov.cn,O
.,O
"
",O
(7)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
100049,O
",",O
China,O
.,O
"
",O
liud@wh.iov.cn,O
.,O
"
",O
(8)African,O
Swine,O
Fever,O
Regional,O
Laboratory,O
of,O
China,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
liud@wh.iov.cn,O
.,O
"
",O
(9)Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
"
",O
China,O
.,O
liud@wh.iov.cn,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12250019001736,O
"
",O
PMID,O
:,O
31828586,O
"


",O
965,O
.,O
J,O
Virol,O
.,O
2020,O
Feb,O
14;94(5,O
),O
.,O
pii,O
:,O
e0160219,O
.,O
doi,O
:,O
10.1128,O
JVI.0160219,O
.,O
Print,O
2020,O
"
",O
Feb,O
14,O
.,O
"

",O
Different,O
Degrees,O
of,O
5'to3,O
',O
DAR,O
Interactions,O
Modulate,O
Zika,O
Virus,O
Genome,O
"
",O
Cyclization,O
and,O
HostSpecific,O
Replication,O
.,O
"

",O
Li,O
XD(1)(2,O
),O
",",O
Deng,O
CL(1,O
),O
",",O
Yuan,O
ZM(1,O
),O
",",O
Ye,O
HQ(3,O
),O
",",O
Zhang,O
B(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
"
",O
China,O
.,O
"
",O
(2)Hunan,O
Normal,O
University,O
",",O
School,O
of,O
Medicine,O
",",O
Changsha,O
",",O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
"
",O
China,O
yehq@wh.iov.cn,O
zhangbo@wh.iov.cn,O
.,O
"

",O
Mosquitoborne,O
flaviviruses,O
",",O
which,O
include,O
many,O
important,O
human,O
pathogens,O
",",O
such,O
"
",O
as,O
West,O
Nile,O
virus,O
(,O
WNV,O
),O
",",O
dengue,O
virus,O
(,O
DENV,O
),O
",",O
and,O
Zika,O
virus,O
(,O
ZIKV,O
),O
",",O
have,O
caused,O
"
",O
numerous,O
emerging,O
epidemics,O
in,O
recent,O
years,O
.,O
Details,O
of,O
the,O
viral,O
genome,O
"
",O
functions,O
necessary,O
for,O
effective,O
viral,O
replication,O
in,O
mosquito,O
and,O
vertebrate,O
"
",O
hosts,O
remain,O
obscure,O
.,O
Here,O
",",O
using,O
ZIKV,O
as,O
a,O
model,O
",",O
we,O
found,O
that,O
the,O
conserved,O
"
",O
"""",O
downstream,O
of,O
AUG,O
region,O
"""",O
(,O
DAR,O
),O
",",O
which,O
is,O
known,O
to,O
be,O
an,O
essential,O
element,O
for,O
"
",O
genome,O
cyclization,O
",",O
is,O
involved,O
in,O
viral,O
replication,O
in,O
a,O
hostspecific,O
manner,O
.,O
"
",O
Mutational,O
analysis,O
of,O
the,O
DAR,O
element,O
showed,O
that,O
a,O
singlenucleotide,O
mismatch,O
"
",O
between,O
the,O
5,O
',O
DAR,O
and,O
the,O
3,O
',O
DAR,O
had,O
little,O
effect,O
on,O
ZIKV,O
replication,O
in,O
"
",O
mammalian,O
cells,O
but,O
dramatically,O
impaired,O
viral,O
propagation,O
in,O
mosquito,O
cells,O
.,O
"
",O
The,O
revertant,O
viruses,O
passaged,O
in,O
mosquito,O
cells,O
generated,O
compensatory,O
mutations,O
"
",O
restoring,O
the,O
base,O
pairing,O
of,O
the,O
DAR,O
",",O
further,O
confirming,O
the,O
importance,O
of,O
the,O
"
",O
complementarity,O
of,O
the,O
DAR,O
in,O
mosquito,O
cells,O
.,O
We,O
demonstrate,O
that,O
a,O
"
",O
singlenucleotide,O
mutation,O
in,O
the,O
DAR,O
is,O
sufficient,O
to,O
destroy,O
longrange,O
RNA,O
"
",O
interaction,O
of,O
the,O
ZIKV,O
genome,O
and,O
affects,O
de,O
novo,O
RNA,O
synthesis,O
at,O
28,O
Â°,O
C,O
instead,O
"
",O
of,O
37,O
Â°,O
C,O
",",O
resulting,O
in,O
the,O
different,O
replication,O
efficiencies,O
of,O
the,O
mutant,O
"
",O
viruses,O
in,O
mosquito,O
and,O
mammalian,O
cells,O
.,O
Our,O
results,O
reveal,O
a,O
novel,O
function,O
of,O
"
",O
the,O
circular,O
form,O
of,O
the,O
flavivirus,O
genome,O
in,O
hostspecific,O
viral,O
replication,O
",",O
"
",O
providing,O
new,O
ideas,O
to,O
further,O
explore,O
the,O
functions,O
of,O
the,O
viral,O
genome,O
during,O
"
",O
host,O
adaptation,O
.,O
IMPORTANCE,O
Flaviviruses,O
naturally,O
cycle,O
between,O
the,O
mosquito,O
"
",O
vector,O
and,O
vertebrate,O
hosts,O
.,O
The,O
disparate,O
hosts,O
provide,O
selective,O
pressures,O
that,O
"
",O
drive,O
virus,O
genome,O
evolution,O
to,O
maintain,O
efficient,O
replication,O
during,O
host,O
"
",O
alteration,O
.,O
Host,O
adaptation,O
may,O
occur,O
at,O
different,O
stages,O
of,O
the,O
viral,O
life,O
"
",O
cycle,O
",",O
since,O
hostspecific,O
viral,O
protein,O
processing,O
and,O
virion,O
conformations,O
have,O
"
",O
been,O
reported,O
in,O
the,O
individual,O
hosts,O
.,O
However,O
",",O
the,O
viral,O
determinants,O
and,O
the,O
"
",O
underlying,O
mechanisms,O
associated,O
with,O
hostspecific,O
functions,O
remain,O
obscure,O
.,O
In,O
"
",O
this,O
study,O
",",O
using,O
Zika,O
virus,O
",",O
we,O
found,O
that,O
the,O
DARmediated,O
genome,O
cyclization,O
"
",O
regulates,O
viral,O
replication,O
differently,O
and,O
is,O
under,O
different,O
selection,O
"
",O
pressures,O
in,O
mammalian,O
and,O
mosquito,O
cells,O
.,O
A,O
more,O
constrained,O
complementarity,O
of,O
"
",O
the,O
DAR,O
is,O
required,O
in,O
mosquito,O
cells,O
than,O
in,O
mammalian,O
cells,O
.,O
Since,O
the,O
DAR,O
"
",O
element,O
is,O
stably,O
maintained,O
among,O
mosquitoborne,O
flaviviruses,O
",",O
our,O
findings,O
"
",O
could,O
provide,O
new,O
information,O
for,O
understanding,O
the,O
role,O
of,O
flavivirus,O
genome,O
"
",O
cyclization,O
in,O
viral,O
adaptation,O
and,O
RNA,O
evolution,O
in,O
the,O
two,O
hosts,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
American,O
Society,O
for,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1128,O
JVI.0160219,O
"
",O
PMCID,O
:,O
PMC7022364,O
[,O
Available,O
on,O
20200814,O
],O
"
",O
PMID,O
:,O
31826997,O
"


",O
966,O
.,O
J,O
Virol,O
.,O
2020,O
Feb,O
14;94(5,O
),O
.,O
pii,O
:,O
e0201519,O
.,O
doi,O
:,O
10.1128,O
JVI.0201519,O
.,O
Print,O
2020,O
"
",O
Feb,O
14,O
.,O
"

",O
Molecular,O
Mechanism,O
for,O
AntibodyDependent,O
Enhancement,O
of,O
Coronavirus,O
Entry,O
.,O
"

",O
Wan,O
Y(#)(1,O
),O
",",O
Shang,O
J(#)(1,O
),O
",",O
Sun,O
S(2,O
),O
",",O
Tai,O
W(3,O
),O
",",O
Chen,O
J(4,O
),O
",",O
Geng,O
Q(1,O
),O
",",O
He,O
L(2,O
),O
",",O
"
",O
Chen,O
Y(2,O
),O
",",O
Wu,O
J(1,O
),O
",",O
Shi,O
Z(4,O
),O
",",O
Zhou,O
Y(2,O
),O
",",O
Du,O
L(5,O
),O
",",O
Li,O
F(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Veterinary,O
and,O
Biomedical,O
Sciences,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
University,O
of,O
Minnesota,O
",",O
Saint,O
Paul,O
",",O
Minnesota,O
",",O
USA,O
.,O
"
",O
(2)Laboratory,O
of,O
Infection,O
and,O
Immunity,O
",",O
Beijing,O
Institute,O
of,O
Microbiology,O
and,O
"
",O
Epidemiology,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Lindsley,O
F.,O
Kimball,O
Research,O
Institute,O
",",O
New,O
York,O
Blood,O
Center,O
",",O
New,O
York,O
",",O
New,O
"
",O
York,O
",",O
USA,O
.,O
"
",O
(4)Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
Hubei,O
"
",O
Province,O
",",O
China,O
.,O
"
",O
(5)Lindsley,O
F.,O
Kimball,O
Research,O
Institute,O
",",O
New,O
York,O
Blood,O
Center,O
",",O
New,O
York,O
",",O
New,O
"
",O
York,O
",",O
USA,O
LDu@nybc.org,O
lifang@umn.edu,O
.,O
"
",O
(6)Department,O
of,O
Veterinary,O
and,O
Biomedical,O
Sciences,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
University,O
of,O
Minnesota,O
",",O
Saint,O
Paul,O
",",O
Minnesota,O
",",O
USA,O
LDu@nybc.org,O
"
",O
lifang@umn.edu,O
.,O
"
",O
(#)Contributed,O
equally,O
"

",O
Antibodydependent,O
enhancement,O
(,O
ADE,O
),O
of,O
viral,O
entry,O
has,O
been,O
a,O
major,O
concern,O
for,O
"
",O
epidemiology,O
",",O
vaccine,O
development,O
",",O
and,O
antibodybased,O
drug,O
therapy,O
.,O
However,O
",",O
the,O
"
",O
molecular,O
mechanism,O
behind,O
ADE,O
is,O
still,O
elusive,O
.,O
Coronavirus,O
spike,O
protein,O
"
",O
mediates,O
viral,O
entry,O
into,O
cells,O
by,O
first,O
binding,O
to,O
a,O
receptor,O
on,O
the,O
host,O
cell,O
"
",O
surface,O
and,O
then,O
fusing,O
viral,O
and,O
host,O
membranes,O
.,O
In,O
this,O
study,O
",",O
we,O
investigated,O
"
",O
how,O
a,O
neutralizing,O
monoclonal,O
antibody,O
(,O
MAb,O
),O
",",O
which,O
targets,O
the,O
receptorbinding,O
"
",O
domain,O
(,O
RBD,O
),O
of,O
Middle,O
East,O
respiratory,O
syndrome,O
(,O
MERS,O
),O
coronavirus,O
spike,O
",",O
"
",O
mediates,O
viral,O
entry,O
using,O
pseudovirus,O
entry,O
and,O
biochemical,O
assays,O
.,O
Our,O
results,O
"
",O
showed,O
that,O
MAb,O
binds,O
to,O
the,O
virus,O
surface,O
spike,O
",",O
allowing,O
it,O
to,O
undergo,O
"
",O
conformational,O
changes,O
and,O
become,O
prone,O
to,O
proteolytic,O
activation,O
.,O
Meanwhile,O
",",O
MAb,O
"
",O
binds,O
to,O
cell,O
surface,O
IgG,O
Fc,O
receptor,O
",",O
guiding,O
viral,O
entry,O
through,O
canonical,O
"
",O
viralreceptordependent,O
pathways,O
.,O
Our,O
data,O
suggest,O
that,O
the,O
antibody,O
Fcreceptor,O
"
",O
complex,O
functionally,O
mimics,O
viral,O
receptor,O
in,O
mediating,O
viral,O
entry,O
.,O
Moreover,O
",",O
we,O
"
",O
characterized,O
MAb,O
dosages,O
in,O
viralreceptordependent,O
",",O
Fcreceptordependent,O
",",O
and,O
"
",O
bothreceptorsdependent,O
viral,O
entry,O
pathways,O
",",O
delineating,O
guidelines,O
on,O
MAb,O
"
",O
usages,O
in,O
treating,O
viral,O
infections,O
.,O
Our,O
study,O
reveals,O
a,O
novel,O
molecular,O
"
",O
mechanism,O
for,O
antibodyenhanced,O
viral,O
entry,O
and,O
can,O
guide,O
future,O
vaccination,O
and,O
"
",O
antiviral,O
strategies,O
.,O
IMPORTANCE,O
Antibodydependent,O
enhancement,O
(,O
ADE,O
),O
of,O
viral,O
"
",O
entry,O
has,O
been,O
observed,O
for,O
many,O
viruses,O
.,O
It,O
was,O
shown,O
that,O
antibodies,O
target,O
one,O
"
",O
serotype,O
of,O
viruses,O
but,O
only,O
subneutralize,O
another,O
",",O
leading,O
to,O
ADE,O
of,O
the,O
latter,O
"
",O
viruses,O
.,O
Here,O
we,O
identify,O
a,O
novel,O
mechanism,O
for,O
ADE,O
:,O
a,O
neutralizing,O
antibody,O
"
",O
binds,O
to,O
the,O
surface,O
spike,O
protein,O
of,O
coronaviruses,O
like,O
a,O
viral,O
receptor,O
",",O
"
",O
triggers,O
a,O
conformational,O
change,O
of,O
the,O
spike,O
",",O
and,O
mediates,O
viral,O
entry,O
into,O
IgG,O
"
",O
Fc,O
receptorexpressing,O
cells,O
through,O
canonical,O
viralreceptordependent,O
pathways,O
.,O
"
",O
We,O
further,O
evaluated,O
how,O
antibody,O
dosages,O
impacted,O
viral,O
entry,O
into,O
cells,O
"
",O
expressing,O
viral,O
receptor,O
",",O
Fc,O
receptor,O
",",O
or,O
both,O
receptors,O
.,O
This,O
study,O
reveals,O
"
",O
complex,O
roles,O
of,O
antibodies,O
in,O
viral,O
entry,O
and,O
can,O
guide,O
future,O
vaccine,O
design,O
"
",O
and,O
antibodybased,O
drug,O
therapy,O
.,O
"

",O
Copyright,O
Â©,O
2020,O
American,O
Society,O
for,O
Microbiology,O
.,O
"

",O
DOI,O
:,O
10.1128,O
JVI.0201519,O
"
",O
PMCID,O
:,O
PMC7022351,O
[,O
Available,O
on,O
20200814,O
],O
"
",O
PMID,O
:,O
31826992,O
"


",O
967,O
.,O
Carbohydr,O
Polym,O
.,O
2020,O
Feb,O
1;229:115487,O
.,O
doi,O
:,O
10.1016,O
j.carbpol.2019.115487,O
.,O
Epub,O
"
",O
2019,O
Oct,O
20,O
.,O
"

",O
Structural,O
characterization,O
and,O
antiviral,O
activity,O
of,O
two,O
fucoidans,O
from,O
the,O
"
",O
brown,O
algae,O
Sargassum,O
henslowianum,O
.,O
"

",O
Sun,O
QL(1,O
),O
",",O
Li,O
Y(2,O
),O
",",O
Ni,O
LQ(2,O
),O
",",O
Li,O
YX(1,O
),O
",",O
Cui,O
YS(3,O
),O
",",O
Jiang,O
SL(1,O
),O
",",O
Xie,O
EY(4,O
),O
",",O
Du,O
"
",O
J(5,O
),O
",",O
Deng,O
F(6,O
),O
",",O
Dong,O
CX(7,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Tianjin,O
Key,O
Laboratory,O
on,O
Technologies,O
Enabling,O
Development,O
of,O
Clinical,O
"
",O
Therapeutics,O
and,O
Diagnosis,O
",",O
School,O
of,O
Pharmacy,O
",",O
Tianjin,O
Medical,O
University,O
",",O
"
",O
Tianjin,O
300070,O
",",O
China,O
;,O
Department,O
of,O
Pharmacognosy,O
",",O
College,O
of,O
Pharmacy,O
",",O
Jiamusi,O
"
",O
University,O
",",O
Jiamusi,O
154007,O
",",O
China,O
.,O
"
",O
(2)State,O
Kay,O
Laboratory,O
of,O
Virology,O
and,O
National,O
Virus,O
Resource,O
Center,O
",",O
Wuhan,O
"
",O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430071,O
",",O
China,O
.,O
"
",O
(3)Tianjin,O
Key,O
Laboratory,O
on,O
Technologies,O
Enabling,O
Development,O
of,O
Clinical,O
"
",O
Therapeutics,O
and,O
Diagnosis,O
",",O
School,O
of,O
Pharmacy,O
",",O
Tianjin,O
Medical,O
University,O
",",O
"
",O
Tianjin,O
300070,O
",",O
China,O
.,O
"
",O
(4)College,O
of,O
Fisheries,O
",",O
Guangdong,O
Ocean,O
University,O
",",O
Zhanjiang,O
524088,O
",",O
China,O
.,O
"
",O
(5)Department,O
of,O
Pharmacognosy,O
",",O
College,O
of,O
Pharmacy,O
",",O
Jiamusi,O
University,O
",",O
Jiamusi,O
"
",O
154007,O
",",O
China,O
.,O
"
",O
(6)State,O
Kay,O
Laboratory,O
of,O
Virology,O
and,O
National,O
Virus,O
Resource,O
Center,O
",",O
Wuhan,O
"
",O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430071,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
df@wh.iov.cn,O
.,O
"
",O
(7)Tianjin,O
Key,O
Laboratory,O
on,O
Technologies,O
Enabling,O
Development,O
of,O
Clinical,O
"
",O
Therapeutics,O
and,O
Diagnosis,O
",",O
School,O
of,O
Pharmacy,O
",",O
Tianjin,O
Medical,O
University,O
",",O
"
",O
Tianjin,O
300070,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
dongcaixia@tmu.edu.cn,O
.,O
"

",O
Purified,O
fucoidans,O
SHAP1,O
and,O
SHAP2,O
with,O
apparent,O
molecular,O
weights,O
of,O
"
",O
6.55,O
â€‰,O
Ã—,O
â€‰,O
105,O
and,O
5.89,O
â€‰,O
Ã—,O
â€‰,O
105,O
",",O
respectively,O
",",O
were,O
isolated,O
from,O
Sargassum,O
"
",O
henslowianum,O
by,O
ionexchange,O
and,O
gelfiltration,O
column,O
chromatography,O
.,O
They,O
are,O
"
",O
both,O
composed,O
of,O
fucose,O
and,O
galactose,O
at,O
a,O
ratio,O
of,O
around,O
0.125694444,O
and,O
31.9,O
%,O
sulfate,O
.,O
"
",O
The,O
backbone,O
of,O
two,O
fucoidans,O
consists,O
of,O
Î±(1â†’3)linked,O
LFucp,O
residues,O
which,O
"
",O
are,O
mainly,O
sulfated,O
on,O
the,O
C2,O
and,O
C4,O
positions,O
.,O
Side,O
chains,O
composed,O
of,O
"
",O
terminally,O
linked,O
Î±LFucp,O
and,O
Î±DGalp,O
residues,O
",",O
and,O
(,O
1â†’2,O
),O
",",O
(,O
1â†’6,O
),O
",",O
and,O
"
",O
"(1â†’2,6)linked",O
Î²DGalp,O
residues,O
attach,O
mainly,O
at,O
O4,O
position,O
of,O
backbone,O
"
",O
residues,O
.,O
Antiviral,O
test,O
showed,O
that,O
the,O
IC50,O
values,O
of,O
SHAP1,O
and,O
SHAP2,O
against,O
"
",O
HSV1,O
were,O
estimated,O
to,O
be,O
0.89,O
and,O
0.82,O
â€‰,O
Î¼g,O
mL,O
by,O
plaque,O
reduction,O
assay,O
",",O
"
",O
respectively,O
",",O
whereas,O
both,O
as,O
low,O
as,O
0.48,O
â€‰,O
Î¼g,O
mL,O
against,O
HSV2,O
.,O
The,O
antiviral,O
"
",O
mechanism,O
of,O
the,O
fucoidans,O
might,O
be,O
at,O
least,O
through,O
blocking,O
HSV2,O
virion,O
"
",O
adsorption,O
to,O
host,O
cells,O
.,O
These,O
results,O
suggest,O
that,O
the,O
fucoidans,O
have,O
potential,O
"
",O
clinical,O
applications,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.carbpol.2019.115487,O
"
",O
PMID,O
:,O
31826428,O
"


",O
968,O
.,O
Front,O
Microbiol,O
.,O
2019,O
Nov,O
21;10:2696,O
.,O
doi,O
:,O
10.3389,O
fmicb.2019.02696,O
.,O
eCollection,O
"
",O
2019,O
.,O
"

",O
Molecular,O
Detection,O
and,O
Genetic,O
Characterization,O
of,O
Novel,O
RNA,O
Viruses,O
in,O
Wild,O
and,O
"
",O
Synanthropic,O
Rodents,O
and,O
Shrews,O
in,O
Kenya,O
.,O
"

",O
Onyuok,O
SO(1)(2)(3)(4,O
),O
",",O
Hu,O
B(1)(2)(4,O
),O
",",O
Li,O
B(1,O
),O
",",O
Fan,O
Y(1,O
),O
",",O
Kering,O
K(1)(4,O
),O
",",O
Ochola,O
"
",O
GO(1)(2)(3)(4,O
),O
",",O
Zheng,O
XS(1,O
),O
",",O
Obanda,O
V(5,O
),O
",",O
Ommeh,O
S(6,O
),O
",",O
Yang,O
XL(1)(2)(4,O
),O
",",O
Agwanda,O
"
",O
B(3,O
),O
",",O
Shi,O
ZL(1)(2)(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)CAS,O
Key,O
Laboratory,O
of,O
Special,O
Pathogens,O
and,O
Biosafety,O
",",O
Wuhan,O
Institute,O
of,O
"
",O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)SinoAfrica,O
Joint,O
Research,O
Center,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(3)Mammalogy,O
Section,O
",",O
National,O
Museums,O
of,O
Kenya,O
",",O
Nairobi,O
",",O
Kenya,O
.,O
"
",O
(4)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(5)Veterinary,O
Services,O
Department,O
",",O
Kenya,O
Wildlife,O
Service,O
",",O
Nairobi,O
",",O
Kenya,O
.,O
"
",O
(6)Institute,O
of,O
Biotechnology,O
Research,O
",",O
Jomo,O
Kenyatta,O
University,O
of,O
Science,O
and,O
"
",O
Technology,O
",",O
Nairobi,O
",",O
Kenya,O
.,O
"

",O
The,O
majority,O
of,O
emerging,O
and,O
reemerging,O
zoonotic,O
viral,O
pathogens,O
are,O
RNA,O
viruses,O
.,O
"
",O
Pathogen,O
discovery,O
programs,O
of,O
emerging,O
infectious,O
diseases,O
(,O
EIDs,O
),O
in,O
wildlife,O
"
",O
have,O
implicated,O
rodents,O
and,O
shrews,O
as,O
hosts,O
of,O
diverse,O
human,O
pathogens,O
",",O
such,O
as,O
"
",O
hantaviruses,O
",",O
arenaviruses,O
",",O
paramyxoviruses,O
",",O
etc,O
.,O
Despite,O
these,O
threats,O
",",O
little,O
"
",O
is,O
known,O
about,O
the,O
diversity,O
of,O
viruses,O
circulating,O
among,O
rodents,O
and,O
shrews,O
in,O
"
",O
Kenya,O
",",O
meaning,O
the,O
risk,O
of,O
infectious,O
disease,O
outbreak,O
from,O
these,O
small,O
mammals,O
"
",O
could,O
be,O
oblivious,O
.,O
This,O
study,O
reports,O
the,O
first,O
surveillance,O
toward,O
"
",O
understanding,O
the,O
diversity,O
of,O
RNA,O
viruses,O
carried,O
by,O
rodents,O
and,O
shrews,O
in,O
areas,O
"
",O
of,O
highpotential,O
contact,O
with,O
humans,O
in,O
Kenya,O
through,O
molecular,O
detection,O
.,O
A,O
"
",O
total,O
of,O
617,O
samples,O
comprising,O
fecal,O
",",O
urine,O
",",O
and,O
tissues,O
from,O
138,O
rodents,O
and,O
5,O
"
",O
shrews,O
were,O
screened,O
for,O
eight,O
different,O
families,O
of,O
viruses,O
using,O
RTPCR,O
assays,O
.,O
"
",O
The,O
results,O
highlight,O
the,O
presence,O
of,O
diverse,O
astroviruses,O
",",O
paramyxoviruses,O
",",O
"
",O
hepeviruses,O
",",O
and,O
arenavirus,O
",",O
circulating,O
in,O
both,O
wild,O
and,O
synanthropic,O
Kenyan,O
"
",O
rodents,O
and,O
shrews,O
.,O
Most,O
of,O
the,O
viruses,O
detected,O
in,O
this,O
study,O
are,O
novel,O
strains,O
"
",O
and,O
some,O
belong,O
to,O
the,O
families,O
that,O
contain,O
important,O
human,O
viral,O
pathogens,O
.,O
"
",O
Notably,O
",",O
a,O
novel,O
arenavirus,O
was,O
detected,O
in,O
Grammomys,O
macmillani,O
",",O
a,O
rodent,O
"
",O
species,O
newly,O
identified,O
to,O
harbor,O
arenavirus,O
",",O
and,O
it,O
potentially,O
represent,O
a,O
"
",O
novel,O
arenavirus,O
species,O
.,O
Our,O
findings,O
demonstrate,O
the,O
need,O
for,O
continued,O
"
",O
pathogen,O
surveillance,O
among,O
these,O
small,O
mammals,O
as,O
well,O
as,O
among,O
the,O
vulnerable,O
"
",O
and,O
exposed,O
livestock,O
and,O
humans,O
.,O
This,O
would,O
help,O
in,O
development,O
and,O
"
",O
implementation,O
of,O
effective,O
preventive,O
and,O
control,O
strategies,O
on,O
EIDs,O
in,O
"
",O
countries,O
with,O
rich,O
wildlife,O
biodiversity,O
like,O
Kenya,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Onyuok,O
",",O
Hu,O
",",O
Li,O
",",O
Fan,O
",",O
Kering,O
",",O
Ochola,O
",",O
Zheng,O
",",O
Obanda,O
",",O
Ommeh,O
",",O
Yang,O
",",O
"
",O
Agwanda,O
and,O
Shi,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fmicb.2019.02696,O
"
",O
PMCID,O
:,O
PMC6881279,O
"
",O
PMID,O
:,O
31824465,O
"


",O
969,O
.,O
Front,O
Microbiol,O
.,O
2019,O
Nov,O
22;10:2637,O
.,O
doi,O
:,O
10.3389,O
fmicb.2019.02637,O
.,O
eCollection,O
"
",O
2019,O
.,O
"

",O
Dengue,O
Virus,O
Infection,O
Activates,O
Interleukin1Î²,O
to,O
Induce,O
Tissue,O
Injury,O
and,O
"
",O
Vascular,O
Leakage,O
.,O
"

",O
Pan,O
P(1,O
),O
",",O
Zhang,O
Q(1,O
),O
",",O
Liu,O
W(1,O
),O
",",O
Wang,O
W(2,O
),O
",",O
Yu,O
Z(1,O
),O
",",O
Lao,O
Z(3,O
),O
",",O
Zhang,O
W(3,O
),O
",",O
Shen,O
"
",O
M(1,O
),O
",",O
Wan,O
P(1,O
),O
",",O
Xiao,O
F(1,O
),O
",",O
Shereen,O
MA(1,O
),O
",",O
Zhang,O
W(4,O
),O
",",O
Tan,O
Q(4,O
),O
",",O
Liu,O
Y(5,O
),O
",",O
Liu,O
"
",O
X(3,O
),O
",",O
Wu,O
K(1,O
),O
",",O
Liu,O
Y(1)(2,O
),O
",",O
Li,O
G(3,O
),O
",",O
Wu,O
J(1)(2,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)Key,O
Laboratory,O
of,O
Virology,O
of,O
Guangzhou,O
",",O
Institute,O
of,O
Medical,O
Microbiology,O
",",O
"
",O
Jinan,O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(3)Center,O
for,O
Animal,O
Experiment,O
",",O
Guangzhou,O
University,O
of,O
Chinese,O
Medicine,O
",",O
"
",O
Guangzhou,O
",",O
China,O
.,O
"
",O
(4)Guangdong,O
LongFan,O
Biological,O
Science,O
and,O
Technology,O
",",O
Foshan,O
",",O
China,O
.,O
"
",O
(5)Guangdong,O
Provincial,O
Hospital,O
of,O
Traditional,O
Chinese,O
Medicine,O
",",O
Guangzhou,O
",",O
"
",O
China,O
.,O
"

",O
Dengue,O
virus,O
(,O
DENV,O
),O
infection,O
causes,O
several,O
diseases,O
ranging,O
from,O
dengue,O
fever,O
"
",O
to,O
lifethreatening,O
dengue,O
hemorrhagic,O
fever,O
and,O
dengue,O
shock,O
syndrome,O
"
",O
characterized,O
by,O
endothelial,O
dysfunction,O
",",O
vascular,O
leakage,O
",",O
and,O
shock,O
.,O
Here,O
",",O
we,O
"
",O
identify,O
a,O
potential,O
mechanism,O
by,O
which,O
DENV,O
induces,O
tissue,O
injury,O
and,O
vascular,O
"
",O
leakage,O
by,O
promoting,O
the,O
activation,O
of,O
interleukin,O
(IL)1Î²,O
.,O
DENV,O
facilitates,O
"
",O
IL1Î²,O
secretion,O
in,O
infected,O
patients,O
",",O
mice,O
",",O
human,O
peripheral,O
blood,O
mononuclear,O
"
",O
cells,O
(,O
PBMCs,O
),O
",",O
mouse,O
bone,O
marrowderived,O
macrophages,O
(,O
BMDMs,O
),O
",",O
and,O
"
",O
monocytedifferentiated,O
macrophages,O
(,O
THP1,O
),O
via,O
activating,O
the,O
NLRP3,O
"
",O
inflammasome,O
.,O
The,O
accumulated,O
data,O
suggest,O
that,O
IL1Î²,O
probably,O
induces,O
vascular,O
"
",O
leakage,O
and,O
tissue,O
injury,O
in,O
interferonalpha,O
beta,O
receptor,O
1,O
deficient,O
C57BL,O
6,O
"
",O
mice,O
(,O
IFNAR,O
  ,O
C57BL,O
6,O
),O
",",O
whereas,O
IL1,O
receptor,O
antagonist,O
(,O
IL1RA,O
),O
alleviates,O
"
",O
these,O
effects,O
of,O
IL1Î²,O
.,O
Finally,O
",",O
administration,O
of,O
recombinant,O
IL1Î²,O
protein,O
"
",O
results,O
in,O
vascular,O
leakage,O
and,O
tissue,O
injury,O
in,O
C57BL,O
6,O
mice,O
.,O
Together,O
",",O
the,O
"
",O
accumulated,O
results,O
demonstrate,O
that,O
IL1Î²,O
contributes,O
to,O
DENVassociated,O
"
",O
pathology,O
and,O
suggest,O
that,O
IL1RA,O
acts,O
as,O
a,O
potential,O
agent,O
for,O
the,O
treatment,O
of,O
"
",O
DENVassociated,O
diseases,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Pan,O
",",O
Zhang,O
",",O
Liu,O
",",O
Wang,O
",",O
Yu,O
",",O
Lao,O
",",O
Zhang,O
",",O
Shen,O
",",O
Wan,O
",",O
Xiao,O
",",O
Shereen,O
",",O
"
",O
Zhang,O
",",O
Tan,O
",",O
Liu,O
",",O
Liu,O
",",O
Wu,O
",",O
Liu,O
",",O
Li,O
and,O
Wu,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fmicb.2019.02637,O
"
",O
PMCID,O
:,O
PMC6883832,O
"
",O
PMID,O
:,O
31824450,O
"


",O
970,O
.,O
Fish,O
Shellfish,O
Immunol,O
.,O
2020,O
Jan;96:223234,O
.,O
doi,O
:,O
10.1016,O
j.fsi.2019.12.010,O
.,O
Epub,O
"
",O
2019,O
Dec,O
9,O
.,O
"

",O
Current,O
use,O
and,O
development,O
of,O
fish,O
vaccines,O
in,O
China,O
.,O
"

",O
Wang,O
Q(1,O
),O
",",O
Ji,O
W(2,O
),O
",",O
Xu,O
Z(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Aquatic,O
Animal,O
Medicine,O
",",O
College,O
of,O
Fisheries,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
430070,O
",",O
China,O
.,O
"
",O
(2)Laboratory,O
for,O
Marine,O
Biology,O
and,O
Biotechnology,O
",",O
Qingdao,O
National,O
Laboratory,O
"
",O
for,O
Marine,O
Science,O
and,O
Technology,O
",",O
Qingdao,O
",",O
266071,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Aquatic,O
Animal,O
Medicine,O
",",O
College,O
of,O
Fisheries,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
430070,O
",",O
China,O
;,O
Laboratory,O
for,O
Marine,O
"
",O
Biology,O
and,O
Biotechnology,O
",",O
Qingdao,O
National,O
Laboratory,O
for,O
Marine,O
Science,O
and,O
"
",O
Technology,O
",",O
Qingdao,O
",",O
266071,O
",",O
China,O
.,O
Electronic,O
address,O
:,O
zhenxu@mail.hzau.edu.cn,O
.,O
"

",O
In,O
the,O
past,O
decades,O
",",O
the,O
aquaculture,O
industry,O
made,O
great,O
progress,O
in,O
China,O
",",O
which,O
"
",O
contributes,O
more,O
than,O
70,O
%,O
yield,O
of,O
the,O
world,O
's,O
farmed,O
fish,O
.,O
Along,O
with,O
the,O
rapid,O
"
",O
growth,O
of,O
fish,O
production,O
",",O
increased,O
emergence,O
and,O
outbreak,O
of,O
numbers,O
of,O
"
",O
diseases,O
pose,O
harm,O
to,O
the,O
aquaculture,O
industry,O
and,O
food,O
safety,O
.,O
From,O
the,O
"
",O
efficient,O
",",O
safe,O
",",O
environmental,O
and,O
ethical,O
aspects,O
",",O
vaccines,O
is,O
definitely,O
the,O
"
",O
most,O
appropriate,O
and,O
focused,O
method,O
to,O
control,O
different,O
kinds,O
of,O
fish,O
diseases,O
.,O
"
",O
In,O
China,O
",",O
researchers,O
have,O
done,O
huge,O
works,O
on,O
the,O
fish,O
vaccines,O
",",O
and,O
so,O
far,O
six,O
"
",O
domestic,O
aquatic,O
vaccine,O
products,O
along,O
with,O
one,O
imported,O
aquatic,O
vaccine,O
have,O
"
",O
obtained,O
the,O
national,O
veterinary,O
medicine,O
certificate,O
.,O
More,O
critically,O
",",O
some,O
new,O
"
",O
vaccines,O
have,O
also,O
entered,O
the,O
field,O
experiment,O
stage,O
and,O
showed,O
broad,O
market,O
"
",O
prospects,O
.,O
In,O
the,O
present,O
review,O
",",O
authors,O
summarize,O
seven,O
aquatic,O
vaccines,O
",",O
"
",O
including,O
the,O
live,O
vaccine,O
against,O
grass,O
carp,O
hemorrhagic,O
disease,O
",",O
the,O
"
",O
inactivated,O
vaccine,O
against,O
Aeromonas,O
hydrophila,O
sepsis,O
in,O
fish,O
",",O
the,O
live,O
vaccine,O
"
",O
against,O
Edwardsiella,O
tarda,O
in,O
turbot,O
",",O
the,O
antiidiotypic,O
antibody,O
vaccine,O
against,O
"
",O
Vibrio,O
alginolyticus,O
",",O
V.,O
parahaemolyticus,O
",",O
and,O
E.,O
tarda,O
in,O
Japanese,O
flounder,O
",",O
the,O
"
",O
cellcultured,O
inactivated,O
vaccine,O
against,O
grass,O
carp,O
hemorrhagic,O
disease,O
",",O
the,O
"
",O
inactivated,O
vaccine,O
against,O
fish,O
infectious,O
spleen,O
and,O
kidney,O
necrosis,O
virus,O
"
",O
(,O
ISKNV,O
),O
",",O
and,O
the,O
genetically,O
engineered,O
live,O
vaccine,O
against,O
V.,O
anguillarum,O
in,O
"
",O
turbot,O
.,O
Moreover,O
",",O
different,O
delivery,O
routes,O
of,O
fish,O
vaccines,O
are,O
also,O
compared,O
in,O
"
",O
this,O
review,O
",",O
along,O
with,O
differential,O
fish,O
immune,O
response,O
after,O
vaccination,O
.,O
All,O
"
",O
these,O
efforts,O
will,O
ultimately,O
benefit,O
the,O
healthy,O
and,O
sustainable,O
development,O
of,O
"
",O
aquaculture,O
industry,O
in,O
China,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Elsevier,O
Ltd.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.fsi.2019.12.010,O
"
",O
PMID,O
:,O
31821845,O
"


",O
971,O
.,O
Viruses,O
.,O
2019,O
Dec,O
6;11(12,O
),O
.,O
pii,O
:,O
E1128,O
.,O
doi,O
:,O
10.339,O
v11121128,O
.,O
"

",O
Suggestive,O
Serological,O
Evidence,O
of,O
Infection,O
with,O
ShrewBorne,O
Imjin,O
Virus,O
"
",O
(,O
Hantaviridae,O
),O
in,O
Humans,O
.,O
"

",O
Qi,O
R(1,O
),O
",",O
Sun,O
XF(2,O
),O
",",O
Qin,O
XR(1,O
),O
",",O
Wang,O
LJ(1,O
),O
",",O
Zhao,O
M(1,O
),O
",",O
Jiang,O
F(3,O
),O
",",O
Wang,O
L(4,O
),O
",",O
Lei,O
"
",O
XY(2,O
),O
",",O
Liu,O
JW(1,O
),O
",",O
Yu,O
XJ(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
School,O
of,O
Health,O
Sciences,O
",",O
Wuhan,O
University,O
",",O
"
",O
Wuhan,O
430071,O
",",O
China,O
.,O
"
",O
(2)School,O
of,O
Public,O
Health,O
",",O
Shandong,O
University,O
",",O
Jinan,O
250012,O
",",O
China,O
.,O
"
",O
(3)Qingdao,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Qingdao,O
266033,O
",",O
China,O
.,O
"
",O
(4)Zibo,O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Zibo,O
255026,O
",",O
China,O
.,O
"

",O
The,O
pathogenicity,O
of,O
the,O
shrewborne,O
Imjin,O
virus,O
(,O
MJNV,O
),O
is,O
unknown,O
.,O
The,O
objective,O
"
",O
of,O
our,O
study,O
was,O
to,O
find,O
serological,O
evidence,O
of,O
MJNV,O
infection,O
in,O
humans,O
.,O
"
",O
Partial,O
MJNV,O
nucleocapsid,O
protein,O
(,O
NP,O
),O
was,O
cloned,O
and,O
expressed,O
as,O
an,O
antigen,O
for,O
"
",O
doubleantigen,O
sandwich,O
ELISA,O
",",O
IgM,O
capture,O
ELISA,O
",",O
and,O
dot,O
blot,O
to,O
detect,O
MJNV,O
"
",O
specific,O
antibodies,O
in,O
hemorrhagic,O
fever,O
with,O
renal,O
syndrome,O
(,O
HFRS,O
),O
patients,O
',O
and,O
"
",O
healthy,O
persons,O
',O
sera,O
from,O
endemic,O
areas,O
in,O
China,O
.,O
The,O
purified,O
recombinant,O
NP,O
"
",O
reacted,O
with,O
neither,O
the,O
90,O
healthy,O
individuals,O
',O
sera,O
from,O
nonendemic,O
areas,O
of,O
"
",O
MJNV,O
nor,O
the,O
100,O
antisera,O
to,O
HFRScausing,O
virus,O
",",O
indicating,O
that,O
the,O
MJNV,O
NP,O
had,O
"
",O
no,O
crossreaction,O
with,O
normal,O
human,O
sera,O
and,O
HFRScausing,O
viral,O
antibodies,O
.,O
As,O
"
",O
determined,O
by,O
screening,O
ELISA,O
and,O
dot,O
blot,O
analysis,O
",",O
IgG,O
antibodies,O
against,O
MJNV,O
"
",O
NP,O
were,O
detected,O
in,O
sera,O
from,O
two,O
of,O
385,O
healthy,O
individuals,O
from,O
MJNVendemic,O
"
",O
areas,O
",",O
suggesting,O
infection,O
with,O
MJNV,O
or,O
MJNVlike,O
thottimvirus,O
.,O
Based,O
on,O
the,O
"
",O
suggestive,O
evidence,O
",",O
healthcare,O
workers,O
should,O
be,O
alert,O
to,O
febrile,O
diseases,O
"
",O
occurring,O
among,O
individuals,O
with,O
exposure,O
to,O
shrewinfested,O
habitats,O
.,O
"

",O
DOI,O
:,O
10.339,O
v11121128,O
"
",O
PMCID,O
:,O
PMC6949945,O
"
",O
PMID,O
:,O
31817575,O
"


",O
972,O
.,O
Viruses,O
.,O
2019,O
Dec,O
3;11(12,O
),O
.,O
pii,O
:,O
E1118,O
.,O
doi,O
:,O
10.339,O
v11121118,O
.,O
"

",O
MonophosphorylLipid,O
A,O
(,O
MPLA,O
),O
is,O
an,O
Efficacious,O
Adjuvant,O
for,O
Inactivated,O
Rabies,O
"
",O
Vaccines,O
.,O
"

",O
Chen,O
C(1)(2)(3,O
),O
",",O
Zhang,O
C(1)(2)(3,O
),O
",",O
Li,O
R(1)(2)(3,O
),O
",",O
Wang,O
Z(1)(2)(3,O
),O
",",O
Yuan,O
"
",O
Y(1)(2)(3,O
),O
",",O
Li,O
H(1)(2)(3,O
),O
",",O
Fu,O
Z(1)(2)(3)(4,O
),O
",",O
Zhou,O
M(1)(2)(3,O
),O
",",O
Zhao,O
L(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
Hubei,O
430070,O
",",O
China,O
.,O
"
",O
(2)College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
Hubei,O
"
",O
430070,O
",",O
China,O
.,O
"
",O
(3)Key,O
Laboratory,O
of,O
Preventive,O
Veterinary,O
Medicine,O
of,O
Hubei,O
Province,O
",",O
Huazhong,O
"
",O
Agricultural,O
University,O
",",O
Wuhan,O
Hubei,O
430070,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Pathology,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
University,O
of,O
"
",O
Georgia,O
",",O
Athens,O
",",O
GA,O
30602,O
",",O
USA,O
.,O
"

",O
Rabies,O
",",O
as,O
one,O
of,O
the,O
most,O
threatening,O
zoonoses,O
in,O
the,O
world,O
",",O
causes,O
a,O
fatal,O
"
",O
central,O
nervous,O
system,O
(,O
CNS,O
),O
disease,O
.,O
So,O
far,O
",",O
vaccination,O
with,O
rabies,O
vaccines,O
"
",O
has,O
been,O
the,O
most,O
effective,O
measure,O
to,O
prevent,O
and,O
control,O
this,O
disease,O
.,O
At,O
"
",O
present,O
",",O
inactivated,O
rabies,O
vaccines,O
are,O
widely,O
used,O
in,O
humans,O
and,O
domestic,O
"
",O
animals,O
.,O
However,O
",",O
humoral,O
immune,O
responses,O
induced,O
by,O
inactivated,O
rabies,O
vaccines,O
"
",O
are,O
relatively,O
low,O
and,O
multiple,O
shots,O
are,O
required,O
to,O
achieve,O
protective,O
"
",O
immunity,O
.,O
Supplementation,O
with,O
an,O
adjuvant,O
is,O
a,O
practical,O
way,O
to,O
improve,O
the,O
"
",O
immunogenicity,O
of,O
inactivated,O
rabies,O
vaccines,O
.,O
In,O
this,O
study,O
",",O
we,O
found,O
that,O
"
",O
monophosphoryllipid,O
A,O
(,O
MPLA,O
),O
",",O
a,O
wellknown,O
TLR4,O
agonist,O
",",O
could,O
significantly,O
"
",O
promote,O
the,O
maturation,O
of,O
bone,O
marrowderived,O
dendritic,O
cells,O
(,O
BMDC,O
),O
through,O
a,O
"
",O
TLR4dependent,O
pathway,O
in,O
vitro,O
and,O
the,O
maturation,O
of,O
conventional,O
DCs,O
(,O
cDCs,O
),O
in,O
"
",O
vivo,O
.,O
We,O
also,O
found,O
that,O
MPLA,O
",",O
serving,O
as,O
an,O
adjuvant,O
for,O
inactivated,O
rabies,O
"
",O
vaccines,O
",",O
could,O
significantly,O
facilitate,O
the,O
generation,O
of,O
T,O
follicular,O
helper,O
"
",O
(,O
Tfh,O
),O
cells,O
",",O
germinal,O
center,O
(,O
GC,O
),O
B,O
cells,O
",",O
and,O
plasma,O
cells,O
(,O
PCs,O
),O
",",O
consequently,O
"
",O
enhancing,O
the,O
production,O
of,O
RABVspecific,O
totalIgG,O
",",O
IgG2a,O
",",O
IgG2b,O
",",O
and,O
the,O
"
",O
virusneutralizing,O
antibodies,O
(,O
VNAs,O
),O
.,O
Furthermore,O
",",O
MPLA,O
could,O
increase,O
the,O
"
",O
survival,O
ratio,O
of,O
mice,O
challenged,O
with,O
virulent,O
RABV,O
.,O
In,O
conclusion,O
",",O
our,O
results,O
"
",O
demonstrate,O
that,O
MPLA,O
serving,O
as,O
an,O
adjuvant,O
enhances,O
the,O
intensity,O
of,O
humoral,O
"
",O
immune,O
responses,O
by,O
activating,O
the,O
cDCTfhGC,O
B,O
axis,O
.,O
Our,O
findings,O
will,O
"
",O
contribute,O
to,O
the,O
improvement,O
of,O
the,O
efficiency,O
of,O
traditional,O
rabies,O
vaccines,O
.,O
"

",O
DOI,O
:,O
10.339,O
v11121118,O
"
",O
PMCID,O
:,O
PMC6950009,O
"
",O
PMID,O
:,O
31816996,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflicts,O
of,O
interest,O
.,O
"


",O
973,O
.,O
Harmful,O
Algae,O
.,O
2019,O
May;85:101699,O
.,O
doi,O
:,O
10.1016,O
j.hal.2019.101699,O
.,O
Epub,O
2019,O
Nov,O
"
",O
8,O
.,O
"

",O
Interaction,O
between,O
cyanophage,O
MaMVDC,O
and,O
eight,O
Microcystis,O
strains,O
",",O
revealed,O
by,O
"
",O
genetic,O
defense,O
systems,O
.,O
"

",O
Wang,O
J(1,O
),O
",",O
Bai,O
P(2,O
),O
",",O
Li,O
Q(3,O
),O
",",O
Lin,O
Y(3,O
),O
",",O
Huo,O
D(2,O
),O
",",O
Ke,O
F(3,O
),O
",",O
Zhang,O
Q(4,O
),O
",",O
Li,O
T(5,O
),O
",",O
"
",O
Zhao,O
J(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
;,O
University,O
of,O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
100049,O
",",O
China,O
;,O
Key,O
Laboratory,O
of,O
"
",O
Combinatorial,O
Biosynthesis,O
and,O
Drug,O
Discovery,O
",",O
Ministry,O
of,O
Education,O
",",O
School,O
of,O
"
",O
Pharmaceutical,O
Sciences,O
",",O
Zhongnan,O
Hospital,O
",",O
Wuhan,O
University,O
",",O
Wuhan,O
430071,O
",",O
"
",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
;,O
University,O
of,O
"
",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
100049,O
",",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
zhangqy@ihb.ac.cn,O
.,O
"
",O
(5)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
.,O
Electronic,O
"
",O
address,O
:,O
litao@ihb.ac.cn,O
.,O
"
",O
(6)State,O
Key,O
Laboratory,O
of,O
Freshwater,O
Ecology,O
and,O
Biotechnology,O
",",O
Institute,O
of,O
"
",O
Hydrobiology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430072,O
",",O
China,O
;,O
State,O
Key,O
"
",O
Laboratory,O
of,O
Protein,O
and,O
Plant,O
Genetic,O
Engineering,O
",",O
College,O
of,O
Life,O
Sciences,O
",",O
"
",O
Peking,O
University,O
",",O
Beijing,O
100871,O
",",O
China,O
.,O
"

",O
Cyanophage,O
MaMVDC,O
is,O
a,O
member,O
of,O
Myoviridae,O
that,O
was,O
reported,O
to,O
specifically,O
"
",O
infect,O
and,O
lyse,O
Microcystis,O
aeruginosa,O
FACHB524,O
among,O
21,O
selected,O
cyanobacterial,O
"
",O
strains,O
.,O
We,O
reidentified,O
the,O
infection,O
specificity,O
of,O
MaMVDC,O
among,O
seven,O
other,O
"
",O
Microcystis,O
strains,O
of,O
different,O
species,O
.,O
In,O
our,O
experiments,O
",",O
MaMVDC,O
infected,O
"
",O
three,O
Microcystis,O
strains,O
but,O
did,O
not,O
form,O
plaque,O
in,O
Microcystis,O
lawns,O
.,O
This,O
"
",O
indicated,O
that,O
MaMVDC,O
is,O
at,O
least,O
a,O
genus,O
rather,O
than,O
strainspecific,O
virus,O
.,O
"
",O
Cyanophage,O
MaMVDC,O
genes,O
were,O
transcribed,O
in,O
M.,O
aeruginosa,O
FACHB524,O
",",O
M.,O
"
",O
flosaquae,O
TF09,O
",",O
M.,O
aeruginosa,O
TA09,O
and,O
M.,O
wesenbergii,O
DW09,O
",",O
and,O
the,O
growth,O
of,O
"
",O
these,O
Microcystis,O
strains,O
was,O
inhibited,O
by,O
the,O
addition,O
of,O
MaMVDC,O
.,O
The,O
predicted,O
"
",O
defense,O
of,O
eight,O
Microcystis,O
strains,O
by,O
CRISPRCas,O
systems,O
has,O
shown,O
mixed,O
"
",O
consistency,O
with,O
the,O
infection,O
experiment,O
results,O
",",O
suggesting,O
other,O
defense,O
or,O
"
",O
antidefense,O
systems,O
play,O
roles,O
during,O
infection,O
process,O
.,O
"
",O
Restrictionmodification,O
(,O
RM,O
),O
system,O
analysis,O
revealed,O
an,O
abundance,O
of,O
four,O
types,O
"
",O
of,O
RM,O
proteins,O
that,O
may,O
play,O
roles,O
in,O
defense,O
against,O
cyanophages,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
The,O
Authors,O
.,O
Published,O
by,O
Elsevier,O
B.V.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.hal.2019.101699,O
"
",O
PMID,O
:,O
31810530,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
974,O
.,O
Viruses,O
.,O
2019,O
Dec,O
2;11(12,O
),O
.,O
pii,O
:,O
E1117,O
.,O
doi,O
:,O
10.339,O
v11121117,O
.,O
"

",O
Ebola,O
Virus,O
Uptake,O
into,O
Polarized,O
Cells,O
from,O
the,O
Apical,O
Surface,O
.,O
"

",O
Hu,O
M(1)(2,O
),O
",",O
Wang,O
F(1)(2,O
),O
",",O
Li,O
W(1,O
),O
",",O
Zhang,O
X(1,O
),O
",",O
Zhang,O
Z(1,O
),O
",",O
Zhang,O
XE(3,O
),O
",",O
Cui,O
Z(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Center,O
for,O
"
",O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
430071,O
",",O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
100049,O
Beijing,O
",",O
China,O
.,O
"
",O
(3)National,O
Laboratory,O
of,O
Biomacromolecules,O
",",O
Institute,O
of,O
Biophysics,O
",",O
Chinese,O
"
",O
Academy,O
of,O
Sciences,O
",",O
100101,O
Beijing,O
",",O
China,O
.,O
"

",O
Ebola,O
virus,O
(,O
EBOV,O
),O
causes,O
severe,O
hemorrhagic,O
fever,O
with,O
high,O
mortality,O
rates,O
.,O
"
",O
EBOV,O
can,O
infect,O
many,O
types,O
of,O
cells,O
.,O
During,O
severe,O
EBOV,O
infection,O
",",O
polarized,O
"
",O
epithelial,O
and,O
endothelial,O
cells,O
are,O
damaged,O
",",O
which,O
promotes,O
vascular,O
instability,O
"
",O
and,O
dysregulation,O
.,O
However,O
",",O
the,O
mechanism,O
causing,O
these,O
symptoms,O
is,O
largely,O
"
",O
unknown,O
.,O
Here,O
",",O
we,O
studied,O
virus,O
infection,O
in,O
polarized,O
Vero,O
C1008,O
cells,O
grown,O
on,O
"
",O
semipermeable,O
Transwell,O
by,O
using,O
EGFPlabeled,O
Ebola,O
viruslike,O
particles,O
(,O
VLPs,O
),O
.,O
"
",O
Our,O
results,O
showed,O
that,O
Ebola,O
VLPs,O
preferred,O
to,O
enter,O
polarized,O
Vero,O
cells,O
from,O
"
",O
the,O
apical,O
cell,O
surface,O
.,O
Furthermore,O
",",O
we,O
showed,O
that,O
the,O
EBOV,O
receptors,O
TIM1,O
and,O
"
",O
Axl,O
were,O
distributed,O
apically,O
",",O
which,O
could,O
be,O
responsible,O
for,O
mediating,O
efficient,O
"
",O
apical,O
viral,O
entry,O
.,O
Macropinocytosis,O
and,O
intracellular,O
receptor,O
NiemannPick,O
type,O
"
",O
C1,O
(,O
NPC1,O
),O
had,O
no,O
polarized,O
distribution,O
",",O
although,O
they,O
played,O
roles,O
in,O
virus,O
"
",O
entry,O
.,O
This,O
study,O
provides,O
a,O
new,O
view,O
of,O
EBOV,O
uptake,O
and,O
cell,O
polarization,O
",",O
which,O
"
",O
facilitates,O
a,O
further,O
understanding,O
of,O
EBOV,O
infection,O
and,O
pathogenesis,O
.,O
"

",O
DOI,O
:,O
10.339,O
v11121117,O
"
",O
PMCID,O
:,O
PMC6949903,O
"
",O
PMID,O
:,O
31810353,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
The,O
"
",O
funders,O
had,O
no,O
role,O
in,O
the,O
design,O
of,O
the,O
study,O
;,O
in,O
the,O
collection,O
",",O
analyses,O
",",O
or,O
"
",O
interpretation,O
of,O
data,O
;,O
in,O
the,O
writing,O
of,O
the,O
manuscript,O
",",O
or,O
in,O
the,O
decision,O
to,O
"
",O
publish,O
the,O
results,O
.,O
"


",O
975,O
.,O
Neurosci,O
Bull,O
.,O
2019,O
Dec,O
5,O
.,O
doi,O
:,O
10.1007,O
s1226401900452y,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
In,O
Vivo,O
Twophoton,O
Calcium,O
Imaging,O
in,O
Dendrites,O
of,O
Rabies,O
Viruslabeled,O
V1,O
"
",O
Corticothalamic,O
Neurons,O
.,O
"

",O
Tang,O
Y(1)(2)(3,O
),O
",",O
Li,O
L(2)(3,O
),O
",",O
Sun,O
L(2)(3,O
),O
",",O
Yu,O
J(2)(3,O
),O
",",O
Hu,O
Z(2,O
),O
",",O
Lian,O
K(1,O
),O
",",O
Cao,O
"
",O
G(2)(3)(4)(5,O
),O
",",O
Dai,O
J(6)(7)(8)(9,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Academician,O
Workstation,O
of,O
Animal,O
Disease,O
Control,O
and,O
Nutrition,O
Immunity,O
in,O
"
",O
Henan,O
Province,O
",",O
Henan,O
Joint,O
International,O
Research,O
Laboratory,O
of,O
Veterinary,O
"
",O
Biologics,O
Research,O
and,O
Application,O
",",O
Anyang,O
Institute,O
of,O
Technology,O
",",O
Anyang,O
",",O
"
",O
455000,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"
",O
(3)College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
"
",O
430070,O
",",O
China,O
.,O
"
",O
(4)Biomedical,O
Center,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"
",O
(5)Key,O
Laboratory,O
of,O
Development,O
of,O
Veterinary,O
Diagnostic,O
Products,O
",",O
Ministry,O
of,O
"
",O
Agriculture,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
"
",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"
",O
(6)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
Huazhong,O
Agricultural,O
"
",O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
jxdai@mail.hzau.edu.cn,O
.,O
"
",O
(7)College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
"
",O
430070,O
",",O
China,O
.,O
jxdai@mail.hzau.edu.cn,O
.,O
"
",O
(8)Biomedical,O
Center,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"
",O
jxdai@mail.hzau.edu.cn,O
.,O
"
",O
(9)Key,O
Laboratory,O
of,O
Development,O
of,O
Veterinary,O
Diagnostic,O
Products,O
",",O
Ministry,O
of,O
"
",O
Agriculture,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
"
",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
jxdai@mail.hzau.edu.cn,O
.,O
"

",O
Monitoring,O
neuronal,O
activity,O
in,O
vivo,O
is,O
critical,O
to,O
understanding,O
the,O
"
",O
physiological,O
or,O
pathological,O
functions,O
of,O
the,O
brain,O
.,O
Twophoton,O
Ca2,O
+,O
imaging,O
in,O
"
",O
vivo,O
using,O
a,O
cranial,O
window,O
and,O
specific,O
neuronal,O
labeling,O
enables,O
realtime,O
",",O
in,O
"
",O
situ,O
",",O
and,O
longterm,O
imaging,O
of,O
the,O
living,O
brain,O
.,O
Here,O
",",O
we,O
constructed,O
a,O
"
",O
recombinant,O
rabies,O
virus,O
containing,O
the,O
Ca2,O
+,O
indicator,O
GCaMP6s,O
along,O
with,O
the,O
"
",O
fluorescent,O
protein,O
DsRed2,O
as,O
a,O
baseline,O
reference,O
to,O
ensure,O
GCaMP6s,O
signal,O
"
",O
reliability,O
.,O
This,O
functional,O
tracer,O
was,O
applied,O
to,O
retrogradely,O
label,O
specific,O
"
",O
V1thalamus,O
circuits,O
and,O
detect,O
spontaneous,O
Ca2,O
+,O
activity,O
in,O
the,O
dendrites,O
of,O
V1,O
"
",O
corticothalamic,O
neurons,O
by,O
in,O
vivo,O
twophoton,O
Ca2,O
+,O
imaging,O
.,O
Notably,O
",",O
we,O
were,O
able,O
"
",O
to,O
record,O
singlespine,O
spontaneous,O
Ca2,O
+,O
activity,O
in,O
specific,O
circuits,O
.,O
Distinct,O
"
",O
spontaneous,O
Ca2,O
+,O
dynamics,O
in,O
dendrites,O
of,O
V1,O
corticothalamic,O
neurons,O
were,O
found,O
"
",O
for,O
different,O
V1thalamus,O
circuits,O
.,O
Our,O
method,O
can,O
be,O
applied,O
to,O
monitor,O
Ca2,O
+,O
"
",O
dynamics,O
in,O
specific,O
input,O
circuits,O
in,O
vivo,O
",",O
and,O
contribute,O
to,O
functional,O
studies,O
"
",O
of,O
defined,O
neural,O
circuits,O
and,O
the,O
dissection,O
of,O
functional,O
circuit,O
connections,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s1226401900452y,O
"
",O
PMID,O
:,O
31808041,O
"


",O
976,O
.,O
Ann,O
Transl,O
Med,O
.,O
2019,O
Oct;7(20):589,O
.,O
doi,O
:,O
10.21037,O
atm.2019.09.81,O
.,O
"

",O
Arthritis,O
caused,O
by,O
Legionella,O
micdadei,O
and,O
Staphylococcus,O
aureus,O
:,O
metagenomic,O
"
",O
nextgeneration,O
sequencing,O
provides,O
a,O
rapid,O
and,O
accurate,O
access,O
to,O
diagnosis,O
and,O
"
",O
surveillance,O
.,O
"

",O
Huang,O
Y(1,O
),O
",",O
Ma,O
Y(1,O
),O
",",O
Miao,O
Q(1,O
),O
",",O
Pan,O
J(1,O
),O
",",O
Hu,O
B(1,O
),O
",",O
Gong,O
Y(2,O
),O
",",O
Lin,O
Y(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
infectious,O
diseases,O
",",O
Zhongshan,O
Hospital,O
",",O
Fudan,O
University,O
",",O
"
",O
Shanghai,O
200032,O
",",O
China,O
.,O
"
",O
(2)Tianjin,O
Medical,O
Laboratory,O
",",O
BGITianjin,O
",",O
BGIShenzhen,O
",",O
Tianjin,O
300308,O
",",O
China,O
.,O
"
",O
(3)Wuhan,O
research,O
and,O
development,O
of,O
infectious,O
diseases,O
department,O
",",O
BGIWuhan,O
",",O
"
",O
Wuhan,O
430075,O
",",O
China,O
.,O
"

",O
Legionella,O
spp,O
.,O
is,O
an,O
important,O
pulmonary,O
pathogen,O
but,O
rarely,O
causes,O
"
",O
extrapulmonary,O
infections,O
.,O
We,O
report,O
a,O
case,O
of,O
joint,O
infection,O
caused,O
by,O
"
",O
Legionella,O
micdadei,O
and,O
Staphylococcus,O
aureus,O
in,O
a,O
54yearold,O
male,O
with,O
"
",O
medication,O
history,O
of,O
oral,O
steroid,O
for,O
systemic,O
lupus,O
erythematosus,O
(,O
SLE,O
),O
.,O
He,O
"
",O
developed,O
arthritis,O
in,O
his,O
right,O
metacarpophalangeal,O
(,O
MCP,O
),O
joints,O
without,O
"
",O
precursor,O
pneumonia,O
.,O
In,O
the,O
joint,O
aspirate,O
",",O
S.,O
aureus,O
was,O
detected,O
through,O
"
",O
culture,O
.,O
The,O
existence,O
of,O
L.,O
micdadei,O
and,O
S.,O
aureus,O
were,O
indicated,O
by,O
metagenomic,O
"
",O
nextgeneration,O
sequencing,O
(,O
mNGS,O
),O
and,O
confirmed,O
by,O
16S,O
rRNA,O
sequence,O
analysis,O
.,O
"
",O
After,O
oral,O
levofloxacin,O
treatment,O
for,O
54,O
days,O
",",O
the,O
patient,O
's,O
symptoms,O
ameliorated,O
"
",O
and,O
blood,O
test,O
results,O
improved,O
",",O
which,O
were,O
consistent,O
with,O
the,O
dynamic,O
trend,O
of,O
"
",O
reads,O
numbers,O
in,O
mNGS,O
data,O
.,O
Our,O
case,O
included,O
",",O
arthritis,O
caused,O
by,O
Legionella,O
"
",O
spp,O
.,O
have,O
been,O
reported,O
in,O
11,O
patients,O
.,O
However,O
",",O
our,O
case,O
is,O
the,O
first,O
to,O
report,O
"
",O
septic,O
arthritis,O
caused,O
by,O
L.,O
micdadei,O
in,O
native,O
joints,O
and,O
monitored,O
by,O
mNGS,O
.,O
"
",O
This,O
case,O
demonstrated,O
an,O
application,O
of,O
mNGS,O
for,O
etiological,O
diagnosis,O
and,O
"
",O
semiquantification,O
in,O
joint,O
aspirate,O
.,O
mNGS,O
may,O
serve,O
as,O
a,O
promising,O
tool,O
for,O
"
",O
rapid,O
and,O
accurate,O
etiological,O
diagnosis,O
and,O
surveillance,O
",",O
contributing,O
to,O
"
",O
appropriate,O
antimicrobial,O
drug,O
applications,O
and,O
timely,O
medication,O
adjustments,O
"
",O
when,O
necessary,O
.,O
"

",O
2019,O
Annals,O
of,O
Translational,O
Medicine,O
.,O
All,O
rights,O
reserved,O
.,O
"

",O
DOI,O
:,O
10.21037,O
atm.2019.09.81,O
"
",O
PMCID,O
:,O
PMC6861802,O
"
",O
PMID,O
:,O
31807570,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
Conflicts,O
of,O
Interest,O
:,O
The,O
authors,O
have,O
no,O
"
",O
conflicts,O
of,O
interest,O
to,O
declare,O
.,O
"


",O
977,O
.,O
Viruses,O
.,O
2019,O
Nov,O
30;11(12,O
),O
.,O
pii,O
:,O
E1113,O
.,O
doi,O
:,O
10.339,O
v11121113,O
.,O
"

",O
Viruses,O
Infecting,O
the,O
Plant,O
Pathogenic,O
Fungus,O
Rhizoctonia,O
solani,O
.,O
"

",O
Abdoulaye,O
AH(1,O
),O
",",O
Foda,O
MF(1)(2)(3,O
),O
",",O
KottaLoizou,O
I(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Plant,O
Science,O
"
",O
and,O
Technology,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
",",O
College,O
of,O
Veterinary,O
"
",O
Medicine,O
",",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
430070,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Biochemistry,O
",",O
Faculty,O
of,O
Agriculture,O
",",O
Benha,O
University,O
",",O
"
",O
Moshtohor,O
",",O
Toukh,O
13736,O
",",O
Egypt,O
.,O
"
",O
(4)Department,O
of,O
Life,O
Sciences,O
",",O
Imperial,O
College,O
London,O
",",O
London,O
SW7,O
2AZ,O
",",O
UK,O
.,O
"

",O
The,O
cosmopolitan,O
fungus,O
Rhizoctonia,O
solani,O
has,O
a,O
wide,O
host,O
range,O
and,O
is,O
the,O
"
",O
causal,O
agent,O
of,O
numerous,O
crop,O
diseases,O
",",O
leading,O
to,O
significant,O
economic,O
losses,O
.,O
"
",O
To,O
date,O
",",O
no,O
cultivars,O
showing,O
complete,O
resistance,O
to,O
R.,O
solani,O
have,O
been,O
"
",O
identified,O
and,O
it,O
is,O
imperative,O
to,O
develop,O
a,O
strategy,O
to,O
control,O
the,O
spread,O
of,O
"
",O
the,O
disease,O
.,O
Fungal,O
viruses,O
",",O
or,O
mycoviruses,O
",",O
are,O
widespread,O
in,O
all,O
major,O
groups,O
"
",O
of,O
fungi,O
and,O
nextgeneration,O
sequencing,O
(,O
NGS,O
),O
is,O
currently,O
the,O
most,O
efficient,O
"
",O
approach,O
for,O
their,O
identification,O
.,O
An,O
increasing,O
number,O
of,O
novel,O
mycoviruses,O
are,O
"
",O
being,O
reported,O
",",O
including,O
doublestranded,O
(,O
ds,O
),O
RNA,O
",",O
circular,O
singlestranded,O
(,O
ss,O
),O
"
",O
DNA,O
",",O
negative,O
sense,O
(,O
),O
ssRNA,O
",",O
and,O
positive,O
sense,O
(+)ssRNA,O
viruses,O
.,O
The,O
majority,O
"
",O
of,O
mycovirus,O
infections,O
are,O
cryptic,O
with,O
no,O
obvious,O
symptoms,O
on,O
the,O
hosts,O
;,O
"
",O
however,O
",",O
some,O
mycoviruses,O
may,O
alter,O
fungal,O
host,O
pathogenicity,O
resulting,O
in,O
"
",O
hypervirulence,O
or,O
hypovirulence,O
and,O
are,O
therefore,O
potential,O
biological,O
control,O
"
",O
agents,O
that,O
could,O
be,O
used,O
to,O
combat,O
fungal,O
diseases,O
.,O
R.,O
solani,O
harbors,O
a,O
range,O
of,O
"
",O
dsRNA,O
and,O
ssRNA,O
viruses,O
",",O
either,O
belonging,O
to,O
established,O
families,O
",",O
such,O
as,O
"
",O
Endornaviridae,O
",",O
Tymoviridae,O
",",O
Partitiviridae,O
",",O
and,O
Narnaviridae,O
",",O
or,O
unclassified,O
",",O
"
",O
and,O
some,O
of,O
them,O
have,O
been,O
associated,O
with,O
hypervirulence,O
or,O
hypovirulence,O
.,O
Here,O
"
",O
we,O
discuss,O
in,O
depth,O
the,O
molecular,O
features,O
of,O
known,O
viruses,O
infecting,O
R.,O
solani,O
"
",O
and,O
their,O
potential,O
as,O
biological,O
control,O
agents,O
.,O
"

",O
DOI,O
:,O
10.339,O
v11121113,O
"
",O
PMCID,O
:,O
PMC6950361,O
"
",O
PMID,O
:,O
31801308,O
"


",O
978,O
.,O
Front,O
Microbiol,O
.,O
2019,O
Nov,O
14;10:2638,O
.,O
doi,O
:,O
10.3389,O
fmicb.2019.02638,O
.,O
eCollection,O
"
",O
2019,O
.,O
"

",O
Evans,O
Blue,O
Inhibits,O
HBV,O
Replication,O
Through,O
a,O
Dual,O
Antiviral,O
Mechanism,O
by,O
"
",O
Targeting,O
Virus,O
Binding,O
and,O
Capsid,O
Assembly,O
.,O
"

",O
Xiao,O
Y(1)(2,O
),O
",",O
Liu,O
C(1,O
),O
",",O
Tang,O
W(1,O
),O
",",O
Zhang,O
H(1,O
),O
",",O
Chen,O
X(1)(2)(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
"
",O
of,O
Sciences,O
",",O
Wuhan,O
",",O
China,O
.,O
"
",O
(2)University,O
of,O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Beijing,O
",",O
China,O
.,O
"
",O
(3)Guangdong,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Institute,O
of,O
Medical,O
Microbiology,O
",",O
Jinan,O
"
",O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"

",O
Chronic,O
hepatitis,O
B,O
(,O
CHB,O
),O
is,O
a,O
global,O
health,O
problem,O
caused,O
by,O
human,O
hepatitis,O
B,O
"
",O
virus,O
(,O
HBV,O
),O
.,O
Current,O
treatment,O
with,O
interferons,O
and,O
nucleos(t)ide,O
analogs,O
(,O
NAs,O
),O
"
",O
can,O
cause,O
population,O
tolerance,O
and,O
drug,O
resistance,O
.,O
Therefore,O
",",O
new,O
antiviral,O
"
",O
drugs,O
",",O
especially,O
those,O
targeting,O
host,O
factors,O
",",O
are,O
urgently,O
needed,O
.,O
Here,O
",",O
we,O
"
",O
identified,O
Evans,O
blue,O
as,O
a,O
new,O
HBV,O
inhibitor,O
by,O
screening,O
an,O
FDA,O
drug,O
library,O
"
",O
using,O
Huh7DhNTCP,O
cells,O
and,O
confirmed,O
the,O
antiviral,O
activity,O
in,O
primary,O
human,O
"
",O
hepatocytes,O
and,O
human,O
sodium,O
taurocholate,O
cotransporting,O
polypeptide,O
"
",O
(hNTCP)transfected,O
porcine,O
primary,O
hepatocytes,O
.,O
Our,O
efficacy,O
study,O
showed,O
that,O
"
",O
Evans,O
blue,O
has,O
an,O
IC50,O
of,O
2,O
Î¼M,O
against,O
HBV,O
infection,O
in,O
Huh7DhNTCP,O
cells,O
",",O
and,O
no,O
"
",O
apparent,O
toxicity,O
at,O
up,O
to,O
1000,O
Î¼M.,O
The,O
IC50,O
of,O
Evans,O
blue,O
against,O
HBV,O
in,O
primary,O
"
",O
human,O
hepatocytes,O
was,O
approximately,O
5,O
Î¼M.,O
Mechanism,O
studies,O
revealed,O
that,O
Evans,O
"
",O
blue,O
has,O
a,O
dual,O
antiHBV,O
effect,O
.,O
It,O
inhibits,O
both,O
the,O
binding,O
of,O
viral,O
preS1,O
to,O
"
",O
host,O
cells,O
through,O
the,O
host,O
factor,O
NTCP,O
and,O
the,O
virus,O
capsid,O
assembly,O
by,O
"
",O
targeting,O
the,O
host,O
factor,O
BK,O
channel,O
.,O
The,O
KD,O
of,O
the,O
direct,O
interaction,O
between,O
"
",O
Evans,O
blue,O
and,O
NTCP,O
is,O
882000000,O
M.,O
Evans,O
blue,O
can,O
suppress,O
capsid,O
assembly,O
at,O
"
",O
micromolar,O
concentrations,O
by,O
reducing,O
the,O
cytosolic,O
calcium,O
ion,O
concentration,O
.,O
"
",O
Since,O
the,O
antiviral,O
effects,O
on,O
HBV,O
binding,O
and,O
assembly,O
are,O
both,O
achieved,O
through,O
"
",O
targeting,O
host,O
factors,O
",",O
Evans,O
blue,O
inhibits,O
the,O
infection,O
of,O
nucleos(t)ide,O
analog,O
"
",O
drugresistant,O
HBV,O
strains,O
in,O
Huh7DhNTCP,O
cells,O
.,O
Taken,O
together,O
",",O
our,O
results,O
"
",O
suggest,O
that,O
Evans,O
blue,O
may,O
be,O
a,O
promising,O
antiHBV,O
drug,O
candidate,O
in,O
the,O
classes,O
"
",O
of,O
both,O
entry,O
and,O
assembly,O
inhibitors,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Xiao,O
",",O
Liu,O
",",O
Tang,O
",",O
Zhang,O
and,O
Chen,O
.,O
"

",O
DOI,O
:,O
10.3389,O
fmicb.2019.02638,O
"
",O
PMCID,O
:,O
PMC6868041,O
"
",O
PMID,O
:,O
31798562,O
"


",O
979,O
.,O
Virol,O
Sin,O
.,O
2019,O
Dec,O
2,O
.,O
doi,O
:,O
10.1007,O
s12250019001754,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Highly,O
Efficient,O
Base,O
Editing,O
in,O
Viral,O
Genome,O
Based,O
on,O
Bacterial,O
Artificial,O
"
",O
Chromosome,O
Using,O
a,O
Cas9Cytidine,O
Deaminase,O
Fused,O
Protein,O
.,O
"

",O
Zheng,O
K(1)(2,O
),O
",",O
Jiang,O
FF(1,O
),O
",",O
Su,O
L(1,O
),O
",",O
Wang,O
X(1,O
),O
",",O
Chen,O
YX(1,O
),O
",",O
Chen,O
HC(1,O
),O
",",O
Liu,O
"
",O
ZF(3,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
and,O
Key,O
Laboratory,O
of,O
"
",O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
"
",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
"
",O
(2)Gene,O
Editing,O
Research,O
Center,O
",",O
Hebei,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
"
",O
Shijiazhuang,O
",",O
50018,O
",",O
China,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Agricultural,O
Microbiology,O
and,O
Key,O
Laboratory,O
of,O
"
",O
Preventive,O
Veterinary,O
Medicine,O
in,O
Hubei,O
Province,O
",",O
College,O
of,O
Veterinary,O
Medicine,O
",",O
"
",O
Huazhong,O
Agricultural,O
University,O
",",O
Wuhan,O
",",O
430070,O
",",O
China,O
.,O
lzf6789@mail.hzau.edu.cn,O
.,O
"

",O
Viruses,O
evolve,O
rapidly,O
and,O
continuously,O
threaten,O
animal,O
health,O
and,O
economy,O
",",O
"
",O
posing,O
a,O
great,O
demand,O
for,O
rapid,O
and,O
efficient,O
genome,O
editing,O
technologies,O
to,O
"
",O
study,O
virulence,O
mechanism,O
and,O
develop,O
effective,O
vaccine,O
.,O
We,O
present,O
a,O
highly,O
"
",O
efficient,O
viral,O
genome,O
manipulation,O
method,O
using,O
CRISPRguided,O
cytidine,O
"
",O
deaminase,O
.,O
We,O
cloned,O
pseudorabies,O
virus,O
genome,O
into,O
bacterial,O
artificial,O
"
",O
chromosome,O
",",O
and,O
used,O
CRISPRguided,O
cytidine,O
deaminase,O
to,O
directly,O
convert,O
"
",O
cytidine,O
(,O
C,O
),O
to,O
uridine,O
(,O
U,O
),O
to,O
induce,O
premature,O
stop,O
mutagenesis,O
in,O
viral,O
genes,O
.,O
"
",O
The,O
editing,O
efficiencies,O
were,O
100,O
%,O
.,O
Comprehensive,O
bioinformatic,O
analysis,O
revealed,O
"
",O
that,O
a,O
large,O
number,O
of,O
editable,O
sites,O
exist,O
in,O
pseudorabies,O
virus,O
(,O
PRV,O
),O
genomes,O
.,O
"
",O
Notably,O
",",O
in,O
our,O
study,O
viral,O
genome,O
exists,O
as,O
a,O
plasmid,O
in,O
E.,O
coli,O
",",O
suggesting,O
"
",O
that,O
this,O
method,O
is,O
virus,O
speciesindependent,O
.,O
This,O
application,O
of,O
baseediting,O
"
",O
provided,O
an,O
alternative,O
approach,O
to,O
generate,O
mutant,O
virus,O
and,O
might,O
accelerate,O
"
",O
study,O
on,O
virulence,O
and,O
vaccine,O
development,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12250019001754,O
"
",O
PMID,O
:,O
31792738,O
"


",O
980,O
.,O
PLoS,O
Pathog,O
.,O
2019,O
Dec,O
2;15(12):e1008156,O
.,O
doi,O
:,O
10.1371,O
journal.ppat.1008156,O
.,O
"
",O
eCollection,O
2019,O
Dec.,O
"

",O
Identification,O
of,O
new,O
antiviral,O
agents,O
against,O
Kaposi,O
's,O
sarcomaassociated,O
"
",O
herpesvirus,O
(,O
KSHV,O
),O
by,O
highthroughput,O
drug,O
screening,O
reveals,O
the,O
role,O
of,O
"
",O
histaminerelated,O
signaling,O
in,O
promoting,O
viral,O
lytic,O
reactivation,O
.,O
"

",O
Chen,O
J(1,O
),O
",",O
Dai,O
L(1,O
),O
",",O
Goldstein,O
A(2,O
),O
",",O
Zhang,O
H(3,O
),O
",",O
Tang,O
W(3,O
),O
",",O
Forrest,O
JC(4,O
),O
",",O
Post,O
"
",O
SR(1,O
),O
",",O
Chen,O
X(3)(5,O
),O
",",O
Qin,O
Z(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Pathology,O
",",O
Winthrop,O
P.,O
Rockefeller,O
Cancer,O
Institute,O
",",O
University,O
"
",O
of,O
Arkansas,O
for,O
Medical,O
Sciences,O
",",O
Little,O
Rock,O
",",O
Arkansas,O
",",O
United,O
States,O
of,O
"
",O
America,O
.,O
"
",O
(2)Departments,O
of,O
Diagnostic,O
Sciences,O
",",O
School,O
of,O
Dentistry,O
",",O
Louisiana,O
State,O
"
",O
University,O
Health,O
Sciences,O
Center,O
",",O
New,O
Orleans,O
",",O
Louisiana,O
",",O
United,O
States,O
of,O
"
",O
America,O
.,O
"
",O
(3)State,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Wuhan,O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
"
",O
of,O
Sciences,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(4)Department,O
of,O
Microbiology,O
&,O
Immunology,O
",",O
University,O
of,O
Arkansas,O
for,O
Medical,O
"
",O
Sciences,O
",",O
Little,O
Rock,O
",",O
Arkansas,O
",",O
United,O
States,O
of,O
America,O
.,O
"
",O
(5)Guangdong,O
Key,O
Laboratory,O
of,O
Virology,O
",",O
Institute,O
of,O
Medical,O
Microbiology,O
",",O
Jinan,O
"
",O
University,O
",",O
Guangzhou,O
",",O
China,O
.,O
"

",O
Kaposi,O
's,O
sarcomaassociated,O
herpesvirus,O
(,O
KSHV,O
),O
causes,O
several,O
human,O
cancers,O
",",O
such,O
"
",O
as,O
Kaposi,O
's,O
sarcoma,O
(,O
KS,O
),O
and,O
primary,O
effusion,O
lymphoma,O
(,O
PEL,O
),O
.,O
Current,O
treatment,O
"
",O
options,O
for,O
KSHV,O
infection,O
and,O
virus,O
associated,O
diseases,O
are,O
sometimes,O
"
",O
ineffective,O
",",O
therefore,O
",",O
more,O
effectively,O
antiviral,O
agents,O
are,O
urgently,O
needed,O
.,O
As,O
"
",O
a,O
herpesvirus,O
",",O
lytic,O
replication,O
is,O
critical,O
for,O
KSHV,O
pathogenesis,O
and,O
"
",O
oncogenesis,O
.,O
In,O
this,O
study,O
",",O
we,O
have,O
established,O
a,O
highthroughput,O
screening,O
assay,O
"
",O
by,O
using,O
an,O
inducible,O
KSHV+,O
cellline,O
",",O
iSLK.219,O
.,O
After,O
screening,O
a,O
compound,O
"
",O
library,O
that,O
consisted,O
of,O
1280,O
Food,O
and,O
Drug,O
Administration,O
(FDA)approved,O
drugs,O
",",O
"
",O
15,O
hit,O
compounds,O
that,O
effectively,O
inhibited,O
KSHV,O
virion,O
production,O
were,O
"
",O
identified,O
",",O
most,O
of,O
which,O
have,O
never,O
been,O
reported,O
with,O
antiKSHV,O
activities,O
.,O
"
",O
Interestingly,O
",",O
3,O
of,O
these,O
drugs,O
target,O
histamine,O
receptors,O
or,O
signaling,O
.,O
Our,O
data,O
"
",O
further,O
confirmed,O
that,O
antagonists,O
targeting,O
different,O
histamine,O
receptors,O
(,O
HxRs,O
),O
"
",O
displayed,O
excellent,O
inhibitory,O
effects,O
on,O
KSHV,O
lytic,O
replication,O
from,O
induced,O
"
",O
iSLK.219,O
or,O
BCBL1,O
cells,O
.,O
In,O
contrast,O
",",O
histamine,O
and,O
specific,O
agonists,O
of,O
HxRs,O
"
",O
promoted,O
viral,O
lytic,O
replication,O
from,O
induced,O
iSLK.219,O
or,O
KSHVinfected,O
primary,O
"
",O
cells,O
.,O
Mechanistic,O
studies,O
indicated,O
that,O
downstream,O
MAPK,O
and,O
PI3,O
K,O
Akt,O
signaling,O
"
",O
pathways,O
were,O
required,O
for,O
histamine,O
receptors,O
mediated,O
promotion,O
of,O
KSHV,O
lytic,O
"
",O
replication,O
.,O
Direct,O
knockdown,O
of,O
HxRs,O
in,O
iSLK.219,O
cells,O
effectively,O
blocked,O
viral,O
"
",O
lytic,O
gene,O
expression,O
during,O
induction,O
.,O
Using,O
samples,O
from,O
a,O
cohort,O
of,O
HIV+,O
"
",O
patients,O
",",O
we,O
found,O
that,O
the,O
KSHV+,O
group,O
has,O
much,O
higher,O
levels,O
of,O
histamine,O
in,O
"
",O
their,O
plasma,O
and,O
saliva,O
than,O
the,O
KSHV,O
group,O
.,O
Taken,O
together,O
",",O
our,O
data,O
have,O
"
",O
identified,O
new,O
antiKSHV,O
agents,O
and,O
provided,O
novel,O
insights,O
into,O
the,O
molecular,O
"
",O
bases,O
of,O
host,O
factors,O
that,O
contribute,O
to,O
lytic,O
replication,O
and,O
reactivation,O
of,O
"
",O
this,O
oncogenic,O
herpesvirus,O
.,O
"

",O
DOI,O
:,O
10.1371,O
journal.ppat.1008156,O
"
",O
PMCID,O
:,O
PMC6907871,O
"
",O
PMID,O
:,O
31790497,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
have,O
declared,O
that,O
no,O
competing,O
"
",O
interests,O
exist,O
.,O
"


",O
981,O
.,O
Mol,O
Plant,O
Microbe,O
Interact,O
.,O
2020,O
Mar;33(3):553560,O
.,O
doi,O
:,O
"
",O
10.1094,O
MPMI11190332R,O
.,O
Epub,O
2020,O
Jan,O
20,O
.,O
"

",O
Genome,O
Editing,O
of,O
a,O
DeoxynivalenolInduced,O
Transcription,O
Factor,O
Confers,O
"
",O
Resistance,O
to,O
Fusarium,O
graminearum,O
in,O
Wheat,O
.,O
"

",O
Brauer,O
EK(1,O
),O
",",O
Balcerzak,O
M(1,O
),O
",",O
Rocheleau,O
H(1,O
),O
",",O
Leung,O
W(1,O
),O
",",O
Schernthaner,O
J(1,O
),O
",",O
"
",O
Subramaniam,O
R(1,O
),O
",",O
Ouellet,O
T(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Ottawa,O
Research,O
and,O
Development,O
Centre,O
",",O
Agriculture,O
and,O
AgriFood,O
Canada,O
",",O
"
",O
Ottawa,O
",",O
ON,O
K1A,O
0C6,O
",",O
Canada,O
.,O
"

",O
Deoxynivalenol,O
(,O
DON,O
),O
is,O
a,O
mycotoxin,O
virulence,O
factor,O
that,O
promotes,O
growth,O
of,O
the,O
"
",O
Fusarium,O
graminearum,O
fungus,O
in,O
wheat,O
floral,O
tissues,O
.,O
To,O
further,O
our,O
understanding,O
"
",O
of,O
the,O
effects,O
of,O
DON,O
exposure,O
on,O
plant,O
cell,O
function,O
",",O
we,O
characterized,O
"
",O
DONinduced,O
transcriptional,O
changes,O
in,O
wheat,O
spikelets,O
.,O
Four,O
hundred,O
wheat,O
genes,O
"
",O
were,O
differentially,O
expressed,O
during,O
infection,O
with,O
wildtype,O
F.,O
graminearum,O
as,O
"
",O
compared,O
with,O
a,O
Î”tri5,O
mutant,O
strain,O
that,O
is,O
unable,O
to,O
produce,O
DON,O
.,O
Most,O
of,O
these,O
"
",O
genes,O
were,O
more,O
induced,O
by,O
the,O
DONproducing,O
strain,O
and,O
included,O
genes,O
involved,O
"
",O
in,O
secondary,O
metabolism,O
",",O
signaling,O
",",O
transport,O
",",O
and,O
stress,O
responses,O
.,O
DON,O
"
",O
induction,O
was,O
confirmed,O
for,O
a,O
subset,O
of,O
the,O
genes,O
",",O
including,O
TaNFXL1,O
",",O
by,O
treating,O
"
",O
tissues,O
with,O
DON,O
directly,O
.,O
Previous,O
work,O
indicates,O
that,O
the,O
NFXL1,O
ortholog,O
"
",O
represses,O
trichotheceneinduced,O
defense,O
responses,O
and,O
bacterial,O
resistance,O
in,O
"
",O
Arabidopsis,O
",",O
but,O
the,O
role,O
of,O
the,O
NFXL,O
family,O
has,O
not,O
been,O
studied,O
in,O
wheat,O
.,O
We,O
"
",O
observed,O
greater,O
DONinduced,O
TaNFXL1,O
gene,O
expression,O
in,O
a,O
susceptible,O
wheat,O
"
",O
genotype,O
relative,O
to,O
the,O
F.,O
graminearumresistant,O
genotype,O
Wuhan,O
1,O
.,O
Functional,O
"
",O
testing,O
using,O
both,O
virusinduced,O
gene,O
silencing,O
and,O
CRISPRmediated,O
genome,O
"
",O
editing,O
indicated,O
that,O
TaNFXL1,O
represses,O
F.,O
graminearum,O
resistance,O
.,O
Together,O
",",O
"
",O
this,O
suggests,O
that,O
targeting,O
the,O
TaNFXL1,O
gene,O
may,O
help,O
to,O
develop,O
disease,O
"
",O
resistance,O
in,O
cultivated,O
wheat,O
.,O
"

",O
DOI,O
:,O
10.1094,O
MPMI11190332R,O
"
",O
PMID,O
:,O
31790345,O
"


",O
982,O
.,O
Mol,O
Ther,O
Oncolytics,O
.,O
2019,O
Oct,O
23;15:201213,O
.,O
doi,O
:,O
10.1016,O
j.omto.2019.10.003,O
.,O
"
",O
eCollection,O
2019,O
Dec,O
20,O
.,O
"

",O
Enhanced,O
Therapeutic,O
Efficacy,O
of,O
a,O
Novel,O
Oncolytic,O
Herpes,O
Simplex,O
Virus,O
Type,O
2,O
"
",O
Encoding,O
an,O
Antibody,O
Against,O
Programmed,O
Cell,O
Death,O
1,O
.,O
"

",O
Zhu,O
Y(1,O
),O
",",O
Hu,O
X(1,O
),O
",",O
Feng,O
L(1,O
),O
",",O
Yang,O
Z(1,O
),O
",",O
Zhou,O
L(1,O
),O
",",O
Duan,O
X(2,O
),O
",",O
Cheng,O
S(1,O
),O
",",O
Zhang,O
"
",O
W(3,O
),O
",",O
Liu,O
B(4,O
),O
",",O
Zhang,O
K(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Molecular,O
Oncology,O
",",O
National,O
Cancer,O
Center,O
National,O
"
",O
Clinical,O
Research,O
Center,O
for,O
Cancer,O
Cancer,O
Hospital,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
"
",O
Sciences,O
and,O
Peking,O
Union,O
Medical,O
College,O
",",O
Beijing,O
100021,O
",",O
China,O
.,O
"
",O
(2)Department,O
of,O
Thoracic,O
Surgery,O
",",O
Beijing,O
Chest,O
Hospital,O
",",O
Capital,O
Medical,O
"
",O
University,O
",",O
Beijing,O
101149,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Immunology,O
",",O
National,O
Cancer,O
Center,O
National,O
Clinical,O
Research,O
"
",O
Center,O
for,O
Cancer,O
Cancer,O
Hospital,O
",",O
Chinese,O
Academy,O
of,O
Medical,O
Sciences,O
and,O
Peking,O
"
",O
Union,O
Medical,O
College,O
",",O
Beijing,O
100021,O
",",O
China,O
.,O
"
",O
(4)National,O
"""",O
111,O
"""",O
Centre,O
for,O
Cellular,O
Regulation,O
and,O
Molecular,O
Pharmaceutics,O
",",O
Key,O
"
",O
Laboratory,O
of,O
Fermentation,O
Engineering,O
(,O
Ministry,O
of,O
Education,O
),O
",",O
Hubei,O
Provincial,O
"
",O
Cooperative,O
Innovation,O
Center,O
of,O
Industrial,O
Fermentation,O
",",O
Hubei,O
Key,O
Laboratory,O
of,O
"
",O
Industrial,O
Microbiology,O
",",O
Hubei,O
University,O
of,O
Technology,O
",",O
Wuhan,O
430068,O
",",O
Hubei,O
",",O
"
",O
China,O
.,O
"

",O
The,O
efficacy,O
of,O
immune,O
checkpoint,O
blockade,O
therapy,O
against,O
immunologically,O
"""",O
cold,O
"""",O
"
",O
tumors,O
can,O
be,O
enhanced,O
by,O
applying,O
the,O
checkpoint,O
inhibitors,O
in,O
combination,O
with,O
"
",O
oncolytic,O
viruses,O
.,O
Â ,O
Alternatively,O
",",O
the,O
oncolytic,O
virus,O
construct,O
has,O
been,O
modified,O
"
",O
to,O
express,O
factors,O
that,O
boost,O
oncolytic,O
virus,O
function,O
.,O
We,O
engineered,O
a,O
novel,O
"
",O
oncolytic,O
herpes,O
simplex,O
virus,O
2,O
(,O
HSV2,O
),O
Â ,O
encoding,O
an,O
antihuman,O
programmed,O
cell,O
"
",O
death,O
1,O
(,O
PD1,O
),O
monoclonal,O
antibody,O
(,O
oHSV2aPD1,O
),O
.,O
This,O
virus,O
resulted,O
in,O
the,O
"
",O
detectable,O
expression,O
of,O
a,O
functional,O
monoclonal,O
antibody,O
against,O
human,O
PD1,O
by,O
"
",O
infecting,O
eukaryotic,O
cells,O
.,O
Therapeutic,O
efficacy,O
of,O
oHSV2aPD1,O
proved,O
superior,O
to,O
"
",O
unmodified,O
Â ,O
oncolytic,O
HSV2,O
treatment,O
or,O
PD1,O
blockade,O
alone,O
and,O
as,O
effective,O
as,O
"
",O
their,O
combination,O
in,O
the,O
poorly,O
immunogenic,O
melanoma,O
models,O
.,O
Additionally,O
",",O
local,O
"
",O
oHSV2aPD1,O
treatment,O
induced,O
a,O
durable,O
antitumor,O
response,O
and,O
activated,O
many,O
"
",O
immune,O
effector,O
cells,O
and,O
molecules,O
both,O
in,O
the,O
tumor,O
microenvironment,O
and,O
in,O
the,O
"
",O
systemic,O
immune,O
system,O
.,O
This,O
Â ,O
provides,O
support,O
for,O
combinatorial,O
strategies,O
"
",O
involving,O
local,O
administration,O
of,O
an,O
oncolytic,O
HSV2,O
expressing,O
a,O
PD1,O
inhibitor,O
.,O
"

",O
Â©,O
2019,O
The,O
Authors,O
.,O
"

",O
DOI,O
:,O
10.1016,O
j.omto.2019.10.003,O
"
",O
PMCID,O
:,O
PMC6880119,O
"
",O
PMID,O
:,O
31788554,O
"


",O
983,O
.,O
BMC,O
Bioinformatics,O
.,O
2019,O
Dec,O
2;20(Suppl,O
16):594,O
.,O
doi,O
:,O
10.1186,O
s1285901930820,O
.,O
"

",O
Predicting,O
virushost,O
association,O
by,O
Kernelized,O
logistic,O
matrix,O
factorization,O
and,O
"
",O
similarity,O
network,O
fusion,O
.,O
"

",O
Liu,O
D(1)(2,O
),O
",",O
Ma,O
Y(1)(2,O
),O
",",O
Jiang,O
X(3)(4,O
),O
",",O
He,O
T(5)(6,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)School,O
of,O
Computer,O
",",O
Central,O
China,O
Normal,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(2)Hubei,O
Provincial,O
Key,O
Laboratory,O
of,O
Artificial,O
Intelligence,O
and,O
Smart,O
Learning,O
",",O
"
",O
Central,O
China,O
Normal,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
(3)School,O
of,O
Computer,O
",",O
Central,O
China,O
Normal,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
xpjiang@mail.ccnu.edu.cn,O
.,O
"
",O
(4)Hubei,O
Provincial,O
Key,O
Laboratory,O
of,O
Artificial,O
Intelligence,O
and,O
Smart,O
Learning,O
",",O
"
",O
Central,O
China,O
Normal,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
xpjiang@mail.ccnu.edu.cn,O
.,O
"
",O
(5)School,O
of,O
Computer,O
",",O
Central,O
China,O
Normal,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
"
",O
tthe@mail.ccnu.edu.cn,O
.,O
"
",O
(6)Hubei,O
Provincial,O
Key,O
Laboratory,O
of,O
Artificial,O
Intelligence,O
and,O
Smart,O
Learning,O
",",O
"
",O
Central,O
China,O
Normal,O
University,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
China,O
.,O
tthe@mail.ccnu.edu.cn,O
.,O
"

",O
BACKGROUND,O
:,O
Viruses,O
are,O
closely,O
related,O
to,O
bacteria,O
and,O
human,O
diseases,O
.,O
It,O
is,O
of,O
"
",O
great,O
significance,O
to,O
predict,O
associations,O
between,O
viruses,O
and,O
hosts,O
for,O
"
",O
understanding,O
the,O
dynamics,O
and,O
complex,O
functional,O
networks,O
in,O
microbial,O
"
",O
community,O
.,O
With,O
the,O
rapid,O
development,O
of,O
the,O
metagenomics,O
sequencing,O
",",O
some,O
"
",O
methods,O
based,O
on,O
sequence,O
similarity,O
and,O
genomic,O
homology,O
have,O
been,O
used,O
to,O
"
",O
predict,O
associations,O
between,O
viruses,O
and,O
hosts,O
.,O
However,O
",",O
the,O
known,O
virushost,O
"
",O
association,O
network,O
was,O
ignored,O
in,O
these,O
methods,O
.,O
"
",O
RESULTS,O
:,O
We,O
proposed,O
a,O
kernelized,O
logistic,O
matrix,O
factorization,O
with,O
integrating,O
"
",O
different,O
information,O
to,O
predict,O
potential,O
virushost,O
associations,O
on,O
the,O
"
",O
heterogeneous,O
network,O
(,O
ILMFVH,O
),O
which,O
is,O
constructed,O
by,O
connecting,O
a,O
virus,O
"
",O
network,O
with,O
a,O
host,O
network,O
based,O
on,O
known,O
virushost,O
associations,O
.,O
The,O
virus,O
"
",O
network,O
is,O
constructed,O
based,O
on,O
oligonucleotide,O
frequency,O
measurement,O
",",O
and,O
the,O
"
",O
host,O
network,O
is,O
constructed,O
by,O
integrating,O
oligonucleotide,O
frequency,O
similarity,O
"
",O
and,O
Gaussian,O
interaction,O
profile,O
kernel,O
similarity,O
through,O
similarity,O
network,O
"
",O
fusion,O
.,O
The,O
host,O
prediction,O
accuracy,O
of,O
our,O
method,O
is,O
better,O
than,O
other,O
methods,O
.,O
"
",O
In,O
addition,O
",",O
case,O
studies,O
show,O
that,O
the,O
host,O
of,O
crAssphage,O
predicted,O
by,O
ILMFVH,O
"
",O
is,O
consistent,O
with,O
presumed,O
host,O
in,O
previous,O
studies,O
",",O
and,O
another,O
potential,O
host,O
"
",O
Escherichia,O
coli,O
is,O
also,O
predicted,O
.,O
"
",O
CONCLUSIONS,O
:,O
The,O
proposed,O
model,O
is,O
an,O
effective,O
computational,O
tool,O
for,O
predicting,O
"
",O
interactions,O
between,O
viruses,O
and,O
hosts,O
effectively,O
",",O
and,O
it,O
has,O
great,O
potential,O
"
",O
for,O
discovering,O
novel,O
hosts,O
of,O
viruses,O
.,O
"

",O
DOI,O
:,O
10.1186,O
s1285901930820,O
"
",O
PMCID,O
:,O
PMC6886165,O
"
",O
PMID,O
:,O
31787095,O
 ,O
[,O
Indexed,O
for,O
MEDLINE,O
],O
"


",O
984,O
.,O
Free,O
Radic,O
Biol,O
Med,O
.,O
2020,O
Feb,O
1;147:2336,O
.,O
doi,O
:,O
"
",O
10.1016,O
j.freeradbiomed.2019.11.033,O
.,O
Epub,O
2019,O
Nov,O
27,O
.,O
"

",O
Maresin,O
1,O
mitigates,O
concanavalin,O
Ainduced,O
acute,O
liver,O
injury,O
in,O
mice,O
by,O
"
",O
inhibiting,O
ROSmediated,O
activation,O
of,O
NFÎºB,O
signaling,O
.,O
"

",O
Zhang,O
P(1,O
),O
",",O
Yin,O
Y(2,O
),O
",",O
Wang,O
T(2,O
),O
",",O
Li,O
W(2,O
),O
",",O
Li,O
C(2,O
),O
",",O
Zeng,O
X(2,O
),O
",",O
Yang,O
W(2,O
),O
",",O
Zhang,O
"
",O
R(2,O
),O
",",O
Tang,O
Y(2,O
),O
",",O
Shi,O
L(2,O
),O
",",O
Li,O
R(3,O
),O
",",O
Tao,O
K(4,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Gastrointestinal,O
Surgery,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
"
",O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
zhangpeng_xt@163.com,O
.,O
"
",O
(2)Department,O
of,O
Gastrointestinal,O
Surgery,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
"
",O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
(3)Department,O
of,O
Gastrointestinal,O
Surgery,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
"
",O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
liruidong@hust.edu.cn,O
.,O
"
",O
(4)Department,O
of,O
Gastrointestinal,O
Surgery,O
",",O
Union,O
Hospital,O
",",O
Tongji,O
Medical,O
"
",O
College,O
",",O
Huazhong,O
University,O
of,O
Science,O
and,O
Technology,O
",",O
Wuhan,O
",",O
430022,O
",",O
China,O
.,O
"
",O
Electronic,O
address,O
:,O
kaixiongtao@hust.edu.cn,O
.,O
"

",O
The,O
liver,O
is,O
the,O
most,O
important,O
metabolic,O
and,O
detoxifying,O
organ,O
in,O
the,O
human,O
"
",O
body,O
",",O
and,O
liver,O
damage,O
can,O
seriously,O
affect,O
bodily,O
function,O
and,O
potentially,O
be,O
"
",O
life,O
threatening,O
.,O
Accumulating,O
evidence,O
suggests,O
that,O
maresin,O
1,O
(,O
36951,O
),O
exhibits,O
"
",O
protective,O
and,O
antiinflammatory,O
effects,O
in,O
some,O
diseases,O
",",O
such,O
as,O
pneumonia,O
and,O
"
",O
colitis,O
;,O
however,O
",",O
its,O
role,O
in,O
acute,O
hepatitis,O
remains,O
unclear,O
.,O
Here,O
",",O
we,O
"
",O
established,O
a,O
concanavalin,O
A,O
(ConA)induced,O
acute,O
liverinjury,O
mouse,O
model,O
to,O
"
",O
determine,O
whether,O
36951,O
administration,O
can,O
attenuate,O
liver,O
damage,O
.,O
Our,O
results,O
"
",O
indicate,O
that,O
36951,O
confers,O
protective,O
effects,O
against,O
ConAinduced,O
acute,O
liver,O
"
",O
injury,O
",",O
improves,O
liver,O
function,O
and,O
survival,O
",",O
and,O
reduces,O
histopathological,O
"
",O
damage,O
.,O
Additionally,O
",",O
36951,O
attenuated,O
the,O
inflammatory,O
response,O
and,O
reduced,O
"
",O
hepatocyte,O
apoptosis,O
while,O
increasing,O
mouse,O
macrophage,O
apoptosis,O
and,O
markedly,O
"
",O
decreasing,O
levels,O
of,O
reactive,O
oxygen,O
species,O
(,O
ROS,O
),O
in,O
macrophages,O
.,O
We,O
also,O
found,O
"
",O
that,O
36951,O
significantly,O
inhibited,O
ConAinduced,O
activation,O
of,O
the,O
nuclear,O
"
",O
factorkappaB,O
(,O
NFÎºB,O
),O
pathway,O
.,O
This,O
work,O
will,O
contribute,O
to,O
a,O
better,O
"
",O
understanding,O
of,O
acute,O
liver,O
injury,O
(,O
ALI,O
),O
and,O
advancement,O
towards,O
its,O
treatment,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
.,O
Published,O
by,O
Elsevier,O
Inc.,O
"

",O
DOI,O
:,O
10.1016,O
j.freeradbiomed.2019.11.033,O
"
",O
PMID,O
:,O
31785331,O
"


",O
985,O
.,O
Virol,O
Sin,O
.,O
2019,O
Nov,O
29,O
.,O
doi,O
:,O
10.1007,O
s12250019001772,O
.,O
[,O
Epub,O
ahead,O
of,O
print,O
],O
"

",O
Genome,O
Analysis,O
of,O
Dasineura,O
jujubifolia,O
Toursvirus,O
2,O
",",O
A,O
Novel,O
Ascovirus,O
.,O
"

",O
Wang,O
J(1,O
),O
",",O
Yang,O
M(2,O
),O
",",O
Xiao,O
H(3,O
),O
",",O
Huang,O
GH(4,O
),O
",",O
Deng,O
F(1,O
),O
",",O
Hu,O
Z(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)State,O
Key,O
Laboratory,O
of,O
Virology,O
and,O
National,O
Virus,O
Resource,O
Center,O
",",O
Wuhan,O
"
",O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(2)Tarim,O
University,O
",",O
Alar,O
",",O
843300,O
",",O
China,O
.,O
ymlzkytd@163.com,O
.,O
"
",O
(3)Tarim,O
University,O
",",O
Alar,O
",",O
843300,O
",",O
China,O
.,O
"
",O
(4)Hunan,O
Provincial,O
Key,O
Laboratory,O
for,O
Biology,O
and,O
Control,O
of,O
Plant,O
Diseases,O
and,O
"
",O
Insect,O
Pests,O
",",O
Institute,O
of,O
Virology,O
",",O
Hunan,O
Agricultural,O
University,O
",",O
Changsha,O
",",O
"
",O
410128,O
",",O
China,O
.,O
"
",O
(5)State,O
Key,O
Laboratory,O
of,O
Virology,O
and,O
National,O
Virus,O
Resource,O
Center,O
",",O
Wuhan,O
"
",O
Institute,O
of,O
Virology,O
",",O
Chinese,O
Academy,O
of,O
Sciences,O
",",O
Wuhan,O
",",O
430071,O
",",O
China,O
.,O
"
",O
huzh@wh.iov.cn,O
.,O
"

",O
So,O
far,O
",",O
ascoviruses,O
have,O
only,O
been,O
identified,O
from,O
Lepidoptera,O
host,O
insects,O
and,O
"
",O
their,O
transmission,O
vectorsendoparasitic,O
wasps,O
.,O
Here,O
",",O
we,O
reported,O
the,O
first,O
"
",O
finding,O
of,O
a,O
complete,O
novel,O
ascovirus,O
genome,O
from,O
a,O
Diptera,O
insect,O
",",O
Dasineura,O
"
",O
jujubifolia,O
.,O
Initially,O
",",O
sequence,O
fragments,O
with,O
homology,O
to,O
ascoviruses,O
were,O
"
",O
incidentally,O
identified,O
during,O
metagenomic,O
sequencing,O
of,O
the,O
mitochondria,O
of,O
D.,O
"
",O
jujubifolia,O
(,O
Cecidomyiidae,O
",",O
Diptera,O
),O
which,O
is,O
a,O
major,O
pest,O
on,O
Ziziphus,O
jujuba,O
.,O
"
",O
Then,O
a,O
full,O
circular,O
viral,O
genome,O
was,O
assembled,O
from,O
the,O
metagenomic,O
data,O
",",O
which,O
"
",O
has,O
an,O
A+T,O
percentage,O
of,O
74,O
%,O
and,O
contains,O
142600,O
Â ,O
bp,O
with,O
141,O
open,O
reading,O
frames,O
"
",O
(,O
ORFs,O
),O
.,O
Among,O
the,O
141,O
ORFs,O
",",O
37,O
were,O
conserved,O
in,O
all,O
sequenced,O
ascoviruses,O
(,O
core,O
"
",O
genes,O
),O
including,O
proteins,O
predicted,O
to,O
participate,O
in,O
DNA,O
replication,O
",",O
gene,O
"
",O
transcription,O
",",O
protein,O
modification,O
",",O
virus,O
assembly,O
",",O
lipid,O
metabolism,O
and,O
"
",O
apoptosis,O
.,O
Multigene,O
families,O
including,O
those,O
encode,O
for,O
baculovirus,O
repeated,O
"
",O
open,O
reading,O
frames,O
(,O
BROs,O
),O
",",O
myristylated,O
membrane,O
proteins,O
",",O
RING,O
Ubox,O
E3,O
"
",O
ubiquitin,O
ligases,O
",",O
and,O
ATPbinding,O
cassette,O
(,O
ABC,O
),O
transporters,O
were,O
found,O
in,O
the,O
"
",O
virus,O
genome,O
.,O
Phylogenetic,O
analysis,O
showed,O
that,O
the,O
newly,O
identified,O
virus,O
"
",O
belongs,O
to,O
genus,O
Toursvirus,O
of,O
Ascoviridae,O
",",O
and,O
is,O
therefore,O
named,O
as,O
Dasineura,O
"
",O
jujubifolia,O
toursvirus,O
2,O
(,O
DjTV2a,O
),O
.,O
The,O
virus,O
becomes,O
the,O
second,O
reported,O
species,O
"
",O
of,O
the,O
genus,O
after,O
Diadromus,O
pulchellus,O
toursvirus,O
1,O
(,O
DpTV1a,O
),O
.,O
The,O
genome,O
"
",O
arrangement,O
of,O
DjTV2a,O
is,O
quite,O
different,O
from,O
that,O
of,O
DpTV1a,O
",",O
suggesting,O
these,O
"
",O
two,O
viruses,O
separated,O
in,O
an,O
early,O
time,O
of,O
evolution,O
.,O
The,O
results,O
suggest,O
that,O
the,O
"
",O
ascoviruses,O
may,O
infect,O
a,O
much,O
broader,O
range,O
of,O
hosts,O
than,O
our,O
previous,O
knowledge,O
",",O
"
",O
and,O
shed,O
lights,O
on,O
the,O
evolution,O
of,O
ascoviruses,O
and,O
particularly,O
on,O
that,O
of,O
the,O
"
",O
toursviruses,O
.,O
"

",O
DOI,O
:,O
10.1007,O
s12250019001772,O
"
",O
PMID,O
:,O
31784872,O
"


",O
986,O
.,O
Sci,O
Rep.,O
2019,O
Nov,O
29;9(1):17876,O
.,O
doi,O
:,O
10.1038,O
s4159801954188w,O
.,O
"

",O
Construction,O
of,O
miRNAtarget,O
networks,O
using,O
microRNA,O
profiles,O
of,O
CVB3infected,O
"
",O
HeLa,O
cells,O
.,O
"

",O
Yao,O
HL(1,O
),O
",",O
Liu,O
M(2)(3,O
),O
",",O
Wang,O
WJ(2)(3,O
),O
",",O
Wang,O
XL(2)(3,O
),O
",",O
Song,O
J(2)(3,O
),O
",",O
Song,O
"
",O
QQ(2)(3,O
),O
",",O
Han,O
J(4)(5,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Department,O
of,O
Biochemistry,O
&,O
Immunology,O
",",O
Capital,O
Institute,O
of,O
Pediatrics,O
",",O
2,O
"
",O
YaBao,O
Rd,O
",",O
Beijing,O
",",O
100020,O
",",O
China,O
.,O
"
",O
(2)State,O
Key,O
Laboratory,O
of,O
Infectious,O
Disease,O
Prevention,O
and,O
Control,O
",",O
"
",O
Collaborative,O
Innovation,O
Center,O
for,O
Diagnosis,O
and,O
Treatment,O
of,O
Infectious,O
"
",O
Diseases,O
",",O
National,O
Institute,O
for,O
Viral,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Chinese,O
"
",O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
155,O
Changbai,O
Rd,O
",",O
Beijing,O
",",O
102206,O
",",O
"
",O
China,O
.,O
"
",O
(3)Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Science,O
",",O
44,O
Xiao,O
"
",O
HongShan,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
430071,O
",",O
China,O
.,O
"
",O
(4)State,O
Key,O
Laboratory,O
of,O
Infectious,O
Disease,O
Prevention,O
and,O
Control,O
",",O
"
",O
Collaborative,O
Innovation,O
Center,O
for,O
Diagnosis,O
and,O
Treatment,O
of,O
Infectious,O
"
",O
Diseases,O
",",O
National,O
Institute,O
for,O
Viral,O
Disease,O
Control,O
and,O
Prevention,O
",",O
Chinese,O
"
",O
Center,O
for,O
Disease,O
Control,O
and,O
Prevention,O
",",O
155,O
Changbai,O
Rd,O
",",O
Beijing,O
",",O
102206,O
",",O
"
",O
China,O
.,O
hanjun_sci@163.com,O
.,O
"
",O
(5)Center,O
for,O
Biosafety,O
MegaScience,O
",",O
Chinese,O
Academy,O
of,O
Science,O
",",O
44,O
Xiao,O
"
",O
HongShan,O
",",O
Wuhan,O
",",O
Hubei,O
",",O
430071,O
",",O
China,O
.,O
hanjun_sci@163.com,O
.,O
"

",O
MicroRNAs,O
(,O
miRNAs,O
),O
play,O
an,O
important,O
role,O
in,O
regulating,O
gene,O
expression,O
in,O
"
",O
multiple,O
biological,O
processes,O
and,O
diseases,O
.,O
Thus,O
",",O
to,O
understand,O
changes,O
in,O
miRNA,O
"
",O
during,O
CVB3,O
infection,O
",",O
specific,O
miRNA,O
expression,O
profiles,O
were,O
investigated,O
at,O
"
",O
3,O
â€‰,O
h,O
",",O
6,O
â€‰,O
h,O
",",O
and,O
9,O
â€‰,O
h,O
postinfection,O
in,O
HeLa,O
cells,O
by,O
smallRNA,O
highthroughput,O
"
",O
sequencing,O
.,O
Biological,O
implications,O
of,O
68,O
differentially,O
expressed,O
miRNAs,O
were,O
"
",O
analyzed,O
through,O
GO,O
and,O
KEGG,O
pathways,O
.,O
Interaction,O
networks,O
between,O
34,O
known,O
"
",O
highly,O
differentially,O
expressed,O
miRNAs,O
and,O
targets,O
were,O
constructed,O
by,O
mirDIP,O
and,O
"
",O
Navigator,O
.,O
The,O
predicted,O
targets,O
showed,O
that,O
FAM135A,O
",",O
IKZF2,O
",",O
PLAG1,O
",",O
ZNF148,O
",",O
PHC3,O
",",O
"
",O
LCOR,O
and,O
DYRK1A,O
",",O
which,O
are,O
associated,O
with,O
cellular,O
differentiation,O
and,O
"
",O
transcriptional,O
regulation,O
",",O
were,O
recognized,O
by,O
8,O
miRNAs,O
or,O
9,O
miRNAs,O
through,O
"
",O
interactional,O
regulatory,O
networks,O
.,O
Seven,O
target,O
genes,O
were,O
confirmed,O
by,O
RTqPCR,O
.,O
"
",O
The,O
results,O
showed,O
that,O
the,O
expression,O
of,O
DYRK1A,O
",",O
FAM135A,O
",",O
PLAG1,O
",",O
ZNF148,O
",",O
and,O
"
",O
PHC3,O
were,O
obviously,O
inhibited,O
at,O
3,O
â€‰,O
h,O
",",O
6,O
â€‰,O
h,O
",",O
and,O
9,O
â€‰,O
h,O
postinfection,O
.,O
The,O
expression,O
"
",O
of,O
LCOR,O
did,O
not,O
show,O
a,O
significant,O
change,O
",",O
and,O
the,O
expression,O
of,O
IKZF2,O
increased,O
"
",O
gradually,O
with,O
prolonged,O
infection,O
time,O
.,O
Our,O
findings,O
improve,O
the,O
understanding,O
"
",O
of,O
the,O
pathogenic,O
mechanism,O
of,O
CVB3,O
infection,O
on,O
cellular,O
differentiation,O
and,O
"
",O
development,O
through,O
miRNA,O
regulation,O
",",O
which,O
has,O
implications,O
for,O
interventional,O
"
",O
approaches,O
to,O
CVB3infection,O
therapy,O
.,O
Our,O
results,O
also,O
provide,O
a,O
new,O
method,O
for,O
"
",O
screening,O
target,O
genes,O
of,O
microRNA,O
regulation,O
in,O
virusinfected,O
cells,O
.,O
"

",O
DOI,O
:,O
10.1038,O
s4159801954188w,O
"
",O
PMCID,O
:,O
PMC6884461,O
"
",O
PMID,O
:,O
31784561,O
"


",O
987,O
.,O
Cent,O
Eur,O
J,O
Immunol,O
.,O
2019;44(4):455462,O
.,O
doi,O
:,O
10.5114,O
ceji.2019.92808,O
.,O
Epub,O
2020,O
"
",O
Jan,O
20,O
.,O
"

",O
Comparative,O
analysis,O
of,O
the,O
safety,O
and,O
efficacy,O
of,O
HBsAg1018,O
versus,O
HBsAgEng,O
:,O
a,O
"
",O
metaanalysis,O
.,O
"

",O
Zhang,O
LL(1,O
),O
",",O
Guo,O
J(1,O
),O
",",O
Duan,O
K(1,O
),O
.,O
"

",O
Author,O
information,O
:,O
"
",O
(1)Wuhan,O
Institute,O
of,O
Biological,O
Products,O
Co.,O
Ltd.,O
",",O
China,O
.,O
"

",O
Introduction,O
:,O
In,O
addition,O
to,O
alum,O
adjuvant,O
",",O
a,O
wide,O
diversity,O
of,O
adjuvants,O
have,O
"
",O
been,O
developed,O
to,O
enhance,O
immune,O
response,O
of,O
hepatitis,O
B,O
virus,O
(,O
HBV,O
),O
vaccine,O
in,O
"
",O
varying,O
subjects,O
",",O
either,O
in,O
healthy,O
vaccinators,O
or,O
subjects,O
with,O
hypoimmunity,O
.,O
"
",O
In,O
this,O
context,O
",",O
a,O
novel,O
HBV,O
vaccine,O
HBsAg1018,O
",",O
formulated,O
with,O
a,O
tolllike,O
"
",O
receptor,O
9,O
agonist,O
",",O
was,O
developed,O
",",O
and,O
is,O
currently,O
in,O
the,O
phase,O
of,O
clinical,O
"
",O
trials,O
.,O
So,O
",",O
the,O
first,O
metaanalysis,O
was,O
performed,O
to,O
examine,O
the,O
safety,O
and,O
"
",O
immune,O
response,O
of,O
HBsAg1018,O
among,O
varying,O
subjects,O
.,O
"
",O
Material,O
and,O
methods,O
:,O
On,O
the,O
basis,O
of,O
inclusion,O
criterion,O
",",O
eligible,O
studies,O
that,O
"
",O
reported,O
safety,O
and,O
immunogenicity,O
induced,O
by,O
HBsAg1018,O
vaccination,O
in,O
"
",O
randomised,O
",",O
controlled,O
trials,O
(,O
RCTs,O
),O
were,O
involved,O
from,O
three,O
databases,O
:,O
PubMed,O
",",O
"
",O
EMBASE,O
",",O
and,O
the,O
Cochrane,O
Library,O
",",O
and,O
further,O
confirmed,O
by,O
two,O
reviewers,O
.,O
"
",O
Metaanalysis,O
was,O
conducted,O
using,O
RevMan,O
5.3,O
.,O
The,O
pooled,O
relative,O
risk,O
(,O
RR,O
),O
for,O
"
",O
safety,O
and,O
immunogenicity,O
was,O
calculated,O
using,O
randomeffects,O
or,O
fixedeffects,O
"
",O
models,O
according,O
to,O
the,O
heterogeneity,O
of,O
included,O
studies,O
.,O
The,O
methodology,O
"
",O
quality,O
of,O
eligible,O
studies,O
was,O
assessed,O
using,O
the,O
Cochrane,O
Handbook,O
for,O
"
",O
Systematic,O
Reviews,O
of,O
Interventions,O
version,O
5.1.0,O
.,O
"
",O
Results,O
:,O
In,O
total,O
5073,O
subjects,O
administrated,O
with,O
HBV,O
vaccine,O
from,O
four,O
eligible,O
"
",O
publications,O
were,O
included,O
in,O
this,O
metaanalysis,O
.,O
The,O
data,O
related,O
to,O
"
",O
immunogenicity,O
and,O
safety,O
post,O
vaccination,O
were,O
pooled,O
for,O
metaanalysis,O
.,O
For,O
"
",O
safety,O
",",O
the,O
combined,O
RRs,O
for,O
adverse,O
reactions,O
were,O
0.98,O
(,O
95,O
%,O
CI,O
:,O
0.891.08,O
),O
",",O
"
",O
1.02,O
(,O
95,O
%,O
CI,O
:,O
0.941.10,O
),O
for,O
AE,O
",",O
0.88,O
(,O
95,O
%,O
CI,O
:,O
0.701.10,O
),O
for,O
SAE,O
",",O
and,O
1.07,O
"
",O
(,O
0.129.17,O
),O
for,O
death,O
.,O
No,O
statistical,O
heterogeneity,O
among,O
RCTs,O
was,O
found,O
(,O
p,O
>,O
"
",O
0.05,O
),O
.,O
For,O
immunogenicity,O
",",O
at,O
four,O
weeks,O
post,O
vaccination,O
",",O
seroprotection,O
rates,O
"
",O
(,O
SPRs,O
),O
in,O
HBsAg1018,O
were,O
significantly,O
superior,O
to,O
the,O
conventional,O
HBV,O
vaccine,O
"
",O
containing,O
alum,O
adjuvant,O
",",O
HBsAgEng,O
(,O
EngerixB,O
Â®,O
",",O
GlaxoSmithKline,O
",",O
Rixensart,O
",",O
"
",O
Belgium,O
),O
(,O
RR,O
:,O
4.35,O
;,O
95,O
%,O
CI,O
:,O
3.355.65,O
),O
.,O
Furthermore,O
",",O
superior,O
immunogenicity,O
of,O
"
",O
HBsAg1018,O
was,O
maintained,O
with,O
RRs,O
up,O
to,O
1.23,O
and,O
95,O
%,O
CI,O
:,O
1.201.27,O
through,O
28,O
"
",O
weeks,O
post,O
vaccination,O
.,O
However,O
",",O
there,O
was,O
considerable,O
heterogeneity,O
with,O
>,O
80,O
%,O
"
",O
I2,O
value,O
(,O
p,O
<,O
0.05,O
),O
.,O
"
",O
Conclusions,O
:,O
In,O
comparison,O
with,O
HBsAgEng,O
",",O
HBsAg1018,O
exhibited,O
superior,O
immune,O
"
",O
response,O
and,O
comparable,O
safety,O
profile,O
with,O
HBsAgEng,O
in,O
varying,O
subjects,O
.,O
"
",O
HBsAg1018,O
is,O
an,O
effective,O
and,O
safe,O
prophylactic,O
measure,O
to,O
prevent,O
HBV,O
"
",O
infection,O
.,O
"

",O
Copyright,O
Â©,O
2019,O
Termedia,O
.,O
"

",O
DOI,O
:,O
10.5114,O
ceji.2019.92808,O
"
",O
PMCID,O
:,O
PMC7050062,O
"
",O
PMID,O
:,O
32140059,O
"

",O
Conflict,O
of,O
interest,O
statement,O
:,O
The,O
authors,O
declare,O
no,O
conflict,O
of,O
interest,O
.,O
"
",O
